PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dai, FY; Qiao, L; Tong, XL; Cao, C; Chen, P; Chen, J; Lu, C; Xiang, ZH				Dai, Fang-yin; Qiao, Liang; Tong, Xiao-ling; Cao, Cun; Chen, Peng; Chen, Jun; Lu, Cheng; Xiang, Zhong-huai			Mutations of an Arylalkylamine-N-acetyltransferase, Bm-iAANAT, Are Responsible for Silkworm Melanism Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBYX-MORI; SYNTHESIS ENZYMES; PAPILIO-XUTHUS; INSECT; PIGMENTATION; DROSOPHILA; GENETICS; SCLEROTIZATION; MELANIZATION; PURIFICATION	Coloration is one of the most variable characters in animals and provides rich material for studying the developmental genetic basis of pigment patterns. In the silkworm, more than 100 gene mutation systems are related to aberrant color patterns. The melanism (mln) is a rare body color mutant that exhibits an easily distinguishable phenotype in both larval and adult silkworms. By positional cloning, we identified the candidate gene of the mln locus, Bm-iAANAT, whose homologous gene (Dat) converts dopamine into N-acetyldopamine, a precursor for N-acetyldopamine sclerotin in Drosophila. In the mln mutant, two types of abnormal Bm-iAANAT transcripts were identified, whose expression levels are markedly lower than the wild type (WT). Moreover, dopamine content was approximately twice as high in the sclerified tissues (head, thoracic legs, and anal plate) of the mutant as in WT, resulting in phenotypic differences between the two. Quantitative reverse transcription PCR analyses showed that other genes involved in the melanin metabolism pathway were regulated by the aberrant Bm-iAANAT activity in mln mutant in different ways and degrees. We therefore propose that greater accumulation of dopamine results from the functional deficiency of BmiAANAT in the mutant, causing a darker pattern in the sclerified regions than in the WT. In summary, our results indicate that Bm-iAANAT is responsible for the color pattern of the silkworm mutant, mln. To our knowledge, this is the first report showing a role for arylalkylamine-N-acetyltransferases in color pattern mutation in Lepidoptera.	[Lu, Cheng] Southwest Univ, Inst Sericulture & Syst Biol, Key Sericultural Lab Agr Minist, Coll Biotechnol, Chongqing 400715, Peoples R China; [Tong, Xiao-ling] Chongqing Univ, Inst Agr & Life Sci, Chongqing 400030, Peoples R China	Southwest University - China; Chongqing University	Lu, C (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, Key Sericultural Lab Agr Minist, Coll Biotechnol, Chongqing 400715, Peoples R China.	lucheng@swu.edu.cn		Dai, Fangyin/0000-0002-0215-2177; Qiao, Liang/0000-0002-4638-3225; Tong, Xiaoling/0000-0002-2649-899X	National Basic Research 973 Program of China [2005CB121000]; Hi-Tech Research and Development 863 Program of China [2006AA10A117]; National Natural Science Foundation of China [30671591]; Science Foundation of Ministry of Education of China [20060635016]; Southwest University of China [2006052]	National Basic Research 973 Program of China(National Basic Research Program of China); Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Ministry of Education of China(Ministry of Education, China); Southwest University of China(Southwest University - China)	This work was supported by National Basic Research 973 Program of China Grant 2005CB121000, Hi-Tech Research and Development 863 Program of China Grant 2006AA10A117, National Natural Science Foundation of China Grant 30671591, Science Foundation of Ministry of Education of China Grant 20060635016, and Technological Innovative Foundation Project for postgraduates of Southwest University of China Grant 2006052.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; CZAPLA TH, 1990, J INSECT PHYSIOL, V36, P647, DOI 10.1016/0022-1910(90)90069-R; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2007, INSECT BIOCHEM MOLEC, V37, P855, DOI 10.1016/j.ibmb.2007.02.014; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Han D, 2002, BIOCHEM J, V368, P333; HIRUMA K, 1985, DEV BIOL, V110, P509, DOI 10.1016/0012-1606(85)90109-5; HIRUMA K, 1984, J EXP ZOOL, V230, P393, DOI 10.1002/jez.1402300308; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Ichihara N, 1997, INSECT BIOCHEM MOLEC, V27, P241, DOI 10.1016/S0965-1748(96)00091-4; Ichihara N, 2001, INSECT BIOCHEM MOLEC, V32, P15, DOI 10.1016/S0965-1748(01)00075-3; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; KIGUCHI K, 1981, J INSECT PHYSIOL, V27, P805, DOI 10.1016/0022-1910(81)90072-X; Koch PB, 2000, PIGM CELL RES, V13, P54, DOI 10.1111/j.0893-5785.2000.130811.x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lu Cheng, 2003, Scientia Agricultura Sinica, V36, P968; Meng Y, 2009, GENES CELLS, V14, P129, DOI 10.1111/j.1365-2443.2008.01257.x; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mizoguchi A, 2002, GEN COMP ENDOCR, V127, P181, DOI 10.1016/S0016-6480(02)00043-6; Rauschenbach IY, 2008, J COMP PHYSIOL B, V178, P315, DOI 10.1007/s00360-007-0224-x; Sasaki K, 2001, J INSECT PHYSIOL, V47, P1205, DOI 10.1016/S0022-1910(01)00105-6; SMITH TJ, 1990, BIOESSAYS, V12, P30, DOI 10.1002/bies.950120107; Suzuki Y, 2002, INSECT BIOCHEM MOLEC, V32, P599, DOI 10.1016/S0965-1748(01)00136-9; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tsugehara T, 2007, COMP BIOCHEM PHYS B, V147, P358, DOI 10.1016/j.cbpb.2006.10.112; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	35	65	84	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19553	19560		10.1074/jbc.M109.096743	http://dx.doi.org/10.1074/jbc.M109.096743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20332088	Green Published, hybrid			2022-12-25	WOS:000278727800065
J	Giesecke, A; Stewart, M				Giesecke, Astrid; Stewart, Murray			Novel Binding of the Mitotic Regulator TPX2 (Target Protein for Xenopus Kinesin-like Protein 2) to Importin-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; STRUCTURAL BASIS; KARYOPHERIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; SPINDLE; RAN; RECOGNITION; MECHANISM; COMPLEX; REQUIREMENTS	Several aspects of mitotic spindle assembly are orchestrated by the Ran GTPase through its modulation of the interaction between spindle assembly factors and importin-alpha. One such factor is TPX2 that promotes microtubule assembly in the vicinity of chromosomes. TPX2 is inhibited when bound to importin-alpha, which occurs when the latter is bound to importin-beta. The importin-alpha:beta interaction is disrupted by the high RanGTP concentration near the chromosomes, releasing TPX2. In more distal regions, where Ran is predominantly GDP-bound, TPX2 remains bound to importin-alpha and so is inhibited. Here we use a combination of structural and biochemical methods to define the basis for TPX2 binding to importin-alpha. A 2.2 angstrom resolution crystal structure shows that the primary nuclear localization signal ((KRKH287)-K-284) of TPX2, which has been shown to be crucial for inhibition, binds to the minor NLS-binding site on importin-alpha. This atypical interaction pattern was confirmed using complementary binding studies that employed importin-alpha variants in which binding to either the major or minor NLS-binding site was impaired, together with competition assays using the SV40 monopartite NLS that binds primarily to the major site. The different way in which TPX2 binds to importin-alpha could account for much of the selectivity necessary during mitosis because this would reduce the competition for binding to importin-alpha from other NLS-containing proteins.	[Giesecke, Astrid; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk			Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust Programme grant (to M. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; COLLEDGE WH, 1986, MOL CELL BIOL, V6, P4136, DOI 10.1128/MCB.6.11.4136; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7	42	65	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17628	17635		10.1074/jbc.M110.102343	http://dx.doi.org/10.1074/jbc.M110.102343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335181	hybrid, Green Published			2022-12-25	WOS:000278133400041
J	Sano, K; Miyamoto, Y; Kawasaki, N; Hashii, N; Itoh, S; Murase, M; Date, K; Yokoyama, M; Sato, C; Kitajima, K; Ogawa, H				Sano, Kotone; Miyamoto, Yasunori; Kawasaki, Nana; Hashii, Noritaka; Itoh, Satsuki; Murase, Misaki; Date, Kimie; Yokoyama, Miki; Sato, Chihiro; Kitajima, Ken; Ogawa, Haruko			Survival Signals of Hepatic Stellate Cells in Liver Regeneration Are Regulated by Glycosylation Changes in Rat Vitronectin, Especially Decreased Sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; LIGAND-BINDING ACTIVITIES; EXTRACELLULAR-MATRIX; COLLAGEN-BINDING; PARTIAL-HEPATECTOMY; PLASMA VITRONECTIN; MASS-SPECTROMETRY; IDENTIFICATION; GLYCOPROTEINS; ACID	The extracellular matrix (ECM) molecules play important roles in many biological and pathological processes. During tissue remodeling, the ECM molecules that are glycosylated are different from those of normal tissue owing to changes in the expression of many proteins that are responsible for glycan synthesis. Vitronectin (VN) is a major ECM molecule that recognizes integrin on hepatic stellate cells (HSCs). The present study attempted to elucidate how changes in VN glycans modulate the survival of HSCs, which play a critical role in liver regeneration. Plasma VN was purified from partially hepatectomized (PH) and sham-operated (SH) rats at 24 h after operation and non-operated (NO) rats. Adhesion of rat HSCs (rHSCs), together with phosphorylation of focal adhesion kinase, in PH-VN was decreased to one-half of that in NO-or SH-VN. Spreading of rHSCs on desialylated NO-VN was decreased to one-half of that of control VN, indicating the importance of sialylation of VN for activation of HSCs. Liquid chromatography/multiple-stage mass spectrometry analysis of Glu-C glycopeptides of each VN determined the site-specific glycosylation. In addition to the major biantennary complex-type N-glycans, hybrid-type N-glycans were site-specifically present at Asn(167). Highly sialylated O-glycans were found to be present in the Thr(110)-Thr(124) region. In PH-VN, the disialyl O-glycans and complex-type N-glycans were decreased while core-fucosylated N-glycans were increased. In addition, immunodetection after two-dimensional PAGE indicated the presence of hyper- and hyposialylated molecules in each VN and showed that hypersialylation was markedly attenuated in PH-VN. This study proposes that the alteration of VN glycosylation modulates the substrate adhesion to rat HSCs, which is responsible for matrix restructuring.	[Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Sano, Kotone; Miyamoto, Yasunori; Murase, Misaki; Date, Kimie; Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Tokyo 1128610, Japan; [Kawasaki, Nana; Hashii, Noritaka; Itoh, Satsuki] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Yokoyama, Miki] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Tokyo 1138510, Japan; [Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648610, Japan	Ochanomizu University; Ochanomizu University; National Institute of Health Sciences - Japan; Tokyo Medical & Dental University (TMDU); Nagoya University	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Asanuma, Kimie/AAW-2543-2020; Miyamoto, Yasunori/M-4825-2019	Naganawa, Shinji/0000-0002-0214-613X; Asanuma, Kimie/0000-0003-4311-0544; Miyamoto, Yasunori/0000-0001-9192-4281	Japan Society for the Promotion of Science [12995]; Hayashi Memorial Foundation for Female Natural Scientists; Ministry of Education, Culture, Sports, Science, and Technology [15040209, 17046004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant 12995 (to K. S.), a fellowship of the Hayashi Memorial Foundation for Female Natural Scientists (to K. S.), and Grants-in-aid for Scientific Research on Priority Areas 15040209 and 17046004 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Asanuma K, 2001, INT CONGR SER, V1223, P97, DOI 10.1016/S0531-5131(01)00417-4; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; FINNE J, 1977, BIOCHEM BIOPH RES CO, V74, P405, DOI 10.1016/0006-291X(77)90318-7; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; Higgins GM, 1931, ARCH PATHOL, V12, P186; Itoh S, 2005, J CHROMATOGR A, V1094, P105, DOI 10.1016/j.chroma.2005.07.100; JEZEQUELCUER M, 1992, LIVER, V12, P140; KATO S, 1985, BIOCHEM J, V229, P521, DOI 10.1042/bj2290521; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; McKeownLongo PJ, 1996, TRENDS GLYCOSCI GLYC, V8, P327, DOI 10.4052/tigg.8.327; ODATAMAI S, 1985, J BIOL CHEM, V260, P57; OGAWA H, 1995, EUR J BIOCHEM, V230, P994, DOI 10.1111/j.1432-1033.1995.tb20647.x; OKAMOTO Y, 1977, BIOCHIM BIOPHYS ACTA, V498, P272, DOI 10.1016/0304-4165(77)90265-3; OKAMOTO Y, 1978, BIOCHIM BIOPHYS ACTA, V542, P21, DOI 10.1016/0304-4165(78)90228-3; Peake PW, 1996, CLIN EXP IMMUNOL, V106, P416, DOI 10.1046/j.1365-2249.1996.d01-833.x; PODACK ER, 1977, J IMMUNOL, V119, P2024; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Sano K, 2008, CARBOHYD RES, V343, P2329, DOI 10.1016/j.carres.2008.03.027; Sano K, 2007, GLYCOBIOLOGY, V17, P784, DOI 10.1093/glycob/cwm031; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Uchibori-Iwaki H, 2000, GLYCOBIOLOGY, V10, P865, DOI 10.1093/glycob/10.9.865; Ueda H, 1999, FEBS LETT, V448, P75, DOI 10.1016/S0014-5793(99)00334-8; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Yasukawa Z, 2007, J BIOCHEM, V141, P429, DOI 10.1093/jb/mvm047; Yasukawa Z, 2006, GLYCOBIOLOGY, V16, P651, DOI 10.1093/glycob/cwj112; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yoneda A, 1996, J BIOCHEM, V120, P954; Yoneda A, 1998, BIOCHEMISTRY-US, V37, P6351, DOI 10.1021/bi972247n; YONEDA A, 1993, EUR J BIOCHEM, V218, P797, DOI 10.1111/j.1432-1033.1993.tb18434.x; Yuan J, 2005, J CHROMATOGR A, V1067, P145, DOI 10.1016/j.chroma.2004.11.070; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	39	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17301	17309		10.1074/jbc.M109.077016	http://dx.doi.org/10.1074/jbc.M109.077016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335177	hybrid, Green Published			2022-12-25	WOS:000278133400007
J	Matrone, MA; Whipple, RA; Thompson, K; Cho, EH; Vitolo, MI; Balzer, EM; Yoon, JR; Ioffe, OB; Tuttle, KC; Tan, M; Martin, SS				Matrone, M. A.; Whipple, R. A.; Thompson, K.; Cho, E. H.; Vitolo, M. I.; Balzer, E. M.; Yoon, J. R.; Ioffe, O. B.; Tuttle, K. C.; Tan, M.; Martin, S. S.			Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells	ONCOGENE			English	Article						microtentacles; tau; microtubule-associated proteins; microtubules; circulating tumor cells	MICROTUBULE-ASSOCIATED PROTEINS; PACLITAXEL SENSITIVITY; CANCER; NEURODEGENERATION; 3-REPEAT-TAU; CHEMOTHERAPY; 4-REPEAT-TAU; DYNAMICS; ADHESION; DISEASE	The cytoskeletal organization of detached and circulating tumor cells (CTCs) is currently not well defined and may provide potential targets for new therapies to limit metastatic tumor spread. In vivo, CTCs reattach in distant tissues by a mechanism that is tubulin-dependent and suppressed by polymerized actin. The cytoskeletal mechanisms that promote reattachment of CTCs match exactly with the mechanisms supporting tubulin microtentacles (McTN), which we have recently identified in detached breast tumor cells. In this study, we aimed to investigate how McTN formation is affected by the microtubule-associated protein, tau, which is expressed in a subset of chemotherapy-resistant breast cancers. We demonstrate that endogenous tau protein localizes to McTNs and is both necessary and sufficient to promote McTN extension in detached breast tumor cells. Tau-induced McTNs increase reattachment of suspended cells and retention of CTCs in lung capillaries. Analysis of patient-matched primary and metastatic tumors reveals that 52% possess tau expression in metastases and 26% display significantly increased tau expression over disease progression. Tau enrichment in metastatic tumors and the ability of tau to promote tumor cell reattachment through McTN formation support a model in which tau-induced microtubule stabilization provides a selective advantage during tumor metastasis. Oncogene (2010) 29, 3217-3227; doi: 10.1038/onc.2010.68; published online 15 March 2010	[Martin, S. S.] Univ Maryland, Greenebaum Canc Ctr, Sch Med, Program Mol Med, Baltimore, MD 21201 USA; [Whipple, R. A.; Thompson, K.; Vitolo, M. I.; Tuttle, K. C.; Tan, M.; Martin, S. S.] Univ Maryland, Marlene & Stewart Greenebaum NCI Canc Ctr, Sch Med, Baltimore, MD 21201 USA; [Yoon, J. R.; Martin, S. S.] Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA; [Ioffe, O. B.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Tan, M.] Univ Maryland, Dept Epidemiol & Prevent Med, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Martin, SS (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Sch Med, Program Mol Med, 655 W Baltimore St,Rm 10-029, Baltimore, MD 21201 USA.	ssmartin@som.umaryland.edu	Cho, Edward/B-3727-2012	Cho, Edward/0000-0002-0278-334X; Vitolo, Michele/0000-0001-8055-9645	National Cancer Institute [R01-CA124704]; USA Medical Research and Materiel Command [BC061047]; Flight Attendants Medical Research Institute [CIA-062497]; NATIONAL CANCER INSTITUTE [K01CA096555, P30CA134274, R01CA124704] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USA Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Flight Attendants Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Grant R01-CA124704 from National Cancer Institute, Breast Cancer Idea Award from USA Medical Research and Materiel Command (BC061047) and a Clinical Innovator Award from Flight Attendants Medical Research Institute (CIA-062497). We thank Dr I-Chu Tseng and the Dr Chen-Yong Lin laboratory for immunohistochemistry assistance, Dr Larry Changwan Lu for his assistance with the statistical analyses, Aric Colunga and the Dr Laure Aurelian laboratory for imaging assistance, Dr William Twaddell for assistance with pathological scoring of vimentin staining, and Dr Michele Weiss for Figure 6 assistance.	Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; BALZER EM, 2009, BREAST CANC RES TREA; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Camara O, 2007, ANN ONCOL, V18, P1484, DOI 10.1093/annonc/mdm206; Cassimeris L, 2001, INT REV CYTOL, V210, P163; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Dickey CA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-6; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; ENGEL LW, 1978, CANCER RES, V38, P3352; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Haier J, 2001, APMIS, V109, P241, DOI 10.1034/j.1600-0463.2001.d01-118.x; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Janni W, 2005, CANCER-AM CANCER SOC, V103, P884, DOI 10.1002/cncr.20834; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; LEE G, 1992, J CELL SCI, V102, P227; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Mialhe A, 2001, CANCER RES, V61, P5024; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Pusztai L, 2009, J CLIN ONCOL, V27, P4287, DOI 10.1200/JCO.2008.21.6887; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Schaap IAT, 2007, J STRUCT BIOL, V158, P282, DOI 10.1016/j.jsb.2006.11.010; Sharma VM, 2007, J CELL SCI, V120, P748, DOI 10.1242/jcs.03378; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wagner P, 2005, CELL CYCLE, V4, P1149, DOI 10.4161/cc.4.9.2038; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WEISS L, 1991, CELL BIOPHYS, V18, P73, DOI 10.1007/BF02989807; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Whipple RA, 2007, EXP CELL RES, V313, P1326, DOI 10.1016/j.yexcr.2007.02.001; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	41	70	71	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 3	2010	29	22					3217	3227		10.1038/onc.2010.68	http://dx.doi.org/10.1038/onc.2010.68			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20228842	Green Accepted			2022-12-25	WOS:000278321100005
J	Imai, K; Togami, H; Okamoto, T				Imai, Kenichi; Togami, Hiroaki; Okamoto, Takashi			Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; T-CELL CLONE; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; EARLY EMBRYOGENESIS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; COMPLEX; TYPE-1	Elucidating the mechanism of human immunodeficiency virus, type 1 (HIV-1) provirus transcriptional silencing in latently infected cells is crucial for understanding the pathophysiological process of HIV-1 infection. It is well established that hypoacetylation of histone proteins by histone deacetylases is involved in the maintenance of HIV-1 latency by repressing viral transcription. Although histone methylation is involved in the organization of chromatin domains and plays a central epigenetic role in gene expression, the role of histone methylation in the maintenance of HIV-1 latency has not been clarified. Here we present evidence that histone H3 Lys9 (H3K9) methyltransferase G9a is responsible for transcriptional repression of HIV-1 by promoting repressive dimethylation at H3K9 and for the maintenance of viral latency. We observed that G9a significantly inhibited basal, as well as, the induced HIV-1 gene expression by tumor necrosis factor-alpha or Tat. Mutant G9a, however, lacking the SET domain responsible for the catalytic activity of histone methyltransferase, did not show such an effect. When G9a expression was knocked down by small interfering RNA, HIV-1 replication was augmented from cells transiently transfected with a full-length HIV-1 clone. Moreover, a specific inhibitor of G9a, BIX01294, could reactivate expression of HIV-1 from latently infected cells such as ACH-2 and OM10.1. Furthermore, chromatin immunoprecipitation assays revealed the presence of G9a and H3K9 dimethylation on nucleosome histones in the vicinity of the HIV-1 long terminal repeat promoter. These results suggest that G9a is responsible for the transcriptional quiescence of latent HIV-1 provirus and provide a molecular basis for understanding the mechanism by which HIV-1 latency is maintained.	[Imai, Kenichi; Togami, Hiroaki; Okamoto, Takashi] Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Human Sciences Foundation; Takeda Science Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Human Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Human Sciences Foundation, and the Takeda Science Foundation.	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BUTERA ST, 1991, J VIROL, V65, P4645, DOI 10.1128/JVI.65.9.4645-4653.1991; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dieudonne M, 2009, EMBO J, V28, P2231, DOI 10.1038/emboj.2009.141; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FOLKS TM, 1988, J IMMUNOL, V140, P1117; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Imai K, 2005, J BIOL CHEM, V280, P26701, DOI 10.1074/jbc.M503313200; Imai K, 2009, FEBS J, V276, P7124, DOI 10.1111/j.1742-4658.2009.07424.x; Imai K, 2009, J IMMUNOL, V182, P3688, DOI 10.4049/jimmunol.0802906; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Victoriano AFB, 2006, ANTIMICROB AGENTS CH, V50, P547, DOI 10.1128/AAC.50.2.547-555.2006; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	61	182	192	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16538	16545		10.1074/jbc.M110.103531	http://dx.doi.org/10.1074/jbc.M110.103531			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335163	Green Published, hybrid			2022-12-25	WOS:000277982600016
J	Ramadoss, P; Chiappini, F; Bilban, M; Hollenberg, AN				Ramadoss, Preeti; Chiappini, Franck; Bilban, Martin; Hollenberg, Anthony N.			Regulation of Hepatic Six Transmembrane Epithelial Antigen of Prostate 4 (STEAP4) Expression by STAT3 and CCAAT/Enhancer-binding Protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-RELATED PROTEIN; INSULIN-RESISTANCE; IN-VIVO; GLUCONEOGENIC GENES; OB/OB MICE; OBESITY; INTERLEUKIN-6; KINASE; TISSUE	STEAP4 is a plasma membrane metalloreductase involved in the transport of iron and copper. Recently, STEAP4 was implicated in promoting insulin sensitivity by acting in white adipose tissue to control the production of inflammatory cytokines such as interleukin 6. Indeed, the loss of STEAP4 expression in mice leads to increased production of inflammatory cytokines in visceral white adipose tissue and systemic insulin resistance. In this study, we demonstrate that in mouse liver STEAP4 is produced at significant levels and that steap4 transcription is induced by interleukin 6. We further demonstrate that the steap4 gene is a direct target of phosphorylated STAT3 in mouse liver. In addition, hepatic STEAP4 expression is regulated by feeding and fasting, and obesity leads to the induction of STEAP4 expression in the liver. Interestingly, the regulation of STEAP4 in both feeding and fasting and the obese state appears to require the transcription factor CCAAT/enhancer-binding protein alpha that may act in concert with STAT3 as they both bind to the proximal steap4 promoter in vivo. Taken together, these data suggest the transcriptional regulation of hepatic STEAP4 may play a critical role in the response to nutritional and inflammatory stress and contributes to the protective effect of STEAP4 in vivo.	[Ramadoss, Preeti; Chiappini, Franck; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Ramadoss, Preeti; Chiappini, Franck; Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bilban, Martin] Ludwig Boltzmann Inst Clin & Expt Oncol, A-1090 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Medical University of Vienna; Ludwig Boltzmann Institute	Hollenberg, AN (corresponding author), 330 Brookline Ave, Boston, MA 02215 USA.	thollenb@bidmc.harvard.edu	Chiappini, Franck/AAB-9894-2021	Chiappini, Franck/0000-0002-2684-1241; Bilban, Martin/0000-0001-7043-7142	American Diabetes Association; Takeda Pharmaceuticals	American Diabetes Association(American Diabetes Association); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	This work was supported by the Smith Family Pinnacle Award from the American Diabetes Association and a grant from Takeda Pharmaceuticals.	Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dongiovanni P, 2008, AM J PATHOL, V172, P738, DOI 10.2353/ajpath.2008.070097; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gum RJ, 2003, MOL ENDOCRINOL, V17, P1131, DOI 10.1210/me.2002-0288; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Li SY, 2005, DIABETES OBES METAB, V7, P448, DOI 10.1111/j.1463-1326.2004.00387.x; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Ramadoss P, 2009, MOL ENDOCRINOL, V23, P827, DOI 10.1210/me.2008-0264; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x	35	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16453	16466		10.1074/jbc.M109.066936	http://dx.doi.org/10.1074/jbc.M109.066936			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304921	Green Published, hybrid			2022-12-25	WOS:000277982600007
J	Lodeiro, MF; Uchida, AU; Arnold, JJ; Reynolds, SL; Moustafa, IM; Cameron, CE				Lodeiro, Maria F.; Uchida, Akira U.; Arnold, Jamie J.; Reynolds, Shelley L.; Moustafa, Ibrahim M.; Cameron, Craig E.			Identification of Multiple Rate-limiting Steps during the Human Mitochondrial Transcription Cycle in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; OPEN COMPLEX-FORMATION; DNA COPY NUMBER; RIBOSOMAL-RNA; YEAST MITOCHONDRIAL; EVOLUTIONARY MEDICINE; PROMOTER RECOGNITION; MAMMALIAN-CELLS; SCHNEIDER CELLS; FACTOR-A	We have reconstituted human mitochondrial transcription in vitro on DNA oligonucleotide templates representing the light strand and heavy strand-1 promoters using protein components (RNA polymerase and transcription factors A and B2) isolated from Escherichia coli. We show that 1 eq of each transcription factor and polymerase relative to the promoter is required to assemble a functional initiation complex. The light strand promoter is at least 2-fold more efficient than the heavy strand-1 promoter, but this difference cannot be explained solely by the differences in the interaction of the transcription machinery with the different promoters. In both cases, the rate-limiting step for production of the first phosphodiester bond is open complex formation. Open complex formation requires both transcription factors; however, steps immediately thereafter only require transcription factor B2. The concentration of nucleotide required for production of the first dinucleotide product is substantially higher than that required for subsequent cycles of nucleotide addition. In vitro, promoter-specific differences in post-initiation control of transcription exist, as well as a second rate-limiting step that controls conversion of the transcription initiation complex into a transcription elongation complex. Rate-limiting steps of the biochemical pathways are often those that are targeted for regulation. Like the more complex multisubunit transcription systems, multiple steps may exist for control of transcription in human mitochondria. The tools and mechanistic framework presented here will facilitate not only the discovery of mechanisms regulating human mitochondrial transcription but also interrogation of the structure, function, and mechanism of the complexes that are regulated during human mitochondrial transcription.	[Lodeiro, Maria F.; Uchida, Akira U.; Arnold, Jamie J.; Reynolds, Shelley L.; Moustafa, Ibrahim M.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 201 Althouse Lab, University Pk, PA 16802 USA.	cec9@psu.edu			Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University	Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University	This work was supported in part by the Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University.	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Arnold JJ, 1999, BIOTECHNIQUES, V27, P450, DOI 10.2144/99273bm11; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bandwar RP, 2002, BIOCHEMISTRY-US, V41, P3586, DOI 10.1021/bi0158472; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; CHANG DD, 1987, BIOCHIM BIOPHYS ACTA, V909, P85, DOI 10.1016/0167-4781(87)90029-7; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Davis CA, 2005, P NATL ACAD SCI USA, V102, P285, DOI 10.1073/pnas.0405779102; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; GAINES G, 1987, J BIOL CHEM, V262, P1907; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; Holstege FCP, 1997, METHODS, V12, P203, DOI 10.1006/meth.1997.0472; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Schon Eric A, 2007, Novartis Found Symp, V287, P214; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TINTUT Y, 1995, J BIOL CHEM, V270, P24392, DOI 10.1074/jbc.270.41.24392; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200	77	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16387	16402		10.1074/jbc.M109.092676	http://dx.doi.org/10.1074/jbc.M109.092676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351113	Green Published, hybrid			2022-12-25	WOS:000277715900075
J	Ramakrishnan, B; Qasba, PK				Ramakrishnan, Boopathy; Qasba, Pradman K.			Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; GALACTOSYLTRANSFERASE-I BETA-4GALT-7; ALPHA-LACTALBUMIN; HEPARAN-SULFATE; BOVINE BETA-1,4-GALACTOSYLTRANSFERASE; LACTOSE SYNTHETASE; GENE FAMILY; PROTEIN; IDENTIFICATION; MECHANISM	The beta 1,4-galactosyltransferase-7 (beta 4Gal-T7) enzyme, one of seven members of the beta 4Gal-T family, transfers in the presence of manganese Gal from UDP-Gal to an acceptor sugar (xylose) that is attached to a side chain hydroxyl group of Ser/Thr residues of proteoglycan proteins. It exhibits the least protein sequence similarity with the other family members, including the well studied family member beta 4Gal-T1, which, in the presence of manganese, transfers Gal from UDP-Gal to GlcNAc. We report here the crystal structure of the catalytic domain of beta 4Gal-T7 from Drosophila in the presence of manganese and UDP at 1.81 angstrom resolution. In the crystal structure, a new manganese ion-binding motif (HXH) has been observed. Superposition of the crystal structures of beta 4Gal-T7 and beta 4Gal-T1 shows that the catalytic pocket and the substrate-binding sites in these proteins are similar. Compared with GlcNAc, xylose has a hydroxyl group (instead of anN-acetyl group) at C2 and lacks the CH2OH group at C5; thus, these protein structures show significant differences in their acceptor-binding site. Modeling of xylose in the acceptor-binding site of the beta 4Gal-T7 crystal structure shows that the aromatic side chain of Tyr(177) interacts strongly with the C5 atom of xylose, causing steric hindrance to any additional group at C5. Because Drosophila Cd7 has a 73% protein sequence similarity to human Cd7, the present crystal structure offers a structure-based explanation for the mutations in human Cd7 that have been linked to Ehlers-Danlos syndrome.	[Qasba, Pradman K.] NCI, Struct Glycobiol Sect, SAIC Frederick Inc, CCRNP,CCR,NIH, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy] NCI, Basic Res Program, SAIC Frederick Inc, CCRNP,CCR,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), NCI, Struct Glycobiol Sect, SAIC Frederick Inc, CCRNP,CCR,NIH, Bldg 469,Rm 221, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Institutes of Health, NCI, Center for Cancer Research [HHSN261200800001E]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC009304] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E from NCI and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. Use of beam line 22-ID/BM of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory, was supported by Contract W-31-109-Eng-38 from the United States Department of Energy, Office of Science, Office of Basic Energy Sciences.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; BOEGGEMAN EE, 1993, PROTEIN ENG, V6, P779, DOI 10.1093/protein/6.7.779; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P57, DOI 10.1093/protein/4.1.57; Conrad H. E., 1998, HEPARIN BINDING PROT; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; Dauter Z, 2002, CURR OPIN STRUC BIOL, V12, P674, DOI 10.1016/S0959-440X(02)00372-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; GEREN CR, 1975, BIOCHEMISTRY-US, V14, P1461, DOI 10.1021/bi00678a017; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Krupicka M, 2009, J PHYS CHEM B, V113, P11314, DOI 10.1021/jp904716t; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2003, J BIOMOL STRUCT DYN, V21, P1; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y	43	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15619	15626		10.1074/jbc.M109.099564	http://dx.doi.org/10.1074/jbc.M109.099564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236943	Green Published, hybrid			2022-12-25	WOS:000277399000080
J	Figueroa, AA; Delaney, S				Figueroa, Amalia Avila; Delaney, Sarah			Mechanistic Studies of Hairpin to Duplex Conversion for Trinucleotide Repeat Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMERIZATION INITIATION SITE; NUCLEOCAPSID-PROTEIN; SECONDARY STRUCTURE; KISSING COMPLEX; STRAND TRANSFER; MELTING CURVES; HUMAN-DISEASE; NMR STRUCTURE; BASE-PAIRS; IN-VITRO	The expansion of a trinucleotide repeat sequence, such as CAG/CTG, has been pinpointed as the molecular basis for a number of neurodegenerative disorders. It has been proposed that as part of the expansion process, these repetitive sequences adopt non-B conformations such as hairpins. However, the prevalence of these hairpins and their contributions to the DNA expansion have not been well defined. In this work, we utilized a molecular beacon strategy to examine the stability of the (CAG)(10) hairpin and also its behavior in the presence of the complementary (CTG)(10) hairpin. We find that the two hairpins represent kinetically trapped species that can coexist but irreversibly convert to duplex upon thermal induction. Furthermore, as monitored by fluorescence and optical analysis, modifications to the base composition of either the loop or stem region have a profound effect on the ability of the trinucleotide repeat hairpins to convert to duplex. Additionally, the rate of duplex formation is also reduced with these loop and stem-modified hairpins. These results demonstrate that the trinucleotide repeat hairpins can convert to duplex via two independent mechanisms as follows: the loop-loop interactions found in kissing hairpins or the stem-stem interactions of a cruciform.	[Figueroa, Amalia Avila; Delaney, Sarah] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Figueroa, Amalia Avila] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Brown University	Delaney, S (corresponding author), Brown Univ, Dept Chem, 324 Brook St, Providence, RI 02912 USA.	sarah_delaney@brown.edu			Brown University; Richard B. Salomon faculty research award; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	Brown University; Richard B. Salomon faculty research award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brown University in the form of start-up funds and a Richard B. Salomon faculty research award (to S. D.).; Supported by a National Science Foundation graduate research fellowship.	Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Bartos JD, 2008, J BIOL CHEM, V283, P21758, DOI 10.1074/jbc.M800856200; BEAUCAGE SL, 2000, CURR PROTOC NUCL ACI; Bernacchi S, 2005, J BIOL CHEM, V280, P40112, DOI 10.1074/jbc.M503230200; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; CHANG KY, 1994, P NATL ACAD SCI USA, V91, P8705, DOI 10.1073/pnas.91.18.8705; Chang KY, 1997, J MOL BIOL, V269, P52, DOI 10.1006/jmbi.1997.1021; Darby RAJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e39; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Ennifar E, 2006, J MOL BIOL, V356, P771, DOI 10.1016/j.jmb.2005.12.022; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; GACY AM, 1994, BIOCHEMISTRY-US, V33, P11951, DOI 10.1021/bi00205a034; Gacy AM, 1998, BIOCHEMISTRY-US, V37, P9426, DOI 10.1021/bi980157s; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; HERR W, 1985, P NATL ACAD SCI USA, V82, P8009, DOI 10.1073/pnas.82.23.8009; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kushon SA, 2001, J AM CHEM SOC, V123, P10805, DOI 10.1021/ja016310e; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Liu HW, 2005, BIOPHYS J, V89, P3470, DOI 10.1529/biophysj.105.065326; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paiva AM, 2005, J AM CHEM SOC, V127, P5581, DOI 10.1021/ja043783n; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Ramalanjaona N, 2007, J MOL BIOL, V374, P1041, DOI 10.1016/j.jmb.2007.10.001; Risitano A, 2003, BIOCHEMISTRY-US, V42, P6507, DOI 10.1021/bi026997v; Ulyanov NB, 2006, J BIOL CHEM, V281, P16168, DOI 10.1074/jbc.M601711200; Van Melckebeke H, 2008, P NATL ACAD SCI USA, V105, P9210, DOI 10.1073/pnas.0712121105; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Volker J, 2002, P NATL ACAD SCI USA, V99, P14700, DOI 10.1073/pnas.222519799; Volker J, 2007, J AM CHEM SOC, V129, P5272, DOI 10.1021/ja070258q; WARSHAW MM, 1966, J MOL BIOL, V20, P29, DOI 10.1016/0022-2836(66)90115-X; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003	44	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14648	14657		10.1074/jbc.M109.061853	http://dx.doi.org/10.1074/jbc.M109.061853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228068	hybrid, Green Published			2022-12-25	WOS:000277299700062
J	Dheda, K; Davids, V; Lenders, L; Roberts, T; Meldau, R; Ling, D; Brunet, L; Smit, RV; Peter, J; Green, C; Badri, M; Sechi, L; Sharma, S; Hoelscher, M; Dawson, R; Whitelaw, A; Blackburn, J; Pai, M; Zumla, A				Dheda, Keertan; Davids, Virginia; Lenders, Laura; Roberts, Teri; Meldau, Richard; Ling, Daphne; Brunet, Laurence; Smit, Richard van Zyl; Peter, Jonathan; Green, Clare; Badri, Motasim; Sechi, Leonardo; Sharma, Surendra; Hoelscher, Michael; Dawson, Rodney; Whitelaw, Andrew; Blackburn, Jonathan; Pai, Madhukar; Zumla, Alimuddin			Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; ACTIVE TUBERCULOSIS; BURDEN; TECHNOLOGIES	Background: The accurate diagnosis of TB in HIV-infected patients, particularly with advanced immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) assay (Clearview-TB (R)-ELISA) may have some utility for the diagnosis of TB in HIV-infected patients; however, the precise subgroup that may benefit from this technology requires clarification. The utility of LAM in sputum samples has, hitherto, not been evaluated. Methods: LAM was measured in sputum and urine samples obtained from 500 consecutively recruited ambulant patients, with suspected TB, from 2 primary care clinics in South Africa. Culture positivity for M. tuberculosis was used as the reference standard for TB diagnosis. Results: Of 440 evaluable patients 120/387 (31%) were HIV-infected. Urine-LAM positivity was associated with HIV positivity (p = 0.007) and test sensitivity, although low, was significantly higher in HIV-infected compared to uninfected patients (21% versus 6%; p<0.001), and also in HIV-infected participants with a CD4 <200 versus <200 cells/mm(3) (37% versus 0%; p = 0.003). Urine-LAM remained highly specific in all 3 subgroups (95%-100%). 25% of smear-negative but culture-positive HIV-infected patients with a CD4 <200 cells/mm(3) were positive for urine-LAM. Sputum-LAM had good sensitivity (86%) but poor specificity (15%) likely due to test cross-reactivity with several mouth-residing organisms including actinomycetes and nocardia species. Conclusions: These preliminary data indicate that in a high burden primary care setting the diagnostic usefulness of urine-LAM is limited, as a rule-in test, to a specific patient subgroup i.e. smear-negative HIV-infected TB patients with a CD4 count <200 cells/mm(3), who would otherwise have required further investigation. However, even in this group sensitivity was modest. Future and adequately powered studies in a primary care setting should now specifically target patients with suspected TB who have advanced HIV infection.	[Dheda, Keertan; Davids, Virginia; Lenders, Laura; Meldau, Richard; Smit, Richard van Zyl; Peter, Jonathan; Dawson, Rodney] Univ Cape Town, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Davids, Virginia; Lenders, Laura; Meldau, Richard; Smit, Richard van Zyl; Peter, Jonathan; Dawson, Rodney] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Roberts, Teri; Blackburn, Jonathan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Badri, Motasim] Univ Cape Town, Dept Med, Clin Res Support Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Green, Clare; Zumla, Alimuddin] UCL, Sch Med, Dept Infect, Ctr Infect Dis & Int Hlth, London W1N 8AA, England; [Blackburn, Jonathan] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Ling, Daphne; Brunet, Laurence; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Sechi, Leonardo] Univ Sardinia, Dipartimento Sci Biomed, Sassari, Italy; [Sharma, Surendra] All India Inst Med Sci, Dept Med, Div Pulm Crit Care & Sleep Med, New Delhi 110029, India; [Whitelaw, Andrew] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School; University of Cape Town; McGill University; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Cape Town; University of Munich	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol & Clin Immunol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Hoelscher, Michael/D-3436-2012; ZUMLA, Alimuddin/ABA-8208-2020; Pai, Madhukar/AAX-9901-2021; Sechi, Leonardo Antonio/Y-3109-2018; PAL, MRINAL/ABG-9676-2020; Brunet, Laurence/J-7099-2014; Badri, Motasim/E-1141-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Brunet, Laurence/0000-0001-8467-4835; sechi, leonardo antonio/0000-0003-0566-2049; Whitelaw, Andrew/0000-0001-9070-5247; Peter, Jonathan/0000-0002-2658-0723; van Zyl-Smit, Richard/0000-0002-4115-5362; Badri, Motasim/0000-0002-5268-6492	European Commission [EU-FP7]; Europe AID ADAT; EDCTP; UK Cambridge Biomedical Research Centre (CBRC); National Institute for Health Research (NIHR); Canadian Institutes of Health Research (CIHR) [MOP-89918]; Medical Research Council (MRC) Career Development Award; NRF/SARChI award; CIHR New Investigator Award	European Commission(European CommissionEuropean Commission Joint Research Centre); Europe AID ADAT; EDCTP; UK Cambridge Biomedical Research Centre (CBRC); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council (MRC) Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF/SARChI award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This study was supported by a TBsusgent grant from the European Commission (EU-FP7; K. D., M. P., M. H.), Europe AID ADAT grant (A. Z. and M. H.), EDCTP (M. H., K. D. and A. Z.), UK Cambridge Biomedical Research Centre (CBRC), National Institute for Health Research (NIHR) (A. Z.), and in by part by the Canadian Institutes of Health Research (CIHR) grant MOP-89918; M. P., K. D.). K. D. is also supported by a Medical Research Council (MRC) Career Development Award and a NRF/SARChI award, and M. P. by a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-1; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Burman William J, 2003, Semin Respir Infect, V18, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daley P, 2009, INT J TUBERC LUNG D, V13, P989; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Doublier S, 2007, AIDS, V21, P423, DOI 10.1097/QAD.0b013e328012c522; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; LAWN SD, 2009, URINE LIPOARABINOMAN; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; MUTETWA R, 2009, INT J TUBERCULOSIS L; New Diagnostics Working Group of the Stop TB Partnership, 2009, PATHW BETT DIAGN TUB; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Quaggin SE, 2009, J CLIN INVEST, V119, P1085, DOI 10.1172/JCI39254; REITHER K, 2009, LOW SENSITIVITY URIN; Shah M, 2009, J ACQ IMMUN DEF SYND; Sittampalam GS, 1996, J IMMUNOL METHODS, V190, P151, DOI 10.1016/0022-1759(95)00262-6; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; *WHO, 2006, STOP TB PARTN; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Organization, 2008, GLOB TUB CONTR SURV	28	109	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9848	10.1371/journal.pone.0009848	http://dx.doi.org/10.1371/journal.pone.0009848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352098	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500016
J	Jung, RE; Segall, JM; Grazioplene, RG; Qualls, C; Sibbitt, WL; Roldan, CA				Jung, Rex E.; Segall, Judith M.; Grazioplene, Rachael G.; Qualls, Clifford; Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.			Cortical Thickness and Subcortical Gray Matter Reductions in Neuropsychiatric Systemic Lupus Erythematosus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; PROTON MR SPECTROSCOPY; SURFACE-BASED ANALYSIS; ANTIPHOSPHOLIPID ANTIBODIES; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; RHESUS-MONKEY; BRAIN-LESIONS	Within systemic lupus erythematosus (SLE) patients can be divided into groups with and without central nervous system involvement, the latter being subcategorized as neuropsychiatric systemic lupus erythematosus (NPSLE). While a number of research groups have investigated NPSLE, there remains a lack of consistent application of this diagnostic criteria within neuroimaging studies. Previous neuroimaging research suggests that SLE patients have reduced subcortical and regional gray matter volumes when compared to controls, and that these group differences may be driven by SLE patients with neuropsychiatric symptoms. The current study sought to compare measures of cortical thickness and subcortical structure volume between NPSLE, SLE, and healthy controls. We hypothesized that patients with NPSLE (N = 21) would have thinner cortex and reduced subcortical gray matter volumes when compared to SLE (N = 16) and control subjects (N = 21). All subjects underwent MRI examinations on a 1.5 Tesla Siemens Sonata scanner. Anatomical reconstruction and segmentation were performed using the FreeSurfer image analysis suite. Cortical and subcortical volumes were extracted from FreeSurfer and analyzed for group differences, controlling for age. The NPSLE group exhibited decreased cortical thickness in clusters of the left frontal and parietal lobes as well as in the right parietal and occipital lobes compared to control subjects. Compared to the SLE group, the NPSLE group exhibited comparable thinning in clusters of the frontal and temporal lobes. Controlling for age, we found that between group effects for subcortical gray matter structures were significant for the thalamus (F = 3.06, p = .04), caudate nucleus (F = 3.19, p = .03), and putamen (F = 4.82, p = .005). These results clarify previous imaging work identifying cortical atrophy in a mixed SLE and NPSLE group, and suggest that neuroanatomical abnormalities are specific to SLE patients diagnosed with neuropsychiatric symptoms. Future work should help elucidate the underlying mechanisms underlying the emerging neurobiological profile seen in NPSLE, as well as clarify the apparent lack of overlap between cortical thinning and functional activation results and other findings pointing to increased functional activation during cognitive tasks.	[Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Jung, Rex E.; Segall, Judith M.; Grazioplene, Rachael G.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Dept Math, Albuquerque, NM 87131 USA; [Sibbitt, Wilmer L., Jr.; Roldan, Carlos A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.	rjung@salud.unm.edu	Sibbitt, Wilmer/AAI-7746-2020	Sibbitt, Wilmer/0000-0001-5872-160X; Jung, Rex/0000-0003-3718-0597	NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute) [R01HL077422-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077422] Funding Source: NIH RePORTER	NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research supported by grant number R01HL077422-01A1 - NIH-NHLBI (National Institutes of Health-National Heart, Lung, and Blood Institute), to Carlos A. Roldan, M. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Appenzeller S, 2006, ANN RHEUM DIS, V65, P1585, DOI 10.1136/ard.2005.049486; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Appenzeller S, 2004, NEUROLOGY, V63, P1808, DOI 10.1212/01.WNL.0000144178.32208.4F; Appenzeller S, 2007, NEUROIMAGE, V34, P694, DOI 10.1016/j.neuroimage.2006.09.029; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BAUM KA, 1993, CLIN NEUROL NEUROSUR, V95, P29, DOI 10.1016/0303-8467(93)90088-X; BENNETT R, 1972, BRIT MED J, V4, P342, DOI 10.1136/bmj.4.5836.342; BLUESTEIN HG, 1987, NEW ENGL J MED, V317, P309, DOI 10.1056/NEJM198707303170509; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bosma GPT, 2002, ARTHRITIS RHEUM, V46, P2665, DOI 10.1002/art.10574; Bosma GPT, 2000, ARTHRITIS RHEUM-US, V43, P48, DOI 10.1002/1529-0131(200001)43:1<48::AID-ANR7>3.0.CO;2-H; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Brooks WM, 1997, J RHEUMATOL, V24, P2323; CARETTE S, 1982, J RHEUMATOL, V9, P855; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chinn RJS, 1997, ARTHRITIS RHEUM-US, V40, P36, DOI 10.1002/art.1780400107; Cotton F, 2004, REV MED INTERNE, V25, P8, DOI 10.1016/S0248-8663(03)00265-0; Csepany T, 2003, J NEUROL, V250, P1348, DOI 10.1007/s00415-003-0223-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FEELY RH, 1976, IRISH MED J, V69, P255; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgibbon BM, 2008, RHEUMATOLOGY, V47, P50, DOI 10.1093/rheumatology/kem287; Friedman SD, 1998, RADIOLOGY, V209, P79, DOI 10.1148/radiology.209.1.9769816; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hachulla E, 1998, LUPUS, V7, P124, DOI 10.1191/096120398678919868; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; Hanly JG, 2004, LUPUS, V13, P861, DOI 10.1191/0961203304lu2024oa; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hughes M, 2007, ACTA RADIOL, V48, P213, DOI 10.1080/02841850601105825; ISHIKAWA O, 1994, J RHEUMATOL, V21, P87; JAREK MJ, 1994, ARTHRITIS RHEUM-US, V37, P1609, DOI 10.1002/art.1780371108; JUNG RE, 2009, HUM BRAIN MAPP; Juranek J, 2008, NEUROIMAGE, V40, P1516, DOI 10.1016/j.neuroimage.2008.01.043; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; LU LH, 2009, CEREB CORTEX; MCCUNE WJ, 1988, ARTHRITIS RHEUM-US, V31, P159, DOI 10.1002/art.1780310202; OMDAL R, 1989, SCAND J RHEUMATOL, V18, P283, DOI 10.3109/03009748909095031; Otte A, 1997, EUR J NUCL MED, V24, P787; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rocca MA, 2006, NEUROIMAGE, V30, P478, DOI 10.1016/j.neuroimage.2005.09.047; Rocca MA, 2002, ANN NEUROL, V51, P330, DOI 10.1002/ana.10120; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sanna G, 2003, J RHEUMATOL, V30, P985; SCHMAHMANN JD, 1990, J COMP NEUROL, V295, P299, DOI 10.1002/cne.902950212; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sibbitt Jr W.L., 2009, SEMIN ARTHRITIS RHEU; Sibbitt WL, 1997, AM J NEURORADIOL, V18, P1271; SIBBITT WL, 1994, AM J NEURORADIOL, V15, P923; Sibbitt WL, 1999, ARTHRITIS RHEUM-US, V42, P2026, DOI 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J; SIBBITT WL, 1995, ARTHRITIS RHEUM-US, V38, P810, DOI 10.1002/art.1780380615; SIBBITT WL, 1989, ANN RHEUM DIS, V48, P1014, DOI 10.1136/ard.48.12.1014; Sibbitt WL, 2002, J RHEUMATOL, V29, P1536; Sundgren PC, 2005, NEURORADIOLOGY, V47, P576, DOI 10.1007/s00234-005-1371-y; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wartenburger I, 2009, NEUROIMAGE, V48, P291, DOI 10.1016/j.neuroimage.2009.06.025; Waterloo K, 1999, J NEUROL, V246, P706, DOI 10.1007/s004150050436; Weiner SM, 2000, ANN RHEUM DIS, V59, P377, DOI 10.1136/ard.59.5.377; WEISBERG LA, 1986, COMPUT RADIOL, V10, P63, DOI 10.1016/0730-4862(86)90022-3; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Zanardi VA, 2001, CLIN RHEUMATOL, V20, P245, DOI 10.1007/s100670170037; 1999, ARTHRITIS RHEUM, V42, P599	77	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9302	10.1371/journal.pone.0009302	http://dx.doi.org/10.1371/journal.pone.0009302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352085	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894500002
J	Genovart, M; Negre, N; Tavecchia, G; Bistuer, A; Parpal, L; Oro, D				Genovart, Meritxell; Negre, Nieves; Tavecchia, Giacomo; Bistuer, Ana; Parpal, Luis; Oro, Daniel			The Young, the Weak and the Sick: Evidence of Natural Selection by Predation	PLOS ONE			English	Article							SUBSTANDARD INDIVIDUALS; SOCKEYE-SALMON; RISK; SIZE; POPULATIONS; GULLS; BEARS; MASS; VULNERABILITY; RECRUITMENT	It is assumed that predators mainly prey on substandard individuals, but even though some studies partially support this idea, evidence with large sample sizes, exhaustive analysis of prey and robust analysis is lacking. We gathered data from a culling program of yellow-legged gulls killed by two methods: by the use of raptors or by shooting at random. We compared both data sets to assess whether birds of prey killed randomly or by relying on specific individual features of the prey. We carried out a meticulous post-mortem examination of individuals, and analysing multiple prey characteristics simultaneously we show that raptors did not hunt randomly, but rather preferentially predate on juveniles, sick gulls, and individuals with poor muscle condition. Strikingly, gulls with an unusually good muscle condition were also predated more than expected, supporting the mass-dependent predation risk theory. This article provides a reliable example of how natural selection may operate in the wild and proves that predators mainly prey on substandard individuals.	[Genovart, Meritxell; Tavecchia, Giacomo; Oro, Daniel] IMEDEA CSIC UIB, Dept Biodivers & Conservat, Populat Ecol Grp, Esporles, Spain; [Bistuer, Ana] Consell Mallorca, Serv Gestio Residus, Palma de Mallorca, Spain; [Negre, Nieves] Fdn Nat Parc, Santa Eugenia, Spain; [Parpal, Luis] Consorci Recuperacio Fauna Illes Balears COFIB, Santa Eugenia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Genovart, M (corresponding author), IMEDEA CSIC UIB, Dept Biodivers & Conservat, Populat Ecol Grp, Esporles, Spain.	m.genovart@uib.es	Tavecchia, Giacomo/N-3961-2014; Oro, Daniel/H-4208-2012; Genovart, Meritxell/L-4873-2014	Tavecchia, Giacomo/0000-0001-5435-2691; Oro, Daniel/0000-0003-4782-3007; Genovart, Meritxell/0000-0003-2919-1288	EMAYA (Empresa Municipal de Agua y Alcantarillado); Spanish Ministry of Science [CGL2006-04325/BOS]; I3P-CSIC fellowship	EMAYA (Empresa Municipal de Agua y Alcantarillado); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); I3P-CSIC fellowship	The authors acknowledge support mainly from TIRME, S. A. and also from EMAYA (Empresa Municipal de Agua y Alcantarillado) and the Spanish Ministry of Science (grant ref. CGL2006-04325/BOS). M. G. was supported by an I3P-CSIC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R., 2008, MODEL BASED INFERENC; BLOKPOEL H, 1991, ACT 20 C INT ORN CHR; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Carlson SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001286; Carlson SM, 2009, EVOLUTION, V63, P1244, DOI 10.1111/j.1558-5646.2009.00643.x; Curio E., 1976, ETHOLOGY PREDATION; Darwin C., 1877, DIFFERENT FORMS FLOW; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Duffy MA, 2005, LIMNOL OCEANOGR, V50, P412, DOI 10.4319/lo.2005.50.2.0412; Endler J.A., 1986, Monographs in Population Biology, pviii; ERRINGTON PL, 1946, Q REV BIOL, V21, P144, DOI 10.1086/395220; FEARE CJ, 1991, BIRD POPULATION STUD, P463; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Hatch Jeremy J., 1996, International Journal of Environmental Health Research, V6, P5, DOI 10.1080/09603129609356867; HEITMEYER ME, 1993, J WILDLIFE MANAGE, V57, P733, DOI 10.2307/3809073; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; MacLeod R, 2007, P ROY SOC B-BIOL SCI, V274, P2587, DOI 10.1098/rspb.2007.0786; MacLeod R, 2006, BIOL LETT-UK, V2, P43, DOI 10.1098/rsbl.2005.0421; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Moller AP, 2000, OECOLOGIA, V122, P500, DOI 10.1007/s004420050972; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Penteriani V, 2008, J AVIAN BIOL, V39, P215, DOI 10.1111/j.0908-8857.2008.04280.x; Quinn TP, 1999, OECOLOGIA, V121, P273, DOI 10.1007/s004420050929; Quinn TP, 2001, EVOL ECOL RES, V3, P917; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICKLEFS RE, 1969, NATURE, V223, P922, DOI 10.1038/223922a0; Sanz-Aguilar A, 2009, ECOGRAPHY, V32, P637, DOI 10.1111/j.1600-0587.2009.05596.x; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; TEMPLE SA, 1987, ECOLOGY, V68, P669, DOI 10.2307/1938472; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578	39	80	80	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9774	10.1371/journal.pone.0009774	http://dx.doi.org/10.1371/journal.pone.0009774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333305	gold, Green Published			2022-12-25	WOS:000275809700013
J	Cestari, I; Ramirez, MI				Cestari, Igor; Ramirez, Marcel I.			Inefficient Complement System Clearance of Trypanosoma cruzi Metacyclic Trypomastigotes Enables Resistant Strains to Invade Eukaryotic Cells	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; MEDIATED LYSIS; MOLECULAR-BASIS; BLOOD-DONORS; ANTIBODIES; PATHWAY; ACTIVATION; INFECTION; SURFACE; SUSCEPTIBILITY	The complement system is the main arm of the vertebrate innate immune system against pathogen infection. For the protozoan Trypanosoma cruzi, the causative agent of Chagas disease, subverting the complement system and invading the host cells is crucial to succeed in infection. However, little attention has focused on whether the complement system can effectively control T. cruzi infection. To address this question, we decided to analyse: 1) which complement pathways are activated by T. cruzi using strains isolated from different hosts, 2) the capacity of these strains to resist the complement-mediated killing at nearly physiological conditions, and 3) whether the complement system could limit or control T. cruzi invasion of eukaryotic cells. The complement activating molecules C1q, C3, mannan-binding lectin and ficolins bound to all strains analysed; however, C3b and C4b deposition assays revealed that T. cruzi activates mainly the lectin and alternative complement pathways in non-immune human serum. Strikingly, we detected that metacyclic trypomastigotes of some T. cruzi strains were highly susceptible to complement-mediated killing in non-immune serum, while other strains were resistant. Furthermore, the rate of parasite invasion in eukaryotic cells was decreased by non-immune serum. Altogether, these results establish that the complement system recognizes T. cruzi metacyclic trypomastigotes, resulting in killing of susceptible strains. The complement system, therefore, acts as a physiological barrier which resistant strains have to evade for successful host infection.	[Cestari, Igor; Ramirez, Marcel I.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Cestari, I (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	marcelr@fiocruz.br			National Council for Scientific and Technological Development (CNPq) [476737/2004-4]; CNPq [141757/2006-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PDEE4261/06-2]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by The National Council for Scientific and Technological Development (CNPq) (476737/2004-4); I. S. Cestari was a recipient of CNPq (141757/2006-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PDEE4261/06-2) scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA IC, 1991, J IMMUNOL, V146, P2394; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; Ambrosio AR, 2005, PARASITE IMMUNOL, V27, P333, DOI 10.1111/j.1365-3024.2005.00782.x; Atayde VD, 2004, INT J PARASITOL, V34, P851, DOI 10.1016/j.ijpara.2004.03.003; Bahia Maria Terezinha, 2002, Rev. Soc. Bras. Med. Trop., V35, P339, DOI 10.1590/S0037-86822002000400010; Barrett VJ, 1997, AM J CLIN PATHOL, V108, P499; Barros VC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006047; BIJOVSKY AT, 1984, ACTA TROP, V41, P207; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cestari ID, 2008, J INFECT DIS, V198, P1276, DOI 10.1086/592167; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; DECASTRO SL, 1993, ACTA TROP, V53, P83, DOI 10.1016/0001-706X(93)90021-3; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000447; ISH C, 1993, SCAND J IMMUNOL, V38, P113, DOI 10.1111/j.1365-3083.1993.tb01701.x; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; JOINER K, 1986, P NATL ACAD SCI USA, V83, P6593, DOI 10.1073/pnas.83.17.6593; JOINER K, 1985, J EXP MED, V161, P1196, DOI 10.1084/jem.161.5.1196; Kipnis T L, 1992, Mediators Inflamm, V1, P309, DOI 10.1155/S0962935192000450; KIPNIS TL, 1985, SCAND J IMMUNOL, V22, P217, DOI 10.1111/j.1365-3083.1985.tb01874.x; KOENE RAP, 1973, J IMMUNOL, V111, P1894; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kollien Astrid H., 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P335; KRETTLI AU, 1979, CLIN EXP IMMUNOL, V37, P416; KRETTLI AU, 1985, CLIN EXP IMMUNOL, V62, P270; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Leon-Perez F, 2007, VECTOR-BORNE ZOONOT, V7, P330, DOI 10.1089/vbz.2006.0604; Moreno I, 2007, MICROBES INFECT, V9, P1574, DOI 10.1016/j.micinf.2007.09.009; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732; Norris KA, 1998, INFECT IMMUN, V66, P2460, DOI 10.1128/IAI.66.6.2460-2465.1998; Parmentier HK, 2004, VET IMMUNOL IMMUNOP, V100, P25, DOI 10.1016/j.vetimm.2004.02.009; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; PEARSON RD, 1980, J IMMUNOL, V125, P2195; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x; Piron M, 2008, TRANSFUSION, V48, P1862, DOI 10.1111/j.1537-2995.2008.01789.x; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; Roellig DM, 2009, INT J PARASITOL, V39, P1603, DOI 10.1016/j.ijpara.2009.06.007; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; SAMANOVIC M, 2009, PLOS PATHOG, V5, P1; Schuster JP, 2000, INT J PARASITOL, V30, P1475, DOI 10.1016/S0020-7519(00)00119-3; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; TAMBOURGI DV, 1993, INFECT IMMUN, V61, P3656, DOI 10.1128/IAI.61.9.3656-3663.1993; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Turner M W, 2000, Rev Immunogenet, V2, P305; WIRTZ GH, 1967, IMMUNOCHEMISTRY, V4, P61, DOI 10.1016/0019-2791(67)90198-X; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; YOSHIDA N, 1987, PARASITE IMMUNOL, V9, P389, DOI 10.1111/j.1365-3024.1987.tb00516.x; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	57	39	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9721	10.1371/journal.pone.0009721	http://dx.doi.org/10.1371/journal.pone.0009721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300530	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400019
J	Kessel, L; Eskildsen, L; van der Poel, M; Larsen, M				Kessel, Line; Eskildsen, Lars; van der Poel, Mike; Larsen, Michael			Non-Invasive Bleaching of the Human Lens by Femtosecond Laser Photolysis	PLOS ONE			English	Article							HUMAN EYE LENS; PROTEIN INTERACTIONS; DAMAGE; SENSITIVITY; ULTRAVIOLET; THRESHOLDS; DEPENDENCE; LESIONS; PULSES	Background: Globally, cataract is the leading cause of blindness and impaired vision. Cataract surgery is an attractive treatment option but it remains unavailable in sufficient quantity for the vast majority of the world population living in areas without access to specialized health care. Reducing blindness from cataract requires solutions that can be applied outside operating theatres. Cataract is a protein conformational disease characterized by accumulation of light absorbing, fluorescent and scattering protein aggregates. The aim of the study was to investigate whether these compounds were susceptible to photobleaching by a non-invasive procedure and whether this would lead to optical rejuvenation of the lens. Methodology/Principal Findings: Nine human donor lenses were treated with an 800 nm infra-red femtosecond pulsed laser in a treatment zone measuring 1 x 1 x 0.52 mm. After laser treatment the age-induced yellow discoloration of the lens was markedly reduced and the transmission of light was increased corresponding to an optical rejuvenation of 3 to 7 years. Conclusions/Significance: The results demonstrate that the age-induced yellowing of the human lens can be bleached by a non-invasive procedure based on femtosecond laser photolysis. Cataract is a disease associated with old age. At the current technological stage, lens aging is delayed but with a treatment covering the entire lens volume complete optical rejuvenation is expected. Thus, femtosecond photolysis has the potential clinical value of replacing invasive cataract surgery by a non-invasive treatment modality that can be placed in mobile units, thus breaking down many of the barriers impeding access to treatment in remote and poor regions of the world.	[Kessel, Line; Eskildsen, Lars; Larsen, Michael] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark; [Eskildsen, Lars; van der Poel, Mike] Tech Univ Denmark, Dept Photon Engn, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Kessel, L (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, Glostrup, Denmark.	line.kessel@dadlnet.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Kessel, Line/0000-0002-9375-1510	Danish Medical Research Council [721-06-0664]; Danish National Advanced Technology Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Advanced Technology Foundation	The study received financial support from the Danish Medical Research Council (grant # 721-06-0664) and the Danish National Advanced Technology Foundation (Hoejteknologifonden). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argirov OK, 2005, ANN NY ACAD SCI, V1043, P166, DOI 10.1196/annals.1333.021; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CAIN CP, 1995, INVEST OPHTH VIS SCI, V36, P879; Cain CP, 1999, INVEST OPHTH VIS SCI, V40, P2343; Cain CP, 2002, HEALTH PHYS, V82, P855, DOI 10.1097/00004032-200206000-00014; Cain CP, 2001, J LASER APPL, V13, P125, DOI 10.2351/1.1356421; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Friedlaender Mitchell H., 2006, International Ophthalmology Clinics, V46, P145, DOI 10.1097/00004397-200604630-00013; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; HAM WT, 1979, PHOTOCHEM PHOTOBIOL, V29, P735, DOI 10.1111/j.1751-1097.1979.tb07759.x; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; Heisterkamp A, 2005, OPT EXPRESS, V13, P3690, DOI 10.1364/OPEX.13.003690; Hermans EA, 2008, OPTOMETRY VISION SCI, V85, P1179, DOI 10.1097/OPX.0b013e31818e8d57; Kessel L, 2005, ACTA OPHTHALMOL SCAN, V83, P221, DOI 10.1111/j.1600-0420.2005.00388.x; Kessel L, 2011, ACTA OPHTHALMOL, V89, pe289, DOI 10.1111/j.1755-3768.2009.01839.x; Kessel L, 2010, J CATARACT REFR SURG, V36, P308, DOI 10.1016/j.jcrs.2009.08.035; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Ortwerth BJ, 2002, EXP EYE RES, V74, P217, DOI 10.1006/exer.2001.1114; Ponce A, 2006, MOL VIS, V12, P879; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rockwell BA, 1999, J LASER APPL, V11, P42, DOI 10.2351/1.521879; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; STRADNER A, 2007, PHYS REV LETT, V99; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; TOTH CA, 1995, INVEST OPHTH VIS SCI, V36, P1910; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; *WHO, 2007, VIS 2020 RIGHT SIGHT, P7	30	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9711	10.1371/journal.pone.0009711	http://dx.doi.org/10.1371/journal.pone.0009711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300521	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400009
J	Stark, MS; Tyagi, S; Nancarrow, DJ; Boyle, GM; Cook, AL; Whiteman, DC; Parsons, PG; Schmidt, C; Sturm, RA; Hayward, NK				Stark, Mitchell S.; Tyagi, Sonika; Nancarrow, Derek J.; Boyle, Glen M.; Cook, Anthony L.; Whiteman, David C.; Parsons, Peter G.; Schmidt, Christopher; Sturm, Richard A.; Hayward, Nicholas K.			Characterization of the Melanoma miRNAome by Deep Sequencing	PLOS ONE			English	Article							CELL-PROLIFERATION; TUMOR INVASION; EXPRESSION; MICRORNAS; MELANOCYTES; PROGRESSION; METASTASIS; REPRESSION; REVEALS; MARKER	Background: MicroRNAs (miRNAs) are 18-23 nucleotide non-coding RNAs that regulate gene expression in a sequence specific manner. Little is known about the repertoire and function of miRNAs in melanoma or the melanocytic lineage. We therefore undertook a comprehensive analysis of the miRNAome in a diverse range of pigment cells including: melanoblasts, melanocytes, congenital nevocytes, acral, mucosal, cutaneous and uveal melanoma cells. Methodology/Principal Findings: We sequenced 12 small RNA libraries using Illumina's Genome Analyzer II platform. This massively parallel sequencing approach of a diverse set of melanoma and pigment cell libraries revealed a total of 539 known mature and mature-star sequences, along with the prediction of 279 novel miRNA candidates, of which 109 were common to 2 or more libraries and 3 were present in all libraries. Conclusions/Significance: Some of the novel candidate miRNAs may be specific to the melanocytic lineage and as such could be used as biomarkers to assist in the early detection of distant metastases by measuring the circulating levels in blood. Follow up studies of the functional roles of these pigment cell miRNAs and the identification of the targets should shed further light on the development and progression of melanoma.	[Stark, Mitchell S.; Tyagi, Sonika; Nancarrow, Derek J.; Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Boyle, Glen M.; Parsons, Peter G.] Queensland Inst Med Res, Drug Discovery Lab, Brisbane, Qld 4006, Australia; [Whiteman, David C.] Queensland Inst Med Res, Canc Control Grp, Brisbane, Qld 4006, Australia; [Cook, Anthony L.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Melanogenix Grp, St Lucia, Qld, Australia; [Schmidt, Christopher] Queensland Inst Med Res, Canc Immunotherapy Grp, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute	Stark, MS (corresponding author), Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia.	Nick.Hayward@qimr.edu.au	hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-3874-2019; Sturm, Richard A/C-9943-2009; Whiteman, David C/P-2728-2014; Parsons, Peter/J-4683-2013; Cook, Anthony/K-9489-2018; Stark, Mitchell S/E-3542-2010; Boyle, Glen/G-1347-2013; Parsons, Peter G/H-8163-2015; hayward, nick/AAV-8802-2020; Stark, Mitchell/K-6794-2019; Schmidt, Christopher W/A-4353-2009; Tyagi, Sonika/L-2256-2019	hayward, nicholas k/0000-0003-4760-1033; Sturm, Richard A/0000-0003-1301-0294; Whiteman, David C/0000-0003-2563-9559; Parsons, Peter/0000-0002-0473-3346; Cook, Anthony/0000-0003-1770-7910; Stark, Mitchell S/0000-0002-4510-2161; Boyle, Glen/0000-0002-1385-529X; Parsons, Peter G/0000-0002-0473-3346; Stark, Mitchell/0000-0002-4510-2161; Schmidt, Christopher W/0000-0002-3955-5076; Tyagi, Sonika/0000-0003-0181-6258	National Health and Medical Research Council of Australia (NHMRC); Cancer Council Queensland	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC)(www.nhmrc.gov.au), and the Cancer Council Queensland (www.cancerqld.org.au). NKH is the recipient of a Senior Principal Research Fellowship from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pollock PM, 2002, MELANOMA RES, V12, P565, DOI 10.1097/00008390-200212000-00006; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	34	163	280	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9685	10.1371/journal.pone.0009685	http://dx.doi.org/10.1371/journal.pone.0009685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300190	gold, Green Published, Green Submitted			2022-12-25	WOS:000275620900017
J	Martin, CM; Wagner, WE				Martin, Cassandra M.; Wagner, William E., Jr.			Female Field Crickets Incur Increased Parasitism Risk When Near Preferred Song	PLOS ONE			English	Article							ACOUSTICALLY-ORIENTING PARASITOIDS; MALE CALLING SONG; MATE CHOICE; ORMIA-OCHRACEA; UNPARASITIZED POPULATIONS; RELATIVE IMPORTANCE; SEASONAL-VARIATION; PREDATION RISK; AGE STRUCTURE; TELEOGRYLLUS	Female animals often prefer males with conspicuous traits because these males provide direct or indirect benefits. Conspicuous male traits, however, can attract predators. This not only increases the risk of predation for conspicuous males but also for the females that prefer them. In the variable field cricket, Gryllus lineaticeps, males that produce preferred song types provide females with greater material benefits, but they are also more likely to attract lethal parasitoid flies. First, we conducted a field experiment that tested the hypothesis that females have a greater risk of fly parasitism when in association with preferred high chirp rate males. Females were nearly twice as likely to be parasitized when caged with high chirp rate song than when caged with low chirp rate song. Females may thus be forced to trade off the quality of the benefits they receive from mating with preferred males and the risk of being killed by a predator when near these males. Second, we assessed female parasitism rates in a natural population. Up to 6% of the females were parasitized in field samples. Because the females we collected could have become parasitized had they not been collected, this provides a minimum estimate of the female parasitism rate in the field. In a laboratory study, we found no difference in the proportion of time parasitized and unparasitized females spent hiding under shelters; thus, differences in activity patterns do not appear to have biased our estimate of female parasitism rates. Overall, our results suggest that female association costs have the potential to shape the evolution of female mating preferences.	[Martin, Cassandra M.; Wagner, William E., Jr.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Martin, CM (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	cassiem@unlserve.unl.edu	Wagner, William E./H-5709-2019; Wagner, William/B-6865-2009	Wagner, William E./0000-0001-6306-7964; Wagner, William/0000-0001-6306-7964	Sigma Xi; American Philosophical Society; Orthopterists' Society; School of Biological Sciences at UNL; US Department of Education; NSF [IOB 0521743, IOS 0818116]; Division Of Integrative Organismal Systems [0818116] Funding Source: National Science Foundation	Sigma Xi; American Philosophical Society; Orthopterists' Society; School of Biological Sciences at UNL; US Department of Education(US Department of Education); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a Grant-In-Aid of Research from Sigma Xi, a Lewis and Clark Award for Exploration and Field Research from the American Philosophical Society, a grant from the Orthopterists' Society, two grants from the School of Biological Sciences at UNL, and two GAANN awards from the US Department of Education to C. M. M., and by NSF grants IOB 0521743 and IOS 0818116 to W. E. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, BEHAV ECOL SOCIOBIOL, V36, P111, DOI 10.1007/BF00170716; ADAMO SA, 1995, J INSECT PHYSIOL, V41, P269, DOI 10.1016/0022-1910(94)00095-X; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Allen GR, 1999, J INSECT BEHAV, V12, P67, DOI 10.1023/A:1020929231430; Andersson Malte, 1994; Bernal XE, 2006, BEHAV ECOL, V17, P709, DOI 10.1093/beheco/arl003; Bertram SM, 2004, ETHOLOGY, V110, P963, DOI 10.1111/j.1439-0310.2004.01031.x; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; Cade WH, 1996, CAN J ZOOL, V74, P393, DOI 10.1139/z96-046; CADE WH, 1984, BEHAVIOUR, V88, P61, DOI 10.1163/156853984X00489; Endler J.A., 1986, Monographs in Population Biology, pviii; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Gong A, 1996, ANIM BEHAV, V52, P1007, DOI 10.1006/anbe.1996.0248; Gray DA, 1999, P ROY SOC B-BIOL SCI, V266, P707, DOI 10.1098/rspb.1999.0693; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Kim TW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000422; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kolluru GR, 1999, J INSECT BEHAV, V12, P611, DOI 10.1023/A:1020923602780; Kolluru GR, 2002, BEHAV ECOL, V13, P607, DOI 10.1093/beheco/13.5.607; Lehmann GUC, 2006, ANIM BEHAV, V71, P1103, DOI 10.1016/j.anbehav.2005.08.009; Lehmann GUC, 2001, ENTOMOL GEN, V25, P135; MURRAY AM, 1995, CAN J ZOOL, V73, P1207, DOI 10.1139/z95-144; POCKLINGTON R, 1995, ANIM BEHAV, V49, P1122, DOI 10.1006/anbe.1995.0141; Ramsauer N, 2000, NATURWISSENSCHAFTEN, V87, P315, DOI 10.1007/s001140050729; SAKALUK SK, 1984, ANIM BEHAV, V32, P659, DOI 10.1016/S0003-3472(84)80141-4; SIMMONS LW, 1994, ETHOLOGY, V98, P333; SLAGSVOLD T, 1995, ANIM BEHAV, V50, P1109, DOI 10.1016/0003-3472(95)80110-3; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Velez MJ, 2006, ETHOLOGY, V112, P1041, DOI 10.1111/j.1439-0310.2006.01262.x; Velez MJ, 2006, ANIM BEHAV, V72, P439, DOI 10.1016/j.anbehav.2006.02.002; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; Wagner WE, 2003, EVOLUTION, V57, P2054, DOI 10.1111/j.0014-3820.2003.tb00385.x; Wagner WE, 2007, ECOL ENTOMOL, V32, P478, DOI 10.1111/j.1365-2311.2007.00898.x; Wagner WE, 2007, EVOLUTION, V61, P617, DOI 10.1111/j.1558-5646.2007.00062.x; WALKER TJ, 1991, FLA ENTOMOL, V74, P554, DOI 10.2307/3495408; Zuk M, 1995, ECOL ENTOMOL, V20, P380, DOI 10.1111/j.1365-2311.1995.tb00471.x; Zuk M, 1998, EVOLUTION, V52, P166, DOI 10.2307/2410931; ZUK M, 1993, BEHAV ECOL SOCIOBIOL, V33, P339; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	43	21	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9592	10.1371/journal.pone.0009592	http://dx.doi.org/10.1371/journal.pone.0009592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231888	gold, Green Published			2022-12-25	WOS:000275328300010
J	Rozenova, KA; Deevska, GM; Karakashian, AA; Nikolova-Karakashian, MN				Rozenova, Krasimira A.; Deevska, Gergana M.; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Studies on the Role of Acid Sphingomyelinase and Ceramide in the Regulation of Tumor Necrosis Factor alpha (TNF alpha)-converting Enzyme Activity and TNF alpha Secretion in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-MEDIATED PHOSPHORYLATION; RICH MEMBRANE RAFTS; CONVERTING-ENZYME; IN-VIVO; STIMULATED MACROPHAGES; CYTOKINE SECRETION; IMMUNE-RESPONSES; DOWN-REGULATION; LIPID RAFTS; LIPOPOLYSACCHARIDE	Acid sphingomyelinase (ASMase) has been proposed to mediate lipopolysaccharide (LPS) signaling in various cell types. This study shows that ASMase is a negative regulator of LPS-induced tumor necrosis factor alpha (TNF alpha) secretion in macrophages. ASMase-deficient (asm(-/-)) mice and isolated peritoneal macrophages produce severalfold more TNF alpha than their wildtype (asm(+/+)) counterparts when stimulated with LPS, whereas the addition of exogenous ceramides or sphingomyelinase reduces the differences. The underlying mechanism for these effects is not transcriptional but post-translational. The TNF alpha converting enzyme (TACE) catalyzes the maturation of the 26-kDa precursor (pro-TNF alpha) to an active 17-kDa form (soluble (s) TNF alpha). In mouse peritoneal macrophages, the activity of TACE was the rate-limiting factor regulating TNF alpha production. A substantial portion of the translated pro-TNF alpha was not processed to sTNF alpha; instead, it was rapidly internalized and degraded in the lysosomes. TACE activity was 2-3-fold higher in asm(-/-) macrophages as compared with asm(-/-) macrophages and was suppressed when cells were treated with exogenous ceramide and sphingomyelinase. Indirect immunofluorescence analyses revealed distinct TNF alpha-positive structures in the close vicinity of the plasma membrane in asm(-/-) but not in asm(+/+) macrophages. asm(-/-) cells also had a higher number of early endosomal antigen 1-positive early endosomes. Experiments that involved inhibitors of TACE, endocytosis, and lysosomal proteolysis suggest that in the asm(-/-) cells a significant portion of pro-TNF alpha was sequestered within the early endosomes, and instead of undergoing lysosomal proteolysis, it was recycled to the plasma membrane and processed to sTNF alpha.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu			NIA, National Institutes of Health [R01 AG 019223, AG 026711]; NATIONAL INSTITUTE ON AGING [R01AG026711, R01AG019223] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG 019223 and AG 026711 from NIA (to M. N. N.- K.).	Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Cook EB, 2008, INVEST OPHTH VIS SCI, V49, P3992, DOI 10.1167/iovs.08-1873; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Ermert M, 2003, CYTOKINE, V22, P89, DOI 10.1016/S1043-4666(03)00117-0; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; FIEREN MWJA, 1992, IMMUNOL LETT, V31, P85, DOI 10.1016/0165-2478(92)90015-G; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Gomez-Gaviro MV, 2002, J BIOL CHEM, V277, P38212, DOI 10.1074/jbc.M205142200; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kim JG, 2000, IMMUNOL INVEST, V29, P257, DOI 10.3109/08820130009060866; KRAMER B, 1995, J BIOL CHEM, V270, P6577; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; MacKenzie S, 2002, J LEUKOCYTE BIOL, V71, P1026; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Ng CG, 2008, P NATL ACAD SCI USA, V105, P16326, DOI 10.1073/pnas.0808720105; O'Donnell PM, 2002, J INTERF CYTOK RES, V22, P539, DOI 10.1089/10799900252982016; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Robertshaw HJ, 2005, BRIT J ANAESTH, V94, P222, DOI 10.1093/bja/aei021; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Solomon KA, 1999, J IMMUNOL, V163, P4105; Solomon KA, 1997, J IMMUNOL, V159, P4524; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thiel KW, 2006, BIOCHEM BIOPH RES CO, V350, P629, DOI 10.1016/j.bbrc.2006.09.095; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Watanabe N, 1998, EUR J BIOCHEM, V253, P576, DOI 10.1046/j.1432-1327.1998.2530576.x; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; ZENTELLA A, 1991, PROG CLIN BIOL RES, V367, P9; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	60	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21103	21113		10.1074/jbc.M109.080671	http://dx.doi.org/10.1074/jbc.M109.080671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20236926	Green Published, hybrid			2022-12-25	WOS:000279228600073
J	Kemp, MG; Akan, Z; Yilmaz, S; Grillo, M; Smith-Roe, SL; Kang, TH; Cordeiro-Stone, M; Kaufmann, WK; Abraham, RT; Sancar, A; Unsal-Kacmaz, K				Kemp, Michael G.; Akan, Zafer; Yilmaz, Secil; Grillo, Mary; Smith-Roe, Stephanie L.; Kang, Tae-Hong; Cordeiro-Stone, Marila; Kaufmann, William K.; Abraham, Robert T.; Sancar, Aziz; Unsal-Kacmaz, Keziban			Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; SINGLE-STRANDED-DNA; MINICHROMOSOME MAINTENANCE PROTEINS; HUMAN CLASPIN; ALTERNATIVE FORM; BINDING PROTEIN; CELL-CYCLE; S-PHASE; ACTIVATION	Mammalian Timeless is a multifunctional protein that performs essential roles in the circadian clock, chromosome cohesion, DNA replication fork protection, and DNA replication/DNA damage checkpoint pathways. The human Timeless exists in a tight complex with a smaller protein called Tipin (Timeless-interacting protein). Here we investigated the mechanism by which the Timeless-Tipin complex functions as a mediator in the ATR-Chk1 DNA damage checkpoint pathway. We find that the Timeless-Tipin complex specifically mediates Chk1 phosphorylation by ATR in response to DNA damage and replication stress through interaction of Tipin with the 34-kDa subunit of replication protein A (RPA). The Tipin-RPA interaction stabilizes Timeless-Tipin and Tipin-Claspin complexes on RPA-coated ssDNA and in doing so promotes Claspin-mediated phosphorylation of Chk1 by ATR. Our results therefore indicate that RPA-covered ssDNA not only supports recruitment and activation of ATR but also, through Tipin and Claspin, it plays an important role in the action of ATR on its critical downstream target Chk1.	[Grillo, Mary; Abraham, Robert T.; Unsal-Kacmaz, Keziban] Pfizer Biopharmaceut, Ctr Integrat Biol & Biotherapeut, Pearl River, NY 10965 USA; [Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Smith-Roe, Stephanie L.; Cordeiro-Stone, Marila; Kaufmann, William K.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Cordeiro-Stone, Marila; Kaufmann, William K.] Univ N Carolina, Sch Med, Ctr Environm Hlth & Susceptibil, Chapel Hill, NC 27599 USA; [Kemp, Michael G.; Cordeiro-Stone, Marila; Kaufmann, William K.; Sancar, Aziz] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Pfizer; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Unsal-Kacmaz, K (corresponding author), Pfizer Biopharmaceut, Ctr Integrat Biol & Biotherapeut, 401 N Middletown Rd, Pearl River, NY 10965 USA.	unsalkk@wyeth.com	Kemp, Michael G./AAT-1545-2021; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Kang, Tae-Hong/Y-8294-2019; Yilmaz, Secil/A-9051-2016	Kemp, Michael G./0000-0001-8203-0745; Kang, Tae-Hong/0000-0002-6013-900X; akan, zafer/0000-0002-4150-1720	National Institutes of Health [GM32833, ES014635, ES015856, T32-ES07017, T32-CA09156]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES015856, T32ES007017, P01ES014635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32833 (to A.S.), ES014635 (to W.K.K.), ES015856 (to M.C.-S.), T32-ES07017 (to S.L.S.-R.), and T32-CA09156 (to M.G.K.).	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Haring SJ, 2010, NUCLEIC ACIDS RES, V38, P846, DOI 10.1093/nar/gkp1062; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lupardus PJ, 2006, MOL BIOL CELL, V17, P1559, DOI 10.1091/mbc.E05-09-0865; Mason AC, 2009, J BIOL CHEM, V284, P5324, DOI 10.1074/jbc.M808963200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	79	79	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16562	16571		10.1074/jbc.M110.110304	http://dx.doi.org/10.1074/jbc.M110.110304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20233725	Green Published, hybrid			2022-12-25	WOS:000277982600019
J	Okuhira, K; Fitzgerald, ML; Tamehiro, N; Ohoka, N; Suzuki, K; Sawada, J; Naito, M; Nishimaki-Mogami, T				Okuhira, Keiichiro; Fitzgerald, Michael L.; Tamehiro, Norimasa; Ohoka, Nobumichi; Suzuki, Kazuhiro; Sawada, Jun-ichi; Naito, Mikihiko; Nishimaki-Mogami, Tomoko			Binding of PDZ-RhoGEF to ATP-binding Cassette Transporter A1 (ABCA1) Induces Cholesterol Efflux through RhoA Activation and Prevention of Transporter Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HIGH-DENSITY-LIPOPROTEIN; LEUKEMIA-ASSOCIATED RHO; HETEROTRIMERIC G-PROTEINS; TANGIER-DISEASE; APOA-I; CELLULAR CHOLESTEROL; ABCA1-DEFICIENT MACROPHAGES; P115 RHOGEF; RECEPTOR	ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux to apolipoprotein A1 (apoA-I) initiates the biogenesis of high density lipoprotein. Here we show that the Rho guanine nucleotide exchange factors PDZ-RhoGEF and LARG bind to the C terminus of ABCA1 by a PDZ-PDZ interaction and prevent ABCA1 protein degradation by activating RhoA. ABCA1 is a protein with a short half-life, and apoA-I stabilizes ABCA1 protein; however, depletion of PDZ-RhoGEF/LARG by RNA interference suppressed the apoA-I stabilization of ABCA1 protein in human primary fibroblasts. Exogenous PDZ-RhoGEF expression activated RhoA and increased ABCA1 protein levels and cholesterol efflux activity. Likewise, forced expression of a constitutively active RhoA mutant significantly increased ABCA1 protein levels, whereas a dominant negative RhoA mutant decreased them. The constitutively active RhoA retarded ABCA1 degradation, thus accounting for its ability to increase ABCA1 protein. Moreover, stimulation with apoA-I transiently activated RhoA, and the pharmacological inhibition of RhoA or the dominant negative RhoA blocked the ability of apoA-I to stabilize ABCA1. Finally, depletion of RhoA or RhoGEFs/RhoA reduces the cholesterol efflux when transcriptional regulation via PPAR gamma is eliminated. Taken together, our results have identified a novel physical and functional interaction between ABCA1 and PDZ-RhoGEF/LARG, which activates RhoA, resulting in ABCA1 stabilization and cholesterol efflux activity.	[Okuhira, Keiichiro; Ohoka, Nobumichi; Suzuki, Kazuhiro; Sawada, Jun-ichi; Naito, Mikihiko; Nishimaki-Mogami, Tomoko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588511, Japan; [Fitzgerald, Michael L.; Tamehiro, Norimasa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA; [Fitzgerald, Michael L.; Tamehiro, Norimasa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	National Institute of Health Sciences - Japan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Okuhira, K (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588511, Japan.	okuhira@nihs.go.jp			National Institutes of Health [HL-074136]; Japan Society for the Promotion of Science; Japan Health Sciences Foundation; Takeda Science Foundation; American Heart Association [09GRNT2260352]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790102] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grant HL-074136 (to M. L. F.). This work was also supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, by a research fund from Japan Health Sciences Foundation, by a Takeda Science Foundation grant (to K. O.), and by American Heart Association Grant 09GRNT2260352 (to M. L. F.).	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bared SM, 2004, MOL BIOL CELL, V15, P5399, DOI 10.1091/mbc.E04-03-0182; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Buechler C, 2002, J BIOL CHEM, V277, P41307, DOI 10.1074/jbc.C200436200; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Togashi H, 2000, J BIOL CHEM, V275, P29570, DOI 10.1074/jbc.M003726200; Walter M, 2004, J BIOL CHEM, V279, P20866, DOI 10.1074/jbc.M401714200; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	55	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16369	16377		10.1074/jbc.M109.061424	http://dx.doi.org/10.1074/jbc.M109.061424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348106	Green Published, hybrid			2022-12-25	WOS:000277715900073
J	Venereau, E; Diveu, C; Grimaud, L; Ravon, E; Froger, J; Preisser, L; Danger, Y; Maillasson, M; Garrigue-Antar, L; Jacques, Y; Chevalier, S; Gascan, H				Venereau, Emilie; Diveu, Caroline; Grimaud, Linda; Ravon, Elisa; Froger, Josy; Preisser, Laurence; Danger, Yannic; Maillasson, Mike; Garrigue-Antar, Laure; Jacques, Yannick; Chevalier, Sylvie; Gascan, Hugues			Definition and Characterization of an Inhibitor for Interleukin-31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6 SIGNAL TRANSDUCER; ONCOSTATIN-M RECEPTOR; CYTOKINE RECEPTOR; ATOPIC-DERMATITIS; NC/NGA MICE; T-CELLS; SCRATCHING BEHAVIOR; SKIN INFLAMMATION; SHARED RECEPTOR; LIF RECEPTOR	Interleukin-31 (IL-31) is a recently described T cell-derived cytokine, mainly produced by T helper type 2 cells and related to the IL-6 cytokine family according to its structure and receptor. IL-31 is the ligand for a heterodimeric receptor composed of a gp130-like receptor (GPL) associated with the oncostatin M receptor (OSMR). A link between IL-31 and atopic dermatitis was shown by studying the phenotype of IL-31 transgenic mice and IL-31 gene haplotypes in patients suffering from dermatitis. In this study, we generated a potent IL-31 antagonist formed by external portions of OSMR and GPL fused with a linker. This fusion protein, OSMR-L-GPL, consisting of 720 amino acids, counteracted the binding of IL-31 to its membrane receptor complex and the subsequent signaling events involving the STATs and MAPK pathways. Neutralizing effects were found in IL-31-sensitive cell lines, including brain-derived cells and primary cultures of keratinocytes.	[Danger, Yannic; Chevalier, Sylvie] INSERM, Unite Mixte 564, F-49033 Angers 09, France; [Froger, Josy; Danger, Yannic] PADAM IBiSA, F-49033 Angers, France; [Preisser, Laurence; Chevalier, Sylvie] Univ Angers, Serv Commun Cytometrie & Analyse Nucleotid, F-49033 Angers, France; [Maillasson, Mike; Garrigue-Antar, Laure; Jacques, Yannick] INSERM, Unite Mixte 892, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gascan, H (corresponding author), INSERM, U564, 4 Rue Larrey, F-49933 Angers 09, France.	hugues.gascan@univ-angers.fr	preisser, laurence/K-7583-2015; Venereau, Emilie/AAN-4856-2020; maillasson, mike/K-9627-2015; Jacques, Yannick/K-9294-2015	Garrigue-Antar, Laure/0000-0001-6331-8882; Venereau, Emilie/0000-0002-6590-7434; Danger, Yannic/0000-0002-5611-5048	Association pour la Recherche contre le Cancer [5176]; Region Pays de la Loire	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Pays de la Loire(Region Pays de la Loire)	This work was supported by Grant 5176 from the Association pour la Recherche contre le Cancer and by the Ciblage Moleculaire et Applications Therapeutiques (CIMATH) Program of the Region Pays de la Loire.	Ancey C, 2003, J BIOL CHEM, V278, P16968, DOI 10.1074/jbc.C300081200; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Diveu C, 2006, J BIOL CHEM, V281, P36673, DOI 10.1074/jbc.M607005200; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heise R, 2009, J INVEST DERMATOL, V129, P240, DOI 10.1038/jid.2008.183; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HONDA M, 1992, J IMMUNOL, V148, P2175; Le Saux S, 2010, J BIOL CHEM, V285, P3470, DOI 10.1074/jbc.M109.049189; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; LIU JW, 1992, J BIOL CHEM, V267, P16763; Metz S, 2008, J BIOL CHEM, V283, P5985, DOI 10.1074/jbc.M706610200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Murakami M, 2004, GROWTH FACTORS, V22, P75, DOI 10.1080/08977190410001715181; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Olivier C, 2000, J BIOL CHEM, V275, P5648, DOI 10.1074/jbc.275.8.5648; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Renne C, 1998, J BIOL CHEM, V273, P27213, DOI 10.1074/jbc.273.42.27213; Schulz F, 2007, J ALLERGY CLIN IMMUN, V120, P1097, DOI 10.1016/j.jaci.2007.07.065; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; SPORENO E, 1994, J BIOL CHEM, V269, P10991; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takaoka A, 2005, EUR J PHARMACOL, V516, P180, DOI 10.1016/j.ejphar.2005.04.040; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; THOMA B, 1994, J BIOL CHEM, V269, P6215; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiesinger MY, 2009, CHEM BIOL, V16, P783, DOI 10.1016/j.chembiol.2009.06.010; Yamaoka K, 2009, INT ARCH ALLERGY IMM, V149, P73, DOI 10.1159/000211376; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	44	20	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14955	14963		10.1074/jbc.M109.049163	http://dx.doi.org/10.1074/jbc.M109.049163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335179	Green Published, hybrid			2022-12-25	WOS:000277399000016
J	Yuan, TC; Wang, YP; Zhao, ZZJ; Gu, HH				Yuan, Taichang; Wang, Yongping; Zhao, Zhizhuang J.; Gu, Haihua			Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATION; ACTIVATION; 1B; SHP-1; SRC; PHOSPHORYLATION; IDENTIFICATION; TRANSFORMATION; EXPRESSION; PTP-MEG2	ErbB family of the receptor protein-tyrosine kinase plays an important role in the progression of human cancers including breast cancer. Finding protein-tyrosine phosphatase (PTPs) that can specifically regulate the function of ErbB should help design novel therapies for treatment. By performing a small interfering RNA screen against 43 human PTPs, we find that knockdown of protein-tyrosine phosphatase PTPN9 significantly increases ErbB2 tyrosyl phosphorylation in the SKBR3 breast cancer cell line. In addition, knockdown of PTPN9 expression also enhances tyrosyl phosphorylation of the ErbB1/epidermal growth factor receptor (EGFR) in the MDA-MB-231 breast cancer cell line. Conversely, increasing expression of PTPN9 wild type (WT) inhibits tyrosyl phosphorylation of ErbB2 and EGFR. To test whether ErbB2 and EGFR are substrates of PTPN9, PTPN9 WT, and a substrate trapping mutant (PTPN9 DA) are overexpressed in SKBR3 and MDA-MB-231 cells. Compared with vector control, expression of PTPN9 WT significantly inhibits whereas expression of PTPN9 DA dramatically enhances tyrosyl phosphorylation of ErbB2 and EGFR, respectively. In contrast, expression of PTPN9 WT or DA mutant does not affect tyrosyl phosphorylation of ErbB3 and Shc. Importantly, coimmunoprecipitation and glutathione S-transferase fusion protein pulldown experiments show that tyrosol-phosphorylated ErbB2 or EGFR is preferentially associated with PTPN9 DA compared with PTPN9 WT, indicating that ErbB2 and EGFR are substrates of PTPN9. Furthermore, PTPN9 WT expression specifically impairs EGF-induced STAT3 and STAT5 activation, and inhibits the cell growth in soft agar. Last, PTPN9 WT expression also reduces invasion and MMP2 expression of MDA-MB-231 cells. Our data suggest PTPN9 as a negative regulator of breast cancer cells by targeting ErbB2 and EGFR and inhibiting STAT activation.	[Yuan, Taichang; Wang, Yongping; Gu, Haihua] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Aurora, CO 80045 USA; [Zhao, Zhizhuang J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gu, HH (corresponding author), Mail Stop 8104,POB 6511, Aurora, CO 80045 USA.	haihua.gu@ucdenver.edu	Gu, Haihua/G-6364-2011		National Institutes of Health [HL076309, HL079441]; Department of Pathology, University of Colorado Denver; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076309, R01HL079441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, University of Colorado Denver; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076309 and HL079441 ( to Z.J.Z) and the start-up fund from the Department of Pathology, University of Colorado Denver ( to H. G).	Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Baum O, 2007, INT J ONCOL, V30, P325; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Campos SM, 2008, CANCER INVEST, V26, P757, DOI 10.1080/07357900801971040; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Sartor CI, 1997, CANCER RES, V57, P978; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	31	63	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14861	14870		10.1074/jbc.M109.099879	http://dx.doi.org/10.1074/jbc.M109.099879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335174	hybrid, Green Published			2022-12-25	WOS:000277399000007
J	Zhou, FL; Zhang, WG; Wei, YC; Meng, S; Bai, GG; Wang, BY; Yang, HY; Tian, W; Meng, X; Zhang, H; Chen, SP				Zhou, Fu-Ling; Zhang, Wang-Gang; Wei, Yong-Chang; Meng, Shan; Bai, Gai-Gai; Wang, Bai-Yan; Yang, Hui-Yun; Tian, Wei; Meng, Xin; Zhang, Hui; Chen, She-Ping			Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PRODUCTS; INDOLEAMINE 2,3-DIOXYGENASE; IN-VITRO; URINARY 8-HYDROXY-2'-DEOXYGUANOSINE; THIOREDOXIN REDUCTASE; PERITONEAL-DIALYSIS; DEPRESSIVE PATIENTS; ANTIOXIDANT STATUS; GENE-EXPRESSION; DNA-DAMAGE	The aims of the present study were to determine the level of oxidative stress and the salient factors leading to the relapse of acute myeloid leukemia (AML). Oxidative stress-related parameters and the expressions of specific genes were monitored in 102 cases of AML during a pretreatment period from a primary status to a relapse status. In addition, age-matched healthy subjects were classified as controls. The activities of adenosine deaminase and xanthine oxidase were higher in the relapse condition, whereas those of glutathione peroxidase, monoamine oxidase, and superoxide dismutase, and the total antioxidant capacity (T-AOC) were lower in the primary condition and in controls. Of particular note, levels of advanced oxidation protein products, malondialdehyde, and 8-hydroxydeoxyguanosine were also significantly higher in relapse patients. Furthermore, real-time PCR with SYBR Green revealed that the expression levels of human thioredoxin (TRX) and indoleamine 2,3-dioxygenase were increased in relapse patients. Pearson correlation analysis revealed that the T-AOC was positively correlated with GSH but negatively correlated with 8-OHdG, TRX, and indoleamine 2,3-dioxygenase. Linear regression showed that a low T-AOC and up-regulated TRX expression were the independent factors correlated with relapse. A strong association between oxidative stress and the incidence of disease relapse was observed, which has potential prognosis implications. These results indicate that oxidative stress is a crucial feature of AML and probably affects the development and relapse of AML.	[Tian, Wei; Meng, Xin; Zhang, Hui; Chen, She-Ping] Xi An Jiao Tong Univ, Dept Clin Hematol, Affiliated Hosp 2, Xian 710004, Peoples R China; [Wei, Yong-Chang] Xi An Jiao Tong Univ, Dept Clin Oncol, Affiliated Hosp 1, Xian 710061, Peoples R China; [Wang, Bai-Yan] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Shanghai Jiao Tong University		zhoufuling@163.com		Zhou, Fuling/0000-0003-0982-0382; Wei, Yongchang/0000-0001-7205-4663	Shaanxi Natural Science Foundation of China [2007C<INF>2</INF>17]	Shaanxi Natural Science Foundation of China	This work was supported by Shaanxi Natural Science Foundation of China Grant 2007C<INF>2</INF>17.	Al-Gayyar MMH, 2007, J PHARM PHARMACOL, V59, P409, DOI 10.1211/jpp.59.3.0011; Austin C, 2009, LEUKEMIA RES, V33, P1297, DOI 10.1016/j.leukres.2009.04.038; Battisti V, 2008, CLIN BIOCHEM, V41, P511, DOI 10.1016/j.clinbiochem.2008.01.027; Boulanger E, 2006, PERITON DIALYSIS INT, V26, P207; Chamuleau MED, 2008, HAEMATOL-HEMATOL J, V93, P1894, DOI 10.3324/haematol.13113; Chandramathi S, 2009, J CANCER RES CLIN, V135, P319, DOI 10.1007/s00432-008-0462-7; Chang D, 2008, BIOMED ENVIRON SCI, V21, P286, DOI 10.1016/S0895-3988(08)60043-4; Corm S, 2009, LEUKEMIA RES, V33, P490, DOI 10.1016/j.leukres.2008.06.014; Dorantes-Acosta E, 2008, PEDIATR BLOOD CANCER, V51, P741, DOI 10.1002/pbc.21706; Erkeland SJ, 2009, LEUKEMIA RES, V33, P1367, DOI 10.1016/j.leukres.2009.02.027; Furuya R, 2009, NEPHRON CLIN PRACT, V112, pC255, DOI 10.1159/000224792; He Yu-Lei, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P88; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Honda M, 2000, LEUKEMIA RES, V24, P461, DOI 10.1016/S0145-2126(00)00006-0; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hwang ES, 2007, TOXICOLOGY, V229, P1, DOI 10.1016/j.tox.2006.10.013; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Koharyova M, 2008, GEN PHYSIOL BIOPHYS, V27, P71; Koptyra M, 2008, LEUKEMIA, V22, P1969, DOI 10.1038/leu.2008.78; Kosova F, 2007, ANN SURG ONCOL, V14, P2616, DOI 10.1245/s10434-007-9425-5; Li RM, 2009, CANCER BIOL THER, V8, P1402, DOI 10.4161/cbt.8.14.8882; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Marbello L, 2008, LEUKEMIA RES, V32, P1221, DOI 10.1016/j.leukres.2008.01.004; Marsche G, 2009, CIRC RES, V104, P750, DOI 10.1161/CIRCRESAHA.108.193169; Mazor D, 2008, PEDIATR BLOOD CANCER, V51, P613, DOI 10.1002/pbc.21665; Montesinos JJ, 2006, LEUKEMIA LYMPHOMA, V47, P1379, DOI 10.1080/10428190500465424; Nigro P, 2008, FREE RADICAL BIO MED, V45, P875, DOI 10.1016/j.freeradbiomed.2008.06.015; Noyan T, 2009, YONSEI MED J, V50, P677, DOI 10.3349/ymj.2009.50.5.677; Oh YK, 2004, BIOCHEM BIOPH RES CO, V319, P41, DOI 10.1016/j.bbrc.2004.04.145; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Pennington JD, 2005, DRUG RESIST UPDATE, V8, P322, DOI 10.1016/j.drup.2005.09.002; Rao AK, 2009, J MOL ENDOCRINOL, V43, P251, DOI 10.1677/JME-09-0053; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Selmeci L, 2008, ACTA PHYSIOL HUNG, V95, P209, DOI 10.1556/APhysiol.95.2008.2.5; Selmeci L, 2005, CLIN CHEM LAB MED, V43, P294, DOI 10.1515/CCLM.2005.050; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; Smits ELJM, 2009, ONCOLOGIST, V14, P240, DOI 10.1634/theoncologist.2008-0165; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Voso MT, 2008, LEUKEMIA, V22, P1685, DOI 10.1038/leu.2008.169; Wei YC, 2009, INT J NEUROPSYCHOPH, V12, P1089, DOI 10.1017/S1461145709000091; WITKO V, 1992, J CLIN LAB ANAL, V6, P47, DOI 10.1002/jcla.1860060110; Yang Y, 2009, ENVIRON TOXICOL, V24, P446, DOI 10.1002/tox.20447; Zamanakou M, 2007, IMMUNOL LETT, V111, P69, DOI 10.1016/j.imlet.2007.06.001; Zhou FL, 2007, LEUKEMIA RES, V31, P387, DOI 10.1016/j.leukres.2006.07.014	48	81	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15010	15015		10.1074/jbc.M110.103713	http://dx.doi.org/10.1074/jbc.M110.103713			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20233720	hybrid, Green Published			2022-12-25	WOS:000277399000022
J	Cox, LE; Ferraiuolo, L; Goodall, EF; Heath, PR; Higginbottom, A; Mortiboys, H; Hollinger, HC; Hartley, JA; Brockington, A; Burness, CE; Morrison, KE; Wharton, SB; Grierson, AJ; Ince, PG; Kirby, J; Shaw, PJ				Cox, Laura E.; Ferraiuolo, Laura; Goodall, Emily F.; Heath, Paul R.; Higginbottom, Adrian; Mortiboys, Heather; Hollinger, Hannah C.; Hartley, Judith A.; Brockington, Alice; Burness, Christine E.; Morrison, Karen E.; Wharton, Stephen B.; Grierson, Andrew J.; Ince, Paul G.; Kirby, Janine; Shaw, Pamela J.			Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; COMMON-CAUSE; ESCRT-III; CELLULAR PATHWAYS; MUSCULAR-ATROPHY; MOUSE MODEL; PROTEIN; AUTOPHAGY; COMPLEX; PHOSPHORYLATION	Background: Amyotrophic lateral sclerosis (ALS), a common late-onset neurodegenerative disease, is associated with fronto-temporal dementia (FTD) in 3-10% of patients. A mutation in CHMP2B was recently identified in a Danish pedigree with autosomal dominant FTD. Subsequently, two unrelated patients with familial ALS, one of whom also showed features of FTD, were shown to carry missense mutations in CHMP2B. The initial aim of this study was to determine whether mutations in CHMP2B contribute more broadly to ALS pathogenesis. Methodology/Principal Findings: Sequencing of CHMP2B in 433 ALS cases from the North of England identified 4 cases carrying 3 missense mutations, including one novel mutation, p. Thr104Asn, none of which were present in 500 neurologically normal controls. Analysis of clinical and neuropathological data of these 4 cases showed a phenotype consistent with the lower motor neuron predominant (progressive muscular atrophy (PMA)) variant of ALS. Only one had a recognised family history of ALS and none had clinically apparent dementia. Microarray analysis of motor neurons from CHMP2B cases, compared to controls, showed a distinct gene expression signature with significant differential expression predicting disassembly of cell structure; increased calcium concentration in the ER lumen; decrease in the availability of ATP; down-regulation of the classical and p38 MAPK signalling pathways, reduction in autophagy initiation and a global repression of translation. Transfection of mutant CHMP2B into HEK-293 and COS-7 cells resulted in the formation of large cytoplasmic vacuoles, aberrant lysosomal localisation demonstrated by CD63 staining and impairment of autophagy indicated by increased levels of LC3-II protein. These changes were absent in control cells transfected with wild-type CHMP2B. Conclusions/Significance: We conclude that in a population drawn from North of England pathogenic CHMP2B mutations are found in approximately 1% of cases of ALS and 10% of those with lower motor neuron predominant ALS. We provide a body of evidence indicating the likely pathogenicity of the reported gene alterations. However, absolute confirmation of pathogenicity requires further evidence, including documentation of familial transmission in ALS pedigrees which might be most fruitfully explored in cases with a LMN predominant phenotype.	[Cox, Laura E.; Ferraiuolo, Laura; Goodall, Emily F.; Heath, Paul R.; Higginbottom, Adrian; Mortiboys, Heather; Hollinger, Hannah C.; Hartley, Judith A.; Brockington, Alice; Burness, Christine E.; Wharton, Stephen B.; Grierson, Andrew J.; Ince, Paul G.; Kirby, Janine; Shaw, Pamela J.] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Morrison, Karen E.] Univ Birmingham, Dept Neurol, Birmingham, East Midlands, England	University of Sheffield; University of Birmingham	Cox, LE (corresponding author), Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England.	pamela.shaw@sheffield.ac.uk	Shaw, Pamela/E-6193-2010; Mortiboys, Heather/E-8838-2010; Ferraiuolo, Laura/E-5834-2010; Heath, Paul/B-4778-2009; Shaw, Pamela J/A-7620-2010; Brockington, Alice R/B-5122-2009; Grierson, Andy/A-5067-2009; Goodall, Emily F/B-4781-2009; Ince, Paul G/A-5064-2009; Kirby, Janine/B-3980-2009	Mortiboys, Heather/0000-0001-6439-0579; Ferraiuolo, Laura/0000-0001-9118-5714; Grierson, Andy/0000-0001-7039-6731; Ince, Paul G/0000-0001-6677-8753; Kirby, Janine/0000-0002-7468-5917; Hollinger, Hannah/0000-0002-8557-7727; Shaw, Pamela/0000-0002-8925-2567; Goodall, Emily/0000-0002-1002-6541; Morrison, Karen Elaine/0000-0003-0216-5717; Wharton, Stephen B/0000-0003-2785-333X	Wellcome Trust [069388/Z/02/Z]; MRC [G0900652, G0400074, G0502157] Funding Source: UKRI; Medical Research Council [G0502157, G0400074, G0900652] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (grant number 069388/Z/02/Z) (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Blair IP, 2008, J NEUROL NEUROSUR PS, V79, P849, DOI 10.1136/jnnp.2007.140541; Borthwick Gillian M, 2006, Ann Neurol, V59, P570, DOI 10.1002/ana.20758; Brockington A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-23; Cannon A, 2006, NEUROSCI LETT, V398, P83, DOI 10.1016/j.neulet.2005.12.056; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gijselinck I, 2009, NEUROBIOL AGING, V30, P1329, DOI 10.1016/j.neurobiolaging.2007.11.002; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Guerreiro RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002450; GUERREIRO RJ, 2009, HUM MUTAT; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Jackson M, 1997, ANN NEUROL, V42, P803, DOI 10.1002/ana.410420518; JONES CT, 1994, MOL CELL PROBE, V8, P329, DOI 10.1006/mcpr.1994.1046; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SHAW PJ, 1991, J NEUROL NEUROSUR PS, V54, P993, DOI 10.1136/jnnp.54.11.993; SIDDIQUE N, 2008, PHYS MED REH CLIN N, V19, pR7; Siddique N, 2008, PHYS MED REH CLIN N, V19, P429, DOI 10.1016/j.pmr.2008.05.001; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; VANES MA, 2009, J NEUROL NEUROSURG P; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663	68	176	182	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9872	10.1371/journal.pone.0009872	http://dx.doi.org/10.1371/journal.pone.0009872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352044	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000275894500025
J	Menalled, LB; Patry, M; Ragland, N; Lowden, PAS; Goodman, J; Minnich, J; Zahasky, B; Park, L; Leeds, J; Howland, D; Signer, E; Tobin, AJ; Brunner, D				Menalled, Liliana B.; Patry, Monica; Ragland, Natalie; Lowden, Phillip A. S.; Goodman, Jennifer; Minnich, Jennie; Zahasky, Benjamin; Park, Larry; Leeds, Janet; Howland, David; Signer, Ethan; Tobin, Allan J.; Brunner, Daniela			Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline	PLOS ONE			English	Article							COENZYME Q(10); COMBINATION THERAPY; MOTOR DEFICITS; INDUCED LUPUS; TETRACYCLINE; PARKINSONS; MICE; NEUROPROTECTION; MITOCHONDRIAL; TRANSLATION	Previous studies of the effects of coenzyme Q10 and minocycline on mouse models of Huntington's disease have produced conflicting results regarding their efficacy in behavioral tests. Using our recently published best practices for husbandry and testing for mouse models of Huntington's disease, we report that neither coenzyme Q10 nor minocycline had significant beneficial effects on measures of motor function, general health (open field, rotarod, grip strength, rearing-climbing, body weight and survival) in the R6/2 mouse model. The higher doses of minocycline, on the contrary, reduced survival. We were thus unable to confirm the previously reported benefits for these two drugs, and we discuss potential reasons for these discrepancies, such as the effects of husbandry and nutrition.	[Menalled, Liliana B.; Patry, Monica; Ragland, Natalie; Goodman, Jennifer; Minnich, Jennie; Zahasky, Benjamin; Brunner, Daniela] PsychoGenics Inc, Tarrytown, NY USA; [Lowden, Phillip A. S.] Birkbeck Coll, Sch Biomed & Chem Sci, London, England; [Park, Larry; Leeds, Janet] CHDI Management CHDI Fdn, Los Angeles, CA USA; [Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA; [Signer, Ethan; Tobin, Allan J.] CHDI Management CHDI Fdn, New York, NY USA; [Brunner, Daniela] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA	University of London; Birkbeck University London; Columbia University; New York State Psychiatry Institute	Menalled, LB (corresponding author), PsychoGenics Inc, Tarrytown, NY USA.	liliana.menalled@psychogenics.com	Longo, Kenneth A/A-5631-2010		CHDI Foundation; Psychogenics	CHDI Foundation; Psychogenics	The study was founded by the CHDI Foundation. Members of that organization are co-authors of this work. They have contributed to the conception of the study as well as the design, provided the mouse line, the data interpretation, decision to publish and the writing of the manuscript. The authors employed by Psychogenics Inc. received salaried funding by Psychogenics. Daniela Brunner in addition was a consultant for CHDI. The authors employed by Psychogenics Inc. contributed to the manuscript by conceiving and designing the experiments, performing the experiments, analyzing the data, contributing reagents/materials/analysis tools, and writing the paper.	Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; Attur MG, 1999, J IMMUNOL, V162, P3160; Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Bantubungi K, 2005, NEUROBIOL DIS, V18, P206, DOI 10.1016/j.nbd.2004.09.017; Beal F, 2004, METHOD ENZYMOL, V382, P473; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Bonelli RM, 2007, EXPERT OPIN PHARMACO, V8, P141, DOI 10.1517/14656566.8.2.141; Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P337, DOI 10.1097/00004850-200411000-00004; Bonelli RM, 2003, NEUROLOGY, V60, P883, DOI 10.1212/01.WNL.0000049936.85487.7A; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; DONNET A, 1992, BIOMED PHARMACOTHER, V46, P171, DOI 10.1016/0753-3322(92)90026-4; DRAGATSIS I, 2009, NEUROBIOLOGY DIS; Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Good ML, 2003, BRIT J DERMATOL, V149, P237, DOI 10.1046/j.1365-2133.2003.05497.x; GORDON P, 2004, PLACEBOCONTROLLED PH, P1845; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Goulden V, 1996, BRIT J DERMATOL, V134, P693, DOI 10.1111/j.1365-2133.1996.tb06972.x; GUERIN C, 1992, BIOCHEM BIOPH RES CO, V188, P740, DOI 10.1016/0006-291X(92)91118-A; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Hersch Steven M, 2004, NeuroRx, V1, P298, DOI 10.1007/BF03206614; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Ibrahim WH, 2000, J NUTR, V130, P2343, DOI 10.1093/jn/130.9.2343; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Ioannidis JPA, 2007, EUR J CLIN INVEST, V37, P340, DOI 10.1111/j.1365-2362.2007.01794.x; Kamzalov S, 2003, J NUTR, V133, P3175, DOI 10.1093/jn/133.10.3175; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lawrenson RA, 2000, DRUG SAFETY, V23, P333, DOI 10.2165/00002018-200023040-00006; Lawson TM, 2001, RHEUMATOLOGY, V40, P329, DOI 10.1093/rheumatology/40.3.329; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Lin SZ, 2003, LIFE SCI, V72, P1635, DOI 10.1016/S0024-3205(02)02442-6; Lonnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; MENALLED L, 2009, NEUROBIOL DIS; Mievis S, 2007, NEUROMOL MED, V9, P47, DOI 10.1385/NMM:9:1:47; MORALES LM, 1989, AM J CLIN NUTR, V50, P145, DOI 10.1093/ajcn/50.1.145; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PALLIER P, 2008, BRAIN RES B; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Schlienger RG, 2000, DERMATOLOGY, V200, P223, DOI 10.1159/000018387; Seaman HE, 2001, J CLIN PHARMACOL, V41, P852, DOI 10.1177/00912700122010753; Settgast AM, 2003, INT J DERMATOL, V42, P316, DOI 10.1046/j.1365-4362.2003.01778.x; Shapiro LE, 1997, ARCH DERMATOL, V133, P1224, DOI 10.1001/archderm.133.10.1224; Shults CW, 2004, EXP NEUROL, V188, P491, DOI 10.1016/j.expneurol.2004.05.003; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Teitelbaum JE, 1998, ARCH PEDIAT ADOL MED, V152, P1132; Thomas M, 2004, MOVEMENT DISORD, V19, P692, DOI 10.1002/mds.20018; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; WAGNER LA, 2008, ANIMAL TRANSLATIONAL; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	77	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9793	10.1371/journal.pone.0009793	http://dx.doi.org/10.1371/journal.pone.0009793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339553	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000275894300019
J	Bradley, LH; Fuqua, J; Richardson, A; Turchan-Cholewo, J; Ai, Y; Kelps, KA; Glass, JD; He, XQ; Zhang, ZM; Grondin, R; Littrell, OM; Huettl, P; Pomerleau, F; Gash, DM; Gerhardt, GA				Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; Glass, John D.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.			Dopamine Neuron Stimulating Actions of a GDNF Propeptide	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; IN-VIVO; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FUNCTIONAL RECOVERY; SUBSTANTIA-NIGRA; FACTOR PRECURSOR; RAT STRIATUM; CELL-DEATH	Background: Neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have shown great promise for protection and restoration of damaged or dying dopamine neurons in animal models and in some Parkinson's disease (PD) clinical trials. However, the delivery of neurotrophic factors to the brain is difficult due to their large size and poor bio-distribution. In addition, developing more efficacious trophic factors is hampered by the difficulty of synthesis and structural modification. Small molecules with neurotrophic actions that are easy to synthesize and modify to improve bioavailability are needed. Methods and Findings: Here we present the neurobiological actions of dopamine neuron stimulating peptide-11 (DNSP-11), an 11-mer peptide from the proGDNF domain. In vitro, DNSP-11 supports the survival of fetal mesencephalic neurons, increasing both the number of surviving cells and neuritic outgrowth. In MN9D cells, DNSP-11 protects against dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA)-induced cell death, significantly decreasing TUNEL-positive cells and levels of caspase-3 activity. In vivo, a single injection of DNSP-11 into the normal adult rat substantia nigra is taken up rapidly into neurons and increases resting levels of dopamine and its metabolites for up to 28 days. Of particular note, DNSP-11 significantly improves apomorphine-induced rotational behavior, and increases dopamine and dopamine metabolite tissue levels in the substantia nigra in a rat model of PD. Unlike GDNF, DNSP-11 was found to block staurosporine- and gramicidin-induced cytotoxicity in nutrient-deprived dopaminergic B65 cells, and its neuroprotective effects included preventing the release of cytochrome c from mitochondria. Conclusions: Collectively, these data support that DNSP-11 exhibits potent neurotrophic actions analogous to GDNF, making it a viable candidate for a PD therapeutic. However, it likely signals through pathways that do not directly involve the GFR alpha 1 receptor.	[Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.; Fuqua, Josh; Richardson, April; Turchan-Cholewo, Jadwiga; Ai, Yi; Kelps, Kristen A.; He, Xiuquan; Zhang, Zhiming; Grondin, Richard; Littrell, O. Meagan; Huettl, Peter; Pomerleau, Francois; Gash, Don M.; Gerhardt, Greg A.] Univ Kentucky, Morris K Udall Parkinsons Dis Res Ctr Excellence, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Bradley, Luke H.] Univ Kentucky, Struct Biol Ctr, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Bradley, LH (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.	lhbradley@uky.edu		Bradley, Luke/0000-0003-1870-0796	NIDA [T32 DA022738]; NIA [T32 AG000242, AG013494]; University of Kentucky College of Medicine; NIH [P20RR20171]; PhRMA Foundation; NINDS [NS039787]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000242, P01AG013494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Kentucky College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support was provided by training research fellowships from NIDA (T32 DA022738, J.F. & K. A. K.) and NIA (T32 AG000242, J.T.-C.). This work was also supported by University of Kentucky College of Medicine Start-up Funds (L. H. B.), NIH COBRE Pilot (P20RR20171, L. H. B.), PhRMA Foundation (L. H. B.), NINDS (NS039787, G. A. G., D. M. G., L. H. B., F. P., P. H., J.F., Y.A., Z.Z., R. G.) and NIA (AG013494, D. M. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; CARLILE GW, MOL PHARM, V57, P2; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dicou E, 1997, J CELL BIOL, V136, P389, DOI 10.1083/jcb.136.2.389; Dicou E, 2006, BIOCHEM BIOPH RES CO, V347, P833, DOI 10.1016/j.bbrc.2006.06.171; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Goldstein NES, 2005, ASSESSMENT, V12, P462, DOI 10.1177/1073191105283065; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; HALL ME, 1989, LC GC-MAG SEP SCI, V7, P258; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hebert MA, 1997, J PHARMACOL EXP THER, V282, P760; Hebert MA, 1996, J PHARMACOL EXP THER, V279, P1181; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hoffman AF, 1997, EXP NEUROL, V147, P130, DOI 10.1006/exnr.1997.6571; Hornykiewicz O, 1987, Adv Neurol, V45, P19; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Ibanez CF, 1998, TRENDS NEUROSCI, V21, P438, DOI 10.1016/S0166-2236(98)01266-1; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Immonen T, 2008, EXP NEUROL, V210, P793, DOI 10.1016/j.expneurol.2007.12.018; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2009, EXP NEUROL, V219, P197, DOI 10.1016/j.expneurol.2009.05.013; Schapira AHV, 1998, ANN NEUROL, V44, pS89, DOI 10.1002/ana.410440714; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Winkler C, 1996, J NEUROSCI, V16, P7206; York B, 2005, FASEB J, V19, P1202, DOI 10.1096/fj.04-3142fje; Yu LY, 2008, J NEUROSCI, V28, P7467, DOI 10.1523/JNEUROSCI.1877-08.2008; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083	52	25	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9752	10.1371/journal.pone.0009752	http://dx.doi.org/10.1371/journal.pone.0009752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305789	Green Published, gold, Green Submitted			2022-12-25	WOS:000276456300006
J	Zhou, JN; Zhao, L; Qin, LP; Wang, J; Jia, YL; Yao, HL; Sang, C; Hu, QH; Shi, SS; Nan, X; Yue, W; Zhuang, FY; Yang, C; Wang, YF; Pei, XT				Zhou, Junnian; Zhao, Lei; Qin, Lipeng; Wang, Jing; Jia, Yali; Yao, Hailei; Sang, Chen; Hu, Qinghua; Shi, Shuangshuang; Nan, Xue; Yue, Wen; Zhuang, Fengyuan; Yang, Chun; Wang, Yunfang; Pei, Xuetao			Epimorphin Regulates Bile Duct Formation via Effects on Mitosis Orientation in Rat Liver Epithelial Stem-Like Cells	PLOS ONE			English	Article							MORPHOGENIC PROTEIN; SPINDLE ORIENTATION; DIFFERENTIATION; INTEGRINS; GROWTH; EXPRESSION; SUBSTRATUM; ADHESION; SHAPE	Understanding how hepatic precursor cells can generate differentiated bile ducts is crucial for studies on epithelial morphogenesis and for development of cell therapies for hepatobiliary diseases. Epimorphin (EPM) is a key morphogen for duct morphogenesis in various epithelial organs. The role of EPM in bile duct formation (DF) from hepatic precursor cells, however, is not known. To address this issue, we used WB-F344 rat epithelial stem-like cells as model for bile duct formation. A micropattern and a uniaxial static stretch device was used to investigate the effects of EPM and stress fiber bundles on the mitosis orientation (MO) of WB cells. Immunohistochemistry of liver tissue sections demonstrated high EPM expression around bile ducts in vivo. In vitro, recombinant EPM selectively induced DF through upregulation of CK19 expression and suppression of HNF3 alpha and HNF6, with no effects on other hepatocytic genes investigated. Our data provide evidence that EPM guides MO of WB-F344 cells via effects on stress fiber bundles and focal adhesion assembly, as supported by blockade EPM, beta 1 integrin, and F-actin assembly. These blockers can also inhibit EPM-induced DF. These results demonstrate a new biophysical action of EPM in bile duct formation, during which determination of MO plays a crucial role.	[Zhou, Junnian; Qin, Lipeng; Jia, Yali; Yao, Hailei; Shi, Shuangshuang; Nan, Xue; Yue, Wen; Wang, Yunfang; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Zhao, Lei; Wang, Jing; Sang, Chen; Hu, Qinghua; Zhuang, Fengyuan; Yang, Chun] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China	Beihang University	Zhou, JN (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China.	yangchun@tsinghua.edu.cn; wangyf1972@gmail.com; peixt@nic.bmi.ac.cn	Jia, Yali/AAH-1668-2022; Jia, Yali/AFL-9551-2022; Zhou, Junnian/CAI-2072-2022; Yang, Chun/A-7467-2008	Zhou, Junnian/0000-0002-7782-234X; Jia, Yali/0000-0002-2896-6021; Yang, Chun/0000-0003-1191-7642	National High Technology Research and Development Program of China [2006AA02A107]; Major State Basic Research Program of China [2005CB522702]; National Nature Science Foundation of China [30671098, 30870602]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (No: 2006AA02A107), the Major State Basic Research Program of China (No: 2005CB522702), and the National Nature Science Foundation of China (No: 30671098 No: 30870602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Chapman L, 1999, FASEB J, V13, pA160; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLARK P, 1993, J CELL SCI, V105, P203; Coffinier C, 2002, DEVELOPMENT, V129, P1829; COLEMAN WB, 1993, AM J PATHOL, V142, P1373; COLEMAN WB, 1998, LIVER GROWTH REPAIR, P50; Couchie D, 2002, DIFFERENTIATION, V69, P209, DOI 10.1046/j.1432-0436.2002.690414.x; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Fan JH, 2009, J CELL PHYSIOL, V220, P72, DOI 10.1002/jcp.21731; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; GERMAIN L, 1988, CANCER RES, V48, P368; GRISHAM JW, 1993, P SOC EXP BIOL MED, V204, P270; HAMMARBACK JA, 1986, DEV BIOL, V117, P655, DOI 10.1016/0012-1606(86)90334-9; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; HIRAI Y, 1994, EUR J BIOCHEM, V225, P1133, DOI 10.1111/j.1432-1033.1994.1133b.x; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Oka Y, 1996, EXP CELL RES, V222, P189, DOI 10.1006/excr.1996.0024; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Simian M, 2001, DEVELOPMENT, V128, P3117; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yanai M, 2008, DEV DYNAM, V237, P1268, DOI 10.1002/dvdy.21520; Yao HL, 2009, DIFFERENTIATION, V77, P154, DOI 10.1016/j.diff.2008.09.017; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zhang LY, 1998, HISTOCHEM J, V30, P903, DOI 10.1023/A:1003485503117	55	14	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9732	10.1371/journal.pone.0009732	http://dx.doi.org/10.1371/journal.pone.0009732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305811	Green Submitted, Green Published, gold			2022-12-25	WOS:000275809600005
J	Sharma, D; Bhattacharya, J				Sharma, Deepak; Bhattacharya, Jayanta			Evolutionary Constraints Acting on DDX3X Protein Potentially Interferes with Rev-Mediated Nuclear Export of HIV-1 RNA	PLOS ONE			English	Article							SEQUENCE; HELICASE; FAMILY; SITES	Differential host-pathogen interactions direct viral replication in infected cells. In HIV-1 infected cells, nuclear export of viral RNA transcripts into cellular cytoplasm is governed by interaction of HIV-1 Rev, Exportin-1 (CRM-1) and DDX3X. Knock down of DDX3X has been shown to drastically impair HIV replication. Here we show that evolutionary forces are responsible for demarking previously unidentified critical functionally important residues on the surface of DDX3X. Using computational approaches, we show that these functional residues, depending on their location, are capable of regulating ATPase and RNA helicase functions of DDX3X. The potential of these residues in designing better blockers against HIV-1 replication was also assessed. Also, using stepwise docking simulations, we could identify DDX3X-CRM-1 interface and its critical functional residues. Our data would help explain the role of DDX3X in HIV-1 Rev function with potential to design new intervention strategies against HIV-1 replication.	[Sharma, Deepak; Bhattacharya, Jayanta] Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Sharma, D (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India.	jbhattacharya@nariindia.org	Sharma, Deepak/GPT-1692-2022	Sharma, Deepak/0000-0001-8436-1759				Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHM H, 2003, CRYST STRC SYMM, V31, P1069; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Harris ME, 2000, ESSAYS BIOCHEM, V36, P115, DOI 10.1042/bse0360115; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JOY S, 2006, SILICO BIOL, V6, P48; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON MA, ARGUSLAB 4 0 1 ARGUS; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9613	10.1371/journal.pone.0009613	http://dx.doi.org/10.1371/journal.pone.0009613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300618	gold, Green Published, Green Submitted			2022-12-25	WOS:000275621000002
J	Snyder, CM; Allan, JE; Bonnett, EL; Doom, CM; Hill, AB				Snyder, Christopher M.; Allan, Jane E.; Bonnett, Elizabeth L.; Doom, Carmen M.; Hill, Ann B.			Cross-Presentation of a Spread-Defective MCMV Is Sufficient to Prime the Majority of Virus-Specific CD8+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS-INFECTION; UL115 GENE-PRODUCT; MAMMALIAN-CELLS; RESPONSES; ANTIGEN; EXPRESSION; PROTECTION; DISTINCT; GENOME	CD8+ T cells can be primed by peptides derived from endogenous proteins (direct presentation), or exogenously acquired protein (cross-presentation). However, the relative ability of these two pathways to prime CD8+ T cells during a viral infection remains controversial. Cytomegaloviruses (CMVs) can infect professional antigen presenting cells (APCs), including dendritic cells, thus providing peptides for direct presentation. However, the viral immune evasion genes profoundly impair recognition of infected cells by CD8+ T cells. Nevertheless, CMV infection elicits a very strong CD8+ T cell response, prompting its recent use as a vaccine vector. We have shown previously that deleting the immune evasion genes from murine cytomegalovirus (MCMV) that target class I MHC presentation, has no impact on the size or breadth of the CD8+ T cell response elicited by infection, suggesting that the majority of MCMV-specific CD8+ T cells in vivo are not directly primed by infected professional APCs. Here we use a novel spread-defective mutant of MCMV, lacking the essential glycoprotein gL, to show that cross-presentation alone can account for the majority of MCMV-specific CD8+ T cell responses to the virus. Our data support the conclusion that cross-presentation is the primary mode of antigen presentation by which CD8+ T cells are primed during MCMV infection.	[Snyder, Christopher M.; Bonnett, Elizabeth L.; Doom, Carmen M.; Hill, Ann B.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Allan, Jane E.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia	Oregon Health & Science University; University of Western Australia	Snyder, CM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	hillan@ohsu.edu	Allan, Jane E/D-3101-2013	Allan, Jane E/0000-0003-2572-9773; Snyder, Christopher/0000-0003-1370-7198	National Institutes of Health (NIH) [RO1 A I47206]; American Heart Association; National Health and Medical Research Council of Australia [9934711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047206] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) RO1 A I47206 and an American Heart Association GIA awarded to A. B. H., a National Health and Medical Research Council of Australia Grant 9934711 to J.E.A., and a post-doctoral training grant from the American Heart Association (# 0725786Z) awarded to C. M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Goodrum F, 2004, BLOOD, V104, P687, DOI 10.1182/blood-2003-12-4344; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; JORDAN MC, 1983, INFECT IMMUN, V41, P841, DOI 10.1128/IAI.41.2.841-843.1983; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; Loewendorf A, 2004, J VIROL, V78, P13062, DOI 10.1128/JVI.78.23.13062-13071.2004; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smith LM, 2008, J VIROL, V82, P6689, DOI 10.1128/JVI.00160-08; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; SPAETE RR, 1993, VIROLOGY, V193, P853, DOI 10.1006/viro.1993.1194; Streblow DN, 2007, J VIROL, V81, P3816, DOI 10.1128/JVI.02425-06; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	34	58	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9681	10.1371/journal.pone.0009681	http://dx.doi.org/10.1371/journal.pone.0009681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300633	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900014
J	Vaiyapuri, S; Harrison, RA; Bicknell, AB; Gibbins, JM; Hutchinson, G				Vaiyapuri, Sakthivel; Harrison, Robert A.; Bicknell, Andrew B.; Gibbins, Jonathan M.; Hutchinson, Gail			Purification and Functional Characterisation of Rhinocerase, a Novel Serine Protease from the Venom of Bitis gabonica rhinoceros	PLOS ONE			English	Article							THROMBIN-LIKE ENZYME; SNAKE-VENOM; PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; COAGULANT ENZYME; PROTEINASES; SEQUENCE; SPECIFICITY; FIBRINOGEN	Background: Serine proteases are a major component of viper venoms and are thought to disrupt several distinct elements of the blood coagulation system of envenomed victims. A detailed understanding of the functions of these enzymes is important both for acquiring a fuller understanding of the pathology of envenoming and because these venom proteins have shown potential in treating blood coagulation disorders. Methodology/Principal Findings: In this study a novel, highly abundant serine protease, which we have named rhinocerase, has been isolated and characterised from the venom of Bitis gabonica rhinoceros using liquid phase isoelectric focusing and gel filtration. Like many viper venom serine proteases, this enzyme is glycosylated; the estimated molecular mass of the native enzyme is approximately 36kDa, which reduces to 31kDa after deglycosylation. The partial amino acid sequence shows similarity to other viper venom serine proteases, but is clearly distinct from the sequence of the only other sequenced serine protease from Bitis gabonica. Other viper venom serine proteases have been shown to exert distinct biological effects, and our preliminary functional characterization of rhinocerase suggest it to be multifunctional. It is capable of degrading alpha and beta chains of fibrinogen, dissolving plasma clots and of hydrolysing a kallikrein substrate. Conclusions/Significance: A novel multifunctional viper venom serine protease has been isolated and characterised. The activities of the enzyme are consistent with the known in vivo effects of Bitis gabonica envenoming, including bleeding disorders, clotting disorders and hypotension. This study will form the basis for future research to understand the mechanisms of serine protease action, and examine the potential for rhinocerase to be used clinically to reduce the risk of human haemostatic disorders such as heart attacks and strokes.	[Vaiyapuri, Sakthivel; Bicknell, Andrew B.; Gibbins, Jonathan M.; Hutchinson, Gail] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Harrison, Robert A.] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England; [Gibbins, Jonathan M.] King Saud Univ, Blood Transfus Res Grp, Riyadh, Saudi Arabia	University of Reading; Liverpool School of Tropical Medicine; University of Liverpool; King Saud University	Vaiyapuri, S (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	e.g.hutchinson@reading.ac.uk	Vaiyapuri, Sakthivel/M-4198-2013	Gibbins, Jonathan/0000-0002-0372-5352; Vaiyapuri, Sakthivel/0000-0002-6006-6517	Felix Trust, London; British Heart Foundation [PG/08/100/26125] Funding Source: researchfish	Felix Trust, London; British Heart Foundation(British Heart Foundation)	This research was funded by the Felix Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY GS, 1976, BIOCHEM J, V153, P409, DOI 10.1042/bj1530409; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714; Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gao R, 1998, TOXICON, V36, P457, DOI 10.1016/S0041-0101(97)00150-5; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; HATTON MWC, 1973, BIOCHEM J, V131, P799, DOI 10.1042/bj1310799; Hubbard GP, 2003, J THROMB HAEMOST, V1, P1079, DOI 10.1046/j.1538-7836.2003.00212.x; ITOH N, 1987, J BIOL CHEM, V262, P3132; Komori Y, 2002, J NAT TOXINS, V11, P205; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; MARKLAND FS, 1982, P NATL ACAD SCI-BIOL, V79, P1688, DOI 10.1073/pnas.79.6.1688; MARSH NA, 1974, BRIT J HAEMATOL, V26, P295, DOI 10.1111/j.1365-2141.1974.tb00474.x; MEIER J, 1991, CRIT REV TOXICOL, V21, P171, DOI 10.3109/10408449109089878; Muanpasitporn C, 2007, TOXICON, V49, P1083, DOI 10.1016/j.toxicon.2007.01.015; Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PIRKLE H, 1986, J BIOL CHEM, V261, P8830; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; VILJOEN CC, 1979, TOXICON, V17, P145, DOI 10.1016/0041-0101(79)90293-9; Wagstaff SC, 2006, PLOS MED, V3, P832, DOI 10.1371/journal.pmed.0030184; Zhang SJ, 2001, J NAT TOXINS, V10, P221; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246; Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200	29	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9687	10.1371/journal.pone.0009687	http://dx.doi.org/10.1371/journal.pone.0009687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300193	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000275620900018
J	Yamashita, A; Nishikawa, S; Rancourt, DE				Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.			Microenvironment Modulates Osteogenic Cell Lineage Commitment in Differentiated Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO; ES CELLS; OSTEOBLASTS; MARROW; MASS	Background: Due to their self-renewal, embryonic stem cells (ESCs) are attractive cells for applications in regenerative medicine and tissue engineering. Although ESC differentiation has been used as a platform for generating bone in vitro and in vivo, the results have been unsatisfactory at best. It is possible that the traditional culture methods, which have been used, are not optimal and that other approaches must be explored. Methodology/Principal Findings: ESCs were differentiated into osteoblast lineage using a micro-mass approach. In response to osteogenic differentiation medium, many cells underwent apoptosis, while others left the micro-mass, forming small aggregates in suspension. These aggregates were cultured in three different culture conditions (adhesion, static suspension, and stirred suspension), then examined for osteogenic potential in vitro and in vivo. In adhesion culture, ESCs primed to become osteoblasts recommitted to the adipocyte lineage in vitro. In a static suspension culture, resulting porous aggregates expressed osteoblasts markers and formed bone in vivo via intermembranous ossification. In a stirred suspension culture, resulting non-porous aggregates suppressed osteoblast differentiation in favor of expanding progenitor cells. Conclusions/Significance: We demonstrate that microenvironment modulates cell fate and subsequent tissue formation during ESC differentiation. For effective tissue engineering using ESCs, it is important to develop optimized cell culture/differentiation conditions based upon the influence of microenvironment.	[Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Yamashita, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	rancourt@ucalgary.ca			Canadian Institutes of Health Research [200605RMF-163344-RMA-CBBA-27639]; Alberta Heritage Foundation of Medical Research; Japanese Society for the Promotion of Science	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation of Medical Research(Alberta Heritage Foundation for Medical Research); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Canadian Institutes of Health Research 200605RMF-163344-RMA-CBBA-27639. AY was supported by postdoctoral fellowships from the Alberta Heritage Foundation of Medical Research and the Japanese Society for the Promotion of Science. DER is an Alberta Heritage Foundation of Medical Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERESFORD JN, 1992, J CELL SCI, V102, P341; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; SARBER R, 1981, MECH AGEING DEV, V17, P107, DOI 10.1016/0047-6374(81)90077-4; Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759; TAIANI J, 2009, STEM CELLS IN PRESS; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Yamashita A, 2005, CLONING STEM CELLS, V7, P232, DOI 10.1089/clo.2005.7.232; Yamashita A, 2006, CLONING STEM CELLS, V8, P3, DOI 10.1089/clo.2006.8.3; Yamashita A, 2009, CELL DEATH DIFFER, V16, P278, DOI 10.1038/cdd.2008.149; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	23	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9663	10.1371/journal.pone.0009663	http://dx.doi.org/10.1371/journal.pone.0009663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300192	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900004
J	Kwakman, PHS; te Velde, AA; de Boer, L; Speijer, D; Vandenbroucke-Grauls, CMJE; Zaat, SAJ				Kwakman, Paulus H. S.; te Velde, Anje A.; de Boer, Leonie; Speijer, Dave; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.			How honey kills bacteria	FASEB JOURNAL			English	Article						antibacterial agents; drug resistance; isolation and purification; methicillin-resistant Staphylococcus aureus; peptides	APIS-MELLIFERA L; POLYACRYLAMIDE-GEL ELECTROPHORESIS; DEPENDENT ROLE CHANGE; HYPOPHARYNGEAL GLAND; NEW-ZEALAND; IDENTIFICATION; PURIFICATION; EXPRESSION; PATHOGENS; PROTEIN	With the rise in prevalence of antibiotic-resistant bacteria, honey is increasingly valued for its antibacterial activity. To characterize all bactericidal factors in a medical-grade honey, we used a novel approach of successive neutralization of individual honey bactericidal factors. All bacteria tested, including Bacillus subtilis, methicillin-resistant Staphylococcus aureus, extended-spectrum beta-lactamase producing Escherichia coli, ciprofloxacin-resistant Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus faecium, were killed by 10-20% (v/v) honey, whereas >40% (v/v) of a honey-equivalent sugar solution was required for similar activity. Honey accumulated up to 5.62 +/- 0.54 mM H2O2 and contained 0.25 +/- 0.01 mM methylglyoxal (MGO). After enzymatic neutralization of these two compounds, honey retained substantial activity. Using B. subtilis for activity-guided isolation of the additional antimicrobial factors, we discovered bee defensin-1 in honey. After combined neutralization of H2O2, MGO, and bee defensin-1, 20% honey had only minimal activity left, and subsequent adjustment of the pH of this honey from 3.3 to 7.0 reduced the activity to that of sugar alone. Activity against all other bacteria tested depended on sugar, H2O2, MGO, and bee defensin-1. Thus, we fully characterized the antibacterial activity of medical-grade honey.-Kwakman, P.H.S., te Velde, A.A., de Boer, L., Speijer, D., Vandenbroucke-Grauls, C.M.J.E., Zaat, S.A.J. How honey kills bacteria. FASEB J. 24, 2576-2582 (2010). www.fasebj.org	[Kwakman, Paulus H. S.; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [te Velde, Anje A.] Univ Amsterdam, Acad Med Ctr, Lab Expt Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Speijer, Dave] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Zaat, SAJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	s.a.zaat@amc.uva.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020; Speijer, Dave/AAE-4613-2019	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Speijer, Dave/0000-0002-2340-2753				Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Bonn D, 2003, LANCET INFECT DIS, V3, P608, DOI 10.1016/S1473-3099(03)00794-1; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; DANKERT J, 1995, INFECT IMMUN, V63, P663, DOI 10.1128/IAI.63.2.663-671.1995; Dixon B, 2003, LANCET INFECT DIS, V3, P116, DOI 10.1016/S1473-3099(03)00524-3; EFEM SEE, 1988, BRIT J SURG, V75, P679, DOI 10.1002/bjs.1800750718; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Gallardo-Chacon JJ, 2008, J APICULT RES, V47, P131, DOI 10.1080/00218839.2008.11101439; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; JONES R, 2001, HONEY HEALING, P1; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Kwakman PHS, 2008, CLIN INFECT DIS, V46, P1677, DOI 10.1086/587892; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LENSKY Y, 1983, COMP BIOCHEM PHYS B, V75, P607, DOI 10.1016/0305-0491(83)90104-9; Lusby P E, 2002, J Wound Ostomy Continence Nurs, V29, P295, DOI 10.1067/mjw.2002.129073; Majno G., 1975, MAN WOUND ANCIENT WO; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; MOLAN PC, 2001, HONEY HEALING, P5; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; RACKER E, 1951, J BIOL CHEM, V190, P685; SASAGAWA H, 1989, APPL ENTOMOL ZOOL, V24, P66, DOI 10.1303/aez.24.66; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Weston RJ, 2000, FOOD CHEM, V70, P427, DOI 10.1016/S0308-8146(00)00127-8; White J. W., 1963, J APICULT RES, V2, P93, DOI [10.1080/00218839.1963.11100066, DOI 10.1080/00218839.1963.11100066]; Yatsunami K., 1984, Honeybee Science, V5, P125	32	255	268	3	142	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2576	2582		10.1096/fj.09-150789	http://dx.doi.org/10.1096/fj.09-150789			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20228250				2022-12-25	WOS:000279343600044
J	Kwon, IK; Wang, R; Thangaraju, M; Shuang, H; Liu, K; Dashwood, R; Dulin, N; Ganapathy, V; Browning, DD				Kwon, I-K; Wang, R.; Thangaraju, M.; Shuang, H.; Liu, K.; Dashwood, R.; Dulin, N.; Ganapathy, V.; Browning, D. D.			PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4	ONCOGENE			English	Article						PKG; cGMP; FOXO; beta-catenin; TCF; colon cancer	DEPENDENT PROTEIN-KINASE; CYCLIC-GMP; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; FUNCTIONAL-ANALYSIS; TUMOR-DEVELOPMENT; BINDING PARTNERS; BREAST-CANCER; PATHWAY	Activation of cGMP-dependent protein kinase (PKG) has anti-tumor effects in colon cancer cells but the mechanisms are not fully understood. This study has examined the regulation of beta-catenin/TCF signaling, as this pathway has been highlighted as central to the anti-tumor effects of PKG. We show that PKG activation in SW620 cells results in reduced beta-catenin expression and a dramatic inhibition of TCF-dependent transcription. PKG did not affect protein stability, nor did it increase phosphorylation of the amino-terminal Ser33/37/Thr41 residues that are known to target beta-catenin for degradation. However, we found that PKG potently inhibited transcription from a luciferase reporter driven by the human CTNNB1 promoter, and this corresponded to reduced beta-catenin mRNA levels. Although PKG was able to inhibit transcription from both the CTNNB1 and TCF reporters, the effect on protein levels was less consistent. Ectopic PKG had a marginal effect on beta-catenin protein levels in SW480 and HCT116 but was able to inhibit TCF-reporter activity by over 80%. Investigation of alternative mechanisms revealed that cJun-N-terminal kinase (JNK) activation was required for the PKG-dependent regulation of TCF activity. PKG activation caused beta-catenin to bind to FOXO4 in colon cancer cells, and this required JNK. Activation of PKG was also found to increase the nuclear content of FOXO4 and increase the expression of the FOXO target genes MnSOD and catalase. FOXO4 activation was required for the inhibition of TCF activity as FOXO4-specific short-interfering RNA completely blocked the inhibitory effect of PKG. These data illustrate a dual-inhibitory effect of PKG on TCF activity in colon cancer cells that involves reduced expression of beta-catenin at the transcriptional level, and also beta-catenin sequestration by FOXO4 activation. Oncogene (2010) 29, 3423-3434; doi:10.1038/onc.2010.91; published online 29 March 2010	[Kwon, I-K; Wang, R.; Thangaraju, M.; Shuang, H.; Liu, K.; Ganapathy, V.; Browning, D. D.] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Dashwood, R.] Oregon State Univ, Linus Pauling Inst, Canc Chemoprotect Program, Corvallis, OR 97331 USA; [Dulin, N.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University System of Georgia; Augusta University; Oregon State University; University of Chicago	Browning, DD (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, CB2605,1459 Laney Walker Blvd,1120,15th St, Augusta, GA 30912 USA.	dbrowning@mcg.edu	Dashwood, Roderick/AAF-2025-2020	Liu, Kebin/0000-0003-1965-7240; Browning, Darren/0000-0003-0497-7620; Wang, Rui/0000-0001-5794-7201	American Cancer Society [RSG-07-174-01-CSM, RSG-09-209-01-TBG]; National Institutes of Health [CA133085]; NATIONAL CANCER INSTITUTE [R01CA133085] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the American Cancer Society (RSG-07-174-01-CSM to DDB and RSG-09-209-01-TBG to KL) and the National Institutes of Health (CA133085 to KL).	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Browning DD, 2008, EXPERT OPIN THER TAR, V12, P367, DOI 10.1517/14728222.12.3.367; Browning DD, 2001, J BIOL CHEM, V276, P13039, DOI 10.1074/jbc.M009187200; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Forte LR, 2004, PHARMACOL THERAPEUT, V104, P137, DOI 10.1016/j.pharmthera.2004.08.007; Forte LR, 2000, ANNU REV PHYSIOL, V62, P673, DOI 10.1146/annurev.physiol.62.1.673; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goluboff ET, 2001, EXPERT OPIN INV DRUG, V10, P1875, DOI 10.1517/13543784.10.10.1875; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; Hou YL, 2006, CELL SIGNAL, V18, P882, DOI 10.1016/j.cellsig.2005.07.015; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kwon IK, 2008, CANCER-AM CANCER SOC, V112, P1462, DOI 10.1002/cncr.23334; Li H, 2002, CANCER BIOL THER, V1, P621, DOI 10.4161/cbt.309; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Liu L, 2001, J PHARMACOL EXP THER, V299, P583; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Maiese K, 2008, CELL CYCLE, V7, P3829, DOI 10.4161/cc.7.24.7231; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Shailubhai K, 2000, CANCER RES, V60, P5151; Soh JW, 2008, MOL CARCINOGEN, V47, P519, DOI 10.1002/mc.20409; Soh JW, 2000, CLIN CANCER RES, V6, P4136; Soh JW, 2001, J BIOL CHEM, V276, P16406, DOI 10.1074/jbc.C100079200; Sparks AB, 1998, CANCER RES, V58, P1130; Strate LL, 2005, CANCER CAUSE CONTROL, V16, P201, DOI 10.1007/s10552-004-3488-4; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Thompson WJ, 2000, CANCER RES, V60, P3338; Uzzau S, 2000, CELL MICROBIOL, V2, P83, DOI 10.1046/j.1462-5822.2000.00041.x; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Zhu B, 2005, J CELL BIOCHEM, V94, P336, DOI 10.1002/jcb.20286	61	58	61	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2010	29	23					3423	3434		10.1038/onc.2010.91	http://dx.doi.org/10.1038/onc.2010.91			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20348951	Green Accepted			2022-12-25	WOS:000278622700010
J	Garcia-Diaz, M; Murray, MS; Kunkel, TA; Chou, KM				Garcia-Diaz, Miguel; Murray, Michael S.; Kunkel, Thomas A.; Chou, Kai-ming			Interaction between DNA Polymerase lambda and Anticancer Nucleoside Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR; GEMCITABINE; CELLS; FIBROBLASTS; METABOLISM; MECHANISM; SOFTWARE; EXTRACTS; CANCER	The anticancer activity of cytarabine (AraC) and gemcitabine (dFdC) is thought to result from chain termination after incorporation into DNA. To investigate their incorporation into DNA at atomic level resolution, we present crystal structures of human DNA polymerase lambda (Pol lambda) bound to gapped DNA and containing either AraC or dFdC paired opposite template dG. These structures reveal that AraC and dFdC can bind within the nascent base pair binding pocket of Pol lambda. Although the conformation of the ribose of AraCTP is similar to that of normal dCTP, the conformation of dFdCTP is significantly different. Consistent with these structures, Pol lambda efficiently incorporates AraCTP but not dFdCTP. The data are consistent with the possibility that Pol lambda could modulate the cytotoxic effect of AraC.	[Chou, Kai-ming] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Genet Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chou, KM (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS 552, Indianapolis, IN 46202 USA.	chouk@iupui.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	National Institutes of Health (NIH) [RO1 CA112446]; NIH, NIEHS [Z01 ES065070]; NATIONAL CANCER INSTITUTE [R01CA112446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1 CA112446 (to K.-m.C.) and by NIH, NIEHS, Division of Intramural Research Project Z01 ES065070 (to T.A.K.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BALZARINI J, 1994, PHARM WORLD SCI, V16, P113, DOI 10.1007/BF01880662; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkes RL, 1995, ANN ONCOL, V6, P57, DOI 10.1093/annonc/6.suppl_3.S57; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Cisneros GA, 2008, DNA REPAIR, V7, P1824, DOI 10.1016/j.dnarep.2008.07.007; Crespan E, 2005, NUCLEIC ACIDS RES, V33, P4117, DOI 10.1093/nar/gki723; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; HIDDEMANN W, 1991, ANN HEMATOL, V62, P119, DOI 10.1007/BF01702925; HUANG P, 1991, CANCER RES, V51, P6110; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; King R S, 1996, Cancer Pract, V4, P353; Konerding D, 2002, BIOCHEMISTRY-US, V41, P839, DOI 10.1021/bi015678l; KUFE DW, 1982, MED PEDIATR ONCOL, P49; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; MIKITA T, 1988, BIOCHEMISTRY-US, V27, P4698, DOI 10.1021/bi00413a018; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Ohba T, 2009, MUTAT RES-GEN TOX EN, V677, P66, DOI 10.1016/j.mrgentox.2009.05.008; Picher AJ, 2006, NUCLEIC ACIDS RES, V34, P3259, DOI 10.1093/nar/gkl377; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Possinger K, 1995, ANTI-CANCER DRUG, V6, P55, DOI 10.1097/00001813-199512006-00009; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; SOMMADOSSI JP, 1993, CLIN INFECT DIS, V16, pS7, DOI 10.1093/clinids/16.Supplement_1.S7; TANAKA M, 1980, ACTA HAEMATOL JAPON, V43, P996; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vermeulen C, 2007, RADIAT RES, V168, P683, DOI 10.1667/RR1057R.1	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16874	16879		10.1074/jbc.M109.094391	http://dx.doi.org/10.1074/jbc.M109.094391			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348107	hybrid, Green Published			2022-12-25	WOS:000277982600051
J	Haug-Schifferdecker, E; Arican, D; Bruckner, R; Heide, L				Haug-Schifferdecker, Elisa; Arican, Deniz; Brueckner, Reinhard; Heide, Lutz			A New Group of Aromatic Prenyltransferases in Fungi, Catalyzing a 2,7-Dihydroxynaphthalene 3-Dimethylallyl-transferase Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPULVINONE DIMETHYLALLYLTRANSFERASE; FOLD RECOGNITION; BIOSYNTHESIS; SYNTHASE; PRENYLATION; SEQUENCE; IDENTIFICATION; PURIFICATION; GENTHREADER; DERIVATIVES	Five fungal genomes from the Ascomycota (sac fungi) were found to contain a gene with sequence similarity to a recently discovered small group of bacterial prenyltransferases that catalyze the C-prenylation of aromatic substrates in secondary metabolism. The genes from Aspergillus terreus NIH2624, Botryotinia fuckeliana B05.10 and Sclerotinia sclerotiorum 1980 were expressed in Escherichia coli, and the resulting His(8)-tagged proteins were purified and investigated biochemically. Their substrate specificity was found to be different from that of any other prenyltransferase investigated previously. Using 2,7-dihydroxynaphthalene (2,7-DHN) and dimethylallyl diphosphate as substrates, they catalyzed a regiospecific Friedel-Crafts alkylation of 2,7-DHN at position 3. Using the enzyme of A. terreus, the Km values for 2,7-DHN and dimethylallyl diphosphate were determined as 324 +/- 25 mu M and 325 +/- 35 mu M, respectively, and k(cat) as 0.026 +/- 0.001 s(-1). A significantly lower level of prenylation activity was found using dihydrophenazine-1-carboxylic acid as aromatic substrate, and only traces of products were detected with aspulvinone E, flaviolin, or 4-hydroxybenzoic acid. No product was formed with L-tryptophan, L-tyrosine, or 4-hydroxyphenylpyruvate. The genes for these fungal prenyltransferases are not located within recognizable secondary metabolic gene clusters. Their physiological function is yet unknown.	[Haug-Schifferdecker, Elisa; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Arican, Deniz; Brueckner, Reinhard] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de		Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bernier D, 2007, SYNTHESIS-STUTTGART, P2249, DOI 10.1055/s-2007-983803; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Koehl P, 2005, NAT CHEM BIOL, V1, P71, DOI 10.1038/nchembio0705-71; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; SAGAMI I, 1985, METHOD ENZYMOL, V110, P320; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J, 2001, MOL CLONING LAB MANU; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Steffensky M, 1998, FEMS MICROBIOL LETT, V161, P69, DOI 10.1111/j.1574-6968.1998.tb12930.x; TAKAHASHI I, 1978, BIOCHEMISTRY-US, V17, P2696, DOI 10.1021/bi00606a037; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211	34	21	28	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16487	16494		10.1074/jbc.M110.113720	http://dx.doi.org/10.1074/jbc.M110.113720			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351110	hybrid, Green Published			2022-12-25	WOS:000277982600010
J	Clarke, CA; Scheurwater, EM; Clarke, AJ				Clarke, Chelsea A.; Scheurwater, Edie M.; Clarke, Anthony J.			The Vertebrate Lysozyme Inhibitor Ivy Functions to Inhibit the Activity of Lytic Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; O-ACETYLPEPTIDOGLYCAN ESTERASE; ESCHERICHIA-COLI K-12; PSEUDOMONAS-AERUGINOSA; PEPTIDOGLYCAN; IDENTIFICATION; ACETYLATION; AUTOLYSINS; RESISTANCE; FAMILY	The proteinaceous inhibitor of vertebrate lysozymes (Ivy) is produced by a collection of Gram-negative bacteria as a stress response to damage to their essential cell wall component peptidoglycan. A paralog of Ivy, Ivyp2 is produced exclusively by a number of pseudomonads, including Pseudomonas aeruginosa, but this protein does not inhibit the lysozymes, and its function was unknown. In this study, we demonstrate that the production of Ivy (homologs of both Ivyp1 and Ivyp2) correlates with bacteria that do not O-acetylate their peptidoglycan, a modification that controls the activity of the lytic transglycosylases. Furthermore, we show that both Ivy proteins are potent inhibitors of the lytic transglycoslyases, enzymes involved in the biosynthesis and maintenance of peptidoglycan. These data suggest that the true physiological function of the Ivy proteins is to control the autolytic activity of lytic transglycosylases within the periplasm of Gram-negative bacteria that do not produce O-acetylated peptidoglycan and that the inhibition of exogenous lysozyme by Ivy is simply a fortuitous coincidence.	[Clarke, Chelsea A.; Scheurwater, Edie M.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	aclarke@uoguelph.ca			Canadian Institutes for Health Research [MOP 49623, MOP 81223]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Operating Grants MOP 49623 and MOP 81223 from the Canadian Institutes for Health Research (to A.J.C.).	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; Deckers D, 2008, APPL ENVIRON MICROB, V74, P4434, DOI 10.1128/AEM.00589-08; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Kyomuhendo P, 2008, J MOL MODEL, V14, P777, DOI 10.1007/s00894-008-0317-9; LAEMMLI UK, 1970, NATURE, V227, P685; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; PAYIE KG, 1995, J BACTERIOL, V177, P4303, DOI 10.1128/jb.177.15.4303-4310.1995; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; ROGERS HJ, 1971, J BACTERIOL, V108, P1235, DOI 10.1128/JB.108.3.1235-1243.1971; ROGERS HJ, 1967, NATURE, V213, P31, DOI 10.1038/213031a0; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMASZ A, 1974, ANN NY ACAD SCI, V235, P439, DOI 10.1111/j.1749-6632.1974.tb43282.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	31	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14843	14847		10.1074/jbc.C110.120931	http://dx.doi.org/10.1074/jbc.C110.120931			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20351104	Green Published, hybrid			2022-12-25	WOS:000277399000001
J	Platzer, B; Fiebiger, E				Platzer, Barbara; Fiebiger, Edda			The Signal Peptide of the IgE Receptor alpha-Chain Prevents Surface Expression of an Immunoreceptor Tyrosine-based Activation Motif-free Receptor Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; DENDRITIC CELLS; QUALITY-CONTROL; ALLERGY; PROTEIN; BETA; RECOGNITION	The high affinity receptor for IgE, Fc epsilon receptor I (Fc epsilon RI), is an activating immune receptor and key regulator of allergy. Antigen-mediated cross-linking of IgE-loaded Fc epsilon RI alpha-chains induces cell activation via immunoreceptor tyrosine-based activation motifs in associated signaling subunits, such as Fc epsilon RI gamma-chains. Here we show that the human Fc epsilon RI alpha-chain can efficiently reach the cell surface by itself as an IgE-binding receptor in the absence of associated signaling subunits when the endogenous signal peptide is swapped for that of murine major histocompatibility complex class-I H2-K-b. This single-chain isoform of Fc epsilon RI exited the endoplasmic reticulum (ER), trafficked to the Golgi and, subsequently, trafficked to the cell surface. Mutational analysis showed that the signal peptide regulates surface expression in concert with other described ER retention signals of Fc epsilon RI-alpha. Once the Fc epsilon RI alpha-chain reached the cell surface by itself, it formed a ligand-binding receptor that stabilized upon IgE contact. Independently of the Fc epsilon RI gamma-chain, this single-chain Fc epsilon RI was internalized after receptor cross-linking and trafficked into a LAMP-1-positive lysosomal compartment like multimeric Fc epsilon RI. These data suggest that the single-chain isoform is capable of shuttling IgE-antigen complexes into antigen loading compartments, which plays an important physiologic role in the initiation of immune responses toward allergens. We propose that, in addition to cytosolic and transmembrane ER retention signals, the Fc epsilon RI alpha-chain signal peptide contains a negative regulatory signal that prevents expression of an immunoreceptor tyrosine-based activation motif-free IgE receptor pool, which would fail to induce cell activation.	[Platzer, Barbara; Fiebiger, Edda] Childrens Hosp Boston, Div Gastroenterol & Nutr, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Fiebiger, E (corresponding author), 300 Longwood Ave,EN720, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu			National Institutes of Health [DK081256, R56AI075037, R01AI075037]; American Gastroenterological Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075037, R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081256 (to B. P.) and R56AI075037 and R01AI075037 (to E. F.). This work was also supported by a Research Scholar Award from the American Gastroenterological Association (to E. F.).	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Castro-Fernandez C, 2005, ENDOCR REV, V26, P479, DOI 10.1210/er.2004-0010; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; Donnadieu E, 2003, IMMUNITY, V18, P665, DOI 10.1016/S1074-7613(03)00115-8; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Fattakhova GV, 2009, MOL IMMUNOL, V46, P793, DOI 10.1016/j.molimm.2008.09.002; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hartman ML, 2008, MOL IMMUNOL, V45, P2307, DOI 10.1016/j.molimm.2007.11.017; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Kinet JP, 1996, EUR RESPIR J, V9, pS116; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; MAURER D, 1995, J IMMUNOL, V154, P6285; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Piersma D, 2006, J CLIN ENDOCR METAB, V91, P1470, DOI 10.1210/jc.2005-2156; Schamel WWA, 2008, ADV EXP MED BIOL, V640, P64, DOI 10.1007/978-0-387-09789-3_6; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; von Bubnoff D, 2003, CLIN EXP DERMATOL, V28, P184, DOI 10.1046/j.1365-2230.2003.01209.x; Wollenberg A, 2000, CLIN EXP DERMATOL, V25, P530, DOI 10.1046/j.1365-2230.2000.00699.x	41	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15314	15323		10.1074/jbc.M110.104281	http://dx.doi.org/10.1074/jbc.M110.104281			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304923	hybrid, Green Published			2022-12-25	WOS:000277399000052
J	Jin, BF; Shen, HX; Lin, SB; Li, JL; Chen, ZR; Griffin, JD; Wu, LZ				Jin, Baofeng; Shen, Huangxuan; Lin, Shuibin; Li, Jian-Liang; Chen, Zirong; Griffin, James D.; Wu, Lizi			The Mastermind-like 1 (MAML1) Co-activator Regulates Constitutive NF-kappa B Signaling and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATORS; NOTCH RECEPTORS; EMBRYONIC LETHALITY; LIVER-REGENERATION; MICE LACKING; CROSS-TALK; APOPTOSIS; ALPHA; EXPRESSION; PATHWAY	Nuclear factor-kappa B (NF-kappa B)-based signaling regulates diverse biological processes, and its deregulation is associated with various disorders including autoimmune diseases and cancer. Identification of novel factors that modulate NF-kappa B function is therefore of significant importance. The Mastermind-like 1 (MAML1) transcriptional co-activator regulates transcriptional activity in the Notch pathway and is emerging as a co-activator of other pathways. In this study, we found that MAML1 regulates NF-kappa B signaling via two mechanisms. First, MAML1 coactivates the NF-kappa B subunit RelA (p65) in NF-kappa B-dependent transcription. Second, MAML1 causes degradation of the inhibitor of NF-kappa B (I kappa B alpha). Maml1-deficient mouse embryonic fibroblasts showed impaired tumor necrosis factor-alpha (TNF alpha)-induced NF-kappa B responses. Moreover, MAML1 expression level directly influences cellular sensitivity to TNF alpha-induced cytotoxicity. In vivo, mice deficient in the Maml1 gene exhibited spontaneous cell death in the liver, with a large increase in the number of apoptotic hepatic cells. These findings indicate that MAML1 is a novel modulator for NF-kappa B signaling and regulates cellular survival.	Univ Florida, Shands Canc Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Li, Jian-Liang] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA; [Griffin, James D.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Griffin, James D.] Harvard Univ, Sch Med, Boston, MA 02115 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wu, LZ (corresponding author), 2033 Mowry Rd, Gainesville, FL 32610 USA.	lzwu@ufl.edu	Li, Jian-Liang/AAE-9315-2019; chen, zirong/S-4042-2016; Li, J L/E-6100-2018	Li, Jian-Liang/0000-0002-6487-081X; chen, zirong/0000-0002-0589-4619; Li, J L/0000-0002-6487-081X	National Institutes of Health [R01 CA097148, R01 CA036167]; University of Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE [R01CA036167, R01CA097148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Shands Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA097148. This work was also supported by the University of Florida Shands Cancer Center startup fund (to L. W.) and National Institutes of Health Grant R01 CA036167 (to J. D. G.).	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; CRESSMAN DE, 1993, ONCOGENE, V8, P2567; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Espinosa L, 2002, J CELL SCI, V115, P1295; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Plumpe J, 2000, AM J PHYSIOL-GASTR L, V278, pG173, DOI 10.1152/ajpgi.2000.278.1.G173; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2004, SEMIN CANCER BIOL, V14, P348, DOI 10.1016/j.semcancer.2004.04.014; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	36	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14356	14365		10.1074/jbc.M109.078865	http://dx.doi.org/10.1074/jbc.M109.078865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231278	Green Published, hybrid			2022-12-25	WOS:000277299700033
J	Richard, D; MacRaild, CA; Riglar, DT; Chan, JA; Foley, M; Baum, J; Ralph, SA; Norton, RS; Cowman, AF				Richard, Dave; MacRaild, Christopher A.; Riglar, David T.; Chan, Jo-Anne; Foley, Michael; Baum, Jake; Ralph, Stuart A.; Norton, Raymond S.; Cowman, Alan F.			Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and the Rhoptry Neck Protein Complex Defines a Key Step in the Erythrocyte Invasion Process of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; TOXOPLASMA-GONDII; MOVING JUNCTION; CHALLENGE INFECTION; VACCINE CANDIDATE; FINE-STRUCTURE; MEROZOITES; ANTIBODY; KNOWLESI; AMA1	Invasion of host cells by apicomplexan parasites, including Plasmodium falciparum and Toxoplasma gondii, is a multistep process. Central to invasion is the formation of a tight junction, an aperture in the host cell through which the parasite pulls itself before settling into a newly formed parasitophorous vacuole. Two protein groups, derived from different secretory organelles, the micronemal protein AMA1 and the rhoptry proteins RON2, RON4, and RON5, have been shown to form part of this structure, with antibodies targeting P. falciparum AMA1 known to inhibit invasion, probably via disruption of its association with the PfRON proteins. Inhibitory AMA1-binding peptides have also been described that block P. falciparum merozoite invasion of the erythrocyte. One of these, R1, blocks invasion some time after initial attachment to the erythrocyte and reorientation of the merozoite to its apical pole. Here we show that the R1 peptide binds the PfAMA1 hydrophobic trough and demonstrate that binding to this region prevents its interaction with the PfRON complex. We show that this defined association between PfAMA1 and the PfRON complex occurs after reorientation and engagement of the actomyosin motor and argue that it precedes rhoptry release. We propose that the formation of the AMA1-RON complex is essential for secretion of the rhoptry contents, which then allows the establishment of parasite infection within the parasitophorous vacuole.	[Richard, Dave; MacRaild, Christopher A.; Riglar, David T.; Chan, Jo-Anne; Baum, Jake; Norton, Raymond S.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Foley, Michael] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; La Trobe University; University of Melbourne	Norton, RS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	rnorton@wehi.edu.au; cowman@wehi.edu.au	; Ralph, Stuart/C-8590-2014	Foley, Michael/0000-0003-1349-4698; Norton, Raymond/0000-0001-8893-0584; Baum, Jake/0000-0002-0275-352X; MacRaild, Christopher/0000-0002-3694-3989; Riglar, David/0000-0002-5004-4373; Ralph, Stuart/0000-0003-0114-7808	National Health and Medical Research Council of Australia (NHMRC); Victorian State Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	This work was supported by the National Health and Medical Research Council of Australia (NHMRC). This work was supported by an NHMRC Institutes Infrastructure Support Scheme grant and a Victorian State Government Operational Infrastructure Support grant.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; AIKAWA M, 1981, J CELL BIOL, V91, P55, DOI 10.1083/jcb.91.1.55; AIKAWA M, 1977, B WORLD HEALTH ORGAN, V55, P139; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; BANNISTER LH, 1989, J PROTOZOOL, V36, P362, DOI 10.1111/j.1550-7408.1989.tb05527.x; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Gupta A, 2005, PROTEIN EXPRES PURIF, V41, P186, DOI 10.1016/j.pep.2005.01.005; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOWARD RF, 1990, EXP PARASITOL, V71, P330, DOI 10.1016/0014-4894(90)90038-E; HOWARD RF, 1984, AM J TROP MED HYG, V33, P1055, DOI 10.4269/ajtmh.1984.33.1055; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Morahan BJ, 2009, EXP PARASITOL, V122, P280, DOI 10.1016/j.exppara.2009.04.013; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; STEWART MJ, 1986, AM J TROP MED HYG, V35, P37, DOI 10.4269/ajtmh.1986.35.37; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x	46	181	190	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14815	14822		10.1074/jbc.M109.080770	http://dx.doi.org/10.1074/jbc.M109.080770			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228060	hybrid, Green Published			2022-12-25	WOS:000277299700078
J	Dolatshad, H; Cary, AJ; Davis, FC				Dolatshad, Hamid; Cary, Andrew J.; Davis, Fred C.			Differential Expression of the Circadian Clock in Maternal and Embryonic Tissues of Mice	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; MOUSE PERIPHERAL-TISSUES; GENE-EXPRESSION; MESSENGER-RNA; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; MOLECULAR CLOCK; NURSING MOTHERS; CELL-CYCLE; FETAL	Background: Molecular feedback loops involving transcription and translation and several key genes are at the core of circadian regulatory cycles affecting cellular pathways and metabolism. These cycles are active in most adult animal cells but little is known about their expression or influence during development. Methodology/Principal Findings: To determine if circadian cycles are active during mammalian development we measured the expression of key circadian genes during embryogenesis in mice using quantitative real-time RT-PCR. All of the genes examined were expressed in whole embryos beginning at the earliest age examined, embryonic day 10. In contrast to adult tissues, circadian variation was absent for all genes at all of the embryonic ages examined in either whole embryos or individual tissues. Using a bioluminescent fusion protein that tracks translation of the circadian gene, per2, we also analyzed protein levels. Similar to mRNA, a protein rhythm was observed in adult tissue but not in embryonic tissues collected in-vivo. In contrast, when tissues were placed in culture for the continuous assay of bioluminescence, rhythms were observed in embryonic (E18) tissues. We found that placing embryonic tissues in culture set the timing (phase) of these rhythms, suggesting the importance of a synchronizing signal for the expression of circadian cycles in developing tissues. Conclusions/Significance: These results show that embryonic tissues express key circadian genes and have the capacity to express active circadian regulatory cycles. In vivo, circadian cycles are not expressed in embryonic tissues as they are in adult tissues. Individual cells might express oscillations, but are not synchronized until later in development.	[Dolatshad, Hamid; Cary, Andrew J.; Davis, Fred C.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Dolatshad, H (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	f.davis@neu.edu		Dolatshad, Hamid/0000-0002-4724-1720	National Institutes of Health [1 R01 MH068796]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant 1 R01 MH068796 to FCD (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; BARR M, 1973, TERATOLOGY, V7, P283, DOI 10.1002/tera.1420070309; BATSCHELET E, 1972, ANIMAL ORIENTATION N, P61; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; DAVIS FC, 2001, HDB BEHAV NEUROBIOLO, P247; DAVIS FC, 1988, AM J PHYSIOL, V255, P439; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; DUNCAN MJ, 1993, DEV BRAIN RES, V73, P205, DOI 10.1016/0165-3806(93)90140-6; El-Hennamy R, 2008, J BIOL RHYTHM, V23, P435, DOI 10.1177/0748730408322635; ENDO A, 1989, GAMETE RES, V22, P435, DOI 10.1002/mrd.1120220409; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujimoto Y, 2006, GENES CELLS, V11, P525, DOI 10.1111/j.1365-2443.2006.00960.x; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Gozeri E, 2008, NEUROENDOCRINOL LETT, V29, P87; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HASTINGS MH, 1999, J NEUROSCI, V11, P1; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Johnson Martin H, 2002, Reprod Biomed Online, V4, P140; Johnson MH, 2000, BIOESSAYS, V22, P57, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;57::AID-BIES10&gt;3.0.CO;2-L; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Kiessling AA, 2009, J ASSIST REPROD GEN, V26, P187, DOI 10.1007/s10815-009-9306-x; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Li XD, 2005, DEV BRAIN RES, V158, P31, DOI 10.1016/j.devbrainres.2005.05.005; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; MOORE RY, 1989, J NEUROSCI, V9, P2151; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Ripperger JA, 2000, GENE DEV, V14, P679; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Sakamoto K, 2002, NEUROREPORT, V13, P1239, DOI 10.1097/00001756-200207190-00003; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura H, 2001, EUR J NEUROSCI, V13, P687, DOI 10.1046/j.0953-816x.2000.01438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	70	53	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9855	10.1371/journal.pone.0009855	http://dx.doi.org/10.1371/journal.pone.0009855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352049	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894500021
J	van Baarle, S; Bramkamp, M				van Baarle, Suey; Bramkamp, Marc			The MinCDJ System in Bacillus subtilis Prevents Minicell Formation by Promoting Divisome Disassembly	PLOS ONE			English	Article							BACTERIAL-CELL DIVISION; SITE SELECTION SYSTEM; ESCHERICHIA-COLI; Z-RING; POLAR LOCALIZATION; CORRECT PLACEMENT; PROPER PLACEMENT; MIND PROTEIN; FTSZ; SPECIFICITY	Background: Cell division in Bacillus subtilis takes place precisely at midcell, through the action of Noc, which prevents division from occurring over the nucleoids, and the Min system, which prevents cell division from taking place at the poles. Originally it was thought that the Min system acts directly on FtsZ, preventing the formation of a Z-ring and, therefore, the formation of a complete cytokinetic ring at the poles. Recently, a new component of the B. subtilis Min system was identified, MinJ, which acts as a bridge between DivIVA and MinCD. Methodology/Principal Findings: We used fluorescence microscopy and molecular genetics to examine the molecular role of MinJ. We found that in the absence of a functional Min system, FtsA, FtsL and PBP-2B remain associated with completed division sites. Evidence is provided that MinCDJ are responsible for the failure of these proteins to localize properly, indicating that MinCDJ can act on membrane integral components of the divisome. Conclusions/Significance: Taken together, we postulate that the main function of the Min system is to prevent minicell formation adjacent to recently completed division sites by promoting the disassembly of the cytokinetic ring, thereby ensuring that cell division occurs only once per cell cycle. Thus, the role of the Min system in rod-shaped bacteria seems not to be restricted to an inhibitory function on FtsZ polymerization, but can act on different levels of the divisome.	[van Baarle, Suey; Bramkamp, Marc] Univ Cologne, Inst Biochem, Cologne, Germany	University of Cologne	van Baarle, S (corresponding author), Univ Cologne, Inst Biochem, Cologne, Germany.	marc.bramkamp@uni-koeln.de		Bramkamp, Marc/0000-0002-7704-3266	Max Planck Society; European Union	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was funded by the Max Planck Society and a European Union Marie-Curie ADOPT program (fellowship for SvB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Harry E., 2006, INT REV CYTOL, V253, P27; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Karoui ME, 2001, MOL MICROBIOL, V42, P1211, DOI 10.1046/j.1365-2958.2001.02710.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENARCIC R, 2009, EMBO J; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mukherjee A, 1998, METHOD ENZYMOL, V298, P296, DOI 10.1016/S0076-6879(98)98026-0; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yu XC, 2000, J BACTERIOL, V182, P6203, DOI 10.1128/JB.182.21.6203-6213.2000	47	41	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9850	10.1371/journal.pone.0009850	http://dx.doi.org/10.1371/journal.pone.0009850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352045	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894500018
J	Bahia, AC; Kubota, MS; Tempone, AJ; Pinheiro, WD; Tadei, WP; Secundino, NFC; Traub-Cseko, YM; Pimenta, PFP				Bahia, Ana C.; Kubota, Marina S.; Tempone, Antonio J.; Pinheiro, Waleria D.; Tadei, Wanderli P.; Secundino, Nagila F. C.; Traub-Csekoe, Yara M.; Pimenta, Paulo F. P.			Anopheles aquasalis Infected by Plasmodium vivax Displays Unique Gene Expression Profiles when Compared to Other Malaria Vectors and Plasmodia	PLOS ONE			English	Article							MOSQUITO; GAMBIAE; MIDGUT; IMMUNITY; STIMULATION; MECHANISM; RESPONSES; CLONING; PCR	Malaria affects 300 million people worldwide every year and is endemic in 22 countries in the Americas where transmission occurs mainly in the Amazon Region. Most malaria cases in the Americas are caused by Plasmodium vivax, a parasite that is almost impossible to cultivate in vitro, and Anopheles aquasalis is an important malaria vector. Understanding the interactions between this vector and its parasite will provide important information for development of disease control strategies. To this end, we performed mRNA subtraction experiments using A. aquasalis 2 and 24 hours after feeding on blood and blood from malaria patients infected with P. vivax to identify changes in the mosquito vector gene induction that could be important during the initial steps of infection. A total of 2,138 clones of differentially expressed genes were sequenced and 496 high quality unique sequences were obtained. Annotation revealed 36% of sequences unrelated to genes in any database, suggesting that they were specific to A. aquasalis. A high number of sequences (59%) with no matches in any databases were found 24 h after infection. Genes related to embryogenesis were down-regulated in insects infected by P. vivax. Only a handful of genes related to immune responses were detected in our subtraction experiment. This apparent weak immune response of A. aquasalis to P. vivax infection could be related to the susceptibility of this vector to this important human malaria parasite. Analysis of some genes by real time PCR corroborated and expanded the subtraction results. Taken together, these data provide important new information about this poorly studied American malaria vector by revealing differences between the responses of A. aquasalis to P. vivax infection, in relation to better studied mosquito-Plasmodium pairs. These differences may be important for the development of malaria transmission-blocking strategies in the Americas.	[Bahia, Ana C.; Kubota, Marina S.; Tempone, Antonio J.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Pinheiro, Waleria D.; Tadei, Wanderli P.] Inst Nacl de Pesquisas da Amazonia, Lab Malaria & Dengue, Manaus, Amazonas, Brazil; [Secundino, Nagila F. C.; Pimenta, Paulo F. P.] Fiocruz MS, Inst Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Institute Nacional de Pesquisas da Amazonia; Fundacao Oswaldo Cruz	Bahia, AC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br; pimenta@cpqrr.fiocruz.br	Nascimento, Ana Cristina Bahia/G-2372-2015; Traub-Cseko, Yara M/F-2723-2015; Tadei, Wanderli Pedro/N-4486-2018; Secundino, Nagila/AAM-4553-2020; Pimenta, Paulo/AAH-1502-2020; Tempone, Antonio J/E-5118-2011	Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; Tadei, Wanderli Pedro/0000-0002-0612-3285; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio a Nucleos de Excelencia (PRONEX, MG); Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia (PRONEX, MG); Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio a Nucleos de Excelencia (PRONEX, MG), Fundacacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; BERTI J, 1993, MEM I OSWALDO CRUZ, V88, P363, DOI 10.1590/S0074-02761993000300004; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; CHADEE DD, 1992, ANN TROP MED PARASIT, V86, P583, DOI 10.1080/00034983.1992.11812713; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; GASS RF, 1979, ACTA TROP, V36, P243; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Giannoni F, 2001, J BIOL CHEM, V276, P700, DOI 10.1074/jbc.M005540200; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta L, 2005, P NATL ACAD SCI USA, V102, P4010, DOI 10.1073/pnas.0409642102; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Jahan N, 1999, PARASITOLOGY, V119, P535, DOI 10.1017/S0031182099005090; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06; Lavazec C, 2005, INSECT MOL BIOL, V14, P163, DOI 10.1111/j.1365-2583.2004.00541.x; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shi L, 2004, INSECT MOL BIOL, V13, P387, DOI 10.1111/j.0962-1075.2004.00496.x; Sodja A, 2007, J INSECT PHYSIOL, V53, P833, DOI 10.1016/j.jinsphys.2007.03.017; Somboon Pradya, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P691; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9795	10.1371/journal.pone.0009795	http://dx.doi.org/10.1371/journal.pone.0009795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339545	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300020
J	Jung, RE; Grazioplene, R; Caprihan, A; Chavez, RS; Haier, RJ				Jung, Rex E.; Grazioplene, Rachael; Caprihan, Arvind; Chavez, Robert S.; Haier, Richard J.			White Matter Integrity, Creativity, and Psychopathology: Disentangling Constructs with Diffusion Tensor Imaging	PLOS ONE			English	Article							BIPOLAR DISORDER; COGNITIVE NEUROSCIENCE; NEUREGULIN-1; BRAIN; SCHIZOPHRENIA; CONNECTIVITY; PERSONALITY; ABNORMALITIES; INTELLIGENCE; ARCHITECTURE	That creativity and psychopathology are somehow linked remains a popular but controversial idea in neuroscience research. Brain regions implicated in both psychosis-proneness and creative cognition include frontal projection zones and association fibers. In normal subjects, we have previously demonstrated that a composite measure of divergent thinking (DT) ability exhibited significant inverse relationships in frontal lobe areas with both cortical thickness and metabolite concentration of N-acetyl-aspartate (NAA). These findings support the idea that creativity may reside upon a continuum with psychopathology. Here we examine whether white matter integrity, assessed by Fractional Anisotropy ( FA), is related to two measures of creativity ( Divergent Thinking and Openness to Experience). Based on previous findings, we hypothesize inverse correlations within fronto-striatal circuits. Seventy-two healthy, young adult (18-29 years) subjects were scanned on a 3 Tesla scanner with Diffusion Tensor Imaging. DT measures were scored by four raters (alpha = .81) using the Consensual Assessment Technique, from which a composite creativity index (CCI) was derived. We found that the CCI was significantly inversely related to FA within the left inferior frontal white matter (t = 5.36, p = .01), and Openness as inversely related to FA within the right inferior frontal white matter (t = 4.61, p = .04). These findings demonstrate an apparent overlap in specific white matter architecture underlying the normal variance of divergent thinking, openness, and psychotic-spectrum traits, consistent with the idea of a continuum.	[Jung, Rex E.; Grazioplene, Rachael; Caprihan, Arvind; Chavez, Robert S.; Haier, Richard J.] Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Jung, Rex E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Mind Res Network, Albuquerque, NM 87131 USA.	rjung@mrn.org	Chavez, Robert S./ABE-9303-2021	Chavez, Robert S./0000-0001-7877-299X; Jung, Rex/0000-0003-3718-0597	The John Templeton Foundation (www.templeton.org)	The John Templeton Foundation (www.templeton.org)	The John Templeton Foundation (www.templeton.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; AMABILE TM, 1982, J PERS SOC PSYCHOL, V43, P997, DOI 10.1037/0022-3514.43.5.997; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Cummings JL, 2008, CNS SPECTRUMS, V13, P1; Dietrich A, 2004, PSYCHON B REV, V11, P1011, DOI 10.3758/BF03196731; Dietrich A, 2007, METHODS, V42, P22, DOI 10.1016/j.ymeth.2006.12.009; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Guilford J.P., 1967, NATURE HUMAN INTELLI; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; HASENFUS N, 1976, BRIT J PSYCHIAT, V129, P346, DOI 10.1192/bjp.129.4.346; Haznedar MM, 2005, BIOL PSYCHIAT, V57, P733, DOI 10.1016/j.biopsych.2005.01.002; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JAMISON KR, 1989, PSYCHIATRY, V52, P125, DOI 10.1080/00332747.1989.11024436; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhn T., 1970, STRUCTURE SCI REVOLU; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Luders E, 2007, NEUROIMAGE, V37, P1457, DOI 10.1016/j.neuroimage.2007.06.028; Ludwig AM, 1998, CREATIVITY RES J, V11, P93, DOI 10.1207/s15326934crj1102_1; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Miller GF, 2007, SCHIZOPHR RES, V93, P317, DOI 10.1016/j.schres.2007.02.007; Nakamura M, 2005, BIOL PSYCHIAT, V58, P468, DOI 10.1016/j.biopsych.2005.04.016; NESSE RM, 2005, EVOLUTIONARY PSYCHOL, P903; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; RINGMAN JM, 2007, BRAIN; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P441, DOI 10.1111/j.1745-6924.2009.01152.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sprooten E, 2009, MOL PSYCHIATR, V14, P237, DOI 10.1038/mp.2008.136; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STERNBERG RJ, 2005, HDB CREATIVITY, P490; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thomson PA, 2007, MOL PSYCHIATR, V12, P94, DOI 10.1038/sj.mp.4001889; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x	56	83	85	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9818	10.1371/journal.pone.0009818	http://dx.doi.org/10.1371/journal.pone.0009818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339554	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894300031
J	Balyasnikova, IV; Ferguson, SD; Sengupta, S; Han, Y; Lesniak, MS				Balyasnikova, Irina V.; Ferguson, Sherise D.; Sengupta, Sadhak; Han, Yu; Lesniak, Maciej S.			Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma	PLOS ONE			English	Article							FACTOR RECEPTOR-VIII; EXPRESSION; GENES; DELIVERY; ANGIOGENESIS; SUPPRESSION; CETUXIMAB; BREAST; ALPHA	Background: Glioblastoma multiforme is the most lethal brain tumor with limited therapeutic options. Antigens expressed on the surface of malignant cells are potential targets for antibody-mediated gene/drug delivery. Principal Findings: In this study, we investigated the ability of genetically modified human mesenchymal stem cells (hMSCs) expressing a single-chain antibody (scFv) on their surface against a tumor specific antigen, EGFRvIII, to enhance the therapy of EGFRvIII expressing glioma cells in vivo. The growth of U87-EGFRvIII was specifically delayed in co-culture with hMSC-scFvEGFRvIII. A significant down-regulation was observed in the expression of pAkt in EGFRvIII expressing glioma cells upon culture with hMSC-scFvEGFRvIII vs. controls as well as in EGFRvIII expressing glioma cells from brain tumors co-injected with hMSC-scFvEGFRvIII in vivo. hMSC expressing scFvEGFRvIII also demonstrated several fold enhanced retention in EGFRvIII expressing flank and intracranial glioma xenografts vs. control hMSCs. The growth of U87-EGFRvIII flank xenografts was inhibited by 50% in the presence of hMSC-scFvEGFRvIII (p<0.05). Moreover, animals co-injected with U87-EGFRvIII and hMSC-scFvEGFRvIII intracranially showed significantly improved survival compared to animals injected with U87-EGFRvIII glioma cells alone or with control hMSCs. This survival was further improved when the same animals received an additional dosage of hMSC-scFvEGFRvIII two weeks after initial tumor implantation. Of note, EGFRvIII expressing brain tumors co-injected with hMSCs had a lower density of CD31 expressing blood vessels in comparison with control tumors, suggesting a possible role in tumor angiogenesis. Conclusions/Significance: The results presented in this study illustrate that genetically modified MSCs may function as a novel therapeutic vehicle for malignant brain tumors.	[Balyasnikova, Irina V.; Ferguson, Sherise D.; Sengupta, Sadhak; Han, Yu; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA	University of Chicago	Balyasnikova, IV (corresponding author), Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA.	mlesniak@surgery.bsd.uchicago.edu	Han, Yu/GZA-9220-2022; Sengupta, Sadhak/D-2526-2009		National Cancer Institute [R01-CA122930, R01-CA138587, R21-CA135728]; National Institute of Neurological Disorders and Stroke [K08-NS046430]; Alliance for Cancer Gene Therapy Young Investigator Award; American Cancer Society [RSG-07-276-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA138587, R01CA122930, R21CA135728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alliance for Cancer Gene Therapy Young Investigator Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute (R01-CA122930, R01-CA138587, R21-CA135728), the National Institute of Neurological Disorders and Stroke (K08-NS046430), The Alliance for Cancer Gene Therapy Young Investigator Award, and the American Cancer Society (RSG-07-276-01-MGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALYASNIKOVA IV, 2009, J TISSUE ENG RE 1124; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Emrich JG, 2002, AM J CLIN ONCOL-CANC, V25, P541, DOI 10.1097/00000421-200212000-00001; Frank RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008314; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GARCIA DP, 1993, CANCER RES, V53, P3217; Han W, 2006, CANCER BIOL THER, V5, P1361, DOI 10.4161/cbt.5.10.3226; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Jost M, 2001, J BIOL CHEM, V276, P6320, DOI 10.1074/jbc.M008210200; Kanehira M, 2007, CANCER GENE THER, V14, P894, DOI 10.1038/sj.cgt.7701079; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kuan CT, 1999, CLIN CANCER RES, V5, P1539; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Lal A, 2002, CANCER RES, V62, P3335; LIBERMANN TA, 1984, CANCER RES, V44, P753; LUETZKENDORF J, 2009, J CELL MOL MED; Luwor RB, 2001, CANCER RES, V61, P5355; Mishima K, 2001, CANCER RES, V61, P5349; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Neyns B, 2009, ANN ONCOL, V20, P1596, DOI 10.1093/annonc/mdp032; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Patel D, 2007, ANTICANCER RES, V27, P3355; Sampson JH, 2000, P NATL ACAD SCI USA, V97, P7503, DOI 10.1073/pnas.130166597; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Schmidt M, 1999, ONCOGENE, V18, P1711, DOI 10.1038/sj.onc.1202489; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wu JL, 2004, NEUROL RES, V26, P785, DOI 10.1179/016164104225014139; Yang BJ, 2009, NEUROSURGERY, V65, P610, DOI 10.1227/01.NEU.0000350227.61132.A7; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181	46	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9750	10.1371/journal.pone.0009750	http://dx.doi.org/10.1371/journal.pone.0009750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305783	Green Published, gold, Green Submitted			2022-12-25	WOS:000276456300004
J	Wang, YX; Khaing, ZZ; Li, N; Hall, B; Schmidt, CE; Ellington, AD				Wang, Yuxuan; Khaing, Zin Z.; Li, Na; Hall, Brad; Schmidt, Christine E.; Ellington, Andrew D.			Aptamer Antagonists of Myelin-Derived Inhibitors Promote Axon Growth	PLOS ONE			English	Article							NOGO-RECEPTOR; OUTGROWTH INHIBITOR; EMERGING CLASS; RNA APTAMERS; GLYCOPROTEIN; IDENTIFICATION; REGENERATION; RHO; ANTIBODIES; PEGAPTANIB	Myelin of the adult central nervous system (CNS) is one of the major sources of inhibitors of axon regeneration following injury. The three known myelin-derived inhibitors (Nogo, MAG, and OMgp) bind with high affinity to the Nogo-66 receptor (NgR) on axons and limit neurite outgrowth. Here we show that RNA aptamers can be generated that bind with high affinity to NgR, compete with myelin-derived inhibitors for binding to NgR, and promote axon elongation of neurons in vitro even in the presence of these inhibitors. Aptamers may have key advantages over protein antagonists, including low immunogenicity and the possibility of ready modification during chemical synthesis for stability, signaling, or immobilization. This first demonstration that aptamers can directly influence neuronal function suggests that aptamers may prove useful for not only healing spinal cord and other neuronal damage, but may be more generally useful as neuromodulators.	[Wang, Yuxuan; Li, Na; Hall, Brad; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Khaing, Zin Z.; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Schmidt, Christine E.] Univ Texas Austin, Cockrell Sch Engn, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wang, YX (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	andy.ellington@mail.utexas.edu	Schmidt, Christine E/P-1613-2016	Khaing, Zin/0000-0001-5652-5891	National Science Foundation; Howard Hughes Medical Institute through the Freshman Research Initiative; Texas Institute for Drug and Diagnostics Development; Gillson Longenbaugh Foundation; Welch Foundation [F-1654]	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute through the Freshman Research Initiative; Texas Institute for Drug and Diagnostics Development; Gillson Longenbaugh Foundation; Welch Foundation(The Welch Foundation)	This work was funded in part by the National Science Foundation, the Howard Hughes Medical Institute through the Freshman Research Initiative, the Texas Institute for Drug and Diagnostics Development, the Gillson Longenbaugh Foundation, and by the Welch Foundation (F-1654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Burmeister PE, 2006, OLIGONUCLEOTIDES, V16, P337, DOI 10.1089/oli.2006.16.337; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Dupuis L, 2008, P NATL ACAD SCI USA, V105, P740, DOI 10.1073/pnas.0703842105; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fiedler M, 2002, PROTEIN ENG, V15, P931, DOI 10.1093/protein/15.11.931; Fish G, 2003, OPHTHALMOLOGY, V110, P979, DOI 10.1016/S0161-6420(03)00085-X; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Martin DF, 2002, RETINA-J RET VIT DIS, V22, P143; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Ng EWM, 2005, CAN J OPHTHALMOL, V40, P352, DOI 10.1016/S0008-4182(05)80078-X; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; PENDERGRAST PS, 2006, GTC BIO 4 ANN C CYT, P109; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Rimmele M, 2003, CHEMBIOCHEM, V4, P963, DOI 10.1002/cbic.200300648; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Seo HS, 2000, J MICROBIOL BIOTECHN, V10, P707; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; Takei Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000062; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354	41	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9726	10.1371/journal.pone.0009726	http://dx.doi.org/10.1371/journal.pone.0009726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300533	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400020
J	Moustafa, A; Evans, AN; Kulis, DM; Hackett, JD; Erdner, DL; Anderson, DM; Bhattacharya, D				Moustafa, Ahmed; Evans, Andrew N.; Kulis, David M.; Hackett, Jeremiah D.; Erdner, Deana L.; Anderson, Donald M.; Bhattacharya, Debashish			Transcriptome Profiling of a Toxic Dinoflagellate Reveals a Gene-Rich Protist and a Potential Impact on Gene Expression Due to Bacterial Presence	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; GENOME; ALEXANDRIUM; SEQUENCE; BIOSYNTHESIS; PHAGOTROPHY; CHLOROPHYLL; DISCOVERY; DINOPHYTA; PROTEINS	Background: Dinoflagellates are unicellular, often photosynthetic protists that play a major role in the dynamics of the Earth's oceans and climate. Sequencing of dinoflagellate nuclear DNA is thwarted by their massive genome sizes that are often several times that in humans. However, modern transcriptomic methods offer promising approaches to tackle this challenging system. Here, we used massively parallel signature sequencing (MPSS) to understand global transcriptional regulation patterns in Alexandrium tamarense cultures that were grown under four different conditions. Methodology/Principal Findings: We generated more than 40,000 unique short expression signatures gathered from the four conditions. Of these, about 11,000 signatures did not display detectable differential expression patterns. At a p-value, < 1E-10, 1,124 signatures were differentially expressed in the three treatments, xenic, nitrogen-limited, and phosphorus-limited, compared to the nutrient-replete control, with the presence of bacteria explaining the largest set of these differentially expressed signatures. Conclusions/Significance: Among microbial eukaryotes, dinoflagellates contain the largest number of genes in their nuclear genomes. These genes occur in complex families, many of which have evolved via recent gene duplication events. Our expression data suggest that about 73% of the Alexandrium transcriptome shows no significant change in gene expression under the experimental conditions used here and may comprise a "core'' component for this species. We report a fundamental shift in expression patterns in response to the presence of bacteria, highlighting the impact of biotic interaction on gene expression in dinoflagellates.	[Moustafa, Ahmed; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Evans, Andrew N.; Erdner, Deana L.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Kulis, David M.; Anderson, Donald M.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Hackett, Jeremiah D.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Austin; Woods Hole Oceanographic Institution; University of Arizona	Moustafa, A (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Moustafa, Ahmed/AAZ-3991-2020; Erdner, Deana L/C-4981-2008; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Erdner, Deana L/0000-0002-1736-8835; Moustafa, Ahmed/0000-0002-0111-3555; Evans, Andrew/0000-0002-5366-9942	National Institutes of Health [R01 ES 013679-01A2]; NIEHS [P50 ES 012742]; NSF [OCE-043072, EF-0732440]; Institutional NRSA [T 32 GM98629]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679, P50ES012742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629, T32GM008629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NSF(National Science Foundation (NSF)); Institutional NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by a collaborative grant from the National Institutes of Health (R01 ES 013679-01A2) awarded to DB, DMA, and M. Bento Soares. Funding support for DMA and DLE was also provided from the Woods Hole Center for Oceans and Human Health from the NSF/NIEHS Centers for Oceans and Human Health program, NIEHS (P50 ES 012742) and (NSF OCE-043072). Additional support came from the National Science Foundation (EF-0732440) in a grant awarded to F. Gerald Plumley, DB, JDH, and DMA. AM was supported by an Institutional NRSA (T 32 GM98629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2001, ENVIRON MICROBIOL, V3, P380, DOI 10.1046/j.1462-2920.2001.00207.x; Anderson DM, 2005, DEEP-SEA RES PT II, V52, P2522, DOI 10.1016/j.dsr2.2005.06.014; ANDERSON DM, 1985, LIMNOL OCEANOGR, V30, P1000, DOI 10.4319/lo.1985.30.5.1000; ANDERSON DM, 1985, J PHYCOL, V21, P200; ANDERSON DM, 1984, J PHYCOL, V20, P418, DOI 10.1111/j.0022-3646.1984.00418.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG JM, 2007, BIOCHEMISTRY; Bhaud Y, 2000, J CELL SCI, V113, P1231; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CALVIN M, 1948, SCIENCE, V107, P476, DOI 10.1126/science.107.2784.476; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Choi JY, 1997, J EUKARYOT MICROBIOL, V44, P412, DOI 10.1111/j.1550-7408.1997.tb05717.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; DELAHABA G, 1959, J BIOL CHEM, V234, P603; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Doucette Gregory J., 1995, Natural Toxins, V3, P65, DOI 10.1002/nt.2620030202; DREBES G, 1982, HELGOLANDER MEERESUN, V35, P501, DOI 10.1007/BF01999138; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fagerberg T, 2009, HARMFUL ALGAE, V8, P823, DOI 10.1016/j.hal.2009.02.002; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; FUKAMI K, 1992, NIPPON SUISAN GAKK, V58, P1073; Gallacher S, 1997, APPL ENVIRON MICROB, V63, P239, DOI 10.1128/AEM.63.1.239-245.1997; GALLERON C, 1978, BIOCHIMIE, V60, P1235; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; HAIDAK DJ, 1966, SCIENCE, V152, P212, DOI 10.1126/science.152.3719.212; HAN JH, 1980, J BACTERIOL, V141, P1466, DOI 10.1128/JB.141.3.1466-1469.1980; HAXO FT, 1976, PLANT PHYSIOL, V57, P297, DOI 10.1104/pp.57.2.297; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hold GL, 2001, FEMS MICROBIOL ECOL, V36, P223, DOI 10.1111/j.1574-6941.2001.tb00843.x; HOLMHANSEN O, 1969, SCIENCE, V163, P87, DOI 10.1126/science.163.3862.87; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacobson DM, 1996, J PHYCOL, V32, P279, DOI 10.1111/j.0022-3646.1996.00279.x; JEON KW, 1967, EXP CELL RES, V48, P236, DOI 10.1016/0014-4827(67)90313-8; Jeong HJ, 2005, AQUAT MICROB ECOL, V40, P133, DOI 10.3354/ame040133; JEONG HJ, 1994, MAR ECOL PROG SER, V106, P173, DOI 10.3354/meps106173; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Legrand C, 1998, AQUAT MICROB ECOL, V15, P65, DOI 10.3354/ame015065; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mayali X, 2008, J PHYCOL, V44, P923, DOI 10.1111/j.1529-8817.2008.00549.x; Mayali X, 2008, APPL ENVIRON MICROB, V74, P2595, DOI 10.1128/AEM.02191-07; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Pfannschmidt T, 2009, ANN BOT-LONDON, V103, P599, DOI 10.1093/aob/mcn081; Pfiester L. A., 1987, BIOL DINOFLAGELLATES, P611; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Scheetz TE, 2004, GENOME RES, V14, P733, DOI 10.1101/gr.1414204; SHIMIZU Y, 1986, ANN NY ACAD SCI, V479, P24, DOI 10.1111/j.1749-6632.1986.tb15558.x; SHIMIZU Y, 1984, J AM CHEM SOC, V106, P6433, DOI 10.1021/ja00333a062; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Trivedi N, 2002, FUTURE GENER COMP SY, V18, P863, DOI 10.1016/S0167-739X(02)00059-6; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	63	113	115	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9688	10.1371/journal.pone.0009688	http://dx.doi.org/10.1371/journal.pone.0009688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300646	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900019
J	Fukumoto, H; Tokuda, T; Kasai, T; Ishigami, N; Hidaka, H; Kondo, M; Allsop, D; Nakagawa, M				Fukumoto, Hiroaki; Tokuda, Takahiko; Kasai, Takashi; Ishigami, Noriko; Hidaka, Hiroya; Kondo, Masaki; Allsop, David; Nakagawa, Masanori			High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients	FASEB JOURNAL			English	Article						amyloid-beta protein; dementia; ELISA; size-exclusion chromatography	MILD COGNITIVE IMPAIRMENT; A-BETA; PROTEIN AGGREGATION; PRECURSOR PROTEIN; BRAIN-TISSUE; DISEASE; DIAGNOSIS; CSF; PEPTIDE; TAU	There is accumulating evidence that soluble amyloid-beta (A beta) oligomers, rather than amyloid fibrils, are the principal pathogenic species in Alzheimer disease (AD). Here, we have developed a novel enzyme-linked immunosorbent assay (ELISA) specific for high-molecular-weight (HMW) A beta oligomers. Analysis of A beta oligomers derived from synthetic A beta 1-42, by size-exclusion chromatography (SEC), revealed that our ELISA specifically detected HMW A beta oligomers of 40-200 kDa. Using this ELISA, we detected significantly higher (P<0.0001) signals in cerebrospinal fluid (CSF) samples from 25 patients with AD or mild cognitive impairment (MCI), compared to 25 age-matched controls. As a test for discriminating between the AD/MCI and control groups, the area under the curve in receiver operating characteristic analysis for the CSF HMW A beta oligomers was greater than that for CSF A beta x-42. Furthermore, the CSF levels of HMW A beta oligomers showed a negative correlation with Mini-Mental State Examination scores in the AD/MCI group. We conclude that the CSF HMW A beta oligomers detected by our ELISA could be useful as a diagnostic marker for AD, and also as a potential surrogate marker for disease severity. Our results support the idea that soluble HMW A beta oligomers play a critical role in the pathogenesis and progression of AD.-Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., Nakagawa, M. High-molecular weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J. 24, 2716-2726 (2010). www.fasebj.org	[Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Neurol, Kamigyo Ku, Kyoto 6028566, Japan; [Fukumoto, Hiroaki] Takeda Pharmaceut Co, Pharmacol Res Div, Osaka, Japan; [Hidaka, Hiroya] Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan; [Allsop, David] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Kyoto Prefectural University of Medicine; Takeda Pharmaceutical Company Ltd; Shinshu University; Lancaster University	Tokuda, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	ttokuda@koto.kpu-m.ac.jp	Allsop, David/B-9725-2008	Allsop, David/0000-0002-0513-5575	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology [20591007]; Japan Society for the Promotion of Science; Research Committee of CNS Degenerative Disease	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Committee of CNS Degenerative Disease	This work was supported in part by a Grant-in-Aid from the Research Committee of CNS Degenerative Disease, the Ministry of Health, Labor, and Welfare of Japan (to M.N.) and by a Grant-in-Aid for Scientific Research (C) (20591007) from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T.T.).	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; El-Agnaf OMA, 2003, LANCET NEUROL, V2, P461, DOI 10.1016/S1474-4422(03)00481-2; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Galasko D, 1997, NEUROLOGY, V48, P632, DOI 10.1212/WNL.48.3.632; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KAMBOH MI, 1988, J LIPID RES, V29, P1535; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tamaoka A, 1997, J NEUROL SCI, V148, P41, DOI 10.1016/S0022-510X(96)00314-0; Tokuda T, 1997, ANN NEUROL, V41, P271, DOI 10.1002/ana.410410220; Tokuda T, 2002, NEUROLOGY, V58, P1415, DOI 10.1212/WNL.58.9.1415; van Helmond Z, 2009, J NEUROSCI METH, V176, P206, DOI 10.1016/j.jneumeth.2008.09.002; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565	48	194	204	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2716	2726		10.1096/fj.09-150359	http://dx.doi.org/10.1096/fj.09-150359			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20339023				2022-12-25	WOS:000285005400013
J	Ernst, A; Campos, B; Meier, J; Devens, F; Liesenberg, F; Wolter, M; Reifenberger, G; Herold-Mende, C; Lichter, P; Radlwimmer, B				Ernst, A.; Campos, B.; Meier, J.; Devens, F.; Liesenberg, F.; Wolter, M.; Reifenberger, G.; Herold-Mende, C.; Lichter, P.; Radlwimmer, B.			De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures	ONCOGENE			English	Article						miR-17-92; glioblastoma; retinoic acid; spheroid culture; CTGF	TUMOR-INITIATING CELLS; TRANS-RETINOIC ACID; STEM-CELLS; GROWTH-FACTOR; NEURAL PRECURSORS; PROGENITOR CELLS; GLIOMA-CELLS; IN-VITRO; EXPRESSION; MICRORNAS	All-trans retinoic acid is a potent promoter of cellular differentiation processes, which is used in cancer therapy. Glioblastoma spheroid cultures are enriched in tumor-initiating cells, and provide a model to test new treatment options in vitro. We investigated the molecular mechanisms of response to exposure to differentiation-promoting conditions in such cultures. Microarray analyses of five independent cultures showed that after induction of differentiation, inhibitors of transforming growth factor beta/bone morphogenetic protein, Wnt/beta-catenin and IGF signaling were upregulated, whereas expression of several microRNAs decreased, particularly that of the miR-17-92 cluster. In primary astrocytic gliomas (n = 82), expression of several members of miR-17-92 was significantly higher relative to those of normal brain (n = 8) and significantly increased with tumor grade progression (P < 0.05). A high-level amplification of the miR-17-92 locus was detected in one glioblastoma specimen. Transfection of inhibitors of miR-17-92 induced increased apoptosis and decreased cell proliferation in glioblastoma spheroids. Mir-17-92 inhibition was also associated with increased messenger RNA (mRNA) and/or protein expression of CDKN1A, E2F1, PTEN and CTGF. The CTGF gene was shown to be a target of miR-17-92 in glioblastoma spheroids by luciferase reporter assays. Our results suggest that miR-17-92 and its target CTGF mediate effects of differentiation-promoting treatment on glioblastoma cells through multiple regulatory pathways. Oncogene (2010) 29, 3411-3422; doi:10.1038/onc.2010.83; published online 22 March 2010	[Ernst, A.; Meier, J.; Devens, F.; Lichter, P.; Radlwimmer, B.] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Campos, B.; Herold-Mende, C.] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, Heidelberg, Germany; [Liesenberg, F.; Wolter, M.; Reifenberger, G.] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf	Radlwimmer, B (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	b.radlwimmer@dkfz.de	Radlwimmer, Bernhard F/I-3229-2013; Reifenberger, Guido/AAE-3599-2019	Radlwimmer, Bernhard F/0000-0002-4553-7800; 	German Bundesministerium fur Bildung und Forschung [01GS0883, 01GS0884, 01GS0886]; European Union [MRTN-CT-2006-035733]; Tumorzentrum Heidelberg-Mannheim; Sibylle Assmus Foundation; Verein zur Forderung der Krebsforschung e.V	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Tumorzentrum Heidelberg-Mannheim(European Commission); Sibylle Assmus Foundation; Verein zur Forderung der Krebsforschung e.V	We thank F Engel, M Zapatka, S Anders and W Huber for bioinformatic support. We also thank S Hofmann for support with array comparative genomic hybridization, A Korshunov for support with specimen analysis and B Malzkorn for sharing data. This study was supported by Grants 01GS0883, 01GS0884 and 01GS0886 of the German Bundesministerium fur Bildung und Forschung, by Grant MRTN-CT-2006-035733 from the European Union FP6 Marie Curie Research Training Network; by a Grant from the Tumorzentrum Heidelberg-Mannheim; by the Sibylle Assmus Foundation; and by the Verein zur Forderung der Krebsforschung e.V.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Das A, 2008, J NEURO-ONCOL, V87, P9, DOI 10.1007/s11060-007-9485-1; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dictus C, 2007, J NEUROSCI METH, V161, P250, DOI 10.1016/j.jneumeth.2006.11.012; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Karmakar S, 2007, APOPTOSIS, V12, P2077, DOI 10.1007/s10495-007-0116-2; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Lu JR, 2008, J NEURO-ONCOL, V87, P271, DOI 10.1007/s11060-008-9518-4; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; MALZKORN B, 2009, BRAIN PATHO IN PRESS; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Navarro A, 2009, ONCOLOGY-BASEL, V76, P162, DOI 10.1159/000201569; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025; Ohno R, 2003, LEUKEMIA, V17, P1454, DOI 10.1038/sj.leu.2403031; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister S, 2007, GENE CHROMOSOME CANC, V46, P839, DOI 10.1002/gcc.20471; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zeng Y, 2009, J CLIN NEUROSCI, V16, P285, DOI 10.1016/j.jocn.2007.11.014	55	119	126	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3411	3422		10.1038/onc.2010.83	http://dx.doi.org/10.1038/onc.2010.83			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20305691				2022-12-25	WOS:000278622700009
J	Walton, KL; Makanji, Y; Chen, J; Wilce, MC; Chan, KL; Robertson, DM; Harrison, CA				Walton, Kelly L.; Makanji, Yogeshwar; Chen, Justin; Wilce, Matthew C.; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.			Two Distinct Regions of Latency-associated Peptide Coordinate Stability of the Latent Transforming Growth Factor-beta 1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CAMURATI-ENGELMANN-DISEASE; DOMAIN-SPECIFIC MUTATIONS; MOLECULAR-WEIGHT COMPLEX; TGF-BETA; BINDING-PROTEIN; EXTRACELLULAR-MATRIX; OVARIAN FAILURE; HUMAN-PLATELETS; STRUCTURAL-CHARACTERIZATION	Transforming growth factor-beta 1 (TGF-beta 1) is secreted as part of an inactive complex consisting of the mature dimer, the TGF-beta 1 propeptide (latency-associated peptide (LAP)), and latent TGF-beta-binding proteins. Using in vitro mutagenesis, we identified the regions of LAP that govern the cooperative assembly and stability of the latent TGF-beta 1 complex. Initially, hydrophobic LAP residues (Ile(53), Leu(54), Leu(57), and Leu(59)), which form a contiguous epitope on one surface of an amphipathic alpha-helix, interact with mature TGF-beta 1 to form the small latent complex. TGF-beta 1 binding is predicted to alter LAP conformation, exposing ionic residues (Arg(45), Arg(50), Lys(56), and Arg(58)) on the other side of the alpha-helix, which form the binding site for latent TGF-beta-binding proteins. The stability of the resultant large latent complex is dependent upon covalent dimerization of LAP, which is facilitated by key residues (Phe(198), Asp(199), Val(200), Leu(208), Phe(217), and Leu(219)) at the dimer interface. Significantly, genetic mutations in LAP (e.g. R218H) that cause the rare bone disorder Camurati-Engelmann disease disrupted dimerization and reduced the stability of the latent TGF-beta 1 complex.	[Walton, Kelly L.; Makanji, Yogeshwar; Chen, Justin; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Chen, Justin; Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University	Harrison, CA (corresponding author), Prince Henrys Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	craig.harrison@princehenrys.org	Walton, Kelly/ABF-7282-2020; Chan, Karen/E-4041-2015	Walton, Kelly/0000-0003-0627-2958; Chan, Karen/0000-0001-9947-4713; Harrison, Craig/0000-0003-1059-3682	National Health and Medical Research Council of Australia [494804, 241000]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council of Australia Project 494804 (to C. A. H.) and Program Grant 241000 (to K. L. W. and D. M. R.) and by the Victorian Government's Operational Infrastructure Support Program.	Altmann CR, 2002, DEV BIOL, V248, P118, DOI 10.1006/dbio.2002.0716; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chen Y, 2005, J MOL BIOL, V345, P175, DOI 10.1016/j.jmb.2004.10.039; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; FROLIK CA, 1983, P NATL ACAD SCI-BIOL, V80, P3676, DOI 10.1073/pnas.80.12.3676; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Janssens K, 2003, J BIOL CHEM, V278, P7718, DOI 10.1074/jbc.M208857200; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Saito T, 2001, J BIOL CHEM, V276, P11469, DOI 10.1074/jbc.C000859200; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Thies RS, 2001, GROWTH FACTORS, V18, P251; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wu SL, 2007, BONE, V40, P1630, DOI 10.1016/j.bone.2007.02.025; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200; Zhao H, 2007, FERTIL STERIL, V88, P1474, DOI 10.1016/j.fertnstert.2007.01.021	61	71	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17029	17037		10.1074/jbc.M110.110288	http://dx.doi.org/10.1074/jbc.M110.110288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308061	Green Published, hybrid			2022-12-25	WOS:000277982600066
J	Buhler, D; Rossmann, R; Landolt, S; Balsiger, S; Fischer, HM; Hennecke, H				Buehler, Doris; Rossmann, Reinhild; Landolt, Sarah; Balsiger, Sylvia; Fischer, Hans-Martin; Hennecke, Hauke			Disparate Pathways for the Biogenesis of Cytochrome Oxidases in Bradyrhizobium japonicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE PROTEIN; THIOL-DISULFIDE OXIDOREDUCTASE; NITROUS-OXIDE REDUCTASE; B SITE FORMATION; C-OXIDASE; CRYSTAL-STRUCTURE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; RNA-POLYMERASE; ACTIVE-SITE	This work addresses the biogenesis of heme-copper terminal oxidases in Bradyrhizobium japonicum, the nitrogen-fixing root nodule symbiont of soybean. B. japonicum has four quinol oxidases and four cytochrome oxidases. The latter include the aa(3)- and cbb(3)-type oxidases. Although both have a Cu-B center in subunit I, the subunit II proteins differ in having either a Cu-A center (in aa(3)) or a covalently bound heme c (in cbb(3)). Two biogenesis factors were genetically studied here, the periplasmically exposed CoxG and ScoI proteins, which are the respective homologs of the mitochondrial copper-trafficking chaperones Cox11 and Sco1 for the formation of the Cu-B center in subunit I and the Cu-A center in subunit II of cytochrome aa(3). We could demonstrate copper binding to ScoI in vitro, a process for which the thiols of cysteine residues 74 and 78 in the ScoI polypeptide were shown to be essential. Knock-out mutations in the B. japonicum coxG and scoI genes led to loss of cytochrome aa(3) assembly and activity in the cytoplasmic membrane, whereas the cbb(3)-type cytochrome oxidase apparently remained unaffected. This suggests that subunit I of the cbb(3)-type oxidase obtains its copper cofactor via a different pathway than cytochrome aa(3). In contrast to the coxG mutation, the scoI mutation caused a decreased symbiotic nitrogen fixation activity. We hypothesize that a periplasmic B. japonicum protein other than any of the identified Cu-A proteins depends on ScoI and is required for an effective symbiosis.	[Buehler, Doris; Rossmann, Reinhild; Landolt, Sarah; Balsiger, Sylvia; Fischer, Hans-Martin; Hennecke, Hauke] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	ETH Zurich	Hennecke, H (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hennecke@micro.biol.ethz.ch			ETH Zurich; Swiss National Foundation for Scientific Research	ETH Zurich(ETH Zurich); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by grants from ETH Zurich and the Swiss National Foundation for Scientific Research.	Abajian C, 2006, J BIOL INORG CHEM, V11, P459, DOI 10.1007/s00775-006-0096-7; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; ARSLAN E, 2001, THESIS FEDERAL I TEC; Badrick AC, 2007, FEBS LETT, V581, P4663, DOI 10.1016/j.febslet.2007.08.058; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2007, STRUCTURE, V15, P1132, DOI 10.1016/j.str.2007.07.011; Banting GS, 2006, EUKARYOT CELL, V5, P568, DOI 10.1128/EC.5.3.568-578.2006; BOTT M, 1992, ARCH MICROBIOL, V158, P335, DOI 10.1007/BF00245362; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bundschuh FA, 2008, BBA-BIOENERGETICS, V1777, P1336, DOI 10.1016/j.bbabio.2008.05.448; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; CAO J, 1992, J BIOL CHEM, V267, P24273; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Carr HS, 2005, J BIOL CHEM, V280, P22664, DOI 10.1074/jbc.M414077200; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Cawthorn TR, 2009, BIOCHEMISTRY-US, V48, P4448, DOI 10.1021/bi802288m; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DEMEREC M, 1968, J GEN MICROBIOL, V50, P1; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2680, DOI 10.1073/pnas.87.7.2680; Gottfert M, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P99; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; Greiner P, 2008, BBA-BIOENERGETICS, V1777, P904, DOI 10.1016/j.bbabio.2008.04.003; HAHN M, 1984, MOL GEN GENET, V193, P46, DOI 10.1007/BF00327412; Haltia T, 2003, BIOCHEM J, V369, P77, DOI 10.1042/BJ20020782; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Imriskova-Sosova I, 2005, BIOCHEMISTRY-US, V44, P16949, DOI 10.1021/bi051343i; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kaneko T, 2002, DNA RES, V9, P225, DOI 10.1093/dnares/9.6.225; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Khalimonchuk O, 2005, CURR GENET, V47, P223, DOI 10.1007/s00294-005-0569-1; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; LOFERER H, 1994, EUR J BIOCHEM, V223, P339, DOI 10.1111/j.1432-1033.1994.tb18999.x; Lu ZH, 2002, ADV PROTEIN CHEM, V60, P93; Mesa S, 2004, PHYSIOL PLANTARUM, V120, P205, DOI 10.1111/j.0031-9317.2004.0211.x; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Rossmann R, 1997, FEBS LETT, V406, P249, DOI 10.1016/S0014-5793(97)00270-6; Saenkham P, 2009, FEMS MICROBIOL LETT, V293, P122, DOI 10.1111/j.1574-6968.2009.01516.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Surpin MA, 1996, GENE, V183, P201, DOI 10.1016/S0378-1119(96)00559-8; Surpin MA, 1999, APPL ENVIRON MICROB, V65, P339; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1991, J BIOENERG BIOMEMBR, V23, P257, DOI 10.1007/BF00762221; Velasco L, 2004, ANTON LEEUW INT J G, V85, P229, DOI 10.1023/B:ANTO.0000020156.42470.db; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200; Ye QL, 2005, BIOCHEMISTRY-US, V44, P2934, DOI 10.1021/bi0480537; Zufferey R, 1997, FEBS LETT, V412, P75, DOI 10.1016/S0014-5793(97)00746-1; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	86	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15704	15713		10.1074/jbc.M109.085217	http://dx.doi.org/10.1074/jbc.M109.085217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335176	hybrid, Green Published			2022-12-25	WOS:000277715900005
J	Chen, JQ; Li, Y; Pan, X; Lei, BK; Chang, C; Liu, ZX; Lu, H				Chen, Jian-Qiang; Li, Yang; Pan, Xian; Lei, Bing-Kun; Chang, Cheng; Liu, Zheng-Xun; Lu, Hong			The Fission Yeast Inhibitor of Growth (ING) Protein Png1p Functions in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4 ACETYLATION; DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; PHD FINGER; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; CELL-SEPARATION; REPAIR; ACETYLTRANSFERASE	In budding yeast and human cells, ING (inhibitor of growth) tumor suppressor proteins play important roles in response to DNA damage by modulating chromatin structure through collaborating with histone acetyltransferase or histone deacetylase complexes. However, the biological functions of ING family proteins in fission yeast are poorly defined. Here, we report that Png1p, a fission yeast ING homolog protein, is required for cell growth under normal and DNA-damaged conditions. Png1p was further confirmed to regulate histone H4acetylation through collaboration with the MYST family histone acetyltransferase 1 (Mst1). Additionally, both fission yeast PNG1 and MST1 can functionally complement their budding yeast correspondence homologs YNG2 and ESA1, respectively. These results suggest that ING proteins in fission yeast might also conserve function, similar to ING proteins in budding yeast and human cells. We also showed that decreased acetylation in Delta png1 cells resulted in genome-wide down-regulation of 756 open reading frames, including the central DNA repair gene RAD22. Overexpression of RAD22 partially rescued the png1 mutant phenotype under both normal and DNA-damaged conditions. Furthermore, decreased expression of RAD22 in Delta png1 cells was confirmed to be caused by decreased H4 acetylation at its promoter. Altogether, these results indicate that Png1p is required for histone H4 acetylation and functions upstream of RAD22 in the DNA damage response pathway.	[Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Lu, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	honglu0211@yahoo.com		Lei, Bingkun/0000-0002-2773-1669; /0000-0003-1726-3037	National Program on Key Basic Research [2009CB825601]; National Natural Science Foundation of China [30771145, 30671175]; Specialized Research Fund for the Doctoral Program of High Education (SRFDP) [20060246017]; Fudan University	National Program on Key Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of High Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fudan University	This work was supported by grants from the National Program on Key Basic Research Project (973 Program, 2009CB825601), the National Natural Science Foundation of China (30771145 and 30671175), the Specialized Research Fund for the Doctoral Program of High Education (SRFDP 20060246017), and the Innovation Fund of Fudan University.	Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CHLEBOWICZ E, 1979, MOL GEN GENET, V167, P279, DOI 10.1007/BF00267420; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Gomez EB, 2008, GENETICS, V179, P757, DOI 10.1534/genetics.107.085779; Gregan J, 2006, NAT PROTOC, V1, P2457, DOI 10.1038/nprot.2006.385; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim WJ, 2000, J BIOL CHEM, V275, P35607, DOI 10.1074/jbc.M007060200; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Minoda A, 2005, MOL BIOL CELL, V16, P316, DOI 10.1091/mbc.E04-06-0519; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nourani A, 2003, J BIOL CHEM, V278, P19171, DOI 10.1074/jbc.C300036200; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; OUSTRIN ML, 1995, BIOCHIMIE, V77, P279, DOI 10.1016/0300-9084(96)88137-5; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Saksouk N, 2008, CELL MOL LIFE SCI, V65, P1013, DOI 10.1007/s00018-008-7459-x; Shen L, 2003, FEBS LETT, V540, P86, DOI 10.1016/S0014-5793(03)00229-1; Shi XB, 2005, J CELL BIOCHEM, V96, P1127, DOI 10.1002/jcb.20625; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	45	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15786	15793		10.1074/jbc.M110.101832	http://dx.doi.org/10.1074/jbc.M110.101832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299455	hybrid, Green Published			2022-12-25	WOS:000277715900016
J	Pfaff, SJ; Fletterick, RJ				Pfaff, Samuel J.; Fletterick, Robert J.			Hormone Binding and Co-regulator Binding to the Glucocorticoid Receptor are Allosterically Coupled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; RETINOID-X-RECEPTOR; HEAT-SHOCK-PROTEIN; NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; LIVING CELLS; TRANSCRIPTIONAL COACTIVATOR; ESTROGEN-RECEPTORS; STEROID-RECEPTORS; COFACTOR BINDING	The glucocorticoid receptor initiates the cellular response to glucocorticoid steroid hormones in vertebrates. Co-regulator proteins dock to the receptor in response to hormone binding and potentiate the transcriptional activity of the receptor by modifying DNA and recruiting essential transcription factors like RNA polymerase II. Hormones and co-regulators bind at distinct sites in the ligand binding domain yet function cooperatively to mediate transcriptional control. This study reveals and quantifies energetic coupling between two binding sites using purified components. Using a library of peptides taken from co-regulator proteins, we determine the pattern of co-regulator binding to the glucocorticoid receptor ligand binding domain. We show that peptides from co-regulators differ in their effects on hormone binding and kinetics. Peptides from DAX1 and SRC1 bind with similar affinity, but DAX1 binding is coupled to hormone binding, and SRC1 is not. Mechanistic details of co-regulator binding and coupling to the hormone binding pocket are uncovered by analysis of properties endowed by mutation of a key residue in the allosteric network connecting the sites.	[Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pfaff, Samuel J.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	robert.fletterick@ucsf.edu						BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P13463, DOI 10.1021/bi00212a011; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Biddie SC, 2009, STRESS, V12, P193, DOI 10.1080/10253890802506409; Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Chrousos GP, 2004, J CLIN ENDOCR METAB, V89, P563, DOI 10.1210/jc.2003-032026; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DALMAN FC, 1991, BIOCHEMISTRY-US, V30, P5605, DOI 10.1021/bi00236a038; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Frego L, 2006, PROTEIN SCI, V15, P722, DOI 10.1110/ps.051781406; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; HUTCHISON KA, 1994, J BIOL CHEM, V269, P27894; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; KATZENELLENBOGEN BS, 1980, ANNU REV PHYSIOL, V42, P17, DOI 10.1146/annurev.ph.42.030180.000313; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Kroe RR, 2007, BIOPHYS CHEM, V128, P156, DOI 10.1016/j.bpc.2007.03.013; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lin SQ, 2002, ANAL BIOCHEM, V300, P15, DOI 10.1006/abio.2001.5437; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Madauss KP, 2008, BIOORG MED CHEM LETT, V18, P6097, DOI 10.1016/j.bmcl.2008.10.021; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Santin EP, 2009, J MED CHEM, V52, P3150, DOI 10.1021/jm900096q; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 1998, TRENDS ENDOCRIN MET, V9, P244, DOI 10.1016/S1043-2760(98)00059-9; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; SCHLATTER LK, 1992, MOL ENDOCRINOL, V6, P132, DOI 10.1210/me.6.1.132; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simmons CA, 2008, PROTEIN EXPRES PURIF, V62, P29, DOI 10.1016/j.pep.2008.07.008; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; Tanaka M, 2003, ENDOCRINOLOGY, V144, P4070, DOI 10.1210/en.2003-0282; Teichert A, 2009, BIOCHEMISTRY-US, V48, P1454, DOI 10.1021/bi801874n; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Warnmark A, 2000, J BIOL CHEM, V275, P15014, DOI 10.1074/jbc.M001007200; Wu J, 2004, MOL ENDOCRINOL, V18, P53, DOI 10.1210/me.2002-0373; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273; Zhu YJ, 1996, GENE EXPRESSION, V6, P185	83	22	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15256	15267		10.1074/jbc.M110.108118	http://dx.doi.org/10.1074/jbc.M110.108118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335180	hybrid, Green Published			2022-12-25	WOS:000277399000046
J	Widenmaier, SB; Kim, SJ; Yang, GK; De Los Reyes, T; Nian, C; Asadi, A; Seino, Y; Kieffer, TJ; Kwok, YN; McIntosh, CHS				Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Seino, Yutaka; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.			A GIP Receptor Agonist Exhibits beta-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved beta-Cell Function and Glycemic Control	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; ACTIVATED PROTEIN-KINASE; DOWN-REGULATION; GLUCOSE-INTOLERANCE; ENTEROINSULAR AXIS; BAX EXPRESSION; ANALOGS; RESISTANCE	Aims: The gastrointestinal hormone GIP promotes pancreatic islet function and exerts pro-survival actions on cultured beta-cells. However, GIP also promotes lipogenesis, thus potentially restricting its therapeutic use. The current studies evaluated the effects of a truncated GIP analog, D-Ala(2)-GIP(1-30) (D-GIP(1-30)), on glucose homeostasis and beta-cell mass in rat models of diabetes. Materials and Methods: The insulinotropic and pro-survival potency of D-GIP(1-30) was evaluated in perfused pancreas preparations and cultured INS-1 beta-cells, respectively, and receptor selectivity evaluated using wild type and GIP receptor knockout mice. Effects of D-GIP(1-30) on beta-cell function and glucose homeostasis, in vivo, were determined using Lean Zucker rats, obese Vancouver diabetic fatty rats, streptozotocin treated rats, and obese Zucker diabetic fatty rats, with effects on beta-cell mass determined in histological studies of pancreatic tissue. Lipogenic effects of D-GIP(1-30) were evaluated on cultured 3T3-L1 adipocytes. Results: Acutely, D-GIP(1-30) improved glucose tolerance and insulin secretion. Chronic treatment with D-GIP(1-30) reduced levels of islet pro-apoptotic proteins in Vancouver diabetic fatty rats and preserved beta-cell mass in streptozotocin treated rats and Zucker diabetic fatty rats, resulting in improved insulin responses and glycemic control in each animal model, with no change in body weight. In in vitro studies, D-GIP(1-30) exhibited equivalent potency to GIP(1-42) on beta-cell function and survival, but greatly reduced action on lipoprotein lipase activity in 3T3-L1 adipocytes. Conclusions: These findings demonstrate that truncated forms of GIP exhibit potent anti-diabetic actions, without pro-obesity effects, and that the C-terminus contributes to the lipogenic actions of GIP.	[Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Widenmaier, Scott B.; Kim, Su-Jin; Yang, Gary K.; De Los Reyes, Thomas; Nian, Cuilan; Asadi, Ali; Kieffer, Timothy J.; Kwok, Yin Nam; McIntosh, Christopher H. S.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V5Z 1M9, Canada; [Seino, Yutaka] Kansai Elect Power Hosp, Dept Diabet & Clin Nutr, Osaka, Japan	University of British Columbia; University of British Columbia	Widenmaier, SB (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707; De los Reyes, Thomas/0000-0002-8649-0965; Yang, Gary/0000-0002-3039-4392	Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada; MSFHR	Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MSFHR(Michael Smith Foundation for Health Research)	These studies were generously supported by funding from the Canadian Institutes of Health Research and the Canadian Diabetes Association to CHMc, the Michael Smith Foundation for Health Research (MSFHR) to CHMc and TJK and scholarships from the Natural Sciences and Engineering Research Council of Canada and MSFHR to SBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ding KH, 2008, J BONE MINER RES, V23, P536, DOI 10.1359/JBMR.071202; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; FUJITA Y, GASTROENTER IN PRESS; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hanke J, 2000, ANAT EMBRYOL, V202, P303, DOI 10.1007/s004290000112; Hanke J, 2001, CELLS TISSUES ORGANS, V169, P113, DOI 10.1159/000047869; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2005, BIOL CHEM, V386, P679, DOI 10.1515/BC.2005.079; Irwin N, 2006, BIOCHEM PHARMACOL, V72, P719, DOI 10.1016/j.bcp.2006.06.013; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kerr BD, 2009, BIOCHEM PHARMACOL, V78, P1008, DOI 10.1016/j.bcp.2009.05.037; Kerr BD, 2009, PEPTIDES, V30, P219, DOI 10.1016/j.peptides.2008.10.017; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kuhn-Wache K, 2000, ADV EXP MED BIOL, V477, P187; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; MAIDA A, 2009, GASTROENTEROLOGY; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; McIntosh CHS, 2006, INT J BIOCHEM CELL B, V38, P860, DOI 10.1016/j.biocel.2005.12.013; Meier JJ, 2004, HORM METAB RES, V36, P859, DOI 10.1055/s-2004-826176; MENEILLY GS, 1993, DIABETES CARE, V16, P110, DOI 10.2337/diacare.16.1.110; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mizuno N, 1998, ENDOCRINOLOGY, V139, P1429, DOI 10.1210/en.139.3.1429; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; PEDERSON RA, 1982, REGUL PEPTIDES, V5, P53, DOI 10.1016/0167-0115(82)90075-1; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; ROSSOWSKI WJ, 1992, REGUL PEPTIDES, V39, P9, DOI 10.1016/0167-0115(92)90003-D; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Topp BG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1730, DOI 10.1152/ajpendo.00572.2007; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178; Widenmaier SB, 2009, J BIOL CHEM, V284, P10764, DOI 10.1074/jbc.M809116200; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033	60	78	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9590	10.1371/journal.pone.0009590	http://dx.doi.org/10.1371/journal.pone.0009590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231880	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328300008
J	Yates, Z; Gunasekaran, K; Zhou, HX; Hu, ZH; Liu, Z; Ketchem, RR; Yan, BX				Yates, Zac; Gunasekaran, Kannan; Zhou, Hongxing; Hu, Zhonghua; Liu, Zhi; Ketchem, Randal R.; Yan, Boxu			Histidine Residue Mediates Radical-induced Hinge Cleavage of Human IgG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-FUNCTIONAL CALCULATIONS; COUPLED ELECTRON-TRANSFER; EPR CONTINUOUS-FLOW; COMPLEMENT ACTIVATION; SEGMENTAL FLEXIBILITY; EFFECTOR FUNCTION; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION; PROTEINS; PEPTIDES	Hydroxyl radicals induce hinge cleavage in a human IgG1 molecule via initial radical formation at the first hinge Cys(231) followed by electron transfer to the upper hinge residues. To enable engineering of a stable monoclonal antibody hinge, we investigated the role of the hinge His(229) residue using structure modeling and site-directed mutagenesis. Direct involvement of His(229) in the reaction mechanism is suggested by a 75-85% reduction of the hinge cleavage for variants in which His(229) was substituted with either Gln, Ser, or Ala. In contrast, mutation of Lys(227) to Gln, Ser, or Ala increased hinge cleavage. However, the H229S/K227S double mutant shows hinge cleavage levels similar to that of the single H229S variant, further revealing the importance of His(229). Examination of the hinge structure shows that His(229) is capable of forming hydrogen bonds with surrounding residues. These observations led us to hypothesize that the imidazole ring of His(229) may function to facilitate the cleavage by forming a transient radical center that is capable of extracting a proton from neighboring residues. The work presented here suggests the feasibility of engineering a new generation of monoclonal antibodies capable of resisting hinge cleavage to improve product stability and efficacy.	[Yates, Zac; Yan, Boxu] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA; [Gunasekaran, Kannan; Zhou, Hongxing; Hu, Zhonghua; Liu, Zhi; Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen	Yan, BX (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA.	yan.boxu@gene.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682				BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Coloma MJ, 1997, J IMMUNOL, V158, P733; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DEAN RT, 1989, FREE RADICAL RES COM, V7, P97, DOI 10.3109/10715768909087929; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Giese B, 2008, CURR OPIN CHEM BIOL, V12, P755, DOI 10.1016/j.cbpa.2008.08.026; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; HART EJ, 1964, SCIENCE, V146, P19, DOI 10.1126/science.146.3640.19; Hawkins CL, 1997, BBA-MOL BASIS DIS, V1360, P84, DOI 10.1016/S0925-4439(96)00069-5; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lassmann G, 2000, J PHYS CHEM A, V104, P9144, DOI 10.1021/jp001437w; Lassmann G, 1999, J PHYS CHEM A, V103, P1283, DOI 10.1021/jp9843454; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Michels DA, 2007, ANAL CHEM, V79, P5963, DOI 10.1021/ac0705521; Navaratnam S, 1998, J CHEM SOC FARADAY T, V94, P2577, DOI 10.1039/a803477j; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; RAO PS, 1975, J PHYS CHEM-US, V79, P1260, DOI 10.1021/j100580a006; Reece SY, 2007, J AM CHEM SOC, V129, P8500, DOI 10.1021/ja0704434; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; RODGERS MAJ, 1970, BIOCHEM BIOPH RES CO, V40, P622, DOI 10.1016/0006-291X(70)90949-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TAN LK, 1990, P NATL ACAD SCI USA, V87, P162, DOI 10.1073/pnas.87.1.162; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147	38	23	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18662	18671		10.1074/jbc.M110.108597	http://dx.doi.org/10.1074/jbc.M110.108597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20304919	hybrid, Green Published			2022-12-25	WOS:000278453900059
J	Kim, KW; Moretti, L; Mitchell, LR; Jung, DK; Lu, B				Kim, K. W.; Moretti, L.; Mitchell, L. R.; Jung, D. K.; Lu, B.			Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2 alpha in caspase-3/7-deficient cells	ONCOGENE			English	Article						autophagy; cancer; ER stress; PERK; radiation	INDUCED APOPTOSIS; MAMMALIAN TARGET; DOWN-REGULATION; CASPASE-3; CANCER; DEATH; INHIBITION; TRANSLATION; RAPAMYCIN; CHAPERONE	As apoptosis defects limit efficacy of anticancer agents, autophagy has been proposed as a novel strategy for radiotherapy enhancement. We previously showed that caspase-3/7 inhibition induces autophagy and promotes radiosensitivity in vitro and in vivo. Therefore, we further investigated the mechanism by which radiation triggers autophagy in caspase-3/7-deficient cells, and found the involvement of endoplasmic reticulum (ER) stress. The ER activates a survival pathway, the unfolded protein response, which involves ER-localized transmembrane proteins such as protein kinase-like ER kinase (PERK), inositol-requiring enzyme-1 and activating transcription factor-6. In this study, we found that PERK is essential for radiation-induced autophagy and radiosensitivity in caspase-3/7 double-knockout cells. Irradiation of these cells increased expression of phosphorylated-eIF2 alpha. Similar results were seen after administration of tunicamycin (TM), a well-known ER stressor. Importantly, we found that the administration of TM with radiation in MCF-7 breast cancer cells, which are lacking functional caspase-3 and relatively resistant to many anticancer agents, enhances radiation sensitivity. Our findings reveal ER stress as a novel potential mechanism of radiation-induced autophagy in caspase-3/7-deficient cells and as a potential strategy to maximize efficiency of radiation therapy in breast cancer. Oncogene (2010) 29, 3241-3251; doi: 10.1038/onc.2010.74; published online 29 March 2010	[Lu, B.] Vanderbilt Univ, Dept Radiat Oncol, Vanderbilt Clin B 902, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University	Lu, B (corresponding author), Vanderbilt Univ, Dept Radiat Oncol, Vanderbilt Clin B 902, Vanderbilt Ingram Canc Ctr, 1301 22nd Ave S, Nashville, TN 37232 USA.	bo.lu@vanderbilt.edu	lu, bo/G-4573-2010		NCI [1R01 CA125842-01A1]; DOD [BC030542]; NATIONAL CANCER INSTITUTE [R01CA125842] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI 1R01 CA125842-01A1 and DOD BC030542.	Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Delom F, 2007, APOPTOSIS, V12, P293, DOI 10.1007/s10495-006-0625-4; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kim KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002275; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Paglin S, 2001, CANCER RES, V61, P439; Palmerini F, 2001, HUM PATHOL, V32, P461, DOI 10.1053/hupa.2001.24328; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Satoh S, 1999, BIOCHEM J, V342, P65, DOI 10.1042/0264-6021:3420065; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	39	95	106	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3241	3251		10.1038/onc.2010.74	http://dx.doi.org/10.1038/onc.2010.74			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20348950	Green Accepted			2022-12-25	WOS:000278321100007
J	Xu, Y; Chen, Q; Li, W; Su, X; Chen, T; Liu, Y; Zhao, Y; Yu, C				Xu, Y.; Chen, Q.; Li, W.; Su, X.; Chen, T.; Liu, Y.; Zhao, Y.; Yu, C.			Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness	ONCOGENE			English	Article						amplified in breast cancer 1; hepatocellular carcinoma; cell proliferation; cell invasion	STEROID-RECEPTOR COACTIVATOR-3; BREAST-CANCER CELLS; SIGNALING PATHWAY; GROWTH; SRC-3; EXPRESSION; MICE; GENE; ACTIVATION; AMPLIFICATION	Amplified in breast cancer 1 (AIB1) is a transcriptional coactivator for nuclear receptors and other transcription factors. AIB1 has an important role in malignancy of several cancers such as breast and prostate cancers. However, its involvement in human hepatocellular carcinoma (HCC) progression remains unclear. Here, we found that AIB1 protein was overexpressed in 23 of 34 human HCC specimens (68%). Down-regulation of AIB1 reduced HCC cell proliferation, migration, invasion, colony formation ability and tumorigenic potential in nude mice. These phenotypic changes caused by AIB1 knockdown correlated with increased expression of the cell cycle inhibitor p21(Cip1/Waf1) and decreased Akt activation and the expression of proliferating cell nuclear antigen (PCNA) and matrix metallopeptidase MMP-9. In agreement with these findings, clinical AIB1-positive HCC expressed higher levels of PCNA than AIB1-negative HCC. A positive correlation was established between the levels of AIB1 protein and PCNA protein in HCC, suggesting that AIB1 may contribute to HCC cell proliferation. In addition, MMP-9 expression in AIB1-postive HCC was significantly higher than that in AIB1-negative HCC, suggesting that AIB1-postive HCC may be more invasive. Collectively, our results show that overexpression of AIB1 promotes human HCC progression by enhancing cell proliferation and invasiveness. Therefore, AIB1 is a master regulator of human HCC growth and might be a useful molecular target for HCC prognosis and treatment. Oncogene (2010) 29, 3386-3397; doi:10.1038/onc.2010.90; published online 22 March 2010	[Xu, Y.; Su, X.; Chen, T.; Liu, Y.; Zhao, Y.; Yu, C.] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China; [Chen, Q.; Li, W.; Su, X.] Xiamen Univ, Affiliated Hosp 1, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University	Yu, C (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China.	cdyu@xmu.edu.cn	xu, yixiang/J-4297-2017	xu, yixiang/0000-0001-5793-7783	National Basic Research Program of China [2008CB517311, 2009CB522200]; National Natural Science Foundation of China [30600566, 30770455]; 111 Project [06016]; Science Planning Program of Fujian Province [2009J1010]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Science Planning Program of Fujian Province	We thank Dr Li Qin for the MMP-9-promoter/reporter plasmid and Dr Jianming Xu for critical reading of the article. This work was supported by Grants from National Basic Research Program of China (973 Program, 2008CB517311 and 2009CB522200), National Natural Science Foundation of China (30600566 and 30770455), 111 Project (06016), and the Science Planning Program of Fujian Province (2009J1010).	Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arii S, 1996, HEPATOLOGY, V24, P316; Bouras T, 2001, CANCER RES, V61, P903; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; KITAMOTO M, 1993, CANCER, V72, P1859, DOI 10.1002/1097-0142(19930915)72:6<1859::AID-CNCR2820720612>3.0.CO;2-A; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Liang JA, 2009, MOL PHARMACOL, V75, P151, DOI 10.1124/mol.108.049502; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Sakakura C, 2000, INT J CANCER, V89, P217; SATO H, 1993, ONCOGENE, V8, P395; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tan JA, 2000, ENDOCRINOLOGY, V141, P3440, DOI 10.1210/en.141.9.3440; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7; Xie D, 2005, HUM PATHOL, V36, P777, DOI 10.1016/j.humpath.2005.05.007; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076	44	45	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3386	3397		10.1038/onc.2010.90	http://dx.doi.org/10.1038/onc.2010.90			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20305690				2022-12-25	WOS:000278622700007
J	Amezcua-Romero, JC; Pantoja, O; Vera-Estrella, R				Amezcua-Romero, Julio C.; Pantoja, Omar; Vera-Estrella, Rosario			Ser(123) Is Essential for the Water Channel Activity of McPIP2;1 from Mesembryanthemum crystallinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE AQUAPORINS; DEPENDENT PROTEIN-KINASE; MAJOR INTRINSIC PROTEIN; PHYSIOLOGICAL FUNCTIONS; PHYSCOMITRELLA-PATENS; SOYBEAN NODULIN-26; PHOSPHORYLATION; GLYCEROL; PERMEABILITY; TRANSPORT	The increased expression of McPIP2;1 (MipC), a root-specific aquaporin (AQP) from Mesembryanthemum crystallinum, under salt stress has suggested a role for this AQP in the salt tolerance of the plant. However, whether McPIP2;1 transports water or another solute and how its activity is regulated are so far unknown. Therefore, wild type (wt) or mutated McPIP2;1 protein was expressed in Xenopus laevis oocytes. Then, the osmotic water permeability (P-f) of the oocytes membrane was assessed by hypotonic challenges. Selectivity of McPIP2;1 to water was determined by radiolabeled glycerol or urea uptake assays. Moreover, swelling and in vitro phosphorylation assays revealed that both water permeation and phosphorylation status of McPIP2;1 were significantly increased by the phosphorylation agonists okadaic acid (OA), phorbol myristate acetate (PMA), and 8-Br-cAMP, and markedly decreased by the inhibitory peptides PKI 14-22 and PKC 20-28, inhibitors of protein kinases A (PKA) and C (PKC), respectively. Substitution of Ser(123) or both, Ser123 and Ser(282), abolished the water channel activity of McPIP2;1 while substitution of Ser(282) only partially inhibited it (51.9% inhibition). Despite lacking Ser(123) and/or Ser(282), the McPIP2;1 mutant forms were still phosphorylated in vitro, which suggests that phosphorylation may have a dual role on this AQP. Our results indicate that McPIP2;1 water permeability depends completely on Ser(123) and is positively regulated by PKA- and PKC-mediated phosphorylation. Regulation of the phosphorylation status of McPIP2;1 may contribute to control water transport through root cells when the plant is subjected to high salinity conditions.	[Amezcua-Romero, Julio C.; Pantoja, Omar; Vera-Estrella, Rosario] Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Vera-Estrella, R (corresponding author), Apdo Postal 510-3,Col Miraval, Cuernavaca, Morelos, Mexico.	rosario@ibt.unam.mx	Pantoja, Omar/H-5981-2012	Pantoja, Omar/0000-0002-6538-9059	DGAPA [IN221308]; CONACYT [57685]	DGAPA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by DGAPA IN221308 and CONACYT 57685 (to R. V.-E.).	Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Daniels MJ, 2005, BIOCHEMISTRY-US, V44, P14443, DOI 10.1021/bi050565d; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustavsson S, 2005, PLANT PHYSIOL, V139, P287, DOI 10.1104/pp.105.063198; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HEI YJ, 1991, MOL PHARMACOL, V39, P233; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181; JOHNSON KD, 1992, PLANT PHYSIOL, V100, P1787, DOI 10.1104/pp.100.4.1787; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Katsuhara M, 2008, PFLUG ARCH EUR J PHY, V456, P687, DOI 10.1007/s00424-007-0434-9; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kirch HH, 2000, PLANT PHYSIOL, V123, P111, DOI 10.1104/pp.123.1.111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; MIAO GH, 1992, J CELL BIOL, V118, P481, DOI 10.1083/jcb.118.2.481; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Vera-Estrella R., 2000, MOL BIOL PHYSL WATER, P339; Wallace IS, 2005, BIOCHEMISTRY-US, V44, P16826, DOI 10.1021/bi0511888; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035	50	10	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16739	16747		10.1074/jbc.M109.053850	http://dx.doi.org/10.1074/jbc.M109.053850			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20332086	Green Published, hybrid			2022-12-25	WOS:000277982600037
J	Collaco, A; Jakab, R; Hegan, P; Mooseker, M; Ameen, N				Collaco, Anne; Jakab, Robert; Hegan, Peter; Mooseker, Mark; Ameen, Nadia			alpha-AP-2 Directs Myosin VI-dependent Endocytosis of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; CELLULAR FUNCTIONS; EPITHELIAL-CELLS; CFTR; LOCALIZATION; DISABLED-2; PROTEIN; DAB2; AP-2; TRAFFICKING	The actin motor myosin VI regulates endocytosis of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestine, but the endocytic adaptor linking CFTR to myosin VI is unknown. Dab2 (Disabled 2) is the binding partner for myosin VI, clathrin, and alpha-AP-2 and directs endocytosis of low density lipoprotein receptor family members by recognizing a phosphotyrosine-binding domain. However, CFTR does not possess a phosphotyrosine-binding domain. We examined whether alpha-AP-2 and/or Dab2 were binding partners for CFTR and the role of myosin VI in localizing endocytic adaptors in the intestine. CFTR co-localized with alpha-AP-2, Dab2, and myosin VI and was identified in a complex with all three endocytic proteins in the intestine. Apical CFTR was increased in the intestines of Dab-2KOmice, suggesting its involvement in regulating surface CFTR. Glutathione S-transferase pulldown assays revealed binding of CFTR to alpha-AP-2 (but not Dab2) in the intestine, whereas Dab-2 interacted with alpha-AP-2. siRNA silencing of alpha-AP-2 in cells significantly reduced CFTR endocytosis, further supporting alpha-AP-2 as the direct binding partner for CFTR. alpha-AP-2 and Dab2 localized to the terminal web regions of enterocytes, but Dab2 accumulated in this location in Snell's Waltzer myosin VI(sv/sv) intestine. Ultrastructural examination revealed that the accumulation of Dab2 correlated with prominent involution and the loss of normal positioning of the inter-microvillar membranes that resulted in expansion of the terminal web region in myosin VI(sv/sv) enterocytes. The findings support alpha-AP-2 in directing myosin VI-dependent endocytosis of CFTR and a requirement for myosin VI in membrane invagination and coated pit formation in enterocytes.	[Ameen, Nadia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Hegan, Peter; Mooseker, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Collaco, Anne; Jakab, Robert; Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Collaco, Anne; Jakab, Robert; Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ameen, N (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,FMP 408, New Haven, CT 06520 USA.	nadia.ameen@yale.edu			National Institutes of Health [R01 DK 077065, DK 25387, GM 073823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK025387, R01DK025387, R01DK077065, R37DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 077065 (to N.A.) and DK 25387 and GM 073823 (to M. M.).	Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; Ameen NA, 2000, HISTOCHEM CELL BIOL, V114, P219; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BAXTER PS, 1988, ARCH DIS CHILD, V63, P1496, DOI 10.1136/adc.63.12.1496; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Gotoh N, 2010, CYTOSKELETON, V67, P178, DOI 10.1002/cm.20435; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hu W, 2001, BIOCHEM J, V354, P561, DOI 10.1042/0264-6021:3540561; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Naren AP, 2000, J CLIN INVEST, V105, P377, DOI 10.1172/JCI8631; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; TAYLOR CJ, 1990, ARCH DIS CHILD, V65, P175, DOI 10.1136/adc.65.2.175; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TRIER JLM, 1994, PHYSL GASTROINTESTIN; Weixel Kelly, 2002, Methods Mol Med, V70, P323; Weixel KM, 2001, PFLUG ARCH EUR J PHY, V443, pS70; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200	36	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17177	17187		10.1074/jbc.M110.127613	http://dx.doi.org/10.1074/jbc.M110.127613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351096	Green Published, hybrid			2022-12-25	WOS:000277982600080
J	Pisterzi, LF; Jansma, DB; Georgiou, J; Woodside, MJ; Chou, JTC; Angers, S; Raicu, V; Wells, JW				Pisterzi, Luca F.; Jansma, David B.; Georgiou, John; Woodside, Michael J.; Chou, Judy Tai-Chieh; Angers, Stephane; Raicu, Valerica; Wells, James W.			Oligomeric Size of the M-2 Muscarinic Receptor in Live Cells as Determined by Quantitative Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HIGHER-ORDER OLIGOMERS; CHOLINERGIC-RECEPTOR; ACETYLCHOLINE-RECEPTOR; LIVING CELLS; SIGNALING COMPLEXES; CALCIUM-PHOSPHATE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MULTIPLE STATES	Fluorescence resonance energy transfer (FRET), measured by fluorescence intensity-based microscopy and fluorescence lifetime imaging, has been used to estimate the size of oligomers formed by the M-2 muscarinic cholinergic receptor. The approach is based on the relationship between the apparent FRET efficiency within an oligomer of specified size (n) and the pairwise FRET efficiency between a single donor and a single acceptor (E). The M-2 receptor was fused at the N terminus to enhanced green or yellow fluorescent protein and expressed in Chinese hamster ovary cells. Emission spectra were analyzed by spectral deconvolution, and apparent efficiencies were estimated by donor-dequenching and acceptor-sensitized emission at different ratios of enhanced yellow fluorescent protein-M-2 receptor to enhanced green fluorescent protein-M-2 receptor. The data were interpreted in terms of a model that considers all combinations of donor and acceptor within a specified oligomer to obtain fitted values of E as follows: n = 2, 0.495 +/- 0.019; n = 4, 0.202 +/- 0.010; n = 6, 0.128 +/- 0.006; n = 8, 0.093 +/- 0.005. The pairwise FRET efficiency determined independently by fluorescence lifetime imaging was 0.20-0.24, identifying the M-2 receptor as a tetramer. The strategy described here yields an explicit estimate of oligomeric size on the basis of fluorescence properties alone. Its broader application could resolve the general question of whether G protein-coupled receptors exist as dimers or larger oligomers. The size of an oligomer has functional implications, and such information can be expected to contribute to an understanding of the signaling process.	[Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Raicu, Valerica] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Pisterzi, Luca F.; Chou, Judy Tai-Chieh; Angers, Stephane; Wells, James W.] Univ Toronto, Leslie L Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Jansma, David B.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Georgiou, John] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodside, Michael J.] Hosp Sick Children, Imaging Facil, Toronto, ON M5G 1X8, Canada	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Raicu, V (corresponding author), Univ Wisconsin, Dept Phys, POB 413, Milwaukee, WI 53211 USA.	vraicu@uwm.edu; jwells@phm.utoronto.ca	Angers, Stephane/E-1432-2014; Georgiou, John/E-9873-2013; Georgiou, John/ABA-1687-2020	Angers, Stephane/0000-0001-7241-9044; Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384	Canadian Institutes of Health Research [MOP 43990, MOP 97978]; Heart and Stroke Foundation of Ontario [T5650, T6280]; University of Wisconsin-Milwaukee Research Growth Initiative; Wisconsin Institute for Biomedical and Health Technologies	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Wisconsin-Milwaukee Research Growth Initiative; Wisconsin Institute for Biomedical and Health Technologies	This work was supported in part by the Canadian Institutes of Health Research Grants MOP 43990 and MOP 97978 (to J. W. W.), the Heart and Stroke Foundation of Ontario Grants T5650 and T6280 (to J. W. W.), the University of Wisconsin-Milwaukee Research Growth Initiative (to V. R.), and the Wisconsin Institute for Biomedical and Health Technologies (to V. R.).	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BERRIE CP, 1979, BIOCHEM BIOPH RES CO, V87, P1000, DOI 10.1016/S0006-291X(79)80006-6; BIRDSALL NJM, 1977, ADV BEHAV BIOL, V24, P25; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Chowdhury EH, 2003, ANAL BIOCHEM, V314, P316, DOI 10.1016/S0003-2697(02)00648-6; Colozo AT, 2007, BIOCHEM PHARMACOL, V74, P236, DOI 10.1016/j.bcp.2007.04.009; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dinant C, 2008, J MICROSC-OXFORD, V231, P97, DOI 10.1111/j.1365-2818.2008.02020.x; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Gazi L, 2003, EUR J BIOCHEM, V270, P3928, DOI 10.1046/j.1432-1033.2003.03773.x; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Green MA, 1997, BIOCHEMISTRY-US, V36, P7380, DOI 10.1021/bi961940s; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Heim R, 1999, METHOD ENZYMOL, V302, P408, DOI 10.1016/S0076-6879(99)02036-4; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P445; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Ma DB, 2004, BIOTECHNOL LETT, V26, P1441, DOI 10.1023/B:BILE.0000045648.00893.c8; MATTERA R, 1985, J BIOL CHEM, V260, P7410; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Park P, 2001, EUR J PHARMACOL, V421, P11, DOI 10.1016/S0014-2999(01)00998-0; Park PSH, 2004, J NEUROCHEM, V90, P537, DOI 10.1111/j.1471-4159.2004.02536.x; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Pathak A, 2005, INT J OBESITY, V29, P176, DOI 10.1038/sj.ijo.0802751; PETERSON GL, 1984, PREP BIOCHEM, V14, P33, DOI 10.1080/10826068408070612; PISTERZI LF, 2009, BIOPHYS J, V96, pA169; Raicu V, 2005, BIOCHEM J, V385, P265, DOI 10.1042/BJ20040226; RAICU V, 2006, P SPIE IMAGING MANIP, V4; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; RASBAND WS, 1997, IMAGEJ VERSION 1 41K; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; SHIOZAKI K, 1992, BIOCHEMISTRY-US, V31, P10634, DOI 10.1021/bi00158a028; Skrabanek L, 2003, NUCLEIC ACIDS RES, V31, P3856, DOI 10.1093/nar/gkg552; Sum CS, 2001, BIOCHEM PHARMACOL, V62, P829; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; Weill C, 1999, J NEUROCHEM, V73, P791, DOI 10.1046/j.1471-4159.1999.0730791.x; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	73	60	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16723	16738		10.1074/jbc.M109.069443	http://dx.doi.org/10.1074/jbc.M109.069443			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304928	Green Published, hybrid			2022-12-25	WOS:000277982600036
J	Bee, C; Moshnikova, A; Mellor, CD; Molloy, JE; Koryakina, Y; Stieglitz, B; Khokhlatchev, A; Herrmann, C				Bee, Christine; Moshnikova, Anna; Mellor, Christopher D.; Molloy, Justin E.; Koryakina, Yulia; Stieglitz, Benjamin; Khokhlatchev, Andrei; Herrmann, Christian			Growth and Tumor Suppressor NORE1A Is a Regulatory Node between Ras Signaling and Microtubule Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; EFFECTOR; RASSF1A; CELLS; IDENTIFICATION; STABILITY; PROTEINS; PATHWAY; FAMILY; SWITCH	NORE1A is a Ras-binding protein that belongs to a group of tumor suppressors known as the Ras association domain family. Their growth- and tumor-suppressive function is assumed to be dependent on association with the microtubule cytoskeleton. However, a detailed understanding of this interplay is still missing. Here, we show that NORE1A directly interacts with tubulin and is capable of nucleating microtubules. Strikingly, the ability to stimulate nucleation is regulated in a dual specific way either via phosphorylation of NORE1A within the Ras-binding domain by Aurora A kinase or via binding to activated Ras. We also demonstrate that NORE1A mediates a negative effect of activated Ras on microtubule nucleation. On the basis of our results, we propose a novel regulatory network composed of the tumor suppressor NORE1A, the mitotic kinase Aurora A, the small GTPase Ras, and the microtubule cytoskeleton.	[Mellor, Christopher D.; Molloy, Justin E.; Stieglitz, Benjamin] Natl Inst Med Res, MRC, London NW7 1AA, England; [Bee, Christine; Herrmann, Christian] Ruhr Univ Bochum, Dept Chem, D-44780 Bochum, Germany; [Moshnikova, Anna; Khokhlatchev, Andrei] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA; [Koryakina, Yulia] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA	MRC National Institute for Medical Research; Ruhr University Bochum; University of Virginia; University of Virginia	Stieglitz, B (corresponding author), Natl Inst Med Res, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	bstiegl@nimr.mrc.ac.uk; ak9k@cms.mail.virginia.edu	Stieglitz, Benjamin/AAY-4140-2020	Stieglitz, Benjamin/0000-0003-3634-6997; Molloy, Justin/0000-0002-8307-2450	German National Academic Foundation; Ruhr University Research School; Deutsche Forschungsgemeinschaft [SFB 642]; Elsa U. Pardee Foundation; CONCERN Foundation; MRC [MC_U117570592] Funding Source: UKRI; Medical Research Council [MC_U117570592] Funding Source: researchfish	German National Academic Foundation; Ruhr University Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elsa U. Pardee Foundation; CONCERN Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German National Academic Foundation, the Ruhr University Research School, the Deutsche Forschungsgemeinschaft (SFB 642), the Elsa U. Pardee Foundation, and the CONCERN Foundation.	Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Song SJ, 2009, CANCER RES, V69, P2314, DOI 10.1158/0008-5472.CAN-08-3984; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Waterman-Storer C M, 2001, Curr Protoc Cell Biol, VChapter 13, DOI 10.1002/0471143030.cb1301s00; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	26	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16258	16266		10.1074/jbc.M109.081562	http://dx.doi.org/10.1074/jbc.M109.081562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20339001	Green Published, hybrid			2022-12-25	WOS:000277715900062
J	Nakamura, T; Hayashi, T; Mimori-Kiyosue, Y; Sakaue, F; Matsuura, K; Iemura, S; Natsume, T; Akiyama, T				Nakamura, Tsutomu; Hayashi, Tomoatsu; Mimori-Kiyosue, Yuko; Sakaue, Fumika; Matsuura, Ken; Iemura, Shun-ichiro; Natsume, Toru; Akiyama, Tetsu			The PX-RICS-14-3-3 zeta/theta Complex Couples N-cadherin-beta-Catenin with Dynein-Dynactin to Mediate Its Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; MEMBRANE DYNAMICS; 14-3-3 PROTEINS; PX-RICS; TRANSPORT; GABARAP; EXIT; PHOSPHOINOSITIDES; IDENTIFICATION; LOCALIZATION	We have recently shown that beta-catenin-facilitated export of cadherins from the endoplasmic reticulum requires PX-RICS, a beta-catenin-interacting GTPase-activating protein for Cdc42. Here we show that PX-RICS interacts with isoforms of 14-3-3 and couples the N-cadherin-beta-catenin complex to the microtubule-based molecular motor dynein-dynactin. Similar to knockdown of PX-RICS, knockdown of either 14-3-3 zeta or -theta resulted in the disappearance of N-cadherin and beta-catenin from the cell-cell boundaries. Furthermore, we found that PX-RICS and 14-3-3 zeta/theta are present in a large multiprotein complex that contains dynein-dynactin components as well as N-cadherin and beta-catenin. Both RNAi- and dynamitin-mediated inhibition of dynein-dynactin function also led to the absence of N-cadherin and beta-catenin at the cell-cell contact sites. Our results suggest that the PX-RICS-14-3-3 zeta/theta complex links the N-cadherin-beta-catenin cargo with the dynein-dynactin motor and thereby mediates its endoplasmic reticulum export.	[Nakamura, Tsutomu; Hayashi, Tomoatsu; Sakaue, Fumika; Matsuura, Ken; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan; [Mimori-Kiyosue, Yuko] RIKEN Ctr Dev Biol, Opt Image Anal Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Iemura, Shun-ichiro; Natsume, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Nakamura, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	nakamura@iam.u-tokyo.ac.jp	Mimori-Kiyosue, Yuko/K-9158-2015; Natsume, Tohru/M-7627-2018	Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Natsume, Tohru/0000-0002-1510-2582; Sakaue, Fumika/0000-0003-1364-8730	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on Priority Areas, Cell Innovation, Genome Network Project, and in part by the Global Centers of Excellence (COE) Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dorner C, 1999, J BIOL CHEM, V274, P33654, DOI 10.1074/jbc.274.47.33654; GALLIN WJ, 1983, P NATL ACAD SCI-BIOL, V80, P1038, DOI 10.1073/pnas.80.4.1038; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hayashi T, 2007, GENES CELLS, V12, P929, DOI 10.1111/j.1365-2443.2007.01101.x; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kurth T, 1999, DEV DYNAM, V215, P155, DOI 10.1002/(SICI)1097-0177(199906)215:2<155::AID-DVDY8>3.0.CO;2-S; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MUKHERJI S, 1995, J BIOL CHEM, V270, P14062, DOI 10.1074/jbc.270.23.14062; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; PEYRIERAS N, 1983, P NATL ACAD SCI-BIOL, V80, P6274, DOI 10.1073/pnas.80.20.6274; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	40	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16145	16154		10.1074/jbc.M109.081315	http://dx.doi.org/10.1074/jbc.M109.081315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308060	Green Published, hybrid			2022-12-25	WOS:000277715900052
J	Pan, BY; Dou, SX; Yang, Y; Xu, YN; Bugnard, E; Ding, XY; Zhang, LY; Wang, PY; Li, M; Xi, XG				Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Bugnard, Elisabeth; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming; Xi, Xu Guang			Mutual Inhibition of RecQ Molecules in DNA Unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; COLI REP HELICASE; C VIRUS HELICASE; CRYSTAL-STRUCTURES; PCRA HELICASE; MECHANISM; TRANSLOCATION; UVRD; MONOMER; SEPARATION	Helicases make conformational changes and mechanical movements through hydrolysis of NTP to unwind duplex DNA (or RNA). Most helicases require a single-stranded overhang for loading onto the duplex DNA substrates. Some helicases have been observed to exhibit an enhanced unwinding efficiency with increasing length of the single-stranded DNA tail both by preventing reannealing of the unwound DNA and by compensating for premature dissociation of the leading monomers. Here we report a previously unknown mutual inhibition of neighboring monomers in DNA unwinding by the monomeric Escherichia coli RecQ helicase. With single molecule fluorescence resonance energy transfer microscopy, we observed that the unwinding initiation of RecQ at saturating concentrations was more delayed for a long rather than a short tailed DNA. In stopped-flow kinetic studies under both single and multiple turnover conditions, the unwinding efficiency decreased with increasing enzyme concentration for long tailed substrates. In addition, preincubation of RecQ and DNA in the presence of 5'-adenylyl-beta,gamma-imidodiphosphate was observed to alleviate the inhibition. We propose that the mutual inhibition effect results from a forced closure of cleft between the two RecA-like domains of a leading monomer by a trailing one, hence the forward movements of both monomers are stalled by prohibition of ATP binding to the leading one. This effect represents direct evidence for the relative movements of the two RecA-like domains of RecQ in DNA unwinding. It may occur for all superfamily I and II helicases possessing two RecA-like domains.	[Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China; [Pan, Bing-Yi; Dou, Shuo-Xing; Yang, Ye; Xu, Ya-Nan; Ding, Xiu-Yan; Zhang, Lingyun; Wang, Peng-Ye; Li, Ming] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Xu, Ya-Nan] Renmin Univ, Dept Phys, Beijing 100872, Peoples R China; [Bugnard, Elisabeth; Xi, Xu Guang] Ctr Univ Orsay, Sect Rech, Inst Curie, CNRS,UMR 3348, F-91405 Orsay, France; [Bugnard, Elisabeth] Univ Paris 11, Fac Pharm, F-92296 Chatenay Malabry, France	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS; Renmin University of China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Dou, SX (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100190, Peoples R China.	sxdou@aphy.iphy.ac.cn; xgxi@curie.u-psud.fr	Xi, Xu Guang/AAK-4511-2020; ruc, phy/E-4170-2012; Yang, Ye/C-8397-2011; 石, 源/D-5929-2012; 王, 鹏业/A-9811-2012	Wang, Peng-Ye/0000-0002-9765-0610; Dou, Shuo-Xing/0000-0002-7201-2081	National Natural Science Foundation of China [10834014, 10674173, 30770517, 30870590]; 973 Project [2009CB930704, 2006CB910302]; Institut Curie and the Centre National de la Recherche Scientifique (CNRS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Institut Curie and the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by National Natural Science Foundation of China Grants 10834014, 10674173, 30770517, and 30870590, 973 Project Grants 2009CB930704 and 2006CB910302, and grants from the Institut Curie and the Centre National de la Recherche Scientifique (CNRS) (to X. G. X.).	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Bennett RJ, 2004, CRIT REV BIOCHEM MOL, V39, P79, DOI 10.1080/10409230490460756; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	27	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15884	15893		10.1074/jbc.M110.104299	http://dx.doi.org/10.1074/jbc.M110.104299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233727	Green Published, hybrid			2022-12-25	WOS:000277715900026
J	Cura, AJ; Carruthers, A				Cura, Anthony J.; Carruthers, Anthony			Acute Modulation of Sugar Transport in Brain Capillary Endothelial Cell Cultures during Activation of the Metabolic Stress Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT1 GLUCOSE-TRANSPORTER; ELECTRON-MICROSCOPIC IMMUNOGOLD; PROTEIN-KINASE; UP-REGULATION; MESSENGER-RNA; CHRONIC HYPOGLYCEMIA; SKELETAL-MUSCLE; BARRIER; ATP; STIMULATION	GLUT1-catalyzed equilibrative sugar transport across the mammalian blood-brain barrier is stimulated during acute and chronic metabolic stress; however, the mechanism of acute transport regulation is unknown. We have examined acute sugar transport regulation in the murine brain microvasculature endothelial cell line bEnd.3. Acute cellular metabolic stress was induced by glucose depletion, by potassium cyanide, or by carbonyl cyanide p-trifluoromethoxyphenylhydrazone, which reduce or deplete intracellular ATP within 15 min. This results in a 1.7-7-fold increase in V-max for zero-trans 3-O-methylglucose uptake (sugar uptake into sugar-free cells) and a 3-10-fold increase in V-max for equilibrium exchange transport (intracellular [sugar] = extracellular [sugar]). GLUT1, GLUT8, and GLUT9 mRNAs are detected in bEnd.3 cells where GLUT1 mRNA levels are 33-fold greater than levels of GLUT8 or GLUT9 mRNA. Neither GLUT1 mRNA nor total protein levels are affected by acute metabolic stress. Cell surface biotinylation reveals that plasma membrane GLUT1 levels are increased 2-3-fold by metabolic depletion, although cell surface Na+, K+-ATPase levels remain unaffected by ATP depletion. Treatment with the AMP-activated kinase agonist, AICAR, increases V-max for net 3-O-methylglucose uptake by 2-fold. Glucose depletion and treatment with potassium cyanide, carbonyl cyanide p-trifluoromethoxyphenylhydrazone, and AICAR also increase AMP-dependent kinase phosphorylation in bEnd.3 cells. These results suggest that metabolic stress rapidly stimulates blood-brain barrier endothelial cell sugar transport by acute up-regulation of plasma membrane GLUT1 levels, possibly involving AMP-activated kinase activity.	[Cura, Anthony J.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044888, R56DK036081, R01DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Barnes K, 2002, J CELL SCI, V115, P2433; Barros LF, 2001, PFLUG ARCH EUR J PHY, V442, P614; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; BOADO RJ, 1995, NEUROSCI LETT, V197, P179, DOI 10.1016/0304-3940(95)11930-U; Boado RJ, 1999, NEUROSCI RES, V34, P217, DOI 10.1016/S0168-0102(99)00056-5; CARRUTHERS A, 1986, J BIOL CHEM, V261, P1028; COOMBER BL, 1985, MICROVASC RES, V30, P99, DOI 10.1016/0026-2862(85)90042-1; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; CORNFORD EM, 1993, J CEREBR BLOOD F MET, V13, P841, DOI 10.1038/jcbfm.1993.106; Cornford EM, 2000, AM J PHYSIOL-HEART C, V279, pH1346, DOI 10.1152/ajpheart.2000.279.3.H1346; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; GORGA FR, 1979, BIOCHEM BIOPH RES CO, V91, P955, DOI 10.1016/0006-291X(79)91972-7; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; HARIK SI, 1994, J APPL PHYSIOL, V77, P896, DOI 10.1152/jappl.1994.77.2.896; HAWORTH RA, 1986, CIRC RES, V58, P157, DOI 10.1161/01.RES.58.1.157; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; HEBERT DN, 1986, J BIOL CHEM, V261, P93; KALARIA RN, 1988, ANN NEUROL, V24, P757, DOI 10.1002/ana.410240610; KUMAGAI AK, 1994, BBA-BIOMEMBRANES, V1193, P24, DOI 10.1016/0005-2736(94)90328-X; KUMAGAI AK, 1995, DIABETES, V44, P1399, DOI 10.2337/diabetes.44.12.1399; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 2001, BLOOD CELL MOL DIS, V27, P139, DOI 10.1006/bcmd.2000.0359; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; MCCALL AL, 1986, AM J PHYSIOL, V251, pE442, DOI 10.1152/ajpendo.1986.251.4.E442; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; SIMONS TJB, 1983, J PHYSIOL-LONDON, V338, P477, DOI 10.1113/jphysiol.1983.sp014685; Simpson IA, 2001, J BIOL CHEM, V276, P12725, DOI 10.1074/jbc.M010897200; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Souza-Menezes J, 2007, CELL PHYSIOL BIOCHEM, V20, P455, DOI 10.1159/000107529; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C	46	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15430	15439		10.1074/jbc.M110.110593	http://dx.doi.org/10.1074/jbc.M110.110593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231288	Green Published, hybrid			2022-12-25	WOS:000277399000063
J	Kim, S; Saeki, Y; Fukunaga, K; Suzuki, A; Takagi, K; Yamane, T; Tanaka, K; Mizushima, T; Kato, K				Kim, Sangwoo; Saeki, Yasushi; Fukunaga, Keisuke; Suzuki, Atsuo; Takagi, Kenji; Yamane, Takashi; Tanaka, Keiji; Mizushima, Tsunehiro; Kato, Koichi			Crystal Structure of Yeast Rpn14, a Chaperone of the 19 S Regulatory Particle of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY PATHWAY; 20S PROTEASOME; COMPLEX; SUBCOMPLEX; ATPASE; SIGNAL	The ubiquitin-proteasome pathway is a major proteolytic system in eukaryotic cells and regulates various cellular processes. The 26 S proteasome, the central enzyme of this pathway, consists of a proteolytic core particle and two 19 S regulatory particles (RPs) composed of ATPase (Rpt) and non-ATPase (Rpn) subunits. Growing evidence indicates that proteasome assembly is assisted by a variety of chaperones. In particular, it has been reported recently that Nas2, Nas6, Rpn14, and Hsm3 bind specific Rpt subunits, thereby contributing to the formation of 19 S RP. Rpn14 transiently binds to the C-terminal domain of the Rpt6 subunit (Rpt6-C) during maturation of the ATPase ring of 19 S RP. In this study, we determined the crystal structure of yeast Rpn14 at 2.0 angstrom resolution, which revealed that this chaperone consists of a unique N-terminal domain with unknown function and a C-terminal domain assuming a canonical seven-bladed beta-propeller fold. The Rpt6-binding site on Rpn14 was predicted based on structural comparison with the complex formed between Nas6 and Rpt3-C. The top face of Rpn14 exhibits a highly acidic surface area, whereas the putative interacting surface of Rpt6-C is basic. By inspection of structural data along with genetic and biochemical data, we determined the specific residues of Rpn14 and Rpt6 for complementary charge interactions that are required for 19 S RP assembly.	[Kim, Sangwoo; Takagi, Kenji; Mizushima, Tsunehiro; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Saeki, Yasushi; Fukunaga, Keisuke; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Suzuki, Atsuo; Yamane, Takashi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Nagoya City University; Tokyo Metropolitan Institute of Medical Science; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp	Kim, Sangwoo/F-8043-2013; Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Kato, Koichi/0000-0001-7187-9612; Mizushima, Tsunehiro/0000-0002-6631-2889	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. M. and K. K.) and the Targeted Proteins Research Program of MEXT (to T. M., K. T., and K. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Leggett David S., 2005, V301, P57; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	39	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15159	15166		10.1074/jbc.M110.104042	http://dx.doi.org/10.1074/jbc.M110.104042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236927	Green Published, hybrid			2022-12-25	WOS:000277399000037
J	Li, PP; Lu, M; Nguyen, MTA; Bae, EJ; Chapman, J; Feng, DR; Hawkins, M; Pessin, JE; Sears, DD; Nguyen, AK; Amidi, A; Watkins, SM; Nguyen, U; Olefsky, JM				Li, Pingping; Lu, Min; Nguyen, M. T. Audrey; Bae, Eun Ju; Chapman, Justin; Feng, Daorong; Hawkins, Meredith; Pessin, Jeffrey E.; Sears, Dorothy D.; Nguyen, Anh-Khoi; Amidi, Arezou; Watkins, Steven M.; Nguyen, UyenThao; Olefsky, Jerrold M.			Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; HEPATIC STEATOSIS; SKELETAL-MUSCLE; FATTY-ACIDS; ADIPOCYTE DEATH; GENE-EXPRESSION; FACTOR-ALPHA; CRUCIAL ROLE; T-CELLS	Obesity represents a state of chronic, low grade inflammation and is associated with infiltration of increased numbers of adipose tissue macrophages (ATMs). Diet-induced obesity leads to an increase in non-inflammatory M1-like ATMs displaying the CD11c surface marker. We assessed the function of CD11c-positive ATMs when insulin resistant high fat diet (HFD) mice become insulin-sensitive after switching from HFD to normal chow (NC). HFD mice rapidly become insulin-sensitive in all major insulin-target tissues, including muscle, liver, and adipose tissue, after the diet switch. In adipose tissue the CD11c-positive macrophages remain constant in number despite the presence of insulin sensitivity, but these macrophages now assume a new phenotype in which they no longer exhibit increased inflammatory pathway markers. Adipose tissue markers of apoptosis and necrosis were elevated on HFD and remain high after the HFD -> NC diet switch. Furthermore, ATM accumulation preceded detectable adipocyte necrosis at the early phase of HFD. Together, these results indicate that 1) CD11c-positive M1-like ATMs can exhibit phenotypic plasticity and that the polarization of these cells between inflammatory and non-inflammatory states is well correlated to the presence of absence of insulin resistance, and 2) adipocyte necrosis and apoptosis can be dissociated from ATM accumulation.	[Sears, Dorothy D.; Nguyen, Anh-Khoi; Amidi, Arezou] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Chapman, Justin] Pfizer Inc, San Diego, CA 92121 USA; [Feng, Daorong; Hawkins, Meredith; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Watkins, Steven M.; Nguyen, UyenThao] Lipom Technol Inc, W Sacramento, CA 95691 USA	University of California System; University of California San Diego; Pfizer; Yeshiva University; Albert Einstein College of Medicine	Olefsky, JM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019; Sears, Dorothy D/AHE-5524-2022	Li, Pingping/0000-0003-0679-270X; Sears, Dorothy D/0000-0002-9260-3540	National Institutes of Health [DK033651, DK074868, DK063491, DK020541, DK048321]; Eunice Kennedy Shriver NICHD/National Institutes of Health [U54 HD 012303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048321, R01DK033651, R37DK033651, P60DK020541, P30DK063491, P01DK074868, P30DK020541, R37DK048321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033651, DK074868, DK063491, DK020541, and DK048321 and Eunice Kennedy Shriver NICHD/National Institutes of Health Cooperative Agreement U54 HD 012303 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kusunoki M, 2003, METABOLISM, V52, P30, DOI 10.1053/meta.2003.50012; Lee JY, 2006, MOL CELLS, V21, P174; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lo CJ, 1999, J SURG RES, V82, P216, DOI 10.1006/jsre.1998.5524; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; MEYDANI SN, 1993, J CLIN INVEST, V92, P105, DOI 10.1172/JCI116537; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sell H, 2007, CURR OPIN LIPIDOL, V18, P258, DOI 10.1097/MOL.0b013e3281338546; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	50	176	185	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15333	15345		10.1074/jbc.M110.100263	http://dx.doi.org/10.1074/jbc.M110.100263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308074	Green Published, hybrid			2022-12-25	WOS:000277399000054
J	Rambhadran, A; Gonzalez, J; Jayaraman, V				Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi			Subunit Arrangement in N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING DOMAIN; CONFORMATIONAL-CHANGES; AMPA RECEPTORS; ACTIVATION; MECHANISM; AGONIST; DESENSITIZATION; CLONING; DISEASE	N-Methyl-D-aspartate (NMDA) receptors, the main mediators of excitatory synaptic transmission, are heterotetrameric receptors. Typically, glycine binding NR1 subunits co-assemble with glutamate binding NR2 subunits to form a functional receptor. Here we have used luminescence resonance energy transfer (LRET) investigations to establish the specific configuration in which these subunits assemble to form the functional tetramer and show that the dimer of dimers structure is formed by the NR1 subunits assembling diagonally to each other. The distances measured by LRET are consistent with the NMDA structure predicted based on cross-linking investigations and on the structure of the full-length alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid (AMPA) receptor structure (1). Additionally, the LRET distances between the NR1 and NR2A subunits within a dimer measured in the desensitized state of the receptor are longer than the distances in the previously published crystal structure of the isolated ligand binding domain of NR1-NR2A. Because the dimer interface in the isolated ligand binding domain crystallizes in the open channel structure, the longer LRET distances would be consistent with the decoupling of the dimer interface in the desensitized state. This is similar to what has been previously observed for the AMPA subtype of the ionotropic glutamate receptors, suggesting a similar mechanism for desensitization in the two subtypes of the glutamate receptor.	[Rambhadran, Anu; Gonzalez, Jennifer; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Ctr Membrane Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102]; American Heart Association [0855081F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102, F31GM082023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102 (to V. J.). This work was also supported by American Heart Association Grant 0855081F.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012	23	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15296	15301		10.1074/jbc.M109.085035	http://dx.doi.org/10.1074/jbc.M109.085035			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304927	Green Published, hybrid			2022-12-25	WOS:000277399000050
J	Tarrago, L; Laugier, E; Zaffagnini, M; Marchand, CH; Le Marechal, P; Lemaire, SD; Rey, P				Tarrago, Lionel; Laugier, Edith; Zaffagnini, Mirko; Marchand, Christophe H.; Le Marechal, Pierre; Lemaire, Stephane D.; Rey, Pascal			Plant Thioredoxin CDSP32 Regenerates 1-Cys Methionine Sulfoxide Reductase B Activity through the Direct Reduction of Sulfenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; ESCHERICHIA-COLI; OXIDATIVE STRESS; REVERSIBLE INACTIVATION; PLASTIDIAL THIOREDOXINS; HYDROGEN-PEROXIDE; REDOX; GLUTAREDOXINS; PEROXIREDOXIN; CHLOROPLAST	Thioredoxins (Trxs) are ubiquitous enzymes catalyzing the reduction of disulfide bonds, thanks to a CXXC active site. Among their substrates, 2-Cys methionine sulfoxide reductases B (2-Cys MSRBs) reduce the R diastereoisomer of methionine sulfoxide (MetSO) and possess two redox-active Cys as follows: a catalytic Cys reducing MetSO and a resolving one, involved in disulfide bridge formation. The other MSRB type, 1-Cys MSRBs, possesses only the catalytic Cys, and their regeneration mechanisms by Trxs remain unclear. The plant plastidial Trx CDSP32 is able to provide 1-Cys MSRB with electrons. CDSP32 includes two Trx modules with one potential active site (219)CGPC(222) and three extra Cys. Here, we investigated the redox properties of recombinant Arabidopsis CDSP32 and delineated the biochemical mechanisms of MSRB regeneration by CDSP32. Free thiol titration and 4-acetamido-4'-maleimidyl-distilbene-2,2'-disulfonic acid alkylation assays indicated that the Trx possesses only two redox-active Cys, very likely the Cys(219) and Cys(222). Protein electrophoresis analyses coupled to mass spectrometry revealed that CDSP32 forms a heterodimeric complex with MSRB1 via reduction of the sulfenic acid formed on MSRB1 catalytic Cys after MetSO reduction. MSR activity assays using variable CDSP32 amounts revealed that MSRB1 reduction proceeds with a 1: 1 stoichiometry, and redox titrations indicated that CDSP32 and MSRB1 possess midpoints potentials of -337 and -328 mV at pH 7.9, respectively, indicating that regeneration of MSRB1 activity by the Trx through sulfenic acid reduction is thermodynamically feasible in physiological conditions.	[Tarrago, Lionel; Laugier, Edith; Rey, Pascal] Univ Aix Marseille 2, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol,Lab Ecophysiol Mo, F-13108 St Paul Les Durance, France; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, Inst Biotechnol Plantes, Unite Mixte Rech 8618, F-91405 Orsay, France; [Marchand, Christophe H.; Le Marechal, Pierre] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, Unite Mixte Rech 8619, F-91405 Orsay, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rey, P (corresponding author), Univ Aix Marseille 2, Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol,Lab Ecophysiol Mo, Batiment 158, F-13108 St Paul Les Durance, France.	pascal.rey@cea.fr	MARCHAND, Christophe H/B-5854-2008; Tarrago, Lionel/CAH-1308-2022; Tarrago, Lionel/N-3534-2016; REY, Pascal/E-5794-2019; Lemaire, Stéphane D/A-3530-2008	MARCHAND, Christophe H/0000-0002-0729-3841; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; REY, Pascal/0000-0001-6512-1418; Lemaire, Stéphane D/0000-0001-6442-0547; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche (Genoplante) [GNP05010G]; Region Provence-Alpes-Cote d'Azur;  [ANR-08-BLAN-0153]	Agence Nationale de la Recherche (Genoplante)(French National Research Agency (ANR)); Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); 	This work was supported by Agence Nationale de la Recherche (Genoplante) Grants GNP05010G ( to E. L. and P. R.) and ANR-08-BLAN-0153 ( to M.Z., C. H. M., P. L. M., and S. D. L.) and by Region Provence-Alpes-Cote d'Azur ( to L. T.).	Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Balmer Y, 2001, FEBS LETT, V492, P58, DOI 10.1016/S0014-5793(01)02229-3; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Broin M, 2000, FEBS LETT, V467, P245, DOI 10.1016/S0014-5793(00)01165-0; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Eymery F, 1999, PLANT PHYSIOL BIOCH, V37, P305, DOI 10.1016/S0981-9428(99)80029-1; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Preger V, 2009, PLANT PHYSIOL, V150, P606, DOI 10.1104/pp.109.139170; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Rey P, 1998, PLANT J, V13, P97, DOI 10.1046/j.1365-313X.1998.00015.x; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, PHOTOSYNTH RES, V74, P259, DOI 10.1023/A:1021218932260; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	58	60	65	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14964	14972		10.1074/jbc.M110.108373	http://dx.doi.org/10.1074/jbc.M110.108373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236937	hybrid, Green Published			2022-12-25	WOS:000277399000017
J	Campos, Y; Qiu, XH; Zanoteli, E; Moshiach, S; Vergani, N; Bongiovanni, A; Harris, AJ; d'Azzo, A				Campos, Yvan; Qiu, Xiaohui; Zanoteli, Edmar; Moshiach, Simon; Vergani, Naja; Bongiovanni, Antonella; Harris, A. John; d'Azzo, Alessandra			Ozz-E3 Ubiquitin Ligase Targets Sarcomeric Embryonic Myosin Heavy Chain during Muscle Development	PLOS ONE			English	Article							SKELETAL-MUSCLE; CHAPERONE UNC-45; THICK FILAMENTS; CARDIOTOXIN INJURY; PROTEIN; EXPRESSION; DEGRADATION; REGENERATION; ISOFORMS; SYSTEM	Muscle contractile proteins are expressed as a series of developmental isoforms that are in constant dynamic remodeling during embryogenesis, but how obsolete molecules are recognized and removed is not known. Ozz is a developmentally regulated protein that functions as the adaptor component of a RING-type ubiquitin ligase complex specific to striated muscle. Ozz(-/-) mutants exhibit defects in myofibrillogenesis and myofiber differentiation. Here we show that Ozz targets the rod portion of embryonic myosin heavy chain and preferentially recognizes the sarcomeric rather than the soluble pool of myosin. We present evidence that Ozz binding to the embryonic myosin isoform within sarcomeric thick filaments marks it for ubiquitination and proteolytic degradation, allowing its replacement with neonatal or adult isoforms. This unique function positions Ozz within a system that facilitates sarcomeric myosin remodeling during muscle maturation and regeneration. Our findings identify Ozz-E3 as the ubiquitin ligase complex that interacts with and regulates myosin within its fully assembled cytoskeletal structure.	[Campos, Yvan; Qiu, Xiaohui; Zanoteli, Edmar; Moshiach, Simon; Vergani, Naja; d'Azzo, Alessandra] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Bongiovanni, Antonella] CNR, Ist Biomed & Immunol Mol, Palermo, Italy; [Harris, A. John] Univ Otago, Sch Med, Dept Physiol, Dunedin, New Zealand	St Jude Children's Research Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Otago	Campos, Y (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	sandra.dazzo@stjude.org	Bongiovanni, Antonella/AAX-5051-2020	Bongiovanni, Antonella/0000-0002-0307-4043	National Institutes of Health [R01 AR049867]; Cancer Center Support [CA021765]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health grants R01 AR049867, the Cancer Center Support Grant CA021765, the Assisi Foundation of Memphis, and the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BANDMAN E, 1992, DEV BIOL, V154, P273, DOI 10.1016/0012-1606(92)90067-Q; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; BROZANSKI BS, 1991, AM J PHYSIOL, V261, pL49, DOI 10.1152/ajplung.1991.261.2.L49; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; DAVIS JS, 1993, BIOCHEMISTRY-US, V32, P4035, DOI 10.1021/bi00066a026; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; HARRIS AJ, 1989, DEVELOPMENT, V107, P751; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KELLY AM, 1969, J CELL BIOL, V42, P135, DOI 10.1083/jcb.42.1.135; Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; LOUGHNA PT, 1990, DEVELOPMENT, V109, P217; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; SAAD AD, 1986, P NATL ACAD SCI USA, V83, P9483, DOI 10.1073/pnas.83.24.9483; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sun YM, 2003, J MUSCLE RES CELL M, V24, P561, DOI 10.1023/B:JURE.0000009895.03111.b3; TRINICK JA, 1982, METHOD ENZYMOL, V85, P17; Wanek LJ, 2000, ANAT REC, V258, P176; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9866	10.1371/journal.pone.0009866	http://dx.doi.org/10.1371/journal.pone.0009866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352047	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894500023
J	Chang, MY; Kim, D; Kim, CH; Kang, HC; Yang, E; Moon, JI; Ko, S; Park, J; Park, KS; Lee, KA; Hwang, DY; Chung, Y; Lanza, R; Kim, KS				Chang, Mi-Yoon; Kim, Dohoon; Kim, Chun-Hyung; Kang, Hoon-Chul; Yang, Eungi; Moon, Jung-Il; Ko, Sanghyeok; Park, Junpil; Park, Kyung-Soon; Lee, Kyung-Ah; Hwang, Dong-Youn; Chung, Young; Lanza, Robert; Kim, Kwang-Soo			Direct Reprogramming of Rat Neural Precursor Cells and Fibroblasts into Pluripotent Stem Cells	PLOS ONE			English	Article							SOMATIC-CELLS; GENERATION; NEURONS; DIFFERENTIATION; TRANSPLANTATION; INDUCTION; DISEASE	Background: Given the usefulness of rats as an experimental system, an efficient method for generating rat induced pluripotent stem (iPS) cells would provide researchers with a powerful tool for studying human physiology and disease. Here, we report direct reprogramming of rat neural precursor (NP) cells and rat embryonic fibroblasts (REF) into iPS cells by retroviral transduction using either three (Oct3/4, Sox2, and Klf4), four (Oct3/4, Sox2, Klf4, and c-Myc), or five (Oct3/4, Sox2, Klf4, c-Myc, and Nanog) genes. Methodology and Principal Findings: iPS cells were generated from both NP and REF using only three (Oct3/4, Sox2, and Klf4) genes without c-Myc. Two factors were found to be critical for efficient derivation and maintenance of rat iPS cells: the use of rat instead of mouse feeders, and the use of small molecules specifically inhibiting mitogen-activated protein kinase and glycogen synthase kinase 3 pathways. In contrast, introduction of embryonic stem cell (ESC) extracts induced partial reprogramming, but failed to generate iPS cells. However, when combined with retroviral transduction, this method generated iPS cells with significantly higher efficiency. Morphology, gene expression, and epigenetic status confirmed that these rat iPS cells exhibited ESC-like properties, including the ability to differentiate into all three germ layers both in vitro and in teratomas. In particular, we found that these rat iPS cells could differentiate to midbrain-like dopamine neurons with a high efficiency. Conclusions/Significance: Given the usefulness of rats as an experimental system, our optimized method would be useful for generating rat iPS cells from diverse tissues and provide researchers with a powerful tool for studying human physiology and disease.	[Chang, Mi-Yoon; Kim, Dohoon; Kim, Chun-Hyung; Kang, Hoon-Chul; Yang, Eungi; Moon, Jung-Il; Ko, Sanghyeok; Park, Junpil; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02178 USA; [Kim, Kwang-Soo] Harvard Stem Cell Inst, Cambridge, MA USA; [Chung, Young; Lanza, Robert] Stem Cell Int Inc, Worcester, MA USA; [Park, Kyung-Soon; Lee, Kyung-Ah; Hwang, Dong-Youn; Kim, Kwang-Soo] Pochon CHA Univ, Coll Med, CHA Stem Cell Inst, Seoul, South Korea	Harvard University; McLean Hospital; Harvard University; Pochon Cha University	Chang, MY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02178 USA.	kskim@mclean.harvard.edu	Chung, Young Gie/AAC-8149-2020	Lanza, Robert/0000-0002-3047-3074	National Institute of Health [MH48866, MH087903]; Korean Stem Cell Research Center; Korean Government (MOEFRD) [KRF-2006-214-H00004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048866, R29MH048866, R33MH087903, R21MH087903] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Stem Cell Research Center; Korean Government (MOEFRD)(Korean Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Health grants MH48866 and MH087903 and by International Collaboration Grants from Korean Stem Cell Research Center and the CHA Stem Cell Institute of the Pochon CHA University; Mi-Yoon Chang was supported by the fellowship from Korea Research Foundation Grant funded by the Korean Government (MOEFRD) (KRF-2006-214-H00004). Stem Cell International, Inc., played a role as a funder due to employment of two of the authors of this study. Dr. Young Chung and Dr. Robert Lanza are employed by Stem Cell International, Inc. The funders therefore had a role in data collection and analysis. The funders had no role in decision to publish or preparation of the manuscript.	Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; BRUNDIN P, 1987, EXP BRAIN RES, V69, P183; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chang MY, 2004, DEV BRAIN RES, V153, P89, DOI 10.1016/j.devbrainres.2004.08.003; CHANG MY, 2008, INT S IPS RES KYOT J; CHANG MY, 2008, SFN ANN M WASH DC; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAHASHI K, 2009, PLOS ONE, V4, P1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	31	51	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9838	10.1371/journal.pone.0009838	http://dx.doi.org/10.1371/journal.pone.0009838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352099	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894500010
J	Hung, AY; Sung, CC; Brito, IL; Sheng, M				Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan			Degradation of Postsynaptic Scaffold GKAP and Regulation of Dendritic Spine Morphology by the TRIM3 Ubiquitin Ligase in Rat Hippocampal Neurons	PLOS ONE			English	Article							RING FINGER PROTEIN; EXCITATORY SYNAPSES; SYNAPTIC PROTEIN; DIFFERENTIAL EXPRESSION; PROTEASOME SYSTEM; DENSITY PROTEINS; SHANK FAMILY; MYOSIN-V; COMPLEX; PSD-95	Changes in neuronal activity modify the structure of dendritic spines and alter the function and protein composition of synapses. Regulated degradation of postsynaptic density (PSD) proteins by the ubiquitin-proteasome system is believed to play an important role in activity-dependent synaptic remodeling. Stimulating neuronal activity in vitro and in vivo induces the ubiquitination and degradation of GKAP/SAPAP and Shank, major scaffold proteins of the PSD. However, the specific ubiquitin ligases that regulate postsynaptic protein composition have not been identified. Here we identify the RING finger-containing protein TRIM3 as a specific E3 ubiquitin ligase for the PSD scaffold GKAP/SAPAP1. Present in PSD fractions from rat brain, TRIM3 stimulates ubiquitination and proteasome-dependent degradation of GKAP, and induces the loss of GKAP and associated scaffold Shank1 from postsynaptic sites. Suppression of endogenous TRIM3 by RNA interference (RNAi) results in increased accumulation of GKAP and Shank1 at synapses, as well as enlargement of dendritic spine heads. RNAi of TRIM3 also prevented the loss of GKAP induced by synaptic activity. Thus, TRIM3 is a novel E3 ligase that mediates activity-dependent turnover of PSD scaffold proteins and is a negative regulator of dendritic spine morphology.	[Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hung, Albert Y.; Sung, Clifford C.; Brito, Ilana L.; Sheng, Morgan] MIT, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hung, Albert Y.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital	Hung, AY (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	msheng@mit.edu	; Brito, Ilana/W-1827-2017	Sheng, Morgan/0000-0002-8703-5366; Brito, Ilana/0000-0002-2250-3480	National Institutes of Health [K08 Award NS41411]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS041411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by National Institutes of Health K08 Award NS41411 (A. Y. H.). M. S. was an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohkawa N, 2001, J NEUROCHEM, V78, P75, DOI 10.1046/j.1471-4159.2001.00373.x; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	52	76	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9842	10.1371/journal.pone.0009842	http://dx.doi.org/10.1371/journal.pone.0009842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352094	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500011
J	You, H; Zhang, WB; Jones, MK; Gobert, GN; Mulvenna, J; Rees, G; Spanevello, M; Blair, D; Duke, M; Brehm, K; McManus, DP				You, Hong; Zhang, Wenbao; Jones, Malcolm K.; Gobert, Geoffrey N.; Mulvenna, Jason; Rees, Glynn; Spanevello, Mark; Blair, David; Duke, Mary; Brehm, Klaus; McManus, Donald P.			Cloning and Characterisation of Schistosoma japonicum Insulin Receptors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE KINASES; HOST-PARASITE INTERPLAY; DIFFERENTIAL REGULATION; LIGAND SPECIFICITY; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GLUCOSE-UPTAKE; BLOOD FLUKES	Background: Schistosomes depend for growth and development on host hormonal signals, which may include the insulin signalling pathway. We cloned and assessed the function of two insulin receptors from Schistosoma japonicum in order to shed light on their role in schistosome biology. Methodology/Principal Findings: We isolated, from S. japonicum, insulin receptors 1 (SjIR-1) and 2 (SjIR-2) sharing close sequence identity to their S. mansoni homologues (SmIR-1 and SmIR-2). SjIR-1 is located on the tegument basal membrane and the internal epithelium of adult worms, whereas SjIR-2 is located in the parenchyma of males and the vitelline tissue of females. Phylogenetic analysis showed that SjIR-2 and SmIR-2 are close to Echinococcus multilocularis insulin receptor (EmIR), suggesting that SjIR-2, SmIR-2 and EmIR share similar roles in growth and development in the three taxa. Structure homology modelling recovered the conserved structure between the SjIRs and Homo sapiens IR (HIR) implying a common predicted binding mechanism in the ligand domain and the same downstream signal transduction processing in the tyrosine kinase domain as in HIR. Two-hybrid analysis was used to confirm that the ligand domains of SjIR-1 and SjIR-2 contain the insulin binding site. Incubation of adult worms in vitro, both with a specific insulin receptor inhibitor and anti-SjIRs antibodies, resulted in a significant decrease in worm glucose levels, suggesting again the same function for SjIRs in regulating glucose uptake as described for mammalian cells. Conclusions: Adult worms of S. japonicum possess insulin receptors that can specifically bind to insulin, indicating that the parasite can utilize host insulin for development and growth by sharing the same pathway as mammalian cells in regulating glucose uptake. A complete understanding of the role of SjIRs in the biology of S. japonicum may result in their use as new targets for drug and vaccine development against schistosomiasis.	[You, Hong; Zhang, Wenbao; Jones, Malcolm K.; Gobert, Geoffrey N.; Mulvenna, Jason; Rees, Glynn; Spanevello, Mark; Duke, Mary; McManus, Donald P.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [You, Hong] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Blair, David] James Cook Univ, Sch Trop Biol, Townsville, Qld, Australia; [Brehm, Klaus] Univ Wurzburg, Inst Hyg & Mikrobiol, Wurzburg, Germany	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; James Cook University; University of Wurzburg	You, H (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	donM@qimr.edu.au	You, Hong/AAB-4649-2020; Mulvenna, Jason/H-7110-2014; Blair, David/O-2786-2019; Jones, Malcolm K/A-1097-2009; Gobert, Geoffrey/A-1468-2011; McManus, Donald P./G-2678-2013; Blair, David/G-6052-2011; Gobert, Geoffrey/V-2985-2019; McManus, Don/AAC-5394-2020	You, Hong/0000-0002-8790-7793; Mulvenna, Jason/0000-0003-3521-8061; Blair, David/0000-0002-4658-3251; Jones, Malcolm K/0000-0002-0035-6141; Blair, David/0000-0002-4658-3251; McManus, Don/0000-0001-6443-1449; Gobert, Geoffrey/0000-0001-5884-6453	National Health and Medical Research Council of Australia [ID 290238, ID 496600]; Wellcome Trust [ID071657MA]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (ID 290238 and ID 496600, http://www.nhmrc.gov.au/), and the Wellcome Trust (ID071657MA, http://www.wellcome.ac.uk/). H. Y. is a recipient of a University of Queensland postgraduate scholarship (Endeavour IPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahier A, 2008, PARASITE, V15, P573, DOI 10.1051/parasite/2008154573; ALBERTS GF, 1994, CIRC RES, V75, P261, DOI 10.1161/01.RES.75.2.261; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Bahia D, 2006, MEM I OSWALDO CRUZ, V101, P137, DOI 10.1590/S0074-02762006000900022; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Bealla MJ, 2002, INT J PARASITOL, V32, P399, DOI 10.1016/S0020-7519(01)00348-4; Bergquist NR, 2005, TRENDS PARASITOL, V21, P112, DOI 10.1016/j.pt.2005.01.001; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Damian RT, 1997, PARASITOLOGY, V115, pS169, DOI 10.1017/S0031182097002357; Davies SJ, 1998, J BIOL CHEM, V273, P11234, DOI 10.1074/jbc.273.18.11234; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Dissous C, 2007, BIOESSAYS, V29, P1281, DOI 10.1002/bies.20662; Dissous C, 2006, FEBS LETT, V580, P2968, DOI 10.1016/j.febslet.2006.03.046; Dozio N, 2001, J INVEST MED, V49, P85, DOI 10.2310/6650.2001.34094; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; ESCOBEDO G, 2009, J HELMINTHOL, P1; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; HAN ZG, 2009, ANN REV GENOMICS HUM; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hu W, 2004, TRENDS MOL MED, V10, P217, DOI 10.1016/j.molmed.2004.03.002; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulstijn M, 2003, PARASITOLOGY, V126, P53, DOI 10.1017/S0031182002002512; Hulstijn M, 2001, MEM I OSWALDO CRUZ, V96, P393, DOI 10.1590/S0074-02762001000300020; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Khayath N, 2007, FEBS J, V274, P659, DOI 10.1111/j.1742-4658.2006.05610.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; Knobloch J, 2006, INT J PARASITOL, V36, P1261, DOI 10.1016/j.ijpara.2006.06.004; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; Konrad C, 2003, INT J PARASITOL, V33, P301, DOI 10.1016/S0020-7519(02)00265-5; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leenstra T, 2006, INFECT IMMUN, V74, P6398, DOI 10.1128/IAI.00757-06; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002; LoVerde PT, 2009, CURR OPIN MICROBIOL, V12, P422, DOI 10.1016/j.mib.2009.06.005; MALCOLM KJ, 2007, INT J BIOCHEM CELL B, V39, P1551; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MCLAREN DJ, 1977, NATURE, V269, P147, DOI 10.1038/269147a0; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Sambrook J., 2001, MOL CLONING; SAPERSTEIN R, 1989, BIOCHEMISTRY-US, V28, P5694, DOI 10.1021/bi00439a053; SHOEMAKER CB, 1992, MOL BIOCHEM PARASIT, V53, P17, DOI 10.1016/0166-6851(92)90003-3; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; YOU H, 2009, INT J PARASITOL; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	71	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9868	10.1371/journal.pone.0009868	http://dx.doi.org/10.1371/journal.pone.0009868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352052	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000275894500024
J	Caljon, G; De Ridder, K; De Baetselier, P; Coosemans, M; Van Den Abbeele, J				Caljon, Guy; De Ridder, Karin; De Baetselier, Patrick; Coosemans, Marc; Van Den Abbeele, Jan			Identification of a Tsetse Fly Salivary Protein with Dual Inhibitory Action on Human Platelet Aggregation	PLOS ONE			English	Article							EXTRACELLULAR ATP; ESCHERICHIA-COLI; DENDRITIC CELLS; GLAND EXTRACTS; APYRASE; EXPRESSION; 5'-NUCLEOTIDASE; RECEPTOR; ACTIVATION; CHEMOTAXIS	Background: Tsetse flies (Glossina sp.), the African trypanosome vectors, rely on anti-hemostatic compounds for efficient blood feeding. Despite their medical importance, very few salivary proteins have been characterized and functionally annotated. Methodology/Principal Findings: Here we report on the functional characterisation of a 5'nucleotidase-related (5'Nuc) saliva protein of the tsetse fly Glossina morsitans morsitans. This protein is encoded by a 1668 bp cDNA corresponding at the genomic level with a single-copy 4 kb gene that is exclusively transcribed in the tsetse salivary gland tissue. The encoded 5'Nuc protein is a soluble 65 kDa glycosylated compound of tsetse saliva with a dual anti-hemostatic action that relies on its combined apyrase activity and fibrinogen receptor (GPIIb/IIIa) antagonistic properties. Experimental evidence is based on the biochemical and functional characterization of recombinant protein and on the successful silencing of the 5'nuc translation in the salivary gland by RNA interference (RNAi). Refolding of a 5'Nuc/SUMO-fusion protein yielded an active apyrase enzyme with K-m and V-max values of 43+/-4 mM and 684+/-49 nmol Pi/minxmg for ATPase and 49+/-11 mu M and 177+/-37 nmol Pi/minxmg for the ADPase activity. In addition, recombinant 5'Nuc was found to bind to GPIIb/IIIa with an apparent K-D of 92+/-25 nM. Consistent with these features, 5'Nuc potently inhibited ADP-induced thrombocyte aggregation and even caused disaggregation of ADP-triggered human platelets. The importance of 5'Nuc for the tsetse fly hematophagy was further illustrated by specific RNAi that reduced the anti-thrombotic activities in saliva by approximately 50% resulting in a disturbed blood feeding process. Conclusions/Significance: These data show that this 5'nucleotidase-related apyrase exhibits GPIIb/IIIa antagonistic properties and represents a key thromboregulatory compound of tsetse fly saliva.	[Caljon, Guy; De Ridder, Karin; Coosemans, Marc; Van Den Abbeele, Jan] Inst Trop Med Antwerp ITM, Unit Entomol, Antwerp, Belgium; [Caljon, Guy; De Baetselier, Patrick] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy; De Baetselier, Patrick] VIB, Dept Mol & Cellular Interact, Ghent, Belgium	Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Caljon, G (corresponding author), Inst Trop Med Antwerp ITM, Unit Entomol, Antwerp, Belgium.	jvdabbeele@itg.be	De Baetselier, Patrick/D-3866-2014; Caljon, Guy/E-1310-2017	Caljon, Guy/0000-0002-4870-3202; Van Den Abbeele, Jan/0000-0002-4533-4480	InterUniversity Attraction Pole [IUAP, P6/15]	InterUniversity Attraction Pole(Belgian Federal Science Policy Office)	This project was supported by InterUniversity Attraction Pole fundings (IUAP, P6/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVESSILVA J, 2010, BMC GENOMIC IN PRESS; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Caljon G, 2006, INFECT IMMUN, V74, P6324, DOI 10.1128/IAI.01046-06; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Cappello M, 1996, AM J TROP MED HYG, V54, P475, DOI 10.4269/ajtmh.1996.54.475; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Champagne Donald E., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P375, DOI 10.2174/1568006043335862; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Faudry E, 2004, J BIOL CHEM, V279, P19607, DOI 10.1074/jbc.M401681200; Fini C, 2000, EUR J BIOCHEM, V267, P4978, DOI 10.1046/j.1432-1327.2000.01545.x; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gounaris K, 2005, TRENDS PARASITOL, V21, P17, DOI 10.1016/j.pt.2004.10.005; GREVELINK SA, 1993, P NATL ACAD SCI USA, V90, P9155, DOI 10.1073/pnas.90.19.9155; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; LERNER EA, 1991, J BIOL CHEM, V266, P11234; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; Lombardo F, 2000, J BIOL CHEM, V275, P23861, DOI 10.1074/jbc.M909547199; MANT MJ, 1981, BRIT J HAEMATOL, V48, P601, DOI 10.1111/j.1365-2141.1981.00601.x; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Reddy VB, 2000, J BIOL CHEM, V275, P15861, DOI 10.1074/jbc.275.21.15861; Reno HE, 2005, AM J TROP MED HYG, V73, P541, DOI 10.4269/ajtmh.2005.73.541; Ribeiro JMC, 1999, J EXP BIOL, V202, P1551; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Sevigny J, 2000, J BIOL CHEM, V275, P5640, DOI 10.1074/jbc.275.8.5640; Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y	45	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9671	10.1371/journal.pone.0009671	http://dx.doi.org/10.1371/journal.pone.0009671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351782	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894400007
J	Bousset, L; Bonnefoy, J; Sourigues, Y; Wien, F; Melki, R				Bousset, Luc; Bonnefoy, Jonathan; Sourigues, Yannick; Wien, Frank; Melki, Ronald			Structure and Assembly Properties of the N-Terminal Domain of the Prion Ure2p in Isolation and in Its Natural Context	PLOS ONE			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; PROTEIN FIBRILS; ALPHA-SYNUCLEIN; YEAST PRIONS; PROPAGATION; HSP70; PSI+; NANOPARTICLES; CONFORMATION	Background: The aggregation of the baker's yeast prion Ure2p is at the origin of the [URE3] trait. The Q- and N-rich N-terminal part of the protein is believed to drive Ure2p assembly into fibrils of amyloid nature and the fibrillar forms of full-length Ure2p and its N-terminal part generated in vitro have been shown to induce [URE3] occurrence when introduced into yeast cells. This has led to the view that the fibrillar form of the N-terminal part of the protein is sufficient for the recruitment of constitutive Ure2p and that it imprints its amyloid structure to full-length Ure2p. Results: Here we generate a set of Ure2p N-terminal fragments, document their assembly and structural properties and compare them to that of full-length Ure2p. We identify the minimal region critical for the assembly of Ure2p N-terminal part into amyloids and show that such fibrils are unable to seed the assembly of full length Ure2p unlike fibrils made of intact Ure2p. Conclusion: Our results clearly indicate that fibrillar Ure2p shares no structural similarities with the amyloid fibrils made of Ure2p N-terminal part. Our results further suggest that the induction of [URE3] by fibrils made of full-length Ure2p is likely the consequence of fibrils growth by depletion of cytosolic Ure2p while it is the consequence of de novo formation of prion particles following, for example, titration within the cells of a specific set of molecular chaperones when fibrils made of Ure2p N-terminal domain are introduced within the cytoplasm.	[Bousset, Luc; Bonnefoy, Jonathan; Sourigues, Yannick; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Wien, Frank] Synchrotron Soleil, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Bousset, L (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr	Wien, Frank/B-7846-2012	Wien, Frank/0000-0002-0752-8735; bousset, luc/0000-0002-0433-4337	Agence Nationale de la Recherche [ANR-06-BLAN-0266]; Centre National de la Recherche Scientifique	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche (ANR-06-BLAN-0266) and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bousset L, 2003, J STRUCT BIOL, V141, P132, DOI 10.1016/S1047-8477(02)00606-8; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Colvin VL, 2007, P NATL ACAD SCI USA, V104, P8679, DOI 10.1073/pnas.0703194104; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 1997, GENETICS, V147, P507; Evans P, 2007, EXP EYE RES, V84, P1001, DOI 10.1016/j.exer.2007.01.016; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; GEIGE R, 1992, CRYSTALLIZATION NUCL, P1; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; Leslie A, 1992, NEWSLETTER PROTEIN C; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Loovers HM, 2007, GENETICS, V175, P621, DOI 10.1534/genetics.106.066019; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; SANDSTROM J, 2000, CIRCULAR DICHROISM P, P459; Savistchenko J, 2008, J BIOL CHEM, V283, P15732, DOI 10.1074/jbc.M800728200; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9760	10.1371/journal.pone.0009760	http://dx.doi.org/10.1371/journal.pone.0009760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339590	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300007
J	Harms, KM; Li, L; Cunningham, LA				Harms, Kate M.; Li, Lu; Cunningham, Lee Anna			Murine Neural Stem/Progenitor Cells Protect Neurons against Ischemia by HIF-1 alpha-Regulated VEGF Signaling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; STROKE-INDUCED NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; RAT-BRAIN; IN-VITRO	Focal cerebral ischemia following middle cerebral artery occlusion (MCAO) stimulates a robust cytogenic response from the adult subventricular zone (SVZ) that includes massive proliferation of neural stem/progenitor cells (NSPCs) and cellular migration into the injury area. To begin to explore beneficial roles of NSPCs in this response, we investigated the ability of embryonic and postnatal NSPCs to promote neuronal survival under conditions of in vivo and in vitro ischemia. Intracerebral transplantation of NSPCs attenuated neuronal apoptosis in response to focal ischemia induced by transient MCAO, and prevented neuronal cell death of cortical neurons in response to oxygen-glucose deprivation (OGD) in culture. NSPC-mediated neuroprotection was blocked by the pharmacological inhibitors of vascular endothelial growth factor (VEGF), SU1498 and Flt-1Fc. Embryonic and postnatal NSPCs were both intrinsically resistant to brief OGD exposure, and constitutively expressed both hypoxia-inducible factor 1 alpha (HIF-1 alpha) transcription factor and its downstream target, VEGF. Genomic deletion of HIF-1 alpha by Cre-mediated excision of exon 2 in NSPC cultures resulted in >50% reduction of VEGF production and ablation of NSPC-mediated neuroprotection. These findings indicate that NSPCs promote neuronal survival under ischemic conditions via HIF-1 alpha-VEGF signaling pathways and support a role for NSPCs in promotion of neuronal survival following stroke.	[Harms, Kate M.; Li, Lu; Cunningham, Lee Anna] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Harms, KM (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA.	LeeAnna@salud.unm.edu			American Heart Association [0810071Z, 09GRNT2290178]; University of New Mexico School of Medicine [C-2310-RAC/Bridge]	American Heart Association(American Heart Association); University of New Mexico School of Medicine	This work was supported by grants from the American Heart Association (www.americanheart.org), 0810071Z (KMH) and 09GRNT2290178 (LAC), and Dedicated Health Research Funds from the University of New Mexico School of Medicine (http://hsc.unm.edu/som/), C-2310-RAC/Bridge (LAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwai M, 2003, J CEREBR BLOOD F MET, V23, P331, DOI 10.1097/01.WCB.0000050060.57184.E7; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Marti Hugo H., 1999, Thrombosis and Haemostasis, V82, P44; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHWEIKI D, 1992, NATURE, V359, P845; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taoufik E, 2008, P NATL ACAD SCI USA, V105, P6185, DOI 10.1073/pnas.0801447105; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Xiong L, 2009, CELL STRESS CHAPERON, V14, P183, DOI 10.1007/s12192-008-0071-z; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	70	77	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9767	10.1371/journal.pone.0009767	http://dx.doi.org/10.1371/journal.pone.0009767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339541	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300011
J	Ramsgaard, L; Englert, JM; Tobolewski, J; Tomai, L; Fattman, CL; Leme, AS; Kaynar, AM; Shapiro, SD; Enghild, JJ; Oury, TD				Ramsgaard, Lasse; Englert, Judson M.; Tobolewski, Jacob; Tomai, Lauren; Fattman, Cheryl L.; Leme, Adriana S.; Kaynar, A. Murat; Shapiro, Steven D.; Enghild, Jan J.; Oury, Tim D.			The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis	PLOS ONE			English	Article							INDUCED LUNG INJURY; EXTRACELLULAR-SUPEROXIDE DISMUTASE; IDIOPATHIC PULMONARY-FIBROSIS; SOLUBLE RECEPTOR; CELL-SURFACE; RAGE; BLEOMYCIN; PATHOGENESIS; PROTEIN; TISSUE	Background: The role of the receptor for advanced glycation end-products (RAGE) has been shown to differ in two different mouse models of asbestos and bleomycin induced pulmonary fibrosis. RAGE knockout (KO) mice get worse fibrosis when challenged with asbestos, whereas in the bleomycin model they are largely protected against fibrosis. In the current study the role of RAGE in a mouse model of silica induced pulmonary fibrosis was investigated. Methodology/Principal Findings: Wild type (WT) and RAGE KO mice received a single intratracheal (i.t.) instillation of silica in saline or saline alone as vehicle control. Fourteen days after treatment mice were subjected to a lung mechanistic study and the lungs were lavaged and inflammatory cells, protein and TGF-beta levels in lavage fluid determined. Lungs were subsequently either fixed for histology or excised for biochemical assessment of fibrosis and determination of RAGE protein- and mRNA levels. There was no difference in the inflammatory response or degree of fibrosis (hydroxyproline levels) in the lungs between WT and RAGE KO mice after silica injury. However, histologically the fibrotic lesions in the RAGE KO mice had a more diffuse alveolar septal fibrosis compared to the nodular fibrosis in WT mice. Furthermore, RAGE KO mice had a significantly higher histologic score, a measure of affected areas of the lung, compared to WT silica treated mice. A lung mechanistic study revealed a significant decrease in lung function after silica compared to control, but no difference between WT and RAGE KO. While a dose response study showed similar degrees of fibrosis after silica treatment in the two strains, the RAGE KO mice had some differences in the inflammatory response compared to WT mice. Conclusions/Significance: Aside from the difference in the fibrotic pattern, these studies showed no indicators of RAGE having an effect on the severity of pulmonary fibrosis following silica injury.	[Ramsgaard, Lasse; Englert, Judson M.; Tobolewski, Jacob; Tomai, Lauren; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Fattman, Cheryl L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Leme, Adriana S.; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Kaynar, A. Murat] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Kaynar, A. Murat] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramsgaard, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu	Kaynar, Ata Murat/ABI-6877-2020	Kaynar, Ata Murat/0000-0001-8847-0450; Enghild, Jan Johannes/0000-0001-9292-9172	National Institutes of Health [R01HL110166, R21ES013986, F30ES016973]; The Lundbeck Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013986, F30ES016973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was received from the National Institutes of Health R01HL110166 and R21ES013986 to Tim D. Oury, F30ES016973 to Judson M. Englert, and The Lundbeck Foundation (www.lundbeck.com) grant to Lasse Ramsgaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N; BROWN RFR, 1988, TOXICOLOGY, V51, P101, DOI 10.1016/0300-483X(88)90084-4; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Gefter JV, 2009, CELL TISSUE RES, V337, P79, DOI 10.1007/s00441-009-0791-0; Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Kim W, 2005, ANN NY ACAD SCI, V1043, P553, DOI 10.1196/annals.1338.063; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; *NAT I OCC SAF HLT, 2008, SIL NUMB DEATHS CRUD; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; TAM PE, 1993, PCR METH APPL, V3, P71; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; VANBARNEVELD PWC, 1987, AM REV RESPIR DIS, V135, P48; *WHO, 2000, 238 WHO G; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	40	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9604	10.1371/journal.pone.0009604	http://dx.doi.org/10.1371/journal.pone.0009604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333255	Green Published, Green Accepted, gold			2022-12-25	WOS:000275809700002
J	Nakajima, M; Takahashi, A; Kou, I; Rodriguez-Fontenla, C; Gomez-Reino, JJ; Furuichi, T; Dai, J; Sudo, A; Uchida, A; Fukui, N; Kubo, M; Kamatani, N; Tsunoda, T; Malizos, KN; Tsezou, A; Gonzalez, A; Nakamura, Y; Ikegawa, S				Nakajima, Masahiro; Takahashi, Atsushi; Kou, Ikuyo; Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Furuichi, Tatsuya; Dai, Jin; Sudo, Akihiro; Uchida, Atsumasa; Fukui, Naoshi; Kubo, Michiaki; Kamatani, Naoyuki; Tsunoda, Tatsuhiko; Malizos, Konstantinos N.; Tsezou, Aspasia; Gonzalez, Antonio; Nakamura, Yusuke; Ikegawa, Shiro			New Sequence Variants in HLA Class II/III Region Associated with Susceptibility to Knee Osteoarthritis Identified by Genome-Wide Association Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; INCREASES SUSCEPTIBILITY; ARTICULAR CHONDROCYTES; OSTEO-ARTHRITIS; GENE; JAPANESE; PHENOTYPES; ANTIGENS; HLA-DQA2; BTNL2	Osteoarthritis (OA) is a common disease that has a definite genetic component. Only a few OA susceptibility genes that have definite functional evidence and replication of association have been reported, however. Through a genome-wide association study and a replication using a total of similar to 4,800 Japanese subjects, we identified two single nucleotide polymorphisms (SNPs) (rs7775228 and rs10947262) associated with susceptibility to knee OA. The two SNPs were in a region containing HLA class II/III genes and their association reached genome-wide significance (combined P = 2.43x10(-8) for rs7775228 and 6.73x10(-8) for rs10947262). Our results suggest that immunologic mechanism is implicated in the etiology of OA.	[Nakajima, Masahiro; Kou, Ikuyo; Furuichi, Tatsuya; Dai, Jin; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain; [Rodriguez-Fontenla, Cristina; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain; [Dai, Jin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Peoples R China; [Sudo, Akihiro; Uchida, Atsumasa] Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Fukui, Naoshi] Natl Hosp Org Sagamihara Natl Hosp, Clin Res Ctr Rheumatol & Allergy, Dept Pathomech, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Kanagawa, Japan; [Malizos, Konstantinos N.] Univ Thessaly, Dept Orthopaed, Larisa, Greece; [Malizos, Konstantinos N.] Inst Biomed Res & Technol, Larisa, Greece; [Tsezou, Aspasia] Univ Thessaly, Sch Med, Dept Biol, Larisa, Greece; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	RIKEN; RIKEN; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Nanjing University; Mie University; RIKEN; RIKEN; University of Thessaly; University of Thessaly; University of Tokyo	Nakajima, M (corresponding author), RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Dai, Jin/GVT-2414-2022; Gonzalez, Antonio/C-4444-2008; Ikegawa, Shiro/N-6895-2015; Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015; Gomez-Reino, Juan/ABI-2853-2020	Dai, Jin/0000-0003-3063-746X; Gonzalez, Antonio/0000-0002-2624-0606; Ikegawa, Shiro/0000-0003-0316-2147; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Gomez-Reino, Juan/0000-0001-5229-6294; Rodriguez Fontenla, Maria Cristina/0000-0002-9829-6393	Ministry of Education, Culture, Sports, Science and Technology; Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional); Foundation Mutua Madrile (Madrid)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional); Foundation Mutua Madrile (Madrid)	The Japanese study is supported by the Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology. The European study is supported by Instituto de Salud Carlos III from the Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional), the Foundation Mutua Madrile (Madrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2007, MOL BIOL CELL, P1577; Andrieu N, 1998, EPIDEMIOL REV, V20, P137, DOI 10.1093/oxfordjournals.epirev.a017976; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CLAYTON J, 1997, GENETIC DIVERSITY HL, P665; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Evans TI, 1995, ARTHRITIS RHEUM, V38, P1754, DOI 10.1002/art.1780381208; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; LANCE EM, 1993, CLIN ORTHOP RELAT R, P266; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moos V, 2002, RHEUMATOLOGY, V41, P666, DOI 10.1093/rheumatology/41.6.666; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Mototani H, 2008, HUM MOL GENET, V17, P1790, DOI 10.1093/hmg/ddn069; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; PATTRICK M, 1989, ANN RHEUM DIS, V48, P470, DOI 10.1136/ard.48.6.470; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; REVELL PA, 1988, ANN RHEUM DIS, V47, P300, DOI 10.1136/ard.47.4.300; Rodriguez-Lopez J, 2009, OSTEOARTHR CARTILAGE, V17, P321, DOI 10.1016/j.joca.2008.07.012; Rudy GB, 1997, J IMMUNOL, V158, P2116; Sakata M, 2003, CLIN EXP RHEUMATOL, V21, P704; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Spector TD, 2006, ARTHRITIS RHEUM-US, V54, P524, DOI 10.1002/art.21624; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wakitani S, 2001, CLIN RHEUMATOL, V20, P417, DOI 10.1007/s100670170006; YU LP, 1991, J IMMUNOL, V147, P4393	28	77	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9723	10.1371/journal.pone.0009723	http://dx.doi.org/10.1371/journal.pone.0009723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305777	gold, Green Submitted, Green Published			2022-12-25	WOS:000276456300012
J	Kraus, VB; Kepler, TB; Stabler, T; Renner, J; Jordan, J				Kraus, Virginia B.; Kepler, Thomas B.; Stabler, Thomas; Renner, Jordan; Jordan, Joanne			First Qualification Study of Serum Biomarkers as Indicators of Total Body Burden of Osteoarthritis	PLOS ONE			English	Article							BIOCHEMICAL MARKERS; KNEE OSTEOARTHRITIS; RADIOGRAPHIC SUBTYPES; POSTMENOPAUSAL WOMEN; HIP OSTEOARTHRITIS; CARTILAGE TURNOVER; MOLECULAR MARKERS; DISEASE-ACTIVITY; MULTIPLE SITES; JOINT DAMAGE	Background: Osteoarthritis (OA) is a debilitating chronic multijoint disease of global proportions. OA presence and severity is usually documented by x-ray imaging but whole body imaging is impractical due to radiation exposure, time and cost. Systemic (serum or urine) biomarkers offer a potential alternative method of quantifying total body burden of disease but no OA-related biomarker has ever been stringently qualified to determine the feasibility of this approach. The goal of this study was to evaluate the ability of three OA-related biomarkers to predict various forms or subspecies of OA and total body burden of disease. Methodology/Principal Findings: Female participants (461) with clinical hand OA underwent radiography of hands, hips, knees and lumbar spine; x-rays were comprehensively scored for OA features of osteophyte and joint space narrowing. Three OA-related biomarkers, serum hyaluronan (sHA), cartilage oligomeric matrix protein (sCOMP), and urinary C-telopeptide of type II collagen (uCTX2), were measured by ELISA. sHA, sCOMP and uCTX2 correlated positively with total osteophyte burden in models accounting for demographics (age, weight, height): R-2 = 0.60, R-2 = 0.47, R-2 = 0.51 (all p < 10(-6)); sCOMP correlated negatively with total joint space narrowing burden: R 2 = 0.69 (p, 10 26). Biomarkers and demographics predicted 35-38% of variance in total burden of OA (total joint space narrowing or osteophyte). Joint size did not determine the contribution to the systemic biomarker concentration. Biomarker correlation with disease in the lumbar spine resembled that in the rest of the skeleton. Conclusions/Significance: We have suspected that the correlation of systemic biomarkers with disease has been hampered by the inability to fully phenotype the burden of OA in a patient. These results confirm the hypothesis, revealed upon adequate patient phenotyping, that systemic joint tissue concentrations of several biomarkers can be quantitative indicators of specific subspecies of OA and of total body burden of disease.	[Kraus, Virginia B.; Stabler, Thomas] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Renner, Jordan; Jordan, Joanne] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Kraus, VB (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	vbk@acpub.duke.edu		Kepler, Thomas/0000-0002-1383-6865	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [UO1 AR050898]; National Institutes of Health/National Institute of Aging [2P60 AG11268, MO1-RR-30]; National Center for Research Resources; General Clinical Research Centers Program; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR050898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health/National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases UO1 AR050898; National Institutes of Health/National Institute of Aging Claude D. Pepper Older Americans Independence Centers 2P60 AG11268; MO1-RR-30, National Center for Research Resources, General Clinical Research Centers Program, National Institutes of Health where this study was conducted; and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Aurich M, 2005, ARTHRITIS RHEUM-US, V52, P112, DOI 10.1002/art.20740; Bauer DC, 2006, OSTEOARTHR CARTILAGE, V14, P723, DOI 10.1016/j.joca.2006.04.001; Birmingham JD, 2006, BIOMARK INSIGHTS, V1, P61; Bruyere O, 2006, ANN RHEUM DIS, V65, P1050, DOI 10.1136/ard.2005.045914; Burnett S, 1994, RADIOGRAPHIC ATLAS O; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Christgau S, 2004, MENOPAUSE, V11, P508, DOI 10.1097/01.WCB.0000121484.18437.98; Christgau S, 2004, CLIN EXP RHEUMATOL, V22, P36; CHUA SD, 2008, OSTEOARTHRITIS CARTI; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Dam EB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2774; Davis CR, 2007, ARTHRITIS RHEUM, V56, P4038, DOI 10.1002/art.23129; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; Garnero P, 2008, OSTEOARTHR CARTILAGE, V16, P660, DOI 10.1016/j.joca.2007.10.002; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; Garnero P, 2001, ANN RHEUM DIS, V60, P619, DOI 10.1136/ard.60.6.619; Garnero P, 2005, J RHEUMATOL, V32, P697; Garnero P, 2004, ARTHRITIS RHEUM-US, V50, P3137, DOI 10.1002/art.20493; Garnero P, 2003, CURR OPIN RHEUMATOL, V15, P641, DOI 10.1097/00002281-200309000-00020; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kraus VB, 2007, OSTEOARTHR CARTILAGE, V15, P120, DOI 10.1016/j.joca.2006.10.002; Manicourt DH, 2006, ARTHRITIS RHEUM, V54, P3205, DOI 10.1002/art.22075; March LM, 1997, BAILLIERE CLIN RHEUM, V11, P817, DOI 10.1016/S0950-3579(97)80011-8; Meulenbelt I, 2007, OSTEOARTHR CARTILAGE, V15, P379, DOI 10.1016/j.joca.2006.09.007; Meulenbelt I, 2006, ANN RHEUM DIS, V65, P360, DOI 10.1136/ard.2005.040642; NAGELKERKE N, 2002, BIOMETRIKA, V78, P691; NELSON A, 2007, CURR PRIM CARE REP, V2, P109; Otterness IG, 2000, OSTEOARTHR CARTILAGE, V8, P180, DOI 10.1053/joca.1999.0288; Pavelka K, 2004, OSTEOARTHR CARTILAGE, V12, P277, DOI 10.1016/j.joca.2004.01.001; Rousseau JC, 2007, NAT CLIN PRACT RHEUM, V3, P346, DOI 10.1038/ncprheum0508; TABASSI NC, 2007, CURR RHEUMATOL REP, V9, P16; VALDES AM, 2008, ANN RHEUM DIS   1203; Vilim V, 2002, OSTEOARTHR CARTILAGE, V10, P707, DOI 10.1053/joca.2002.0819; Wagner JA, 2007, CLIN PHARMACOL THER, V81, P104, DOI 10.1038/sj.clpt.6100017; Young-Min SA, 2001, ANN RHEUM DIS, V60, P545; Zhang YQ, 2008, RHEUM DIS CLIN N AM, V34, P515, DOI 10.1016/j.rdc.2008.05.007	40	60	63	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9739	10.1371/journal.pone.0009739	http://dx.doi.org/10.1371/journal.pone.0009739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305824	Green Submitted, Green Published, gold			2022-12-25	WOS:000275809600011
J	Losel, RM; Schnetzke, U; Brinkkoetter, PT; Song, H; Beck, G; Schnuelle, P; Hoger, S; Wehling, M; Yard, BA				Loesel, Ralf M.; Schnetzke, Ulf; Brinkkoetter, Paul T.; Song, Hui; Beck, Grietje; Schnuelle, Peter; Hoeger, Simone; Wehling, Martin; Yard, Benito A.			N-Octanoyl Dopamine, a Non-Hemodyanic Dopamine Derivative, for Cell Protection during Hypothermic Organ Preservation	PLOS ONE			English	Article							COLD-PRESERVATION; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; ENDOTHELIAL-CELLS; GRAFT-SURVIVAL; RAT-LIVER; INJURY; PRETREATMENT; CATECHOLAMINES; CALCIUM	Background: Although donor dopamine treatment reduces the requirement for post transplantation dialysis in renal transplant recipients, implementation of dopamine in donor management is hampered by its hemodynamic side-effects. Therefore novel dopamine derivatives lacking any hemodynamic actions and yet are more efficacious in protecting tissue from cold preservation injury are warranted. We hypothesized that variation of the molecular structure would yield more efficacious compounds avoid of any hemodynamic effects. Methodology/Principal Findings: To this end, we assessed protection against cold preservation injury in HUVEC by the attenuation of lactate dehydrogenase (LDH) release. Modification of dopamine by an alkanoyl group increased cellular uptake and significantly improved efficacy of protection. Further variation revealed that only compounds bearing two hydroxy groups in ortho or para position at the benzene nucleus, i.e. strong reductants, were protective. However, other reducing agents like N-acetyl cysteine and ascorbate, or NADPH oxidase inhibition did not prevent cellular injury following cold storage. Unlike dopamine, a prototypic novel compound caused no hemodynamic side-effects. Conclusions/Significance: In conclusion, we demonstrate that protection against cold preservation injury by catecholamines is exclusively governed by strong reducing capacity and sufficient lipophilicity. The novel dopamine derivatives might be of clinical relevance in donor pre-conditioning as they are completely devoid of hemodynamic action, their increased cellular uptake would reduce time of treatment and therefore also may have a potential use for non-heart beating donors.	[Loesel, Ralf M.; Wehling, Martin] Univ Med Ctr Mannheim, Dept Clin Pharmacol, Mannheim, Germany; [Schnetzke, Ulf; Brinkkoetter, Paul T.; Song, Hui; Schnuelle, Peter; Hoeger, Simone; Yard, Benito A.] Univ Med Ctr Mannheim, Dept Nephrol, Mannheim, Germany; [Beck, Grietje] Univ Med Ctr Mannheim, Dept Anaesthesiol, Mannheim, Germany; [Song, Hui] Shandong Univ, Sch Dent, Jinan 250100, Peoples R China; [Brinkkoetter, Paul T.] Univ Cologne, Dept Med, Ctr Mol Med & Cologne Excellence Cluster Cellular, Cologne, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Shandong University; University of Cologne	Losel, RM (corresponding author), Univ Med Ctr Mannheim, Dept Clin Pharmacol, Mannheim, Germany.	ralf.loesel@ohm-hochschule.de		Losel, Ralf/0000-0001-9010-5217	Else-Kroener-Stiftung; Medical School Mannheim	Else-Kroener-Stiftung; Medical School Mannheim	The author's laboratories were supported by grants from the Else-Kroener-Stiftung to B. A. Y. and funds from the Medical School Mannheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkkoetter PT, 2008, CELL PHYSIOL BIOCHEM, V22, P195, DOI 10.1159/000149797; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; Dragun D, 2001, KIDNEY INT, V60, P1173, DOI 10.1046/j.1523-1755.2001.0600031173.x; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Gottmann U, 2005, TRANSPLANTATION, V79, P1344, DOI 10.1097/01.TP.0000159030.86574.6C; Haddad P, 1999, CRYOBIOLOGY, V39, P69, DOI 10.1006/cryo.1999.2186; Hoeger S, 2009, TRANSPLANTATION, V87, P52, DOI 10.1097/TP.0b013e318191b2ca; Juste RN, 1998, INTENS CARE MED, V24, P1217, DOI 10.1007/s001340050747; Kouwenhoven EA, 2001, KIDNEY INT, V59, P1142; Rauen U, 2006, CORNEA, V25, P68, DOI 10.1097/01.ico.0000167880.96439.c6; Salahudeen AA, 2001, TRANSPLANTATION, V72, P1498, DOI 10.1097/00007890-200111150-00005; Schnuelle P, 2004, AM J TRANSPLANT, V4, P419, DOI 10.1111/j.1600-6143.2004.00331.x; Schnuelle P, 1999, KIDNEY INT, V56, P738, DOI 10.1046/j.1523-1755.1999.00567.x; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; SCHNUELLE P, 2009, JAMA IN PRESS; Shoskes DA, 1996, J UROLOGY, V155, P1831, DOI 10.1016/S0022-5347(01)66023-3; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Wyllie S, 2003, LIVER TRANSPLANT, V9, P401, DOI 10.1053/jlts.2003.50065; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x	19	28	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9713	10.1371/journal.pone.0009713	http://dx.doi.org/10.1371/journal.pone.0009713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300525	gold, Green Published, Green Submitted			2022-12-25	WOS:000275716400011
J	Buckingham, G; Goodale, MA				Buckingham, Gavin; Goodale, Melvyn A.			Lifting without Seeing: The Role of Vision in Perceiving and Acting upon the Size Weight Illusion	PLOS ONE			English	Article							PERCEPTION; CUES; HEAVINESS; OBJECTS	Background: Our expectations of an object's heaviness not only drive our fingertip forces, but also our perception of heaviness. This effect is highlighted by the classic size-weight illusion (SWI), where different-sized objects of identical mass feel different weights. Here, we examined whether these expectations are sufficient to induce the SWI in a single wooden cube when lifted without visual feedback, by varying the size of the object seen prior to the lift. Methodology/Principal Findings: Participants, who believed that they were lifting the same object that they had just seen, reported that the weight of the single, standard-sized cube that they lifted on every trial varied as a function of the size of object they had just seen. Seeing the small object before the lift made the cube feel heavier than it did after seeing the large object. These expectations also affected the fingertip forces that were used to lift the object when vision was not permitted. The expectation-driven errors made in early trials were not corrected with repeated lifting, and participants failed to adapt their grip and load forces from the expected weight to the object's actual mass in the same way that they could when lifting with vision. Conclusions/Significance: Vision appears to be crucial for the detection, and subsequent correction, of the ostensibly non-visual grip and load force errors that are a common feature of this type of object interaction. Expectations of heaviness are not only powerful enough to alter the perception of a single object's weight, but also continually drive the forces we use to lift the object when vision is unavailable.	[Buckingham, Gavin; Goodale, Melvyn A.] Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada	Western University (University of Western Ontario)	Buckingham, G (corresponding author), Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada.	gbucking@uwo.ca	Buckingham, Gavin/A-8715-2008; Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Lauwereyns, Jan/0000-0003-0551-2550; Buckingham, Gavin/0000-0002-6950-5504	Department of Foreign Affairs and International Trade (DFAIT) Canada	Department of Foreign Affairs and International Trade (DFAIT) Canada	This work was supported by a Department of Foreign Affairs and International Trade (DFAIT) Canada postdoctoral fellowship, awarded to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1970, PERCEPT PSYCHOPHYS, V8, P1, DOI 10.3758/BF03208919; Bridgeman B, 2005, PSYCHON B REV, V12, P549, DOI 10.3758/BF03193803; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; GRANIT R, 1972, BRAIN, V95, P451; Haffenden AM, 1998, J COGNITIVE NEUROSCI, V10, P122, DOI 10.1162/089892998563824; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; KOSELEFF P, 1957, ACTA PSYCHOL, V13, P242, DOI 10.1016/0001-6918(57)90023-9; MASIN CM, 1988, PERCEPT PSYCHOPHYS, V44, P309; Streit M, 2007, PSYCHON B REV, V14, P1001, DOI 10.3758/BF03194135; Valdez AB, 2008, PERCEPT PSYCHOPHYS, V70, P647, DOI 10.3758/PP.70.4.647; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	19	76	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9709	10.1371/journal.pone.0009709	http://dx.doi.org/10.1371/journal.pone.0009709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	569SM	20300575	Green Published, Green Submitted, gold			2022-12-25	WOS:000275621000019
J	Rezaee, F; Rellick, SL; Piedimonte, G; Akers, SM; O'Leary, HA; Martin, K; Craig, MD; Gibson, LF				Rezaee, Fariba; Rellick, Stephanie L.; Piedimonte, Giovanni; Akers, Stephen M.; O'Leary, Heather A.; Martin, Karen; Craig, Michael D.; Gibson, Laura F.			Neurotrophins Regulate Bone Marrow Stromal Cell IL-6 Expression through the MAPK Pathway	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-6 TRANSGENIC MICE; BRONCHIAL EPITHELIAL-CELLS; FACTOR ENHANCES SURVIVAL; SUBSTANCE-P; GRANULOCYTE-MACROPHAGE; TRANSCRIPTION FACTOR; PC12 CELLS	Background: The host's response to infection is characterized by altered levels of neurotrophins and an influx of inflammatory cells to sites of injured tissue. Progenitor cells that give rise to the differentiated cellular mediators of inflammation are derived from bone marrow progenitor cells where their development is regulated, in part, by cues from bone marrow stromal cells (BMSC). As such, alteration of BMSC function in response to elevated systemic mediators has the potential to alter their function in biologically relevant ways, including downstream alteration of cytokine production that influences hematopoietic development. Methodology/Principal Findings: In the current study we investigated BMSC neurotrophin receptor expression by flow cytometric analysis to determine differences in expression as well as potential to respond to NGF or BDNF. Intracellular signaling subsequent to neurotrophin stimulation of BMSC was analyzed by western blot, microarray analysis, confocal microscopy and real-time PCR. Analysis of BMSC Interleukin-6 (IL-6) expression was completed using ELISA and real-time PCR. Conclusion: BMSC established from different individuals had distinct expression profiles of the neurotrophin receptors, TrkA, TrkB, TrkC, and p75(NTR). These receptors were functional, demonstrated by an increase in Akt-phosphorylation following BMSC exposure to recombinant NGF or BDNF. Neurotrophin stimulation of BMSC resulted in increased IL-6 gene and protein expression which required activation of ERK and p38 MAPK signaling, but was not mediated by the NFkB pathway. BMSC response to neurotrophins, including the up-regulation of IL-6, may alter their support of hematopoiesis and regulate the availability of inflammatory cells for migration to sites of injury or infection. As such, these studies are relevant to the growing appreciation of the interplay between neurotropic mediators and the regulation of hematopoiesis.	[Rezaee, Fariba; Piedimonte, Giovanni] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; [Martin, Karen] W Virginia Univ, Sch Med, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Rellick, Stephanie L.; Akers, Stephen M.; O'Leary, Heather A.; Martin, Karen; Craig, Michael D.; Gibson, Laura F.] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Gibson, Laura F.] W Virginia Univ, Sch Med, Dept Microbiol & Immunol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Rezaee, F (corresponding author), W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA.	lgibson@hsc.wvu.edu	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Gibson, Laura/0000-0002-7291-9046; Martin, Karen/0000-0001-8916-4092; O'Leary, Heather/0000-0003-1321-1520	National Institutes of Health [R01 HL056888, R01 CA134573, P20 RR016440, R01HL61007]; Microscope Imaging Facility [P20 RR016440]; West Virginia University Flow Cytometry Core Facility [P20 RR016440, S10 RR020866]; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, S10RR020866] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007, R01HL056888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microscope Imaging Facility; West Virginia University Flow Cytometry Core Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was received from the National Institutes of Health R01 HL056888 (LFG), NIH R01 CA134573 (LFG), P20 RR016440 (LFG) and NIH R01HL61007 (GP), Microscope Imaging Facility (P20 RR016440), and West Virginia University Flow Cytometry Core Facility (P20 RR016440 and S10 RR020866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOE L, 1993, GROWTH FACTORS, V9, P149, DOI 10.3109/08977199309010830; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; Boissiere F, 1997, EXP NEUROL, V145, P245, DOI 10.1006/exnr.1997.6443; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; BOYLE MDP, 1985, J IMMUNOL, V134, P564; Bracci-Laudiero L, 2005, BLOOD, V106, P3507, DOI 10.1182/blood-2004-10-4055; BRACCI-LAUDIERO L, 1992, NEUROSCI LETT, V147, P9; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Calza L, 1997, MOL BRAIN RES, V51, P60, DOI 10.1016/S0169-328X(97)00213-1; CANEVA L, 1995, BLOOD CELL MOL DIS, V21, P73, DOI 10.1006/bcmd.1995.0011; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; FATTORI E, 1994, BLOOD, V83, P2570; Freund-Michel V, 2006, CELL SIGNAL, V18, P621, DOI 10.1016/j.cellsig.2005.06.007; Furuno T, 2006, NEUROSCI LETT, V392, P240, DOI 10.1016/j.neulet.2005.09.031; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; GORDON M Y, 1983, International Journal of Cell Cloning, V1, P429; GORDON MY, 1983, BRIT J HAEMATOL, V53, P317, DOI 10.1111/j.1365-2141.1983.tb02026.x; Hamada A, 1996, BRIT J HAEMATOL, V93, P299, DOI 10.1046/j.1365-2141.1996.5151055.x; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; KANNAN Y, 1993, INT ARCH ALLERGY IMM, V102, P362, DOI 10.1159/000236584; KANNAN Y, 1991, BLOOD, V77, P1320; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KHAIR OA, 1994, EUR RESPIR J, V7, P2109, DOI 10.1183/09031936.94.07122109; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kobayashi H, 2001, NEUROSCI LETT, V305, P157, DOI 10.1016/S0304-3940(01)01854-7; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li N, 2007, BIOCHEM BIOPH RES CO, V356, P561, DOI 10.1016/j.bbrc.2007.03.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markel TA, 2008, AM J PHYSIOL-REG I, V294, pR1491, DOI 10.1152/ajpregu.00031.2008; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; NOMA T, 1987, IMMUNOL LETT, V15, P249, DOI 10.1016/0165-2478(87)90032-0; Nowicki M, 2006, J CLIN PATHOL, V59, P935, DOI 10.1136/jcp.2005.034629; Nowicki M, 2007, J CLIN PATHOL, V60, P749, DOI 10.1136/jcp.2006.041475; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Rameshwar P, 2001, J NEUROIMMUNOL, V121, P22, DOI 10.1016/S0165-5728(01)00443-X; Raychaudhuri SP, 2004, PROG BRAIN RES, V146, P433; Raychaudhuri SP, 1998, ACTA DERM-VENEREOL, V78, P84; Rodriguez MDC, 2004, BLOOD, V103, P3349, DOI 10.1182/blood-2003-10-3438; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schonhoff CM, 2001, J NEUROCHEM, V78, P631, DOI 10.1046/j.1471-4159.2001.00432.x; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Scicchitano MS, 2008, BLOOD CELL MOL DIS, V40, P370, DOI 10.1016/j.bcmd.2007.10.009; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Simone MD, 1999, HEMATOL ONCOL, V17, P1; Sio SWS, 2008, J IMMUNOL, V180, P8333, DOI 10.4049/jimmunol.180.12.8333; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Washiyama K, 1996, AM J PATHOL, V148, P929; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; Yamaguchi M, 2008, AM J ORTHOD DENTOFAC, V133, P690, DOI 10.1016/j.ajodo.2006.03.043; Yoon SO, 1998, J NEUROSCI, V18, P3273; Yu M, 2002, TOXICOL SCI, V68, P488, DOI 10.1093/toxsci/68.2.488; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	69	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9690	10.1371/journal.pone.0009690	http://dx.doi.org/10.1371/journal.pone.0009690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300619	Green Published, gold, Green Submitted			2022-12-25	WOS:000275621000008
J	Poage, GM; Christensen, BC; Houseman, EA; McClean, MD; Wiencke, JK; Posner, MR; Clark, JR; Nelson, HH; Marsit, CJ; Kelsey, KT				Poage, Graham M.; Christensen, Brock C.; Houseman, E. Andres; McClean, Michael D.; Wiencke, John K.; Posner, Marshall R.; Clark, John R.; Nelson, Heather H.; Marsit, Carmen J.; Kelsey, Karl T.			Genetic and Epigenetic Somatic Alterations in Head and Neck Squamous Cell Carcinomas Are Globally Coordinated but Not Locally Targeted	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; COPY NUMBER; PROMOTER METHYLATION; HIGH-RESOLUTION; CANCER PATIENTS; POOR-PROGNOSIS; BREAST-CANCER; SURVIVAL; ARRAY	Background: Solid tumors, including head and neck squamous cell carcinomas (HNSCC), arise as a result of genetic and epigenetic alterations in a sustained stress environment. Little work has been done that simultaneously examines the spectrum of both types of changes in human tumors on a genome-wide scale and results so far have been limited and mixed. Since it has been hypothesized that epigenetic alterations may act by providing the second carcinogenic hit in gene silencing, we sought to identify genome-wide DNA copy number alterations and CpG dinucleotide methylation events and examine the global/local relationships between these types of alterations in HNSCC. Methodology/Principal Findings: We have extended a prior analysis of 1,413 cancer-associated loci for epigenetic changes in HNSCC by integrating DNA copy number alterations, measured at 500,000 polymorphic loci, in a case series of 19 primary HNSCC tumors. We have previously demonstrated that local copy number does not bias methylation measurements in this array platform. Importantly, we found that the global pattern of copy number alterations in these tumors was significantly associated with tumor methylation profiles (p<0.002). However at the local level, gene promoter regions did not exhibit a correlation between copy number and methylation (lowest q = 0.3), and the spectrum of genes affected by each type of alteration was unique. Conclusion/Significance: This work, using a novel and robust statistical approach demonstrates that, although a "second hit'' mechanism is not likely the predominant mode of action for epigenetic dysregulation in cancer, the patterns of methylation events are associated with the patterns of allele loss. Our work further highlights the utility of integrative genomics approaches in exploring the driving somatic alterations in solid tumors.	[Poage, Graham M.; Kelsey, Karl T.] Brown Univ, Dept Mol Pharmacol, Providence, RI 02912 USA; [Poage, Graham M.; Kelsey, Karl T.] Brown Univ, Dept Physiol, Providence, RI 02912 USA; [Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.] Brown Univ, Dept Pathol, Providence, RI 02912 USA; [Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.] Brown Univ, Dept Lab Med, Providence, RI 02912 USA; [Christensen, Brock C.; Houseman, E. Andres; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Houseman, E. Andres] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [McClean, Michael D.] Boston Univ, Dept Environm Hlth, Boston, MA 02215 USA; [Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Posner, Marshall R.] Dana Farber Canc Inst, Dept Med Oncol Solid Tumor Oncol, Boston, MA 02115 USA; [Clark, John R.] Massachusetts Gen Hosp, Dept Med Hematol Oncol, Boston, MA 02114 USA; [Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Brown University; Brown University; Brown University; Brown University; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Poage, GM (corresponding author), Brown Univ, Dept Mol Pharmacol, Providence, RI 02912 USA.	Karl_Kelsey@Brown.edu	McClean, Michael D/J-2934-2015; Kelsey, Karl T/I-1252-2014; Christensen, Brock/B-8460-2009	McClean, Michael/0000-0002-3902-8823; Houseman, Eugene Andres/0000-0003-0703-1830; Marsit, Carmen/0000-0003-4566-150X; Nelson, Heather/0000-0003-1901-9513	Flight Attendant Medical Research Institute; National Institutes of Health [5R01CA078609-10, 2R01CA100679-06A1, 5RO1ES006717-13]; NATIONAL CANCER INSTITUTE [R01CA100679, R01CA078609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006717] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Flight Attendant Medical Research Institute (C. M. and M. M.), and the National Institutes of Health (5R01CA078609-10, 2R01CA100679-06A1, 5RO1ES006717-13) (K.K. and J.W.). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andrews J, PLOS ONE, V5, pe8665; Arnold CN, 2004, CANCER BIOL THER, V3, P960, DOI 10.4161/cbt.3.10.1113; Ashman JNE, 2003, BRIT J CANCER, V89, P864, DOI 10.1038/sj.bjc.6601199; Bauer VL, 2008, J MOL MED, V86, P1353, DOI 10.1007/s00109-008-0397-0; Bergamo NA, 2005, CLIN CANCER RES, V11, P621; Bockmuhl U, 2000, AM J PATHOL, V157, P369, DOI 10.1016/S0002-9440(10)64549-X; Bockmuhl U, 2001, OTOLARYNG HEAD NECK, V124, P451, DOI 10.1067/mhn.2001.114794; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Costello Joseph F., 2009, V507, P131, DOI 10.1007/978-1-59745-522-0_11; Dikshit RP, 2007, CANCER-AM CANCER SOC, V110, P1745, DOI 10.1002/cncr.22975; Ell SR, 2002, LARYNGOSCOPE, V112, P1094, DOI 10.1097/00005537-200206000-00029; Furniss CS, 2007, INT J CANCER, V120, P2386, DOI 10.1002/ijc.22633; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Hassan KMA, 2001, HUM GENET, V109, P452; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Houseman EA, 2009, BIOINFORMATICS, V25, P1999, DOI 10.1093/bioinformatics/btp364; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Huang Jing, 2004, Human Genomics, V1, P287; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jun P, 2009, NEURO-ONCOLOGY, V11, P414, DOI 10.1215/15228517-2008-096; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Li XH, 2008, CANCER PREV RES, V1, P413, DOI 10.1158/1940-6207.CAPR-08-0121; Lin LJ, 2008, ONCOLOGY-BASEL, V75, P102, DOI 10.1159/000155813; Marsit CJ, 2008, CANCER-AM CANCER SOC, V113, P1566, DOI 10.1002/cncr.23770; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Miracca EC, 1999, BRIT J CANCER, V81, P677, DOI 10.1038/sj.bjc.6690747; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Ohta S, 2009, ORAL SURG ORAL MED O, V107, P81, DOI 10.1016/j.tripleo.2008.08.027; Park JJ, 2008, GENE, V407, P139, DOI 10.1016/j.gene.2007.10.011; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Singh B, 2001, CANCER RES, V61, P4506; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Wolff E, 1998, ORAL ONCOL, V34, P186, DOI 10.1016/S1368-8375(97)00079-1; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang QF, 2002, CLIN CANCER RES, V8, P2890; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739	53	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9651	10.1371/journal.pone.0009651	http://dx.doi.org/10.1371/journal.pone.0009651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300172	Green Submitted, Green Published, gold			2022-12-25	WOS:000275620600007
J	Kim, D; Shu, S; Coppola, MD; Kaneko, S; Yuan, ZQ; Cheng, JQ				Kim, Donghwa; Shu, Shaokun; Coppola, Marc D.; Kaneko, Satoshi; Yuan, Zeng-qiang; Cheng, Jin Q.			Regulation of Proapoptotic Mammalian ste20-Like Kinase MST2 by the IGF1-Akt Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES APOPTOSIS; PROTEIN-KINASE; PROTEOLYTIC ACTIVATION; AKT PHOSPHORYLATES; HIPPO PATHWAY; DROSOPHILA; GROWTH; TRANSCRIPTION; SURVIVAL	Background: Hippo, a Drosophila serine/threonine kinase, promotes apoptosis and restricts cell growth and proliferation. Its mammalian homolog MST2 has been shown to play similar role and be regulated by Raf-1 via a kinase-independent mechanism and by RASSF family proteins through forming complex with MST2. However, regulation of MST2 by cell survival signal remains largely unknown. Methodology/Principal Findings: Using immunoblotting, in vitro kinase and in vivo labeling assays, we show that IGF1 inhibits MST2 cleavage and activation induced by DNA damage through the phosphatidylinosotol 3-kinase (PI3K)/Akt pathway. Akt phosphorylates a highly conserved threonine-117 residue of MST2 in vitro and in vivo, which leads to inhibition of MST2 cleavage, nuclear translocation, autophosphorylation-Thr180 and kinase activity. As a result, MST2 proapoptotic and growth arrest function was significantly reduced. Further, inverse correlation between pMST2-T117/pAkt and pMST2-T180 was observed in human breast tumors. Conclusions/Significance: Our findings demonstrate for the first time that extracellular cell survival signal IGF1 regulates MST2 and that Akt is a key upstream regulator of MST2.	[Kim, Donghwa; Shu, Shaokun; Coppola, Marc D.; Kaneko, Satoshi; Yuan, Zeng-qiang; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Kim, D (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA107078, CA137041]; Department of Defense [W81XWH-08-2-0101]; Bankhead-Coley [ID 09BB-05]; NATIONAL CANCER INSTITUTE [R01CA137041, R01CA107078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health CA107078 and CA137041, Department of Defense W81XWH-08-2-0101 and Bankhead-Coley Grant ID 09BB-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	42	36	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9616	10.1371/journal.pone.0009616	http://dx.doi.org/10.1371/journal.pone.0009616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231902	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328300023
J	Moore, M; Walsh, M; Bailey, J; Brunson, D; Gulland, F; Landry, S; Mattila, D; Mayo, C; Slay, C; Smith, J; Rowles, T				Moore, Michael; Walsh, Michael; Bailey, James; Brunson, David; Gulland, Frances; Landry, Scott; Mattila, David; Mayo, Charles; Slay, Christopher; Smith, Jamison; Rowles, Teresa			Sedation at Sea of Entangled North Atlantic Right Whales (Eubalaena glacialis) to Enhance Disentanglement	PLOS ONE			English	Article								Background: The objective of this study was to enhance removal of fishing gear from right whales (Eubalaena glacialis) at sea that evade disentanglement boat approaches. Titrated intra muscular injections to achieve sedation were undertaken on two free swimming right whales. Methodology/Principal Findings: Following initial trials with beached whales, a sedation protocol was developed for right whales. Mass was estimated from sighting and necropsy data from comparable right whales. Midazolam (0.01 to 0.025 mg/ kg) was first given alone or with meperidine (0.17 to 0.25 mg/kg) either once or four times over two hours to whale # 1102 by cantilevered pole syringe. In the last attempt on whale # 1102 there appeared to be a mild effect in 20-30 minutes, with duration of less than 2 hours that included exhalation before the blowhole fully cleared the water. Boat avoidance, used as a measure of sedation depth, was not reduced. A second severely entangled animal in 2009, whale # 3311, received midazolam (0.03 mg/kg) followed by butorphanol (0.03 mg/kg) an hour later, delivered ballistically. Two months later it was then given midazolam (0.07 mg/kg) and butorphanol (0.07 mg/kg) simultaneously. The next day both drugs at 0.1 mg/kg were given as a mixture in two darts 10 minutes apart. The first attempt on whale # 3311 showed increased swimming speed and boat avoidance was observed after a further 20 minutes. The second attempt on whale # 3311 showed respiration increasing mildly in frequency and decreasing in strength. The third attempt on whale # 3311 gave a statistically significant increase in respiratory frequency an hour after injection, with increased swimming speed and marked reduction of boat evasion that enabled decisive cuts to entangling gear. Conclusions/Significance: We conclude that butorphanol and midazolam delivered ballistically in appropriate dosages and combinations may have merit in future refractory free swimming entangled right whale cases until other entanglement solutions are developed.	[Moore, Michael] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Walsh, Michael; Bailey, James] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Brunson, David] Pfizer Inc, Vet Specialty Team Sedat Pain Management & Anesth, Madison, WI USA; [Gulland, Frances] Marine Mammal Ctr, Sausalito, CA USA; [Landry, Scott; Mayo, Charles] Provincetown Ctr Coastal Studies, Provincetown, MA USA; [Mattila, David] Natl Oceanog Atmospher Adm, Hawaiian Islands Humpback Whale Natl Marine Sanct, Natl Ocean Serv, Kihei, HI USA; [Slay, Christopher] Coastwise Consulting Inc, Athens, GA USA; [Smith, Jamison] Natl Oceanog Atmospher Adm, Protected Resources Div, Natl Marine Fisheries Serv, Gloucester, MA USA; [Rowles, Teresa] Natl Oceanog Atmospher Adm, Marine Mammal Conservat Div, Natl Marine Fisheries Serv, Silver Spring, MD USA	Woods Hole Oceanographic Institution; State University System of Florida; University of Florida; Pfizer; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Moore, M (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mmoore@whoi.edu	Moore, Michael/E-1707-2015	Moore, Michael/0000-0003-3074-6631	Cecil H; Ida M. Green Technology Innovation Program (WHOI); North Pond Foundation; Sloan and Wick Simmonds; Northeast Consortium; National Oceanic Atmospheric Administration (NOAA); Georgia Department of Natural Resources; Florida Fish and Wildlife Conservation Commission; Provincetown Center for Coastal Studies; Coastwise Consulting; Atlantic Large Whale Disentanglement Network; Aquatic Animal Health Program; University of Florida	Cecil H; Ida M. Green Technology Innovation Program (WHOI); North Pond Foundation; Sloan and Wick Simmonds; Northeast Consortium; National Oceanic Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Georgia Department of Natural Resources; Florida Fish and Wildlife Conservation Commission; Provincetown Center for Coastal Studies; Coastwise Consulting; Atlantic Large Whale Disentanglement Network; Aquatic Animal Health Program; University of Florida(University of Florida)	This work was funded by Cecil H. and Ida M. Green Technology Innovation Program (WHOI), North Pond Foundation, Sloan and Wick Simmonds, Northeast Consortium, National Oceanic Atmospheric Administration (NOAA), Georgia Department of Natural Resources, Florida Fish and Wildlife Conservation Commission, Provincetown Center for Coastal Studies, Coastwise Consulting, the Atlantic Large Whale Disentanglement Network, and Aquatic Animal Health Program, University of Florida. NOAA was centrally involved in the permitting and undertaking of the work. The Marine Mammal Protection Act of 1972 demands that this be so. The paper was drafted by all of the authors with no influence from NOAA as an agency in terms of how it was written. Coastwise Consulting provided logistic support for the 2009 field work. Provincetown Center for Coastal Studies provided support for ballistic technology development. Woods Hole Oceanographic Institution funded initial concept development. University of Florida funded drug acquisition. Despite some of the authors being employees of the above sources of funds, the administrators of the funds so granted had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Inc. had no financial involvement in the project.	BRUNSON D, 2002, P AM ASS ZOO VET, P320; CHITTICK E, 2006, P INT ASS AQ AN MED, P144; Geraci JR., 2005, MARINE MAMMALS ASHOR; Gulland Frances M. D., 2008, Aquatic Mammals, V34, P182, DOI 10.1578/AM.34.2.2008.182; Haulena M, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P655; JOSEPH BE, 1988, J WILDLIFE DIS, V24, P691, DOI 10.7589/0090-3558-24.4.691; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lien J., 1986, Whalewatcher, V20, P3; Moore M.J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P301; Moore Michael J., 2004, Journal of Cetacean Research and Management, V6, P199; Reidarson TH, 1998, J ZOO WILDLIFE MED, V29, P451; SCHEVILL WE, 1967, SCIENCE, V157, P630, DOI 10.1126/science.157.3789.630; WALSH M, 2006, P AM ASS ZOO VET	13	24	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9597	10.1371/journal.pone.0009597	http://dx.doi.org/10.1371/journal.pone.0009597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231895	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300014
J	Noda, K; Melhorn, MI; Zandi, S; Frimmel, S; Tayyari, F; Hisatomi, T; Almulki, L; Pronczuk, A; Hayes, KC; Hafezi-Moghadam, A				Noda, Kousuke; Melhorn, Mark I.; Zandi, Souska; Frimmel, Sonja; Tayyari, Faryan; Hisatomi, Toshio; Almulki, Lama; Pronczuk, Andrzej; Hayes, K. C.; Hafezi-Moghadam, Ali			An animal model of spontaneous metabolic syndrome: Nile grass rat	FASEB JOURNAL			English	Article						type 2 diabetes; nutrition; hypertension; atherosclerosis; dyslipidemia; leptin	ARVICANTHIS-NILOTICUS; DIURNAL RODENT; ONSET OBESITY; UP-REGULATION; IN-VIVO; ADIPONECTIN; FAT; PATHOPHYSIOLOGY; ASSOCIATIONS; ADIPOCYTES	Metabolic syndrome (MetS) is a prevalent and complex disease, characterized by the variable coexistence of obesity, dyslipidemia, hyperinsulinaemia, and hypertension. The alarming rise in the prevalence of metabolic disorders makes it imperative to innovate preventive or therapeutic measures for MetS and its complications. However, the elucidation of the pathogenesis of MetS has been hampered by the lack of realistic models. For example, the existing animal models of MetS, i.e., genetically engineered rodents, imitate certain aspects of the disease, while lacking other important components. Defining the natural course of MetS in a spontaneous animal model of the disease would be desirable. Here, we introduce the Nile grass rat (NGR), Arvicanthis niloticus, as a novel model of MetS. Studies of over 1100 NGRs in captivity, fed normal chow, revealed that most of these animals spontaneously develop dyslipidemia (P<0.01), and hyperglycemia (P<0.01) by 1 yr of age. Further characterization showed that the diabetic rats develop liver steatosis, abdominal fat accumulation, nephropathy, atrophy of pancreatic islets of Langerhans, fatty streaks in the aorta, and hypertension (P<0.01). Diabetic NGRs in the early phase of the disease develop hyperinsulinemia, and show a strong inverse correlation between plasma adiponectin and HbA1c levels (P<0.01). These data indicate that the NGR is a valuable, spontaneous model for exploring the etiology and pathophysiology of MetS as well as its various complications.-Noda, K., Melhorn, M.I., Zandi, S., Frimmel, S., Tayyari, F., Hisatomi, T., Almulki, L., Pronczuk, A., Hayes, K.C., Hafezi-Moghadam, A. An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J. 24, 2443-2453 (2010). www.fasebj.org	[Noda, Kousuke; Melhorn, Mark I.; Zandi, Souska; Frimmel, Sonja; Tayyari, Faryan; Hisatomi, Toshio; Almulki, Lama; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Noda, Kousuke; Melhorn, Mark I.; Zandi, Souska; Frimmel, Sonja; Tayyari, Faryan; Hisatomi, Toshio; Almulki, Lama; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Pronczuk, Andrzej; Hayes, K. C.] Brandeis Univ, Dept Biol, Foster Biomed Res Lab, Waltham, MA 02254 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Brandeis University	Hafezi-Moghadam, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Angiogenesis Lab, 325 Cambridge St,3rd Floor, Boston, MA 02114 USA.	ali_hafezi-moghadam@hms.harvard.edu	Tayyari, Faryan/AAS-9020-2020	Hafezi-Moghadam, Ali/0000-0002-5336-0697; Hisatomi, Toshio/0000-0003-2552-9595; Zandi, Souska/0000-0001-9351-4278	U.S. National Institute of Health [AI050775]; American Health Assistance Foundation; Malaysian Palm Oil Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Malaysian Palm Oil Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Rebecca C. Garland for her help with manuscript preparation and insightful discussions. This work was supported by U.S. National Institute of Health grant AI050775 (A.H.-M.), the American Health Assistance Foundation (A.H.-M.), and the Malaysian Palm Oil Board.	Ayyobi AF, 2003, AM J CARDIOL, V92, p27J, DOI 10.1016/S0002-9149(03)00613-1; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Borch-Johnsen K, 2009, DIABETOLOGIA, V52, P2247, DOI 10.1007/s00125-009-1526-1; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hanley AJG, 2007, J CLIN ENDOCR METAB, V92, P2665, DOI 10.1210/jc.2006-2614; Hiraoka-Yamamoto J, 2004, CLIN EXP PHARMACOL P, V31, P107, DOI 10.1111/j.1440-1681.2004.04121.x; Kolovou GD, 2005, POSTGRAD MED J, V81, P358, DOI 10.1136/pgmj.2004.025601; Lambert CM, 2005, J BIOL RHYTHM, V20, P206, DOI 10.1177/0748730405275135; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Novak CM, 2002, BRAIN RES, V951, P255, DOI 10.1016/S0006-8993(02)03168-2; Novak CM, 2007, PHYSIOL BEHAV, V90, P125, DOI 10.1016/j.physbeh.2006.09.012; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Qi NR, 2005, HYPERTENSION, V45, P1004, DOI 10.1161/01.HYP.0000161995.64192.2b; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schwartz MD, 2005, J BIOL RHYTHM, V20, P526, DOI 10.1177/0748730405280924; SHIMABUKURO M, 1997, P NATL ACAD SCI US; Tkac I, 2005, DIABETES RES CLIN PR, V68, pS2, DOI 10.1016/j.diabres.2005.03.002; Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	32	44	45	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2443	2453		10.1096/fj.09-152678	http://dx.doi.org/10.1096/fj.09-152678			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20335226	Green Published			2022-12-25	WOS:000279343600031
J	Ohtsu, I; Wiriyathanawudhiwong, N; Morigasaki, S; Nakatani, T; Kadokura, H; Takagi, H				Ohtsu, Iwao; Wiriyathanawudhiwong, Natthawut; Morigasaki, Susumu; Nakatani, Takeshi; Kadokura, Hiroshi; Takagi, Hiroshi			The L-Cysteine/L-Cystine Shuttle System Provides Reducing Equivalents to the Periplasm in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND-FORMATION; HYDROGEN-PEROXIDE; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; PROTEIN; TRANSPORTER; GLUTATHIONE; GENE; EXPRESSION; K-12	Intracellular thiols like L-cysteine and glutathione play a critical role in the regulation of cellular processes. Escherichia coli has multiple L-cysteine transporters, which export L-cysteine from the cytoplasm into the periplasm. However, the role of L-cysteine in the periplasm remains unknown. Here we show that an L-cysteine transporter, YdeD, is required for the tolerance of E. coli cells to hydrogen peroxide. We also present evidence that L-cystine, a product from the oxidation of L-cysteine by hydrogen peroxide, is imported back into the cytoplasm in a manner dependent on FliY, the periplasmic L-cystine-binding protein. Remarkably, this protein, which is involved in the recycling of the oxidized L-cysteine, is also found to be important for the hydrogen peroxide resistance of this organism. Furthermore, our analysis of the transcription of relevant genes revealed that the transcription of genes encoding FliY and YdeD is highly induced by hydrogen peroxide rather than by L-cysteine. These findings led us to propose that the inducible L-cysteine/L-cystine shuttle system plays an important role in oxidative stress tolerance through providing a reducing equivalent to the periplasm in E. coli.	[Ohtsu, Iwao; Wiriyathanawudhiwong, Natthawut; Morigasaki, Susumu; Nakatani, Takeshi; Kadokura, Hiroshi; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Ohtsu, I (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	iohtsu@bs.naist.jp	Morigasaki, Susumu/Q-6981-2017; Kadokura, Hiroshi/AAE-1645-2019	Morigasaki, Susumu/0000-0002-6938-5119; Takagi, Hiroshi/0000-0002-1786-3174; Kadokura, Hiroshi/0000-0001-7308-7141; Ohtsu, Iwao/0000-0002-3553-0306	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ajinomoto Co., Inc.; JSPS [21580092]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto Co., Inc.; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI (Grant-in-Aid for Young Scientists on priority areas (B) and funding from the NAIST Global COE Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to I. O.). This work was also supported in part by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Applied Genomics" from MEXT of Japan and by a grant from Ajinomoto Co., Inc. (to I. O. and H. T.). This work was further supported in part by an international research fellowship from the Global COE Program in NAIST from MEXT of Japan and a Grant-in-Aid for Scientific Research (C) (21580092) from JSPS (to H. K.).	Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BUTLER JD, 1993, LIFE SCI, V52, P1209, DOI 10.1016/0024-3205(93)90103-A; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; DENK D, 1987, J GEN MICROBIOL, V133, P515; Eser M, 2009, P NATL ACAD SCI USA, V106, P1572, DOI 10.1073/pnas.0812596106; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981; HOHMANN S, 2003, YEAST STRESS RESPONS, P242; Hung J, 2003, FEMS MICROBIOL LETT, V227, P93, DOI 10.1016/S0378-1097(03)00653-0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEHMANN A, 1993, EUR J NEUROSCI, V5, P1398, DOI 10.1111/j.1460-9568.1993.tb00926.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Ozkan Y, 2002, INT J CARDIOL, V82, P269, DOI 10.1016/S0167-5273(02)00010-4; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sambrook J., 1989, MOLECULAR CLONING LA; SORENSEN MA, 1991, J BACTERIOL, V173, P5244, DOI 10.1128/jb.173.16.5244-5246.1991; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Tao K, 2008, FEMS MICROBIOL LETT, V289, P41, DOI 10.1111/j.1574-6968.2008.01372.x; WINTERHALTER C, 1997, MICROORGANISMS PROCE; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	37	81	85	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17479	17487		10.1074/jbc.M109.081356	http://dx.doi.org/10.1074/jbc.M109.081356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351115	Green Published, hybrid			2022-12-25	WOS:000278133400026
J	Xu, Y; Lee, SH; Kim, HS; Kim, NH; Piao, S; Park, SH; Jung, YS; Yook, JI; Park, BJ; Ha, NC				Xu, Y.; Lee, S-H; Kim, H. S.; Kim, N. H.; Piao, S.; Park, S-H; Jung, Y. S.; Yook, J. I.; Park, B-J; Ha, N-C			Role of CK1 in GSK3 beta-mediated phosphorylation and degradation of Snail	ONCOGENE			English	Article						snail; casein kinase 1; EMT; GSK3 beta; metastasis	CASEIN KINASE-I; EPITHELIAL-MESENCHYMAL TRANSITIONS; BETA-CATENIN; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; GENE-EXPRESSION; BREAST-CANCER; WNT; EPSILON; PROTEIN	The epithelial to mesenchymal transition (EMT) that occurs during embryonic development has begun to attract attention as a potential mechanism for tumor cell metastasis. Snail is a well-known Zn-finger transcription factor that promotes EMT by repressing E-cadherin expression. It is known that Snail is phosphorylated by GSK3 beta and degraded by beta-TrCP-mediated ubiquitination. Here we described another protein kinase, CK1, whose phosphorylation of Snail is required for the subsequent GSK3 beta phosphorylation. Specific inhibition or depletion of CK1 epsilon inhibits the phosphorylation and degradation of Snail and promotes cell migration, suggesting a central role of CK1 epsilon in the EMT process. Furthermore, our study uncovered distinct roles and steps of Snail phosphorylation by CK1 epsilon and GSK3 beta. Taken together, we identified CK1 epsilon as a new component of the Snail-mediated EMT process, providing insight into the mechanism of human cancer metastasis. Oncogene (2010) 29, 3124-3133; doi: 10.1038/onc.2010.77; published online 22 March 2010	[Xu, Y.; Piao, S.; Park, S-H; Ha, N-C] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea; [Xu, Y.; Piao, S.; Park, S-H; Ha, N-C] Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea; [Lee, S-H; Jung, Y. S.; Park, B-J] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Kim, H. S.; Kim, N. H.; Yook, J. I.] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol, Seoul 120749, South Korea	Pusan National University; Pusan National University; Pusan National University; Yonsei University; Yonsei University Health System	Ha, NC (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, 30 Jangjeon Dong, Pusan 609735, South Korea.	hnc@pusan.ac.kr		Kim, Nam Hee/0000-0002-3087-5276; Kim, Hyun Sil/0000-0003-3614-1764; Yook, Jong In/0000-0002-7318-6112	Ministry for Health, Welfare and Family affairs, Republic of Korea [0920140]	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	We thank Xiao Ling Jin for assisting in DNA construction and protein purification. This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920140).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Birchmeier W, 1991, CURR OPIN CELL BIOL, V3, P832, DOI 10.1016/0955-0674(91)90057-6; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; COBB MH, 1983, J BIOL CHEM, V258, P2472; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dahlberg CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004766; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Santos JA, 1996, J CELL SCI, V109, P1847; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tuazon P. T., 1991, ADV 2 MESSENGER PHOS, V23, P123; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	44	65	70	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3124	3133		10.1038/onc.2010.77	http://dx.doi.org/10.1038/onc.2010.77			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20305697				2022-12-25	WOS:000278133100009
J	Lee, AJ; Wu, XF; Cheng, HY; Zhou, XF; Cheng, XH; Sun, SC				Lee, Andrew Joon; Wu, Xuefeng; Cheng, Hanyin; Zhou, Xiaofei; Cheng, Xuhong; Sun, Shao-Cong			CARMA1 Regulation of Regulatory T Cell Development Involves Modulation of Interleukin-2 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME CYLD; C-REL; RECEPTOR; LINEAGE; PHOSPHORYLATION; ENTEROPATHY; COMMITMENT; ACTIVATION; EXPRESSION	T cell receptor-stimulated NF-kappa B activation requires CARMA1 and is negatively regulated by the deubiquitinase CYLD. Recent studies suggest that CARMA1 regulates regulatory T cell (Treg) development, although the role of NF-kappa B in this event is incompletely understood. We show that CYLD deficiency causes constitutive NF-kappa B activation in thymocytes, which is associated with enhanced frequency of Treg cells. The NF-kappa B activation in CYLD-deficient thymocytes is independent of CARMA1, because the NF-kappa B activation was also detected in CYLD/CARMA1 double knock-out thymocytes. Interestingly, although loss of CYLD causes NF-kappa B activation in the CARMA1-deficient thymocytes, the CYLD deficiency fails to rescue the defect of CARMA1 knock-out mice in Treg development. Furthermore, inhibition of canonical NF-kappa B by an I kappa B alpha transgene only partially inhibits Treg development. We demonstrate that CARMA1 regulates IL-2 receptor signaling and controls the IL-2-stimulated maturation of Treg precursors to mature Tregs. These results suggest that the role of CARMA1 in Treg regulation involves both NF-kappa B activation and IL-2 receptor signaling.	[Lee, Andrew Joon; Wu, Xuefeng; Cheng, Hanyin; Zhou, Xiaofei; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sun, Shao-Cong] Univ Texas, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Lee, Andrew Joon] Penn State Univ, Coll Med, MD PhD Program, Hershey, PA 17033 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Lee, Andrew/GVU-2817-2022; Wu, Xuefeng/F-5003-2011; zhou, xiaofei/A-9844-2013		National Institutes of Health [AI064639, GM084459, GM084459S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008445, R01GM084459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064639, GM084459, and GM084459S1.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhou P, 2005, J IMMUNOL, V174, P3447, DOI 10.4049/jimmunol.174.6.3447	36	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15696	15703		10.1074/jbc.M109.095190	http://dx.doi.org/10.1074/jbc.M109.095190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233721	Green Published, hybrid			2022-12-25	WOS:000277715900004
J	van Mourik, A; Steeghs, L; van Laar, J; Meiring, HD; Hamstra, HJ; van Putten, JPM; Wosten, MMSM				van Mourik, Andries; Steeghs, Liana; van Laar, Jacoline; Meiring, Hugo D.; Hamstra, Hendrik-Jan; van Putten, Jos P. M.; Wosten, Marc M. S. M.			Altered Linkage of Hydroxyacyl Chains in Lipid A of Campylobacter jejuni Reduces TLR4 Activation and Antimicrobial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; SALMONELLA; ENDOTOXIN; HEMA; 4-AMINO-4-DEOXY-L-ARABINOSE; TOLL-LIKE-RECEPTOR-4; LIPOOLIGOSACCHARIDES; TYPHIMURIUM	Modification of the lipid A moiety of bacterial lipopolysaccharide influences cell wall properties, endotoxic activity, and bacterial resistance to antimicrobial peptides. Known modifications are variation in the number or length of acyl chains and/or attached phosphoryl groups. Here we identified two genes (gnnA and gnnB) in the major foodborne pathogen Campylobacter jejuni that enable the synthesis of a GlcN3N precursor UDP 2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose (UDP-GlcNAc3N) in the lipid A backbone. Mass spectrometry of purified lipooligosaccharide verified that the gene products facilitate the formation of a 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N) disaccharide lipid A backbone when compared with the beta-1'-6-linked D-glucosamine (GlcN) disaccharide observed in Escherichia coli lipid A. Functional assays showed that inactivation of the gnnA or gnnB gene enhanced the TLR4-MD2-mediated NF-kappa B activation. The mutants also displayed increased susceptibility to killing by the antimicrobial peptides polymyxin B, colistin and the chicken cathelicidin-1. The gnnA and gnnB genes are organized in one operon with hemH, encoding a ferrochelatase catalyzing the last step in heme biosynthesis. These results indicate that lipid A modification resulting in amide-linked acyl chains in the lipid A is an effective mechanism to evade activation of the innate host defense and killing by antimicrobial peptides.	[van Mourik, Andries; Steeghs, Liana; van Laar, Jacoline; van Putten, Jos P. M.; Wosten, Marc M. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Meiring, Hugo D.; Hamstra, Hendrik-Jan] NVI, NL-3720 AL Bilthoven, Netherlands	Utrecht University	Wosten, MMSM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	M.Wosten@uu.nl		van Putten, Jos/0000-0002-4126-8172; Wosten, Marc/0000-0002-7464-7232	NWO-VIDI [917.66.330]; ZonMW [9120-6150]	NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by NWO-VIDI Grant 917.66.330 (to M. M. S. M. W.) and ZonMW Grant 9120-6150 (to J. P. M. v. P.).	Baysse C, 2001, FEMS MICROBIOL LETT, V205, P57, DOI 10.1016/S0378-1097(01)00441-4; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Geurtsen J, 2007, J BIOL CHEM, V282, P37875, DOI 10.1074/jbc.M706391200; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LABIGNEROUSSEL A, 1987, J BACTERIOL, V169, P5320, DOI 10.1128/jb.169.11.5320-5323.1987; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Marsden GL, 2009, J BACTERIOL, V191, P2392, DOI 10.1128/JB.01397-08; McNicholas PM, 1997, FEMS MICROBIOL LETT, V146, P143, DOI 10.1016/S0378-1097(96)00467-3; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Moran AP, 1997, J INFECT DIS, V176, pS115, DOI 10.1086/513781; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; Sweet CR, 2004, J BIOL CHEM, V279, P25411, DOI 10.1074/jbc.M400597200; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	45	40	40	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15828	15836		10.1074/jbc.M110.102061	http://dx.doi.org/10.1074/jbc.M110.102061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351099	hybrid, Green Published			2022-12-25	WOS:000277715900020
J	Vukcevic, M; Zorzato, F; Spagnoli, G; Treves, S				Vukcevic, Mirko; Zorzato, Francesco; Spagnoli, Giulio; Treves, Susan			Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 RYANODINE RECEPTORS; MESENCHYMAL STEM-CELLS; KAPPA-B; CYTOKINE PRODUCTION; CA-2+ OSCILLATIONS; IMMUNE-RESPONSES; GENE-EXPRESSION; T-CELLS; ATP; MACROPHAGES	Spontaneous Ca2+ oscillations have been observed in a number of excitable and non-excitable cells, but in most cases their biological role remains elusive. In the present study we demonstrate that spontaneous Ca2+ oscillations occur in immature human monocyte-derived dendritic cells but not in dendritic cells stimulated to undergo maturation with lipopolysaccharide or other toll like-receptor agonists. We investigated the mechanism and role of spontaneous Ca2+ oscillations in immature dendritic cells and found that they are mediated by the inositol 1,4,5-trisphosphate receptor as they were blocked by pretreatment of cells with the inositol 1,4,5-trisphosphate receptor antagonist Xestospongin C and 2-aminoethoxydiphenylborate. A component of the Ca2+ signal is also due to influx from the extracellular environment and may be involved in maintaining the level of the intracellular Ca2+ stores. As to their biological role, our results indicate that they are intimately linked to the "immature" phenotype and are associated with the translocation of the transcription factor NFAT into the nucleus. In fact, once the Ca2+ oscillations are blocked with 2-aminoethoxydiphenylborate or by treating the cells with lipopolysaccharide, NFAT remains cytoplasmic. The results presented in this report provide novel insights into the physiology of monocyte-derived dendritic cells and into the mechanisms involved in maintaining the cells in the immature stage.	[Vukcevic, Mirko; Zorzato, Francesco; Treves, Susan] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland; [Vukcevic, Mirko; Zorzato, Francesco; Treves, Susan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Spagnoli, Giulio] Univ Basel Hosp, Inst Surg Res, CH-4031 Basel, Switzerland; [Zorzato, Francesco; Treves, Susan] Univ Ferrara, Dept Expt & Diagnost Med, Gen Pathol Sect, I-44100 Ferrara, Italy	University of Basel; University of Basel; University of Basel; University of Ferrara	Treves, S (corresponding author), Univ Basel Hosp, Dept Anesthesia, Hebelstr 20, CH-4031 Basel, Switzerland.	susan.treves@unibas.ch		Treves, Susan/0000-0002-0007-9631	Swiss National Science Foundation [SNF 3200B0-114597, SNF 3200B0-104060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051532, R01GM051532] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Swiss National Science Foundation Grants SNF 3200B0-114597 and 3200B0-104060.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bracci L, 2008, J IMMUNOTHER, V31, P466, DOI 10.1097/CJI.0b013e318174a52a; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hengge UR, 2004, DERMATOL SURG, V30, P1101, DOI 10.1111/j.1524-4725.2004.30335.x; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koski GK, 1999, J IMMUNOL, V163, P82; KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lee JI, 1999, TRANSPLANTATION, V68, P1255, DOI 10.1097/00007890-199911150-00007; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Myers JT, 2002, J LEUKOCYTE BIOL, V72, P677; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sauer H, 1998, EXP CELL RES, V238, P13, DOI 10.1006/excr.1997.3809; Schnurr M, 2003, BLOOD, V102, P613, DOI 10.1182/blood-2002-12-3745; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Urosevic M, 2004, AM J CLIN DERMATOL, V5, P453, DOI 10.2165/00128071-200405060-00010; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Wang TF, 2006, ACTA PHARMACOL SIN, V27, P861, DOI 10.1111/j.1745-7254.2006.00397.x; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	52	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16003	16011		10.1074/jbc.M109.066704	http://dx.doi.org/10.1074/jbc.M109.066704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348098	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000277715900038
J	Zhou, Z; Li, XG; Deng, CW; Ney, PA; Huang, SM; Bungert, J				Zhou, Zhuo; Li, Xingguo; Deng, Changwang; Ney, Paul A.; Huang, Suming; Bungert, Joerg			USF and NF-E2 Cooperate to Regulate the Recruitment and Activity of RNA Polymerase II in the beta-Globin Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; HYPERSENSITIVE SITE 2; UPSTREAM STIMULATORY FACTOR; CONTROL REGION FUNCTION; LOOP-HELIX PROTEINS; ERYTHROID-CELLS; IN-VIVO; DOWNSTREAM PROMOTER; CHROMATIN DOMAIN; BARRIER-ELEMENT	The human beta-globin gene is expressed at high levels in erythroid cells and regulated by proximal and distal cis-acting DNA elements, including promoter, enhancer, and a locus control region (LCR). Transcription complexes are recruited not only to the globin gene promoters but also to the LCR. Previous studies have implicated the ubiquitously expressed transcription factor USF and the tissue-restricted activator NF-E2 in the recruitment of transcription complexes to the beta-globin gene locus. Here we demonstrate that although USF is required for the efficient association of RNA polymerase II (Pol II) with immobilized LCR templates, USF and NF-E2 together regulate the association of Pol II with the adult beta-globin gene promoter. Recruitment of Pol II to the LCR occurs in undifferentiated murine erythroleukemia cells, but phosphorylation of LCR-associated Pol II at serine 5 of the C-terminal domain is mediated by erythroid differentiation and requires the activity of NF-E2. Furthermore, we provide evidence showing that USF interacts with NF-E2 in erythroid cells. The data provide mechanistic insight into how ubiquitous and tissue-restricted transcription factors cooperate to regulate the recruitment and activity of transcription complexes in a tissue-specific chromatin domain.	[Bungert, Joerg] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Powell Gene Therapy Ctr,Ctr Epigenet, Gainesville, FL 32610 USA; [Zhou, Zhuo; Li, Xingguo; Deng, Changwang; Huang, Suming; Bungert, Joerg] Univ Florida, Genet Inst, Gainesville, FL 32610 USA; [Ney, Paul A.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; St Jude Children's Research Hospital	Bungert, J (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Powell Gene Therapy Ctr,Ctr Epigenet, 1600 Archer Rd,POB 100245, Gainesville, FL 32610 USA.	jbungert@ufl.edu	Li, Xingguo/T-9582-2019	Li, Xingguo/0000-0002-2801-7555; Li, Xing-Guo/0000-0003-1952-3445	National Institutes of Health [DK052356, HL091929]; American Heart Association [AHAGRNT2260915]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052356 (to J.B.) and HL091929 (to S. H.). This work was also supported by American Heart Association Grant AHAGRNT2260915 (to J.B.).	Amrolia PJ, 1997, P NATL ACAD SCI USA, V94, P10051, DOI 10.1073/pnas.94.19.10051; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; BUNGERT J, 1992, J MOL BIOL, V223, P885, DOI 10.1016/0022-2836(92)90250-N; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Elnitski L, 1997, J BIOL CHEM, V272, P369; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Gallagher PG, 2009, BLOOD, V113, P1547, DOI 10.1182/blood-2008-06-164954; Gong QH, 1996, MOL CELL BIOL, V16, P6055; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kang SHL, 2002, NUCLEIC ACIDS RES, V30; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Levings PP, 2006, FEBS J, V273, P746, DOI 10.1111/j.1742-4658.2005.05107.x; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Liang S, 2008, J CELL BIOCHEM, V105, P9, DOI 10.1002/jcb.21820; Liang SY, 2009, MOL CELL BIOL, V29, P5900, DOI 10.1128/MCB.00419-09; Lin IJ, 2009, J BIOL CHEM, V284, P20130, DOI 10.1074/jbc.M109.001461; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Loyd MR, 2003, BLOOD, V102, P4223, DOI 10.1182/blood-2003-02-0574; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Nagai T, 1998, J BIOL CHEM, V273, P5358, DOI 10.1074/jbc.273.9.5358; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005	70	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15894	15905		10.1074/jbc.M109.098376	http://dx.doi.org/10.1074/jbc.M109.098376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236933	Green Published, hybrid			2022-12-25	WOS:000277715900027
J	Shakoury-Elizeh, M; Protchenko, O; Berger, A; Cox, J; Gable, K; Dunn, TM; Prinz, WA; Bard, M; Philpott, CC				Shakoury-Elizeh, Minoo; Protchenko, Olga; Berger, Alvin; Cox, James; Gable, Kenneth; Dunn, Teresa M.; Prinz, William A.; Bard, Martin; Philpott, Caroline C.			Metabolic Response to Iron Deficiency in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-BINDING PROTEIN; SQUALENE EPOXIDASE; FERRIC REDUCTASE; LIPID PARTICLES; BUDDING YEAST; RESISTANCE; STORAGE; BIOSYNTHESIS; DEPRIVATION; ERGOSTEROL	Iron is an essential cofactor for enzymes involved in numerous cellular processes, yet little is known about the impact of iron deficiency on cellular metabolism or iron proteins. Previous studies have focused on changes in transcript and proteins levels in iron-deficient cells, yet these changes may not reflect changes in transport activity or flux through a metabolic pathway. We analyzed the metabolomes and transcriptomes of yeast grown in iron-rich and iron-poor media to determine which bio-synthetic processes are altered when iron availability falls. Iron deficiency led to changes in glucose metabolism, amino acid biosynthesis, and lipid biosynthesis that were due to deficiencies in specific iron-dependent enzymes. Iron-sulfur proteins exhibited loss of iron cofactors, yet amino acid synthesis was maintained. Ergosterol and sphingolipid biosynthetic pathways had blocks at points where heme and diiron enzymes function, whereas Ole1, the essential fatty acid desaturase, was resistant to iron depletion. Iron-deficient cells exhibited depletion of most iron enzyme activities, but loss of activity during iron deficiency did not consistently disrupt metabolism. Amino acid homeostasis was robust, but iron deficiency impaired lipid synthesis, altering the properties and functions of cellular membranes.	[Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Prinz, William A.] NIDDK, Lab Cell Biol & Biochem, NIH, Bethesda, MD 20892 USA; [Berger, Alvin] Metabolon Inc, Durham, NC 27713 USA; [Cox, James] Univ Utah, Metabol Core Res Facil, Salt Lake City, UT 84132 USA; [Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Metabolon; Utah System of Higher Education; University of Utah; Uniformed Services University of the Health Sciences - USA; Indiana University System; Indiana University-Purdue University Indianapolis	Philpott, CC (corresponding author), Bldg 10,Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Berger, Alvin/AAE-5353-2022; Protchenko, Olga/AAU-9237-2021	Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health, NIDDK [P30 DK072437]; NIH [GM62104]; Center of Excellence in Molecular Hematology; United States Public Health Service, NINDS, NIH [NS47717]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105, ZIADK054507, ZIADK060004] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Public Health Service, NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIDDK (to M. S.-E., O.P., W. A. P., and C. C. P.), by NIH Grant NIDDK P30 DK072437 (to J.C.), and by NIH Grant GM62104 (to M. B.). This work was also supported by the Center of Excellence in Molecular Hematology and by United States Public Health Service Grant NS47717 awarded by NINDS, NIH (to T. M. D.).	Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; BERTELLO LE, 1995, BIOCHEM J, V310, P255, DOI 10.1042/bj3100255; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DAUM G, 1998, YEAST, V1471, P1510; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; HUNG CY, 1995, BIOCHEM J, V307, P107, DOI 10.1042/bj3070107; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kennedy MA, 2001, BBA-GENE STRUCT EXPR, V1517, P177, DOI 10.1016/S0167-4781(00)00246-3; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEES ND, 2003, LIPID METABOLISM MEM, P213; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, MOL CELLULAR BIOL YE, P283; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; MBAYA B, 1989, LIPIDS, V24, P1020, DOI 10.1007/BF02544072; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stehling O., 2007, METHOD MOL BIOL, P325; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	50	118	124	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14823	14833		10.1074/jbc.M109.091710	http://dx.doi.org/10.1074/jbc.M109.091710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231268	Green Published, hybrid			2022-12-25	WOS:000277299700079
J	Gelling, M; Montes, I; Moorhouse, TP; Macdonald, DW				Gelling, Merryl; Montes, Inigo; Moorhouse, Tom P.; Macdonald, David W.			Captive Housing during Water Vole (Arvicola terrestris) Reintroduction: Does Short-Term Social Stress Impact on Animal Welfare?	PLOS ONE			English	Article							PLASMA-CORTICOSTERONE CONCENTRATIONS; LEUKOCYTE COPING CAPACITY; NEUTROPHIL ACTIVATION; IMMUNE FUNCTION; WILD; BEHAVIOR; DENSITY; RATS; TRANSLOCATION; RESTRAINT	Background: Animals captive bred for reintroduction are often housed under conditions which are not representative of their preferred social structure for at least part of the reintroduction process. Specifically, this is most likely to occur during the final stages of the release programme, whilst being housed during transportation to the release site. The degree of social stress experienced by individuals during this time may negatively impact upon their immunocompetence. Methodology/Principal Findings: We examined two measure of stress-body weight and Leukocyte Coping Capacity (LCC) - to investigate the effects of group size upon captive-bred water voles destined for release within a reintroduction program. Water voles were housed in laboratory cages containing between one and eight individuals. LCC scores were negatively correlated with group size, suggesting that individuals in larger groups experienced a larger degree of immunosuppression than did individuals housed in smaller groups or individually. During the course of the study mean body weights increased, in contrast to expectations from a previous study. This was attributed to the individuals sampled being sub-adults and thus growing in length and weight during the course of the investigation. Conclusions/Significance: The reintroduction process will inevitably cause some stress to the release cohort. However, for water voles we conclude that the stress experienced may be reduced by decreasing group size within captive colony and/or transportation housing practises. These findings are of significance to other species' reintroductions, in highlighting the need to consider life-history strategies when choosing housing systems for animals being maintained in captivity prior to release to the wild. A reduction in stress experienced at the pre-release stage may improve immunocompetence and thus animal welfare and initial survival post-release.	[Gelling, Merryl; Montes, Inigo; Moorhouse, Tom P.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Gelling, M (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	merryl.gelling@zoo.ox.ac.uk	Gelling, Merryl/I-8448-2012	Moorhouse, Tom/0000-0002-8889-2175	Environment Agency and Peoples Trust for Endangered Species (PTES); Holly Hill Trust; PTES	Environment Agency and Peoples Trust for Endangered Species (PTES); Holly Hill Trust; PTES	M. Gelling was funded by the Environment Agency and Peoples Trust for Endangered Species (PTES) with contributions from D. Gow Consultancies. PTES also funded I. Montes for the duration of the study. T. Moorhouse was funded by the Holly Hill Trust and PTES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altholtz LY, 2006, J AM ASSOC LAB ANIM, V45, P17; Armstrong DP, 1999, BIOL CONSERV, V89, P329, DOI 10.1016/S0006-3207(99)00012-9; BOND M, 1997, ORANGUTAN SPECIES SU, P77; Burman O, 2008, PHYSIOL BEHAV, V93, P89, DOI 10.1016/j.physbeh.2007.08.001; Calvete C, 2005, J WILDLIFE MANAGE, V69, P1063, DOI 10.2193/0022-541X(2005)069[1063:QLASOT]2.0.CO;2; CODDINGTON EJ, 1995, GEN COMP ENDOCR, V100, P33, DOI 10.1006/gcen.1995.1129; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Egger G, 2001, INFLAMMATION, V25, P129, DOI 10.1023/A:1007174723608; Ford WCL, 1997, INT J ANDROL, V20, P44; Gelling M, 2009, ANIM WELFARE, V18, P1; Gregory LF, 1996, GEN COMP ENDOCR, V104, P312, DOI 10.1006/gcen.1996.0176; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Honess PE, 2005, ANIM WELFARE, V14, P291; Hu TH, 1999, CELL SIGNAL, V11, P355, DOI 10.1016/S0898-6568(99)00007-8; JEFFERIES DJ, 1989, MAMMAL REV, V19, P111, DOI 10.1111/j.1365-2907.1989.tb00406.x; KOFKE WA, 1995, J NEUROSURG ANESTH, V7, P280, DOI 10.1097/00008506-199510000-00007; Kunz-Ebrecht SR, 2003, BRAIN BEHAV IMMUN, V17, P373, DOI 10.1016/S0889-1591(03)00029-1; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; Letty J, 2000, ANIM CONSERV, V3, P211, DOI 10.1017/S1367943000000925; Mathews F, 2002, VET REC, V150, P785, DOI 10.1136/vr.150.25.785; McLaren Graeme, 2006, P120; McLaren GW, 2004, ANIM WELFARE, V13, P337; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Montes I, 2004, ANIM WELFARE, V13, P355; Moorhouse TP, 2007, J ZOOL, V271, P19, DOI 10.1111/j.1469-7998.2006.00175.x; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Moorhouse TP, 2008, J ANIM ECOL, V77, P1288, DOI 10.1111/j.1365-2656.2008.01431.x; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Mugnai C, 2009, APPL ANIM BEHAV SCI, V118, P91, DOI 10.1016/j.applanim.2009.02.007; O'Malley J, 2008, J AM ASSOC LAB ANIM, V47, P9; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Ostrakhovitch EA, 2001, BIOCHEM PHARMACOL, V62, P743, DOI 10.1016/S0006-2952(01)00707-9; PENG X, 1989, LAB ANIM, V23, P302, DOI 10.1258/002367789780746042; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Sanidas D, 2000, EXP PHYSIOL, V85, P263, DOI 10.1111/j.1469-445X.2000.02023.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Strachan R, 1993, WATER VOLE ARVICOLA; STRACHAN R, 2006, WATERVOLE CONSERVATI; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Yildiz A, 2007, ASIAN AUSTRAL J ANIM, V20, P263; Zhou J, 1999, AM J PHYSIOL-REG I, V277, pR757, DOI 10.1152/ajpregu.1999.277.3.R757	44	14	14	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9791	10.1371/journal.pone.0009791	http://dx.doi.org/10.1371/journal.pone.0009791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352093	Green Published, gold			2022-12-25	WOS:000275894500006
J	Lind, J; Lindenfors, P				Lind, Johan; Lindenfors, Patrik			The Number of Cultural Traits Is Correlated with Female Group Size but Not with Male Group Size in Chimpanzee Communities	PLOS ONE			English	Article							PAN-TROGLODYTES; EVOLUTION	What determines the number of cultural traits present in chimpanzee (Pan troglodytes) communities is poorly understood. In humans, theoretical models suggest that the frequency of cultural traits can be predicted by population size. In chimpanzees, however, females seem to have a particularly important role as cultural carriers. Female chimpanzees use tools more frequently than males. They also spend more time with their young, skewing the infants' potential for social learning towards their mothers. In Gombe, termite fishing has been shown to be transmitted from mother to offspring. Lastly, it is female chimpanzees that transfer between communities and thus have the possibility of bringing in novel cultural traits from other communities. From these observations we predicted that females are more important cultural carriers than males. Here we show that the reported number of cultural traits in chimpanzee communities correlates with the number of females in chimpanzee communities, but not with the number of males. Hence, our results suggest that females are the carriers of chimpanzee culture.	[Lind, Johan] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Lind, J (corresponding author), Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden.	johan.lind@zoologi.su.se	Lindenfors, Patrik/G-6401-2011; Lindenfors, Patrik/N-2801-2019	Lindenfors, Patrik/0000-0003-3245-0850; Lindenfors, Patrik/0000-0003-3245-0850	Swedish Research Council (PL); CULTAPTATION [FP6-2004-NEST-PATH-043434]	Swedish Research Council (PL)(Swedish Research Council); CULTAPTATION	This study was funded through a research grant from the Swedish Research Council (PL) and it was also supported by the CULTAPTATION project (European Commission contract FP6-2004-NEST-PATH-043434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Enquist M, 2008, THEOR POPUL BIOL, V74, P46, DOI 10.1016/j.tpb.2008.04.007; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; HANNAH AC, 1987, PRIMATES, V28, P31, DOI 10.1007/BF02382181; Hrubesch C, 2009, ANIM COGN, V12, P209, DOI 10.1007/s10071-008-0183-y; IUCN, 2014, IUCN RED LIST THREAT; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Lycett SJ, 2009, J HUM EVOL, V57, P337, DOI 10.1016/j.jhevol.2009.05.015; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Nishida T., 1987, P165; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; R Core Team, 2022, R LANG ENV STAT COMP; Strimling P, 2009, THEOR POPUL BIOL, V76, P77, DOI 10.1016/j.tpb.2009.04.006; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wrangham R. W, 2000, PRIMATE MALES CAUSES	23	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9241	10.1371/journal.pone.0009241	http://dx.doi.org/10.1371/journal.pone.0009241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352086	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500001
J	Gosoniu, L; Veta, AM; Vounatsou, P				Gosoniu, Laura; Veta, Andre Mia; Vounatsou, Penelope			Bayesian Geostatistical Modeling of Malaria Indicator Survey Data in Angola	PLOS ONE			English	Article							TRANSMISSION	The 2006-2007 Angola Malaria Indicator Survey (AMIS) is the first nationally representative household survey in the country assessing coverage of the key malaria control interventions and measuring malaria-related burden among children under 5 years of age. In this paper, the Angolan MIS data were analyzed to produce the first smooth map of parasitaemia prevalence based on contemporary nationwide empirical data in the country. Bayesian geostatistical models were fitted to assess the effect of interventions after adjusting for environmental, climatic and socio-economic factors. Non-linear relationships between parasitaemia risk and environmental predictors were modeled by categorizing the covariates and by employing two non-parametric approaches, the B-splines and the P-splines. The results of the model validation showed that the categorical model was able to better capture the relationship between parasitaemia prevalence and the environmental factors. Model fit and prediction were handled within a Bayesian framework using Markov chain Monte Carlo (MCMC) simulations. Combining estimates of parasitaemia prevalence with the number of children under 5 we obtained estimates of the number of infected children in the country. The population-adjusted prevalence ranges from 3.76% in Namibe province to 32.65% in Malanje province. The odds of parasitaemia in children living in a household with at least 0.2 ITNs per person was by 41% lower (CI: 14%, 60%) than in those with fewer ITNs. The estimates of the number of parasitaemic children produced in this paper are important for planning and implementing malaria control interventions and for monitoring the impact of prevention and control activities.	[Gosoniu, Laura; Vounatsou, Penelope] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Veta, Andre Mia] LDA, COSEP Consultoria, Luanda, Angola	University of Basel; Swiss Tropical & Public Health Institute	Gosoniu, L (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	laura.gosoniu@unibas.ch		Vounatsou, Penelope/0000-0002-4904-5352	United States Agency for International Development (USAID)/Angola; President's Malaria Initiative (PMI); United Nations Development Programme (UNDP); Swiss National Science Foundation (SNF) [IZLSZ3 122926]	United States Agency for International Development (USAID)/Angola(United States Agency for International Development (USAID)); President's Malaria Initiative (PMI)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); United Nations Development Programme (UNDP); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Funding for the Angola Malaria Indicator Survey (MIS) was provided by the United States Agency for International Development (USAID)/Angola, the President's Malaria Initiative (PMI) and the United Nations Development Programme (UNDP)-managed Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). This investigation received financial support from the Swiss National Science Foundation (SNF) (Project No. IZLSZ3 122926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; *PMI, 2006, PRES MAL IN; RUEBUSH TK, 2005, PRESIDENTS INITIATIV; UNICEF, 2008, PROGR REP MAL NO MOR; *UNICEF, 2003, MICS MULT IND CLUST; WHO/UNICEF, 2005, WORLD MAL REP; *WHO UNICEF, 2005, SUMM COUNTR PROF HIV; 2007, ANGOLA MALARIA INDIC	15	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9322	10.1371/journal.pone.0009322	http://dx.doi.org/10.1371/journal.pone.0009322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351775	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894400002
J	Panova, M; Bostrom, J; Hofving, T; Areskoug, T; Eriksson, A; Mehlig, B; Makinen, T; Andre, C; Johannesson, K				Panova, Marina; Bostrom, Johan; Hofving, Tobias; Areskoug, Therese; Eriksson, Anders; Mehlig, Bernhard; Makinen, Tuuli; Andre, Carl; Johannesson, Kerstin			Extreme Female Promiscuity in a Non-Social Invertebrate Species	PLOS ONE			English	Article							MICROSATELLITE DNA MARKERS; MULTIPLE PATERNITY; GENETIC BENEFITS; LITTORINA-SAXATILIS; NATURAL-POPULATION; MATING FREQUENCY; SEXUAL CONFLICT; NUPTIAL GIFTS; MATE CHOICE; POLYANDRY	Background: While males usually benefit from as many matings as possible, females often evolve various methods of resistance to matings. The prevalent explanation for this is that the cost of additional matings exceeds the benefits of receiving sperm from a large number of males. Here we demonstrate, however, a strongly deviating pattern of polyandry. Methodology/Principal Findings: We analysed paternity in the marine snail Littorina saxatilis by genotyping large clutches (53-79) of offspring from four females sampled in their natural habitats. We found evidence of extreme promiscuity with 15-23 males having sired the offspring of each female within the same mating period. Conclusions/Significance: Such a high level of promiscuity has previously only been observed in a few species of social insects. We argue that genetic bet-hedging (as has been suggested earlier) is unlikely to explain such extreme polyandry. Instead we propose that these high levels are examples of convenience polyandry: females accept high numbers of matings if costs of refusing males are higher than costs of accepting superfluous matings.	[Panova, Marina; Bostrom, Johan; Hofving, Tobias; Areskoug, Therese; Eriksson, Anders; Andre, Carl; Johannesson, Kerstin] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden; [Eriksson, Anders; Mehlig, Bernhard] Univ Gothenburg, Dept Phys, Gothenburg, Sweden; [Makinen, Tuuli] Univ Alaska Museum N, Fairbanks, AK USA	University of Gothenburg; University of Gothenburg; University of Alaska System; University of Alaska Fairbanks	Panova, M (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	Marina.Panova@marecol.gu.se	Mehlig, Bernhard/N-6491-2013; Eriksson, Anders/C-9767-2010; Johannesson, Kerstin/B-5528-2013; Panova, Marina/D-2633-2015; Panova, Marina/V-3533-2019; Johannesson, Kerstin/X-7994-2019; Hofving, Tobias/AAK-9174-2021; Andre, Carl/B-4237-2010	Eriksson, Anders/0000-0003-3436-3726; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Panova, Marina/0000-0002-4147-6473; Johannesson, Kerstin/0000-0003-0176-7986; Andre, Carl/0000-0003-4404-7292; Makinen, Tuuli Elina/0000-0001-5163-8459; Mehlig, Bernhard/0000-0002-3672-6538; Hofving, Tobias/0000-0002-9855-4268	Swedish Research Council; Linnaeus Centre for Marine Evolutionary Biology; Thorden Foundation; Centre for Theoretical Biology at Gothenburg University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Centre for Marine Evolutionary Biology; Thorden Foundation; Centre for Theoretical Biology at Gothenburg University	This study was supported by the Swedish Research Council (grants to KJ, CA), the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se/), the Thorden Foundation and the Centre for Theoretical Biology at Gothenburg University (http://www.ctbio.science.gu.se/theoretical_biology/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G., 2005, SEXUAL CONFLICT, P360; Balloux F, 2003, GENETICS, V165, P2313; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Blyth JE, 2005, HEREDITY, V95, P174, DOI 10.1038/sj.hdy.6800713; Blyth JE, 2006, J INSECT BEHAV, V19, P447, DOI 10.1007/s10905-006-9034-3; Buckland-Nicks J, 1999, INVERTEBR REPROD DEV, V36, P145, DOI 10.1080/07924259.1999.9652691; Buckland-Nicks J, 1998, MICRON, V29, P267, DOI 10.1016/S0968-4328(97)00064-4; COHEN AC, 1960, BIOMETRICS, V16, P203, DOI 10.2307/2527552; Denny AJ, 2004, NATURWISSENSCHAFTEN, V91, P396, DOI 10.1007/s00114-004-0546-4; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Dunn DW, 2005, BEHAV ECOL SOCIOBIOL, V58, P128, DOI 10.1007/s00265-005-0922-x; Engqvist L, 2006, BEHAV ECOL, V17, P435, DOI 10.1093/beheco/arj046; Eriksson A, 2010, MOL ECOL RESOUR, V10, P282, DOI 10.1111/j.1755-0998.2009.02753.x; Fox CW, 2003, EVOL ECOL RES, V5, P273; Garant D, 2005, BEHAV ECOL SOCIOBIOL, V57, P240, DOI 10.1007/s00265-004-0854-x; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hollander J, 2005, ANIM BEHAV, V70, P1209, DOI 10.1016/j.anbehav.2005.03.014; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Madsen T, 2005, MOL ECOL, V14, P1783, DOI 10.1111/j.1365-294X.2005.02505.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Mikhailova N, 1998, HYDROBIOLOGIA, V378, P33, DOI 10.1023/A:1003221117784; Pai A, 2002, J EVOLUTION BIOL, V15, P1076, DOI 10.1046/j.1420-9101.2002.00456.x; Panova M, 2008, J MOLLUS STUD, V74, P111, DOI 10.1093/mollus/eym052; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Rivera A Cordero, 2002, J Insect Sci, V2, P14; SAUR M, 1990, DEV HYDROB, V56, P261, DOI 10.1007/BF00028082; Sherman PW, 1998, AM NAT, V151, P392, DOI 10.1086/286127; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Sokolov EP, 2002, MOL ECOL NOTES, V2, P27, DOI 10.1046/j.1471-8278 .2001.00133.x; Song SD, 2007, MOL ECOL, V16, P2353, DOI 10.1111/j.1365-294X.2007.03277.x; Tarpy DR, 2000, AM NAT, V155, P820, DOI 10.1086/303358; Thiel M, 2003, BEHAV ECOL SOCIOBIOL, V55, P113, DOI 10.1007/s00265-003-0677-1; Thornhill R., 1983, pi; Tie AD, 2000, MOL ECOL, V9, P108, DOI 10.1046/j.1365-294x.2000.00764-2.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Trontti K, 2007, BEHAV ECOL, V18, P298, DOI 10.1093/beheco/arl083; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Van Gossum H, 2001, BEHAV ECOL SOCIOBIOL, V51, P69; Voigt CC, 2008, BIOL LETTERS, V4, P476, DOI 10.1098/rsbl.2008.0282; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Wedell N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-204; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	52	47	48	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9640	10.1371/journal.pone.0009640	http://dx.doi.org/10.1371/journal.pone.0009640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300171	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620600005
J	Di Pasquale, G; Kaludov, N; Agbandje-McKenna, M; Chiorini, JA				Di Pasquale, Giovanni; Kaludov, Nikola; Agbandje-McKenna, Mavis; Chiorini, John A.			BAAV Transcytosis Requires an Interaction with beta-1-4 Linked-Glucosamine and gp96	PLOS ONE			English	Article							BOVINE ADENOASSOCIATED VIRUS; GROWTH-FACTOR RECEPTOR; BLOOD-BRAIN-BARRIER; ESCHERICHIA-COLI; TYPE-2 INFECTION; EPITHELIAL-CELLS; INNER-EAR; PROTEIN; BINDING; CORECEPTOR	Cell surface carbohydrates play an important role in virus entry and intracellular trafficking. Bovine Adeno-Associated Virus (BAAV) uses plasma membrane gangliosides for transduction and infection. In addition, independent of the infectious pathway, BAAV also has the ability to pass through barrier epithelia and endothelia using a transcytosis pathway dependent upon the presence of cell surface carbohydrates. Thus, in order to better define the carbohydrate interactions that are necessary for BAAV infection or transcytosis, a glycan microarray composed of both natural and synthetic carbohydrates was probed with HA-tagged BAAV particles. This identified chitotriose, a trimer of beta-1-4-linked N-acetyl glucosamine, as having an interaction with BAAV. Competition experiments showed that the BAAV interaction with this carbohydrate is not necessary for infection but is instead important in the transcytosis pathway. The beta-1-4-linked N-acetyl glucosamine modification has been reported on gp96, a glycoprotein involved in the transcytosis of bacteria and toxins. Significantly, immunoprecipitation and competition experiments with an anti-gp96 antibody and a soluble form of gp96, respectively, showed this glycoprotein can also interact with BAAV to serve as a receptor for its transcytosis.	[Di Pasquale, Giovanni; Kaludov, Nikola; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Agbandje-McKenna, Mavis] Univ Florida, Coll Med, Dept Biochem & Mol Biol, McKnight Brain Inst, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of Florida	Di Pasquale, G (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov			National Institutes of Health [R01 GM082946]; NIH National Institute of Dental and Craniofacial Research; National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is also supported by National Institutes of Health R01 GM082946 to MAM and an NIH National Institute of Dental and Craniofacial Research intramural grant to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Consortium for Functional Glycomics is funded by National Institute of General Medical Sciences grant GM62116.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Di Pasquale G, 2005, MOL THER, V11, P849, DOI 10.1016/j.ymthe.2005.02.004; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duque S., 2009, MOL THER; ETZIER M, 1970, BIOCHEMISTRY-US, V9, P869; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Lopez-Bueno A, 2008, J VIROL, V82, P1195, DOI 10.1128/JVI.01692-07; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Palermo LM, 2006, J VIROL, V80, P8482, DOI 10.1128/JVI.00683-06; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; SHIBATA S, 2009, GENE THER IN PRESS; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9336	10.1371/journal.pone.0009336	http://dx.doi.org/10.1371/journal.pone.0009336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231878	Green Submitted, gold, Green Published			2022-12-25	WOS:000275328300002
J	Anelli, V; Gault, CR; Snider, AJ; Obeid, LM				Anelli, Viviana; Gault, Christopher R.; Snider, Ashley J.; Obeid, Lina M.			Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro	FASEB JOURNAL			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNALING PATHWAYS; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR RELEASE; MASS-SPECTROMETRY; POOR SURVIVAL; G-PROTEIN; VEGF-C; 1-PHOSPHATE	Sphingosine-1-phosphate (S1P) is an important bioactive sphingolipid involved in angiogenesis and lymphangiogenesis, 2 important processes that influence the growth, survival, and spread of tumors. S1P acts as an extracellular mediator through binding to 5 highly specific S1P receptors, S1P(1-5). Sphingosine kinase-1 (SK1), one of 2 known sphingosine kinase enzymes responsible for S1P production, appears to be overexpressed in many tumors. Although a role for S1P in angiogenesis and lymphangiogenesis has been established, it is unclear whether S1P secreted from cancer cells has a paracrine function in a tumor environment. Here we investigated whether modulation of cellular SK1 could initiate a paracrine angiogenic and lymphangiogenic switch. We found that SK1 overexpression in HEK cells or its down-regulation in glioma or breast cancer cells modulated extracellular S1P levels accordingly, which in turn increased or decreased both migration and tube formation in cocultured vascular or lymphatic endothelial cells. In contrast, down-regulation of sphingosine kinase 2 in both glioma and breast cancer cells had no appreciable effect on cellular or secreted S1P levels. In addition, vascular endothelial growth factors VEGF and VEGF-C down-regulation in cancer cells appeared insufficient to block the angiogenic and lymphangiogenic switch triggered by these cells. Moreover, S1P initiated endothelial cell sprouting in 3-dimensional collagen matrices, which is representative of a multistep angiogenic process. Our data collectively demonstrate for the first time that SK1 plays an essential role in regulating in vitro paracrine angiogenesis and lymphangiogenesis.-Anelli, V., Gault, C. R., Snider, A.J., Obeid, L. M. Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. FASEB J. 24, 2727-2738 (2010). www.fasebj.org	[Obeid, Lina M.] Med Univ S Carolina, Div Gen Internal Med Geriatr, Dept Med, Charleston, SC 29425 USA; [Anelli, Viviana; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Anelli, Viviana] Univ Milan, Dept Med Chem Biochem & Biotechnol, Milan, Italy; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; University of Milan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Div Gen Internal Med Geriatr, Dept Med, MSC 779, Charleston, SC 29425 USA.	obeidl@musc.edu		ANELLI, Viviana Vittoria/0000-0003-1964-3252; obeid, lina/0000-0002-0734-0847	National Institutes of Health [NIH/NIGMS GM062887, NIH/NCI CA097132, NIH/P20 RR17677]; Hollings Cancer Center [P30-CA-56036]; NATIONAL CANCER INSTITUTE [P30CA056036, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Kathy Wiita-Fisk for administrative assistance. The authors also thank the Lipidomics Core at the Medical University of South Carolina. Grant support came from National Institutes of Health grants NIH/NIGMS GM062887 (L.M.O.), NIH/NCI CA097132 (L.M.O.), NIH/P20 RR17677 for the Centers of Biomedical Research Excellence (COBRE) Lipidomics Core, and Hollings Cancer Center core grant P30-CA-56036 for the Microscopy Core.	Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; English DK, 1999, J HEMATOTHER, V8, P1, DOI 10.1089/106161299320514; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Joukov V, 1996, EMBO J, V15, P290; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	39	72	74	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2727	2738		10.1096/fj.09-150540	http://dx.doi.org/10.1096/fj.09-150540			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20335228	Green Published			2022-12-25	WOS:000285005400014
J	Denda-Nagai, K; Aida, S; Saba, K; Suzuki, K; Moriyama, S; Oo-puthinan, S; Tsuiji, M; Morikawa, A; Kumamoto, Y; Sugiura, D; Kudo, A; Akimoto, Y; Kawakami, H; Bovin, NV; Irimura, T				Denda-Nagai, Kaori; Aida, Satoshi; Saba, Kengo; Suzuki, Kiwamu; Moriyama, Saya; Oo-puthinan, Sarawut; Tsuiji, Makoto; Morikawa, Akiko; Kumamoto, Yosuke; Sugiura, Daisuke; Kudo, Akihiko; Akimoto, Yoshihiro; Kawakami, Hayato; Bovin, Nicolai V.; Irimura, Tatsuro			Distribution and Function of Macrophage Galactose-type C-type Lectin 2 (MGL2/CD301b) EFFICIENT UPTAKE AND PRESENTATION OF GLYCOSYLATED ANTIGENS BY DENDRITIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGALACTOSAMINE-SPECIFIC LECTIN; IN-VIVO; MOLECULAR-CLONING; CROSS-PRESENTATION; EXPRESSION; MONOCYTES; DISTINCT; MUC1; DIFFERENTIATION; INTERNALIZATION	Dendritic cells (DCs) express cell surface lectins that are potentially involved in the recognition, uptake, and presentation of glycosylated foreign substances. A unique calcium-type (C-type) lectin, the macrophage galactose (Gal)-type C-type lectin (MGL/CD301) expressed on DCs, is thought to participate in the recognition of molecules from both altered self and pathogens due to its monosaccharide specificity for Gal and N-acetylgalactosamine (GalNAc). Although mice have two MGL genes, Mgl1 and Mgl2, their distinct roles have not been previously explored. The present report characterizes the properties of MGL2 by examining its distribution and its role in antigen presentation by DCs. We generated an MGL2-specific monoclonal antibody and examined MGL2 expression in tissues by immunohistochemistry and in isolated cells by flow cytometry. The cells reactive with this antibody were shown to be a portion of MGL1-expressing cells, mostly conventional DCs. Internalization of soluble polyacrylamide polymers (PAA) with a-GalNAc residues (GalNAc-PAA) by bone marrow-derived DCs (BM-DCs) was mediated by MGL2, as revealed by a comparison of Mgl1(-/-) and Mgl2(-/-) BM-DCs with wild-type BM-DCs. Biotinylated GalNAc-PAA conjugated to streptavidin (SAv) was more efficiently presented to SAv-primed T cells by BM-DCs than beta-N-acetylglucosamine-PAA conjugated to SAv or SAv alone as shown by thymidine uptake and cytokine production. This is the first report that demonstrates the involvement of GalNAc residues in antigen uptake and presentation by DCs that lead to CD4(+) T cell activation.	[Irimura, Tatsuro] Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tsuiji, Makoto] Hoshi Univ, Dept Microbiol, Sch Pharm & Pharmaceut Sci, Tokyo 1428501, Japan; [Kudo, Akihiko; Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Div Microscop Anat, Mitaka, Tokyo 1818611, Japan; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	University of Tokyo; Hoshi University; Kyorin University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Irimura, T (corresponding author), Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp	Tsuiji, Makoto/G-1411-2010; Bovin, Nicolai/P-2948-2017; Kudo, Akihiko/ACZ-3340-2022	Tsuiji, Makoto/0000-0002-5607-4880; Bovin, Nicolai/0000-0001-8669-4477; Kudo, Akihiko/0000-0002-2630-5991; Kumamoto, Yosuke/0000-0001-9369-4934; Denda-Nagai, Kaori/0000-0001-8325-3289; Sugiura, Daisuke/0000-0002-3865-3889	Ministry of Education, Science, Sports, and Culture of Japan; Research Association for Biotechnology; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Association for Biotechnology; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, the Research Association for Biotechnology, and the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceutical and Medical Device Agency.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bovin NV, 1998, GLYCOCONJUGATE J, V15, P431, DOI 10.1023/A:1006963717646; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Clark G, 2005, CELL IMMUNOL, V236, P21, DOI 10.1016/j.cellimm.2005.08.005; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Denda-Nagai K, 2000, GLYCOCONJUGATE J, V17, P649, DOI 10.1023/A:1011039013134; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Imai Y, 1995, IMMUNOLOGY, V86, P591; KIMURA T, 1995, J BIOL CHEM, V270, P16056, DOI 10.1074/jbc.270.27.16056; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; Monti P, 2004, J IMMUNOL, V172, P7341, DOI 10.4049/jimmunol.172.12.7341; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Onami TM, 2002, MOL CELL BIOL, V22, P5173, DOI 10.1128/MCB.22.14.5173-5181.2002; Oo-Puthinan S, 2008, BBA-GEN SUBJECTS, V1780, P89, DOI 10.1016/j.bbagen.2007.10.017; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rughetti A, 2005, J IMMUNOL, V174, P7764, DOI 10.4049/jimmunol.174.12.7764; Saba K, 2009, AM J PATHOL, V174, P144, DOI 10.2353/ajpath.2009.080235; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Suzuki N, 1996, J IMMUNOL, V156, P128; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2007, EUR J IMMUNOL, V37, P2075, DOI 10.1002/eji.200636838; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; YAMAMOTO K, 1994, BIOCHEMISTRY-US, V33, P8159, DOI 10.1021/bi00192a021	48	51	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19193	19204		10.1074/jbc.M110.113613	http://dx.doi.org/10.1074/jbc.M110.113613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20304916	Green Published, hybrid			2022-12-25	WOS:000278727800029
J	Heras, B; Totsika, M; Jarrott, R; Shouldice, SR; Guncar, G; Achard, MES; Wells, TJ; Argente, MP; McEwan, AG; Schembri, MA				Heras, Begona; Totsika, Makrina; Jarrott, Russell; Shouldice, Stephen R.; Guncar, Gregor; Achard, Maud E. S.; Wells, Timothy J.; Argente, M. Pilar; McEwan, Alastair G.; Schembri, Mark A.			Structural and Functional Characterization of Three DsbA Paralogues from Salmonella enterica Serovar Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; UROPATHOGENIC ESCHERICHIA-COLI; FORMATION IN-VIVO; NEISSERIA-MENINGITIDIS; FORMATION INVIVO; ARYLSULFATE SULFOTRANSFERASE; OXIDOREDUCTASE DSBA; CRYSTAL-STRUCTURE; SECRETION SYSTEM; NUCLEIC-ACIDS	In prototypic Escherichia coli K-12 the introduction of disulfide bonds into folding proteins is mediated by the Dsb family of enzymes, primarily through the actions of the highly oxidizing protein EcDsbA. Homologues of the Dsb catalysts are found in most bacteria. Interestingly, pathogens have developed distinct Dsb machineries that play a pivotal role in the biogenesis of virulence factors, hence contributing to their pathogenicity. Salmonella enterica serovar (sv.) Typhimurium encodes an extended number of sulfhydryl oxidases, namely SeDsbA, SeDsbL, and SeSrgA. Here we report a comprehensive analysis of the sv. Typhimurium thiol oxidative system through the structural and functional characterization of the three Salmonella DsbA paralogues. The three proteins share low sequence identity, which results in several unique three-dimensional characteristics, principally in areas involved in substrate binding and disulfide catalysis. Furthermore, the Salmonella DsbA-like proteins also have different redox properties. Whereas functional characterization revealed some degree of redundancy, the properties of SeDsbA, SeDsbL, and SeSrgA and their expression pattern in sv. Typhimurium indicate a diverse role for these enzymes in virulence.	[Heras, Begona; Jarrott, Russell; Shouldice, Stephen R.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Totsika, Makrina; Achard, Maud E. S.; Wells, Timothy J.; Argente, M. Pilar; McEwan, Alastair G.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Guncar, Gregor] Jozef Stefan Inst, Ljubljana 1000, Slovenia	University of Queensland; University of Queensland; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Heras, B (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80, Brisbane, Qld 4072, Australia.	b.heras@imb.uq.edu.au	Heras, Begona/H-8686-2014; Schembri, Mark A/C-7262-2009; Totsika, Makrina/A-8993-2011; Wells, Timothy/AAG-3311-2021; Wells, Timothy/M-2025-2016	Heras, Begona/0000-0003-3469-7988; Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Guncar, Gregor/0000-0003-4500-6951; Wells, Timothy/0000-0001-7766-5404; Jarrott, Russell/0000-0003-4326-1203; McEwan, Alastair/0000-0002-2419-1003	Australian Research Council; Australian National Health and Medical Research Council; University of Queensland; Australian Synchrotron	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Australian Synchrotron	This work was supported in part by the Australian Research Council (to B. H., M. A. S., and A. G. M.), the Australian National Health and Medical Research Council (to B. H., M. A. S., and A. G. M.), and the University of Queensland (Postdoctoral Fellowship, to S. R. S.).; We thank Professor Jenny Martin for support and advice. We acknowledge use of the Australian Synchrotron and the support of PX1 3BM1 beamline scientists Julian Adams and Tom Caradoc-Davies. We thank Karl Byriel and Gordon King for support and access to the University of Queensland (UQ) ROCX Diffraction facility. We thank David Low for providing the anti-PefA polyclonal serum.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W.L., 2002, DELANO SCI; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jarrott R, 2010, ACTA CRYSTALLOGR F, V66, P601, DOI 10.1107/S1744309110011942; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kankwatira AM, 2004, TROP DOCT, V34, P198, DOI 10.1177/004947550403400404; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Turcot I, 2001, CAN J MICROBIOL, V47, P711, DOI 10.1139/cjm-47-8-711; Vivian JP, 2008, J BIOL CHEM, V283, P32452, DOI 10.1074/jbc.M803990200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yun HJ, 2001, MICROBIOL IMMUNOL, V45, P673, DOI 10.1111/j.1348-0421.2001.tb01301.x; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	50	41	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18423	18432		10.1074/jbc.M110.101360	http://dx.doi.org/10.1074/jbc.M110.101360			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20233716	hybrid, Green Published			2022-12-25	WOS:000278453900036
J	Bolos, M; Fernandez, S; Torres-Aleman, I				Bolos, Marta; Fernandez, Silvia; Torres-Aleman, Ignacio			Oral Administration of a GSK3 Inhibitor Increases Brain Insulin-like Growth Factor I Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BINDING-PROTEINS; ALZHEIMERS-DISEASE; CHOROID-PLEXUS; CEREBROSPINAL-FLUID; MESSENGER-RNA; RAT-BRAIN; SERUM; MEGALIN; EXPRESSION; RECEPTORS	Reduced brain input of serum insulin-like growth factor I (IGF-I), a potent neurotrophic peptide, may be associated with neurodegenerative processes. Thus, analysis of the mechanisms involved in passage of blood-borne IGF-I into the brain may shed light onto pathological mechanisms in neurodegeneration and provide new drug targets. A site of entrance of serum IGF-I into the brain is the choroid plexus. The transport mechanism for IGF-I in this specialized epithelium involves the IGF-I receptor and the membrane multicargo transporter megalin/LRP2. We have now analyzed this process in greater detail and found that the IGF-I receptor interacts with the transmembrane region of megalin, whereas the perimembrane domain of megalin is required for IGF-I internalization. Furthermore, a GSK3 site within the Src homology 3 domain of the C-terminal region of megalin is a key regulator of IGF-I transport. Thus, inhibition of GSK3 markedly increased internalization of IGF-I, whereas mutation of this GSK3 site abrogated this increase. Notably, oral administration of a GSK3 inhibitor to adult wild-type mice or to amyloid precursor protein/presenilin 1 mice modeling Alzheimer amyloidosis significantly increased brain IGF-I content. These results indicate that pharmacological modulation of IGF-I transport by megalin may be used to increase brain availability of serum IGF-I. Interestingly, GSK3 inhibitors such as those under development to treat Alzheimer disease may show therapeutic efficacy in part by increasing brain IGF-I levels, an effect already reported for other neuroprotective compounds.	[Torres-Aleman, Ignacio] CSIC, Inst Cajal, E-28002 Madrid, Spain; Ciberned, Madrid 28002, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Torres-Aleman, I (corresponding author), CSIC, Inst Cajal, Avda Dr Arce 37, E-28002 Madrid, Spain.	torres@cajal.csic.es	Fernandez, Silvia/Z-4848-2019; Bolos Jurado, Marta/J-7620-2014; Torres-Aleman, Ignacio/A-1613-2008	Bolos Jurado, Marta/0000-0003-2652-8607; Torres-Aleman, Ignacio/0000-0001-8107-7947	Comunidad Autonoma de Madrid (Neurodegs consortium); Ciberned	Comunidad Autonoma de Madrid (Neurodegs consortium)(Comunidad de Madrid); Ciberned(Instituto de Salud Carlos III)	This work was supported by Comunidad Autonoma de Madrid (Neurodegs consortium) and Ciberned.	Armstrong CS, 2000, J NEUROSCI RES, V59, P649, DOI 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR8>3.0.CO;2-W; Barth JL, 2001, TRENDS CARDIOVAS MED, V11, P26, DOI 10.1016/S1050-1738(01)00080-9; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carro E, 2000, J NEUROSCI, V20, P2926; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carro Eva, 2006, Keio Journal of Medicine, V55, P59, DOI 10.2302/kjm.55.59; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Chun JT, 1999, EXP NEUROL, V157, P194, DOI 10.1006/exnr.1999.7052; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DAVIDSON DA, 1990, J HISTOCHEM CYTOCHEM, V38, P1289, DOI 10.1177/38.9.2167329; Davila D, 2007, FRONT BIOSCI-LANDMRK, V12, P3194, DOI 10.2741/2306; Eliakim A, 1997, AM J PHYSIOL-REG I, V273, pR1557, DOI 10.1152/ajpregu.1997.273.4.R1557; GEARY ES, 1989, HORM METAB RES, V21, P1, DOI 10.1055/s-2007-1009135; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Larsson M, 2003, BIOCHEM J, V373, P381, DOI 10.1042/BJ20021958; Martinez A, 2008, J ALZHEIMERS DIS, V15, P181; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Obermayr RP, 2005, EXP GERONTOL, V40, P157, DOI 10.1016/j.exger.2004.11.001; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salehi Z, 2008, BIOFACTORS, V33, P99, DOI 10.1002/biof.5520330202; Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	34	29	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17693	17700		10.1074/jbc.M109.096594	http://dx.doi.org/10.1074/jbc.M109.096594			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351102	Green Published, hybrid			2022-12-25	WOS:000278133400047
J	Honaker, Y; Piwnica-Worms, H				Honaker, Y.; Piwnica-Worms, H.			Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction	ONCOGENE			English	Article						cell cycle; Chk1; beta-TrCP; ubiquitin	BETA-TRCP; S-PHASE; DNA-DAMAGE; MEDIATED DEGRADATION; PHOSPHATASE; PHOSPHORYLATION; CHECKPOINT; INHIBITOR; TRANSITION; PATHWAY	The Cdc25A protein phosphatase drives cell-cycle transitions by activating cyclin-dependent protein kinases. Failure to regulate Cdc25A leads to deregulated cell-cycle progression, bypass of cell-cycle checkpoints and genome instability. Ubiquitin-mediated proteolysis has an important role in balancing Cdc25A levels. Cdc25A contains a DS(82)G motif whose phosphorylation is targeted by beta-TrCP E3 ligase during interphase. Targeting beta-TrCP to Cdc25A requires phosphorylation of serines 79 (S79) and 82 (S82). Here, we report that casein kinase 1 alpha (CK1 alpha) phosphorylates Cdc25A on both S79 and S82 in a hierarchical manner requiring prior phosphorylation of S76 by Chk1 or GSK-3 beta. This facilitates beta-TrCP binding and ubiquitin-mediated proteolysis of Cdc25A throughout interphase and after exposure to genotoxic stress. The priming of Cdc25A by at least three kinases (Chk1, GSK-3 beta, CK1 alpha), some of which also require priming, ensures diverse extra- and intracellular signals interface with Cdc25A to precisely control cell division. Oncogene (2010) 29, 3324-3334; doi:10.1038/onc.2010.96; published online 29 March 2010	[Honaker, Y.; Piwnica-Worms, H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, H.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Piwnica-Worms, H.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Piwnica-Worms, H (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	hpiwnica@cellbiology.wustl.edu	Piwnica-Worms, Helen/C-5214-2012		National Institutes of Health [GM047017, P50 CA94056]; NCI Cancer Center [P30 CA91842]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P50CA094056, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Van Leung-Pineda and Dr Tiebang Kang for helpful suggestions. We also thank Chris Ryan for editorial assistance. We thank Chris Ryan, Yonghao Hou, Mei-Shya Chen, Dr Jiandong Chen and Dr Binhua P Zhou for providing expression plasmids. This work was supported by grants from the National Institutes of Health (GM047017 and P50 CA94056). We acknowledge the p50 Molecular Imaging Center and the Alvin J. Siteman Cancer Center at Washington University School of Medicine for the use of the High Throughput Core. The Siteman Cancer Center was supported in part by an NCI Cancer Center Support Grant No. P30 CA91842. H.P.-W. is an Investigator of the Howard Hughes Medical Institute.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Donzelli M, 2004, CELL CYCLE, V3, P469; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ray D, 2005, MOL CELL BIOL, V25, P3338, DOI 10.1128/MCB.25.8.3338-3347.2005; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	38	42	45	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2010	29	23					3324	3334		10.1038/onc.2010.96	http://dx.doi.org/10.1038/onc.2010.96			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20348946	Green Accepted			2022-12-25	WOS:000278622700002
J	Ladner, CL; Chen, M; Smith, DP; Platt, GW; Radford, SE; Langen, R				Ladner, Carol L.; Chen, Min; Smith, David P.; Platt, Geoffrey W.; Radford, Sheena E.; Langen, Ralf			Stacked Sets of Parallel, In-register beta-Strands of beta(2)-Microglobulin in Amyloid Fibrils Revealed by Site-directed Spin Labeling and Chemical Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; HUMAN PRION PROTEIN; DISULFIDE BOND; LIMITED PROTEOLYSIS; ALPHA-SYNUCLEIN; HIGH-PRESSURE; H/D-EXCHANGE; SIDE-CHAINS; BETA-2-MICROGLOBULIN; VITRO	beta(2)-microglobulin (beta 2m) is a 99-residue protein with an immunoglobulin fold that forms beta-sheet-rich amyloid fibrils in dialysis-related amyloidosis. Here the environment and accessibility of side chains within amyloid fibrils formed in vitro from beta(2)m with a long straight morphology are probed by site-directed spin labeling and accessibility to modification with N-ethyl maleimide using 19 site-specific cysteine variants. Continuous wave electron paramagnetic resonance spectroscopy of these fibrils reveals a core predominantly organized in a parallel, in-register arrangement, by contrast with other beta(2)m aggregates. A continuous array of parallel, in-register beta-strands involving most of the polypeptide sequence is inconsistent with the cryo-electron microscopy structure, which reveals an architecture based on subunit repeats. To reconcile these data, the number of spins in close proximity required to give rise to spin exchange was determined. Systematic studies of a model protein system indicated that juxtaposition of four spin labels is sufficient to generate exchange narrowing. Combined with information about side-chain mobility and accessibility, we propose that the amyloid fibrils of beta(2)m consist of about six beta(2)m monomers organized in stacks with a parallel, in-register array. The results suggest an organization more complex than the accordion-like beta-sandwich structure commonly proposed for amyloid fibrils.	[Ladner, Carol L.; Smith, David P.; Platt, Geoffrey W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Chen, Min; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	University of Leeds; University of Southern California	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk; langen@usc.edu	Platt, Geoffrey/D-2416-2013	Ladner-Keay, Carol/0000-0003-0273-713X; Radford, Sheena/0000-0002-3079-8039; Smith, David/0000-0001-5177-8574; Platt, Geoffrey/0000-0003-1754-0110	National Institutes of Health [AG027936]; Wellcome Trust [080859/B/06/Z, GR075675MA, WT069851MA]; Hillblom Foundation; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027936. This work was also supported by Wellcome Trust Grants 080859/B/06/Z, GR075675MA, and WT069851MA and the Hillblom Foundation.	Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Koteiche HA, 1998, BIOCHEMISTRY-US, V37, P12681, DOI 10.1021/bi9814078; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lietzow MA, 2004, BIOCHEMISTRY-US, V43, P3137, DOI 10.1021/bi0360962; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Platt GW, 2009, ANGEW CHEM INT EDIT, V48, P5705, DOI 10.1002/anie.200901343; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	54	48	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17137	17147		10.1074/jbc.M110.117234	http://dx.doi.org/10.1074/jbc.M110.117234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335170	Green Published, hybrid			2022-12-25	WOS:000277982600076
J	Nguyen, DT; Gopfert, JC; Ikezawa, N; MacNevin, G; Kathiresan, M; Conrad, J; Spring, O; Ro, DK				Nguyen, Don Trinh; Goepfert, Jens Christian; Ikezawa, Nobuhiro; MacNevin, Gillian; Kathiresan, Meena; Conrad, Juergen; Spring, Otmar; Ro, Dae-Kyun			Biochemical Conservation and Evolution of Germacrene A Oxidase in Asteraceae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPITATE GLANDULAR TRICHOMES; ANTIMALARIAL-DRUG PRECURSOR; KAPPA-B KINASE; SESQUITERPENE LACTONE; FUNCTIONAL-CHARACTERIZATION; BARNADESIOIDEAE ASTERACEAE; HETEROLOGOUS EXPRESSION; EUDESMANE DERIVATIVES; ARTEMISINIC ACID; CANCER CELLS	Sesquiterpene lactones are characteristic natural products in Asteraceae, which constitutes similar to 8% of all plant species. Despite their physiological and pharmaceutical importance, the biochemistry and evolution of sesquiterpene lactones remain unexplored. Here we show that germacrene A oxidase (GAO), evolutionarily conserved in all major subfamilies of Asteraceae, catalyzes three consecutive oxidations of germacrene A to yield germacrene A acid. Furthermore, it is also capable of oxidizing non-natural substrate amorphadiene. Co-expression of lettuce GAO with germacrene synthase in engineered yeast synthesized aberrant products, costic acids and ilicic acid, in an acidic condition. However, cultivation in a neutral condition allowed the de novo synthesis of a single novel compound that was identified as germacrene A acid by gas and liquid chromatography and NMR analyses. To trace the evolutionary lineage of GAO in Asteraceae, homologous genes were further isolated from the representative species of three major subfamilies of Asteraceae (sunflower, chicory, and costus from Asteroideae, Cichorioideae, and Carduoideae, respectively) and also from the phylogenetically basal species, Barnadesia spinosa, from Barnadesioideae. The recombinant GAOs from these genes clearly showed germacrene A oxidase activities, suggesting that GAO activity is widely conserved in Asteraceae including the basal lineage. All GAOs could catalyze the three-step oxidation of non-natural substrate amorphadiene to artemisinic acid, whereas amorphadiene oxidase diverged from GAO displayed negligible activity for germacrene A oxidation. The observed amorphadiene oxidase activity in GAOs suggests that the catalytic plasticity is embedded in ancestral GAO enzymes that may contribute to the chemical and catalytic diversity in nature.	[Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Goepfert, Jens Christian; Spring, Otmar] Univ Hohenheim, Inst Bot, D-70599 Stuttgart, Germany	University of Calgary; University Hohenheim	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Nguyen, Trinh-Don/0000-0002-2759-5791	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Canada Foundation for Innovation; German Research Foundation (Deutsche Forschungsgemeinschaft)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant, the Canada Research Chair program, and the Canada Foundation for Innovation (to D.-K.R.) and also by a German Research Foundation (Deutsche Forschungsgemeinschaft) grant (to O.S. and J.C.G.).	Abou-Douh AM, 2008, CHEM PHARM BULL, V56, P1535, DOI 10.1248/cpb.56.1535; ASAKAWA Y, 1981, PHYTOCHEMISTRY, V20, P257, DOI 10.1016/0031-9422(81)85102-3; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; BOHM BA, 1995, SYST BOT, V20, P22, DOI 10.2307/2419629; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Christensen SB, 1999, BIOORGAN MED CHEM, V7, P1273; CRONQUIST A, 1977, BRITTONIA, V29, P137, DOI 10.2307/2805847; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; de Kraker JW, 2001, PHYTOCHEMISTRY, V58, P481, DOI 10.1016/S0031-9422(01)00291-6; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Faraldos JA, 2007, TETRAHEDRON, V63, P7733, DOI 10.1016/j.tet.2007.04.037; FISCHER NH, 1990, RECENT ADV PHYTOCHEM, V24, P161; FURUYA Y, 1994, CANCER RES, V54, P6167; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hernandez V, 2001, PLANTA MED, V67, P726, DOI 10.1055/s-2001-18342; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KNOCHE H, 1969, SCIENCE, V166, P239, DOI 10.1126/science.166.3902.239; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Leon LG, 2009, BIOORGAN MED CHEM, V17, P6251, DOI 10.1016/j.bmc.2009.07.053; Mendiondo ME, 1997, BIOCHEM SYST ECOL, V25, P673, DOI 10.1016/S0305-1978(97)00060-4; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Pittayakhajonwut P, 2009, PLANTA MED, V75, P1431, DOI 10.1055/s-0029-1185698; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinson A, 2008, BIOORG MED CHEM LETT, V18, P4015, DOI 10.1016/j.bmcl.2008.06.008; Sessa RA, 2000, J BIOL CHEM, V275, P26877; SPRING O, 1991, MODERN PHYTOCHEMICAL, V25, P319; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; VIDARI G, 1976, PHYTOCHEMISTRY, V15, P1953, DOI 10.1016/S0031-9422(00)88853-6; Wesolowska A, 2006, J ETHNOPHARMACOL, V107, P254, DOI 10.1016/j.jep.2006.03.003; Zheng QX, 2003, J NAT PROD, V66, P1078, DOI 10.1021/np0205856; Zidorn C, 2008, PHYTOCHEMISTRY, V69, P2270, DOI 10.1016/j.phytochem.2008.06.013; [No title captured]	46	100	112	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16588	16598		10.1074/jbc.M110.111757	http://dx.doi.org/10.1074/jbc.M110.111757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351109	Green Published, hybrid			2022-12-25	WOS:000277982600022
J	Bernal-Bayard, J; Cardenal-Munoz, E; Ramos-Morales, F				Bernal-Bayard, Joaquin; Cardenal-Munoz, Elena; Ramos-Morales, Francisco			The Salmonella Type III Secretion Effector, Salmonella Leucine-rich Repeat Protein (SIrP), Targets the Human Chaperone ERdj3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; ANTIGEN PRESENTATION; PEPTIDE SUBSTRATE; SIGNAL SEQUENCES; DNAJ HOMOLOG; TYPHIMURIUM; HSP40; FAMILY	Effectors of the type III secretion systems (T3SS) are key elements in the interaction between many Gram-negative pathogens and their hosts. SlrP is an effector that is translocated into the eukaryotic host cell through the two virulence-associated T3SS of Salmonella enterica. We found previously that this effector is an E3 ubiquitin ligase for mammalian thioredoxin. Here, we identified ERdj3, an endoplasmic reticulum lumenal chaperone of the Hsp40/DnaJ family, as a new target for SlrP. Experiments with truncated forms of ERdj3 showed that domain II was essential for the interaction with SlrP. Confocal microscopy and subcellular fractionation demonstrated that, in transfected HeLa cells, SlrP was partially located in the endoplasmic reticulum. The presence of SlrP interfered with the binding of ERdj3 to a denatured substrate. Taken together, these data suggest that the role of SlrP in the interaction between Salmonella and the host cell is exerted through the modulation of the function of two independent targets: thioredoxin in the cytosol, and ERdj3 in the endoplasmic reticulum.	[Bernal-Bayard, Joaquin; Cardenal-Munoz, Elena; Ramos-Morales, Francisco] Univ Seville, Fac Biol, Dept Genet, E-41080 Seville, Spain	University of Sevilla	Ramos-Morales, F (corresponding author), Univ Seville, Fac Biol, Dept Genet, Avda Reina Mercedes 6, E-41012 Seville, Spain.	framos@us.es	Ramos-Morales, Francisco/C-5734-2008; Bayard, Joaquin Bernal/E-9836-2016; Cardenal-Munoz, Elena/J-5819-2019	Ramos-Morales, Francisco/0000-0002-1151-4547; Bayard, Joaquin Bernal/0000-0003-1199-3629; Cardenal-Munoz, Elena/0000-0003-4757-9323	Spanish Ministry of Science and Innovation [SAF2007-60738]; European Regional Development Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [P08-CVI-03487]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by Grants SAF2007-60738 from the Spanish Ministry of Science and Innovation and the European Regional Development Fund and P08-CVI-03487 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain.	Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HARPER JW, 1993, CELL, V75, P805; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Nakanishi K, 2004, CELL STRESS CHAPERON, V9, P253, DOI 10.1379/CSC-52.1; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Sherman F., 1986, METHODS YEAST GENETI; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Tobar JA, 2006, INFECT IMMUN, V74, P6438, DOI 10.1128/IAI.00063-06; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	41	53	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16360	16368		10.1074/jbc.M110.100669	http://dx.doi.org/10.1074/jbc.M110.100669			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335166	Green Published, hybrid			2022-12-25	WOS:000277715900072
J	Lin, YF; Xu, XS; Cape, A; Li, SH; Li, XJ				Lin, Yung-Feng; Xu, Xingshun; Cape, Austin; Li, Shihua; Li, Xiao-Jiang			Huntingtin-associated Protein-1 Deficiency in Orexin-producing Neurons Impairs Neuronal Process Extension and Leads to Abnormal Behavior in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; JOUBERT-SYNDROME; FEEDING-BEHAVIOR; AXONAL-TRANSPORT; HYPOCRETIN; SLEEP; BRAIN; HAP1; AHI1; INTERACTS	Huntingtin-associated protein-1 (Hap1) is a neuronal protein that associates with huntingtin, the Huntington disease protein. Although Hap1 and huntingtin are known to be involved in intracellular trafficking, whether and how the impairment of Hap1-associated trafficking leads to neurological pathology and symptoms remain to be seen. As Hap1 is enriched in neuronal cells in the brain, addressing this issue is important in defining the role of defective intracellular trafficking in the selective neuropathology associated with Hap1 dysfunction. Here, we find that Hap1 is abundantly expressed in orexin (hypocretin)-producing neurons (orexin neurons), which are distinctly distributed in the hypothalamus and play an important role in the regulation of feeding and behavior. We created conditional Hap1 knock-out mice to selectively deplete Hap1 in orexin neurons via the Cre-loxP system. These mice show process fragmentation of orexin neurons and reductions in food intake, body weight, and locomotor activity. Sucrose density gradient fractionation reveals that loss of Hap1 in the mouse brain also reduces the distribution of trafficking protein complexes and cargo proteins in the fractions that are enriched in synaptosomes. These results suggest that Hap1 is critical for the transport of multiple proteins to the nerve terminals to maintain the integrity of neuronal processes and that selective disruption of the processes of orexin neurons can cause abnormal feeding and locomotor activity.	[Lin, Yung-Feng; Xu, Xingshun; Cape, Austin; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu	Xu, Xingshun/AAF-8183-2020; Lin, Yung-Feng/H-3289-2019	Xu, Xingshun/0000-0003-0205-6342	National Institutes of Health [NS036232, NS045016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS036232 (to X.-J.L.) and NS045016 (to S. L.).	Akimoto-Takano S, 2005, NEUROENDOCRINOLOGY, V82, P256, DOI 10.1159/000092754; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Kirouac GJ, 2005, BRAIN RES, V1059, P179, DOI 10.1016/j.brainres.2005.08.035; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kotz CM, 2005, AM J PHYSIOL-REG I, V289, pR359, DOI 10.1152/ajpregu.00717.2004; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Peyron C, 1998, J NEUROSCI, V18, P9996; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sawai N, 2010, NEUROSCI LETT, V468, P51, DOI 10.1016/j.neulet.2009.10.061; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Uldry M, 2004, EMBO J, V23, P531, DOI 10.1038/sj.emboj.7600072; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamamoto Y, 2000, MOL BRAIN RES, V78, P108, DOI 10.1016/S0169-328X(00)00080-2; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003	41	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15941	15949		10.1074/jbc.M110.107318	http://dx.doi.org/10.1074/jbc.M110.107318			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304926	hybrid, Green Published			2022-12-25	WOS:000277715900031
J	Svensson, SL; Pasupuleti, M; Walse, B; Malmsten, M; Morgelin, M; Sjogren, C; Olin, AI; Collin, M; Schmidtchen, A; Palmer, R; Egesten, A				Svensson, Sara L.; Pasupuleti, Mukesh; Walse, Bjorn; Malmsten, Martin; Morgelin, Matthias; Sjogren, Camilla; Olin, Anders I.; Collin, Mattias; Schmidtchen, Artur; Palmer, Ruth; Egesten, Arne			Midkine and Pleiotrophin Have Bactericidal Properties PRESERVED ANTIBACTERIAL ACTIVITY IN A FAMILY OF HEPARIN-BINDING GROWTH FACTORS DURING EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; EPITHELIAL-CELLS; EXPRESSION; GENE; PROTEIN; CHEMOKINES; CYTOKINE; IMMUNITY; PURIFICATION	Antibacterial peptides of the innate immune system combat pathogenic microbes, but often have additional roles in promoting inflammation and as growth factors during tissue repair. Midkine (MK) and pleiotrophin (PTN) are the only two members of a family of heparin-binding growth factors. They show restricted expression during embryogenesis and are up-regulated in neoplasia. In addition, MK shows constitutive and inflammation-dependent expression in some non-transformed tissues of the adult. In the present study, we show that both MK and PTN display strong antibacterial activity, present at physiological salt concentrations. Electron microscopy of bacteria and experiments using artificial lipid bilayers suggest that MK and PTN exert their antibacterial action via a membrane disruption mechanism. The predicted structure of PTN, employing the previously solved MK structure as a template, indicates that both molecules consist of two domains, each containing three antiparallel beta-sheets. The antibacterial activity was mapped to the unordered C-terminal tails of both molecules and the last beta-sheets of the N-terminals. Analysis of the highly conserved MK and PTN orthologues from the amphibian Xenopus laevis and the fish Danio rerio suggests that they also harbor antibacterial activity in the corresponding domains. In support of an evolutionary conserved function it was found that the more distant orthologue, insect Miple2 from Drosophila melanogaster, also displays strong antibacterial activity. Taken together, the findings suggest that MK and PTN, in addition to their earlier described activities, may have previously unrealized important roles as innate antibiotics.	[Svensson, Sara L.; Olin, Anders I.; Egesten, Arne] Lund Univ, Univ Hosp, Sect Resp Med & Allergol, SE-22185 Lund, Sweden; [Pasupuleti, Mukesh; Schmidtchen, Artur] Lund Univ, Univ Hosp, Dermatol Sect, SE-22185 Lund, Sweden; [Morgelin, Matthias; Olin, Anders I.; Collin, Mattias] Lund Univ, Univ Hosp, Sect Infect Med, Dept Clin Sci Lund, SE-22185 Lund, Sweden; [Walse, Bjorn] SARom AB, SE-22007 Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Sjogren, Camilla; Palmer, Ruth] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Uppsala University; Umea University	Egesten, A (corresponding author), BMC B14,Tornavagen 10, SE-22184 Lund, Sweden.	arne.egesten@med.lu.se	Nordin, Sara/G-5361-2011; Collin, Mattias/C-6398-2009; Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015; Pasupuleti, Mukesh/AAF-4066-2020	Collin, Mattias/0000-0002-6166-7410; Pasupuleti, Mukesh/0000-0001-6337-6257; Walse, Bjorn/0000-0003-1513-9040	Swedish Research Council [20674]; Swedish Heart and Lung Foundation [20080246]; Medical Faculty at Lund University; Swedish Government Funds for Clinical Research; Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty at Lund University; Swedish Government Funds for Clinical Research; Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund	This work was supported by grants from the Swedish Research Council (Project 20674), the Swedish Heart and Lung Foundation (Project 20080246), the Medical Faculty at Lund University, Swedish Government Funds for Clinical Research (ALF), and the Foundations of Bergh, Crafoord, Ihre, Hedberg, Kock, Marianne & Marcus Wallenberg, and Osterlund.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Englund C, 2006, DEV GENES EVOL, V216, P10, DOI 10.1007/s00427-005-0025-8; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FABRI L, 1993, J CHROMATOGR, V646, P213, DOI 10.1016/S0021-9673(99)87023-X; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Keates S, 2007, J IMMUNOL, V178, P8013, DOI 10.4049/jimmunol.178.12.8013; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; KOJIMA S, 1995, BIOCHEM BIOPH RES CO, V206, P468, DOI 10.1006/bbrc.1995.1066; Krishnakumari V, 2008, PEPTIDES, V29, P7, DOI 10.1016/j.peptides.2007.10.015; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P208, DOI 10.1002/ibd.21011; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Lucas S, 2010, PEDIATR INT, V52, P75, DOI 10.1111/j.1442-200X.2009.02885.x; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; MURPHY CJ, 1993, J CELL PHYSIOL, V155, P408, DOI 10.1002/jcp.1041550223; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; SEKIGUCHI K, 1995, J BIOCHEM-TOKYO, V118, P94, DOI 10.1093/oxfordjournals.jbchem.a124898; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; TSUTSUI J, 1993, CANCER RES, V53, P1281; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Yan WK, 2010, PROTEIN EXPRES PURIF, V70, P270, DOI 10.1016/j.pep.2009.10.015; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yoshida Y, 2008, INTERNAL MED, V47, P83, DOI 10.2169/internalmedicine.47.0260; You ZB, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-6; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	59	39	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16105	16115		10.1074/jbc.M109.081232	http://dx.doi.org/10.1074/jbc.M109.081232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308059	Green Published, hybrid			2022-12-25	WOS:000277715900048
J	Miwa, N; Ogawa, M; Shinmyo, Y; Hiraoka, Y; Takamatsu, K; Kawamura, S				Miwa, Naofumi; Ogawa, Motoyuki; Shinmyo, Yukiko; Hiraoka, Yoshiki; Takamatsu, Ken; Kawamura, Satoru			Dicalcin Inhibits Fertilization through Its Binding to a Glycoprotein in the Egg Envelope in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; ZONA-PELLUCIDA; SPERM BINDING; VITELLINE ENVELOPE; MOUSE SPERM; PROTEIN; IDENTIFICATION; OOCYTES; P26OLF; CLONING	Fertilization comprises oligosaccharide-mediated sperm-egg interactions, including sperm binding to an extracellular egg envelope, sperm penetration through the envelope, and fusion with an egg plasma membrane. We show that Xenopus dicalcin, an S100-like Ca2+-binding protein, present in the extracellular egg envelope (vitelline envelope (VE)), is a suppressive mediator of sperm-egg interaction. Preincubation with specific antibody greatly increased the efficiency of in vitro fertilization, whereas prior application of exogenous dicalcin substantially inhibited fertilization as well as sperm binding to an egg and in vitro sperm penetration through the VE protein layer. Dicalcin showed binding to protein cores of gp41 and gp37, constituents of VE, in a Ca2+-dependent manner and increased in vivo reactivity of VE with a lectin, Ricinus communis agglutinin I, which was accounted for by increased binding ability of gp41 to the lectin and greater exposure of gp41 to an external environment. Our findings strongly suggest that dicalcin regulates the distribution of oligosaccharides within the VE through its binding to the protein core of gp41, probably by modulating configuration of oligosaccharides on gp41 and the three-dimensional structure of VE framework, and thereby plays a pivotal role in sperm-egg interactions during fertilization.	Toho Univ, Sch Med, Dept Physiol, Ohta Ku, Tokyo 1438540, Japan; [Ogawa, Motoyuki] Kitasato Univ, Sch Med, Dept Med Educ, Kanagawa 2288555, Japan; [Shinmyo, Yukiko; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hiraoka, Yoshiki] Keio Univ, Sch Med, Dept Anat, Shinjyuku Ku, Tokyo 1600016, Japan	Kitasato University; Osaka University; Keio University		nmiwa@med.toho-u.ac.jp			Japan Society for the Promotion of Science; Toho University School of Medicine; Grants-in-Aid for Scientific Research [22590213] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University School of Medicine(Toho University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (to N. M. and S. K.) and by the Project Research of Toho University School of Medicine (to N. M.).	Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; BERTRAND E, 1995, HUM REPROD, V10, P1189, DOI 10.1093/oxfordjournals.humrep.a136116; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; David G, 1997, J PHYSIOL-LONDON, V504, P83, DOI 10.1111/j.1469-7793.1997.083bf.x; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Kubo H, 1997, DEV GROWTH DIFFER, V39, P405; LARABELL CA, 1988, CELL TISSUE RES, V251, P129, DOI 10.1007/BF00215457; LINDSAY LL, 1989, DEV BIOL, V135, P202, DOI 10.1016/0012-1606(89)90170-X; LINDSAY LL, 1988, J EXP ZOOL, V245, P286, DOI 10.1002/jez.1402450309; Litscher ES, 2007, HISTOL HISTOPATHOL, V22, P337, DOI 10.14670/HH-22.337; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Miwa N, 1998, BIOCHEM BIOPH RES CO, V251, P860, DOI 10.1006/bbrc.1998.9571; Miwa N, 2001, EUR J BIOCHEM, V268, P6029, DOI 10.1046/j.0014-2956.2001.02511.x; Miwa N, 2000, J BIOL CHEM, V275, P27245; Miwa N, 2007, DNA SEQUENCE, V18, P400, DOI 10.1080/10425170701241470; Mori E, 1997, BIOCHEM BIOPH RES CO, V238, P95, DOI 10.1006/bbrc.1997.7249; OIKAWA T, 1973, NATURE, V241, P256, DOI 10.1038/241256a0; Pramanik A, 2001, SPRINGER SERIES CHEM, V65, P101; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICHTER HP, 1980, CELL BIOL INT REP, V4, P985, DOI 10.1016/0309-1651(80)90171-X; Talevi R, 1997, HUM REPROD, V12, P2773, DOI 10.1093/humrep/12.12.2773; Tian JD, 1997, J CELL BIOL, V136, P1099, DOI 10.1083/jcb.136.5.1099; Uebi T, 2007, FEBS J, V274, P4863, DOI 10.1111/j.1742-4658.2007.06007.x; Vo LH, 2003, BIOL REPROD, V69, P1822, DOI 10.1095/biolreprod.103.015370; Vo LH, 2000, BIOL REPROD, V62, P766, DOI 10.1095/biolreprod62.3.766; WOLF DP, 1976, BIOCHEMISTRY-US, V15, P3671, DOI 10.1021/bi00662a005; Yanagimachi R., 1994, P189	36	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15627	15636		10.1074/jbc.M109.079483	http://dx.doi.org/10.1074/jbc.M109.079483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299459	hybrid, Green Published			2022-12-25	WOS:000277399000081
J	Dickinson, GD; Churchill, GC; Brailoiu, E; Patel, S				Dickinson, George D.; Churchill, Grant C.; Brailoiu, Eugen; Patel, Sandip			Deviant Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Ca2+ Signaling upon Lysosome Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-MOBILIZING MESSENGER; CALCIUM; NAADP; STORES; RELEASE; MEGANEURITES; INHIBITORS; ORGANELLES; BETA	Accumulating evidence suggests that the endolysosomal system is a novel intracellular Ca2+ pool mobilized by the second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). Although lysosomes in neurons are known to proliferate in numerous neurodegenerative diseases and during the normal course of aging, little is known concerning the effect of lysosomal proliferation on Ca2+ homeostasis. Here, we induce proliferation of lysosomes in primary cultures of rat hippocampal neurons and PC12 cells through chronic treatment with the cathepsin inhibitor, Z-Phe-Ala-diazomethylketone. We demonstrate that lysosome proliferation increases the size of the lysosomal Ca2+ pool and enhances Ca2+ signals in response to direct cellular delivery of NAADP and glutamate, an identified NAADP-producing agonist. Our data suggest that deregulated lysosomal Ca2+ signaling through NAADP may contribute to neuronal dysfunction and highlight the usefulness of lysosomal hydrolase inhibition in probing NAADP action.	[Dickinson, George D.; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of London; University College London; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Dickinson, George/H-6609-2016; Dickinson, George/D-1461-2009; Patel, Sandip/O-9591-2015	Dickinson, George/0000-0001-7711-0388; Dickinson, George/0000-0001-7711-0388; Patel, Sandip/0000-0001-7247-2013	Alzheimer's Research Trust, Research into Ageing; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/D012694/1]; BBSRC [BB/D012694/1, BB/G008523/1, BB/G013721/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish	Alzheimer's Research Trust, Research into Ageing; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Alzheimer's Research Trust, Research into Ageing, and the Biotechnology and Biological Sciences Research Council (Grant BB/G013721/1 to S. P. and Grant BB/D012694/1 to G. C. C.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Bednarski E, 1997, J NEUROSCI, V17, P4006; BERG TO, 1994, EUR J BIOCHEM, V221, P595, DOI 10.1111/j.1432-1033.1994.tb18771.x; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bi XN, 1999, EXP NEUROL, V158, P312, DOI 10.1006/exnr.1999.7087; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2003, BIOCHEM J, V373, P313, DOI 10.1042/BJ20030472; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Holtzman E, 1989, LYSOSOMES; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; IVY GO, 1992, ANN NY ACAD SCI, V674, P89, DOI 10.1111/j.1749-6632.1992.tb27479.x; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lynch G, 2003, NEUROCHEM RES, V28, P1725, DOI 10.1023/A:1026069223763; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2004, BIOL CELL, V96, P19, DOI 10.1016/j.biolcel.2003.12.001; Saftig Paul, 2005, P37; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yong AP, 1999, EXP NEUROL, V157, P150, DOI 10.1006/exnr.1999.7038	41	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13321	13325		10.1074/jbc.C110.112573	http://dx.doi.org/10.1074/jbc.C110.112573			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20231291	Green Published, hybrid			2022-12-25	WOS:000276987700002
J	Barnett, DJ; Levine, R; Thompson, CB; Wijetunge, GU; Oliver, AL; Bentley, MA; Neubert, PD; Pirrallo, RG; Links, JM; Balicer, RD				Barnett, Daniel J.; Levine, Roger; Thompson, Carol B.; Wijetunge, Gamunu U.; Oliver, Anthony L.; Bentley, Melissa A.; Neubert, Patrick D.; Pirrallo, Ronald G.; Links, Jonathan M.; Balicer, Ran D.			Gauging US Emergency Medical Services Workers' Willingness to Respond to Pandemic Influenza Using a Threat- and Efficacy-Based Assessment Framework	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PUBLIC-HEALTH; PREPAREDNESS; DUTY; WILL	Background: Emergency Medical Services workers' willingness to report to duty in an influenza pandemic is essential to healthcare system surge amidst a global threat. Application of Witte's Extended Parallel Process Model (EPPM) has shown utility for revealing influences of perceived threat and efficacy on non-EMS public health providers' willingness to respond in an influenza pandemic. We thus propose using an EPPM-informed assessment of EMS workers' perspectives toward fulfilling their influenza pandemic response roles. Methodology/Principal Findings: We administered an EPPM-informed snapshot survey about attitudes and beliefs toward pandemic influenza response, to a nationally representative, stratified random sample of 1,537 U. S. EMS workers from May-June 2009 (overall response rate: 49%). Of the 586 respondents who met inclusion criteria (currently active EMS providers in primarily EMS response roles), 12% indicated they would not voluntarily report to duty in a pandemic influenza emergency if asked, 7% if required. A majority (52%) indicated their unwillingness to report to work if risk of disease transmission to family existed. Confidence in personal safety at work (OR = 3.3) and a high threat/high efficacy ("concerned and confident'') EPPM profile (OR = 4.7) distinguished those who were more likely to voluntarily report to duty. Although 96% of EMS workers indicated that they would probably or definitely report to work if they were guaranteed a pandemic influenza vaccine, only 59% had received an influenza immunization in the preceding 12 months. Conclusions/Significance: EMS workers' response willingness gaps pose a substantial challenge to prehospital surge capacity in an influenza pandemic. "Concerned and confident'' EMS workers are more than four times as likely to fulfill pandemic influenza response expectations. Confidence in workplace safety is a positively influential modifier of their response willingness. These findings can inform insights into interventions for enhancing EMS workers' willingness to respond in the face of a global infectious disease threat.	[Barnett, Daniel J.; Links, Jonathan M.] Johns Hopkins Preparedness & Emergency Response R, Baltimore, MD USA; [Barnett, Daniel J.; Links, Jonathan M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Levine, Roger] Amer Inst Res, San Mateo, CA USA; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Wijetunge, Gamunu U.; Oliver, Anthony L.; Neubert, Patrick D.] US Dept Transportat, Off Emergency Med Serv, Natl Highway Traff Safety Adm, Washington, DC USA; [Oliver, Anthony L.; Neubert, Patrick D.] Assoc Sch Publ Hlth, Washington, DC USA; [Bentley, Melissa A.] Natl Registry Emergency Med Technicians, Columbus, OH USA; [Pirrallo, Ronald G.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Pirrallo, Ronald G.] Milwaukee Cty Emergency Med Serv, Milwaukee Cty, WI USA; [Balicer, Ran D.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; American Institutes for Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical College of Wisconsin; Ben Gurion University	Barnett, DJ (corresponding author), Johns Hopkins Preparedness & Emergency Response R, Baltimore, MD USA.	dbarnett@jhsph.edu		Oliver, Anthony/0000-0002-7968-5975; Barnett, Daniel/0000-0003-1382-6197; Pirrallo, Ronald/0000-0002-8321-3866	Preparedness & Emergency Response Research Center [1P01tP00288-01, 104264]	Preparedness & Emergency Response Research Center	Preparedness & Emergency Response Research Center (PERRC)[CDC/Grant# 1P01tP00288-01; Grant# 104264]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99; Barnett DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006365; BISH A, 2010, BR J HLTH PSYCHOL; Brown William E Jr, 2002, Prehosp Emerg Care, V6, P433, DOI 10.1080/10903120290938085; Chaffee Mary, 2009, Disaster Med Public Health Prep, V3, P42, DOI 10.1097/DMP.0b013e31818e8934; Cone David C, 2006, Am J Disaster Med, V1, P28; Cowan AE, 2005, BIOSECUR BIOTERROR, V3, P16, DOI 10.1089/bsp.2005.3.16; Damery S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-142; Dawson Drew E, 2003, Prehosp Emerg Care, V7, P114, DOI 10.1080/10903120390937210; DiMaggio C, 2005, BIOSECUR BIOTERROR, V3, P331, DOI 10.1089/bsp.2005.3.331; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Ehrenstein BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-311; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; *I MED, 2007, EM MED SERV CROSSR, P1; *I MED, 2008, RES PRIOR EM PREP RE, P1; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Katz AR, 2006, J AM DENT ASSOC, V137, P461, DOI 10.14219/jada.archive.2006.0217; National Highway Traffic Safety Administration, 2007, NAT EMS SCOP PRACT M; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Reilly MJ, 2007, PREHOSP DISASTER MED, V22, P297, DOI 10.1017/S1049023X00004908; SHAPIRA Y, 1991, ISRAEL J MED SCI, V27, P704; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Slovic P., 1985, PERILOUS PROGR MANAG, P91; *WHO, 2009, PREP 2 WAV LESS CURR; *WHO, 2009, INFL A H1N1 UPD 29; WHO (World Health Organization), 2009, CLIN FEAT SEV CAS PA; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; World Health Organization, 2009, INFL A H1N1 STAT WHO	31	44	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9856	10.1371/journal.pone.0009856	http://dx.doi.org/10.1371/journal.pone.0009856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FT	20352050	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894500022
J	Kim, K; Kim, KH; Cheong, J				Kim, KyeongJin; Kim, Kook Hwan; Cheong, JaeHun			Hepatitis B Virus X Protein Impairs Hepatic Insulin Signaling Through Degradation of IRS1 and Induction of SOCS3	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; FATTY LIVER; IN-VIVO; RESISTANCE; INFECTION; RECEPTOR; PATHWAYS; INFLAMMATION	Background: Hepatitis B virus (HBV) is a major cause of chronic liver diseases, and frequently results in hepatitis, cirrhosis, and ultimately hepatocellular carcinoma. The role of HCV in associations with insulin signaling has been elucidated. However, the pathogenesis of HBV-associated insulin signaling remains to be clearly characterized. Therefore, we have attempted to determine the mechanisms underlying the HBV-associated impairment of insulin signaling. Methodology: The expressions of insulin signaling components were investigated in HBx-transgenic mice, HBx-constitutive expressing cells, and transiently HBx-transfected cells. Protein and gene expression was examined by Western blot, immunohistochemistry, RT-PCR, and promoter assay. Protein-protein interaction was detected by coimmunoprecipitation. Principal Findings: HBx induced a reduction in the expression of IRS1, and a potent proteasomal inhibitor blocked the downregulation of IRS1. Additionally, HBx enhanced the expression of SOCS3 and induced IRS1 ubiquitination. Also, C/EBP alpha and STAT3 were involved in the HBx-induced expression of SOCS3. HBx interfered with insulin signaling activation and recovered the insulin-mediated downregulation of gluconeogenic genes. Conclusions/Significance: These results provide direct experimental evidences for the contribution of HBx in the impairment of insulin signaling.	[Kim, KyeongJin; Kim, Kook Hwan; Cheong, JaeHun] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea	Pusan National University	Kim, K (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea.	molecule85@pusan.ac.kr		Kim, Kook Hwan/0000-0003-2702-9156	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080907]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2503, DOI 10.1210/me.2006-0498; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Custro N, 2001, DIABETES METAB, V27, P476; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fan JG, 2008, J GASTROEN HEPATOL, V23, P679, DOI 10.1111/j.1440-1746.2008.05361.x; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Hajjou M, 2005, J MED VIROL, V77, P57, DOI 10.1002/jmv.20427; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim K, 2008, BIOCHEM J, V416, P219, DOI 10.1042/BJ20081336; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kong HJ, 2003, HEPATOLOGY, V38, P1258, DOI 10.1053/jhep.2003.50451; Krebs DL, 2000, J CELL SCI, V113, P2813; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Mohammad Alizadeh Amir Houshang, 2006, Indian J Gastroenterol, V25, P286; Murakami S, 1999, INTERVIROLOGY, V42, P81, DOI 10.1159/000024969; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park MJ, 2007, BIOCHEM J, V402, P567, DOI 10.1042/BJ20061549; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sangiorgio L, 2000, DIABETES RES CLIN PR, V48, P147, DOI 10.1016/S0168-8227(99)00135-7; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; SHIMADA M, 2000, GEOMECH RES SER, V2, P1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; WHITE MF, 1994, J BIOL CHEM, V269, P1; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yang J.J., 2004, SHAANXI AGR SCI, V1, P6; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X	51	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e8649	10.1371/journal.pone.0008649	http://dx.doi.org/10.1371/journal.pone.0008649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351777	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400001
J	Zimic, M; Velazco, A; Comina, G; Coronel, J; Fuentes, P; Luna, CG; Sheen, P; Gilman, RH; Moore, DAJ				Zimic, Mirko; Velazco, Abner; Comina, German; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.			Development of Low-Cost Inverted Microscope to Detect Early Growth of Mycobacterium tuberculosis in MODS Culture	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY	Background: The microscopic observation drug susceptibility (MODS) assay for rapid, low-cost detection of tuberculosis and multidrug resistant tuberculosis depends upon visualization of the characteristic cording colonies of Mycobacterium tuberculosis in liquid media. This has conventionally required an inverted light microscope in order to inspect the MODS culture plates from below. Few tuberculosis laboratories have this item and the capital cost of $5,000 for a high-end microscope could be a significant obstacle to MODS roll-out. Methodology: We hypothesized that the precise definition provided by costly high-specification inverted light microscopes might not be necessary for pattern recognition. Significance: In this work we describe the development of a low-cost artesenal inverted microscope that can operate in both a standard or digital mode to effectively replace the expensive commercial inverted light microscope, and an integrated system that could permit a local and remote diagnosis of tuberculosis.	[Zimic, Mirko; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lima, Peru; [Zimic, Mirko; Coronel, Jorge; Fuentes, Patricia; Luna, Carmen G.; Sheen, Patricia; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lab Enfermedades Infecciosas, Lima, Peru; [Velazco, Abner; Comina, German] Univ Nacl Ingn, Fac Ciencias, Lab Peliculas Delgadas, Lima, Peru; [Gilman, Robert H.; Moore, David A. J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, Fac Med, Dept Infect Dis & Immun, London, England; [Moore, David A. J.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, Clin Res Unit, London WC1, England	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University Nacional de Ingenieria Lima; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lima, Peru.	mzimic@jhsph.edu		Coronel, Jorge/0000-0002-4580-6716; Comina, German/0000-0003-2114-0486	Wellcome Trust Career Development Fellowship [078067/Z/05]; Peruvian FINCYT Proyecto de Interes Nacional [PIN 061]; National Institutes of Health [5D43TW006581]; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER	Wellcome Trust Career Development Fellowship(Wellcome Trust); Peruvian FINCYT Proyecto de Interes Nacional; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was funded by the Wellcome Trust Career Development Fellowship [078067/Z/05], by the Peruvian FINCYT Proyecto de Interes Nacional [PIN 061] and by the National Institutes of Health award 5D43TW006581 "Infectious Diseases Training Program in Peru''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias M, 2007, CLIN INFECT DIS, V44, P674, DOI 10.1086/511639; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Park WG, 2002, J CLIN MICROBIOL, V40, P4750, DOI 10.1128/JCM.40.12.4750-4752.2002; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Zimic M, 2009, T ROY SOC TROP MED H, V103, P638, DOI 10.1016/j.trstmh.2008.10.015	8	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9577	10.1371/journal.pone.0009577	http://dx.doi.org/10.1371/journal.pone.0009577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351778	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400005
J	Carrasco, DI; Bichler, EK; Seburn, KL; Pinter, MJ				Carrasco, Dario I.; Bichler, Edyta K.; Seburn, Kevin L.; Pinter, Martin J.			Nerve Terminal Degeneration Is Independent of Muscle Fiber Genotype in SOD1(G93A) Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; NEUROMUSCULAR-JUNCTION; MOUSE MODEL; MOTONEURON DISEASE; EXTEND SURVIVAL; IN-VIVO; CELLS; UNIT; SUBSETS	Background: Motor neuron degeneration in SOD1(G93A) transgenic mice begins at the nerve terminal. Here we examine whether this degeneration depends on expression of mutant SOD1 in muscle fibers. Methodology/Principal Findings: Hindlimb muscles were transplanted between wild-type and SOD1(G93A) transgenic mice and the innervation status of neuromuscular junctions (NMJs) was examined after 2 months. The results showed that muscles from SOD1(G93A) mice did not induce motor terminal degeneration in wildtype mice and that muscles from wildtype mice did not prevent degeneration in SOD1(G93A) transgenic mice. Control studies demonstrated that muscles transplanted from SOD1(G93A) mice continued to express mutant SOD1 protein. Experiments on wildtype mice established that the host supplied terminal Schwann cells (TSCs) at the NMJs of transplanted muscles. Conclusions/Significance: These results indicate that expression of the mutant protein in muscle is not needed to cause motor terminal degeneration in SOD1(G93A) transgenic mice and that a combination of motor terminals, motor axons and Schwann cells, all of which express mutant protein may be sufficient.	[Carrasco, Dario I.; Bichler, Edyta K.; Pinter, Martin J.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Seburn, Kevin L.] Jackson Lab, Bar Harbor, ME 04609 USA	Emory University; Jackson Laboratory	Carrasco, DI (corresponding author), Emory Univ, Dept Physiol, Atlanta, GA 30322 USA.	mpinter@emory.edu			National Institutes of Health (NIH) [NS31621]; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031621] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS31621 (M.J.P.) and by generous funding provided by the ALS Association (K.L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; CARLSON BM, 1976, EXP NEUROL, V52, P421, DOI 10.1016/0014-4886(76)90214-4; Carrasco DI, 2004, J NEUROPHYSIOL, V92, P1175, DOI 10.1152/jn.00157.2004; CARRASCO DI, 2006, 6784 SOC NEUR; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Colomar A, 2004, GLIA, V47, P284, DOI 10.1002/glia.20086; COTE C, 1986, AM J PHYSIOL, V250, pC828, DOI 10.1152/ajpcell.1986.250.6.C828; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frankel WN, 1998, NEURON, V20, P183, DOI 10.1016/S0896-6273(00)80447-X; Frey D, 2000, J NEUROSCI, V20, P2534; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1994; HANSENSMITH FM, 1979, J NEUROL SCI, V41, P149, DOI 10.1016/0022-510X(79)90035-2; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Miller SW, 1998, J APPL PHYSIOL, V84, P1865, DOI 10.1152/jappl.1998.84.6.1865; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; MORGAN JE, 1989, MUSCLE NERVE, V12, P401, DOI 10.1002/mus.880120511; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; Pinter MJ, 2001, METH NE FRO NEUROSCI, P231; PINTER MJ, 1995, J NEUROSCI, V15, P3447; Pinter MJ, 1997, J NEUROSCI, V17, P4500; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2; Sanes JR, 1998, J PHYSIOLOGY-PARIS, V92, P167, DOI 10.1016/S0928-4257(98)80004-1; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; SUGIURA Y, 2004, INVOLVEMENT SKELETAL; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	33	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9802	10.1371/journal.pone.0009802	http://dx.doi.org/10.1371/journal.pone.0009802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339550	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300024
J	Ross, JV; House, T; Keeling, MJ				Ross, Joshua V.; House, Thomas; Keeling, Matt J.			Calculation of Disease Dynamics in a Population of Households	PLOS ONE			English	Article							EPIDEMIC MODELS; SIR EPIDEMICS; NETWORK; COMMUNITY; TRANSMISSION; INTEGRALS; INVASION; NUMBERS; SIZE	Early mathematical representations of infectious disease dynamics assumed a single, large, homogeneously mixing population. Over the past decade there has been growing interest in models consisting of multiple smaller subpopulations (households, workplaces, schools, communities), with the natural assumption of strong homogeneous mixing within each subpopulation, and weaker transmission between subpopulations. Here we consider a model of SIRS (susceptible-infectious-recovered-susceptible) infection dynamics in a very large (assumed infinite) population of households, with the simplifying assumption that each household is of the same size (although all methods may be extended to a population with a heterogeneous distribution of household sizes). For this households model we present efficient methods for studying several quantities of epidemiological interest: (i) the threshold for invasion; (ii) the early growth rate; (iii) the household offspring distribution; (iv) the endemic prevalence of infection; and (v) the transient dynamics of the process. We utilize these methods to explore a wide region of parameter space appropriate for human infectious diseases. We then extend these results to consider the effects of more realistic gamma-distributed infectious periods. We discuss how all these results differ from standard homogeneous-mixing models and assess the implications for the invasion, transmission and persistence of infection. The computational efficiency of the methodology presented here will hopefully aid in the parameterisation of structured models and in the evaluation of appropriate responses for future disease outbreaks.	[Ross, Joshua V.] Univ Cambridge, Kings Coll, Cambridge, England; [House, Thomas; Keeling, Matt J.] Univ Warwick, Biol Sci & Math Inst, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick	Ross, JV (corresponding author), Univ Cambridge, Kings Coll, Cambridge, England.	jvr25@cam.ac.uk	Ross, Joshua V/C-2761-2009; Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; House, Thomas/0000-0001-5835-8062; Ross, Joshua/0000-0002-9918-8167	Medical Research Council [G0701256]; Wellcome Trust; EPSRC [EP/H016139/1] Funding Source: UKRI; MRC [G0701256] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H016139/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported by funding from the Medical Research Council (Grant Number G0701256; www.mrc.ac.uk), and the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY CL, 1991, BIOMETRICS, V47, P961, DOI 10.2307/2532652; ALTMANN M, 1995, J MATH BIOL, V33, P661, DOI 10.1007/BF00298647; ANDERSON R M, 1991; Andersson H, 2000, SPRINGER LECT NOTES, V151; Bailey NTJ, 1957, MATH THEORY EPIDEMIC; BALL F, 1986, ADV APPL PROBAB, V18, P289, DOI 10.2307/1427301; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2001, ADV APPL PROBAB, V33, P99, DOI 10.1017/S000186780001065X; Ball F, 1999, MATH BIOSCI, V156, P41, DOI 10.1016/S0025-5564(98)10060-3; Ball F, 1997, ANN APPL PROBAB, V7, P46; Ball F, 2009, ADV APPL PROBAB, V41, P765, DOI 10.1239/aap/1253281063; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Becker NG, 1998, MATH BIOSCI, V147, P23, DOI 10.1016/S0025-5564(97)00079-5; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Dangerfield CE, 2009, J R SOC INTERFACE, V6, P761, DOI 10.1098/rsif.2008.0410; DANIELS HE, 1967, 5TH P BERK S MATH ST, V4, P281; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Ghoshal G, 2004, MATH BIOSCI, V190, P71, DOI 10.1016/j.mbs.2004.02.006; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; James A, 2007, P ROY SOC B-BIOL SCI, V274, P741, DOI 10.1098/rspb.2006.0219; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 1997, P ROY SOC B-BIOL SCI, V264, P1149, DOI 10.1098/rspb.1997.0159; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klovdahl AS, 2001, SEX TRANSM DIS, V28, P25, DOI 10.1097/00007435-200101000-00006; Koopman JS, 2002, MATH BIOSCI, V180, P49, DOI 10.1016/S0025-5564(02)00124-4; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Pollett PK, 2003, MATH BIOSCI, V182, P213, DOI 10.1016/S0025-5564(02)00161-X; Pollett PK, 2002, J APPL PROBAB, V39, P901, DOI 10.1017/S0021900200022142; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Ross JV, 2009, THEOR POPUL BIOL, V75, P123, DOI 10.1016/j.tpb.2008.12.002; WATTS D, 1998, COLLECTIVE DYNAMICS; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	51	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9666	10.1371/journal.pone.0009666	http://dx.doi.org/10.1371/journal.pone.0009666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305791	Green Published, Green Submitted, gold			2022-12-25	WOS:000276456300001
J	Amdam, GV; Fennern, E; Baker, N; Rascon, B				Amdam, Gro V.; Fennern, Erin; Baker, Nicholas; Rascon, Brenda			Honeybee Associative Learning Performance and Metabolic Stress Resilience Are Positively Associated	PLOS ONE			English	Article							DIVISION-OF-LABOR; SUCROSE RESPONSIVENESS; PROBOSCIS EXTENSION; SOCIAL-ROLE; MORTALITY; TACTILE; BEES; LIFE; IQ; PLASTICITY	Background: Social-environmental influences can affect animal cognition and health. Also, human socio-economic status is a covariate factor connecting psychometric test-performance (a measure of cognitive ability), educational achievement, lifetime health, and survival. The complimentary hypothesis, that mechanisms in physiology can explain some covariance between the same traits, is disputed. Possible mechanisms involve metabolic biology affecting integrity and stability of physiological systems during development and ageing. Knowledge of these relationships is incomplete, and underlying processes are challenging to reveal in people. Model animals, however, can provide insights into connections between metabolic biology and physiological stability that may aid efforts to reduce human health and longevity disparities. Results: We document a positive correlation between a measure of associative learning performance and the metabolic stress resilience of honeybees. This relationship is independent of social factors, and may provide basic insights into how central nervous system (CNS) function and metabolic biology can be associated. Controlling for social environment, age, and learning motivation in each bee, we establish that learning in Pavlovian conditioning to an odour is positively correlated with individual survival time in hyperoxia. Hyperoxia induces oxidative metabolic damage, and provides a measure of metabolic stress resistance that is often related to overall lifespan in laboratory animals. The positive relationship between Pavlovian learning ability and stress resilience in the bee is not equally established in other model organisms so far, and contrasts with a genetic cost of improved associative learning found in Drosophila melanogaster. Conclusions: Similarities in the performances of different animals need not reflect common functional principles. A correlation of honeybee Pavlovian learning and metabolic stress resilience, thereby, is not evidence of a shared biology that will give insight about systems integrity in people. Yet, the means to resolve difficult research questions often come from findings in distant areas of science while the model systems that turn out to be valuable are sometimes the least predictable. Our results add to recent findings indicating that honeybees can become instrumental to understanding how metabolic biology influences life outcomes.	[Amdam, Gro V.; Fennern, Erin; Baker, Nicholas] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.; Rascon, Brenda] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Amdam, GV (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Gro.Amdam@asu.edu		Fennern, Erin/0000-0002-7501-3354	Research Council of Norway [175413, 180504, 185306, 191699]; National Institute on Aging (NIA) [P01 AG22500]; The PEW Charitable Trust; Wissenschaftskolleg zu Berlin; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The PEW Charitable Trust; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Research Council of Norway (# 175413, 180504, 185306, and 191699), the National Institute on Aging (NIA P01 AG22500), The PEW Charitable Trust, and the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Amdam GV, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1003; Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BITTERMAN ME, 1975, SCIENCE, V188, P699, DOI 10.1126/science.188.4189.699; Burger JMS, 2008, EVOLUTION, V62, P1294, DOI 10.1111/j.1558-5646.2008.00376.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Douglas RM, 2008, PHYSIOLOGY, V23, P333, DOI 10.1152/physiol.00023.2008; Espinoza SE, 2008, J AM GERIATR SOC, V56, P1744, DOI 10.1111/j.1532-5415.2008.01845.x; FINCH CE, 1990, LONGEVITY SENESCENCE, P67; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; GOLSTEIN P, 2003, MOL CELL BIOL, V4, P1; Hall PA, 2009, PSYCHOSOM MED, V71, P196, DOI 10.1097/PSY.0b013e318190d7f0; Hemmingsson T, 2009, J EPIDEMIOL COMMUN H, V63, P697, DOI 10.1136/jech.2008.079160; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Jokela M, 2009, PSYCHOSOM MED, V71, P322, DOI 10.1097/PSY.0b013e31819b69f6; Kanazawa Satoshi, 2008, Biodemography Soc Biol, V54, P200, DOI 10.1080/19485565.2008.9989142; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Mery F, 2004, ANIM BEHAV, V68, P589, DOI 10.1016/j.anbehav.2003.12.005; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Montgomery DC., 2017, DESIGN ANAL EXPT, V9th edn; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nelson F.C., 1927, AM BEE J, V67, P242; Ramsden E, 2007, J HIST BEHAV SCI, V43, P109, DOI 10.1002/jhbs.20219; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROTHENBUHLER WC, 1989, APIDOLOGIE, V20, P433, DOI 10.1051/apido:19890508; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Scheiner R, 2010, APIDOLOGIE, V41, P29, DOI 10.1051/apido/2009040; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Sloan FA, 2010, AM J PUBLIC HEALTH, V100, P357, DOI 10.2105/AJPH.2008.158188; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WHALLEY LJ, 2001, BMJ-BRIT MED J, V322, pE819; Winston M.L., 1987, BIOL HONEY BEE, P296; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5	59	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9740	10.1371/journal.pone.0009740	http://dx.doi.org/10.1371/journal.pone.0009740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305818	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809600012
J	Kadir, SHSA; Miragoli, M; Abu-Hayyeh, S; Moshkov, AV; Xie, QL; Keitel, V; Nikolaev, VO; Williamson, C; Gorelik, J				Kadir, Siti H. Sheikh Abdul; Miragoli, Michele; Abu-Hayyeh, Shadi; Moshkov, Alexey V.; Xie, Qilian; Keitel, Verena; Nikolaev, Viacheslav O.; Williamson, Catherine; Gorelik, Julia			Bile Acid-Induced Arrhythmia Is Mediated by Muscarinic M-2 Receptors in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; INTRAHEPATIC CHOLESTASIS; OBSTETRIC CHOLESTASIS; PREGNANCY; IDENTIFICATION; INHIBITION; ACTIVATION; EXPRESSION; FAMILY	Background: Intrahepatic cholestasis of pregnancy (ICP) is a common disease affecting up to 5% of pregnancies and which can cause fetal arrhythmia and sudden intrauterine death. We previously demonstrated that bile acid taurocholate (TC), which is raised in the bloodstream of ICP, can acutely alter the rate and rhythm of contraction and induce abnormal calcium destabilization in cultured neonatal rat cardiomyocytes (NRCM). Apart from their hepatic functions bile acids are ubiquitous signalling molecules with diverse systemic effects mediated by either the nuclear receptor FXR or by a recently discovered G-protein coupled receptor TGR5. We aim to investigate the mechanism of bile-acid induced arrhythmogenic effects in an in-vitro model of the fetal heart. Methods and Results: Levels of bile acid transporters and nuclear receptor FXR were studied by quantitative real time PCR, western blot and immunostaining, which showed low levels of expression. We did not observe functional involvement of the canonical receptors FXR and TGR5. Instead, we found that TC binds to the muscarinic M-2 receptor in NRCM and serves as a partial agonist of this receptor in terms of inhibitory effect on intracellular cAMP and negative chronotropic response. Pharmacological inhibition and siRNA-knockdown of the M-2 receptor completely abolished the negative effect of TC on contraction, calcium transient amplitude and synchronisation in NRCM clusters. Conclusion: We conclude that in NRCM the TC-induced arrhythmia is mediated by the partial agonism at the M2 receptor. This mechanism might serve as a promising new therapeutic target for fetal arrhythmia.	[Kadir, Siti H. Sheikh Abdul; Miragoli, Michele; Moshkov, Alexey V.; Xie, Qilian; Nikolaev, Viacheslav O.; Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kadir, Siti H. Sheikh Abdul; Abu-Hayyeh, Shadi; Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Keitel, Verena] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Kadir, Siti H. Sheikh Abdul] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Xie, Qilian] Hebei Med Univ, Hosp 1, Ctr Heart, Shijiazhuang, Hebei Province, Peoples R China	Imperial College London; Imperial College London; Heinrich Heine University Dusseldorf; Universiti Teknologi MARA; Hebei Medical University	Kadir, SHSA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	j.gorelik@imperial.ac.uk	Moshkov, Alexey/C-2825-2014; Nikolaev, Vyacheslav/AAT-7746-2020; Keitel, Verena/AAF-3471-2019; Keitel, Verena/AAH-9016-2021; Moshkov, Alexey/AAO-9902-2020; Sheikh Abdul Kadir, Siti Hamimah/ABA-7769-2021; Miragoli, Michele/K-6418-2016	Moshkov, Alexey/0000-0002-1858-6738; Keitel, Verena/0000-0003-1383-7662; Moshkov, Alexey/0000-0002-1858-6738; Sheikh Abdul Kadir, Siti Hamimah/0000-0002-1671-4839; Miragoli, Michele/0000-0002-4058-4368; Williamson, Catherine/0000-0002-6226-7611; Gorelik, Julia/0000-0003-1148-9158	Action Medical Research; Institute of Obstetrics and Gynaecology Trust; Universiti Teknologi MARA in Malaysia; Biomedical Research Centre at Imperial College Healthcare NHS Trust	Action Medical Research; Institute of Obstetrics and Gynaecology Trust; Universiti Teknologi MARA in Malaysia; Biomedical Research Centre at Imperial College Healthcare NHS Trust	This work was supported by Action Medical Research, the Institute of Obstetrics and Gynaecology Trust, Universiti Teknologi MARA in Malaysia and the Biomedical Research Centre at Imperial College Healthcare NHS Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin P, 1999, Ethn Health, V4, P35; Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; CAULFIELD MP, 1993, PROGR BRAIN RES, V98, P293; CLARK WA, 1991, AM J PHYSIOL, V261, P530; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; DANIELSSON H, 1975, ANNU REV BIOCHEM, V44, P233, DOI 10.1146/annurev.bi.44.070175.001313; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; Eloranta JJ, 2008, PHYSIOLOGY, V23, P286, DOI 10.1152/physiol.00020.2008; FISK NM, 1988, BRIT J OBSTET GYNAEC, V95, P1137, DOI 10.1111/j.1471-0528.1988.tb06791.x; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Gorelik J, 2002, CLIN SCI, V103, P191, DOI 10.1042/cs1030191; Gorelik J, 2006, CARDIOVASC RES, V72, P422, DOI 10.1016/j.cardiores.2006.09.009; Guo GL, 2006, BBA-MOL CELL BIOL L, V1761, P1401, DOI 10.1016/j.bbalip.2006.09.018; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IACONO G, 1989, AM J PHYSIOL, V256, pH1407, DOI 10.1152/ajpheart.1989.256.5.H1407; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; KHLKAMP V, 1985, PFLUGERS ARCH, V403, P266; KORTH M, 1988, CIRC RES, V62, P1080, DOI 10.1161/01.RES.62.6.1080; LAATIKAINEN T, 1984, INT J GYNECOL OBSTET, V22, P91, DOI 10.1016/0020-7292(84)90019-5; LAATIKAINEN TJ, 1975, AM J OBSTET GYNECOL, V122, P852, DOI 10.1016/0002-9378(75)90727-9; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Otte K, 2003, MOL CELL BIOL, V23, P864, DOI 10.1128/MCB.23.3.864-872.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Raufman JP, 2003, DIGEST DIS SCI, V48, P1431, DOI 10.1023/A:1024733500950; Raufman JP, 2002, EUR J PHARMACOL, V457, P77, DOI 10.1016/S0014-2999(02)02690-0; REID R, 1976, BRIT MED J, V1, P870, DOI 10.1136/bmj.1.6014.870; REYES H, 1982, HEPATOLOGY, V2, P87; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164	44	85	87	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9689	10.1371/journal.pone.0009689	http://dx.doi.org/10.1371/journal.pone.0009689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300620	Green Published, Green Submitted, gold			2022-12-25	WOS:000275621000007
J	Knubel, CP; Martinez, FF; Fretes, RE; Lujan, CD; Theumer, MG; Cervi, L; Motran, CC				Paola Knubel, Carolina; Fabian Martinez, Fernando; Fretes, Ricardo E.; Diaz Lujan, Cintia; Gustavo Theumer, Martin; Cervi, Laura; Cristina Motran, Claudia			Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi	FASEB JOURNAL			English	Article						Infection; parasites; immunomodulation; kynurenines	NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE SYNTHASE; T-CELL PROLIFERATION; INTERFERON-GAMMA; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; HUMAN-FIBROBLASTS; INTRACELLULAR PATHOGENS; ALTERNATIVE ACTIVATION; TOXOPLASMA-GONDII	Indoleamine 2,3-dioxigenase (IDO) is an inflammatory cytokine-inducible rate-limiting enzyme of the tryptophan (Trp) catabolism, which is involved in the inhibition of intracellular pathogen replication as well as in immunomodulation. Here we demonstrated the effect of IDO-dependent Trp catabolism on Trypanosoma cruzi resistance to acute infection. Infection with T. cruzi resulted in the systemic activation of IDO. The blocking of IDO activity in vivo impaired resistance to the infection and exacerbated the parasite load and infection-associated pathology. In addition, IDO activity was critical to controlling the parasite's replication in macrophages (Mos), despite the high production of nitric oxide produced by IDO-blocked T. cruzi-infected Mos. Analysis of the mechanisms by which IDO controls the parasite replication revealed that T. cruzi amastigotes were sensitive to L-kynurenine downstream metabolites 3-hydroxykynurenine (3-HK) and 3-hydroxyanthranilic acid, while 3-HK also affected the trypomastigote stage. Finally, 3-HK treatment of mice acutely infected with T. cruzi was able to control the parasite and to improve the survival of lethally infected mice. During infection, IDO played a critical role in host defense against T. cruzi; therefore, the intervention of IDO pathway could be useful as a novel antitrypanosomatid therapeutic strategy.-Knubel, C. P., Martinez, F. F., Fretes, R. E., Diaz Lujan, C., Theumer, M. G., Cervi, L., Motran, C. C. Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi. FASEB J. 24, 2689-2701 (2010). www.fasebj.org	[Paola Knubel, Carolina; Fabian Martinez, Fernando; Gustavo Theumer, Martin; Cervi, Laura; Cristina Motran, Claudia] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina; [Fretes, Ricardo E.; Diaz Lujan, Cintia] Univ Nacl Cordoba, Fac Med, Inst Biol Celular, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Motran, CC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina.	cmotran@fcq.unc.edu.ar	Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901	Agencia Nacional de Promocion Cientifica y Tecnica [PICT 25511]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba	Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	C.P.K. thanks Agencia Nacional de Promocion Cientifica y Tecnica, and F. F. M. thanks the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina for the fellowships granted. C.C.M., L.C., and M.G.T. are members of the Scientific Career of CONICET of Argentina. The authors are grateful to Cecilia Sampedro and Carlos Mas [Centro de Investigaciones en Quimica Biologica de Cordoba (CIQUIBIC)-CONICET] for assistance with video microscopy. The authors thank Eva Acosta Rodriguez for critical reading of the manuscript and native speaker Dr. Paul Hobson, who revised the manuscript. This work was supported by grants from CONICET of Argentina, Agencia Nacional de Promocion Cientifica y Tecnica (PICT 25511), Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, and Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (grants to C.M.). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no competing interests.	Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; BLASI E, 1993, ANTIMICROB AGENTS CH, V37, P2422, DOI 10.1128/AAC.37.11.2422; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Ceravolo IP, 1999, INFECT IMMUN, V67, P2233; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Cummings KL, 2004, INFECT IMMUN, V72, P4081, DOI 10.1128/IAI.72.7.4081-4089.2004; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; GUPTA SL, 1994, INFECT IMMUN, V62, P2277, DOI 10.1128/IAI.62.6.2277-2284.1994; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hwang SL, 2005, CELL RES, V15, P167, DOI 10.1038/sj.cr.7290282; Koga R, 2006, J IMMUNOL, V177, P7059, DOI 10.4049/jimmunol.177.10.7059; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; MacKenzie CR, 1998, J INFECT DIS, V178, P875, DOI 10.1086/515347; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; Motran CC, 1998, EXP PARASITOL, V88, P223, DOI 10.1006/expr.1998.4255; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; ORTIZORTIZ L, 1976, INT ARCH ALLER A IMM, V50, P232, DOI 10.1159/000231501; PETRAY P, 1995, IMMUNOL LETT, V47, P121, DOI 10.1016/0165-2478(95)00083-H; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Shoda LKM, 2001, INFECT IMMUN, V69, P2162, DOI 10.1128/IAI.69.4.2162-2171.2001; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Sulsen VP, 2008, ANTIMICROB AGENTS CH, V52, P2415, DOI 10.1128/AAC.01630-07; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994; Vincendeau P, 1999, ADV EXP MED BIOL, V467, P525; Widner B, 1997, CLIN CHEM, V43, P2424; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	47	42	42	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2689	2701		10.1096/fj.09-150920	http://dx.doi.org/10.1096/fj.09-150920			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20233946				2022-12-25	WOS:000285005400011
J	Xu, HX; Zhang, Z; Li, M; Zhang, RW				Xu, Hongxia; Zhang, Zhuo; Li, Mao; Zhang, Ruiwen			MDM2 Promotes Proteasomal Degradation of p21(Waf1) via a Conformation Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; RESONANCE ENERGY-TRANSFER; REG-GAMMA-PROTEASOME; CELL-CYCLE; HUMAN MALIGNANCIES; ONCOPROTEIN MDM2; LIGASE ACTIVITY; 20S PROTEASOME; CANCER-THERAPY; C-TERMINUS	MDM2 plays a major role in cancer development and progression via both p53-dependent and -independent functions. One of its p53-independent functions is the induction of the ubiquitin-independent proteasomal degradation of p21(Waf1). The present study was designed to characterize the mechanism(s) by which MDM2 induces p21(Waf1) degradation. We first determined the regions of MDM2 required for p21(Waf1) degradation using pulldown assays and Western blotting and then examined the mechanisms using limited proteolysis and fluorescence resonance energy transfer assays. We found that the MDM2-p21(Waf1) interaction depended on the central domain of MDM2 and that nuclear localization of both proteins was necessary for p21(Waf1) degradation. Specifically, amino acids 226-250 of MDM2 were required for p21(Waf1) binding and degradation, and amino acids 251-260 were necessary for p21(Waf1) degradation. The latter region induced a conformation change in p21(Waf1), increasing its interaction with the C8 subunit of the proteasome, leading to its degradation. When MDM2 lacked either segment (aa 226-250 or aa 251-260), its capacity to promote p21(Waf1) degradation and cell cycle progression was significantly reduced. In summary, the present study elucidated a previously unknown mechanism by which MDM2 promotes the degradation of an intact protein (p21(Waf1)) through an ubiquitin-independent proteasomal degradation pathway. Because MDM2 also increases the degradation of other proteins in a ubiquitin-independent manner, this mechanism may underlie part of its tumorigenic properties.	[Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Ctr Comprehens Canc, Div Clin Pharmacol, Birmingham, AL 35294 USA; [Xu, Hongxia] Third Mil Med Univ, Coll Prevent Med, Chongqing 400038, Peoples R China	University of Alabama System; University of Alabama Birmingham; Army Medical University	Zhang, RW (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Ctr Comprehens Canc, Div Clin Pharmacol, 1825 Univ Blvd,Shelby Bldg,Rm 603, Birmingham, AL 35294 USA.	ruiwen.zhang@ccc.uab.edu	Xu, Hongxia/AAN-8608-2021	xu, hongxia/0000-0001-5215-734X	NCI, National Institutes of Health [R01CA112029, R01CA121211]; Department of Defense Prostate Cancer Research [W81XWH-04-1-0845]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Grants R01CA112029 and R01CA121211 (to R.Z.).; Supported in part by a post-doctoral fellowship from the Department of Defense Prostate Cancer Research Program (Grant W81XWH-04-1-0845). 3 Present address: Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294.	BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BARTEK J, 1991, ONCOGENE, V6, P1699; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; Gerards WLH, 1998, J MOL BIOL, V275, P113, DOI 10.1006/jmbi.1997.1429; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Onel K, 2004, MOL CANCER RES, V2, P1; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Romero P, 1998, Pac Symp Biocomput, P437; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Schon O, 2004, J MOL BIOL, V336, P197, DOI 10.1016/j.jmb.2003.11.051; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25	44	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18407	18414		10.1074/jbc.M109.059568	http://dx.doi.org/10.1074/jbc.M109.059568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20308078	Green Published, hybrid			2022-12-25	WOS:000278453900034
J	Steiger, D; Fetchko, M; Vardanyan, A; Atanesyan, L; Steiner, K; Turski, ML; Thiele, DJ; Georgiev, O; Schaffner, W				Steiger, Dominik; Fetchko, Michael; Vardanyan, Alla; Atanesyan, Lilit; Steiner, Kurt; Turski, Michelle L.; Thiele, Dennis J.; Georgiev, Oleg; Schaffner, Walter			The Drosophila Copper Transporter Ctr1C Functions in Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MTF-1; HOMOLOGOUS RECOMBINATION; CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; SEX-CHROMOSOMES; X-CHROMOSOME; MELANOGASTER; HOMEOSTASIS; EVOLUTION; PROTEIN	Living organisms have evolved intricate systems to harvest trace elements from the environment, to control their intracellular levels, and to ensure adequate delivery to the various organs and cellular compartments. Copper is one of these trace elements. It is at the same time essential for life but also highly toxic, not least because it facilitates the generation of reactive oxygen species. In mammals, copper uptake in the intestine and copper delivery into other organs are mediated by the copper importer Ctr1. Drosophila has three Ctr1 homologs: Ctr1A, Ctr1B, and Ctr1C. Earlier work has shown that Ctr1A is an essential gene that is ubiquitously expressed throughout development, whereas Ctr1B is responsible for efficient copper uptake in the intestine. Here, we characterize the function of Ctr1C and show that it functions as a copper importer in the male germline, specifically in maturing spermatocytes and mature sperm. We further demonstrate that loss of Ctr1C in a Ctr1B mutant background results in progressive loss of male fertility that can be rescued by copper supplementation to the food. These findings hint at a link between copper and male fertility, which might also explain the high Ctr1 expression in mature mammalian spermatozoa. In both mammals and Drosophila, the X chromosome is known to be inactivated in the male germline. In accordance with such a scenario, we provide evidence that in Drosophila, the autosomal Ctr1C gene originated as a retrogene copy of the X-linked Ctr1A, thus maintaining copper delivery during male spermatogenesis.	[Georgiev, Oleg; Schaffner, Walter] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Turski, Michelle L.; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Zurich; Duke University	Schaffner, W (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	walter.schaffner@imls.uzh.ch	Steiger, Dominik/F-1092-2010	Steiger, Dominik/0000-0003-2191-8091	Kanton Zurich; Swiss National Science Foundation; National Institutes of Health [GM062555]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062555] Funding Source: NIH RePORTER	Kanton Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Kanton Zurich and the Swiss National Science Foundation (to W. S.), and by National Institutes of Health Grant GM062555 (to D. J. T.).	Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; HIDIROGLOU M, 1984, J DAIRY SCI, V67, P1147, DOI 10.3168/jds.S0022-0302(84)81416-2; Hua HQ, 2010, J BIOL INORG CHEM, V15, P107, DOI 10.1007/s00775-009-0599-0; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Knopfel M, 2005, BIOCHEM BIOPH RES CO, V330, P645, DOI 10.1016/j.bbrc.2005.03.023; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; SHOUP JR, 1967, J CELL BIOL, V32, P663, DOI 10.1083/jcb.32.3.663; Southon A, 2008, J EXP BIOL, V211, P709, DOI 10.1242/jeb.014159; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	41	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17089	17097		10.1074/jbc.M109.090282	http://dx.doi.org/10.1074/jbc.M109.090282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351114	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000277982600072
J	Hong, BS; Allali-Hassani, A; Tempel, W; Finerty, PJ; MacKenzie, F; Dimov, S; Vedadi, M; Park, HW				Hong, Bum Soo; Allali-Hassani, Abdellah; Tempel, Wolfram; Finerty, Patrick J., Jr.; MacKenzie, Farrell; Dimov, Svetoslav; Vedadi, Masoud; Park, Hee-Won			Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3 SINGLE AMINO ACID NEAR THE ACTIVE SITE INFLUENCES INHIBITOR SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-METABOLISM; CHOLINE/ETHANOLAMINE KINASE; PROTEIN; CANCER; SEQUENCE; ALPHA; PHOSPHORYLCHOLINE; EXPRESSION; REVEALS; CELLS	Human choline kinase (ChoK) catalyzes the first reaction in phosphatidylcholine biosynthesis and exists as ChoK alpha (alpha 1 and alpha 2) and ChoK beta isoforms. Recent studies suggest that ChoK is implicated in tumorigenesis and emerging as an attractive target for anticancer chemotherapy. To extend our understanding of the molecular mechanism of ChoK inhibition, we have determined the high resolution x-ray structures of the ChoK alpha 1 and ChoK beta isoforms in complex with hemi-cholinium-3 (HC-3), a known inhibitor of ChoK. In both structures, HC-3 bound at the conserved hydrophobic groove on the C-terminal lobe. One of the HC-3 oxazinium rings complexed with ChoK alpha 1 occupied the choline-binding pocket, providing a structural explanation for its inhibitory action. Interestingly, the HC-3 molecule co-crystallized with ChoK beta was phosphorylated in the choline binding site. This phosphorylation, albeit occurring at a very slow rate, was confirmed experimentally by mass spectroscopy and radioactive assays. Detailed kinetic studies revealed that HC-3 is a much more potent inhibitor for ChoK alpha isoforms (alpha 1 and alpha 2) compared with ChoK beta. Mutational studies based on the structures of both inhibitor-bound ChoK complexes demonstrated that Leu-401 of ChoK alpha 2 (equivalent to Leu-419 of ChoK alpha 1), or the corresponding residue Phe-352 of ChoK beta, which is one of the hydrophobic residues neighboring the active site, influences the plasticity of the HC-3-binding groove, thereby playing a key role in HC-3 sensitivity and phosphorylation.	[Hong, Bum Soo; Allali-Hassani, Abdellah; Tempel, Wolfram; Finerty, Patrick J., Jr.; MacKenzie, Farrell; Dimov, Svetoslav; Vedadi, Masoud; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Vedadi, M (corresponding author), Univ Toronto, Struct Genom Consortium, MaRS S Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	mvedadi@uhnres.utoronto.ca; heewon.park@utoronto.ca			Structural Genomics Consortium; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Use of the Advanced Photon Source was supported by the U. S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Allali-Hassani A, 2004, BIOCHEM J, V384, P577, DOI 10.1042/BJ20041082; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1393, P179, DOI 10.1016/S0005-2760(98)00062-9; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; BROSTROM MA, 1973, J BIOL CHEM, V248, P2364; Campos J, 2000, BIOORG MED CHEM LETT, V10, P767, DOI 10.1016/S0960-894X(00)00080-9; Conejo-Garcia A, 2005, EUR J MED CHEM, V40, P315, DOI 10.1016/j.ejmech.2004.09.016; Conejo-Garcia A, 2004, J MED CHEM, V47, P5433, DOI 10.1021/jm0496537; Conejo-Garcia A, 2003, EUR J MED CHEM, V38, P109, DOI 10.1016/S0223-5234(02)00004-1; CUADRADO A, 1993, ONCOGENE, V8, P2959; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EXTON JH, 1990, J BIOL CHEM, V265, P1; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAMZA M, 1983, BIOCHEM PHARMACOL, V32, P1893, DOI 10.1016/0006-2952(83)90055-2; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; JIMENEZ B, 1995, J CELL BIOCHEM, V57, P141, DOI 10.1002/jcb.240570114; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Lacal JC, 1999, EUR J CANCER, V35, pS133, DOI 10.1016/S0959-8049(99)80913-7; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; MACARA IG, 1989, MOL CELL BIOL, V9, P325, DOI 10.1128/MCB.9.1.325; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Milanese L, 2006, CHEMMEDCHEM, V1, P1216, DOI 10.1002/cmdc.200600158; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; RATNAM S, 1995, ARCH BIOCHEM BIOPHYS, V323, P313, DOI 10.1006/abbi.1995.9959; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; SHEFF KY, 1990, J PHARMACOL EXP THER, V255, P357; Srivani P, 2009, J MOL GRAPH MODEL, V27, P676, DOI 10.1016/j.jmgm.2008.10.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	47	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16330	16340		10.1074/jbc.M109.039024	http://dx.doi.org/10.1074/jbc.M109.039024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299452	hybrid, Green Published			2022-12-25	WOS:000277715900069
J	Jiang, RT; Martz, A; Gonin, S; Taly, A; de Carvalho, LP; Grutter, T				Jiang, Ruotian; Martz, Adeline; Gonin, Sophie; Taly, Antoine; de Carvalho, Lia Prado; Grutter, Thomas			A Putative Extracellular Salt Bridge at the Subunit Interface Contributes to the Ion Channel Function of the ATP-gated P2X2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND TRANSMEMBRANE DOMAIN; P2X(2) RECEPTOR; BINDING-SITE; POLAR RESIDUES; TASTE-BUDS; IDENTIFICATION; MUTAGENESIS; AGONISTS; NEURONS; MOTIONS	The recent crystal structure of the ATP-gated P2X4 receptor revealed a static view of its architecture, but the molecular mechanisms underlying the P2X channels activation are still unknown. By using a P2X2 model based on the x-ray structure, we sought salt bridges formed between charged residues located in a region that directly connects putative ATP-binding sites to the ion channel. To reveal their significance for ion channel activation, we made systematic charge exchanges and measured the effects on ATP sensitivity. We found that charge reversals at the interfacial residues Glu(63) and Arg(274) produced gain-of-function phenotypes that were cancelled upon paired charge swapping. These results suggest that a putative intersubunit salt bridge formed between Glu(63) and Arg(274) contributes to the ion channel function. Engineered cysteines E63C and R274C formed redox-dependent cross-links in the absence of ATP. By contrast, the presence of ATP reduced the rate of disulfide bond formation, indicating that ATP binding might trigger relative movement of adjacent subunits at the level of Glu(63) and Arg(274), allowing the transmembrane helices to open the channel.	[Jiang, Ruotian; Martz, Adeline; Gonin, Sophie; Taly, Antoine; de Carvalho, Lia Prado; Grutter, Thomas] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophysicochim Recepteurs Canaux,UMR 7199, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grutter, T (corresponding author), Univ Strasbourg, Fac Pharm, CNRS, Lab Biophysicochim Recepteurs Canaux,UMR 7199, 74 Route Rhin,BP 24, F-67401 Illkirch Graffenstaden, France.	grutter@unistra.fr	Jiang, Ruotian/S-3594-2018; Taly, Antoine/B-3339-2008	Taly, Antoine/0000-0001-5109-0091; Grutter, Thomas/0000-0002-4351-9203; Jiang, Ruotian/0000-0001-5322-6802	Agence National de la Recherche [06-0050-01]; CNRS; China Scholarship Council; NATIONAL EYE INSTITUTE [R01EY011708, R01EY017123] Funding Source: NIH RePORTER	Agence National de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Agence National de la Recherche Grant 06-0050-01 and CNRS ( Programme d'Incitation a la Mobilite).; Recipient of a fellowship from the China Scholarship Council.; Recipient of a fellowship from CNRS.	Adriouch S, 2009, PURINERG SIGNAL, V5, P151, DOI 10.1007/s11302-009-9134-6; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Faiman GA, 1996, PROTEIN ENG, V9, P315, DOI 10.1093/protein/9.3.315; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2003, J NEUROSCI, V23, P7426; Le Novere N, 1999, NUCLEIC ACIDS RES, V27, P340, DOI 10.1093/nar/27.1.340; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006	40	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15805	15815		10.1074/jbc.M110.101980	http://dx.doi.org/10.1074/jbc.M110.101980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308075	Green Published, hybrid			2022-12-25	WOS:000277715900018
J	Shim, M; Foley, J; Anna, C; Mishina, Y; Eling, T				Shim, Minsub; Foley, Julie; Anna, Colleen; Mishina, Yuji; Eling, Thomas			Embryonic Expression of Cyclooxygenase-2 Causes Malformations in Axial Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRAL COLUMN; BREAST-CANCER; CELLS; MICE; P53; APOPTOSIS; PHOSPHORYLATION; CHONDROGENESIS; ACCUMULATION; SCLEROTOME	Cyclooxygenases (COXs) have important functions in various physiological and pathological processes. COX-2 expression is highly induced by a variety of stimuli and is observed during certain periods of embryonic development. In this report, the direct effect of COX-2 expression on embryonic development is examined in a novel COX-2 transgenic mouse model that ubiquitously expresses human COX-2 from the early stages of embryonic development. COX-2 transgenic fetuses exhibit severe skeletal malformations and die shortly after birth. Skeletal malformations are localized along the entire vertebral column and rib cage and are linked to defective formation of cartilage anlagen. The cartilage anlagen of axial skeleton fail to properly develop in transgenic embryos because of impaired precartilaginous sclerotomal condensation, which results from the reduction of cell number in the sclerotome. Despite the ubiquitous expression of COX-2, the number of apoptotic cells is highly increased in the sclerotome of transgenic embryos but not in other tissues, suggesting that it is a tissue-specific response. Therefore, the loss of sclerotomal cells due to an increased apoptosis is probably responsible for axial skeletal malformations in transgenic fetuses. In addition, the sclerotomal accumulation of p53 protein is observed in transgenic embryos, suggesting that COX-2 may induce apoptosis via the up-regulation of p53. Our results demonstrate that the aberrant COX-2 signaling during embryonic development is teratogenic and suggest a possible association of COX-2 with fetal malformations of unknown etiology.	[Shim, Minsub; Anna, Colleen; Eling, Thomas] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Foley, Julie] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Michigan System; University of Michigan	Eling, T (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	eling@niehs.nih.gov			National Institutes of Health; NIEHS; Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES010016, ZIAES050144, ZIGES102505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health, NIEHS, Intramural Research Program.	Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Christ B, 2000, ANAT EMBRYOL, V202, P179, DOI 10.1007/s004290000114; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Fukuda N, 2006, ONCOGENE, V25, P3509, DOI 10.1038/sj.onc.1209393; Hermanova M, 2008, EUR J GASTROEN HEPAT, V20, P732, DOI 10.1097/MEG.0b013e3282f945fb; Kaplan Kevin M, 2005, Spine J, V5, P564, DOI 10.1016/j.spinee.2004.10.044; Legan M, 2006, WORLD J GASTROENTERO, V12, P3425, DOI 10.3748/wjg.v12.i21.3425; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; MONTARRAS D, 1991, NEW BIOL, V3, P592; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Parman T, 2002, FASEB J, V16, P1001, DOI 10.1096/fj.01-0140com; Peters H, 1999, DEVELOPMENT, V126, P5399; RANDALL CL, 1991, ALCOHOL CLIN EXP RES, V15, P673, DOI 10.1111/j.1530-0277.1991.tb00577.x; RANDALL CL, 1991, TERATOLOGY, V44, P521, DOI 10.1002/tera.1420440506; Ristimaki A, 2002, CANCER RES, V62, P632; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Slater D, 1999, J MOL ENDOCRINOL, V22, P125, DOI 10.1677/jme.0.0220125; Stanfield KM, 2003, BIRTH DEFECTS RES A, V67, P54, DOI 10.1002/bdra.10032; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Tyl RW, 2007, BIRTH DEFECTS RES B, V80, P451, DOI 10.1002/bdrb.20134; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Xu Z, 2006, CANCER RES, V66, P6657, DOI 10.1158/0008-5472.CAN-05-3624; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	36	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16206	16217		10.1074/jbc.M109.078576	http://dx.doi.org/10.1074/jbc.M109.078576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236942	Green Published, hybrid			2022-12-25	WOS:000277715900057
J	Patel, SA; Simon, MC				Patel, Shetal A.; Simon, M. Celeste			Functional Analysis of the Cdk7.Cyclin H.Mat1 Complex in Mouse Embryonic Stem Cells and Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-ACTIVATING KINASE; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR TFIIH; RING FINGER PROTEIN; C-TERMINAL DOMAIN; CATALYTIC SUBUNIT; GENERAL TRANSCRIPTION; REGULATORY CIRCUITRY; CHEMICAL GENETICS; DROSOPHILA EMBRYO	The trimeric Cdk7.cyclin H.Mat1 complex functions in cell cycle regulation, as the Cdk-activating kinase, and in transcription, as a module of the general transcription factor TFIIH. As a component of TFIIH, Cdk7 phosphorylates serines 5 and 7 of the carboxyl-terminal domain of RNA polymerase II and can also directly phosphorylate transcription factors to regulate gene expression. Here we have investigated the function of the Cdk7.cyclin H.Mat1 complex in murine embryonic stem (ES) cells and preimplantation embryos to determine whether it regulates the unique cell cycle structure and transcriptional network of pluripotent cells. We demonstrate that depletion of cyclin H leads to differentiation of ES cells independent of changes in cell cycle progression. In contrast, we observed that developmental genes are acutely up-regulated after cyclin H down-regulation, likely perturbing normal ES self-renewal pathways. We further demonstrate that Spt5, a known phosphorylation target of Cdk7, similarly regulates ES pluripotency and gene expression. Consistent with its function in ES cells, cyclin H depletion from mouse embryos also leads to defects in the expansion of the inner cell mass of blastocysts, a transient pluripotent stem cell population in vivo. Our findings indicate that cyclin H has an essential function in promoting the self-renewal of the pluripotent stem cells of blastocyst stage embryos. Collectively, these studies demonstrate a critical and novel role for cyclin H in maintaining ES cell identity and suggest that cyclin H has important functions in early embryonic development.	[Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Patel, Shetal A.; Simon, M. Celeste] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Howard Hughes Med Inst, 451 BRB II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		medical scientist training grant; Developmental Biology Training Grant [2-T32-HD-007516-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER	medical scientist training grant; Developmental Biology Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by a medical scientist training grant and Developmental Biology Training Grant 2-T32-HD-007516-11.	Aguilar-Fuentes J, 2006, J CELL SCI, V119, P3866, DOI 10.1242/jcs.03150; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BROWN AJ, 1994, MOL BIOL CELL, V5, P921, DOI 10.1091/mbc.5.8.921; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Helenius K, 2009, MOL CELL BIOL, V29, P315, DOI 10.1128/MCB.00347-08; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Korsisaari N, 2002, J CELL SCI, V115, P4275, DOI 10.1242/jcs.00121; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PINES J, 2001, CURRENT PROTOCOLS CE, V8; POON RYC, 1994, J CELL SCI, V107, P2789; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sano M, 2007, CELL METAB, V5, P129, DOI 10.1016/j.cmet.2007.01.003; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638	63	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15587	15598		10.1074/jbc.M109.081687	http://dx.doi.org/10.1074/jbc.M109.081687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231280	Green Published, hybrid			2022-12-25	WOS:000277399000077
J	Asnaghi, L; Vass, WC; Quadri, R; Day, PM; Qian, X; Braverman, R; Papageorge, AG; Lowy, DR				Asnaghi, L.; Vass, W. C.; Quadri, R.; Day, P. M.; Qian, X.; Braverman, R.; Papageorge, A. G.; Lowy, D. R.			E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases	ONCOGENE			English	Article						E-cadherin; NSCLC; tumorigenesis; cell migration; Rho-family GTPases	BETA-CATENIN; FACTOR RECEPTOR; FAMILY GTPASES; BREAST-CANCER; ACTIVATING PROTEIN; REDUCED EXPRESSION; TISSUE MICROARRAY; TUMOR PROGRESSION; TYROSINE KINASES; ALPHA-CATENIN	Non-small cell lung cancers (NSCLC) that express the cell surface adhesion protein E-cadherin may carry a better prognosis than E-cadherin-negative tumors. Here, we found substantial inhibition of anchorage-independent growth in soft agar and cell migration in each of four NSCLC lines stably transfected with E-cadherin. The inhibitory effects were independent of the EGFR and beta-catenin/Wnt-signaling pathways. However, E-cadherin expression was associated with an adhesion-dependent reduction in the activity of Rho family proteins, RhoA in two lines and Cdc42 in the other two. The reduction of RhoA activity was dependent on DLC-1 Rho-GAP and p190 Rho-GAP and associated with an increase in a membrane-associated p190 Rho-GAP/p120 Ras-GAP complex. In parental cells with high levels of RhoAGTP, siRNA-mediated knock-down of RhoA reduced cell migration and agar growth in a manner analogous to E-cadherin. In parental cells with high levels of Cdc42-GTP, transfection of a Cdc42 dominant-negative mutant reduced cell growth and migration similarly to cells expressing E-cadherin. Thus, E-cadherin can negatively regulate cell proliferation and migration in NSCLC by reducing the level of the predominant active form of Rho family protein, RhoA or Cdc42. These proteins can be considered downstream effectors of E-cadherin and might represent therapeutic targets in some NSCLC. Oncogene (2010) 29, 2760-2771; doi: 10.1038/onc. 2010.39; published online 15 March 2010	[Asnaghi, L.; Vass, W. C.; Quadri, R.; Day, P. M.; Qian, X.; Braverman, R.; Papageorge, A. G.; Lowy, D. R.] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lowy, DR (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, 37 Convent Dr MSC 4264,Bldg 37,Rm 4106,37 Convent, Bethesda, MD 20892 USA.	lowyd@mail.nih.gov			National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Margaret Wheelock, Wen Jin Wu, Dianne Hirsch and Silvio Gutkind for providing plasmids, Drs Curt Harris and Terry Moody for providing NSCLC cell lines, Dr Cynthia Masison and Mike Radanovich for technical assistance and Dr Giovanna Tosato for helpful discussions. This research has been supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; BOHM M, 1994, CLIN EXP METASTAS, V12, P55, DOI 10.1007/BF01784334; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; CAPUZZO F, 2005, J NATL CANCER I, V97, P743; Chong IW, 2007, ONCOL REP, V18, P17; Deeb G, 2004, MODERN PATHOL, V17, P430, DOI 10.1038/modpathol.3800041; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Fei QY, 2002, LUNG CANCER, V37, P147, DOI 10.1016/S0169-5002(02)00077-6; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukata M, 1999, J CELL SCI, V112, P4491; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hajra KM, 2002, CANCER RES, V62, P1613; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hlubek F, 2007, FRONT BIOSCI, V12, P458, DOI 10.2741/2075; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kris MG, 2005, ONCOLOGIST, V10, P23, DOI 10.1634/theoncologist.10-90002-23; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Molina-Ortiz I, 2009, J BIOL CHEM, V284, P15147, DOI 10.1074/jbc.M807834200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Pirinen RT, 2001, J CLIN PATHOL, V54, P391, DOI 10.1136/jcp.54.5.391; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toyoyama H, 1999, ONCOL REP, V6, P81; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; van de Wetering M, 2001, CANCER RES, V61, P278; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	66	54	56	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2010	29	19					2760	2771		10.1038/onc.2010.39	http://dx.doi.org/10.1038/onc.2010.39			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	595DW	20228844	Green Accepted, Green Submitted			2022-12-25	WOS:000277591900002
J	Seidel, A; Ye, Y; de Armas, LR; Soto, M; Yarosh, W; Marcsisin, RA; Tran, D; Selsted, ME; Camerini, D				Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Tran, Dat; Selsted, Michael E.; Camerini, David			Cyclic and Acyclic Defensins Inhibit Human Immunodeficiency Virus Type-1 Replication by Different Mechanisms	PLOS ONE			English	Article							ALPHA-DEFENSINS; THETA-DEFENSINS; HIV-1 INFECTION; ANTIMICROBIAL PEPTIDES; CELLS; BETA-DEFENSIN-2; RETROCYCLIN; EXPRESSION; BINDING; FUSION	Defensins are antimicrobial peptides expressed by plants and animals. In mammals there are three subfamilies of defensins, distinguished by structural features: alpha, beta and theta. Alpha and beta-defensins are linear peptides with broad anti-microbial activity that are expressed by many mammals including humans. In contrast, theta-defensins are cyclic anti-microbial peptides made by several non-human primates but not humans. All three defensin types have anti-HIV-1 activity, but their mechanisms of action differ. We studied the anti-HIV-1 activity of one defensin from each group, HNP-1 (alpha), HBD-2 (beta) and RTD-1 (theta). We examined how each defensin affected HIV-1 infection and demonstrated that the cyclic defensin RTD-1 inhibited HIV-1 entry, while acyclic HNP-1 and HBD-2 inhibited HIV-1 replication even when added 12 hours post-infection and blocked viral replication after HIV-1 cDNA formation. We further found that all three defensins downmodulated CXCR4. Moreover, RTD-1 inactivated X4 HIV-1, while HNP-1 and HBD-2 inactivated both X4 and R5 HIV-1. The data presented here show that acyclic and cyclic defensins block HIV-1 replication by shared and diverse mechanisms. Moreover, we found that HNP-1 and RTD-1 directly inhibited firefly luciferase enzymatic activity, which may affect the interpretation of previously published data.	[Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Camerini, David] Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92717 USA; [Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Camerini, David] Univ Calif Irvine, Ctr Virus Res, Irvine, CA USA; [Seidel, Aprille; Ye, Ying; de Armas, Lesley R.; Soto, Maira; Yarosh, William; Marcsisin, Renee A.; Tran, Dat; Selsted, Michael E.; Camerini, David] Univ Calif Irvine, Ctr Immunol, Irvine, CA USA; [Tran, Dat; Selsted, Michael E.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Seidel, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92717 USA.	david.camerini@uci.edu			National Institutes of Health (NIH) [AI 60438, AI 22931, DE 15517]; George and Dottie Hewitt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022931, R37AI022931, R21AI060438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Dottie Hewitt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants AI 60438 awarded to DC and AI 22931 and DE 15517 awarded to MES. DT was supported by a George and Dottie Hewitt Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp S, 2005, EUR J MED RES, V10, P1; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Braida L, 2004, AIDS, V18, P1598, DOI 10.1097/01.aids.0000131363.82951.fb; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Jia HP, 2001, GENE, V263, P211; Jia HP, 2001, J PEDIATR-US, V138, P109, DOI 10.1067/mpd.2001.109375; Jotwani R, 2004, J DENT RES, V83, P371, DOI 10.1177/154405910408300504; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Sawaki K, 2002, ANTICANCER RES, V22, P2103; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J BIOL CHEM, V260, P4579; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabattoni D, 2004, JAIDS-J ACQ IMM DEF, V35, P455, DOI 10.1097/00126334-200404150-00003; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tunzi CR, 2000, PEDIATR RES, V48, P30, DOI 10.1203/00006450-200007000-00008; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Yang BL, 2005, T NONFERR METAL SOC, V15, P1; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zaharatos GJ, 2004, JAIDS-J ACQ IMM DEF, V36, P993, DOI 10.1097/00126334-200408150-00001; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhang LQ, 2004, SCIENCE, V303, P467	49	50	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9737	10.1371/journal.pone.0009737	http://dx.doi.org/10.1371/journal.pone.0009737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305815	gold, Green Published			2022-12-25	WOS:000275809600009
J	Potdar, VA; Chadha, MS; Jadhav, SM; Mullick, J; Cherian, SS; Mishra, AC				Potdar, Varsha A.; Chadha, Mandeep S.; Jadhav, Santosh M.; Mullick, Jayati; Cherian, Sarah S.; Mishra, Akhilesh C.			Genetic Characterization of the Influenza A Pandemic (H1N1) 2009 Virus Isolates from India	PLOS ONE			English	Article							MAMMALIAN-CELLS; HEMAGGLUTININ; EMERGENCE; OUTBREAK; POULTRY	Background: The Influenza A pandemic H1N1 2009 (H1N1pdm) virus appeared in India in May 2009 and thereafter outbreaks with considerable morbidity and mortality have been reported from many parts of the country. Continuous monitoring of the genetic makeup of the virus is essential to understand its evolution within the country in relation to global diversification and to track the mutations that may affect the behavior of the virus. Methods: H1N1pdm viruses were isolated from both recovered and fatal cases representing major cities and sequenced. Phylogenetic analyses of six concatenated whole genomes and the hemagglutinin (HA) gene of seven more isolates from May-September 2009 was performed with reference to 685 whole genomes of global isolates available as of November 24, 2009. Molecular characterization of all the 8 segments was carried out for known pathogenic markers. Results: The first isolate of May 2009 belonged to clade 5. Although clade 7 was the dominant H1N1pdm lineage in India, both clades 6 and 7 were found to be co-circulating. The neuraminidase of all the Indian isolates possessed H275, the marker for sensitivity to the neuraminidase inhibitor Oseltamivir. Some of the mutations in HA are at or in the vicinity of antigenic sites and may therefore be of possible antigenic significance. Among these a D222G mutation in the HA receptor binding domain was found in two of the eight Indian isolates obtained from fatal cases. Conclusions: The majority of the 13 Indian isolates grouped in the globally most widely circulating H1N1pdm clade 7. Further, correlations of the mutations specific to clade 7 Indian isolates to viral fitness and adaptability in the country remains to be understood. The D222G mutation in HA from isolates of fatal cases needs to be studied for pathogenicity.	[Potdar, Varsha A.; Chadha, Mandeep S.; Jadhav, Santosh M.; Mullick, Jayati; Cherian, Sarah S.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Potdar, VA (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	acm1750@rediffmail.com	Jadhav, Santoshkumar/AAB-7634-2021; Potdar, Varsha/ABA-3799-2021; Cherian, /411001/H-1332-2016; Cherian, Sarah/ABA-6207-2021	Potdar, Varsha/0000-0002-7535-7878; 	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gupta R., 2017, DTU HLTH TECH; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KIBOURNE ED, 2006, EMERG INFECT DIS, V12, P9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; NELSON M, 2009, EARLY DIVERSIFICATIO; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; *WHO, PAND H1N1 2009 24 AP; World Health Organization, 2009, CDC PROT REAL TIM RT; World Health Organization, PAND H1N1 2009 UPD 7; [No title captured]	30	95	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9693	10.1371/journal.pone.0009693	http://dx.doi.org/10.1371/journal.pone.0009693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300625	Green Submitted, Green Published, gold			2022-12-25	WOS:000275621000011
J	Chandrasekar, G; Archer, A; Gustafsson, JA; Lendahl, MA				Chandrasekar, Gayathri; Archer, Amena; Gustafsson, Jan-Ake; Lendahl, Monika Andersson			Levels of 17 beta-Estradiol Receptors Expressed in Embryonic and Adult Zebrafish Following In Vivo Treatment of Natural or Synthetic Ligands	PLOS ONE			English	Article							HUMAN ESTROGEN-RECEPTOR; TROUT ONCORHYNCHUS-MYKISS; DANIO-RERIO; GENES; 4-NONYLPHENOL; NONYLPHENOL; BINDING; BRAIN; CHEMICALS; ALPHA	The nuclear receptors encompass a group of regulatory proteins involved in a number of physiological processes. The estrogen receptors (ERs), of which one alpha and one beta form exist in mammals function as transcription factors in response to 17 beta-estradiol (E2). In zebrafish there are three gene products of estrogen receptors and they are denoted esr1 (ERalpha), esr2a (ERbeta2) and esr2b (ERbeta1). Total RNA of zebrafish early life stages (<3, 6, 12, 24, 48, 72, 96 and 120 hours post fertilization) and of adult fish (liver, intestine, eye, heart, brain, ovary, testis, gill, swim bladder and kidney) were isolated following in vivo exposures. Using specific primers for each of the three zebrafish ERs the expression levels were quantified using real time PCR methodology. It was shown that in absence of exposure all three estrogen receptors were expressed in adult fish. The levels of expression of two of these three ER genes, the esr1 and esr2a were altered in organs such as liver, intestine, brain and testis in response to ligand (E2, diethylstilbestrol or 4-nonylphenol). During embryogenesis two of the three receptor genes, esr1 and esr2b were expressed, and in presence of ligand the mRNA levels of these two genes increased. The conclusions are i) estrogen receptor genes are expressed during early development ii) altered expression of esr genes in response to ligand is dependent on the cellular context; iii) the estrogenic ligand 4-nonylphenol, a manufactured compound commonly found in sewage of water treatment plants, acts as an agonist of the estrogen receptor during development and has both agonist and antagonist properties in tissues of adult fish. This knowledge of esr gene function in development and in adult life will help to understand mechanisms of interfering mimicking endocrine chemicals in vivo.	[Chandrasekar, Gayathri; Archer, Amena; Gustafsson, Jan-Ake; Lendahl, Monika Andersson] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet	Chandrasekar, G (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	Monika.Andersson.Lendahl@ki.se	Andersson Lendahl, Monika/ABE-5981-2021	Archer, Amena/0000-0002-0400-4151; Andersson Lendahl, Monika/0000-0002-5690-8515	Karolinska Institutet; Center of Biosciences; Swedish Society of Medicine	Karolinska Institutet(Karolinska Institutet); Center of Biosciences; Swedish Society of Medicine	This project is supported by funds at Karolinska Institutet, Center of Biosciences and by The Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademollo N, 2008, ENVIRON INT, V34, P984, DOI 10.1016/j.envint.2008.03.001; AMORES A, 1998, DEV DYNAMICS SCI, P1711; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Chiang EFL, 2001, MOL BIOL EVOL, V18, P542, DOI 10.1093/oxfordjournals.molbev.a003833; Costache AD, 2005, MOL ENDOCRINOL, V19, P2979, DOI 10.1210/me.2004-0435; Cristofaro PA, 2006, CRIT CARE MED, V34, P2188, DOI 10.1097/01.CCM.0000227173.13497.56; Del Giacco L, 2000, DEV GENES EVOL, V210, P41, DOI 10.1007/PL00008187; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; GIGER W, 1984, SCIENCE, V225, P623, DOI 10.1126/science.6740328; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ishibashi H, 2006, CHEMOSPHERE, V65, P1019, DOI 10.1016/j.chemosphere.2006.03.034; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kinnberg K, 2000, MAR ENVIRON RES, V50, P169, DOI 10.1016/S0141-1136(00)00078-7; KORACH KS, 1987, J STEROID BIOCHEM, V27, P281, DOI 10.1016/0022-4731(87)90319-0; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lahnsteiner F, 2005, AQUAT TOXICOL, V71, P297, DOI 10.1016/j.aquatox.2004.11.007; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liedtke A, 2008, ENVIRON TOXICOL, V23, P59, DOI 10.1002/tox.20305; Liu RZ, 2005, FEBS J, V272, P3561, DOI 10.1111/j.1742-4658.2005.04775.x; Liu RZ, 2004, GENE EXPR PATTERNS, V4, P379, DOI 10.1016/j.modgep.2004.01.010; Luo Q, 2005, COMP BIOCHEM PHYS C, V140, P123, DOI 10.1016/j.cca.2005.01.008; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Meucci V, 2006, AQUAT TOXICOL, V77, P167, DOI 10.1016/j.aquatox.2005.11.008; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Sabo-Attwood T, 2007, J MOL ENDOCRINOL, V39, P223, DOI 10.1677/JME-07-0038; Sawyer SJ, 2006, GEN COMP ENDOCR, V147, P108, DOI 10.1016/j.ygcen.2005.12.010; Seo JS, 2006, BIOCHEM BIOPH RES CO, V346, P213, DOI 10.1016/j.bbrc.2006.05.123; Shelby MD, 1996, ENVIRON HEALTH PERSP, V104, P1296, DOI 10.2307/3432965; Shrader EA, 2003, ECOTOXICOLOGY, V12, P485, DOI 10.1023/B:ECTX.0000003034.69538.eb; Sumpter JP, 2008, WATER SCI TECHNOL, V57, P125, DOI 10.2166/wst.2008.796; Tingaud-Sequeira A, 2004, GENE EXPR PATTERNS, V4, P561, DOI 10.1016/j.modgep.2004.02.002; Ton C, 2006, BIRTH DEFECTS RES A, V76, P553, DOI 10.1002/bdra.20281; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Xia YY, 2008, BIOMED ENVIRON SCI, V21, P1, DOI 10.1016/S0895-3988(08)60001-X; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	54	68	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9678	10.1371/journal.pone.0009678	http://dx.doi.org/10.1371/journal.pone.0009678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300630	Green Submitted, Green Published, gold			2022-12-25	WOS:000275620900012
J	Zingaretti, C; Falugi, F; Nardi-Dei, V; Pietrocola, G; Mariani, M; Liberatori, S; Gallotta, M; Tontini, M; Tani, C; Speziale, P; Grandi, G; Margarit, I				Zingaretti, Chiara; Falugi, Fabiana; Nardi-Dei, Vincenzo; Pietrocola, Giampiero; Mariani, Massimo; Liberatori, Sabrina; Gallotta, Marilena; Tontini, Marta; Tani, Chiara; Speziale, Pietro; Grandi, Guido; Margarit, Immaculada			Streptococcus pyogenes SpyCEP: a chemokine-inactivating protease with unique structural and biochemical features	FASEB JOURNAL			English	Article						group A Streptococcus; IL-8 cleavage; serine protease; ScpC	INVASIVE DISEASE; C5A PEPTIDASE; CLEAVAGE; SURFACE; IDENTIFICATION; DEGRADATION; RESISTANCE; PROTEINS; VACCINE; SCPC	SpyCEP is a 170-kDa multidomain serine protease expressed on the surface of the human pathogen Streptococcus pyogenes, which plays an important role in infection by catalyzing cleavage and inactivation of the neutrophil chemoatractant interleukin-8. In this study, we investigated the biochemical features and maturation process of SpyCEP, starting from a recombinant form of the protease expressed and purified from Escherichia coli. We show that active recombinant SpyCEP differs from other bacterial proteases in that it is constituted by 2 noncovalently linked fragments derived from autocatalytic processing, an N-terminal fragment of 210 aa bearing one of the 3 catalytic triad residues, and a 1369-residue C-terminal polypeptide containing the remaining 2 catalytic amino acids. The same type of organization is present in the enzyme obtained from S. pyogenes. Furthermore, N-terminal SpyCEP is not involved in the folding of the mature enzyme. The 2 protease fragments were separately expressed in E. coli as soluble polypeptides that, when combined, reconstituted a fully active enzyme complex. Therefore, SpyCEP appears to possess a completely new structural architecture that has not been described so far for other microbial proteases.-Zingaretti, C., Falugi, F., Nardi-Dei, V., Pietrocola, G., Mariani, M., Liberatori, S., Gallotta, M., Tontini, M., Tani, C., Speziale, P., Grandi, G., Margarit, I. Streptococcus pyogenes SpyCEP: a chemokine-inactivating protease with unique structural and biochemical features. FASEB J. 24, 2839-2848 (2010). www.fasebj.org	[Zingaretti, Chiara; Falugi, Fabiana; Nardi-Dei, Vincenzo; Mariani, Massimo; Liberatori, Sabrina; Gallotta, Marilena; Tontini, Marta; Tani, Chiara; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines & Diagnost, Siena, Italy; [Zingaretti, Chiara] Ist Nazl Genet Mol, Milan, Italy; [Pietrocola, Giampiero; Speziale, Pietro] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy	Novartis; University of Pavia	Margarit, I (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	immaculada.margarit_y_ros@novartis.com	Liberatori, Sabrina/GYU-1878-2022	PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; Grandi, Guido/0000-0001-9724-2185; Liberatori, Sabrina/0000-0003-3524-0429				Anderson ET, 2002, EUR J BIOCHEM, V269, P4839, DOI 10.1046/j.1432-1033.2002.03183.x; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Chhatwal GS, 2005, TRENDS MOL MED, V11, P152, DOI 10.1016/j.molmed.2005.02.001; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Fritzer A, 2009, BIOCHEM J, V422, P533, DOI 10.1042/BJ20090278; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Khan AR, 1998, PROTEIN SCI, V7, P815; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Siezen RJ, 1999, ANTON LEEUW INT J G, V76, P139, DOI 10.1023/A:1002036906922; Sjolinder H, 2008, INFECT IMMUN, V76, P3959, DOI 10.1128/IAI.00128-08; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Turner CE, 2009, VACCINE, V27, P4923, DOI 10.1016/j.vaccine.2009.06.042; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	26	30	30	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2839	2848		10.1096/fj.09-145631	http://dx.doi.org/10.1096/fj.09-145631			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20339024				2022-12-25	WOS:000285005400024
J	Pontier, SM; Huck, L; White, DE; Rayment, J; Sanguin-Gendreau, V; Hennessy, B; Zuo, D; St-Arnaud, R; Mills, GB; Dedhar, S; Marshall, CJ; Muller, WJ				Pontier, S. M.; Huck, L.; White, D. E.; Rayment, J.; Sanguin-Gendreau, V.; Hennessy, B.; Zuo, D.; St-Arnaud, R.; Mills, G. B.; Dedhar, S.; Marshall, C. J.; Muller, W. J.			Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer	ONCOGENE			English	Article						integrin-linked kinase; ErbB2; mammary tumorigenesis	EPITHELIAL-SPECIFIC DISRUPTION; GLYCOGEN-SYNTHASE KINASE; TRANSGENIC MOUSE MODEL; PROTEIN-KINASE; CELL-SURVIVAL; GROWTH-FACTOR; THERAPEUTIC TARGET; MET AMPLIFICATION; B/AKT ACTIVATION; LUNG-CANCER	Elevated expression of the integrin-linked kinase (ILK) has been observed in a variety of cancers and has been further correlated with poor clinical outcome. Here, we show that mammary epithelial disruption of ILK results in a profound block in mammary tumor induction. Consistent with these observations, inhibition of ILK function in ErbB2-expressing cells with small molecule inhibitor or RNA interference resulted in profound block in their in vitro invasive properties due to the induction of apoptotic cell death. The rare ILK-deficient tumors that eventually arose overcame this block in tumor induction by an upregulation of ErB3 phosphorylation. These observations provide direct evidence that ILK has a critical role in the initiation phase of ErbB2 tumor induction. Oncogene (2010) 29, 3374-3385; doi:10.1038/onc.2010.86; published online 22 March 2010	[Pontier, S. M.; Huck, L.; Rayment, J.; Sanguin-Gendreau, V.; Zuo, D.; Muller, W. J.] McGill Univ, Goodman Canc Ctr, Dept Med, Montreal, PQ H3A 1A3, Canada; [White, D. E.; Marshall, C. J.] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, London, England; [Hennessy, B.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [St-Arnaud, R.] Shriners Hosp Crippled Children, Genet Unit, Montreal, PQ, Canada; [Dedhar, S.] Univ British Columbia, BC Canc Agcy, Dept Biochem, Vancouver, BC, Canada	McGill University; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; McGill University; British Columbia Cancer Agency; University of British Columbia	Muller, WJ (corresponding author), McGill Univ, Goodman Canc Ctr, Dept Med, 1160 Ave Pins Ouest,Room 509, Montreal, PQ H3A 1A3, Canada.	william.muller@mcgill.ca	Pontier, Stéphanie/A-3836-2015	Pontier, Stéphanie/0000-0002-9124-9228; Rayment, Jonathan/0000-0003-4955-8876; Hennessy, Bryan/0000-0002-7871-6477; Dedhar, Shoukat/0000-0003-4355-1657	The Terry Fox Foundation through an award from the National Cancer Institute of Canada (NCIC); US Department of Defense (BCRP/CDMRP Era of Hope Postdoctoral award); Cancer Research UK; Canadian Institutes of Health Research (CIHR)/Canadian Breast Cancer Research Alliance (CBCRA) [64280]; National Institutes of Health [5PO1GA-099031-05]	The Terry Fox Foundation through an award from the National Cancer Institute of Canada (NCIC); US Department of Defense (BCRP/CDMRP Era of Hope Postdoctoral award)(United States Department of Defense); Cancer Research UK(Cancer Research UK); Canadian Institutes of Health Research (CIHR)/Canadian Breast Cancer Research Alliance (CBCRA)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Cynthia Lavoie, Vassilios Papavassiliou, Celine Champigny and Kay Savage for excellent technical help during the project. We also thank all members of the Muller laboratory for their critical commentaries as well as Richard Lamb and Maria Cerone for critical discussions and reading. SMP was funded by a fellowship of The Terry Fox Foundation through an award from the National Cancer Institute of Canada (NCIC). DW was funded by the US Department of Defense (BCRP/CDMRP Era of Hope Postdoctoral award) as well as JR. CJM is a Cancer Research UK Gibb Fellow. WJM was supported by CRC Chair in Molecular Oncology. This work was supported by grants from Cancer Research UK, the Canadian Institutes of Health Research (CIHR)/Canadian Breast Cancer Research Alliance (CBCRA) (#64280), the US Department of Defense and the National Institutes of Health 5PO1GA-099031-05.	Ahmed F, 2002, CANCER RES, V62, P7166; Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Cowin P, 2007, J MAMMARY GLAND BIOL, V12, P99, DOI 10.1007/s10911-007-9041-9; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hennessy BT, 2007, CLIN CANCER RES, V13, P7421, DOI 10.1158/1078-0432.CCR-07-0760; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Somasiri A, 2001, J CELL SCI, V114, P1125; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078	47	36	39	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3374	3385		10.1038/onc.2010.86	http://dx.doi.org/10.1038/onc.2010.86			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20305688				2022-12-25	WOS:000278622700006
J	Deshane, J; Kim, J; Bolisetty, S; Hock, TD; Hill-Kapturczak, N; Agarwal, A				Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam			Sp1 Regulates Chromatin Looping between an Intronic Enhancer and Distal Promoter of the Human Heme Oxygenase-1 Gene in Renal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; CARBON-MONOXIDE; 1ST INTRON; IN-VIVO; EXPRESSION; INDUCTION; RECEPTOR; ELEMENTS; REGION; MCP-1	HO-1(heme oxygenase-1) is an inducible microsomal enzyme that catalyzes the degradation of pro-oxidant heme. The goal of this study was to characterize a minimal enhancer region within the human HO-1 gene and delineate its role in modulating HO-1 expression by participation with its promoter elements in renal epithelial cells. Deletion analysis and site-directed mutagenesis identified a 220-bp minimal enhancer in intron 1 of the HO-1 gene, which regulates hemin-mediated HO-1 gene expression. Small interfering RNA, decoy oligonucleotides, site-directed mutagenesis, and chromatin immunoprecipitation assays confirmed the functional interaction of Sp1 with a consensus binding sequence within the 220-bp region. Mutations of regulatory elements within the -4.5 kb promoter region (a cyclic AMP response and a downstream NF-E2/AP-1 element, both located at -4.0 kb, and/or an E-box sequence located at -44 bp) resulted in the loss of enhancer activity. A chromosome conformation capture assay performed in human renal epithelial (HK-2) cells demonstrated hemin-inducible chromatin looping between the intronic enhancer and the -4.0 kb promoter region in a time-dependent manner. Restriction digestion with ApaLI (which cleaves the 220-bp enhancer) led to a loss of stimulus-dependent chromatin looping. Sp1 small interfering RNA and mithramycin A, a Sp1 binding site inhibitor, resulted in loss of the loop formation between the intronic enhancer and the distal HO-1 promoter by the chromosome conformation capture assay. These results provide novel insight into the complex molecular interactions that underlie human HO-1 regulation in renal epithelial cells.	[Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam] Univ Alabama Birmingham, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA; [Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Deshane, Jessy; Hock, Thomas D.; Agarwal, Anupam] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Kim, Junghyun] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Agarwal, A (corresponding author), THT 647 Univ Alabama Birmingham, Div Nephrol, 1900 Univ Blvd, Birmingham, AL 35294 USA.	agarwal@uab.edu	Bolisetty, Subhashini/F-6496-2011		National Institutes of Health [DK059600, DK075332, DK079337, DK071875]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337, R01DK075532, R01DK071875, R01DK059600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK059600, DK075332, DK079337, and DK071875 (to A.A.).	ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Adoue V, 2008, J MOL BIOL, V384, P1048, DOI 10.1016/j.jmb.2008.10.019; AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; ALAM J, 1989, J BIOL CHEM, V264, P17637; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Flodby P, 2007, BIOCHEM BIOPH RES CO, V356, P26, DOI 10.1016/j.bbrc.2007.02.076; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Inguaggiato P, 2001, KIDNEY INT, V60, P2181, DOI 10.1046/j.1523-1755.2001.00046.x; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Miele Adriana, 2008, V464, P105; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nawrocki AR, 2002, J BIOL CHEM, V277, P14647, DOI 10.1074/jbc.M111549200; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; Ryter SW, 2006, CURR OPIN PHARMACOL, V6, P257, DOI 10.1016/j.coph.2006.03.002; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Sridhar P, 1999, MOL CELL BIOL, V19, P4219; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang X, 1998, ENDOCRINOLOGY, V139, P1054, DOI 10.1210/en.139.3.1054; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; ZHANG K, 1987, GENE, V57, P27, DOI 10.1016/0378-1119(87)90173-9	51	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16476	16486		10.1074/jbc.M109.058586	http://dx.doi.org/10.1074/jbc.M109.058586			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351094	Green Published, hybrid			2022-12-25	WOS:000277982600009
J	Takabayashi, T; Xie, MJ; Takeuchi, S; Kawasaki, M; Yagi, H; Okamoto, M; Tariqur, RM; Malik, F; Kuroda, K; Kubota, C; Fujieda, S; Nagano, T; Sato, M				Takabayashi, Tetsuji; Xie, Min-Jue; Takeuchi, Seiji; Kawasaki, Motomi; Yagi, Hideshi; Okamoto, Masayuki; Tariqur, Rahman M.; Malik, Fawzia; Kuroda, Kazuki; Kubota, Chikara; Fujieda, Shigeharu; Nagano, Takashi; Sato, Makoto			LL5 beta Directs the Translocation of Filamin A and SHIP2 to Sites of Phosphatidylinositol 3,4,5-Triphosphate (PtdIns(3,4,5)P-3) Accumulation, and PtdIns(3,4,5)P-3 Localization Is Mutually Modified by Co-recruited SHIP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; PROTEIN; BINDING; LAMELLIPODIA; ASSOCIATION; MIGRATION; MEMBRANE; ADAPTER	Phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P-3) accumulates at the leading edge of migrating cells and works, at least partially, as both a compass to indicate directionality and a hub for subsequent intracellular events. However, how PtdIns(3,4,5)P-3 regulates the migratory machinery has not been fully elucidated. Here, we demonstrate a novel mechanism for efficient lamellipodium formation that depends on PtdIns(3,4,5)P-3 and the reciprocal regulation of PtdIns(3,4,5)P-3 itself. LL5 beta, whose subcellular localization is directed by membrane PtdIns(3,4,5)P-3, recruits the actin-cross-linking protein Filamin A to the plasma membrane, where PtdIns(3,4,5)P-3 accumulates, with the Filamin A-binding Src homology 2 domain-containing inositol polyphosphate 5-phosphatase 2 (SHIP2). A large and dynamic lamellipodium was formed in the presence of Filamin A and LL5 beta by the application of epidermal growth factor. Conversely, depletion of either Filamin A or LL5 beta or the overexpression of either an F-actin-cross-linking mutant of Filamin A or a mutant of LL5 beta without its PtdIns(3,4,5)P-3-interacting region inhibited such events in COS-7 cells. Because F-actin initially polymerizes near the plasma membrane, it is likely that membrane-recruited Filamin A efficiently cross-links newly polymerized F-actin, leading to enhanced lamellipodium formation at the site of PtdIns(3,4,5)P-3 accumulation. Moreover, we demonstrate that co-recruited SHIP2 dephosphorylates PtdIns(3,4,5)P-3 at the same location.	[Takabayashi, Tetsuji; Xie, Min-Jue; Takeuchi, Seiji; Kawasaki, Motomi; Yagi, Hideshi; Okamoto, Masayuki; Tariqur, Rahman M.; Malik, Fawzia; Kuroda, Kazuki; Kubota, Chikara; Nagano, Takashi; Sato, Makoto] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Cell Biol & Neurosci, Fukui 9101193, Japan; [Takabayashi, Tetsuji; Okamoto, Masayuki; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan; [Kubota, Chikara] Univ Fukui, Fac Med Sci, Dept Surg, Div Orthoped Surg & Rehabil Med, Fukui 9101193, Japan; [Xie, Min-Jue; Takeuchi, Seiji; Yagi, Hideshi; Kuroda, Kazuki; Sato, Makoto] Univ Fukui, Res & Educ Program Life Sci, Fukui 9101193, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Sato, M (corresponding author), 23 Matsuokashimoaizuki, Fukui 9101193, Japan.	makosato@u-fukui.ac.jp	Rahman, Mohammad Tariqur/G-1728-2011	Rahman, Mohammad Tariqur/0000-0003-3600-3265; Yagi, Hideshi/0000-0002-8506-8965	21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program); University of Fukui; Toray Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Fukui; Toray Science Foundation(Toray Industries, Inc.); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the 21st Century Center of Excellence program (Biomedical Imaging Technology Integration Program), the Project Allocation Fund of the University of Fukui, the Toray Science Foundation, and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Kagawa S, 2008, ENDOCRINOLOGY, V149, P642, DOI 10.1210/en.2007-0820; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LEVI L, 1993, BIOCHIM BIOPHYS ACTA, V1216, P342, DOI 10.1016/0167-4781(93)90171-9; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Navolanic PM, 2003, INT J ONCOL, V22, P237; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	27	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16155	16165		10.1074/jbc.M109.081901	http://dx.doi.org/10.1074/jbc.M109.081901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236936	Green Published, hybrid			2022-12-25	WOS:000277715900053
J	Berry, DC; Soltanian, H; Noy, N				Berry, Daniel C.; Soltanian, Hooman; Noy, Noa			Repression of Cellular Retinoic Acid-binding Protein II during Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; ACTIVATED RECEPTOR; C/EBP-ALPHA; ADIPOGENESIS; CAMP; GENE; GROWTH; CELLS; SUPPRESSION; BETA/DELTA	In preadipocytes, retinoic acid (RA) regulates gene expression by activating the nuclear RA receptor (RAR) and its cognate intracellular lipid-binding protein CRABP-II. It was previously reported that RA inhibits adipocyte differentiation but only when administered early during the differentiation program. The data presented here indicate that the diminished ability of RA to activate RAR following induction of differentiation stems from down-regulation of CRABP-II. The observations show that expression of CRABP-II in preadipocytes is repressed by all three components of the classical hormonal mixture that induces adipocyte differentiation, i.e. isobutylmethylxanthine, insulin, and dexamethasone. Isobutylmethylxanthine-dependent activation of protein kinase A triggered the phosphorylation of the transcription factor cAMP-response element-binding protein, which induced the expression of the cAMP-response element-binding protein family repressor cAMP-response element modulator. In turn, cAMP-response element modulator was found to associate with a cognate response element in the CRABP-II promoter and to repress CRABP-II expression. The data further show that CRABP-II is a direct target gene for the glucocorticoid receptor and that it is subjected to dexamethasone-induced glucocorticoid receptor-mediated repression during adipogenesis. Finally, the observations demonstrate that permanent repression of CRABP-II in mature adipocytes is exerted by the master regulator of adipocyte differentiation CCAAT/enhancer-binding protein alpha and is directly mediated through CCAAT/enhancer-binding protein alpha-response elements in the CRABP-II promoter. Taken together, the observations emphasize the important role of CRABP-II in regulating the transcriptional activity of RA through RAR, and they demonstrate that repression of this gene is critical for allowing adipogenesis to proceed.	[Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Soltanian, Hooman] Case Med Ctr, Dept Plast Surg, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, W333 10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health [DK060684, DK073195T32]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319, R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK060684 (to N.N.); Supported by National Institutes of Health Grant DK073195T32.	Bakker AHF, 2004, OBES RES, V12, P488, DOI 10.1038/oby.2004.55; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Detry C, 2008, BONE, V42, P422, DOI 10.1016/j.bone.2007.10.016; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Manor D, 2003, CANCER RES, V63, P4426; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Smas CM, 1999, J BIOL CHEM, V274, P12632, DOI 10.1074/jbc.274.18.12632; Soliera AR, 2008, BLOOD, V112, P1942, DOI 10.1182/blood-2007-09-114975; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	36	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15324	15332		10.1074/jbc.M110.110635	http://dx.doi.org/10.1074/jbc.M110.110635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228061	Green Published, hybrid			2022-12-25	WOS:000277399000053
J	Gandhi, PS; Chen, ZW; Di Cera, E				Gandhi, Prafull S.; Chen, Zhiwei; Di Cera, Enrico			Crystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR; SUBSTRATE RECOGNITION; ALPHA-THROMBIN; SITE GEOMETRY; COMPLEX; BINDING; CLEAVAGE; PEPTIDE; FIBRINOGEN; RESIDUES	Abundant structural information exists on how thrombin recognizes ligands at the active site or at exosites separate from the active site region, but remarkably little is known about how thrombin recognizes substrates that bridge both the active site and exosite I. The case of the protease-activated receptor PAR1 is particularly relevant in view of the plethora of biological effects associated with its activation by thrombin. Here, we present the 1.8 angstrom resolution structure of thrombin S195A in complex with a 30-residue long uncleaved extracellular fragment of PAR1 that documents for the first time a productive binding mode bridging the active site and exosite I. The structure reveals two unexpected features of the thrombin-PAR1 interaction. The acidic P3 residue of PAR1, Asp(39), does not hinder binding to the active site and actually makes favorable interactions with Gly(219) of thrombin. The tethered ligand domain shows a considerable degree of disorder even when bound to thrombin. The results fill a significant gap in our understanding of the molecular mechanisms of recognition by thrombin in ways that are relevant to other physiological substrates.	[Gandhi, Prafull S.; Chen, Zhiwei; Di Cera, Enrico] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu			National Institutes of Health [HL49413, HL58141, HL73813, HL95315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049413, R44HL095315, R01HL073813, R01HL058141, R29HL049413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141 HL73813, and HL95315 (to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTUNIK HD, 1989, J MOL BIOL, V210, P813, DOI 10.1016/0022-2836(89)90110-1; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Cleary DB, 2002, ARCH BIOCHEM BIOPHYS, V403, P179, DOI 10.1016/S0003-9861(02)00220-5; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Isetti G, 2007, BIOCHEMISTRY-US, V46, P2444, DOI 10.1021/bi0622120; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Myles T, 2001, EUR J BIOCHEM, V268, P70, DOI 10.1046/j.1432-1327.2001.01844.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pechik I, 2006, BIOCHEMISTRY-US, V45, P3588, DOI 10.1021/bi0525369; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; RICHARDSON MA, 1992, NATURE, V360, P261, DOI 10.1038/360261a0; Rose T, 2002, J BIOL CHEM, V277, P18875, DOI 10.1074/jbc.M110977200; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; Yang LK, 2006, P NATL ACAD SCI USA, V103, P879, DOI 10.1073/pnas.0507700103; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200	62	51	52	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15393	15398		10.1074/jbc.M110.115337	http://dx.doi.org/10.1074/jbc.M110.115337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236938	hybrid, Green Published			2022-12-25	WOS:000277399000059
J	Yu, WH; Li, RF; Gui, B; Shang, YF				Yu, Wenhua; Li, Ruifang; Gui, Bin; Shang, Yongfeng			sZIP, an Alternative Splice Variant of ZIP, Antagonizes Transcription Repression and Growth Inhibition by ZIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; BREAST-CANCER; ANDROGEN RECEPTOR; EGFR; PROTEIN; ESTROGEN; MECHANISMS; CROSSTALK; INVASION; SUBUNIT	Recently, we reported a novel transcriptional repressor, ZIP (for zinc finger and G-patch domain-containing), which recruits the Mi-2/NuRD (nucleosome remodeling and deacetylase) complex and represses the expression of epidermal growth factor receptor (EGFR). In doing so, ZIP inhibits cell proliferation and suppresses breast carcinogenesis. Here, we report the cloning and the characterization of an alternatively spliced isoform of ZIP, sZIP. sZIP is an N-terminal truncated form of ZIP, lacking the zinc finger but retaining part of the G-patch domain and C-terminal coiled-coil domain of ZIP. We showed that sZIP could interact with the NuRD complex but lost its DNA-binding capacity. We demonstrated that sZIP antagonizes the transcription repression by ZIP by competing for the binding of the NuRD complex and that sZIP alleviates the growth inhibitory effect of ZIP on hepatocarcinoma cells through attenuating the transcriptional repression of EGFR. Our data provide a finely tuned mechanism for EGFR regulation and add another player for transcription repression.	[Yu, Wenhua; Li, Ruifang; Gui, Bin; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Minist Educ,Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Minist Educ,Key Lab Carcinogenesis & Translat Res, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn			National Natural Science Foundation of China [30830032, 30921062, 30600319]; Ministry of Science and Technology of China [2005CB522404, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y. S.) and 30600319 (to W. Y.) from the National Natural Science Foundation of China and 973 Program Grants 2005CB522404 and 2007CB914503 (to Y. S.) from the Ministry of Science and Technology of China.	Barrett-Lee PJ, 2005, ENDOCR-RELAT CANCER, V12, pS125, DOI 10.1677/erc.1.01024; Bonaccorsi L, 2004, INT J CANCER, V112, P78, DOI 10.1002/ijc.20362; Bonaccorsi L, 2007, J MOL ENDOCRINOL, V38, P51, DOI 10.1677/jme.1.02155; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Gilmore JL, 2006, BIOCHEM J, V396, P79, DOI 10.1042/BJ20051687; Italiano A, 2009, INT J CANCER, V125, P2479, DOI 10.1002/ijc.24610; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Liang J, 2009, EMBO REP, V10, P51, DOI 10.1038/embor.2008.223; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Moutinho C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-10; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	30	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14301	14307		10.1074/jbc.M110.107508	http://dx.doi.org/10.1074/jbc.M110.107508			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233718	Green Published, hybrid			2022-12-25	WOS:000277299700027
J	Macatangay, BJC; Szajnik, ME; Whiteside, TL; Riddler, SA; Rinaldo, CR				Macatangay, Bernard J. C.; Szajnik, Marta E.; Whiteside, Theresa L.; Riddler, Sharon A.; Rinaldo, Charles R.			Regulatory T Cell Suppression of Gag-Specific CD8(+) T Cell Polyfunctional Response After Therapeutic Vaccination of HIV-1-Infected Patients on ART	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; TYPE-1 INFECTION; IMMUNODEFICIENCY; SUBSETS; DESIGN	We tested the hypothesis that therapeutic vaccination against HIV-1 can increase the frequency and suppressive function of regulatory, CD4(+) T cells (Treg), thereby masking enhancement of HIV-1-specific CD8(+) T cell response. HIV-1-infected subjects on antiretroviral therapy (N = 17) enrolled in a phase I therapeutic vaccine trial received 2 doses of autologous dendritic cells (DC) loaded with HIV-1 peptides. The frequency of CD4(+)CD25(hi)FOXP3(+) Treg in blood was determined prior to and after vaccination in subjects and normal controls. Polyfunctional CD8(+) T cell responses were determined pre- and post-vaccine (N = 7) for 5 immune mediators after in vitro stimulation with Gag peptide, staphylococcal enterotoxin B (SEB), or medium alone. Total vaccine response (post-vaccine-pre-vaccine) was compared in the Treg(+) and Treg-depleted (Treg-) sets. After vaccination, 12/17 subjects showed a trend of increased Treg frequency (P = 0.06) from 0.74% to 1.2%. The increased frequency did not correlate with CD8(+) T cell vaccine response by enzyme linked immunosorbent assay for interferon gamma production. Although there was no significant change in CD8(+) T cell polyfunctional response after vaccination, Treg depletion increased the polyfunctionality of the total vaccine response (P = 0.029), with a >2-fold increase in the percentage of CD8(+) T cells producing multiple immune mediators. In contrast, depletion of Treg did not enhance polyfunctional T cell response to SEB, implying specificity of suppression to HIV-1 Gag. Therapeutic immunization with a DC-based vaccine against HIV-1 caused a modest increase in Treg frequency and a significant increase in HIV-1-specific, Treg suppressive function. The Treg suppressive effect masked an increase in the vaccine-induced anti-HIV-1-specific polyfunctional response. The role of Treg should be considered in immunotherapeutic trials of HIV-1 infection.	[Macatangay, Bernard J. C.; Riddler, Sharon A.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Szajnik, Marta E.; Whiteside, Theresa L.] Univ Pittsburgh, Dept Pathol, Inst Canc, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Pathol, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Macatangay, BJC (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	macatangaybj@upmc.edu		Macatangay, Bernard/0000-0002-0405-0991	NIH [U19-AI55794, PO1-DE12321, R37-AI41870]; NIR/NCRR/GCRC [MO1-RR-000056]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI055794, R37AI041870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012321] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIR/NCRR/GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by NIH grants: U19-AI55794, PO1-DE12321, R37-AI41870, and NIR/NCRR/GCRC grant MO1-RR-000056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld MA, 2001, J VIROL, V75, P1301, DOI 10.1128/JVI.75.3.1301-1311.2001; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Connolly NC, 2008, CLIN VACCINE IMMUNOL, V15, P284, DOI 10.1128/CVI.00221-07; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Huang XL, 2009, CLIN VACCINE IMMUNOL, V16, P1504, DOI 10.1128/CVI.00104-09; Ivars Fredrik, 2007, Chem Immunol Allergy, V93, P137, DOI 10.1159/000100862; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Lopez M, 2006, IMMUNOBIOLOGY, V211, P127, DOI 10.1016/j.imbio.2005.11.003; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Peretz Y, 2007, CLIN IMMUNOL, V124, P57, DOI 10.1016/j.clim.2007.04.004; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Seddiki Nabila, 2008, Curr HIV/AIDS Rep, V5, P20, DOI 10.1007/s11904-008-0004-6; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	27	47	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9852	10.1371/journal.pone.0009852	http://dx.doi.org/10.1371/journal.pone.0009852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352042	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000275894500019
J	Saari, S; Sundell, J; Huitu, O; Helander, M; Ketoja, E; Ylonen, H; Saikkonen, K				Saari, Susanna; Sundell, Janne; Huitu, Otso; Helander, Marjo; Ketoja, Elise; Ylonen, Hannu; Saikkonen, Kari			Fungal-Mediated Multitrophic Interactions - Do Grass Endophytes in Diet Protect Voles from Predators?	PLOS ONE			English	Article							PERFORMANCE; CONSUMPTION; COMMUNITY; WEASELS	Plant-associated micro-organisms such as mycotoxin-producing endophytes commonly have direct negative effects on herbivores. These effects may be carried over to natural enemies of the herbivores, but this has been rarely explored. We examined how feeding on Neotyphodium endophyte infected (E+) and endophyte free (E-) meadow ryegrass (Scherodonus pratensis) affects body mass, population size and mobility of sibling voles (Microtus levis), and whether the diet mediates the vulnerability of voles to least weasel (Mustela nivalis nivalis) predation. Because least weasels are known to be olfactory hunters, we also examined whether they are able to distinguish olfactory cues of voles fed on E+ and E- diets. Neither body mass of voles nor population size differed between diets. However, contrary to our prediction, least weasels preyed more often on voles fed with E- grass than on voles fed with E+ grass. The mobility of voles fed on E+ grass was reduced compared to voles fed on E- grass, but this effect was unrelated to risk of predation. Least weasels appeared unable to distinguish between excrement odours of voles between the two treatments. Our results suggest that consumption of endophytic grass is not directly deleterious to sibling voles. What's more, consumption of endophytes appears to be advantageous to voles by reducing risk of mammalian predation. Our study is thus the first to demonstrate an effect of plant-associated microbial symbionts on herbivore-predator interactions in vertebrate communities.	[Saari, Susanna; Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Saari, Susanna; Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Sundell, Janne; Ylonen, Hannu] Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, Konnevesi, Finland; [Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland; [Ketoja, Elise] MTT Agrifood Res Finland, Serv Unit, Jokioinen, Finland; [Sundell, Janne] Univ Helsinki, Lammi Biol Stn, Lammi, Finland	Natural Resources Institute Finland (Luke); University of Turku; University of Jyvaskyla; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Helsinki	Saari, S (corresponding author), MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland.	susanna.saari@mtt.fi	Saari, Susanna/A-1677-2016	Saari, Susanna/0000-0002-3746-4728; Helander, Marjo/0000-0002-9759-4321	Academy of Finland; Marjatta and Eino Kolli Foundation; Olvi Foundation	Academy of Finland(Academy of Finland); Marjatta and Eino Kolli Foundation; Olvi Foundation	This study is part of Endophytic Fungi in Ecological Plant Production Programme no. 110658, funded by the Academy of Finland, Niemi Foundation, Marjatta and Eino Kolli Foundation and Olvi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.aka.fi/fi/A/, http://www.olvisaatio.fi/web/olvisaatio/, https://www.kollinsaatio.com/. There is no URL for Niemi Foundation.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; BACON CW, 1977, APPL ENVIRON MICROB, V34, P576, DOI 10.1128/AEM.34.5.576-581.1977; Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Barker GM, 1996, BIOL CONTROL, V7, P281, DOI 10.1006/bcon.1996.0095; Bultman TL, 2003, OIKOS, V102, P491, DOI 10.1034/j.1600-0706.2003.11477.x; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; COLEY AB, 1995, J ENV QUAL, V24; Conover MR, 1998, J MAMMAL, V79, P457, DOI 10.2307/1382976; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Durham WF, 1998, CAN J ZOOL, V76, P960, DOI 10.1139/cjz-76-5-960; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; HAMETAHTI L, 1988, RETKEILYKASVIO FIELD; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; Huitu O, 2008, OECOLOGIA, V156, P333, DOI 10.1007/s00442-008-0984-3; Justus M, 1997, PHYTOCHEMISTRY, V44, P51, DOI 10.1016/S0031-9422(96)00535-3; KORPIMAKI E, 1991, OECOLOGIA, V88, P552, DOI 10.1007/BF00317719; KREBS CJ, 1999, ECOLOGICAL METHODOLO, P94; Leuchtmann Adrian, 1992, Natural Toxins, V1, P150, DOI 10.1002/nt.2620010303; Little T, 1978, AGR EXPT DESIGN ANAL; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sundell J, 2004, BEHAV ECOL SOCIOBIOL, V56, P263, DOI 10.1007/s00265-004-0777-6; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; WOLDEMICHAEL GM, 2002, BIOCH SYST ECOL, V30, P264; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2	32	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9845	10.1371/journal.pone.0009845	http://dx.doi.org/10.1371/journal.pone.0009845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352096	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500013
J	Uemura, M; Niwa, Y; Kakazu, N; Adachi, N; Kinoshita, K				Uemura, Munehiro; Niwa, Youko; Kakazu, Naoki; Adachi, Noritaka; Kinoshita, Kazuo			Chromosomal Manipulation by Site-Specific Recombinases and Fluorescent Protein-Based Vectors	PLOS ONE			English	Article							CRE-LOXP; TRANSLOCATION; GENOME; RANGE	Feasibility of chromosomal manipulation in mammalian cells was first reported 15 years ago. Although this technique is useful for precise understanding of gene regulation in the chromosomal context, a limited number of laboratories have used it in actual practice because of associated technical difficulties. To overcome the practical hurdles, we developed a Cre-mediated chromosomal recombination system using fluorescent proteins and various site-specific recombinases. These techniques enabled quick construction of targeting vectors, easy identification of chromosome-rearranged cells, and rearrangement leaving minimum artificial elements at junctions. Applying this system to a human cell line, we successfully recapitulated two types of pathogenic chromosomal translocations in human diseases: MYC/IgH and BCR/ABL1. By inducing recombination between two loxP sites targeted into the same chromosome, we could mark cells harboring deletion or duplication of the inter-loxP segments with different colors of fluorescence. In addition, we demonstrated that the intrachromosomal recombination frequency is inversely proportional to the distance between two recombination sites, implicating a future application of this frequency as a proximity sensor. Our method of chromosomal manipulation can be employed for particular cell types in which gene targeting is possible (e. g. embryonic stem cells). Experimental use of this system would open up new horizons in genome biology, including the establishment of cellular and animal models of diseases caused by translocations and copy-number variations.	[Uemura, Munehiro; Niwa, Youko; Kinoshita, Kazuo] Shiga Med Ctr, Res Inst, Moriyama, Japan; [Kakazu, Naoki] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan	Shimane University; Yokohama City University	Uemura, M (corresponding author), Shiga Med Ctr, Res Inst, Moriyama, Japan.	kkinoshi.shigamed@mac.com		Kakazu, Naoki/0000-0001-7251-069X	Japanese Society for the Promotion of Science [KAKENHI 20590326]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (KAKENHI 20590326) from Japanese Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Golic KG, 1996, GENETICS, V144, P1693; Golic MM, 1996, GENETICS, V143, P385; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOZIER J, 1980, INT J CANCER, V26, P281, DOI 10.1002/ijc.2910260305; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu PT, 1998, GENETICS, V150, P1155; MATSUZAKI H, 1990, J BACTERIOL, V172, P610, DOI 10.1128/jb.172.2.610-618.1990; QIN MM, 1994, P NATL ACAD SCI USA, V91, P1706, DOI 10.1073/pnas.91.5.1706; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Smith AJH, 2002, ONCOGENE, V21, P4521, DOI 10.1038/sj.onc.1205530; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	23	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9846	10.1371/journal.pone.0009846	http://dx.doi.org/10.1371/journal.pone.0009846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352097	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500014
J	Chun, JN; Choi, B; Lee, KW; Lee, DJ; Kang, DH; Lee, JY; Song, IS; Kim, HI; Lee, SH; Kim, HS; Lee, NK; Lee, SY; Lee, KJ; Kim, J; Kang, SW				Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Sang-Hee; Kim, Hyeon Soo; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won			Cytosolic Hsp60 Is Involved in the NF-kappa B-Dependent Survival of Cancer Cells via IKK Regulation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN; KINASE-ALPHA; OSTEOCLAST DIFFERENTIATION; GENE-EXPRESSION; CHAPERONIN GROEL; SERINE-PROTEASE; ACTIVATION; APOPTOSIS; COMPLEX	Cytoplasmic presence of Hsp60, which is principally a nuclear gene-encoded mitochondrial chaperonin, has frequently been stated, but its role in intracellular signaling is largely unknown. In this study, we demonstrate that the cytosolic Hsp60 promotes the TNF-alpha-mediated activation of the IKK/NF-kappa B survival pathway via direct interaction with IKK alpha/beta in the cytoplasm. Selective loss or blockade of cytosolic Hsp60 by specific antisense oligonucleotide or neutralizing antibody diminished the IKK/NF-kappa B activation and the expression of NF-kappa B target genes, such as Bfl-1/A1 and MnSOD, which thus augmented intracellular ROS production and ASK1-dependent cell death, in response to TNF-alpha. Conversely, the ectopic expression of cytosol-targeted Hsp60 enhanced IKK/NF-kappa B activation. Mechanistically, the cytosolic Hsp60 enhanced IKK activation via upregulating the activation-dependent serine phosphorylation in a chaperone-independent manner. Furthermore, transgenic mouse study showed that the cytosolic Hsp60 suppressed hepatic cell death induced by diethylnitrosamine in vivo. The cytosolic Hsp60 is likely to be a regulatory component of IKK complex and it implicates the first mitochondrial factor that regulates cell survival via NF-kappa B pathway.	[Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Chun, Jung Nyeo; Choi, Boae; Lee, Kyung Wha; Lee, Doo Jae; Kang, Dong Hoon; Lee, Joo Young; Song, In Sung; Kim, Hye In; Lee, Na Kyung; Lee, Soo Young; Lee, Kong-Joo; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Lee, Soo Young; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Lee, Soo Young; Kim, Jaesang; Kang, Sang Won] Ewha Womans Univ, Coll Nat Sci, Seoul, South Korea; [Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Lee, Sang-Hee] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon, South Korea; [Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Korea Basic Science Institute (KBSI); Korea University; Korea University Medicine (KU Medicine)	Chun, JN (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	kangsw@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Ministry of Education, Science Technology; KOSEF [R15-2006-020]; National R&D Program for Cancer Control, Ministry of Health Welfare [0420190]; Korea Ministry of Education, Science Technology	Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KOSEF(Korea Science and Engineering Foundation); National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by 21C Frontier Functional Proteomics Project (FPR08-B1-190) funded by the Ministry of Education, Science & Technology and by KOSEF through the Center for Cell Signaling & Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University. This study was also supported in part by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare (0420190). J.N. Chun, K. W. Lee, J.Y. Lee, B. A. Choi, and H. I. Kim were supported by Brain Korea 21 grant from the Korea Ministry of Education, Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozner P, 2002, J ALZHEIMERS DIS, V4, P479; Briones P, 1997, J INHERIT METAB DIS, V20, P569, DOI 10.1023/A:1005303008439; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; CAPPELLO F, 2008, CANC BIOL THER, V7; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hehner SP, 2000, MOL CELL BIOL, V20, P2556, DOI 10.1128/MCB.20.7.2556-2568.2000; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lai HC, 2007, AM J PHYSIOL-ENDOC M, V292, pE292, DOI 10.1152/ajpendo.00189.2006; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Park SG, 2003, J BIOL CHEM, V278, P39851, DOI 10.1074/jbc.M301618200; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; STEINHOFF U, 1994, P NATL ACAD SCI USA, V91, P5085, DOI 10.1073/pnas.91.11.5085; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WHITE ZW, 1995, J BIOL CHEM, V270, P20404, DOI 10.1074/jbc.270.35.20404; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	71	81	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9422	10.1371/journal.pone.0009422	http://dx.doi.org/10.1371/journal.pone.0009422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351780	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894400003
J	Sheward, WJ; Naylor, E; Knowles-Barley, S; Armstrong, JD; Brooker, GA; Seckl, JR; Turek, FW; Holmes, MC; Zee, PC; Harmar, AJ				Sheward, W. John; Naylor, Erik; Knowles-Barley, Seymour; Armstrong, J. Douglas; Brooker, Gillian A.; Seckl, Jonathan R.; Turek, Fred W.; Holmes, Megan C.; Zee, Phyllis C.; Harmar, Anthony J.			Circadian Control of Mouse Heart Rate and Blood Pressure by the Suprachiasmatic Nuclei: Behavioral Effects Are More Significant than Direct Outputs	PLOS ONE			English	Article							VPAC(2) RECEPTOR; CLOCK GENE; SLEEP; RHYTHMICITY; MICE; VARIABILITY; ONSET; RESPONSIVENESS; ASSOCIATION; HOMEOSTASIS	Background: Diurnal variations in the incidence of events such as heart attack and stroke suggest a role for circadian rhythms in the etiology of cardiovascular disease. The aim of this study was to assess the influence of the suprachiasmatic nucleus (SCN) circadian clock on cardiovascular function. Methodology/Principal Findings: Heart rate (HR), blood pressure (BP) and locomotor activity (LA) were measured in circadian mutant (Vipr2(-/-)) mice and wild type littermates, using implanted radio-telemetry devices. Sleep and wakefulness were studied in similar mice implanted with electroencephalograph (EEG) electrodes. There was less diurnal variation in the frequency and duration of bouts of rest/activity and sleep/wake in Vipr2(-/-) mice than in wild type (WT) and short "ultradian" episodes of arousal were more prominent, especially in constant conditions (DD). Activity was an important determinant of circadian variation in BP and HR in animals of both genotypes; altered timing of episodes of activity and rest (as well as sleep and wakefulness) across the day accounted for most of the difference between Vipr2(-/-) mice and WT. However, there was also a modest circadian rhythm of resting HR and BP that was independent of LA. Conclusions/Significance: If appropriate methods of analysis are used that take into account sleep and locomotor activity level, mice are a good model for understanding the contribution of circadian timing to cardiovascular function. Future studies of the influence of sleep and wakefulness on cardiovascular physiology may help to explain accumulating evidence linking disrupted sleep with cardiovascular disease in man.	[Sheward, W. John; Brooker, Gillian A.; Seckl, Jonathan R.; Holmes, Megan C.; Harmar, Anthony J.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Naylor, Erik; Zee, Phyllis C.] Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Knowles-Barley, Seymour; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Turek, Fred W.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Edinburgh; Northwestern University; University of Edinburgh; Northwestern University	Sheward, WJ (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	tony.harmar@ed.ac.uk	Seckl, Jonathan R/C-3555-2013; Zee, Phyllis C/GPF-3704-2022	Armstrong, Douglas/0000-0002-5397-3864; Naylor, Erik/0000-0002-7508-9244; Harmar, Anthony/0000-0002-3838-9264	Medical Research Council [G9719726]; Wellcome Trust; British Heart Foundation Centre of Research Excellence Award [RE/08/001]; National Institutes of Health (NIH) [T32 AG020506-02]; EPSRC; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER; Medical Research Council [G0700704B] Funding Source: researchfish; MRC [G9719726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation Centre of Research Excellence Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (G9719726) and the Wellcome Trust. The authors also acknowledge the support of the British Heart Foundation Centre of Research Excellence Award RE/08/001. E.N. was supported by National Institutes of Health (NIH) training grant T32 AG020506-02 and S.K.-B. by the EPSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ HR, 1993, CIRCULATION, V88, P2284, DOI 10.1161/01.CIR.88.5.2284; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Ibuka N, 1980, Waking Sleeping, V4, P167; JANSSEN BJA, 1994, PHYSIOL BEHAV, V55, P307, DOI 10.1016/0031-9384(94)90138-4; Kerkhof GA, 1998, AM J HYPERTENS, V11, P373, DOI 10.1016/S0895-7061(97)00461-5; Kim SM, 2008, AM J PHYSIOL-REG I, V294, pR1427, DOI 10.1152/ajpregu.00074.2008; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819, DOI 10.1152/ajpregu.1994.267.3.R819; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Laposky AD, 2008, AM J PHYSIOL-REG I, V295, pR2059, DOI 10.1152/ajpregu.00026.2008; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; LEHMANN U, 1976, INT J CHRONOBIOL, V4, P223; Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Naylor E, 2000, J NEUROSCI, V20, P8138; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; SANO H, 1995, JPN CIRC J, V59, P565, DOI 10.1253/jcj.59.565; Scheer FAJL, 1999, J BIOL RHYTHM, V14, P202, DOI 10.1177/074873099129000614; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sei H, 2008, ENDOCRINOLOGY, V149, P3576, DOI 10.1210/en.2007-1714; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; Turek FW DC, 2005, PRINCIPLES PRACTICE, P318; Van Dongen HPA, 2001, CHRONOBIOL INT, V18, P85, DOI 10.1081/CBI-100001178; Van Vliet BN, 2003, J PHYSIOL-LONDON, V549, P313, DOI 10.1113/jphysiol.2003.041897; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; WELSH DK, 1986, J COMP PHYSIOL A, V158, P827, DOI 10.1007/BF01324824; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20	51	57	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9783	10.1371/journal.pone.0009783	http://dx.doi.org/10.1371/journal.pone.0009783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339544	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894300016
J	Hartman, AL; Norais, C; Badger, JH; Delmas, S; Haldenby, S; Madupu, R; Robinson, J; Khouri, H; Ren, QH; Lowe, TM; Maupin-Furlow, J; Pohlschroder, M; Daniels, C; Pfeiffer, F; Allers, T; Eisen, JA				Hartman, Amber L.; Norais, Cedric; Badger, Jonathan H.; Delmas, Stephane; Haldenby, Sam; Madupu, Ramana; Robinson, Jeffrey; Khouri, Hoda; Ren, Qinghu; Lowe, Todd M.; Maupin-Furlow, Julie; Pohlschroder, Mecky; Daniels, Charles; Pfeiffer, Friedhelm; Allers, Thorsten; Eisen, Jonathan A.			The Complete Genome Sequence of Haloferax volcanii DS2, a Model Archaeon	PLOS ONE			English	Article							HALOBACTERIUM SPECIES NRC-1; HALOPHILIC ARCHAEON; ESCHERICHIA-COLI; IN-VIVO; PHOSPHOTRANSFERASE SYSTEM; HALOARCULA-HISPANICA; RNA POLYADENYLATION; SIGNAL-TRANSDUCTION; PYROCOCCUS-ABYSSI; BACTERIAL GENOMES	Background: Haloferax volcanii is an easily culturable moderate halophile that grows on simple defined media, is readily transformable, and has a relatively stable genome. This, in combination with its biochemical and genetic tractability, has made Hfx. volcanii a key model organism, not only for the study of halophilicity, but also for archaeal biology in general. Methodology/Principal Findings: We report here the sequencing and analysis of the genome of Hfx. volcanii DS2, the type strain of this species. The genome contains a main 2.848 Mb chromosome, three smaller chromosomes pHV1, 3, 4 (85, 438, 636 kb, respectively) and the pHV2 plasmid (6.4 kb). Conclusions/Significance: The completed genome sequence, presented here, provides an invaluable tool for further in vivo and in vitro studies of Hfx. volcanii.	[Hartman, Amber L.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Hartman, Amber L.; Badger, Jonathan H.; Madupu, Ramana; Robinson, Jeffrey; Khouri, Hoda; Ren, Qinghu; Eisen, Jonathan A.] J Craig Venter Inst, Inst Genom Res, Rockville, MD USA; [Norais, Cedric] Univ Paris Sud, Inst Genet & Microbiol, Paris, France; [Lowe, Todd M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Maupin-Furlow, Julie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Pohlschroder, Mecky] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Delmas, Stephane; Haldenby, Sam; Allers, Thorsten] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Daniels, Charles] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Hartman, Amber L.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Pfeiffer, Friedhelm] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Norais, Cedric] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	Johns Hopkins University; J. Craig Venter Institute; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; University of Pennsylvania; University of Nottingham; University System of Ohio; Ohio State University; University of California System; University of California Davis; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Hartman, AL (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	jaeisen@ucdavis.edu	Maupin-Furlow, Julie/AAW-4035-2020; Uthandi, Sivakumar/C-3277-2018; Allers, Thorsten/G-5503-2010; Eisen, Jonathan A./H-2706-2019; Pfeiffer, Friedhelm/K-1757-2019; Lowe, Todd Michael/ABJ-5261-2022; Pohlschroder, Mechy/P-3206-2019	Maupin-Furlow, Julie/0000-0001-6105-0923; Uthandi, Sivakumar/0000-0002-7116-1317; Allers, Thorsten/0000-0002-7308-3332; Eisen, Jonathan A./0000-0002-0159-2197; Pfeiffer, Friedhelm/0000-0003-4691-3246; Scholz, Amber/0000-0002-3461-0881; Delmas, Stephane/0000-0001-5523-7548	National Science Foundation [EF-024349, EF-0949453]; Biotechnology and Biological Sciences Research Council [BB/C501641/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The genome sequencing and initial analysis of the data was supported by grant EF-024349 from the National Science Foundation. Later work was supported in part by grant EF-0949453 from the National Science Foundation. Additional funding came from multiple sources supporting the work in labs other than the Eisen lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Alloing G, 2006, J BACTERIOL, V188, P6308, DOI 10.1128/JB.00585-06; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beard SJ, 2002, FEMS MICROBIOL LETT, V213, P149, DOI 10.1111/j.1574-6968.2002.tb11299.x; Bertani G, 1999, J BACTERIOL, V181, P2992, DOI 10.1128/JB.181.10.2992-3002.1999; Bidle KA, 2008, MICROBIOL-SGM, V154, P1436, DOI 10.1099/mic.0.2007/015586-0; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brenneis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004484; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; CHARLEBOIS RL, 1991, J MOL BIOL, V222, P509, DOI 10.1016/0022-2836(91)90493-P; CHARLEBOIS RL, 1987, P NATL ACAD SCI USA, V84, P8530, DOI 10.1073/pnas.84.23.8530; CHARLEBOIS RL, 1989, CAN J MICROBIOL, V35, P21, DOI 10.1139/m89-004; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; CLINE SW, 1992, J BACTERIOL, V174, P1076, DOI 10.1128/jb.174.3.1076-1080.1992; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; COHEN A, 1992, P NATL ACAD SCI USA, V89, P1602, DOI 10.1073/pnas.89.5.1602; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; DasSarma S, 2001, PHOTOSYNTH RES, V70, P3, DOI 10.1023/A:1013879706863; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; DOOLITTLE WF, 1992, BIOCHEM SOC SYMP, P73; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Eisen JA, 1997, NAT MED, V3, P1076, DOI 10.1038/nm1097-1076; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EISEN JA, 1999, EVOLUTION DNA REPAIR; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Ferrer C, 1996, J BACTERIOL, V178, P309, DOI 10.1128/jb.178.1.309-313.1996; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Guy CP, 2006, J MOL BIOL, V358, P46, DOI 10.1016/j.jmb.2006.02.010; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hand NJ, 2006, J BACTERIOL, V188, P1251, DOI 10.1128/JB.188.4.1251-1259.2006; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Helm RA, 2003, GENETICS, V165, P951; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; HOFMAN JD, 1986, NUCLEIC ACIDS RES, V14, P6983, DOI 10.1093/nar/14.17.6983; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; HOLMES ML, 1991, J BACTERIOL, V173, P3807, DOI 10.1128/JB.173.12.3807-3813.1991; HOLMES ML, 1991, J BACTERIOL, V173, P642, DOI 10.1128/jb.173.2.642-648.1991; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jokela M, 2004, NUCLEIC ACIDS RES, V32, P2430, DOI 10.1093/nar/gkh558; Karadzic IM, 2005, PROTEOMICS, V5, P354, DOI 10.1002/pmic.200400950; Kirkland PA, 2008, J PROTEOME RES, V7, P5033, DOI 10.1021/pr800517a; Kirkland PA, 2006, ANAL BIOCHEM, V351, P254, DOI 10.1016/j.ab.2006.01.017; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Konrad Z, 2002, FEMS MICROBIOL LETT, V209, P197, DOI 10.1111/j.1574-6968.2002.tb11131.x; Konrad Z, 2002, BIOCHEM J, V366, P959, DOI 10.1042/BJ20020757; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurz Matthias, 2006, Saline Syst, V2, P10, DOI 10.1186/1746-1448-2-10; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; LOPEZGARCIA P, 1995, J BACTERIOL, V177, P1405, DOI 10.1128/jb.177.5.1405-1408.1995; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACKWAN RR, 2006, GENETICS; MacNeill SA, 2009, BIOCHEM SOC T, V37, P108, DOI 10.1042/BST0370108; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; McCready S, 1996, MUTAT RES-DNA REPAIR, V364, P25, DOI 10.1016/0921-8777(96)00018-3; McGeoch AT, 2008, NAT REV MOL CELL BIO, V9, P569, DOI 10.1038/nrm2426; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; MEVARECH M, 1985, J BACTERIOL, V162, P461, DOI 10.1128/JB.162.1.461-462.1985; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; MOJICA FJM, 1994, J BACTERIOL, V176, P4966, DOI 10.1128/jb.176.16.4966-4973.1994; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; MORIMOTO S, 2007, GENOME LEVEL T UNPUB; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; Nandi Tannistha, 2004, In Silico Biology, V4, P573; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; OREN A, 2008, CORRECT NAMES TAXA F; Ortenberg R, 2000, MOL MICROBIOL, V35, P1493, DOI 10.1046/j.1365-2958.2000.01815.x; PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995; PFEIFER F, 1985, MOL GEN GENET, V198, P449, DOI 10.1007/BF00332938; PFEIFER F, 1990, NUCLEIC ACIDS RES, V18, P6921, DOI 10.1093/nar/18.23.6921; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; ROBINSON NP, 2007, P NATL ACAD SCI US; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rose RW, 2002, J BACTERIOL, V184, P3260, DOI 10.1128/JB.184.12.3260-3267.2002; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; SAPIENZA C, 1982, NATURE, V299, P182, DOI 10.1038/299182a0; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Shingaki R, 2003, CAN J MICROBIOL, V49, P313, DOI 10.1139/W03-041; Sicheritz-Ponten T, 2001, NUCLEIC ACIDS RES, V29, P545, DOI 10.1093/nar/29.2.545; SIMSEK M, 1982, P NATL ACAD SCI-BIOL, V79, P7268, DOI 10.1073/pnas.79.23.7268; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; TRIESELMANN BA, 1992, J BACTERIOL, V174, P30, DOI 10.1128/jb.174.1.30-34.1992; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; VOLCANI BE, 1936, NATURE; Ward N, 2001, NATURE, V414, P148, DOI 10.1038/35102737; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wimmer F, 2008, FEBS LETT, V582, P3771, DOI 10.1016/j.febslet.2008.10.004; Woods WG, 1999, J BACTERIOL, V181, P7140, DOI 10.1128/JB.181.22.7140-7142.1999; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Wuichet K, 2007, METHOD ENZYMOL, V422, P3, DOI 10.1016/S0076-6879(06)22001-9; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; YURISTDOUTSCH S, 2009, J BACTERIOL; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041; Zhao A, 2006, MOL MICROBIOL, V59, P743, DOI 10.1111/j.1365-2958.2005.04975.x; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	164	183	378	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9605	10.1371/journal.pone.0009605	http://dx.doi.org/10.1371/journal.pone.0009605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333302	Green Submitted, Green Published, gold			2022-12-25	WOS:000275809700003
J	Mahajan, K; Coppola, D; Challa, S; Fang, B; Chen, YA; Zhu, WW; Lopez, AS; Koomen, J; Engelman, RW; Rivera, C; Muraoka-Cook, RS; Cheng, JQ; Schonbrunn, E; Sebti, SM; Earp, HS; Mahajan, NP				Mahajan, Kiran; Coppola, Domenico; Challa, Sridevi; Fang, Bin; Chen, Y. Ann; Zhu, Weiwei; Lopez, Alexis S.; Koomen, John; Engelman, Robert W.; Rivera, Charlene; Muraoka-Cook, Rebecca S.; Cheng, Jin Q.; Schoenbrunn, Ernst; Sebti, Said M.; Earp, H. Shelton; Mahajan, Nupam P.			Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation	PLOS ONE			English	Article							PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; FOXO TRANSCRIPTION FACTORS; CANCER DRUG DISCOVERY; BREAST-CANCER; ONCOGENIC TRANSFORMATION; PHOSPHATIDIC-ACID; PI3K/AKT PATHWAY; AKT PATHWAY; GENE	The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development. Most studies have focused on its activation by Receptor Tyrosine Kinase (RTK) mediated Phosphatidylinositol-3-OH kinase (PI3K) activation or loss of Phosphatase and Tensin homolog (PTEN). We have uncovered that growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain. Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation. Mice expressing activated Ack1 specifically in the prostate exhibit AKT Tyr176-phosphorylation and develop murine prostatic intraepithelial neoplasia (mPINs). Further, expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1 were positively correlated with the severity of disease progression, and inversely correlated with the survival of breast cancer patients. Thus, RTK/Ack1/AKT pathway provides a novel target for drug discovery.	[Mahajan, Kiran; Challa, Sridevi; Schoenbrunn, Ernst; Sebti, Said M.; Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL USA; [Coppola, Domenico; Lopez, Alexis S.; Engelman, Robert W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL USA; [Fang, Bin; Koomen, John] H Lee Moffitt Canc Ctr & Res Inst, Prote Facil, Tampa, FL USA; [Chen, Y. Ann; Zhu, Weiwei] H Lee Moffitt Canc Ctr & Res Inst, Div Biostat, Tampa, FL USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Rivera, Charlene; Muraoka-Cook, Rebecca S.; Earp, H. Shelton] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Mahajan, K (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL USA.	nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020; Koomen, John/D-1844-2013	Mahajan, Kiran/0000-0001-7192-396X; Chen, yian/0000-0003-1468-3490; CHALLA, SRIDEVI/0000-0002-5308-9243; Schonbrunn, Ernst/0000-0002-3589-3510	Moffitt Support Grant; National Institutes of Health (NIH) [R01CA120304]; Department of Defense [W81XWH-09-1-0187]; NATIONAL CANCER INSTITUTE [R01CA120304] Funding Source: NIH RePORTER	Moffitt Support Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was funded by Moffitt Support Grant (to N. P. M.). This work was partially supported by grants from National Institutes of Health (NIH) (R01CA120304 to H. S. E.) and the Department of Defense (W81XWH-09-1-0187 to C. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kiyono M, 2000, J BIOL CHEM, V275, P29788, DOI 10.1074/jbc.M001378200; MAHAJAN K, 2010, PROSTATE MA IN PRESS; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Matsumoto J, 2002, JPN J CANCER RES, V93, P1317, DOI 10.1111/j.1349-7006.2002.tb01240.x; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Sakurada A, 1997, JPN J CANCER RES, V88, P1025, DOI 10.1111/j.1349-7006.1997.tb00324.x; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SANTI SA, 2009, AM J PHYSL CELL PHYS; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tibes R, 2008, BRIT J HAEMATOL, V140, P344, DOI 10.1111/j.1365-2141.2007.06920.x; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	45	106	124	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9646	10.1371/journal.pone.0009646	http://dx.doi.org/10.1371/journal.pone.0009646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333297	Green Published, gold, Green Submitted			2022-12-25	WOS:000275809700005
J	Cai, QL; Verma, SC; Kumar, P; Ma, M; Robertson, ES				Cai, Qiliang; Verma, Suhbash C.; Kumar, Pankaj; Ma, Michelle; Robertson, Erle S.			Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification	PLOS ONE			English	Article							HIPPEL-LINDAU GENE; KAPPA-B ACTIVATION; TRANSCRIPTIONAL ACTIVITY; FIBRONECTIN MATRIX; NUCLEAR EXPORT; P53 ACTIVITY; DNA-BINDING; IN-VIVO; PROTEIN; PVHL	The hypoxic microenvironment contributes to embryonic development and tumor progression through stabilization of the potent transcriptional factor HIF alpha. In normoxia, the tumor suppressor protein VHL acts as an E3 ubiquitin ligase to target HIFa for proteolytic destruction. Increasing evidence shows that VHL is a multifunctional adaptor involved in inhibition of HIF alpha-dependent and independent cellular processes. However, the molecular effect of hypoxic stress on VHL functions remains elusive. Here we report that PIASy, a SUMO E3 ligase upregulated in hypoxia, interacts with VHL and induces VHL SUMOylation on lysine residue 171. Moreover, PIASy-mediated SUMO1 modification induces VHL oligomerization and abrogates its inhibitory function on tumor cell growth, migration and clonogenicity. Knockdown of PIASy by small interfering RNA leads to reduction of VHL oligomerization and increases HIF1 alpha degradation. These findings reveal a unique molecular strategy for inactivation of VHL under hypoxic stress.	[Cai, Qiliang] Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cai, QL (corresponding author), Univ Penn, Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA.	erle@upenn.edu			National Cancer Institute [5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01, 1R01CA138434-01A209]; National Institute of Allergy and Infectious Diseases [5R01AI067037-04]; National Institute of Dental and Craniofacial Research [5R01DE017338-03]; NATIONAL CANCER INSTITUTE [R01CA108461, R00CA126182, R01CA137894, R01CA091792, R01CA138434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Cancer Institute 5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01 and 1R01CA138434-01A209; National Institute of Allergy and Infectious Diseases 5R01AI067037-04 and National Institute of Dental and Craniofacial Research 5R01DE017338-03 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cai QL, 2006, PLOS PATHOG, V2, P1002, DOI 10.1371/journal.ppat.0020116; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lieubeau-Teillet B, 1998, CANCER RES, V58, P4957; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Patocs A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-29; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; RUSSELL RC, 2008, EMBO REP; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; VANHAGEN M, 2009, NUCL ACIDS RES; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	52	74	78	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9720	10.1371/journal.pone.0009720	http://dx.doi.org/10.1371/journal.pone.0009720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300531	Green Published, Green Submitted, gold			2022-12-25	WOS:000275716400018
J	Onum, H; Tabara, Y; Kawamura, R; Tanaka, T; Ohashi, J; Nishida, W; Takata, Y; Ochi, M; Yamada, K; Kawamoto, R; Kohara, K; Miki, T; Makino, H; Osawa, H				Onum, Hiroshi; Tabara, Yasuharu; Kawamura, Ryoichi; Tanaka, Takashi; Ohashi, Jun; Nishida, Wataru; Takata, Yasunori; Ochi, Masaaki; Yamada, Kazuya; Kawamoto, Ryuichi; Kohara, Katsuhiko; Miki, Tetsuro; Makino, Hideichi; Osawa, Haruhiko			A at Single Nucleotide Polymorphism-358 Is Required for G at-420 to Confer the Highest Plasma Resistin in the General Japanese Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM RESISTIN; MESSENGER-RNA; ASSOCIATION; PROMOTER; MACROPHAGES; GENOTYPE; GLUCOSE; OBESITY	Insulin resistance is a feature of type 2 diabetes. Resistin, secreted from adipocytes, causes insulin resistance in mice. We previously reported that the G/G genotype of single nucleotide polymorphism (SNP) at 2420 (rs1862513) in the human resistin gene (RETN) increased susceptibility to type 2 diabetes by enhancing its promoter activity. Plasma resistin was highest in Japanese subjects with G/G genotype, followed by C/G, and C/C. In this study, we cross-sectionally analyzed plasma resistin and SNPs in the RETN region in 2,019 community-dwelling Japanese subjects. Plasma resistin was associated with SNP-638 (rs34861192), SNP-537 (rs34124816), SNP-420, SNP-358 (rs3219175), SNP+299 (rs3745367), and SNP+1263 (rs3745369) (P, 10(-13) in all cases). SNP-638, SNP -420, SNP-358, and SNP+157 were in the same linkage disequilibrium (LD) block. SNP-358 and SNP-638 were nearly in complete LD (r(2) = 0.98), and were tightly correlated with SNP-420 (r(2) = 0.50, and 0.51, respectively). The correlation between either SNP-358 (or SNP-638) or SNP-420 and plasma resistin appeared to be strong (risk alleles for high plasma resistin; A at SNP-358, r(2) = 0.5224, P = 4.94610 2324; G at SNP-420, r(2) = 0.2616, P = 1.71610(-133)). In haplotypes determined by SNP-420 and SNP-358, the estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively, and C-A was rare (0.0011), suggesting that subjects with A at 2358, generally had G at -420. This G-A haplotype conferred the highest plasma resistin (8.24 ng/ml difference/allele compared to C-G, P < 0.0001). In THP-1 cells, the RETN promoter with the G-A haplotype showed the highest activity. Nuclear proteins specifically recognized one base difference at SNP-358, but not at SNP-638. Therefore, A at -358 is required for G at 2420 to confer the highest plasma resistin in the general Japanese population. In Caucasians, the association between SNP-420 and plasma resistin is not strong, and A at 2358 may not exist, suggesting that SNP-358 could explain this ethnic difference.	[Onum, Hiroshi; Kawamura, Ryoichi; Nishida, Wataru; Takata, Yasunori; Ochi, Masaaki; Makino, Hideichi; Osawa, Haruhiko] Ehime Univ, Dept Mol & Genet Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Onum, Hiroshi; Tabara, Yasuharu; Kohara, Katsuhiko; Miki, Tetsuro; Osawa, Haruhiko] Ehime Univ, Ehime Proteomed Res Ctr, Matsuyama, Ehime 790, Japan; [Tabara, Yasuharu] Ehime Univ, Dept Basic Med Res & Educ, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Tanaka, Takashi] Osaka Ohtani Univ, Fac Pharm, Mol Biol Lab, Osaka, Japan; [Ohashi, Jun] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Life Syst Med Sci, Ibaraki, Japan; [Yamada, Kazuya] Matsumoto Univ, Fac Human Hlth Sci, Dept Hlth & Nutr Sci, Nagano, Japan; [Kawamoto, Ryuichi] Ehime Univ, Dept Community Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kohara, Katsuhiko; Miki, Tetsuro] Ehime Univ, Dept Geriatr Med, Grad Sch Med, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; Ehime University; University of Tsukuba; Ehime University; Ehime University	Onum, H (corresponding author), Ehime Univ, Dept Mol & Genet Med, Grad Sch Med, Matsuyama, Ehime 790, Japan.	harosawa@m.ehime-u.ac.jp	OHASHI, JUN/G-5907-2015		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ehime University; Takeda Science Foundation; Setsuro Fujii Memorial; Osaka Foundation for Promotion of Fundamental Medical Research; Mr. Takashi Ikeda	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Setsuro Fujii Memorial; Osaka Foundation for Promotion of Fundamental Medical Research; Mr. Takashi Ikeda	This work was supported by grants from Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Ehime University, Takeda Science Foundation, Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research, and by a fund from Mr. Takashi Ikeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO H, 2009, DIABETOLOGIA; Azuma K, 2004, HORM METAB RES, V36, P564, DOI 10.1055/s-2004-825762; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cho YM, 2004, DIABETOLOGIA, V47, P559, DOI 10.1007/s00125-003-1319-x; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; GERBER M, 2005, J CLIN ENDOCRINOL ME; Hivert MF, 2009, DIABETES, V58, P750, DOI 10.2337/db08-1339; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; McCarthy Mark I, 2006, Curr Diab Rep, V6, P147, DOI 10.1007/s11892-006-0026-7; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Osawa H, 2005, BIOCHEM BIOPH RES CO, V335, P596, DOI 10.1016/j.bbrc.2005.07.122; Osawa H, 2002, DIABETES, V51, P863, DOI 10.2337/diabetes.51.3.863; Osawa H, 2007, DIABETES CARE, V30, P1501, DOI 10.2337/dc06-1936; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; QATANANI M, 2009, J CLIN INVEST; Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tejero ME, 2008, HEREDITY, V101, P60, DOI 10.1038/hdy.2008.28	29	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9718	10.1371/journal.pone.0009718	http://dx.doi.org/10.1371/journal.pone.0009718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300528	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400016
J	Parnell, AC; Inger, R; Bearhop, S; Jackson, AL				Parnell, Andrew C.; Inger, Richard; Bearhop, Stuart; Jackson, Andrew L.			Source Partitioning Using Stable Isotopes: Coping with Too Much Variation	PLOS ONE			English	Article							MIXING MODELS; TROPHIC STRUCTURE; CONSUMER-DIET; ECOLOGY; NICHE; UNCERTAINTY	Background: Stable isotope analysis is increasingly being utilised across broad areas of ecology and biology. Key to much of this work is the use of mixing models to estimate the proportion of sources contributing to a mixture such as in diet estimation. Methodology: By accurately reflecting natural variation and uncertainty to generate robust probability estimates of source proportions, the application of Bayesian methods to stable isotope mixing models promises to enable researchers to address an array of new questions, and approach current questions with greater insight and honesty. Conclusions: We outline a framework that builds on recently published Bayesian isotopic mixing models and present a new open source R package, SIAR. The formulation in R will allow for continued and rapid development of this core model into an all-encompassing single analysis suite for stable isotope research.	[Parnell, Andrew C.] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Inger, Richard; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Sch Biosci, Penryn, Cornwall, England; [Jackson, Andrew L.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland	University College Dublin; University of Exeter; Trinity College Dublin	Parnell, AC (corresponding author), Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland.	A.Jackson@tcd.ie	Jackson, Andrew L/D-3441-2009; Parnell, Andrew/C-7284-2014; Inger, Richard/D-3445-2009; Bearhop, Stuart/G-3105-2012	Jackson, Andrew L/0000-0001-7334-0434; Parnell, Andrew/0000-0001-7956-7939; Inger, Richard/0000-0003-1660-3706; Bearhop, Stuart/0000-0002-5864-0129	NERC [NE/ F021690/1]; Natural Environment Research Council [NE/F021690/1] Funding Source: researchfish; NERC [NE/F021690/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Authors AJ, AP and SB hold faculty positions in their respective institutions. No other funds are directly linked to the work described in this manuscript. RI is funded as a postdoctoral researcher on NERC standard grant NE/ F021690/1 http://www.nerc.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Cremona F, 2009, BIOGEOCHEMISTRY, V94, P81, DOI 10.1007/s10533-009-9309-9; Evans M., 1993, STAT DISTRIBUTIONS; Gibbs MM, 2008, ESTUAR COAST, V31, P344, DOI 10.1007/s12237-007-9012-9; Hall-Aspland SA, 2005, OECOLOGIA, V143, P143, DOI 10.1007/s00442-004-1783-0; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Parnell A., 2008, SIAR STABLE ISOTOPE; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Samelius G, 2007, J ANIM ECOL, V76, P873, DOI 10.1111/j.1365-2656.2007.01278.x; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semmens BX, 2009, ECOL LETT, V12, pE6, DOI 10.1111/j.1461-0248.2009.01283.x; Soto-Jimenez MF, 2008, MAR ENVIRON RES, V66, P451, DOI 10.1016/j.marenvres.2008.07.009; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wilson RM, 2009, ESTUAR COAST, V32, P999, DOI 10.1007/s12237-009-9183-7; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	26	1981	2076	48	665	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9672	10.1371/journal.pone.0009672	http://dx.doi.org/10.1371/journal.pone.0009672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300637	Green Published, gold			2022-12-25	WOS:000275620900007
J	Hsieh, PJ; Tse, PU				Hsieh, Po-Jang; Tse, Peter U.			BOLD Signal in Both Ipsilateral and Contralateral Retinotopic Cortex Modulates with Perceptual Fading	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; FILLING-IN; VISUOMOTOR CONTROL; DISTINCT MODES; ATTENTION; BRIGHTNESS; AREAS; FIELD; TASK; REPRESENTATION	Under conditions of visual fixation, perceptual fading occurs when a stationary object, though present in the world and continually casting light upon the retina, vanishes from visual consciousness. The neural correlates of the consciousness of such an object will presumably modulate in activity with the onset and cessation of perceptual fading. Method: In order to localize the neural correlates of perceptual fading, a green disk that had been individually set to be equiluminant with the orange background, was presented in one of the four visual quadrants; Subjects indicated with a button press whether or not the disk was subjectively visible as it perceptually faded in and out. Results: Blood oxygen-level dependent (BOLD) signal in V1 and ventral retinotopic areas V2v and V3v decreases when the disk subjectively disappears, and increases when it subjectively reappears. This effect occurs in early visual areas both ipsilaterally and contralaterally to the fading figure. That is, it occurs regardless of whether the fading stimulus is presented inside or outside of the corresponding portion of visual field. In addition, we find that the microsaccade rate rises before and after perceptual transitions from not seeing to seeing the disk, and decreases before perceptual transitions from seeing to not seeing the disk. These BOLD signal changes could be driven by a global process that operates across contralateral and ipsilateral visual cortex or by a confounding factor, such as microsaccade rate.	[Hsieh, Po-Jang; Tse, Peter U.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Hsieh, PJ (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	pjh@mit.edu			NIH [R03 MH0609660-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by NIH R03 MH0609660-01 grant to PUT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; ANSTIS S, COLOUR VISION PHYSL, P156; ARRINGTON KF, 1994, VISION RES, V34, P3371, DOI 10.1016/0042-6989(94)90071-X; Binsted G, 2005, EXP BRAIN RES, V162, P89, DOI 10.1007/s00221-004-2108-6; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BREWER AA, 2004, SOC NEUR M; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Caplovitz GR, 2008, HUM BRAIN MAPP, V29, P651, DOI 10.1002/hbm.20429; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Danckert J, 2001, EXP BRAIN RES, V137, P303; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GERRITS HJM, 1966, VISION RES, V6, P427, DOI 10.1016/0042-6989(66)90051-4; GERRITS HJM, 1970, EXPT BRAIN RES, V72, P279; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hagenbeek RF, 2002, BRAIN COGNITION, V49, P34, DOI 10.1006/brcg.2001.1481; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hsieh PJ, 2009, VISION RES, V49, P439, DOI 10.1016/j.visres.2008.12.004; Hsieh PJ, 2006, VISION RES, V46, P2251, DOI 10.1016/j.visres.2005.11.030; HSIEH PJ, 2010, HUMAN BRAIN MAPPING; Hsieh PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005163; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Khan MA, 2005, EXP BRAIN RES, V164, P395, DOI 10.1007/s00221-005-2325-7; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Krigolson A, 2006, EXP BRAIN RES, V170, P127, DOI 10.1007/s00221-006-0386-x; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Macknik S. L., 2009, COGNITIVE NEUROSCIEN; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2007, SCI AM, V297, P56, DOI 10.1038/scientificamerican0807-56; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Neumann H, 2001, BIOL CYBERN, V85, P355, DOI 10.1007/s004220100258; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Pollen DA, 2003, CEREB CORTEX, V13, P807, DOI 10.1093/cercor/13.8.807; Previc F H, 1995, Int J Neurosci, V80, P247, DOI 10.3109/00207459508986103; RAMACHANDRAN VS, 1992, SCI AM, V266, P86, DOI 10.1038/scientificamerican0592-86; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Spillmann L., 2003, FILLING IN PERCEPTUA, P81, DOI DOI 10.1093/ACPROF:OSO/9780195140132.003.0005; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Troxler D, 1804, OPHTHALMOLOGISCHES B, P51; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; VONGRUNAU M, 1994, PERCEPT PSYCHOPHYS, V56, P211, DOI 10.3758/BF03213899; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WHISHAW IQ, 1994, BEHAV BRAIN SCI, V17, P173, DOI 10.1017/S0140525X00033884	67	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9638	10.1371/journal.pone.0009638	http://dx.doi.org/10.1371/journal.pone.0009638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300177	Green Submitted, gold, Green Published			2022-12-25	WOS:000275620600003
J	Holm, AK; Blank, LM; Oldiges, M; Schmid, A; Solem, C; Jensen, PR; Vemuri, GN				Holm, Anders K.; Blank, Lars M.; Oldiges, Marco; Schmid, Andreas; Solem, Christian; Jensen, Peter R.; Vemuri, Goutham N.			Metabolic and Transcriptional Response to Cofactor Perturbations in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH AVAILABILITY; NETWORK; FLUX; CLONING; ARCA	Metabolic cofactors such as NADH and ATP play important roles in a large number of cellular reactions, and it is of great interest to dissect the role of these cofactors in different aspects of metabolism. Toward this goal, we overexpressed NADH oxidase and the soluble F1-ATPase in Escherichia coli to lower the level of NADH and ATP, respectively. We used a global interaction network, comprising of protein interactions, transcriptional regulation, and metabolic networks, to integrate data from transcription profiles, metabolic fluxes, and the metabolite levels. We identified high-scoring networks for the two strains. The results revealed a smaller, but denser network for perturbations of ATP level, compared with that of NADH level. The action of many global transcription factors such as ArcA, Fnr, CRP, and IHF commonly involved both NADH and ATP, whereas others responded to either ATP or NADH. Overexpressing NADH oxidase invokes response in widespread aspects of metabolism involving the redox cofactors (NADH and NADPH), whereas ATPase has a more focused response to restore ATP level by enhancing proton translocation mechanisms and repressing biosynthesis. Interestingly, NADPH played a key role in restoring redox homeostasis through the concerted activity of isocitrate dehydrogenase and UdhA transhydrogenase. We present a reconciled network of regulation that illustrates the overlapping and distinct aspects of metabolism controlled by NADH and ATP. Our study contributes to the general understanding of redox and energy metabolism and should help in developing metabolic engineering strategies in E. coli.	[Holm, Anders K.; Solem, Christian; Jensen, Peter R.] Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark; [Blank, Lars M.; Schmid, Andreas] TU Dortmund, Lab Chem Biotechnol, D-44227 Dortmund, Germany; [Oldiges, Marco] Forschungszentrum Julich, Inst Biotechnol, D-52425 Julich, Germany; [Vemuri, Goutham N.] Chalmers Univ Technol, Dept Chem & Biol Engn, Syst Biol Div, S-41296 Gothenburg, Sweden	Technical University of Denmark; Dortmund University of Technology; Helmholtz Association; Research Center Julich; Chalmers University of Technology	Jensen, PR (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	prj@bio.dtu.dk	jensen, Peter Ruhdal/AAC-4891-2019; Schmid, Andreas/L-5886-2017; Blank, Lars M./A-6761-2012	Schmid, Andreas/0000-0002-6684-9088; Jensen, Peter Ruhdal/0000-0003-2080-2070; Blank, Lars M./0000-0003-0961-4976; Oldiges, Marco/0000-0003-0704-5597; Hansen, Anders Cai Holm/0000-0001-7706-2304; Solem, Christian/0000-0002-3898-280X				Akinterinwa O, 2008, CURR OPIN BIOTECH, V19, P461, DOI 10.1016/j.copbio.2008.08.002; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Vemuri GN, 2006, BIOTECHNOL BIOENG, V94, P538, DOI 10.1002/bit.20853; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005; WORKMAN C, 2002, GENOME BIOL, V0003; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882	35	98	101	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17498	17506		10.1074/jbc.M109.095570	http://dx.doi.org/10.1074/jbc.M109.095570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20299454	hybrid, Green Published			2022-12-25	WOS:000278133400028
J	Vuppalanchi, D; Coleman, J; Yoo, S; Merianda, TT; Yadhati, AG; Hossain, J; Blesch, A; Willis, DE; Twiss, JL				Vuppalanchi, Deepika; Coleman, Jennifer; Yoo, Soonmoon; Merianda, Tanuja T.; Yadhati, Akshay G.; Hossain, Jobayer; Blesch, Armin; Willis, Dianna E.; Twiss, Jeffery L.			Conserved 3 '-Untranslated Region Sequences Direct Subcellular Localization of Chaperone Protein mRNAs in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; HIPPOCAMPAL-NEURONS; TRANSLATIONAL CONTROL; C-JUN; BINDING PROTEINS; NOGO RECEPTOR; AXON GROWTH; NANOS RNA; TRANSPORT; CYTOSKELETAL	mRNA localization provides polarized cells with a locally renewable source of proteins. In neurons, mRNA translation can occur at millimeters to centimeters from the cell body, giving the dendritic and axonal processes a means to autonomously respond to their environment. Despite that hundreds of mRNAs have been detected in neuronal processes, there are no reliable means to predict mRNA localization elements. Here, we have asked what RNA elements are needed for localization of transcripts encoding endoplasmic reticulum chaperone proteins in neurons. The 3'-untranslated regions (UTRs) of calreticulin and Grp78/BiP mRNAs show no homology to one another, but each shows extensive regions of high sequence identity to their 3'UTRs in mammalian orthologs. These conserved regions are sufficient for subcellular localization of reporter mRNAs in neurons. The 3'UTR of calreticulin has two conserved regions, and either of these is sufficient for axonal and dendritic targeting. However, only nucleotides 1315-1412 show ligand responsiveness to neurotrophin 3 (NT3) and myelin-associated glycoprotein (MAG). This NT3- and MAG-dependent axonal mRNA transport requires activation of JNK, both for calreticulin mRNA and for other mRNAs whose axonal levels are commonly regulated by NT3 and MAG.	[Twiss, Jeffery L.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Vuppalanchi, Deepika; Coleman, Jennifer; Yoo, Soonmoon; Merianda, Tanuja T.; Yadhati, Akshay G.; Hossain, Jobayer] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Willis, Dianna E.] Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Blesch, Armin] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Drexel University; University of Delaware; Nemours Alfred I. duPont Hospital for Children; University of California System; University of California San Diego	Twiss, JL (corresponding author), Drexel Univ, Dept Biol, 3141 Chestnut St,Stratton Hall 118, Philadelphia, PA 19104 USA.	jeff.twiss@drexel.edu		Blesch, Armin/0000-0003-1133-1174; Yoo, Soonmoon/0000-0002-1645-6809	National Institutes of Health [R01-NS049041, R01-NS041596, K99-NR010797]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049041, R01NS041596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K99NR010797, R00NR010797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS049041 and R01-NS041596 (to J. L. T.) and K99-NR010797 (to D. E. W.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Bassell GJ, 1998, J NEUROSCI, V18, P251; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Goslin K., 1998, CULTURING NERVE CELL, P339; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MOHR E, 1992, EUR J NEUROSCI, V4, P870, DOI 10.1111/j.1460-9568.1992.tb00197.x; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; OCHS S, 1972, SCIENCE, V176, P252, DOI 10.1126/science.176.4032.252; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Smith DS, 1997, J NEUROSCI, V17, P646; Sotelo-Silveira J, 2008, J NEUROCHEM, V104, P545, DOI 10.1111/j.1471-4159.2007.04999.x; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; TIEDGE H, 1993, J NEUROSCI, V13, P4214; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Twiss JL, 2000, NEUROBIOL DIS, V7, P416, DOI 10.1006/nbdi.2000.0293; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Vuppalanchi D, 2009, RESULTS PROBL CELL D, V48, P193, DOI 10.1007/400_2009_16; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; WENSLEY CH, 1995, J NEUROSCI, V15, P4827; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	58	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18025	18038		10.1074/jbc.M109.061333	http://dx.doi.org/10.1074/jbc.M109.061333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20308067	Green Published, hybrid			2022-12-25	WOS:000278133400078
J	Goh, ETH; Pardo, OE; Michael, N; Niewiarowski, A; Totty, N; Volkova, D; Tsaneva, IR; Seckl, MJ; Gout, I				Goh, Eddy T. H.; Pardo, Olivier E.; Michael, Nicholas; Niewiarowski, Andrew; Totty, Nick; Volkova, Dariya; Tsaneva, Irina R.; Seckl, Michael J.; Gout, Ivan			Involvement of Heterogeneous Ribonucleoprotein F in the Regulation of Cell Proliferation via the Mammalian Target of Rapamycin/S6 Kinase 2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; PROTEIN-KINASE; HNRNP-H; SUBCELLULAR-LOCALIZATION; MESSENGER-RNA; PHOSPHORYLATION; ACTIVATION; BINDING; MTOR; IDENTIFICATION	The S6 kinases (S6Ks) have been linked to a number of cellular processes, including translation, insulin metabolism, cell survival, and RNA splicing. Signaling via the phosphotidylinositol 3-kinase and mammalian target of rapamycin (mTOR) pathways is critical in regulating the activity and subcellular localization of S6Ks. To date, nuclear functions of both S6K isoforms, S6K1 and S6K2, are not well understood. To better understand S6K nuclear roles, we employed affinity purification of S6Ks from nuclear preparations followed by mass spectrometry analysis for the identification of novel binding partners. In this study, we report that in contrast to S6K1, the S6K2 isoform specifically associates with a number of RNA-binding proteins, including heterogeneous ribonucleoproteins (hnRNPs). We focused on studying the mechanism and physiological relevance of the S6K2 interaction with hnRNP F/H. Interestingly, the S6K2-hnRNP F/H interaction was not affected by mitogenic stimulation, whereas mTOR binding to hnRNP F/H was induced by serum stimulation. In addition, we define a new role of hnRNP F in driving cell proliferation, which could be partially attenuated by rapamycin treatment. S6K2-driven cell proliferation, on the other hand, could be blocked by small interfering RNA-mediated down-regulation of hnRNP F. These results demonstrate that the specific interaction between mTOR and S6K2 with hnRNPs is implicated in the regulation of cell proliferation.	[Goh, Eddy T. H.; Niewiarowski, Andrew; Tsaneva, Irina R.; Gout, Ivan] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England; [Michael, Nicholas; Totty, Nick] Canc Res UK, London WC2A 3PX, England; [Pardo, Olivier E.; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; [Volkova, Dariya; Gout, Ivan] Inst Mol Biol & Genet, UA-143 Kiev, Ukraine	University of London; University College London; Cancer Research UK; Imperial College London; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Gout, I (corresponding author), UCL, Res Dept Struct & Mol Biol, Gower St, London WC1E 6BT, England.	i.gout@ucl.ac.uk	Pardo, Oliver/AEM-2071-2022	Pardo, Oliver/0000-0003-2223-1435				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Balcazar N, 2009, J BIOL CHEM, V284, P7832, DOI 10.1074/jbc.M807458200; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chou MY, 1999, MOL CELL BIOL, V19, P69; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Cruz R, 2005, J LEUKOCYTE BIOL, V78, P1378, DOI 10.1189/jlb.0405225; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Filonenko VV, 2004, EXP ONCOL, V26, P294; Fogel BL, 2000, J BIOL CHEM, V275, P32371, DOI 10.1074/jbc.M005000200; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacquenet S, 2001, J BIOL CHEM, V276, P40464, DOI 10.1074/jbc.M104070200; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; Oberg D, 2005, J VIROL, V79, P9254, DOI 10.1128/JVI.79.14.9254-9269.2005; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Panasyuk G, 2006, J BIOL CHEM, V281, P31188, DOI 10.1074/jbc.M602618200; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; Rossi R, 2007, FEBS LETT, V581, P4058, DOI 10.1016/j.febslet.2007.07.047; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Yoshida T, 1999, GENES CELLS, V4, P707, DOI 10.1046/j.1365-2443.1999.00295.x; Yoshida T, 1999, FEBS LETT, V457, P251, DOI 10.1016/S0014-5793(99)01048-0; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	57	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17065	17076		10.1074/jbc.M109.078782	http://dx.doi.org/10.1074/jbc.M109.078782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308064	hybrid, Green Published			2022-12-25	WOS:000277982600070
J	Huang, H; Weiner, BE; Zhang, HJ; Fuller, BE; Gao, Y; Wile, BM; Zhao, K; Arnett, DR; Chazin, WJ; Fanning, E				Huang, Hao; Weiner, Brian E.; Zhang, Haijiang; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Zhao, Kun; Arnett, Diana R.; Chazin, Walter J.; Fanning, Ellen			Structure of a DNA Polymerase alpha-Primase Domain That Docks on the SV40 Helicase and Activates the Viral Primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; LARGE T-ANTIGEN; C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; PRIMER SYNTHESIS; ORIGIN DNA; B-SUBUNIT; COMPLEX; INITIATION; REPLISOME	DNA polymerase alpha-primase (pol-prim) plays a central role in DNA replication in higher eukaryotes, initiating synthesis on both leading and lagging strand single-stranded DNA templates. Pol-prim consists of a primase heterodimer that synthesizes RNA primers, a DNA polymerase that extends them, and a fourth subunit, p68 (also termed B-subunit), that is thought to regulate the complex. Although significant knowledge about single-subunit primases of prokaryotes has accumulated, the functions and regulation of pol-prim remain poorly understood. In the SV40 replication model, the p68 subunit is required for primosome activity and binds directly to the hexameric viral helicase T antigen, suggesting a functional link between T antigen-p68 interaction and primosome activity. To explore this link, we first mapped the interacting regions of the two proteins and discovered a previously unrecognized N-terminal globular domain of p68 (p68N) that physically interacts with the T antigen helicase domain. NMR spectroscopy was used to determine the solution structure of p68N and map its interface with the T antigen helicase domain. Structure-guided mutagenesis of p68 residues in the interface diminished T antigen-p68 interaction, confirming the interaction site. SV40 primosome activity of corresponding pol-prim mutants decreased in proportion to the reduction in p68N-T antigen affinity, confirming that p68-T antigen interaction is vital for primosome function. A model is presented for how this interaction regulates SV40 primosome activity, and the implications of our findings are discussed in regard to the molecular mechanisms of eukaryotic DNA replication initiation.	[Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Weiner, Brian E.; Fuller, Brian E.; Gao, Yue; Wile, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Huang, Hao; Zhang, Haijiang; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu; ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, GM65484, P30 CA068485, P30 ES00267]; Alexander von Humboldt-Foundation; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E. F.), GM65484 (to W. J. C.), P30 CA068485 (to the Vanderbilt-Ingram Cancer Center), and P30 ES00267 (to the Vanderbilt Center in Molecular Toxicology). This work was also supported by a grant from Alexander von Humboldt-Foundation (to E. F.).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Case DA, 2006, AMBER; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P533; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gai DH, 2004, J BIOL CHEM, V279, P38952, DOI 10.1074/jbc.M406160200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; MOAREFI IF, 1993, J VIROL, V67, P4992, DOI 10.1128/JVI.67.8.4992-5002.1993; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	68	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17112	17122		10.1074/jbc.M110.116830	http://dx.doi.org/10.1074/jbc.M110.116830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20234039	hybrid, Green Published			2022-12-25	WOS:000277982600074
J	Castilho, A; Strasser, R; Stadlmann, J; Grass, J; Jez, J; Gattinger, P; Kunert, R; Quendler, H; Pabst, M; Leonard, R; Altmann, F; Steinkellner, H				Castilho, Alexandra; Strasser, Richard; Stadlmann, Johannes; Grass, Josephine; Jez, Jakub; Gattinger, Pia; Kunert, Renate; Quendler, Heribert; Pabst, Martin; Leonard, Renaud; Altmann, Friedrich; Steinkellner, Herta			In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODY; SIALIC ACID TRANSPORTER; N-ACETYLNEURAMINIC ACID; LC-ESI-MS; ARABIDOPSIS-THALIANA; ANTIINFLAMMATORY ACTIVITY; VIRAL VECTORS; FC GLYCANS; EXPRESSION; GLYCOSYLATION	Many therapeutic proteins are glycosylated and require terminal sialylation to attain full biological activity. Current manufacturing methods based on mammalian cell culture allow only limited control of this important posttranslational modification, which may lead to the generation of products with low efficacy. Here we report in vivo protein sialylation in plants, which have been shown to be well suited for the efficient generation of complex mammalian glycoproteins. This was achieved by the introduction of an entire mammalian biosynthetic pathway in Nicotiana benthamiana, comprising the coordinated expression of the genes for (i) biosynthesis, (ii) activation, (iii) transport, and (iv) transfer of Neu5Ac to terminal galactose. We show the transient overexpression and functional integrity of six mammalian proteins that act at various stages of the biosynthetic pathway and demonstrate their correct subcellular localization. Co-expression of these genes with a therapeutic glycoprotein, a human monoclonal antibody, resulted in quantitative sialylation of the Fc domain. Sialylation was at great uniformity when glycosylation mutants that lack plant-specific N-glycan residues were used as expression hosts. Finally, we demonstrate efficient neutralization activity of the sialylated monoclonal antibody, indicating full functional integrity of the reporter protein. We report for the first time the incorporation of the entire biosynthetic pathway for protein sialylation in a multicellular organism naturally lacking sialylated glycoconjugates. Besides the biotechnological impact of the achievement, this work may serve as a general model for the manipulation of complex traits into plants.	[Castilho, Alexandra; Strasser, Richard; Jez, Jakub; Gattinger, Pia; Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Stadlmann, Johannes; Grass, Josephine; Pabst, Martin; Leonard, Renaud; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Kunert, Renate] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; [Quendler, Heribert] Polymun Sci GmbH, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	herta.steinkellner@boku.ac.at	Pabst, Martin/GOH-1766-2022; Kunert, Renate E/B-9185-2018; Castilho, Alexandra/AAC-8927-2020; Stadlmann, Johannes/AAC-3157-2021; Strasser, Richard/AAD-2916-2020; Steinkellner, Herta/N-4267-2016	Pabst, Martin/0000-0001-9897-0723; Kunert, Renate E/0000-0002-3397-3621; Castilho, Alexandra/0000-0003-4114-7861; Stadlmann, Johannes/0000-0001-5693-6690; Steinkellner, Herta/0000-0003-4823-1505; Strasser, Richard/0000-0001-8764-6530; Leonard, Renaud/0000-0001-5023-1032; Altmann, Friedrich/0000-0002-0112-7877; Jez, Jakub/0000-0002-6481-4383; Gattinger, Pia/0000-0001-6724-8543	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) [LS 154]; Austrian Science Fund (FWF) [P18-314, L575-B13, P19092]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) (Grant LS 154) and Austrian Science Fund (FWF) (Grants P18-314, L575-B13, and P19092 to R. S.).	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bakker H, 2008, CARBOHYD RES, V343, P2148, DOI 10.1016/j.carres.2008.01.010; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bork K, 2009, J PHARM SCI-US, V98, P3499, DOI 10.1002/jps.21684; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Choi BK, 2008, GLYCOCONJUGATE J, V25, P581, DOI 10.1007/s10719-008-9123-y; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Fleischer S, 1974, Methods Enzymol, V31, P6; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Misaki R, 2006, BIOCHEM BIOPH RES CO, V339, P1184, DOI 10.1016/j.bbrc.2005.11.130; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schuster Manfred, 2007, Biotechnology Journal, V2, P700, DOI 10.1002/biot.200600255; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Takashima S, 2006, J BIOCHEM, V139, P279, DOI 10.1093/jb/mvj029; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759	34	153	168	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15923	15930		10.1074/jbc.M109.088401	http://dx.doi.org/10.1074/jbc.M109.088401			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20305285	Green Published, hybrid			2022-12-25	WOS:000277715900029
J	Lee, IO; Kim, JH; Choi, YJ; Pillinger, MH; Kim, SY; Blaser, MJ; Lee, YC				Lee, In Ohk; Kim, Jie Hyun; Choi, Yeun Jung; Pillinger, Michael H.; Kim, Seok-Yong; Blaser, Martin J.; Lee, Yong Chan			Helicobacter pylori CagA Phosphorylation Status Determines the gp130-activated SHP2/ERK and JAK/STAT Signal Transduction Pathways in Gastric Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; IV SECRETION; IN-VIVO; PHOSPHOTYROSINE PHOSPHATASE; HUMAN KERATINOCYTES; ACTIVATION; GP130; GENE; INTERLEUKIN-6; INFECTION	The Helicobacter pylori protein CagA may undergo tyrosine phosphorylation following its entry into human gastric epithelial cells with downstream effects on signal transduction. Disruption of the gp130 receptor that modulates the balance of the SHP2/ERK and JAK/STAT pathways enhanced peptic ulceration and gastric cancer in gp130 knock-out mice. In this study, we evaluated the effect of translocated CagA in relation to its tyrosine phosphorylation status on the gp130-mediated signal switch between the SHP2/ERK and JAK/STAT3 pathways. We showed that in the presence of CagA, SHP2 was recruited to gp130. Phosphorylated CagA showed enhanced SHP2 binding activity and ERK1/2 phosphorylation, whereas unphosphorylated CagA showed preferential STAT3 activation. These findings indicate that the phosphorylation status of CagA affects the signal switch between the SHP2/ERK and JAK/STAT3 pathways through gp130, providing a novel mechanism to explain H. pylori signaling.	[Lee, In Ohk; Kim, Jie Hyun; Choi, Yeun Jung; Lee, Yong Chan] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120752, South Korea; [Lee, In Ohk; Choi, Yeun Jung; Lee, Yong Chan] Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Pillinger, Michael H.; Blaser, Martin J.] NYU, Dept Med, Langone Sch Med, New York, NY 10016 USA; [Pillinger, Michael H.] Hosp Joint Dis & Med Ctr, Dept Rheumatol, New York, NY 10003 USA; [Kim, Seok-Yong] Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju 361763, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; New York University; NYU Langone Medical Center; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Chungbuk National University	Lee, YC (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seodaemunku Shinchondong 134, Seoul 120752, South Korea.	leeyc@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Pillinger, Michael/0000-0003-3168-1542; Lee, Yong Chan/0000-0001-8800-6906	National Institutes of Health [R01GM63270]; Korea Research Foundation; Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund) [KRF-2004-015-C00444]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM63270. This work was also supported by the Korea Research Foundation and Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund) Grant KRF-2004-015-C00444.	AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Ando T, 1998, INFECT IMMUN, V66, P4742, DOI 10.1128/IAI.66.10.4742-4747.1998; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; BLASER MJ, 1995, CANCER RES, V55, P2111; Bode JG, 2003, J IMMUNOL, V171, P257, DOI 10.4049/jimmunol.171.1.257; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Chatterjee M, 2002, BLOOD, V100, P3311, DOI 10.1182/blood-2002-01-0102; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Pillinger MH, 2007, J BIOL CHEM, V282, P18722, DOI 10.1074/jbc.M703022200; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Wang TC, 2002, NAT MED, V8, P1080, DOI 10.1038/nm1002-1080; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamazaki S, 2003, J INFECT DIS, V187, P334, DOI 10.1086/367807; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	63	96	98	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16042	16050		10.1074/jbc.M110.111054	http://dx.doi.org/10.1074/jbc.M110.111054			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348091	Green Published, hybrid			2022-12-25	WOS:000277715900042
J	Guo, LW; Hajipour, AR; Ruoho, AE				Guo, Lian-Wang; Hajipour, Abdol R.; Ruoho, Arnold E.			Complementary Interactions of the Rod PDE6 Inhibitory Subunit with the Catalytic Subunits and Transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHODIESTERASE GAMMA-SUBUNIT; CGMP-BINDING-SITES; CYCLIC-GMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; PHOTORECEPTOR PHOSPHODIESTERASE; G-PROTEIN; RETINAL RODS; VISUAL TRANSDUCTION; CRYSTAL-STRUCTURE; TERMINAL REGION	Activation of the cyclic GMP phosphodiesterase (PDE6) by transducin is the central event of visual signal transduction. How the PDE6 inhibitory gamma-subunit (P gamma) interacts with the catalytic subunits (P alpha beta) and the transducin alpha-subunit (alpha(t)) in this process is not entirely clear. Here we have investigated this issue, taking advantage of site-specific label transfer from throughout the full-length P gamma molecule to both alpha(t) and P alpha beta. The interaction profiling and pull-down experiments revealed that the P gamma C-terminal domain accounted for the major interaction with alpha(t) bound with guanosine 5'-3-O-(thio)triphosphate (alpha(t)GTP gamma S) in comparison with the central region, whereas an opposite pattern was observed for the P gamma-P alpha beta interaction. This complementary feature was further exhibited when both alpha(t)GTP gamma S and P alpha beta were present and competing for P gamma interaction, with the P gamma C-terminal domain favoring alpha(nu), whereas the central region demonstrated a preference for P alpha beta. Furthermore, alpha(t)GTP gamma S co-immunoprecipitated with PDE6 and vice versa in a P gamma-dependent manner. Either P alpha beta or alpha(t)GTP gamma S could be pulled down by the Btn-P gamma molecules on streptavidin beads that were saturated by the other partner, indicating simultaneous binding of these two partners to P gamma. These data together indicate that complementary P gamma interactions with its two targets facilitate the alpha(t)center dot PDE6 "transducisome" formation. Thus, our study provides new insights into the molecular mechanisms of PDE6 activation.	[Guo, Lian-Wang; Hajipour, Abdol R.; Ruoho, Arnold E.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Coll Chem, Pharmaceut Lab, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Guo, LW (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	lianwangguo@wisc.edu			National Institutes of Health [GM33138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33138 (to A. E. R. and L.-W.G.).	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CATTY P, 1992, J BIOL CHEM, V267, P19489; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; CLERC A, 1992, J BIOL CHEM, V267, P19948; CLERC A, 1992, J BIOL CHEM, V267, P6620; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; COTE RH, 2006, PHOTORECEPTOR PHOSPH, P165; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Granovsky Alexey E., 1998, Cell Biochemistry and Biophysics, V28, P115, DOI 10.1007/BF02737808; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; NAVON SE, 1988, J BIOL CHEM, V263, P489; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Tsang SH, 2006, J NEUROSCI, V26, P4472, DOI 10.1523/JNEUROSCI.4775-05.2006; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200	46	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15209	15219		10.1074/jbc.M109.086116	http://dx.doi.org/10.1074/jbc.M109.086116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231289	Green Published, hybrid			2022-12-25	WOS:000277399000042
J	Tubio, MR; Fernandez, N; Fitzsimons, CP; Copsel, S; Santiago, S; Shayo, C; Davio, C; Monczor, F				Rosario Tubio, Maria; Fernandez, Natalia; Fitzsimons, Carlos Patricio; Copsel, Sabrina; Santiago, Sergio; Shayo, Carina; Davio, Carlos; Monczor, Federico			Expression of a G Protein-coupled Receptor (GPCR) Leads to Attenuation of Signaling by Other GPCRs EXPERIMENTAL EVIDENCE FOR A SPONTANEOUS GPCR CONSTITUTIVE INACTIVE FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX MODEL; GTP-BINDING PROTEINS; BREAST-CANCER CELLS; INVERSE AGONIST; OCCUPANCY MODEL; HISTAMINE-H-2-RECEPTOR GENE; MOLECULAR-CLONING; TISSUE EXPRESSION; HISTAMINE-H2-RECEPTOR; ACTIVATION	The idea of G protein-coupled receptors (GPCRs) coupling to G protein solely in their active form was abolished when it was found that certain ligands induce a G protein-coupled but inactive receptor form. This receptor form interferes with signaling of other receptors by sequestering G protein. However, the spontaneous existence of this receptor species has never been established. The aim of the present work was to evaluate the existence of the spontaneous conformation of the receptor inactively coupled to G protein able to interfere with the response of other GPCRs. According to the law of mass action, receptor overexpression should lead to increased amounts of all spontaneously occurring species. Based on this, we generated Chinese hamster ovary (CHO-K1)-derived cell lines expressing various amounts of the human histamine H2 receptor. In these systems, the signaling of other endogenously and transiently expressed GPCRs was attenuated proportionally to human H2 receptor expression levels. G protein transfection specifically reverted this attenuation, strongly suggesting hijacking of the G protein from a common pool. Similar attenuation effects were observed when the beta(2)-adrenergic receptor was overexpressed, suggesting that this is a more general phenomenon. Moreover, in human mammary MDA-MB-231 cells, a consistent increase in the response of other GPCRs was observed when endogenous expression of beta(2)-adrenergic receptor was knocked down using specific small interfering RNAs. Our findings show that GPCRs may interact with the signaling of other receptors by modulating the availability of the G protein and suggest the existence of GPCR spontaneous coupling to G proteins in an inactive form.	[Rosario Tubio, Maria; Fernandez, Natalia; Copsel, Sabrina; Santiago, Sergio; Davio, Carlos; Monczor, Federico] Univ Buenos Aires, Fac Farm & Bioquim, Lab Farmacol Receptores, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina; [Fitzsimons, Carlos Patricio] Leiden Univ, Dept Med Pharmacol, Leiden Amsterdam Ctr Drug Res, NL-2300 Leiden, Netherlands; [Shayo, Carina] Inst Biol & Med Expt, Lab Farmacol & Patol Mol, RA-1428 Buenos Aires, DF, Argentina; [Fernandez, Natalia; Copsel, Sabrina; Shayo, Carina; Davio, Carlos; Monczor, Federico] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	University of Buenos Aires; Leiden University; Leiden University - Excl LUMC; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Monczor, F (corresponding author), Junin 956 PP, RA-1113 Buenos Aires, DF, Argentina.	monczorf@ffyb.uba.ar	Copsel, Sabrina/I-2245-2019	Copsel, Sabrina/0000-0001-5465-9052; Fitzsimons, Carlos P./0000-0002-1556-2650	Agencia Nacional de Promocion Cientifica y Tecnologia [PICT 06-192, PICT 05-38318]; Universidad de Buenos Aires [UBACyT B808]	Agencia Nacional de Promocion Cientifica y Tecnologia(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grants PICT 06-192, PICT 05-38318 from the Agencia Nacional de Promocion Cientifica y Tecnologia, and UBACyT B808 from the Universidad de Buenos Aires.	Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; BATZRI S, 1986, PHARMACOLOGY, V32, P241, DOI 10.1159/000138176; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Cilluffo MC, 1998, INVEST OPHTH VIS SCI, V39, P1429; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; DASSO LLT, 1992, MOL PHARMACOL, V42, P453; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; Fitzsimons CP, 2004, J BIOL CHEM, V279, P34431, DOI 10.1074/jbc.M400738200; GANTZ I, 1991, BIOCHEM BIOPH RES CO, V178, P1386, DOI 10.1016/0006-291X(91)91047-G; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; George SE, 1997, J NEUROCHEM, V69, P1278; Hasseldine ARG, 2003, BRIT J PHARMACOL, V138, P1358, DOI 10.1038/sj.bjp.0705191; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Li SY, 2005, INT J ONCOL, V27, P1329; Matsuda N, 2004, J PHARMACOL EXP THER, V309, P786, DOI 10.1124/jpet.103.063065; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Monczor F, 2006, BIOCHEM PHARMACOL, V71, P1219, DOI 10.1016/j.bcp.2005.12.037; Monczor F, 2003, MOL PHARMACOL, V64, P512, DOI 10.1124/mol.64.2.512; Nakamura M, 2007, J MOL ENDOCRINOL, V39, P375, DOI 10.1677/JME-07-0036; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; Rising TJ, 1985, FRONTIERS HISTAMINE, P61; RUAT M, 1991, BIOCHEM BIOPH RES CO, V179, P1470, DOI 10.1016/0006-291X(91)91738-X; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; Shapira M, 2000, CELL MOL NEUROBIOL, V20, P291, DOI 10.1023/A:1007058008477; Shayo C, 2001, MOL PHARMACOL, V60, P1049, DOI 10.1124/mol.60.5.1049; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; Stickle D, 1996, BBA-MOL CELL RES, V1310, P242, DOI 10.1016/0167-4889(95)00147-6; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; TRAIFFORT E, 1995, BIOCHEM BIOPH RES CO, V211, P570, DOI 10.1006/bbrc.1995.1851; Weiss JM, 1996, J THEOR BIOL, V178, P169, DOI 10.1006/jtbi.1996.0015; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Weiss JM, 1996, J THEOR BIOL, V181, P381, DOI 10.1006/jtbi.1996.0139; WIELAND T, 1992, N-S ARCH PHARMACOL, V346, P475	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14990	14998		10.1074/jbc.M109.099689	http://dx.doi.org/10.1074/jbc.M109.099689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299453	Green Published, hybrid			2022-12-25	WOS:000277399000020
J	Sakasai, R; Teraoka, H; Takagi, M; Tibbetts, RS				Sakasai, Ryo; Teraoka, Hirobumi; Takagi, Masatoshi; Tibbetts, Randal S.			Transcription-dependent Activation of Ataxia Telangiectasia Mutated Prevents DNA-dependent Protein Kinase-mediated Cell Death in Response to Topoisomerase I Poison	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; HELA-CELLS; DAMAGE; REPAIR; REPLICATION; PHOSPHORYLATION; 53BP1; ATM; DOWNSTREAM	Camptothecin (CPT) is a topoisomerase I inhibitor, derivatives of which are being used for cancer chemotherapy. CPT-induced DNA double-strand breaks (DSBs) are considered a major cause of its tumoricidal activity, and it has been shown that CPT induces DNA damage signaling through the phosphatidylinositol 3-kinase-related kinases, including ATM (ataxia telangiectasia mutated), ATR (ATM and Rad3-related), and DNA-PK (DNA-dependent protein kinase). In addition, CPT causes DNA strand breaks mediated by transcription, although the downstream signaling events are less well characterized. In this study, we show that CPT-induced activation of ATM requires transcription. Mechanistically, transcription inhibition suppressed CPT-dependent activation of ATM and blocked recruitment of the DNA damage mediator p53-binding protein 1 (53BP1) to DNA damage sites, whereas ATM inhibition abrogated CPT-induced G(1)/S and S phase checkpoints. Functional inactivation of ATM resulted in DNA replication-dependent hyperactivation of DNA-PK in CPT-treated cells and dramatic CPT hypersensitivity. On the other hand, simultaneous inhibition of ATM and DNA-PK partially restored CPT resistance, suggesting that activation of DNA-PK is proapoptotic in the absence of ATM. Correspondingly, comet assay and cell cycle synchronization experiments suggested that transcription collapse occurring as the result of CPT treatment are converted to frank double-strand breaks when ATM-deficient cells bypass the G(1)/S checkpoint. Thus, ATM suppresses DNA-PK-dependent cell death in response to topoisomerase poisons, a finding with potential clinical implications.	[Sakasai, Ryo; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo 1010062, Japan; [Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo 1138519, Japan; [Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Wisconsin System; University of Wisconsin Madison	Sakasai, R (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka 8128582, Japan.	sakasai@surg2.med.kyushu-u.ac.jp	Takagi, Masatoshi/F-3713-2011	Takagi, Masatoshi/0000-0002-7580-9184; Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437	National Institutes of Health [CA124722]; American Cancer Society; Greater Milwaukee Foundation; Japan Society for the Promotion of Science for Exploratory Research [20659047]; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; Japan Society for the Promotion of Science for Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722. This work was also supported by a grant from the American Cancer Society, a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation, and by Grant-in-aid 20659047 from Japan Society for the Promotion of Science for Exploratory Research (to H. T.).	Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cobb LJ, 2006, CANCER RES, V66, P10878, DOI 10.1158/0008-5472.CAN-06-0585; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Gurley KE, 2009, EMBO REP, V10, P87, DOI 10.1038/embor.2008.214; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MIMORI T, 1986, J BIOL CHEM, V261, P375; Nakamura H, 2002, J RADIAT RES, V43, P167, DOI 10.1269/jrr.43.167; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sakasai R, 2010, DNA REPAIR, V9, P76, DOI 10.1016/j.dnarep.2009.10.008; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang JL, 2002, CELL CYCLE, V1, P267, DOI 10.4161/cc.1.4.137; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200	32	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15201	15208		10.1074/jbc.M110.101808	http://dx.doi.org/10.1074/jbc.M110.101808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304914	Green Published, hybrid			2022-12-25	WOS:000277399000041
J	Kim, JI; Cali, I; Surewicz, K; Kong, QZ; Raymond, GJ; Atarashi, R; Race, B; Qing, LT; Gambetti, P; Caughey, B; Surewicz, WK				Kim, Jae-Il; Cali, Ignazio; Surewicz, Krystyna; Kong, Qingzhong; Raymond, Gregory J.; Atarashi, Ryuichiro; Race, Brent; Qing, Liuting; Gambetti, Pierluigi; Caughey, Byron; Surewicz, Witold K.			Mammalian Prions Generated from Bacterially Expressed Prion Protein in the Absence of Any Mammalian Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SCRAPIE; DISEASE; STRAINS; ANIMALS; HUMANS; MICE	Transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative diseases that are associated with the conformational conversion of a normal prion protein, PrPC, to a misfolded aggregated form, PrPSc. The protein-only hypothesis asserts that PrPSc itself represents the infectious TSE agent. Although this model is supported by rapidly growing experimental data, unequivocal proof has been elusive. The protein misfolding cyclic amplification reactions have been recently shown to propagate prions using brain-derived or recombinant prion protein, but only in the presence of additional cofactors such as nucleic acids and lipids. Here, using a protein misfolding cyclic amplification variation, we show that prions causing transmissible spongiform encephalopathy in wild-type hamsters can be generated solely from highly purified, bacterially expressed recombinant hamster prion protein without any mammalian or synthetic cofactors (other than buffer salts and detergent). These findings provide strong support for the protein-only hypothesis of TSE diseases, as well as argue that cofactors such as nucleic acids, other polyanions, or lipids are nonobligatory for prion protein conversion to the infectious form.	[Kim, Jae-Il; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cali, Ignazio; Kong, Qingzhong; Qing, Liuting; Gambetti, Pierluigi] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Raymond, Gregory J.; Atarashi, Ryuichiro; Race, Brent; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	cali, ignazio/AAS-1127-2020	cali, ignazio/0000-0001-5770-3848	National Institutes of Health [NS44158, AG14359]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NS44158 (to W. K. S.) and AG14359 (to P. G., W. K. S., and Q. K.) and by the Intramural Research Program of the NIAID.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; HILMERT H, 1984, BIOSCIENCE REP, V4, P165, DOI 10.1007/BF01120313; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RUBENSTEIN R, 1994, ARCH VIROL, V139, P301, DOI 10.1007/BF01310793; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	29	167	169	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14083	14087		10.1074/jbc.C110.113464	http://dx.doi.org/10.1074/jbc.C110.113464			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20304915	Green Published, hybrid			2022-12-25	WOS:000277299700003
J	Shimotsuma, M; Okamura, E; Matsuzaki, H; Fukamizu, A; Tanimoto, K				Shimotsuma, Motoshi; Okamura, Eiichi; Matsuzaki, Hitomi; Fukamizu, Akiyoshi; Tanimoto, Keiji			DNase I Hypersensitivity and epsilon-Globin Transcriptional Enhancement Are Separable in Locus Control Region (LCR) HS1 Mutant Human beta-Globin YAC Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ARTIFICIAL CHROMOSOME; DOMINANT CONTROL REGION; ERYTHROID-DIFFERENTIATION; DEVELOPMENTAL REGULATION; GENE-TRANSCRIPTION; ERYTHROLEUKEMIA-CELLS; FACTOR GATA-1; EXPRESSION; SITES; DELETION	Expression of the five beta-like globin genes (epsilon, G gamma, A gamma, delta, beta) in the human beta-globin locus depends on enhancement by the locus control region, which consists of five DNase I hypersensitive sites (5'HS1 through 5'HS5). We report here a novel enhancer activity in 5'HS1 that appears to be potent in transfected K562 cells. Deletion analyses identified a core activating element that bound to GATA-1, and a two-nucleotide mutation that disrupted GATA-1 binding in vitro abrogated 5'HS1 enhancer activity in transfection experiments. To determine the in vivo role of this GATA site, we generated multiple lines of human beta-globin YAC transgenic mice bearing the same two-nucleotide mutation. In the mutant mice, epsilon-, but not gamma-globin, gene expression in primitive erythroid cells was severely attenuated, while adult beta-globin gene expression in definitive erythroid cells was unaffected. Interestingly, DNaseI hypersensitivity near the 5'HS1 mutant sequence was eliminated in definitive erythroid cells, whereas it was only mildly affected in primitive erythroid cells. We therefore conclude that, although the GATA site in 5'HS1 is critical for efficient epsilon-globin gene expression, hypersensitive site formation per se is independent of 5'HS1 function, if any, in definitive erythroid cells.	[Shimotsuma, Motoshi; Okamura, Eiichi; Matsuzaki, Hitomi; Fukamizu, Akiyoshi; Tanimoto, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba	Tanimoto, K (corresponding author), Tennoudai 1-1-1, Tsukuba, Ibaraki 3058577, Japan.	keiji@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014; fukamizu, akiyoshi/J-5350-2012	fukamizu, akiyoshi/0000-0002-8786-6020; Matsuzaki, Hitomi/0000-0002-8890-5933; Tanimoto, Keiji/0000-0003-1971-6546; Okamura, Eiichi/0000-0002-1713-9290	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Scientific Research (A) and for Young Scientists (S).	Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Bender MA, 2001, BLOOD, V98, P2022, DOI 10.1182/blood.V98.7.2022; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Bungert J, 1999, MOL CELL BIOL, V19, P3062; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Emery DW, 1998, BLOOD CELL MOL DIS, V24, P322, DOI 10.1006/bcmd.1998.0200; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; Fang XD, 2005, MOL CELL BIOL, V25, P7033, DOI 10.1128/MCB.25.16.7033-7041.2005; Fedosyuk H, 2007, BLOOD CELL MOL DIS, V39, P44, DOI 10.1016/j.bcmd.2007.02.006; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GAENSLER KML, 1991, GENOMICS, V10, P976, DOI 10.1016/0888-7543(91)90188-K; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; GROSVELD F, 1990, ANN NY ACAD SCI, V612, P152; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; KULOZIK AE, 1991, J CLIN INVEST, V87, P2142, DOI 10.1172/JCI115246; LEONARD M, 1993, BLOOD, V82, P1071; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; MOON AM, 1991, BLOOD, V77, P2272; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ren SC, 1996, NUCLEIC ACIDS RES, V24, P342, DOI 10.1093/nar/24.2.342; Shimotsuma M, 2007, MOL CELL BIOL, V27, P5664, DOI 10.1128/MCB.00602-07; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tanimoto K, 2000, GENE DEV, V14, P2778, DOI 10.1101/gad.822500; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P3130, DOI 10.1093/nar/27.15.3130; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14495	14503		10.1074/jbc.M110.116525	http://dx.doi.org/10.1074/jbc.M110.116525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231293	hybrid, Green Published			2022-12-25	WOS:000277299700046
J	Bertaso, F; Roussignol, G; Worley, P; Bockaert, J; Fagni, L; Ango, F				Bertaso, Federica; Roussignol, Gautier; Worley, Paul; Bockaert, Joel; Fagni, Laurent; Ango, Fabrice			Homer1a-Dependent Crosstalk Between NMDA and Metabotropic Glutamate Receptors in Mouse Neurons	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; BETA-GAMMA-SUBUNITS; CHANNEL FUNCTION; CA2+ CHANNELS; MODULATION; HOMER; PROTEINS; ACTIVATION; EXPRESSION; MEMBRANE	Background: A large number of evidences suggest that group-I metabotropic glutamate receptors (mGluR1a, 1b, 1c, 5a, 5b) can modulate NMDA receptor activity. Interestingly, a physical link exists between these receptors through a Homer-Shank multi-protein scaffold that can be disrupted by the immediate early gene, Homer1a. Whether such a versatile link supports functional crosstalk between the receptors is unknown. Methodology/Principal Findings: Here we used biochemical, electrophysiological and molecular biological approaches in cultured mouse cerebellar neurons to investigate this issue. We found that Homer1a or dominant negative Shank3 mutants that disrupt the physical link between the receptors allow inhibition of NMDA current by group-I mGluR agonist. This effect is antagonized by pertussis toxin, but not thapsigargin, suggesting the involvement of a G protein, but not intracellular calcium stores. Also, this effect is voltage-sensitive, being present at negative, but not positive membrane potentials. In the presence of DHPG, an apparent NMDA "tail current'' was evoked by large pulse depolarization, only in neurons transfected with Homer1a. Co-immunoprecipitation experiments showed interaction between G-protein beta gamma subunits and NMDA receptor in the presence of Homer1a and group-I mGluR agonist. Conclusions/Significance: Altogether these results suggest a direct inhibition of NMDA receptor-channel by Gbetagamma subunits, following disruption of the Homer-Shank3 complex by the immediate early gene Homer1a. This study provides a new molecular mechanism by which group-I mGluRs could dynamically regulate NMDA receptor function.	[Bertaso, Federica; Roussignol, Gautier; Bockaert, Joel; Fagni, Laurent; Ango, Fabrice] Univ Montpellier 1 & 2, INSERM U661, CNRS UMR 5203, Dept Neurobiol,Inst Genom Fonct, Montpellier, France; [Worley, Paul] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Johns Hopkins University	Bertaso, F (corresponding author), Univ Montpellier 1 & 2, INSERM U661, CNRS UMR 5203, Dept Neurobiol,Inst Genom Fonct, Montpellier, France.	laurent.fagni@igf.cnrs.fr	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Ango, Fabrice/0000-0002-5548-209X	Agence Nationale pour la Recherche (French National agency for Research) [ANR-08-MNPS-037-01 - SynGen]; European Commission [222918]	Agence Nationale pour la Recherche (French National agency for Research)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Agence Nationale pour la Recherche (French National agency for Research, ANR-08-MNPS-037-01 - SynGen) and European Commission (contract number 222918 - REPLACES - FP7 - Thematic priority HEALTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Blaabjerg M, 2003, EXP NEUROL, V183, P573, DOI 10.1016/S0014-4886(03)00204-8; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; SHIGEMOTO R, 1993, J NEUROCHEM, V61; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	20	73	76	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9755	10.1371/journal.pone.0009755	http://dx.doi.org/10.1371/journal.pone.0009755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305784	gold, Green Submitted, Green Published			2022-12-25	WOS:000276456300015
J	Csaszar, NBM; Ralph, PJ; Frankham, R; Berkelmans, R; van Oppen, MJH				Csaszar, Nikolaus B. M.; Ralph, Peter J.; Frankham, Richard; Berkelmans, Ray; van Oppen, Madeleine J. H.			Estimating the Potential for Adaptation of Corals to Climate Warming	PLOS ONE			English	Article							GREAT-BARRIER-REEF; GENE-EXPRESSION; EXCITATION-ENERGY; BLEACHING EVENTS; HEAT; DIVERSITY; STRESS; SYMBIODINIUM; TEMPERATURE; ENVIRONMENTS	The persistence of tropical coral reefs is threatened by rapidly increasing climate warming, causing a functional breakdown of the obligate symbiosis between corals and their algal photosymbionts (Symbiodinium) through a process known as coral bleaching. Yet the potential of the coral-algal symbiosis to genetically adapt in an evolutionary sense to warming oceans is unknown. Using a quantitative genetics approach, we estimated the proportion of the variance in thermal tolerance traits that has a genetic basis (i.e. heritability) as a proxy for their adaptive potential in the widespread Indo-Pacific reef-building coral Acropora millepora. We chose two physiologically different populations that associate respectively with one thermo-tolerant (Symbiodinium clade D) and one less tolerant symbiont type (Symbiodinium C2). In both symbiont types, pulse amplitude modulated (PAM) fluorometry and high performance liquid chromatography (HPLC) analysis revealed significant heritabilities for traits related to both photosynthesis and photoprotective pigment profile. However, quantitative real-time polymerase chain reaction (qRT-PCR) assays showed a lack of heritability in both coral host populations for their own expression of fundamental stress genes. Coral colony growth, contributed to by both symbiotic partners, displayed heritability. High heritabilities for functional key traits of algal symbionts, along with their short clonal generation time and high population sizes allow for their rapid thermal adaptation. However, the low overall heritability of coral host traits, along with the corals' long generation time, raise concern about the timely adaptation of the coral-algal symbiosis in the face of continued rapid climate warming.	[Csaszar, Nikolaus B. M.; Ralph, Peter J.] Univ Technol Sydney, Dept Environm Sci, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Frankham, Richard] Macquarie Univ, Sydney, NSW 2109, Australia; [Frankham, Richard] Australian Museum, Sydney, NSW 2000, Australia; [Csaszar, Nikolaus B. M.; Berkelmans, Ray; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Technology Sydney; Macquarie University; Australian Museum; Australian Institute of Marine Science	Csaszar, NBM (corresponding author), Univ Technol Sydney, Dept Environm Sci, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia.	m.vanoppen@aims.gov.au	Ralph, Peter/L-1527-2019; Ralph, Peter J/C-5029-2009; van Oppen, Madeleine JH/C-3261-2008	Ralph, Peter/0000-0002-3103-7346; Ralph, Peter J/0000-0002-3103-7346; van Oppen, Madeleine/0000-0003-4607-0744	Marine Tropical Sciences Research Facility [2.5i.2]; Australian Institute of Marine Science; University of Technology Sydney; Australian Coral Reef Society	Marine Tropical Sciences Research Facility; Australian Institute of Marine Science; University of Technology Sydney; Australian Coral Reef Society	This work was funded by the Marine Tropical Sciences Research Facility (project 2.5i.2), the Australian Institute of Marine Science, the University of Technology Sydney, and the Australian Coral Reef Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cammack KM, 2009, THERIOGENOLOGY, V71, P651, DOI 10.1016/j.theriogenology.2008.09.029; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; DAVIES PS, 1989, MAR BIOL, V101, P389; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Falconer D.S., 1996, INTRO QUANTITATIVE G, P464; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gattuso JP, 1999, AM ZOOL, V39, P160; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Halliwell B., 1989, FREE RADICAL BIO MED, P86; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 1996, PLANT CELL ENVIRON, V19, P1359, DOI 10.1111/j.1365-3040.1996.tb00014.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Hohenboken WD, 2004, NEW ZEAL J AGR RES, V47, P119, DOI 10.1080/00288233.2004.9513579; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 1999, AM ZOOL, V39, P146; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krebs RA, 1998, EVOLUTION, V52, P841, DOI 10.1111/j.1558-5646.1998.tb03708.x; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Richmond Robert H., 1997, P175; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Turner P, 2002, MAR TECHNOL SOC J, V36, P70, DOI 10.4031/002533202787914160; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; WILKERSON FP, 1988, CORAL REEFS, V7, P29, DOI 10.1007/BF00301979; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Young AJ, 1997, PURE APPL CHEM, V69, P2125, DOI 10.1351/pac199769102125	71	96	99	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9751	10.1371/journal.pone.0009751	http://dx.doi.org/10.1371/journal.pone.0009751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305781	Green Published, gold			2022-12-25	WOS:000276456300005
J	Lombaert, E; Guillemaud, T; Cornuet, JM; Malausa, T; Facon, B; Estoup, A				Lombaert, Eric; Guillemaud, Thomas; Cornuet, Jean-Marie; Malausa, Thibaut; Facon, Benoit; Estoup, Arnaud			Bridgehead Effect in the Worldwide Invasion of the Biocontrol Harlequin Ladybird	PLOS ONE			English	Article							HARMONIA-AXYRIDIS PALLAS; BIOLOGICAL INVASION; COLEOPTERA; COCCINELLIDAE; HISTORY; PATHWAYS; ABC	Recent studies of the routes of worldwide introductions of alien organisms suggest that many widespread invasions could have stemmed not from the native range, but from a particularly successful invasive population, which serves as the source of colonists for remote new territories. We call here this phenomenon the invasive bridgehead effect. Evaluating the likelihood of such a scenario is heuristically challenging. We solved this problem by using approximate Bayesian computation methods to quantitatively compare complex invasion scenarios based on the analysis of population genetics (microsatellite variation) and historical (first observation dates) data. We applied this approach to the Harlequin ladybird Harmonia axyridis (HA), a coccinellid native to Asia that was repeatedly introduced as a biocontrol agent without becoming established for decades. We show that the recent burst of worldwide invasions of HA followed a bridgehead scenario, in which an invasive population in eastern North America acted as the source of the colonists that invaded the European, South American and African continents, with some admixture with a biocontrol strain in Europe. This demonstration of a mechanism of invasion via a bridgehead has important implications both for invasion theory (i. e., a single evolutionary shift in the bridgehead population versus multiple changes in case of introduced populations becoming invasive independently) and for ongoing efforts to manage invasions by alien organisms (i. e., heightened vigilance against invasive bridgeheads).	[Lombaert, Eric; Guillemaud, Thomas; Malausa, Thibaut] Univ Nice Sophia Antipolis, Equipe Biol Populat & Interact, CNRS, INRA,IBSV,UMR 1301, Sophia Antipolis, France; [Cornuet, Jean-Marie; Facon, Benoit; Estoup, Arnaud] Montpellier SupAgro, Cirad, INRA, IRD,Ctr Biol & Gest Populat,UMR, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Lombaert, E (corresponding author), Univ Nice Sophia Antipolis, Equipe Biol Populat & Interact, CNRS, INRA,IBSV,UMR 1301, Sophia Antipolis, France.	estoup@supagro.inra.fr	Malausa, Thibaut/X-1614-2018; guillemaud, thomas/B-4899-2012	Malausa, Thibaut/0000-0003-1681-7958; guillemaud, thomas/0000-0003-0451-1644	Agence Nationale de la Recherche [ANR-06-BDIV-008-01, ANR-09-BLAN-0145-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Agence Nationale de la Recherche (ANR-06-BDIV-008-01 and ANR-09-BLAN-0145-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens T, 2003, BELG J ZOOL, V133, P195; Beaumont MA, 2002, GENETICS, V162, P2025; CHAPIN JB, 1991, P ENTOMOL SOC WASH, V93, P630; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hanfling B, 2002, MAR ECOL PROG SER, V238, P307, DOI 10.3354/meps238307; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Koch R L, 2003, J Insect Sci, V3, P32; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Krafsur ES, 1997, BIOL CONTROL, V8, P207, DOI 10.1006/bcon.1997.0508; LaMana ML, 1996, BIOL CONTROL, V6, P232, DOI 10.1006/bcon.1996.0029; Loiseau A, 2009, MOL ECOL RESOUR, V9, P934, DOI 10.1111/j.1755-0998.2009.02517.x; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; ONGAGNA P, 1993, ENTOMOPHAGA, V38, P125, DOI 10.1007/BF02373146; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Poutsma J, 2008, BIOCONTROL, V53, P103, DOI 10.1007/s10526-007-9140-y; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Saini E. D., 2004, RIA, Revista de Investigaciones Agropecuarias, V33, P151; Stals R, 2007, S AFR J SCI, V103, P123; Tavare S, 1997, GENETICS, V145, P505; TEDDERS WL, 1994, ENTOMOL NEWS, V105, P228; Vila Montserrat, 2009, V3, P265; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	29	315	334	2	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9743	10.1371/journal.pone.0009743	http://dx.doi.org/10.1371/journal.pone.0009743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305822	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809600015
J	Lundholm, J; MacIvor, JS; MacDougall, Z; Ranalli, M				Lundholm, Jeremy; MacIvor, J. Scott; MacDougall, Zachary; Ranalli, Melissa			Plant Species and Functional Group Combinations Affect Green Roof Ecosystem Functions	PLOS ONE			English	Article							RETENTION; URBAN; BIODIVERSITY; DIVERSITY; PRODUCTIVITY; BUILDINGS; RUNOFF	Background: Green roofs perform ecosystem services such as summer roof temperature reduction and stormwater capture that directly contribute to lower building energy use and potential economic savings. These services are in turn related to ecosystem functions performed by the vegetation layer such as radiation reflection and transpiration, but little work has examined the role of plant species composition and diversity in improving these functions. Methodology/Principal Findings: We used a replicated modular extensive (shallow growing-medium) green roof system planted with monocultures or mixtures containing one, three or five life-forms, to quantify two ecosystem services: summer roof cooling and water capture. We also measured the related ecosystem properties/processes of albedo, evapotranspiration, and the mean and temporal variability of aboveground biomass over four months. Mixtures containing three or five life-form groups, simultaneously optimized several green roof ecosystem functions, outperforming monocultures and single life-form groups, but there was much variation in performance depending on which life-forms were present in the three life-form mixtures. Some mixtures outperformed the best monocultures for water capture, evapotranspiration, and an index combining both water capture and temperature reductions. Combinations of tall forbs, grasses and succulents simultaneously optimized a range of ecosystem performance measures, thus the main benefit of including all three groups was not to maximize any single process but to perform a variety of functions well. Conclusions/Significance: Ecosystem services from green roofs can be improved by planting certain life-form groups in combination, directly contributing to climate change mitigation and adaptation strategies. The strong performance by certain mixtures of life-forms, especially tall forbs, grasses and succulents, warrants further investigation into niche complementarity or facilitation as mechanisms governing biodiversity-ecosystem functioning relationships in green roof ecosystems.	[Lundholm, Jeremy; MacIvor, J. Scott; MacDougall, Zachary; Ranalli, Melissa] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Saint Marys University - Canada	Lundholm, J (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	jlundholm@smu.ca	Lundholm, Jeremy T/G-2638-2010		National Sciences and Engineering Research Council of Canada (NSERC); CGS; Saint Mary's University; Mountain Equipment Co-op	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CGS; Saint Mary's University; Mountain Equipment Co-op	Funding was provided by National Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to J.L., IPS to S.M. and CGS to M.R. (www.nserc-crsng.gc.ca), Saint Mary's University, and Mountain Equipment Co-op (http://www.mec.ca/Main/explore.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Alexandria E, 2008, BUILD ENVIRON, V43, P480, DOI 10.1016/j.buildenv.2006.10.055; [Anonymous], 1996, BOUNDARY LAYER CLIMA; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Banting D., 2005, REPORT ENV BENEFITS; BASS B, 2002, NRCC46737 I RES CONS; Brenneisen Stephan, 2006, Urban Habitats, V4, P27; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carter T, 2008, J ENVIRON MANAGE, V87, P350, DOI 10.1016/j.jenvman.2007.01.024; Carter T, 2007, LANDSCAPE URBAN PLAN, V80, P84, DOI 10.1016/j.landurbplan.2006.06.005; Darlington AB, 2001, ENVIRON SCI TECHNOL, V35, P240, DOI 10.1021/es0010507; Dietz ME, 2006, ENVIRON SCI TECHNOL, V40, P1335, DOI 10.1021/es051644f; Dunnett Nigel, 2008, Urban Ecosystems, V11, P385, DOI 10.1007/s11252-008-0064-9; Eumorfopoulou E, 1998, ENERG BUILDINGS, V27, P29, DOI 10.1016/S0378-7788(97)00023-6; FOGARTY C, 2009, NOVA WEATHER; Frumkin H, 2002, PUBLIC HEALTH REP, V117, P201, DOI 10.1093/phr/117.3.201; *GREEN ROOFS HLTH, 2009, 2008 GREEN ROOF IND; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Knapp AK, 1998, AM J BOT, V85, P940, DOI 10.2307/2446360; Kohler M., 2002, Environmental Management and Health, V13, P382, DOI 10.1108/09566160210439297; Kohler M., 2006, URBAN HABITATS, V4, P3; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lazzarin RA, 2005, ENERG BUILDINGS, V37, P1260, DOI 10.1016/j.enbuild.2005.02.001; LIU K, 2005, 3 N AM GREEN ROOF C; Lundholm J., 2006, URBAN HABITATS, V4, P87; Maneewan S, 2005, SOL ENERGY, V78, P495, DOI 10.1016/j.solener.2004.08.003; Mentens J, 2006, LANDSCAPE URBAN PLAN, V77, P217, DOI 10.1016/j.landurbplan.2005.02.010; Miltner RJ, 2004, LANDSCAPE URBAN PLAN, V69, P87, DOI 10.1016/j.landurbplan.2003.10.032; MITSCH WJ, 1995, ECOL APPL, V5, P830, DOI 10.2307/1941991; Monterusso MA, 2005, HORTSCIENCE, V40, P391, DOI 10.21273/HORTSCI.40.2.391; Mueller KE, 2006, ENVIRON SCI TECHNOL, V40, P6662, DOI 10.1021/es060776l; Niachou A, 2001, ENERG BUILDINGS, V33, P719, DOI 10.1016/S0378-7788(01)00062-7; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Onmura S, 2001, ENERG BUILDINGS, V33, P653, DOI 10.1016/S0378-7788(00)00134-1; PACALA S, 2002, BIODIVERSITY COMPOSI, P151; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Ranalli M., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, DOI 10.1079/PAVSNNR20083034; Ridgwell A, 2009, CURR BIOL, V19, P146, DOI 10.1016/j.cub.2008.12.025; SLATTERTHWAITE D, 2008, ENVIRON URBAN, V20, P539; Spolek Graig, 2008, Urban Ecosystems, V11, P349, DOI 10.1007/s11252-008-0061-z; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; THURING C, 2007, NATIVE PLANT SOC B C, V12, P3; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 2002, BIODIVERSITY COMPOSI, P9; *US GEN SERV ADM, 2008, SUST MATT; *USDA, 2009, NAT RES CONS SERV PL; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Villarreal EL, 2005, ECOL ENG, V25, P1, DOI 10.1016/j.ecoleng.2004.11.008; Wolf D, 2008, ECOL ENG, V33, P179, DOI 10.1016/j.ecoleng.2008.02.008; 2009, SHEFFIELD WEATHER ST; 2009, BBC WEATHER AVERAGE; 2009, NATL OCEANIC ATMOSPH; 2009, BIZEE DEGREE DAYS WE	57	205	210	6	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9677	10.1371/journal.pone.0009677	http://dx.doi.org/10.1371/journal.pone.0009677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300196	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900011
J	Baran, R; Castelblanco, L; Tang, G; Shapiro, I; Goncharov, A; Jin, YS				Baran, Renee; Castelblanco, Liliana; Tang, Garland; Shapiro, Ian; Goncharov, Alexandr; Jin, Yishi			Motor Neuron Synapse and Axon Defects in a C. elegans Alpha-Tubulin Mutant	PLOS ONE			English	Article							PRESYNAPTIC ACTIVE ZONES; CAENORHABDITIS-ELEGANS; MICROTUBULE DYNAMICS; BETA-TUBULIN; NERVOUS-SYSTEM; GENE; MUTATIONS; PROTEIN; DOUBLECORTIN; TRANSPORT	Regulation of microtubule dynamics underlies many fundamental cellular mechanisms including cell division, cell motility, and transport. In neurons, microtubules play key roles in cell migration, axon outgrowth, control of axon and synapse growth, and the regulated transport of vesicles and structural components of synapses. Loss of synapse and axon integrity and disruption of axon transport characterize many neurodegenerative diseases. Recently, mutations that specifically alter the assembly or stability of microtubules have been found to directly cause neurodevelopmental defects or neurodegeneration in vertebrates. We report here the characterization of a missense mutation in the C-terminal domain of C. elegans alpha-tubulin, tba-1(ju89), that disrupts motor neuron synapse and axon development. Mutant ju89 animals exhibit reduction in the number and size of neuromuscular synapses, altered locomotion, and defects in axon extension. Although null mutations of tba-1 show a nearly wild-type pattern, similar axon outgrowth defects were observed in animals lacking the beta-tubulin TBB-2. Genetic analysis reveals that tba-1(ju89) affects synapse development independent of its role in axon outgrowth. tba-1(ju89) is an altered function allele that most likely perturbs interactions between TBA-1 and specific microtubule-associated proteins that control microtubule dynamics and transport of components needed for synapse and axon growth.	[Baran, Renee; Castelblanco, Liliana; Tang, Garland; Shapiro, Ian] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA; [Goncharov, Alexandr; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, San Diego, CA 92103 USA; [Goncharov, Alexandr; Jin, Yishi] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA	Occidental College; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Baran, R (corresponding author), Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA.	baran@oxy.edu		Jin, Yishi/0000-0002-9371-9860	NIH [NS35546]; Occidental College Undergraduate Research Center; NSF [RUI 064227]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035546, R37NS035546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Occidental College Undergraduate Research Center; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: NIH NS35546 to YJ (www.nih.gov). AG is an HHMI associate, and YJ is an HHMI investigator (www.hhmi.org). LC and GT were supported by the Occidental College Undergraduate Research Center (www.oxy.edu/urc) and NSF RUI 064227 to RB (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bamber BA, 1999, J NEUROSCI, V19, P5348; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; BRENNER S, 1974, GENETICS, V77, P71; Brown MA, 2009, MED J AUSTRALIA, V190, P3, DOI 10.5694/j.1326-5377.2009.tb02249.x; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ellis GC, 2004, J CELL SCI, V117, P457, DOI 10.1242/jcs.00869; ERRICO A, 2002, HUM MOL GENET, V11, P183; Fallet-Bianco C, 2008, BRAIN, V131, P2304, DOI 10.1093/brain/awn155; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; FUKUSHIGE T, 1993, J MOL BIOL, V234, P1290, DOI 10.1006/jmbi.1993.1685; FUKUSHIGE T, 1995, BBA-GENE STRUCT EXPR, V1261, P401, DOI 10.1016/0167-4781(95)00028-F; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Imai Y, 2004, CURR OPIN NEUROBIOL, V14, P384, DOI 10.1016/j.conb.2004.04.002; Jin S, 2009, DEVELOPMENT, V136, P1571, DOI 10.1242/dev.029983; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jin YS, 1999, J NEUROSCI, V19, P539; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Lu CG, 2005, GENETICS, V170, P115, DOI 10.1534/genetics.104.030106; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moccia R, 2003, J NEUROSCI, V23, P9409; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schaefer MKE, 2007, J NEUROSCI, V27, P8779, DOI 10.1523/JNEUROSCI.1599-07.2007; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Szymanski D, 2002, CURR BIOL, V12, pR767, DOI 10.1016/S0960-9822(02)01288-5; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	68	22	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9655	10.1371/journal.pone.0009655	http://dx.doi.org/10.1371/journal.pone.0009655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300184	Green Published, gold			2022-12-25	WOS:000275620600010
J	Ilsar, R; Chawantanpipat, C; Chan, KH; Dobbins, TA; Waugh, R; Hennessy, A; Celermajer, DS; Ng, MKC				Ilsar, Rahn; Chawantanpipat, Chirapan; Chan, Kim H.; Dobbins, Timothy A.; Waugh, Richard; Hennessy, Annemarie; Celermajer, David S.; Ng, Martin K. C.			Measurement of Pulmonary Flow Reserve and Pulmonary Index of Microcirculatory Resistance for Detection of Pulmonary Microvascular Obstruction	PLOS ONE			English	Article							IDEAL CORONARY VASODILATOR; ARTERIAL-HYPERTENSION; INTRACORONARY PAPAVERINE; EXPERIMENTAL VALIDATION; CARDIAC-OUTPUT; BLOOD-FLOW; THERMODILUTION; ADENOSINE; DISEASE; REPRODUCIBILITY	Background: The pulmonary microcirculation is the chief regulatory site for resistance in the pulmonary circuit. Despite pulmonary microvascular dysfunction being implicated in the pathogenesis of several pulmonary vascular conditions, there are currently no techniques for the specific assessment of pulmonary microvascular integrity in humans. Peak hyperemic flow assessment using thermodilution-derived mean transit-time (T-mn) facilitate accurate coronary microcirculatory evaluation, but remain unvalidated in the lung circulation. Using a high primate model, we aimed to explore the use of T-mn as a surrogate of pulmonary blood flow for the purpose of measuring the novel indices Pulmonary Flow Reserve [PFR = (maximum hyperemic)/(basal flow)] and Pulmonary Index of Microcirculatory Resistance [PIMR = (maximum hyperemic distal pulmonary artery pressure) 6(maximum hyperemic T-mn)]. Ultimately, we aimed to investigate the effect of progressive pulmonary microvascular obstruction on PFR and PIMR. Methods and Results: Temperature-and pressure-sensor guidewires (TPSG) were placed in segmental pulmonary arteries (SPA) of 13 baboons and intravascular temperature measured. T-mn and hemodynamics were recorded at rest and following intra-SPA administration of the vasodilator agents adenosine (10-400 mu g/kg/min) and papaverine (3-24 mg). Temperature did not vary with intra-SPA sensor position (0.010 +/- 0.009 v 0.010 +/- 0.009 degrees C; distal v proximal; p = 0.1), supporting T-mn use in lung for the purpose of hemodynamic indices derivation. Adenosine (to 200 mu g/kg/min) & papaverine (to 24 mg) induced dose-dependent flow augmentations (40 +/- 67% & 35 +/- 13% T-mn reductions v baseline, respectively; p < 0.0001). PFR and PIMR were then calculated before and after progressive administration of ceramic microspheres into the SPA. Cumulative microsphere doses progressively reduced PFR (1.41 +/- 0.06, 1.26 +/- 0.19, 1.17 +/- 0.07 & 1.01 +/- 0.03; for 0, 10(4), 10(5) & 10(6) microspheres; p = 0.009) and increased PIMR (5.7 +/- 0.6, 6.3 +/- 1.0, 6.8 +/- 0.6 & 7.6 +/- 0.6 mmHg. sec; p = 0.0048). Conclusions: Thermodilution-derived mean transit time can be accurately and reproducibly measured in the pulmonary circulation using TPSG. Mean transit time-derived PFR and PIMR can be assessed using a TPSG and adenosine or papaverine as hyperemic agents. These novel indices detect progressive pulmonary microvascular obstruction and thus have with a potential role for pulmonary microcirculatory assessment in humans.	[Ilsar, Rahn; Chawantanpipat, Chirapan; Chan, Kim H.; Waugh, Richard; Celermajer, David S.; Ng, Martin K. C.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Ilsar, Rahn; Celermajer, David S.; Ng, Martin K. C.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Dobbins, Timothy A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Hennessy, Annemarie] Univ Western Sydney, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Western Sydney University	Ilsar, R (corresponding author), Royal Prince Alfred Hosp, Sydney, NSW, Australia.	mkcng@med.usyd.edu.au	Dobbins, Timothy A/I-5819-2013; Dobbins, Timothy/AAS-1422-2020; Hennessy, Annemarie/HGB-5049-2022	Dobbins, Timothy A/0000-0003-1841-9056; Dobbins, Timothy/0000-0003-1841-9056; Hennessy, Annemarie/0000-0002-5975-2843	National Health and Medical Research Council of Australia [512404]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by a National Health and Medical Research Council of Australia (www.nhmrc.gov.au), Project Grant #512404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger WR, 2007, CLIN CHEST MED, V28, P255, DOI 10.1016/j.ccm.2006.11.009; Barbato E, 2004, EUR HEART J, V25, P219, DOI 10.1016/j.ehj.2003.11.009; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; BHATTACHARYA J, 1980, SCIENCE, V210, P327, DOI 10.1126/science.7423192; Bressollette E, 2001, CHEST, V120, P809, DOI 10.1378/chest.120.3.809; BUSH A, 1989, BRIT J CLIN PHARMACO, V27, P165, DOI 10.1111/j.1365-2125.1989.tb05347.x; CELERMAJER DS, 1993, CIRCULATION, V87, P440, DOI 10.1161/01.CIR.87.2.440; De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223; DOUCETTE JW, 1992, CIRCULATION, V85, P1899, DOI 10.1161/01.CIR.85.5.1899; Fearon WF, 2004, CIRCULATION, V109, P2269, DOI 10.1161/01.CIR.0000128669.99355.CB; Fearon WF, 2003, CIRCULATION, V108, P2198, DOI 10.1161/01.CIR.0000099521.31396.9D; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie Nazzareno, 2006, Proc Am Thorac Soc, V3, P571, DOI 10.1513/pats.200605-113LR; Glenny RW, 1999, J APPL PHYSIOL, V86, P623, DOI 10.1152/jappl.1999.86.2.623; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Ilsar R, 2009, CLIN EXP PHARMACOL P, V36, P797, DOI 10.1111/j.1440-1681.2009.05160.x; Johnson BD, 2000, J APPL PHYSIOL, V88, P1650, DOI 10.1152/jappl.2000.88.5.1650; Kern MJ, 2000, CIRCULATION, V101, P1344, DOI 10.1161/01.CIR.101.11.1344; Lovering AT, 2007, AM J PHYSIOL-HEART C, V292, pH1777, DOI 10.1152/ajpheart.01024.2006; LUMB A, 2000, APPL RESP PHYSL; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522; Ogawa K, 2001, ANESTHESIOLOGY, V94, P668, DOI 10.1097/00000542-200104000-00022; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Pijls NHJ, 2002, CIRCULATION, V105, P2482, DOI 10.1161/01.CIR.0000017199.09457.3D; Radegran G, 2001, ACTA PHYSIOL SCAND, V171, P177, DOI 10.1046/j.1365-201x.2001.00796.x; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595; WILSON RF, 1986, CIRCULATION, V73, P444, DOI 10.1161/01.CIR.73.3.444; ZIJLSTRA F, 1986, CATHETER CARDIO DIAG, V12, P298, DOI 10.1002/ccd.1810120505	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9601	10.1371/journal.pone.0009601	http://dx.doi.org/10.1371/journal.pone.0009601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231900	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300017
J	Oberst, A; Pop, C; Tremblay, AG; Blais, V; Denault, JB; Salvesen, GS; Green, DR				Oberst, Andrew; Pop, Cristina; Tremblay, Alexandre G.; Blais, Veronique; Denault, Jean-Bernard; Salvesen, Guy S.; Green, Douglas R.			Inducible Dimerization and Inducible Cleavage Reveal a Requirement for Both Processes in Caspase-8 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERCHAIN PROTEOLYSIS; SPECIFICITY; MECHANISM; DEATH; MODEL	Caspase-8 is a cysteine protease activated by membrane-bound receptors at the cytosolic face of the cell membrane, initiating the extrinsic pathway of apoptosis. Caspase-8 activation relies on recruitment of inactive monomeric zymogens to activated receptor complexes, where they produce a fully active enzyme composed of two catalytic domains. Although in vitro studies using drug-mediated affinity systems or kosmotropic salts to drive dimerization have indicated that uncleaved caspase-8 can be readily activated by dimerization alone, in vivo results using mouse models have reached the opposite conclusion. Furthermore, in addition to interdomain autoprocessing, caspase-8 can be cleaved by activated executioner caspases, and reports of whether this cleavage event can lead to activation of caspase-8 have been conflicting. Here, we address these questions by carrying out studies of the activation characteristics of caspase-8 mutants bearing prohibitive mutations at the interdomain cleavage sites both in vitro and in cell lines lacking endogenous caspase-8, and we find that elimination of these cleavage sites precludes caspase-8 activation by prodomain-driven dimerization. We then further explore the consequences of interdomain cleavage of caspase-8 by adapting the tobacco etch virus protease to create a system in which both the cleavage and the dimerization of caspase-8 can be independently controlled in living cells. We find that unlike the executioner caspases, which are readily activated by interdomain cleavage alone, neither dimerization nor cleavage of caspase-8 alone is sufficient to activate caspase-8 or induce apoptosis and that only the coordinated dimerization and cleavage of the zymogen produce efficient activation in vitro and apoptosis in cellular systems.	[Pop, Cristina; Salvesen, Guy S.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tremblay, Alexandre G.; Blais, Veronique; Denault, Jean-Bernard] Univ Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital; University of Sherbrooke	Salvesen, GS (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@burnham.org; green@stjude.org	Green, Douglas R/N-8083-2018; Denault, Jean-Bernard/AAC-5945-2019	Green, Douglas R/0000-0002-7332-1417; 	National Institutes of Health [AI47891, AI44828, CA69381]; Canadian Institutes of Health Research; Cancer Research Society; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047891, R01AI044828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI47891 (to D. R. G.), AI44828 (to D. R. G.), and CA69381 (to D. R. G. and G. S. S.). This work was also supported in part by Canadian Institutes of Health Research and Cancer Research Society operating grants (to J.-B. D.).	Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Denault JB, 2003, CURR PROTOC PROTEIN; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Denault Jean-Bernard, 2008, V414, P191; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Spencer DM, 1996, CURR BIOL, V6, P839, DOI 10.1016/S0960-9822(02)00607-3; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340	40	147	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16632	16642		10.1074/jbc.M109.095083	http://dx.doi.org/10.1074/jbc.M109.095083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308068	Green Published, hybrid			2022-12-25	WOS:000277982600027
J	Guo, NX; Baglole, CJ; O'Loughlin, CW; Feldon, SE; Phipps, RP				Guo, Naxin; Baglole, Carolyn J.; O'Loughlin, Charles W.; Feldon, Steven E.; Phipps, Richard P.			Mast Cell-derived Prostaglandin D-2 Controls Hyaluronan Synthesis in Human Orbital Fibroblasts via DP1 Activation IMPLICATIONS FOR THYROID EYE DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAVES OPHTHALMOPATHY; THYROTROPIN RECEPTOR; GROWTH-FACTOR; ALLERGIC INFLAMMATION; TISSUE-INJURY; D SYNTHASE; EXPRESSION; CRTH2; GAMMA; LYMPHOCYTES	Thyroid eye disease (TED) is a debilitating disorder characterized by the accumulation of adipocytes and hyaluronan (HA). Production of HA by fibroblasts leads to remarkable increases in tissue volume and to the anterior displacement of the eyes. Prostaglandin D-2 (PGD(2)), mainly produced by mast cells, promotes orbital fibroblast adipogenesis. The mechanism by which PGD(2) influences orbital fibroblasts and their synthesis of HA is poorly understood. We report here that mast cell-derived PGD(2) is a key factor that promotes HA biosynthesis by orbital fibroblasts. Primary orbital fibroblasts from TED patients were isolated and used to test the effects of PGD(2), prostaglandin J(2), as well as prostaglandin D receptor (DP) agonists and antagonists on HA synthesis. The expression of HA synthase (HAS), hyaluronidase, DP1, and DP2 mRNA levels was assessed by PCR. Small interfering RNAs against HAS1 or HAS2 were used to assess the importance of HAS isoforms on HA production. Treatment of human orbital fibroblasts with PGD(2) and PGJ(2) increased HA synthesis and HAS mRNA. HAS2 was the dominant isoform responsible for HA production by PGD(2). The effect of PGD(2) on HA production was mimicked by the selective DP1 agonist BW245C. The DP1 antagonist MK-0524 completely blocked PGD(2)-induced HA synthesis. Human mast cells (HMC-1) produced PGD(2). Co-culture of HMC-1 cells with orbital fibroblasts induced HA production and inhibition of mast cell-derived PGD(2) prevented HA synthesis. Mast cell-derived PGD(2) increased HA production via activation of DP1. Selectively targeting the production of PGD(2) and/or activation of DP1 may prevent pathological changes associated with TED.	[Baglole, Carolyn J.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14642 USA; [Guo, Naxin; O'Loughlin, Charles W.; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Dept Ophthalmol, Sch Med & Dent, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Phipps, Richard P.] Univ Rochester, Lung Biol & Dis Program, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Dept Environm Med, Sch Med & Dent, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu		Feldon, Steven/0000-0003-0603-9312	Research to Prevent Blindness Foundation Grant [EY017123, EY011708]; Parker B. Francis Fellowship; American Thoracic Society; NATIONAL EYE INSTITUTE [R01EY017123, R01EY011708] Funding Source: NIH RePORTER	Research to Prevent Blindness Foundation Grant(Research to Prevent Blindness (RPB)); Parker B. Francis Fellowship; American Thoracic Society; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by EY017123 and EY011708 and a Research to Prevent Blindness Foundation Grant.; Supported by a Parker B. Francis Fellowship and an American Thoracic Society Research Grant.	Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Bartalena L, 2009, NEW ENGL J MED, V360, P994, DOI 10.1056/NEJMcp0806317; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Borrello MA, 1996, CELL IMMUNOL, V173, P198, DOI 10.1006/cimm.1996.0268; Boschi A, 2005, BRIT J OPHTHALMOL, V89, P724, DOI 10.1136/bjo.2004.050807; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2009, BRIT J BIOMED SCI, V66, P28; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Costagliola S, 2000, J CLIN INVEST, V105, P803, DOI 10.1172/JCI7665; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gianoukakis AG, 2007, ENDOCRINOLOGY, V148, P54, DOI 10.1210/en.2006-0736; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; HUFNAGEL TJ, 1984, OPHTHALMOLOGY, V91, P1411; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kahaly G, 1998, THYROID, V8, P429, DOI 10.1089/thy.1998.8.429; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Khoo TK, 2008, THYROID, V18, P1291, DOI 10.1089/thy.2008.0255; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Lauer SA, 2008, OPHTHAL PLAST RECONS, V24, P257, DOI 10.1097/IOP.0b013e318177ebac; Leblanc Y, 2009, BIOORG MED CHEM LETT, V19, P2125, DOI 10.1016/j.bmcl.2009.03.010; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lehmann GM, 2008, PPAR RES, V2008, DOI 10.1155/2008/895901; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Many MC, 1999, J IMMUNOL, V162, P4966; Margulis A, 2009, J IMMUNOL, V183, P1739, DOI 10.4049/jimmunol.0803951; Marzoll A, 2009, J CELL MOL MED, V13, P3713, DOI 10.1111/j.1582-4934.2009.00736.x; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Royer JF, 2008, EUR J CLIN INVEST, V38, P663, DOI 10.1111/j.1365-2362.2008.01989.x; Schwartz JI, 2009, AM J THER, V16, P215, DOI 10.1097/MJT.0b013e31818f9c68; Smith TJ, 1999, ENDOCRINOLOGY, V140, P3518, DOI 10.1210/en.140.8.3518; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; SMITH TJ, 1991, J CLIN ENDOCR METAB, V72, P1169, DOI 10.1210/jcem-72-5-1169; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427, DOI 10.2174/15680266106061427; van Steensel L, 2009, INVEST OPHTH VIS SCI, V50, P3091, DOI 10.1167/iovs.08-2443; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Weinberg E, 2009, J CELL BIOCHEM, V108, P207, DOI 10.1002/jcb.22242; Xue L, 2009, CLIN EXP IMMUNOL, V156, P126, DOI 10.1111/j.1365-2249.2008.03871.x; Yamada M, 2002, AUTOIMMUNITY, V35, P403, DOI 10.1080/0891693021000026319; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x	71	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15794	15804		10.1074/jbc.M109.074534	http://dx.doi.org/10.1074/jbc.M109.074534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308056	Green Published, hybrid			2022-12-25	WOS:000277715900017
J	Jee, J; Mizuno, T; Kamada, K; Tochio, H; Chiba, Y; Yanagi, K; Yasuda, G; Hiroaki, H; Hanaoka, F; Shirakawa, M				Jee, JunGoo; Mizuno, Takeshi; Kamada, Katsuhiko; Tochio, Hidehito; Chiba, Yasumasa; Yanagi, Ken-ichiro; Yasuda, Gentaro; Hiroaki, Hidekazu; Hanaoka, Fumio; Shirakawa, Masahiro			Structure and Mutagenesis Studies of the C-terminal Region of Licensing Factor Cdt1 Enable the Identification of Key Residues for Binding to Replicative Helicase Mcm Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DNA-REPLICATION; ORIGIN RECOGNITION; EUKARYOTIC ORIGINS; RE-REPLICATION; COMPLEX; INHIBITION; GEMININ; CDC6; NMR	In eukaryotes, DNA replication is fired once in a single cell cycle before cell division starts to maintain stability of the genome. This event is tightly controlled by a series of proteins. Cdt1 is one of the licensing factors and is involved in recruiting replicative DNA helicase Mcm2-7 proteins into the pre-replicative complex together with Cdc6. In Cdt1, the C-terminal region serves as a binding site for Mcm2-7 proteins, although the details of these interactions remain largely unknown. Here, we report the structure of the region and the key residues for binding to Mcm proteins. We determined the solution structure of the C-terminal fragment, residues 450-557, of mouse Cdt1 by NMR. The structure consists of a winged-helix domain and shows unexpected similarity to those of the C-terminal domain of Cdc6 and the central fragment of Cdt1, thereby implying functional and evolutionary relationships. Structure-based mutagenesis and an in vitro binding assay enabled us to pinpoint the region that interacts with Mcm proteins. Moreover, by performing in vitro binding and budding yeast viability experiments, we showed that similar to 45 residues located in the N-terminal direction of the structural region are equally crucial for recognizing Mcm proteins. Our data suggest the possibility that winged-helix domain plays a role as a common module to interact with replicative helicase in the DNA replication-licensing process.	[Jee, JunGoo] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Mizuno, Takeshi; Kamada, Katsuhiko; Yanagi, Ken-ichiro; Yasuda, Gentaro; Hanaoka, Fumio] RIKEN, Discovery Res Inst, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Chiba, Yasumasa] Ajinomoto Co Inc, Kawasaki, Kanagawa 2108681, Japan; [Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	Tokyo Metropolitan University; RIKEN; Kyoto University; Ajinomoto Co Inc; Kobe University; Gakushuin University	Jee, J (corresponding author), Tokyo Metropolitan Univ, Ctr Prior Areas, 1-1 Minami Osawa, Tokyo 1920397, Japan.	jee-jungoo@tmu.ac.jp; fumio.hanaoka@gakushuin.ac.jp	HIROAKI, HIDEKAZU/N-1658-2019; Mizuno, Takeshi/I-4432-2017; Kamada, Katsuhiko/M-3666-2017; Tochio, Hidehito/GWV-0429-2022; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011	HIROAKI, HIDEKAZU/0000-0003-1621-5893; Mizuno, Takeshi/0000-0003-3664-7212; Kamada, Katsuhiko/0000-0001-8523-3417; Tochio, Hidehito/0000-0003-3843-3330; 				Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cunningham EL, 2005, CURR OPIN STRUC BIOL, V15, P68, DOI 10.1016/j.sbi.2005.01.003; Cvetic C, 2005, SEMIN CELL DEV BIOL, V16, P343, DOI 10.1016/j.semcdb.2005.02.009; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kasiviswanathan R, 2005, NUCLEIC ACIDS RES, V33, P4940, DOI 10.1093/nar/gki807; Khayrutdinov BI, 2009, PROTEIN SCI, V18, P2252, DOI 10.1002/pro.236; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Wilce JA, 2001, NAT STRUCT BIOL, V8, P206, DOI 10.1038/84934; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; You ZY, 1999, MOL CELL BIOL, V19, P8003	56	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15931	15940		10.1074/jbc.M109.075333	http://dx.doi.org/10.1074/jbc.M109.075333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335175	Green Published, hybrid			2022-12-25	WOS:000277715900030
J	Lechardeur, D; Fernandez, A; Robert, B; Gaudu, P; Trieu-Cuot, P; Lamberet, G; Gruss, A				Lechardeur, Delphine; Fernandez, Annabelle; Robert, Bruno; Gaudu, Philippe; Trieu-Cuot, Patrick; Lamberet, Gilles; Gruss, Alexandra			The 2-Cys Peroxiredoxin Alkyl Hydroperoxide Reductase C Binds Heme and Participates in Its Intracellular Availability in Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; RESPIRATION METABOLISM; REGULATORY MOTIFS; ESCHERICHIA-COLI; IRON ACQUISITION; OXIDATIVE STRESS; RESONANCE RAMAN; PROTEIN PHUS; GENE; DETOXIFICATION	Heme is a redox-reactive molecule with vital and complex roles in bacterial metabolism, survival, and virulence. However, few intracellular heme partners were identified to date and are not well conserved in bacteria. The opportunistic pathogen Streptococcus agalactiae (group B Streptococcus) is a heme auxotroph, which acquires exogenous heme to activate an aerobic respiratory chain. We identified the alkyl hydroperoxide reductase AhpC, a member of the highly conserved thiol-dependent 2-Cys peroxiredoxins, as a heme-binding protein. AhpC binds hemin with a K-d of 0.5 mu M and a 1: 1 stoichiometry. Mutagenesis of cysteines revealed that hemin binding is dissociable from catalytic activity and multimerization. AhpC reductase activity was unchanged upon interaction with heme in vitro and in vivo. A group B Streptococcus ahpC mutant displayed attenuation of two heme-dependent functions, respiration and activity of a heterologous catalase, suggesting a role for AhpC in heme intracellular fate. In support of this hypothesis, AhpC-bound hemin was protected from chemical degradation in vitro. Our results reveal for the first time a role for AhpC as a heme-binding protein.	[Lechardeur, Delphine; Fernandez, Annabelle; Gaudu, Philippe; Lamberet, Gilles; Gruss, Alexandra] INRA, Inst Micalis, UMR 1319, F-78352 Jouy En Josas, France; [Robert, Bruno] Commissariat Energie Atom, Inst Biol & Technol Saclay, CNRS, URA 2096, F-91400 Gif Sur Yvette, France; [Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, URA 2172, F-75015 Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lechardeur, D (corresponding author), INRA, Inst Micalis, UMR 1319, Batiment 222, F-78352 Jouy En Josas, France.	delphine.lechardeur@jouy.inra.fr	GAUDU, Philippe/AAE-9696-2022; Robert, Bruno/D-1264-2012; GAUDU, Philippe/AFE-8376-2022	Robert, Bruno/0000-0001-5999-4538; Gruss, Alexandra/0000-0001-7426-5229; Lechardeur, Delphine/0000-0002-5331-4607; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Agence Nationale de la Recherche, France	Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported in part by a grant for the "StrepRespire" Project from the Agence Nationale de la Recherche, France.	BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Clancy A, 2006, MOL MICROBIOL, V59, P707, DOI 10.1111/j.1365-2958.2005.04974.x; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gaillot O, 1997, GENE, V204, P213, DOI 10.1016/S0378-1119(97)00548-9; Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Immenschuh S, 1997, BIOCHEM BIOPH RES CO, V231, P667, DOI 10.1006/bbrc.1997.6166; IMMENSCHUH S, 1995, BIOCHEMISTRY-US, V34, P13407, DOI 10.1021/bi00041a018; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Kawazu S, 2005, FEBS J, V272, P1784, DOI 10.1111/j.1742-4658.2005.04611.x; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KITAGAWA T, 1977, BIOCHIM BIOPHYS ACTA, V495, P1, DOI 10.1016/0005-2795(77)90234-3; KREMER ML, 1989, EUR J BIOCHEM, V185, P651, DOI 10.1111/j.1432-1033.1989.tb15162.x; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Moore R W, 1978, Methods Enzymol, V52, P324; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; MULLEREBERHARD U, 1985, BIOCHEM PHARMACOL, V34, P719, DOI 10.1016/0006-2952(85)90749-X; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Obinger C, 1997, ARCH BIOCHEM BIOPHYS, V342, P58, DOI 10.1006/abbi.1997.9988; OTHMAN S, 1994, BIOCHEMISTRY-US, V33, P15437, DOI 10.1021/bi00255a026; Perally S, 2008, J PROTEOME RES, V7, P4557, DOI 10.1021/pr800395x; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Rochat T, 2005, MICROBIOL-SGM, V151, P3011, DOI 10.1099/mic.0.27861-0; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schneider S, 2006, J BIOL CHEM, V281, P32606, DOI 10.1074/jbc.M607516200; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Smalley JW, 2001, CLIN DIAGN LAB IMMUN, V8, P509, DOI 10.1128/CDLI.8.3.509-514.2001; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tong Y, 2007, J BIOL INORG CHEM, V12, P735, DOI 10.1007/s00775-007-0226-x; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2001, ARCH BIOCHEM BIOPHYS, V387, P137, DOI 10.1006/abbi.2000.2250; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	70	39	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16032	16041		10.1074/jbc.M109.024505	http://dx.doi.org/10.1074/jbc.M109.024505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332091	Green Published, hybrid			2022-12-25	WOS:000277715900041
J	Wang, YJ; Solt, LA; Burris, TP				Wang, Yongjun; Solt, Laura A.; Burris, Thomas P.			Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; FIBROBLAST GROWTH FACTOR-21; FACTOR-BINDING SITES; ROR-ALPHA; NUCLEAR RECEPTOR; PPAR-ALPHA; GENE-EXPRESSION; CIRCADIAN TRANSCRIPTION; METABOLIC REGULATOR; LIPID-METABOLISM	Fibroblast growth factor 21 (FGF21) is a hormone produced by fat and the liver that plays an important role in lipid metabolism. FGF21 expression is induced by peroxisome proliferator-actived receptor alpha in response to physiological conditions requiring increased fatty acid oxidation. Retinoic acid receptor-related receptor alpha (ROR alpha) is another nuclear receptor that plays a critical role in lipid metabolism as well as in regulation of the circadian rhythm. In this study we demonstrate that ROR alpha directly regulates the expression and secretion of FGF21. A canonical ROR response element was identified in the proximal promoter of the FGF21 gene and shown to exhibit functional activity. Overexpression of ROR alpha in HepG2 cells resulted in increased expression and secretion of FGF21. Suppression of ROR alpha expression caused a decrease in FGF21 expression and secretion, suggesting that ROR alpha contributes to the basal expression of FGF21. These data suggest that one mechanism by which ROR alpha regulates lipid metabolism may be by modulation of FGF21 secretion. Furthermore, this study identifies a clear link between ROR alpha, a key regulator of the mammalian clock, and FGF21, an important hormone regulating glucose and lipid homeostasis.	[Wang, Yongjun; Solt, Laura A.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011	Burris, Thomas P/0000-0003-2922-4449; 	National Institutes of Health [DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 ( to T. P. B.).	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; KNUTSSON A, 1988, SCAND J WORK ENV HEA, V14, P317, DOI 10.5271/sjweh.1913; KNUTSSON A, 1986, LANCET, V2, P89; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	44	85	91	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15668	15673		10.1074/jbc.M110.102160	http://dx.doi.org/10.1074/jbc.M110.102160			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332535	Green Published, hybrid			2022-12-25	WOS:000277715900002
J	Li, MX; Zhong, ZY; Zhu, JW; Xiang, DB; Dai, N; Cao, XJ; Qing, Y; Yang, ZZ; Xie, JY; Li, ZP; Baugh, L; Wang, G; Wang, D				Li, Mengxia; Zhong, Zhaoyang; Zhu, Jianwu; Xiang, Debing; Dai, Nan; Cao, Xiaojing; Qing, Yi; Yang, Zhenzhou; Xie, Jiayin; Li, Zengpeng; Baugh, Laura; Wang, Ge; Wang, Dong			Identification and Characterization of Mitochondrial Targeting Sequence of Human Apurinic/Apyrimidinic Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; IMPORT RECEPTORS TOM20; PREPROTEIN TRANSLOCASE; MAMMALIAN-CELLS; REPAIR PROTEIN; DNA-REPAIR; APE1/REF-1; LOCALIZATION; APE/REF-1; REF-1	Dually targeted mitochondrial proteins usually possess an unconventional mitochondrial targeting sequence (MTS), which makes them difficult to predict by current bioinformatics approaches. Human apurinic/apyrimidinic endonuclease (APE1) plays a central role in the cellular response to oxidative stress. It is a dually targeted protein preferentially residing in the nucleus with conditional distribution in the mitochondria. However, the mitochondrial translocation mechanism of APE1 is not well characterized because it harbors an unconventional MTS that is difficult to predict by bioinformatics analysis. Two experimental approaches were combined in this study to identify the MTS of APE1. First, the interactions between the peptides from APE1 and the three purified translocase receptors of the outer mitochondrial membrane (Tom) were evaluated using a peptide array screen. Consequently, the intracellular distribution of green fluorescent protein-tagged, truncated, or mutated APE1 proteins was traced by tag detection. The results demonstrated that the only MTS of APE1 is harbored within residues 289-318 in the C terminus, which is normally masked by the intact N-terminal structure. As a dually targeted mitochondrial protein, APE1 possesses a special distribution pattern of different subcellular targeting signals, the identification of which sheds light on future prediction of MTSs.	[Wang, Dong] Third Mil Med Univ, Ctr Canc, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China; [Xiang, Debing; Li, Zengpeng] Third Mil Med Univ, Daping Hosp, Dept Pathol Res, Inst Surg, Chongqing 400042, Peoples R China; [Baugh, Laura] Univ Dallas, Dept Biol, Irving, TX 75062 USA	Army Medical University; Army Medical University	Wang, D (corresponding author), Third Mil Med Univ, Ctr Canc, Inst Surg Res, Daping Hosp, 10 Changjiang Zhi Rd, Chongqing 400042, Peoples R China.	dongwang64@hotmail.com	Xiang, Debing/AAZ-7727-2020		National Natural Science Foundation of China [30670628]; Natural Science Research Foundation of the Third Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research Foundation of the Third Military Medical University	This work was supported by National Natural Science Foundation of China Grant 30670628 (to D. W.) and by the Natural Science Research Foundation of the Third Military Medical University ( to Z.Z.).	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Li MX, 2008, FREE RADICAL BIO MED, V45, P592, DOI 10.1016/j.freeradbiomed.2008.05.007; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919	29	62	70	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14871	14881		10.1074/jbc.M109.069591	http://dx.doi.org/10.1074/jbc.M109.069591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231292	Green Published, hybrid			2022-12-25	WOS:000277399000008
J	Moriguchi, T; Kezuka, Y; Nonaka, T; Ebizuka, Y; Fujii, I				Moriguchi, Tomomi; Kezuka, Yuichiro; Nonaka, Takamasa; Ebizuka, Yutaka; Fujii, Isao			Hidden Function of Catalytic Domain in 6-Methylsalicylic Acid Synthase for Product Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I POLYKETIDE SYNTHASE; PENICILLIUM-PATULUM; ASPERGILLUS-TERREUS; DIRECTED MUTAGENESIS; GENE-CLUSTER; BIOSYNTHESIS; IDENTIFICATION; THIOESTERASE; SITE; ATX	Functional investigation of the proposed dehydratase domain of ATX, a 6-methylsalicylic acid synthase from Aspergillus terreus, revealed that the domain is not involved in dehydration of the beta-hydroxytriketide intermediate tethered on the acyl carrier protein but catalyzes thioester hydrolysis to release the product from the acyl carrier protein. Thus, we renamed this domain the thioester hydrolase (TH) domain. The intermediate bound to the TH domain of mutant H972A formed in the presence of NADPH was released as 6-methylsalicylic acid by both the intact ATX and by THID (a 541-amino acid region containing TH domain and its downstream) protein, in trans. Furthermore, THID showed a catalytic activity to hydrolyze a model substrate, 6-methylsalicylic acid-N-acetylcysteamine. The TH domain is the first example of a product-releasing domain that is located in the middle of a multidomain iterative type I polyketide synthase. Moreover, it is functionally different from serine protease-type thioesterase domains of iterative type I polyketide synthases.	[Kezuka, Yuichiro; Nonaka, Takamasa; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Iwate Medical University; University of Tokyo	Fujii, I (corresponding author), Iwate Med Univ, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ifujii@iwate-med.ac.jp		Kezuka, Yuichiro/0000-0003-4039-3825	Japan Society for the Promotion of Science [19310139]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research B 19310139 from the Japan Society for the Promotion of Science (to I. F.) and by a Grant-in-aid for Scientific Research on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to I. F.).	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bailey AM, 2007, CHEM COMMUN, P4053, DOI 10.1039/b708614h; BECK J, 1990, EUR J BIOCHEM, V192, P487, DOI 10.1111/j.1432-1033.1990.tb19252.x; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; DIMROTH P, 1970, EUR J BIOCHEM, V13, P98, DOI 10.1111/j.1432-1033.1970.tb00904.x; DIMROTH P, 1976, EUR J BIOCHEM, V68, P591, DOI 10.1111/j.1432-1033.1976.tb10847.x; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Fujii I, 1996, MOL GEN GENET, V253, P1, DOI 10.1007/s004380050289; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Kealey JT, 1998, P NATL ACAD SCI USA, V95, P505, DOI 10.1073/pnas.95.2.505; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Moriguch T, 2008, CHEMBIOCHEM, V9, P1207, DOI 10.1002/cbic.200700691; Moriguchi T, 2006, CHEMBIOCHEM, V7, P1869, DOI 10.1002/cbic.200600235; PAZIRANDEH M, 1991, J BIOL CHEM, V266, P20946; Richardson MT, 1999, METAB ENG, V1, P180, DOI 10.1006/mben.1999.0113; SCOTT AI, 1976, BIOORG CHEM, V3, P238; Shoolingin-Jordan P. M., 1999, COMPREHENSIVE NATURA, P345; SINGH N, 1984, J BIOL CHEM, V259, P3605; SPENCER JB, 1992, BIOCHEM J, V288, P839, DOI 10.1042/bj2880839; SPENCER JB, 1992, BIOCHEMISTRY-US, V31, P9107, DOI 10.1021/bi00152a055; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	35	29	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15637	15643		10.1074/jbc.M110.107391	http://dx.doi.org/10.1074/jbc.M110.107391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304931	Green Published, hybrid			2022-12-25	WOS:000277399000082
J	Bishop, JR; Foley, E; Lawrence, R; Esko, JD				Bishop, Joseph R.; Foley, Erin; Lawrence, Roger; Esko, Jeffrey D.			Insulin-dependent Diabetes Mellitus in Mice Does Not Alter Liver Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSAMINYL N-DEACETYLASE; GLOMERULAR BASEMENT-MEMBRANE; LDL RECEPTOR; TRANSMEMBRANE DOMAIN; KNOCKOUT MICE; RATS; GLYCOSAMINOGLYCANS; METABOLISM; LIPOPROTEINS; ASSOCIATION	Diabetes-associated hyperlipidemia is generally attributed to reduced clearance of plasma lipoproteins, especially remnant lipoproteins enriched in cholesterol and triglycerides. Hepatic clearance of remnants occurs via low density lipoprotein receptors and the heparan sulfate proteoglycan, syndecan-1. Previous studies have suggested alterations in heparan sulfate proteoglycan metabolism in rat and mouse diabetic models, consistent with the idea that diabetic dyslipidemia might be caused by alterations in proteoglycan expression in the liver. In this study we analyzed the content and composition of liver heparan sulfate in streptozotocin-induced insulin-deficient diabetic mice that displayed fasting hypertriglyceridemia and delayed clearance of dietary triglyceride-rich lipoproteins. No differences between normal and diabetic littermates in liver heparan sulfate content, sulfation, syndecan-1 protein levels, or affinity for heparin-binding ligands, such as apolipoprotein E or fibroblast growth factor-2, were noted. Decreased incorporation of [S-35] sulfate in insulin-deficient mice in vivo was observed, but the decrease was due to increased plasma inorganic sulfate, which reduced the efficiency of labeling of liver heparan sulfate. These results show that hyperlipidemia in insulin-deficient mice is not due to changes in hepatic heparan sulfate composition.	[Bishop, Joseph R.; Foley, Erin; Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Foley, Erin] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [GM33063]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by National Institutes of Health Grant GM33063 (to J.D.E.). This work was also supported by an American Heart Association scientist development grant (to J.R.B.).	ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BARON H, 1976, DIABETES, V25, P509, DOI 10.2337/diabetes.25.6.509; Blazquez-Medela AM, 2010, CURR DIABETES REV, V6, P68, DOI 10.2174/157339910790909422; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; COHEN MP, 1981, J LAB CLIN MED, V98, P715; COHEN MP, 1984, DIABETES, V33, P8, DOI 10.2337/diabetes.33.1.8; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; EBARA T, 1994, METABOLISM, V43, P299, DOI 10.1016/0026-0495(94)90096-5; ESKO JD, 1986, J BIOL CHEM, V261, P5725; FAN MY, 1992, DIABETES METAB, V18, P98; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Goldberg Ronald B., 2003, Cardiology Clinics, V21, P399, DOI 10.1016/S0733-8651(03)00074-2; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Haffner SM, 1998, ENDOCR REV, V19, P583, DOI 10.1210/er.19.5.583; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; KJELLEN L, 1983, DIABETES, V32, P337, DOI 10.2337/diabetes.32.4.337; KOFOEDENEVOLDSEN A, 1992, KIDNEY INT, V41, P763, DOI 10.1038/ki.1992.119; KOFOEDENEVOLDSEN A, 1991, DIABETES, V40, P1449, DOI 10.2337/diabetes.40.11.1449; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEVY E, 1985, BIOCHIM BIOPHYS ACTA, V834, P376, DOI 10.1016/0005-2760(85)90011-6; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; MIETTINEN HM, 1994, J CELL SCI, V107, P1571; Olsson U, 2001, DIABETES, V50, P2126, DOI 10.2337/diabetes.50.9.2126; Oturai P, 1999, EXP CLIN ENDOCR DIAB, V107, P453, DOI 10.1055/s-0029-1212137; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SPIRO MJ, 1987, DIABETOLOGIA, V30, P259, DOI 10.1007/BF00270425; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; UNGER E, 1991, J BIOL CHEM, V266, P8671; van den Born J, 2006, J BIOL CHEM, V281, P29606, DOI 10.1074/jbc.M601552200; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116	36	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14658	14662		10.1074/jbc.M110.112391	http://dx.doi.org/10.1074/jbc.M110.112391			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236939	hybrid, Green Published			2022-12-25	WOS:000277299700063
J	Han, GS; Carman, GM				Han, Gil-Soo; Carman, George M.			Characterization of the Human LPIN1-encoded Phosphatidate Phosphatase Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHY FLD MUTATION; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PHOSPHATIDYLCHOLINE BREAKDOWN; SUBCELLULAR-LOCALIZATION; PARTIAL-PURIFICATION; ACID PHOSPHATASE; LIPID-METABOLISM	The human LPIN1 gene encodes the protein lipin 1, which possesses phosphatidate (PA) phosphatase (3-sn-phosphatidate phosphohydrolase; EC 3.1.3.4) activity (Han, G.-S., Wu, W.-I., and Carman, G. M. (2006) J. Biol. Chem. 281, 9210-9218). In this work, we characterized human lipin 1 alpha, beta, and gamma isoforms that were expressed in Escherichia coli and purified to near homogeneity. PA phosphatase activities of the alpha, beta, and gamma isoforms were dependent on Mg2+ or Mn2+ ions at pH 7.5 at 37 degrees C. The activities were inhibited by concentrations of Mg2+ and Mn2+ above their optimums and by Ca2+, Zn2+, N-ethylmaleimide, propranolol, and the sphingoid bases sphingosine and sphinganine. The activities were thermally labile at temperatures above 40 degrees C. The alpha, beta, and gamma activities followed saturation kinetics with respect to the molar concentration of PA (K-m values of 0.35, 0.24, and 0.11 mM, respectively) but followed positive cooperative (Hill number similar to 2) kinetics with respect to the surface concentration of PA (K-m values of 4.2, 4.5, and 4.3 mol %, respectively) in Triton X-100/PA-mixed micelles. The turnover numbers (k(cat)) for the alpha, beta, and gamma isoforms were 68.8 +/- 3.5, 42.8 +/- 2.5, and 5.7 +/- 0.2 s(-1), respectively, whereas their energy of activation values were 14.2, 15.5, and 18.5 kcal/mol, respectively. The isoform activities were dependent on PA as a substrate and required at least one unsaturated fatty acyl moiety for maximum activity.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-28140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.).	BHAT BG, 1995, BIOCHEMISTRY-US, V34, P11237, DOI 10.1021/bi00035a033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; BUTTERWITH SC, 1984, BIOCHEM J, V220, P825, DOI 10.1042/bj2200825; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Dennis EA, 1983, ENZYMES, P307; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; EXTON JH, 1990, J BIOL CHEM, V265, P1; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSAKA K, 1975, J BIOCHEM-TOKYO, V77, P501, DOI 10.1093/oxfordjournals.jbchem.a130751; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MULLMANN TJ, 1991, J BIOL CHEM, V266, P2013; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; Noguchi K, 2001, BIOCHEM BIOPH RES CO, V281, P1313, DOI 10.1006/bbrc.2001.4498; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Siess EA, 2005, BIOL CHEM, V386, P1197, DOI 10.1515/BC.2005.137; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tanyi JL, 2003, CANCER RES, V63, P1073; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WU WI, 1993, J BIOL CHEM, V268, P13830; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	65	103	110	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14628	14638		10.1074/jbc.M110.117747	http://dx.doi.org/10.1074/jbc.M110.117747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231281	hybrid, Green Published			2022-12-25	WOS:000277299700060
J	Kashyap, V; Gudas, LJ				Kashyap, Vasundhra; Gudas, Lorraine J.			Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATORS; HISTONE DEACETYLASE COMPLEX; POLYCOMB TARGET GENES; DNA METHYLATION; CO-REPRESSOR; DEVELOPMENTAL REGULATORS; LYSINE-27 METHYLATION; HORMONE-RECEPTORS; SIGNALING PATHWAY; CPG ISLANDS	Retinoic acid (RA), a vitamin A metabolite, regulates transcription by binding to RA receptor (RAR) and retinoid X receptor (RXR) heterodimers. This transcriptional response is determined by receptor interactions with transcriptional regulators and chromatin modifying proteins. We compared transcriptional responses of three RA target genes (Hoxa1, Cyp26a1, RAR beta(2)) in primary embryo fibroblasts (mouse embryonic fibroblasts), immortalized fibroblasts (Balb/c3T3), and F9 teratocarcinoma stem cells. Hoxa1 and Cyp26a1 transcripts are not expressed, but RAR beta(2) transcripts are induced by RA in mouse embryonic fibroblasts and Balb/c3T3 cells. Retinoid receptors (RAR gamma, RXR alpha), coactivators (pCIP (NCOA3, SRC3)), and p300 and RNA polymerase II are recruited only to the RAR beta(2) RA response element (RARE) in Balb/c3T3, whereas these proteins are recruited to RAREs of all three genes by RA in F9 cells. In F9, RA reduces polycomb (PcG) protein Suz12 and the associated H3K27me3 repressive epigenetic modification at the RAREs of all three genes. In contrast, in Balb/c3T3 cells cultured in the +/-RA, Suz12 is not associated with the Hoxa1, RAR beta(2), and Cyp26a1 RAREs, whereas low levels of the H3K27me3 mark are seen at these RAREs. Thus, Suz12 is not required for gene repression in the absence of RA. Even though the Hoxa1 RARE and proximal promoter show high levels of H3K9, K14 acetylation in Balb/c3T3, the Hoxa1 gene is not transcriptionally activated by RA. In Balb/c3T3, CpG islands are methylated in the Cyp26a1 promoter region but not in the Hoxa1 promoter or in these promoters in F9 cells. We have delineated the complex mechanisms that control RA-mediated transcription in fibroblasts versus stem cells.	[Kashyap, Vasundhra; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu	Kashyap, Vasundhra/H-8970-2019		National Institutes of Health [R01CA043796]; Department of Defense [W81XWH-08-1-0317]; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043796 ( to L. J. G.).; Supported by Department of Defense Predoctoral Award W81XWH-08-1-0317.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bovenzi V, 1999, ANTI-CANCER DRUG, V10, P471, DOI 10.1097/00001813-199906000-00007; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Cho JH, 2001, ENDOCRINOLOGY, V142, P3389, DOI 10.1210/en.142.8.3389; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Glass CK, 2000, GENE DEV, V14, P121; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Herman JG, 2000, CURR TOP MICROBIOL, V249, P35; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Ivanova T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-4; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kastner P, 1997, DEVELOPMENT, V124, P313; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; Means AL, 1996, CELL GROWTH DIFFER, V7, P989; Missaghian E, 2009, J ENDOCRINOL, V202, P99, DOI 10.1677/JOE-08-0353; MONK M, 1987, DEVELOPMENT, V99, P371; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; SCHRODER EW, 1982, P NATL ACAD SCI-BIOL, V79, P1549, DOI 10.1073/pnas.79.5.1549; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Thompson JR, 1998, DEV DYNAM, V211, P97, DOI 10.1002/(SICI)1097-0177(199801)211:1<97::AID-AJA9>3.3.CO;2-M; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; Wei LN, 2003, ANNU REV PHARMACOL, V43, P47, DOI 10.1146/annurev.pharmtox.43.100901.140301; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yin H, 2000, BLOOD, V95, P111, DOI 10.1182/blood.V95.1.111.001k20_111_119; Zhuang Y, 2003, MOL CANCER RES, V1, P619	88	64	64	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14534	14548		10.1074/jbc.M110.115345	http://dx.doi.org/10.1074/jbc.M110.115345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231276	Green Published, hybrid			2022-12-25	WOS:000277299700050
J	Schults, MA; Timmermans, L; Godschalk, RW; Theys, J; Wouters, BG; van Schooten, FJ; Chiu, RK				Schults, Marten A.; Timmermans, Leen; Godschalk, Roger W.; Theys, Jan; Wouters, Bradly G.; van Schooten, Frederik J.; Chiu, Roland K.			Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; ARNT TRANSCRIPTION FACTOR; ENDOTHELIAL GROWTH-FACTOR; CARBONIC-ANHYDRASES; SIGNALING PATHWAYS; FACTOR 1-ALPHA; CROSS-TALK; ENOLASE 1; FACTOR-I; EXPRESSION	The hypoxia-inducible factor 1 (HIF-1) pathway is induced in many tumors and associated with poorer outcome. The hypoxia-responsive transcription factor HIF-1 alpha dimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT), which is also an important binding partner for the aryl hydrocarbon receptor (AhR). AhR is an important mediator in the metabolic activation and detoxification of carcinogens, such as the environmental pollutant benzo[a] pyrene (BaP). We hypothesized that HIF-1 alpha activation attenuates BaP-induced AhR-mediated gene expression, which may lead to increased genetic instability and malignant progression. Human lung carcinoma cells (A549) were simultaneously stimulated with CoCl2, which leads to HIF-1 alpha stabilization and varying concentrations of BaP. Both quantitative PCR and immunoblot analysis indicated that induction of the hypoxia response pathway significantly reduced the levels of AhR downstream targets CYP1A1 and CYP1B1 and AhR protein binding to ARNT. We further demonstrate that the BaP-induced hypoxanthine-guanine phosphoribosyltransferase mutation frequency and gamma-H2AX foci were markedly amplified when the HIF-1 pathway was induced. BaP-DNA adducts were only marginally increased, and transient strand breaks were diminished by HIF-1 induction, indicating changes in DNA repair. These data indicate that concurrent exposure of tumor cells to hypoxia and exogenous genotoxins can enhance genetic instability.	[Schults, Marten A.; Timmermans, Leen; Godschalk, Roger W.; van Schooten, Frederik J.; Chiu, Roland K.] Maastricht Univ, Dept Hlth Risk Anal & Toxicol, NUTRIM Res Inst, NL-6200 MD Maastricht, Netherlands; [Theys, Jan] Maastricht Univ, Dept Radiat Oncol MAASTRO, NL-6200 MD Maastricht, Netherlands; [Wouters, Bradly G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5S 1A1, Canada	Maastricht University; Maastricht University; University of Toronto	Chiu, RK (corresponding author), Maastricht Univ, Dept Hlth Risk Anal & Toxicol, NUTRIM Res Inst, POB 616, NL-6200 MD Maastricht, Netherlands.	r.chiu@grat.unimaas.nl	Theys, Jan/K-6685-2015; Wouters, Bradly/T-1525-2017; Theys, Jan/AAI-9211-2021	Wouters, Bradly/0000-0002-8187-592X; Theys, Jan/0000-0002-9718-8251	Province of Limburg, The Netherlands; European Network of Excellence (NoE) [FOOD-CT-2005-513943]	Province of Limburg, The Netherlands(Netherlands Government); European Network of Excellence (NoE)	This work was supported by the Province of Limburg, The Netherlands, and the European Network of Excellence (NoE) "Environmental Cancer, Nutrition and Individual Susceptibility" (ECNIS) Sixth Framework Program (FP6, FOOD-CT-2005-513943).	Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gassmann M, 1997, KIDNEY INT, V51, P567, DOI 10.1038/ki.1997.81; Godschalk RWL, 1998, CARCINOGENESIS, V19, P819, DOI 10.1093/carcin/19.5.819; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jiang BH, 1997, CANCER RES, V57, P5328; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Langie SAS, 2007, DNA REPAIR, V6, P852, DOI 10.1016/j.dnarep.2007.02.012; Lee K, 2006, CHEM RES TOXICOL, V19, P1284, DOI 10.1021/tx060068d; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Nie MH, 2001, ENVIRON TOXICOL PHAR, V10, P17, DOI 10.1016/S1382-6689(01)00065-5; Papp-Szabo E, 2005, INT J CANCER, V116, P679, DOI 10.1002/ijc.21088; Pollenz RS, 1999, MOL PHARMACOL, V56, P1127, DOI 10.1124/mol.56.6.1127; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Ravi R, 2000, GENE DEV, V14, P34; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Reynolds TY, 1996, CANCER RES, V56, P5754; See KY, 2000, MUTAT RES-REV MUTAT, V463, P215, DOI 10.1016/S1383-5742(00)00047-8; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shimada T, 2003, TOXICOL APPL PHARM, V187, P1, DOI 10.1016/S0041-008X(02)00035-2; Takacova M, 2009, BIOCHEM J, V419, P419, DOI 10.1042/BJ20080952; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Wykoff CC, 2000, CANCER RES, V60, P7075; Yuan JL, 2000, CANCER RES, V60, P4372; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhong H, 1999, CANCER RES, V59, P5830; Zundel W, 2000, GENE DEV, V14, P391	40	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14558	14564		10.1074/jbc.M109.076323	http://dx.doi.org/10.1074/jbc.M109.076323			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20228066	Green Published, hybrid			2022-12-25	WOS:000277299700052
J	Arias, P; Cudeiro, J				Arias, Pablo; Cudeiro, Javier			Effect of Rhythmic Auditory Stimulation on Gait in Parkinsonian Patients with and without Freezing of Gait	PLOS ONE			English	Article							ATTENTIONAL COST; DISEASE PATIENTS; VARIABILITY; WALKING; MOTOR; CUES; METRONOME; PEOPLE; ONSET; TASK	Freezing of gait (FOG) in Parkinson's disease (PD) rises in prevalence when the effect of medications decays. It is known that auditory rhythmic stimulation improves gait in patients without FOG (PD-FOG), but its putative effect on patients with FOG (PD+FOG) at the end of dose has not been evaluated yet. This work evaluates the effect of auditory rhythmic stimulation on PD+FOG at the end of dose. 10 PD+ FOG and 9 PD-FOG patients both at the end of dose periods, and 10 healthy controls were asked to perform several walking tasks. Tasks were performed in the presence and absence of auditory sensory stimulation. All PD+ FOG suffered FOG during the task. The presence of auditory rhythmic stimulation (10% above preferred walking cadence) led PD+ FOG to significantly reduce FOG. Velocity and cadence were increased, and turn time reduced in all groups. We conclude that auditory stimulation at the frequency proposed may be useful to avoid freezing episodes in PD+ FOG.	[Arias, Pablo; Cudeiro, Javier] Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med, INEF, La Coruna, Spain	Universidade da Coruna	Arias, P (corresponding author), Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, Dept Med, INEF, La Coruna, Spain.	jcud@udc.es	Arias, Pablo/C-7926-2015; Arias, Pablo/AAP-9721-2021	Arias, Pablo/0000-0002-9029-5310; Cudeiro, Javier/0000-0002-6597-6077	Xunta de Galicia, Spain [2007/000140-0, PGIDIT06PXIC137004PN]	Xunta de Galicia, Spain(Xunta de Galicia)	Work was supported by Xunta de Galicia (Conselleria de Educacion-2007/000140-0 and Direccion Xeral de I+D+i; PGIDIT06PXIC137004PN), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Cubo E, 2004, PARKINSONISM RELAT D, V10, P507, DOI 10.1016/j.parkreldis.2004.05.001; Del Olmo M, 2006, PARKINSONISM RELAT D, V12, P155, DOI 10.1016/j.parkreldis.2005.11.002; Ebersbach G, 1999, MOVEMENT DISORD, V14, P619, DOI 10.1002/1531-8257(199907)14:4<619::AID-MDS1011>3.0.CO;2-X; Enzensberger W, 1996, LANCET, V347, P1337, DOI 10.1016/S0140-6736(96)90987-3; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 2003, PHYSICA A, V321, P565, DOI 10.1016/S0378-4371(02)01744-2; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hong M, 2009, NEUROREHAB NEURAL RE, V23, P166, DOI 10.1177/1545968308320639; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Kompoliti K, 2000, MOVEMENT DISORD, V15, P309, DOI 10.1002/1531-8257(200003)15:2<309::AID-MDS1016>3.0.CO;2-P; Kuo SH, 2008, MOVEMENT DISORD, V23, P616, DOI 10.1002/mds.21917; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miller RA, 1996, ELECTROMYOGR MOTOR C, V101, P1, DOI 10.1016/0013-4694(95)00209-X; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Nieuwboer A, 1997, Physiother Res Int, V2, P125, DOI 10.1002/pri.94; Nieuwboer A, 2000, PHYS THER, V80, P1087, DOI 10.1093/ptj/80.11.1087; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nieuwboer A, 2004, BRAIN, V127, P1650, DOI 10.1093/brain/awh189; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Okuma Y, 2006, J NEUROL, V253, P27, DOI 10.1007/s00415-006-7007-2; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Rochester L, 2007, J NEURAL TRANSM, V114, P1243, DOI 10.1007/s00702-007-0756-y; Rochester L, 2005, ARCH PHYS MED REHAB, V86, P999, DOI 10.1016/j.apmr.2004.10.040; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Willems AM, 2007, MOVEMENT DISORD, V22, P1871, DOI 10.1002/mds.21445	43	102	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9675	10.1371/journal.pone.0009675	http://dx.doi.org/10.1371/journal.pone.0009675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339591	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894300003
J	Jones, DR; Taylor, WA; Bate, C; David, M; Tayebi, M				Jones, Daryl Rhys; Taylor, William Alexander; Bate, Clive; David, Monique; Tayebi, Mourad			A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODY; SCRAPIE AGENT; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; PROTEIN; DISEASE; MICE; BRAIN; DELAYS; INFECTION	The development of antibodies effective in crossing the blood brain barrier (BBB), capable of accessing the cytosol of affected cells and with higher affinity for PrPSc would be of paramount importance in arresting disease progression in its late stage and treating individuals with prion diseases. Antibody-based therapy appears to be the most promising approach following the exciting report from White and colleagues, establishing the "proof-of-principle'' for prion-immunotherapy. After passive transfer, anti-prion antibodies were shown to be very effective in curing peripheral but not central rodent prion disease, due to the fact that these anti-prion antibodies are relatively large molecules and cannot therefore cross the BBB. Here, we show that an anti-prion antibody derived from camel immunised with murine scrapie material adsorbed to immunomagnetic beads is able to prevent infection of susceptible N2a cells and cure chronically scrapie-infected neuroblastoma cultures. This antibody was also shown to transmigrate across the BBB and cross the plasma membrane of neurons to target cytosolic PrPC. In contrast, treatment with a conventional anti- prion antibody derived from mouse immunised with recombinant PrP protein was unable to prevent recurrence of PrPSc replication. Furthermore, our camelid antibody did not display any neurotoxic effects following treatment of susceptible N2a cells as evidenced by TUNEL staining. These findings demonstrate the potential use of anti- prion camelid antibodies for the treatment of prion and other related diseases via non-invasive means.	[Jones, Daryl Rhys; Taylor, William Alexander; Bate, Clive; Tayebi, Mourad] Royal Vet Coll, Dept Pathol & Infect Dis, Hertford, England; [David, Monique] Multiple Sclerosis Res Ctr New York, New York, NY USA	University of London; University of London Royal Veterinary College	Jones, DR (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hertford, England.	mtayebi@rvc.ac.uk	TAYEBI, MOURAD/F-7404-2010	TAYEBI, MOURAD/0000-0001-8664-6918	UK Royal Society; The Royal Veterinary College	UK Royal Society(Royal Society of London); The Royal Veterinary College	This study was supported by the UK Royal Society and The Royal Veterinary College Internal Grant Scheme to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; ADJOU KT, 1995, ANTIMICROB AGENTS CH, V39, P2810, DOI 10.1128/AAC.39.12.2810; Adjou KT, 2000, J COMP PATHOL, V122, P3, DOI 10.1053/jcpa.1999.0338; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campana V, 2009, BIOCHEM J, V418, P507, DOI 10.1042/BJ20081541; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; Dumoulin M, 2004, BIOCHIMIE, V86, P589, DOI 10.1016/j.biochi.2004.09.012; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mazzoni IE, 2005, BIOCHEM CELL BIOL, V83, P644, DOI 10.1139/o05-058; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Pilon J, 2007, NEUROSCI LETT, V429, P161, DOI 10.1016/j.neulet.2007.10.015; PRUSINER SB, 1994, ANNU REV MICROBIOL, V48, P655, DOI 10.1146/annurev.mi.48.100194.003255; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Regina A, 1999, J NEUROCHEM, V73, P1954; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Tayebi M, 2004, MOL MED, V10, P104, DOI 10.2119/2004-00027.Tayebi; Tayebi M, 2006, IMMUNOL LETT, V105, P123, DOI 10.1016/j.imlet.2006.03.001; Tayebi M, 2009, J GEN VIROL, V90, P777, DOI 10.1099/vir.0.005041-0; Tayebi M, 2007, EXPERT REV ANTI-INFE, V5, P631, DOI 10.1586/14787210.5.4.631; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wuertzer CA, 2008, MOL THER, V16, P481, DOI 10.1038/sj.mt.6300387	49	27	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9804	10.1371/journal.pone.0009804	http://dx.doi.org/10.1371/journal.pone.0009804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339552	Green Published, gold			2022-12-25	WOS:000275894300026
J	Madar, A; Greenfield, A; Vanden-Eijnden, E; Bonneau, R				Madar, Aviv; Greenfield, Alex; Vanden-Eijnden, Eric; Bonneau, Richard			DREAM3: Network Inference Using Dynamic Context Likelihood of Relatedness and the Inferelator	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; ESCHERICHIA-COLI; EXPRESSION DATA; GENE NETWORKS; INFORMATION; MODEL; CHALLENGES; SELECTION; SYSTEMS	Background: Many current works aiming to learn regulatory networks from systems biology data must balance model complexity with respect to data availability and quality. Methods that learn regulatory associations based on unit-less metrics, such as Mutual Information, are attractive in that they scale well and reduce the number of free parameters (model complexity) per interaction to a minimum. In contrast, methods for learning regulatory networks based on explicit dynamical models are more complex and scale less gracefully, but are attractive as they may allow direct prediction of transcriptional dynamics and resolve the directionality of many regulatory interactions. Methodology: We aim to investigate whether scalable information based methods (like the Context Likelihood of Relatedness method) and more explicit dynamical models (like Inferelator 1.0) prove synergistic when combined. We test a pipeline where a novel modification of the Context Likelihood of Relatedness (mixed-CLR, modified to use time series data) is first used to define likely regulatory interactions and then Inferelator 1.0 is used for final model selection and to build an explicit dynamical model. Conclusions/Significance: Our method ranked 2nd out of 22 in the DREAM3 100-gene in silico networks challenge. Mixed-CLR and Inferelator 1.0 are complementary, demonstrating a large performance gain relative to any single tested method, with precision being especially high at low recall values. Partitioning the provided data set into four groups (knock-down, knock-out, time-series, and combined) revealed that using comprehensive knock-out data alone provides optimal performance. Inferelator 1.0 proved particularly powerful at resolving the directionality of regulatory interactions, i.e. "who regulates who" (approximately 93% of identified true positives were correctly resolved). Performance drops for high in-degree genes, i.e. as the number of regulators per target gene increases, but not with out-degree, i.e. performance is not affected by the presence of regulatory hubs.	[Madar, Aviv; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Greenfield, Alex; Vanden-Eijnden, Eric; Bonneau, Richard] NYU, Sch Med, Computat Biol Program, New York, NY 10003 USA; [Vanden-Eijnden, Eric] NYU, Courant Inst Math Sci, Dept Math, New York, NY 10003 USA; [Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10003 USA	New York University; New York University; New York University; New York University	Madar, A (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	Bonneau@nyu.edu	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/AAO-1540-2020; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/D-1023-2013		National Science Foundation (NSF) [DMS02-09959, DMS02-39625, DMS07959, DMS07-08140, DBI-08207]; Office of Naval Research (ONR) [N00014-04-1-0565]; Department of Defense (DOD) [USAMRAA W81XWH-04-1-0307]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Department of Defense (DOD)(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work of E.V.-E. was partially supported by National Science Foundation (NSF) grants DMS02-09959, DMS02-39625 and DMS07959, DMS02-39625 and DMS07-08140, and Office of Naval Research (ONR) grant N00014-04-1-0565. The work of R. B. was partially supported by NSF grant DBI-08207, and Department of Defense (DOD) grant USAMRAA W81XWH-04-1-0307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Babu M. Madan, 2009, V541, P163, DOI 10.1007/978-1-59745-243-4_8; Bansal M., 2007, MOL SYSTEMS BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chang WC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-44; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Cover TM, 1991, ELEMENTS INFORM THEO; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N., 1999, LEARNING BAYESIAN NE, P206; Gilchrist M, 2008, NATURE, V451, P1022, DOI 10.1038/nature06779; Gowda T, 2009, ANN NY ACAD SCI, V1158, P276, DOI 10.1111/j.1749-6632.2008.03763.x; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Herrgard MJ, 2004, CURR OPIN BIOTECH, V15, P70, DOI 10.1016/j.copbio.2003.11.002; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lauria M, 2009, ANN NY ACAD SCI, V1158, P257, DOI 10.1111/j.1749-6632.2008.03761.x; Madar A, 2009, IEEE ENG MED BIO, P5448, DOI 10.1109/IEMBS.2009.5334018; Madar Aviv, 2009, V541, P181, DOI 10.1007/978-1-59745-243-4_9; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; R Core Team, 2022, R LANG ENV STAT COMP; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Scheinine A, 2009, ANN NY ACAD SCI, V1158, P287, DOI 10.1111/j.1749-6632.2008.04100.x; Shannon C.E., 1948, BELL SYST TECH J, V27, P623, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang RS, 2007, BIOINFORMATICS, V23, P3056, DOI 10.1093/bioinformatics/btm465; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Zhao WT, 2008, IEEE ACM T COMPUT BI, V5, P262, DOI 10.1109/TCBB.2007.1067; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	48	66	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9803	10.1371/journal.pone.0009803	http://dx.doi.org/10.1371/journal.pone.0009803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339551	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300025
J	Qiu, AQ; Oishi, K; Miller, MI; Lyketsos, CG; Mori, S; Albert, M				Qiu, Anqi; Oishi, Kenichi; Miller, Michael I.; Lyketsos, Constantine G.; Mori, Susumu; Albert, Marilyn			Surface-Based Analysis on Shape and Fractional Anisotropy of White Matter Tracts in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; FIBER TRACTS; HUMAN BRAIN; DIFFUSION; REGISTRATION; HIPPOCAMPAL; DEMENTIA; IMAGES; ATLAS; HYPOMETABOLISM	Background: White matter disruption has been suggested as one of anatomical features associated with Alzheimer's disease (AD). Diffusion tensor imaging (DTI), which has been widely used in AD studies, obtains new insights into the white matter structure. Methods: We introduced surface-based geometric models of the deep white matter tracts extracted from DTI, allowing the characterization of their shape variations relative to an atlas as well as fractional anisotropy (FA) variations on the atlas surface through large deformation diffeomorphic metric mapping (LDDMM). We applied it to assess local shapes and FA variations of twenty-three deep white matter tracts in 13 patients with AD and 19 healthy control subjects. Results: Our results showed regionally-specific shape abnormalities and FA reduction in the cingulum tract and the sagittal stratum tract in AD, suggesting that disruption in the white matter tracts near the temporal lobe may represent the secondary consequence of the medial temporal lobe pathology in AD. Moreover, the regionally-specific patterns of FA and shape of the white matter tracts were shown to be of sufficient sensitivity to robustly differentiate patients with AD from healthy comparison controls when compared with the mean FA and volumes within the regions of the white matter tracts. Finally, greater FA or deformation abnormalities of the white matter tracts were associated with lower MMSE scores. Conclusion: The regionally-specific shape and FA patterns could be potential imaging markers for differentiating AD from normal aging.	[Qiu, Anqi] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Oishi, Kenichi; Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD USA; [Albert, Marilyn] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Qiu, AQ (corresponding author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Oishi, Kenichi/H-1371-2013; Miller, Michael I./A-3213-2010	Qiu, Anqi/0000-0002-0215-6338; Oishi, Kenichi/0000-0002-1200-8611; 	National University of Singapore [R-397-000-058-133]; Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC) [082-101-0025]; A* STAR's Singapore Institute for Clinical Sciences (SICS) [SICS-09/1/1/001]; National Institute on Aging [P50-AG005146, P50-AG 021334]; National Institute of Research Resources, NCRR [P41-RR15241]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000975, R01EB008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334, P50AG005146] Funding Source: NIH RePORTER	National University of Singapore(National University of Singapore); Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC)(Agency for Science Technology & Research (A*STAR)); A* STAR's Singapore Institute for Clinical Sciences (SICS)(Agency for Science Technology & Research (A*STAR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Research Resources, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National University of Singapore: start-up grant R-397-000-058-133 (AQ); the Agency for Science, Technology and Research's (A*STAR) Science and Engineering Research Council (SERC) 082-101-0025 ( AQ); A* STAR's Singapore Institute for Clinical Sciences (SICS) SICS-09/1/1/001 (AQ); the National Institute on Aging (P50-AG005146 and P50-AG 021334); and the National Institute of Research Resources (NCRR, P41-RR15241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2006, ALZ DIS ASSOC DIS, V20, P224, DOI 10.1097/01.wad.0000213857.89613.10; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Chiang MC, 2008, IEEE T MED IMAGING, V27, P442, DOI 10.1109/TMI.2007.907326; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Csernansky JG, 2004, AM J PSYCHIAT, V161, P896, DOI 10.1176/appi.ajp.161.5.896; Duda R.O., 2006, PATTERN CLASSIFICATI; Dupuis P, 1998, Q APPL MATH, V56, P587, DOI 10.1090/qam/1632326; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Huang H, 2008, MAGN RESON IMAGING, V26, P1294, DOI 10.1016/j.mri.2008.03.005; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Irfanoglu MO, 2008, LECT NOTES COMPUT SC, V5242, P1014, DOI 10.1007/978-3-540-85990-1_122; Jolliffe, 2002, PRINCIPAL COMPONENT; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Lenglet C, 2006, IEEE T MED IMAGING, V25, P685, DOI 10.1109/TMI.2006.873299; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2007, LECT NOTES COMPUT SC, V4792, P161; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Qiu AQ, 2007, LECT NOTES COMPUT SC, V4791, P186; Qiu AQ, 2006, IEEE T MED IMAGING, V25, P1296, DOI 10.1109/TMI.2006.882143; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; ROSS ED, 1980, ARCH NEUROL-CHICAGO, V37, P193, DOI 10.1001/archneur.1980.00500530031001; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Thompson PM, 2003, J NEUROSCI, V23, P994; Vaillant M, 2005, LECT NOTES COMPUT SC, V3565, P381; Vaillant M, 2007, NEUROIMAGE, V34, P1149, DOI 10.1016/j.neuroimage.2006.08.053; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang YQ, 2005, ENVIRON SCI POLICY, V8, P179, DOI 10.1016/j.envsci.2004.09.005	54	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9811	10.1371/journal.pone.0009811	http://dx.doi.org/10.1371/journal.pone.0009811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339558	gold, Green Published			2022-12-25	WOS:000275894300030
J	Caldara, R; Zhou, XY; Miellet, S				Caldara, Roberto; Zhou, Xinyue; Miellet, Sebastien			Putting Culture Under the 'Spotlight' Reveals Universal Information Use for Face Recognition	PLOS ONE			English	Article							EYE-MOVEMENTS; PERCEPTUAL SPAN; FIXATION; AREA; OWN; FEATURES; SALIENCY; GAZE	Background: Eye movement strategies employed by humans to identify conspecifics are not universal. Westerners predominantly fixate the eyes during face recognition, whereas Easterners more the nose region, yet recognition accuracy is comparable. However, natural fixations do not unequivocally represent information extraction. So the question of whether humans universally use identical facial information to recognize faces remains unresolved. Methodology/Principal Findings: We monitored eye movements during face recognition of Western Caucasian (WC) and East Asian (EA) observers with a novel technique in face recognition that parametrically restricts information outside central vision. We used 'Spotlights' with Gaussian apertures of 2 degrees, 5 degrees or 8 degrees dynamically centered on observers' fixations. Strikingly, in constrained Spotlight conditions (2 degrees and 5 degrees) observers of both cultures actively fixated the same facial information: the eyes and mouth. When information from both eyes and mouth was simultaneously available when fixating the nose (8 degrees), as expected EA observers shifted their fixations towards this region. Conclusions/Significance: Social experience and cultural factors shape the strategies used to extract information from faces, but these results suggest that external forces do not modulate information use. Human beings rely on identical facial information to recognize conspecifics, a universal law that might be dictated by the evolutionary constraints of nature and not nurture.	[Caldara, Roberto; Miellet, Sebastien] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland; [Caldara, Roberto; Miellet, Sebastien] Univ Glasgow, Ctr Cognit Neuroimaging, Glasgow, Lanark, Scotland; [Zhou, Xinyue] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	University of Glasgow; University of Glasgow; Sun Yat Sen University	Caldara, R (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	r.caldara@psy.gla.ac.uk	Miellet, Sebastien/AFL-6215-2022; Miellet, Sebastien/H-5101-2011; Caldara, Roberto/H-1929-2011	Miellet, Sebastien/0000-0002-3519-033X; Caldara, Roberto/0000-0002-8260-9949; Lauwereyns, Jan/0000-0003-0551-2550	Economic and Social Research Council and Medical Research Council [ESRC/RES-060-25-0010]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; Medical Research Council [MC_G1001214] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI; MRC [MC_G1001214] Funding Source: UKRI	Economic and Social Research Council and Medical Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by The Economic and Social Research Council and Medical Research Council (ESRC/RES-060-25-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Argyle M., 1976, GAZE MUTUAL GAZE; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Caldara R, 2009, HUM BRAIN MAPP, V30, P1615, DOI 10.1002/hbm.20626; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; CROVITZ HF, 1962, AM J PSYCHOL, V75, P271, DOI 10.2307/1419611; DAVIDOFF J, 2008, COGNITION; DAVIES G, 1977, PERCEPTION, V6, P263, DOI 10.1068/p060263; Evans K, 2009, Q J EXP PSYCHOL, V62, P276, DOI 10.1080/17470210802373720; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; Galton Francis, 1883, INQUIRIES HUMAN FACU, DOI DOI 10.1037/14178-000; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Groner R, 1984, THEORETICAL APPL ASP, P523; GRONWALL DM, 1971, BRIT J PSYCHOL, V62, P175, DOI 10.1111/j.2044-8295.1971.tb02028.x; HAIG ND, 1986, PERCEPTION, V15, P235, DOI 10.1068/p150235; Hall E.T., 1966, HIDDEN DIMENSION; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 2001, FRAGMENTS OBJECTS SE, P463, DOI DOI 10.1016/S0166-4115(01)80034-0; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JACK RE, 2009, CULTURAL CONFUSIONS; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KELLY D, FRONTIERS P IN PRESS; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kuhn G, 2005, PERCEPTION, V34, P1155, DOI 10.1068/p3409bn1; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Michel C, 2007, COGNITIVE SCI, V31, P911, DOI 10.1080/03640210701530805; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; Miellet S, 2004, BRAIN LANG, V90, P299, DOI 10.1016/S0093-934X(03)00442-5; Miellet S, 2009, PSYCHOL SCI, V20, P721, DOI 10.1111/j.1467-9280.2009.02364.x; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; PORTA DG, 1593, REFRACTIONE OPTICES; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2009, J EXP PSYCHOL LEARN, V35, P254, DOI 10.1037/a0013508; Rowley HA, 1998, IEEE T PATTERN ANAL, V20, P23, DOI 10.1109/34.655647; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Triandis H.C., 1995, INDIVIDUALISM COLLEC; Turati C, 2002, J EXP CHILD PSYCHOL, V83, P239, DOI 10.1016/S0022-0965(02)00148-0; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	69	111	114	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9708	10.1371/journal.pone.0009708	http://dx.doi.org/10.1371/journal.pone.0009708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580NO	20305776	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000276456300011
J	Curnow, SJ; Fairclough, M; Schmutz, C; Kissane, S; Denniston, AKO; Nash, K; Buckley, CD; Lord, JM; Salmon, M				Curnow, S. John; Fairclough, Marianne; Schmutz, Caroline; Kissane, Steve; Denniston, Alastair K. O.; Nash, Kate; Buckley, Christopher D.; Lord, Janet M.; Salmon, Mike			Distinct Types of Fibrocyte Can Differentiate from Mononuclear Cells in the Presence and Absence of Serum	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; MONOCYTES; FIBROBLASTS; TISSUE	Background: Fibrocytes are bone-marrow derived cells, expressing both haematopoietic and stromal cell markers, which contribute to tissue repair as well as pathological fibrosis. The differentiation of fibrocytes remains poorly characterised and this has limited understanding of their biology and function. In particular two methods are used to generate fibrocytes in vitro that differ fundamentally by the presence or absence of serum. Methodology/Principal Findings: We show here that fibrocytes grown in the absence of serum (SF) differentiate more efficiently from peripheral blood mononuclear cells than CD14(+) monocytes, and respond to serum by losing their spindle-shaped fibrocyte morphology. Although fibrocytes generated in the presence of serum (SC) express the same range of markers, they differentiate more efficiently from CD14(+) monocytes and do not change their morphology in response to serum. Transcriptional analysis revealed that both types of fibrocyte are distinct from each other, fibroblasts and additional monocyte-derived progeny. The gene pathways that differ significantly between SF and SC fibrocytes include those involved in cell migration, immune responses and response to wounding. Conclusions/Significance: These data show that SF and SC fibrocytes are distinct but related cell types, and suggest that they will play different roles during tissue repair and fibrosis where changes in serum proteins may occur.	[Curnow, S. John; Fairclough, Marianne; Schmutz, Caroline; Kissane, Steve; Denniston, Alastair K. O.; Nash, Kate; Buckley, Christopher D.; Lord, Janet M.; Salmon, Mike] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Curnow, SJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England.	s.j.curnow@bham.ac.uk	Denniston, Alastair/ABD-1238-2020; Buckley, Christopher/AAN-6378-2021	Denniston, Alastair/0000-0001-7849-0087; Buckley, Christopher/0000-0001-6924-6402; Lord, Janet/0000-0003-1030-6786; Curnow, John/0000-0002-2660-0392	Arthritis Research Campaign [16390]; Wellcome Trust [VS/06/BIR/A6]; Medical Research Council UK [G0600416]; Birmingham Eye Foundation [257549]; Medical Research Council [G9818340, G9818340B, G0600416] Funding Source: researchfish; National Institute for Health Research [CL-2009-09-002] Funding Source: researchfish; MRC [G9818340, G0600416] Funding Source: UKRI	Arthritis Research Campaign(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Birmingham Eye Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Arthritis Research Campaign (16390), The Wellcome Trust (VS/06/BIR/A6), Medical Research Council UK (Clinical Training Fellowship to AD; G0600416) and the Birmingham Eye Foundation (Registered [UK] Charity 257549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bahnelli C, 2007, IMMUNOBIOLOGY, V212, P693, DOI 10.1016/j.imbio.2007.09.009; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Filer A, 2009, ARTHRITIS RHEUM, V60, P1604, DOI 10.1002/art.24574; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Hong KM, 2005, FASEB J, V19, P2029, DOI 10.1096/fj.05-4295fje; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Uehara H, 2010, DIGEST DIS SCI, V55, P253, DOI 10.1007/s10620-009-0730-7	21	47	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9730	10.1371/journal.pone.0009730	http://dx.doi.org/10.1371/journal.pone.0009730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305780	Green Published, gold, Green Submitted			2022-12-25	WOS:000276456300013
J	Kleinau, G; Jaeschke, H; Worth, CL; Mueller, S; Gonzalez, J; Paschke, R; Krause, G				Kleinau, Gunnar; Jaeschke, Holger; Worth, Catherine L.; Mueller, Sandra; Gonzalez, Jorge; Paschke, Ralf; Krause, Gerd			Principles and Determinants of G-Protein Coupling by the Rhodopsin-Like Thyrotropin Receptor	PLOS ONE			English	Article							LUTEINIZING-HORMONE RECEPTOR; 2ND INTRACELLULAR LOOP; HETEROTRIMERIC G-PROTEIN; HUMAN FSH RECEPTOR; PHOSPHOLIPASE-C; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURES; LUTROPIN-RECEPTOR; ALPHA-SUBUNIT; GONADOTROPIN RECEPTORS	In this study we wanted to gain insights into selectivity mechanisms between G-protein-coupled receptors (GPCR) and different subtypes of G-proteins. The thyrotropin receptor (TSHR) binds G-proteins promiscuously and activates both Gs (cAMP) and Gq (IP). Our goal was to dissect selectivity patterns for both pathways in the intracellular region of this receptor. We were particularly interested in the participation of poorly investigated receptor parts. We systematically investigated the amino acids of intracellular loop (ICL) 1 and helix 8 using site-directed mutagenesis alongside characterization of cAMP and IP accumulation. This approach was guided by a homology model of activated TSHR in complex with heterotrimeric Gq, using the X-ray structure of opsin with a bound G-protein peptide as a structural template. We provide evidence that ICL1 is significantly involved in G-protein activation and our model suggests potential interactions with subunits G alpha as well as G beta gamma. Several amino acid substitutions impaired both IP and cAMP accumulation. Moreover, we found a few residues in ICL1 (L440, T441, H443) and helix 8 (R687) that are sensitive for Gq but not for Gs activation. Conversely, not even one residue was found that selectively affects cAMP accumulation only. Together with our previous mutagenesis data on ICL2 and ICL3 we provide here the first systematically completed map of potential interfaces between TSHR and heterotrimeric G-protein. The TSHR/Gq-heterotrimer complex is characterized by more selective interactions than the TSHR/Gs complex. In fact the receptor interface for binding Gs is a subset of that for Gq and we postulate that this may be true for other GPCRs coupling these G-proteins. Our findings support that G-protein coupling and preference is dominated by specific structural features at the intracellular region of the activated GPCR but is completed by additional complementary recognition patterns between receptor and G-protein subtypes.	[Kleinau, Gunnar; Worth, Catherine L.; Krause, Gerd] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Jaeschke, Holger; Mueller, Sandra; Gonzalez, Jorge; Paschke, Ralf] Univ Leipzig, Dept Internal Med Neurol & Dermatol, Leipzig, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Leipzig University	Kleinau, G (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	GKrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Kleinau, Sandra/0000-0002-9729-2286; Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft [KL2334/2-1, PA423/14-1, KR1273/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (KL2334/2-1; PA423/14-1; KR1273/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier A, 1997, MOL CELL ENDOCRINOL, V127, P81, DOI 10.1016/S0303-7207(96)03996-2; Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Bhatia J, 1996, J PHOTOCH PHOTOBIO B, V35, P19, DOI 10.1016/1011-1344(96)07309-5; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Cetani F, 1996, FEBS LETT, V378, P27, DOI 10.1016/0014-5793(95)01384-9; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Claus M, 2006, J MOL MED, V84, P943, DOI 10.1007/s00109-006-0087-8; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Evans PD, 1995, PROG BRAIN RES, V106, P259; Feng XY, 2008, ENDOCRINOLOGY, V149, P1705, DOI 10.1210/en.2007-1341; Fernandez LM, 1997, MOL CELL ENDOCRINOL, V128, P161, DOI 10.1016/S0303-7207(97)04035-5; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Herrlich A, 1996, J BIOL CHEM, V271, P16764, DOI 10.1074/jbc.271.28.16764; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2008, CELL MOL LIFE SCI, V65, P4028, DOI 10.1007/s00018-008-8530-3; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Joost P, 2002, GENOME BIOL, V3; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; KOSUGI S, 1994, FEBS LETT, V341, P162, DOI 10.1016/0014-5793(94)80449-4; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kuhn B, 1999, BIOCHEMISTRY-US, V38, P12490, DOI 10.1021/bi990755m; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Minegishi T, 1997, LIFE SCI, V60, P2043, DOI 10.1016/S0024-3205(97)00191-4; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mueller S, 2009, THYROID, V19, P765, DOI 10.1089/thy.2009.0006; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagashima T, 2001, THYROID, V11, P551, DOI 10.1089/105072501750302859; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; QUINTANA J, 1994, J BIOL CHEM, V269, P8772; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Timossi C, 2002, MOL CELL ENDOCRINOL, V189, P157, DOI 10.1016/S0303-7207(01)00720-1; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; van Koppen CJ, 2008, N-S ARCH PHARMACOL, V378, P503, DOI 10.1007/s00210-008-0318-3; Van Sande J, 2006, J CLIN ENDOCR METAB, V91, P1099, DOI 10.1210/jc.2005-1324; WANG Z, 1993, MOL ENDOCRINOL, V7, P85, DOI 10.1210/me.7.1.85; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	76	38	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9745	10.1371/journal.pone.0009745	http://dx.doi.org/10.1371/journal.pone.0009745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305779	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000276456300014
J	Segal, BH; Han, W; Bushey, JJ; Joo, M; Bhatti, Z; Feminella, J; Dennis, CG; Vethanayagam, RR; Yull, FE; Capitano, M; Wallace, PK; Minderman, H; Christman, JW; Sporn, MB; Chan, J; Vinh, DC; Holland, SM; Romani, LR; Gaffen, SL; Freeman, ML; Blackwell, TS				Segal, Brahm H.; Han, Wei; Bushey, Jennifer J.; Joo, Myungsoo; Bhatti, Zahida; Feminella, Joy; Dennis, Carly G.; Vethanayagam, R. Robert; Yull, Fiona E.; Capitano, Maegan; Wallace, Paul K.; Minderman, Hans; Christman, John W.; Sporn, Michael B.; Chan, Jefferson; Vinh, Donald C.; Holland, Steven M.; Romani, Luigina R.; Gaffen, Sarah L.; Freeman, Michael L.; Blackwell, Timothy S.			NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NF-KAPPA-B; SMOKE-INDUCED EMPHYSEMA; CUL3-BASED E3 LIGASE; CDDO-IMIDAZOLIDE; HOST-DEFENSE; DEFICIENT MICE; ENHANCES SUSCEPTIBILITY; SYNTHETIC TRITERPENOIDS; INFLAMMATORY RESPONSES	Background: Chronic granulomatous disease (CGD), an inherited disorder of the NADPH oxidase in which phagocytes are defective in generating superoxide anion and downstream reactive oxidant intermediates (ROIs), is characterized by recurrent bacterial and fungal infections and by excessive inflammation (e. g., inflammatory bowel disease). The mechanisms by which NADPH oxidase regulates inflammation are not well understood. Methodology/Principal Findings: We found that NADPH oxidase restrains inflammation by modulating redox-sensitive innate immune pathways. When challenged with either intratracheal zymosan or LPS, NADPH oxidase-deficient p47(phox-/-) mice and gp91(phox)-deficient mice developed exaggerated and progressive lung inflammation, augmented NF-kappa B activation, and elevated downstream pro-inflammatory cytokines (TNF-alpha, IL-17, and G-CSF) compared to wildtype mice. Replacement of functional NADPH oxidase in bone marrow-derived cells restored the normal lung inflammatory response. Studies in vivo and in isolated macrophages demonstrated that in the absence of functional NADPH oxidase, zymosan failed to activate Nrf2, a key redox-sensitive anti-inflammatory regulator. The triterpenoid, CDDO-Im, activated Nrf2 independently of NADPH oxidase and reduced zymosan-induced lung inflammation in CGD mice. Consistent with these findings, zymosan-treated peripheral blood mononuclear cells from X-linked CGD patients showed impaired Nrf2 activity and increased NF-kB activation. Conclusions/Significance: These studies support a model in which NADPH oxidase-dependent, redox-mediated signaling is critical for termination of lung inflammation and suggest new potential therapeutic targets for CGD.	[Segal, Brahm H.; Bushey, Jennifer J.; Feminella, Joy; Dennis, Carly G.; Vethanayagam, R. Robert; Minderman, Hans] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Segal, Brahm H.; Capitano, Maegan] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Segal, Brahm H.; Bhatti, Zahida] Univ Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA; [Han, Wei; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Joo, Myungsoo] Pusan Natl Univ, Sch Oriental Med, Div Appl Med, Yangsan, South Korea; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Wallace, Paul K.; Minderman, Hans] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Christman, John W.] Univ Illinois, Sect Pulm Crit Care & Sleep Med, Chicago, IL USA; [Sporn, Michael B.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Chan, Jefferson] Univ So Calif, Sch Med, Dept Pathol, Irvine, CA USA; [Vinh, Donald C.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Romani, Luigina R.] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Freeman, Michael L.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Blackwell, Timothy S.] Dept Vet Affairs, Nashville, TN USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Vanderbilt University; Pusan National University; Vanderbilt University; Roswell Park Cancer Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Dartmouth College; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Perugia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University	Segal, BH (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Romani, Luigina/O-9987-2018; Segal, Brahm/AAW-2706-2020; Wallace, PK/ABB-7704-2022	Wallace, PK/0000-0001-7823-9917; Romani, Luigina/0000-0002-1356-525X; Freeman, Michael/0000-0003-1881-366X; VINH, DONALD/0000-0003-1347-7767	Chronic Granulomatous Disorder Research Trust; NIH/NIAID [R01AI079253]; NIH/NCI [CA115556]; NIH [HL61419]; U.S. Department of Veterans Affairs (TSB); Korea Healthcare Technology RD [A084891]; NCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [R01CA115556, P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103643, R01HL061419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, R01AI079253] Funding Source: NIH RePORTER	Chronic Granulomatous Disorder Research Trust; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs (TSB)(US Department of Veterans Affairs); Korea Healthcare Technology RD; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Chronic Granulomatous Disorder Research Trust and NIH/NIAID R01AI079253 (BHS), NIH/NCI CA115556 (MLF), NIH HL61419 (TSB), the U.S. Department of Veterans Affairs (TSB), and Korea Healthcare Technology R&D Project A084891 (MJ). This research was supported, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BROWN KL, 2008, CLIN IMMUNOL; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; George-Chandy A, 2008, EUR J IMMUNOL, V38, P1118, DOI 10.1002/eji.200737348; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Ji Y, 2006, MOL CANCER THER, V5, P1452, DOI 10.1158/1535-7163.MCT-06-0136; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; KENSLER TW, 2006, ANN REV PHARM TOXICO; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rahman I, 2006, CURR DRUG TARGETS, V7, P707, DOI 10.2174/138945006777435254; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Rusyn I, 2000, CANCER RES, V60, P4798; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Schappi MG, 2008, J PATHOL, V214, P434, DOI 10.1002/path.2298; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Sekhar KR, 2003, CANCER RES, V63, P5636; Siddiqui S, 2007, CLIN INFECT DIS, V45, P673, DOI 10.1086/520985; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tasaka S, 2008, ANTIOXID REDOX SIGN, V10, P739, DOI 10.1089/ars.2007.1940; Thimmulappa R. K., 2006, BIOCH BIOPHYS RES CO; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Wei Y, 2009, AM J PHYSIOL-CELL PH, V297, pC907, DOI 10.1152/ajpcell.00536.2008; Yao HW, 2008, AM J PATHOL, V172, P1222, DOI 10.2353/ajpath.2008.070765; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	65	136	138	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9631	10.1371/journal.pone.0009631	http://dx.doi.org/10.1371/journal.pone.0009631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300512	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000275716400001
J	McGaughran, A; Holland, BR				McGaughran, Angela; Holland, Barbara R.			Testing the Effect of Metabolic Rate on DNA Variability at the Intra-Specific Level	PLOS ONE			English	Article							CYTOCHROME-B EVOLUTION; MITOCHONDRIAL-DNA; MOLECULAR EVOLUTION; GENERATION TIME; BODY-SIZE; NUCLEOTIDE SUBSTITUTION; SPONTANEOUS MUTATION; TEMPERATURE; TEMPO; TURTLES	We tested the metabolic rate hypothesis (whereby rates of mtDNA evolution are postulated to be mediated primarily by mutagenic by-products of respiration) by examining whether mass-specific metabolic rate was correlated with root-to-tip distance on a set of mtDNA trees for the springtail Cryptopygus antarcticus travei from sub-Antarctic Marion Island. Using Bayesian analyses and a novel application of the comparative phylogenetic method, we did not find significant evidence that contemporary metabolic rates directly correlate with mutation rate (i.e., root-to-tip distance) once the underlying phylogeny is taken into account. However, we did find significant evidence that metabolic rate is dependent on the underlying mtDNA tree, or in other words, lineages with related mtDNA also have similar metabolic rates. We anticipate that future analyses which apply this methodology to datasets with longer sequences, more taxa, or greater variability will have more power to detect a significant direct correlation between metabolic rate and mutation rate. We conclude with suggestions for future analyses that would extend the preliminary approach applied here, in particular highlighting ways to tease apart oxidative stress effects from the effects of population size and/or selection coefficients operating on the molecular evolutionary rate.	[McGaughran, Angela; Holland, Barbara R.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; [Holland, Barbara R.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	McGaughran, A (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	ang.mcgaughran@gmail.com	Holland, Barbara/G-1646-2013; McGaughran, Angela/C-5916-2014	Holland, Barbara/0000-0002-4628-7938; McGaughran, Angela/0000-0002-3429-8699	New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship	New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship	AM was supported by a New Zealand Tertiary Education Commission Top Achievers Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; AVISE JC, 1992, MOL BIOL EVOL, V9, P457; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Barraclough TG, 1996, P ROY SOC B-BIOL SCI, V263, P589, DOI 10.1098/rspb.1996.0088; Bleiweiss R, 1998, MOL BIOL EVOL, V15, P481, DOI 10.1093/oxfordjournals.molbev.a025947; BLOCK W, 1975, OIKOS, V26, P15, DOI 10.2307/3543271; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; BOWEN BW, 1993, P NATL ACAD SCI USA, V90, P5574, DOI 10.1073/pnas.90.12.5574; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; DESALLE R, 1988, EVOLUTION, V42, P1076, DOI 10.1111/j.1558-5646.1988.tb02525.x; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gillooly JF, 2007, BIOL LETTERS, V3, P655, DOI 10.1098/rsbl.2007.0403; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gissi C, 2000, MOL BIOL EVOL, V17, P1022, DOI 10.1093/oxfordjournals.molbev.a026383; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; MARTIN AP, 1995, MOL BIOL EVOL, V12, P1124; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; MASON JM, 1985, ENVIRON MUTAGEN, V7, P663, DOI 10.1002/em.2860070506; McGaughran A, 2009, J INSECT PHYSIOL, V55, P129, DOI 10.1016/j.jinsphys.2008.10.009; MCGAUGHRAN A, 2010, METABOLIC RATE GENET, DOI DOI 10.1007/S00300-010-0767-2; McGaughran A, 2008, MOL PHYLOGENET EVOL, V46, P606, DOI 10.1016/j.ympev.2007.10.003; Mindell DP, 1996, ANNU REV ECOL SYST, V27, P279, DOI 10.1146/annurev.ecolsys.27.1.279; Mindell DP, 1996, MOL BIOL EVOL, V13, P422, DOI 10.1093/oxfordjournals.molbev.a025601; MINDELL DP, 1989, CLADISTICS, V5, P49, DOI 10.1111/j.1096-0031.1989.tb00482.x; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; NOTHEL H, 1987, P NATL ACAD SCI USA, V84, P1045, DOI 10.1073/pnas.84.4.1045; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; Spradling TA, 2001, J MAMMAL, V82, P65, DOI 10.1644/1545-1542(2001)082<0065:DIROCB>2.0.CO;2; TEMPLETON AR, 1992, GENETICS, V132, P619; WOODRUFF RC, 1984, HEREDITY, V53, P223, DOI 10.1038/hdy.1984.78; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; Zhang GY, 1995, P INT C BAS, V4, P297	53	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9686	10.1371/journal.pone.0009686	http://dx.doi.org/10.1371/journal.pone.0009686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300626	Green Published, gold, Green Submitted			2022-12-25	WOS:000275621000006
J	Zhu, WY; Wang, LH; Yang, YL; Jia, J; Fu, SH; Feng, Y; He, Y; Li, JP; Liang, GD				Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Jia, Juan; Fu, Shihong; Feng, Yun; He, Ying; Li, Jin-Ping; Liang, Guodong			Interaction of E2 Glycoprotein with Heparan Sulfate Is Crucial for Cellular Infection of Sindbis Virus	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; BINDING; CELLS; PROTEOGLYCAN; ATTACHMENT; GLYCOSAMINOGLYCANS; ALPHAVIRUSES; REPLICATION; ASSOCIATION; ADAPTATION	Cell culture-adapted strains of Sindbis virus (SINV) initially attach to cells by the ability to interact with heparan sulfate (HS) through selective mutation for positively charged amino acid (aa) scattered in E2 glycoprotein (W. B. Klimstra, K. D. Ryman, and R. E. Johnston, J. Virol. 72: 7357-7366, 1998). Here we have further confirmed that interaction of E2 protein with HS is crucial for cellular infection of SINV based on the reverse genetic system of XJ-160 virus, a Sindbis-like virus (SINLV). Both SINV YN87448 and SINLV XJ-160 displayed similar infectivity on BHK-21, Vero, or C6/36 cells, but XJ-160 failed to infect mouse embryonic fibroblast (MEF) cells. The molecular mechanisms underlying the selective infectivity of XJ-160 were approached by substituting the E1, E2, or both genes of XJ-160 with that of YN87448, and the chimeric virus was denominated as XJ-160/E1, XJ-160/E2, or XJ-160/E1E2, respectively. In contrast to the parental XJ-160, all chimeric viruses became infectious to wild-type MEF cells (MEF-wt). While MEF-Ext(-/-) cells, producing shortened HS chains, were resistant not only to XJ-160, but also to YN87448 as well as the chimeric viruses, indicating that the inability of XJ-160 to infect MEF-wt cells likely due to its incompetent discrimination of cellular HS. Treatment with heparin or HS-degrading enzyme resulted in a substantial decrease in plaque formation by YN87448, XJ-160/E2, and XJ-160/E1E2, but had marginal effect on XJ-160 and XJ-160/E1, suggesting that E2 glycoprotein from YN87448 plays a more important role than does E1 in mediating cellular HS-related cell infection. In addition, the peptide containing 145-150 aa from E2 gene of YN87448 specifically bound to heparin, while the corresponding peptide from the E2 gene of XJ-160 essentially showed no binding to heparin. As a new dataset, these results clearly confirm an essential role of E2 glycoprotein, especially the domain of 145-150 aa, in SINV cellular infection through the interaction with HS.	[Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Fu, Shihong; Feng, Yun; He, Ying; Liang, Guodong] Chinese Ctr Dis Control & Prevent, IVDC, China CDC,Inst Viral Dis Control & Prevent, Dept Viral Encephalitis, Beijing, Peoples R China; [Zhu, Wuyang; Wang, Lihua; Yang, Yiliang; Fu, Shihong; Feng, Yun; He, Ying; Liang, Guodong] State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Jia, Juan; Li, Jin-Ping] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Chinese Center for Disease Control & Prevention; Uppsala University	Zhu, WY (corresponding author), Chinese Ctr Dis Control & Prevent, IVDC, China CDC,Inst Viral Dis Control & Prevent, Dept Viral Encephalitis, Beijing, Peoples R China.	gdliang@hotmail.com			National Natural Science Foundation of China [30170046, 30970160]; Major Science and Technology Project for Infectious Disease [2008ZX10004-001, 2009ZX10004-705]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]; Swedish Research Council [K2009-67X-21128-01-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project for Infectious Disease; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the grants from the National Natural Science Foundation of China (No. 30170046; 30970160), the Major Science and Technology Project for Infectious Disease (No. 2008ZX10004-001; 2009ZX10004-705), the Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105) and the Swedish Research Council (K2009-67X-21128-01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JS, 2006, VIROLOGY, V347, P183, DOI 10.1016/j.virol.2005.11.034; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Deardorff ER, 2009, EMERG INFECT DIS, V15, P519, DOI 10.3201/eid1504.081008; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; Griffin D.E., 2001, FIELDS VIROLOGY, P917; Heil ML, 2001, J VIROL, V75, P6303, DOI 10.1128/JVI.75.14.6303-6309.2001; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Klimstra WB, 1999, J VIROL, V73, P10387, DOI 10.1128/JVI.73.12.10387-10398.1999; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; Knight RL, 2009, J VIROL, V83, P5640, DOI 10.1128/JVI.02427-08; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Lin CS, 2000, J MOL BIOL, V303, P7, DOI 10.1006/jmbi.2000.4121; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu LM, 2003, MOL CELL BIOCHEM, V245, P121, DOI 10.1023/A:1022870128494; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; RICE CM, 1982, J MOL BIOL, V154, P325, DOI 10.1016/0022-2836(82)90067-5; Ryman KD, 2007, J VIROL, V81, P3563, DOI 10.1128/JVI.02494-06; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Yang Y, 2005, MOL CELLS, V20, P173; Young DS, 2008, EMERG INFECT DIS, V14, P454, DOI 10.3201/eid1403.070816; ZHOU GL, 1998, ZHONGHUA SHI YAN HE, V12, P81; Zhu WY, 2009, VIRUS RES, V142, P204, DOI 10.1016/j.virusres.2009.01.017; Zhu WY, 2009, ARCH VIROL, V154, P245, DOI 10.1007/s00705-008-0298-0	40	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9656	10.1371/journal.pone.0009656	http://dx.doi.org/10.1371/journal.pone.0009656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300181	gold, Green Published, Green Submitted			2022-12-25	WOS:000275620600011
J	Pan, H; Myerson, JW; Ivashyna, O; Soman, NR; Marsh, JN; Hood, JL; Lanza, GM; Schlesinger, PH; Wickline, SA				Pan, Hua; Myerson, Jacob W.; Ivashyna, Olena; Soman, Neelesh R.; Marsh, Jon N.; Hood, Joshua L.; Lanza, Gregory M.; Schlesinger, Paul H.; Wickline, Samuel A.			Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures	FASEB JOURNAL			English	Article						molecular imaging; targeted drug delivery; biomarker; nanoparticles; liposome	ADHESION MOLECULES; MELITTIN; ANGIOGENESIS; BINDING; MICROPARTICLES; KINETICS; DELIVERY	Current strategies for deploying synthetic nanocarriers involve the creation of agents that incorporate targeting ligands, imaging agents, and/or therapeutic drugs into particles as an integral part of the formulation process. Here we report the development of an amphipathic peptide linker that enables postformulation editing of payloads without the need for reformulation to achieve multiplexing capability for lipidic nanocarriers. To exemplify the flexibility of this peptide linker strategy, 3 applications were demonstrated: converting nontargeted nanoparticles into targeting vehicles; adding cargo to preformulated targeted nanoparticles for in vivo site-specific delivery; and labeling living cells for in vivo tracking. This strategy is expected to enhance the clinical application of molecular imaging and/or targeted therapeutic agents by offering extended flexibility for multiplexing targeting ligands and/or drug payloads that can be selected after base nanocarrier formulation.-Pan, H., Myerson, J. W., Ivashyna, O., Soman, N. R., Marsh, J. N., Hood, J. L., Lanza, G. M., Schlesinger, P. H., Wickline, S. A.. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 24, 2928-2937 (2010). www.fasebj.org	[Wickline, Samuel A.] Washington Univ, Sch Med, C TRAIN, Dept Med, St Louis, MO 63108 USA; [Myerson, Jacob W.; Soman, Neelesh R.; Lanza, Gregory M.; Wickline, Samuel A.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63108 USA; [Ivashyna, Olena; Schlesinger, Paul H.; Wickline, Samuel A.] Washington Univ, Sch Med, Dept Mol & Cell Biol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wickline, SA (corresponding author), Washington Univ, Sch Med, C TRAIN, Dept Med, 4320 Forest Pk Ave,Suite 101,Campus Box 8215, St Louis, MO 63108 USA.	wicklines@aol.com	Hood, Joshua L./I-9797-2019; Pan, Hua/C-7662-2011; Schlesinger, Paul H/C-6049-2012	Hood, Joshua L./0000-0003-3998-4118; 	National Institutes of Health [HL073646, CA119342]; NATIONAL CANCER INSTITUTE [U54CA119342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Stacy J. Allen, Michael J. Scott, and Xiaoxia Yang for critical support with the animal study, Eric T. Christenson for helpful discussions, Ralph Fuhrhop for the PFC nanoparticle formulation, and Huiying Zhang for assisting with the histological analysis. This work was supported by National Institutes of Health grants HL073646 and CA119342 to S.A.W.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; BAZZO R, 1988, EUR J BIOCHEM, V173, P139, DOI 10.1111/j.1432-1033.1988.tb13977.x; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; BLONDELLE SE, 1993, BIOCHIM BIOPHYS ACTA, V1202, P331, DOI 10.1016/0167-4838(93)90024-L; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; DAWSON CR, 1978, BIOCHIM BIOPHYS ACTA, V510, P75, DOI 10.1016/0005-2736(78)90131-1; DEGRADO WF, 1982, BIOPHYS J, V37, P329, DOI 10.1016/S0006-3495(82)84681-X; DEMPSEY CE, 1991, FEBS LETT, V281, P240, DOI 10.1016/0014-5793(91)80402-O; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; GEVOD VS, 1984, BIOPHYS J, V45, P1079, DOI 10.1016/S0006-3495(84)84255-1; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Kelly KA, 2006, MOL IMAGING BIOL, V8, P201, DOI 10.1007/s11307-006-0043-6; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; Li D, 2007, J BIOMAT SCI-POLYM E, V18, P545, DOI 10.1163/156856207780852532; McAteer MA, 2008, ARTERIOSCL THROM VAS, V28, P77, DOI 10.1161/ATVBAHA.107.145466; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; MOLLAY C, 1973, BIOCHIM BIOPHYS ACTA, V316, P196, DOI 10.1016/0005-2760(73)90009-X; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Namiki Y, 2009, NAT NANOTECHNOL, V4, P598, DOI [10.1038/NNANO.2009.202, 10.1038/nnano.2009.202]; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Rex S, 2000, BIOPHYS CHEM, V85, P209, DOI 10.1016/S0301-4622(00)00121-6; Rivett DE, 1996, BIOCHEM J, V316, P525, DOI 10.1042/bj3160525; Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391; SESSA G, 1969, J BIOL CHEM, V244, P3575; Soman NR, 2008, NANO LETT, V8, P1131, DOI 10.1021/nl073290r; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; STROM R, 1978, FEBS LETT, V96, P45, DOI 10.1016/0014-5793(78)81059-X; Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; Waters EA, 2008, MAGN RESON MED, V60, P1232, DOI 10.1002/mrm.21794; WEISSMANN G, 1969, BIOCHEM PHARMACOL, V18, P1771, DOI 10.1016/0006-2952(69)90167-1; WERKMEISTER JA, 1993, BIOCHIM BIOPHYS ACTA, V1157, P50, DOI 10.1016/0304-4165(93)90077-L; Willmann JK, 2008, RADIOLOGY, V248, P936, DOI 10.1148/radiol.2483072231; Winter PM, 2006, ARTERIOSCL THROM VAS, V26, P2103, DOI 10.1161/01.ATV.0000235724.11299.76; Wu TC, 2007, CANCER RES, V67, P6003, DOI 10.1158/0008-5472.CAN-07-1543	38	28	35	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2928	2937		10.1096/fj.09-153130	http://dx.doi.org/10.1096/fj.09-153130			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20335225	Green Published			2022-12-25	WOS:000285005400032
J	Henry, RI; Cobbold, SA; Allen, RJW; Khan, A; Hayward, R; Lehane, AM; Bray, PG; Howitt, SM; Biagini, GA; Saliba, KJ; Kirk, K				Henry, Roselani I.; Cobbold, Simon A.; Allen, Richard J. W.; Khan, Asif; Hayward, Rhys; Lehane, Adele M.; Bray, Patrick G.; Howitt, Susan M.; Biagini, Giancarlo A.; Saliba, Kevin J.; Kirk, Kiaran			An Acid-loading Chloride Transport Pathway in the Intraerythrocytic Malaria Parasite, Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; INTRACELLULAR PH; HUMAN ERYTHROCYTES; H+-ATPASE; FLUORESCENT INDICATOR; ACIDIFICATION; CHLOROQUINE; EXCHANGERS; EXTRUSION; LACTATE	The intraerythrocytic malaria parasite exerts tight control over its ionic composition. In this study, a combination of fluorescent ion indicators and Cl-36(-) flux measurements was used to investigate the transport of Cl- and the Cl--dependent transport of "H+-equivalents" in mature (trophozoite stage) parasites, isolated from their host erythrocytes. Removal of extracellular Cl-, resulting in an outward [Cl-] gradient, gave rise to a cytosolic alkalinization (i.e. a net efflux of H+-equivalents). This was reversed on restoration of extracellular Cl-. The flux of H+-equivalents was inhibited by 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and, when measured in ATP-depleted parasites, showed a pronounced dependence on the pH of the parasite cytosol; the flux was low at cytosolic pH values < 7.2 but increased steeply with cytosolic pH at values > 7.2. Cl-36(-) influx measurements revealed the presence of a Cl- uptake mechanism with characteristics similar to those of the Cl--dependent H+-equivalent flux. The intracellular concentration of Cl- in the parasite was estimated to be similar to 48 mM in situ. The data are consistent with the intraerythrocytic parasite having in its plasma membrane a 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid-sensitive transporter that, under physiological conditions, imports Cl- together with H+-equivalents, resulting in an intracellular Cl- concentration well above that which would occur if Cl- ions were distributed passively in accordance with the parasite's large, inwardly negative membrane potential.	[Henry, Roselani I.; Cobbold, Simon A.; Allen, Richard J. W.; Khan, Asif; Hayward, Rhys; Lehane, Adele M.; Howitt, Susan M.; Saliba, Kevin J.; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Bray, Patrick G.; Biagini, Giancarlo A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Saliba, Kevin J.] Australian Natl Univ, Sch Med, Canberra, ACT 0200, Australia	Australian National University; Liverpool School of Tropical Medicine; University of Liverpool; Australian National University	Kirk, K (corresponding author), Australian Natl Univ, Res Sch Biol, RN Robertson Bldg,Bldg 46, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	Howitt, Susan M/C-9308-2009; Allen, Richard/B-4752-2008; Biagini, Giancarlo A/F-3449-2011; Saliba, Kevin J/C-9166-2009; Lehane, Adele M/B-4127-2012; Kirk, Kiaran/C-8299-2009	Howitt, Susan M/0000-0002-2192-2317; Biagini, Giancarlo A/0000-0001-6356-6595; Saliba, Kevin J/0000-0003-3345-8440; Lehane, Adele M/0000-0002-0050-9101; Kirk, Kiaran/0000-0002-5613-2622; Cobbold, Simon/0000-0002-9927-8998; Henry, Roselani/0000-0001-7448-7358	Australian National Health and Medical Research Council; Australian Research Council; Leverhulme Trust	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leverhulme Trust(Leverhulme Trust)	This work was supported by grants from the Australian National Health and Medical Research Council (to K. K.), the Australian Research Council (to K. K. and K. J. S.), and the Leverhulme Trust (to G. A. B.).	Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; CHAO AC, 1990, J MEMBRANE BIOL, V113, P193, DOI 10.1007/BF01870071; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Eladari D, 1998, AM J PHYSIOL-RENAL, V275, pF334, DOI 10.1152/ajprenal.1998.275.3.F334; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; GRAF J, 1988, RENAL PHYSIOL BIOCH, V11, P202; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; KANAANI J, 1991, J CELL PHYSIOL, V149, P469, DOI 10.1002/jcp.1041490316; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Kummerow D, 2000, J MEMBRANE BIOL, V176, P207, DOI 10.1007/s002320001089; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; MASON MJ, 1989, AM J PHYSIOL, V256, pC428, DOI 10.1152/ajpcell.1989.256.2.C428; MERCK E, 1974, CLIN LAB 11 EDITION, P528; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Spillman NJ, 2008, MOL BIOCHEM PARASIT, V162, P96, DOI 10.1016/j.molbiopara.2008.07.001; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wunsch S, 1997, Behring Inst Mitt, P44	29	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18615	18626		10.1074/jbc.M110.120980	http://dx.doi.org/10.1074/jbc.M110.120980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20332090	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000278453900055
J	Page, RM; Gutsmiedl, A; Fukumori, A; Winkler, E; Haass, C; Steiner, H				Page, Richard M.; Gutsmiedl, Amelie; Fukumori, Akio; Winkler, Edith; Haass, Christian; Steiner, Harald			beta-Amyloid Precursor Protein Mutants Respond to gamma-Secretase Modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FAMILIAL ALZHEIMERS-DISEASE; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; GXXXG MOTIFS; A-BETA-42; PRESENILIN; MUTATIONS; APP	Pathogenic generation of the 42-amino acid variant of the amyloid beta-peptide (A beta) by beta- and gamma-secretase cleavage of the beta-amyloid precursor protein (APP) is believed to be causative for Alzheimer disease (AD). Lowering of A beta(42) production by gamma-secretase modulators (GSMs) is a hopeful approach toward AD treatment. The mechanism of GSM action is not fully understood. Moreover, whether GSMs target the A beta domain is controversial. To further our understanding of the mode of action of GSMs and the cleavage mechanism of gamma-secretase, we analyzed mutations located at different positions of the APP transmembrane domain around or within the A beta domain regarding their response to GSMs. We found that A beta(42)-increasing familial AD mutations of the gamma-secretase cleavage site domain responded robustly to A beta(42)-lowering GSMs, especially to the potent compound GSM-1, irrespective of the amount of A beta(42) produced. We thus expect that familial AD patients carrying mutations at the gamma-secretase cleavage sites of APP should respond to GSM-based therapeutic approaches. Systematic phenylalanine-scanning mutagenesis of this region revealed a high permissiveness to GSM-1 and demonstrated a complex mechanism of GSM action as other A beta species (A beta(41), A beta(39)) could also be lowered besides A beta(42). Moreover, certain mutations simultaneously increased A beta(42) and the shorter peptide A beta(38), arguing that the proposed precursor-product relationship of these A beta species is not general. Finally, mutations of residues in the proposed GSM-binding site implicated in A beta(42) generation (Gly-29, Gly-33) and potentially in GSM-binding (Lys-28) were also responsive to GSMs, a finding that may question APP substrate targeting of GSMs.	[Steiner, Harald] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis DZNE, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie; Hans and Ilse Breuer Foundation; Center for Integrated Protein Science Munich; The LMUexcellent program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Hans and Ilse Breuer Foundation; Center for Integrated Protein Science Munich; The LMUexcellent program	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.)) and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie ("Degenerative Dementias: Target identification, Validation and Translation into Treatment Strategies" (to C. H. and H. S.)), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and the Center for Integrated Protein Science Munich.; Supported by a research professorship from The LMUexcellent program. To whom correspondence may be addressed: German Center for Neurodegenerative Diseases (DZNE) and Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University, Schillerstr. 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: christian.haass@med.uni-muenchen.de.	Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Guardia-Laguarta C, 2010, J NEUROPATH EXP NEUR, V69, P53, DOI 10.1097/NEN.0b013e3181c6b84d; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Herl L, 2009, MOL CELL NEUROSCI, V41, P166, DOI 10.1016/j.mcn.2009.02.008; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tan JX, 2008, J NEUROCHEM, V107, P722, DOI 10.1111/j.1471-4159.2008.05643.x; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	47	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17798	17810		10.1074/jbc.M110.103283	http://dx.doi.org/10.1074/jbc.M110.103283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348104	Green Published, hybrid			2022-12-25	WOS:000278133400058
J	Rickheit, G; Wartosch, L; Schaffer, S; Stobrawa, SM; Novarino, G; Weinert, S; Jentsch, TJ				Rickheit, Gesa; Wartosch, Lena; Schaffer, Sven; Stobrawa, Sandra M.; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.			Role of ClC-5 in Renal Endocytosis Is Unique among ClC Exchangers and Does Not Require PY-motif-dependent Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL; DENTS-DISEASE; PROXIMAL TUBULE; MEDIATED ENDOCYTOSIS; IMPAIRS ENDOCYTOSIS; ALBUMIN ENDOCYTOSIS; BINDING PROTEINS; LIDDLES-SYNDROME	Inactivation of the mainly endosomal 2Cl(-)/H+-exchanger ClC-5 severely impairs endocytosis in renal proximal tubules and underlies the human kidney stone disorder Dent's disease. In heterologous expression systems, interaction of the E3 ubiquitin ligases WWP2 and Nedd4-2 with a "PY-motif" in the cytoplasmic C terminus of ClC-5 stimulates its internalization from the plasma membrane and may influence receptor-mediated endocytosis. We asked whether this interaction is relevant in vivo and generated mice in which the PY-motif was destroyed by a point mutation. Unlike ClC-5 knock-out mice, these knock-in mice displayed neither low molecular weight proteinuria nor hyperphosphaturia, and both receptor-mediated and fluid-phase endocytosis were normal. The abundances and localizations of the endocytic receptor megalin and of the Na+-coupled phosphate transporter NaPi-2a (Npt2) were not changed, either. To explore whether the discrepancy in results from heterologous expression studies might be due to heteromerization of ClC-5 with ClC-3 or ClC-4 in vivo, we studied knock-in mice additionally deleted for those related transporters. Disruption of neither ClC-3 nor ClC-4 led to proteinuria or impaired proximal tubular endocytosis by itself, nor in combination with the PY-mutant of ClC-5. Endocytosis of cells lacking ClC-5 was not impaired further when ClC-3 or ClC-4 was additionally deleted. We conclude that ClC-5 is unique among CLC proteins in being crucial for proximal tubular endocytosis and that PY-motif-dependent ubiquitylation of ClC-5 is dispensable for this role.	[Rickheit, Gesa; Wartosch, Lena; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Rickheit, Gesa; Wartosch, Lena; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Rickheit, Gesa; Schaffer, Sven; Stobrawa, Sandra M.; Jentsch, Thomas J.] Univ Hamburg, ZMNH, D-20146 Hamburg, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Weinert, Stefanie/AAR-1481-2021	Weinert, Stefanie/0000-0003-3036-1440; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [FOR667, Je164/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft Grant FOR667, Je164/6.	ABBATE M, 1994, J AM SOC NEPHROL, V4, P2003; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2009, J CELL SCI, V122, P1229, DOI 10.1242/jcs.037317; Murer H, 1999, AM J PHYSIOL-RENAL, V277, pF676, DOI 10.1152/ajprenal.1999.277.5.F676; Nagasawa Y, 2001, NEPHROL DIAL TRANSPL, V16, P923, DOI 10.1093/ndt/16.5.923; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wilson Karen H S, 2005, BMC Nephrol, V6, P17, DOI 10.1186/1471-2369-6-17; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	57	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17595	17603		10.1074/jbc.M110.115600	http://dx.doi.org/10.1074/jbc.M110.115600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351103	Green Published, hybrid			2022-12-25	WOS:000278133400038
J	Altaf, M; Auger, A; Monnet-Saksouk, J; Brodeur, J; Piquet, S; Cramet, M; Bouchard, N; Lacoste, N; Utley, RT; Gaudreau, L; Cote, J				Altaf, Mohammed; Auger, Andreanne; Monnet-Saksouk, Julie; Brodeur, Joelle; Piquet, Sandra; Cramet, Myriam; Bouchard, Nathalie; Lacoste, Nicolas; Utley, Rhea T.; Gaudreau, Luc; Cote, Jacques			NuA4-dependent Acetylation of Nucleosomal Histones H4 and H2A Directly Stimulates Incorporation of H2A.Z by the SWR1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE GENOME; VARIANT H2A.Z; DNA-DAMAGE; HETEROCHROMATIN BOUNDARIES; TELOMERIC HETEROCHROMATIN; ACETYLTRANSFERASE COMPLEX; DEPENDENT ACETYLATION; IN-VIVO; NUA4	Structural and functional analyses of nucleosomes containing histone variant H2A.Z have drawn a lot of interest over the past few years. Important work in budding yeast has shown that H2A.Z (Htz1)-containing nucleosomes are specifically located on the promoter regions of genes, creating a specific chromatin structure that is poised for disassembly during transcription activation. The SWR1 complex is responsible for incorporation of Htz1 into nucleosomes through ATP-dependent exchange of canonical H2A-H2B dimers for Htz1-H2B dimers. Interestingly, the yeast SWR1 complex is functionally linked to the NuA4 acetyltransferase complex in vivo. NuA4 and SWR1 are physically associated in higher eukaryotes as they are homologous to the TIP60/p400 complex, which encompasses both histone acetyltransferase (Tip60) and histone exchange (p400/Domino) activities. Here we present work investigating the impact of NuA4-dependent acetylation on SWR1-driven incorporation of H2A.Z into chromatin. Using in vitro histone exchange assays with native chromatin, we demonstrate that prior chromatin acetylation by NuA4 greatly stimulates the exchange of H2A for H2A. Z. Interestingly, we find that acetylation of H2A or H4 N-terminal tails by NuA4 can independently stimulate SWR1 activity. Accordingly, we demonstrate that mutations of H4 or H2A N-terminal lysine residues have similar effects on H2A. Z incorporation in vivo, and cells carrying mutations in both tails are nonviable. Finally, depletion experiments indicate that the bromodomain-containing protein Bdf1 is important for NuA4-dependent stimulation of SWR1. These results provide important mechanistic insight into the functional cross-talk between chromatin acetylation and ATP-dependent exchange of histone H2A variants.	[Altaf, Mohammed; Auger, Andreanne; Monnet-Saksouk, Julie; Piquet, Sandra; Cramet, Myriam; Bouchard, Nathalie; Lacoste, Nicolas; Utley, Rhea T.; Cote, Jacques] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ G1R 2J6, Canada; [Brodeur, Joelle; Gaudreau, Luc] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	Laval University; University of Sherbrooke	Cote, J (corresponding author), 9 McMahon St, Quebec City, PQ G1R 2J6, Canada.	jacques.cote@crhdq.ulaval.ca	Cote, Jacques/I-8901-2014	Cote, Jacques/0000-0001-6751-555X; saksouk, julie/0000-0003-1885-1762	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to L. G. and J. C.).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Owen-Hughes T, 1999, METH MOL B, V119, P319; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	57	106	109	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15966	15977		10.1074/jbc.M110.117069	http://dx.doi.org/10.1074/jbc.M110.117069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332092	Green Published, hybrid			2022-12-25	WOS:000277715900034
J	Krejsa, CM; Franklin, CC; White, CC; Ledbetter, JA; Schieven, GL; Kavanagh, TJ				Krejsa, Cecile M.; Franklin, Christopher C.; White, Collin C.; Ledbetter, Jeffrey A.; Schieven, Gary L.; Kavanagh, Terrance J.			Rapid Activation of Glutamate Cysteine Ligase following Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; APOPTOTIC CELL-DEATH; HAMSTER V79 CELLS; MODIFIER SUBUNIT; RAT-KIDNEY; GLUTATHIONE BIOSYNTHESIS; CATALYTIC SUBUNIT; HEAVY SUBUNIT; LIGHT SUBUNIT; MICE	Glutamate cysteine ligase (GCL) catalyzes the rate-limiting step in the formation of the cellular antioxidant glutathione (GSH). The GCL holoenzyme consists of two separately coded proteins, a catalytic subunit (GCLC) and a modifier subunit (GCLM). Both GCLC and GLCM are controlled transcriptionally by a variety of cellular stimuli, including oxidative stress. This study addresses post-translational control of GCL activity, which increased rapidly in human lymphocytes following oxidative stress. Activation of GCL occurred within minutes of treatment and without any change in GCL protein levels and coincided with an increase in the proportion of GCLC in the holoenzyme form. Likewise, GCLM shifted from the monomeric form to holoenzyme and higher molecular weight species. Normal rat tissues also showed a distribution of monomeric and higher molecular weight forms. Neither GCL activation, nor the formation of holoenzyme, required a covalent intermolecular disulfide bridge between GCLC and GCLM. However, in immunoprecipitation studies, a neutralizing epitope associated with enzymatic activity was protected following cellular oxidative stress. Thus, the N-terminal portion of GCLC may undergo a change that stabilizes the GCL holoenzyme. Our results suggest that a dynamic equilibrium exists between low and high activity forms of GCL and is altered by transient oxidative stress. This provides a mechanism for the rapid post-translational activation of GCL and maintenance of cellular GSH homeostasis.	[Krejsa, Cecile M.; White, Collin C.; Kavanagh, Terrance J.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Ledbetter, Jeffrey A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Franklin, Christopher C.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Schieven, Gary L.] Bristol Myers Squibb Co, Res & Dev, Immunol Drug Discovery, Princeton, NJ 08543 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb	Kavanagh, TJ (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Box 354695, Seattle, WA 98195 USA.	tjkav@u.washington.edu			National Institutes of Health [R01ES10849, P01AG01751, P42ES04696, P30ES07033, T32ES07032, R01CA90473]; Bristol-Myers Squibb Pharmaceutical Research Institute; NATIONAL CANCER INSTITUTE [R01CA090473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032, R01ES010849, P30ES007033, P42ES004696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb Pharmaceutical Research Institute(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES10849 (to T. J. K.), P01AG01751 (to T. J. K.), P42ES04696 (to T. J. K.), P30ES07033 (to T. J. K.), T32ES07032 (to C. M. K.), and R01CA90473 (to C. C. F.). This work was also supported by the Bristol-Myers Squibb Pharmaceutical Research Institute.	Backos DS, 2010, TOXICOL APPL PHARM, V243, P35, DOI 10.1016/j.taap.2009.11.010; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Botta D, 2004, FREE RADICAL BIO MED, V37, P632, DOI 10.1016/j.freeradbiomed.2004.05.027; Botta D, 2008, DRUG METAB REV, V40, P465, DOI [10.1080/03602530802186587, 10.1080/03602530802186587 ]; Chang LS, 1996, J PROTEIN CHEM, V15, P321, DOI 10.1007/BF01887121; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; FORMAN HJ, 1995, BIOTHIOLS HLTH DIS, P189; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; GIPP JJ, 1995, BIOCHEM BIOPH RES CO, V206, P584, DOI 10.1006/bbrc.1995.1083; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; HAMEL DM, 1991, TOXICOL METHOD, V1, P273; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Krzywanski DM, 2004, ARCH BIOCHEM BIOPHYS, V423, P116, DOI 10.1016/j.abb.2003.11.004; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Ochi T, 1995, ARCH TOXICOL, V70, P96, DOI 10.1007/BF02733669; Ochi T, 1996, TOXICOLOGY, V112, P45, DOI 10.1016/0300-483X(96)03348-3; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; SEELIG GF, 1984, J BIOL CHEM, V259, P9345; SEELIG GF, 1984, J BIOL CHEM, V259, P3534; SEITZ J, 1991, ELECTROPHORESIS, V12, P1051, DOI 10.1002/elps.1150121210; Siitonen T, 1999, ANN ONCOL, V10, P1361, DOI 10.1023/A:1008382912096; SONG JY, 1995, HISTOCHEM J, V27, P914; Sun WM, 1996, BIOCHEM J, V320, P321, DOI 10.1042/bj3200321; Thompson SA, 1999, TOXICOL LETT, V110, P1, DOI 10.1016/S0378-4274(99)00133-2; Toroser D, 2006, BBA-GEN SUBJECTS, V1760, P233, DOI 10.1016/j.bbagen.2005.10.010; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; Tu ZH, 1998, ARCH BIOCHEM BIOPHYS, V354, P247, DOI 10.1006/abbi.1998.0676; WHITE CC, 1999, CURRENT PROTOCOLS TO; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Yang Y, 2007, BIOCHEM PHARMACOL, V74, P372, DOI 10.1016/j.bcp.2007.02.003	39	70	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16116	16124		10.1074/jbc.M110.116210	http://dx.doi.org/10.1074/jbc.M110.116210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332089	Green Published, hybrid			2022-12-25	WOS:000277715900049
J	Kumar, A; Hou, X; Lee, C; Li, Y; Maminishkis, A; Tang, ZS; Zhang, F; Langer, HF; Arjunan, P; Dong, LJ; Wu, ZJ; Zhu, LY; Wang, LC; Min, W; Colosi, P; Chavakis, T; Li, X				Kumar, Anil; Hou, Xu; Lee, Chunsik; Li, Yang; Maminishkis, Arvydas; Tang, Zhongshu; Zhang, Fan; Langer, Harald F.; Arjunan, Pachiappan; Dong, Lijin; Wu, Zhijian; Zhu, Linda Y.; Wang, Lianchun; Min, Wang; Colosi, Peter; Chavakis, Triantafyllos; Li, Xuri			Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3 beta Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PDGF-D; RETINAL NEOVASCULARIZATION; INTRAVITREAL INJECTION; FACTOR VEGF; MACULAR DEGENERATION; PEGAPTANIB SODIUM; INHIBITION; EXPRESSION; SURVIVAL	Platelet-derived growth factor-DD (PDGF-DD) is a recently discovered member of the PDGF family. The role of PDGF-DD in pathological angiogenesis and the underlying cellular and molecular mechanisms remain largely unexplored. In this study, using different animal models, we showed that PDGF-DD expression was up-regulated during pathological angiogenesis, and inhibition of PDGF-DD suppressed both choroidal and retinal neovascularization. We also demonstrated a novel mechanism mediating the function of PDGF-DD. PDGF-DD induced glycogen synthase kinase-3 beta (GSK3 beta) Ser(9) phosphorylation and Tyr(216) dephosphorylation in vitro and in vivo, leading to increased cell survival. Consistently, GSK3 beta activity was required for the antiangiogenic effect of PDGF-DD targeting. Moreover, PDGF-DD regulated the expression of GSK3 beta and many other genes important for angiogenesis and apoptosis. Thus, we identified PDGF-DD as an important target gene for antiangiogenic therapy due to its pleiotropic effects on vascular and non-vascular cells. PDGF-DD inhibition may offer new therapeutic options to treat neovascular diseases.	[Kumar, Anil; Hou, Xu; Lee, Chunsik; Li, Yang; Maminishkis, Arvydas; Tang, Zhongshu; Zhang, Fan; Arjunan, Pachiappan; Dong, Lijin; Wu, Zhijian; Zhu, Linda Y.; Colosi, Peter; Li, Xuri] NEI, NIH, Rockville, MD 20852 USA; [Langer, Harald F.; Chavakis, Triantafyllos] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hou, Xu] Fourth Mil Med Univ, Xijing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Min, Wang] Yale Univ, Dept Pathol Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Langer, Harald F.] Univ Tubingen, Dept Cardiovasc Med, D-72076 Tubingen, Germany	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Air Force Military Medical University; University System of Georgia; University of Georgia; Yale University; Eberhard Karls University of Tubingen	Li, X (corresponding author), NEI, NIH, 5635 Fishers Lane, Rockville, MD 20852 USA.	lixur@nei.nih.gov	Chavakis, Triantafyllos/ABE-8845-2020; wu, zhi/GXH-3041-2022; Kumar, Anil/K-8504-2012; Arjunan, Pachiappan/AAG-3297-2021	Maminishkis, Arvydas/0000-0003-3345-3375	NEI; American Health Assistance Foundation; NATIONAL CANCER INSTITUTE [ZIABC010664] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000419, ZICEY000458, ZIAEY000447, ZIAEY000443] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NEI. This work was also supported by the Macular Degeneration Research program of the American Health Assistance Foundation.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Au PYB, 2005, ONCOGENE, V24, P3196, DOI 10.1038/sj.onc.1208516; Avci B, 2009, INVEST OPHTH VIS SCI, V50, P3438, DOI 10.1167/iovs.08-2871; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; BETSHOLTZ C, 1984, CELL, V39, P447, DOI 10.1016/0092-8674(84)90452-5; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Chang YZ, 2006, ARTERIOSCL THROM VAS, V26, P501, DOI 10.1161/01.ATV.0000201070.71787.b8; Chang YZ, 2004, AM J PHYSIOL-HEART C, V287, pH2201, DOI 10.1152/ajpheart.00520.2004; Choi SE, 2007, J VASC RES, V44, P365, DOI 10.1159/000102321; D'Antoni ML, 2008, AM J PHYSIOL-LUNG C, V294, pL764, DOI 10.1152/ajplung.00436.2007; Davies MH, 2008, INVEST OPHTH VIS SCI, V49, P4195, DOI 10.1167/iovs.07-1491; DeNiro M, 2009, EXP EYE RES, V89, P700, DOI 10.1016/j.exer.2009.06.013; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fischer JW, 2001, ARTERIOSCL THROM VAS, V21, P777, DOI 10.1161/01.ATV.21.5.777; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Funa K, 2003, ACTA BIOCHIM POL, V50, P647; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hernandez-Pastor LJ, 2008, AM J HEALTH-SYST PH, V65, P1805, DOI 10.2146/ajhp070342; Hinton DR, 1998, ARCH OPHTHALMOL-CHIC, V116, P203; Inan UU, 2007, INVEST OPHTH VIS SCI, V48, P1773, DOI 10.1167/iovs.06-0828; Julien S, 2008, MOL VIS, V14, P1358; Karvinen H, 2009, EUR J CLIN INVEST, V39, P320, DOI 10.1111/j.1365-2362.2009.02095.x; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; Klyve P, 1996, ACTA OPHTHALMOL SCAN, V74, P26; Kojima T, 2007, AM J PATHOL, V170, P764, DOI 10.2353/ajpath.2007.060487; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; KVANTA A, 1995, CURR EYE RES, V14, P1015, DOI 10.3109/02713689508998523; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liu G, 2008, HUM PATHOL, V39, P393, DOI 10.1016/j.humpath.2007.07.008; Loberg RD, 2002, J BIOL CHEM, V277, P41667, DOI 10.1074/jbc.M206405200; Lu J, 2009, CIRC RES, V104, P619, DOI 10.1161/CIRCRESAHA.108.190116; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Manzano RPA, 2006, RETINA-J RET VIT DIS, V26, P257, DOI 10.1097/00006982-200603000-00001; Mendes CT, 2009, EUR ARCH PSY CLIN N, V259, P16, DOI 10.1007/s00406-008-0828-5; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Molander C, 2000, EXP CELL RES, V258, P65, DOI 10.1006/excr.2000.4917; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ray S, 2005, J BIOL CHEM, V280, P8494, DOI 10.1074/jbc.M413570200; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Rodrigues EB, 2009, PROG RETIN EYE RES, V28, P117, DOI 10.1016/j.preteyeres.2008.11.005; Rosenmuller T, 2001, J CELL PHYSIOL, V188, P369, DOI 10.1002/jcp.1126; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Semkova I, 2006, FASEB J, V20, P1689, DOI 10.1096/fj.05-5653fje; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Silva RLE, 2006, J CELL PHYSIOL, V208, P161, DOI 10.1002/jcp.20645; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Stahl A, 2009, GRAEF ARCH CLIN EXP, V247, P767, DOI 10.1007/s00417-009-1058-x; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Takahashi-Yanaga F, 2009, J PHARMACOL SCI, V109, P179, DOI 10.1254/jphs.08R28FM; Tuuminen R, 2009, ARTERIOSCL THROM VAS, V29, P691, DOI 10.1161/ATVBAHA.108.178558; Uutela M, 2001, CIRCULATION, V103, P2242; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; van Wijngaarden P, 2008, CLIN EXP OPTOM, V91, P427, DOI 10.1111/j.1444-0938.2008.00305.x; Wagsater D, 2009, ATHEROSCLEROSIS, V202, P415, DOI 10.1016/j.atherosclerosis.2008.04.050; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Williams AJ, 2006, AM J OPHTHALMOL, V142, P683, DOI 10.1016/j.ajo.2006.04.032; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhu Wen-Hui, 2002, Angiogenesis, V5, P81, DOI 10.1023/A:1021509004829	80	27	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15500	15510		10.1074/jbc.M110.113787	http://dx.doi.org/10.1074/jbc.M110.113787			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231273	Green Published, hybrid			2022-12-25	WOS:000277399000069
J	Mitsuishi, Y; Hasegawa, H; Matsuo, A; Araki, W; Suzuki, T; Tagami, S; Okochi, M; Takeda, M; Roepman, R; Nishimura, M				Mitsuishi, Yachiyo; Hasegawa, Hiroshi; Matsuo, Akinori; Araki, Wataru; Suzuki, Toshiharu; Tagami, Shinji; Okochi, Masayasu; Takeda, Masatoshi; Roepman, Ronald; Nishimura, Masaki			Human CRB2 Inhibits gamma-Secretase Cleavage of Amyloid Precursor Protein by Binding to the Presenilin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; ALZHEIMERS-DISEASE; APH-1 INTERACTS; BETA-PEPTIDE; N-CADHERIN; TNF-ALPHA; A-BETA; NICASTRIN; MODULATION; NOTCH	Drosophila Crumbs has been reported to attenuate Notch signaling by inhibition of gamma-secretase cleavage at the wing margins. gamma-Secretase is an intramembrane protease that is responsible for the generation of amyloid-beta (A beta) peptides from the beta-amyloid precursor protein (APP). Here, we re-examined gamma-secretase inhibition by human CRB2, which is the most abundant Crumbs ortholog in the brain. Transfected CRB2 inhibited proteolytic production of A beta and APP intracellular domains from APP C-terminal fragments in HEK293 and SH-SY5Y cells. Conversely, knockdown of endogenous CRB2 increased gamma-secretase cleavage products in SH-SY5Y cells. CRB2 inhibition of gamma-cleavage was also detected in cell-free assays. CRB2 interacted with the gamma-secretase complex, but was not a competitive substrate for gamma-cleavage. The transmembrane domain of CRB2 was indispensable for inhibition of A beta generation and mediated CRB2 binding with the gamma-secretase complex. In addition, the cytoplasmic domain appeared to play a supportive role in gamma-secretase inhibition, whereas mutational disruption of the two protein-binding motifs involved in the formation of cell adhesion complexes did not affect gamma-secretase inhibition. Co-overexpression of presenilin-1 or APH-1 abrogated gamma-secretase inhibition probably through prevention of the incorporation of CRB2 into the gamma-secretase complex. Our results suggest that CRB2 functions as an inhibitory binding protein that is involved in the formation of a mature but inactive pool of the gamma-secretase complex.	[Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan; [Araki, Wataru] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Kodaira, Tokyo 1878502, Japan; [Suzuki, Toshiharu] Hokkaido Univ, Neurosci Lab, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Tagami, Shinji; Okochi, Masayasu; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Div Psychiat & Behav Prote, Dept Postgenom & Dis, Suita, Osaka 5650871, Japan; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Shiga University of Medical Science; National Center for Neurology & Psychiatry - Japan; Hokkaido University; Osaka University; Radboud University Nijmegen	Nishimura, M (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan.	mnishimu@belle.shiga-med.ac.jp	Roepman, Ronald/B-1339-2014; Suzuki, Toshiharu/B-5342-2013; Araki, Wataru/G-7913-2014	Roepman, Ronald/0000-0002-5178-8163; Araki, Wataru/0000-0001-8467-6937; Okochi, Masayasu/0000-0002-2318-7651	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation [05-26]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported in part by a grant-in-aid for scientific research on Priority Area-Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M.N.), and a grant from the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (05-26) ( to M. T., M.O., S. T., and M.N.).	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Berezovska O, 2001, J BIOL CHEM, V276, P30018, DOI 10.1074/jbc.M008268200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lleo A, 2005, J BIOL CHEM, V280, P27303, DOI 10.1074/jbc.M413969200; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Pardossi-Piquard R, 2007, BIOCHEMISTRY-US, V46, P13704, DOI 10.1021/bi701347w; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Takeda K, 2004, EUR J NEUROSCI, V19, P258, DOI 10.1111/j.0953-816X.2003.03135.x; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; van den Hurk JAJM, 2005, MOL VIS, V11, P263; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	47	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14920	14931		10.1074/jbc.M109.038760	http://dx.doi.org/10.1074/jbc.M109.038760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299451	Green Published, hybrid			2022-12-25	WOS:000277399000013
J	Wang, YB; Weiss, LM; Orlofsky, A				Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos			Coordinate Control of Host Centrosome Position, Organelle Distribution, and Migratory Response by Toxoplasma gondii via Host mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; ADENOMATOUS POLYPOSIS-COLI; MICROTUBULE STABILIZATION; GSK3-BETA PHOSPHORYLATION; CELL-MIGRATION; KINASE-B; RICTOR; AKT; POLARIZATION; ASSOCIATION	The invasion of host cells by Toxoplasma gondii is accompanied by a reorganization of host cell structure, in which the host centrosome and Golgi apparatus are localized to the vacuole, and mitochondria, microtubules, and endolysosomes are recruited to the vacuole perimeter. The mechanism and functional significance of this process have not been well defined. Here, we report that the centrosome-vacuole association was abolished in mammalian target of rapamycin complex 2 (mTORC2)-deficient cells, which also displayed a disordered distribution of perivacuolar host mitochondria and lysosomes. Infection of fibroblasts led to stable, mTORC2-dependent activation of Akt, and Akt inhibition mimicked the effect of mTORC2 ablation on centrosome, mitochondria, and lysosome localization. Mobilization of the centrosome by Akt inhibition was abrogated by inhibitors of glycogen synthase kinase 3 (GSK3), implying that the centrosome is constrained to the vacuole through an mTORC2-Akt-GSK3 pathway. Infected cells were incapable of migration in a wounded monolayer model, and this effect was associated with the inability of centrosomes to reorient in the direction of migration. Both migration and centrosome reorientation were fully restored upon ablation of mTORC2. These findings provide the first linkage of host signals to parasite-mediated host cell reorganization and demonstrate migratory suppression as a novel functional consequence of this process that is associated with mTORC2-mediated centrosome constraint.	[Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Weiss, Louis M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Orlofsky, A (corresponding author), Albert Einstein Coll Med, Dept Pathol, G704,1300 Morris Pk Ave, Bronx, NY 10461 USA.	amos.orlofsky@einstein.yu.edu	Wang, Yubao/L-3912-2014		National Institutes of Health [AI-55358, AI-39454]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055358, R01AI039454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55358 (to A. O.) and AI-39454 (to L. M. W.).	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Martin AM, 2007, J EUKARYOT MICROBIOL, V54, P25, DOI 10.1111/j.1550-7408.2006.00230.x; Nakaar V, 2003, J CELL SCI, V116, P2311, DOI 10.1242/jcs.00382; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sinai AP, 1997, J CELL SCI, V110, P2117; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	48	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15611	15618		10.1074/jbc.M109.095778	http://dx.doi.org/10.1074/jbc.M109.095778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236941	hybrid, Green Published			2022-12-25	WOS:000277399000079
J	Holzbauer, SM; DeVries, AS; Sejvar, JJ; Lees, CH; Adjemian, J; McQuiston, JH; Medus, C; Lexau, CA; Harris, JR; Recuenco, SE; Belay, ED; Howell, JF; Buss, BF; Hornig, M; Gibbins, JD; Brueck, SE; Smith, KE; Danila, RN; Lipkin, WI; Lachance, DH; Dyck, PJB; Lynfield, R				Holzbauer, Stacy M.; DeVries, Aaron S.; Sejvar, James J.; Lees, Christine H.; Adjemian, Jennifer; McQuiston, Jennifer H.; Medus, Carlota; Lexau, Catherine A.; Harris, Julie R.; Recuenco, Sergio E.; Belay, Ermias D.; Howell, James F.; Buss, Bryan F.; Hornig, Mady; Gibbins, John D.; Brueck, Scott E.; Smith, Kirk E.; Danila, Richard N.; Lipkin, W. Ian; Lachance, Daniel H.; Dyck, P. James. B.; Lynfield, Ruth			Epidemiologic Investigation of Immune-Mediated Polyradiculoneuropathy among Abattoir Workers Exposed to Porcine Brain	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SEMPLE RABIES VACCINE; AUTOANTIBODIES; NEURITIS	Background: In October 2007, a cluster of patients experiencing a novel polyradiculoneuropathy was identified at a pork abattoir (Plant A). Patients worked in the primary carcass processing area (warm room); the majority processed severed heads (head-table). An investigation was initiated to determine risk factors for illness. Methods and Results: Symptoms of the reported patients were unlike previously described occupational associated illnesses. A case-control study was conducted at Plant A. A case was defined as evidence of symptoms of peripheral neuropathy and compatible electrodiagnostic testing in a pork abattoir worker. Two control groups were used - randomly selected non-ill warm-room workers (n = 49), and all non-ill head-table workers (n = 56). Consenting cases and controls were interviewed and blood and throat swabs were collected. The 26 largest U. S. pork abattoirs were surveyed to identify additional cases. Fifteen cases were identified at Plant A; illness onsets occurred during May 2004 - November 2007. Median age was 32 years (range, 21-55 years). Cases were more likely than warm-room controls to have ever worked at the head-table (adjusted odds ratio [AOR], 6.6; 95% confidence interval [CI], 1.6-26.7), removed brains or removed muscle from the backs of heads (AOR, 10.3; 95% CI, 1.5-68.5), and worked within 0-10 feet of the brain removal operation (AOR, 9.9; 95% CI, 1.2-80.0). Associations remained when comparing head-table cases and head-table controls. Workers removed brains by using compressed air that liquefied brain and generated aerosolized droplets, exposing themselves and nearby workers. Eight additional cases were identified in the only two other abattoirs using this technique. The three abattoirs that used this technique have stopped brain removal, and no new cases have been reported after 24 months of follow up. Cases compared to controls had higher median interferon-gamma (IFN gamma) levels (21.7 pg/ml; vs 14.8 pg/ml, P < 0.001). Discussion: This novel polyradiculoneuropathy was associated with removing porcine brains with compressed air. An autoimmune mechanism is supported by higher levels of IFN gamma in cases than in controls consistent with other immune mediated illnesses occurring in association with neural tissue exposure. Abattoirs should not use compressed air to remove brains and should avoid procedures that aerosolize CNS tissue. This outbreak highlights the potential for respiratory or mucosal exposure to cause an immune-mediated illness in an occupational setting.	[Holzbauer, Stacy M.; DeVries, Aaron S.; Lees, Christine H.; Medus, Carlota; Lexau, Catherine A.; Smith, Kirk E.; Danila, Richard N.; Lynfield, Ruth] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA; [Holzbauer, Stacy M.; Adjemian, Jennifer; Harris, Julie R.; Buss, Bryan F.; Gibbins, John D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Sejvar, James J.; McQuiston, Jennifer H.; Recuenco, Sergio E.; Belay, Ermias D.] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; [Howell, James F.] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Buss, Bryan F.] Nebraska Dept Hlth & Human Serv, Div Publ Hlth, Lincoln, NE USA; [Hornig, Mady; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Gibbins, John D.; Brueck, Scott E.] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Lachance, Daniel H.; Dyck, P. James. B.] Mayo Clin, Dept Neurol, Rochester, MN USA	Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Columbia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Mayo Clinic	Holzbauer, SM (corresponding author), Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA.	Aaron.DeVries@state.mn.us	Belay, Ermias/A-8829-2013; Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; DeVries, Aaron/0000-0001-9211-0722; Belay, Ermias/0000-0002-9837-0960; Recuenco-Cabrera, Sergio/0000-0002-8446-7411	National Institutes of Health [U54AI5758]; Emerging Infections Program [5U01CI000313]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerging Infections Program; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Laboratory work performed by W. I. Lipkin and M. Hornig at the Columbia University Northeast Biodefense Center was funded by the National Institutes of Health award U54AI5758. Epidemiologic investigation was supported by the Emerging Infections Program Grant CFDA Number 93-283 Grant # 5U01CI000313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY O, 1977, EUR J IMMUNOL, V7, P213, DOI 10.1002/eji.1830070405; Adjemian JZ, 2009, INT J OCCUP ENV HEAL, V15, P331; Bour-Jordan W, 2005, J IMMUNOL, V175, P5649, DOI 10.4049/jimmunol.175.9.5649; *CDCP, 2008, MMWR-MORBID MORTAL W, V57, P122; Csurhes PA, 2005, J NEUROL NEUROSUR PS, V76, P1431, DOI 10.1136/jnnp.2004.052282; DICKER R, 2008, FIELD EPIDEMIOLOGY, P138; Elkarim RA, 1998, CLIN IMMUNOL IMMUNOP, V88, P241, DOI 10.1006/clin.1998.4573; FULLER C, 2008, 6 INT C EM INF DIS A; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; HEMACHUDHA T, 1988, NEUROLOGY, V38, P375, DOI 10.1212/WNL.38.3.375; HEMACHUDHA T, 1987, NEUROLOGY, V37, P550, DOI 10.1212/WNL.37.4.550; Jander S, 2001, J NEUROIMMUNOL, V114, P253, DOI 10.1016/S0165-5728(00)00460-4; JAVIER RS, 1989, J NEUROL SCI, V93, P221, DOI 10.1016/0022-510X(89)90192-5; Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070; Lachance DH, 2010, LANCET NEUROL, V9, P55, DOI 10.1016/S1474-4422(09)70296-0; LISAK RP, 1975, BIOMEDICINE, V22, P81; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; Piyasirisilp S, 1999, ANN NEUROL, V45, P595, DOI 10.1002/1531-8249(199905)45:5<595::AID-ANA7>3.0.CO;2-M; Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9; SMITH ME, 1979, J NEUROPATH EXP NEUR, V38, P377, DOI 10.1097/00005072-197907000-00003; Udawat H, 2001, J Assoc Physicians India, V49, P384; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YVES R, 2008, ARTHRIT CARE RES, V59, P1341	23	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9782	10.1371/journal.pone.0009782	http://dx.doi.org/10.1371/journal.pone.0009782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333310	Green Published, gold			2022-12-25	WOS:000275809700017
J	Inskeep, WP; Rusch, DB; Jay, ZJ; Herrgard, MJ; Kozubal, MA; Richardson, TH; Macur, RE; Hamamura, N; Jennings, RD; Fouke, BW; Reysenbach, AL; Roberto, F; Young, M; Schwartz, A; Boyd, ES; Badger, JH; Mathur, EJ; Ortmann, AC; Bateson, M; Geesey, G; Frazier, M				Inskeep, William P.; Rusch, Douglas B.; Jay, Zackary J.; Herrgard, Markus J.; Kozubal, Mark A.; Richardson, Toby H.; Macur, Richard E.; Hamamura, Natsuko; Jennings, Ryan deM.; Fouke, Bruce W.; Reysenbach, Anna-Louise; Roberto, Frank; Young, Mark; Schwartz, Ariel; Boyd, Eric S.; Badger, Jonathan H.; Mathur, Eric J.; Ortmann, Alice C.; Bateson, Mary; Geesey, Gill; Frazier, Marvin			Metagenomes from High-Temperature Chemotrophic Systems Reveal Geochemical Controls on Microbial Community Structure and Function	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; ARCHAEON PYROCOCCUS-FURIOSUS; MAMMOTH HOT-SPRINGS; HYPERTHERMOPHILIC ARCHAEON; GEOTHERMAL SPRINGS; GENOME SEQUENCE; SP NOV.; MOLECULAR CHARACTERIZATION; BACTERIAL COMMUNITIES; DEPOSITIONAL FACIES	The Yellowstone caldera contains the most numerous and diverse geothermal systems on Earth, yielding an extensive array of unique high-temperature environments that host a variety of deeply-rooted and understudied Archaea, Bacteria and Eukarya. The combination of extreme temperature and chemical conditions encountered in geothermal environments often results in considerably less microbial diversity than other terrestrial habitats and offers a tremendous opportunity for studying the structure and function of indigenous microbial communities and for establishing linkages between putative metabolisms and element cycling. Metagenome sequence (14-15,000 Sanger reads per site) was obtained for five high-temperature (>65 degrees C) chemotrophic microbial communities sampled from geothermal springs (or pools) in Yellowstone National Park (YNP) that exhibit a wide range in geochemistry including pH, dissolved sulfide, dissolved oxygen and ferrous iron. Metagenome data revealed significant differences in the predominant phyla associated with each of these geochemical environments. Novel members of the Sulfolobales are dominant in low pH environments, while other Crenarchaeota including distantly-related Thermoproteales and Desulfurococcales populations dominate in suboxic sulfidic sediments. Several novel archaeal groups are well represented in an acidic (pH 3) Fe-oxyhydroxide mat, where a higher O-2 influx is accompanied with an increase in archaeal diversity. The presence or absence of genes and pathways important in S oxidation-reduction, H-2-oxidation, and aerobic respiration (terminal oxidation) provide insight regarding the metabolic strategies of indigenous organisms present in geothermal systems. Multiple-pathway and protein-specific functional analysis of metagenome sequence data corroborated results from phylogenetic analyses and clearly demonstrate major differences in metabolic potential across sites. The distribution of functional genes involved in electron transport is consistent with the hypothesis that geochemical parameters (e.g., pH, sulfide, Fe, O-2) control microbial community structure and function in YNP geothermal springs.	[Inskeep, William P.; Jay, Zackary J.; Kozubal, Mark A.; Macur, Richard E.; Jennings, Ryan deM.; Young, Mark; Boyd, Eric S.; Bateson, Mary; Geesey, Gill] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Inskeep, William P.; Jay, Zackary J.; Kozubal, Mark A.; Macur, Richard E.; Jennings, Ryan deM.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Rusch, Douglas B.; Badger, Jonathan H.; Frazier, Marvin] J Craig Venter Inst, Rockville, MD USA; [Herrgard, Markus J.; Richardson, Toby H.; Schwartz, Ariel; Mathur, Eric J.] Synthet Genom Inc, La Jolla, CA USA; [Hamamura, Natsuko; Reysenbach, Anna-Louise] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Fouke, Bruce W.] Univ Illinois, Urbana, IL 61801 USA; [Roberto, Frank] Idaho Natl Lab, Idaho Falls, ID USA; [Young, Mark; Bateson, Mary] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Boyd, Eric S.; Geesey, Gill] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Ortmann, Alice C.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; Ehime University; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Idaho National Laboratory; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of South Alabama	Inskeep, WP (corresponding author), Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA.	binskeep@montana.edu; drusch@jcvi.org	Roberto, Frank F/GWC-2615-2022; Hamamura, Natsuko/D-8837-2013; Hamamura, Natsuko/AAY-9454-2021	Roberto, Frank F/0000-0001-5459-0892; Hamamura, Natsuko/0000-0002-6641-1975; Jay, Zackary/0000-0003-3062-4933	U.S. National Aeronautics and Space Administration [NAG5-8807, NNG04GR46G]; U.S. National Science Foundation [BIO 0342269]; Montana Agricultural Experiment Station [911398]	U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); U.S. National Science Foundation(National Science Foundation (NSF)); Montana Agricultural Experiment Station	This work was supported by the Thermal Biology Institute via projects from the U.S. National Aeronautics and Space Administration (Exobiology Program NAG5-8807, NNG04GR46G), Dr. William Apel (Idaho National Laboratory, Idaho Falls, Idaho, USA), the U.S. National Science Foundation Research Coordination Network (BIO 0342269) focused on Yellowstone National Park, and the Montana Agricultural Experiment Station (Project 911398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1111/j.1574-6976.2001.tb00576.x; Anderson IJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-145; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P682, DOI 10.1128/AEM.02019-07; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Ball J.W., 2002, 02382 US GEOL SURV, P104; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Boyd ES, 2007, APPL ENVIRON MICROB, V73, P6669, DOI 10.1128/AEM.01321-07; Boyd ES, 2009, ENVIRON MICROBIOL, V11, P950, DOI 10.1111/j.1462-2920.2008.01820.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brugger Kim, 2007, Archaea, V2, P127, DOI 10.1155/2007/745987; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Cozen AE, 2009, J BACTERIOL, V191, P782, DOI 10.1128/JB.00965-08; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dhillon A, 2005, APPL ENVIRON MICROB, V71, P4592, DOI 10.1128/AEM.71.8.4592-4601.2005; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Fouke BW, 2003, CAN J EARTH SCI, V40, P1531, DOI 10.1139/E03-067; Fouke BW, 2000, J SEDIMENT RES, V70, P565, DOI 10.1306/2DC40929-0E47-11D7-8643000102C1865D; Fournier R. O., 2005, GEOTHERMAL BIOL GEOC, P3; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; FUCHS G, 2007, SCIENCE, V318, P1782; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1111/j.1574-6968.2000.tb09346.x; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; Inskeep WP, 2005, GEOBIOLOGY, V3, P297, DOI 10.1111/j.1472-4669.2006.00059.x; Inskeep WP, 2004, GEOCHIM COSMOCHIM AC, V68, P3141, DOI 10.1016/j.gca.2003.09.020; Ishikawa R, 2002, ARCH MICROBIOL, V179, P42, DOI 10.1007/s00203-002-0496-1; Itoh T, 1999, INT J SYST BACTERIOL, V49, P1157, DOI 10.1099/00207713-49-3-1157; Kawashima T, 2000, P NATL ACAD SCI USA, V97, P14257, DOI 10.1073/pnas.97.26.14257; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Komorowski L, 2002, BIOL CHEM, V383, P1791, DOI 10.1515/BC.2002.200; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kozubal M, 2008, APPL ENVIRON MICROB, V74, P942, DOI 10.1128/AEM.01200-07; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Q, 2008, BIOINFORMATICS, V24, P597, DOI 10.1093/bioinformatics/btn004; LUBBEN M, 1994, MOL MICROBIOL, V13, P327, DOI 10.1111/j.1365-2958.1994.tb00426.x; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Malasarn D, 2004, SCIENCE, V306, P455, DOI 10.1126/science.1102374; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P2263, DOI 10.1099/ijs.0.63708-0; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Pereira MM, 2004, J BIOENERG BIOMEMBR, V36, P93, DOI 10.1023/B:JOBB.0000019601.74394.67; Purschke WG, 1997, J BACTERIOL, V179, P1344, DOI 10.1128/jb.179.4.1344-1353.1997; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Santini JM, 2007, BBA-BIOENERGETICS, V1767, P189, DOI 10.1016/j.bbabio.2007.01.009; Schelert J, 2006, J BACTERIOL, V188, P7141, DOI 10.1128/JB.00558-06; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Shock E. L., 2005, GEOTHERMAL BIOL GEOC, P95; Simbahan J, 2005, APPL ENVIRON MICROB, V71, P8836, DOI 10.1128/AEM.71.12.8836-8845.2005; STAUFFER RE, 1984, GEOCHIM COSMOCHIM AC, V48, P2547, DOI 10.1016/0016-7037(84)90305-3; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vadas A, 1999, J BIOL CHEM, V274, P36715, DOI 10.1074/jbc.274.51.36715; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Young M., 2005, GEOTHERMAL BIOL GEOC, P289, DOI DOI 10.1146/ANNUREV-MICRO-092412-155633	101	147	148	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9773	10.1371/journal.pone.0009773	http://dx.doi.org/10.1371/journal.pone.0009773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333304	Green Published, gold, Green Submitted			2022-12-25	WOS:000275809700012
J	Oh, WJ; Westmoreland, JJ; Summers, R; Condie, BG				Oh, Won-Jong; Westmoreland, Joby J.; Summers, Ryan; Condie, Brian G.			Cleft Palate Is Caused by CNS Dysfunction in Gad1 and Viaat Knockout Mice	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; GREEN FLUORESCENT PROTEIN; ARTHROGRYPOSIS MULTIPLEX CONGENITA; MIDGESTATION MOUSE EMBRYOS; SYMPATHETIC-NERVOUS-SYSTEM; NEURAL PROGENITOR CELLS; TRANSGENIC MICE; TRANSPORTER GENE; BETA-3 SUBUNIT	Background: Previous studies have shown that disruption of GABA signaling in mice via mutations in the Gad1, Gabrb3 or Viaat genes leads to the development of non-neural developmental defects such as cleft palate. Studies of the Gabrb3 and Gad1 mutant mice have suggested that GABA function could be required either in the central nervous system or in the palate itself for normal palatogenesis. Methodology/Principal Findings: To further examine the role of GABA signaling in palatogenesis we used three independent experimental approaches to test whether Gad1 or Viaat function is required in the fetal CNS for normal palate development. We used oral explant cultures to demonstrate that the Gad1 and Viaat mutant palates were able to undergo palatogenesis in culture, suggesting that there is no defect in the palate tissue itself in these mice. In a second series of experiments we found that the GABA(A) receptor agonist muscimol could rescue the cleft palate phenotype in Gad1 and Viaat mutant embryos. This suggested that normal multimeric GABA(A) receptors in the CNS were necessary for normal palatogenesis. In addition, we showed that CNS-specific inactivation of Gad1 was sufficient to disrupt palate development. Conclusions/Significance: Our results are consistent with a role for Gad1 and Viaat in the central nervous system for normal development of the palate. We suggest that the alterations in GABA signaling lead to non-neural defects such as cleft palate as a secondary effect due to alterations in or elimination of fetal movements.	[Oh, Won-Jong; Summers, Ryan; Condie, Brian G.] Univ Georgia, Dept Genet, Dev Biol Grp, Athens, GA 30602 USA; [Oh, Won-Jong; Westmoreland, Joby J.] Med Coll Georgia, Inst Mol Med, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Oh, WJ (corresponding author), Univ Georgia, Dept Genet, Dev Biol Grp, Athens, GA 30602 USA.	bcondie@uga.edu		Summers, Ryan/0000-0002-3621-8664	National Institutes of Health [R01MH06479]; University of Georgia; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health award R01MH064794 (BGC) and lab startup funds from the University of Georgia (BGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Briner W, 2001, BMC Pharmacol, V1, P2, DOI 10.1186/1471-2210-1-2; Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Choi DS, 1997, DEVELOPMENT, V124, P1745; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; de Vries JIP, 2006, ULTRASOUND OBST GYN, V27, P701, DOI 10.1002/uog.2740; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ferguson C, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-85; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hooper SB, 2006, CLIN EXP PHARMACOL P, V33, P273, DOI 10.1111/j.1440-1681.2006.04358.x; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Inanlou MR, 2005, DEV DYNAM, V233, P772, DOI 10.1002/dvdy.20381; Iseki S, 2007, BIRTH DEFECTS RES A, V79, P688, DOI 10.1002/bdra.20400; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Kanno K, 2004, AM J MED GENET A, V127A, P11, DOI 10.1002/ajmg.a.20649; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Katarova Z, 1998, EUR J NEUROSCI, V10, P989, DOI 10.1046/j.1460-9568.1998.00109.x; Katarova Z, 2000, J COMP NEUROL, V424, P607, DOI 10.1002/1096-9861(20000904)424:4<607::AID-CNE4>3.0.CO;2-C; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Ma L, 1999, LEARN MEMORY, V6, P267; Maddox Dennis M., 2001, BMC Developmental Biology, V1, P1, DOI 10.1186/1471-213X-1-1; Makinae K, 2000, J NEUROCHEM, V75, P1429, DOI 10.1046/j.1471-4159.2000.0751429.x; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Moore-Scott BA, 2003, GENESIS, V35, P164, DOI 10.1002/gene.10179; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Mukhopadhyay P, 2004, BIRTH DEFECTS RES A, V70, P912, DOI 10.1002/bdra.20095; NAPOLITANO L, 1958, J BIOPHYS BIOCHEM CY, V4, P685, DOI 10.1083/jcb.4.6.685; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Oh WJ, 2005, GENE, V351, P39, DOI 10.1016/j.gene.2005.01.009; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Riemersma S, 1996, J CLIN INVEST, V98, P2358, DOI 10.1172/JCI119048; SADLER TW, 2005, LANGMANS ESSENTIAL M, P96; Scapoli L, 2002, HUM GENET, V110, P15, DOI 10.1007/s00439-001-0639-5; SHIOTA K, 1990, ACTA ANAT, V137, P59; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Te Pas AB, 2008, J PEDIATR-US, V152, P607, DOI 10.1016/j.jpeds.2007.10.041; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Vieira AR, 2008, AM J MED GENET A, V146A, P2828, DOI 10.1002/ajmg.a.32260; VINCENT A, 1995, LANCET, V346, P24, DOI 10.1016/S0140-6736(95)92652-6; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEE EL, 1986, J CRAN GENET DEV BIO, V6, P53; WEE EL, 1983, TERATOLOGY, V28, P15, DOI 10.1002/tera.1420280104; Wen PH, 2005, DEVELOPMENT, V132, P3873, DOI 10.1242/dev.01946; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; ZIMMERMAN EF, 1989, TERATOLOGY, V40, P593, DOI 10.1002/tera.1420400607	77	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9758	10.1371/journal.pone.0009758	http://dx.doi.org/10.1371/journal.pone.0009758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333300	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809700008
J	Isodono, K; Takahashi, T; Imoto, H; Nakanishi, N; Ogata, T; Asada, S; Adachi, A; Ueyama, T; Oh, H; Matsubara, H				Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Nakanishi, Naohiko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki			PARM-1 Is an Endoplasmic Reticulum Molecule Involved in Endoplasmic Reticulum Stress-Induced Apoptosis in Rat Cardiac Myocytes	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; HEART-FAILURE; TRANSCRIPTION FACTOR; CARDIOMYOCYTE DEATH; CREB/ATF-FAMILY; ISCHEMIC-HEART; FAILING HEART; CELLS; ACTIVATION; DISEASE	To identify novel transmembrane and secretory molecules expressed in cardiac myocytes, signal sequence trap screening was performed in rat neonatal cardiac myocytes. One of the molecules identified was a transmembrane protein, prostatic androgen repressed message-1 (PARM-1). While PARM-1 has been identified as a gene induced in prostate in response to castration, its function is largely unknown. Our expression analysis revealed that PARM-1 was specifically expressed in hearts and skeletal muscles, and in the heart, cardiac myocytes, but not non-myocytes expressed PARM-1. Immunofluorescent staining showed that PARM-1 was predominantly localized in endoplasmic reticulum (ER). In Dahl salt-sensitive rats, high-salt diet resulted in hypertension, cardiac hypertrophy and subsequent heart failure, and significantly stimulated PARM-1 expression in the hearts, with a concomitant increase in ER stress markers such as GRP78 and CHOP. In cultured cardiac myocytes, PARM-1 expression was stimulated by proinflammatory cytokines, but not by hypertrophic stimuli. A marked increase in PARM-1 expression was observed in response to ER stress inducers such as thapsigargin and tunicamycin, which also induced apoptotic cell death. Silencing PARM-1 expression by siRNAs enhanced apoptotic response in cardiac myocytes to ER stresses. PARM-1 silencing also repressed expression of PERK and ATF6, and augmented expression of CHOP without affecting IRE-1 expression and JNK and Caspase-12 activation. Thus, PARM-1 expression is induced by ER stress, which plays a protective role in cardiac myocytes through regulating PERK, ATF6 and CHOP expression. These results suggested that PARM-1 is a novel ER transmembrane molecule involved in cardiac remodeling in hypertensive heart disease.	[Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Nakanishi, Naohiko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Isodono, Koji; Takahashi, Tomosaburo; Imoto, Hiroko; Ogata, Takehiro; Asada, Satoshi; Adachi, Atsuo; Ueyama, Tomomi; Oh, Hidemasa; Matsubara, Hiroaki] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Kyoto University	Isodono, K (corresponding author), Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan.	ttaka@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Mitsubishi Pharma Research Foundation; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Mitsubishi Pharma Research Foundation and Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Blum A, 2001, ANNU REV MED, V52, P15, DOI 10.1146/annurev.med.52.1.15; Bruyninx M, 1999, ENDOCRINOLOGY, V140, P4789, DOI 10.1210/en.140.10.4789; Conraads VM, 2002, INT J CARDIOL, V85, P33, DOI 10.1016/S0167-5273(02)00232-2; Cornet AM, 2003, PROSTATE, V56, P220, DOI 10.1002/pros.10254; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fisher SA, 2000, CIRC RES, V87, P856, DOI 10.1161/01.RES.87.10.856; Fladeby C, 2008, INT J CANCER, V122, P1229, DOI 10.1002/ijc.23185; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Horio T, 1998, ENDOCRINOLOGY, V139, P4576, DOI 10.1210/en.139.11.4576; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Klotz S, 2006, HYPERTENSION, V47, P901, DOI 10.1161/01.HYP.0000215579.81408.8e; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Ogata T, 2007, BIOCHEM BIOPH RES CO, V359, P341, DOI 10.1016/j.bbrc.2007.05.104; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	41	45	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9746	10.1371/journal.pone.0009746	http://dx.doi.org/10.1371/journal.pone.0009746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305782	Green Submitted, Green Published, gold			2022-12-25	WOS:000276456300003
J	Frak, V; Nazir, T; Goyette, M; Cohen, H; Jeannerod, M				Frak, Victor; Nazir, Tatjana; Goyette, Michel; Cohen, Henri; Jeannerod, Marc			Grip Force Is Part of the Semantic Representation of Manual Action Verbs	PLOS ONE			English	Article							MOTOR; LANGUAGE; BRAIN; PERCEPTION; MOVEMENTS; CORTEX; DAMAGE	Motor actions and action verbs activate similar cortical brain regions. A functional interference can be taken as evidence that there is a parallel treatment of these two types of information and would argue for the biological grounding of language in action. A novel approach examining the relationship between language and grip force is presented. With eyes closed and arm extended, subjects listened to words relating (verbs) or not relating (nouns) to a manual action while holding a cylinder with an integrated force sensor. There was a change in grip force when subjects heard verbs that related to manual action. Grip force increased from about 100 ms following the verb presentation, peaked at 380 ms and fell abruptly after 400 ms, signalling a possible inhibition of the motor simulation evoked by these words. These observations reveal the intimate relationship that exists between language and grasp and show that it is possible to elucidate online new aspects of sensorimotor interaction.	[Frak, Victor] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Frak, Victor; Goyette, Michel] Univ Montreal, Inst Readaptat Gingras Lindsay Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Nazir, Tatjana; Jeannerod, Marc] Inst Cognit Sci, UMR 5015, CNRS, Bron, France; [Cohen, Henri] Univ Paris 05, UMR 8189, CNRS, Boulogne, France	University of Quebec; University of Quebec Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Frak, V (corresponding author), Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.	frak.victor@uqam.ca		Nazir, Tatjana/0000-0002-6313-9259; Frak, Victor/0000-0002-3311-777X	Fondation de l'Institut de Readaptation de Montreal, Canada	Fondation de l'Institut de Readaptation de Montreal, Canada	This work was aided by a grant from Fondation de l'Institut de Readaptation de Montreal, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Bourbonnais D, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-2; BROCA P, 1861, B SOC ANTHROPOL PAR, V2, P235; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Frak V, 2006, BRAIN COGNITION, V60, P43, DOI 10.1016/j.bandc.2005.09.010; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Goldenberg G, 2003, NEUROPSYCHOLOGIA, V41, P1565, DOI 10.1016/S0028-3932(03)00120-9; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grafton ST, 1998, J NEUROSCI, V18, P9420; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Johnson-Frey SH, 2004, BRAIN COGNITION, V55, P328, DOI 10.1016/j.bandc.2004.02.032; Lakoff George, 1987, WOMEN FIRE DANGEROUS, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Liepmann H., 1905, MUNCHEN MED WOCHEN, V49, P2375; Liepmann H. K., 1905, MUNCHEN MED WOCHEN, V49, P2322; Nazir TA, 2008, Q J EXP PSYCHOL, V61, P933, DOI 10.1080/17470210701625667; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRICE CJ, 1994, BRAIN, V117, P1255, DOI 10.1093/brain/117.6.1255; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; [No title captured]	31	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9728	10.1371/journal.pone.0009728	http://dx.doi.org/10.1371/journal.pone.0009728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570ZC	20300535	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000275716400021
J	Morgan, OW; Bramley, A; Fowlkes, A; Freedman, DS; Taylor, TH; Gargiullo, P; Belay, B; Jain, S; Cox, C; Kamimoto, L; Fiore, A; Finelli, L; Olsen, SJ; Fry, AM				Morgan, Oliver W.; Bramley, Anna; Fowlkes, Ashley; Freedman, David S.; Taylor, Thomas H.; Gargiullo, Paul; Belay, Brook; Jain, Seema; Cox, Chad; Kamimoto, Laurie; Fiore, Anthony; Finelli, Lyn; Olsen, Sonja J.; Fry, Alicia M.			Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease	PLOS ONE			English	Article							H1N1 INFLUENZA; UNITED-STATES; OVERWEIGHT; PREVALENCE; MORTALITY	Background: Severe illness due to 2009 pandemic A(H1N1) infection has been reported among persons who are obese or morbidly obese. We assessed whether obesity is a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1), independent of chronic medical conditions considered by the Advisory Committee on Immunization Practices (ACIP) to increase the risk of influenza-related complications. Methodology/Principal Findings: We used a case-cohort design to compare cases of hospitalizations and deaths from 2009 pandemic A(H1N1) influenza occurring between April-July, 2009, with a cohort of the U. S. population estimated from the 2003-2006 National Health and Nutrition Examination Survey (NHANES); pregnant women and children < 2 years old were excluded. For hospitalizations, we defined categories of relative weight by body mass index (BMI, kg/m(2)); for deaths, obesity or morbid obesity was recorded on medical charts, and death certificates. Odds ratio (OR) of being in each BMI category was determined; normal weight was the reference category. Overall, 361 hospitalizations and 233 deaths included information to determine BMI category and presence of ACIP-recognized medical conditions. Among >= 20 year olds, hospitalization was associated with being morbidly obese (BMI >= 40) for individuals with ACIP-recognized chronic conditions (OR = 4.9, 95% Cl 2.4-9.9) and without ACIP-recognized chronic conditions (OR = 4.7, 95% Cl 1.3-17.2). Among 2-19 year olds, hospitalization was associated with being underweight (BMI <= 5(th) percentile) among those with (OR = 12.5, 95% Cl 3.4-45.5) and without (OR = 5.5, 95% Cl 1.3-22.5) ACIP-recognized chronic conditions. Death was not associated with BMI category among individuals 2-19 years old. Among individuals aged >= 20 years without ACIP-recognized chronic medical conditions death was associated with obesity (OR = 3.1, 95% Cl: 1.5-6.6) and morbid obesity (OR = 7.6, 95% Cl 2.1-27.9). Conclusions/Significance: Our findings support observations that morbid obesity may be associated with hospitalization and possibly death due to 2009 pandemic H1N1 infection. These complications could be prevented by early antiviral therapy and vaccination.	[Morgan, Oliver W.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect, Atlanta, GA 30333 USA; [Morgan, Oliver W.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Surveillance Serv, Atlanta, GA USA; [Bramley, Anna; Fowlkes, Ashley; Gargiullo, Paul; Jain, Seema; Cox, Chad; Kamimoto, Laurie; Fiore, Anthony; Finelli, Lyn; Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Freedman, David S.; Belay, Brook] Ctr Dis Control & Prevent, Div Nutr & Phys Activ & Obes, Atlanta, GA USA; [Taylor, Thomas H.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Morgan, OW (corresponding author), Ctr Dis Control & Prevent, Div Emerging Infect, Atlanta, GA 30333 USA.	afry@cdc.gov	Fiore, Anthony/AAO-8956-2020; Finelli, Lyn/AAK-2360-2020	Freedman, David/0000-0001-8014-0289				Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; CDC, 2009, CDC PROT REALT RTPCR; CDC, 2009, UPD INT REC US ANT M; CDC, SAS PROGR CDC GROWTH; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; KIRKWOOD BR, 2001, ESSENTIALS MED STAT; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LARUCHE GV, 2009, WEEKLY EPIDEMIOLOGIC, V84, P301; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO, 2009, PAND H1N1 2009 UPD; *WHO CONS OB, 2000, TECHN REP SER WHO CO, V894; Wolter K. M., 1985, INTRO VARIANCE ESTIM	25	303	315	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9694	10.1371/journal.pone.0009694	http://dx.doi.org/10.1371/journal.pone.0009694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300571	Green Submitted, Green Published, gold			2022-12-25	WOS:000275621000012
J	Pescador, N; Villar, D; Cifuentes, D; Garcia-Rocha, M; Ortiz-Barahona, A; Vazquez, S; Ordonez, A; Cuevas, Y; Saez-Morales, D; Garcia-Bermejo, ML; Landazuri, MO; Guinovart, J; del Peso, L				Pescador, Nuria; Villar, Diego; Cifuentes, Daniel; Garcia-Rocha, Mar; Ortiz-Barahona, Amaya; Vazquez, Silvia; Ordonez, Angel; Cuevas, Yolanda; Saez-Morales, David; Laura Garcia-Bermejo, Maria; Landazuri, Manuel O.; Guinovart, Joan; del Peso, Luis			Hypoxia Promotes Glycogen Accumulation through Hypoxia Inducible Factor (HIF)-Mediated Induction of Glycogen Synthase 1	PLOS ONE			English	Article							PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; MUSCLE CULTURES; HIF-ALPHA; FACTOR-I; INHIBITION; METABOLISM; EXPRESSION; MECHANISM; PATHWAY	When oxygen becomes limiting, cells reduce mitochondrial respiration and increase ATP production through anaerobic fermentation of glucose. The Hypoxia Inducible Factors (HIFs) play a key role in this metabolic shift by regulating the transcription of key enzymes of glucose metabolism. Here we show that oxygen regulates the expression of the muscle glycogen synthase (GYS1). Hypoxic GYS1 induction requires HIF activity and a Hypoxia Response Element within its promoter. GYS1 gene induction correlated with a significant increase in glycogen synthase activity and glycogen accumulation in cells exposed to hypoxia. Significantly, knockdown of either HIF1 alpha or GYS1 attenuated hypoxia-induced glycogen accumulation, while GYS1 overexpression was sufficient to mimic this effect. Altogether, these results indicate that GYS1 regulation by HIF plays a central role in the hypoxic accumulation of glycogen. Importantly, we found that hypoxia also upregulates the expression of UTP: glucose-1-phosphate urydylyltransferase (UGP2) and 1,4-alpha glucan branching enzyme (GBE1), two enzymes involved in the biosynthesis of glycogen. Therefore, hypoxia regulates almost all the enzymes involved in glycogen metabolism in a coordinated fashion, leading to its accumulation. Finally, we demonstrated that abrogation of glycogen synthesis, by knock-down of GYS1 expression, impairs hypoxic preconditioning, suggesting a physiological role for the glycogen accumulated during chronic hypoxia. In summary, our results uncover a novel effect of hypoxia on glucose metabolism, further supporting the central importance of metabolic reprogramming in the cellular adaptation to hypoxia.	[Pescador, Nuria; Villar, Diego; Ortiz-Barahona, Amaya; Cuevas, Yolanda; del Peso, Luis] Univ Autonoma Madrid, Dept Bioquim, Madrid, Spain; [Pescador, Nuria; Villar, Diego; Ortiz-Barahona, Amaya; Cuevas, Yolanda; del Peso, Luis] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Cifuentes, Daniel; Garcia-Rocha, Mar; Guinovart, Joan] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Vazquez, Silvia; Landazuri, Manuel O.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Saez-Morales, David; Laura Garcia-Bermejo, Maria] Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain; [Ordonez, Angel] Hosp Ramon & Cajal, Serv Anat Patol, E-28034 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; Autonomous University of Madrid; Hospital de La Princesa; Hospital Universitario Ramon y Cajal	Pescador, N (corresponding author), Univ Autonoma Madrid, Dept Bioquim, Madrid, Spain.	luis.peso@uam.es	Pescador, Nuria/ABG-8337-2020; del Peso, Luis/K-9391-2014; Villar, Diego/K-8595-2017; García-Bermejo, María Laura/E-1542-2015	del Peso, Luis/0000-0003-4014-5688; Villar, Diego/0000-0002-8614-6232; García-Bermejo, María Laura/0000-0002-8167-2276; Vazquez Cuesta, Silvia Noemi/0000-0002-9065-9487; Garcia-Rocha, Mar/0000-0003-2467-2090; Cifuentes Buira, Daniel/0000-0001-5442-4843	Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion [SAF2005-00180, SAF2008-03147, SAF2004-0824]; Red Cardiovascular (RECAVA); Comunidad Autonoma de Madrid [S-SAL-0311_2006]	Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Cardiovascular (RECAVA); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by grants from Ministerio de Ciencia y Tecnologia/Ministerio de Ciencia e Innovacion (SAF2005-00180 and SAF2008-03147 to L. P. and SAF2004-0824 to M. O. L.), Red Cardiovascular (RECAVA) and Comunidad Autonoma de Madrid (S-SAL-0311_2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Gutmann I., 1974, METHODS ENZYMATIC AN; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KEIKO NT, 1997, EUROPEAN J BIOCH, V246, P486; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sridharan V, 2007, AM J PHYSIOL-CELL PH, V292, pC719, DOI 10.1152/ajpcell.00100.2006; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vigoda A, 2003, MOL CELL BIOCHEM, V254, P311, DOI 10.1023/A:1027302021428; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhao JH, 2004, TOXICOL APPL PHARM, V196, P404, DOI 10.1016/j.taap.2004.01.012	38	175	183	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9644	10.1371/journal.pone.0009644	http://dx.doi.org/10.1371/journal.pone.0009644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300197	Green Published, gold			2022-12-25	WOS:000275620900002
J	Le Jeune, A; Torelli, R; Sanguinetti, M; Giard, JC; Hartke, A; Auffray, Y; Benachour, A				Le Jeune, Andre; Torelli, Riccardo; Sanguinetti, Maurizio; Giard, Jean-Christophe; Hartke, Axel; Auffray, Yanick; Benachour, Abdellah			The Extracytoplasmic Function Sigma Factor SigV Plays a Key Role in the Original Model of Lysozyme Resistance and Virulence of Enterococcus faecalis	PLOS ONE			English	Article							PEPTIDOGLYCAN O-ACETYLTRANSFERASE; N-ACETYLGLUCOSAMINE DEACETYLASE; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; LACTOCOCCUS-LACTIS; TEICHOIC-ACIDS; ANTIMICROBIAL PEPTIDES; LIPOTEICHOIC ACID; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE	Background: Enterococcus faecalis is one of the leading agents of nosocomial infections. To cause diseases, pathogens or opportunistic bacteria have to adapt and survive to the defense systems encountered in the host. One of the most important compounds of the host innate defense response against invading microorganisms is lysozyme. It is found in a wide variety of body fluids, as well as in cells of the innate immune system. Lysozyme could act either as a muramidase and/or as a cationic antimicrobial peptide. Like Staphylococcus aureus, E. faecalis is one of the few bacteria that are completely lysozyme resistant. Results: This study revealed that oatA (O-acetyl transferase) and dlt (D-Alanylation of lipoteicoic acids) genes contribute only partly to the lysozyme resistance of E. faecalis and that a specific transcriptional regulator, the extracytoplasmic function SigV sigma factor plays a key role in this event. Indeed, the sigV single mutant is as sensitive as the oatA/dltA double mutant, and the sigV/oatA/dltA triple mutant displays the highest level of lysozyme sensitivity suggesting synergistic effects of these genes. In S. aureus, mutation of both oatA and dlt genes abolishes completely the lysozyme resistance, whereas this is not the case in E. faecalis. Interestingly SigV does not control neither oatA nor dlt genes. Moreover, the sigV mutants clearly showed a reduced capacity to colonize host tissues, as they are significantly less recovered than the parental JH2-2 strain from organs of mice subjected to intravenous or urinary tract infections. Conclusions: This work led to the discovery of an original model of lysozyme resistance mechanism which is obviously more complex than those described for other Gram positive pathogens. Moreover, our data provide evidences for a direct link between lysozyme resistance and virulence of E. faecalis.	[Le Jeune, Andre; Giard, Jean-Christophe; Hartke, Axel; Auffray, Yanick; Benachour, Abdellah] Univ Caen Basse Normandie, USC INRA 2017, EA956, Lab Microbiol Environm, Caen, France; [Torelli, Riccardo; Sanguinetti, Maurizio] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	INRAE; Universite de Caen Normandie; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Le Jeune, A (corresponding author), Univ Caen Basse Normandie, USC INRA 2017, EA956, Lab Microbiol Environm, Caen, France.	abdellah.benachour@unicaen.fr	Torelli, Riccardo/K-8822-2018; Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019	Torelli, Riccardo/0000-0001-7927-4343; Sanguinetti, Maurizio/0000-0002-9780-7059; giard, jean-christophe/0000-0001-8588-2732	Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-PATHO-008-01]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	A. Le Jeune is funded by a thesis grant awarded by the Ministere de l'Enseignement Superieur et de la Recherche. This study was partly supported by grants of the Agence Nationale de la Recherche in the frame of a trans-national ERA-NET PathoGenomics program (ANR-06-PATHO-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; BATISH VK, 1984, NEW ZEAL J DAIRY SCI, V19, P189; Benachour A, 2005, J BACTERIOL, V187, P1022, DOI 10.1128/JB.187.3.1022-1035.2005; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Binks MJ, 2005, J BIOL CHEM, V280, P20120, DOI 10.1074/jbc.M414194200; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Cox KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005366; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; DEVRIESE LA, 1992, J APPL BACTERIOL, V72, P29, DOI 10.1111/j.1365-2672.1992.tb04877.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Franz CMAP, 2003, INT J FOOD MICROBIOL, V88, P105, DOI 10.1016/S0168-1605(03)00174-0; FRERE J, 1993, CURR MICROBIOL, V27, P97, DOI 10.1007/BF01570865; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; Giaouris E, 2008, APPL ENVIRON MICROB, V74, P4764, DOI 10.1128/AEM.00078-08; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Ibrahim HR, 2002, CURR PHARM DESIGN, V8, P671, DOI 10.2174/1381612023395349; Kak V, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P355; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; MANSON JM, 2006, PATHOGENOMICS, P125; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; REED LJ, 1938, AM J HYG, V27; Sambrook J., 2002, MOL CLONING LAB MANU; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Singh KV, 2007, J INFECT DIS, V195, P1671, DOI 10.1086/517524; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980; Yother J, 2002, J BACTERIOL, V184, P6085, DOI 10.1128/JB.184.22.6085-6092.2002	59	56	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9658	10.1371/journal.pone.0009658	http://dx.doi.org/10.1371/journal.pone.0009658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300180	Green Submitted, gold, Green Published			2022-12-25	WOS:000275620600013
J	Abbassi, F; Lequin, O; Piesse, C; Goasdoue, N; Foulon, T; Nicolas, P; Ladram, A				Abbassi, Feten; Lequin, Olivier; Piesse, Christophe; Goasdoue, Nicole; Foulon, Thierry; Nicolas, Pierre; Ladram, Ali			Temporin-SHf, a New Type of Phe-rich and Hydrophobic Ultrashort Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; THERMOTROPIC PHASE-BEHAVIOR; PHOSPHOLIPID-MEMBRANES; BIOLOGICAL-ACTIVITY; AROMATIC RESIDUES; MOLECULAR-CLONING; NMR-SPECTROSCOPY; SKIN SECRETIONS; DERMASEPTIN B2; LIPID-BILAYERS	Because issues of cost and bioavailability have hampered the development of gene-encoded antimicrobial peptides to combat infectious diseases, short linear peptides with high microbial cell selectivity have been recently considered as antibiotic substitutes. A new type of short antimicrobial peptide, designated temporin-SHf, was isolated and cloned from the skin of the frog Pelophylax saharica. Temporin-SHf has a highly hydrophobic sequence (FFFLSRIFa) and possesses the highest percentage of Phe residues of any known peptide or protein. Moreover, it is the smallest natural linear antimicrobial peptide found to date, with only eight residues. Despite its small size and hydrophobicity, temporin-SHf has broad-spectrum microbicidal activity against Gram-positive and Gram-negative bacteria and yeasts, with no hemolytic activity. CD and NMR spectroscopy combined with restrained molecular dynamics calculations showed that the peptide adopts a well defined non-amphipathic alpha-helical structure from residue 3 to 8, when bound to zwitterionic dodecyl phosphocholine or anionic SDS micelles. Relaxation enhancement caused by paramagnetic probes showed that the peptide adopts nearly parallel orientations to the micelle surface and that the helical structure is stabilized by a compact hydrophobic core on one face that penetrates into the micelle interior. Differential scanning calorimetry on multilamellar vesicles combined with membrane permeabilization assays on bacterial cells indicated that temporin-SHf disrupts the acyl chain packing of anionic lipid bilayers, thereby triggering local cracks and microbial membrane disintegration through a detergent-like effect probably via the carpet mechanism. The short length, compositional simplicity, and broad-spectrum activity of temporin-SHf make it an attractive candidate to develop new antibiotic agents.	[Ladram, Ali] Univ Paris 06, Biogenese Signaux Peptid ER3, F-75005 Paris, France; [Lequin, Olivier; Goasdoue, Nicole] Univ Paris 06, CNRS, Unite Mixte Rech 7203, Lab Biomol, F-75005 Paris, France; [Piesse, Christophe] Univ Paris 06, IFR Plate Forme Ingn Prot & Synth Peptid 83, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Ladram, A (corresponding author), Univ Paris 06, ER3, Batiment A,5 Eme Etage,Case Courier 29,7 Quai St, F-75005 Paris, France.	ali.ladram@upmc.fr	Nicolas, Pierre/C-7908-2009	LEQUIN, Olivier/0000-0001-5307-3068	Universite Pierre et Marie Curie	Universite Pierre et Marie Curie	This work was supported by grants from the Universite Pierre et Marie Curie. The nucleotide sequence(s) reported in this paper has been submitted to the GenBank (TM)/EBI Data Bank with accession number(s) FN557009, FN557010, FN557011, FN557012, and FN557013.	Abbassi F, 2008, PEPTIDES, V29, P1526, DOI 10.1016/j.peptides.2008.05.008; Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Amiche M, 1999, FEBS LETT, V456, P352, DOI 10.1016/S0014-5793(99)00964-3; Amiche M, 2008, PEPTIDES, V29, P2074, DOI 10.1016/j.peptides.2008.06.017; Banerjee R, 2002, FEBS LETT, V523, P152, DOI 10.1016/S0014-5793(02)02974-5; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; Conlon JM, 2008, PEPTIDES, V29, P1815, DOI 10.1016/j.peptides.2008.05.029; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HARWIG SSL, 1995, FEBS LETT, V362, P65, DOI 10.1016/0014-5793(95)00210-Z; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Marenah L, 2006, J ENDOCRINOL, V188, P1, DOI 10.1677/joe.1.06293; MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3; MOR A, 1994, J BIOL CHEM, V269, P1934; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SIMMACO M, 1994, J BIOL CHEM, V269, P11956; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; Thrippleton MJ, 2003, ANGEW CHEM INT EDIT, V42, P3938, DOI 10.1002/anie.200351947; van Kan EJM, 2003, BBA-BIOMEMBRANES, V1615, P84, DOI 10.1016/S0005-2736(03)00233-5; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Woody R. W., 1992, ADV BIOPHYS CHEM, V2, P37; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	51	64	70	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16880	16892		10.1074/jbc.M109.097204	http://dx.doi.org/10.1074/jbc.M109.097204			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308076	Green Published, hybrid			2022-12-25	WOS:000277982600052
J	Sanjo, H; Zajonc, DM; Braden, R; Norris, PS; Ware, CF				Sanjo, Hideki; Zajonc, Dirk M.; Braden, Rebecca; Norris, Paula S.; Ware, Carl F.			Allosteric Regulation of the Ubiquitin: NIK and Ubiquitin: TRAF3 E3 Ligases by the Lymphotoxin-beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; TUMOR-CELLS; PROTEIN; DEGRADATION; PATHWAYS; COMPLEX; KINASE; VIRUS	The lymphotoxin-beta receptor (LT beta R) activates the NF-kappa B2 transcription factors, p100 and RelB, by regulating the NF-kappa B-inducing kinase (NIK). Constitutive proteosomal degradation of NIK limits NF-kappa B activation in unstimulated cells by the ubiquitin: NIK E3 ligase comprised of subunits TNFR-associated factors (TRAF) 3, TRAF2, and cellular inhibitor of apoptosis (cIAP). However, the mechanism releasing NIK from constitutive degradation remains unclear. We found that insertion of a charge-repulsion mutation in the receptor-binding crevice of TRAF3 ablated binding of both LT beta R and NIK suggesting a common recognition site. A homologous mutation in TRAF2 inhibited cIAP interaction and blocked NIK degradation. Furthermore, the recruitment of TRAF3 and TRAF2 to the ligated LT beta R competitively displaced NIK from TRAF3. Ligated LT beta R complexed with TRAF3 and TRAF2 redirected the specificity of the ubiquitin ligase reaction to polyubiquitinate TRAF3 and TRAF2, leading to their proteosomal degradation. Stimulus-dependent degradation of TRAF3 required the RING domain of TRAF2, but not of TRAF3, implicating TRAF2 as a key E3 ligase in TRAF turnover. The combined action of competitive displacement of NIK and TRAF degradation halted NIK turnover, and promoted its association with IKK alpha and signal transmission. These results indicate the LT beta R modifies the ubiquitin: NIK E3 ligase, and also acts as an allosteric regulator of the ubiquitin: TRAF E3 ligase.	[Sanjo, Hideki; Braden, Rebecca; Norris, Paula S.; Ware, Carl F.] La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Ware, CF (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	cware@liai.org			US Public Health Service, National Institutes of Healt [CA069381, R37AI033068, AI048073]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R37AI033068] Funding Source: NIH RePORTER	US Public Health Service, National Institutes of Healt(United States Department of Health & Human ServicesUnited States Public Health Service); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grants CA069381, R37AI033068, and AI048073 (to C. F. W.) from the US Public Health Service, National Institutes of Health. This work was also supported by the Uehara Memorial Foundation.	Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Chung JY, 2002, J CELL SCI, V115, P679; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Csomos RA, 2009, BIOCHEM J, V420, P83, DOI 10.1042/BJ20082140; De Trez C, 2008, CYTOKINE GROWTH F R, V19, P277, DOI 10.1016/j.cytogfr.2008.04.013; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Ely KR, 2007, ADV EXP MED BIOL, V597, P114; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Grammer A C, 2000, Adv Immunol, V76, P61; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vondenhoff MFR, 2007, EUR J IMMUNOL, V37, pS46, DOI 10.1002/eji.200737528; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	39	54	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17148	17155		10.1074/jbc.M110.105874	http://dx.doi.org/10.1074/jbc.M110.105874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348096	Green Published, hybrid			2022-12-25	WOS:000277982600077
J	Liechti, LA; Berneche, S; Bargeton, B; Iwaszkiewicz, J; Roy, S; Michielin, O; Kellenberger, S				Liechti, Luz Angelica; Berneche, Simon; Bargeton, Benoite; Iwaszkiewicz, Justyna; Roy, Sophie; Michielin, Olivier; Kellenberger, Stephan			A Combined Computational and Functional Approach Identifies New Residues Involved in pH-dependent Gating of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; ACID; BRAIN; H+; DESENSITIZATION; ION-CHANNEL-1; ARCHITECTURE; CONTRIBUTES; SENSITIVITY; ISCHEMIA	Acid-sensing ion channels (ASICs) are key receptors for extracellular protons. These neuronal nonvoltage-gated Na+ channels are involved in learning, the expression of fear, neuro-degeneration after ischemia, and pain sensation. We have applied a systematic approach to identify potential pH sensors in ASIC1a and to elucidate the mechanisms by which pH variations govern ASIC gating. We first calculated the pK(a) value of all extracellular His, Glu, and Asp residues using a Poisson-Boltzmann continuum approach, based on the ASIC three-dimensional structure, to identify candidate pH-sensing residues. The role of these residues was then assessed by site-directed mutagenesis and chemical modification, combined with functional analysis. The localization of putative pH-sensing residues suggests that pH changes control ASIC gating by protonation/deprotonation of many residues per subunit in different channel domains. Analysis of the function of residues in the palm domain close to the central vertical axis of the channel allowed for prediction of conformational changes of this region during gating. Our study provides a basis for the intrinsic ASIC pH dependence and describes an approach that can also be applied to the investigation of the mechanisms of the pH dependence of other proteins.	[Liechti, Luz Angelica; Bargeton, Benoite; Roy, Sophie; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Berneche, Simon; Iwaszkiewicz, Justyna; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics	Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Stephan.Kellenberger@unil.ch	Michielin, Olivier/ABE-7924-2020; Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094; Iwaszkiewicz, Justyna/0000-0003-3494-589X; Kellenberger, Stephan/0000-0003-1755-6198	Swiss National Science Foundation [31003A0- 117717, 3232B0- 103172, 3200B0- 103173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31003A0- 117717 from the Swiss National Science Foundation (to S. K.) and by SCORE Grants 3232B0- 103172 and 3200B0- 103173 from the Swiss National Science Foundation (to O. M.).	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v; Sanchez R, 2000, METH MOL B, V143, P97; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	46	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16315	16329		10.1074/jbc.M109.092015	http://dx.doi.org/10.1074/jbc.M109.092015			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299463	Green Published, hybrid			2022-12-25	WOS:000277715900068
J	Effantin, G; Maurizi, MR; Steven, AC				Effantin, Gregory; Maurizi, Michael R.; Steven, Alasdair C.			Binding of the ClpA Unfoldase Opens the Axial Gate of ClpP Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASES; AAA PLUS PROTEINS; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; COMPLEX-FORMATION; HSP100 CHAPERONE; SERINE PROTEASES; 20S PROTEASOMES; N-TERMINUS; PROTEOLYSIS	ClpP is a serine protease whose active sites are sequestered in a cavity enclosed between two heptameric rings of subunits. The ability of ClpP to process folded protein substrates depends on its being partnered by an AAA+ ATPase/unfoldase, ClpA or ClpX. In active complexes, substrates are unfolded and fed along an axial channel to the degradation chamber inside ClpP. We have used cryoelectron microscopy at similar to 11-angstrom resolution to investigate the three-dimensional structure of ClpP complexed with either one or two end-mounted ClpA hexamers. In the absence of ClpA, the apical region of ClpP is sealed; however, it opens on ClpA binding, creating an access channel. This region is occupied by the N-terminal loops (residues 1-17) of ClpP, which tend to be poorly visible in crystal structures, indicative of conformational variability. Nevertheless, we were able to model the closed-to-open transition that accompanies ClpA binding in terms of movements of these loops; in particular, "up" conformations of the loops correlate with the open state. The main part of ClpP, the barrel formed by 14 copies of residues 18-193, is essentially unchanged by the interaction with ClpA. Using difference mapping, we localized the binding site for ClpA to a peripheral pocket between adjacent ClpP subunits. Based on these observations, we propose that access to the ClpP degradation chamber is controlled allosterically by hinged movements of its N-terminal loops, which the symmetry-mismatched binding of ClpA suffices to induce.	[Steven, Alasdair C.] NIAMS, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA; [Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Steven, AC (corresponding author), NIAMS, Struct Biol Res Lab, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov			NIAMS; NCI of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Programs of NIAMS and NCI of the National Institutes of Health.	Adams P, 2009, J BIOL CHEM, V284, P22012, DOI 10.1074/jbc.M109.031807; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Choi KH, 2005, BIOCHEMISTRY-US, V44, P13921, DOI 10.1021/bi0505060; EFFANTIN G, 2010, STRUCTURE IN PRESS; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11031, DOI 10.1021/bi8010169; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	45	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14834	14840		10.1074/jbc.M109.090498	http://dx.doi.org/10.1074/jbc.M109.090498			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236930	Green Published, hybrid			2022-12-25	WOS:000277299700080
J	Jakobsson, HE; Jernberg, C; Andersson, AF; Sjolund-Karlsson, M; Jansson, JK; Engstrand, L				Jakobsson, Hedvig E.; Jernberg, Cecilia; Andersson, Anders F.; Sjolund-Karlsson, Maria; Jansson, Janet K.; Engstrand, Lars			Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; HELICOBACTER-PYLORI; INTESTINAL MICROFLORA; MACROLIDE RESISTANCE; CLARITHROMYCIN; GENES; POPULATIONS; PERSISTENCE; DIVERSITY	Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer. However, the long-term consequences of this treatment on the human indigenous microbiota are relatively unexplored. Here we studied short-and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine. The bacterial compositions in samples collected over a four-year period were monitored by analyzing the 16S rRNA gene using 454-based pyrosequencing and terminal-restriction fragment length polymorphism (T-RFLP). While the microbial communities of untreated control subjects were relatively stable over time, dramatic shifts were observed one week after antibiotic treatment with reduced bacterial diversity in all treated subjects in both locations. While the microbiota of the different subjects responded uniquely to the antibiotic treatment some general trends could be observed; such as a dramatic decline in Actinobacteria in both throat and feces immediately after treatment. Although the diversity of the microbiota subsequently recovered to resemble the pre treatment states, the microbiota remained perturbed in some cases for up to four years post treatment. In addition, four years after treatment high levels of the macrolide resistance gene erm(B) were found, indicating that antibiotic resistance, once selected for, can persist for longer periods of time than previously recognized. This highlights the importance of a restrictive antibiotic usage in order to prevent subsequent treatment failure and potential spread of antibiotic resistance.	[Jakobsson, Hedvig E.; Jernberg, Cecilia; Andersson, Anders F.; Sjolund-Karlsson, Maria; Engstrand, Lars] Swedish Inst Infect Dis, Dept Bacteriol, Solna, Sweden; [Jakobsson, Hedvig E.; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden; [Jansson, Janet K.] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Uppsala University; Swedish University of Agricultural Sciences; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jakobsson, HE (corresponding author), Swedish Inst Infect Dis, Dept Bacteriol, Solna, Sweden.	lars.engstrand@smi.se	Andersson, Anders/J-9310-2019; Jansson, Janet/H-5478-2018	Andersson, Anders/0000-0002-3627-6899; Jansson, Janet/0000-0002-5487-4315	Ekhaga foundation; Soderberg foundation; U. S. Department of Energy [DE-AC02-05CH11231]	Ekhaga foundation; Soderberg foundation; U. S. Department of Energy(United States Department of Energy (DOE))	The Ekhaga foundation and the Soderberg foundation, and in part by the U. S. Department of Energy Contact DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Adamsson I, 1999, J ANTIMICROB CHEMOTH, V44, P629, DOI 10.1093/jac/44.5.629; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Buhling A, 2001, ALIMENT PHARM THER, V15, P1445, DOI 10.1046/j.1365-2036.2001.01033.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Cresti S, 2002, ANTIMICROB AGENTS CH, V46, P1816, DOI 10.1128/AAC.46.6.1816-1822.2002; de Boer WA, 2000, BRIT MED J, V320, P31, DOI 10.1136/bmj.320.7226.31; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Donskey CJ, 2003, J MICROBIOL METH, V54, P249, DOI 10.1016/S0167-7012(03)00059-9; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Graham DY, 2000, GASTROENTEROLOGY, V118, pS2, DOI 10.1016/S0016-5085(00)70003-5; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; HAYEK LC, 1996, SURVEYING NATURAL PO; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Jakobsson H, 2007, SCAND J INFECT DIS, V39, P757, DOI 10.1080/00365540701299608; Jernberg C, 2005, APPL ENVIRON MICROB, V71, P501, DOI 10.1128/AEM.71.1.501-506.2005; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jonsson M, 2005, INT J ANTIMICROB AG, V25, P68, DOI 10.1016/j.ijantimicag.2004.08.011; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Krogius-Kurikka L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-68; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; ROUND JL, 2009, NAT REV IMMUNOL; Sjolund M, 2005, EMERG INFECT DIS, V11, P1389; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Tanaka J, 2005, J MED MICROBIOL, V54, P309, DOI 10.1099/jmm.0.45814-0; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS JD, 1992, J ANTIMICROB CHEMOTH, V30, P27, DOI 10.1093/jac/30.1.27; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	45	710	757	4	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9836	10.1371/journal.pone.0009836	http://dx.doi.org/10.1371/journal.pone.0009836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352091	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894500009
J	Hadano, S; Otomo, A; Kunita, R; Suzuki-Utsunomiya, K; Akatsuka, A; Koike, M; Aoki, M; Uchiyama, Y; Itoyama, Y; Ikeda, JE				Hadano, Shinji; Otomo, Asako; Kunita, Ryota; Suzuki-Utsunomiya, Kyoko; Akatsuka, Akira; Koike, Masato; Aoki, Masashi; Uchiyama, Yasuo; Itoyama, Yasuto; Ikeda, Joh-E			Loss of ALS2/Alsin Exacerbates Motor wDysfunction in a SOD1(H46R)-Expressing Mouse ALS Model by Disturbing Endolysosomal Trafficking	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ASCENDING SPASTIC PARALYSIS; NUCLEOTIDE EXCHANGE FACTOR; INFANTILE-ONSET; SUPEROXIDE-DISMUTASE; ENDOSOME TRAFFICKING; NEURON DEGENERATION; BULBAR INVOLVEMENT; TRANSGENIC MICE; SITE MUTATION	Background: ALS2/alsin is a guanine nucleotide exchange factor for the small GTPase Rab5 and involved in macropinocytosis-associated endosome fusion and trafficking, and neurite outgrowth. ALS2 deficiency accounts for a number of juvenile recessive motor neuron diseases (MNDs). Recently, it has been shown that ALS2 plays a role in neuroprotection against MND-associated pathological insults, such as toxicity induced by mutant Cu/Zn superoxide dismutase (SOD1). However, molecular mechanisms underlying the relationship between ALS2-associated cellular function and its neuroprotective role remain unclear. Methodology/Principal Findings: To address this issue, we investigated the molecular and pathological basis for the phenotypic modification of mutant SOD1-expressing mice by ALS2 loss. Genetic ablation of Als2 in SOD1(H46R), but not SOD1(G93A), transgenic mice aggravated the mutant SOD1-associated disease symptoms such as body weight loss and motor dysfunction, leading to the earlier death. Light and electron microscopic examinations revealed the presence of degenerating and/or swollen spinal axons accumulating granular aggregates and autophagosome-like vesicles in early-and even pre-symptomatic SOD1(H46R) mice. Further, enhanced accumulation of insoluble high molecular weight SOD1, poly-ubiquitinated proteins, and macroautophagy-associated proteins such as polyubiquitin-binding protein p62/SQSTM1 and a lipidated form of light chain 3 (LC3-II), emerged in ALS2-deficient SOD1(H46R) mice. Intriguingly, ALS2 was colocalized with LC3 and p62, and partly with SOD1 on autophagosome/endosome hybrid compartments, and loss of ALS2 significantly lowered the lysosome-dependent clearance of LC3 and p62 in cultured cells. Conclusions/Significance: Based on these observations, although molecular basis for the distinctive susceptibilities to ALS2 loss in different mutant SOD1-expressing ALS models is still elusive, disturbance of the endolysosomal system by ALS2 loss may exacerbate the SOD1(H46R)-mediated neurotoxicity by accelerating the accumulation of immature vesicles and misfolded proteins in the spinal cord. We propose that ALS2 is implicated in endolysosomal trafficking through the fusion between endosomes and autophagosomes, thereby regulating endolysosomal protein degradation in vivo.	[Hadano, Shinji; Ikeda, Joh-E] Tokai Univ, Grad Sch Med, Neurodegenerat Dis Res Ctr, Kanagawa 2591100, Japan; [Hadano, Shinji; Otomo, Asako; Kunita, Ryota; Suzuki-Utsunomiya, Kyoko; Ikeda, Joh-E] Tokai Univ, Dept Mol Life Sci, Sch Med, Kanagawa 2591100, Japan; [Hadano, Shinji; Ikeda, Joh-E] Tokai Univ, Inst Med Sci, Kanagawa 2591100, Japan; [Akatsuka, Akira] Tokai Univ, Teaching & Res Support Ctr, Kanagawa 2591100, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 113, Japan; [Aoki, Masashi; Itoyama, Yasuto] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Ikeda, Joh-E] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	Tokai University; Tokai University; Tokai University; Tokai University; Juntendo University; Tohoku University; University of Ottawa; Children's Hospital of Eastern Ontario	Hadano, S (corresponding author), Tokai Univ, Grad Sch Med, Neurodegenerat Dis Res Ctr, Kanagawa 2591100, Japan.	shinji@is.icc.u-tokai.ac.jp; jei@m.med.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019; Koike, Masato/F-9584-2010; Hadano, Shinji/ABA-5052-2021	Otomo, Asako/0000-0002-7849-4309; Koike, Masato/0000-0002-3174-5684; Hadano, Shinji/0000-0002-4997-3968	Japan Society for the Promotion of Science; Japan Brain Foundation (SH), The Ichiro Kanehara Foundation; Tokai University School of Medicine Research Aid; Tokai University School of Medicine Project Research; Tokai University General Research Organization; Ministry of Health, Labour and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Brain Foundation (SH), The Ichiro Kanehara Foundation; Tokai University School of Medicine Research Aid; Tokai University School of Medicine Project Research; Tokai University General Research Organization; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (SH), Japan Brain Foundation (SH), The Ichiro Kanehara Foundation (SH), a Tokai University School of Medicine Research Aid (SH), a Tokai University School of Medicine Project Research (SH), and a Research Aid from the Tokai University General Research Organization ( SH). This work was also supported in part by the Ministry of Health, Labour and Welfare (JEI). AO, RK, and KSU receive support for a Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; BENHAMIDA M, 1990, BRAIN, V113, P347; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; Cai HB, 2008, NEURODEGENER DIS, V5, P359, DOI 10.1159/000151295; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Deng HX, 2007, HUM MOL GENET, V16, P2911, DOI 10.1093/hmg/ddm251; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herzfeld T, 2009, NEUROGENETICS, V10, P59, DOI 10.1007/s10048-008-0148-y; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jacquier A, 2009, HUM MOL GENET, V18, P2127, DOI 10.1093/hmg/ddp136; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Lai C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-23; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; LermanSagie T, 1996, J CHILD NEUROL, V11, P54, DOI 10.1177/088307389601100114; Lin X, 2007, NEUROBIOL AGING, V28, P1628, DOI 10.1016/j.neurobiolaging.2006.07.014; Mintchev N, 2009, NEUROLOGY, V72, P28, DOI 10.1212/01.wnl.0000338530.77394.60; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otomo A, 2008, BIOCHEM BIOPH RES CO, V370, P87, DOI 10.1016/j.bbrc.2008.01.177; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perrin FE, 2006, J NEUROCHEM, V98, P1959, DOI 10.1111/j.1471-4159.2006.04024.x; Puttaparthi K, 2007, EXP NEUROL, V206, P53, DOI 10.1016/j.expneurol.2007.03.024; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Shirakawa K, 2009, NEUROLOGY, V73, P2124, DOI 10.1212/WNL.0b013e3181c67be0; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Sztriha L, 2008, CLIN GENET, V73, P591, DOI 10.1111/j.1399-0004.2008.00993.x; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Verschuuren-Bemelmans CC, 2008, EUR J HUM GENET, V16, P1407, DOI 10.1038/ejhg.2008.108; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	62	91	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9805	10.1371/journal.pone.0009805	http://dx.doi.org/10.1371/journal.pone.0009805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339559	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894300027
J	Raichlen, DA; Gordon, AD; Harcourt-Smith, WEH; Foster, AD; Haas, WR				Raichlen, David A.; Gordon, Adam D.; Harcourt-Smith, William E. H.; Foster, Adam D.; Haas, Wm. Randall, Jr.			Laetoli Footprints Preserve Earliest Direct Evidence of Human-Like Bipedal Biomechanics	PLOS ONE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HOMINID FOOTPRINTS; BENT-HIP; WALKING; LOCOMOTION; SPEED; COSTS	Background: Debates over the evolution of hominin bipedalism, a defining human characteristic, revolve around whether early bipeds walked more like humans, with energetically efficient extended hind limbs, or more like apes with flexed hind limbs. The 3.6 million year old hominin footprints at Laetoli, Tanzania represent the earliest direct evidence of hominin bipedalism. Determining the kinematics of Laetoli hominins will allow us to understand whether selection acted to decrease energy costs of bipedalism by 3.6 Ma. Methodology/Principal Findings: Using an experimental design, we show that the Laetoli hominins walked with weight transfer most similar to the economical extended limb bipedalism of humans. Humans walked through a sand trackway using both extended limb bipedalism, and more flexed limb bipedalism. Footprint morphology from extended limb trials matches weight distribution patterns found in the Laetoli footprints. Conclusions: These results provide us with the earliest direct evidence of kinematically human-like bipedalism currently known, and show that extended limb bipedalism evolved long before the appearance of the genus Homo. Since extended-limb bipedalism is more energetically economical than ape-like bipedalism, energy expenditure was likely an important selection pressure on hominin bipeds by 3.6 Ma.	[Raichlen, David A.; Foster, Adam D.; Haas, Wm. Randall, Jr.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Harcourt-Smith, William E. H.] Lehman Coll, Dept Anthropol, Bronx, NY USA; [Harcourt-Smith, William E. H.] Amer Museum Nat Hist, Div Vertebrate Paleontol, New York, NY 10024 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Albany; City University of New York (CUNY) System; Lehman College (CUNY); American Museum of Natural History (AMNH)	Raichlen, DA (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	raichlen@email.arizona.edu	Gordon, Adam/AAB-9006-2019	Gordon, Adam/0000-0002-1807-4644; Haas, Randall/0000-0002-7742-2127; Foster, Adam/0000-0002-1265-8171	University of Arizona	University of Arizona	Funding was provided from the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1984, AM J PHYS ANTHROPOL, V63, P23, DOI 10.1002/ajpa.1330630105; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berge C, 2006, CR PALEVOL, V5, P561, DOI 10.1016/j.crpv.2005.09.001; Carey TS, 2005, J HUM EVOL, V48, P25, DOI 10.1016/j.jhevol.2004.10.001; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; D'Aout K, 2010, AM J PHYS ANTHROPOL, V141, P515, DOI 10.1002/ajpa.21169; Darwin C., 1871, DECENT MAN SELECTION; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; DELOISON Y, 1992, CR ACAD SCI II, V315, P103; FEIBEL CS, 2005, EVOLUTIONARY ANTHR, V4, P149; HARCOURTSMITH WEH, 2005, AM J PHYS ANTHR S, V40, P116, DOI DOI 10.1002/AJPA.20217; HAY RL, 1982, SCI AM, V246, P50, DOI 10.1038/scientificamerican0282-50; HAY RL, 1987, LAETOLI PLIOCENE SIT, P23; Imhauser CW, 2004, CLIN BIOMECH, V19, P161, DOI 10.1016/j.clinbiomech.2003.10.007; Kullmer O, 2003, COUR FOR SEKENBG, V243, P85; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1981, PHILOS T R SOC B, V292, P95, DOI 10.1098/rstb.1981.0017; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; MELDRUM D, 2007, CENOZOIC VERTEBRATE; MELDRUM DJ, 2004, J SCI EXPLOR, V18, P65; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Raichlen DA, 2008, J HUM EVOL, V54, P112, DOI 10.1016/j.jhevol.2007.07.005; Robbins L.M., 1987, P497; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Schmitt S, 2004, BIOMED TECH, V49, P61, DOI 10.1515/BMT.2004.012; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; TUTTLE R, 1991, BIPEDIE CHEZ HOMINID, P203; Tuttle R.H., 1985, P129; Tuttle R.H., 1987, P503; TUTTLE RH, 1996, THEY STAND TODAY KAU, V6, P97; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WHITE TD, 1980, SCIENCE, V208, P175, DOI 10.1126/science.208.4440.175; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409	41	103	103	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9769	10.1371/journal.pone.0009769	http://dx.doi.org/10.1371/journal.pone.0009769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339543	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300013
J	Tiefenbach, J; Moll, PR; Nelson, MR; Hu, C; Baev, L; Kislinger, T; Krause, HM				Tiefenbach, Jens; Moll, Pamela R.; Nelson, Meryl R.; Hu, Chun; Baev, Lilia; Kislinger, Thomas; Krause, Henry M.			A Live Zebrafish-Based Screening System for Human Nuclear Receptor Ligand and Cofactor Discovery	PLOS ONE			English	Article							THYROID-HORMONE; IN-VIVO; N-COR; REPRESS TRANSCRIPTION; ESTROGEN-RECEPTOR; DRUG DISCOVERY; PROTEIN-KINASE; BETA GENE; PHOSPHORYLATION; ACTIVATION	Nuclear receptors (NRs) belong to a superfamily of transcription factors that regulate numerous homeostatic, metabolic and reproductive processes. Taken together with their modulation by small lipophilic molecules, they also represent an important and successful class of drug targets. Although many NRs have been targeted successfully, the majority have not, and one third are still orphans. Here we report the development of an in vivo GFP-based reporter system suitable for monitoring NR activities in all cells and tissues using live zebrafish (Danio rerio). The human NR fusion proteins used also contain a new affinity tag cassette allowing the purification of receptors with bound molecules from responsive tissues. We show that these constructs 1) respond as expected to endogenous zebrafish hormones and cofactors, 2) facilitate efficient receptor and cofactor purification, 3) respond robustly to NR hormones and drugs and 4) yield readily quantifiable signals. Transgenic lines representing the majority of human NRs have been established and are available for the investigation of tissue-and isoform-specific ligands and cofactors.	[Tiefenbach, Jens; Moll, Pamela R.; Nelson, Meryl R.; Hu, Chun; Baev, Lilia; Krause, Henry M.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada; [Tiefenbach, Jens; Nelson, Meryl R.; Krause, Henry M.] InDanio Biosci Inc, Toronto, ON, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kislinger, Thomas] Campbell Family Canc Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tiefenbach, J (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON, Canada.	h.krause@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Krause, Henry/0000-0002-6182-7074	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors would like to thank the Canadian Institutes of Health Research for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanza C, 1998, J CELL BIOL, V141, P1301, DOI 10.1083/jcb.141.6.1301; Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chang IF, 2006, PROTEOMICS, V6, P6158, DOI 10.1002/pmic.200600225; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Dias JM, 1998, ANAL BIOCHEM, V258, P96, DOI 10.1006/abio.1998.2583; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Luria A, 2004, P NATL ACAD SCI USA, V101, P8987, DOI 10.1073/pnas.0307053101; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; Maggi A, 2005, NAT REV DRUG DISCOV, V4, P249, DOI 10.1038/nrd1661; Messier N, 2000, MOL CELL ENDOCRINOL, V165, P57, DOI 10.1016/S0303-7207(00)00266-5; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Nagel SC, 2001, ENDOCRINOLOGY, V142, P4721, DOI 10.1210/en.142.11.4721; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Palanker L, 2006, DEVELOPMENT, V133, P3549, DOI 10.1242/dev.02512; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; SCHUELER PA, 1990, MOL ENDOCRINOL, V4, P227, DOI 10.1210/mend-4-2-227; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Shoji W, 1998, DEVELOPMENT, V125, P1275; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Taylor D, 2009, J MECH BEHAV BIOMED, V2, P1, DOI 10.1016/j.jmbbm.2008.10.001; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Ulisse S, 1996, P NATL ACAD SCI USA, V93, P1205, DOI 10.1073/pnas.93.3.1205; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Wegner GJ, 2002, ANAL CHEM, V74, P5161, DOI 10.1021/ac025922u; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yang L, 2006, EJC SUPPL, V4, P6, DOI 10.1016/j.ejcsup.2006.04.010; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P195, DOI 10.1080/10408440601123578	57	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9797	10.1371/journal.pone.0009797	http://dx.doi.org/10.1371/journal.pone.0009797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339547	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300022
J	Waddell, SJ; Popper, SJ; Rubins, KH; Griffiths, MJ; Brown, PO; Levin, M; Relman, DA				Waddell, Simon J.; Popper, Stephen J.; Rubins, Kathleen H.; Griffiths, Michael J.; Brown, Patrick O.; Levin, Michael; Relman, David A.			Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MICROARRAY ANALYSIS; ENDOTHELIAL-CELLS; GAMMA-RECEPTOR; HOST RESPONSE; ALPHA; CYTOKINES; INNATE; IFNS; IDENTIFICATION	Interferons are key modulators of the immune system, and are central to the control of many diseases. The response of immune cells to stimuli in complex populations is the product of direct and indirect effects, and of homotypic and heterotypic cell interactions. Dissecting the global transcriptional profiles of immune cell populations may provide insights into this regulatory interplay. The host transcriptional response may also be useful in discriminating between disease states, and in understanding pathophysiology. The transcriptional programs of cell populations in health therefore provide a paradigm for deconvoluting disease-associated gene expression profiles. We used human cDNA microarrays to (1) compare the gene expression programs in human peripheral blood mononuclear cells (PBMCs) elicited by 6 major mediators of the immune response: interferons alpha, beta, omega and gamma, IL12 and TNF alpha; and (2) characterize the transcriptional responses of purified immune cell populations (CD4(+) and CD8(+) T cells, B cells, NK cells and monocytes) to IFN gamma stimulation. We defined a highly stereotyped response to type I interferons, while responses to IFN gamma and IL12 were largely restricted to a subset of type I interferon-inducible genes. TNF alpha stimulation resulted in a distinct pattern of gene expression. Cell type-specific transcriptional programs were identified, highlighting the pronounced response of monocytes to IFN gamma, and emergent properties associated with IFN-mediated activation of mixed cell populations. This information provides a detailed view of cellular activation by immune mediators, and contributes an interpretive framework for the definition of host immune responses in a variety of disease settings.	[Waddell, Simon J.; Griffiths, Michael J.; Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Popper, Stephen J.; Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Waddell, SJ (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	swaddell@sgul.ac.uk	Waddell, Simon J/A-9170-2013; Pacific-Southwest, RCE/B-6155-2009	Waddell, Simon J/0000-0002-3684-9116; Relman, David A./0000-0001-8331-1354; Levin, Michael/0000-0003-2767-6919	Burroughs Wellcome-Wellcome Trust; Horn Foundation; Thomas C. and Joan M. Merigan Endowed Professorship; Stanford University Digestive Diseases Center (National Institutes of Health) [P30 DK56339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Burroughs Wellcome-Wellcome Trust(Burroughs Wellcome Fund); Horn Foundation; Thomas C. and Joan M. Merigan Endowed Professorship; Stanford University Digestive Diseases Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Burroughs Wellcome-Wellcome Trust Infectious Diseases Initiative Award to M. Levin, D. Beatty, and D.A. Relman. P.O. Brown and D. A. Relman were supported by the Horn Foundation. D. A. Relman was supported by the Thomas C. and Joan M. Merigan Endowed Professorship. This work includes data generated through the support of the Stanford University Digestive Diseases Center (National Institutes of Health P30 DK56339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2001, GENOMICS, V77, P50, DOI 10.1006/geno.2001.6623; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baig E, 2008, ANTIVIR THER, V13, P409; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Daryadel A, 2009, J IMMUNOL, V182, P6527, DOI 10.4049/jimmunol.0803846; de Jong R, 1998, SCIENCE, V280, P1435; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kovarik P, 2007, IMMUNOBIOLOGY, V212, P895, DOI 10.1016/j.imbio.2007.09.011; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; ORTALDO JR, 1984, P NATL ACAD SCI-BIOL, V81, P4926, DOI 10.1073/pnas.81.15.4926; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Popper SJ, 2009, J INFECT DIS, V200, P657, DOI 10.1086/603538; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schlaak JF, 2002, J BIOL CHEM, V277, P49428, DOI 10.1074/jbc.M205571200; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zimmerer JM, 2008, CLIN CANCER RES, V14, P5900, DOI 10.1158/1078-0432.CCR-08-0846	71	113	117	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9753	10.1371/journal.pone.0009753	http://dx.doi.org/10.1371/journal.pone.0009753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339534	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000275894300006
J	Kim, M; Long, TI; Arakawa, K; Wang, RW; Yu, MC; Laird, PW				Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Wang, Renwei; Yu, Mimi C.; Laird, Peter W.			DNA Methylation as a Biomarker for Cardiovascular Disease Risk	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; EXPRESSION; HYPOMETHYLATION; ATHEROSCLEROSIS; PATTERNS; MICE	Background: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). Methodology/Principal Findings: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45-74 years recruited during 1993-1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P= 0.01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P= 0.03) but not in women (P= 0.53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5.8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P= 0.007). Conclusions/Significance: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.	[Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Laird, Peter W.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Kim, Myungjin; Long, Tiffany I.; Arakawa, Kazuko; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Wang, Renwei; Yu, Mimi C.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Southern California; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities	Kim, M (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Sch Biol Sci, Seoul, South Korea.	plaird@usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641	Ministry of Education, Science, and Technology (MEST) [KRF-2008-532-C00010]	Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST) (KRF-2008-532-C00010) to M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Magliano DJ, 2006, ANN MED, V38, P34, DOI 10.1080/07853890500300311; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Saw SM, 2001, AM J CLIN NUTR, V73, P232; Seow A, 2006, JNCI-J NATL CANCER I, V98, P135, DOI 10.1093/jnci/djj015; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Trinh BN, 2002, HUM GENET, V111, P299, DOI 10.1007/s00439-002-0779-2; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WHO, 2004, LANCET, V363, P902; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Yang TH, 2006, NUTR CANCER, V55, P224, DOI 10.1207/s15327914nc5502_14; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zhou Beifan, 2002, Obes Rev, V3, P147, DOI 10.1046/j.1467-789X.2002.00068.x	26	274	289	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9692	10.1371/journal.pone.0009692	http://dx.doi.org/10.1371/journal.pone.0009692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300621	gold, Green Submitted, Green Published			2022-12-25	WOS:000275621000010
J	Dotov, DG; Nie, L; Chemero, A				Dotov, Dobromir G.; Nie, Lin; Chemero, Anthony			A Demonstration of the Transition from Ready-to-Hand to Unready-to-Hand	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; TIMING ERRORS; 1/F NOISE; HEARTBEAT; SEQUENCES; COGNITION; DYNAMICS; BEHAVIOR	The ideas of continental philosopher Martin Heidegger have been influential in cognitive science and artificial intelligence, despite the fact that there has been no effort to analyze these ideas empirically. The experiments reported here are designed to lend empirical support to Heidegger's phenomenology and more specifically his description of the transition between ready-to-hand and unready-to-hand modes in interactions with tools. In experiment 1, we found that a smoothly coping cognitive system exhibits 1/f(beta) type positively correlated noise and that its correlated character is reduced when the system is perturbed. This indicates that the participant and tool constitute a self-assembled, extended device during smooth coping and this device is disrupted by the perturbation. In experiment 2, we examine the re-organization of awareness that occurs when a smoothly coping, self-assembled, extended cognitive system is perturbed. We found that the disruption is accompanied by a change in attention which interferes with participants' performance on a simultaneous cognitive task. Together these experiments show that a smoothly coping participant-tool system can be temporarily disrupted and that this disruption causes a change in the participant's awareness. Since these two events follow as predictions from Heidegger's work, our study offers evidence for the hypothesized transition from readiness-to-hand to unreadiness-to-hand.	[Dotov, Dobromir G.] Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA; [Nie, Lin; Chemero, Anthony] Franklin & Marshall Coll, Sci & Philosoph Studies Mind Program, Lancaster, PA 17604 USA	University of Connecticut; Franklin & Marshall College	Dotov, DG (corresponding author), Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA.	tony.chemero@fandm.edu	Dotov, Dobromir/HGF-2586-2022; Dotov, Dobromir G/J-8257-2015	Dotov, Dobromir G/0000-0002-5543-360X	University of Connecticut Research Foundation; Franklin & Marshall College Hackman Scholars Program	University of Connecticut Research Foundation; Franklin & Marshall College Hackman Scholars Program	Dobromir Dotov was supported by a grant from the University of Connecticut Research Foundation. Lin Nie was supported by the Franklin & Marshall College Hackman Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, P 6 NAT C ART INT, V278, P268; AGRE PE, 1995, ARTIF INTELL, V72, P1, DOI 10.1016/0004-3702(94)00054-5; [Anonymous], 2004, REALITY RES CHILDREN; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Blattner W., 2006, HEIDEGGERS BEING TIM; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Chen YQ, 2001, J MOTOR BEHAV, V33, P3, DOI 10.1080/00222890109601897; Clark A, 2008, SUPERSIZING MIND EMB; Clark A, 1998, BEING THERE PUTTING; Ding MZ, 2002, BRAIN COGNITION, V48, P98, DOI 10.1006/brcg.2001.1306; Dreyfus, 1991, BEING IN THE WORLD C; DREYFUS H, 1965, ALCHEMY ARTIFICIAL I, P3244; Dreyfus Hubert, 1979, WHAT COMPUTERS CANT; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Gallagher Shaun., 2021, PHENOMENOLOGICAL MIN, V3rd ed., DOI 10.4324/9780203086599; GOPHER D, 1982, J EXP PSYCHOL HUMAN, V8, P146, DOI 10.1037/0096-1523.8.1.146; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Holden JG, 2009, PSYCHOL REV, V116, P318, DOI 10.1037/a0014849; Ivanov PC, 2001, CHAOS, V11, P641, DOI 10.1063/1.1395631; Kahneman D., 1973, ATTENTION EFFORT; Leistedt S, 2007, CLIN NEUROPHYSIOL, V118, P940, DOI 10.1016/j.clinph.2007.01.003; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; McClamrock R., 1995, EXISTENTIAL COGNITIO; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; SPERLING G, 1978, ATTENTION PERFORM, V7, P675; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Treffner PJ, 1999, ECOL PSYCHOL, V11, P103, DOI 10.1207/s15326969eco1102_1; Turvey, 1987, INFORM NATURAL LAWS; Van Orden GC, 2005, J EXP PSYCHOL GEN, V134, P117, DOI 10.1037/0096-3445.134.1.117; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; VANGELDER T, 1995, J PHILOS, V92, P345, DOI 10.2307/2941061; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; WEST BJ, 1999, PHYSL PROMISCUITY PR; West BJ, 2006, ADV CHEM PHYS, V133, P1; Wheeler M., 1996, ROBOTS ROTHKO BRINGI, P209; WHEELER Michael, 2005, RECONSTRUCTING COGNI; Wickens C.D., 1991, MULTIPLE TASK PERFOR, V1991, P3, DOI [10.1201/9781003069447-2, DOI 10.1201/9781003069447-2]; Wilson RA., 2004, BOUNDARIES MIND INDI; Winograd T., 1986, UNDERSTANDING COMPUT	45	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9433	10.1371/journal.pone.0009433	http://dx.doi.org/10.1371/journal.pone.0009433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	565XA	20231883	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300005
J	Chen, NC; Yang, F; Capecci, LM; Gu, ZY; Schafer, AI; Durante, W; Yang, XF; Wang, H				Chen, Natalie C.; Yang, Fan; Capecci, Louis M.; Gu, Ziyu; Schafer, Andrew I.; Durante, William; Yang, Xiao-Feng; Wang, Hong			Regulation of homocysteine metabolism and methylation in human and mouse tissues	FASEB JOURNAL			English	Article						gene expression; homocysteine metabolism; methylation	CYSTATHIONINE BETA-SYNTHASE; S-ADENOSYLHOMOCYSTEINE HYDROLASE; GLYCINE N-METHYLTRANSFERASE; ENDOTHELIAL-CELL GROWTH; PLASMA HOMOCYSTEINE; DNA METHYLATION; KNOCKOUT MOUSE; MICE DEFICIENT; FOLIC-ACID; LIVER	Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Homocysteine (Hcy) metabolism involves multiple enzymes; however, tissue Hcy metabolism and its relevance to methylation remain unknown. Here, we established gene expression profiles of 8 Hcy metabolic and 12 methylation enzymes in 20 human and 19 mouse tissues through bioinformatic analysis using expression sequence tag clone counts in tissue cDNA libraries. We analyzed correlations between gene expression, Hcy, S-adenosylhomocysteine (SAH), and S-adenosylmethionine (SAM) levels, and SAM/SAH ratios in mouse tissues. Hcy metabolic and methylation enzymes were classified into two types. The expression of Type 1 enzymes positively correlated with tissue Hcy and SAH levels. These include cystathionine beta-synthase, cystathionine-gamma-lyase, paraxonase 1, 5,10-methylenetetrahydrofolate reductase, betaine: homocysteine methyltransferase, methionine adenosyltransferase, phosphatidylethanolamine N-methyltransferases and glycine N-methyltransferase. Type 2 enzyme expressions correlate with neither tissue Hcy nor SAH levels. These include SAH hydrolase, methionyl-tRNA synthase, 5-methyltetrahydrofolate:Hcy methyltransferase, S-adenosylmethionine decarboxylase, DNA methyltransferase 1/3a, isoprenylcysteine carboxyl methyltransferases, and histone-lysine N-methyltransferase. SAH is the only Hcy metabolite significantly correlated with Hcy levels and methylation enzyme expression. We established equations expressing combined effects of methylation enzymes on tissue SAH, SAM, and SAM/SAH ratios. Our study is the first to provide panoramic tissue gene expression profiles and mathematical models of tissue methylation regulation.-Chen, N. C., Yang, F., Capecci, L. M., Gu, Z., Schafer, A. I., Durante, W., Yang, X.-F., Wang, H. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J. 24, 2804-2817 (2010). www.fasebj.org	[Wang, Hong] Temple Univ, Sch Med, Dept Pharmacol, MRB, Philadelphia, PA 19140 USA; [Yang, Xiao-Feng; Wang, Hong] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Wang, Hong] Temple Univ, Sch Med, Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Schafer, Andrew I.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Durante, William] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Cornell University; University of Missouri System; University of Missouri Columbia	Wang, H (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, MRB, 3420 N Broad St, Philadelphia, PA 19140 USA.	xfyang@temple.edu; hongw@temple.edu			NIH [HL67033, HL82774, HL77288, HL094451, HL74966]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077288, R01HL094451, R01HL074966, R01HL067033, R01HL082774] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by NIH grants HL67033, HL82774, and HL77288 (H.W.), HL094451 (X.F.Y.), and HL74966 (W.D.).	Barak AJ, 1996, ALCOHOL, V13, P395, DOI 10.1016/0741-8329(96)00030-4; Bazzano LA, 2009, AM J MED SCI, V338, P48, DOI 10.1097/MAJ.0b013e3181aaefd6; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Choumenkovitch SF, 2002, J NUTR, V132, P2157, DOI 10.1093/jn/132.8.2157; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; COX R, 1977, BIOCHIM BIOPHYS ACTA, V474, P493, DOI 10.1016/0005-2787(77)90070-3; De Franchis R, 1998, EUR J PEDIATR, V157, pS67, DOI 10.1007/PL00014309; DEGUCHI T, 1971, J BIOL CHEM, V246, P3175; Devlin AM, 2004, BLOOD, V103, P2624, DOI 10.1182/blood-2003-09-3078; Flynn J, 1998, BIOCHEMISTRY-US, V37, P15162, DOI 10.1021/bi9810609; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; HELLAND S, 1983, CANCER RES, V43, P1847; HELLAND S, 1983, CANCER RES, V43, P4142; HOFFMAN DR, 1981, LIPIDS, V16, P561, DOI 10.1007/BF02534900; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Igolnikov AC, 2006, J HEPATOL, V44, P586, DOI 10.1016/j.jhep.2005.08.026; Jacobs RL, 2001, J BIOL CHEM, V276, P43740, DOI 10.1074/jbc.M107553200; Jacobsen DW, 1998, CLIN CHEM, V44, P1833; Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; KERR SJ, 1972, J BIOL CHEM, V247, P4248; Kharbanda KK, 2009, SEMIN LIVER DIS, V29, P155, DOI 10.1055/s-0029-1214371; Lee ME, 1999, TRENDS CARDIOVAS MED, V9, P49, DOI 10.1016/S1050-1738(99)00002-X; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Luka Z, 2006, TRANSGENIC RES, V15, P393, DOI 10.1007/s11248-006-0008-1; Mager A, 2009, AM J CARDIOL, V104, P745, DOI 10.1016/j.amjcard.2009.05.011; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Matthews RG, 2007, CLIN CHEM LAB MED, V45, P1700, DOI 10.1515/CCLM.2007.324; MCKEEVER MP, 1991, CLIN SCI, V81, P551, DOI 10.1042/cs0810551; Meigs JB, 2001, DIABETES CARE, V24, P1403, DOI 10.2337/diacare.24.8.1403; Nieman KM, 2004, J BIOL CHEM, V279, P45708, DOI 10.1074/jbc.M408664200; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; PERNA AF, 1993, J CLIN INVEST, V91, P2497; PERNA AF, 1995, KIDNEY INT, V47, P247, DOI 10.1038/ki.1995.31; Perna AF, 1997, J AM SOC NEPHROL, V8, pA1148; Pontius JU, 2003, NCBI HDB, V1, P1; Qi ZX, 2003, GENET MED, V5, P458, DOI 10.1097/01.GIM.0000095001.12570.A8; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Song YQ, 2009, DIABETES, V58, P1921, DOI 10.2337/db09-0087; Stead LM, 2000, BIOCHEM J, V350, P685, DOI 10.1042/0264-6021:3500685; SVARDAL A, 1986, J BIOL CHEM, V261, P3156; Tessari P, 2005, DIABETES, V54, pA326; UELAND PM, 1984, J BIOL CHEM, V259, P2360; Wang H, 2002, BLOOD, V99, P939; Wang H, 1997, J BIOL CHEM, V272, P25380, DOI 10.1074/jbc.272.40.25380; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208	55	114	122	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2804	2817		10.1096/fj.09-143651	http://dx.doi.org/10.1096/fj.09-143651			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20305127	Green Published			2022-12-25	WOS:000285005400021
J	Kim, ED; Buckley, R; Learman, S; Richard, J; Parke, C; Worthylake, DK; Wojcik, EJ; Walker, RA; Kim, S				Kim, Elizabeth D.; Buckley, Rebecca; Learman, Sarah; Richard, Jessica; Parke, Courtney; Worthylake, David K.; Wojcik, Edward J.; Walker, Richard A.; Kim, Sunyoung			Allosteric Drug Discrimination Is Coupled to Mechanochemical Changes in the Kinesin-5 Motor Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE PROTEIN KSP; TRANSFORM INFRARED-SPECTROSCOPY; PRINCIPAL-COMPONENTS-ANALYSIS; TRITYL-L-CYSTEINE; SECONDARY STRUCTURE; SMALL-MOLECULE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL; BINDING REGION	Essential in mitosis, the human Kinesin-5 protein is a target for > 80 classes of allosteric compounds that bind to a surface exposed site formed by the L5 loop. Not established is why there are differing efficacies in drug inhibition. Here we compare the ligand-bound states of two L5-directed inhibitors against 15 Kinesin-5 mutants by ATPase assays and IR spectroscopy. Biochemical kinetics uncovers functional differences between individual residues at the N or C termini of the L5 loop. Infrared evaluation of solution structures and multivariate analysis of the vibrational spectra reveal that mutation and/or ligand binding not only can remodel the allosteric binding surface but also can transmit long range effects. Changes in L5-localized 310 helix and disordered content, regardless of substitution or drug potency, are experimentally detected. Principal component analysis couples these local structural events to two types of rearrangements in beta-sheet hydrogen bonding. These transformations in beta-sheet contacts are correlated with inhibitory drug response and are corroborated by wild type Kinesin-5 crystal structures. Despite considerable evolutionary divergence, our data directly support a theorized conserved element for long distance mechanochemical coupling in kinesin, myosin, and F-1-ATPase. These findings also suggest that these relatively rapid IR approaches can provide structural biomarkers for clinical determination of drug sensitivity and drug efficacy in nucleotide triphosphatases.	[Kim, Elizabeth D.; Buckley, Rebecca; Richard, Jessica; Parke, Courtney; Worthylake, David K.; Wojcik, Edward J.; Kim, Sunyoung] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Learman, Sarah; Walker, Richard A.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Virginia Polytechnic Institute & State University	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; OSER/Carilion Biomedical Institute; National Science Foundation; ASPIRES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066328, R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; OSER/Carilion Biomedical Institute; National Science Foundation(National Science Foundation (NSF)); ASPIRES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. J. W.). This work was also supported by grants from the Louisiana Board of Regents (to S. K. and to D. K. W.), the OSER/Carilion Biomedical Institute (to E. J. W. and S. K.), ASPIRES (to S. K., R. A. W., and E. J. W.), and the National Science Foundation (to R. A. W.).	Banci L, 2006, ACTA CRYSTALLOGR D, V62, P1208, DOI 10.1107/S0907444906029350; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2004, BIOCHEMISTRY-US, V43, P13072, DOI 10.1021/bi049264e; Brier S, 2006, RAPID COMMUN MASS SP, V20, P456, DOI 10.1002/rcm.2329; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Cox CD, 2005, BIOORG MED CHEM LETT, V15, P2041, DOI 10.1016/j.bmcl.2005.02.055; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fraley ME, 2006, BIOORG MED CHEM LETT, V16, P1775, DOI 10.1016/j.bmcl.2006.01.030; Garbaccio RM, 2006, BIOORG MED CHEM LETT, V16, P1780, DOI 10.1016/j.bmcl.2005.12.094; Garcia-Saez I, 2007, J BIOL CHEM, V282, P9740, DOI 10.1074/jbc.M608883200; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Hotha S, 2003, ANGEW CHEM INT EDIT, V42, P2379, DOI 10.1002/anie.200351173; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jun B, 2010, J BIOL CHEM, V285, P11073, DOI 10.1074/jbc.C110.103762; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Lin Z, 2004, AM J HUM GENET, V75, P850, DOI 10.1086/425587; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marshall CG, 2009, ARCH BIOCHEM BIOPHYS, V484, P1, DOI 10.1016/j.abb.2009.01.015; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sunder-Plassmann N, 2005, BIOORGAN MED CHEM, V13, P6094, DOI 10.1016/j.bmc.2005.06.027; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhang B, 2008, BIOCHEM BIOPH RES CO, V372, P565, DOI 10.1016/j.bbrc.2008.05.074	56	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18650	18661		10.1074/jbc.M109.092072	http://dx.doi.org/10.1074/jbc.M109.092072			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20299460	Green Published, hybrid			2022-12-25	WOS:000278453900058
J	Crouch, EC; Hirche, TO; Shao, BH; Boxio, R; Wartelle, J; Benabid, R; McDonald, B; Heinecke, J; Matalon, S; Belaaouaj, A				Crouch, Erika C.; Hirche, Tim O.; Shao, Baohai; Boxio, Rachel; Wartelle, Julien; Benabid, Rym; McDonald, Barbara; Heinecke, Jay; Matalon, Sadis; Belaaouaj, Azzaq			Myeloperoxidase-dependent Inactivation of Surfactant Protein D in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; D ENHANCES PHAGOCYTOSIS; RECOMBINANT SP-D; HYPOCHLOROUS ACID; HUMAN-NEUTROPHILS; HOST-DEFENSE; STRUCTURAL-CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; PULMONARY COLLECTINS; ALVEOLAR MACROPHAGES	Surfactant protein D (SP-D) plays diverse and important roles in innate immunity and pulmonary homeostasis. Neutrophils and myeloperoxidase (MPO) colocalized with SP-D in a murine bacterial pneumonia model of acute inflammation, suggesting that MPO-derived reactive species might alter the function of SP-D. Exposure of SP-D to the complete MPO-H2O2-halide system caused loss of SP-D-dependent aggregating activity. Hypochlorous acid (HOCl), the major oxidant generated by MPO, caused a similar loss of aggregating activity, which was accompanied by the generation of abnormal disulfide-cross-linked oligomers. A full-length SP-D mutant lacking N-terminal cysteine residues and truncation mutants lacking the N-terminal domains were resistant to the oxidant-induced alterations in disulfide bonding. Mass spectroscopy of HOCl-treated human SP-D demonstrated several modifications, but none involved key ligand binding residues. There was detectable oxidation of cysteine 15, but no HOCl-induced cysteine modifications were observed in the C-terminal lectin domain. Together, the findings localize abnormal disulfide cross-links to the N-terminal domain. MPO-deficient mice showed decreased cross-linking of SP-D and increased SP-D-dependent aggregating activity in the pneumonia model. Thus, MPO-derived oxidants can lead to modifications of SP-D structure with associated alterations in its characteristic aggregating activity.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Shao, Baohai; Heinecke, Jay] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35205 USA; [Hirche, Tim O.; Boxio, Rachel; Wartelle, Julien; Benabid, Rym; Belaaouaj, Azzaq] CHU Reims, INSERM Avenir EA 4303, IFR 53, F-51092 Reims, France	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crouch, EC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid, St Louis, MO 63110 USA.	crouch@path.wustl.edu	Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456; Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL-44015, HL-29594, 1U01ES015676, HL-086798, DK17047, K99HL-091055]; Conseil Regional Champagne-Ardenne; INSERM Avenir Program; University of Washington Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091055, R01HL044015, P01HL029594, R00HL091055, R01HL086798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conseil Regional Champagne-Ardenne(Region Grand-Est); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Washington Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-44015 and HL-29594 (to E. C. C.), 1U01ES015676 (to S. M.), HL-086798 and DK17047 (to J. H.), and K99HL-091055 (to B. S.). This work was also supported by grants from Conseil Regional Champagne-Ardenne, the INSERM Avenir Program (to R. B. and A. B.), FRM, and ANR (to A. B.), and the Mass Spectrometry Core (University of Washington Diabetes Endocrinology Research Center).	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; Clark H, 2002, IMMUNOBIOLOGY, V205, P619, DOI 10.1078/0171-2985-00159; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CROUCH E, 1993, AM J PATHOL, V142, P241; CROUCH E, 1992, AM J PHYSIOL, V263, pL60, DOI 10.1152/ajplung.1992.263.1.L60; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Crouch E C, 2000, Respir Res, V1, P93; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Davis IC, 2002, FREE RADICAL BIO MED, V33, P1703, DOI 10.1016/S0891-5849(02)01170-X; Drapeau G R, 1977, Methods Enzymol, V47, P189; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Haddad IY, 1996, AM J PHYSIOL-LUNG C, V270, pL281, DOI 10.1152/ajplung.1996.270.2.L281; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Hawgood S, 2001, ANNU REV PHYSIOL, V63, P495, DOI 10.1146/annurev.physiol.63.1.495; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hirche TO, 2005, J IMMUNOL, V174, P1557, DOI 10.4049/jimmunol.174.3.1557; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; King CC, 1997, J LEUKOCYTE BIOL, V61, P293, DOI 10.1002/jlb.61.3.293; Kishore U, 2001, Results Probl Cell Differ, V33, P225; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lessig J, 2005, CHEM PHYS LIPIDS, V135, P201, DOI 10.1016/j.chemphyslip.2005.02.015; Leth-Larsen R, 1999, BIOCHEM J, V343, P645, DOI 10.1042/0264-6021:3430645; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Matalon S, 2009, FASEB J, V23, P1415, DOI 10.1096/fj.08-120568; Naskalski JW, 2002, CLIN CHEM LAB MED, V40, P463, DOI 10.1515/CCLM.2002.080; NASKALSKI JW, 1994, ANN BIOL CLIN-PARIS, V52, P451; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Rothmann AB, 1997, EUR J BIOCHEM, V243, P630, DOI 10.1111/j.1432-1033.1997.t01-1-00630.x; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; Whiteman M, 2003, ARTHRITIS RHEUM-US, V48, P3140, DOI 10.1002/art.11284; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200; Zhu S, 1998, AM J PHYSIOL-LUNG C, V275, pL1031, DOI 10.1152/ajplung.1998.275.6.L1031	62	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16757	16770		10.1074/jbc.M109.097048	http://dx.doi.org/10.1074/jbc.M109.097048			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20228064	Green Published, hybrid			2022-12-25	WOS:000277982600039
J	Horta, BB; de Oliveira, MA; Discola, KF; Cussiol, JRR; Netto, LES				Horta, Bruno Brasil; de Oliveira, Marcos Antonio; Discola, Karen Fulan; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo			Structural and Biochemical Characterization of Peroxiredoxin Q beta from Xylella fastidiosa CATALYTIC MECHANISM AND HIGH REACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE PEROXIDASES; THIOREDOXIN PEROXIDASE; GENE FAMILY; CYSTEINE; EXPRESSION; PROTEINS; PEROXYNITRITE; TRYPAREDOXIN; OXIDATION; ANTIGEN	The phytopathogenic bacterium Xylella fastidiosa is the etiological agent of various plant diseases. To survive under oxidative stress imposed by the host, microorganisms express antioxidant proteins, including cysteine-based peroxidases named peroxiredoxins. This work is a comprehensive analysis of the catalysis performed by PrxQ from X. fastidiosa (XfPrxQ) that belongs to a peroxiredoxin class still poorly characterized and previously considered as moderately reactive toward hydroperoxides. Contrary to these assumptions, our competitive kinetics studies have shown that the second-order rate constants of the peroxidase reactions of XfPrxQ with hydrogen peroxide and peroxynitrite are in the order of 107 and 106 M-1 s(-1), respectively, which are as fast as the most efficient peroxidases. The XfPrxQ disulfides were only slightly reducible by dithiothreitol; therefore, the identification of a thioredoxin system as the probable biological reductant of XfPrxQ was a relevant finding. We also showed by site-specific mutagenesis and mass spectrometry that an intramolecular disulfide bond between Cys-47 and Cys-83 is generated during the catalytic cycle. Furthermore, we elucidated the crystal structure of XfPrxQ C47S in which Ser-47 and Cys-83 lie similar to 12.3 angstrom apart. Therefore, significant conformational changes are required for disulfide bond formation. In fact, circular dichroism data indicated that there was a significant redox-dependent unfolding of alpha-helices, which is probably triggered by the peroxidatic cysteine oxidation. Finally, we proposed a model that takes data from this work as well data as from the literature into account.	[Horta, Bruno Brasil; Discola, Karen Fulan; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; [de Oliveira, Marcos Antonio] Univ Estadual Paulista, Dept Biol, BR-11330900 Sao Vicente, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Netto, LES (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, BR-05508900 Sao Paulo, Brazil.	nettoles@ib.usp.br	Discola, Karen F/J-5025-2014; de Oliveira, Marcos A/K-5746-2015; Netto, Luis/A-3783-2008; Cussiol, José Renato/E-5142-2015	de Oliveira, Marcos A/0000-0002-1192-7296; Netto, Luis/0000-0002-4250-9177; Cussiol, José Renato/0000-0001-5909-8215	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Brazilian Synchrotron Light Laboratory [D03B-MX1 7568]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Synchrotron Light Laboratory	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (as part of Projeto Milenio Redoxoma), and the Brazilian Synchrotron Light Laboratory under Proposal D03B-MX1 7568 (performed on beamline W01B-MX2).	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; AMARO AA, 1998, CITRUS VARIEGATED CH, P123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; D'Ambrosio K, 2009, PROTEINS, V76, P995, DOI 10.1002/prot.22408; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohe L, 2002, METHOD ENZYMOL, V347, P244; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hammad Y, 2001, CAN J MICROBIOL, V47, P541, DOI 10.1139/cjm-47-6-541; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Kong W, 2000, BIOCHEM J, V351, P107, DOI 10.1042/0264-6021:3510107; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Koszelak-Rosenblum M, 2008, J BIOL CHEM, V283, P24962, DOI 10.1074/jbc.M804358200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liao SJ, 2009, J MOL BIOL, V390, P951, DOI 10.1016/j.jmb.2009.05.030; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; OTOOLE PW, 1991, J BACTERIOL, V173, P505, DOI 10.1128/jb.173.2.505-513.1991; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; POOLE LB, 2008, CURR PROTOC TOXICOL, V38; Poole Leslie B., 2007, V44, P61; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Segel I.H., 1993, ENZYME KINETICS, P606; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; Netto LES, 2007, COMP BIOCHEM PHYS C, V146, P180, DOI 10.1016/j.cbpc.2006.07.014; Stork T, 2009, ARCH MICROBIOL, V191, P141, DOI 10.1007/s00203-008-0438-7; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; TORIAN BE, 1990, P NATL ACAD SCI USA, V87, P6358, DOI 10.1073/pnas.87.16.6358; Trivelli X, 2003, BIOCHEMISTRY-US, V42, P14139, DOI 10.1021/bi035551r; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo Madia, 2007, V44, P83; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Wakita M, 2007, J BIOL CHEM, V282, P27792, DOI 10.1074/jbc.M702855200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wrzaczek M, 2009, P NATL ACAD SCI USA, V106, P5412, DOI 10.1073/pnas.0808980106; YAMAGUCHI R, 1992, INFECT IMMUN, V60, P1210, DOI 10.1128/IAI.60.3.1210-1216.1992; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	65	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16051	16065		10.1074/jbc.M109.094839	http://dx.doi.org/10.1074/jbc.M109.094839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335172	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000277715900043
J	Schwendener, S; Raynard, S; Paliwal, S; Cheng, A; Kanagaraj, R; Shevelev, I; Stark, JM; Sung, P; Janscak, P				Schwendener, Sybille; Raynard, Steven; Paliwal, Shreya; Cheng, Anita; Kanagaraj, Radhakrishnan; Shevelev, Igor; Stark, Jeremy M.; Sung, Patrick; Janscak, Pavel			Physical Interaction of RECQ5 Helicase with RAD51 Facilitates Its Anti-recombinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; STRAND EXCHANGE; DNA HELICASE; SRS2; PROTEIN; FILAMENT; COMPLEX; PROMOTES; ROLES; HOP2	Homologous recombination (HR) provides an efficient mechanism for error-free repair of DNA double-strand breaks (DSBs). However, HR can be also harmful as inappropriate or untimely HR events can give rise to lethal recombination intermediates and chromosome rearrangements. A critical step of HR is the formation of a RAD51 filament on single-stranded (ss) DNA, which mediates the invasion of a homologous DNA molecule. In mammalian cells, several DNA helicases have been implicated in the regulation of this process. RECQ5, a member of the RecQ family of DNA helicases, interacts physically with the RAD51 recombinase and disrupts RAD51 presynaptic filaments in a reaction dependent on ATP hydrolysis. Here, we have precisely mapped the RAD51-interacting domain of RECQ5 and generated mutants that fail to interact with RAD51. We show that although these mutants retain normal ATPase activity, they are impaired in their ability to displace RAD51 from ssDNA. Moreover, we show that ablation of RECQ5-RAD51 complex formation by a point mutation alleviates the inhibitory effect of RECQ5 on HR-mediated DSB repair. These findings provide support for the proposal that interaction with RAD51 is critical for the anti-recombinase attribute of RECQ5.	[Schwendener, Sybille; Paliwal, Shreya; Kanagaraj, Radhakrishnan; Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Raynard, Steven; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Cheng, Anita; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Shevelev, Igor] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic	University of Zurich; Yale University; City of Hope; Beckman Research Institute of City of Hope; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Janscak, P (corresponding author), Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch	Kanagaraj, Raj R./O-3205-2016; Janscak, Pavel/G-6189-2014; Janscak, Pavel/Q-3795-2018	Janscak, Pavel/0000-0002-1748-7789; Radhakrishnan, Kanagaraj/0000-0003-0906-5399	National Institutes of Health [R01CA120954, ES015632]; Swiss National Science Foundation [3100A0-116008]; Stiftung zur Krebsbekaempfung; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung zur Krebsbekaempfung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA120954 (to J. M. S.) and ES015632 (to P. S.). This work was also supported by grants from the Swiss National Science Foundation (3100A0-116008) and Stiftung zur Krebsbekaempfung (to P. J.).	Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; LYNN RM, 1989, PROTEINS, V6, P231, DOI 10.1002/prot.340060305; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Zheng L, 2009, NUCLEIC ACIDS RES, V37, P2645, DOI 10.1093/nar/gkp147	33	63	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15739	15745		10.1074/jbc.M110.110478	http://dx.doi.org/10.1074/jbc.M110.110478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348101	Green Published, hybrid			2022-12-25	WOS:000277715900009
J	Altimimi, HF; Fung, EH; Winkfein, RJ; Schnetkamp, PPM				Altimimi, Haider F.; Fung, Eric H.; Winkfein, Robert J.; Schnetkamp, Paul P. M.			Residues Contributing to the Na+-binding Pocket of the SLC24 Na+/Ca2+-K+ Exchanger NCKX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; RETINAL CONE PHOTORECEPTORS; ROD OUTER SEGMENTS; NA/CA-K EXCHANGER; MOLECULAR-CLONING; NA+-CA2+ EXCHANGER; CRYSTAL-STRUCTURE; GENE FAMILY; CA2+; TRANSPORT	Na+/Ca2+-K+ exchangers (NCKX; gene family SLC24) are plasma membrane Ca2+ transporters that mediate the extrusion of one Ca2+ ion and one K+ ion in exchange for four Na+ ions. NCKX is modeled to have two sets of five transmembrane segments separated by a large cytosolic loop; within each set of transmembrane segments are regions of internal symmetry termed alpha(1) and alpha(2) repeats. The central residues that are important for Ca2+ and K+ liganding and transport have been identified in NCKX2, and they comprise three central acidic residues, Glu(188) in alpha(1) and Asp(548) and Asp(575) in alpha(2), as well as Ser/Thr residues one-helical turn away from these residues. In this study, we have scanned through more than 100 single-residue substitutions of NCKX2 for shifts in Na+ affinity using a fluorescence assay to monitor changes in free Ca2+ in HEK293 cells treated with gramicidin to control intracellular Na+. We have identified 31 residues that, when substituted, result in shifts in Na+ affinity, either toward higher or lower K-m values when compared with wild type NCKX2 (K-m for Na+ 58 mM). These residues include the central acidic residues Glu(188), Asp(548), and Asp(575), and their neighboring residues in alpha(1) and alpha(2), in addition to a number of newly investigated residues in transmembrane segment 3. Our results relate the identification of residues important for Na+ transport in this study to those previously identified as important in the counter-transport of Ca2+ and K+, lending support to the alternating access model of transmembrane transport.	[Altimimi, Haider F.; Fung, Eric H.; Winkfein, Robert J.; Schnetkamp, Paul P. M.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary	Schnetkamp, PPM (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca	Altimimi, Haider/K-8658-2012	Altimimi, Haider/0000-0002-4516-141X	Canadian Institutes of Health Research [MOP 81327]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP 81327 from the Canadian Institutes of Health Research (to P. P. M. S.).	Altimimi HF, 2007, J BIOL CHEM, V282, P3720, DOI 10.1074/jbc.M609285200; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Dong H, 2006, AM J PHYSIOL-HEART C, V291, pH1226, DOI 10.1152/ajpheart.00196.2006; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; MOTULSKY H, 2004, FITTING MODELS BIOL, P134; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Paillart C, 2007, J GEN PHYSIOL, V129, P1, DOI 10.1085/jgp.200609652; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P198; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; Sharon D, 2002, INVEST OPHTH VIS SCI, V43, P1971; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15245	15255		10.1074/jbc.M109.090738	http://dx.doi.org/10.1074/jbc.M109.090738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231282	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000277399000045
J	Nasie, I; Steiner-Mordoch, S; Gold, A; Schuldiner, S				Nasie, Iris; Steiner-Mordoch, Sonia; Gold, Ayala; Schuldiner, Shimon			Topologically Random Insertion of EmrE Supports a Pathway for Evolution of Inverted Repeats in Ion-coupled Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; X-RAY-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BIOLOGY; BACILLUS-SUBTILIS; PROTON RELEASE; CROSS-LINKING; MECHANISM; IDENTIFICATION; REVEALS	Inverted repeats in ion-coupled transporters have evolved independently in many unrelated families. It has been suggested that this inverted symmetry is an essential element of the mechanism that allows for the conformational transitions in transporters. We show here that small multidrug transporters offer a model for the evolution of such repeats. This family includes both homodimers and closely related heterodimers. In the former, the topology determinants, evidently identical in each protomer, are weak, and we show that for EmrE, an homodimer from Escherichia coli, the insertion into the membrane is random, and dimers are functional whether they insert into the cytoplasmic membrane with the N- and C-terminal domains facing the inside or the outside of the cell. Also, mutants designed to insert with biased topology are functional regardless of the topology. In the case of EbrAB, a heterodimer homologue supposed to interact antiparallel, we show that one of the subunits, EbrB, can also function as a homodimer, most likely in a parallel mode. In addition, the EmrE homodimer can be forced to an antiparallel topology by fusion of an additional transmembrane segment. The simplicity of the mechanism of coupling ion and substrate transport and the few requirements for substrate recognition provide the robustness necessary to tolerate such a unique and unprecedented ambiguity in the interaction of the subunits and in the dimer topology relative to the membrane. The results suggest that the small multidrug transporters are at an evolutionary junction and provide a model for the evolution of structure of transport proteins.	[Nasie, Iris; Steiner-Mordoch, Sonia; Gold, Ayala; Schuldiner, Shimon] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander A Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	National Institutes of Health [NS16708]; Israel Science Foundation [119/04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708. This work was also supported by Grant 119/04 from the Israel Science Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Godsey MH, 2002, J BIOL CHEM, V277, P40169, DOI 10.1074/jbc.R200018200; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAL N, 2009, S P NATL ACAD SCI US, V106, P9051; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	53	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15234	15244		10.1074/jbc.M110.108746	http://dx.doi.org/10.1074/jbc.M110.108746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308069	Green Published, hybrid			2022-12-25	WOS:000277399000044
J	Eftychiou, E				Eftychiou, Eftychia			Routes to Lenition: An Acoustic Study	PLOS ONE			English	Article							FRICATIVE-VOWEL COARTICULATION; ANTICIPATORY LABIAL COARTICULATION; PERCEPTUAL EVIDENCE; VCV UTTERANCES; SPEECH; CHILDREN; ADULTS; IDENTIFICATION; FEATURES; SPOKEN	Background: Vowel lenition and its link with coarticulation have been the subject of extensive debate in the literature. The aims of the present paper are to demonstrate how vowel lenition and coarticulation are linked in Cypriot Greek (henceforth CG), to determine the nature of vowel lenition, and to illustrate how vowel lenition and coarticulation result from aerodynamic phenomena. Methodology/Principal Findings: Eight speakers were recorded producing utterances ending in either /i/ or /u/. Acoustic measures such as V(1)F2 and stop duration were employed to determine whether lenition of the vowels results in coarticulation with the preceding consonant. Results show that there is extensive stop-vowel coarticulation in CG and that stop production is as variable as vowel production, with full vowels never co-occurring with canonical consonants, indicating the existence of two routes to lenition in CG. Conclusions/Significance: These findings suggest that lenition in the final syllable is a consequence of the supralaryngeal articulation coupled with a marginal glottal setting.	Univ Cambridge, Phonet Lab, Cambridge, England	University of Cambridge	Eftychiou, E (corresponding author), Univ Cambridge, Phonet Lab, Cambridge, England.	eftychiou.e@gmail.com			A.G. Leventis Foundation; Cambridge Commonwealth Trust	A.G. Leventis Foundation; Cambridge Commonwealth Trust	The author was supported by the A.G. Leventis Foundation and the Cambridge Commonwealth Trust during the preparation of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adank P, 2004, J ACOUST SOC AM, V116, P3099, DOI 10.1121/1.1795335; AOYAGI M, 2007, PERCEPTUAL EFFECT VO, P785; AOYAGI M, 2006, PERCEPTUAL EFFECTS V; ARVANITI A, 1994, J PHONETICS, V22, P239, DOI 10.1016/S0095-4470(19)30203-7; ARVANITI A, 1991, PHONETICS MODERN GRE; Arvaniti Amalia., 1999, J INT PHON ASSOC, V29, P167, DOI [10.1017/S0025100300006538, DOI 10.1017/S0025100300006538]; Arvaniti Amalia., 1999, J INT PHON ASSOC, V29, P173, DOI [10.1017/S002510030000654S, DOI 10.1017/S002510030000654X]; Baltazani M., 2007, THEOR APPL LING 17 I, P31; Barbosa PlinioA., 2004, J INT PHON ASSOC, V34, P227, DOI [10.1017/S0025100304001756, DOI 10.1017/S0025100304001756]; Bauer L, 2008, J LINGUIST, V44, P605, DOI 10.1017/S0022226708005331; BECKMAN M, 1984, PHONETICA, V41, P61, DOI 10.1159/000261712; BECKMAN M, 1996, IS SYLLABLE NOT SYLL, P95; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Bonneau A, 2000, J PHONETICS, V28, P495, DOI 10.1006/jpho.2001.0130; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; Browman Catherine, 1986, PHONOLOGY YB, V3, P219, DOI [DOI 10.1017/S0952675700000658, 10.1017/S0952675700000658]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; CRYSTAL TH, 1982, J ACOUST SOC AM, V72, P705, DOI 10.1121/1.388251; Dauer R., 1980, J INT PHON ASSOC, V10, P17, DOI [10.1017/S0025100300002073, DOI 10.1017/S0025100300002073]; DAUER RM, 1980, STRESS RHYTHM MODERN; Davidson L, 2006, PHONETICA, V63, P79, DOI 10.1159/000095304; FARNETANI E, 1999, COARTICULATION MODEL; Gordon Matthew., 1998, BERKELEY LINGUISTIC, V24, P93; KLATT DH, 1975, J SPEECH HEAR RES, V18, P686, DOI 10.1044/jshr.1804.686; Lehiste I., 1970, SUPRASEGMENTALS; LOBANOV BM, 1971, J ACOUST SOC AM, V49, P606, DOI 10.1121/1.1912396; LOUKINA A, 2008, REGIONAL PHONETIC VA; MADDIESON I, 1997, PHONETIC UNIVERSALS; MCGOWAN RS, 1988, J ACOUST SOC AM, V83, P229, DOI 10.1121/1.396425; Mo Y, 2007, P 16 INT C PHON SCI, P445; Modarresi G, 2004, J PHONETICS, V32, P291, DOI 10.1016/j.wocn.2003.11.002; MOK P, 2006, INFLUENCES VOWEL TO; Newton B.E., 1972, CYPRIOT GREEK ITS PH; Nicolaidis K., 2001, J INT PHON ASSOC, V31, P67, DOI [10.1017/S0025100301001062, DOI 10.1017/S0025100301001062]; NITTROUER S, 1989, J SPEECH HEAR RES, V32, P120, DOI 10.1044/jshr.3201.120; NITTROUER S, 1989, J ACOUST SOC AM, V86, P1266, DOI 10.1121/1.398741; OHALA JJ, 1981, ARTICULATORY CONSTRA; OHALA JJ, 1983, ORIGIN SOUND PATTERN; OHMAN SEG, 1966, J ACOUST SOC AM, V39, P151, DOI 10.1121/1.1909864; Ostry DJ, 1996, J NEUROSCI, V16, P1570; PAYNE E, 2000, CONSONANT GEMINATION; PERKELL JS, 1992, J ACOUST SOC AM, V91, P2911, DOI 10.1121/1.403778; PRICE PJ, 1980, PHONETICA, V37, P327, DOI 10.1159/000260001; REPP BH, 1989, J ACOUST SOC AM, V85, P379, DOI 10.1121/1.397689; RODGERS J, 1998, VOWEL DEVOICING ENGL; SERENO JA, 1987, J ACOUST SOC AM, V81, P512, DOI 10.1121/1.394917; SMITH C, 2003, FRENCH LANGUAGE STUD, V13, P177; SOLI SD, 1981, J ACOUST SOC AM, V70, P976, DOI 10.1121/1.387032; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; Trudgill Peter, 2003, J GREEK LINGUIST, V4, P45, DOI DOI 10.1075/JGL.4.04TRU; VARDEN JK, 1998, HIGH VOWEL DEVOICING; WHALEN DH, 1981, J ACOUST SOC AM, V69, P275, DOI 10.1121/1.385348; WINITZ H, 1972, J ACOUST SOC AM, V51, P1309, DOI 10.1121/1.1912976; YENIKOMSHIAN GH, 1981, J ACOUST SOC AM, V70, P966, DOI 10.1121/1.387031; [No title captured]	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9828	10.1371/journal.pone.0009828	http://dx.doi.org/10.1371/journal.pone.0009828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FS	20351788	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894400028
J	Wu, CY; Yeh, YC; Yang, YC; Chou, C; Liu, MT; Wu, HS; Chan, JT; Hsiao, PW				Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Chou, Ching; Liu, Ming-Tsan; Wu, Ho-Sheng; Chan, Jia-Tsrong; Hsiao, Pei-Wen			Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus	PLOS ONE			English	Article							CONFERRED COMPLETE PROTECTION; HUMAN-PAPILLOMAVIRUS; IMMUNE-RESPONSES; MEMBRANE ASSOCIATION; HETEROLOGOUS STRAINS; GLYCAN ANALYSIS; MATRIX PROTEIN; M1 PROTEIN; VACCINE; HEMAGGLUTININ	Background: Influenza A viruses are major human and animal pathogens with huge economic and societal impact from illness, hospitalizations, and deaths. Virus-like particles (VLPs) of influenza virus have been suggested as a vaccine candidate offering improved safety and efficacy. To develop this concept further, we established a flexible platform to efficiently generate different subtypes of mammalian-expressed influenza VLPs. Here we demonstrate that these mammalian VLPs strongly resemble the authentic viruses in structure, particle size and composition of host factors, and even glycosylation of viral antigens. Methodology/Principal Findings: In this study, a mammalian VLP system was established by stable co-expression of four influenza structural proteins (HA, NA, M1, and M2) in a Vero cell line. By replacing the surface glycoproteins of HA and NA, we converted the H3N2-VLP subtype to H5N1-VLP. After centrifugation purification of conditioned media, the particle morphologies, average sizes, and hemagglutination abilities of secreted VLPs were characterized, and the VLP constituents were identified by LC/MS/MS. Protease protection assays demonstrated that specific cellular proteins that co-purified with influenza virions were integrated into mammalian VLPs. The glycosylation profiles of mammalian VLPs as revealed by deglycosylation assays were similar to that of progeny viruses produced from Vero cells. Vaccination of mice with 2.5 mg and above of H5N1-VLP elicited H5-specific IgG1 antibodies and resulted in full protection against lethal infection with homologous virus. These results provide compelling evidence that mammalian VLPs closely emulate the exterior of authentic virus particles not only in antigen presentation but also in biological properties and should provide promising vaccine candidates. Conclusions/Significance: This flexible mammalian influenza VLP system offers a superior alternative to the conventional reverse genetic vaccine platform without concerns over inadequate presentation of immune antigens or limitations imposed by the manipulation of real viruses.	[Wu, Chia-Ying; Yeh, Yi-Chun; Yang, Yu-Chih; Chou, Ching; Hsiao, Pei-Wen] Acad Sinica, Agr Biotech Res Ctr, Taipei 115, Taiwan; [Liu, Ming-Tsan; Wu, Ho-Sheng] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Chan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; Academia Sinica - Taiwan	Wu, CY (corresponding author), Acad Sinica, Agr Biotech Res Ctr, Taipei 115, Taiwan.	pwhsiao@gate.sinica.edu.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	National Science Council [NSC 95-2745-B-001-003]; Summit Project from Academia Sinica;  [NSC 98-3112-B-001-023]	National Science Council(Ministry of Science and Technology, Taiwan); Summit Project from Academia Sinica; 	This study was financially supported by a National Science Council grant (NSC 95-2745-B-001-003) and the Summit Project from Academia Sinica. Also, Core Facilities for Proteomics Research is supported by NSC 98-3112-B-001-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Blonder J, 2004, J INVEST DERMATOL, V123, P691, DOI 10.1111/j.0022-202X.2004.23421.x; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Evans TG, 2001, J INFECT DIS, V183, P1485, DOI 10.1086/320190; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Galarza JM, 2005, VIRAL IMMUNOL, V18, P365, DOI 10.1089/vim.2005.18.365; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; GREGORIADES A, 1981, J VIROL, V40, P323, DOI 10.1128/JVI.40.1.323-328.1981; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; JOHANSSON BE, 1989, VIROLOGY, V171, P634, DOI 10.1016/0042-6822(89)90638-7; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; McMurry JA, 2008, HUM VACCINES, V4, P148, DOI 10.4161/hv.4.2.5169; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nicholson KG, 2009, EXPERT REV VACCINES, V8, P373, DOI 10.1586/ERV.09.17; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; PANDEY A, 2010, HUM VACCIN, V6; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; ROBERTSON JS, 1987, J GEN VIROL, V68, P1205, DOI 10.1099/0022-1317-68-4-1205; Romanova J, 2003, VIROLOGY, V307, P90, DOI 10.1016/S0042-6822(02)00064-8; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Sambhara S, 2009, EXPERT REV VACCINES, V8, P375, DOI [10.1586/erv.09.10, 10.1586/ERV.09.10]; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schwarzer J, 2008, ELECTROPHORESIS, V29, P4203, DOI 10.1002/elps.200800042; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; Trollfors B, 2006, ACTA PAEDIATR, V95, P774, DOI 10.1080/08035250600729126; von Haller PD, 2001, PROTEOMICS, V1, P1010; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	48	67	84	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9784	10.1371/journal.pone.0009784	http://dx.doi.org/10.1371/journal.pone.0009784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339535	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300017
J	Webb, RL; Findlay, KA; Green, MA; Beckett, TL; Murphy, MP				Webb, Robin L.; Findlay, Kirk A.; Green, Michael A.; Beckett, Tina L.; Murphy, M. Paul			Efficient Activation of Reconstructed Rat Embryos by Cyclin-Dependent Kinase Inhibitors	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; ADULT SOMATIC-CELLS; OOCYTE ACTIVATION; FETAL FIBROBLASTS; AMINO-ACIDS; IN-VITRO; PREIMPLANTATION DEVELOPMENT; PARTHENOGENETIC ACTIVATION; MICROTUBULE ORGANIZATION; TRANSFECTED FETAL	Background: Over the last decade a number of species, from farm animals to rodents, have been cloned using somatic cell nuclear transfer technology (SCNT). This technique has the potential to revolutionize the way that genetically modified animals are made. In its current state, the process of SCNT is very inefficient (<5% success rate), with several technical and biological hurdles hindering development. Yet, SCNT provides investigators with powerful advantages over other approaches, such as allowing for prescreening for the desired level of transgene expression and eliminating the excess production of undesirable wild-type animals. The rat plays a significant role in biomedical research, but SCNT has been problematic for this species. In this study, we address one aspect of the problem by evaluating methods of activation in artificially constructed rat embryos. Principal Findings: We demonstrate that treatment with a calcium ionophore (ionomycin) combined with a variety of cyclin-dependent kinase inhibitors is an effective way to activate rat embryos. This is in contrast to methods developed for the mouse embryo, which tolerates much less specific chemical treatments. Methods developed to activate mouse embryos do not translate well to rat embryos. Conclusions: Activation methods developed for one species will not necessarily translate to another species, even if it is closely related. Further, the parthenogenic response to chemical activators is not always a reliable indicator of how reconstructed embryos will react to the same activation method. A better understanding of rat oocyte physiology, although essential for developing better models of disease, may also provide insights that will be useful for making the SCNT process more efficient.	[Webb, Robin L.; Murphy, M. Paul] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Webb, Robin L.; Beckett, Tina L.; Murphy, M. Paul] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Findlay, Kirk A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Green, Michael A.] Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA	University of Kentucky; University of Kentucky; Mayo Clinic; University of Kentucky	Webb, RL (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	mpmurp3@email.uky.edu			Alzheimer's Association [NIRG-04-1114]; National Institutes of Health (NIH) [R01 NS058382, P20 RR020171, P01 AG005119, P30 AG005144, T32 HL086341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005144, P01AG005119] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by Alzheimer's Association grant NIRG-04-1114 (to M. P. M.). Authors were also supported by National Institutes of Health (NIH) grants R01 NS058382, P20 RR020171, P01 AG005119, P30 AG005144, and T32 HL086341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2000, MOL REPROD DEV, V55, P422, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;422::AID-MRD10&gt;3.0.CO;2-C; Alberio R, 2001, MOL REPROD DEV, V59, P371, DOI 10.1002/mrd.1043; Alberio R, 2001, INT J DEV BIOL, V45, P797; Avery B, 1998, MOL REPROD DEV, V50, P334, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;334::AID-MRD10&gt;3.0.CO;2-4; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Colman A, 1999, Cloning, V1, P185; Ferber IA, 1996, J IMMUNOL, V156, P5; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; Galli C, 2008, REPROD DOMEST ANIM, V43, P331, DOI 10.1111/j.1439-0531.2008.01181.x; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hayes E, 2001, PHYSIOL GENOMICS, V5, P193, DOI 10.1152/physiolgenomics.2001.5.4.193; Heindryckx B, 2001, Cloning, V3, P41, DOI 10.1089/15204550152475545; HOLM S, 1979, SCAND J STAT, V6, P65; Iannaccone P, 2001, ZYGOTE, V9, P135, DOI 10.1017/S0967199401001149; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Katoh M, 2004, MUTAT RES-GEN TOX EN, V560, P199, DOI 10.1016/j.mrgentox.2004.03.003; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; Kishigami Satoshi, 2009, V518, P207, DOI 10.1007/978-1-59745-202-1_15; Koo OJ, 2009, ZYGOTE, V17, P37, DOI 10.1017/S096719940800498X; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lane M, 1998, HUM REPROD, V13, P991, DOI 10.1093/humrep/13.4.991; Li ZY, 2006, DEV BIOL, V293, P439, DOI 10.1016/j.ydbio.2006.02.016; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Machaty Z, 1998, REPROD FERT DEVELOP, V10, P599, DOI 10.1071/RD98048; Matsumoto H, 1998, HUM REPROD, V13, P398, DOI 10.1093/humrep/13.2.398; Matsumoto Hiromichi, 1995, Journal of Reproduction and Development, V41, P263, DOI 10.1262/jrd.41.263; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Mizutani E, 2004, J REPROD DEVELOP, V50, P139, DOI 10.1262/jrd.50.139; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Otaegui P J, 1999, Cloning, V1, P111, DOI 10.1089/15204559950019997; OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307; PANITCH HS, 1987, LANCET, V1, P893; Petr J, 2000, J EXP ZOOL, V287, P304, DOI 10.1002/1097-010X(20000901)287:4&lt;304::AID-JEZ5&gt;3.0.CO;2-6; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Roh S, 2003, REPROD FERT DEVELOP, V15, P135, DOI 10.1071/RD02096; Roh S, 2009, REPROD FERT DEVELOP, V21, P882, DOI 10.1071/RD09063; Ross PJ, 2006, CLONING STEM CELLS, V8, P275, DOI 10.1089/clo.2006.8.275; SCHLEGEL R, 1990, CELL GROWTH DIFFER, V1, P171; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Shinozawa T, 2004, MOL REPROD DEV, V68, P313, DOI 10.1002/mrd.20083; Siripattarapravat K, 2009, NAT METHODS, V6, P733, DOI [10.1038/NMETH.1369, 10.1038/nmeth.1369]; Tanuma N, 1999, J NEUROIMMUNOL, V96, P73, DOI 10.1016/S0165-5728(99)00018-1; Tao T, 2000, ZYGOTE, V8, P69, DOI 10.1017/S0967199400000848; Tomioka I, 2007, J REPROD DEVELOP, V53, P835, DOI 10.1262/jrd.18144; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wall R J, 2001, Cloning Stem Cells, V3, P209, DOI 10.1089/15362300152725936; Wang WH, 1999, MOL REPROD DEV, V53, P99, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;99::AID-MRD12&gt;3.0.CO;2-G; WANI NA, 2009, BIOL REPROD; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 1997, NATURE, V386, P200, DOI 10.1038/386200a0; Yo JG, 2007, CLONING STEM CELLS, V9, P382, DOI 10.1089/clo.2006.0081; Zakhartchenko V, 2001, MOL REPROD DEV, V60, P362, DOI 10.1002/mrd.1098; ZHANG X, 1990, BIOL REPROD, V42, P662, DOI 10.1095/biolreprod42.4.662; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	67	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9799	10.1371/journal.pone.0009799	http://dx.doi.org/10.1371/journal.pone.0009799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333307	Green Submitted, Green Published, gold			2022-12-25	WOS:000275809700018
J	Berge, T; Sundvold-Gjerstad, V; Granum, S; Andersen, TCB; Holthe, GB; Claesson-Welsh, L; Andreotti, AH; Inngjerdingen, M; Spurkland, A				Berge, Tone; Sundvold-Gjerstad, Vibeke; Granum, Stine; Andersen, Thorny C. B.; Holthe, Gunn B.; Claesson-Welsh, Lena; Andreotti, Amy H.; Inngjerdingen, Marit; Spurkland, Anne			T Cell Specific Adapter Protein (TSAd) Interacts with Tec Kinase ITK to Promote CXCL12 Induced Migration of Human and Murine T Cells	PLOS ONE			English	Article							TYROSINE KINASE; CUTTING EDGE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION SITES; FUNCTIONAL-ACTIVITY; FACTOR-I; CHEMOKINE; ACTIVATION; RECEPTOR; DOMAIN	Background: The chemokine CXCL12/SDF-1 alpha interacts with its G-protein coupled receptor CXCR4 to induce migration of lymphoid and endothelial cells. T cell specific adapter protein (TSAd) has been found to promote migration of Jurkat T cells through interaction with the G protein beta subunit. However, the molecular mechanisms for how TSAd influences cellular migration have not been characterized in detail. Principal Findings: We show that TSAd is required for tyrosine phosphorylation of the Lck substrate IL2-inducible T cell kinase (Itk). Presence of Itk Y511 was necessary to boost TSAd's effect on CXCL12 induced migration of Jurkat T cells. In addition, TSAd's ability to promote CXCL12-induced actin polymerization and migration of Jurkat T lymphocytes was dependent on the Itk-interaction site in the proline-rich region of TSAd. Furthermore, TSAd-deficient murine thymocytes failed to respond to CXCL12 with increased Itk phosphorylation, and displayed reduced actin polymerization and cell migration responses. Conclusion: We propose that TSAd, through its interaction with both Itk and Lck, primes Itk for Lck mediated phosphorylation and thereby regulates CXCL12 induced T cell migration and actin cytoskeleton rearrangements.	[Berge, Tone; Sundvold-Gjerstad, Vibeke; Granum, Stine; Andersen, Thorny C. B.; Holthe, Gunn B.; Inngjerdingen, Marit; Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Andreotti, Amy H.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Oslo; Uppsala University; Iowa State University	Berge, T (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	anne.spurkland@medisin.uio.no	Spurkland, Anne/L-3369-2019	Spurkland, Anne/0000-0003-4421-0766	Norwegian Research Council [177789/V40, 155329/310]; Norwegian Cancer Society; Novo Nordisk; University of Oslo EMBIO; University of Oslo; Anders Jahre Research Foundation; Unifor; Blix Family Foundation for Medical Research	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordisk(Novo Nordisk); University of Oslo EMBIO; University of Oslo; Anders Jahre Research Foundation; Unifor; Blix Family Foundation for Medical Research	The work was supported by grants from the Norwegian Research Council (grants no 177789/V40 and 155329/310), the Norwegian Cancer Society, Novo Nordisk, University of Oslo EMBIO, University of Oslo, Anders Jahre Research Foundation, Unifor and The Blix Family Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbal C, 1999, INT IMMUNOL, V11, P1451, DOI 10.1093/intimm/11.9.1451; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Choi YB, 1999, J IMMUNOL, V163, P5242; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dai KZ, 2004, J IMMUNOL, V172, P6144, DOI 10.4049/jimmunol.172.10.6144; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Ghosh MC, 2009, BLOOD, V113, P575, DOI 10.1182/blood-2008-04-151803; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Granum S, 2008, J BIOL CHEM, V283, P21909, DOI 10.1074/jbc.M800871200; Granum S, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-15; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Inngjerdingen M, 2002, BLOOD, V99, P4318, DOI 10.1182/blood.V99.12.4318; Kolltveit KM, 2008, MOL IMMUNOL, V45, P2380, DOI 10.1016/j.molimm.2007.11.005; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagel J. E., 2004, BMC Immunology, V5; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Onai N, 2000, BLOOD, V96, P2074; Park D, 2007, BLOOD, V109, P5122, DOI 10.1182/blood-2005-10-061838; Park E, 2009, EXP MOL MED, V41, P728, DOI 10.3858/emm.2009.41.10.079; Peacock JW, 1999, J IMMUNOL, V162, P215; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spurkland A, 1998, J BIOL CHEM, V273, P4539, DOI 10.1074/jbc.273.8.4539; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; Sundvold-Gjerstad V, 2005, EUR J IMMUNOL, V35, P1612, DOI 10.1002/eji.200425638; SUNDVOLDGJERSTA.V, 2007, LYMPHOCYTE ACTIVATIO, P211; Suzuki G, 1998, INT IMMUNOL, V10, P1049, DOI 10.1093/intimm/10.8.1049; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Taub Dennis D, 2004, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0629s61; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059; Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x	55	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9761	10.1371/journal.pone.0009761	http://dx.doi.org/10.1371/journal.pone.0009761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305788	Green Published, gold, Green Submitted			2022-12-25	WOS:000276456300009
J	Gurley, ES; Rahman, M; Hossain, MJ; Nahar, N; Faiz, MA; Islam, N; Sultana, R; Khatun, S; Uddin, MZ; Haider, MS; Islam, MS; Ahmed, BN; Rahman, MW; Mondal, UK; Luby, SP				Gurley, Emily S.; Rahman, Mahmudur; Hossain, M. Jahangir; Nahar, Nazmun; Faiz, M. Abul; Islam, Nazrul; Sultana, Rebeca; Khatun, Selina; Uddin, Mohammad Zashim; Haider, M. Sabbir; Islam, M. Saiful; Ahmed, Be-Nazir; Rahman, Muhammad Waliur; Mondal, Utpal Kumar; Luby, Stephen P.			Fatal Outbreak from Consuming Xanthium strumarium Seedlings during Time of Food Scarcity in Northeastern Bangladesh	PLOS ONE			English	Article							WESTERN UTTAR-PRADESH; COCKLEBUR; CHILDREN; REDEFINITION; INTOXICATION; PRINCIPLE	Background: An outbreak characterized by vomiting and rapid progression to unconsciousness and death was reported in Sylhet Distrct in northeastern Bangladesh following destructive monsoon floods in November 2007. Methods and Findings: We identified cases presenting to local hospitals and described their clinical signs and symptoms. We interviewed patients and their families to collect illness histories and generate hypotheses about exposures associated with disease. An epidemiological study was conducted in two outbreak villages to investigate risk factors for developing illness. 76 patients were identified from 9 villages; 25% (19/76) died. Common presenting symptoms included vomiting, elevated liver enzymes, and altered mental status. In-depth interviews with 33 cases revealed that 31 (94%) had consumed ghagra shak, an uncultivated plant, in the hours before illness onset. Ghagra shak was consumed as a main meal by villagers due to inaccessibility of other foods following destructive monsoon flooding and rises in global food prices. Persons who ate this plant were 34.2 times more likely (95% CI 10.2 to 115.8, p-value<0.000) than others to develop vomiting and unconsciousness during the outbreak in our multivariate model. Ghagra shak is the local name for Xanthium strumarium, or common cocklebur. Conclusions: The consumption of Xanthium strumarium seedlings in large quantities, due to inaccessibility of other foods, caused this outbreak. The toxic chemical in the plant, carboxyatratyloside, has been previously described and eating X. strumarium seeds and seedlings has been associated with fatalities in humans and livestock. Unless people are able to meet their nutritional requirements with safe foods, they will continue to be at risk for poor health outcomes beyond undernutrition.	[Gurley, Emily S.; Hossain, M. Jahangir; Nahar, Nazmun; Sultana, Rebeca; Islam, M. Saiful; Rahman, Muhammad Waliur; Mondal, Utpal Kumar; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Programme Infect Dis & Vaccine Sci, Dhaka 1000, Bangladesh; [Rahman, Mahmudur; Khatun, Selina; Haider, M. Sabbir; Ahmed, Be-Nazir] Govt Bangladesh, Minist Hlth & Family Welf, IEDCR, Dhaka, Bangladesh; [Faiz, M. Abul] Govt Bangladesh, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Dhaka, Bangladesh; [Islam, Nazrul] Bangabandhu Sheikh Mujib Med Univ, Dept Virol, Dhaka, Bangladesh; [Uddin, Mohammad Zashim] Univ Dhaka, Dept Bot, Dhaka 1000, Bangladesh; [Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Dhaka; Centers for Disease Control & Prevention - USA	Gurley, ES (corresponding author), Int Ctr Diarrhoeal Dis Res, Programme Infect Dis & Vaccine Sci, GPO Box 128, Dhaka 1000, Bangladesh.	egurley@icddrb.org		Sultana, Rebeca/0000-0002-4180-5679; Nahar, Nazmun/0000-0002-4530-6009	Centers for Disease Control and Prevention, USA (CDC) [U01 CI000298]; Government of the People's Republic of Bangladesh (GoB); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000298] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, USA (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Government of the People's Republic of Bangladesh (GoB); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the Centers for Disease Control and Prevention, USA (CDC), cooperative agreement U01 CI000298, and by the Government of the People's Republic of Bangladesh (GoB). ICDDR, B acknowledges with gratitude the commitment of CDC and the GoB to the authors' research efforts. Co-authors on this paper include representatives from both the Centers for Disease Control and Prevention and the GoB, the two organizations who provided financial support for this work. These co-authors, and therefore CDC and the Government of Bangladesh, were both involved in hypothesis generation, study design, data interpretation, and review of the manuscript for publication.	Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; COLE RJ, 1980, J AGR FOOD CHEM, V28, P1330, DOI 10.1021/jf60232a043; FAO, 2008, SPEC REP FAO WFP CRO; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HATCH RC, 1982, AM J VET RES, V43, P111; Loewenberg S, 2008, LANCET, V372, P1209, DOI 10.1016/S0140-6736(08)61502-0; Mendez MD, 1998, VET HUM TOXICOL, V40, P144; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; STUART BP, 1981, VET PATHOL, V18, P368, DOI 10.1177/030098588101800310; Turgut M, 2005, ANN TROP PAEDIATR, V25, P125, DOI 10.1179/146532805X45728; Vashishtha VM, 2007, INDIAN J MED RES, V125, P756; Vashishtha VM, 2007, INDIAN J MED RES, V125, P523; Vashishtha VM, 2007, INDIAN PEDIATR, V44, P522; Witte S T, 1990, J Vet Diagn Invest, V2, P263	14	20	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9756	10.1371/journal.pone.0009756	http://dx.doi.org/10.1371/journal.pone.0009756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305785	Green Submitted, gold, Green Published			2022-12-25	WOS:000276456300007
J	He, ZS; Zhang, J; Shi, XH; Hu, LL; Kong, XY; Cai, YD; Chou, KC				He, Zhisong; Zhang, Jian; Shi, Xiao-He; Hu, Le-Le; Kong, Xiangyin; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN SUBCELLULAR LOCATION; SUPPORT VECTOR MACHINES; STRUCTURAL CLASS PREDICTION; ENZYME SUBFAMILY CLASSES; COUPLED RECEPTOR CLASSES; INFLUENZA-A VIRUS; APOPTOSIS PROTEINS; DOMAIN COMPOSITION; PERSONALIZED DRUG	Background: Study of drug-target interaction networks is an important topic for drug development. It is both time-consuming and costly to determine compound-protein interactions or potential drug-target interactions by experiments alone. As a complement, the in silico prediction methods can provide us with very useful information in a timely manner. Methods/Principal Findings: To realize this, drug compounds are encoded with functional groups and proteins encoded by biological features including biochemical and physicochemical properties. The optimal feature selection procedures are adopted by means of the mRMR (Maximum Relevance Minimum Redundancy) method. Instead of classifying the proteins as a whole family, target proteins are divided into four groups: enzymes, ion channels, G-protein-coupled receptors and nuclear receptors. Thus, four independent predictors are established using the Nearest Neighbor algorithm as their operation engine, with each to predict the interactions between drugs and one of the four protein groups. As a result, the overall success rates by the jackknife cross-validation tests achieved with the four predictors are 85.48%, 80.78%, 78.49%, and 85.66%, respectively. Conclusion/Significance: Our results indicate that the network prediction system thus established is quite promising and encouraging.	[He, Zhisong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Zhang, Jian] Yangpu Dist Cent Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Shi, Xiao-He; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Shi, Xiao-He; Kong, Xiangyin] SJTUSM, Shanghai, Peoples R China; [He, Zhisong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University	He, ZS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009; He, Zhisong/AAD-7727-2019	He, Zhisong/0000-0002-1502-4801; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2004CB518603]; CAS [KSCX2-YW-R-112]	National Basic Research Program of China(National Basic Research Program of China); CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This research is supported by the grant of National Basic Research Program of China (2004CB518603), grant from the Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baudin B, 2000, CLIN CHEM LAB MED, V38, P853, DOI 10.1515/CCLM.2000.123; BERESFORD AP, 1993, DRUG METAB REV, V25, P503, DOI 10.3109/03602539308993984; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou K. C., 2006, EXCLI J, V5, P55; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2006, BIOCHEM BIOPH RES CO, V339, P1015, DOI 10.1016/j.bbrc.2005.10.196; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2003, BIOCHEM BIOPH RES CO, V310, P675, DOI 10.1016/j.bbrc.2003.09.053; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2006, CURR MED CHEM, V13, P3263, DOI 10.2174/092986706778773077; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Diao Y, 2008, AMINO ACIDS, V34, P111, DOI 10.1007/s00726-007-0550-z; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Gao Y, 2005, AMINO ACIDS, V28, P373, DOI 10.1007/s00726-005-0206-9; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Goto S, 1998, BIOINFORMATICS, V14, P591, DOI 10.1093/bioinformatics/14.7.591; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Johnson DE, 2000, DRUG DISCOV TODAY, V5, P445, DOI 10.1016/S1359-6446(00)01559-2; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Knowles J, 2003, NAT REV DRUG DISCOV, V2, P63, DOI 10.1038/nrd986; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2007, J COMPUT CHEM, V28, P1463, DOI 10.1002/jcc.20554; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Mucchielli-Giorgi MH, 1999, BIOINFORMATICS, V15, P176, DOI 10.1093/bioinformatics/15.2.176; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; Nagamine N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000397; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pan YX, 2003, J PROTEIN CHEM, V22, P395, DOI 10.1023/A:1025350409648; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Vina D, 2009, MOL PHARMACEUT, V6, P825, DOI 10.1021/mp800102c; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2008, CURR TOP MED CHEM, V8, P1573, DOI 10.2174/156802608786786534; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang T, 2008, PROTEIN PEPTIDE LETT, V15, P915, DOI 10.2174/092986608785849308; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xiao X, 2005, AMINO ACIDS, V28, P29, DOI 10.1007/s00726-004-0154-9; Xiao X, 2008, J THEOR BIOL, V254, P691, DOI 10.1016/j.jtbi.2008.06.016; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163; Xiao ZJ, 2006, LEUKEMIA RES, V30, P54, DOI 10.1016/j.leukres.2005.05.012; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	111	267	273	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9603	10.1371/journal.pone.0009603	http://dx.doi.org/10.1371/journal.pone.0009603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300175	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620600001
J	Richardson, TO; Robinson, EJH; Christensen, K; Jensen, HJ; Franks, NR; Sendova-Franks, AB				Richardson, Thomas O.; Robinson, Elva J. H.; Christensen, Kim; Jensen, Henrik J.; Franks, Nigel R.; Sendova-Franks, Ana B.			Record Dynamics in Ants	PLOS ONE			English	Article							INFORMATION; CORPULENCE	The success of social animals (including ourselves) can be attributed to efficiencies that arise from a division of labour. Many animal societies have a communal nest which certain individuals must leave to perform external tasks, for example foraging or patrolling. Staying at home to care for young or leaving to find food is one of the most fundamental divisions of labour. It is also often a choice between safety and danger. Here we explore the regulation of departures from ant nests. We consider the extreme situation in which no one returns and show experimentally that exiting decisions seem to be governed by fluctuating record signals and ant-ant interactions. A record signal is a new 'high water mark' in the history of a system. An ant exiting the nest only when the record signal reaches a level it has never perceived before could be a very effective mechanism to postpone, until the last possible moment, a potentially fatal decision. We also show that record dynamics may be involved in first exits by individually tagged ants even when their nest mates are allowed to re-enter the nest. So record dynamics may play a role in allocating individuals to tasks, both in emergencies and in everyday life. The dynamics of several complex but purely physical systems are also based on record signals but this is the first time they have been experimentally shown in a biological system.	[Richardson, Thomas O.; Sendova-Franks, Ana B.] Univ W England, Bristol Inst Technol, Dept Math & Stat, Bristol BS16 1QY, Avon, England; [Richardson, Thomas O.; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Robinson, Elva J. H.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Robinson, Elva J. H.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Christensen, Kim; Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England; [Christensen, Kim] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London, England; [Jensen, Henrik J.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England	University of West England; University of Bristol; University of York - UK; University of York - UK; Imperial College London; Imperial College London; Imperial College London	Richardson, TO (corresponding author), Univ W England, Bristol Inst Technol, Dept Math & Stat, Bristol BS16 1QY, Avon, England.	tom.richardson@bristol.ac.uk	Richardson, Thomas/H-9898-2019; Jensen, Henrik/D-2347-2010; Robinson, Elva J H/AAC-9785-2019; Franks, Nigel/AAG-8207-2019	Richardson, Thomas/0000-0002-0220-4897; Franks, Nigel/0000-0001-8139-9604; Christensen, Kim/0000-0002-7648-7332; Robinson, Elva/0000-0003-4914-9327	Engineering and Physical Sciences Research Council [EP/E061796/1]; EPSRC [EP/D076226/1]; Engineering and Physical Sciences Research Council [EP/D076226/1, EP/E061761/1] Funding Source: researchfish; EPSRC [EP/E061796/1, EP/E061761/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TOR and ABS-F gratefully acknowledge Engineering and Physical Sciences Research Council grant EP/E061796/1. NRF and EJHR gratefully acknowledge EPSRC grant EP/D076226/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2004, COMPLEXITY, V10, P49, DOI 10.1002/cplx.20049; Balankin AS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065106; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P217; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; DENNY MW, 2008, J EXP BIOL, V31, P295; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; GLICK N, 1978, AM MATH MON, V85, P2, DOI 10.2307/2978044; Hall M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011904; Holldobler B., 1990, pi; Krug J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07001; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Nevzorov V. B., 2001, RECORDS MATH THEORY; Oliveira LP, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104526; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Seeley T., 1995, WISDOM HIVE SOCIAL P; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; SIBANI P, 1993, PHYS REV LETT, V71, P1482, DOI 10.1103/PhysRevLett.71.1482; SIBANI P, 1995, PHYS REV LETT, V75, P2055, DOI 10.1103/PhysRevLett.75.2055	23	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9621	10.1371/journal.pone.0009621	http://dx.doi.org/10.1371/journal.pone.0009621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300174	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000275620600002
J	Mkrtchyan, H; Gross, M; Hinreiner, S; Polytiko, A; Manvelyan, M; Mrasek, K; Kosyakova, N; Ewers, E; Nelle, H; Liehr, T; Volleth, M; Weise, A				Mkrtchyan, Hasmik; Gross, Madeleine; Hinreiner, Sophie; Polytiko, Anna; Manvelyan, Marina; Mrasek, Kristin; Kosyakova, Nadezda; Ewers, Elisabeth; Nelle, Heike; Liehr, Thomas; Volleth, Marianne; Weise, Anja			Early Embryonic Chromosome Instability Results in Stable Mosaic Pattern in Human Tissues	PLOS ONE			English	Article							COPY-NUMBER-VARIATION	The discovery of copy number variations (CNV) in the human genome opened new perspectives on the study of the genetic causes of inherited disorders and the aetiology of common diseases. Here, a single-cell-level investigation of CNV in different human tissues led us to uncover the phenomenon of mitotically derived genomic mosaicism, which is stable in different cell types of one individual. The CNV mosaic ratios were different between the 10 individuals studied. However, they were stable in the T lymphocytes, immortalized B lymphoblastoid cells, and skin fibroblasts analyzed in each individual. Because these cell types have a common origin in the connective tissues, we suggest that mitotic changes in CNV regions may happen early during embryonic development and occur only once, after which the stable mosaic ratio is maintained throughout the differentiated tissues. This concept is further supported by a unique study of immortalized B lymphoblastoid cell lines obtained with 20 year difference from two subjects. We provide the first evidence of somatic mosaicism for CNV, with stable variation ratios in different cell types of one individual leading to the hypothesis of early embryonic chromosome instability resulting in stable mosaic pattern in human tissues. This concept has the potential to open new perspectives in personalized genetic diagnostics and can explain genetic phenomena like diminished penetrance in autosomal dominant diseases. We propose that further genomic studies should focus on the single-cell level, to better understand the aetiology of aging and diseases mediated by somatic mutations.	[Mkrtchyan, Hasmik; Gross, Madeleine; Hinreiner, Sophie; Mrasek, Kristin; Kosyakova, Nadezda; Ewers, Elisabeth; Nelle, Heike; Liehr, Thomas; Weise, Anja] Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany; [Polytiko, Anna] Natl Med Ctr Mother & Child, Minsk, BELARUS; [Manvelyan, Marina] Yerevan State Univ, Dept Genet & Cytol, Yerevan 375049, Armenia; [Volleth, Marianne] Inst Human Genet, Magdeburg, Germany	Friedrich Schiller University of Jena; Yerevan State University	Mkrtchyan, H (corresponding author), Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany.	aweise@mti.uni-jena.de	Weise, Anja/H-6669-2019; Liehr, Thomas/H-2852-2019; Mkrtchyan, Hasmik/F-7635-2012	Weise, Anja/0000-0003-3988-8919; Liehr, Thomas/0000-0003-1672-3054; Manvelyan, Marine/0000-0002-8202-0341	University of Jena; IZKF Jena; Evangelische Studienwerk e. V. Villigst; DFG [436 ARM 17/2/04]; UICC [ICR/05/030]; Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung [70-3125-Li1]; Stiftung Leukamie; Stefan-Morsch Foundation; Monika Kutzner Foundation	University of Jena; IZKF Jena; Evangelische Studienwerk e. V. Villigst; DFG(German Research Foundation (DFG)); UICC; Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung(Deutsche Krebshilfe); Stiftung Leukamie; Stefan-Morsch Foundation; Monika Kutzner Foundation	This work was supported, in part, by a grant from the University of Jena, the IZKF Jena (Start-up S16), the Evangelische Studienwerk e. V. Villigst, the DFG (436 ARM 17/2/04), the UICC (ICR/05/030), the Deutsche Krebshilfe/Mildred Scheel Stiftung fur Krebsforschung (70-3125-Li1), the Stiftung Leukamie, the Stefan-Morsch Foundation and the Monika Kutzner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; DAVIS MM, 1988, NATURE, V335, P744, DOI 10.1038/335744b0; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Iourov IY, 2006, INT REV CYTOL, V249, P143, DOI 10.1016/S0074-7696(06)49003-3; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; ODONOVAN MR, 1995, MUTAGENESIS, V10, P371, DOI 10.1093/mutage/10.4.371; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Polityko AD, 2009, EUR J MED GENET, V52, P207, DOI 10.1016/j.ejmg.2009.03.016; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; VERMA RS, 1989, HUMAN CHROMOSOMES MA; Weise A, 2008, INT J MOL MED, V21, P189; Wu D, 2009, NAT MED, V15, P215, DOI 10.1038/nm.1862; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	24	44	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9591	10.1371/journal.pone.0009591	http://dx.doi.org/10.1371/journal.pone.0009591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231887	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300009
J	Porro, A; Haber, M; Diolaiti, D; Iraci, N; Henderson, M; Gherardi, S; Valli, E; Munoz, MA; Xue, CY; Flemming, C; Schwab, M; Wong, JH; Marshall, GM; Della Valle, G; Norris, MD; Perini, G				Porro, Antonio; Haber, Michelle; Diolaiti, Daniel; Iraci, Nunzio; Henderson, Michelle; Gherardi, Samuele; Valli, Emanuele; Munoz, Marcia A.; Xue, Chengyuan; Flemming, Claudia; Schwab, Manfred; Wong, Jason H.; Marshall, Glenn M.; Della Valle, Giuliano; Norris, Murray D.; Perini, Giovanni			Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; N-MYC; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; STEM-CELLS; TARGET GENES; IN-VIVO; C-MYC; EXPRESSION; PROTEIN	Increased expression of specific ATP-binding cassette (ABC) transporters is known to mediate the efflux of chemotherapeutic agents from cancer cells. Therefore, establishing how ABC transporter genes are controlled at their transcription level may help provide insight into the role of these multifaceted transporters in the malignant phenotype. We have investigated ABC transporter gene expression in a large neuroblastoma data set of 251 tumor samples. Clustering analysis demonstrated a strong association between differential ABC gene expression patterns in tumor samples and amplification of the MYCN oncogene, suggesting a correlation with MYCN function. Using expression profiling and chromatin immunoprecipitation studies, we show that MYCN oncoprotein coordinately regulates transcription of specificABCtransporter genes, by acting as either an activator or a repressor. Finally, we extend these notions to c-MYC showing that it can also regulate the same set of ABC transporter genes in other tumor cells through similar dynamics. Overall our findings provide insight into MYC-driven molecular mechanisms that contribute to coordinate transcriptional regulation of a large set of ABC transporter genes, thus affecting global drug efflux.	[Norris, Murray D.] UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia; [Porro, Antonio; Diolaiti, Daniel; Iraci, Nunzio; Gherardi, Samuele; Valli, Emanuele; Della Valle, Giuliano; Perini, Giovanni] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Schwab, Manfred] German Canc Res Ctr, Div Tumor Genet, D-69120 Heidelberg, Germany; [Wong, Jason H.] Univ New S Wales, Canc Res Ctr, Sydney, NSW 2052, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of Bologna; Helmholtz Association; German Cancer Research Center (DKFZ); University of New South Wales Sydney	Norris, MD (corresponding author), UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, POB 81, Randwick, NSW 2031, Australia.	mnorris@ccia.unsw.edu.au; giovanni.perini@unibo.it	Wong, Jason/A-9466-2008; diolaiti, daniel/A-7168-2012; Porro, Antonio/E-4363-2013; Valli, Emanuele/ABD-7213-2020; henderson, Michelle/G-6657-2012; Iraci, Nunzio/M-7451-2016	Wong, Jason/0000-0003-2953-7728; Valli, Emanuele/0000-0002-0928-8624; Iraci, Nunzio/0000-0003-2146-9329; Haber, Michelle/0000-0003-2036-8817; Norris, Murray/0000-0002-0632-4589; Porro, Antonio/0000-0003-2131-7771; Munoz, Marcia/0000-0001-7603-0351	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Dean M, 2001, J LIPID RES, V42, P1007; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Hendig D, 2009, MOL CELL BIOCHEM, V328, P85, DOI 10.1007/s11010-009-0077-6; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Lutz W, 1996, ONCOGENE, V13, P803; Mack JT, 2006, BIOMED PHARMACOTHER, V60, P587, DOI 10.1016/j.biopha.2006.07.090; Malynn BA, 2000, GENE DEV, V14, P1390; Manohar CF, 2004, ONCOGENE, V23, P753, DOI 10.1038/sj.onc.1207151; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nishimura S, 2007, HUM PATHOL, V38, P134, DOI 10.1016/j.humpath.2006.06.026; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Oevermann L, 2009, INT J CANCER, V124, P2303, DOI 10.1002/ijc.24207; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Porro A., 2007, EPIGENOME NETWORK EX; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Soichi O, 2007, NEUROSURGERY, V60, P707, DOI 10.1227/01.NEU.0000255395.15657.06; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tsuda H, 2005, CLIN CANCER RES, V11, P6880, DOI 10.1158/1078-0432.CCR-05-0751; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	49	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19532	19543		10.1074/jbc.M109.078584	http://dx.doi.org/10.1074/jbc.M109.078584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20233711	Green Published, hybrid			2022-12-25	WOS:000278727800063
J	Vitu, E; Kim, S; Sevier, CS; Lutzky, O; Heldman, N; Bentzur, M; Unger, T; Yona, M; Kaiser, CA; Fass, D				Vitu, Elvira; Kim, Sunghwan; Sevier, Carolyn S.; Lutzky, Omer; Heldman, Nimrod; Bentzur, Moran; Unger, Tamar; Yona, Meital; Kaiser, Chris A.; Fass, Deborah			Oxidative Activity of Yeast Ero1p on Protein Disulfide Isomerase and Related Oxidoreductases of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CRYSTAL-STRUCTURE; BOND FORMATION; REDOX ENVIRONMENT; MAMMALIAN-CELLS; IN-VIVO; SITES; DOMAIN; REDUCTION; OXIDASE	The sulfhydryl oxidase Ero1 oxidizes protein disulfide isomerase (PDI), which in turn catalyzes disulfide formation in proteins folding in the endoplasmic reticulum (ER). The extent to which other members of the PDI family are oxidized by Ero1 and thus contribute to net disulfide formation in the ER has been an open question. The yeast ER contains four PDI family proteins with at least one potential redox-active cysteine pair. We monitored the direct oxidation of each redox-active site in these proteins by yeast Ero1p in vitro. In this study, we found that the Pdi1p amino-terminal domain was oxidized most rapidly compared with the other oxidoreductase active sites tested, including the Pdi1p carboxyl-terminal domain. This observation is consistent with experiments conducted in yeast cells. In particular, the amino-terminal domain of Pdi1p preferentially formed mixed disulfides with Ero1p in vivo, and we observed synthetic lethality between a temperature-sensitive Ero1p variant and mutant Pdi1p lacking the amino-terminal active-site disulfide. Thus, the amino-terminal domain of yeast Pdi1p is on a preferred pathway for oxidizing the ER thiol pool. Overall, our results provide a rank order for the tendency of yeast ER oxidoreductases to acquire disulfides from Ero1p.	[Vitu, Elvira; Lutzky, Omer; Heldman, Nimrod; Bentzur, Moran; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Unger, Tamar; Yona, Meital] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Kim, Sunghwan; Sevier, Carolyn S.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Weizmann Institute of Science; Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il	Vitu, Elvira/V-8201-2017	Kim, Sunghwan/0000-0002-1927-9617; Sevier, Carolyn/0000-0003-3245-6988	National Institutes of Health [RO1 GM046941]; NIGMS; U.S.-Israel Binational Science Foundation; Kimmelman Center for Macromolecular Assemblies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Kimmelman Center for Macromolecular Assemblies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1 GM046941 (to C. A. K.) from NIGMS. This work was also supported by a grant from the U.S.-Israel Binational Science Foundation (to D. F. and C. A. K.) and by the Kimmelman Center for Macromolecular Assemblies (to D. F.).	Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kimura T, 2005, J BIOL CHEM, V280, P31438, DOI 10.1074/jbc.M503377200; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; LYLES MM, 1994, J BIOL CHEM, V269, P30946; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; THORPE C, 2010, ANTIOXID REDOX SIGNA; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Westphal V, 1999, J MOL BIOL, V286, P1229, DOI 10.1006/jmbi.1999.2560; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	41	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18155	18165		10.1074/jbc.M109.064931	http://dx.doi.org/10.1074/jbc.M109.064931			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20348090	hybrid, Green Published			2022-12-25	WOS:000278453900006
J	Gupta, V; Kalaiarasan, P; Faheem, M; Singh, N; Iqbal, MA; Bamezai, RNK				Gupta, Vibhor; Kalaiarasan, Ponnusamy; Faheem, Mohammad; Singh, Nishant; Iqbal, Mohammad Askandar; Bamezai, Rameshwar N. K.			Dominant Negative Mutations Affect Oligomerization of Human Pyruvate Kinase M-2 Isozyme and Promote Cellular Growth and Polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL EXTENSION CE; BLOOM-SYNDROME CELLS; NUCLEAR TRANSLOCATION; ALLOSTERIC REGULATION; TUMOR-MARKER; M2; PROTEIN; BINDING; CANCER; GENE	This study was designed to understand the mechanism and functional implication of the two heterozygous mutations (H391Y and K422R) of human pyruvate kinase M2 isozyme (PKM2) observed earlier in a Bloom syndrome background. The co-expression of homotetrameric wild type and mutant PKM2 in the cellular milieu resulting in the interaction between the two at the monomer level was substantiated further by in vitro experiments. The cross-monomer interaction significantly altered the oligomeric state of PKM2 by favoring dimerization and heterotetramerization. In silico study provided an added support in showing that hetero-oligomerization was energetically favorable. The hetero-oligomeric populations of PKM2 showed altered activity and affinity, and their expression resulted in an increased growth rate of Escherichia coli as well as mammalian cells, along with an increased rate of polyploidy. These features are known to be essential to tumor progression. This study provides insight in understanding the modulated role of large oligomeric multifunctional proteins such as PKM2 by affecting cellular behavior, which is an essential observation to understand tumor sustenance and progression and to design therapeutic intervention in future.	[Gupta, Vibhor; Kalaiarasan, Ponnusamy; Faheem, Mohammad; Singh, Nishant; Iqbal, Mohammad Askandar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Shri Mata Vaishno Devi Univ, Katra Jammu 182320, Jammu & Kashmir, India.	bamezai@hotmail.com	Singh, Nishant/T-9054-2019	Singh, Nishant/0000-0002-8466-8862; Iqbal, Mohammad Askandar/0000-0003-3485-3530	University Grants Commission, Government of India; Council of Scientific and Industrial Research	University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by University Grants Commission, Government of India, for providing funds (to R. N. K. B.), and a Council of Scientific and Industrial Research fellowship (to V. G.).	Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Asou H, 2003, GENE CHROMOSOME CANC, V36, P167, DOI 10.1002/gcc.10161; Bagewadi B, 2004, J VIROL, V78, P11890, DOI 10.1128/JVI.78.21.11890-11903.2004; BAMEZAI R, 1987, HUM GENET, V75, P356, DOI 10.1007/BF00284107; BAMEZAI R, 1986, EXP CELL RES, V164, P163, DOI 10.1016/0014-4827(86)90463-5; Bamezai R., 1996, Indian Journal of Experimental Biology, V34, P298; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Dridi W, 2003, CANCER GENET CYTOGEN, V143, P39, DOI 10.1016/S0165-4608(02)00837-3; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Feiden Sandra, 2007, Reproduction, V134, P81, DOI 10.1530/REP-06-0250; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Grasberger H, 2005, MOL ENDOCRINOL, V19, P1779, DOI 10.1210/me.2004-0426; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; Hassan NMM, 2008, CANCER LETT, V270, P108, DOI 10.1016/j.canlet.2008.04.052; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huqun, 2003, CANCER SCI, V94, P718, DOI 10.1111/j.1349-7006.2003.tb01508.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; MASTERS M, 1971, NATURE-NEW BIOL, V232, P137, DOI 10.1038/newbio232137a0; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; MAZUREK S, 2010, INT J BIOCH IN PRESS; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Reddy BSN, 2000, INT J DERMATOL, V39, P760, DOI 10.1046/j.1365-4362.2000.00047.x; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shindyalov IN, 2001, NUCLEIC ACIDS RES, V29, P228, DOI 10.1093/nar/29.1.228; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Vertessy BG, 1999, BIOCHEM BIOPH RES CO, V254, P430, DOI 10.1006/bbrc.1998.9957; Wang H, 2002, DIABETES, V51, P2861, DOI 10.2337/diabetes.51.9.2861; Wenstrup RJ, 1996, CONNECT TISSUE RES, V35, P249, DOI 10.3109/03008209609029198; Wijnhoven SWP, 2007, CANCER RES, V67, P4648, DOI 10.1158/0008-5472.CAN-06-4681; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	53	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16864	16873		10.1074/jbc.M109.065029	http://dx.doi.org/10.1074/jbc.M109.065029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304929	Green Published, hybrid			2022-12-25	WOS:000277982600050
J	Pagliai, FA; Gardner, CL; Pande, SG; Lorca, GL				Pagliai, Fernando A.; Gardner, Christopher L.; Pande, Santosh G.; Lorca, Graciela L.			LVIS553 Transcriptional Regulator Specifically Recognizes Novobiocin as an Effector Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; LACTIC-ACID BACTERIA; PROMOTE PROTEIN STABILITY; ESCHERICHIA-COLI; DNA-BINDING; MARR FAMILY; BACILLUS-SUBTILIS; DEINOCOCCUS-RADIODURANS; MULTIDRUG TRANSPORTER; NEGATIVE REGULATOR	In this study we aimed to identify small molecules with high affinity involved in the allosteric regulation of LVIS553, a MarR member from Lactobacillus brevis ATCC367. Using high throughput screening, novobiocin was found to specifically bind LVIS553 with a K-D = 33.8 +/- 2.9 mu M consistent with a biologically relevant ligand. Structure guided site-directed mutagenesis identified Lys(9) as a key residue in novobiocin recognition. The results found in vitro were correlated in vivo. An increased tolerance to the antibiotic was observed when LVIS553 and the downstream putative transport protein LVIS552 were either expressed in a low copy plasmid in L. brevis or as a single copy chromosomal insertion in Bacillus subtilis. We provide evidence that LVIS553 is involved in the specific regulation of a new mechanism of tolerance to novobiocin.	[Pagliai, Fernando A.; Gardner, Christopher L.; Pande, Santosh G.; Lorca, Graciela L.] Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Inst Food & Agr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Inst Food & Agr Sci, Gainesville, FL 32610 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019	Gardner, Christopher/0000-0001-6416-8476; Pagliai, Fernando A./0000-0002-0434-4594	NIAID [R03AI078001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078001] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI078001 from the NIAID.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Coq AMCL, 2008, PLASMID, V60, P212, DOI 10.1016/j.plasmid.2008.08.002; Dangel V, 2008, ARCH MICROBIOL, V190, P509, DOI 10.1007/s00203-008-0396-0; Eustaquio AS, 2005, MICROBIOL-SGM, V151, P1949, DOI 10.1099/mic.0.27669-0; GOMBERT ME, 1984, ANTIMICROB AGENTS CH, V26, P933, DOI 10.1128/AAC.26.6.933; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; HOOPER DC, 1982, ANTIMICROB AGENTS CH, V22, P662, DOI 10.1128/AAC.22.4.662; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; Kim JY, 2009, J BACTERIOL, V191, P3273, DOI 10.1128/JB.00151-09; Kumaraswami M, 2009, NUCLEIC ACIDS RES, V37, P1211, DOI 10.1093/nar/gkn1046; Lorca GL, 2007, BBA-BIOMEMBRANES, V1768, P1342, DOI 10.1016/j.bbamem.2007.02.007; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lorca Graciela L., 2009, P115; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Middleton R, 2004, PLASMID, V51, P238, DOI 10.1016/j.plasmid.2004.01.006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nobeli I, 2006, BIOESSAYS, V28, P534, DOI 10.1002/bies.20414; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Perez-Rueda E, 2004, COMPUT BIOL CHEM, V28, P341, DOI 10.1016/j.compbiolchem.2004.09.004; PETITGLATRON MF, 1992, J GEN MICROBIOL, V138, P1089, DOI 10.1099/00221287-138-6-1089; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; SIMPSON WJ, 1992, LETT APPL MICROBIOL, V14, P13, DOI 10.1111/j.1472-765X.1992.tb00636.x; Suzuki K, 2005, APPL ENVIRON MICROB, V71, P5089, DOI 10.1128/AEM.71.9.5089-5097.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wilkinson SP, 2004, J BIOL CHEM, V279, P51442, DOI 10.1074/jbc.M405586200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilkinson SP, 2005, J MOL BIOL, V350, P617, DOI 10.1016/j.jmb.2005.05.027; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yu LL, 2009, BIOCHEMISTRY-US, V48, P2099, DOI 10.1021/bi801662s; Zianni Michael, 2006, J Biomol Tech, V17, P103	43	17	17	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16921	16930		10.1074/jbc.M110.111138	http://dx.doi.org/10.1074/jbc.M110.111138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308066	Green Published, hybrid			2022-12-25	WOS:000277982600055
J	Boukerche, H; Aissaoui, H; Prevost, C; Hirbec, H; Das, SK; Su, ZZ; Sarkar, D; Fisher, PB				Boukerche, H.; Aissaoui, H.; Prevost, C.; Hirbec, H.; Das, S. K.; Su, Z-Z; Sarkar, D.; Fisher, P. B.			Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappa B	ONCOGENE			English	Article						mda-9/syntenin; src; NF-kappa B	HUMAN-MELANOMA CELLS; PROTEIN-KINASE; PDZ DOMAINS; C-SRC; METASTATIC PHENOTYPE; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; TYROSINE KINASE; FAMILY KINASES	The scaffolding postsynaptic density-95/disks large/zonula occludens-1 (PDZ) domain-containing protein melanoma differentiation associated gene-9 (MDA-9)/syntenin is a tandem PDZ protein overexpressed in human melanoma, and breast and gastric cancer cells. MDA-9/syntenin affects cancer cell motility and invasion through distinct biochemical and signaling pathways, including focal adhesion kinase and p38 mitogen-activated protein kinase (MAPK), resulting in activation of the nuclear factor (NF)-kappa B pathway. MDA-9/syntenin also promotes melanoma metastasis by activating c-Src, but how c-Src regulates NF-kappa B activation is unclear. Using a human melanoma model, we document that MDA-9/synteninc-Src interactions are positive regulators of NF-kappa B activation. Inhibition of c-Src by PP2 treatment, by blocking c-Src or mda-9/syntenin expression with small interfering RNA, or in c-Src (-/-) knockout cell lines, reduces NF-kappa B activation following overexpression of mda-9/syntenin or c-Src. Deletion or point mutations of the PDZ binding motif preventing MDA-9/syntenin association with c-Src reveals that both PDZ domains, with PDZ2 being the dominant module, are required for activating downstream signaling pathways, including p38 MAPK and NF-kappa B. We also document that MDA-9/syntenin-c-Src complexes functionally cooperate with NF-kappa B to promote anchorage-independent growth, motility and invasion of melanoma cells. These findings underscore PDZ domains of MDA-9/syntenin as promising potential therapeutic targets for intervening in a decisive component of cancer progression, namely, metastatic tumor spread. Oncogene (2010) 29, 3054-3066; doi: 10.1038/onc.2010.65; published online 15 March 2010	[Fisher, P. B.] Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Boukerche, H.] Univ Lyon 1, INSERM, Fac Med Rene Laennec, Unite Rech Hematol,EA4174, F-69372 Lyon 08, France; [Hirbec, H.] INSERM, U583, Montpellier, France; [Sarkar, D.; Fisher, P. B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Dept Human & Mol Genet, 1101 E Marshall St,Sanger Hall Bldg,Room 11-015, Richmond, VA 23298 USA.	habib.boukerche@sante.univ-lyon1.fr; pbfisher@vcu.edu	Hirbec, Helene/ABE-4188-2021	Hirbec, Helene/0000-0002-5593-5255	National Institutes of Health, National Cancer Institute [R01 CA035675, CA097318]; Samuel Waxman Cancer Research Foundation (SWCRF); National Foundation for Cancer Research (NFCR); Goldhirsh Foundation; Dana Foundation; Ligue nationale contre le Cancer and Association pour la Recherche sur le Cancer [1019]; NATIONAL CANCER INSTITUTE [R01CA097318, R01CA035675] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation (SWCRF); National Foundation for Cancer Research (NFCR); Goldhirsh Foundation; Dana Foundation; Ligue nationale contre le Cancer and Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute Grants R01 CA035675 and CA097318, the Samuel Waxman Cancer Research Foundation (SWCRF), the National Foundation for Cancer Research (NFCR) (PBF); the Goldhirsh Foundation and the Dana Foundation (DS); and the Ligue nationale contre le Cancer and Association pour la Recherche sur le Cancer grant 1019 (HB). DS is the Harrison Endowed Scholar in Cancer Research and PBF holds the Thelma Newmeyer Corman Chair in Cancer Research at the VCU Massey Cancer Center. PBF is a SWCRF Investigator.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Baril P, 2002, INT J CANCER, V99, P315, DOI 10.1002/ijc.10324; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Boukerche H, 2000, CANCER RES, V60, P5848; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2004, GENE, V343, P191, DOI 10.1016/j.gene.2004.09.002; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Chu Quincy S C, 2007, Invest New Drugs, V25, P359, DOI 10.1007/s10637-006-9031-6; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FIDLER IJ, 1991, ANTICANCER RES, V11, P17; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Helmke BM, 2004, ONCOL REP, V12, P221; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Lin JJ, 1996, MOL CELL DIFFER, V4, P317; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; Liu AMF, 2005, J BIOL CHEM, V280, P34617, DOI 10.1074/jbc.M504264200; Matsuo Y, 2006, J BIOL CHEM, V281, P36767, DOI 10.1074/jbc.M604371200; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Perez DG, 2009, CANCER-AM CANCER SOC, V115, P119, DOI 10.1002/cncr.23987; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Sarkar D, 2004, PHARMACOL THERAPEUT, V104, P101, DOI 10.1016/j.pharmthera.2004.08.004; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Ten RM, 1999, J IMMUNOL, V163, P3851; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Zhang Q, 2001, J BIOL CHEM, V276, P43216, DOI 10.1074/jbc.M105996200; Zhou J, 2004, INVEST OPHTH VIS SCI, V45, P2314, DOI 10.1167/iovs.03-1210	50	57	61	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 27	2010	29	21					3054	3066		10.1038/onc.2010.65	http://dx.doi.org/10.1038/onc.2010.65			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20228839	Green Accepted, Green Submitted			2022-12-25	WOS:000278133100003
J	Brandao, TAS; Hengge, AC; Johnson, SJ				Brandao, Tiago A. S.; Hengge, Alvan C.; Johnson, Sean J.			Insights into the Reaction of Protein-tyrosine Phosphatase 1B CRYSTAL STRUCTURES FOR TRANSITION STATE ANALOGS OF BOTH CATALYTIC STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ACID CATALYSIS; ACTIVE-SITE; PHOSPHORYL TRANSFER; INSULIN-RECEPTOR; PTP1B INHIBITOR; MOLECULAR-BASIS; YERSINIA; INTERMEDIATE; MECHANISM; VANADATE	Catalysis by protein-tyrosine phosphatase 1B (PTP1B) occurs through a two-step mechanism involving a phosphocysteine intermediate. We have solved crystal structures for the transition state analogs for both steps. Together with previously reported crystal structures of apo-PTP1B, the Michaelis complex of an inactive mutant, the phosphoenzyme intermediate, and the product complex, a full picture of all catalytic steps can now be depicted. The transition state analog for the first catalytic step comprises a ternary complex between the catalytic cysteine of PTP1B, vanadate, and the peptide DADEYL, a fragment of a physiological substrate. The equatorial vanadate oxygen atoms bind to the P-loop, and the apical positions are occupied by the peptide tyrosine oxygen and by the PTP1B cysteine sulfur atom. The vanadate assumes a trigonal bipyramidal geometry in both transition state analog structures, with very similar apical O-O distances, denoting similar transition states for both phosphoryl transfer steps. Detailed interactions between the flanking peptide and the enzyme are discussed.	[Brandao, Tiago A. S.; Hengge, Alvan C.; Johnson, Sean J.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Hengge, AC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	alvan.hengge@usu.edu; sean.johnson@usu.edu	Hengge, Alvan C/C-8667-2011; Johnson, Sean/G-8191-2012; Brandao, Tiago/N-6623-2017	Hengge, Alvan C/0000-0002-5696-2087; Johnson, Sean/0000-0001-7992-2494; Brandao, Tiago/0000-0002-7783-3014	National Institutes of Health [GM47297]; Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047297, R29GM047297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47297 (to A. C. H.).; Recipient of a fellowship from Coordenacao de Aperfeic oamento de Pessoal de NIvel Superior (Brazil).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ala PJ, 2006, J BIOL CHEM, V281, P32784, DOI 10.1074/jbc.M606873200; Alhambra C, 1998, J AM CHEM SOC, V120, P3858, DOI 10.1021/ja972578n; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen HS, 2000, J BIOL CHEM, V275, P7101, DOI 10.1074/jbc.275.10.7101; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Asthagiri D, 2002, J AM CHEM SOC, V124, P10225, DOI 10.1021/ja020046n; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Baxter NJ, 2006, P NATL ACAD SCI USA, V103, P14732, DOI 10.1073/pnas.0604448103; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Brandao TAS, 2007, J ORG CHEM, V72, P3800, DOI 10.1021/jo070090r; Brandao TAS, 2009, J AM CHEM SOC, V131, P778, DOI 10.1021/ja807418b; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Deng H, 2002, BIOCHEMISTRY-US, V41, P5865, DOI 10.1021/bi016097z; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; DRUECKHAMMER DG, 1989, J ORG CHEM, V54, P70, DOI 10.1021/jo00262a021; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2006, ACTA CRYSTALLOGR D, V62, P1435, DOI 10.1107/S0907444906037784; Fauman EB, 1996, J BIOL CHEM, V271, P18780, DOI 10.1074/jbc.271.31.18780; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Guo XL, 2002, J BIOL CHEM, V277, P41014, DOI 10.1074/jbc.M207347200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; Hengge AC, 2002, ACCOUNTS CHEM RES, V35, P105, DOI 10.1021/ar000143q; HENGGE AC, 1994, J AM CHEM SOC, V116, P11256, DOI 10.1021/ja00104a007; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Hengge AC, 1997, BIOCHEMISTRY-US, V36, P7928, DOI 10.1021/bi970364c; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; Humphry T, 2004, J AM CHEM SOC, V126, P11864, DOI 10.1021/ja047110g; Humphry T, 2008, J AM CHEM SOC, V130, P17858, DOI 10.1021/ja8059864; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; JONES JP, 1991, BIOCHEMISTRY-US, V30, P3634, DOI 10.1021/bi00229a007; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Kirby AJ, 2005, J AM CHEM SOC, V127, P7033, DOI 10.1021/ja0502876; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; Li SQ, 2005, STRUCTURE, V13, P1643, DOI 10.1016/j.str.2005.07.019; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELANDER L, 1987, REACTION RATES ISOTO, P1; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; NOURELDEEN AF, 1985, J BIOL CHEM, V260, P6836; Orth ES, 2008, J AM CHEM SOC, V130, P2436, DOI 10.1021/ja710693x; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Phan J, 2003, BIOCHEMISTRY-US, V42, P13113, DOI 10.1021/bi030156m; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; *RIG CORP, 2006, CRYSTALCLEAR INT PRO; Rye CS, 2005, CURR MED CHEM, V12, P3127, DOI 10.2174/092986705774933452; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; Shen K, 2001, J BIOL CHEM, V276, P47311, DOI 10.1074/jbc.M106568200; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; WOLFENDEN R, 1978, TRANSITION STATES BI, P555; Zalatan JG, 2007, J AM CHEM SOC, V129, P9789, DOI 10.1021/ja072196+; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhao Y, 1996, BIOCHEMISTRY-US, V35, P11797, DOI 10.1021/bi960471r	79	102	105	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15874	15883		10.1074/jbc.M109.066951	http://dx.doi.org/10.1074/jbc.M109.066951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236928	hybrid, Green Published			2022-12-25	WOS:000277715900025
J	Majtan, T; Liu, L; Carpenter, JF; Kraus, JP				Majtan, Tomas; Liu, Lu; Carpenter, John F.; Kraus, Jan P.			Rescue of Cystathionine beta-Synthase (CBS) Mutants with Chemical Chaperones PURIFICATION AND CHARACTERIZATION OF EIGHT CBS MUTANT ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; REACTION-MECHANISM; REDOX REGULATION; LIGAND SWITCH; ACTIVE CORE; PROTEIN; HEME; MUTATIONS; HOMOCYSTINURIA; DISORDERS	Missense mutations represent the most common cause of many genetic diseases including cystathionine beta-synthase (CBS) deficiency. Many of these mutations result in misfolded proteins, which lack biological function. The presence of chemical chaperones can sometimes alleviate or even restore protein folding and activity of mutant proteins. We present the purification and characterization of eight CBS mutants expressed in the presence of chemical chaperones such as ethanol, dimethyl sulfoxide, or trimethylamine-N-oxide. Preliminary screening in Escherichia coli crude extracts showed that their presence during protein expression had a significant impact on the amount of recovered CBS protein, formation of tetramers, and catalytic activity. Subsequently, we purified eight CBS mutants to homogeneity (P49L, P78R, A114V, R125Q, E176K, P422L, I435T, and S466L). The tetrameric mutant enzymes fully saturated with heme had the same or higher specific activities than wild type CBS. Thermal stability measurements demonstrated that the purified mutants are equally or more thermostable than wild type CBS. The response to S-adenosyl-L-methionine stimulation or thermal activation varied. The lack of response of R125Q and E176K to both stimuli indicated that their specific conformations were unable to reach the activated state. Increased levels of molecular chaperones in crude extracts, particularly DnaJ, indicated a rather indirect effect of the chemical chaperones on folding of CBS mutants. In conclusion, the chemical chaperones present in the expression medium were able to fully restore the activity of eight CBS mutants by improving their protein folding. This finding could have direct implications for the development of a therapeutical approach to pyridoxine unresponsive homocystinuria.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Majtan, Tomas; Kraus, Jan P.] Univ Colorado Denver, Sch Med, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO 80045 USA; [Majtan, Tomas] Slovak Acad Sci, Inst Mol Biol, Dept Genom & Biotechnol, Bratislava 84551, Slovakia; [Liu, Lu; Carpenter, John F.] Univ Colorado Denver, Sch Pharm, Dept Pharmaceut Sci, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Slovak Academy of Sciences; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kraus, JP (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, 12800 E 19th Ave, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Majtan, Tomas/AAE-8426-2021	Majtan, Tomas/0000-0002-2751-2124	National Institutes of Health [HL065217-06A2]; American Heart Association [09GRNT2110159, 0920079G]; Jerome Lejeune Foundation; Margie McGlynn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jerome Lejeune Foundation; Margie McGlynn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065217-06A2 (to J. P. K.). This work was also supported by American Heart Association Grant-in-Aid 09GRNT2110159, a grant from the Jerome Lejeune Foundation (to J. P. K.), and a generous gift from Margie McGlynn.; Recipient of Postdoctoral Fellowship 0920079G from the American Heart Association.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; Frank N, 2006, BIOCHEMISTRY-US, V45, P11021, DOI 10.1021/bi060737m; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; KRAUS JP, 1983, ARCH BIOCHEM BIOPHYS, V222, P44, DOI 10.1016/0003-9861(83)90500-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nascimento C, 2008, PROTEIN J, V27, P392, DOI 10.1007/s10930-008-9149-9; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Sideras K, 2009, ADV CLIN CHEM, V47, P1, DOI 10.1016/S0065-2423(09)47001-X; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Staretz-Chacham O, 2009, PEDIATRICS, V123, P1191, DOI 10.1542/peds.2008-0635; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9	38	54	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15866	15873		10.1074/jbc.M110.107722	http://dx.doi.org/10.1074/jbc.M110.107722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308073	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000277715900024
J	Herrera, M; Garvin, JL				Herrera, Marcela; Garvin, Jeffrey L.			Angiotensin II Stimulates Thick Ascending Limb NO Production via AT(2) Receptors and Akt1-dependent Nitric-oxide Synthase 3 (NOS3) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-SENSITIVE RATS; TYPE-2 RECEPTOR; NACL ABSORPTION; ANG-II; CHLORIDE ABSORPTION; INDUCED INHIBITION; ENDOTHELIAL-CELLS; ENOS ACTIVATION; L-ARGININE; PHOSPHORYLATION	Angiotensin II (Ang II) acutely stimulates thick ascending limb (TAL) NO via an unknown mechanism. In endothelial cells, activation of Ang II type 2 receptor (AT(2)) stimulates NO. Akt1 activates NOS3 by direct phosphorylation. We hypothesized that Ang II stimulates TAL NO production via AT(2)-mediated Akt1 activation, which phosphorylates NOS3 at serine 1177. We measured NO production by fluorescence microscopy. In isolated TALs, Ang II (100 nM) increased NO production by 1.1 +/- 0.2 fluorescence units/min (p < 0.01). Ang II increased cGMP accumulation by 4.9 +/- 1.3 fmol/mu g (p < 0.01). Upon adding the AT(2) antagonist PD123319 (1 mu M), Ang II failed to stimulate NO (0.1 +/- 0.1 fluorescence units/min; p < 0.001 versus Ang II); adding the AT(1) antagonist losartan (1 mu M) resulted in Ang II stimulating NO by 0.9 +/- 0.1 fluorescence units/min. Akt inhibitor (5 mu M) blocked Ang II-stimulated NO (-0.1 +/- 0.2 fluorescence units/min versus inhibitor alone). Phospho-Akt1 increased by 72% after 5 min (p < 0.006), returning to basal after 10 min. Phospho-Akt2 did not change after 5 min but increased by 115 and 163% after 10 and 15 min (p < 0.02). Phospho-Akt3 did not change. An AT(2) agonist increased pAkt1 by 78% (p < 0.02), PI3K inhibition blocked this effect. In TALs transduced with dominant negative Akt1, Ang II failed to stimulate NO(0.1 +/- 0.2 fluorescence units/min versus 1.2 +/- 0.2 for controls; p < 0.001). Ang II increased phospho-NOS3 at serine 1177 by 130% (p < 0.01) and 150% after 5 and 10 min (p < 0.02). Ang II increased phospho-NOS3 at serine 633 by 50% after 5 min (p < 0.01). Akt inhibition prevented NOS3 phosphorylation. We concluded that Ang II enhances TAL NO production via activation of AT(2) and Akt1-dependent phosphorylation of NOS3 at serines 1177 and 633.	[Herrera, Marcela; Garvin, Jeffrey L.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Herrera, M (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, E&R 7018,2799 W Grand Blvd, Detroit, MI 48202 USA.	mherrer1@hfhs.org			NHLBI, National Institutes of Health [PO1HL-28982, PO1HL-90550, RO1HL-70985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090550, P01HL028982, R01HL070985] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grants PO1HL-28982, PO1HL-90550, and RO1HL-70985 ( to J.L.G.).	Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047, DOI 10.1152/ajpcell.1998.274.4.C1047; Batenburg WW, 2004, CIRCULATION, V109, P2296, DOI 10.1161/01.CIR.0000128696.12245.57; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Cervenka L, 1998, AM J PHYSIOL-RENAL, V274, pF940, DOI 10.1152/ajprenal.1998.274.5.F940; Dickhout JG, 2002, CIRC RES, V91, P487, DOI 10.1161/01.RES.0000035243.66189.92; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia NH, 1999, HYPERTENSION, V34, P508, DOI 10.1161/01.HYP.34.3.508; GARVIN J L, 1988, American Journal of Physiology, V255, pF57; HALL JE, 1977, AM J PHYSIOL, V232, pF538, DOI 10.1152/ajprenal.1977.232.6.F538; HARRIS PJ, 1985, AM J PHYSIOL, V248, pF621, DOI 10.1152/ajprenal.1985.248.5.F621; HARRIS PJ, 1984, CLIN SCI, V66, P541, DOI 10.1042/cs0660541; Helle F, 2009, AM J PHYSIOL-RENAL, V296, pF78, DOI 10.1152/ajprenal.90518.2008; Herrera M, 2006, AM J PHYSIOL-RENAL, V290, pF1279, DOI 10.1152/ajprenal.00465.2005; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hiyoshi H, 2005, HYPERTENSION, V45, P967, DOI 10.1161/01.HYP.0000164571.77710.19; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Ikenaga H, 1996, AM J PHYSIOL-RENAL, V271, pF365, DOI 10.1152/ajprenal.1996.271.2.F365; KOST CK, 1993, HYPERTENSION, V21, P420, DOI 10.1161/01.HYP.21.4.420; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Lerolle N, 2004, AM J PHYSIOL-RENAL, V287, pF404, DOI 10.1152/ajprenal.00265.2003; Liu RS, 2004, HYPERTENSION, V43, P649, DOI 10.1161/01.HYP.0000116222.57000.85; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Majid DSA, 2005, AM J PHYSIOL-RENAL, V288, pF412, DOI 10.1152/ajprenal.00294.2004; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF274, DOI 10.1152/ajprenal.00382.2003; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF281, DOI 10.1152/ajprenal.00383.2003; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2002, HYPERTENSION, V39, P591, DOI 10.1161/hy0202.103287; Ortiz PA, 2002, AM J PHYSIOL-RENAL, V283, pF957, DOI 10.1152/ajprenal.00102.2002; Ortiz PA, 2001, AM J PHYSIOL-RENAL, V281, pF819, DOI 10.1152/ajprenal.0075.2001; Padia SH, 2006, HYPERTENSION, V47, P537, DOI 10.1161/01.HYP.0000196950.48596.21; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Plato CF, 2001, AM J PHYSIOL-RENAL, V281, pF679, DOI 10.1152/ajprenal.2001.281.4.F679; Plato CF, 1999, AM J PHYSIOL-RENAL, V276, pF159, DOI 10.1152/ajprenal.1999.276.1.F159; Pollock JS, 2006, HYPERTENSION, V47, P19, DOI 10.1161/01.HYP.0000196276.29211.6f; Ramseyer VD, 2009, HYPERTENSION, V53, P313, DOI 10.1161/HYPERTENSIONAHA.108.124107; ROMAN RJ, 1991, HYPERTENSION, V17, P1018, DOI 10.1161/01.HYP.17.6.1018; Saito S, 1996, Hypertens Res, V19, P201, DOI 10.1291/hypres.19.201; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Silva GB, 2009, AM J PHYSIOL-RENAL, V297, pF646, DOI 10.1152/ajprenal.00270.2009; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Szentivanyi M, 2002, AM J PHYSIOL-REG I, V283, pR266, DOI 10.1152/ajpregu.00461.2001; Welch WJ, 2001, KIDNEY INT, V59, P1257, DOI 10.1046/j.1523-1755.2001.0590041257.x; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27; Zhang Z, 2005, AM J PHYSIOL-HEART C, V288, pH29, DOI 10.1152/ajpheart.00623.2004	54	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14932	14940		10.1074/jbc.M110.109041	http://dx.doi.org/10.1074/jbc.M110.109041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20299462	Green Published, hybrid			2022-12-25	WOS:000277399000014
J	Loesch, M; Zhi, HY; Hou, SW; Qi, XM; Li, RS; Basir, Z; Iftner, T; Cuenda, A; Chen, G				Loesch, Mathew; Zhi, Hui-Ying; Hou, Song-Wang; Qi, Xiao-Mei; Li, Rong-Shan; Basir, Zainab; Iftner, Thomas; Cuenda, Ana; Chen, Guan			p38 gamma MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D-RECEPTOR; BREAST-CANCER CELLS; TRANSCRIPTION FACTORS; RAS TRANSFORMATION; ESTROGEN-RECEPTOR; SB 203580; IN-VITRO; P38; EXPRESSION	Mitogen-activated protein kinases (MAPKs) regulate gene expression through transcription factors. However, the precise mechanisms in this critical signal event are largely unknown. Here, we show that the transcription factor c-Jun is activated by p38 gamma MAPK, and the activated c-Jun then recruits p38 gamma as a cofactor into the matrix metalloproteinase 9 (MMP9) promoter to induce its trans-activation and cell invasion. This signaling event was initiated by hyperexpressed p38 gamma that led to increased c-Jun synthesis, MMP9 transcription, and MMP9-dependent invasion through p38 gamma interacting with c-Jun. p38 gamma requires phosphorylation and its C terminus to bind c-Jun, whereas both c-Jun and p38 gamma are required for the trans-activation of MMP9. The active p38 gamma/c-Jun/MMP9 pathway also exists in human colon cancer, and there is a coupling of increased p38 gamma and MMP9 expression in the primary tissues. These results reveal a new paradigm in which a MAPK acts both as an activator and a cofactor of a transcription factor to regulate gene expression leading to an invasive response.	[Loesch, Mathew; Zhi, Hui-Ying; Hou, Song-Wang; Qi, Xiao-Mei; Chen, Guan] Milwaukee Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Li, Rong-Shan; Basir, Zainab] Milwaukee Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Chen, Guan] Milwaukee Med Coll Wisconsin, Res Serv, Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Iftner, Thomas] Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, Sect Expt Virol, D-72076 Tubingen, Germany; [Cuenda, Ana] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Chen, G (corresponding author), Milwaukee Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	gchen@mcw.edu	Iftner, Thomas/ABF-9029-2020		National Institutes of Health [2R01 CA91576]; Department of Veterans Affairs; Breast Cancer Show House (Cancer Center, Medical College of Wisconsin); NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Breast Cancer Show House (Cancer Center, Medical College of Wisconsin); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 2R01 CA91576. This work was also supported by the Department of Veterans Affairs (Merit Review) and the Breast Cancer Show House (Cancer Center, Medical College of Wisconsin).	Adiseshaiah P, 2008, BIOCHEM BIOPH RES CO, V371, P304, DOI 10.1016/j.bbrc.2008.04.063; Allgayer H, 1999, BRIT J CANCER, V80, P1884, DOI 10.1038/sj.bjc.6690616; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Baumgartner M, 2008, MOL CELL BIOL, V28, P642, DOI 10.1128/MCB.01024-07; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Canning MT, 2001, EXP CELL RES, V267, P88, DOI 10.1006/excr.2001.5243; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; GALANG CK, 1994, ONCOGENE, V9, P2913; Goruppi S, 2007, MOL CELL BIOL, V27, P993, DOI 10.1128/MCB.00996-06; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hall-Jackson CA, 1999, ONCOGENE, V18, P2047, DOI 10.1038/sj.onc.1202603; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Illemann M, 2006, MOL CANCER RES, V4, P293, DOI 10.1158/1541-7786.MCR-06-0003; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Lubbe WJ, 2006, CLIN CANCER RES, V12, P1876, DOI 10.1158/1078-0432.CCR-05-2686; MAGRISSO IJ, 1993, LAB INVEST, V69, P674; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rylski M, 2009, MOL CELL NEUROSCI, V40, P98, DOI 10.1016/j.mcn.2008.09.005; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; Simon C, 1998, CANCER RES, V58, P1135; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	51	71	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15149	15158		10.1074/jbc.M110.105429	http://dx.doi.org/10.1074/jbc.M110.105429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231272	Green Published, hybrid			2022-12-25	WOS:000277399000036
J	Skals, M; Jensen, UB; Ousingsawat, J; Kunzelmann, K; Leipziger, J; Praetorius, HA				Skals, Marianne; Jensen, Uffe B.; Ousingsawat, Jiraporn; Kunzelmann, Karl; Leipziger, Jens; Praetorius, Helle A.			Escherichia coli alpha-Hemolysin Triggers Shrinkage of Erythrocytes via K(Ca)3.1 and TMEM16A Channels with Subsequent Phosphatidylserine Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; RECEPTOR ACTIVATION; SHEEP ERYTHROCYTES; GARDOS-CHANNEL; OUTER-LEAFLET; DEATH; APOPTOSIS; MEMBRANE; MACROPHAGES; MORPHOLOGY	alpha-Hemolysin from Escherichia coli (HlyA) readily lyse erythrocytes from various species. We have recently demonstrated that this pore-forming toxin provokes distinct shrinkage and crenation before it finally leads to swelling and lysis of erythrocytes. The present study documents the underlying mechanism for this severe volume reduction. We show that HlyA-induced shrinkage and crenation of human erythrocytes occur subsequent to a significant rise in [Ca2+](i). The Ca2+-activated K+ channel K(Ca)3.1 (or Gardos channel) is essential for the initial shrinkage, because both clotrimazole and TRAM-34 prevent the shrinkage and potentiate hemolysis produced by HlyA. Notably, the recently described Ca2+-activated Cl- channel TMEM16A contributes substantially to HlyA-induced cell volume reduction. Erythrocytes isolated from TMEM16A(-/-) mice showed significantly attenuated crenation and increased lysis compared with controls. Additionally, we found that HlyA leads to acute exposure of phosphatidylserine in the outer leaflet of the plasma membrane. This exposure was considerably reduced by K(Ca)3.1 antagonists. In conclusion, this study shows that HlyA triggers acute erythrocyte shrinkage, which depends on Ca2+-activated efflux of K+ via K(Ca)3.1 and Cl- via TMEM16A, with subsequent phosphatidylserine exposure. This mechanism might potentially allow HlyA-damaged erythrocytes to be removed from the bloodstream by macrophages and thereby reduce the risk of intravascular hemolysis.	[Skals, Marianne; Leipziger, Jens; Praetorius, Helle A.] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Jensen, Uffe B.] Aarhus Univ, Inst Human Genet, DK-8000 Aarhus C, Denmark; [Jensen, Uffe B.] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Ousingsawat, Jiraporn; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany	Aarhus University; Aarhus University; Aarhus University; University of Regensburg	Praetorius, HA (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 1180, DK-8000 Aarhus C, Denmark.	hp@fi.au.dk	Jensen, Uffe Birk/ABA-8306-2021; Jensen, Uffe Birk/E-6066-2017	Jensen, Uffe Birk/0000-0002-6205-6355; Jensen, Uffe Birk/0000-0002-6205-6355; Leipziger, Jens/0000-0002-6719-7034; Kunzelmann, Karl/0000-0002-4583-7037; Praetorius, Helle/0000-0002-0970-5061	Danish Medical Research Council; Danish National Research Foundation; German Research Foundation [SFB699 A6/A7, KU 756/8-2]; Danish National Research Foundation (Danmarks Grundforskningsfond)	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); German Research Foundation(German Research Foundation (DFG)); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond)	This work was supported by the Danish Medical Research Council, the Danish National Research Foundation, and German Research Foundation Grants SFB699 A6/A7 and KU 756/8-2. The Water and Salt Research Center at the Aarhus University is established and supported by the Danish National Research Foundation (Danmarks Grundforskningsfond).	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; BORGERS M, 1983, J HISTOCHEM CYTOCHEM, V31, P1109, DOI 10.1177/31.9.6411806; Bracci R, 2002, ACTA PAEDIATR, V91, P130, DOI 10.1080/080352502320764328; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; CONNOR J, 1989, P NATL ACAD SCI USA, V86, P3184, DOI 10.1073/pnas.86.9.3184; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Foller M, 2007, CELL PHYSIOL BIOCHEM, V20, P1051, DOI 10.1159/000110715; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; HOFFMAN JF, 1974, J PHYSIOL-LONDON, V239, P519, DOI 10.1113/jphysiol.1974.sp010581; HUBER SM, 2008, ACTA PHYSL, V192, P54; HUNTER MJ, 1977, J PHYSIOL-LONDON, V268, P35, DOI 10.1113/jphysiol.1977.sp011845; JAY AWL, 1975, BIOPHYS J, V15, P205, DOI 10.1016/S0006-3495(75)85812-7; JORGENSEN SE, 1983, TOXICON, V21, P717, DOI 10.1016/0041-0101(83)90277-5; JORGENSEN SE, 1980, INFECT IMMUN, V27, P988, DOI 10.1128/IAI.27.3.988-994.1980; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KNAUF PA, 1977, J GEN PHYSIOL, V69, P363, DOI 10.1085/jgp.69.3.363; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang KS, 2002, CELL PHYSIOL BIOCHEM, V12, P365, DOI 10.1159/000067907; Lang PA, 2004, CELL MICROBIOL, V6, P391, DOI 10.1111/j.1462-5822.2004.00369.x; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lew VL, 2005, BLOOD, V105, P361, DOI 10.1182/blood-2004-01-0125; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MCMANUS M, 1993, AM J PHYSIOL, V265, pC562, DOI 10.1152/ajpcell.1993.265.2.C562; Menestrina G, 1996, J MEMBRANE BIOL, V149, P113, DOI 10.1007/s002329900012; Myssina S, 2004, CELL PHYSIOL BIOCHEM, V14, P241, DOI 10.1159/000080333; Piagnerelli M., 2007, Transfusion Alternatives in Transfusion Medicine, V9, P143, DOI 10.1111/j.1778-428X.2007.00072.x; Piagnerelli M, 2007, J CLIN PATHOL, V60, P549, DOI 10.1136/jcp.2006.037523; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; SARKADI B, 1976, J MEMBRANE BIOL, V26, P357, DOI 10.1007/BF01868883; SHORT EC, 1971, INFECT IMMUN, V3, P678, DOI 10.1128/IAI.3.5.678-687.1971; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Sluyter R, 2007, BIOCHEM BIOPH RES CO, V355, P169, DOI 10.1016/j.bbrc.2007.01.124; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V17, P29, DOI 10.1159/000091457; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; WHITE JG, 1974, AM J PATHOL, V77, P135	42	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15557	15565		10.1074/jbc.M109.082578	http://dx.doi.org/10.1074/jbc.M109.082578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231275	hybrid, Green Published			2022-12-25	WOS:000277399000074
J	Le Marchand, SJ; Piston, DW				Le Marchand, Sylvain J.; Piston, David W.			Glucose Suppression of Glucagon Secretion METABOLIC AND CALCIUM RESPONSES FROM alpha-CELLS IN INTACT MOUSE PANCREATIC ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC CA2+ CONCENTRATION; BETA-CELLS; DELTA-CELLS; B-CELLS; INSULIN-SECRETION; A-CELLS; FLUORESCENT PROTEIN; CARDIAC MYOCYTES; IDENTIFIED ALPHA; GENE-EXPRESSION	Glucagon is released from alpha-cells present in intact pancreatic islets at glucose concentrations below 4 mM, whereas higher glucose levels inhibit its secretion. The mechanisms underlying the suppression of alpha-cell secretory activity are poorly understood, but two general types of models have been proposed as follows: direct inhibition by glucose or paracrine inhibition from non-alpha-cells within the islet of Langerhans. To identify alpha-cells for analysis, we utilized transgenic mice expressing fluorescent proteins targeted specifically to these cells. Measurements of glucagon secretion from pure populations of flow-sorted alpha-cells show that contrary to its effect on intact islets, glucose does stimulate glucagon secretion from isolated alpha-cells. This observation argues against a direct inhibition of glucagon secretion by glucose and supports the paracrine inhibition model. Imaging of cellular metabolism by two-photon excitation of NAD(P) H autofluorescence indicates that glucose is metabolized in alpha-cells and that glucokinase is the likely rate-limiting step in this process. Imaging calcium dynamics of alpha-cells in intact islets reveals that inhibiting concentrations of glucose increase the intracellular calcium concentration and the frequency of alpha-cell calcium oscillations. Application of candidate paracrine inhibitors leads to reduced glucagon secretion but did not decrease the alpha-cell calcium activity. Taken together, the data suggest that suppression occurs downstream from alpha-cell calcium signaling, presumably at the level of vesicle trafficking or exocytotic machinery.	[Le Marchand, Sylvain J.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 702 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health [DK53434, GM72048, RR25649]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053434, P30DK020593, P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53434, GM72048, and RR25649.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; BARLOW CH, 1976, SCIENCE, V193, P909, DOI 10.1126/science.181843; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; Cejvan K, 2003, DIABETES, V52, P1176, DOI 10.2337/diabetes.52.5.1176; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; COORE HG, 1964, BIOCHEM J, V91, P56, DOI 10.1042/bj0910056; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; FLETCHER DJ, 1983, ENDOCRINOLOGY, V113, P1791, DOI 10.1210/endo-113-5-1791; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GILON P, 1992, J BIOL CHEM, V267, P20713; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; GORUS FK, 1984, J BIOL CHEM, V259, P1196; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Heimberg H, 1996, P NATL ACAD SCI USA, V93, P7036, DOI 10.1073/pnas.93.14.7036; HEIMBERG H, 1995, J BIOL CHEM, V270, P8971, DOI 10.1074/jbc.270.15.8971; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HOENIG M, 1986, ENDOCRINOLOGY, V119, P2502, DOI 10.1210/endo-119-6-2502; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Magnuson MA, 2004, FRONT DIABETES, V16, P1; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matsuda M, 2002, METABOLISM, V51, P1111, DOI 10.1053/meta.2002.34700; MEDA P, 1986, DIABETES, V35, P232, DOI 10.2337/diabetes.35.2.232; Mercan D, 1999, BIOCHEM BIOPH RES CO, V262, P346, DOI 10.1006/bbrc.1999.1219; MICHAELS RL, 1981, SCIENCE, V214, P801, DOI 10.1126/science.6117129; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; OSTENSON CG, 1979, DIABETOLOGIA, V17, P325, DOI 10.1007/BF01235889; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P817, DOI 10.1210/endo-117-3-817; Piston DW, 1999, METHOD ENZYMOL, V307, P351; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, BIOPHYS J, V90, P2641, DOI 10.1529/biophysj.105.069906; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SANDISON DR, 1995, APPL OPTICS, V34, P3576, DOI 10.1364/AO.34.003576; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; UNGER RH, 1971, NEW ENGL J MED, V285, P443; UNGER RH, 1981, DIABETOLOGIA, V20, P1; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; WEIR GC, 1984, METABOLISM, V33, P447, DOI 10.1016/0026-0495(84)90146-X; WEIR GC, 1986, HORM RES, V24, P62, DOI 10.1159/000180540; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	82	99	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14389	14398		10.1074/jbc.M109.069195	http://dx.doi.org/10.1074/jbc.M109.069195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231269	Green Published, hybrid			2022-12-25	WOS:000277299700036
J	McCormick, WD; Atkinson-Dell, R; Campion, KL; Mun, HC; Conigrave, AD; Ward, DT				McCormick, Wanda D.; Atkinson-Dell, Rebecca; Campion, Katherine L.; Mun, Hee-Chang; Conigrave, Arthur D.; Ward, Donald T.			Increased Receptor Stimulation Elicits Differential Calcium-sensing Receptor(T888) Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BOVINE PARATHYROID CELLS; EXTRACELLULAR CA2+-SENSING RECEPTOR; TRANSFECTED HEK293 CELLS; N-LINKED GLYCOSYLATION; L-AMINO-ACIDS; CA2+ OSCILLATIONS; CA-0(2+)-SENSING RECEPTOR; HORMONE-SECRETION; PHOSPHORYLATION	The calcium-sensing receptor (CaR) elicits oscillatory Ca-i(2+) mobilization associated with dynamic, inhibitory protein kinase C-mediated phosphorylation of CaRT888. While modest CaR stimulation elicits Ca-i(2+) oscillations, greater stimulation either increases oscillation frequency or elicits sustained responses by an unknown mechanism. Here, moderate CaR stimulation (2.5 mM Ca-o(2+), 10 min) increased CaRT888 phosphorylation (160 kDa mature receptor) 5-fold in CaR stably transfected HEK-293 cells, whereas 3-5 mM Ca-o(2+) treatments were without apparent effect. Treatment with 2 mM Ca-o(2+) caused sustained CaRT888 phosphorylation (>= 20 min) and oscillatory Ca-i(2+) mobilization. However, 5 mM Ca-o(2+) increased CaRT888 phosphorylation only briefly while eliciting sustained Ca-i(2+) mobilization, suggesting that greater CaR activation induces rapid CaRT888 dephosphorylation, thus permitting sustained Ca-i(2+) responses. Indeed, 5 mM Ca-o(2+) stimulated protein phosphatase 2A activity and induced CaRT888 dephosphorylation following acute phorbol ester pretreatment, the latter effect being mimicked by CaR-positive allosteric modulators (NPS-R467 and L-Phe). Finally, the phosphatase inhibitor calyculin-A reversed CaR-induced inhibition of parathyroid hormone secretion from bovine parathyroid slices and normal human parathyroid cells, demonstrating the physiological importance of phosphorylation status on parathyroid function. Therefore, high Ca-o(2+)-stimulated protein kinase C acts in concert with high Ca-o(2+)- induced phosphatase activity to generate and maintain CaR-induced Ca-i(2+) oscillations via the dynamic phosphorylation and dephosphorylation of CaRT888.	[Ward, Donald T.] Univ Manchester, Fac Life Sci, Core Technol Facil, Manchester M13 9NT, Lancs, England; [Mun, Hee-Chang; Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Manchester; University of Sydney	Ward, DT (corresponding author), Univ Manchester, Fac Life Sci, Core Technol Facil, Floor 2,46 Grafton St, Manchester M13 9NT, Lancs, England.	d.ward@manchester.ac.uk	Centeno, Patricia Pacios/O-8368-2016; Atkinson-Dell, Rebecca/A-4353-2016	Conigrave, Arthur/0000-0002-7232-3891; McCormick, Wanda/0000-0002-6287-7321; Ward, Donald/0000-0003-1342-9458	United Kingdom Biotechnology and Biological Sciences Research Council; Kidney Research UK [IN4/2008]; National Health and Medical Research Council (Australia); Biotechnology and Biological Sciences Research Council [BBS/B/04986] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kidney Research UK(Kidney Research UK (KRUK)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a United Kingdom Biotechnology and Biological Sciences Research Council studentship (to W. M.) and by a grant from Kidney Research UK (IN4/2008).; Supported by a project grant from the National Health and Medical Research Council (Australia).	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; CLARKE BL, 1993, ENDOCRINOLOGY, V132, P1168, DOI 10.1210/en.132.3.1168; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2004, J BIOL CHEM, V279, P38151, DOI 10.1074/jbc.M406373200; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Galitzer H, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-17; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Kim CH, 2005, J BIOL CHEM, V280, P25409, DOI 10.1074/jbc.M502644200; KOBAYASHI N, 1988, P NATL ACAD SCI USA, V85, P4857, DOI 10.1073/pnas.85.13.4857; MEMBRENO L, 1989, ENDOCRINOLOGY, V124, P789, DOI 10.1210/endo-124-2-789; MORRISSEY JJ, 1988, AM J PHYSIOL, V254, pE63, DOI 10.1152/ajpendo.1988.254.1.E63; Mun HC, 2009, J CLIN ENDOCR METAB, V94, P3567, DOI 10.1210/jc.2008-2714; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; NEMETH EF, 1986, J BIOL CHEM, V261, P2668; NYGREN P, 1988, BIOCHIM BIOPHYS ACTA, V968, P253, DOI 10.1016/0167-4889(88)90014-6; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P163, DOI 10.1113/jphysiol.1993.sp019765; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Young SH, 2002, J BIOL CHEM, V277, P46871, DOI 10.1074/jbc.M207083200; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001	35	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14170	14177		10.1074/jbc.M109.071084	http://dx.doi.org/10.1074/jbc.M109.071084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233724	Green Published, hybrid			2022-12-25	WOS:000277299700013
J	van Noort, SP; Nunes, MC; Weedall, GD; Hviid, L; Gomes, MGM				van Noort, Sander P.; Nunes, Marta C.; Weedall, Gareth D.; Hviid, Lars; Gomes, M. Gabriela M.			Immune Selection and Within-Host Competition Can Structure the Repertoire of Variant Surface Antigens in Plasmodium falciparum - A Mathematical Model	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; NATURALLY ACQUIRED-IMMUNITY; SEVERE CHILDHOOD MALARIA; VAR GENES; INFECTED ERYTHROCYTES; DIFFERENTIAL EXPRESSION; CLINICAL IMMUNITY; ANTIBODY-RESPONSE; HUMAN VOLUNTEERS; SEVERE DISEASE	Background: The evolutionary mechanisms structuring the expression pattern of variant surface antigen (VSA) families that allow pathogens to evade immune responses and establish chronic and repeated infections pose major challenges to theoretical research. In Plasmodium falciparum, the best-studied VSA family is erythrocyte membrane protein 1 (PfEMP1). Each parasite genome encodes about 60 PfEMP1 variants, which are important virulence factors and major targets of host antibody responses. Transcriptional switching is the basis of clonal PfEMP1 variation and immune evasion. A relatively conserved subset of PfEMP1 variants tends to dominate in non-immune patients and in patients with severe malaria, while more diverse subsets relate to uncomplicated infection and higher levels of pre-existing protective immunity. Methodology/Principal Findings: Here, we use the available molecular and serological evidence regarding VSAs, in particular PfEMP1, to formulate a mathematical model of the evolutionary mechanisms shaping VSA organization and expression patterns. The model integrates the transmission dynamics between hosts and the competitive interactions within hosts, based on the hypothesis that the VSAs can be organized into so-called dominance blocks, which characterize their competitive potential. The model reproduces immunological trends observed in field data, and predicts an evolutionary stable balance between inter-clonally conserved dominance blocks that are highly competitive within-host and diverse blocks that are favoured by immune selection at the population level. Conclusions/Significance: The application of a monotonic dominance profile to VSAs encoded by a gene family generates two opposing selective forces and, consequently, two distinct clusters of genes emerge in adaptation to naive and partially immune hosts, respectively.	[van Noort, Sander P.; Weedall, Gareth D.; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Nunes, Marta C.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Hviid, Lars] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Hviid, Lars] Rigshosp, DK-2100 Copenhagen, Denmark	Instituto Gulbenkian de Ciencia; University of Witwatersrand; University of Copenhagen; Rigshospitalet; University of Copenhagen	van Noort, SP (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	vnoort@igc.gulbenkian.pt	Hviid, Lars/G-3705-2012; Gomes, Gabriela/H-7218-2014	Hviid, Lars/0000-0002-1698-4927; Gomes, Gabriela/0000-0002-1454-4979; Weedall, Gareth/0000-0002-8927-1063; Nunes, Marta/0000-0003-3788-878X	Fundacion para a Ciencia e a Tecnologia (FCT); European Commission [MEXT-CT-2004-14338, EC-ICT-231807]	Fundacion para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by Fundacion para a Ciencia e a Tecnologia (FCT) and the European Commission (grants MEXT-CT-2004-14338 and EC-ICT-231807 (EPIWORK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kirchgessner AL, 2002, ENDOCR REV, V23, P1, DOI 10.1210/er.23.1.1; Krause DR, 2007, INFECT IMMUN, V75, P5967, DOI 10.1128/IAI.00327-07; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nielsen MA, 2005, J INFECT DIS, V192, P520, DOI 10.1086/431678; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Phiri H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-214; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-18; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; WARIMWE G, 2009, P NATL ACAD IN PRESS	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9778	10.1371/journal.pone.0009778	http://dx.doi.org/10.1371/journal.pone.0009778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339540	Green Submitted, gold, Green Published			2022-12-25	WOS:000275894300015
J	Kang, J; Robinson, HPC; Feng, JF				Kang, Jing; Robinson, Hugh P. C.; Feng, Jianfeng			Diversity of Intrinsic Frequency Encoding Patterns in Rat Cortical Neurons-Mechanisms and Possible Functions	PLOS ONE			English	Article							FAST-SPIKING CELLS; PARAMETRIC WORKING-MEMORY; WEAKLY ELECTRIC FISH; PREFRONTAL CORTEX; GNATHONEMUS-PETERSII; SYNAPTIC INPUT; NEURAL CODES; MODEL; DISCRIMINATION; RESPONSES	Extracellular recordings of single neurons in primary and secondary somatosensory cortices of monkeys in vivo have shown that their firing rate can increase, decrease, or remain constant in different cells, as the external stimulus frequency increases. We observed similar intrinsic firing patterns (increasing, decreasing or constant) in rat somatosensory cortex in vitro, when stimulated with oscillatory input using conductance injection (dynamic clamp). The underlying mechanism of this observation is not obvious, and presents a challenge for mathematical modelling. We propose a simple principle for describing this phenomenon using a leaky integrate-and-fire model with sinusoidal input, an intrinsic oscillation and Poisson noise. Additional enhancement of the gain of encoding could be achieved by local network connections amongst diverse intrinsic response patterns. Our work sheds light on the possible cellular and network mechanisms underlying these opposing neuronal responses, which serve to enhance signal detection.	[Kang, Jing; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Warwick; Fudan University; University of Cambridge	Kang, J (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	hpcr@cam.ac.uk; Jianfeng.Feng@warwick.ac.uk		Kang, Jing/0000-0002-2770-1099; feng, jianfeng/0000-0002-9328-5732; Robinson, Hugh/0000-0002-5048-9954	Warwick Postgraduate Research Fellowship; Institute of Advance Study Early Career Fellowship; Engineering and Physical Sciences Research Council, United Kingdom; European Commission [012788]	Warwick Postgraduate Research Fellowship; Institute of Advance Study Early Career Fellowship; Engineering and Physical Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was funded by the Warwick Postgraduate Research Fellowship, Institute of Advance Study Early Career Fellowship, Code, Analysis, Repository and Modelling for e-Neuroscience (Engineering and Physical Sciences Research Council, United Kingdom), and European Commission Framework Program 6 Grant (Contract No. 012788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown D, 1999, PHYS REV LETT, V82, P4731, DOI 10.1103/PhysRevLett.82.4731; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Destexhe A, 2009, DYNAMIC CLAMP PRINCI; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; Feng JF, 2004, J COMPUT NEUROSCI, V16, P237, DOI 10.1023/B:JCNS.0000025687.78916.5a; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goenechea L, 2004, J COMP PHYSIOL A, V190, P907, DOI 10.1007/s00359-004-0548-x; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Miller P, 2006, P NATL ACAD SCI USA, V103, P201, DOI 10.1073/pnas.0508072103; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; SAKMANN B, 1995, SINGLE CHANNEL RECOR, V22; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Tateno T, 2009, J NEUROPHYSIOL, V101, P1056, DOI 10.1152/jn.91057.2008; VONDEREMDE G, 1992, J COMP PHYSIOL A, V171, P683, DOI 10.1007/BF00194116; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P83, DOI 10.1007/BF00217439; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9608	10.1371/journal.pone.0009608	http://dx.doi.org/10.1371/journal.pone.0009608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333256	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809700004
J	Tortosa, P; Charlat, S; Labbe, P; Dehecq, JS; Barre, H; Weill, M				Tortosa, Pablo; Charlat, Sylvain; Labbe, Pierrick; Dehecq, Jean-Sebastien; Barre, Helene; Weill, Mylene			Wolbachia Age-Sex-Specific Density in Aedes albopictus: A Host Evolutionary Response to Cytoplasmic Incompatibility?	PLOS ONE			English	Article							DROSOPHILA-SIMULANS; INFECTION; DIPTERA; CHIKUNGUNYA; CULICIDAE; POPULATIONS; EXPRESSION; DYNAMICS; LIFE	Background: Wolbachia bacteria have invaded many arthropod species by inducing Cytoplasmic Incompatibility (CI). These symbionts represent fascinating objects of study for evolutionary biologists, but also powerful potential biocontrol agents. Here, we assess the density dynamics of Wolbachia infections in males and females of the mosquito Aedes albopitcus, an important vector of human pathogens, and interpret the results within an evolutionary framework. Methodology/Principal Findings: Wolbachia densities were measured in natural populations and in age controlled mosquitoes using quantitative PCR. We show that the density dynamics of the wAlbA Wolbachia strain infecting Aedes albopictus drastically differ between males and females, with a very rapid decay of infection in males only. Conclusions/Significance: Theory predicts that Wolbachia and its hosts should cooperate to improve the transmission of infection to offspring, because only infected eggs are protected from the effects of CI. However, incompatible matings effectively lower the fertility of infected males, so that selection acting on the host genome should tend to reduce the expression of CI in males, for example, by reducing infection density in males before sexual maturation. The rapid decay of one Wolbachia infection in Aedes albopictus males, but not in females, is consistent with this prediction. We suggest that the commonly observed reduction in CI intensity with male age reflects a similar evolutionary process. Our results also highlight the importance of monitoring infection density dynamics in both males and females to assess the efficiency of Wolbachia-based control strategies.	[Tortosa, Pablo; Labbe, Pierrick; Weill, Mylene] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, France; [Charlat, Sylvain] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Dehecq, Jean-Sebastien] Direct Reg Affaires Sanit & Sociales Reunion, St Denis, France; [Barre, Helene] Univ Corse, Lab Parasites & Ecosyst Mediterraneens, Corte, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Tortosa, P (corresponding author), Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France.	pablo.tortosa@ird.fr	Labbé, Pïerrick/AAL-5806-2020	Labbé, Pïerrick/0000-0003-0806-1919; Weill, Mylene/0000-0002-4043-1601; Tortosa, Pablo/0000-0002-7928-7264; Charlat, Sylvain/0000-0003-0760-0087; Barre-Cardi, Helene/0000-0003-1029-9256	ANR CHIKVENDOM Sante-Environnement; Region Languedoc Roussillon	ANR CHIKVENDOM Sante-Environnement(French National Research Agency (ANR)); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France)	This work was funded by ANR CHIKVENDOM Sante-Environnement (Ministere delegue a la recherche); Region Reunion (http://www.regionreunion.com/fr/spip/spip.php?page=accueilv2); and Region Languedoc Roussillon (http://www.laregion.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2008, J VECTOR ECOL, V33, P173, DOI 10.3376/1081-1710(2008)33[173:RWDOFA]2.0.CO;2; Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Crawley MJ., 2007, R BOOK; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Dobson SL, 2002, GENETICS, V160, P1087; Duron O, 2007, HEREDITY, V98, P368, DOI 10.1038/sj.hdy.6800948; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Engelstadter J, 2007, J EVOLUTION BIOL, V20, P685, DOI 10.1111/j.1420-9101.2006.01257.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hornett EA, 2009, CURR BIOL, V19, P1628, DOI 10.1016/j.cub.2009.07.071; Jamnongluk W, 2000, J MED ENTOMOL, V37, P53, DOI 10.1603/0022-2585-37.1.53; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; Koehncke A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004425; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; Rasgon JL, 2003, GENETICS, V165, P2029; Riparbelli MG, 2007, MECH DEVELOP, V124, P699, DOI 10.1016/j.mod.2007.07.001; ROGERS SO, 1988, PLANT MOL BIOL MANUE; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	35	72	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9700	10.1371/journal.pone.0009700	http://dx.doi.org/10.1371/journal.pone.0009700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300514	Green Published, Green Submitted, gold			2022-12-25	WOS:000275716400005
J	Bottoms, SE; Howell, JE; Reinhardt, AK; Evans, IC; McAnulty, RJ				Bottoms, Stephen E.; Howell, Jane E.; Reinhardt, Alistair K.; Evans, Iona C.; McAnulty, Robin J.			TGF-beta Isoform Specific Regulation of Airway Inflammation and Remodelling in a Murine Model of Asthma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BRONCHOALVEOLAR LAVAGE FLUID; SUBEPITHELIAL FIBROSIS; BRONCHIAL-ASTHMA; GENE-EXPRESSION; MESSENGER-RNA; PROTEOGLYCAN DEPOSITION; ALVEOLAR MACROPHAGES; TARGETED DISRUPTION; ALLERGEN CHALLENGE	The TGF-beta family of mediators are thought to play important roles in the regulation of inflammation and airway remodelling in asthma. All three mammalian isoforms of TGF-beta, TGF-beta(1-3), are expressed in the airways and TGF-beta(1) and -beta(2) are increased in asthma. However, there is little information on the specific roles of individual TGF-beta isoforms. In this study we assess the roles of TGF-beta(1) and TGF-beta(2) in the regulation of allergen-induced airway inflammation and remodelling associated with asthma, using a validated murine model of ovalbumin sensitization and challenge, and isoform specific TGF-beta neutralising antibodies. Antibodies to both isoforms inhibited TGF-beta mediated Smad signalling. Anti-TGF-beta(1) and anti-TGF-beta(2) inhibited ovalbumin-induced sub-epithelial collagen deposition but anti-TGF-beta(1) also specifically regulated airway and fibroblast decorin deposition by TGF-beta(1). Neither antibody affected the allergen-induced increase in sub-epithelial fibroblast-like cells. Anti-TGF-beta(1) also specifically inhibited ovalbumin-induced increases in monocyte/ macrophage recruitment. Whereas, both TGF-beta(1) and TGF-beta(2) were involved in regulating allergen-induced increases in eosinophil and lymphocyte numbers. These data show that TGF-beta(1) and TGF-beta(2) exhibit a combination of specific and shared roles in the regulation of allergen-induced airway inflammation and remodelling. They also provide evidence in support of the potential for therapeutic regulation of specific subsets of cells and extracellular matrix proteins associated with inflammation and remodelling in airway diseases such as asthma and COPD, as well as other fibroproliferative diseases.	[Bottoms, Stephen E.; Howell, Jane E.; Reinhardt, Alistair K.; Evans, Iona C.; McAnulty, Robin J.] UCL, Ctr Resp Res, Lung Pathobiol Grp, London, England	University of London; University College London	Bottoms, SE (corresponding author), UCL, Ctr Resp Res, Lung Pathobiol Grp, London, England.	r.mcanulty@ucl.ac.uk	McAnulty, Robin J/C-2502-2008	McAnulty, Robin J/0000-0003-1936-4245; Evans, Iona/0000-0002-0225-3154	Asthma UK [04/017]; Wellcome Trust [060109]	Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from Asthma UK www.asthma.org.uk (grant number 04/017) and the Wellcome Trust www.wellcome.ac.uk (grant number 060109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DH, 1991, J IMMUNOL, V147, P609; Alcorn JF, 2007, AM J RESP CRIT CARE, V176, P974, DOI 10.1164/rccm.200702-334OC; AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BOULET LP, 1995, AM J RESP CRIT CARE, V152, P865, DOI 10.1164/ajrccm.152.3.7663797; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Cabiling DS, 2007, PLAST RECONSTR SURG, V120, P614, DOI 10.1097/01.prs.0000270292.89388.a3; Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Coker RK, 1996, EUR RESPIR J, V9, P2501, DOI 10.1183/09031936.96.09122501; Coker RK, 2001, THORAX, V56, P549, DOI 10.1136/thorax.56.7.549; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; FUKUSHIMA D, 1993, J BIOL CHEM, V268, P22710; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gabbrielli S., 1994, Pathologica (Genoa), V86, P157; Hill C, 2001, J ENDOCRINOL, V170, P647, DOI 10.1677/joe.0.1700647; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Hoshino M, 1998, J ALLERGY CLIN IMMUN, V102, P783, DOI 10.1016/S0091-6749(98)70018-1; Howell JE, 2006, CURR DRUG TARGETS, V7, P547, DOI 10.2174/138945006776818692; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Leung SY, 2006, J PHARMACOL EXP THER, V319, P586, DOI 10.1124/jpet.106.109314; Luttmann W, 1998, SCAND J IMMUNOL, V47, P127; Magnan A, 1997, CLIN EXP ALLERGY, V27, P389; McAnulty R.J., 2002, ASTHMA COPD BASIC ME, P139; MCANULTY RJ, 2007, THERAPEUTIC STRATEGI, P15; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; PELTON RW, 1991, AM J RESP CELL MOL, V5, P522, DOI 10.1165/ajrcmb/5.6.522; Pini L, 2006, AM J PHYSIOL-LUNG C, V290, pL1052, DOI 10.1152/ajplung.00122.2005; Redington AE, 1998, J PATHOL, V186, P410, DOI 10.1002/(SICI)1096-9896(199812)186:4<410::AID-PATH198>3.0.CO;2-9; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Reinhardt AK, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-30; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; ROCHE WR, 1989, LANCET, V1, P520; Rosendahl A, 2001, AM J RESP CELL MOL, V25, P60, DOI 10.1165/ajrcmb.25.1.4396; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221; Scherf W, 2005, EUR J IMMUNOL, V35, P198, DOI 10.1002/eji.200425209; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Torrego A, 2007, THORAX, V62, P307, DOI 10.1136/thx.2006.063487; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Vignola AM, 1996, CLIN EXP IMMUNOL, V106, P114, DOI 10.1046/j.1365-2249.1996.d01-811.x; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Zhang-Hoover J, 2000, IMMUNOLOGY, V101, P501, DOI 10.1046/j.1365-2567.2000.00143.x; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	65	61	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9674	10.1371/journal.pone.0009674	http://dx.doi.org/10.1371/journal.pone.0009674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300191	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900009
J	Azuaje, F; Devaux, Y; Wagner, DR				Azuaje, Francisco; Devaux, Yvan; Wagner, Daniel R.			Integrative Pathway-Centric Modeling of Ventricular Dysfunction after Myocardial Infarction	PLOS ONE			English	Article							GENE-EXPRESSION; BIOMARKER; BIOLOGY	Background: A significant proportion of myocardial infarction (MI) patients undergo complex, coordinated perturbations at the molecular level that may eventually drive the occurrence of ventricular dysfunction and heart failure. Despite advances in the elucidation of key processes implicated in this condition, traditional methods relying on gene expression data and the identification of individual biomarkers in isolation pose major limitations not only for improving prediction power, but also for model interpretability. Mechanisms underlying clinical responses after MI remain elusive and there is no biomarker with the capacity to accurately predict ventricular dysfunction after MI. This calls for the exploration of system-level modeling of ventricular dysfunction in post-MI patients. Within this discovery framework key perturbations and predictive patterns are characterized by the integrated biological activity levels observed in pathways, rather than in individual genes. Methodology/Principal Findings: Here we report an integrative approach to identifying pathways related with ventricular dysfunction post MI with potential prognostic and therapeutic value. We found that a diversity of pathway-level perturbations can be profiled in samples of patients with ventricular dysfunction post MI, most of which represent major reductions of gene expression. Highly perturbed pathways included those implicated in antigen-dependent B-cell activation and the synthesis of leucine. By analyzing patient-specific samples encoded with information derived from highly-perturbed pathways, it is possible to visualize differential prognostic patterns and to perform computational classification of patients with areas under the receiver operating characteristic curve above 0.75. We also demonstrate how the integration of the outcomes generated by different pathway-based analysis models may improve ventricular dysfunction prediction performance. Significance: This research offers an alternative, comprehensive view of key relationships and perturbations that may trigger the emergence or prevention of ventricular dysfunction post-MI.	[Azuaje, Francisco; Devaux, Yvan; Wagner, Daniel R.] Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Wagner, Daniel R.] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Azuaje, F (corresponding author), Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	Francisco.Azuaje@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020	Devaux, Yvan/0000-0002-5321-8543	Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; Fonds National de la Recherche of Luxembourg	Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; Fonds National de la Recherche of Luxembourg(Luxembourg National Research Fund)	This research was supported in part by grants from the Societe pour la Recherche sur les Maladies Cardiovasculaires; Ministere de la Culture, de l'Enseignement Superieur et de la Recherche; and Fonds National de la Recherche of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Azuaje F, 2009, BRIEF BIOINFORM, V10, P367, DOI 10.1093/bib/bbp008; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cleary JG, 1995, ED INN EC BUS ADM, P108; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Grivas PD, 2009, CELL ONCOL, V31, P235, DOI 10.3233/CLO-2009-0467; HABASHY HO, 2009, BREAST CANC IN PRESS; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Kittleson MM, 2005, TRENDS CARDIOVAS MED, V15, P130, DOI 10.1016/j.tcm.2005.05.007; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; StatSoft Inc, 2008, STAT DAT AN SOFTW SY; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun S, 2010, J PROTEOME RES, V9, P70, DOI 10.1021/pr9002118; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61	30	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9661	10.1371/journal.pone.0009661	http://dx.doi.org/10.1371/journal.pone.0009661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300185	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620600015
J	Audet, M; Lagace, M; Silversides, DW; Bouvier, M				Audet, Martin; Lagace, Monique; Silversides, David W.; Bouvier, Michel			Protein-protein interactions monitored in cells from transgenic mice using bioluminescence resonance energy transfer	FASEB JOURNAL			English	Article						beta-arrestin2; beta 2-adrenergic receptor; Renilla luciferase; green fluorescent protein	BETA-ADRENERGIC RECEPTORS; LIVING CELLS; BETA-2-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; TRANSFER BRET; LIVE CELLS; CONFORMATIONAL-CHANGES; GENE-EXPRESSION; LEYDIG-CELLS; RAT TESTIS	Monitoring the dynamics of protein-protein interactions in their natural environment remains a challenge. Resonance energy transfer approaches represent a promising avenue to directly probe these interactions in real time. The present study aims at establishing a proof of principle that bioluminescence resonance energy transfer (BRET) can be used to study the regulation of protein-protein interaction in cells from transgenic animals. A transgenic mouse line coexpressing the beta(2)-adrenergic receptor fused to Renilla luciferase (beta(2)AR-Rluc) and beta arrestin-2 fused to a green fluorescent protein (GFP2-beta arr2) was generated. The fusion proteins were found to be functional in the transgenic animals and the beta(2)AR-Rluc maintained pharmacological properties, comparable to that of the native receptor. Sufficiently high luminescence signal was generated to allow detection of BRET in testis cells where the beta(2)AR-Rluc transgene was expressed at levels significantly higher than that of the endogenous receptor in this tissue but remain within physiological range when compared with other beta(2)AR-expressing tissues. Stimulation with a beta-adrenergic agonist led to a significant dose-and time-dependent increase in BRET, which reflected ligand-promoted recruitment of beta arr2 to the receptor. Our study demonstrates that BRET can be used to monitor the dynamic regulation of protein-protein interactions in cells derived from transgenic mice.-Audet, M., Lagace, M., Silversides, D. W., Bouvier, M. Protein-protein interactions monitored in cells from transgenic mice using bioluminescence resonance energy transfer. FASEB J. 24, 2829-2838 (2010). www.fasebj.org	[Audet, Martin; Lagace, Monique; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Audet, Martin; Lagace, Monique; Bouvier, Michel] Univ Montreal, Grp Rech Univ Med, Montreal, PQ H3C 3J7, Canada; [Silversides, David W.] Univ Montreal, Fac Med Vet, Dept Vet Biomed, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Bouvier, M (corresponding author), CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100	Canadian Institute for Health Research (CIHR) [GOP-48289]; CIHR/Canadian Hypertension Society/Pfizer; Fonds de la Recherche en Sante du Quebec	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Canadian Hypertension Society/Pfizer(Canadian Institutes of Health Research (CIHR)Pfizer); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	The authors thank Drs. Mounia Azzi, Patricia Rene, Louis Gaboury, and Fadi Hamdan for their assistance in the development of some of the methods, as well as Marc Palardy, Celine Forget, and Diana Raiwet for their roles in the vector design, construction, generation of transgenic mouse lines, Southern blot analysis, and animal colony maintenance. The authors are also grateful to Dr. Hiroyuki Kobayashi for his critical reading of the manuscript. This work was supported by grants of the Canadian Institute for Health Research (CIHR) to M.B. and D.W.S. (GOP-48289). M.A. held studentships from the CIHR/Canadian Hypertension Society/Pfizer joint program and the Fonds de la Recherche en Sante du Quebec. M.B. holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Azzi M, 2001, MOL PHARMACOL, V60, P999, DOI 10.1124/mol.60.5.999; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BREUILLER M, 1988, BIOCHEM BIOPH RES CO, V151, P1454, DOI 10.1016/S0006-291X(88)80525-4; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Coulon V, 2008, BIOPHYS J, V94, P1001, DOI 10.1529/biophysj.107.117275; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De A, 2009, FASEB J, V23, P2702, DOI 10.1096/fj.08-118919; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ducros M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004418; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gunnarsson D, 2007, TOXICOL LETT, V168, P51, DOI 10.1016/j.toxlet.2006.10.015; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; HAMDAN FF, 2006, CURR PROTOC NEUROSCI; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hara M, 2004, AM J PHYSIOL-CELL PH, V287, pC932, DOI 10.1152/ajpcell.00151.2004; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; HEDGER MP, 1987, ENDOCRINOLOGY, V121, P1824, DOI 10.1210/endo-121-5-1824; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Lissandron V, 2007, CELL SIGNAL, V19, P2296, DOI 10.1016/j.cellsig.2007.07.004; METHOT D, 1995, NUCLEIC ACIDS RES, V23, P4551, DOI 10.1093/nar/23.22.4551; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TOLSZCZUK M, 1988, J ANDROL, V9, P172; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Xia ZY, 2009, CURR OPIN BIOTECH, V20, P37, DOI 10.1016/j.copbio.2009.01.001; Xie Y, 2008, AM J PHYSIOL-CELL PH, V295, pC388, DOI 10.1152/ajpcell.00178.2008; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	42	21	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2829	2838		10.1096/fj.09-144816	http://dx.doi.org/10.1096/fj.09-144816			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20335229				2022-12-25	WOS:000285005400023
J	Fuster, JJ; Gonzalez, JM; Edo, MD; Viana, R; Boya, P; Cervera, J; Verges, M; Rivera, J; Andres, V				Fuster, Jose J.; Gonzalez, Jose M.; Edo, Maria D.; Viana, Rosa; Boya, Patricia; Cervera, Javier; Verges, Marcel; Rivera, Jose; Andres, Vicente			Tumor suppressor p27(Kip1) undergoes endolysosomal degradation through its interaction with sorting nexin 6	FASEB JOURNAL			English	Article						SNX6; proteolysis; endosome; lysosome; cell cycle	CDK INHIBITOR P27; CELL-CYCLE ARREST; C-FOS; DOWN-REGULATION; EGF RECEPTOR; MICE LACKING; LAMIN A/C; S PHASE; MIGRATION; GROWTH	A large body of evidence supports the hypothesis that proteasomal degradation of the growth suppressor p27(Kip1) (p27) facilitates mammalian cell cycle progression. However, very few studies have addressed the possibility of proteasome-independent mechanisms of p27 proteolysis. Here we provide evidence for a novel pathway of p27 degradation via the lysosome that is mediated by its interaction with the endosomal protein sorting nexin 6 (SNX6), a member of the sorting nexin family of vesicular trafficking regulators. p27 and SNX6 interact in vitro and in vivo in mammalian cells, partially colocalize in endosomes, and are present in purified endosomal fractions. Gain-and loss-of-function studies revealed that SNX6 induces endosomal accumulation of p27. Moreover, p27 is detected in lysosomes and inhibition of lysosome-dependent proteolysis impairs serum-mediated down-regulation of p27 in a SNX6-dependent manner. To validate the localization of p27 in these organelles, we analyzed several cell lines using two different anti-p27 antibodies, several organelle-specific markers [e.g., early endosome antigen 1, lysosomal-associated membrane protein (LAMP) 1, LAMP2, and LysoTracker], and overexpression of fluorescent p27 and SNX6. Remarkably, silencing of SNX6 attenuates p27 down-regulation in the G(1) phase of the mitotic cell cycle and delays cell cycle progression. We therefore conclude that, in addition to the proteasome-dependent pathway, SNX6-mediated endolysosomal degradation of p27 also contributes to cell cycle progression in mammalian cells.-Fuster, J. J., Gonzalez, J. M., Edo, M. D., Viana, R., Boya, P., Cervera, J., Verges, M., Rivera, J., Andres, V. Tumor suppressor p27(Kip1) undergoes endolysosomal degradation through its interaction with sorting nexin 6. FASEB J. 24, 2998-3009 (2010). www.fasebj.org	[Fuster, Jose J.; Rivera, Jose; Andres, Vicente] CNIC, Lab Mol & Genet Cardiovasc Pathophysiol, Dept Atherothrombosis & Cardiovasc Imaging, Madrid 28029, Spain; [Fuster, Jose J.; Gonzalez, Jose M.; Edo, Maria D.; Viana, Rosa; Andres, Vicente] CSIC, Inst Biomed Valencia, Lab Vasc Biol, Dept Mol & Cellular Pathol & Therapy, Valencia, Spain; [Boya, Patricia] CSIC, Ctr Invest Biol, Dept Cellular & Mol Physiopathol, Dev Differentiat & Degenerat Lab, Madrid, Spain; [Cervera, Javier] Ctr Invest Principe Felipe, Mol Recognit Lab, Valencia, Spain; [Verges, Marcel] Ctr Invest Principe Felipe, Lab Epithelial Cell Biol, Valencia, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Prince Felipe Research Center; Prince Felipe Research Center	Andres, V (corresponding author), CNIC, Lab Mol & Genet Cardiovasc Pathophysiol, Dept Atherothrombosis & Cardiovasc Imaging, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	vandres@cnic.es	Andres, Vicente/I-6440-2014; Fuster, José J/D-3685-2011; Rivera-Torres, José/P-2793-2015; Viana, Rosa/L-1922-2014; Gonzalez-Granado, Jose M/A-2952-2015; Verges, Marcel/L-5784-2014; Boya, Patricia/P-8345-2019; Boya, Patricia/K-2911-2014	Andres, Vicente/0000-0002-0125-7209; Fuster, José J/0000-0002-5970-629X; Rivera-Torres, José/0000-0003-0365-9604; Viana, Rosa/0000-0002-0036-0669; Gonzalez-Granado, Jose M/0000-0002-1177-869X; Verges, Marcel/0000-0002-2606-223X; Boya, Patricia/0000-0003-3045-951X; Boya, Patricia/0000-0003-3045-951X	Spanish Ministry of Science and Innovation (MICINN); European Regional Development Fund [SAF2004-3057, SAF2007-62110]; Instituto de Salud Carlos III (ISCIII) [RD06/0014/0021]; Fundacion Ramon Areces; European Social Fund; Pro-CNIC Foundation	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; European Social Fund(European Social Fund (ESF)); Pro-CNIC Foundation	The authors thank M. A. Ibanez for help with the preparation and analysis of endosomal fractions, M. J. Andres-Manzano for help preparing the figures, and colleagues who generously provided reagents (Bruno Amati, European Institute of Oncology, Milan, Italy; Jun-ya Kato, Institute of Science and Technology, Nara, Japan; Jennifer Lippincott-Schwartz, NIH, Bethesda, MD, USA; W. Tony Parks, University of Washington, Seattle, WA, USA; Bert Vogelstein, Johns Hopkins University, Baltimore, MD, USA; Gabriel Gil, IMIM, Barcelona, Spain; Pascual Sanz, IBV-CSIC, Valencia, Spain; and Michael Clague, University of Liverpool, Liverpool, UK). This work was supported by grants to V.A. from the Spanish Ministry of Science and Innovation (MICINN) and the European Regional Development Fund (grants SAF2004-3057 and SAF2007-62110), Instituto de Salud Carlos III (ISCIII; grant RD06/0014/0021, RECAVA), and Fundacion Ramon Areces. J.M.G. was supported by ISCIII, and J.J.F. by the CSIC-I3P predoctoral fellowship program cosponsored by the European Social Fund. The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Aniento F, 1996, FEBS LETT, V390, P47, DOI 10.1016/0014-5793(96)00625-4; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; BIN Z, 2006, P NATL ACAD SCI USA, V103, P16776; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; BORRIELLO A, 2007, CELL CYCLE, V6, P9; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Delmas C, 2003, J BIOL CHEM, V278, P12443, DOI 10.1074/jbc.M209523200; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Diez-Juan A, 2004, BLOOD, V103, P158, DOI 10.1182/blood-2003-07-2319; Diez-Juan A, 2003, CIRC RES, V92, P402, DOI 10.1161/01.RES.0000059306.71961.ED; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; HIROKI A, 2006, J NEUROCHEM, V99, P733; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	59	25	27	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2010	24	8					2998	3009		10.1096/fj.09-138255	http://dx.doi.org/10.1096/fj.09-138255			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20228253	Green Submitted			2022-12-25	WOS:000285005400038
J	Shen, WY; Li, JQ; Dauk, M; Huang, Y; Periappuram, C; Wei, YD; Zou, JT				Shen, Wenyun; Li, John Qiang; Dauk, Melanie; Huang, Yi; Periappuram, Cyril; Wei, Yangdou; Zou, Jitao			Metabolic and Transcriptional Responses of Glycerolipid Pathways to a Perturbation of Glycerol 3-Phosphate Metabolism in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN ISOFORMS; WILD-TYPE ARABIDOPSIS; FATTY-ACID SYNTHESIS; LIPID-SYNTHESIS; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEFICIENT; MUTANT; PLANT; BIOSYNTHESIS; MEMBRANE	Glycerolipid synthesis in plants involves two major metabolic pathways compartmentalized in the chloroplasts and cytosol, respectively. Although these two parallel pathways are regulated with considerable flexibility, the factors mediating this process remain unclear. To investigate the influence of glycerol 3-phosphate (Gly-3-P) on the interactions of the glycerolipid pathways, we generated transgenic Arabidopsis lines with a feedback-resistant Gly-3-P dehydrogenase gene (gpsA(FR)) from Escherichia coli. gpsA(FR) was detected in the cytosol, but augmented Gly-3-P levels were observed in the cytosol as well as in chloroplasts. Glycerolipid composition and fatty acid positional distribution analyses revealed an altered fatty acid flux that affected not only the molar ratios of glycerolipid species but also their fatty acid composition. To decipher this complex pathway, a transgenic line was subjected to lipidomic analysis and a global gene-expression survey. The results revealed that changes in Gly-3-P metabolism caused altered expression of a broad array of genes. When viewed from the perspective of glycerolipid metabolism, coherent networks emerged, revealing that many enzymatic components of the glycerolipid pathways operate in a modular manner under the influence of Gly-3-P. Transcript levels of the enzymes involved in the prokaryotic pathway were mostly induced, whereas genes of the eukaryotic pathway enzymes were largely suppressed. Hence, the gene-expression changes were consistent with the detected biochemical phenotype. Our results suggest that Gly-3-P modulates the balance of the two glycerolipid pathways in Arabidopsis by influencing both metabolic flux and gene transcription.	[Shen, Wenyun; Li, John Qiang; Dauk, Melanie; Huang, Yi; Periappuram, Cyril; Zou, Jitao] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; [Li, John Qiang; Wei, Yangdou] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada	National Research Council Canada; University of Saskatchewan	Zou, JT (corresponding author), 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	Jitao.Zou@nrc-cnrc.gc.ca			Saskatchewan Canola Development commission; National Research Council Canada-Genomic and Health Initiatives; Genome Prairie; Genome Canada; National Research Council Canada [50160]	Saskatchewan Canola Development commission; National Research Council Canada-Genomic and Health Initiatives; Genome Prairie; Genome Canada(Genome Canada); National Research Council Canada	This work was supported in part by the Saskatchewan Canola Development commission, the National Research Council Canada-Genomic and Health Initiatives, Genome Prairie, and Genome Canada. This research is National Research Council Canada Publication 50160.	Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BELL RM, 1975, J BIOL CHEM, V250, P7153; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonaventure G, 2002, PLANT PHYSIOL, V128, P223, DOI 10.1104/pp.010397; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCKMAN JA, 1990, PHYTOCHEMISTRY, V29, P1447, DOI 10.1016/0031-9422(90)80098-2; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; BROWSE J, 1986, PLANT PHYSIOL, V81, P859, DOI 10.1104/pp.81.3.859; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FLIEGE R, 1978, BIOCHIM BIOPHYS ACTA, V502, P232, DOI 10.1016/0005-2728(78)90045-2; FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629; Frentzen Margrit, 1993, P195; GARDINER SE, 1982, PLANT PHYSIOL, V70, P1316, DOI 10.1104/pp.70.5.1316; GARDINER SE, 1983, BIOCHEM J, V210, P949, DOI 10.1042/bj2100949; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GHOSH S, 1988, ARCH BIOCHEM BIOPHYS, V262, P508, DOI 10.1016/0003-9861(88)90402-X; GUERRA DJ, 1986, PLANT PHYSIOL, V82, P448, DOI 10.1104/pp.82.2.448; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Heinz E., 1977, Lipids and lipid polymers in higher plants., P102; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; JOHNSON G, 1989, PLANT PHYSIOL, V91, P924, DOI 10.1104/pp.91.3.924; Kachroo A, 2004, P NATL ACAD SCI USA, V101, P5152, DOI 10.1073/pnas.0401315101; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; MCKEE JWA, 1979, ARCH BIOCHEM BIOPHYS, V197, P322, DOI 10.1016/0003-9861(79)90252-2; Millenaar FF, 2000, PLANT J, V23, P623, DOI 10.1046/j.1365-313x.2000.00832.x; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Quettier AL, 2008, PLANT PHYSIOL, V148, P519, DOI 10.1104/pp.108.123703; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; ROUGHAN PG, 1979, BIOCHEM J, V184, P193, DOI 10.1042/bj1840193; SAUER A, 1983, Z NATURFORSCH C, V38, P399; SCHMIDT H, 1993, BIOCHEM J, V289, P777, DOI 10.1042/bj2890777; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; SIEBERTZ HP, 1977, Z NATURFORSCH C, V32, P193; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wei YD, 2004, J BIOL CHEM, V279, P429, DOI 10.1074/jbc.M308363200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WU JR, 1994, PLANT PHYSIOL, V106, P143, DOI 10.1104/pp.106.1.143	52	25	34	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22955	22963		10.1074/jbc.M109.097758	http://dx.doi.org/10.1074/jbc.M109.097758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20304913	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000279999900030
J	Greenhough, A; Wallam, CA; Hicks, DJ; Moorghen, M; Williams, AC; Paraskeva, C				Greenhough, A.; Wallam, C. A.; Hicks, D. J.; Moorghen, M.; Williams, A. C.; Paraskeva, C.			The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells	ONCOGENE			English	Article						Bim; COX-2; ERK; colorectal cancer; apoptosis; PGE2	CARCINOMA CELLS; BAX ACTIVATION; KEY ROLES; IN-VITRO; BCL-X; APOPTOSIS; PROMOTES; GROWTH; EXPRESSION; SURVIVAL	Overexpression of cyclooxygenase-2 (COX-2) and elevated levels of its enzymatic product prostaglandin E2 (PGE(2)) occur in the majority of colorectal cancers and have important roles in colorectal tumorigenesis. However, despite the established prosurvival role of PGE(2) in cancer, the underlying mechanisms are not fully understood. Here, we have shown that PGE(2) suppresses apoptosis via repression of the proapoptotic BH3-only protein Bim in human colorectal adenoma cells. Repression of Bim expression was dependent upon PGE(2)-mediated activation of the Raf-MEK-ERK1/2 pathway, which promoted Bim phosphorylation and proteasomal degradation. Reduction of Bim expression using RNA interference reduced spontaneous apoptosis in adenoma cells and abrogated PGE(2)-dependent apoptosis suppression. Treatment of COX-2-expressing colorectal carcinoma cells with COX-2-selective NSAIDs-induced Bim expression, suggesting that Bim repression via PGE(2) signalling may be opposed by COX-2 inhibition. Examination of Bim expression in two established in vitro models of the adenoma-carcinoma sequence revealed that downregulation of Bim expression was associated with tumour progression towards an anchorage-independent phenotype. Finally, immunohistochemical analyses revealed that Bim expression is markedly reduced in approximately 40% of human colorectal carcinomas in vivo. These observations highlight the COX-2/PGE(2) pathway as an important negative regulator of Bim expression in colorectal tumours and suggest that Bim repression may be an important step during colorectal cancer tumorigenesis. Oncogene (2010) 29, 3398-3410; doi:10.1038/onc.2010.94; published online 29 March 2010	[Greenhough, A.; Wallam, C. A.; Hicks, D. J.; Williams, A. C.; Paraskeva, C.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Canc Res UK Colorectal Tumour Biol Grp, Bristol BS8 1TD, Avon, England; [Moorghen, M.] Bristol Royal Infirm & Gen Hosp, Dept Clin Pathol, Bristol, Avon, England	University of Bristol; Bristol Royal Infirmary	Greenhough, A (corresponding author), Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Canc Res UK Colorectal Tumour Biol Grp, Bristol BS8 1TD, Avon, England.	a.greenhough@bristol.ac.uk	Greenhough, Alexander/Y-6728-2019; Greenhough, Alexander/J-9308-2012	Greenhough, Alexander/0000-0002-8306-811X; Greenhough, Alexander/0000-0002-8306-811X; Williams, Ann/0000-0002-6009-7137	Citrina Foundation; John James Bristol Foundation; Cancer Research UK programme	Citrina Foundation; John James Bristol Foundation; Cancer Research UK programme(Cancer Research UK)	We thank Debbie Martin and Gini Tilly for help with histology; David Huang for provision of Bim wild-type and null iMEF cells; Andy Silver and Nirosha Suraweera for sequencing analysis; Andy Herman for help with flow cytometry, and members of the CP group for useful discussion. This work was funded by the Citrina Foundation, the John James Bristol Foundation, and by a Cancer Research UK programme grant.	Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; BEDI A, 1995, CANCER RES, V55, P1811; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Clemo NK, 2008, CARCINOGENESIS, V29, P849, DOI 10.1093/carcin/bgn004; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Crew TE, 2000, CARCINOGENESIS, V21, P69, DOI 10.1093/carcin/21.1.69; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elder DJE, 2002, J PATHOL, V198, P428, DOI 10.1002/path.1232; Elder DJE, 1998, NAT MED, V4, P392, DOI 10.1038/nm0498-392; Elder DJE, 1996, CANCER RES, V56, P2273; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Greenhough A, 2007, INT J CANCER, V121, P2172, DOI 10.1002/ijc.22917; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; HAGUE A, 1994, ONCOGENE, V9, P3367; HALL PA, 1994, J CELL SCI, V107, P3569; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; Hawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Krajewska M, 1996, CANCER RES, V56, P2422; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Loveridge CJ, 2008, ONCOGENE, V27, P2648, DOI 10.1038/sj.onc.1210891; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; PARASKEVA C, 1989, CANCER RES, V49, P1282; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rice PL, 2004, CANCER RES, V64, P8148, DOI 10.1158/0008-5472.CAN-04-1517; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Wickenden JA, 2008, ONCOGENE, V27, P7150, DOI 10.1038/onc.2008.335; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; WILLIAMS AC, 1990, CANCER RES, V50, P4724; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yang F, 2009, J VIB CONTROL, V15, P233, DOI 10.1177/1077546308091220; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510	74	35	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3398	3410		10.1038/onc.2010.94	http://dx.doi.org/10.1038/onc.2010.94			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20348947	Green Accepted			2022-12-25	WOS:000278622700008
J	Di, AK; Kawamura, T; Gao, XP; Tang, HY; Berdyshev, E; Vogel, SM; Zhao, YY; Sharma, T; Bachmaier, K; Xu, JS; Malik, AB				Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Tang, Haiyang; Berdyshev, Evgeny; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.			A Novel Function of Sphingosine Kinase 1 Suppression of JNK Activity in Preventing Inflammation and Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; LUNG VASCULAR-PERMEABILITY; TOLL-LIKE RECEPTOR; ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-MECHANISMS; ADHESION MOLECULES; SIGNALING PATHWAYS; BETA(2) INTEGRINS	The mechanism underlying the protective effect of sphingosine kinase 1 (SphK1) in inflammatory injury is not clear. We demonstrated using SphK1-null mice (SphK1(-/-)) the crucial role of SphK1 in suppressing lipopolysaccharide-induced neutrophil oxidant production and sequestration in lungs and mitigating lung inflammatory injury. This effect of SphK1 was independent of the production of sphingosine 1-phosphate, the product of SphK1 activity. The anti-inflammatory effect of SphK1 in the lipopolysaccharide model was mediated through SphK1 interaction with JNK. SphK1 stabilization of JNK in turn inhibited JNK binding to the JNK-interacting protein 3 (JIP3) and thus abrogated the activation of NADPH oxidase and oxidant generation and resultant NF-kappa B activation. Therefore, SphK1-mediated down-regulation of JNK activity serves to dampen inflammation and tissue injury.	[Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Di, Anke; Kawamura, Takeshi; Gao, Xiao-Pei; Vogel, Stephen M.; Zhao, You-Yang; Sharma, Tiffany; Bachmaier, Kurt; Xu, Jingsong; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Tang, Haiyang; Xu, Jingsong] Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60612 USA; [Berdyshev, Evgeny] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Di, AK (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, E403 MSB,835 S Wolcott Ave, Chicago, IL 60612 USA.	ankedi@uic.edu	Bachmaier, Kurt/B-6331-2014; Bachmaier, Kurt/AHC-5491-2022; TANG, HAIYANG/J-4006-2013	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128; ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [P01 HL77806]; Parker B. Francis Fellowship in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL77806. This work was also supported by a Parker B. Francis Fellowship in Pulmonary Research.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beaven MA, 2007, IMMUNITY, V26, P271, DOI 10.1016/j.immuni.2007.03.002; Bhattacharya J, 2004, AM J RESP CRIT CARE, V170, P928, DOI 10.1164/rccm.2408008; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Chen CC, 2004, MOL PHARMACOL, V66, P683; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; French KJ, 2003, CANCER RES, V63, P5962; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hordijk PL, 2003, CELL BIOCHEM BIOPHYS, V38, P305, DOI 10.1385/CBB:38:3:305; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Kawasumi M, 2002, NEUROSIGNALS, V11, P236, DOI 10.1159/000067424; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Malik AB, 1996, PHARMACOL REV, V48, P213; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Olivera A, 2008, PROSTAG OTH LIPID M, V86, P1, DOI 10.1016/j.prostaglandins.2008.02.005; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; SMITH CW, 1993, SEMIN HEMATOL, V30, P45; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TATE RM, 1983, AM REV RESPIR DIS, V128, P552, DOI 10.1164/arrd.1983.128.3.552; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407	52	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15848	15857		10.1074/jbc.M109.075549	http://dx.doi.org/10.1074/jbc.M109.075549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299461	Green Published, hybrid			2022-12-25	WOS:000277715900022
J	Taube, JH; Allton, K; Duncan, SA; Shen, LL; Barton, MC				Taube, Joseph H.; Allton, Kendra; Duncan, Stephen A.; Shen, Lanlan; Barton, Michelle Craig			Foxa1 Functions as a Pioneer Transcription Factor at Transposable Elements to Activate Afp during Differentiation of Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FETOPROTEIN GENE; GROWTH-FACTOR-BETA; SMAD INTERACTION MOTIF; RETINOIC ACID; CHROMATIN-STRUCTURE; IN-VIVO; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAYS; SELF-RENEWAL; TGF-BETA	Epigenetic control of genes that are silent in embryonic stem cells, but destined for expression during differentiation, includes distinctive hallmarks, such as simultaneous activating/repressing (bivalent) modifications of chromatin and DNA hypomethylation at enhancers of gene expression. Although alpha-fetoprotein (Afp) falls into this class of genes, as it is silent in pluripotent stem cells and activated during differentiation of endoderm, we find that Afp chromatin lacks bivalent histone modifications. However, critical regulatory sites for Afp activation, overlapping Foxa1/p53/Smad-binding elements, are located within a 300-bp region lacking DNA methylation, due to transposed elements underrepresented in CpG sequences: a short interspersed transposable element and a medium reiterated sequence 1 element. Forkhead family member Foxa1 is activated by retinoic acid treatment of embryonic stem cells, binds its DNA consensus site within the short interspersed transposable/medium reiterated sequence 1 elements, and displaces linker histone H1 from silent Afp chromatin. Small interfering RNA depletion of Foxa1 showed that Foxa1 is essential in providing chromatin access to transforming growth factor beta-activated Smad2 and Smad4 and their subsequent DNA binding. Together these transcription factors establish highly acetylated chromatin and promote expression of Afp. Foxa1 acts as a pioneer transcription factor in de novo activation of Afp, by exploiting a lack of methylation at juxtaposed transposed elements, to bind and poise chromatin for intersection with transforming growth factor beta signaling during differentiation of embryonic stem cells.	[Taube, Joseph H.; Allton, Kendra; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Grad Sch Biomed Sci, Dept Biochem & Mol Biol,Program Genes & Dev, Houston, TX 77030 USA; [Shen, Lanlan] Baylor Coll Med, USDA Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; United States Department of Agriculture (USDA); Medical College of Wisconsin	Barton, MC (corresponding author), 1515 Holcombe Blvd,Box 1000, Houston, TX 77030 USA.	mbarton@mdanderson.org		Duncan, Stephen/0000-0002-2507-7827; Taube, Joseph/0000-0002-3636-5189; Barton, Michelle/0000-0002-4042-1374; Allton, KENDRA/0000-0002-4204-0807	National Institutes of Health [GM53683, GM081627, T32 HD007325]; National Institutes of Health NCI Cancer Center; American Legion Auxiliary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053683, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Legion Auxiliary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53683 and GM081627 (to M. C. B.) and a National Institutes of Health NCI Cancer Center Support grant to the University of Texas M. D. Anderson Cancer Center.; Supported by National Institutes of Health Training Grant T32 HD007325 and the American Legion Auxiliary.	ALEXANDER F, 1984, J MOL BIOL, V173, P159, DOI 10.1016/0022-2836(84)90187-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borger DR, 2000, VIROLOGY, V270, P397, DOI 10.1006/viro.2000.0282; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Carnell AN, 2003, TOXICOL SCI, V75, P229, DOI 10.1093/toxsci/kfg138; CASCIO S, 1991, DEVELOPMENT, V113, P217; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Defacque H, 1997, LEUKEMIA, V11, P221, DOI 10.1038/sj.leu.2400568; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Germain S, 2000, GENE DEV, V14, P435; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; GORIN MB, 1981, J BIOL CHEM, V256, P1954; Grandel H, 2002, DEVELOPMENT, V129, P2851; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jacob A, 1999, EXP CELL RES, V250, P1, DOI 10.1006/excr.1999.4512; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nunes I, 1996, CANCER RES, V56, P495; Ogden SK, 2001, J BIOL CHEM, V276, P42057, DOI 10.1074/jbc.C100381200; PIQUETPELLORCE C, 1994, EXP CELL RES, V213, P340, DOI 10.1006/excr.1994.1208; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; SCHMID P, 1990, DIFFERENTIATION, V45, P96, DOI 10.1111/j.1432-0436.1990.tb00462.x; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; SHIOJIRI N, 1981, J EMBRYOL EXP MORPH, V62, P139; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Teratani T, 2005, HEPATOLOGY, V41, P836, DOI 10.1002/hep.20629; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wilkinson DS, 2008, MOL CELL BIOL, V28, P1988, DOI 10.1128/MCB.01442-07; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	72	54	57	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16135	16144		10.1074/jbc.M109.088096	http://dx.doi.org/10.1074/jbc.M109.088096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348100	Green Published, hybrid			2022-12-25	WOS:000277715900051
J	Brakemann, T; Weber, G; Andresen, M; Groenhof, G; Stiel, AC; Trowitzsch, S; Eggeling, C; Grubmuller, H; Hell, SW; Wahl, MC; Jakobs, S				Brakemann, Tanja; Weber, Gert; Andresen, Martin; Groenhof, Gerrit; Stiel, Andre C.; Trowitzsch, Simon; Eggeling, Christian; Grubmueller, Helmut; Hell, Stefan W.; Wahl, Markus C.; Jakobs, Stefan			Molecular Basis of the Light-driven Switching of the Photochromic Fluorescent Protein Padron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MECHANISM	Reversibly switchable fluorescent proteins can be repeatedly photoswitched between a fluorescent and a nonfluorescent state by irradiation with the light of two different wavelengths. The molecular basis of the switching process remains a controversial topic. Padron0.9 is a reversibly switchable fluorescent protein with "positive" switching characteristics, exhibiting excellent spectroscopic properties. Its chromophore is formed by the amino acids Cys-Tyr-Gly. We obtained high resolution x-ray structures of Padron0.9 in both the fluorescent and the nonfluorescent states and used the structural information for molecular dynamics simulations. We found that in Padron0.9 the chromophore undergoes a cis-trans isomerization upon photoswitching. The molecular dynamics simulations clarified the protonation states of the amino acid residues within the chromophore pocket that influence the protonation state of the chromophore. We conclude that a light driven cis-trans isomerization of the chromophore appears to be the fundamental switching mechanism in all photochromic fluorescent proteins known to date. Distinct absorption cross-sections for the switching wavelengths in the fluorescent and the nonfluorescent state are not essential for efficient photochromism in fluorescent proteins, although they may facilitate the switching process.	[Brakemann, Tanja; Andresen, Martin; Stiel, Andre C.; Eggeling, Christian; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Weber, Gert; Trowitzsch, Simon; Wahl, Markus C.] Max Planck Inst Biophys Chem, Dept Cellular Biochem Xray Crystallog, D-37077 Gottingen, Germany; [Groenhof, Gerrit; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Free University of Berlin	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.	sjakobs@gwdg.de	Jakobs, Stefan/F-4898-2012; Weber, Gert/I-1800-2013; Trowitzsch, Simon/O-4957-2016; Wahl, Markus C./D-6365-2017; Stiel, Andre/B-1644-2014	Jakobs, Stefan/0000-0002-8028-3121; Weber, Gert/0000-0003-3624-1060; Trowitzsch, Simon/0000-0001-9143-766X; Wahl, Markus C./0000-0002-2811-5307; Stiel, Andre/0000-0001-8675-6797; Groenhof, Gerrit/0000-0001-8148-5334	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (to S. W. H.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Fron E, 2007, J AM CHEM SOC, V129, P4870, DOI 10.1021/ja069365v; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Klingen AR, 2006, PHOTOCH PHOTOBIO SCI, V5, P588, DOI 10.1039/b515479k; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Moors SLC, 2008, J CHEM THEORY COMPUT, V4, P1012, DOI 10.1021/ct8000359; Nienhaus GU, 2009, CHEMPHYSCHEM, V10, P1369, DOI 10.1002/cphc.200800839; Oelgemoller M, 2002, J CHEM SOC PERK T 2, P1760, DOI 10.1039/b203167a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; Schafer LV, 2007, ANGEW CHEM INT EDIT, V46, P530, DOI 10.1002/anie.200602315; Schuttrigkeit TA, 2006, CHEM PHYS, V323, P149, DOI 10.1016/j.chemphys.2005.09.039; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199	28	52	54	0	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14603	14609		10.1074/jbc.M109.086314	http://dx.doi.org/10.1074/jbc.M109.086314			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236929	Green Published, hybrid			2022-12-25	WOS:000277299700057
J	Schmidt, DR; Holmstrom, SR; Tacer, KF; Bookout, AL; Kliewer, SA; Mangelsdorf, DJ				Schmidt, Daniel R.; Holmstrom, Sam R.; Tacer, Klementina Fon; Bookout, Angie L.; Kliewer, Steven A.; Mangelsdorf, David J.			Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FEEDBACK-REGULATION; LITHOCHOLIC ACID; X-RECEPTOR; LIVER; ACTIVATION; CANCER; HOMEOSTASIS; ENZYMES	Bile acids are required for proper absorption of dietary lipids, including fat-soluble vitamins. Here, we show that the dietary vitamins A and D inhibit bile acid synthesis by repressing hepatic expression of the rate-limiting enzyme CYP7A1. Receptors for vitamin A and D induced expression of Fgf15, an intestine-derived hormone that acts on liver to inhibit Cyp7a1. These effects were mediated through distinct cis-acting response elements in the promoter and intron of Fgf15. Interestingly, transactivation of both response elements appears to be required to maintain basal Fgf15 expression levels in vivo. Furthermore, whereas induction of Fgf15 by vitamin D is mediated through its receptor, the induction of Fgf15 by vitamin A is mediated through the retinoid X receptor/farnesoid X receptor heterodimer and is independent of bile acids, suggesting that this heterodimer functions as a distinct dietary vitamin A sensor. Notably, vitamin A treatment reversed the effects of the bile acid sequestrant cholestyramine on Fgf15, Shp, and Cyp7a1 expression, suggesting a potential therapeutic benefit of vitamin A under conditions of bile acid malabsorption. These results reveal an unexpected link between the intake of fat-soluble vitamins A and D and bile acid metabolism, which may have evolved as a means for these dietary vitamins to regulate their own absorption.	[Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Holmstrom, Sam R.; Tacer, Klementina Fon; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas		steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796	National Institutes of Health [U19DK62434, GM07062, CA114109]; Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-1558]; NATIONAL CANCER INSTITUTE [R01CA114109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U19DK62434 (to D. J. M.), GM07062 (to D. R. S. and A. L. B.), and CA114109 (to S. A. K.). This work was also supported by the Howard Hughes Medical Institute and Robert A. Welch Foundation Grants I-1275 (to D. J. M.) and I-1558 (to S. A. K.).	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Crestani M, 1998, J LIPID RES, V39, P2192; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Gilardi F, 2007, PHARMACOL THERAPEUT, V116, P449, DOI 10.1016/j.pharmthera.2007.08.003; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haussler MR, 1997, J ENDOCRINOL, V154, pS57; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hofmann AF, 2009, CLIN GASTROENTEROL H, V7, P1151, DOI 10.1016/j.cgh.2009.07.026; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mangelsdorf DJ, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P863; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; Nehring JA, 2007, P NATL ACAD SCI USA, V104, P10006, DOI 10.1073/pnas.0703512104; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; ROSS AC, 1993, J NUTR, V123, P346, DOI 10.1093/jn/123.suppl_2.346; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Walters JRF, 2009, CLIN GASTROENTEROL H, V7, P1189, DOI 10.1016/j.cgh.2009.04.024; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S	38	149	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14486	14494		10.1074/jbc.M110.116004	http://dx.doi.org/10.1074/jbc.M110.116004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233723	Green Published, hybrid			2022-12-25	WOS:000277299700045
J	Liu, ZB; Hou, YF; Zhu, J; Hu, DL; Jin, W; Ou, ZL; Di, GH; Wu, J; Shen, ZZ; Shao, ZM				Liu, Z-B; Hou, Y-F; Zhu, J.; Hu, D-L; Jin, W.; Ou, Z-L; Di, G-H; Wu, J.; Shen, Z-Z; Shao, Z-M			Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner	ONCOGENE			English	Article						PA-MSHA vaccine; breast tumor; EGFR; mannose; sugar binding	UROPATHOGENIC ESCHERICHIA-COLI; GROWTH-FACTOR RECEPTOR; EPITHELIAL-CELLS; IN-VITRO; CARBOHYDRATE INTERACTIONS; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; ADHERENCE	To identify more therapeutic targets and clarify the detailed mechanisms of Pseudomonas aeruginosa-mannose-sensitive hemagglutinin (PA-MSHA) on breast cancer cells both in vitro and in vivo. PA-MSHA was administered to epidermal growth factor receptor (EGFR)positive human breast cancer cell lines MDA-MB-231HM and MDA-MB-468 in vitro and to mice bearing tumor xenografts. The mannose cocultured test was used to detect the effect of mannose on PA-MSHA-induced cell proliferation, cell cycle arrest, apoptosis, and EGFR pathway signaling. We found that cells stimulated with PA-MSHA exhibited a downregulation of EGFR signaling. The addition of mannose partially inhibited the PA-MSHA-stimulated cell anti-proliferative effect, cell apoptosis, cell cycle arrest, activation of apoptosis-associated caspases, and even downregulation of the EGFR signaling pathway. In vivo, PA-MSHA treatment significantly suppressed mammary tumorigenesis in xenografts in mice and decreased lung metastasis in MDA-MB-231HM cell-transplanted mice. Tumor sample analyses confirmed inhibition of the EGFR pathway in the PA-MSHA-treated mice. In conclusion, this study showed that the involvement of the mannose-mediated EGFR pathway has a critical function in the preclinical rationale for the development of PA-MSHA for the treatment of human breast cancer. It also suggests the potentially beneficial use of PA-MSHA in adjuvant therapy for breast tumors with EGFR overexpression. Oncogene (2010) 29, 2996-3009; doi:10.1038/onc.2010.70; published online 15 March 2010	[Liu, Z-B; Hou, Y-F; Jin, W.; Ou, Z-L; Di, G-H; Wu, J.; Shen, Z-Z; Shao, Z-M] Fudan Univ, Dept Breast Surg, Breast Canc Inst, Canc Hosp, Shanghai 200032, Peoples R China; [Liu, Z-B; Hou, Y-F; Jin, W.; Ou, Z-L; Di, G-H; Wu, J.; Shen, Z-Z; Shao, Z-M] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Liu, Z-B; Hou, Y-F; Jin, W.; Ou, Z-L; Di, G-H; Wu, J.; Shen, Z-Z; Shao, Z-M] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Zhu, J.; Hu, D-L] Shanghai Homejoy Pharmaceut Co Ltd, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Dept Breast Surg, Breast Canc Inst, Canc Hosp, 399 Ling Ling Rd, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907	Fudan University [EHF159201]; National Basic Research Program of China [2006CB910501]; National Natural Science Foundation of China [30371580, 30572109]; Shanghai Science and Technology Committee [06DJ14004, 06DZ19504, 08ZR1403500]	Fudan University; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	We are grateful to Professor Xi-Liang Zha for providing technical assistance. This work was supported in part by the Key Discipline Innovation Personnel Training Program of Fudan University (Contract grant number: EHF159201), National Basic Research Program of China (Contract grant number: 2006CB910501), the National Natural Science Foundation of China (Contract grant numbers: 30371580 and 30572109), and the Shanghai Science and Technology Committee (Contract grant numbers: 06DJ14004, 06DZ19504, and 08ZR1403500).	Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; DUGUID JAMES P., 1968, ARCH IMMUNOL THER EXP, V16, P173; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; ESHDAT Y, 1984, BIOL CELL, V51, P259, DOI 10.1111/j.1768-322X.1984.tb00307.x; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; HARPER M, 1978, J MED MICROBIOL, V11, P117, DOI 10.1099/00222615-11-2-117; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Karlsson KA, 2001, ADV EXP MED BIOL, V491, P431; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; King SS, 2000, AM J VET RES, V61, P446, DOI 10.2460/ajvr.2000.61.446; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; KORHONEN TK, 1981, INFECT IMMUN, V32, P796, DOI 10.1128/IAI.32.2.796-804.1981; Lage A, 2003, ANN MED, V35, P327, DOI 10.1080/07853890310010889; Liu B, 2009, AUTOPHAGY, V5, P432, DOI 10.4161/auto.5.3.7924; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; McEwan NA, 2008, VET DERMATOL, V19, P221, DOI 10.1111/j.1365-3164.2008.00678.x; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Schaerli P, 1998, CELL MOL LIFE SCI, V54, P129, DOI 10.1007/s000180050132; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; STEPINSKA M, 1995, FEMS IMMUNOL MED MIC, V12, P187, DOI 10.1016/0928-8244(95)00066-6; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	31	28	42	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	20					2996	3009		10.1038/onc.2010.70	http://dx.doi.org/10.1038/onc.2010.70			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20228837				2022-12-25	WOS:000277890400010
J	Sierra, R; Rodriguez, LM; Chaves, D; Pinzon, A; Grajales, A; Rojas, A; Mutis, G; Cardenas, M; Burbano, D; Jimenez, P; Bernal, A; Restrepo, S				Sierra, Roberto; Rodriguez-R, Luis M.; Chaves, Diego; Pinzon, Andres; Grajales, Alejandro; Rojas, Alejandro; Mutis, Gabriel; Cardenas, Martha; Burbano, Daniel; Jimenez, Pedro; Bernal, Adriana; Restrepo, Silvia			Discovery of Phytophthora infestans Genes Expressed in Planta through Mining of cDNA Libraries	PLOS ONE			English	Article							LATE BLIGHT; RXLR EFFECTORS; POTATO GENES; DISEASE RESISTANCE; SEQUENCE; REVEALS; PROTEIN; ACTIVATION; GENERATION; TOMATO	Background: Phytophthora infestans (Mont.) de Bary causes late blight of potato and tomato, and has a broad host range within the Solanaceae family. Most studies of the Phytophthora - Solanum pathosystem have focused on gene expression in the host and have not analyzed pathogen gene expression in planta. Methodology/Principal Findings: We describe in detail an in silico approach to mine ESTs from inoculated host plants deposited in a database in order to identify particular pathogen sequences associated with disease. We identified candidate effector genes through mining of 22,795 ESTs corresponding to P. infestans cDNA libraries in compatible and incompatible interactions with hosts from the Solanaceae family. Conclusions/Significance: We annotated genes of P. infestans expressed in planta associated with late blight using different approaches and assigned putative functions to 373 out of the 501 sequences found in the P. infestans genome draft, including putative secreted proteins, domains associated with pathogenicity and poorly characterized proteins ideal for further experimental studies. Our study provides a methodology for analyzing cDNA libraries and provides an understanding of the plant - oomycete pathosystems that is independent of the host, condition, or type of sample by identifying genes of the pathogen expressed in planta.	[Sierra, Roberto; Rodriguez-R, Luis M.; Chaves, Diego; Pinzon, Andres; Grajales, Alejandro; Rojas, Alejandro; Mutis, Gabriel; Cardenas, Martha; Bernal, Adriana; Restrepo, Silvia] Univ Los Andes, Dept Ciencias Biol, Bogota Dist Capital, Colombia; [Burbano, Daniel] Univ Los Andes, Direcc Tecnol Informat, Bogota Dist Capital, Colombia; [Jimenez, Pedro] Univ Los Andes, Programa Biol Aplicada, Bogota Dist Capital, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Sierra, R (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	srestrep@uniandes.edu.co	Rojas, J Alejandro/D-9273-2016; Restrepo, Silvia/G-1297-2010; Rojas, J Alejandro/AAH-7285-2019; Grajales, Alejandro/AAU-6606-2020; Rodriguez-R, Luis M./S-6996-2018	Rojas, J Alejandro/0000-0001-5492-5963; Rojas, J Alejandro/0000-0001-5492-5963; Grajales, Alejandro/0000-0003-3984-3323; Rodriguez-R, Luis M./0000-0001-7603-3093; Restrepo, Silvia/0000-0001-9016-1040; Cardenas, Martha/0000-0002-2009-4126; Pinzon, Andres/0000-0002-4133-810X; Bernal, Adriana/0000-0002-3557-697X; Sierra, Roberto/0000-0002-8657-1781				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beyer K, 2001, MOL PLANT PATHOL, V2, P125, DOI 10.1046/j.1364-3703.2001.00059.x; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huitema E, 2003, METH MOL B, V236, P79; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Kamoun S, 2005, PLANT DIS, V89, P692, DOI 10.1094/PD-89-0692; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YJ, 2009, PHYSIOL PLANTARUM, V136, P19, DOI 10.1111/j.1399-3054.2009.01209.x; MORGAN W, 2007, CURR OPIN MICROBIOL; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronning CM, 2003, PLANT PHYSIOL, V131, P419, DOI 10.1104/pp.013581; Ros B, 2004, MOL PLANT PATHOL, V5, P191, DOI [10.1111/j.1364-3703.2004.00221.x, 10.1111/J.1364-3703.2004.00221.X]; Ros B, 2008, PHYSIOL PLANTARUM, V133, P386, DOI 10.1111/j.1399-3054.2008.01048.x; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Tian ZD, 2006, PLANT CELL REP, V25, P1094, DOI 10.1007/s00299-006-0169-7; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang BL, 2005, PLANT SCI, V169, P1155, DOI 10.1016/j.plantsci.2005.07.020; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9847	10.1371/journal.pone.0009847	http://dx.doi.org/10.1371/journal.pone.0009847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352100	Green Submitted, gold, Green Published			2022-12-25	WOS:000275894500015
J	Cazorla, M; Jouvenceau, A; Rose, C; Guilloux, JP; Pilon, C; Dranovsky, A; Premont, J				Cazorla, Maxime; Jouvenceau, Anne; Rose, Christiane; Guilloux, Jean-Philippe; Pilon, Catherine; Dranovsky, Alex; Premont, Joel			Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC RECEPTOR TRKB; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; MOTOR-NEURONS; SOCIAL DEFEAT; BDNF FUNCTION; BRAIN; ACTIVATION	In the last decades, few mechanistically novel therapeutic agents have been developed to treat mental and neurodegenerative disorders. Numerous studies suggest that targeting BDNF and its TrkB receptor could be a promising therapeutic strategy for the treatment of brain disorders. However, the development of potent small ligands for the TrkB receptor has proven to be difficult. By using a peptidomimetic approach, we developed a highly potent and selective TrkB inhibitor, cyclotraxin-B, capable of altering TrkB-dependent molecular and physiological processes such as synaptic plasticity, neuronal differentiation and BDNF-induced neurotoxicity. Cyclotraxin-B allosterically alters the conformation of TrkB, which leads to the inhibition of both BDNF-dependent and -independent ( basal) activities. Finally, systemic administration of cyclotraxin-B to mice results in TrkB inhibition in the brain with specific anxiolytic-like behavioral effects and no antidepressant-like activity. This study demonstrates that cyclotraxin-B might not only be a powerful tool to investigate the role of BDNF and TrkB in physiology and pathology, but also represents a lead compound for the development of new therapeutic strategies to treat brain disorders.	[Cazorla, Maxime; Dranovsky, Alex] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY 10027 USA; [Cazorla, Maxime; Jouvenceau, Anne; Rose, Christiane; Guilloux, Jean-Philippe; Pilon, Catherine; Premont, Joel] Univ Paris 05, INSERM, UMR 894, Ctr Psychiat & Neurosci, Paris, France	Columbia University; New York State Psychiatry Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cazorla, M (corresponding author), Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY 10027 USA.	mc3195@columbia.edu	Dranovsky, Alex/P-4357-2018; Guilloux, Jean-Philippe/B-3726-2015; Jouvenceau, Anne/A-9694-2016; JP, Guilloux/Z-5069-2019; Cazorla, Maxime/M-6425-2014	Dranovsky, Alex/0000-0001-7896-3243; Guilloux, Jean-Philippe/0000-0003-0982-3751; JP, Guilloux/0000-0003-0982-3751; Cazorla, Maxime/0000-0002-8260-1154	INSERM; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088, R01MH091844] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been supported by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; BRAHIMI F, 2009, PEPTIDES; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Durany N, 2004, EUR PSYCHIAT, V19, P326, DOI 10.1016/j.eurpsy.2004.06.020; Fletcher JM, 2008, J BIOL CHEM, V283, P33375, DOI 10.1074/jbc.M802789200; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Hu P, 2003, J NEUROCHEM, V84, P1421, DOI 10.1046/j.1471-4159.2003.01599.x; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ibanez CF, 1998, TRENDS NEUROSCI, V21, P438, DOI 10.1016/S0166-2236(98)01266-1; IBANEZ CF, 1995, TRENDS BIOTECHNOL, V13, P217, DOI 10.1016/S0167-7799(00)88949-0; ILAG LL, 1994, J BIOL CHEM, V269, P19941; Ivanisevic L, 2007, J BIOL CHEM, V282, P16754, DOI 10.1074/jbc.M701996200; IWAKURA Y, 2008, J BIOL CHEM; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kim HJ, 2003, NEUROBIOL DIS, V14, P110, DOI 10.1016/S0969-9961(03)00103-7; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Marin P, 1997, J NEUROSCI, V17, P3445; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mojsilovic-Petrovic J, 2006, J NEUROSCI, V26, P9250, DOI 10.1523/JNEUROSCI.1856-06.2006; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; O'Leary PD, 1998, J NEUROCHEM, V70, P1712; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Pattarawarapan M, 2003, J MED CHEM, V46, P5277, DOI 10.1021/jm030221q; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sadick MD, 1997, EXP CELL RES, V234, P354, DOI 10.1006/excr.1997.3614; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Xie YM, 2000, J BIOL CHEM, V275, P29868, DOI 10.1074/jbc.M005071200; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zorner B, 2003, BIOL PSYCHIAT, V54, P972, DOI 10.1016/S0006-3223(03)00418-9; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	60	65	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9777	10.1371/journal.pone.0009777	http://dx.doi.org/10.1371/journal.pone.0009777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333308	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809700015
J	Lokesh, B; Rashmi, PR; Amruta, BS; Srisathiyanarayanan, D; Murthy, MRN; Savithri, HS				Lokesh, Bhushan; Rashmi, Panigrahi R.; Amruta, Bhat S.; Srisathiyanarayanan, Dharmaiah; Murthy, Mathur R. N.; Savithri, Handanahal S.			NSs Encoded by Groundnut Bud Necrosis Virus Is a Bifunctional Enzyme	PLOS ONE			English	Article							STIMULATED NUCLEOSIDE TRIPHOSPHATASE; COMPLETE NUCLEOTIDE-SEQUENCE; RNA HELICASE; MUTATIONAL ANALYSIS; S-RNA; GENOME ORGANIZATION; PROTEIN; DNA; TOSPOVIRUS; 5'-TRIPHOSPHATASE	Groundnut bud necrosis virus (GBNV), a member of genus Tospovirus in the family Bunyaviridae, infects a large number of leguminosae and solanaceae plants in India. With a view to elucidate the function of nonstructural protein, NSs encoded by the small RNA genome (S RNA), the NSs protein of GBNV-tomato (Karnataka) [1] was over-expressed in E. coli and purified by Ni-NTA chromatography. The purified rNSs protein exhibited an RNA stimulated NTPase activity. Further, this activity was metal ion dependent and was inhibited by adenosine 5' (beta, gamma imido) triphosphate, an ATP analog. The rNSs could also hydrolyze dATP. Interestingly, in addition to the NTPase and dATPase activities, the rNSs exhibited ATP independent 5' RNA/DNA phosphatase activity that was completely inhibited by AMP. The 5' alpha phosphate could be removed from ssDNA, ssRNA, dsDNA and dsRNA thus confirming that rNSs has a novel 5' alpha phosphatase activity. K189A mutation in the Walker motif A (GxxxxGKT) resulted in complete loss of ATPase activity, but the 5' phosphatase activity was unaffected. On the other hand, D159A mutation in the Walker motif B (DExx) resulted in partial loss of both the activities. These results demonstrate for the first time that NSs is a bifunctional enzyme, which could participate in viral movement, replication or in suppression of the host defense mechanism.	[Lokesh, Bhushan; Amruta, Bhat S.; Srisathiyanarayanan, Dharmaiah; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Rashmi, Panigrahi R.; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Lokesh, B (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in	Panigrahi, Rashmi/AAK-2432-2020; Dharmaiah, Srisathiyanarayanan/B-2887-2009	Panigrahi, Rashmi/0000-0002-1727-9269; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962	Department of Biotechnology and Department of Science and Technology New Delhi, India	Department of Biotechnology and Department of Science and Technology New Delhi, India	Department of Biotechnology and Department of Science and Technology New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram M, 2004, ANN APPL BIOL, V145, P285, DOI 10.1111/j.1744-7348.2004.tb00385.x; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bhat AI, 2002, CURR SCI INDIA, V82, P1389; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; BROYLES SS, 1987, J VIROL, V61, P1738, DOI 10.1128/JVI.61.5.1738-1742.1987; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; Gowda S, 1998, ARCH VIROL, V143, P2381, DOI 10.1007/s007050050468; GROSS CH, 1995, J VIROL, V69, P4727, DOI 10.1128/JVI.69.8.4727-4736.1995; Jain R. K., 2004, Indian Phytopathology, V57, P169; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kadare G, 1997, J VIROL, V71, P2583; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; RICHARD M, 2009, VIRUSES, V1, P1003; Satyanarayana T, 1996, J GEN VIROL, V77, P2347, DOI 10.1099/0022-1317-77-9-2347; Satyanarayana T, 1996, ARCH VIROL, V141, P85, DOI 10.1007/BF01718590; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Umamaheswaran K., 2003, Indian Phytopathology, V56, P168; Venkat H, 2008, CURR SCI INDIA, V95, P952; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; Zhong WD, 1999, VIROLOGY, V261, P216, DOI 10.1006/viro.1999.9871; [No title captured]	43	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9757	10.1371/journal.pone.0009757	http://dx.doi.org/10.1371/journal.pone.0009757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305786	Green Submitted, Green Published, gold			2022-12-25	WOS:000276456300016
J	Schacht, A; Martin-Loeches, M; Casado, P; Rahman, RA; Sel, A; Sommer, W				Schacht, Annekathrin; Martin-Loeches, Manuel; Casado, Pilar; Rahman, Rasha Abdel; Sel, Alejandra; Sommer, Werner			How Is Sentence Processing Affected by External Semantic and Syntactic Information? Evidence from Event-Related Potentials	PLOS ONE			English	Article							BRAIN POTENTIALS; NEURAL BASIS; COMPREHENSION; LANGUAGE; AGREEMENT; INDEPENDENCE; PERSPECTIVE; HEURISTICS; N400	Background: A crucial question for understanding sentence comprehension is the openness of syntactic and semantic processes for other sources of information. Using event-related potentials in a dual task paradigm, we had previously found that sentence processing takes into consideration task relevant sentence-external semantic but not syntactic information. In that study, internal and external information both varied within the same linguistic domain-either semantic or syntactic. Here we investigated whether across-domain sentence-external information would impact within-sentence processing. Methodology: In one condition, adjectives within visually presented sentences of the structure [Det]-[Noun]-[Adjective]-[Verb] were semantically correct or incorrect. Simultaneously with the noun, auditory adjectives were presented that morphosyntactically matched or mismatched the visual adjectives with respect to gender. Findings: As expected, semantic violations within the sentence elicited N400 and P600 components in the ERP. However, these components were not modulated by syntactic matching of the sentence-external auditory adjective. In a second condition, syntactic within-sentence correctness-variations were combined with semantic matching variations between the auditory and the visual adjective. Here, syntactic within-sentence violations elicited a LAN and a P600 that did not interact with semantic matching of the auditory adjective. However, semantic mismatching of the latter elicited a frontocentral positivity, presumably related to an increase in discourse level complexity. Conclusion: The current findings underscore the open versus algorithmic nature of semantic and syntactic processing, respectively, during sentence comprehension.	[Schacht, Annekathrin; Rahman, Rasha Abdel; Sommer, Werner] Humboldt Univ, Dept Psychol, Berlin, Germany; [Martin-Loeches, Manuel; Casado, Pilar; Sel, Alejandra] UCM, ISCII, Ctr Human Evolut & Behav, Madrid, Spain; [Martin-Loeches, Manuel] Univ Complutense Madrid, Dept Psychobiol, Madrid, Spain	Humboldt University of Berlin; Complutense University of Madrid; Complutense University of Madrid	Schacht, A (corresponding author), Humboldt Univ, Dept Psychol, Berlin, Germany.	schachta@hu-berlin.de	Schacht, Annekathrin/B-2521-2014; Sommer, Werner/N-1945-2019; Rahman, Rasha Abdel/J-4687-2015; Martin-Loeches, Manuel/G-4288-2017; Casado, Pilar/GPX-1002-2022; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Rahman, Rasha Abdel/0000-0002-8438-1570; Martin-Loeches, Manuel/0000-0002-3487-8423; Sommer, Werner/0000-0001-5266-3445; Sel, Alex/0000-0002-1601-8833; Schacht, Anne/0000-0001-9471-3842; Lauwereyns, Jan/0000-0003-0551-2550; Casado, PILAR/0000-0002-3991-4155	German Academic Exchange Service; Spanish Ministerio de Education y Ciencia	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Ministerio de Education y Ciencia(Spanish Government)	This research was supported by a grant by the German Academic Exchange Service and the Spanish Ministerio de Education y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Berwick R.C., 1984, GRAMMATICAL BASIS LI; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Filik R, 2008, J COGNITIVE NEUROSCI, V20, P1315, DOI 10.1162/jocn.2008.20090; FRAZIER L, 1987, ATTENTION PERFORM, P559; Friederici AD, 1996, J PSYCHOLINGUIST RES, V25, P157, DOI 10.1007/BF01708424; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Johnson-Laird, 1983, MENTAL MODELS; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1999, LANGUAGE DIVERSITY C; Kutas M., 2006, HDB PSYCHOLINGUISTIC; Marslen-Wilson William., 1987, MODULARITY KNOWLEDGE; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; McClelland JL, 1989, LANG COGNITIVE PROC, V4, pSI287, DOI 10.1080/01690968908406371; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sebastian N., 2000, LEXESP LEXICO INFORM; Severens E, 2008, BRAIN RES, V1228, P135, DOI 10.1016/j.brainres.2008.05.092; Townsend D.J., 2001, SENTENCE COMPREHENSI; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vissers CTWM, 2007, BIOL PSYCHOL, V75, P8, DOI 10.1016/j.biopsycho.2006.10.004; Waters GS, 1996, PSYCHOL REV, V103, P761, DOI 10.1037/0033-295X.103.4.761	40	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9742	10.1371/journal.pone.0009742	http://dx.doi.org/10.1371/journal.pone.0009742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EG	20305820	Green Published, Green Accepted, gold			2022-12-25	WOS:000275809600014
J	Xu, ZJ; Xia, B; Gong, Q; Bailey, J; Groves, B; Radeke, M; Wood, SA; Szumlinski, KK; Ma, D				Xu, Zhuojin; Xia, Bin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Radeke, Monte; Wood, Stephen A.; Szumlinski, Karen K.; Ma, Dzwokai			Identification of a Deubiquitinating Enzyme as a Novel AGS3-Interacting Protein	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; BETA-GAMMA-SUBUNITS; TETRATRICOPEPTIDE REPEAT; GOLGI MEMBRANES; REGULATOR AGS3; ALPHA-SUBUNITS; HT-29 CELLS; FAT FACETS; UBIQUITIN; ACTIVATOR	Activator of G protein Signaling 3 (AGS3) is a receptor-independent G protein activator that has been implicated in multiple biological events such as brain development, neuroplasticity and addiction, cardiac function, Golgi structure/function, macroautophagy and metabolism. However, how AGS3 is regulated is little known. We demonstrate here that AGS3 interacts with a ubiquitin specific protease USP9x, and this interaction is at least partially mediated through the C-terminal G protein regulatory domain of AGS3. Knockdown of USP9x causes a moderate reduction in the level of AGS3. In contrast, overexpression of either USP9x or its deubiquitinating domain UCH increases the amount of AGS3, whereas expression of the mutant UCH domain that lacks deubiquitinating activity does not have the same effect. As previously observed in AGS3 knockdown cells, the localization of several marker proteins of the late Golgi compartments is disturbed in cells depleted of USP9x. Taken together, our study suggests that USP9x can modulate the level of a subpopulation of AGS3, and this modulation plays a role in regulating the structure of the late Golgi compartments. Finally, we have found that levels of AGS3 and USP9x are co-regulated in the prefrontal cortex of rats withdrawn from repeated cocaine treatment. In conjunction with the above data, this observation indicates a potential role of USP9X in the regulation of the AGS3 level during cocaine-induced neuroplasticity.	[Xu, Zhuojin; Xia, Bin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [Xu, Zhuojin; Gong, Qiang; Bailey, Jeffrey; Groves, Benjamin; Radeke, Monte; Szumlinski, Karen K.; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Xia, Bin] Sichuan Univ, Dept Pediat, W China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Wood, Stephen A.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cellular & Mol Therapies, Nathan, Qld 4111, Australia	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Sichuan University; Griffith University	Xu, ZJ (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu	Gong, Qiang/D-5337-2009; Szumlinski, Karen K./J-9617-2015; Gong, Qiang/H-3234-2014; Wood, Stephen A/E-8357-2011	Szumlinski, Karen K./0000-0003-1078-1077; Wood, Stephen A/0000-0002-2576-7457; /0000-0002-6129-2938	American Heart Association (AHA) [07651554]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024038] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the American Heart Association (AHA) award (# 07651554) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) 2008 Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; SCHWICKART M, 2009, NATURE; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; VURAL A, 2010, MOL CELLULA IN PRESS; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	43	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9725	10.1371/journal.pone.0009725	http://dx.doi.org/10.1371/journal.pone.0009725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305814	gold, Green Published			2022-12-25	WOS:000275809600002
J	Jiang, SX; Lee, BC; Fu, YG; Avraham, S; Lim, B; Avraham, HK				Jiang, Shuxian; Lee, Byeong-Chel; Fu, Yigong; Avraham, Shalom; Lim, Bing; Avraham, Hava Karsenty			Reconstitution of Mammary Epithelial Morphogenesis by Murine Embryonic Stem Cells Undergoing Hematopoietic Stem Cell Differentiation	PLOS ONE			English	Article							IN-VIVO; LIFE SPAN; GLAND; MICROENVIRONMENT; EXPRESSION; GROWTH; MODEL	Background: Mammary stem cells are maintained within specific microenvironments and recruited throughout lifetime to reconstitute de novo the mammary gland. Mammary stem cells have been isolated through the identification of specific cell surface markers and in vivo transplantation into cleared mammary fat pads. Accumulating evidence showed that during the reformation of mammary stem cell niches by dispersed epithelial cells in the context of the intact epithelium-free mammary stroma, non-mammary epithelial cells may be sequestered and reprogrammed to perform mammary epithelial cell functions and to adopt mammary epithelial characteristics during reconstruction of mammary epithelium in regenerating mammary tissue in vivo. Methodology/Principal Findings: To examine whether other types of progenitor cells are able to contribute to mammary branching morphogenesis, we examined the potential of murine embryonic stem (mES) cells, undergoing hematopoietic differentiation, to support mammary reconstitution in vivo. We observed that cells from day 14 embryoid bodies (EBs) under hematopoietic differentiation condition, but not supernatants derived from these cells, when transplanted into denuded mammary fat pads, were able to contribute to both the luminal and myoepithelial lineages in branching ductal structures resembling the ductal-alveolar architecture of the mammary tree. No teratomas were observed when these cells were transplanted in vivo. Conclusions/Significance: Our data provide evidence for the dominance of the tissue-specific mammary stem cell niche and its role in directing mES cells, undergoing hematopoietic differentiation, to reprogram into mammary epithelial cells and to promote mammary epithelial morphogenesis. These studies should also provide insights into regeneration of damaged mammary gland and the role of the mammary microenvironment in reprogramming cell fate.	[Jiang, Shuxian; Fu, Yigong; Avraham, Shalom; Avraham, Hava Karsenty] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; [Jiang, Shuxian; Fu, Yigong; Avraham, Shalom; Lim, Bing; Avraham, Hava Karsenty] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Pittsburgh, PA USA; [Lim, Bing] Genome Inst Singapore, Singapore, Singapore	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Jiang, SX (corresponding author), Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA.	havraham@bidmc.harvard.edu		Avraham, Hava/0000-0002-7545-3640	National Institutes of Health [CA096805, CA13522]; Career Enhancement Award [K18 PAR-02-069, DK-47636]; NATIONAL CANCER INSTITUTE [R01CA096805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Enhancement Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (Grant CA 096805 and CA13522, H. A., Career Enhancement Award K18 PAR-02-069, H. A., and DK-47636, B. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2009, CELL CYCLE, V8, P1127, DOI 10.4161/cc.8.8.8189; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; DANIEL CW, 1965, SCIENCE, V149, P634, DOI 10.1126/science.149.3684.634; DANIEL CW, 1971, EXP CELL RES, V65, P27, DOI 10.1016/S0014-4827(71)80046-0; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; DEOME KB, 1959, CANCER RES, V19, P515; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH GH, 1991, J VIROL, V65, P6365, DOI 10.1128/JVI.65.11.6365-6370.1991; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	21	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9707	10.1371/journal.pone.0009707	http://dx.doi.org/10.1371/journal.pone.0009707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300573	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000275621000018
J	Katriel, G; Stone, L				Katriel, Guy; Stone, Lewi			Pandemic Dynamics and the Breakdown of Herd Immunity	PLOS ONE			English	Article							INFLUENZA EPIDEMICS	In this note we discuss the issues involved in attempting to model pandemic dynamics. More specifically, we show how it may be possible to make projections for the ongoing H1N1 pandemic as extrapolated from knowledge of seasonal influenza. We derive first-approximation parameter estimates for the SIR model to describe seasonal influenza, and then explore the implications of the existing classical epidemiological theory for the case of a pandemic virus. In particular, we note the dramatic nonlinear increase in attack rate as a function of the percentage of susceptibles initially present in the population. This has severe consequences for the pandemic, given the general lack of immunity in the global population.	[Katriel, Guy; Stone, Lewi] Tel Aviv Univ, George S Wise Fac Life Sci, Biomath Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University	Katriel, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Biomath Unit, IL-69978 Tel Aviv, Israel.	haggaika@yahoo.com		Katriel, Guy/0000-0001-7411-4789; Stone, Lewi/0000-0002-6465-579X	EU [FP7]; Israel Science Foundation; Israel Ministry of Health	EU(European Commission); Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health	The authors acknowledge the support of EU-FP7 grant Epiwork, the Israel Science Foundation, and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; COX NJ, 2007, ANNU REV MED, V51, P407; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mccaw JM, 2009, SCIENCE, V325, P1071, DOI 10.1126/science.325_1071a; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; REVERE P, 2009, SWINE FLU THIS FALL; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	21	19	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9565	10.1371/journal.pone.0009565	http://dx.doi.org/10.1371/journal.pone.0009565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300617	Green Submitted, Green Published, gold			2022-12-25	WOS:000275621000001
J	Wright, B; Gibson, T; Spencer, J; Lovegrove, JA; Gibbins, JM				Wright, Bernice; Gibson, Trevor; Spencer, Jeremy; Lovegrove, Julie A.; Gibbins, Jonathan M.			Platelet-Mediated Metabolism of the Common Dietary Flavonoid, Quercetin	PLOS ONE			English	Article							O-METHYLTRANSFERASE ACTIVITY; ESSENTIAL COMPONENTS; ACTIVATION PATHWAY; SMALL-INTESTINE; IDENTIFICATION; INGESTION; RAT; BIOAVAILABILITY; PROCYANIDINS; FLAVAN-3-OLS	Background: Flavonoid metabolites remain in blood for periods of time potentially long enough to allow interactions with cellular components of this tissue. It is well-established that flavonoids are metabolised within the intestine and liver into methylated, sulphated and glucuronidated counterparts, which inhibit platelet function. Methodology/Principal Findings: We demonstrate evidence suggesting platelets which contain metabolic enzymes, as an alternative location for flavonoid metabolism. Quercetin and a plasma metabolite of this compound, 4'-O-methyl quercetin (tamarixetin) were shown to gain access to the cytosolic compartment of platelets, using confocal microscopy. High performance liquid chromatography (HPLC) and mass spectrometry (MS) showed that quercetin was transformed into a compound with a mass identical to tamarixetin, suggesting that the flavonoid was methylated by catechol-O-methyl transferase (COMT) within platelets. Conclusions/Significance: Platelets potentially mediate a third phase of flavonoid metabolism, which may impact on the regulation of the function of these cells by metabolites of these dietary compounds.	[Wright, Bernice; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England; [Gibson, Trevor] Univ Reading, Bioctr Facil, Reading, Berks, England; [Spencer, Jeremy; Lovegrove, Julie A.] Univ Reading, Sch Food & Nutr Sci, Reading, Berks, England; [Gibbins, Jonathan M.] King Saud Univ, Blood Transfus Res Grp, Riyadh, Saudi Arabia	University of Reading; University of Reading; University of Reading; King Saud University	Wright, B (corresponding author), Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England.	b.wright@rdg.ac.uk		Gibbins, Jonathan/0000-0002-0372-5352	Biotechnology and Biological Sciences Research Council [BBS/S/A/2004/10967]; Medical Research Council [G0400883]; British Heart Foundation [RG/05/007]; MRC [G0400883] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (grant code: BBS/S/A/2004/10967; URL: http://www.bbsrc.ac.uk/), Medical Research Council (grant code: G0400883; URL: http://www.mrc.ac.uk/index.htm) and British Heart Foundation (grant code: RG/05/007; URL: http://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crespy V, 1999, AM J PHYSIOL-GASTR L, V277, pG120, DOI 10.1152/ajpgi.1999.277.1.G120; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; DELUCA G, 1976, ITAL J BIOCHEM, V25, P213; Dingemanse J, 2000, EUR J PHARM SCI, V12, P159, DOI 10.1016/S0928-0987(00)00151-2; Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753; Fiorani M, 2005, BRIT J NUTR, V94, P338, DOI 10.1079/BJN20051504; Fiorani M, 2002, FREE RADICAL BIO MED, V32, P64, DOI 10.1016/S0891-5849(01)00762-6; Frame LT, 2000, DRUG METAB DISPOS, V28, P1063; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Guerrero JA, 2005, J THROMB HAEMOST, V3, P369, DOI 10.1111/j.1538-7836.2004.01099.x; Guerrero JA, 2007, BRIT J CLIN PHARMACO, V64, P133, DOI 10.1111/j.1365-2125.2007.02881.x; Harada M, 1999, BIOSCI BIOTECH BIOCH, V63, P973, DOI 10.1271/bbb.63.973; Heptinstall S, 2006, J CARDIOVASC PHARM, V47, pS197, DOI 10.1097/00005344-200606001-00015; Hollman PCH, 1997, BIOMED PHARMACOTHER, V51, P305, DOI 10.1016/S0753-3322(97)88045-6; Hollman PCH, 1996, ANAL CHEM, V68, P3511, DOI 10.1021/ac960461w; Hubbard GP, 2006, BRIT J NUTR, V96, P482, DOI 10.1079/BJN20061831; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Kinouchi S, 2008, NEUROSCI LETT, V434, P124, DOI 10.1016/j.neulet.2008.01.039; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V277, P507, DOI 10.1006/bbrc.2000.3701; Masuda M, 2002, ANN CLIN BIOCHEM, V39, P589, DOI 10.1258/000456302760413379; Nowell SA, 1998, J BIOL CHEM, V273, P33342, DOI 10.1074/jbc.273.50.33342; PLOW EF, 2000, HEMATOLOGY BASIC PRI, P1741; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Spencer JPE, 2003, BIOCHEM J, V372, P173, DOI 10.1042/BJ20021972; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Spencer JPE, 1999, FEBS LETT, V458, P224, DOI 10.1016/S0014-5793(99)01160-6; STRAMENTINOLI G, 1978, THROMB HAEMOSTASIS, V39, P238; Tsang C, 2005, BRIT J NUTR, V94, P170, DOI 10.1079/BJN20051480; Vafeiadou K, 2008, ARCH BIOCHEM BIOPHYS, V478, P195, DOI 10.1016/j.abb.2008.07.014; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yodogawa S, 2003, BIOL PHARM BULL, V26, P1120, DOI 10.1248/bpb.26.1120	33	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9673	10.1371/journal.pone.0009673	http://dx.doi.org/10.1371/journal.pone.0009673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300638	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000275620900008
J	Zhang, NX; Cannon, RD; Holland, BR; Patchett, ML; Schmid, J				Zhang, Ningxin; Cannon, Richard D.; Holland, Barbara R.; Patchett, Mark L.; Schmid, Jan			Impact of Genetic Background on Allele Selection in a Highly Mutable Candida albicans Gene, PNG2	PLOS ONE			English	Article							HUMAN COMMENSAL YEAST; ENDOPLASMIC-RETICULUM; ANTIGENIC VARIATION; EXPRESSION; SEQUENCE; GENOME; FUNGAL; CELL; PROTEINS; ADHESIN	In many microbes rapid mutation of highly mutable contingency genes continually replenishes a pool of variant alleles from which the most suitable are selected, assisting in rapid adaptation and evasion of the immune response. In some contingency genes mutability is achieved through DNA repeats within the coding region. The fungal human pathogen Candida albicans has 2600 repeat-containing ORFs. For those investigated (ALS genes, HYR1, HYR2, CEK1, RLM1) many protein variants with differing amino acid repeat regions exist, as expected for contingency genes. However, specific alleles dominate in different clades, which is unexpected if allele variation is used for short-term adaptation. Generation of new alleles of repeat-containing C. albicans ORFs has never been observed directly. Here we present evidence for restrictions on the emergence of new alleles in a highly mutable C. albicans repeat-containing ORF, PNG2, encoding a putative secreted or cell surface glycoamidase. In laboratory cultures new PNG2 alleles arose at a rate of 2.8 x 10(-5) (confidence interval 3.3 x 10(-6) -9.9 x 10(-5)) per cell per division, comparable to rates measured for contingency genes. Among 80 clinical isolates 17 alleles of different length and 23 allele combinations were distinguishable; sequence differences between repeat regions of identical size suggest the existence of 36 protein variants. Specific allele combinations predominated in different genetic backgrounds, as defined by DNA fingerprinting and multilocus sequence typing. Given the PNG2 mutation rate, this is unexpected, unless in different genetic backgrounds selection favors different alleles. Specific alleles or allele combinations were not preferentially associated with C. albicans isolates from particular body sites or geographical regions. Our results suggest that the mutability of PNG2 is not used for short-term adaptation or evasion of the immune system. Nevertheless the large number of alleles observed indicates that mutability of PNG2 may assist C. albicans strains from different genetic backgrounds optimize their interaction with the host in the long term.	[Zhang, Ningxin; Patchett, Mark L.; Schmid, Jan] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Cannon, Richard D.] Univ Otago, Dept Oral Sci, Dunedin, New Zealand; [Holland, Barbara R.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Massey University; University of Otago; Massey University	Zhang, NX (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	j.schmid@massey.ac.nz	Holland, Barbara/G-1646-2013; Schmid, Jan/A-6863-2011	Holland, Barbara/0000-0002-4628-7938; Schmid, Jan/0000-0001-8794-4175; Cannon, Richard/0000-0002-5398-2066	Royal Society of New Zealand [MAU 902]	Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by Marsden grant MAU 902 from the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1998, EUR J BIOCHEM, V252, P118, DOI 10.1046/j.1432-1327.1998.2520118.x; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; FtouhiPaquin N, 1997, J BIOL CHEM, V272, P22960, DOI 10.1074/jbc.272.36.22960; Giblin L, 2001, GENE, V272, P157, DOI 10.1016/S0378-1119(01)00548-0; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Higy M, 2005, BIOCHEMISTRY-US, V44, P2039, DOI 10.1021/bi047976z; Holmes AR, 2006, MOL MICROBIOL, V62, P170, DOI 10.1111/j.1365-2958.2006.05357.x; HOYER LL, 1995, MOL MICROBIOL, V15, P39, DOI 10.1111/j.1365-2958.1995.tb02219.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; JEFFREY NW, 1998, MOL MICROBIOL, V30, P767; Jeng HW, 2005, MED MYCOL, V43, P209, DOI 10.1080/13693780410001731637; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Lott TJ, 1999, MICROBIOL-UK, V145, P1137, DOI 10.1099/13500872-145-5-1137; Lott TJ, 2005, FUNGAL GENET BIOL, V42, P444, DOI 10.1016/j.fgb.2005.01.012; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Perfect SE, 1998, PLANT J, V15, P273, DOI 10.1046/j.1365-313X.1998.00196.x; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; Schmid J, 1999, MICROBIOL-UK, V145, P2405, DOI 10.1099/00221287-145-9-2405; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Sumita T, 2005, EUKARYOT CELL, V4, P1872, DOI 10.1128/EC.4.11.1872-1881.2005; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang NX, 2009, INFECT GENET EVOL, V9, P493, DOI 10.1016/j.meegid.2009.01.007; Zhang NX, 2003, GENOME RES, V13, P2005, DOI 10.1101/gr.1024903; Zhao XM, 2007, FUNGAL GENET BIOL, V44, P1298, DOI 10.1016/j.fgb.2007.05.004	48	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9614	10.1371/journal.pone.0009614	http://dx.doi.org/10.1371/journal.pone.0009614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231904	Green Published, gold			2022-12-25	WOS:000275328300022
J	Hassani, BK; Steunou, AS; Liotenberg, S; Reiss-Husson, F; Astier, C; Ouchane, S				Hassani, Bahia Khalfaoui; Steunou, Anne-Soisig; Liotenberg, Sylviane; Reiss-Husson, Francoise; Astier, Chantal; Ouchane, Soufian			Adaptation to Oxygen ROLE OF TERMINAL OXIDASES IN PHOTOSYNTHESIS INITIATION IN THE PURPLE PHOTOSYNTHETIC BACTERIUM, RUBRIVIVAX GELATINOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; RHODOBACTER-SPHAEROIDES 2.4.1; GENE-EXPRESSION; NITROGENASE ACTIVITY; CAPSULATUS; PROKARYOTES; COMPLEXES; EVOLUTION; SUBUNITS; PROTEIN	The appearance of oxygen in the Earth's atmosphere via oxygenic photosynthesis required strict anaerobes and obligate phototrophs to cope with the presence of this toxic molecule. Here we show that in the anoxygenic phototroph Rubrivivax gelatinosus, the terminal oxidases (cbb(3), bd, and caa(3)) expand the range of ambient oxygen tensions under which the organism can initiate photosynthesis. Unlike the wild type, the cbb(3)(-)/bd(-) double mutant can start photosynthesis only in deoxygenated medium or when oxygen is removed, either by sparging cultures with nitrogen or by co-inoculation with strict aerobes bacteria. In oxygenated environments, this mutant survives nonphoto-synthetically until the O-2 tension is reduced. The cbb(3) and bd oxidases are therefore required not only for respiration but also for reduction of the environmental O-2 pressure prior to anaerobic photosynthesis. Suppressor mutations that restore respiration simultaneously restore photosynthesis in nondeoxygenated medium. Furthermore, induction of photosystem in the cbb(3)(-) mutant led to a highly unstable strain. These results demonstrate that photosynthetic metabolism in environments exposed to oxygen is critically dependent on the O-2 -detoxifying action of terminal oxidases.	[Ouchane, Soufian] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Paris 11, F-91405 Orsay, France; Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Ouchane, S (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	souchane@cgm.cnrs-gif.fr	OUCHANE, Soufian/HHM-5430-2022; Ouchane, Soufian/ABE-2609-2020	Ouchane, Soufian/0000-0002-8161-3866; Steunou, Anne Soisig/0000-0002-0731-0226; LIOTENBERG, Sylviane/0000-0003-4510-8608	French Agence Nationale de la Recherche [ANR BLAN06-2_147814]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was financially supported by French Agence Nationale de la Recherche Grant ANR BLAN06-2_147814).	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; DALDAL F, 1987, J MOL BIOL, V195, P1, DOI 10.1016/0022-2836(87)90322-6; Falkowski PG, 2006, SCIENCE, V311, P1724, DOI 10.1126/science.1125937; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Jones KM, 2002, J BACTERIOL, V184, P2491, DOI 10.1128/JB.184.9.2491-2499.2002; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Oh JI, 2001, MOL MICROBIOL, V39, P1116, DOI 10.1046/j.1365-2958.2001.02299.x; Ouchane S, 2005, MOL MICROBIOL, V57, P261, DOI 10.1111/j.1365-2958.2005.04685.x; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Steunou AS, 2004, J BACTERIOL, V186, P3133, DOI 10.1128/JB.186.10.3133-3142.2004; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Valladares A, 2003, MOL MICROBIOL, V47, P1239, DOI 10.1046/j.1365-2958.2003.03372.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zeilstra-Ryalls JH, 1998, METHOD ENZYMOL, V297, P151; ZeilstraRyalls JH, 1996, J BACTERIOL, V178, P985, DOI 10.1128/jb.178.4.985-993.1996; ZeilstraRyalls JH, 1997, J BACTERIOL, V179, P7264, DOI 10.1128/jb.179.23.7264-7273.1997; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	35	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19891	19899		10.1074/jbc.M109.086066	http://dx.doi.org/10.1074/jbc.M109.086066			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20335164	Green Published, hybrid			2022-12-25	WOS:000279012000022
J	Derbyshire, ER; Deng, S; Marletta, MA				Derbyshire, Emily R.; Deng, Sarah; Marletta, Michael A.			Incorporation of Tyrosine and Glutamine Residues into the Soluble Guanylate Cyclase Heme Distal Pocket Alters NO and O-2 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; NITRIC-OXIDE; CARBON-MONOXIDE; LIGAND-BINDING; TRUNCATED HEMOGLOBINS; BACILLUS-SUBTILIS; OXYGEN; DOMAIN; ACTIVATION; SENSOR	Nitric oxide (NO) is the physiologically relevant activator of the mammalian hemoprotein soluble guanylate cyclase (sGC). The heme cofactor of alpha 1 beta 1 sGC has a high affinity for NO but has never been observed to form a complex with oxygen. Introduction of a key tyrosine residue in the sGC heme binding domain beta 1(1-385) is sufficient to produce an oxygen-binding protein, but this mutation in the full-length enzyme did not alter oxygen affinity. To evaluate ligand binding specificity in full-length sGC we mutated several conserved distal heme pocket residues (beta 1 Val-5, Phe-74, Ile-145, and Ile-149) to introduce a hydrogen bond donor in proximity to the heme ligand. We found that the NO coordination state, NO dissociation, and enzyme activation were significantly affected by the presence of a tyrosine in the distal heme pocket; however, the stability of the reduced porphyrin and the proteins affinity for oxygen were unaltered. Recently, an atypical sGC from Drosophila, Gyc-88E, was shown to form a stable complex with oxygen. Sequence analysis of this protein identified two residues in the predicted heme pocket (tyrosine and glutamine) that may function to stabilize oxygen binding in the atypical cyclase. The introduction of these residues into the rat beta 1 distal heme pocket (Ile-145 -> Tyr and Ile-149 -> Gln) resulted in an sGC construct that oxidized via an intermediate with an absorbance maximum at 417 nm. This absorbance maximum is consistent with globin Fe-II-O-2 complexes and is likely the first observation of a FeII-O-2 complex in the full-length alpha 1 beta 1 protein. Additionally, these data suggest that atypical sGCs stabilize O-2 binding by a hydrogen bonding network involving tyrosine and glutamine.	[Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, Berkeley, CA 94720 USA; [Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; [Deng, Sarah] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Derbyshire, Emily R.; Marletta, Michael A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Marletta, MA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, 570 Stanley Hall, Berkeley, CA 94720 USA.	marletta@berkeley.edu			National Institutes of Health [GM077365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077365 (to M. A. M.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Boon EM, 2006, J BIOL CHEM, V281, P21892, DOI 10.1074/jbc.M600557200; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Das TK, 2004, J BIOL CHEM, V279, P10433, DOI 10.1074/jbc.M309590200; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Huang SH, 2007, BIOCHEMISTRY-US, V46, P15115, DOI 10.1021/bi701771r; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Li ZQ, 2005, BIOCHEMISTRY-US, V44, P939, DOI 10.1021/bi0489208; Makino R, 2003, J BIOL CHEM, V278, P11130, DOI 10.1074/jbc.M209026200; Marti MA, 2007, PROTEINS, V68, P480, DOI 10.1002/prot.21454; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Mishra S, 2010, J AM CHEM SOC, V132, P2968, DOI 10.1021/ja9078144; Morton DB, 2004, J BIOL CHEM, V279, P50651, DOI 10.1074/jbc.C400461200; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; SANDERS KM, 1992, JPN J PHARMACOL, V58, pP220; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Vermeersch P, 2007, CIRCULATION, V116, P936, DOI 10.1161/CIRCULATIONAHA.106.677245; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Warner T D, 1994, Adv Pharmacol, V26, P171, DOI 10.1016/S1054-3589(08)60054-X; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	45	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17471	17478		10.1074/jbc.M109.098269	http://dx.doi.org/10.1074/jbc.M109.098269			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20231286	Green Published, hybrid			2022-12-25	WOS:000278133400025
J	Ohashi, M; Eagle, RA; Trowsdale, J				Ohashi, Maki; Eagle, Robert A.; Trowsdale, John			Post-translational Modification of the NKG2D Ligand RAET1G Leads to Cell Surface Expression of a Glycosylphosphatidylinositol-linked Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; NK CYTOTOXICITY; TUMOR-CELLS; AMINO-ACID; RECEPTOR; STRESS; BINDING; MICA; MOLECULES; PROTEINS	NKG2D is an important activating receptor on lymphocytes. In human, it interacts with two groups of ligands: the major histocompatibility complex class I chain-related A/B (MICA/B) family and the UL-16 binding protein (ULBP) family, also known as retinoic acid early transcript (RAET1). MIC proteins are membrane-anchored, but all of the ULBP/RAET1 proteins, except for RAET1E and RAET1G, are glycosylphosphatidylinositol (GPI)-anchored. To address the reason for these differences we studied the association of RAET1G with the membrane. Using epitope-tagged RAET1G protein in conjunction with antibodies to different parts of the molecule and in pulse-chase experiments, we showed that the C terminus of the protein was cleaved soon after protein synthesis. Endoglycosidase H and peptide N-glycosidase treatment and cell surface immunoprecipitation indicated that most of the protein stayed in the endoplasmic reticulum, but some of the cleaved form was modified in the Golgi and transported to the cell surface. We examined the possibility of GPI anchoring of the protein in three ways: (i) Phosphatidylinositol (PI)-specific phospholipase C released the PI-linked form of the protein. (ii) The surface expression pattern of RAET1G decreased in cells defective in GPI anchoring through mutant GPI-amidase. (iii) Site-directed mutagenesis, to disrupt residues predicted to facilitate GPI-anchoring, resulted in diminished surface expression of RAET1G. Thus, a form of RAET1G is GPI-anchored, in line with most other ULBP/RAET1 family proteins. The cytoplasmic tail and transmembrane domains appear to result from gene duplication and frameshift mutation. Together with our previous results, our data suggest that RAET1G is regulated post-translationally to produce a GPI-anchored isoform.	[Ohashi, Maki; Eagle, Robert A.; Trowsdale, John] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Eagle, Robert A.] CALTECH, Pasadena, CA 91125 USA; [Trowsdale, John] Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England	University of Cambridge; California Institute of Technology; University of Cambridge	Ohashi, M (corresponding author), Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	mo325@cam.ac.uk; jt233@cam.ac.uk	Eagle, Robert/A-2679-2011	Eagle, Robert/0000-0003-0304-6111	Cancer Research United Kingdom; MRC [G9800943, G0401569] Funding Source: UKRI; Medical Research Council [G0401569, G9800943] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from Cancer Research United Kingdom.	Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bohme U, 2002, J CELL SCI, V115, P805; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Cao W, 2008, INT IMMUNOL, V20, P981, DOI 10.1093/intimm/dxn057; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Eagle RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004503; Ebihara T, 2007, INT IMMUNOL, V19, P1145, DOI 10.1093/intimm/dxm073; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; KODUKULA K, 1993, J CELL BIOL, V120, P657, DOI 10.1083/jcb.120.3.657; LEELAYUWAT C, 1994, IMMUNOGENETICS, V40, P339, DOI 10.1007/BF01246675; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Ohishi K, 2003, J BIOL CHEM, V278, P13959, DOI 10.1074/jbc.M300586200; Pende D, 2002, CANCER RES, V62, P6178; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wittenbrink M, 2009, EUR J IMMUNOL, V39, P1642, DOI 10.1002/eji.200839074	31	11	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16408	16415		10.1074/jbc.M109.077636	http://dx.doi.org/10.1074/jbc.M109.077636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20304922	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000277982600002
J	Valliere-Douglass, JF; Eakin, CM; Wallace, A; Ketchem, RR; Wang, W; Treuheit, MJ; Balland, A				Valliere-Douglass, John F.; Eakin, Catherine M.; Wallace, Alison; Ketchem, Randal R.; Wang, Wesley; Treuheit, Michael J.; Balland, Alain			Glutamine-linked and Non-consensus Asparagine-linked Oligosaccharides Present in Human Recombinant Antibodies Define Novel Protein Glycosylation Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXY AMINO-ACID; POSTTRANSLATIONAL N-GLYCOSYLATION; X-SER/THR SEQUON; MASS-SPECTROMETRY; STRUCTURAL REQUIREMENTS; ACTIVE-SITE; HUMAN-IGG; OLIGOSACCHARYLTRANSFERASE; PEPTIDES; GLYCOPROTEIN	We report the presence of oligosaccharide structures on a glutamine residue present in the V-L domain sequence of a recombinant human IgG2 molecule. Residue Gln-106, present in the QGT sequence following the rule of an asparagine-linked consensus motif, was modified with biantennary fucosylated oligosaccharide structures. In addition to the glycosylated glutamine, analysis of a lectin-enriched antibody population showed that 4 asparagine residues: heavy chain Asn-162, Asn-360, and light chain Asn-164, both of which are present in the IgG1 and IgG2 constant domain sequences, and Asn-35, which was present in CDRL1, were also modified with oligosaccharide structures at low levels. The primary sequences around these modified residues do not adhere to the N-linked consensus sequon, NX(S/T). Modeling of these residues from known antibody crystal structures and sequence homology comparison indicates that non-consensus glycosylation occurs on Asn residues in the context of a reverse consensus motif (S/T) XN located on highly flexile turns within 3 residues of a conformational change. Taken together our results indicate that protein glycosylation is governed by more diversified requirements than previously appreciated.	[Valliere-Douglass, John F.; Eakin, Catherine M.; Wallace, Alison; Wang, Wesley; Treuheit, Michael J.; Balland, Alain] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA; [Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen	Balland, A (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA.	ballanda@amgen.com	Valliere-Douglass, John F/F-1618-2013; Ketchem, Randal/AAB-4372-2020; Ketchem, Randal R/K-2258-2017	Ketchem, Randal/0000-0002-7821-2682; Ketchem, Randal R/0000-0002-7821-2682				Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BAUSE E, 1982, BIOCHEM J, V203, P761, DOI 10.1042/bj2030761; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Fan JQ, 1997, J BIOL CHEM, V272, P27058, DOI 10.1074/jbc.272.43.27058; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; GLABE CG, 1980, J BIOL CHEM, V255, P9236; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kabat EA, 1991, SEQUENCES PROTEINS I; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Marshall R D, 1974, Biochem Soc Symp, P17; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mimura Y, 2007, J IMMUNOL METHODS, V326, P116, DOI 10.1016/j.jim.2007.07.014; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; Valliere-Douglass JF, 2009, GLYCOBIOLOGY, V19, P144, DOI 10.1093/glycob/cwn116; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241	40	62	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16012	16022		10.1074/jbc.M109.096412	http://dx.doi.org/10.1074/jbc.M109.096412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233717	hybrid, Green Published			2022-12-25	WOS:000277715900039
J	Lynagh, T; Lynch, JW				Lynagh, Timothy; Lynch, Joseph W.			An Improved Ivermectin-activated Chloride Channel Receptor for Inhibiting Electrical Activity in Defined Neuronal Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; MAMMALIAN NEURONS; GABA(A) RECEPTOR; CAENORHABDITIS-ELEGANS; ALLATOSTATIN RECEPTOR; GINKGOLIDE BINDING; P-GLYCOPROTEIN; SUBUNIT; GLUTAMATE; MICE	The ability to silence the electrical activity of defined neuronal populations in vivo is dramatically advancing our understanding of brain function. This technology may eventually be useful clinically for treating a variety of neuropathological disorders caused by excessive neuronal activity. Several neuronal silencing methods have been developed, with the bacterial light-activated halorhodopsin and the invertebrate allatostatin-activated G protein-coupled receptor proving the most successful to date. However, both techniques may be difficult to implement clinically due to their requirement for surgically implanted stimulus delivery methods and their use of nonhuman receptors. A third silencing method, an invertebrate glutamate-gated chloride channel receptor (GluClR) activated by ivermectin, solves the stimulus delivery problem as ivermectin is a safe, well tolerated drug that reaches the brain following systemic administration. However, the limitations of this method include poor functional expression, possibly due to the requirement to coexpress two different subunits in individual neurons, and the nonhuman origin of GluClR. Here, we describe the development of a modified human alpha 1 glycine receptor as an improved ivermectin-gated silencing receptor. The crucial development was the identification of a mutation, A288G, which increased ivermectin sensitivity almost 100-fold, rendering it similar to that of GluClR. Glycine sensitivity was eliminated via the F207A mutation. Its large unitary conductance, homomeric expression, and human origin may render the F207A/A288G alpha 1 glycine receptor an improved silencing receptor for neuroscientific and clinical purposes. As all known highly ivermectin-sensitive GluClRs contain an endogenous glycine residue at the corresponding location, this residue appears essential for exquisite ivermectin sensitivity.	[Lynagh, Timothy] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynagh, T (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Lynagh, Timothy/0000-0003-4888-4098				Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Chen XB, 2009, NEUROPHARMACOLOGY, V56, P318, DOI 10.1016/j.neuropharm.2008.07.001; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cotreau MM, 2003, J CLIN PHARMACOL, V43, P1108, DOI 10.1177/0091270003257456; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; FRANKE C, 1986, J COMP PHYSIOL A, V159, P591, DOI 10.1007/BF00612033; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Griffin J, 2005, J VET PHARMACOL THER, V28, P257, DOI 10.1111/j.1365-2885.2005.00655.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Keck T, 2009, REV NEUROSCIENCE, V20, P13; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lee VK, 2009, COMPARATIVE MED, V59, P227; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lespine A, 2007, EUR J PHARM SCI, V30, P84, DOI 10.1016/j.ejps.2006.10.004; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; McKellar QA, 1996, J VET PHARMACOL THER, V19, P331, DOI 10.1111/j.1365-2885.1996.tb00062.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Siva N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2755; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vafa B, 1999, J NEUROCHEM, V73, P2158; Wehr M, 2009, J NEUROPHYSIOL, V102, P2554, DOI 10.1152/jn.00480.2009; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yamakura T, 1999, J BIOL CHEM, V274, P23006, DOI 10.1074/jbc.274.33.23006; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	47	60	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14890	14897		10.1074/jbc.M110.107789	http://dx.doi.org/10.1074/jbc.M110.107789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20308070	hybrid, Green Published			2022-12-25	WOS:000277399000010
J	Krause, A; Hoffmann, I				Krause, Annekatrin; Hoffmann, Ingrid			Polo-Like Kinase 2-Dependent Phosphorylation of NPM/B23 on Serine 4 Triggers Centriole Duplication	PLOS ONE			English	Article							CENTROSOME DUPLICATION; HUMAN-CELLS; BOX DOMAIN; SUBCELLULAR-LOCALIZATION; S-PHASE; NUCLEOPHOSMIN; MITOSIS; PLK1; BIOGENESIS; ACTIVATION	Duplication of the centrosome is well controlled during faithful cell division while deregulation of this process leads to supernumary centrosomes, chromosome missegregation and aneuploidy, a hallmark of many cancer cells. We previously reported that Polo-like kinase 2 (Plk2) is activated near the G1/S phase transition, and regulates the reproduction of centrosomes. In search for Plk2 interacting proteins we have identified NPM/B23 (Nucleophosmin) as a novel Plk2 binding partner. We find that Plk2 and NPM/B23 interact in vitro in a Polo-box dependent manner. An association between both proteins was also observed in vivo. Moreover, we show that Plk2 phosphorylates NPM/B23 on serine 4 in vivo in S-phase. Notably, expression of a non-phosphorylatable NPM/B23 S4A mutant interferes with centriole reduplication in S-phase arrested cells and leads to a dilution of centriole numbers in unperturbed U2OS cells. The corresponding phospho-mimicking mutants have the opposite effect and their expression leads to the accumulation of centrioles. These findings suggest that NPM/B23 is a direct target of Plk2 in the regulation of centriole duplication and that phosphorylation on serine 4 can trigger this process.	[Krause, Annekatrin; Hoffmann, Ingrid] German Canc Res Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krause, A (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	Ingrid.Hoffmann@dkfz.de			Deutsche Jose Carreras Leukamiestiftung	Deutsche Jose Carreras Leukamiestiftung	This work was supported in part by the Deutsche Jose Carreras Leukamiestiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bernard K, 2003, CANCER RES, V63, P6716; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; CHAN PK, 1990, BIOCHEM J, V270, P549, DOI 10.1042/bj2700549; Cizmecioglu O, 2008, CELL CYCLE, V7, P3548, DOI 10.4161/cc.7.22.7071; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lowery DM, 2004, CELL CYCLE, V3, P128; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Paoletti A, 1996, J CELL SCI, V109, P3089; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Yao JH, 2004, FEBS LETT, V575, P112, DOI 10.1016/j.febslet.2004.08.047; Zatsepina OV, 1999, J CELL SCI, V112, P455; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	43	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9849	10.1371/journal.pone.0009849	http://dx.doi.org/10.1371/journal.pone.0009849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352051	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894500017
J	D'Amico, G; Robinson, SD; Germain, M; Reynolds, LE; Thomas, GJ; Elia, G; Saunders, G; Fruttiger, M; Tybulewicz, V; Mavria, G; Hodivala-Dilke, KM				D'Amico, Gabriela; Robinson, Stephen D.; Germain, Mitchel; Reynolds, Louise E.; Thomas, Gareth J.; Elia, George; Saunders, Garry; Fruttiger, Marcus; Tybulewicz, Victor; Mavria, Georgia; Hodivala-Dilke, Kairbaan M.			Endothelial-Rac1 Is Not Required for Tumor Angiogenesis unless alpha v beta 3-Integrin Is Absent	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; ADVANCED SOLID TUMORS; GROWTH-FACTOR; PATHOLOGICAL ANGIOGENESIS; CILENGITIDE EMD-121974; VASCULAR DEVELOPMENT; INTEGRIN INHIBITORS; RAC1 ACTIVATION; CRE-RECOMBINASE	Endothelial cell migration is an essential aspect of tumor angiogenesis. Rac1 activity is needed for cell migration in vitro implying a requirement for this molecule in angiogenesis in vivo. However, a precise role for Rac1 in tumor angiogenesis has never been addressed. Here we show that depletion of endothelial Rac1 expression in adult mice, unexpectedly, has no effect on tumor growth or tumor angiogenesis. In addition, repression of Rac1 expression does not inhibit VEGF-mediated angiogenesis in vivo or ex vivo, nor does it affect chemotactic migratory responses to VEGF in 3-dimensions. In contrast, the requirement for Rac1 in tumor growth and angiogenesis becomes important when endothelial beta 3-integrin levels are reduced or absent: the enhanced tumor growth, tumor angiogenesis and VEGF-mediated responses in beta 3-null mice are all Rac1-dependent. These data indicate that in the presence of alpha v beta 3-integrin Rac1 is not required for tumor angiogenesis.	[D'Amico, Gabriela; Robinson, Stephen D.; Germain, Mitchel; Reynolds, Louise E.; Elia, George; Saunders, Garry; Hodivala-Dilke, Kairbaan M.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Adhes & Angiogenesis Lab, London, England; [Thomas, Gareth J.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Tumor Biol Ctr, London, England; [Fruttiger, Marcus] UCL, Inst Ophthalmol, London, England; [Tybulewicz, Victor] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Mavria, Georgia] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; MRC National Institute for Medical Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	D'Amico, G (corresponding author), Univ Helsinki, Biomedicum, Helsinki, Finland.	gabriela.damico@helsinki.fi; k.hodivala-dilke@qmul.ac.uk	D'Amico, Gabriela/H-6310-2011; D'Amico, Gabriela/AAD-1182-2020	Fruttiger, Marcus/0000-0002-6962-5485; Robinson, Stephen/0000-0002-6606-7588; Tybulewicz, Victor/0000-0003-2439-0798; D'Amico, Gabriela/0000-0002-5619-6749; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X	Cancer Research UK; Medical Research Council, Breast Cancer Campaign; The Association for International Cancer Research; The Health Foundation; MRC [G0501711, MC_U117527252] Funding Source: UKRI; Cancer Research UK [12007] Funding Source: researchfish; Medical Research Council [MC_U117527252, G0501711] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council, Breast Cancer Campaign(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Association for International Cancer Research; The Health Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Cancer Research UK, the Medical Research Council, Breast Cancer Campaign, The Association for International Cancer Research, and The Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Andrade SP, 1997, MICROVASC RES, V54, P253, DOI 10.1006/mvre.1997.2047; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Eskens FALM, 2003, EUR J CANCER, V39, P917, DOI 10.1016/S0959-8049(03)00057-1; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Gustafsson E, 2001, J CELL SCI, V114, P671; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Le Gat L, 2003, CELL COMMUN ADHES, V10, P129, DOI 10.1080/15419060390262543; Liu ZJ, 2003, FASEB J, V17, P1931, DOI 10.1096/fj.02-1171fje; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; MECHTERSHEIMER G, 1994, LAB INVEST, V70, P740; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nystrom ML, 2006, CANCER RES, V66, P10833, DOI 10.1158/0008-5472.CAN-06-1640; Oxboel J, 2009, ONCOL REP, V21, P769, DOI 10.3892/or_00000283; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Robinson SD, 2004, ARTERIOSCL THROM VAS, V24, P2108, DOI 10.1161/01.ATV.0000143857.27408.de; ROBINSON SD, 2009, J BIOL CHEM; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sato T, 2002, APMIS, V110, P347, DOI 10.1034/j.1600-0463.2002.100410.x; Sato T, 2001, ANTICANCER RES, V21, P643; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200	68	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9766	10.1371/journal.pone.0009766	http://dx.doi.org/10.1371/journal.pone.0009766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339539	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000275894300010
J	Qiu, JZ; Wang, DC; Xiang, H; Feng, HH; Jiang, YSA; Xia, LJ; Dong, J; Lu, J; Yu, L; Deng, XM				Qiu, Jiazhang; Wang, Dacheng; Xiang, Hua; Feng, Haihua; Jiang, Youshuai; Xia, Lijie; Dong, Jing; Lu, Jing; Yu, Lu; Deng, Xuming			Subinhibitory Concentrations of Thymol Reduce Enterotoxins A and B and alpha-Hemolysin Production in Staphylococcus aureus Isolates	PLOS ONE			English	Article							VIRULENCE; EXPRESSION; TOXIN; EVOLUTION; GENES; SARA; ANTIVIRULENCE; CLINDAMYCIN; RESISTANCE; INFECTION	Background: Targeting bacterial virulence factors is now gaining interest as an alternative strategy to develop new types of anti-infective agents. It has been shown that thymol, when used at low concentrations, can inhibit the TSST-1 secretion in Staphylococcus aureus. However, there are no data on the effect of thymol on the production of other exotoxins (e. g., alpha-hemolysin and enterotoxins) by S. aureus. Methodology/Principal Findings: Secretion of alpha-hemolysin, SEA and SEB in both methicillin-sensitive and methicillin-resistant S. aureus isolates cultured with graded subinhibitory concentrations of thymol was detected by immunoblot analysis. Hemolysin and tumor necrosis factor (TNF) release assays were performed to elucidate the biological relevance of changes in a-hemolysin, SEA and SEB secretion induced by thymol. In addition, the influence of thymol on the transcription of hla, sea, and seb (the genes encoding alpha-hemolysin, SEA and SEB, respectively) was analyzed by quantitative RT-PCR. Thymol inhibited transcription of hla, sea and seb in S. aureus, resulting in a reduction of alpha-hemolysin, SEA and SEB secretion and, thus, a reduction in hemolytic and TNF-inducing activities. Conclusions/Significance: Subinhibitory concentrations of thymol decreased the production of alpha-hemolysin, SEA and SEB in both MSSA and MRSA in a dose-dependent manner. These data suggest that thymol may be useful for the treatment of S. aureus infections when used in combination with beta-lactams and glycopeptide antibiotics, which induce expression of alpha-hemolysin and enterotoxins at subinhibitory concentrations. Furthermore, the structure of thymol may potentially be used as a basic structure for development of drugs aimed against these bacterial virulence factors.	[Qiu, Jiazhang; Wang, Dacheng; Xiang, Hua; Feng, Haihua; Dong, Jing; Lu, Jing; Yu, Lu; Deng, Xuming] Jilin Univ, Inst Zoonoses, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Jiang, Youshuai] Heilongjiang August First Agr Univ, Coll Life Sci & Technol, Daqing, Heilongjiang, Peoples R China; [Xia, Lijie] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Jilin University; Yangzhou University	Qiu, JZ (corresponding author), Jilin Univ, Inst Zoonoses, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	yulu225@126.com; dengxm@jlu.edu.cn			973 programme of China [2006CB504402]	973 programme of China(National Basic Research Program of China)	The study was supported by a grant from 973 programme of China (2006CB504402). http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4; Alam K, 1999, PHARMACOL RES, V40, P159, DOI 10.1006/phrs.1999.0472; *APPL BIOS, 1997, US B APPL BIOS, V2; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; BI X, 2009, J APPL MICR IN PRESS; Blickwede M, 2005, FEMS MICROBIOL LETT, V252, P73, DOI 10.1016/j.femsle.2005.08.022; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PF, 1998, J BACTERIOL, V180, P6232; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; Didry N, 1994, Pharm Acta Helv, V69, P25, DOI 10.1016/0031-6865(94)90027-2; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Guo N, 2009, J MED MICROBIOL, V58, P1074, DOI 10.1099/jmm.0.008052-0; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Koszczol C, 2006, J ANTIMICROB CHEMOTH, V58, P564, DOI 10.1093/jac/dkl291; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nostro A, 2004, FEMS MICROBIOL LETT, V230, P191, DOI 10.1016/S0378-1097(03)00890-5; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Robledo S, 2005, ANTIMICROB AGENTS CH, V49, P1652, DOI 10.1128/AAC.49.4.1652-1655.2005; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; Sambanthamoorthy K, 2006, MICROBIOL-SGM, V152, P2559, DOI 10.1099/mic.0.29071-0; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; Smith-Palmer A, 2004, J MED MICROBIOL, V53, P1023, DOI 10.1099/jmm.0.45567-0; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRANTER HS, 1993, J APPL BACTERIOL, V74, P253, DOI 10.1111/j.1365-2672.1993.tb03023.x; Yoh K, 2000, NEPHROL DIAL TRANSPL, V15, P1170, DOI 10.1093/ndt/15.8.1170	39	104	110	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9736	10.1371/journal.pone.0009736	http://dx.doi.org/10.1371/journal.pone.0009736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305813	Green Submitted, Green Published, gold			2022-12-25	WOS:000275809600008
J	Romanowska, M; Reilly, L; Palmer, CNA; Gustafsson, MCU; Foerster, J				Romanowska, Malgorzata; Reilly, Louise; Palmer, Colin N. A.; Gustafsson, Mattias C. U.; Foerster, John			Activation of PPAR beta/delta Causes a Psoriasis-Like Skin Disease In Vivo	PLOS ONE			English	Article							QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; KAPPA-B; RECEPTORS; IL-1; DIFFERENTIATION; EXPRESSION; SYSTEM; CYP1A1	Background: Psoriasis is one of the most frequent skin diseases world-wide. The disease impacts enormously on affected patients and poses a huge financial burden on health care providers. Several lines of evidence suggest that the nuclear hormone receptor peroxisome proliferator activator (PPAR) beta/delta, known to regulate epithelial differentiation and wound healing, contributes to psoriasis pathogenesis. It is unclear, however, whether activation of PPAR beta/delta is sufficient to trigger psoriasis-like changes in vivo. Methodology/Principal Findings: Using immunohistochemistry, we define the distribution of PPAR beta/delta in the skin lesions of psoriasis. By expression profiling, we confirm that PPAR beta/delta is overexpressed in the vast majority of psoriasis patients. We further establish a transgenic model allowing inducible activation of PPAR beta/delta in murine epidermis mimicking its distribution in psoriasis lesions. Upon activation of PPAR beta/delta, transgenic mice sustain an inflammatory skin disease strikingly similar to psoriasis, featuring hyperproliferation of keratinocytes, dendritic cell accumulation, and endothelial activation. Development of this phenotype requires the activation of the Th17 subset of T cells, shown previously to be central to psoriasis. Moreover, gene dysregulation in the transgenic mice is highly similar to that in psoriasis. Key transcriptional programs activated in psoriasis, including IL1-related signalling and cholesterol biosynthesis, are replicated in the mouse model, suggesting that PPAR beta/delta regulates these transcriptional changes in psoriasis. Finally, we identify phosphorylation of STAT3 as a novel pathway activated by PPAR beta/delta and show that inhibition of STAT3 phosphorylation blocks disease development. Conclusions: Activation of PPAR beta/delta in the epidermis is sufficient to trigger inflammatory changes, immune activation, and signalling, and gene dysregulation characteristic of psoriasis.	[Romanowska, Malgorzata; Reilly, Louise; Foerster, John] Univ Dundee, Div Expt Med, Dundee, Scotland; [Palmer, Colin N. A.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Gustafsson, Mattias C. U.] Lund Univ, Dept Lab Med, Div Med Microbiol, Lund, Sweden	University of Dundee; University of Dundee; Lund University	Romanowska, M (corresponding author), Univ Dundee, Div Expt Med, Dundee, Scotland.	j.foerster@dundee.ac.uk	Palmer, Colin NA/C-7053-2008; Gustafsson, Mattias C. U./A-7451-2010	Palmer, Colin NA/0000-0002-6415-6560; Gustafsson, Mattias C. U./0000-0003-3260-0724	Cancer Research United Kingdom; Anonymous Trust; Tenovus Scotland	Cancer Research United Kingdom(Cancer Research UK); Anonymous Trust; Tenovus Scotland	The work presented here was in part funded by Cancer Research United Kingdom (role: fellowship for JF), the Anonymous Trust (role: provision of funds for consumables), and Tenovus Scotland (role: provision of funds for consumables). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Campbell SJ, 1996, J CELL SCI, V109, P2619; Chiaro CR, 2008, BIOCHEMISTRY-US, V47, P8445, DOI 10.1021/bi800712f; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Debets R, 1997, J IMMUNOL, V158, P2955; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di-Poi N, 2005, MOL CELL BIOL, V25, P1696, DOI 10.1128/MCB.25.5.1696-1712.2005; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; Gelfand JM, 2005, J AM ACAD DERMATOL, V52, P23, DOI 10.1016/j.jaad.2004.07.045; Gisondi P, 2008, AM J CLIN NUTR, V88, P1242, DOI 10.3945/ajcn.2008.26427; Hall JM, 2007, MOL ENDOCRINOL, V21, P1756, DOI 10.1210/me.2007-0060; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Kang Kihwa, 2007, Curr Atheroscler Rep, V9, P72, DOI 10.1007/BF02693931; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1238, DOI 10.1093/gerona/60.10.1238; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; PIQUERAS L, 2006, ARTERIOSCLER THROMB; Poikolainen K, 1999, ARCH DERMATOL, V135, P1490, DOI 10.1001/archderm.135.12.1490; ROBERTSON RW, 1994, NUCLEIC ACIDS RES, V22, P1741, DOI 10.1093/nar/22.9.1741; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Rosenfield RL, 1999, J INVEST DERMATOL, V112, P226, DOI 10.1046/j.1523-1747.1999.00487.x; Rowe JM, 2008, J INVEST DERMATOL, V128, P1866, DOI 10.1038/sj.jid.5701236; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schmitt JM, 2006, DERMATOLOGY, V213, P102, DOI 10.1159/000093848; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Short B, 2009, J CELL BIOL, V186, P769, DOI 10.1083/jcb.1866if; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sun L, 2008, CHINESE MED J-PEKING, V121, P2305, DOI 10.1097/00029330-200811020-00017; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Trivedi NR, 2006, J INVEST DERMATOL, V126, P2002, DOI 10.1038/sj.jid.5700336; vanderVleuten CJM, 1996, ARCH DERMATOL RES, V288, P366, DOI 10.1007/s004030050065; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Wu Y, 2008, J DRUGS DERMATOL, V7, P373	56	67	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9701	10.1371/journal.pone.0009701	http://dx.doi.org/10.1371/journal.pone.0009701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300524	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400006
J	Buganim, Y; Goldstein, I; Lipson, D; Milyavsky, M; Polak-Charcon, S; Mardoukh, C; Solomon, H; Kalo, E; Madar, S; Brosh, R; Perelman, M; Navon, R; Goldfinger, N; Barshack, I; Yakhini, Z; Rotter, V				Buganim, Yosef; Goldstein, Ido; Lipson, Doron; Milyavsky, Michael; Polak-Charcon, Sylvie; Mardoukh, Corine; Solomon, Hilla; Kalo, Eyal; Madar, Shalom; Brosh, Ran; Perelman, Marina; Navon, Roy; Goldfinger, Naomi; Barshack, Iris; Yakhini, Zohar; Rotter, Varda			A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; ALZ-50 CLONE 1; CHROMOSOMAL-ABERRATIONS; DROSOPHILA-TRITHORAX; LUNG ADENOCARCINOMAS; PROSTATE-CANCER; ACUTE LEUKEMIAS; PHD FINGER; NEUROBLASTOMA; DNA	Partial gain of chromosome arm 17q is an abundant aberrancy in various cancer types such as lung and prostate cancer with a prominent occurrence and prognostic significance in neuroblastoma - one of the most common embryonic tumors. The specific genetic element/s in 17q responsible for the cancer-promoting effect of these aberrancies is yet to be defined although many genes located in 17q have been proposed to play a role in malignancy. We report here the characterization of a naturally-occurring, non-reciprocal translocation der(X)t(X;17) in human lung embryonal-derived cells following continuous culturing. This aberrancy was strongly correlated with an increased proliferative capacity and with an acquired ability to form colonies in vitro. The breakpoint region was mapped by fluorescence in situ hybridization (FISH) to the 17q24.3 locus. Further characterization by a custom-made comparative genome hybridization array (CGH) localized the breakpoint within the Bromodomain PHD finger Transcription Factor gene (BPTF), a gene involved in transcriptional regulation and chromatin remodeling. Interestingly, this translocation led to elevation in the mRNA levels of the endogenous BPTF. Knock-down of BPTF restricted proliferation suggesting a role for BPTF in promoting cellular growth. Furthermore, the BPTF chromosomal region was found to be amplified in various human tumors, especially in neuroblastomas and lung cancers in which 55% and 27% of the samples showed gain of 17q24.3, respectively. Additionally, 42% percent of the cancer cell lines comprising the NCI-60 had an abnormal BPTF locus copy number. We suggest that deregulation of BPTF resulting from the translocation may confer the cells with the observed cancer-promoting phenotype and that our cellular model can serve to establish causality between 17q aberrations and carcinogenesis.	[Buganim, Yosef; Goldstein, Ido; Milyavsky, Michael; Solomon, Hilla; Kalo, Eyal; Madar, Shalom; Brosh, Ran; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Lipson, Doron; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Polak-Charcon, Sylvie; Mardoukh, Corine; Perelman, Marina; Barshack, Iris] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Navon, Roy; Yakhini, Zohar] Agilent Technol, Tel Aviv, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Chaim Sheba Medical Center; Agilent Technologies	Buganim, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	varda.rotter@weizmann.ac.il	Brosh, Ran/H-7309-2019; Brosh, Ran/HDL-9562-2022; Goldstein, Ido/Y-6554-2019	Brosh, Ran/0000-0001-9714-8623; Goldstein, Ido/0000-0003-0139-1499; Yakhini, Zohar/0000-0002-0420-5412	Flight Attendant Medical Research Institute (FAMRI); EC [LSHC-CT-2004-503576]; Yad Abraham Center for Cancer Diagnosis and Therapy	Flight Attendant Medical Research Institute (FAMRI); EC(European CommissionEuropean Commission Joint Research Centre); Yad Abraham Center for Cancer Diagnosis and Therapy	This research was supported by a Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI), EC FP6 Grant LSHC-CT-2004-503576 and the Yad Abraham Center for Cancer Diagnosis and Therapy. This publication reflects the authors' views and not necessarily those of the European Community. The EC is not liable for any use that may be made of the information contained herein. VR is the incumbent of the Norman and Helen Asher Professorial Chair Cancer Research at the Weizmann Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Agilent Technologies (www.home.agilent.com) participated in the CGH study design and analysis but not in data collection, decision to publish, or preparation of the manuscript.	Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Beser AR, 2007, PATHOL ONCOL RES, V13, P180, DOI 10.1007/BF02893497; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Bown N, 2001, MED PEDIATR ONCOL, V36, P14, DOI 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.3.CO;2-7; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; Doerks T, 2001, TRENDS BIOCHEM SCI, V26, P145, DOI 10.1016/S0968-0004(00)01769-2; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Jones MH, 2000, GENOMICS, V63, P35, DOI 10.1006/geno.1999.6070; Jordan-Sciutto KL, 1999, J BIOL CHEM, V274, P35262, DOI 10.1074/jbc.274.49.35262; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Lastowska M, 2002, GENE CHROMOSOME CANC, V34, P428, DOI 10.1002/gcc.10089; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lipson D, 2007, BIOINFORMATICS, V23, pE77, DOI 10.1093/bioinformatics/btl316; Meddeb M, 1996, GENE CHROMOSOME CANC, V17, P156, DOI 10.1002/(SICI)1098-2264(199611)17:3<156::AID-GCC3>3.0.CO;2-3; Milyavsky M, 2005, CANCER RES, V65, P4530, DOI 10.1158/0008-5472.CAN-04-3880; Milyavsky M, 2003, CANCER RES, V63, P7147; Raidl M, 2004, J HEPATOL, V40, P660, DOI 10.1016/j.jhep.2003.12.020; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sun JL, 2008, PROSTATE, V68, P691, DOI 10.1002/pros.20754; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Van Roy N, 1997, EUR J CANCER, V33, P1974, DOI 10.1016/S0959-8049(97)00319-5; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yen CC, 2007, LUNG CANCER, V57, P292, DOI 10.1016/j.lungcan.2007.04.007; Zhu P, 1996, BBA-GENE STRUCT EXPR, V1309, P5, DOI 10.1016/S0167-4781(96)00127-3	35	43	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9657	10.1371/journal.pone.0009657	http://dx.doi.org/10.1371/journal.pone.0009657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300178	Green Submitted, Green Published, gold			2022-12-25	WOS:000275620600012
J	Chino, A; Watanabe, K; Moriya, H				Chino, Ayako; Watanabe, Kenji; Moriya, Hisao			Plasmid Construction Using Recombination Activity in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA	Background: Construction of plasmids is crucial in modern genetic manipulation. As of now, the common method for constructing plasmids is to digest specific DNA sequences with restriction enzymes and to ligate the resulting DNA fragments with DNA ligase. Another potent method to construct plasmids, known as gap-repair cloning (GRC), is commonly used in the budding yeast Saccharomyces cerevisiae. GRC makes use of the homologous recombination activity that occurs within the yeast cells. Due to its flexible design and efficiency, GRC has been frequently used for constructing plasmids with complex structures as well as genome-wide plasmid collections. Although there have been reports indicating GRC feasibility in the fission yeast Schizosaccharomyces pombe, this species is not commonly used for GRC as systematic studies of reporting GRC efficiency in S. pombe have not been performed till date. Methodology/Principal Findings: We investigated GRC efficiency in S. pombe in this study. We first showed that GRC was feasible in S. pombe by constructing a plasmid that contained the LEU2 auxotrophic marker gene in vivo and showed sufficient efficiency with short homology sequences (>25 bp). No preference was shown for the sequence length from the cut site in the vector plasmid. We next showed that plasmids could be constructed in a proper way using 3 DNA fragments with 70% efficiency without any specific selections being made. The GRC efficiency with 3 DNA fragments was dramatically increased >95% in lig4 Delta mutant cell, where non-homologous end joining is deficient. Following this approach, we successfully constructed plasmid vectors with leu1+, ade6+, his5+, and lys1+ markers with the low-copy stable plasmid pDblet as a backbone by applying GRC in S. pombe. Conclusions/Significance: We concluded that GRC was sufficiently feasible in S. pombe for genome-wide gene functional analysis as well as for regular plasmid construction. Plasmids with different markers constructed in this research are available from NBRP-yeast (http://yeast.lab.nig.ac.jp/).	[Chino, Ayako; Moriya, Hisao] Okayama Univ, Okayama 7008530, Japan; [Chino, Ayako; Moriya, Hisao] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1028666, Japan; [Watanabe, Kenji] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Okayama University; Japan Science & Technology Agency (JST); University of Shizuoka	Chino, A (corresponding author), Okayama Univ, Okayama 7008530, Japan.	hisaom@cc.okayama-u.ac.jp	Watanabe, Kenji/N-2012-2015; Moriya, Hisao/B-2424-2011	Watanabe, Kenji/0000-0002-0463-4831; Moriya, Hisao/0000-0001-7638-3640	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the PRESTO program, Japan Science and Technology Agency (HM); the Special Coordination Fund for Promoting Sciences and Technology, Ministry of Education, Culture, Sports, Science, and Technology (HM); a Grant-in-Aid for Scientific Research on Innovative Areas "The Physicochemical Field for Genetic Activities'', Ministry of Education, Culture, Sports, Science, and Technology (HM); and by a Grant for Industrial Technology Research Program, New Energy and Industrial Technology Development Organization (KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amberg DC., 2005, METHODS YEAST GENETI; BRUN C, 1995, GENE, V164, P173, DOI 10.1016/0378-1119(95)00497-T; Egel R, 2004, MOL BIOL SCHIZOSACCH; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang LL, 2004, METHODS, V33, P199, DOI 10.1016/j.ymeth.2003.11.014; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	14	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9652	10.1371/journal.pone.0009652	http://dx.doi.org/10.1371/journal.pone.0009652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300182	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620600008
J	King, MO; Owen, JP; Schwabl, HG				King, Marisa O.; Owen, Jeb P.; Schwabl, Hubert G.			Are Maternal Antibodies Really That Important? Patterns in the Immunologic Development of Altricial Passerine House Sparrows (Passer domesticus)	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; HUMORAL IMMUNE-RESPONSE; BURSAL DISEASE VIRUS; ESCHERICHIA-COLI; PASSIVE-IMMUNITY; CHICKEN EGGS; IMMUNOGLOBULINS; PROTECTION; BIRD; SIZE	Background: Maternal antibodies are believed to play an integral role in protecting immunologically immature wild-passerines from environmental antigens. This study comprehensively examines the early development of the adaptive immune system in an altricial-developing wild passerine species, the house sparrow (Passer domestics), by characterizing the half-life of maternal antibodies in nestling plasma, the onset of de novo synthesis of endogenous antibodies by nestlings, and the timing of immunological independence, where nestlings rely entirely on their own antibodies for immunologic protection. Methodology/Principal Findings: In an aviary study we vaccinated females against a novel antigen that these birds would not otherwise encounter in their natural environment, and measured both antigen-specific and total antibody concentration in the plasma of females, yolks, and nestlings. We traced the transfer of maternal antibodies from females to nestlings through the yolk and measured catabolisation of maternal antigen-specific antibodies in nestlings during early development. By utilizing measurements of non-specific and specific antibody levels in nestling plasma we were able to calculate the half-life of maternal antibodies in nestling plasma and the time point at which nestling were capable of synthesizing antibodies themselves. Based on the short half-life of maternal antibodies, the rapid production of endogenous antibodies by nestlings and the relatively low transfer of maternal antibodies to nestlings, our findings suggest that altricial-developing sparrows achieve immunologic independence much earlier than precocial birds. Conclusions/Significance: To our knowledge, this is the first in depth analyses performed on the adaptive immune system of a wild-passerine species. Our results suggest that maternal antibodies may not confer the immunologic protection or immune priming previously proposed in other passerine studies. Further research needs to be conducted on other altricial passerines to determine if the results of our study are a species-specific phenomenon or if they apply to all altricial-developing birds.	[King, Marisa O.; Schwabl, Hubert G.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Washington State University; Washington State University	King, MO (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	MOKing979@gmail.com		Owen, Jeb/0000-0002-2042-0526	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR)	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR)(United States Environmental Protection Agency)	The United States Environmental Protection Agency (EPA) under the Science to Achieve Results (STAR) Graduate Fellowship Program has funded the research described in this paper wholly. The EPA has not officially endorsed this publication and the views expressed herein may not reflect the views of the EPA. The EPA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2006, VET MICROBIOL, V114, P16, DOI 10.1016/j.vetmic.2005.10.037; Abou Elazab MF, 2009, J VET MED SCI, V71, P417, DOI 10.1292/jvms.71.417; ANDERSON RW, 1995, BIOSYSTEMS, V34, P87, DOI 10.1016/0303-2647(94)01444-C; Apanius V, 1998, AVIAN GROWTH DEV EVO, V8, P203; AR A, 1978, EVOLUTION, V32, P655, DOI 10.1111/j.1558-5646.1978.tb04610.x; Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Castinel A, 2008, J WILDLIFE DIS, V44, P8, DOI 10.7589/0090-3558-44.1.8; Chaffer M, 1997, AVIAN PATHOL, V26, P377, DOI 10.1080/03079459708419220; Cichon M, 2006, J EVOLUTION BIOL, V19, P1701, DOI 10.1111/j.1420-9101.2006.01110.x; DARBYSHIRE JH, 1985, RES VET SCI, V38, P14, DOI 10.1016/S0034-5288(18)31841-1; Dhondt AA, 2008, AVIAN PATHOL, V37, P635, DOI 10.1080/03079450802499100; FAHEY KJ, 1987, AUST VET J, V64, P203, DOI 10.1111/j.1751-0813.1987.tb15182.x; Forsman AM, 2008, MOL ECOL, V17, P3697, DOI 10.1111/j.1365-294X.2008.03860.x; Fouchet D, 2007, J R SOC INTERFACE, V4, P479, DOI 10.1098/rsif.2006.0189; Gasparini J, 2006, CAN J ZOOL, V84, P623, DOI 10.1139/Z06-024; Gasparini J, 2009, J AVIAN BIOL, V40, P271, DOI 10.1111/j.1600-048X.2008.04590.x; GLICK B, 1983, BIOSCIENCE, V33, P187, DOI 10.2307/1309273; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Glick B, 1983, AVIAN BIOL, V7, P443; Goldammer A, 2002, BLOOD, V100, P353, DOI 10.1182/blood-2002-01-0128; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Hansen P, 1998, J IMMUNOL METHODS, V215, P1, DOI 10.1016/S0022-1759(98)00050-7; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; HELLER ED, 1990, AVIAN PATHOL, V19, P345, DOI 10.1080/03079459008418685; Huber SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008605; KALETA EF, 1977, BERL MUNCH TIERARZTL, V90, P131; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; KASPERS B, 1991, J VET MED A, V38, P73, DOI 10.1111/j.1439-0442.1991.tb00986.x; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; LAWRENCE EC, 1981, CLIN EXP IMMUNOL, V43, P450; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; LESLIE GA, 1975, AM J VET RES, V36, P482; LESLIE GA, 1973, J IMMUNOL, V110; LOEKEN MR, 1983, IMMUNOLOGY, V49, P21; Lozano GA, 2002, CAN J ZOOL, V80, P918, DOI 10.1139/Z02-063; Lyche JL, 2006, J TOXICOL ENV HEAL A, V69, P139, DOI 10.1080/15287390500259418; MARTIN LN, 1973, P ROYAL SOC EXPT BIO, V143; Moller AP, 2007, FUNCT ECOL, V21, P363, DOI 10.1111/j.1365-2435.2006.01215.x; Mondal SP, 2001, VET IMMUNOL IMMUNOP, V79, P31, DOI 10.1016/S0165-2427(01)00248-3; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; PATTERSON R, 1962, J GEN PHYSL, V45; Pendleton AR, 2006, VIROLOGY, V345, P337, DOI 10.1016/j.virol.2005.09.069; POLSON A, 1990, IMMUNOL INVEST, V19, P253; Rose M.E., 1981, P341; Saino N, 1997, J ANIM ECOL, V66, P827, DOI 10.2307/5998; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Tizard I, 2002, SEMIN AVIAN EXOT PET, V11, P2, DOI 10.1053/saep.2002.28216; Tschirren B, 2009, IBIS, V151, P160, DOI 10.1111/j.1474-919X.2008.00880.x; Wang YW, 2004, POULTRY SCI, V83, P2039, DOI 10.1093/ps/83.12.2039; YAMAMOTO H, 1975, JPN J VET RES, V23, P131	54	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9639	10.1371/journal.pone.0009639	http://dx.doi.org/10.1371/journal.pone.0009639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300173	Green Published, gold, Green Submitted			2022-12-25	WOS:000275620600004
J	Cat, AND; Griol-Charhbili, V; Loufrani, L; Labat, C; Benjamin, L; Farman, N; Lacolley, P; Henrion, D; Jaisser, F				Cat, Aurelie Nguyen Dinh; Griol-Charhbili, Violaine; Loufrani, Laurent; Labat, Carlos; Benjamin, Laura; Farman, Nicolette; Lacolley, Patrick; Henrion, Daniel; Jaisser, Frederic			The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure	FASEB JOURNAL			English	Article						aldosterone; hypertension; myoendothelial crosstalk	SPONTANEOUSLY HYPERTENSIVE-RAT; ACTIVATED POTASSIUM CHANNELS; RENIN-ANGIOTENSIN SYSTEM; VASCULAR SMOOTH-MUSCLE; OXIDATIVE STRESS; TRANSGENIC MICE; HEART-FAILURE; ALDOSTERONE; EXPRESSION; KIDNEY	Pathophysiological aldosterone (aldo)/mineralocorticoid receptor (MR) signaling has significant effects on the cardiovascular system, resulting in hypertension and cardiovascular remodeling; however, the specific contribution of the vascular MR to blood pressure regulation remains to be established. To address this question, we generated a mouse model with conditional overexpression of the MR in endothelial cells (MR-EC). In basal conditions, MR-EC mice developed moderate hypertension that could be reversed by canrenoate, a pharmacological MR antagonist. MR-EC mice presented increased contractile response of resistance arteries to vaso-constrictors ( phenylephrine, thromboxane A(2) analog, angiotensin II, and endothelin 1) in the absence of vascular morphological alterations. The acute blood pressure response to angiotensin II or endothelin 1 infusion was increased in MR-EC mice compared with that in littermate controls. These observations demonstrate that enhanced MR activation in the endothelium generates an increase in blood pressure, independent of stimulation of renal tubular Na+ transport by aldo/MR or direct activation of smooth muscle MR and establish one mechanism by which endothelial MR activation per se may contribute to impaired vascular reactivity.-Nguyen Dinh Cat, A., Griol-Charhbili, V., Loufrani, L., Labat, C., Benjamin, L., Farman, N., Lacolley, P., Henrion, D., and Jaisser, F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J. 24, 2454-2463 (2010). www.fasebj.org	[Jaisser, Frederic] Ctr Rech Cordeliers, INSERM, UMRS 872, Team 1,U872, F-75006 Paris, France; [Cat, Aurelie Nguyen Dinh; Griol-Charhbili, Violaine; Farman, Nicolette; Jaisser, Frederic] Univ Paris 06, Paris, France; [Loufrani, Laurent; Henrion, Daniel] Fac Med, CNRS, INSERM, UMR, Angers, France; [Labat, Carlos; Lacolley, Patrick] Fac Med Vandoeuvre Nancy, INSERM, U961, F-54505 Vandoeuvre Les Nancy, France; [Labat, Carlos; Lacolley, Patrick] Henri Poincare Univ, Nancy, France; [Benjamin, Laura] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Benjamin, Laura] Harvard Univ, Sch Med, Boston, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jaisser, F (corresponding author), Ctr Rech Cordeliers, INSERM, UMRS 872, Team 1,U872, 15 Rue Ecole Med, F-75006 Paris, France.	frederic.jaisser@crc.jussieu.fr	Henrion, Daniel/J-8141-2015; Henrion, Daniel/N-7023-2015; loufrani, laurent/K-1713-2015; Labat, Carlos/F-7492-2010; Jaisser, Frederic/P-4287-2017; Lacolley, Patrick/G-3118-2013; Henrion, Daniel/AAK-1995-2021; CAT, Aurelie NGUYEN DINH/H-8182-2013	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Labat, Carlos/0000-0002-5275-3405; Jaisser, Frederic/0000-0001-9051-1901; Henrion, Daniel/0000-0003-1094-0285; 	Agence Nationale pour la Recherche [ANR005-PCOD005, ANR-09-BLAN-0156-01]; GENZYME; European Section of the Aldosterone Concil (ESAC); Leducq Fondation (Transatlantic Network of Excellence in Cardiovascular Disease); Fondation de France; Centre de Recherche Industrielle et Technique	Agence Nationale pour la Recherche(French National Research Agency (ANR)); GENZYME(Sanofi-AventisGenzyme Corporation); European Section of the Aldosterone Concil (ESAC); Leducq Fondation (Transatlantic Network of Excellence in Cardiovascular Disease); Fondation de France(Fondation de France); Centre de Recherche Industrielle et Technique	The authors are highly indebted to N. Panek-Huet for her major contribution in animal handling; S. Messaoudi, J. Faugeroux, S. El Moghrabi, and M. Muffat-Joly and the Centre d'Explorations Fonctionnelles Integrees at Bichat Federative Research Institute 02 helped with phenotypic characterization. A.N.D.C. held a Ph.D. grant from INSERM/Conseil Regional Ile de France; V.G.-C. held a Lefoulon-Delalande fellowship. This work was supported by grants from the Agence Nationale pour la Recherche (ANR005-PCOD005 and ANR-09-BLAN-0156-01), the GENZYME Research Innovation Program, the European Section of the Aldosterone Concil (ESAC), the Leducq Fondation (Transatlantic Network of Excellence in Cardiovascular Disease), the Fondation de France, and the Centre de Recherche Industrielle et Technique. The authors report no conflicts of interest.	Adler GK, 2007, HYPERTENSION, V50, P31, DOI 10.1161/HYPERTENSIONAHA.107.090894; Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Bichara M, 2006, GLYCOBIOLOGY, V16, P36, DOI 10.1093/glycob/cwj035; Cat AND, 2009, ENDOCRINOLOGY, V150, P2202, DOI 10.1210/en.2008-1531; Cat AND, 2009, HYPERTENSION, V54, pE126; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Delano FA, 2004, MICROCIRCULATION, V11, P69, DOI 10.1080/10739680490266207; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Iglarz M, 2004, AM J HYPERTENS, V17, P597, DOI 10.1016/j.amjhyper.2004.04.005; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Konishi A, 2003, J STEROID BIOCHEM, V85, P439, DOI 10.1016/S0960-0760(03)00198-5; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Loufrani L, 2002, CIRC RES, V91, P1183, DOI 10.1161/01.RES.0000047505.11002.81; Mercier N, 2006, CARDIOVASC RES, V72, P349, DOI 10.1016/j.cardiores.2006.08.008; Milik E, 2007, J PHYSIOL PHARMACOL, V58, P745; Montezano AC, 2008, HYPERTENSION, V52, P1016, DOI 10.1161/HYPERTENSIONAHA.108.121269; Mukai Y, 2006, J CLIN INVEST, V116, P334, DOI 10.1172/JCI26223; Nietlispach F, 2007, HYPERTENSION, V50, P82, DOI 10.1161/HYPERTENSIONAHA.107.088955; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Ohtani T, 2007, AM J PHYSIOL-REG I, V292, pR946, DOI 10.1152/ajpregu.00402.2006; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Park JB, 2001, HYPERTENSION, V37, P1444, DOI 10.1161/01.HYP.37.6.1444; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pu Q, 2003, HYPERTENSION, V42, P49, DOI 10.1161/01.HYP.0000078357.92682.EC; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRCULATIONAHA.105.539122; Sainte Marie Y, 2007, AM J PATHOL, V171, P846, DOI 10.2353/ajpath.2007.060991; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Sato A, 2003, HYPERTENSION, V41, P64, DOI 10.1161/01.HYP.0000044937.95080.E9; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Skott O, 2006, PHARMACOL THERAPEUT, V111, P495, DOI 10.1016/j.pharmthera.2005.10.010; Struthers AD, 2004, MOL CELL ENDOCRINOL, V217, P239, DOI 10.1016/j.mce.2003.10.024; Takeda M, 2007, HYPERTENS RES, V30, P427, DOI 10.1291/hypres.30.427; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1; Virdis A, 2002, HYPERTENSION, V40, P504, DOI 10.1161/01.HYP.0000034738.79310.06; Wong S, 2007, ENDOCRINOLOGY, V148, P1511, DOI 10.1210/en.2006-0965	44	112	113	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2454	2463		10.1096/fj.09-147926	http://dx.doi.org/10.1096/fj.09-147926			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20299606				2022-12-25	WOS:000279343600032
J	Lee, HH; Vo, MT; Kim, HJ; Lee, UH; Kim, CW; Kim, HK; Ko, MS; Lee, WH; Cha, SJ; Min, YJ; Choi, DH; Suh, HS; Lee, BJ; Park, JW; Cho, WJ				Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Lee, Unn Hwa; Kim, Chae Won; Kim, Hong Kyeung; Ko, Myoung Seok; Lee, Won Hyuck; Cha, Seung Joo; Min, Young Joo; Choi, Dae Hwa; Suh, Ho Seok; Lee, Byung Ju; Park, Jeong Woo; Cho, Wha Ja			Stability of the LATS2 Tumor Suppressor Gene Is Regulated by Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA TURNOVER; AU-RICH ELEMENTS; DOWN-REGULATION; HUMAN HOMOLOG; PROMOTER HYPERMETHYLATION; DROSOPHILA LATS; PROTEIN; EXPRESSION; PROLIFERATION	LATS2 is a tumor suppressor gene implicated in the control of cell growth and the cell cycle. Here, we investigated the post-transcriptional regulation of LATS2 expression by tristetraprolin (TTP). Our results show that the expression level of LATS2 is inversely correlated with TTP expression in human cancer cell lines. Overexpression of TTP reduced the expression level of LATS2. Conversely, treatment with small interfering RNA against TTP increased the expression level of LATS2 through stabilization of LATS2 mRNA and suppressed the proliferation of A549 human lung cancer cells. LATS2 mRNA contains AU-rich elements (AREs) within the 3'-untranslated region, and TTP destabilized a luciferase mRNA containing LATS2 ARE. In addition, RNA electrophoretic mobility shift assay revealed that TTP directly bound to the ARE of LATS2 mRNA. These results establish LATS2 mRNA as a physiological target of TTP and suggest the possibility that TTP controls cell growth through regulation of LATS2 mRNA stability.	[Ko, Myoung Seok; Lee, Won Hyuck] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Cha, Seung Joo; Min, Young Joo; Cho, Wha Ja] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 682060, South Korea; [Choi, Dae Hwa] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Surg, Ulsan 682060, South Korea; [Suh, Ho Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Dermatol, Ulsan 682060, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital		jwpark@ulsan.ac.kr; wjcho26@ulsan.ac.kr			Ministry of Health and Welfare (Republic of Korea) [0720220]; Korea Research Foundation [KRF-2005-C00009]; National Research Foundation of Korea, Ministry of Education, Science, and Technology [2009-0070260, 2009-0094051]; Ministry of Education and Human Resources Development [BRL-2009-0087350]; Ulsan University Hospital [UUH-2006-8]	Ministry of Health and Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); National Research Foundation of Korea, Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Ministry of Education and Human Resources Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ulsan University Hospital	This work was supported in part by National R&D Program for Cancer Control Grant 0720220 from the Ministry of Health and Welfare (Republic of Korea), Korea Research Foundation Grant KRF-2005-C00009, National Research Foundation of Korea Priority Research Center Program Grants 2009-0070260 and 2009-0094051 from the Ministry of Education, Science, and Technology, Korea Research Foundation Grant BRL-2009-0087350 from the Korean Government (Ministry of Education and Human Resources Development), and Biomedical Research Center Promotion Fund Grant UUH-2006-8 from Ulsan University Hospital.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cho WJ, 2009, MOL CELLS, V28, P521, DOI 10.1007/s10059-009-0158-0; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim SY, 2002, CYTOTECHNOLOGY, V40, P75, DOI 10.1023/A:1023918206060; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Takahashi Y, 2007, J CANCER RES CLIN, V133, P501, DOI 10.1007/s00432-007-0194-0; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	46	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17329	17337		10.1074/jbc.M109.094235	http://dx.doi.org/10.1074/jbc.M109.094235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335167	Green Published, hybrid			2022-12-25	WOS:000278133400010
J	Lee, KS; Lee, YS; Lee, JM; Ito, K; Cinghu, S; Kim, JH; Jang, JW; Li, YH; Goh, YM; Chi, XZ; Wee, H; Lee, HW; Hosoya, A; Chung, JH; Jang, JJ; Kundu, JK; Surh, YJ; Kim, WJ; Ito, Y; Jung, HS; Bae, SC				Lee, K-S; Lee, Y-S; Lee, J-M; Ito, K.; Cinghu, S.; Kim, J-H; Jang, J-W; Li, Y-H; Goh, Y-M; Chi, X-Z; Wee, H.; Lee, H-W; Hosoya, A.; Chung, J-H; Jang, J-J; Kundu, J. K.; Surh, Y-J; Kim, W-J; Ito, Y.; Jung, H-S; Bae, S-C			Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer	ONCOGENE			English	Article						RUNX3; lung; adenocarcinoma; adenoma; tumor suppressor	ATYPICAL ADENOMATOUS HYPERPLASIA; PROMOTER HYPERMETHYLATION; EPIGENETIC INACTIVATION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; GASTRIC-CANCER; STEM-CELLS; GENE; EXPRESSION; GROWTH	Human lung adenocarcinoma, the most prevalent form of lung cancer, is characterized by many molecular abnormalities. K-ras mutations are associated with the initiation of lung adenocarcinomas, but K-ras-independent mechanisms may also initiate lung tumors. Here, we find that the runt-related transcription factor Runx3 is essential for normal murine lung development and is a tumor suppressor that prevents lung adenocarcinoma. Runx3-/- mice, which die soon after birth, exhibit alveolar hyperplasia. Importantly, Runx3-/- bronchioli exhibit impaired differentiation, as evidenced by the accumulation of epithelial cells containing specific markers for both alveolar (that is SP-B) and bronchiolar (that is CC10) lineages. Runx3-/- epithelial cells also express Bmi1, which supports self-renewal of stem cells. Lung adenomas spontaneously develop in aging Runx3+/- mice (similar to 18 months after birth) and invariably exhibit reduced levels of Runx3. As K-ras mutations are very rare in these adenomas, Runx3+/- mice provide an animal model for lung tumorigenesis that recapitulates the preneoplastic stage of human lung adenocarcinoma development, which is independent of K-Ras mutation. We conclude that Runx3 is essential for lung epithelial cell differentiation, and that downregulation of Runx3 is causally linked to the preneoplastic stage of lung adenocarcinoma. Oncogene (2010) 29, 3349-3361; doi:10.1038/onc.2010.79; published online 15 March 2010	[Lee, K-S] Chungbuk Natl Univ, Dept Biochem, Tumor Res Ctr, Sch Med,Inst Tumor Res,Coll Med, Cheongju 361763, Chungbuk, South Korea; [Lee, J-M; Jung, H-S] Yonsei Univ, Div Anat & Dev Biol, Coll Dent, Seoul 120749, South Korea; [Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Sakamoto Nagasaki, Japan; [Lee, H-W] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Lab Anim Res Ctr, Seoul 120749, South Korea; [Hosoya, A.] Matsumoto Dent Univ, Dept Oral Histol, Shiojiri Nagano, Japan; [Chung, J-H; Jang, J-J] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kundu, J. K.; Surh, Y-J] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, W-J] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju 361763, Chungbuk, South Korea; [Kim, W-J] Inst Tumor Res, Cheongju, South Korea; [Ito, Y.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	Chungbuk National University; Yonsei University; Yonsei University Health System; Nagasaki University; Yonsei University; Matsumoto Dental University; Seoul National University (SNU); Seoul National University (SNU); Chungbuk National University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lee, KS (corresponding author), Chungbuk Natl Univ, Dept Biochem, Tumor Res Ctr, Sch Med,Inst Tumor Res,Coll Med, Cheongju 361763, Chungbuk, South Korea.	klee-2005@chungbuk.ac.kr; scbae@chungbuk.ac.kr	Jung, Han-Sung/I-3848-2012; Jang, JaJune/F-6647-2011; Chung, Jin-Haeng/F-3706-2011; Kundu, Joydeb/E-6004-2010	Lee, Jong-Min/0000-0002-9466-7644; Jung, Han-Sung/0000-0003-2795-531X; Jung, Han Sung/0000-0002-5563-7039	Korea Science and Engineering Foundation [R16-2003-002-0100102006, R13-2003-013-05001-0]; Korea Research Foundation [KRF-2005-217-E00002]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by research grants from the Korea Science and Engineering Foundation (R16-2003-002-0100102006 to S-C Bae and R13-2003-013-05001-0 to H-S Jung) and a grant from the Basic Research Promotion Fund of the Korea Research Foundation (KRF-2005-217-E00002 to K-S Lee).	Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Bea S, 2001, CANCER RES, V61, P2409; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cazorla M, 1998, MOL CARCINOGEN, V21, P251, DOI 10.1002/(SICI)1098-2744(199804)21:4<251::AID-MC4>3.0.CO;2-N; Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Dimri GP, 2002, CANCER RES, V62, P4736; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Guo WH, 2002, ONCOGENE, V21, P8351, DOI 10.1038/sj.onc.1206037; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496; Ito T, 2008, ASIAN ECON POLICY R, V3, P237, DOI 10.1111/j.1748-3131.2008.00107.x; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Kato N, 2003, AM J PATHOL, V163, P387, DOI 10.1016/S0002-9440(10)63668-1; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Malkinson AM, 1998, EXP LUNG RES, V24, P541, DOI 10.3109/01902149809087385; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mori M, 1998, ULTRASTRUCT PATHOL, V22, P459, DOI 10.3109/01913129809032282; Mundlos S, 1997, FASEB J, V11, P125, DOI 10.1096/fasebj.11.2.9039954; Okuda, 1996, Mol Diagn, V1, P139, DOI 10.1016/S1084-8592(96)70029-2; Osanai M, 2001, ULTRASTRUCT PATHOL, V25, P367, DOI 10.1080/019131201317101243; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; Petersen I, 2001, ANAL CELL PATHOL, V22, P111, DOI 10.1155/2001/374304; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Sato K, 2006, ONCOL REP, V15, P129; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tozawa T, 2004, CANCER SCI, V95, P736, DOI 10.1111/j.1349-7006.2004.tb03254.x; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Westra WH, 1996, CANCER RES, V56, P2224; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Xiao WH, 2004, WORLD J GASTROENTERO, V10, P376; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zochbauer-Muller S, 2000, Chest Surg Clin N Am, V10, P691	57	57	58	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2010	29	23					3349	3361		10.1038/onc.2010.79	http://dx.doi.org/10.1038/onc.2010.79			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	608YU	20228843				2022-12-25	WOS:000278622700004
J	Gascoyne, DM; Dunne, J; Behjati, S; Sebire, NJ; Anderson, J; Latchman, DS				Gascoyne, D. M.; Dunne, J.; Behjati, S.; Sebire, N. J.; Anderson, J.; Latchman, D. S.			EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A	ONCOGENE			English	Article						EWS/ETS; Ewing's sarcoma; EFT; BRN3A; POU4F1	EWINGS-SARCOMA; DNA-BINDING; GENE-EXPRESSION; FUSION PROTEIN; NEUROECTODERMAL TUMORS; INHIBITS PROLIFERATION; EWS-FLI1 ONCOPROTEIN; SENSORY NEURONS; TARGET GENE; CELL-LINES	Ewing's sarcoma family tumors (ESFTs or EFTs) express neuronal markers, which indicates they may originate from cells at least partly committed to neuronal lineage. However, recent publications suggest EFT originates in mesenchymal stem cells, and EWS/ETS fusion proteins characteristic of EFT activate neuronal marker expression to confer a neural phenotype on EFT. Here we show that the neuronal marker BRN3A/POU4F1 is expressed abundantly at the protein level in primary EFT but not in rhabdomyosarcoma and neuroblastoma, and EFT cells exhibit high activity of the BRN3A proximal autoregulatory region. EWS/FLI-1 siRNA reduces BRN3A expression and promoter activity and EWS/ETS proteins are bound to the BRN3A locus, suggesting a direct function for EWS/ETS proteins in control of BRN3A expression. Differentiation-associated and autoregulatory activities of BRN3A are respectively impaired and altered in EFT cells, and EWS/FLI-1 siRNA can restore some BRN3A function. A potentially novel function for BRN3A in EFT cells is identified. These results extend the hypothesis that EWS/ETS proteins induce expression of neuronal markers such as BRN3A in EFT by showing that the function of those same markers may be restricted or controlled in an EWS/ETS-dependent manner. Oncogene (2010) 29, 3134-3145; doi: 10.1038/onc.2010.72; published online 29 March 2010	[Gascoyne, D. M.; Behjati, S.; Anderson, J.] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [Dunne, J.] Barts & London Queen Marys Sch Med & Dent, Canc Res UK Med Oncol Lab, London, England; [Sebire, N. J.] Great Ormond St Hosp Sick Children, Dept Paediat Pathol, London WC1N 3JH, England; [Latchman, D. S.] Univ London, Birkbeck Coll, London, England	University of London; University College London; Cancer Research UK; University of London; Queen Mary University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; Birkbeck University London	Gascoyne, DM (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Level 4 Acad Block, Oxford OX3 9DU, England.	duncan.gascoyne@ndcls.ox.ac.uk		Anderson, William/0000-0001-7509-3203; Sebire, Neil/0000-0001-5348-9063	MRC; BBSRC; CR-UK; Great Ormond Street Hospital Childrens Charity [V0907] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CR-UK(Cancer Research UK); Great Ormond Street Hospital Childrens Charity	We thank Sue Burchill (Leeds, UK) and Peter Houghton (Memphis, USA) for cell lines, Eric Turner (San Diego, USA) for alpha-Brn3a antiserum, Seong-Jin Kim (Bethesda, USA) for TGFbRII (-1670/+36), Sian Gibson and Dyanne Rampling for technical assistance and James Diss for PC-3 cells and useful discussions. Funding was provided by MRC and BBSRC (DMG and DSL), and CR-UK (JD).	Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; COLLUM RG, 1992, NUCLEIC ACIDS RES, V20, P4919, DOI 10.1093/nar/20.18.4919; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Eliazer S, 2003, MOL CELL BIOL, V23, P482, DOI 10.1128/MCB.23.2.482-492.2003; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Frass B, 2002, BBA-GENE STRUCT EXPR, V1579, P207, DOI 10.1016/S0167-4781(02)00540-7; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Gonzalez I, 2004, CLIN CANCER RES, V10, P751, DOI 10.1158/1078-0432.CCR-0778-03; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Jaishankar S, 1999, ONCOGENE, V18, P5592, DOI 10.1038/sj.onc.1202940; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Landuzzi L, 2000, AM J PATHOL, V157, P2123, DOI 10.1016/S0002-9440(10)64850-X; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; LeblondFrancillard M, 1997, J CLIN ENDOCR METAB, V82, P89, DOI 10.1210/jc.82.1.89; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; May WA, 1997, NAT GENET, V17, P495, DOI 10.1038/ng1297-495; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Perez-Sanchez C, 2002, NUCLEIC ACIDS RES, V30, P4872, DOI 10.1093/nar/gkf610; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Radig K, 1998, PATHOL RES PRACT, V194, P157, DOI 10.1016/S0344-0338(98)80016-2; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Rorie CJ, 2004, CANCER RES, V64, P1266, DOI 10.1158/0008-5472.CAN-03-3274; Smith MD, 1997, MOL CELL BIOL, V17, P345, DOI 10.1128/MCB.17.1.345; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; THEIL T, 1993, NUCLEIC ACIDS RES, V21, P5921, DOI 10.1093/nar/21.25.5921; THIELE CJ, 1990, CANCER INVEST, V8, P629, DOI 10.3109/07357909009018932; Torchia EC, 2003, CANCER RES, V63, P3464; Trieu M, 1999, J NEUROSCI, V19, P6549; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Yamaki K, 2005, MENT RETARD, V43, P1, DOI 10.1352/0047-6765(2005)43<1:BWSAAW>2.0.CO;2; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594	50	1	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3134	3145		10.1038/onc.2010.72	http://dx.doi.org/10.1038/onc.2010.72			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20348952				2022-12-25	WOS:000278133100010
J	Li, CY; Chen, SZ; Yue, P; Deng, XM; Lonial, S; Khuri, FR; Sun, SY				Li, Chunyang; Chen, Shuzhen; Yue, Ping; Deng, Xingming; Lonial, Sagar; Khuri, Fadlo R.; Sun, Shi-Yong			Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent I kappa B alpha Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC RETINOID CD437; LUNG-CARCINOMA CELLS; CANCER-CELLS; ACTIVATION; APOPTOSIS; DEATH; CALPASTATIN; THERAPY; TARGET; PROTEOLYSIS	The proteasome, a key component of the ubiquitin-proteasome pathway, has emerged as an important cancer therapeutic target. PS-341 (also called Bortezomib or Velcade) is the first proteasome inhibitor approved for newly diagnosed and relapsed multiple myeloma and is currently being tested in many clinical trials against other types of cancers. One proposed mechanism by which PS-341 exerts its anticancer effect is inactivation of nuclear factor-kappa B (NF-kappa B) through prevention of I kappa B alpha degradation. In this study, we show that PS-341 at concentrations that effectively inhibited the growth of human cancer cells, instead of increasing I kappa B alpha stability, paradoxically induced I kappa B alpha degradation. As a result, PS-341 facilitated p65 nuclear translocation and increased NF-kappa B activity. Moreover, I kappa B alpha degradation by PS-341 occurred early before induction of apoptosis and could not be inhibited by a pan-caspase inhibitor or caspase-8 silencing; however, it could be prevented with calpain inhibitors, calcium-chelating agents, calpain knockdown, or calpastatin overexpression. In agreement, PS-341 increased calpain activity. These data together indicate that PS-341 induces a calpain-mediated I kappa B alpha degradation independent of caspases. In the presence of a calpain inhibitor, the apoptosis-inducing activity of PS-341 was dramatically enhanced. Collectively, these unexpected findings suggest not only a novel paradigm regarding the relationship between proteasome inhibition and NF-kappa B activity but also a strategy to enhance the anticancer efficacy of PS-341.	[Sun, Shi-Yong] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA; [Deng, Xingming] Emory Univ, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Sch Med, 1365-C Clifton Rd NE,Ste C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Chen, Shuzhen/GXG-9004-2022; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Chen, Shu-zhen/0000-0003-4881-0558	National Institutes of Health [CA128613]; Department of Defense [W81XWH-04-1-0142]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128613 (to S.-Y.S. and F. R. K. for Project 2). This work was also supported by Department of Defense VITAL Grant W81XWH-04-1-0142 (to S.-Y.S. for Project 4).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Calvaruso G, 2006, MOL CELL BIOCHEM, V287, P13, DOI 10.1007/s11010-005-9016-3; Delobel P, 2005, FEBS LETT, V579, P1, DOI 10.1016/j.febslet.2004.11.018; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hu XT, 2003, CYTOKINE, V21, P286, DOI 10.1016/S1043-4666(03)00107-8; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lamkanfi M, 2006, J CELL BIOL, V173, P165, DOI 10.1083/jcb.200509092; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Scagliotti G, 2006, CRIT REV ONCOL HEMAT, V58, P177, DOI 10.1016/j.critrevonc.2005.12.001; Schaecher K, 2004, NEUROCHEM RES, V29, P1443, DOI 10.1023/B:NERE.0000026410.56000.dd; Schenkein David P, 2005, Clin Lung Cancer, V7 Suppl 2, pS49, DOI 10.3816/CLC.2005.s.008; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 1997, CANCER RES, V57, P4931; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zavrski I, 2005, ANTI-CANCER DRUG, V16, P475, DOI 10.1097/00001813-200506000-00002; Zou W, 2006, CLIN CANCER RES, V12, P273, DOI 10.1158/1078-0432.CCR-05-0503	36	82	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16096	16104		10.1074/jbc.M109.072694	http://dx.doi.org/10.1074/jbc.M109.072694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335171	Green Published, hybrid			2022-12-25	WOS:000277715900047
J	Loukili, N; Rosenblatt-Velin, N; Rolli, J; Levrand, S; Feihl, F; Waeber, B; Pacher, P; Liaudet, L				Loukili, Noureddine; Rosenblatt-Velin, Nathalie; Rolli, Joelle; Levrand, Sandra; Feihl, Francois; Waeber, Bernard; Pacher, Pal; Liaudet, Lucas			Oxidants Positively or Negatively Regulate Nuclear Factor kappa B in a Context-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN PHOSPHATASE 2A; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; KINASE; ACTIVATION; INHIBITION; PEROXYNITRITE; PHOSPHORYLATION	Redox-based mechanisms play critical roles in the regulation of multiple cellular functions. NF-kappa B, a master regulator of inflammation, is an inducible transcription factor generally considered to be redox-sensitive, but the modes of interactions between oxidant stress and NF-kappa B are incompletely defined. Here, we show that oxidants can either amplify or suppress NF-kappa B activation in vitro by interfering both with positive and negative signals in the NF-kappa B pathway. NF-kappa B activation was evaluated in lung A549 epithelial cells stimulated with tumor necrosis factor alpha (TNF alpha), either alone or in combination with various oxidant species, including hydrogen peroxide or peroxynitrite. Exposure to oxidants after TNF alpha stimulation produced a robust and long lasting hyperactivation of NF-kappa B by preventing resynthesis of the NF-kappa B inhibitor I kappa B, thereby abrogating the major negative feedback loop of NF-kappa B. This effect was related to continuous activation of inhibitor of kappa B kinase (IKK), due to persistent IKK phosphorylation consecutive to oxidant-mediated inactivation of protein phosphatase 2A. In contrast, exposure to oxidants before TNF alpha stimulation impaired IKK phosphorylation and activation, leading to complete prevention of NF-kappa B activation. Comparable effects were obtained when interleukin-1 beta was used instead of TNF alpha as the NF-kappa B activator. This study demonstrates that the influence of oxidants on NF-kappa B is entirely context-dependent, and that the final outcome (activation versus inhibition) depends on a balanced inhibition of protein phosphatase 2A and IKK by oxidant species. Our findings provide a new conceptual framework to understand the role of oxidant stress during inflammatory processes.	[Loukili, Noureddine; Rolli, Joelle; Levrand, Sandra; Liaudet, Lucas] BH 08 621 Univ Hosp, Dept Intens Care Med, Div Pathophysiol, CH-1011 Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas] Univ Med Ctr, Dept Med, CH-1011 Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Feihl, Francois; Waeber, Bernard; Liaudet, Lucas] Fac Biol & Med, CH-1011 Lausanne, Switzerland; [Pacher, Pal] NIH, Lab Physiol Studies, NIAA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Liaudet, L (corresponding author), BH 08 621 Univ Hosp, Dept Intens Care Med, Div Pathophysiol, CH-1011 Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Liaudet, Lucas/E-1322-2017; Pacher, Pal/B-6378-2008	Liaudet, Lucas/0000-0003-2670-4930; Rosenblatt, Nathalie/0000-0003-2011-2862; Pacher, Pal/0000-0001-7036-8108	Swiss National Fund for Scientific Research [PP00B-68882/1, 320000-118174/1]; NIAAA, National Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Swiss National Fund for Scientific Research Grants PP00B-68882/1 and 320000-118174/1 (to L. L.). This work was also supported by the Intramural Research Program of the NIAAA, National Institutes of Health (to P. P.).	Barisic S, 2008, CELL DEATH DIFFER, V15, P1681, DOI 10.1038/cdd.2008.98; Bjelakovic G, 2007, JNCI-J NATL CANCER I, V99, P742, DOI 10.1093/jnci/djk211; Byun MS, 2002, EXP MOL MED, V34, P332, DOI 10.1038/emm.2002.47; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Levrand S, 2005, J BIOL CHEM, V280, P34878, DOI 10.1074/jbc.M501977200; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanchez-Alcazar JA, 2003, BIOCHEM J, V370, P609, DOI 10.1042/BJ20021623; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200	31	61	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15746	15752		10.1074/jbc.M110.103259	http://dx.doi.org/10.1074/jbc.M110.103259			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299457	Green Published, hybrid			2022-12-25	WOS:000277715900010
J	Meyer, MB; Goetsch, PD; Pike, JW				Meyer, Mark B.; Goetsch, Paul D.; Pike, J. Wesley			A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1 alpha,25-Dihydroxyvitamin D-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; LIGAND GENE-EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; NUCLEAR RECEPTOR; DNA-BINDING; PARATHYROID-HORMONE; CO-REPRESSOR; ACTIVATION; ELEMENTS; INACTIVATION	CYP24A1 expression is up-regulated by 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) via a vitamin D receptor (VDR)/retinoid X receptor (RXR) heterodimer that binds to two vitamin D response elements (VDREs) located near the proximal promoter. Interestingly, although 1,25(OH)(2)D-3 induced VDR/RXR binding to the VDRE-containing proximal promoter, the VDR/RXR heterodimer also localized to a cluster of at least four potential enhancers located in intergenic regions 50-69 kb downstream of the human CYP24A1 gene and 35-45 kb downstream of the mouse Cyp24a1 gene as revealed by ChIP-chip and ChIP-seq analyses. To address whether this downstream region and potential VDREs located within mediated CYP24A1 induction, we constructed recombinant wild-type and mutant bacterial artificial chromosome clones that spanned mouse and human loci and contained luciferase reporters inserted into their 3'-untranslated regions. The activity of these clones in stably transfected cells revealed that both the proximal and the putative downstream elements contributed to CYP24A1 up-regulation by 1,25(OH)(2)D-3. Further analysis using transfected enhancer fragments led to the identification of contributing regulatory elements in several of these downstream regions. Additional studies of coregulator recruitment using ChIP-chip analysis revealed both similarities and differences between the region located proximal to and those located downstream of the promoter. Recruitment of these coregulators was likely responsible for the increase in RNA polymerase II and histone H4 acetylation, which was also observed in response to 1,25(OH)(2)D-3 at the enhancer sites across the locus. We conclude that a more complex mechanism is responsible for the striking CYP24A1 up-regulation induced by the vitamin D hormone in target cells.	[Meyer, Mark B.; Goetsch, Paul D.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281, R01DK073995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-072281 (to J. W. P.).	Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DeLuca HF, 1998, NUTR REV, V56, pS4; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kuan Pei Fen, 2008, Pac Symp Biocomput, P515; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Miele Adriana, 2008, V464, P105; Murayama A, 1999, ENDOCRINOLOGY, V140, P2224, DOI 10.1210/en.140.5.2224; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nerenz RD, 2008, MOL ENDOCRINOL, V22, P1044, DOI 10.1210/me.2007-0380; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; OHYAMA Y, 1993, BIOCHEMISTRY-US, V32, P76, DOI 10.1021/bi00052a011; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pike JW, 2007, J BONE MINER RES, V22, pV16, DOI [10.1359/jbmr.07s207, 10.1359/JBMR.07S207]; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; TANAKA Y, 1984, AM J PHYSIOL, V246, pE168, DOI 10.1152/ajpendo.1984.246.2.E168; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong Y, 2009, J BIOL CHEM, V284, P11059, DOI 10.1074/jbc.M806561200; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	55	105	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15599	15610		10.1074/jbc.M110.119958	http://dx.doi.org/10.1074/jbc.M110.119958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236932	hybrid, Green Published			2022-12-25	WOS:000277399000078
J	Sertich, JJW; Loewen, MA				Sertich, Joseph J. W.; Loewen, Mark A.			A New Basal Sauropodomorph Dinosaur from the Lower Jurassic Navajo Sandstone of Southern Utah	PLOS ONE			English	Article							EARLY EVOLUTION; THEROPOD; REMAINS; ORIGIN; ELLIOT; SKULL	Background: Basal sauropodomorphs, or 'prosauropods, 'are a globally widespread paraphyletic assemblage of terrestrial herbivorous dinosaurs from the Late Triassic and Early Jurassic. In contrast to several other landmasses, the North American record of sauropodomorphs during this time interval remains sparse, limited to Early Jurassic occurrences of a single well-known taxon from eastern North America and several fragmentary specimens from western North America. Methodology/Principal Findings: On the basis of a partial skeleton, we describe here a new basal sauropodomorph dinosaur from the Lower Jurassic Navajo Sandstone of southern Utah, Seitaad ruessi gen. et sp. nov. The partially articulated skeleton of Seitaad was likely buried post-mortem in the base of a collapsed dune foreset. The new taxon is characterized by a plate-like medial process of the scapula, a prominent proximal expansion of the deltopectoral crest of the humerus, a strongly inclined distal articular surface of the radius, and a proximally and laterally hypertrophied proximal metacarpal I. Conclusions/Significance: Phylogenetic analysis recovers Seitaad as a derived basal sauropodomorph closely related to plateosaurid or massospondylid 'prosauropods' and its presence in western North America is not unexpected for a member of this highly cosmopolitan clade. This occurrence represents one of the most complete vertebrate body fossil specimens yet recovered from the Navajo Sandstone and one of the few basal sauropodomorph taxa currently known from North America.	[Sertich, Joseph J. W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Loewen, Mark A.] Utah Museum Nat Hist, Salt Lake City, UT USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sertich, JJW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	jsertich@ic.sunysb.edu			Utah Museum of Natural History	Utah Museum of Natural History	Funding for fieldwork was provided by the Utah Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Bai Z.-Q., 1990, YUXIWENBO, V1, P14; Barrett Paul M., 2005, Palaeontologia Africana, V41, P123; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Barrett PM, 2004, S AFR J SCI, V100, P501; Blakey R.C., 1994, MESOZOIC SYSTEMS ROC, P273; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; BONAPARTE J F, 1969, Zoological Journal of the Linnean Society, V48, P471, DOI 10.1111/j.1096-3642.1969.tb00725.x; Bonaparte J.F., 1986, P247; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Brady LF, 1936, AM J SCI, V31, P150; Brady LF, 1935, AM J SCI, V30, P210; Claessens LPAM, 2004, P ROY SOC B-BIOL SCI, V271, P1461, DOI 10.1098/rspb.2004.2743; Colbert E. H., 1964, American Museum Novitates, VNo. 2181, P1; COOPER M R, 1984, Palaeontologia Africana, V25, P203; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; CRUICKSHANK ARI, 1975, S AFR J SCI, V71, P89; Fedak T, 2006, J VERTEBR PALEONTOL, V26, p60A; Fedak TJ, 2007, SPEC PAP PALAEONTOL, P245; GALTON P M, 1971, Journal of Paleontology, V45, P781; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2007, Revue de Paleobiologie, V26, P505; GALTON PM, 1976, POSTILLA, V169, P1; Gauffre F-X, 1993, NEUES JB GEOLOGIE PA, V11, P648; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; GOW C E, 1990, Palaeontologia Africana, V27, P59; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Leal LA, 2004, ZOOTAXA, P1; Loewen M, 2005, J VERTEBR PALEONTOL, V25, p84A; Loope DB, 2003, J GEOL, V111, P223, DOI 10.1086/345843; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P95; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Middleton L.T., 1983, EOLIAN SEDIMENTS PRO, P613; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Pol D, 2005, J VERTEBR PALEONTOL, V25, p100A; RMIS R.B., 2005, VERTEBRATE PALEONTOL, V11, P55; ROMER A, 1968, NOTES COMMENTS VERTE; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1989, J VERTEBR PALEONTOL, V9, pA38; SHUBIN NH, 1994, IN THE SHADOW OF THE DINOSAURS, P242; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SMITH ND, 2007, 003 US GEOL SURV NAT, DOI DOI 10.3133/OF2007-1047.SRP003; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Tykoski R. S., 2005, MESA SOUTHWEST MUS B, V11, P72; Upchurch P, 2007, SPEC PAP PALAEONTOL, P57; *USGS, 2009, SO COL PLAT REG GEOL; van Heerden Jacques, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1, P39; von HUENE FRIEDRICH, 1929, PALAEONTOL ZEITSCHR, V11, P269; VONHUENE F, 1926, GEOLOGISCHE PALAEONT, P137; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates A.M., 2004, GEOSCIENCE AFRICA, V2, P670; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417; YATES AM, 2009, P ROYAL SOC LONDON B; Young C. C., 1941, Bulletin of the Geological Society of China, V21, P205; YOUNG C. C., 1947, PALEONTOL SINICA NEW SER, V12, P1; Young C. C., 1942, Bulletin of the Geological Society of China, V22, P63; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1; ZHANG Y, 1994, COMPLETE OSTEOLOGY P	77	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9789	10.1371/journal.pone.0009789	http://dx.doi.org/10.1371/journal.pone.0009789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352090	Green Published, gold			2022-12-25	WOS:000275894500005
J	Mishiba, K; Yamasaki, S; Nakatsuka, T; Abe, Y; Daimon, H; Oda, M; Nishihara, M				Mishiba, Kei-ichiro; Yamasaki, Satoshi; Nakatsuka, Takashi; Abe, Yoshiko; Daimon, Hiroyuki; Oda, Masayuki; Nishihara, Masahiro			Strict De Novo Methylation of the 35S Enhancer Sequence in Gentian	PLOS ONE			English	Article							MOSAIC VIRUS-35S PROMOTER; DNA METHYLATION; HERBICIDE-RESISTANCE; CYTOSINE METHYLATION; GENE-EXPRESSION; GENOME; PLANTS; AGROBACTERIUM; REGION; TRANSFORMATION	A novel transgene silencing phenomenon was found in the ornamental plant, gentian (Gentiana triflora x G. scabra), in which the introduced Cauliflower mosaic virus (CaMV) 35S promoter region was strictly methylated, irrespective of the transgene copy number and integrated loci. Transgenic tobacco having the same vector did not show the silencing behavior. Not only unmodified, but also modified 35S promoters containing a 35S enhancer sequence were found to be highly methylated in the single copy transgenic gentian lines. The 35S core promoter (290)-introduced transgenic lines showed a small degree of methylation, implying that the 35S enhancer sequence was involved in the methylation machinery. The rigorous silencing phenomenon enabled us to analyze methylation in a number of the transgenic lines in parallel, which led to the discovery of a consensus target region for de novo methylation, which comprised an asymmetric cytosine (CpHpH; H is A, C or T) sequence. Consequently, distinct footprints of de novo methylation were detected in each (modified) 35S promoter sequence, and the enhancer region (2148 to 285) was identified as a crucial target for de novo methylation. Electrophoretic mobility shift assay (EMSA) showed that complexes formed in gentian nuclear extract with the 2149 to 2124 and 2107 to 283 region probes were distinct from those of tobacco nuclear extracts, suggesting that the complexes might contribute to de novo methylation. Our results provide insights into the phenomenon of sequence-and species-specific gene silencing in higher plants.	[Mishiba, Kei-ichiro; Yamasaki, Satoshi; Daimon, Hiroyuki; Oda, Masayuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Nakatsuka, Takashi; Abe, Yoshiko; Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan	Osaka Metropolitan University; Iwate Biotechnology Research Center	Mishiba, K (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan.	mishiba@plant.osakafu-u.ac.jp	Mishiba, Kei-ichiro/A-5844-2013	Mishiba, Kei-ichiro/0000-0002-3827-1020; Nishihara, Masahiro/0000-0002-1454-8785	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20780005]; Sumitomo Foundation [050356]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation	This work was supported by Grant-in-Aid for Scientific Research 20780005 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/), and by Grant for Basic Science Research Projects 050356 from The Sumitomo Foundation (http://www.sumitomo.or.jp/e/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annadana S, 2002, MOL BREEDING, V8, P335, DOI 10.1023/A:1015212312928; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; BENFEY PN, 1990, EMBO J, V9, P1677, DOI 10.1002/j.1460-2075.1990.tb08291.x; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dominguez A, 2002, MOL GENET GENOMICS, V267, P544, DOI 10.1007/s00438-002-0688-z; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOBBS SLA, 1990, PLANT MOL BIOL, V15, P851, DOI 10.1007/BF00039425; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Igasaki Tomohiro, 2002, Bulletin of the Forestry and Forest Products Research Institute, V1, P235; Kanazawa A, 2007, PLANT BIOLOGY, V9, P435, DOI 10.1055/s-2006-924633; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kobayashi H, 1998, PLANT SCI, V131, P173, DOI 10.1016/S0168-9452(97)00236-7; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; LAM E, 1990, J BIOL CHEM, V265, P9909; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; MATZKE AJM, 1994, MOL GEN GENET, V244, P219, DOI 10.1007/BF00285449; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; McCabe MS, 1999, THEOR APPL GENET, V99, P587, DOI 10.1007/s001220051272; Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461; Mishiba K, 2005, PLANT J, V44, P541, DOI 10.1111/j.1365-313X.2005.02556.x; Mishiba K, 2009, BREEDING SCI, V59, P119, DOI 10.1270/jsbbs.59.119; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Nagaya S, 2005, PLANT CELL PHYSIOL, V46, P438, DOI 10.1093/pcp/pci039; Nakatsuka T, 2009, EUPHYTICA, V168, P113, DOI 10.1007/s10681-009-9899-2; NARAYAN RKJ, 1987, PLANT SYST EVOL, V157, P161, DOI 10.1007/BF00936195; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; VANDERMEER IM, 1990, PLANT MOL BIOL, V15, P95, DOI 10.1007/BF00017727; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wada Y, 2005, PLANT BIOTECHNOL, V22, P71, DOI DOI 10.5511/plantbiotechnology.22.71; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	46	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9670	10.1371/journal.pone.0009670	http://dx.doi.org/10.1371/journal.pone.0009670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351783	Green Submitted, gold, Green Published			2022-12-25	WOS:000275894400006
J	Huijbers, IJ; Iravani, M; Popov, S; Robertson, D; Al-Sarraj, S; Jones, C; Isacke, CM				Huijbers, Ivo J.; Iravani, Marjan; Popov, Sergey; Robertson, David; Al-Sarraj, Safa; Jones, Chris; Isacke, Clare M.			A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion	PLOS ONE			English	Article							TGF-BETA; MANNOSE RECEPTOR; TRANSMEMBRANE GLYCOPROTEIN; MATRIX; EXPRESSION; BRAIN; GENE; UPARAP/ENDO180; PROLIFERATION; INHIBITOR	Background: Glioblastoma multiforme (GBM, WHO grade IV) is the most common and most malignant of astrocytic brain tumors, and is associated with rapid invasion into neighboring tissue. In other tumor types it is well established that such invasion involves a complex interaction between tumor cells and locally produced extracellular matrix. In GBMs, surprisingly little is known about the associated matrix components, in particular the fibrillar proteins such as collagens that are known to play a key role in the invasion of other tumor types. Methodology/Principal Findings: In this study we have used both the Masson's trichrome staining and a high resolution multiple immunofluorescence labeling method to demonstrate that intratumoral fibrillar collagens are an integral part of the extracellular matrix in a subset of GBMs. Correlated with this collagen deposition we observed high level expression of the collagen-binding receptor Endo180 (CD280) in the tumor cells. Further, interrogation of multiple expression array datasets identified Endo180 as one of the most highly upregulated transcripts in grade IV GBMs compared to grade III gliomas. Using promoter analysis studies we show that this increased expression is, in part, mediated via TGF-beta signaling. Functionally, we demonstrate that Endo180 serves as the major collagen internalization receptor in GBM cell lines and provide the first evidence that this activity is critical for the invasion of GBM cells through fibrillar collagen matrices. Conclusions/Significance: This study demonstrates, for the first time, that fibrillar collagens are extensively deposited in GBMs and that the collagen internalization receptor Endo180 is both highly expressed in these tumors and that it serves to mediate the invasion of tumor cells through collagen-containing matrices. Together these data provide important insights into the mechanism of GBM invasion and identify Endo180 as a potential target to limit matrix turnover by glioma cells and thereby restrict tumor progression.	[Huijbers, Ivo J.; Iravani, Marjan; Robertson, David; Isacke, Clare M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Popov, Sergey; Jones, Chris] Royal Marsden NHS Trust, Inst Canc Res, Sutton, Surrey, England; [Al-Sarraj, Safa] Kings Coll Hosp London, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; King's College Hospital NHS Foundation Trust; King's College Hospital	Huijbers, IJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	clare.isacke@icr.ac.uk	Huijbers, Ivo/I-3229-2019; Jones, Chris/ABE-6059-2021	Jones, Chris/0000-0001-8118-2296; Iravani, Marjan/0000-0002-8620-3073; Isacke, Clare/0000-0002-9222-3345	Breakthrough Breast Cancer [BC06/07]; Royal Marsden NHS Foundation Trust Charity; NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre	Breakthrough Breast Cancer; Royal Marsden NHS Foundation Trust Charity; NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was funded by Breakthrough Breast Cancer BC06/07 (IJH, MI, DR, CMI) and Royal Marsden NHS Foundation Trust Charity (SP). The authors acknowledge NHS funding to the National Institute for Health Research (NIHR) Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; CERDANICOLAS M, 1993, ACTA NEUROPATHOL, V85, P349, DOI 10.1007/BF00334444; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; GLADSON CL, 1995, J CELL SCI, V108, P947; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Knott JCA, 1998, INT J CANCER, V75, P864, DOI 10.1002/(SICI)1097-0215(19980316)75:6<864::AID-IJC8>3.0.CO;2-T; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luwor RB, 2008, J CLIN NEUROSCI, V15, P845, DOI 10.1016/j.jocn.2008.01.003; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; Ranuncolo SM, 2002, J SURG ONCOL, V79, P30, DOI 10.1002/jso.10045; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Sheikh H, 2000, J CELL SCI, V113, P1021; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Williams MJ, 2005, BRAIN RES, V1058, P62, DOI 10.1016/j.brainres.2005.07.078; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zamecnik J, 2004, NEUROPATH APPL NEURO, V30, P338, DOI 10.1046/j.1365-2990.2003.0541.x	44	148	153	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9808	10.1371/journal.pone.0009808	http://dx.doi.org/10.1371/journal.pone.0009808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339555	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300028
J	Lykidis, A; Perez-Pantoja, D; Ledger, T; Mavromatis, K; Anderson, IJ; Ivanova, NN; Hooper, SD; Lapidus, A; Lucas, S; Gonzalez, B; Kyrpides, NC				Lykidis, Athanasios; Perez-Pantoja, Danilo; Ledger, Thomas; Mavromatis, Kostantinos; Anderson, Iain J.; Ivanova, Natalia N.; Hooper, Sean D.; Lapidus, Alla; Lucas, Susan; Gonzalez, Bernardo; Kyrpides, Nikos C.			The Complete Multipartite Genome Sequence of Cupriavidus necator JMP134, a Versatile Pollutant Degrader	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; GENE-CLUSTER; TETRAHYDROFURFURYL ALCOHOL; MICROBIAL-METABOLISM; PLASMID PJP4; NITRIC-OXIDE; DEGRADATION; DEHYDROGENASE; BURKHOLDERIA; ACID	Background: Cupriavidus necator JMP134 is a Gram-negative beta-proteobacterium able to grow on a variety of aromatic and chloroaromatic compounds as its sole carbon and energy source. Methodology/ Principal Findings: Its genome consists of four replicons (two chromosomes and two plasmids) containing a total of 6631 protein coding genes. Comparative analysis identified 1910 core genes common to the four genomes compared (C. necator JMP134, C. necator H16, C. metallidurans CH34, R. solanacearum GMI1000). Although secondary chromosomes found in the Cupriavidus, Ralstonia, and Burkholderia lineages are all derived from plasmids, analyses of the plasmid partition proteins located on those chromosomes indicate that different plasmids gave rise to the secondary chromosomes in each lineage. The C. necator JMP134 genome contains 300 genes putatively involved in the catabolism of aromatic compounds and encodes most of the central ring-cleavage pathways. This strain also shows additional metabolic capabilities towards alicyclic compounds and the potential for catabolism of almost all proteinogenic amino acids. This remarkable catabolic potential seems to be sustained by a high degree of genetic redundancy, most probably enabling this catabolically versatile bacterium with different levels of metabolic responses and alternative regulation necessary to cope with a challenging environment. From the comparison of Cupriavidus genomes, it is possible to state that a broad metabolic capability is a general trait for Cupriavidus genus, however certain specialization towards a nutritional niche (xenobiotics degradation, chemolithoautotrophy or symbiotic nitrogen fixation) seems to be shaped mostly by the acquisition of "specialized" plasmids. Conclusions/Significance: The availability of the complete genome sequence for C. necator JMP134 provides the groundwork for further elucidation of the mechanisms and regulation of chloroaromatic compound biodegradation.	[Lykidis, Athanasios; Mavromatis, Kostantinos; Anderson, Iain J.; Ivanova, Natalia N.; Hooper, Sean D.; Lapidus, Alla; Lucas, Susan; Kyrpides, Nikos C.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Perez-Pantoja, Danilo; Ledger, Thomas; Gonzalez, Bernardo] Pontificia Univ Catolica Chile, NM PFG, NM EMBA,Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago, Chile; [Perez-Pantoja, Danilo; Ledger, Thomas; Gonzalez, Bernardo] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Ledger, Thomas; Gonzalez, Bernardo] Univ Adolfo Ibanez, Fac Ingn & Ciencia, Santiago, Chile	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Adolfo Ibanez	Lykidis, A (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	alykidis@lbl.gov	González, Bernardo/AAW-9578-2021; Lapidus, Alla L/I-4348-2013; Kyrpides, Nikos C./A-6305-2014; Perez-Pantoja, Danilo/ABD-1286-2020; Pérez-Pantoja, Danilo/AAF-4197-2019; Ledger, Thomas/AAO-6775-2021	Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Pérez-Pantoja, Danilo/0000-0001-5720-2162; Ledger, Thomas/0000-0002-3109-2070; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy's Office of Science; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]; FONDECYT [1070343]; Millennium Nuclei [P/04-007-F, P/06-009-F]; research program FONDAP [1501-0001];  [PBCT RED-12]	US Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nuclei; research program FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); 	The work presented in this article was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory under contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support from the FONDECYT grant 1070343; the Millennium Nuclei grants P/04-007-F and P/06-009-F; the research program FONDAP 1501-0001 and the grant PBCT RED-12 is acknowledged. D. P. P. is a CONICYT-DAAD PhD fellow.	Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Barrett CF, 2006, APPL ENVIRON MICROB, V72, P1198, DOI 10.1128/AEM.72.2.1198-1206.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; CLEMENT P, 1995, FEMS MICROBIOL LETT, V127, P51, DOI 10.1111/j.1574-6968.1995.tb07449.x; Copley SD, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P227; Cramm R, 1997, J BACTERIOL, V179, P6769, DOI 10.1128/jb.179.21.6769-6777.1997; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; DAUBARAS DL, 1995, APPL ENVIRON MICROB, V61, P1279, DOI 10.1128/AEM.61.4.1279-1289.1995; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Egland PG, 2000, J BACTERIOL, V182, P100, DOI 10.1128/JB.182.1.100-106.2000; Ensign SA, 1998, ARCH MICROBIOL, V169, P179, DOI 10.1007/s002030050558; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Flavier AB, 1998, MOL MICROBIOL, V28, P475, DOI 10.1046/j.1365-2958.1998.00804.x; Garg RP, 2000, MOL MICROBIOL, V38, P359, DOI 10.1046/j.1365-2958.2000.02131.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; GHOSAL D, 1985, P NATL ACAD SCI USA, V82, P1638, DOI 10.1073/pnas.82.6.1638; Inoue H, 1997, J BACTERIOL, V179, P3956, DOI 10.1128/jb.179.12.3956-3962.1997; ITOH Y, 2007, HISTIDINE CATABOLISM, P371; JANSSEN DB, 2003, BACTERIAL GROWTH HAL, P207; JENNI B, 1988, SYST APPL MICROBIOL, V10, P126, DOI 10.1016/S0723-2020(88)80026-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laemmli CM, 2000, J BACTERIOL, V182, P4165, DOI 10.1128/JB.182.15.4165-4172.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; MASSEY LK, 1976, BACTERIOL REV, V40, P42, DOI 10.1128/MMBR.40.1.42-54.1976; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Muller RH, 1996, APPL ENVIRON MICROB, V62, P147, DOI 10.1128/AEM.62.1.147-151.1996; Muller S, 1999, J BIOTECHNOL, V75, P81, DOI 10.1016/S0168-1656(99)00130-3; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Perez-Pantoja D, 2000, APPL ENVIRON MICROB, V66, P1602, DOI 10.1128/AEM.66.4.1602-1608.2000; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Plumeier I, 2002, J BACTERIOL, V184, P4054, DOI 10.1128/JB.184.15.4054-4064.2002; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; Rees E, 1997, APPL ENVIRON MICROB, V63, P800, DOI 10.1128/AEM.63.2.800-802.1997; Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897; Revelles O, 2005, J BACTERIOL, V187, P7500, DOI 10.1128/JB.187.21.7500-7510.2005; Santana M, 2001, J BACTERIOL, V183, P687, DOI 10.1128/JB.183.2.687-699.2001; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; SCHLOMANN M, 1990, J BACTERIOL, V172, P5112, DOI 10.1128/jb.172.9.5112-5118.1990; SIDDIQUI RA, 1993, J BACTERIOL, V175, P5867, DOI 10.1128/JB.175.18.5867-5876.1993; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Sluis MK, 2002, J BACTERIOL, V184, P2969, DOI 10.1128/JB.184.11.2969-2977.2002; Stigter ECA, 1997, J MOL CATAL B-ENZYM, V2, P291, DOI 10.1016/S1381-1177(96)00030-6; Stoorvogel J, 1996, EUR J BIOCHEM, V235, P690, DOI 10.1111/j.1432-1033.1996.00690.x; TAYLOR DG, 1980, J GEN MICROBIOL, V118, P159; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Zarnt G, 2001, J BACTERIOL, V183, P1954, DOI 10.1128/JB.183.6.1954-1960.2001; Zarnt G, 1997, APPL ENVIRON MICROB, V63, P4891, DOI 10.1128/AEM.63.12.4891-4898.1997	66	74	359	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9729	10.1371/journal.pone.0009729	http://dx.doi.org/10.1371/journal.pone.0009729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339589	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894300005
J	Arvand, M; Raoult, D; Feil, EJ				Arvand, Mardjan; Raoult, Didier; Feil, Edward J.			Multi-Locus Sequence Typing of a Geographically and Temporally Diverse Sample of the Highly Clonal Human Pathogen Bartonella quintana	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ROCHALIMAEA-QUINTANA; GENETIC-VARIANTS; HENSELAE; ENDOCARDITIS; PCR; IDENTIFICATION; POPULATION; BACTEREMIA; PATIENT	Bartonella quintana is a re-emerging pathogen and the causative agent of a variety of disease manifestations in humans including trench fever. Various typing methods have been developed for B. quintana, but these tend to be limited by poor resolution and, in the case of gel-based methods, a lack of portability. Multilocus sequence typing (MLST) has been used to study the molecular epidemiology of a large number of pathogens, including B. henselae, a close relative of B. quintana. We developed a MLST scheme for B. quintana based on the 7 MLST loci employed for B. henselae with two additional loci to cover underrepresented regions of the B. quintana chromosome. A total of 16 B. quintana isolates spanning over 60 years and three continents were characterized. Allelic variation was detected in five of the nine loci. Although only 8/4270 (0.002%) of the nucleotide sites examined were variable over all loci, these polymorphisms resolved the 16 isolates into seven sequence types (STs). We also demonstrate that MLST can be applied on uncultured isolates by direct PCR from cardiac valve tissue, and suggest this method presents a promising approach for epidemiological studies in this highly clonal organism. Phylogenetic and clustering analyses suggest that two of the seven STs form a distinct lineage within the population.	[Arvand, Mardjan] Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany; [Raoult, Didier] Univ Mediterranee, IFR 48, CNRS,Unite Rickettsies UMR 6020, Fac Med Marseille, Marseille, France; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Bath	Arvand, M (corresponding author), Ctr Hlth Protect, Hesse State Hlth Off, Dillenburg, Germany.	mardjan.arvand@hlpug.hessen.de	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; ANDERSON B, 1994, J CLIN MICROBIOL, V32, P942, DOI 10.1128/JCM.32.4.942-948.1994; Arvand M, 2006, MICROBES INFECT, V8, P1315, DOI 10.1016/j.micinf.2005.12.015; Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0; Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891; Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06; Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303; DRANCOURT M, 1995, NEW ENGL J MED, V332, P419, DOI 10.1056/NEJM199502163320702; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Foucault C, 2005, J CLIN MICROBIOL, V43, P41, DOI 10.1128/JCM.43.1.41-48.2005; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Kelly P, 2006, EMERG INFECT DIS, V12, P1869; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; La VD, 2005, EMERG INFECT DIS, V11, P1287, DOI 10.3201/eid1108.050101; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; Maurin M, 1996, CLIN MICROBIOL REV, V9, P273, DOI 10.1128/CMR.9.3.273; MAURIN M, 1994, J CLIN MICROBIOL, V32, P1166, DOI 10.1128/JCM.32.5.1166-1171.1994; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; MOOSER H, 1948, Schweiz Z Pathol Bakteriol, V11, P513; O'Rourke LG, 2005, EMERG INFECT DIS, V11, P1931, DOI 10.3201/eid1112.030045; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995; ROUX V, 1995, J CLIN MICROBIOL, V33, P1573, DOI 10.1128/JCM.33.6.1573-1579.1995; Sander A, 1999, J CLIN MICROBIOL, V37, P3097, DOI 10.1128/JCM.37.10.3097-3101.1999; Schmidt HU, 1996, EUR J CLIN MICROBIOL, V15, P736, DOI 10.1007/BF01691961; SPACH DH, 1995, NEW ENGL J MED, V332, P424, DOI 10.1056/NEJM199502163320703; Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992; Woolley MW, 2007, J CLIN MICROBIOL, V45, P2040, DOI 10.1128/JCM.00175-07; Yerebakan C, 2008, ACTA CARDIOL, V63, P519, DOI 10.2143/AC.63.4.2033053; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	37	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9765	10.1371/journal.pone.0009765	http://dx.doi.org/10.1371/journal.pone.0009765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333257	Green Published, gold, Green Submitted			2022-12-25	WOS:000275809700009
J	Patarroyo, MA; Bermudez, A; Lopez, C; Yepes, G; Patarroyo, ME				Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina; Yepes, Gloria; Patarroyo, Manuel E.			3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; NEW-WORLD MONKEYS; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; HLA-DR4 DRA-ASTERISK-0101; AOTUS-NANCYMAAE; AMINO-ACIDS; DIVERSITY	T-cell receptor gene rearrangements were studied in Aotus monkeys developing high antibody titers and sterilizing immunity against the Plasmodium falciparum malaria parasite upon vaccination with the modified synthetic peptide 24112, which was identified in the Merozoite Surface Protein 2 (MSP-2) and is known to bind to HLA-DR beta 1*0403 molecules with high capacity. Spectratyping analysis showed a preferential usage of V beta 12 and V beta 6 TCR gene families in 67% of HLA-DR beta 1*0403-like genotyped monkeys. Docking of peptide 24112 into the HLA-DR beta 1*0401-HA peptide-HA1.7TCR complex containing the VDJ rearrangements identified in fully protected monkeys showed a different structural signature compared to nonprotected monkeys. These striking results show the exquisite specificity of the TCR/pMHCII complex formation needed for inducing sterilizing immunity and provide important hints for a logical and rational methodology to develop multiepitopic, minimal subunit-based synthetic vaccines against infectious diseases, among them malaria.	[Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina; Yepes, Gloria; Patarroyo, Manuel E.] Fdn Inst Inmunol Colombia, Bogota, Cundinamarca, Colombia; [Patarroyo, Manuel A.; Bermudez, Adriana; Lopez, Carolina] Univ Rosario, Bogota, Cundinamarca, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota, Cundinamarca, Colombia	Universidad del Rosario; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia, Bogota, Cundinamarca, Colombia.	mepatarr@mail.com	Bermudez, Adriana/I-7935-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; López-Santana, Carolina/L-8580-2016	Bermudez, Adriana/0000-0003-2669-7259; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; López-Santana, Carolina/0000-0003-1313-7607	Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain)	Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain); Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain)	This research has been supported by the Asociacion para la Investigacion Solidaria SADAR (Pamplona, Spain 2009) and the Agencia Espanola de Cooperacion Internacional para el Desarrollo AECID (Madrid, Spain 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bentley GA, 1996, ANNU REV IMMUNOL, V14, P563, DOI 10.1146/annurev.immunol.14.1.563; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; Cifuentes G, 2003, J MED CHEM, V46, P2250, DOI 10.1021/jm020440w; Coppel RL, 2009, TRENDS PARASITOL, V25, P205, DOI 10.1016/j.pt.2009.02.006; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Favre N, 1998, IMMUNOGENETICS, V48, P253, DOI 10.1007/s002510050429; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kriener K, 2000, IMMUNOGENETICS, V51, P169, DOI 10.1007/s002510050028; Kriener K, 2001, HUM IMMUNOL, V62, P1, DOI 10.1016/S0198-8859(00)00233-0; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lu J, 2004, BLOOD, V103, P4588, DOI 10.1182/blood-2003-11-3959; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Moncada CA, 2005, IMMUNOGENETICS, V57, P42, DOI 10.1007/s00251-004-0758-y; Nino-Vasquez JJ, 2000, IMMUNOGENETICS, V51, P219, DOI 10.1007/s002510050035; Ocampo M, 2000, J PEPT RES, V55, P216, DOI 10.1034/j.1399-3011.2000.00174.x; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Patarroyo ME, 2004, CHEMBIOCHEM, V5, P1588, DOI 10.1002/cbic.200400116; Pico de Coana Y, 2004, CYTOKINE, V27, P129, DOI 10.1016/j.cyto.2004.04.004; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Prato S, 2005, EUR J IMMUNOL, V35, P681, DOI 10.1002/eji.200425771; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; RODRIGUEZ R, 1990, AM J TROP MED HYG, V43, P339, DOI 10.4269/ajtmh.1990.43.339; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9771	10.1371/journal.pone.0009771	http://dx.doi.org/10.1371/journal.pone.0009771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333301	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809700010
J	Nijland, R; Burgess, JG; Errington, J; Veening, JW				Nijland, Reindert; Burgess, J. Grant; Errington, Jeff; Veening, Jan-Willem			Transformation of Environmental Bacillus subtilis Isolates by Transiently Inducing Genetic Competence	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COMK; EXPRESSION; PROTOPLASTS; SPORULATION; INITIATION; STRAINS; PROTEIN; CYCLE	Domesticated laboratory strains of Bacillus subtilis readily take up and integrate exogenous DNA. In contrast, "wild'' ancestors or Bacillus strains recently isolated from the environment can only be genetically modified by phage transduction, electroporation or protoplast transformation. Such methods are laborious, have a variable yield or cannot efficiently be used to alter chromosomal DNA. A major disadvantage of using laboratory strains is that they have often lost, or do not display ecologically relevant physiologies such as the ability to form biofilms. Here we present a method that allows genetic transformation by natural competence in several environmental isolates of B. subtilis. Competence in these strains was established by expressing the B. subtilis competence transcription factor ComK from an IPTG-inducible promoter construct present on an unstable plasmid. This transiently activates expression of the genes required for DNA uptake and recombination in the host strain. After transformation, the comK encoding plasmid is lost easily because of its intrinsic instability and the transformed strain returns to its wild state. Using this method, we have successfully generated mutants and introduced foreign DNA into a number of environmental isolates and also B. subtilis strain NCIB3610, which is widely used to study biofilm formation. Application of the same method to strains of B. licheniformis was unsuccessful. The efficient and rapid approach described here may facilitate genetic studies in a wider array of environmental B. subtilis strains.	[Nijland, Reindert; Burgess, J. Grant] Univ Newcastle, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England; [Errington, Jeff; Veening, Jan-Willem] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Nijland, R (corresponding author), Univ Newcastle, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England.	rijnland@gmail.com	Nijland, Reindert/B-8206-2008; Errington, Jeff/G-1832-2011	Nijland, Reindert/0000-0003-0049-3768; Errington, Jeff/0000-0002-6977-9388; Veening, Jan-Willem/0000-0002-3162-6634	Intra-European Marie Curie; European Community's [MEIF-CT-2007-039139, PIEF-GA-2008-219592]	Intra-European Marie Curie(European Commission); European Community's(European Commission)	This research was funded by Intra-European Marie Curie Fellowships to JWV and RN from the European Community's Sixth and Seventh Framework Programmes, under grant agreements MEIF-CT-2007-039139 and PIEF-GA-2008-219592, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Duitman EH, 2007, APPL ENVIRON MICROB, V73, P3490, DOI 10.1128/AEM.02751-06; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; ISHIWA H, 1985, JAPANESE J GENETICS, V60, P8; JANDOVA Z, 1987, FOLIA MICROBIOL, V32, P82, DOI 10.1007/BF02877262; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Niu DD, 2007, J IND MICROBIOL BIOT, V34, P357, DOI 10.1007/s10295-007-0204-x; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Romero D, 2006, J MICROBIOL METH, V66, P556, DOI 10.1016/j.mimet.2006.01.005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Susanna KA, 2006, APPL ENVIRON MICROB, V72, P404, DOI 10.1128/AEM.72.1.404-411.2006; TAVARES P, 1992, J MOL BIOL, V225, P81, DOI 10.1016/0022-2836(92)91027-M; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; Turgay K, 1998, EMBO J, V17, P6730; Ussery DW, 2004, MICROBIOL-SGM, V150, P3519, DOI 10.1099/mic.0.27628-0; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Veening JW, 2006, J APPL MICROBIOL, V101, P531, DOI 10.1111/j.1365-2672.2006.02911.x; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0	30	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9724	10.1371/journal.pone.0009724	http://dx.doi.org/10.1371/journal.pone.0009724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300532	gold, Green Published, Green Submitted			2022-12-25	WOS:000275716400022
J	Tibber, M; Saygin, AP; Grant, S; Melmoth, D; Rees, G; Morgan, M				Tibber, Marc; Saygin, Ayse Pinar; Grant, Simon; Melmoth, Dean; Rees, Geraint; Morgan, Michael			The Neural Correlates of Visuospatial Perceptual and Oculomotor Extrapolation	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; ILLUSORY CONTOURS; BOUNDARY COMPLETION; VOLITIONAL SACCADES; FMRI ACTIVATION; GLOBAL SHAPES; ATTENTION; INTERPOLATION; INTEGRATION; MOTION	The human visual system must perform complex visuospatial extrapolations (VSE) across space and time in order to extract shape and form from the retinal projection of a cluttered visual environment characterized by occluded surfaces and moving objects. Even if we exclude the temporal dimension, for instance when judging whether an extended finger is pointing towards one object or another, the mechanisms of VSE remain opaque. Here we investigated the neural correlates of VSE using functional magnetic resonance imaging in sixteen human observers while they judged the relative position of, or saccaded to, a (virtual) target defined by the extrapolated path of a pointer. Using whole brain and region of interest (ROI) analyses, we compared the brain activity evoked by these VSE tasks to similar control judgements or eye movements made to explicit (dot) targets that did not require extrapolation. The data show that activity in an occipitotemporal region that included the lateral occipital cortex (LOC) was significantly greater during VSE than during control tasks. A similar, though less pronounced, pattern was also evident in regions of the fronto-parietal cortex that included the frontal eye fields. However, none of the ROIs examined exhibited a significant interaction between target type (extrapolated/explicit) and response type (oculomotor/perceptual). These findings are consistent with a close association between visuoperceptual and oculomotor responses, and highlight a critical role for the LOC in the process of VSE.	[Tibber, Marc; Saygin, Ayse Pinar; Grant, Simon; Melmoth, Dean; Morgan, Michael] City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Res Labs, London, England; [Saygin, Ayse Pinar; Rees, Geraint; Morgan, Michael] UCL, Inst Cognit Neurosci, London, England; [Saygin, Ayse Pinar; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Saygin, Ayse Pinar] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA	City University London; Wellcome Research Laboratories; University of London; University College London; University of London; University College London; University of California System; University of California San Diego	Tibber, M (corresponding author), City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Res Labs, London, England.	mtibber@yahoo.com	Grant, Simon/H-3939-2019; Rees, Geraint/C-1493-2008; Saygin, Ayse Pinar/A-7126-2009	Rees, Geraint/0000-0002-9623-7007; Saygin, Ayse Pinar/0000-0002-0859-9500; Grant, Simon/0000-0001-6141-538X	Wellcome Trust [079766]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant no. 079766-www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2004, J COGNITIVE NEUROSCI, V16, P794, DOI 10.1162/089892904970825; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Angelucci A, 2002, J NEUROSCI, V22, P8633; Ashida H, 2004, NEUROPSYCHOLOGIA, V42, P1515, DOI 10.1016/j.neuropsychologia.2004.03.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craighero L, 2004, CURR BIOL, V14, P331, DOI 10.1016/j.cub.2004.01.054; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; de'Sperati C, 2006, VISION RES, V46, P2593, DOI 10.1016/j.visres.2005.12.019; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; FIELD D, 2001, VISUAL NEUROSCIENCES, P1069; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottesman CV, 1999, BEHAV RES METH INS C, V31, P86, DOI 10.3758/BF03207697; GREGORY RL, 1972, NATURE, V238, P51, DOI 10.1038/238051a0; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Hess RF, 2001, VISION RES, V41, P1023, DOI 10.1016/S0042-6989(01)00020-7; HIRSCH J, 1995, P NATL ACAD SCI USA, V92, P6469, DOI 10.1073/pnas.92.14.6469; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hoffman JE, 1998, ATTENTION, P119; Hu SY, 2009, EUR J NEUROSCI, V29, P2083, DOI 10.1111/j.1460-9568.2009.06757.x; Intraub H, 2008, PSYCHOL SCI, V19, P1007, DOI 10.1111/j.1467-9280.2008.02192.x; Intraub H, 2008, PERCEPT PSYCHOPHYS, V70, P1337, DOI 10.3758/PP.70.7.1337; Kellman PJ, 2007, PSYCHOL REV, V114, P488, DOI 10.1037/0033-295X.114.2.488; Kellman PJ, 2005, PSYCHOL REV, V112, P586, DOI 10.1037/0033-295X.112.3.586; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KELLMAN PJ, 2001, FRAGMENTS OBJECTS SE, P181; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Larsson J, 1999, EUR J NEUROSCI, V11, P4024, DOI 10.1046/j.1460-9568.1999.00805.x; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Liu LC, 2006, NEUROSCIENCE, V141, P1585, DOI 10.1016/j.neuroscience.2006.04.062; Makin ADJ, 2008, VISION RES, V48, P1884, DOI 10.1016/j.visres.2008.05.023; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McSorley E, 2005, VISION RES, V45, P2492, DOI 10.1016/j.visres.2005.04.012; McSorley E, 2004, EXP BRAIN RES, V155, P320, DOI 10.1007/s00221-003-1729-5; Melmoth DR, 2009, NEUROPSYCHOLOGIA, V47, P3217, DOI 10.1016/j.neuropsychologia.2009.07.024; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; MINGUZZI GF, 1986, PERCEPTION ILLUSORY, P71; Montaser-Kouhsari L, 2007, J NEUROSCI, V27, P2186, DOI 10.1523/JNEUROSCI.4173-06.2007; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Murray MM, 2004, J NEUROSCI, V24, P6898, DOI 10.1523/JNEUROSCI.1996-04.2004; Neppi-Modona M, 2004, CURR BIOL, V14, P1174, DOI 10.1016/j.cub.2004.06.047; Park S, 2007, NEURON, V54, P335, DOI 10.1016/j.neuron.2007.04.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Predebon J, 2004, PERCEPT MOTOR SKILL, V98, P47; Rauschenberger R, 2006, PSYCHOL SCI, V17, P358, DOI 10.1111/j.1467-9280.2006.01711.x; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Schneider WX, 2002, ATTENTION PERFORM, V19, P609; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Shipley TF, 2003, PERCEPTION, V32, P985, DOI 10.1068/p3420; Singh M, 2005, P NATL ACAD SCI USA, V102, P939, DOI 10.1073/pnas.0408444102; Singh M, 2007, VISION RES, V47, P783, DOI 10.1016/j.visres.2006.11.022; Smith DT, 2004, CURR BIOL, V14, P792, DOI 10.1016/j.cub.2004.04.035; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tibber MS, 2008, INVEST OPHTH VIS SCI, V49, P474, DOI 10.1167/iovs.07-0921; Tibber MS, 2009, J VISION, V9, DOI 10.1167/9.12.21; Tibber MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004585; TIBBER MS, 2008, J VIS, V8; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WATT RJ, 1984, VISION RES, V24, P1377, DOI 10.1016/0042-6989(84)90193-7	81	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9664	10.1371/journal.pone.0009664	http://dx.doi.org/10.1371/journal.pone.0009664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300627	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000275621000004
J	Roed, C; Omland, LH; Engsig, FN; Skinhoj, P; Obel, N				Roed, Casper; Omland, Lars Haukali; Engsig, Frederik Neess; Skinhoj, Peter; Obel, Niels			Long-Term Mortality in Patients Diagnosed with Meningococcal Disease: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							BACTERIAL-MENINGITIS	Background: In contrast to the case fatality rate of patients diagnosed with meningococcal disease (MD) the long-term mortality in these patients is poorly documented. Methodology/Principal Findings: We performed a nationwide, population-based cohort study including all Danish patients diagnosed with MD from 1977 through 2006 and alive one year after diagnosis. Data was retrieved from the Danish National Hospital Register, the Danish Civil Registration System and the Danish Register of Causes of Death. For each patient four age-and gender-matched individuals were identified from the population cohort. The siblings of the MD patients and of the individuals from the population cohort were identified. We constructed Kaplan-Meier survival curves and used Cox regression analysis, cumulative incidence function and subdistribution hazard regression to estimate mortality rate ratios (MRR) and analyze causes of death. We identified 4,909 MD patients, 19,636 individuals from the population cohort, 8,126 siblings of MD patients and 31,140 siblings of the individuals from the population cohort. The overall MRR for MD patients was 1.27 (95% confidence interval (CI), 1.12-1.45), adjusted MRR, 1.21 (95% CI, 1.06-1.37). MD was associated with increased risk of death due to nervous system diseases (MRR 3.57 (95% CI, 1.82-7.00). No increased mortality due to infections, neoplasms or cardiovascular diseases was observed. The MRR for siblings of MD patients compared with siblings of the individuals from the population cohort was 1.17 (95% CI, 0.92-1.48). Conclusions: Patients surviving the acute phase of MD have increased long-term mortality, but the excess risk of death is small and stems mainly from nervous system diseases.	[Roed, Casper; Omland, Lars Haukali; Engsig, Frederik Neess; Skinhoj, Peter; Obel, Niels] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Roed, C (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	casper.roed@rh.regionh.dk	Engsig, Frederik/GWM-4899-2022	Roed, Casper/0000-0001-8987-5230; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045	Research Foundation at Copenhagen University Hospital, Rigshospitalet; Faculty of Health Science, Copenhagen University	Research Foundation at Copenhagen University Hospital, Rigshospitalet; Faculty of Health Science, Copenhagen University	The study was financed by The Research Foundation at Copenhagen University Hospital, Rigshospitalet and by The Faculty of Health Science, Copenhagen University. The funders had no role in the study design; in the collection, management, analysis, and interpretation of data; in the preparation, review, or approval of the manuscript, or in the decision to submit the article for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], POPULATIONS ELECTION; Buysse CMP, 2008, ARCH PEDIAT ADOL MED, V162, P1036, DOI 10.1001/archpedi.162.11.1036; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; HOGASEN K, 1993, SCAND J IMMUNOL, V37, P487, DOI 10.1111/j.1365-3083.1993.tb03323.x; Howitz M, 2009, EPIDEMIOL INFECT, V137, P1631, DOI 10.1017/S0950268809002428; Howitz MF, 2008, EPIDEMIOL INFECT, V136, P1088, DOI 10.1017/S0950268807009466; Juel K, 1999, DAN MED BULL, V46, P354; KJERSEM H, 1986, INFECTION, V14, P55, DOI 10.1007/BF01644442; Kleinbaum D, 2005, SURVIVAL ANAL SELF L, P391, DOI DOI 10.1007/0-387-29150-4; RIORDAN FAI, 1995, EUR J PEDIATR, V154, P472; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SAMUELSSON S, 1999, THESIS U SO DENMARK; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Sorensen HT, 1998, J CLIN EPIDEMIOL, V51, P717, DOI 10.1016/S0895-4356(98)00064-X; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	20	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9662	10.1371/journal.pone.0009662	http://dx.doi.org/10.1371/journal.pone.0009662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300639	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900003
J	Shyu, C; Brown, CJ; Ytreberg, FM				Shyu, Conrad; Brown, Celeste J.; Ytreberg, F. Marty			Computational Study of Evolutionary Selection Pressure on Rainbow Trout Estrogen Receptors	PLOS ONE			English	Article							THERMODYNAMIC INTEGRATION; CRYSTALLOGRAPHY; SIMULATIONS; MECHANICS; EFFICIENT; ALPHA	Molecular dynamics simulations were used to determine the binding affinities between the hormone 17 beta-estradiol (E2) and different estrogen receptor (ER) isoforms in the rainbow trout, Oncorhynchus mykiss. Previous phylogenetic analysis indicates that a whole genome duplication prior to the divergence of ray-finned fish led to two distinct ER beta isoforms, ER beta 1 and ER beta 2, and the recent whole genome duplication in the ancestral salmonid created two ER alpha isoforms, ER alpha 1 and ER alpha 2. The objective of our computational studies is to provide insight into the underlying evolutionary pressures on these isoforms. For the ER alpha subtype our results show that E2 binds preferentially to ER alpha 1 over ER alpha 2. Tests of lineage specific dN/dS ratios indicate that the ligand binding domain of the ER alpha 2 gene is evolving under relaxed selection relative to all other ER alpha genes. Comparison with the highly conserved DNA binding domain suggests that ER alpha 2 may be undergoing neofunctionalization possibly by binding to another ligand. By contrast, both ER beta 1 and ER beta 2 bind similarly to E2 and the best fitting model of selection indicates that the ligand binding domain of all ERb genes are evolving under the same level of purifying selection, comparable to ER alpha 1.	[Shyu, Conrad; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Brown, Celeste J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Shyu, C (corresponding author), Univ Idaho, Dept Phys, Moscow, ID USA.	ytreberg@uidaho.edu			Idaho NSF-EPSCoR; IBEST ( Initiative for Bioinformatics and Evolutionary Studies); NIH/NCRR [P20RR16448, P20RR016454]; BANTech; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM083827] Funding Source: NIH RePORTER	Idaho NSF-EPSCoR; IBEST ( Initiative for Bioinformatics and Evolutionary Studies); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BANTech; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Idaho NSF-EPSCoR (http://www.webs.uidaho.edu/epscor) and the IBEST ( Initiative for Bioinformatics and Evolutionary Studies) (http://www.ibest.uidaho.edu/home/home.php) at the University of Idaho. F. M. Y. and C. J. B. were supported by NIH/NCRR P20RR16448 and P20RR016454. Additional funding was provided by BANTech (http://www.phys.uidaho.edu/bantech) at the University of Idaho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Allendorf F.W., 1984, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Berendsen H., 1981, INTERMOLECULAR FORCE; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Broyden C. G., 1970, J I MATH ITS APPL, V6, P76, DOI [10.1093/imamat/6.1.76, DOI 10.1093/IMAMAT/6.1.76]; Chipot C., 2007, SPRINGER SERIES CHEM; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; DREAN Y, 1995, MOL CEL ENDORINOL, V109, P27; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; MITCHELL MJ, 1991, J COMPUT CHEM, V12, P271, DOI 10.1002/jcc.540120218; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030; Nagler JJ, 2000, J MOL ENDOCRINOL, V25, P243, DOI 10.1677/jme.0.0250243; Pakdel F, 2000, ENDOCRINOLOGY, V141, P571, DOI 10.1210/en.141.2.571; PETIT F, 1995, EUR J BIOCHEM, V233, P584, DOI 10.1111/j.1432-1033.1995.584_2.x; Ruff M, 2000, BREAST CANCER RES, V2, P353, DOI 10.1186/bcr80; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shirts MR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873592; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Shyu C, 2009, J COMPUT CHEM, V30, P2297, DOI 10.1002/jcc.21231; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	35	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9392	10.1371/journal.pone.0009392	http://dx.doi.org/10.1371/journal.pone.0009392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231885	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300003
J	Zhong, JX; Yang, P; Muta, K; Dong, R; Marrero, M; Gong, FL; Wang, CY				Zhong, Jixin; Yang, Ping; Muta, Kenjiro; Dong, Robert; Marrero, Mario; Gong, Feili; Wang, Cong-Yi			Loss of Jak2 Selectively Suppresses DC-Mediated Innate Immune Response and Protects Mice from Lethal Dose of LPS-Induced Septic Shock	PLOS ONE			English	Article							DENDRITIC CELL-DIFFERENTIATION; LISTERIA-MONOCYTOGENES; ADAPTIVE IMMUNITY; T-CELLS; MYELOID DIFFERENTIATION; CYTOKINE RECEPTORS; IL-2 PRODUCTION; SEVERE SEPSIS; IN-VIVO; INFECTION	Given the importance of Jak2 in cell signaling, a critical role for Jak2 in immune cells especially dendritic cells (DCs) has long been proposed. The exact function for Jak2 in DCs, however, remained poorly understood as Jak2 deficiency leads to embryonic lethality. Here we established Jak2 deficiency in adult Cre(+/+) Jak2(fl/fl) mice by tamoxifen induction. Loss of Jak2 significantly impaired DC development as manifested by reduced BMDC yield, smaller spleen size and reduced percentage of DCs in total splenocytes. Jak2 was also crucial for the capacity of DCs to mediate innate immune response. Jak2(-/) DCs were less potent in response to inflammatory stimuli and showed reduced capacity to secrete proinflammatory cytokines such as TNF alpha and IL-12. As a result, Jak2(-/-) mice were defective for the early clearance of Listeria after infection. However, their potency to mediate adaptive immune response was not affected. Unlike DCs, Jak2(-/-) macrophages showed similar capacity secretion of proinflammatory cytokines, suggesting that Jak2 selectively modulates innate immune response in a DC-dependent manner. Consistent with these results, Jak2(-/-) mice were remarkably resistant to lethal dose of LPS-induced septic shock, a deadly sepsis characterized by the excessive innate immune response, and adoptive transfer of normal DCs restored their susceptibility to LPS-induced septic shock. Mechanistic studies revealed that Jak2/SATA5 signaling is pivotal for DC development and maturation, while the capacity for DCs secretion of proinflammatory cytokines is regulated by both Jak2/STAT5 and Jak2/STAT6 signaling.	[Zhong, Jixin; Gong, Feili] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China; [Zhong, Jixin; Yang, Ping; Dong, Robert; Wang, Cong-Yi] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Yang, Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China; [Muta, Kenjiro; Marrero, Mario] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	Huazhong University of Science & Technology; University System of Georgia; Augusta University; Huazhong University of Science & Technology; University System of Georgia; Augusta University	Zhong, JX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China.	flgong@163.com; cwang@mcg.edu	Zhong, Jixin/ABE-3768-2020; Zhong, Jixin/G-5355-2012; Zhong, Jixin/A-3077-2012	Wang, Cong-Yi/0000-0001-7914-168X; Zhong, Jixin/0000-0002-3534-7480	Juvenile Diabetes Research Foundation (JDRF) [1-2007-181, 1-2007-192]; NIH/NIDDK [DK074957]; National Key Basic Research Program of China [2007CB512402]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074957] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Juvenile Diabetes Research Foundation (JDRF, 1-2007-181 and 1-2007-192) and NIH/NIDDK (DK074957) to CYW, and supported in part by the National Key Basic Research Program of China (2007CB512402) to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Carrillo-Esper Raul, 2003, Cir Cir, V71, P252; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Chiang PH, 2004, J IMMUNOL, V172, P1355, DOI 10.4049/jimmunol.172.3.1355; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Das UN, 2000, CRIT CARE, V4, P290, DOI 10.1186/cc711; Efron P, 2003, SHOCK, V20, P386, DOI 10.1097/01.SHK.0000092698.10326.6f; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Heymann WR, 2007, J AM ACAD DERMATOL, V57, P700, DOI 10.1016/j.jaad.2007.04.020; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; KHWANNIMIT B, 2009, EPIDEMIOL INFECT, P1; Kumar R, 1997, CANCER BIOTHER RADIO, V12, P333, DOI 10.1089/cbr.1997.12.333; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Lang CH, 2005, PEDIATR NEPHROL, V20, P306, DOI 10.1007/s00467-004-1607-9; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Nelson DP, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000346928.90369.10; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Park WR, 2001, EUR J IMMUNOL, V31, P1456, DOI 10.1002/1521-4141(200105)31:5<1456::AID-IMMU1456>3.0.CO;2-A; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; RANE SG, 1994, ONCOGENE, V9, P2415; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sakr Y, 2007, SHOCK, V28, P636, DOI 10.1097/shk.0b013e3180cab855; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Sayyah J, 2009, CURR ONCOL REP, V11, P117, DOI 10.1007/s11912-009-0018-2; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shasby DM, 2004, AM J RESP CRIT CARE, V169, P144, DOI 10.1164/rccm.2311003; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Warner EA, 2008, FUTURE MICROBIOL, V3, P177, DOI 10.2217/17460913.3.2.177; Watanabe S, 1996, CURR OPIN GENET DEV, V6, P587, DOI 10.1016/S0959-437X(96)80088-8; Wen HT, 2008, J LEUKOCYTE BIOL, V83, P439, DOI 10.1189/jlb.0607357; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05; Yu G, 2008, J GENE MED, V10, P754, DOI 10.1002/jgm.1201	58	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9593	10.1371/journal.pone.0009593	http://dx.doi.org/10.1371/journal.pone.0009593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231889	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300011
J	Mailloux, RJ; Harper, ME				Mailloux, Ryan J.; Harper, Mary-Ellen			Glucose regulates enzymatic sources of mitochondrial NADPH in skeletal muscle cells; a novel role for glucose-6-phosphate dehydrogenase	FASEB JOURNAL			English	Article						glucose signaling; isocitrate dehydrogenase; oxidative stress	INSULIN-RESISTANCE; HEPG2 CELLS; METABOLISM; HEXOKINASES; SUSCEPTIBILITY; DEHYDROGENASE; ADAPTATION; EXPRESSION; OXIDATION; NETWORK	Reduced nicotinamide adenine dinucleotide ( NADPH) is a functionally important metabolite required to support numerous cellular processes. However, despite the identification of numerous NADPH-producing enzymes, the mechanisms underlying how the organellar pools of NADPH are maintained remain elusive. Here, we have identified glucose-6-phosphate dehydrogenase (G6PDH) as an important source of NADPH in mitochondria. Activity analysis, submitochondrial fractionation, fluorescence microscopy, and protease sensitivity assays revealed that G6PDH is localized to the mitochondrial matrix. 6-ANAM, a specific G6PDH inhibitor, depleted mitochondrial NADPH pools and increased oxidative stress revealing the importance of G6PDH in NADPH maintenance. We also show that glucose availability and differences in metabolic state modulate the enzymatic sources of NADPH in mitochondria. Indeed, cells cultured in high glucose (HG) not only adopted a glycolytic phenotype but also relied heavily on matrix-associated G6PDH as a source of NADPH. In contrast, cells exposed to low-glucose (LG) concentrations, which displayed increased oxygen consumption, mitochondrial metabolic efficiency, and decreased glycolysis, relied predominantly on isocitrate dehydrogenase ( ICDH) as the principal NADPH-producing enzyme in the mitochondria. Culturing glycolytic cells in LG for 48 h decreased G6PDH and increased ICDH protein levels in the mitochondria, further pointing to the regulatory role of glucose. 2-Deoxyglucose treatment also prevented the increase of mitochondrial G6PDH in response to HG. The role of glucose in regulating enzymatic sources of mitochondrial NADPH pool maintenance was confirmed using human myotubes from obese adults with a history of type 2 diabetes mellitus (post-T2DM). Myotubes from post-T2DM participants failed to increase mitochondrial G6PDH in response to HG in contrast to mitochondria in myotubes from control participants (non-T2DM). Hence, we not only identified a matrix-associated G6PDH but also provide evidence that metabolic state/glucose availability modulate enzymatic sources of NADPH.-Mailloux, R.J., Harper, M.-E. Glucose regulates enzymatic sources of mitochondrial NADPH in skeletal muscle cells; a novel role for glucose-6-phosphate dehydrogenase. FASEB J. 24, 2495-2506 (2010). www.fasebj.org	[Mailloux, Ryan J.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009	Harper, Mary-Ellen/0000-0003-3864-5886; Mailloux, Ryan/0000-0003-3986-9830	Institute of Nutrition Metabolism and Diabetes [57810]; Heart and Stroke Foundation of Canada [PRG6242]	Institute of Nutrition Metabolism and Diabetes; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This research was funded by a Canadian Institutes of Health Research: Institute of Nutrition Metabolism and Diabetes operating grant (57810; M.E.H.) and a Heart and Stroke Foundation of Canada program grant (PRG6242) supporting the fellowship of R.J.M. The authors are grateful to the patients and to Drs. Robert Dent (Ottawa Hospital and University of Ottawa) and Ruth McPherson (University of Ottawa Heart Institute) for initially providing and conducting the muscle biopsies, respectively, and to Dr. Sheila Costford (University of Ottawa) for the cell stock preparations.	CAMPBELL WH, 1979, MOL CELL BIOCHEM, V25, P33; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; Li DY, 2009, CANCER BIOTHER RADIO, V24, P81, DOI 10.1089/cbr.2008.0494; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Merritt TJS, 2009, GENETICS, V182, P565, DOI 10.1534/genetics.109.100677; Miyagi H, 2009, J BIOL CHEM, V284, P7553, DOI 10.1074/jbc.M804100200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; PROSTKO CR, 1989, BIOCHEM J, V258, P295, DOI 10.1042/bj2580295; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Salati LM, 2001, ANNU REV NUTR, V21, P121, DOI 10.1146/annurev.nutr.21.1.121; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wagle A, 1998, J BIOL CHEM, V273, P14968, DOI 10.1074/jbc.273.24.14968; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; ZORATTI N, 1995, BIOCHIM BIOPHYS ACTA, V1241, P139	39	50	51	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2495	2506		10.1096/fj.09-151803	http://dx.doi.org/10.1096/fj.09-151803			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20228249				2022-12-25	WOS:000279343600036
J	Chang, JS; Huypens, P; Zhang, YB; Black, C; Kralli, A; Gettys, TW				Chang, Ji Suk; Huypens, Peter; Zhang, Yubin; Black, Chelsea; Kralli, Anastasia; Gettys, Thomas W.			Regulation of NT-PGC-1 alpha Subcellular Localization and Function by Protein Kinase A-dependent Modulation of Nuclear Export by CRM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1; PPAR-GAMMA COACTIVATOR-1; MITOCHONDRIAL BIOGENESIS; RECEPTOR-ALPHA; HEPATIC GLUCONEOGENESIS; ADAPTIVE THERMOGENESIS; ENERGY-METABOLISM; KAPPA-B; C-FOS; PGC-1-ALPHA	Peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) plays a central role in the regulation of cellular energy metabolism and metabolic adaptation to environmental and nutritional stimuli. We recently described a novel, biologically active splice variant of PGC-1 alpha (NT-PGC-1 alpha, amino acids 1-270) that retains the ability to interact with and transactivate nuclear hormone receptors through its N-terminal transactivation domain. Whereas PGC-1 alpha is an unstable nuclear protein sensitive to ubiquitin-mediated targeting to the proteasome, NT-PGC-1 alpha is relatively stable and predominantly cytoplasmic, suggesting that its ability to interact with and activate nuclear receptors and transcription factors is dependent upon regulated access to the nucleus. We provide evidence that NT-PGC-1 alpha interacts with the nuclear exportin, CRM1, through a specific leucine-rich domain (nuclear export sequence) that regulates its export to the cytoplasm. The nuclear export of NT-PGC-1 alpha is inhibited by protein kinase A-dependent phosphorylation of Ser-194, Ser-241, and Thr-256 on NT-PGC-1 alpha, which effectively increases its nuclear concentration. Using site-directed mutagenesis to prevent or mimic phosphorylation at these sites, we show that the transcriptional activity of NT-PGC-1 alpha is regulated in part through regulation of its subcellular localization. These findings suggest that the function of NT-PGC-1 alpha as a transcriptional co-activator is regulated by protein kinase A-dependent inhibition of CRM1-mediated export from the nucleus.	[Chang, Ji Suk; Huypens, Peter; Zhang, Yubin; Black, Chelsea; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Zhang, Yubin] China Pharmaceut Univ, Dept Biochem, Nanjing 210009, Peoples R China	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; China Pharmaceutical University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Chang, Ji Suk/N-1957-2017; Gettys, Thomas W/N-1964-2017	Gettys, Thomas W/0000-0001-7125-7995; Huypens, Peter/0000-0001-7922-5787	National Institutes of Health [RO1 DK 074772, P20-RR021945, DK064951]; NIH Clinical Nutrition Research Unit Center [1P30 DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074772, P30DK072476, R01DK064951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Clinical Nutrition Research Unit Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 074772 and P20-RR021945 (to T. W. G.), NIH Clinical Nutrition Research Unit Center Grant 1P30 DK072476, and NIH Grant DK064951 (to A. K.).	Bereziat V, 2005, BIOCHIMIE, V87, P951, DOI 10.1016/j.biochi.2005.05.010; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kilstrup-Nielsen C, 2003, EMBO J, V22, P89, DOI 10.1093/emboj/cdg010; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Sadana P, 2007, BIOCHEM J, V403, P511, DOI 10.1042/BJ20061526; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	55	58	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18039	18050		10.1074/jbc.M109.083121	http://dx.doi.org/10.1074/jbc.M109.083121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351112	Green Published, hybrid			2022-12-25	WOS:000278133400079
J	Lee, YC; Huang, CF; Murshed, M; Chu, K; Araujo, JC; Ye, X; deCrombrugghe, B; Yu-Lee, LY; Gallick, GE; Lin, SH				Lee, Y-C; Huang, C-F; Murshed, M.; Chu, K.; Araujo, J. C.; Ye, X.; deCrombrugghe, B.; Yu-Lee, L-Y; Gallick, G. E.; Lin, S-H			Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts	ONCOGENE			English	Article						dasatinib; Src family kinase; osteoblast; prostate cancer; bone metastasis	FIBROBLAST-GROWTH-FACTOR; PROSTATE-CANCER CELLS; BONE-FORMATION; COLLAGEN-SYNTHESIS; TUMOR PROGRESSION; SECRETED ISOFORM; PROTEIN-KINASE; EXPRESSION; PP60C-SRC; METASTASIS	Dasatinib, a dual Src family kinase and Abl inhibitor, is being tested clinically for the treatment of prostate cancer bone metastasis. Bidirectional interactions between osteoblasts and prostate cancer cells are critical in the progression of prostate cancer in bone, but the effect of dasatinib on osteoblasts is unknown. We found that dasatinib inhibited proliferation of primary mouse osteoblasts isolated from mouse calvaria and the immortalized MC3T3-E1 cell line. In calvarial osteoblasts from Col-luc transgenic mice carrying osteoblast-specific Col1 alpha 1 promoter reporter, luciferase activity was inhibited. Dasatinib also inhibited fibroblast growth factor-2-induced osteoblast proliferation, but strongly promoted osteoblast differentiation, as reflected by stimulation of alkaline phosphatase activity, osteocalcin secretion and osteoblast mineralization. To determine how dasatinib blocks proliferative signaling in osteoblasts, we analyzed the expression of a panel of tyrosine kinases, including Src, Lyn, Fyn, Yes and Abl, in osteoblasts. In the Src family kinases, only Src was activated at a high level. Abl was expressed at a low level in osteoblasts. Phosphorylation of Src-Y419 or Abl-Y245 was inhibited by dasatinib treatment. Knockdown of either Src or Abl by lenti-shRNA in osteoblasts enhances osteoblast differentiation, suggesting that dasatinib enhances osteoblast differentiation through inhibition of both Src and Abl. Oncogene (2010) 29, 3196-3207; doi: 10.1038/onc.2010.73; published online 15 March 2010	[Lee, Y-C; Huang, C-F; Ye, X.; Lin, S-H] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Huang, C-F] Natl Taiwan Univ, Coll Med, Grad Inst Pharm, Natl Taiwan Univ Hosp,Dept Pharm, Taipei 10764, Taiwan; [Murshed, M.; Chu, K.; Araujo, J. C.; Gallick, G. E.; Lin, S-H] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [deCrombrugghe, B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; [Yu-Lee, L-Y] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; National Taiwan University; National Taiwan University Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 1515 Holcombe Blvd,Box 89, Houston, TX 77030 USA.	slin@mdanderson.org		Huang, Chih-Fen/0000-0003-1311-8828	National Institutes of Health [CA111479, P50 CA140388, DK53176]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA111479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Karen Philips for editing the paper. This study was supported by National Institutes of Health Grants CA111479 (SH Lin), P50 CA140388 (SH Lin, GE Gallick) and DK53176 (LY Yu-Lee), and by the Prostate Cancer Foundation (SH Lin).	Araujo J, 2009, INT J CANCER, V124, P1, DOI 10.1002/ijc.23998; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Autzen P, 1998, BRIT J CANCER, V78, P1219, DOI 10.1038/bjc.1998.658; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brownlow N, 2009, LEUKEMIA, V23, P590, DOI 10.1038/leu.2008.237; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S; Dorkin TJ, 1999, J PATHOL, V189, P564, DOI 10.1002/(SICI)1096-9896(199912)189:4<564::AID-PATH480>3.0.CO;2-1; Dorkin TJ, 1999, ONCOGENE, V18, P2755, DOI 10.1038/sj.onc.1202624; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98, DOI 10.1210/endo-123-1-98; HANNON RA, 2009, J BONE MINER RES; Ito H, 2003, SURGERY, V134, P221, DOI 10.1067/msy.2003.224; Jacob K, 1999, CANCER RES, V59, P4453; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Lin SH, 2008, ONCOGENE, V27, P5195, DOI 10.1038/onc.2008.156; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; MCCARTHY TL, 1989, ENDOCRINOLOGY, V125, P2118, DOI 10.1210/endo-125-4-2118; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nelson JB, 1999, UROLOGY, V53, P1063, DOI 10.1016/S0090-4295(98)00658-X; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Vakar-Lopez F, 2004, J PATHOL, V203, P688, DOI 10.1002/path.1568; Ye XC, 2007, FRONT BIOSCI, V12, P3273, DOI 10.2741/2311	48	66	68	0	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3196	3207		10.1038/onc.2010.73	http://dx.doi.org/10.1038/onc.2010.73			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20228840	Green Accepted			2022-12-25	WOS:000278321100003
J	Brechbuhl, HM; Gould, N; Kachadourian, R; Riekhof, WR; Voelker, DR; Day, BJ				Brechbuhl, Heather M.; Gould, Neal; Kachadourian, Remy; Riekhof, Wayne R.; Voelker, Dennis R.; Day, Brian J.			Glutathione Transport Is a Unique Function of the ATP-binding Cassette Protein ABCG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDUCTANCE REGULATOR PROTEIN; ALVEOLAR FLUID GLUTATHIONE; SIDE POPULATION; EXPRESSION CONFERS; CENTRAL MODULATOR; OXIDATIVE STRESS; REDOX STATE; STEM-CELLS; RESISTANCE; DEFICIENCY	Glutathione (GSH) transport is vital for maintenance of intracellular and extracellular redox balance. Only a few human proteins have been identified as transporters of GSH, glutathione disulfide (GSSG) and/or GSH conjugates (GS-X). Human epithelial MDA1586, A549, H1975, H460, HN4, and H157 cell lines were exposed to 2',5'-dihydroxychalcone, which induces a GSH efflux response. A real-time gene superarray for 84 proteins found in families that have a known role in GSH, GSSG, and/or GS-X transport was employed to help identify potential GSH transporters. ABCG2 was identified as the only gene in the array that closely corresponded with the magnitude of 2',5'-dihydroxychalcone (2',5'-DHC)-induced GSH efflux. The role of human ABCG2 as a novel GSH transporter was verified in a Saccharomyces cerevisiae galactose-inducible gene expression system. Yeast expressing human ABCG2 had 2.5-fold more extracellular GSH compared with those not expressing ABCG2. GSH efflux in ABCG2-expressing yeast was abolished by the ABCG2 substrate methotrexate (10 mu M), indicating competitive inhibition. In contrast, 2',5'-DHC treatment of ABCG2-expressing yeast increased extracellular GSH levels in a dose-dependent manner with a maximum 3.5-fold increase in GSH after 24 h. In addition, suppression of ABCG2 with short hairpin RNA or ABCG2 overexpression in human epithelial cells decreased or increased extracellular GSH levels, respectively. Our data indicate that ABCG2 is a novel GSH transporter.	[Kachadourian, Remy; Riekhof, Wayne R.; Voelker, Dennis R.; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Immunol, Aurora, CO 80045 USA; [Gould, Neal; Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Pharmaceut Sci, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Day, BJ (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	dayb@njhealth.org			National Institutes of Health [R01 HL084469, R01 HL075523, R01 ES0175825, R37-GM32453, 1F32-GM076798]; American Cancer Society [PF-06-288-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075523, R01HL084469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076798, R37GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL084469 (to B.J.D.), R01 HL075523 (to B.J.D), R01 ES0175825, R37-GM32453 (to D.R.V), and 1F32-GM076798 (to W.R.R.). This work was also supported by American Cancer Society Great-West Division Postdoctoral Fellowship Award PF-06-288-01-CSM (to W.R.R.).	Adachi T, 2007, J EXP THER ONCOL, V6, P335; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Day Regina M., 2005, Dose-Response, V3, P425, DOI 10.2203/dose-response.003.03.010; Eisenblatter T, 2003, BRAIN RES, V971, P221, DOI 10.1016/S0006-8993(03)02401-6; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hagmann W, 1999, EUR J BIOCHEM, V265, P281, DOI 10.1046/j.1432-1327.1999.00735.x; Han Y, 2008, EUR J PHARM SCI, V35, P30, DOI 10.1016/j.ejps.2008.06.001; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; ISHIKAWA T, 1989, J BIOL CHEM, V264, P17343; JEDLITSCHKY G, 1994, CANCER RES, V54, P4833; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Majka SM, 2005, STEM CELLS, V23, P1073, DOI 10.1634/stemcells.2005-0039; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Miyake K, 1999, CANCER RES, V59, P8; Mogi M, 2003, J BIOL CHEM, V278, P39068, DOI 10.1074/jbc.M306362200; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Naylor CS, 2005, BONE MARROW TRANSPL, V35, P353, DOI 10.1038/sj.bmt.1704762; Noble M, 2003, ANN NY ACAD SCI, V991, P251; PACHT ER, 1991, CHEST, V100, P1397, DOI 10.1378/chest.100.5.1397; Pacht ER, 1997, CHEST, V112, P785, DOI 10.1378/chest.112.3.785; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Rothnie A, 2008, MOL PHARMACOL, V74, P1630, DOI 10.1124/mol.108.049080; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Sadzuka Y, 2001, TOXICOL LETT, V123, P159, DOI 10.1016/S0378-4274(01)00391-5; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; Ueda T, 2005, J BIOL CHEM, V280, P991, DOI 10.1074/jbc.M409796200; Urquhart BL, 2008, PHARMACOGENET GENOM, V18, P439, DOI 10.1097/FPC.0b013e3282f974dc; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200	50	54	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16582	16587		10.1074/jbc.M109.090506	http://dx.doi.org/10.1074/jbc.M109.090506			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20332504	Green Published, hybrid			2022-12-25	WOS:000277982600021
J	Cao, AQ; Li, H; Zhou, Y; Wu, MH; Liu, JW				Cao, Aiqin; Li, Hai; Zhou, Yue; Wu, Minhao; Liu, Jingwen			Long Chain Acyl-CoA Synthetase-3 Is a Molecular Target for Peroxisome Proliferator-activated Receptor delta in HepG2 Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; 3T3-L1 ADIPOCYTES; LIPID-METABOLISM; ADIPOSE-TISSUE; EXPRESSION; GENE; DROPLETS; AGONIST; DIET	ACSL3 is a member of the long chain acyl-CoA synthetase (ACSL) family that plays key roles in fatty acid metabolism in various tissues in an isozyme-specific manner. Our previous studies showed that ACSL3 was transcriptionally up-regulated by the cytokine oncostatin M (OSM) in HepG2 cells, accompanied by reduced cellular triglyceride content and enhanced beta-oxidation. In this study, we investigated the molecular mechanism underlying the OSM-induced activation of ACSL3 gene transcription in HepG2 cells. We showed that OSM treatment resulted in a coordinated elevation of mRNA levels of ACSL3 and peroxisome proliferator-activated receptor delta (PPAR delta). The effect of OSM on ACSL3 mRNA expression was inhibited by cellular depletion of PPAR delta. By utilizing a PPAR delta agonist, L165041, we demonstrated that activation of PPAR delta led to increases in ACSL3 promoter activity, mRNA level, and protein level in HepG2 cells. Analysis of the ACSL3 promoter sequence identified two imperfect PPAR-responsive elements (PPRE) located in the ACSL3 promoter region -944 to -915, relative to the transcription start site. The up-regulation of ACSL3 promoter activity by PPAR delta was abolished by deletion of this PPRE-containing region or mutation to disrupt the binding sites. Direct interactions of PPAR delta with ACSL3-PPRE sequences were demonstrated by gel mobility shift and chromatin immunoprecipitation assays. Finally, we provided in vivo evidence showing that activation of PPAR delta by L165041 in hamsters increased ACSL3 mRNA and protein levels in the liver. These new findings define ACSL3 as a novel molecular target of PPAR delta in HepG2 cells and provide a regulatory mechanism for ACSL3 transcription in liver tissue.	[Cao, Aiqin; Li, Hai; Zhou, Yue; Wu, Minhao; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Wu, Minhao] Stanford Univ, Div Endocrinol, Dept Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Liu, JW (corresponding author), 3801 Miranda Ave, Palo Alto, CA 94304 USA.	jingwen.liu@va.gov			Department of Veterans Affairs (Office of Research and Development, Medical Research Service); National Center for Complementary and Alterative Medicine [1RO1 AT002543-01A1, 1R21AT003195-01A2]; NATIONAL CANCER INSTITUTE [R01CA127250] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); National Center for Complementary and Alterative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	The work was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and National Center for Complementary and Alterative Medicine Grants 1RO1 AT002543-01A1 and 1R21AT003195-01A2.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi KC, 2007, BIOCHEM BIOPH RES CO, V357, P62, DOI 10.1016/j.bbrc.2007.03.114; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197, DOI 10.1093/oxfordjournals.jbchem.a123737; Fujino T, 1997, J BIOCHEM-TOKYO, V122, P212; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Minekura H, 2001, GENE, V278, P185, DOI 10.1016/S0378-1119(01)00714-4; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; SCATENA R, 2008, B PPAR RES; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu MH, 2009, LIPIDS, V44, P989, DOI 10.1007/s11745-009-3341-3; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429	30	28	29	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16664	16674		10.1074/jbc.M110.112805	http://dx.doi.org/10.1074/jbc.M110.112805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308079	Green Published, hybrid			2022-12-25	WOS:000277982600030
J	Queiroga, CSF; Almeida, AS; Martel, C; Brenner, C; Alves, PM; Vieira, HLA				Queiroga, Claudia S. F.; Almeida, Ana S.; Martel, Cecile; Brenner, Catherine; Alves, Paula M.; Vieira, Helena L. A.			Glutathionylation of Adenine Nucleotide Translocase Induced by Carbon Monoxide Prevents Mitochondrial Membrane Permeabilization and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE; TRANSITION PORE; BRAIN; INHIBITION; BAX; RESPIRATION; ASTROCYTES; EXPRESSION; OXIDATION; DEPLETION	The present work demonstrates the ability of CO to prevent apoptosis in a primary culture of astrocytes. For the first time, the antiapoptotic behavior can be clearly attributed to the inhibition of mitochondrial membrane permeabilization (MMP), a key event in the intrinsic apoptotic pathway. In isolated non-synaptic mitochondria, CO partially inhibits (i) loss of potential, (ii) the opening of a nonspecific pore through the inner membrane, (iii) swelling, and (iv) cytochrome c release, which are induced by calcium, diamide, or atractyloside (a ligand of ANT). CO directly modulates ANT function by enhancing ADP/ATP exchange and prevents its pore-forming activity. Additionally, CO induces reactive oxygen species (ROS) generation, and its prevention by beta-carotene decreases CO cytoprotection in intact cells as well as in isolated mitochondria, revealing the key role of ROS. On the other hand, CO induces a slight increase in mitochondrial oxidized glutathione, which is essential for apoptosis modulation by (i) delaying astrocytic apoptosis, (ii) decreasing MMP, and (iii) enhancing ADP/ATP translocation activity of ANT. Moreover, CO and GSSG trigger ANT glutathionylation, a post-translational process regulating protein function in response to redox cellular changes. In conclusion, CO protects astrocytes from apoptosis by preventing MMP, acting on ANT (glutathionylation and inhibition of its pore activity) via a preconditioning-like process mediated by ROS and GSSG.	[Vieira, Helena L. A.] Inst Tecnol Quim & Biol, IBET, P-2781901 Oeiras, Portugal; [Queiroga, Claudia S. F.; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Martel, Cecile; Brenner, Catherine] Univ Versailles St Quentin, CNRS, UMR 8159, F-78035 Versailles, France; [Martel, Cecile] Hop Paul Brousse, PRES UniverSud Paris, INSERM, U602, F-94805 Villejuif, France	Universidade Nova de Lisboa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Vieira, HLA (corresponding author), Inst Tecnol Quim & Biol, IBET, Apartado 12, P-2781901 Oeiras, Portugal.	hvieira@itqb.unl.pt	Alves, Paula M/C-1070-2008; Vieira, Helena/AAZ-9562-2021	Alves, Paula M/0000-0003-1445-3556; Queiroga, Claudia/0000-0002-3984-9576; Vieira, Helena/0000-0001-9415-3742; Almeida, Ana Sofia/0000-0001-7654-9049	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/64327/2006]; Helena L. A. Vieira Fellowship [SFRH/BPD/27125/2006]; Claudia S. F. Queiroga Fellowship [SFRH/BD/43387/2008]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Helena L. A. Vieira Fellowship; Claudia S. F. Queiroga Fellowship	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia Project PTDC/SAU-NEU/64327/2006, Helena L. A. Vieira Fellowship SFRH/BPD/27125/2006, and Claudia S. F. Queiroga Fellowship SFRH/BD/43387/2008.	Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Belzacq AS, 2003, CANCER RES, V63, P541; Belzacq-Casagrande AS, 2009, FRONT BIOSCI-LANDMRK, V14, P3550, DOI 10.2741/3470; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM SOC SYMP, V66, P167, DOI 10.1042/bss0660167; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Dore S, 2002, FREE RADICAL BIO MED, V32, P1276, DOI 10.1016/S0891-5849(02)00805-5; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Hirrlinger J, 2005, METHOD ENZYMOL, V400, P395, DOI 10.1016/S0076-6879(05)00023-6; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Muyderman H, 2004, J NEUROSCI, V24, P8019, DOI 10.1523/JNEUROSCI.1103-04.2004; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sandouka A, 2005, CELL MOL BIOL, V51, P425, DOI 10.1170/T646; Santos SS, 2005, J NEUROSCI RES, V79, P26, DOI 10.1002/jnr.20279; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Stroev SA, 2005, NEUROSCI RES, V53, P39, DOI 10.1016/j.neures.2005.05.010; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Vaillancourt F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2503; Verrier F, 2004, ONCOGENE, V23, P8049, DOI 10.1038/sj.onc.1208001; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Wiegand F, 1999, J CEREBR BLOOD F MET, V19, P1229, DOI 10.1097/00004647-199911000-00007; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	48	105	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17077	17088		10.1074/jbc.M109.065052	http://dx.doi.org/10.1074/jbc.M109.065052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348099	Green Published, hybrid			2022-12-25	WOS:000277982600071
J	Lammich, S; Buell, D; Zilow, S; Ludwig, AK; Nuscher, B; Lichtenthaler, SF; Prinzen, C; Fahrenholz, F; Haass, C				Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Prinzen, Claudia; Fahrenholz, Falk; Haass, Christian			Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5 '-Untranslated Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; OPEN READING FRAMES; MESSENGER-RNA; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; DISINTEGRIN-METALLOPROTEASE; UPSTREAM AUGS; TRANSLATIONAL REGULATION; 5-UNTRANSLATED REGION	Proteolytic processing of the amyloid precursor protein by alpha-secretase prevents formation of the amyloid beta-peptide (A beta),which is the main constituent of amyloid plaques in brains of Alzheimer disease (AD) patients. alpha-Secretase activity is decreased in AD, and overexpression of the alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) in an AD animal model prevents amyloid pathology. ADAM10 has a 444-nucleotide-long, very GC-rich 5'-untranslated region (5'-UTR) with two upstream open reading frames. Because similar properties of 5'-UTRs are found in transcripts of many genes, which are regulated by translational control mechanisms, we asked whether ADAM10 expression is translationally controlled by its 5'-UTR. We demonstrate that the 5'-UTR of ADAM10 represses the rate of ADAM10 translation. In the absence of the 5'-UTR, we observed a significant increase of ADAM10 protein levels in HEK293 cells, whereas mRNA levels were not changed. Moreover, the 5'-UTR of ADAM10 inhibits translation of a luciferase reporter in an in vitro transcription/translation assay. Successive deletion of the first half of the ADAM10 5'-UTR revealed a striking increase in ADAM10 protein expression in HEK293 cells, suggesting that this part of the 5'-UTR contains inhibitory elements for translation. Moreover, we detect an enhanced alpha-secretase activity and consequently reduced A beta levels in the conditioned medium of HEK293 cells expressing both amyloid precursor protein and a 5'-UTR-ADAM10 deletion construct lacking the first half of the 5'-UTR. Thus, we provide evidence that the 5'-UTR of ADAM10 may have an important role for post-transcriptional regulation of ADAM10 expression and consequently A beta production.	[Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Prinzen, Claudia] Johannes Gutenberg Univ Mainz, Inst Biochem, D-55099 Mainz, Germany; [Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Clin Res Grp, D-55131 Mainz, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lammich, S (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis DZNE, Schillerstr 44, D-80336 Munich, Germany.	sven.lammich@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575	Deutsche Forschungsgemeinschaft [SFB596]; Hans and Ilse Breuer Foundation; Ludwig-Maximilians-University, Munich; Bundesministerium fur Bildung und Forschung; Center of Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans and Ilse Breuer Foundation; Ludwig-Maximilians-University, Munich; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Center of Integrated Protein Science Munich (CIPSM)	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center SFB596 "Molecular Mechanisms of Neurodegeneration," to S. L., S. F. L., and C. H.), a fellowship of the Hans and Ilse Breuer Foundation (S. Z.), a predoctoral fellowship (Molekulare Medizin-Forrderung der Forschung und Lehre, FoFoLe) by the Ludwig-Maximilians-University, Munich (D. B.), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation, and Translation into Treatment Strategies" (S. F. L. and C. H.)), and by the Center of Integrated Protein Science Munich (CIPSM).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; de la Torre TV, 2004, BIOCHEM BIOPH RES CO, V314, P1028, DOI 10.1016/j.bbrc.2003.12.186; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; HAASS C, 1992, NATURE, V359, P325; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hernandez-Sanchez C, 2003, EMBO J, V22, P5582, DOI 10.1093/emboj/cdg515; HORVATH P, 1995, CELL GROWTH DIFFER, V6, P1103; Howard L, 1996, BIOCHEM J, V317, P45, DOI 10.1042/bj3170045; Ko SY, 2007, CANCER LETT, V245, P33, DOI 10.1016/j.canlet.2005.10.019; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Lee J, 2002, NUCLEIC ACIDS RES, V30, P5110, DOI 10.1093/nar/gkf664; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Li Y, 2009, NUCLEIC ACIDS RES, V37, P2227, DOI 10.1093/nar/gkp087; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oh ST, 2009, J CUTAN PATHOL, V36, P395, DOI 10.1111/j.1600-0560.2008.01082.x; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Wood MW, 1996, J BIOL CHEM, V271, P8115, DOI 10.1074/jbc.271.14.8115; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15753	15760		10.1074/jbc.M110.110742	http://dx.doi.org/10.1074/jbc.M110.110742			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348102	Green Published, hybrid			2022-12-25	WOS:000277715900011
J	Radichev, IA; Remacle, AG; Shiryaev, SA; Purves, AN; Johnson, SL; Pellecchia, M; Strongin, AY				Radichev, Ilian A.; Remacle, Albert G.; Shiryaev, Sergey A.; Purves, Angela N.; Johnson, Sherida L.; Pellecchia, Maurizio; Strongin, Alex Y.			Biochemical Characterization of the Cellular Glycosylphosphatidylinositol-linked Membrane Type-6 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-1-PROTEINASE INHIBITOR; PERICELLULAR PROTEOLYSIS; IV COLLAGENASE; CADHERIN SUPERFAMILY; TISSUE INHIBITORS; CATALYTIC DOMAIN; CANCER-CELLS; ACTIVATION; MT1-MMP; SURFACE	Ubiquitously expressed membrane type-1 matrix metalloproteinase (MT1-MMP), an archetype member of the MMP family, binds tissue inhibitor of metalloproteinases-2 (TIMP-2), activates matrix metalloproteinase-2 (MMP-2), and stimulates cell migration in various cell types. In contrast with MT1MMP, the structurally similar MT6-MMP associates with the lipid raft compartment of the plasma membrane using a GPI anchor. As a result, MT6-MMP is functionally distinct from MT1-MMP. MT6-MMP is insufficiently characterized as yet. In addition, a number of its biochemical features are both conflicting and controversial. To reassess the biochemical features of MT6-MMP, we have expressed theMT6-MMPconstruct tagged with a FLAG tag in breast carcinoma MCF-7 and fibrosarcoma HT1080 cells. Wethen used phosphatidylinositol-specific phospholipase C to release MT6-MMP from the cell surface and characterized the solubilized MT6-MMP fractions. We now are confident that cellular MT6-MMP partially exists in its complex with TIMP-2. Both TIMP-1 and TIMP-2 are capable of inhibiting the proteolytic activity of MT6-MMP. MT6-MMP does not stimulate cell migration. MT6-MMP, however, generates a significant level of gelatinolysis of the fluorescein isothiocyanate-labeled gelatin and exhibits an intrinsic, albeit low, ability to activate MMP-2. As a result, it is exceedingly difficult to record the activation of MMP-2 by cellular MT6-MMP. Because of its lipid raft localization, cellular MT6-MMP is inefficiently internalized. MT6-MMP is predominantly localized in the cell-to-cell junctions. Because MT6-MMP has been suggested to play a role in disease, including cancer and autoimmune multiple sclerosis, the identity of its physiologically relevant cleavage targets remains to be determined.	[Radichev, Ilian A.; Remacle, Albert G.; Shiryaev, Sergey A.; Purves, Angela N.; Johnson, Sherida L.; Pellecchia, Maurizio; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@burnham.org	Pellecchia, Maurizio/Y-7072-2018; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	Agrawal A, 2010, CHEMMEDCHEM, V5, P195, DOI 10.1002/cmdc.200900516; Angst BD, 2001, J CELL SCI, V114, P629; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BOOHER RN, 1987, J MED CHEM, V30, P580, DOI 10.1021/jm00386a023; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; HSIEH P, 1980, J CELL BIOL, V87, P14, DOI 10.1083/jcb.87.1.14; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Li W, 2004, CANCER RES, V64, P8657, DOI 10.1158/0008-5472.CAN-04-3019; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nie J, 2003, CANCER RES, V63, P6758; Nie J, 2007, J BIOL CHEM, V282, P6438, DOI 10.1074/jbc.M607337200; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Radichev IA, 2009, BIOCHEM J, V420, P37, DOI 10.1042/BJ20090082; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; SIRES UI, 1994, BIOCHEM BIOPH RES CO, V204, P613, DOI 10.1006/bbrc.1994.2503; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Velasco G, 2000, CANCER RES, V60, P877; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; ZHANG Z, 1994, BBA-GEN SUBJECTS, V1199, P224, DOI 10.1016/0304-4165(94)90119-8; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	52	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16076	16086		10.1074/jbc.M110.107094	http://dx.doi.org/10.1074/jbc.M110.107094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308072	Green Published, hybrid			2022-12-25	WOS:000277715900045
J	Yoneda, K; Demitsu, T; Nakai, K; Moriue, T; Ogawa, W; Igarashi, J; Kosaka, H; Kubota, Y				Yoneda, Kozo; Demitsu, Toshio; Nakai, Kozo; Moriue, Tetsuya; Ogawa, Wataru; Igarashi, Junsuke; Kosaka, Hiroaki; Kubota, Yasuo			Activation of Vascular Endothelial Growth Factor Receptor 2 in a Cellular Model of Loricrin Keratoderma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SYMMETRIC ERYTHROKERATODERMA; PHOSPHOINOSITIDE 3-KINASE; VOHWINKELS-KERATODERMA; 3T3-L1 ADIPOCYTES; MUTANT LORICRIN; MOLECULAR-BASIS; SKIN DISEASES; FACTOR VEGF; MUTATION; GENE	Loricrin is a major constituent of the epidermal cornified cell envelope. Recently, heterozygous loricrin gene mutations have been identified in two dominantly inherited skin diseases, Vohwinkel syndrome with ichthyosis and progressive symmetric erythrokeratoderma, collectively termed loricrin keratoderma. We generated stable HaCaT cell lines that express wildtype (WT) loricrin and a mutant form found in Vohwinkel syndrome with ichthyosis, using an ecdysone-inducible promoter system. The cells expressing the mutant loricrin grew more rapidly than those expressing WT loricrin after induction for 5 days. Confocal immunofluorescence microscopy revealed that phospho-Akt occurred in the nucleolus where the mutant loricrin was also located. The level of activity of Akt kinase was about nine times higher in cells with the mutant than in those with WT loricrin. ERK1/2, the epidermal growth factor receptor, vascular endothelial growth factor (VEGF) receptor 2 and Stat3 were all phosphorylated in cells with the mutant loricrin. The docking proteins, Gab1 and c-Cbl, were also tyrosine-phosphorylated in these cells. Furthermore, chromatin immunoprecipitation assays showed that Stat3 protein bound to the VEGF promoter in cells with the mutant. Thus, this study suggests that VEGF release and the subsequent activation of VEGF receptor 2 link loricrin gene mutations to rapid cell proliferation in a cellular model of loricrin keratoderma.	[Yoneda, Kozo; Nakai, Kozo; Moriue, Tetsuya; Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Kagawa 7610793, Japan; [Igarashi, Junsuke; Kosaka, Hiroaki] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa 7610793, Japan; [Demitsu, Toshio] Jichi Med Univ, Omiya Med Ctr, Dept Dermatol, Saitama 3308503, Japan; [Ogawa, Wataru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan	Kagawa University; Kagawa University; Jichi Medical University; Kobe University	Yoneda, K (corresponding author), Kagawa Univ, Fac Med, Dept Dermatol, Kagawa 7610793, Japan.	kyoneda@med.kagawa-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020		Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan	Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan	This work was supported by grants from the Ministries of Health, Labor, and Welfare and Education, Culture, Sports, Science, and Technology of Japan.	Armstrong DKB, 1998, J INVEST DERMATOL, V111, P702, DOI 10.1046/j.1523-1747.1998.00343.x; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Cascio S, 2009, J CELL PHYSIOL, V221, P189, DOI 10.1002/jcp.21843; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Gedicke MM, 2006, BRIT J DERMATOL, V154, P167, DOI 10.1111/j.1365-2133.2005.06995.x; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Ishida-Yamamoto A, 1998, HISTOL HISTOPATHOL, V13, P819, DOI 10.14670/HH-13.819; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; Ishida-Yamamoto A, 2003, J DERMATOL SCI, V31, P3, DOI 10.1016/S0923-1811(02)00143-3; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V115, P1088, DOI 10.1046/j.1523-1747.2000.00163.x; IshidaYamamoto A, 1997, AM J HUM GENET, V61, P581, DOI 10.1086/515518; Kalinin A, 2001, J CELL SCI, V114, P3069; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Korge BP, 1997, J INVEST DERMATOL, V109, P604, DOI 10.1111/1523-1747.ep12337534; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Marchand-Adam S, 2005, AM J RESP CELL MOL, V32, P470, DOI 10.1165/rcmb.2004-0205OC; Matsumoto K, 2001, BRIT J DERMATOL, V145, P657, DOI 10.1046/j.1365-2133.2001.04412.x; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; O'Driscoll J, 2002, CLIN EXP DERMATOL, V27, P243, DOI 10.1046/j.1365-2230.2002.01031.x; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Piossek C, 1999, J BIOL CHEM, V274, P5612, DOI 10.1074/jbc.274.9.5612; Saez E, 2000, P NATL ACAD SCI USA, V97, P14512, DOI 10.1073/pnas.260499497; Sakaue H, 1997, MOL ENDOCRINOL, V11, P1552, DOI 10.1210/me.11.10.1552; Song S, 2008, BRIT J DERMATOL, V159, P714, DOI 10.1111/j.1365-2133.2008.08657.x; Suga Y, 2000, J CELL BIOL, V151, P401, DOI 10.1083/jcb.151.2.401; Suzuki A, 2003, CANCER RES, V63, P674; Takahashi H, 1999, J DERMATOL SCI, V19, P44, DOI 10.1016/S0923-1811(98)00049-8; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; YONEDA K, 1990, J INVEST DERMATOL, V94, P724, DOI 10.1111/1523-1747.ep12876298; Yoneda K, 2004, J BIOL CHEM, V279, P7296, DOI 10.1074/jbc.M307242200; YONEDA K, 1992, J BIOL CHEM, V267, P18060; YONEDA K, 1993, P NATL ACAD SCI USA, V90, P10754, DOI 10.1073/pnas.90.22.10754; Yoneda Kozo, 1992, Journal of Dermatology (Tokyo), V19, P761; Yoneda Kozo, 2004, Journal of Dermatological Science, V34, P124; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	40	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16184	16194		10.1074/jbc.M109.056424	http://dx.doi.org/10.1074/jbc.M109.056424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236940	Green Published, hybrid			2022-12-25	WOS:000277715900055
J	Torres-Altoro, MI; Kuntz, CP; Nichols, DE; Barker, EL				Torres-Altoro, Melissa I.; Kuntz, Charles P.; Nichols, David E.; Barker, Eric L.			Structural Analysis of the Extracellular Entrance to the Serotonin Transporter Permeation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITES; TRANSMEMBRANE DOMAIN; EXTERNAL LOOP; SUBSTRATE; DOPAMINE; RESIDUES; COCAINE; LEUT	Neurotransmitter transporters are responsible for removal of biogenic amine neurotransmitters after release into the synapse. These transporters are the targets for many clinically relevant drugs, such as antidepressants and psychostimulants. A high resolution crystal structure for the monoamine transporters has yet to be solved. We have developed a homology model for the serotonin transporter (SERT) based on the crystal structure of the leucine transporter (LeuT(Aa)) from Aquifex aeolicus. The objective of the present studies is to identify the structural determinants forming the entrance to the substrate permeation pathway based on predictions from the SERT homology model. Using the substituted cysteine accessibility method, we identified residues predicted to reside at the entrance to the substrate permeation pathway that were reactive with methanethiosulfonate (MTS) reagents. Of these residues, Gln(332) in transmembrane helix(TMH) VI was protected against MTS inactivation in the presence of serotonin. Surprisingly, the reactivity of Gln(332) to MTS reagents was enhanced in the presence of cocaine. Bifunctional MTS cross-linkers also were used to examine the distances between helices predicted to form the entrance into the substrate and ion permeation pathway. Our studies suggest that substrate and ligand binding may induce conformational shifts in TMHI and/or VI, providing new opportunities to refine existing homology models of SERT and related monoamine transporters.	[Torres-Altoro, Melissa I.; Kuntz, Charles P.; Nichols, David E.; Barker, Eric L.] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Barker, EL (corresponding author), 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	barkerel@purdue.edu		Torres-Altoro, Melissa/0000-0002-2574-2356	National Institutes of Health [DA018682]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA018682 (to E. L. B. and D. E. N.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ravna AW, 2006, BIOORG MED CHEM LETT, V16, P5594, DOI 10.1016/j.bmcl.2006.08.028; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres-Altoro MI, 2008, PROTEIN SCI, V17, P1761, DOI 10.1110/ps.036749.108; WANG JB, 1995, J NEUROCHEM, V64, P1416; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231	32	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15369	15379		10.1074/jbc.M109.088138	http://dx.doi.org/10.1074/jbc.M109.088138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304925	Green Published, hybrid			2022-12-25	WOS:000277399000057
J	Gordon, PM; Fisher, DE				Gordon, Peter M.; Fisher, David E.			Role for the Proapoptotic Factor BIM in Mediating Imatinib-induced Apoptosis in a c-KIT-dependent Gastrointestinal Stromal Tumor Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY; MESSENGER-RNA; PROTEIN BIM; SURVIVAL; PHOSPHORYLATION; INACTIVATION; INHIBITION; MECHANISMS; PROMOTES; CANCER	The c-KIT receptor tyrosine kinase is constitutively activated and oncogenic in the majority of gastrointestinal stromal tumors. The identification of selective inhibitors of c-KIT, such as imatinib, has provided a novel therapeutic approach in the treatment of this chemotherapy refractory tumor. However, despite the clinical importance of these findings and the potential it provides as a model system for understanding targeted therapy, this approach has not yielded curative outcomes in most patients, and the biochemical pathways connecting c-KIT inhibition to cell death are not completely understood. Here, we show that inhibition of c-KIT with imatinib in gastrointestinal stromal tumors (GISTs) triggered the up-regulation of the proapoptotic protein BIM via both transcriptional and post-translational mechanisms. The inhibition of c-KIT by imatinib increased levels of the dephosphorylated and deubiquitinated form of BIM as well as triggered the accumulation of the transcription factor FOXO3a on the BIM promoter to activate transcription of BIM mRNA. Furthermore, using RNA interference directed against BIM, we demonstrated that BIM knockdown attenuated the effects of imatinib, suggesting that BIM functionally contributes to imatinib-induced apoptosis in GIST. The identification and characterization of the pathways that mediate imatinib-induced cell death in GIST provide for a better understanding of targeted therapy and may facilitate the development of new therapeutic approaches to further exploit these pathways.	[Gordon, Peter M.; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Gordon, Peter M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Gordon, Peter M.] Childrens Hosp Boston, Boston, MA 02115 USA; [Gordon, Peter M.; Fisher, David E.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 55 Fruit St, Boston, MA 02114 USA.	dfisher3@partners.org			National Institutes of Health [AR043369-14]; Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR043369-14. This work was also supported by the Melanoma Research Alliance (to D. E. F.).	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Bauer S, 2010, CANCER RES, V70, P150, DOI 10.1158/0008-5472.CAN-09-1449; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Duensing A, 2004, CANCER INVEST, V22, P106, DOI 10.1081/CNV-120027585; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Liu Y, 2008, CANCER RES, V68, P9015, DOI 10.1158/0008-5472.CAN-08-1935; Liu Y, 2007, CANCER RES, V67, P2685, DOI 10.1158/0008-5472.CAN-06-3497; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Miselli F, 2008, TRANSL ONCOL, V1, P177, DOI 10.1593/tlo.08157; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quek R, 2009, HEMATOL ONCOL CLIN N, V23, P69, DOI 10.1016/j.hoc.2008.11.006; Sambol EB, 2006, CANCER RES, V66, P5858, DOI 10.1158/0008-5472.CAN-05-2933; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0	36	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14109	14114		10.1074/jbc.M109.078592	http://dx.doi.org/10.1074/jbc.M109.078592			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231287	Green Published, hybrid			2022-12-25	WOS:000277299700006
J	Ooki, A; Yamashita, K; Kikuchi, S; Sakuramoto, S; Katada, N; Kokubo, K; Kobayashi, H; Kim, MS; Sidransky, D; Watanabe, M				Ooki, A.; Yamashita, K.; Kikuchi, S.; Sakuramoto, S.; Katada, N.; Kokubo, K.; Kobayashi, H.; Kim, M. S.; Sidransky, D.; Watanabe, M.			Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer	ONCOGENE			English	Article						HOP homeobox; gastric cancer; methylation; prognosis	ABERRANT METHYLATION; DNA METHYLATION; EXPRESSION; HYPERMETHYLATION; ESTROGEN; PGP9.5; INACTIVATION; CHEMOTHERAPY; MANAGEMENT; SCORE	HOP homeobox (HOPX) is an unusual homeobox gene encoding three spliced transcript variants, among which the only HOPX-beta promoter harbors CpG islands. The characteristics of its promoter methylation was analyzed using bisulfite sequencing and quantitative-methylation-specific polymerase chain reaction (Q-MSP), and the effects of HOPX expression were also examined. HOPX-beta expression was silenced in all gastric cancer cell lines tested; its expression could be restored by treatment with demethylating agent. On Q-MSP, HOPX-beta hypermethylation (cut-off value of 3.55) was found in 84% (67 out of 80) of primary tumor tissues and 10% (8 out of 80) of the corresponding normal tissues and could discriminate normal from tumor tissues (P<0.0001). The prognosis of the advanced cases with HOPX-beta hypermethylation was as poor as those with stage IV disease when cut-off value was set at 11.28. This finding was validated in an independent cohort of 90 advanced gastric cancers. The HOPX-beta hypermethylation was also an independent prognostic factor (P = 0.029) on multivariate analysis. Exogenous HOPX expression significantly inhibited cell proliferation, colony formation and invasion as well as enhanced apoptosis. Taken together, HOPX-beta promoter methylation is a frequent and cancer-specific event in gastric cancer. Quantitative assessment of HOPX-beta methylation has great clinical potential as a marker of tumor aggressiveness. Oncogene (2010) 29, 3263-3275; doi: 10.1038/onc.2010.76; published online 15 March 2010	[Ooki, A.; Yamashita, K.; Kikuchi, S.; Sakuramoto, S.; Katada, N.; Watanabe, M.] Kitasato Univ Hosp, Dept Surg, Kanagawa, Japan; [Kokubo, K.; Kobayashi, H.] Kitasato Univ, Sch Allied Hlth Sci, Dept Med Engn & Technol, Kanagawa 2288555, Japan; [Kim, M. S.; Sidransky, D.] Johns Hopkins Univ, Dept Otolaryngol, Head & Neck Canc Res Inst, Baltimore, MD USA	Kitasato University; Kitasato University; Johns Hopkins University	Ooki, A (corresponding author), Kitasato Univ, Dept Surg, Kitasato 1-15-1, Kanagawa 2288555, Japan.	sp9y9tq9@piano.ocn.ne.jp; gekaw@med.kitasato-u.ac.jp	Kokubo, Kenichi/E-6667-2011	Kokubo, Kenichi/0000-0003-0922-7933	Ministry of Health, Labour and Welfare of Japan; Japanese Foundation for Multidisciplinary Treatment of Cancer	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer)	This work was supported, in part, by the Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan and by the Japanese Foundation for Multidisciplinary Treatment of Cancer.	Brena RM, 2006, J MOL MED, V84, P365, DOI 10.1007/s00109-005-0034-0; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen Y, 2007, INT J CANCER, V121, P1021, DOI 10.1002/ijc.22753; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kook H, 2006, BIOCHEMISTRY-US, V45, P10584, DOI 10.1021/bi060641s; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lehnert T, 2002, BRIT J SURG, V89, P471, DOI 10.1046/j.0007-1323.2002.02067.x; Liu JW, 2007, INT J CANCER, V121, P1994, DOI 10.1002/ijc.22934; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy AM, 1999, ANN SURG, V229, P303, DOI 10.1097/00000658-199903000-00001; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; OOKI A, 2009, INT J CANC IN PRESS; Oshimo Y, 2004, INT J CANCER, V110, P212, DOI 10.1002/ijc.20090; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; Park J, 2004, ONCOGENE, V23, P3474, DOI 10.1038/sj.onc.1207470; REMMELE W, 1987, PATHOLOGE, V8, P138; REMMELE W, 1993, PATHOL RES PRACT, V189, P862; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Takahashi T, 2005, INT J CANCER, V115, P503, DOI 10.1002/ijc.20910; Tokumaru Y, 2003, ONCOGENE, V22, P6954, DOI 10.1038/sj.onc.1206403; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Waki T, 2003, CANCER SCI, V94, P360, DOI 10.1111/j.1349-7006.2003.tb01447.x; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Yamaguchi S, 2009, INT J CANCER, V124, P2577, DOI 10.1002/ijc.24217; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yamashita K, 2008, MOL CANCER RES, V6, P31, DOI 10.1158/1541-7786.MCR-07-0213; Yamashita K, 2009, CANCER SCI, V100, P195, DOI 10.1111/j.1349-7006.2008.01022.x; Zhang YJ, 2008, J GASTROEN HEPATOL, V23, P856, DOI 10.1111/j.1440-1746.2007.05140.x; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	39	53	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3263	3275		10.1038/onc.2010.76	http://dx.doi.org/10.1038/onc.2010.76			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20228841				2022-12-25	WOS:000278321100009
J	Riegelhaupt, PM; Frame, IJ; Akabas, MH				Riegelhaupt, Paul M.; Frame, I. J.; Akabas, Myles H.			Transmembrane Segment 11 Appears to Line the Purine Permeation Pathway of the Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE ACCESSIBILITY METHOD; INTRAERYTHROCYTIC MALARIA PARASITE; MAJOR FACILITATOR SUPERFAMILY; PLASMA-MEMBRANE; S-6-(4-NITROBENZYL)-MERCAPTOPURINE RIBOSIDE; LINING RESIDUES; CELLULAR UPTAKE; CHANNEL; NITROBENZYLTHIOINOSINE; IDENTIFICATION	Purine transport is essential for malaria parasites to grow because they lack the enzymes necessary for de novo purine biosynthesis. The Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1) is a member of the equilibrative nucleoside transporter (ENT) gene family. PfENT1 is a primary purine transport pathway across the P. falciparum plasma membrane because PfENT1 knock-out parasites are not viable at physiologic extracellular purine concentrations. Topology predictions and experimental data indicate that ENT family members have eleven transmembrane (TM) segments although their tertiary structure is unknown. In the current work, we showed that a naturally occurring polymorphism, F394L, in TM11 affects transport substrate K-m. We investigated the structure and function of the TM11 segment using the substituted cysteine accessibility method. We showed that mutation to Cys of two highly conserved glycine residues in a GXXXG motif significantly reduces PfENT1 protein expression levels. We speculate that the conserved TM11 GXXXG glycines may be critical for folding and/or assembly. Small, cysteine-specific methanethiosulfonate (MTS) reagents reacted with four TM11 Cys substitution mutants, L393C, I397C, T400C, and Y403C. Larger MTS reagents do not react with the more cytoplasmic positions. Hypoxanthine, a transported substrate, protected L393C, I397C, and T400C from covalent modification by the MTS reagents. Plotted on an alpha-helical wheel, Leu-393, Ile-397, and Thr-400 lie on one face of the helix in a 60 degrees arc suggesting that TM11 is largely alpha helical. We infer that they line a water-accessible surface, possibly the purine permeation pathway. These results advance our understanding of the ENT structure.	[Riegelhaupt, Paul M.; Frame, I. J.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846; Frame, I.J./0000-0002-7560-7427	National Institutes of Health [T32-GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Medical Scientist Training Program Grant T32-GM007288 (to P.M.R.).	Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Arendt CS, 2010, J BIOL CHEM, V285, P6024, DOI 10.1074/jbc.M109.074351; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Cox J, 2007, TRENDS PARASITOL, V23, P142, DOI 10.1016/j.pt.2007.02.002; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Endres CJ, 2004, BIOCHEM J, V380, P131, DOI 10.1042/BJ20031880; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Harrington SE, 2009, STRUCTURE, V17, P1092, DOI 10.1016/j.str.2009.06.009; Hoque KM, 2008, AM J PHYSIOL-REG I, V294, pR1988, DOI 10.1152/ajpregu.00016.2008; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Robillard KR, 2008, MOL PHARMACOL, V74, P264, DOI 10.1124/mol.107.041871; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schramm VL, 2004, NUCLEOS NUCLEOT NUCL, V23, P1305, DOI 10.1081/NCN-200027564; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wang XC, 2008, BIOCHEMISTRY-US, V47, P5709, DOI 10.1021/bi8001314; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387	56	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17001	17010		10.1074/jbc.M110.115758	http://dx.doi.org/10.1074/jbc.M110.115758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335165	Green Published, hybrid			2022-12-25	WOS:000277982600063
J	Smith, L; Page, RC; Xu, Z; Kohli, E; Litman, P; Nix, JC; Ithychanda, SS; Liu, JM; Qin, J; Misra, S; Liedtke, CM				Smith, Laura; Page, Richard C.; Xu, Zhen; Kohli, Ekta; Litman, Paul; Nix, Jay C.; Ithychanda, Sujay S.; Liu, Jianmin; Qin, Jun; Misra, Saurav; Liedtke, Carole M.			Biochemical Basis of the Interaction between Cystic Fibrosis Transmembrane Conductance Regulator and Immunoglobulin-like Repeats of Filamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL ACTIVITY; AIRWAY EPITHELIAL-CELLS; STRUCTURAL BASIS; PLASMA-MEMBRANE; MOLECULAR-BASIS; CFTR; PROTEIN; BINDING; NMR; PHOSPHORYLATION	Mutations in the chloride channel cystic fibrosis transmembrane regulator (CFTR) cause cystic fibrosis, a genetic disorder characterized by defects in CFTR biosynthesis, localization to the cell surface, or activation by regulatory factors. It was discovered recently that surface localization of CFTR is stabilized by an interaction between the CFTR N terminus and the multidomain cytoskeletal protein filamin. The details of the CFTR-filamin interaction, however, are unclear. Using x-ray crystallography, we show how the CFTR N terminus binds to immunoglobulin-like repeat 21 of filamin A (FlnA-Ig21). CFTR binds to beta-strands C and D of FlnA-Ig21 using backbone-backbone hydrogen bonds, a linchpin serine residue, and hydrophobic side-chain packing. We use NMR to determine that the CFTR N terminus also binds to several other immunoglobulin-like repeats from filamin A in vitro. Our structural data explain why the cystic fibrosis-causing S13F mutation disrupts CFTR-filamin interaction. We show that FlnA-Ig repeats transfected into cultured Calu-3 cells disrupt CFTR-filamin interaction and reduce surface levels of CFTR. Our findings suggest that filamin A stabilizes surface CFTR by anchoring it to the actin cytoskeleton through interactions with multiple filamin Ig repeats. Such an interaction mode may allow filamins to cluster multiple CFTR molecules and to promote colocalization of CFTR and other filamin-binding proteins in the apical plasma membrane of epithelial cells.	[Page, Richard C.; Xu, Zhen; Kohli, Ekta; Ithychanda, Sujay S.; Liu, Jianmin; Qin, Jun; Misra, Saurav] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Smith, Laura; Litman, Paul; Liedtke, Carole M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Willard Alan Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Smith, Laura; Litman, Paul; Liedtke, Carole M.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Misra, S (corresponding author), Cleveland Clin, Dept Mol Cardiol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	misras@ccf.org; carole.liedtke@case.edu	Ithychanda, Sujay Subbayya/C-7792-2011	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Page, Richard/0000-0002-3006-3171; Misra, Saurav/0000-0002-1385-8554; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL 58598]; Ralph Wilson Medical Research Foundation; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph Wilson Medical Research Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL 58598 (to C. M. L.). This work was also supported by the Ralph Wilson Medical Research Foundation (S. M.) and by funds from a Cystic Fibrosis Foundation Research Development Program (C. M. L.).	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Auerbach M, 2007, AM J PHYSIOL-CELL PH, V293, pC294, DOI 10.1152/ajpcell.00413.2006; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang SY, 2002, J CELL SCI, V115, P783; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton J.W., 2007, GNU OCTAVE HIGH LEVE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; GODDARD TD, 2006, SPARKY3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nguyen TD, 2006, BIOCHEM BIOPH RES CO, V342, P245, DOI 10.1016/j.bbrc.2006.01.127; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rasband W., 2006, IMAGEJ; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; van Holde K.E., 1998, PRINCIPLES PHYS BIOC, Vsecond; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17166	17176		10.1074/jbc.M109.080911	http://dx.doi.org/10.1074/jbc.M109.080911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351101	hybrid, Green Published			2022-12-25	WOS:000277982600079
J	Aziz, MH; Hafeez, BB; Sand, JM; Pierce, DB; Aziz, SW; Dreckschmidt, NE; Verma, AK				Aziz, M. H.; Hafeez, B. B.; Sand, J. M.; Pierce, D. B.; Aziz, S. W.; Dreckschmidt, N. E.; Verma, A. K.			Protein kinase C epsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2)	ONCOGENE			English	Article						PKC epsilon; Stat3; human cancer	INDUCED CUTANEOUS DAMAGE; EPIDERMAL JB6 CELLS; PROSTATE-CANCER; TRANSGENIC MICE; BREAST-CANCER; SIGNAL-TRANSDUCTION; UBIQUITIN LIGASE; STAT3; CARCINOMA; ACTIVATION	Protein kinase C epsilon (PKC epsilon), a novel calcium-independent PKC isoform, has been shown to be a transforming oncogene. PKC epsilon-mediated oncogenic activity is linked to its ability to promote cell survival. However, the mechanisms by which PKC epsilon signals cell survival remain elusive. We found that signal transducers and activators of transcription 3 (Stat3), which is constitutively activated in a wide variety of human cancers, is a protein partner of PKC epsilon. Stat3 has two conserved amino-acid (Tyr705 and Ser727) residues, which are phosphorylated during Stat3 activation. PKC epsilon interacts with Stat3 alpha isoform, which has Ser727, and not with Stat3 beta isoform, which lacks Ser727. PKC epsilon-Stat3 interaction and Stat3-Ser727 phosphorylation was initially observed during induction of squamous cell carcinomas and in prostate cancer. Now we present that (1) PKC epsilon physically interacts with Stat3 alpha isoform in various human cancer cells: skin melanomas (MeWo and WM266-4), gliomas (T98G and MO59K), bladder (RT-4 and UM-UC-3), colon (Caco-2), lung (H1650), pancreatic (PANC-1), and breast (MCF-7 and MDA: MB-231); (2) inhibition of PKC epsilon expression using specific siRNA inhibits Stat3Ser727 phosphorylation, Stat3-DNA binding, Stat3-regulated gene expression as well as cell invasion; and (3) PKC epsilon mediates Stat3Ser727 phosphorylation through integration with the MAPK cascade (RAF-1, MEK1/2, and ERK1/2). The results indicate that PKC epsilon-mediated Stat3Ser727 phosphorylation is essential for constitutive activation of Stat3 and cell invasion in various human cancers. Oncogene (2010) 29, 3100-3109; doi: 10.1038/onc.2010.63; published online 15 March 2010	[Aziz, M. H.; Hafeez, B. B.; Sand, J. M.; Pierce, D. B.; Aziz, S. W.; Dreckschmidt, N. E.; Verma, A. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Paul P Carbone Comprehens Canc,WIMR, Madison, WI 53792 USA; [Sand, J. M.] Wisconsin Inst Med Res, Mol & Environm Toxicol Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Verma, AK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Paul P Carbone Comprehens Canc,WIMR, Room 7103,1111 Highland Ave, Madison, WI 53792 USA.	akverma@facstaff.wisc.edu			DOD [W81XWH]; NIH [CA35368]; NATIONAL CANCER INSTITUTE [R01CA035368] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in parts by DOD Grant W81XWH and NIH Grant CA35368 to AKV.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Aziz MH, 2007, CANCER RES, V67, P1385, DOI 10.1158/0008-5472.CAN-06-3350; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Christine R, 2005, CANCER RES, V65, P195; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Jansen AP, 2001, CANCER RES, V61, P808; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mochly-Rosen D, 1998, ADV PHARMACOL, V44, P91, DOI 10.1016/S1054-3589(08)60126-X; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nikitakis NG, 2004, CURR CANCER DRUG TAR, V4, P637, DOI 10.2174/1568009043332736; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Reddig PJ, 2000, CANCER RES, V60, P595; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Wheeler DL, 2005, PHOTOCHEM PHOTOBIOL, V81, P9, DOI 10.1562/2004-08-12-RA-271.1; Wheeler DL, 2004, CANCER RES, V64, P7756, DOI 10.1158/0008-5472.CAN-04-1881; Wheeler DL, 2003, CANCER RES, V63, P6547; Wu DQ, 2004, ONCOGENE, V23, P8659, DOI 10.1038/sj.onc.1207900; Wu DQ, 2002, CANCER RES, V62, P2423; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zykova TA, 2005, CARCINOGENESIS, V26, P331, DOI 10.1093/carcin/bgh334	43	88	89	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3100	3109		10.1038/onc.2010.63	http://dx.doi.org/10.1038/onc.2010.63			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20228845	Green Accepted			2022-12-25	WOS:000278133100007
J	Wang, Y; Klumpp, S; Amin, HM; Liang, H; Li, J; Estrov, Z; Zweidler-McKay, P; Brandt, SJ; Agulnick, A; Nagarajan, L				Wang, Y.; Klumpp, S.; Amin, H. M.; Liang, H.; Li, J.; Estrov, Z.; Zweidler-McKay, P.; Brandt, S. J.; Agulnick, A.; Nagarajan, L.			SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability	ONCOGENE			English	Article						tumor suppressor; null mouse; LIM code; p53; lymphoma; SSBP2	DNA-BINDING PROTEINS; B-CELL; TRANSCRIPTION FACTOR; LIM-DOMAIN; MYELOGENOUS LEUKEMIA; GENE-EXPRESSION; DIFFERENTIATION; SURVIVAL; PROLIFERATION; ABUNDANCE	SSBP proteins bind and stabilize transcriptional cofactor LIM domain-binding protein1 (LDB1) from proteosomal degradation to promote tissue-specific transcription through an evolutionarily conserved pathway. The human SSBP2 gene was isolated as a candidate tumor suppressor from a critical region of loss in chromosome 5q14.1. By gene targeting, we show increased predisposition to B-cell lymphomas and carcinomas in Ssbp2(-/-) mice. Remarkably, loss of Ssbp2 causes increased LDB1 turnover in the thymus, a pathway exploited in Trp53(-/-) Ssbp2(-/-) mice to develop highly aggressive, immature thymic lymphomas. Using T-cell differentiation as a model, we report a stage-specific upregulation of Ssbp2 expression, which in turn regulates LDB1 turnover under physiological conditions. Furthermore, transcript levels of pT alpha, a target of LDB1-containing complex, and a critical regulator T-cell differentiation are reduced in Ssbp2(-/-) immature thymocytes. Our findings suggest that disruption of the SSBP2-regulated pathways may be an infrequent but critical step in malignant transformation of multiple tissues. Oncogene (2010) 29, 3044-3053; doi: 10.1038/onc.2010.78; published online 29 March 2010	[Wang, Y.; Liang, H.; Li, J.; Nagarajan, L.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Klumpp, S.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Amin, H. M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Estrov, Z.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zweidler-McKay, P.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Brandt, S. J.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Brandt, S. J.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Brandt, S. J.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA; [Brandt, S. J.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Agulnick, A.] Novocell Inc, La Jolla, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Nagarajan, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Box 45,1515 Holcombe Blvd, Houston, TX 77030 USA.	lnagaraj@mdanderson.org		Zweidler-McKay, Patrick/0000-0001-6621-523X	NCI [CA16672];  [HL744409]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074449, R01HL049118] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Xiaoping Ma and Mayur Patel for expert technical assistance, Samuel Pfaff and Dong Er Zhang for housing the Ssbp2<SUP>-/-</SUP> mice in the early stages of these investigations, Gigi Lozano, Richard Behringer, present and former members of the Nagarajan laboratory for helpful discussions, Kim-Anh Vu for assistance with the histology photographs. These studies were supported by HL744409 to LN. The genotyping, flow cytometry facilities and veterinary services were supported by NCI core Grant CA16672.	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Baseta JG, 2000, J IMMUNOL, V165, P5621, DOI 10.4049/jimmunol.165.10.5621; Cai Y, 2008, BIOCHEM BIOPH RES CO, V373, P303, DOI 10.1016/j.bbrc.2008.06.027; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Castro P, 2002, GENOMICS, V80, P78, DOI 10.1006/geno.2002.6805; Cerretini R, 2006, EUR J HAEMATOL, V76, P284, DOI 10.1111/j.1600-0609.2005.00616.x; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Fleisig HB, 2007, ONCOGENE, V26, P4797, DOI 10.1038/sj.onc.1210281; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Koch JG, 2007, MAMM GENOME, V18, P300, DOI 10.1007/s00335-007-9028-2; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Liu JW, 2008, CLIN CANCER RES, V14, P3754, DOI 10.1158/1078-0432.CCR-07-4763; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Natkunam Y, 2008, J CLIN ONCOL, V26, P447, DOI 10.1200/JCO.2007.13.0690; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Rothenberg EV, 2007, CURR OPIN HEMATOL, V14, P322, DOI 10.1097/MOH.0b013e3281de72a8; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Tremblay M, 2003, J BIOL CHEM, V278, P12680, DOI 10.1074/jbc.M209870200; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; van Meyel DJ, 2003, DEVELOPMENT, V130, P1915, DOI 10.1242/dev.00389; Wu HK, 1996, ONCOGENE, V12, P1205; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Zhang XB, 2008, J CLIN INVEST, V118, P1502, DOI 10.1172/JCI34371	38	22	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3044	3053		10.1038/onc.2010.78	http://dx.doi.org/10.1038/onc.2010.78			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20348955	Green Accepted			2022-12-25	WOS:000278133100002
J	Liu, RM; Choi, J; Wu, JH; Pravia, KAG; Lewis, KM; Brand, JD; Mochel, NSR; Krzywanski, DM; Lambeth, JD; Hagood, JS; Forman, HJ; Thannickal, VJ; Postlethwait, EM				Liu, Rui-Ming; Choi, Jinah; Wu, Jian-He; Pravia, Kimberly A. Gaston; Lewis, Karen M.; Brand, Jeffrey D.; Mochel, N. S. Reyes; Krzywanski, David M.; Lambeth, J. David; Hagood, James S.; Forman, Henry Jay; Thannickal, Victor J.; Postlethwait, Edward M.			Oxidative Modification of Nuclear Mitogen-activated Protein Kinase Phosphatase 1 Is Involved in Transforming Growth Factor beta 1-induced Expression of Plasminogen Activator Inhibitor 1 in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; NADPH OXIDASE; MAP KINASE; UP-REGULATION; NAD(P)H OXIDASE; CROSS-TALK; KAPPA-B; NOX4; P38; APOPTOSIS	Transforming growth factor beta(TGF-beta) stimulates reactive oxygen species (ROS) production in various cell types, which mediates many of the effects of TGF-beta. The molecular mechanisms whereby TGF-beta increases ROS production and ROS modulate the signaling processes of TGF-beta, however, remain poorly defined. In this study, we show that TGF-beta 1 stimulates NADPH oxidase 4 (Nox4) expression and ROS generation in the nucleus of murine embryo fibroblasts (NIH3T3 cells). This is associated with an increase in protein thiol modification and inactivation of MAPK phosphatase 1 (MKP-1), a nuclear phosphatase. Furthermore, knockdown of MKP-1 using small interfering RNA enhances TGF-beta 1-induced phosphorylation of JNK and p38 as well as the expression of plasminogen activator inhibitor 1 (PAI-1), a TGF-beta-responsive gene involved in the pathogenesis of many diseases. Knockdown of Nox4 with Nox4 small interfering RNA, on the other hand, reduces TGF-beta 1-stimulated ROS production, p38 phosphorylation, and PAI-1 expression. TGF-beta also increased the nuclear level of Nox4 protein as well as PAI-1 expression in human lung fibroblasts (CCL-210 cells), suggesting that TGF-beta may induce PAI-1 expression by a similar mechanism in human lung fibroblasts. In summary, in this study we have identified nuclear MAPK phosphatase MKP-1 as a novel molecular target of ROS in TGF-beta signaling pathways. Our data suggest that increased generation of ROS by Nox4 mediates TGF-beta 1-induced PAI-1 gene expression at least in part through oxidative modification and inhibition of MKP-1 leading to a sustained activation of JNK and p38 MAPKs.	[Liu, Rui-Ming; Wu, Jian-He; Pravia, Kimberly A. Gaston; Lewis, Karen M.; Brand, Jeffrey D.; Postlethwait, Edward M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Krzywanski, David M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Hagood, James S.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Choi, Jinah; Mochel, N. S. Reyes; Forman, Henry Jay] Univ Calif, Dept Nat Sci, Merced, CA 95343 USA; [Lambeth, J. David] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Merced; Emory University	Liu, RM (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA.	rliu@uab.edu		Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [ES011831, HL088141, HL54696, ES05511, HL067967, CA105116]; American Lung Association; University of California at Merced; NATIONAL CANCER INSTITUTE [R01CA105116, R56CA105116] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088141, R01HL054696, R01HL067967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES005511, R01ES005511, R01ES011831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; University of California at Merced(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES011831 and HL088141 (to R.-M. L.); HL54696 (to E. M. P.); ES05511 (to H. J. F.); HL067967 (to V. J. T.); and CA105116 (to J. D. L.). This work was also supported by funds from the American Lung Association (to R.-M. L.) and start-up funds from University of California at Merced (to J. C.).	Albright CD, 2003, J CELL BIOCHEM, V89, P254, DOI 10.1002/jcb.10498; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu RM, 2004, AM J PHYSIOL-LUNG C, V286, pL121, DOI 10.1152/ajplung.00231.2003; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Mishra OP, 2004, NEUROSCIENCE, V129, P665, DOI 10.1016/j.neuroscience.2004.09.005; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sturrock A, 2007, AM J PHYSIOL-LUNG C, V292, pL1543, DOI 10.1152/ajplung.00430.2006; THANNICKAL VJ, 1993, AM J PHYSIOL, V265, pL622, DOI 10.1152/ajplung.1993.265.6.L622; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vayalil PK, 2005, AM J PHYSIOL-LUNG C, V289, pL937, DOI 10.1152/ajplung.00150.2005; Vayalil PK, 2007, AM J PHYSIOL-LUNG C, V293, pL1281, DOI 10.1152/ajplung.00128.2007; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	44	92	93	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16239	16247		10.1074/jbc.M110.111732	http://dx.doi.org/10.1074/jbc.M110.111732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20228065	Green Published, hybrid			2022-12-25	WOS:000277715900060
J	Aziz, A; Hess, JF; Budamagunta, MS; Voss, JC; FitzGerald, PG				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; Voss, John C.; FitzGerald, Paul G.			Site-directed Spin Labeling and Electron Paramagnetic Resonance Determination of Vimentin Head Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; IN-VITRO; MOLECULAR ARCHITECTURE; CROSS-LINKING; KINASE-A; PHOSPHORYLATION; PROTEIN; DESMIN; IDENTIFICATION; SEQUENCE	Intermediate filament (IF) proteins have been predicted to have a conserved tripartite domain structure consisting of a largely alpha-helical central rod domain, flanked by head and tail domains. However, crystal structures have not been reported for any IF or IF protein. Although progress has been made in determining central rod domain structure, no structural data have been reported for either the head or tail domains. We used site-directed spin labeling and electron paramagnetic resonance to analyze 45 different spin labeled mutants spanning the head domain of vimentin. The data, combined with results from a previous study, provide strong evidence that the polypeptide backbones of the head domains form a symmetric dimer of closely apposed backbones that fold back onto the rod domain, imparting an asymmetry to the dimer. By following the behavior of spin labels during the process of in vitro assembly, we show that head domain structure is dynamic, changing as a result of filament assembly. Finally, because the vimentin head domain is the major site of the phosphorylation that induces disassembly at mitosis, we studied the effects of phosphorylation on head domain structure and demonstrate that phosphorylation drives specific head domain regions apart. These data provide the first evidence-based model of IF head domain structure.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	FitzGerald, PG (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Voss, John/0000-0001-9279-209X	National Institutes of Health [EY017575, P30 EY012576, AG029246]; National Institutes of Health National Center for Research Resources [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017575 (to P. G. F.) and P30 EY012576 and AG029246 (to J.C.V.). This work was also supported in part by Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Institutes of Health National Center for Research Resources.	ALBERS K, 1992, INT REV CYTOL, V134, P243, DOI 10.1016/S0074-7696(08)62030-6; ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; Aziz A, 2009, J BIOL CHEM, V284, P7330, DOI 10.1074/jbc.M809029200; Chomiki N, 2001, EUR J BIOCHEM, V268, P903, DOI 10.1046/j.1432-1327.2001.01946.x; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; DELACOURTE A, 1982, BIOCHIM BIOPHYS ACTA, V709, P99, DOI 10.1016/0167-4838(82)90426-5; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7; GEISLER N, 1989, EUR J BIOCHEM, V183, P441, DOI 10.1111/j.1432-1033.1989.tb14947.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Hess JF, 2005, J BIOL CHEM, V280, P2141, DOI 10.1074/jbc.M412254200; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; HOFMANN I, 1992, J CELL SCI, V101, P687; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PARRY D, 1985, CELLULAR MOL BIOL IN, P175; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; PARRY DAD, 1985, INT J BIOL MACROMOL, V7, P203, DOI 10.1016/0141-8130(85)90003-0; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Pittenger JT, 2008, BIOCHEMISTRY-US, V47, P10863, DOI 10.1021/bi801137m; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; RAATS JMH, 1990, J CELL BIOL, V111, P1971, DOI 10.1083/jcb.111.5.1971; RAATS JMH, 1992, PROG NUCLEIC ACID RE, V43, P67, DOI 10.1016/S0079-6603(08)61044-2; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Shoeman RL, 2002, EXP CELL RES, V279, P344, DOI 10.1006/excr.2002.5618; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; TRAUB P, 1993, J MOL BIOL, V230, P837, DOI 10.1006/jmbi.1993.1205; TRAUB P, 1984, J CELL SCI, V65, P1; TRAUB P, 1992, J CELL SCI, V101, P363; TRAUB P, 1983, J CELL SCI, V63, P43	52	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15278	15285		10.1074/jbc.M109.075598	http://dx.doi.org/10.1074/jbc.M109.075598			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231271	Green Published, hybrid			2022-12-25	WOS:000277399000048
J	Moullintraffort, L; Bruneaux, M; Nazabal, A; Allegro, D; Giudice, E; Zal, F; Peyrot, V; Barbier, P; Thomas, D; Garnier, C				Moullintraffort, Laura; Bruneaux, Matthieu; Nazabal, Alexis; Allegro, Diane; Giudice, Emmanuel; Zal, Franck; Peyrot, Vincent; Barbier, Pascale; Thomas, Daniel; Garnier, Cyrille			Biochemical and Biophysical Characterization of the Mg2+-induced 90-kDa Heat Shock Protein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; STRUCTURAL-ANALYSIS; SUBSTRATE-BINDING; ATP HYDROLYSIS; RECONSTRUCTION; DISTINCT; SYSTEMS; STATES	The 90-kDa heat shock protein (Hsp90) is involved in the regulation and activation of numerous client proteins essential for diverse functions such as cell growth and differentiation. Although the function of cytosolic Hsp90 is dependent on a battery of cochaperone proteins regulating both its ATPase activity and its interaction with client proteins, little is known about the real Hsp90 molecular mechanism. Besides its highly flexible dimeric state, Hsp90 is able to self-oligomerize in the presence of divalent cations or under heat shock. In addition to dimers, oligomers exhibit a chaperone activity. In this work, we focused on Mg2+-induced oligomers that we named Type I, Type II, and Type III in increasing molecular mass order. After stabilization of these quaternary structures, we optimized a purification protocol. Combining analytical ultracentrifugation, size exclusion chromatography coupled to multiangle laser light scattering, and high mass matrix-assisted laser desorption/ionization time of flight mass spectrometry, we determined biochemical and biophysical characteristics of each Hsp90 oligomer. We demonstrate that Type I oligomer is a tetramer, and Type II is an hexamer, whereas Type III is a dodecamer. These even-numbered structures demonstrate that the building brick for oligomerization is the dimer up to the Type II, whereas Type III probably results from the association of two Type II. Moreover, the Type II oligomer structure, studied by negative stain transmission electron microscopy tomography, exhibits a "nest-like" shape that forms a "cozy chaperoning chamber" where the client protein folding/protection could occur.	[Moullintraffort, Laura; Giudice, Emmanuel; Thomas, Daniel; Garnier, Cyrille] Univ Rennes 1, CNRS, UMR 6026, F-35042 Rennes, France; [Bruneaux, Matthieu; Zal, Franck] Univ Paris 06, Equipe Ecophysiol Invertebres Marins Milieux Extr, CNRS, UMR 7144,Stn Biol Roscoff, F-29682 Roscoff, France; [Nazabal, Alexis; Barbier, Pascale] INSERM, CRO2, UMR 911, CH-8952 Zurich, Switzerland; [Allegro, Diane; Peyrot, Vincent] Univ Mediterranee, Fac Pharm, INSERM, CRO2,UMR 911, F-13385 Marseille 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Garnier, C (corresponding author), Univ Rennes 1, CNRS, UMR 6026, Campus Beaulieu Batiment 13,263 Ave Gen Leclerc, F-35042 Rennes, France.	cyrille.garnier@univ-rennes1.fr	peyrot, vincent/B-6365-2015; THOMAS, Danniel/AAJ-5033-2020; Giudice, Emmanuel/AFT-2595-2022; Barbier, Pascale/AAE-1781-2019	THOMAS, Danniel/0000-0002-9650-0434; Bruneaux, Matthieu/0000-0001-6997-192X; GARNIER, Cyrille/0000-0002-5715-8218; Le Breton, Laura/0000-0002-5599-3244; GIUDICE, Emmanuel/0000-0001-7209-7890	Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest; Region Bretagne Ph. D. grant	Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest; Region Bretagne Ph. D. grant	This work was supported by a grant from the Ligue contre le Cancer Conseil Scientifique Interregional Grand-Ouest (to C. G.) and a Region Bretagne Ph. D. grant (to L. M.) and research grant (to D. T.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aherne Wynne, 2003, Methods Mol Med, V85, P149; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Bruneaux M, 2008, CURR PROTEIN PEPT SC, V9, P150, DOI 10.2174/138920308783955270; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Garnier C, 2001, EUR J BIOCHEM, V268, P2402, DOI 10.1046/j.1432-1327.2001.02121.x; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; HICKEY E, 1986, GENE, V43, P147, DOI 10.1016/0378-1119(86)90018-1; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Laue T.M., 1992, COMPUTER AIDED INTER; Le Bras G, 2007, J MED CHEM, V50, P6189, DOI 10.1021/jm0707774; LEMAIRE M, 1980, ANAL BIOCHEM, V106, P12, DOI 10.1016/0003-2697(80)90112-8; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; MINTON AP, 1994, MODERN ANAL ULTRACEN; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; RADANYI C, 1989, J BIOL CHEM, V264, P2568; Radanyi C, 2009, CANCER LETT, V274, P88, DOI 10.1016/j.canlet.2008.09.001; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; Zhao C, 2004, CELL SIGNAL, V16, P313, DOI 10.1016/j.cellsig.2003.08.005	45	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15100	15110		10.1074/jbc.M109.094698	http://dx.doi.org/10.1074/jbc.M109.094698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228408	Green Published, hybrid			2022-12-25	WOS:000277399000031
J	Shor, B; Wu, J; Shakey, Q; Toral-Barza, L; Shi, C; Follettie, M; Yu, K				Shor, Boris; Wu, Jiang; Shakey, Quazi; Toral-Barza, Lourdes; Shi, Celine; Follettie, Max; Yu, Ker			Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; NUCLEAR-LOCALIZATION; SIGNALING PATHWAYS; RAPAMYCIN; PROTEIN; REPRESSION; ACTIVATION; MECHANISMS; INHIBITORS; REVEALS	The mammalian target of rapamycin (mTOR) regulates growth via promoting translation and transcription. Here, employing an mTOR active-site inhibitor WYE-125132 (WYE-132), we have performed quantitative phospho-proteomics and identified a Ser-75-containing phosphopeptide from Maf1, a known repressor of RNA polymerase III (Pol III) transcription. Treatment of cancer cells with WYE-132 or the rapamycin analog CCI-779 led to a rapid loss of the phosphorylation at Ser-75, whereas this effect was not seen in cells treated with cytotoxic agents or unrelated inhibitors. WYE-132-induced Maf1 dephosphorylation correlated with its accumulation in the nucleus and a marked decline in the cellular levels of pre-tRNAs. Depletion of cellular Maf1 via small interfering RNA increased basal pre-tRNA and rendered tRNA synthesis refractory to mTOR inhibitors. Maf1 mutant proteins carrying S75A alone or with S60A, T64A, and S68A (Maf1-S75A, Maf1-4A) progressively enhanced basal repression of tRNA in actively proliferating cells and attenuated amino acid-induced tRNA transcription. Gene alignment revealed conservation of all four Ser/Thr sites in high eukaryotes, further supporting a critical role of these residues in Maf1 function. Interestingly, mTOR inhibition led to an increase in the occupancy of Maf1 on a set of Pol III-dependent genes, with concomitant reduction in the binding of Pol III and Brf1. Unexpectedly, mTORC1 itself was also enriched at the same set of Pol III templates, but this association was not influenced by mTOR inhibitor treatment. Our results highlight a new and unique mode of regulation of Pol III transcription by mTOR and suggest that normalization of Pol III activity may contribute to the therapeutic efficacy of mTOR inhibitors.	[Shor, Boris; Toral-Barza, Lourdes; Shi, Celine; Yu, Ker] Wyeth Res, Discovery Oncol, Pearl River, NY 10965 USA; [Wu, Jiang; Shakey, Quazi; Follettie, Max] Wyeth Res, Biol Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Shor, B (corresponding author), Wyeth Res, Discovery Oncol, 401 N Middletown Rd, Pearl River, NY 10965 USA.	shorb@wyeth.com; yuker2b@gmail.com						Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Clarke EM, 1996, J BIOL CHEM, V271, P22189, DOI 10.1074/jbc.271.36.22189; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIG JR, 1977, MOL GEN GENET, V158, P117; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; Saxena A, 2005, MOL CELL BIOL, V25, P9406, DOI 10.1128/MCB.25.21.9406-9418.2005; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179; WHITE RJ, 1990, EMBO J, V9, P3713, DOI 10.1002/j.1460-2075.1990.tb07584.x; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m; YU K, 2010, J CANC RES, V70, P621; Yu K, 2008, CANCER BIOL THER, V7, P307; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; Zask A, 2008, J MED CHEM, V51, P1319, DOI 10.1021/jm7012858; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	50	126	129	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15380	15392		10.1074/jbc.M109.071639	http://dx.doi.org/10.1074/jbc.M109.071639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20233713	Green Published, hybrid			2022-12-25	WOS:000277399000058
J	Ziegeler, G; Ming, J; Koseki, JC; Sevinc, S; Chen, T; Ergun, S; Qin, XB; Aktas, BH				Ziegeler, Gudrun; Ming, Jie; Koseki, Jana C.; Sevinc, Sema; Chen, Ting; Ergun, Suleyman; Qin, Xuebin; Aktas, Bertal H.			Embryonic Lethal Abnormal Vision-like HuR-dependent mRNA Stability Regulates Post-transcriptional Expression of Cyclin-dependent Kinase Inhibitor p27Kip1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; GROWTH-FACTOR; ELAV PROTEIN; RICH ELEMENT; S-PHASE; P27(KIP1); P27; TRANSLATION; CARCINOMAS	The cyclin-dependent kinase inhibitor p27(Kip1) plays a critical role in regulating entry into and exit from the cell cycle. Posttranscriptional regulation of p27(Kip1) expression is of significant interest. The embryonic lethal abnormal vision (ELAV)-like RNA-binding protein HuR is thought be important for the translation of p27(Kip1), however, different reports attributed diametrically opposite roles to HuR. We report here an alternative mechanism wherein HuR regulates stability of the p27(Kip1) mRNA. Specifically, human and mouse p27(Kip1) mRNAs interact with HuR protein through multiple U-rich elements in both 5' and 3' untranslated regions (UTR). These interactions, which occur in vitro and in vivo, stabilize p27(Kip1) mRNA and play a critical role in its accumulation. Deleting HuR binding sites or knocking down HuR expression destabilizes p27(Kip1) mRNA and reduces its accumulation. We also identified a CT repeat in the 5' UTR of full-length p27(Kip1) mRNA isoforms that interact with a similar to 41-kDa protein and represses p27(Kip1) expression. This CT-rich element and diffuse elements in the 3' UTR regulate post-transcriptional expression of p27(Kip1) at the level of translation. This is the first demonstration that HuR-dependent mRNA stability and HuR-independent mRNA translation plays a critical role in the regulation of post-transcriptional p27(Kip1) expression.	[Ziegeler, Gudrun; Ming, Jie; Koseki, Jana C.; Sevinc, Sema; Chen, Ting; Ergun, Suleyman; Qin, Xuebin; Aktas, Bertal H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ming, Jie] Tongji Med Sch HUST, Union Hosp, Breast & Thyroid Res Ctr, Wuhan 430022, Peoples R China; [Qin, Xuebin; Aktas, Bertal H.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital	Aktas, BH (corresponding author), Lab Translat Res, 1 Kendall Sq,Bldg 600,3rd Floor, Cambridge, MA 02139 USA.	huseyin_Aktas@hms.harvard.edu	Chen, Ting/A-2124-2012	Chen, Ting/0000-0003-1725-7956				Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Atasoy U, 1998, J CELL SCI, V111, P3145; Ayrault O, 2009, MOL CANCER RES, V7, P33, DOI 10.1158/1541-7786.MCR-08-0369; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Elledge SJ, 1996, TRENDS CELL BIOL, V6, P388, DOI 10.1016/0962-8924(96)10030-1; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRANA X, 1995, ONCOGENE, V11, P211; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; LEE WH, 1995, ANN NY ACAD SCI, V752, P432, DOI 10.1111/j.1749-6632.1995.tb17453.x; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Rodolico V, 2005, ORAL ONCOL, V41, P268, DOI 10.1016/j.oraloncology.2004.08.014; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sgambato A, 2000, CANCER-AM CANCER SOC, V89, P2247, DOI 10.1002/1097-0142(20001201)89:11<2247::AID-CNCR13>3.0.CO;2-5; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Tan P, 1997, CANCER RES, V57, P1259; Woenckhaus C, 2005, HISTOL HISTOPATHOL, V20, P501, DOI 10.14670/HH-20.501; Zafon C, 2008, ENDOCR PATHOL, V19, P184, DOI 10.1007/s12022-008-9037-z; Zhao ZQ, 2000, NUCLEIC ACIDS RES, V28, P2695, DOI 10.1093/nar/28.14.2695	35	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15408	15419		10.1074/jbc.M110.113365	http://dx.doi.org/10.1074/jbc.M110.113365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20332085	Green Published, hybrid			2022-12-25	WOS:000277399000061
J	Alger, HM; Brown, JM; Sawyer, JK; Kelley, KL; Shah, R; Wilson, MD; Willingham, MC; Rudel, LL				Alger, Heather M.; Brown, J. Mark; Sawyer, Janet K.; Kelley, Kathryn L.; Shah, Ramesh; Wilson, Martha D.; Willingham, Mark C.; Rudel, Lawrence L.			Inhibition of Acyl-Coenzyme A: Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; LOW-DENSITY-LIPOPROTEIN; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; TRIACYLGLYCEROL-HYDROLASE; ATHEROSCLEROSIS; MICE; ESTER; POPULATION; ABSORPTION	Acyl-CoA: cholesterol O-acyl transferase 2 (ACAT2) promotes cholesterol absorption by the intestine and the secretion of cholesteryl ester-enriched very low density lipoproteins by the liver. Paradoxically, mice lacking ACAT2 also exhibit mild hypertriglyceridemia. The present study addresses the unexpected role of ACAT2 in regulation of hepatic triglyceride (TG) metabolism. Mouse models of either complete genetic deficiency or pharmacological inhibition of ACAT2 were fed low fat diets containing various amounts of cholesterol to induce hepatic steatosis. Mice genetically lacking ACAT2 in both the intestine and the liver were dramatically protected against hepatic neutral lipid ( TG and cholesteryl ester) accumulation, with the greatest differences occurring in situations where dietary cholesterol was elevated. Further studies demonstrated that liver-specific depletion of ACAT2 with antisense oligonucleotides prevents dietary cholesterol-associated hepatic steatosis both in an inbred mouse model of non-alcoholic fatty liver disease (SJL/J) and in a humanized hyperlipidemic mouse model (LDLr-/-, apoB(100/100)). All mouse models of diminished ACAT2 function showed lowered hepatic triglyceride concentrations and higher plasma triglycerides secondary to increased hepatic secretion of TG into nascent very low density lipoproteins. This work demonstrates that inhibition of hepatic ACAT2 can prevent dietary cholesterol-driven hepatic steatosis in mice. These data provide the first evidence to suggest that ACAT2-specific inhibitors may hold unexpected therapeutic potential to treat both atherosclerosis and non-alcoholic fatty liver disease.	[Alger, Heather M.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Brown, J. Mark; Sawyer, Janet K.; Kelley, Kathryn L.; Shah, Ramesh; Wilson, Martha D.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Willingham, Mark C.] Wake Forest Univ, Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Rudel, LL (corresponding author), Wake Forest Univ, Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lrudel@wfubmc.edu	Alger, Heather/AAK-1019-2020	Alger, Heather/0000-0003-1795-9675	National Institutes of Health [HL-49373]; Amgen; Glaxo-Smith Kline; National Institutes of Health NHLBI Pathway to Independence [1K99-HL096166]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL096166, K99HL096166, P01HL049373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); Glaxo-Smith Kline(GlaxoSmithKline); National Institutes of Health NHLBI Pathway to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-49373 (to L. L. R.). L. L. R. has ongoing collaborations with Amgen and Glaxo-Smith Kline. He participates in a speaker's bureau for Merck-Schering Plough.; Supported by National Institutes of Health NHLBI Pathway to Independence Grant 1K99-HL096166.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alam M, 2006, J LIPID RES, V47, P375, DOI 10.1194/jlr.M500344-JLR200; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; DAVIS RA, 1982, J BIOL CHEM, V257, P2634; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; DEMEL RA, 1985, J BIOL CHEM, V260, P9589; Dolinsky VW, 2004, CELL MOL LIFE SCI, V61, P1633, DOI 10.1007/s00018-004-3426-3; Fan JG, 2008, J DIGEST DIS, V9, P63, DOI 10.1111/j.1751-2980.2008.00323.x; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; NISHINA PM, 1993, LIPIDS, V28, P599, DOI 10.1007/BF02536053; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; VANHARKEN DR, 1969, J BIOL CHEM, V244, P2278; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; WILSON MD, 1994, J LIPID RES, V35, P943	32	59	61	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14267	14274		10.1074/jbc.M110.118422	http://dx.doi.org/10.1074/jbc.M110.118422			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231283	Green Published, hybrid			2022-12-25	WOS:000277299700023
J	Billard, JM				Billard, Jean-marie			Long-Term Depression in the Hippocampal CA1 Area of Aged Rats, Revisited: Contribution of Temporal Constraints Related to Slice Preparation	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; NEUROMODULATOR D-SERINE; SYNAPTIC PLASTICITY; IN-VIVO; INCREASED SUSCEPTIBILITY; CA2+ HOMEOSTASIS; MEMORY; POTENTIATION; INDUCTION; LTD	Background: The effects of low-frequency conditioning stimulation (LFS, 900 pulses at 1 Hz) of glutamatergic afferents in CA1 hippocampal area using slices from two different strains of adult (3-5 month-old) and aged (23-27 month-old) rats were reinvestigated regarding the discrepancies in the literature concerning the expression of long-term depression (LTD) in the aging brain. Methodology/Principal Findings: N-methyl-D-aspartate receptor (NMDA-R) dependent LTD was examined in both adult (n = 21) and aged (n = 22) Sprague-Dawley rats. While equivalent amounts of LTD could be obtained in both ages, there was significant variability depending upon the time between the slices were made and when they were tested. LTD was not apparent if slices were tested within 3 hours of dissection. The amount of LTD increased over the next three hours but more in adult than in aged rats. This age-related impairment was abolished by exogenous D-serine, thus reflecting the reduced activation of the NMDA-R glycine-binding site by the endogenous agonist in aged rats. Then, the amount of LTD reached asymptote at 5-7 hours following dissection. Similar temporal profiles of LTD expression were seen in young and aged Wistar rats. Conclusions/Significance: Taken together, these results sound a cautionary note regarding the existence of an experimental "window of opportunity'' for studying the effects of aging on LTD expression in hippocampal slice preparation.	Univ Paris 05, Fac Med Rene Descartes, Ctr Psychiat & Neurosci, UMR894, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Billard, JM (corresponding author), Univ Paris 05, Fac Med Rene Descartes, Ctr Psychiat & Neurosci, UMR894, Paris, France.	jean-marie.billard@inserm.fr	Billard, Jean-Marie/ABD-4987-2020		Institut National de la Sante et de la Recherche Scientifique (INSERM)	Institut National de la Sante et de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Institut National de la Sante et de la Recherche Scientifique (INSERM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billard JM, 2006, MAGNESIUM RES, V19, P199; Billard JM, 2007, EUR J NEUROSCI, V25, P2260, DOI 10.1111/j.1460-9568.2007.05488.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; BURKE JP, 1994, J NEUROSCI, V14, P5120; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Doyle CA, 1997, NEUROSCIENCE, V77, P75, DOI 10.1016/S0306-4522(96)00427-7; Eichenbaum H, 1996, LEARN MEMORY, V3, P61, DOI 10.1101/lm.3.2-3.61; ERRINGTON ML, 1995, J NEUROPHYSIOL, V74, P1793, DOI 10.1152/jn.1995.74.4.1793; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Foster TC, 1998, TRENDS NEUROSCI, V21, P286, DOI 10.1016/S0166-2236(98)01259-4; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Hansel C, 1996, J PHYSIOLOGY-PARIS, V90, P317, DOI 10.1016/S0928-4257(97)87906-5; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Hsu KS, 2002, HIPPOCAMPUS, V12, P787, DOI 10.1002/hipo.10032; Junjaud G, 2006, J NEUROCHEM, V98, P1159, DOI 10.1111/j.1471-4159.2006.03944.x; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Kumar A, 2005, BRAIN RES, V1031, P125, DOI 10.1016/j.brainres.2004.10.023; Kumar A, 2007, J NEUROPHYSIOL, V98, P594, DOI 10.1152/jn.00249.2007; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Manahan-Vaughan D, 2000, CEREB CORTEX, V10, P482, DOI 10.1093/cercor/10.5.482; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 1996, J NEUROSCI, V16, P5382; Roman FS, 1999, PROG NEUROBIOL, V58, P61, DOI 10.1016/S0301-0082(98)00076-8; Schuchmann S, 2000, J NEUROPHYSIOL, V83, P1710, DOI 10.1152/jn.2000.83.3.1710; Taubenfeld SM, 2002, J NEUROCHEM, V81, P1348, DOI 10.1046/j.1471-4159.2002.00936.x; Thiels E, 1996, HIPPOCAMPUS, V6, P43, DOI 10.1002/(SICI)1098-1063(1996)6:1<43::AID-HIPO8>3.0.CO;2-8; Toescu EC, 2004, J CELL MOL MED, V8, P181, DOI 10.1111/j.1582-4934.2004.tb00273.x; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; van Dam EJM, 2004, EUR J NEUROSCI, V19, P112, DOI 10.1111/j.1460-9568.2004.03103.x; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; Xiong H, 2004, NEUROBIOL AGING, V25, P349, DOI 10.1016/S0197-4580(03)00123-4; Xiong J, 2002, J NEUROSCI, V22, P10761; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9843	10.1371/journal.pone.0009843	http://dx.doi.org/10.1371/journal.pone.0009843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352095	Green Published, gold			2022-12-25	WOS:000275894500012
J	Li, S; Rao, LL; Bai, XW; Zheng, R; Ren, XP; Li, JZ; Wang, ZJ; Liu, H; Zhang, K				Li, Shu; Rao, Li-Lin; Bai, Xin-Wen; Zheng, Rui; Ren, Xiao-Peng; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan; Zhang, Kan			Progression of the "Psychological Typhoon Eye" and Variations Since the Wenchuan Earthquake	PLOS ONE			English	Article								Background: In 2008 after a massive earthquake jolted Wenchuan, China, we reported an effect that we termed a "Psychological Typhoon Eye'': the closer to the center of the devastated area, the lower the level of concern felt by residents about safety and health. We now report on the progression of this effect and the development of new variations after the quake as well as investigating potential explanations. Methodology/Principal Findings: We conducted two sequential surveys of 5,216 residents in non-devastated and devastated areas in September-October 2008 and April-May 2009. Respondents were asked five questions to assess their concerns about safety and health. A MANCOVA showed a significant inverse effect of residential devastation level on the estimated number of medical and psychological workers needed, the estimated probability of an epidemic outbreak, and the estimated number of self-protective behaviors needed (Ps < 0.001), in spite of the passage of one year. The level of post-earthquake concern decreased significantly with an increase in the residential devastation level. Additionally, we observed two variations in the "Psychological Typhoon Eye'' effect, in that the respondents' concern decreased with increasing relational distance between a respondent and victims who had suffered either physical or economic damage. Conclusions/Significance: The previously reported effect of a "Psychological Typhoon Eye'' remains robust over a 1-year period. We found that the "psychological immunization'' theory did not provide a satisfactory explanation for these intriguing results. Our findings may be useful in understanding how people become resilient to threats.	[Li, Shu; Rao, Li-Lin; Bai, Xin-Wen; Zheng, Rui; Ren, Xiao-Peng; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Rao, Li-Lin; Li, Jin-Zhen; Wang, Zuo-Jun; Liu, Huan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, S (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	lishu@psych.ac.cn; zhangk@psych.ac.cn	Xinwen, Bai/A-3827-2014	Xinwen, Bai/0000-0002-4750-4164; li, shu/0000-0003-4402-1674	Chinese Academy of Sciences [KSCX2-YW-R-130, KKCX1-YW-05]; National Natural Science Foundation of China [70871110]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-130; KKCX1-YW-05) and the National Natural Science Foundation of China (No. 70871110). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAPLOW T, 1982, AM SOCIOL REV, V47, P383, DOI 10.2307/2094994; Festinger L., 1957, THEORY COGNITIVE DIS, V2; HENDERSON AS, 1972, LANCET, V1, P1111; Li S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004964; SILVERMAN RA, 1987, J CRIM LAW CRIM, V78, P272, DOI 10.2307/1143450; *XINH NEWS AG, 2009, CHIN AL PREV SWIN FL; *XINH NEWS AG, 2009, DEATH TOLL CHIN MAY; *XINH NEWS AG, 2009, CHIN REP SUSP CAS A; 2009, NATURE, V459, P139	9	22	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9727	10.1371/journal.pone.0009727	http://dx.doi.org/10.1371/journal.pone.0009727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EG	20305817	gold, Green Submitted, Green Published			2022-12-25	WOS:000275809600003
J	Boscolo, S; Lorenzon, A; Sblattero, D; Florian, F; Stebel, M; Marzari, R; Not, T; Aeschlimann, D; Ventura, A; Hadjivassiliou, M; Tongiorgi, E				Boscolo, Sabrina; Lorenzon, Andrea; Sblattero, Daniele; Florian, Fiorella; Stebel, Marco; Marzari, Roberto; Not, Tarcisio; Aeschlimann, Daniel; Ventura, Alessandro; Hadjivassiliou, Marios; Tongiorgi, Enrico			Anti Transglutaminase Antibodies Cause Ataxia in Mice	PLOS ONE			English	Article							TISSUE-TYPE TRANSGLUTAMINASE; CELIAC-DISEASE; GLUTEN ATAXIA; CEREBELLAR-ATAXIA; INTRAVENOUS IMMUNOGLOBULIN; HUMAN BRAIN; IN-VIVO; AUTOANTIBODIES; IDENTIFICATION; CONSTRUCTION	Background: Celiac disease (CD) is an autoimmune gastrointestinal disorder characterized by the presence of anti-transglutaminase 2 (TG2) and anti-gliadin antibodies. Amongst the neurological dysfunctions associated with CD, ataxia represents the most common one. Methods: We analyzed by immunohistochemistry, the anti-neural reactivity of the serum from 20 CD patients. To determine the role of anti-TG2 antibodies in ataxia, two anti-TG2 single chain variable fragments (scFv), isolated from a phage-display IgA antibody library, were characterized by immunohistochemistry and ELISA, and injected in mice to study their effects on motor coordination. We found that 75% of the CD patient population without evidence of neurological involvement, has circulating anti-neural IgA and/or IgG antibodies. Two anti-TG2 scFvs, cloned from one CD patient, stained blood vessels but only one reacted with neurons. This anti-TG2 antibody showed cross reactivity with the transglutaminase isozymes TG3 and TG6. Intraventricular injection of the anti-TG2 or the anti-TG2/3/6 cross-reactive scFv provoked transient, equally intensive ataxia in mice. Conclusion: The serum from CD patients contains anti-TG2, TG3 and TG6 antibodies that may potentially cause ataxia.	[Boscolo, Sabrina; Tongiorgi, Enrico] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Lorenzon, Andrea; Stebel, Marco] Univ Trieste, CSPA, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Not, Tarcisio; Ventura, Alessandro] Univ Trieste, Inst Childhood Dis, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, Trieste, Italy; [Aeschlimann, Daniel] Cardiff Univ, Sch Dent, Matrix Biol & Tissue Repair Res Unit, Cardiff, S Glam, Wales; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Clin Neurol, Sheffield S10 2JF, S Yorkshire, England	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; IRCCS Burlo Garofolo; University of Trieste; Cardiff University; University of Sheffield	Boscolo, S (corresponding author), Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy.	sboscolo@units.it	ghebretinsae, selamawit/B-1448-2012; Not, Tarcisio/K-2616-2018	Not, Tarcisio/0000-0003-1059-3009; Lorenzon, Andrea/0000-0002-5766-9034; Ventura, Alessandro/0000-0002-4657-1760; Aeschlimann, Daniel/0000-0003-0930-7706; Sblattero, Daniele/0000-0003-4309-242X; Tongiorgi, Enrico/0000-0003-0485-0603	Telethon Foundation [E. 1270, E. 1141]; Fondazione Cassa di Risparmio di Trieste; National Ataxia Foundation; Bardhan Research and Education Trust of Rotherham; Ryder Briggs Trust	Telethon Foundation(Fondazione Telethon); Fondazione Cassa di Risparmio di Trieste; National Ataxia Foundation; Bardhan Research and Education Trust of Rotherham; Ryder Briggs Trust	This study was supported by Telethon Foundation (http://www.telethon.it/Pagine/homepage.aspx) grants E. 1270 to A. V. and E. T. and E. 1141 to D. S., Fondazione Cassa di Risparmio di Trieste to E. T., R. M. and A. V., National Ataxia Foundation (http://www.ataxia.org/) award to E. T., and grants from the Bardhan Research and Education Trust of Rotherham and the Ryder Briggs Trust to D. A., N. W. and M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CDC, 2004, MOL CELL NEUROSCI, V25, P493, DOI 10.1016/j.mcn.2003.11.016; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Baumgartner W, 2007, J VASC RES, V44, P234, DOI 10.1159/000100422; Boscolo S, 2006, J IMMUNOL METHODS, V309, P139, DOI 10.1016/j.jim.2005.11.020; Boscolo S, 2007, ANN NY ACAD SCI, V1107, P319, DOI 10.1196/annals.1381.034; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Cannistraci C, 2007, J EUR ACAD DERMATOL, V21, P509, DOI 10.1111/j.1468-3083.2006.02017.x; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Festoff BW, 2002, J NEUROCHEM, V81, P708, DOI 10.1046/j.1471-4159.2002.00850.x; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Hadjivassiliou M, 2006, NEUROLOGY, V66, P373, DOI 10.1212/01.wnl.0000196480.55601.3a; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hadjivassiliou M, 2002, NEUROLOGY, V58, P1221, DOI 10.1212/WNL.58.8.1221; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Luostarinen L, 2001, EUR NEUROL, V46, P187, DOI 10.1159/000050802; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Nanri K, 2009, INTERNAL MED, V48, P783, DOI 10.2169/internalmedicine.48.1802; OHASHI H, 1995, J BIOCHEM-TOKYO, V118, P1271, DOI 10.1093/oxfordjournals.jbchem.a125018; Picarelli A, 1996, LANCET, V348, P1065, DOI 10.1016/S0140-6736(96)03060-7; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Pratesi R, 1998, SCAND J GASTROENTERO, V33, P817; Sander HW, 2003, LANCET, V362, P1548, DOI 10.1016/S0140-6736(03)14743-5; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Sblattero D, 2004, J AUTOIMMUN, V22, P65, DOI 10.1016/j.jaut.2003.09.004; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Sblattero Daniele, 2000, Human Antibodies, V9, P199; Schrodl D, 2004, J AUTOIMMUN, V22, P335, DOI 10.1016/j.jaut.2004.02.001; Souayah N, 2008, EUR J NEUROL, V15, P1300, DOI 10.1111/j.1468-1331.2008.02305.x; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603	41	65	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9698	10.1371/journal.pone.0009698	http://dx.doi.org/10.1371/journal.pone.0009698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300628	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000275621000015
J	Zhou, Q; Gheiratmand, L; Chen, YX; Lim, TK; Zhang, J; Li, SW; Xia, NS; Liu, BH; Lin, QS; He, CY				Zhou, Qing; Gheiratmand, Ladan; Chen, Yixin; Lim, Teck Kwang; Zhang, Jun; Li, Shaowei; Xia, Ningshao; Liu, Binghai; Lin, Qingsong; He, Cynthia Y.			A Comparative Proteomic Analysis Reveals a New Bi-Lobe Protein Required for Bi-Lobe Duplication and Cell Division in Trypanosoma brucei	PLOS ONE			English	Article							FLAGELLUM ATTACHMENT; AFRICAN TRYPANOSOMES; GOLGI DUPLICATION; CYTOKINESIS; SEGREGATION; MEMBRANE; CYTOSKELETAL; EXPRESSION; DYNAMICS; CENTRIN	A Golgi-associated bi-lobed structure was previously found to be important for Golgi duplication and cell division in Trypanosoma brucei. To further understand its functions, comparative proteomics was performed on extracted flagellar complexes (including the flagellum and flagellum-associated structures such as the basal bodies and the bi-lobe) and purified flagella to identify new bi-lobe proteins. A leucine-rich repeats containing protein, TbLRRP1, was characterized as a new bi-lobe component. The anterior part of the TbLRRP1-labeled bi-lobe is adjacent to the single Golgi apparatus, and the posterior side is tightly associated with the flagellar pocket collar marked by TbBILBO1. Inducible depletion of TbLRRP1 by RNA interference inhibited duplication of the bi-lobe as well as the adjacent Golgi apparatus and flagellar pocket collar. Formation of a new flagellum attachment zone and subsequent cell division were also inhibited, suggesting a central role of bi-lobe in Golgi, flagellar pocket collar and flagellum attachment zone biogenesis.	[Zhou, Qing; Gheiratmand, Ladan; Lim, Teck Kwang; Liu, Binghai; Lin, Qingsong; He, Cynthia Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chen, Yixin; Zhang, Jun; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China	National University of Singapore; Xiamen University	Zhou, Q (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyc@nus.edu.sg	Lin, Qingsong/H-9794-2012; Xia, NS/G-4647-2010; Chen, YX/G-3937-2010; Zhang, Jun/G-4598-2010; Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019; He, Cynthia/H-9789-2012	Lin, Qingsong/0000-0001-9117-8514; Zhang, Jun/0000-0002-6601-9180; Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Xia, Ningshao/0000-0003-0179-5266	Singapore Biomedical Research Council [07/1/21/19/515]; Singapore National Research Foundation	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore)	This study is supported by Singapore Biomedical Research Council (grant number: 07/1/21/19/515). CYH is a research fellow of the Singapore National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bastin P, 1999, J CELL SCI, V112, P3769; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Fevre EM, 2006, ADV PARASIT, V61, P167, DOI 10.1016/S0065-308X(05)61005-6; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; ISMACH R, 1989, J PROTOZOOL, V36, P617, DOI 10.1111/j.1550-7408.1989.tb01105.x; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MCKEITHAN TW, 1981, J CELL BIOL, V91, P352, DOI 10.1083/jcb.91.2.352; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; RUBEN L, 1983, BIOCHIM BIOPHYS ACTA, V758, P104, DOI 10.1016/0304-4165(83)90290-8; Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; SILVA NLD, 1989, MOL BIOCHEM PARASIT, V37, P129, DOI 10.1016/0166-6851(89)90109-6; Tan HT, 2008, MOL CELL PROTEOMICS, V7, P1174, DOI 10.1074/mcp.M700483-MCP200; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yelinek JT, 2009, TRAFFIC, V10, P300, DOI 10.1111/j.1600-0854.2008.00873.x	37	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9660	10.1371/journal.pone.0009660	http://dx.doi.org/10.1371/journal.pone.0009660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300570	gold, Green Published, Green Submitted			2022-12-25	WOS:000275621000003
J	Chatagnon, A; Ballestar, E; Esteller, M; Dante, R				Chatagnon, Amandine; Ballestar, Esteban; Esteller, Manel; Dante, Robert			A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2/TFF1 Gene	PLOS ONE			English	Article							CANCER-CELL-LINES; DNA METHYLATION; BREAST-CANCER; PS2 GENE; CHROMATIN-STRUCTURE; EPIGENETIC REGULATION; ACTIVE CHROMATIN; PROMOTER DNA; EXPRESSION; TRANSCRIPTION	Background: In human Estrogen Receptor alpha (ER alpha)-positive breast cancers, 59 end dense methylation of the estrogen-regulated pS2/TFF1 gene correlates with its transcriptional inhibition. However, in some ER alpha-rich biopsies, pS2 expression is observed despite the methylation of its TATA-box region. Herein, we investigated the methylation-dependent mechanism of pS2 regulation. Methodology/Principal Findings: We observed interplay between Methyl-CpG Binding Domain protein 2 (MBD2) transcriptional repressor and ER alpha transactivator: (i) the pS2 gene is poised for transcription upon demethylation limited to the enhancer region containing the estrogen responsive element (ERE); (ii) MBD2-binding sites overlapped with the methylation status of the pS2 59 end; (iii) MBD2 depletion elevated pS2 expression and ectopic expression of ER alpha partially overcame the inhibitory effect of MBD2 when the ERE is unmethylated. Furthermore, serial chromatin immunoprecipitation assays indicated that MBD2 and ER alpha could simultaneously occupy the same pS2 DNA molecule; (iv) concomitant ectopic ER alpha expression and MBD2 depletion resulted in synergistic transcriptional stimulation, while the pS2 promoter remains methylated. Conclusions/Significance: MBD2 and ER alpha drive opposite effects on pS2 expression, which are associated with specific steady state levels of histone H3 acetylation and methylation marks. Thus, epigenetic silencing of pS2 could be dependent on balance of the relative intracellular concentrations of ER alpha and MBD2.	[Chatagnon, Amandine; Dante, Robert] INSERM, U590, F-69008 Lyon, France; [Ballestar, Esteban; Esteller, Manel] ICO IDIBELL, PEBC, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Chatagnon, A (corresponding author), INSERM, U590, F-69008 Lyon, France.	dante@univ-lyon1.f	Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440	Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire); Institut National contre le Cancer (EpiPro and CircBio)	Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire); Institut National contre le Cancer (EpiPro and CircBio)	The present work was supported by the Ligue Nationale contre le Cancer (Comite du Rhene and Comite de la Loire), the Institut National contre le Cancer (EpiPro and CircBio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; Auriol E, 2005, NUCLEIC ACIDS RES, V33, P4243, DOI 10.1093/nar/gki729; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HUANG LH, 1984, NATURE, V308, P293, DOI 10.1038/308293a0; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Martin V, 1998, BIOL CHEM, V379, P409, DOI 10.1515/bchm.1998.379.4-5.409; Martin V, 1997, J CELL BIOCHEM, V65, P95, DOI 10.1002/(SICI)1097-4644(199704)65:1<95::AID-JCB10>3.0.CO;2-G; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; METZGER D, 1995, MOL ENDOCRINOL, V9, P579, DOI 10.1210/me.9.5.579; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9665	10.1371/journal.pone.0009665	http://dx.doi.org/10.1371/journal.pone.0009665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300195	Green Published, Green Submitted, gold			2022-12-25	WOS:000275620900005
J	Conte, D; MacWilliams, HK; Ceccarelli, A				Conte, Daniele; MacWilliams, Harry K.; Ceccarelli, Adriano			BTG Interacts with Retinoblastoma to Control Cell Fate in Dictyostelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PC3/BTG/TOB FAMILY; GENE-EXPRESSION; DIFFERENTIATION; DISCOIDEUM; GROWTH; VECTORS; PROTEIN; MEMBER; CAMP	Background: In the genesis of many tissues, a phase of cell proliferation is followed by cell cycle exit and terminal differentiation. The latter two processes overlap: genes involved in the cessation of growth may also be important in triggering differentiation. Though conceptually distinct, they are often causally related and functional interactions between the cell cycle machinery and cell fate control networks are fundamental to coordinate growth and differentiation. A switch from proliferation to differentiation may also be important in the life cycle of single-celled organisms, and genes which arose as regulators of microbial differentiation may be conserved in higher organisms. Studies in microorganisms may thus contribute to understanding the molecular links between cell cycle machinery and the determination of cell fate choice networks. Methodology/Principal Findings: Here we show that in the amoebozoan D. discoideum, an ortholog of the metazoan antiproliferative gene btg controls cell fate, and that this function is dependent on the presence of a second tumor suppressor ortholog, the retinoblastoma-like gene product. Specifically, we find that btg-overexpressing cells preferentially adopt a stalk cell (and, more particularly, an Anterior-Like Cell) fate. No btg-dependent preference for ALC fate is observed in cells in which the retinoblastoma-like gene has been genetically inactivated. Dictyostelium btg is the only example of non-metazoan member of the BTG family characterized so far, suggesting that a genetic interaction between btg and Rb predated the divergence between dictyostelids and metazoa. Conclusions/Significance: While the requirement for retinoblastoma function for BTG antiproliferative activity in metazoans is known, an interaction of these genes in the control of cell fate has not been previously documented. Involvement of a single pathway in the control of mutually exclusive processes may have relevant implication in the evolution of multicellularity.	[Conte, Daniele; Ceccarelli, Adriano] Univ Turin, Dipartimento Sci Clin & Biol, Orbassano, Italy; [MacWilliams, Harry K.] Univ Munich, Dept Biol 2, Biozentrum, Munich, Germany	University of Turin; University of Munich	Conte, D (corresponding author), Univ Turin, Dipartimento Sci Clin & Biol, Orbassano, Italy.	adriano.ceccarelli@unito.it			Italian Ministry of University and Scientific Research	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant to A. C. from the Italian Ministry of University and Scientific Research (prin 2006-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Ceccarelli A, 2000, DIFFERENTIATION, V66, P189, DOI 10.1046/j.1432-0436.2000.660405.x; Coyne C, 1999, DEV GENES EVOL, V209, P63, DOI 10.1007/s004270050228; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; ESCH RK, 1991, GENE DEV, V5, P9, DOI 10.1101/gad.5.1.9; FAIX J, 1992, J CELL SCI, V102, P203; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fukuzawa M, 2006, DEVELOPMENT, V133, P1715, DOI 10.1242/dev.02327; Gaudet P, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e5; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; HARWOOD AJ, 1990, NUCLEIC ACIDS RES, V18, P4292, DOI 10.1093/nar/18.14.4292; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Keller T, 2008, DEVELOPMENT, V135, P1635, DOI 10.1242/dev.020883; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; MacWilliams H, 2006, DEVELOPMENT, V133, P1287, DOI 10.1242/dev.02287; MacWilliams H, 2001, DIFFERENTIATION, V67, P12, DOI 10.1046/j.1432-0436.2001.067001012.x; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Muller-Taubenberger A, 2009, CELL MOTIL CYTOSKEL, V66, P929, DOI 10.1002/cm.20386; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SIVE H, EARLY DEV XENOPUS LE, P249; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; Thompson CRL, 2000, DEV BIOL, V227, P56, DOI 10.1006/dbio.2000.9877; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tsujioka M, 2007, EUKARYOT CELL, V6, P568, DOI 10.1128/EC.00373-06; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171	30	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9676	10.1371/journal.pone.0009676	http://dx.doi.org/10.1371/journal.pone.0009676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300194	gold, Green Published, Green Submitted			2022-12-25	WOS:000275620900010
J	Bruyere, F; Melen-Lamalle, L; Blacher, S; Detry, B; Masset, A; Lecomte, J; Lambert, V; Maillard, C; Hoyer-Hansen, G; Lund, LR; Foidart, JM; Noel, A				Bruyere, Francoise; Melen-Lamalle, Laurence; Blacher, Silvia; Detry, Benoit; Masset, Anne; Lecomte, Julie; Lambert, Vincent; Maillard, Catherine; Hoyer-Hansen, Gunilla; Lund, Leif R.; Foidart, Jean-Michel; Noel, Agnes			Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BREAST-CANCER; TUMOR-GROWTH; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; TYPE-1; MICE; VASCULARIZATION; MORPHOGENESIS	The purpose of this study is to explore the function of plasminogen activator inhibitor-1 (PAI-1) during pathological lymphangiogenesis. PAI-1, the main physiological inhibitor of plasminogen activators is involved in pathological angiogenesis at least by controlling extracellular proteolysis and by regulating endothelial cell survival and migration. Protease system's role in lymphangiogenesis is unknown yet. Thus, based on its important pro-angiogenic effect, we hypothesized that PAI-1 may regulate lymphangiogenesis associated at least with metastatic dissemination of cancer cells. To address this issue, we studied the impact of PAI-1 deficiency in various murine models of tumoral lymphangiogenesis. Wild-type PAI-1 proficient mice were used as controls. We provide for the first time evidence that PAI-1 is dispensable for tumoral lymphangiogenesis associated with breast cancers either induced by mammary carcinoma cell injection or spontaneously appearing in transgenic mice expressing the polyomavirus middle T antigen (PymT) under the control of a mouse mammary tumor virus long-terminal repeat promoter (MMTV-LTR). We also investigated inflammation-related lymphatic vessel recruitment by using two inflammatory models. PAI-1 deficiency did neither affect the development of lymphangioma nor burn-induced corneal lymphangiogenesis. These novel data suggest that vascular remodelling associated with lymphangiogenesis and angiogenesis involve different molecular determinants. PAI-1 does not appear as a potential therapeutic target to counteract pathological lymphangiogenesis.	[Bruyere, Francoise; Melen-Lamalle, Laurence; Blacher, Silvia; Detry, Benoit; Masset, Anne; Lecomte, Julie; Lambert, Vincent; Maillard, Catherine; Foidart, Jean-Michel; Noel, Agnes] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium; [Lambert, Vincent] Ctr Hosp Univ, Dept Ophthalmol, Liege, Belgium; [Hoyer-Hansen, Gunilla; Lund, Leif R.] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Foidart, Jean-Michel] Ctr Hosp Univ, Dept Gynecol, Liege, Belgium	University of Liege; University of Liege; Rigshospitalet; University of Copenhagen; University of Liege	Bruyere, F (corresponding author), Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, Liege, Belgium.	agnes.noel@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	European Union [FP7-2007-2011, 201279]; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (F.N.R.S., Belgium); Fondation contre le Cancer; Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); "Region Wallonne"; Televie-FNRS	European Union(European Commission); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (F.N.R.S., Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer; Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); "Region Wallonne"; Televie-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the European Union Framework Program projects (FP7-2007-2011 "MICROENVIMET'' No 201279), the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), the Fondation contre le Cancer, the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the D.G.T.R.E. from the "Region Wallonne", the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium). FB, BD, AM and JL are recipients of a Televie-FNRS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Aurora AB, 2005, J IMMUNOL, V175, P6319, DOI 10.4049/jimmunol.175.10.6319; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Blacher S, 2009, EXP EYE RES, V89, P274, DOI 10.1016/j.exer.2009.02.021; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; FENTON BM, 1979, MICROVASC RES, V18, P153, DOI 10.1016/0026-2862(79)90025-6; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Gutierrez LS, 2000, CANCER RES, V60, P5839; HENNO A, 2008, BR J DERMATOL; Hojilla CV, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1980; Jost M, 2007, AM J PATHOL, V171, P1369, DOI 10.2353/ajpath.2007.070074; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Lambert V, 2003, INVEST OPHTH VIS SCI, V44, P2791, DOI 10.1167/iovs.02-1179; Lambert V, 2001, FASEB J, V15, P1021, DOI 10.1096/fj.00-0393com; Lee C., 2005, J CANC MOL, V1, P25, DOI DOI 10.29685/JCM.200510.0003; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Maillard C, 2005, NEOPLASIA, V7, P57, DOI 10.1593/neo.04406; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; PHILIPJOET F, 1995, EUR RESPIR J, V8, P1352, DOI 10.1183/09031936.95.08081352; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thiele W, 2006, J BIOTECHNOL, V124, P224, DOI 10.1016/j.jbiotec.2006.01.007; Tsuchiya Hiroyuki, 1995, General and Diagnostic Pathology, V141, P41; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	41	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9653	10.1371/journal.pone.0009653	http://dx.doi.org/10.1371/journal.pone.0009653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300183	Green Submitted, Green Published, gold			2022-12-25	WOS:000275620600009
J	Monfregola, J; Napolitano, G; D'Urso, M; Lappalainen, P; Ursini, MV				Monfregola, Jlenia; Napolitano, Gennaro; D'Urso, Michele; Lappalainen, Pekka; Ursini, Matilde Valeria			Functional Characterization of Wiskott-Aldrich Syndrome Protein and Scar Homolog (WASH), a Bi-modular Nucleation-promoting Factor Able to Interact with Biogenesis of Lysosome-related Organelle Subunit 2 (BLOS2) and gamma-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; CYTOSKELETAL DYNAMICS; N-WASP; ACTIN; ACTIVATION; PALLIDIN; DOMAINS	The Arp2/3 complex is essential for actin filament nucleation in a variety of cellular processes. The activation of the Arp2/3 complex is mediated by nucleation-promoting factors, such as the Wiskott-Aldrich syndrome family proteins, which share a WCA (WH2 domain, central region, acidic region) catalytic module at the C-terminal region, required for Arp2/3 activation, but diverge at the N-terminal region, required for binding to specific activators. Here, we report the characterization of WASH, a new member of the WAS family that has nucleation-promoting factor activity and recently has been demonstrated to play a role in endosomal sorting. We found that overexpression of the WASH-WCA domain induced disruption of the actin cytoskeleton, whereas overexpression of full-length WASH in mammalian cells did not affect stress fiber organization. Furthermore, our analysis has revealed that nerve growth factor treatment of PC12 cells overexpressing full-length WASH leads to disruption of the actin cytoskeleton. We have also found that WASH interacts through its N-terminal region with BLOS2, a centrosomal protein belonging to the BLOC-1 complex that functions as a scaffolding factor in the biogenesis of lysosome-related organelles. In addition to BLOS2, WASH also interacts with centrosomal gamma-tubulin and with pallidin, an additional component of the BLOC-1 complex. Collectively, our data propose that WASH is a bimodular protein in which the C terminus is involved in Arp2/3-mediated actin nucleation, whereas the N-terminal portion is required for its regulation and localization in the cells. Moreover, our data suggest that WASH is also a component of the BLOC-1 complex that is associated with the centrosomes.	[Monfregola, Jlenia; Napolitano, Gennaro; D'Urso, Michele; Ursini, Matilde Valeria] Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Helsinki	Ursini, MV (corresponding author), Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy.	ursini@igb.cnr.it	Monfregola, Jlenia/AAW-9055-2021; Napolitano, Gennaro/O-5377-2016	Napolitano, Gennaro/0000-0002-8615-4654; Lappalainen, Pekka/0000-0001-6227-0354	Telethon [GGP08125]; Istituto Banco di Napoli Fondazione	Telethon(Fondazione Telethon); Istituto Banco di Napoli Fondazione	This work was supported by Telethon Grant GGP08125 (to M.V.U.) and Istituto Banco di Napoli Fondazione.	Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Callebaut I, 1998, FEBS LETT, V441, P181, DOI 10.1016/S0014-5793(98)01541-5; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Gianfrancesco F, 2001, CYTOGENET CELL GENET, V94, P98, DOI 10.1159/000048796; Goldberg DJ, 2000, J NEUROSCI RES, V60, P458, DOI 10.1002/(SICI)1097-4547(20000515)60:4<458::AID-JNR4>3.3.CO;2-Q; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Monfregola J, 2005, J CELL PHYSIOL, V204, P839, DOI 10.1002/jcp.20332; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pommereit D, 2007, J CELL SCI, V120, P2694, DOI 10.1242/jcs.03475; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Wang ZQ, 2004, J MOL BIOL, V343, P71, DOI 10.1016/j.jmb.2004.08.034	31	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16951	16957		10.1074/jbc.M109.078501	http://dx.doi.org/10.1074/jbc.M109.078501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308062	Green Published, hybrid			2022-12-25	WOS:000277982600058
J	Nguyen, TT; Johnsen, IB; Knetter, CF; Drablos, F; Fitzgerald, KA; Lien, E; Anthonsen, MW				Nguyen, Thuy Thanh; Johnsen, Ingvild B.; Knetter, Cathrine F.; Drablos, Finn; Fitzgerald, Katherine A.; Lien, Egil; Anthonsen, Marit W.			Differential Gene Expression Downstream of Toll-like Receptors (TLRs) ROLE OF c-Src AND ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; INNATE IMMUNE-RESPONSE; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; TYROSINE KINASE; DAI DLM-1/ZBP1; IRF FAMILY; IN-VIVO; INFECTION; PROMOTER	Interferon regulatory factors (IRFs) are crucial for transcription during innate immune responses. We have previously shown that the tyrosine kinase c-Src enhances IRF-3-dependent transcription in response to viral double-stranded RNA. In this study, we show that c-Src has distinct roles in Toll-like receptor (TLR)-mediated activation of IRF-5 and IRF-3. Surprisingly, c-Src inhibition markedly enhanced IRF-5 activation after treatment with unmethylated CpG, while suppressing IRF-3 activation. Also, CpG-elicited interleukin-6 mRNA production was increased, whereas IP10 mRNA synthesis was reduced in cells deficient in c-Src. Interestingly, c-Src regulated TLR-stimulated induction of activating transcription factor 3 (ATF3), a transcriptional repressor. Depletion of ATF3 by small interfering RNA markedly enhanced interleukin-6 production after CpG treatment, whereas IP10 production was reduced. These results demonstrate functional specificity for c-Src in TLR-stimulated responses and suggest that c-Src modulation and ATF3 activity may contribute to differential regulation of IRF-3-versus IRF-5-mediated gene expression.	[Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Lab Ctr, Fac Med, Dept Lab Med Childrens & Womens Hlth, N-7006 Trondheim, Norway; [Drablos, Finn] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7006 Trondheim, Norway; [Knetter, Cathrine F.; Fitzgerald, Katherine A.; Lien, Egil] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Lab Ctr, Fac Med, Dept Lab Med Childrens & Womens Hlth, Losgt 3, N-7006 Trondheim, Norway.	marit.w.anthonsen@ntnu.no	Drablos, Finn/L-4970-2019; Fitzgerald, Katherine/ABE-6317-2020	Drablos, Finn/0000-0001-5794-828X; Fitzgerald, Kate/0000-0003-3175-609X; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776	National Programme for Research in Functional Genomics in Norway and Mid-Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318] Funding Source: NIH RePORTER	National Programme for Research in Functional Genomics in Norway and Mid-Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Programme for Research in Functional Genomics in Norway and Mid-Norway (to M. W. A.), the Research Council of Norway (to M. W. A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I. B. J. and M. W. A.), and the Cancer Fund at St. Olavs Hospital (to M. W. A.).	Aas PA, 2009, DNA REPAIR, V8, P822, DOI 10.1016/j.dnarep.2009.03.008; Altmayr F, 2010, J BIOL CHEM, V285, P3525, DOI 10.1074/jbc.M109.066787; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	35	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17011	17019		10.1074/jbc.M109.068817	http://dx.doi.org/10.1074/jbc.M109.068817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351107	hybrid, Green Published			2022-12-25	WOS:000277982600064
J	Playford, MP; Nurminen, E; Pentikainen, OT; Milgram, SL; Hartwig, JH; Stossel, TP; Nakamura, F				Playford, Martin P.; Nurminen, Elisa; Pentikainen, Olli T.; Milgram, Sharon L.; Hartwig, John H.; Stossel, Thomas P.; Nakamura, Fumihiko			Cystic Fibrosis Transmembrane Conductance Regulator Interacts with Multiple Immunoglobulin Domains of Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CHLORIDE CHANNELS; PLASMA-MEMBRANE; MOLECULAR-BASIS; CFTR; BINDING; CELLS; CYTOSKELETON; COMPETITION; EXPRESSION	Mutations of the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) that impair its apical localization and function cause cystic fibrosis. A previous report has shown that filamin A (FLNa), an actin-cross-linking and -scaffolding protein, interacts directly with the cytoplasmic N terminus of CFTR and that this interaction is necessary for stability and confinement of the channel to apical membranes. Here, we report that the CFTR N terminus has sequence similarity to known FLNa-binding partner-binding sites. FLNa has 24 Ig (IgFLNa) repeats, and a CFTR peptide pulled down repeats 9, 12, 17, 19, 21, and 23, which share sequence similarity yet differ from the other FLNa Ig domains. Using known structures of IgFLNa.partner complexes as templates, we generated in silico models of IgFLNa.CFTR peptide complexes. Point and deletion mutants of IgFLNa and CFTR informed by the models, including disease-causing mutations L15P and W19C, disrupted the binding interaction. The model predicted that a P5L CFTR mutation should not affect binding, but a synthetic P5L mutant peptide had reduced solubility, suggesting a different disease-causing mechanism. Taken together with the fact that FLNa dimers are elongated (similar to 160 nm) strands, whereas CFTR is compact (6 similar to 8 nm), we propose that a single FLNa molecule can scaffold multiple CFTR partners. Unlike previously defined dimeric FLNa.partner complexes, the FLNa-monomeric CFTR interaction is relatively weak, presumptively facilitating dynamic clustering of CFTR at cell membranes. Finally, we show that deletion of all CFTR interacting domains from FLNa suppresses the surface expression of CFTR on baby hamster kidney cells.	[Hartwig, John H.; Stossel, Thomas P.; Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Nurminen, Elisa; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Nurminen, Elisa; Pentikainen, Olli T.] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Playford, Martin P.; Milgram, Sharon L.] NHLBI, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Jyvaskyla; University of Jyvaskyla; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nakamura, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA.	fnakamura@rics.bwh.harvard.edu	Pentikäinen, Olli T/E-1980-2012; Nakamura, Fumihiko/N-5476-2016	Pentikäinen, Olli T/0000-0001-7188-4016; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [HL-19429, HL-56252]; HUSEC Seed Fund for Interdisciplinary Science; Sigrid Juselius Foundation; University of Jyvaskyla; Finnish IT Center for Science Computational Grant [jyy2516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HUSEC Seed Fund for Interdisciplinary Science; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Jyvaskyla; Finnish IT Center for Science Computational Grant(Finnish IT center for science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-19429 (to T. P. S.) and HL-56252 (to J. H. H.). This work was also supported by the HUSEC Seed Fund for Interdisciplinary Science (T. P. S. and F. N.), the Sigrid Juselius Foundation (O. T. P.), the University of Jyvaskyla (E. N.), and the Finnish IT Center for Science Computational Grant for Project jyy2516 (to O. T. P.).	Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cantiello HF, 1996, EXP PHYSIOL, V81, P505, DOI 10.1113/expphysiol.1996.sp003953; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; Ramjeesingh M, 2003, BIOCHEM J, V375, P633, DOI 10.1042/BJ20030774; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780	32	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17156	17165		10.1074/jbc.M109.080523	http://dx.doi.org/10.1074/jbc.M109.080523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351098	hybrid, Green Published			2022-12-25	WOS:000277982600078
J	Suhaiman, L; De Blas, GA; Obeid, LM; Darszon, A; Mayorga, LS; Belmonte, SA				Suhaiman, Laila; De Blas, Gerardo A.; Obeid, Lina M.; Darszon, Alberto; Mayorga, Luis S.; Belmonte, Silvia A.			Sphingosine 1-Phosphate and Sphingosine Kinase Are Involved in a Novel Signaling Pathway Leading to Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERMATOGENIC CELLS; PROTEIN-KINASE; SPERM CAPACITATION; PLASMA-MEMBRANE; EXTRACELLULAR RELEASE; MOLECULAR-CLONING; PERTUSSIS TOXIN; RAB3A TRIGGERS; MAST-CELLS; EGG ZP3	Regulated secretion is a central issue for the specific function of many cells; for instance, mammalian sperm acrosomal exocytosis is essential for egg fertilization. Sphingosine 1-phosphate is a bioactive sphingolipid that regulates crucial physiological processes. Here we report that this lipid triggers acrosomal exocytosis in human sperm by a mechanism involving a G(i)-coupled receptor. Real-time imaging showed a remarkable increase of cytosolic calcium upon activation with sphingosine 1-phosphate and pharmacological experiments indicate that the process requires extracellular calcium influx through voltage and store-operated calcium channels and efflux from intracellular stores through inositol 1,4,5-trisphosphate-sensitive calcium channels. Sphingosine 1-phosphate-induced exocytosis requires phospholipase C and protein kinase C activation. We investigated possible sources of the lipid. Western blot indicates that sphingosine kinase 1 is present in spermatozoa. Indirect immunofluorescence showed that phorbol ester, a potent protein kinase C activator that can also trigger acrosomal exocytosis, redistributes sphingosine kinase 1 to the acrosomal region. Functional assays showed that phorbol ester-induced exocytosis depends on the activation of sphingosine kinase 1. Furthermore, incorporation of P-32 to sphingosine demonstrates that cells treated with the phorbol ester increase their sphingosine kinase activity that yields sphingosine 1-phosphate. We present here the first evidence indicating that human spermatozoa produce sphingosine 1-phosphate when challenged with an exocytic stimulus. These observations point to a new role of sphingosine 1-phosphate in a signaling cascade that facilitates acrosome reaction providing some clues about novel lipid molecules involved in exocytosis.	[Suhaiman, Laila; Mayorga, Luis S.; Belmonte, Silvia A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol,Consejo Nacl Invest Cient, RA-5500 Mendoza, Argentina; [De Blas, Gerardo A.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62250, Morelos, Mexico; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Universidad Nacional Autonoma de Mexico; Medical University of South Carolina; Medical University of South Carolina	Belmonte, SA (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol,Consejo Nacl Invest Cient, CC56, RA-5500 Mendoza, Argentina.	sbelmont@fcm.uncu.edu.ar	Belmonte, Silvia Alejandra Alejandra/AAW-5131-2021	Darszon, Alberto/0000-0002-2502-0505; Mayorga, Luis S/0000-0002-5995-0671; obeid, lina/0000-0002-0734-0847	Florencio Fiorini Foundation (Argentina); Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Florencio Fiorini Foundation (Argentina); Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Florencio Fiorini Foundation (Argentina) and Secretaria de Ciencia, Tecnica y Postgrado (National University of Cuyo) (to S. A. B.), grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) (to Claudia Tomes and L. S. M.) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) (to L. S. M.).	Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; Bohring C, 1999, ELECTROPHORESIS, V20, P971, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<971::AID-ELPS971>3.0.CO;2-6; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Breitbart H, 1999, REV REPROD, V4, P151; Breitbart H, 2003, CELL MOL BIOL, V49, P321; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Delgado-Buenrostro NL, 2005, MOL REPROD DEV, V70, P198, DOI 10.1002/mrd.20192; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; ENDO Y, 1987, DEV BIOL, V119, P210, DOI 10.1016/0012-1606(87)90222-3; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; French KJ, 2003, CANCER RES, V63, P5962; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Gonzalez-Martinez MT, 2001, DEV BIOL, V236, P220, DOI 10.1006/dbio.2001.0323; Gupta Satish K, 2007, Soc Reprod Fertil Suppl, V63, P203; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Babak AK, 2006, J NEUROPHYSIOL, V96, P2688, DOI 10.1152/jn.00118.2006; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; KATADA T, 1984, J BIOL CHEM, V259, P3568; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kirkman-Brown JC, 2003, DEV BIOL, V259, P71, DOI 10.1016/S0012-1606(03)00137-4; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kopf G.S., 1988, Progress in Clinical and Biological Research, V267, P357; KUROSE H, 1983, J BIOL CHEM, V258, P4870; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Matsumoto K, 2005, J HISTOCHEM CYTOCHEM, V53, P243, DOI 10.1369/jhc.4B6507.2005; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; Melaine N, 2006, INT J ANDROL, V29, P392, DOI 10.1111/j.1365-2605.2005.00616.x; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Murase T, 1996, BIOCHEM J, V320, P1017, DOI 10.1042/bj3201017; Muratori M, 2009, INT J ANDROL, V32, P25, DOI 10.1111/j.1365-2605.2008.00875.x; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; O'Toole CMB, 1996, MOL HUM REPROD, V2, P921, DOI 10.1093/molehr/2.12.921; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; POWIS G, 1994, CANCER METAST REV, V13, P91, DOI 10.1007/BF00690420; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Raggers RJ, 1999, J CELL SCI, V112, P415; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Serrano-Sanchez M, 2008, ENDOCRINOLOGY, V149, P4669, DOI 10.1210/en.2008-1756; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Taylor Caroline J., 2006, Angiogenesis, V9, P39, DOI 10.1007/s10456-006-9028-y; Trevino CL, 2006, J CELL PHYSIOL, V206, P449, DOI 10.1002/jcp.20487; Way AL, 2002, J ANDROL, V23, P352; WEST RE, 1985, J BIOL CHEM, V260, P4428; Yanagimachi R., 1994, P189; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084	78	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16302	16314		10.1074/jbc.M109.072439	http://dx.doi.org/10.1074/jbc.M109.072439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20236935	hybrid, Green Published			2022-12-25	WOS:000277715900067
J	Unal, H; Jagannathan, R; Bhat, MB; Karnik, SS				Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhat, Manjunatha B.; Karnik, Sadashiva S.			Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; AT(1) RECEPTOR; CONSTITUTIVE ACTIVATION; ALPHA(1)-ADRENERGIC RECEPTOR; CONTACT POINTS; BINDING; IDENTIFICATION; ANTAGONISTS	The orientation of the second extracellular loop (ECL2) is divergent in G-protein coupled receptor (GPCR) structures determined. This discovery provoked the question, is the ECL2 conformation differentially regulated in the GPCRs that respond to diffusible ligands? We have determined the conformation of the ECL2 of the angiotensin II type 1 receptor by reporter-cysteine accessibility mapping in different receptor states (i.e. empty, agonist-bound and antagonist-bound). We introduced cysteines at each position of ECL2 of an N-terminal epitope-tagged receptor surrogate lacking all non-essential cysteines and then measured reaction of these with a cysteine-reactive biotin probe. The ability of biotinylated mutant receptors to react with a steptavidin-HRP-conjugated antibody was used as the basis for examining differences in accessibility. Two segments of ECL2 were accessible in the empty receptor, indicating an open conformation of ECL2. These segments were inaccessible in the ligand-bound states of the receptor. Using the accessibility constraint, we performed molecular dynamics simulation to predict ECL2 conformation in different states of the receptor. Analysis suggested that a lid conformation similar to that of ECL2 in rhodopsin was induced upon binding both agonist and antagonist, but exposing different accessible segments delimited by the highly conserved disulfide bond. Our study reveals the ability of ECL2 to interact with diffusing ligands and to adopt a ligand-specific lid conformation, thus, slowing down dissociation of ligands when bound. Distinct conformations induced by the bound agonist and the antagonist around the conserved disulfide bond suggest an important role for this disulfide bond in producing different functional states of the receptor.	[Unal, Hamiyet; Jagannathan, Rajaganapathi; Karnik, Sadashiva S.] Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Bhat, Manjunatha B.] Cleveland Clin Fdn, Lerner Res Inst, Ctr Anesthesiol Res, Cleveland, OH 44195 USA; [Unal, Hamiyet; Bhat, Manjunatha B.; Karnik, Sadashiva S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Karnik, SS (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [R01 HL57470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL57470 (to S. S. K.). This work was also supported by an assistantship from the Department of BGES, Cleveland State University.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Bourne HR, 2000, SCIENCE, V289, P733, DOI 10.1126/science.289.5480.733; BUMPUS FM, 1977, HYPERTENSION PHYSIOP, P183; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Feng YH, 2000, FEBS LETT, V484, P133, DOI 10.1016/S0014-5793(00)02141-4; GARCIA KC, 1992, SCIENCE, V257, P502, DOI 10.1126/science.1636085; GOGONEA C, 2006, J MOL MODEL, V12, P1610; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JI H, 1994, J BIOL CHEM, V269, P16533; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Liao YH, 2002, HYPERTENS RES, V25, P641; MARSHALL GR, 1974, RECENT ADV RENAL PHY, P215; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; NIKIFOROVICH GV, 1994, BIOCHEMISTRY-US, V33, P3591, DOI 10.1021/bi00178a016; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; Nouet S, 1999, J MED CHEM, V42, P4572, DOI 10.1021/jm991050l; OHYAMA K, 1995, REGUL PEPTIDES, V57, P141, DOI 10.1016/0167-0115(95)00030-F; Ojima M, 1997, EUR J PHARMACOL, V319, P137, DOI 10.1016/S0014-2999(96)00837-0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMANEN J, 1994, ANGIOTENSIN 2 RECEPT, V2, P11; SCHAMBYE HT, 1994, P NATL ACAD SCI USA, V91, P7046, DOI 10.1073/pnas.91.15.7046; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang WZ, 2000, CHINESE MED J-PEKING, V113, P867; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhao MM, 1996, MOL PHARMACOL, V50, P1118; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	58	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16341	16350		10.1074/jbc.M109.094870	http://dx.doi.org/10.1074/jbc.M109.094870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20299456	Green Published, hybrid			2022-12-25	WOS:000277715900070
J	Ma, JT; Benz, C; Grimaldi, R; Stockdale, C; Wyatt, P; Frearson, J; Hammarton, TC				Ma, Jiangtao; Benz, Corinna; Grimaldi, Raffaella; Stockdale, Christopher; Wyatt, Paul; Frearson, Julie; Hammarton, Tansy C.			Nuclear DBF-2-related Kinases Are Essential Regulators of Cytokinesis in Bloodstream Stage Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HUMAN AFRICAN TRYPANOSOMIASIS; MITOTIC EXIT NETWORK; NDR-PROTEIN-KINASE; CELL-CYCLE; TUMOR-SUPPRESSOR; RNA INTERFERENCE; INDUCIBLE EXPRESSION; SIGNALING PATHWAY; SLEEPING SICKNESS	Nuclear DBF-2-related (NDR) kinases are essential regulators of cell cycle progression, growth, and development in many organisms and are activated by the binding of an Mps One Binder (MOB) protein partner, autophosphorylation, and phosphorylation by an upstream STE20 family kinase. In the protozoan parasite, Trypanosoma brucei, the causative agent of human African trypanosomiasis, the NDR kinase, PK50, is expressed in proliferative life cycle stages and was shown to complement a yeast NDR kinase mutant cell line. However, the function of PK50 and a second NDR kinase, PK53, in T. brucei has not been determined to date, although trypanosome MOB1 is known to be essential for cytokinesis, suggesting the NDR kinases may also be involved in this process. Here, we show that specific depletion of PK50 or PK53 from bloodstream stage trypanosomes resulted in the rapid accumulation of cells with two nuclei and two kinetoplasts, indicating that cytokinesis was specifically inhibited. This led to a deregulation of the cell cycle and cell death and provides genetic validation of these kinases as potential novel drug targets for human African trypanosomiasis. Recombinant active PK50 and PK53 were produced and biochemically characterized. Both enzymes autophosphorylated, were able to trans-phosphorylate generic kinase substrates in vitro, and were active in the absence of phosphorylation by an upstream kinase. Additionally, both enzymes were active in the absence of MOB1 binding, which was also demonstrated to likely be a feature of the kinases in vivo. Biochemical characterization of recombinant PK50 and PK53 has revealed key kinetic differences between them, and the identification of in vitro peptide substrates in this study paves the way for high throughput inhibitor screening of these kinases.	[Hammarton, Tansy C.] Univ Glasgow, Div Infect & Immun, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Hammarton, Tansy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Grimaldi, Raffaella; Wyatt, Paul; Frearson, Julie] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Drug Discovery Unit,James Black Ctr, Dundee DD1 5EH, Scotland	University of Glasgow; University of Glasgow; University of Dundee	Hammarton, TC (corresponding author), Level 6 Glasgow Biomed Res Ctr,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	t.hammarton@bio.gla.ac.uk	Hammarton, Tansy/A-5632-2011; Benz, Corinna/AAD-8702-2021	Hammarton, Tansy/0000-0002-0799-6600; Benz, Corinna/0000-0003-4367-2758; Wyatt, Paul/0000-0002-0397-245X	Medical Research Council [G120/1001, G0900239]; Research Councils UK Academic Fellowship [GR/T28003/01]; Wellcome Trust [WT077705]; MRC [G0900239, G120/1001] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK Academic Fellowship(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Career Development Fellowship G120/1001 (to T. C. H.), Medical Research Council New Investigator Research Grant G0900239 (to T. C. H.), Research Councils UK Academic Fellowship GR/T28003/01 (to T. C. H.), a Wellcome Trust Value in People award (to C. B.), and Wellcome Trust Strategic Award WT077705 (Drug Discovery for Tropical Disease Initiative).	Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; BURNHAM KP, 2002, MODEL SELECTION INFE, P362; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen YL, 2003, MOL BIOCHEM PARASIT, V126, P275, DOI 10.1016/S0166-6851(02)00276-1; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; Garcia-Salcedo JA, 2002, MOL MICROBIOL, V45, P307, DOI 10.1046/j.1365-2958.2002.03019.x; Geng W, 2000, GENETICS, V156, P1817; Gonzalez-Novo A, 2009, MOL MICROBIOL, V72, P1364, DOI 10.1111/j.1365-2958.2009.06729.x; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2005, MOL CELL BIOL, V25, P8259, DOI 10.1128/MCB.25.18.8259-8272.2005; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hirabayashi S, 2008, ONCOGENE, V27, P4281, DOI 10.1038/onc.2008.66; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Ross H, 2002, BIOCHEM J, V366, P977, DOI 10.1042/BJ20020786; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Segel I. H., 1993, ENZYME KINETICS BEHA, P274; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772, DOI 10.1128/MCB.5.7.1772; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Vieth M, 2004, BBA-PROTEINS PROTEOM, V1697, P243, DOI 10.1016/j.bbapap.2003.11.028; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	62	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15356	15368		10.1074/jbc.M109.074591	http://dx.doi.org/10.1074/jbc.M109.074591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231285	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000277399000056
J	Wagoner, KR; Czajkowski, C				Wagoner, Kelly R.; Czajkowski, Cynthia			Stoichiometry of Expressed alpha(4)beta(2)delta gamma-Aminobutyric Acid Type A Receptors Depends on the Ratio of Subunit cDNA Transfected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT GABA(A) RECEPTOR; DELTA-SUBUNIT; DENTATE GYRUS; ETHANOL SENSITIVITY; CA1 HIPPOCAMPUS; GRANULE CELLS; BINDING-SITE; ION-CHANNEL; INHIBITION; ARRANGEMENT	The gamma-aminobutyric acid type A receptor (GABA(A)R) is the target of many depressants, including benzodiazepines, anesthetics, and alcohol. Although the highly prevalent alpha beta gamma GABA(A)R subtype mediates the majority of fast synaptic inhibition in the brain, receptors containing delta subunits also play a key role, mediating tonic inhibition and the actions of endogenous neurosteroids and alcohol. However, the fundamental properties of delta-containing GABA(A)Rs, such as subunit stoichiometry, are not well established. To determine subunit stoichiometry of expressed delta-containing GABA(A)Rs, we inserted the alpha-bungarotoxin binding site tag in the alpha(4), beta(2), and delta subunit N termini. An enhanced green fluorescent protein tag was also inserted into the beta(2) subunit to shift its molecular weight, allowing us to separate subunits using SDS-PAGE. Tagged alpha(4)beta(2)delta GABA(A)Rs were expressed in HEK293T cells using various ratios of subunit cDNA, and receptor subunit stoichiometry was determined by quantitating fluorescent alpha-bungarotoxin bound to each subunit on Western blots of surface immunopurified tagged GABA(A)Rs. The results demonstrate that the subunit stoichiometry of alpha(4)beta(2)delta GABA(A)Rs is regulated by the ratio of subunit cDNAs transfected. Increasing the ratio of delta subunit cDNA transfected increased delta subunit incorporation into surface receptors with a concomitant decrease in beta(2) subunit incorporation. Because receptor subunit stoichiometry can directly influence GABA(A)R pharmacological and functional properties, considering how the transfection protocols used affect subunit stoichiometry is essential when studying heterologously expressed alpha(4)beta(2)delta GABA(A)Rs. Successful bungarotoxin binding site tagging of GABA(A)R subunits is a novel tool with which to accurately quantitate subunit stoichiometry and will be useful for monitoring GABA(A)R trafficking in live cells.	Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53711 USA; [Czajkowski, Cynthia] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), 601 Sci Dr, Madison, WI 53711 USA.	czajkowski@physiology.wisc.edu			National Institutes of Health [T32 GM008688, F31AA016898, NS34727]; Alcohol Beverage Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727, R56NS034727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA016898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcohol Beverage Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 GM008688 and F31AA016898 (to K. R. W.) and Grant NS34727 (to C. C.). This work was also supported by funds from the Alcohol Beverage Medical Research Foundation (to C. C.).	Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Boileau AJ, 2005, J NEUROSCI, V25, P11219, DOI 10.1523/JNEUROSCI.3751-05.2005; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 1998, MOL PHARMACOL, V53, P295, DOI 10.1124/mol.53.2.295; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2007, ALCOHOL, V41, P155, DOI 10.1016/j.alcohol.2007.03.006; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; BOTZOLAKIS EJ, 2007, SOC NEUR ANN M SAN D; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chang YC, 1996, J NEUROSCI, V16, P5415; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOU TC, 1974, MOL PHARMACOL, V10, P235; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; IM WB, 1995, J BIOL CHEM, V270, P26063, DOI 10.1074/jbc.270.44.26063; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Nelson KR, 2003, SOC WORK HEALTH CARE, V36, P63, DOI 10.1300/J010v36n03_04; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Shen H, 2009, BIOCHEM SOC T, V37, P1378, DOI 10.1042/BST0371378; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Smith SS, 2005, J PHYSIOL-LONDON, V564, P421, DOI 10.1113/jphysiol.2004.077297; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Tretter V, 1997, J NEUROSCI, V17, P2728; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x	47	30	31	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14187	14194		10.1074/jbc.M110.104257	http://dx.doi.org/10.1074/jbc.M110.104257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233712	Green Published, hybrid			2022-12-25	WOS:000277299700015
J	Cheng, Y; Li, HJ; Ren, XC; Niu, TK; Hait, WN; Yang, JM				Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Hait, William N.; Yang, Jinming			Cytoprotective Effect of the Elongation Factor-2 Kinase-Mediated Autophagy in Breast Cancer Cells Subjected to Growth Factor Inhibition	PLOS ONE			English	Article							ANTI-HER2 MONOCLONAL-ANTIBODY; RESISTANCE; DEATH; PHOSPHORYLATION; ACTIVATION; RADIATION; CAPACITY; RECEPTOR; MCF-7	Background: Autophagy is a highly conserved and regulated cellular process employed by living cells to degrade proteins and organelles as a response to metabolic stress. We have previously reported that eukaryotic elongation factor-2 kinase (eEF-2 kinase, also known as Ca2+/calmodulin-dependent protein kinase III) can positively modulate autophagy and negatively regulate protein synthesis. The purpose of the current study was to determine the role of the eEF-2 kinase-regulated autophagy in the response of breast cancer cells to inhibitors of growth factor signaling. Methodology/Principal Findings: We found that nutrient depletion or growth factor inhibitors activated autophagy in human breast cancer cells, and the increased activity of autophagy was associated with a decrease in cellular ATP and an increase in activities of AMP kinase and eEF-2 kinase. Silencing of eEF-2 kinase relieved the inhibition of protein synthesis, led to a greater reduction of cellular ATP, and blunted autophagic response. We further showed that suppression of eEF-2 kinase-regulated autophagy impeded cell growth in serum/nutrient-deprived cultures and handicapped cell survival, and enhanced the efficacy of the growth factor inhibitors such as trastuzumab, gefitinib, and lapatinib. Conclusion/Significance: The results of this study provide new evidence that activation of eEF-2 kinase-mediated autophagy plays a protective role for cancer cells under metabolic stress conditions, and that targeting autophagic survival may represent a novel approach to enhancing the effectiveness of growth factor inhibitors.	[Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA USA; [Cheng, Yan; Li, Huaijun; Ren, Xingcong; Niu, Tingkuang; Yang, Jinming] Milton S Hershey Med Ctr, Hershey, PA USA; [Yang, Jinming] Soochow Univ, Sch Med, Dept Pharmacol, Suzhou, Peoples R China; [Hait, William N.] OrthoBiotech Res & Dev, Raritan, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Soochow University - China	Cheng, Y (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA.	jyang2@hmc.psu.edu			Department of Defense [BC050789]; National Cancer Institute [CA 135038]; NATIONAL CANCER INSTITUTE [R01CA135038] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Defense BC050789 and from the National Cancer Institute CA 135038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; KROEMER G, 2005, LYSOSOMES AUTOPHAGY; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li B, 2003, CANCER RES, V63, P7443; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Paglin S, 2001, CANCER RES, V61, P439; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rexer BN, 2009, CELL CYCLE, V8, P18, DOI 10.4161/cc.8.1.7324; Rez G, 1999, CARCINOGENESIS, V20, P1893, DOI 10.1093/carcin/20.10.1893; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Toth S, 2001, ACTA BIOL HUNG, V52, P393; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; WELSH GI, 1992, BIOCHEM J, V284, P19, DOI 10.1042/bj2840019; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yang XH, 2001, CANCER RES, V61, P348; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378	38	63	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9715	10.1371/journal.pone.0009715	http://dx.doi.org/10.1371/journal.pone.0009715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300520	gold, Green Published, Green Submitted			2022-12-25	WOS:000275716400013
J	Rahman, MJ; Degano, IR; Singh, M; Fernandez, C				Rahman, Muhammad Jubayer; Degano, Irene Roman; Singh, Mahavir; Fernandez, Carmen			Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model	PLOS ONE			English	Article							T-CELL; NEWBORN MICE; EARLY-LIFE; B-CELL; RESPONSES; IMMUNIZATION; VACCINE; HEMAGGLUTININ; INTRANASAL; SENSITIZATION	Background: It has been proposed that the immune system could be primed as early as during the fetal life and this might have an impact on postnatal vaccination. Therefore, we addressed in murine models whether gestational treatment with mycobacterial antigens could induce better immune responses in the postnatal life. Methods/Findings: BALB/c mice were treated subcutaneously (s.c.) at the second week of gestation with antigen (Ag)85A or heparin-binding hemagglutinin (HBHA) in the absence of adjuvant. Following birth, offspring mice were immunized intranasally (i.n.) with the same antigens formulated with the adjuvant cholera toxin (CT) at week 1 and week 4. One week after the last immunization, we assessed antigen-specific recall interferon gamma (IFN-c) responses by in vitro restimulation of lung-derived lymphocytes. Protection against infection was assessed by challenge with high dose Mycobacterium bovis Bacille Calmette-Guerin (BCG) given i.n. We found that recall IFN-c responses were higher in the offspring born to the treated mother compared to the untreated-mother. More importantly, we observed that the offspring born to the treated mother controlled infection better than the offspring born to the untreated mother. Since the gestational treatment was done in absence of adjuvant, essentially there was no antibody production observed in the pregnant mice and therefore no influence of maternal antibodies was expected. We hypothesized that the effect of maternal treatment with antigen on the offspring occurred due to antigen transportation through placenta. To trace the antigens, we conjugated fluorescent nanocrystals with Ag85A (Qdot-ITK-Ag85A). After inoculation in the pregnant mice, Qdot-ITK-Ag85A conjugates were detected in the liver, spleen of pregnant females and in all the fetuses and placentas examined. Conclusion: The fetal immune system could be primed in utero by mycobacterial antigens transported through the placenta.	[Rahman, Muhammad Jubayer; Degano, Irene Roman; Fernandez, Carmen] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Singh, Mahavir] Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany	Stockholm University; Lionex Diagnostics & Therapeutics GmbH	Rahman, MJ (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	jubayer.rahman@imun.su.se	Degano, Irene/ABG-5341-2020; Degano, Irene Roman/C-1826-2012	Degano, Irene R./0000-0003-1914-6934	European Commission [LSHP-CT-2005 018736]; Boehringer Ingelheim Fonds	European Commission(European CommissionEuropean Commission Joint Research Centre); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This study has been supported by a grant from the European Commission, Sixth Framework Program, LSHP-CT-2005 018736. IRD received partial support from Boehringer Ingelheim Fonds. None of the commercial funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 1999, IMMUNOL TODAY, V20, P330, DOI 10.1016/S0167-5699(99)01473-5; Bjarnarson SP, 2005, EUR J IMMUNOL, V35, P1037, DOI 10.1002/eji.200425850; CARLIER Y, 1980, AM J TROP MED HYG, V29, P74, DOI 10.4269/ajtmh.1980.29.74; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Devereux G, 2001, CLIN EXP ALLERGY, V31, P1686, DOI 10.1046/j.1365-2222.2001.01215.x; GILL TJ, 1983, J CLIN INVEST, V72, P987, DOI 10.1172/JCI111071; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Giri PK, 2006, FEMS IMMUNOL MED MIC, V47, P233, DOI 10.1111/j.1574-695X.2006.00087.x; Herz U, 2001, INT ARCH ALLERGY IMM, V124, P193, DOI 10.1159/000053708; Herz U, 2000, AM J RESP CRIT CARE, V162, pS62, DOI 10.1164/ajrccm.162.supplement_2.ras-1; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; IGUCHI T, 1993, BIOL REPROD, V48, P188, DOI 10.1095/biolreprod48.1.188; IVANYI L, 1977, CLIN EXP IMMUNOL, V30, P252; Jakobsen H, 2002, INFECT IMMUN, V70, P1443, DOI 10.1128/IAI.70.3.1443-1452.2002; Jones AC, 1996, PEDIATR ALLERGY IMMU, V7, P109, DOI 10.1111/j.1399-3038.1996.tb00117.x; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; LEE CJ, 1980, IMMUNOLOGY, V41, P45; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pravieux JJ, 2007, J COMP PATHOL, V137, pS32, DOI 10.1016/j.jcpa.2007.04.009; Rahman MJ, 2009, VACCINE, V27, P4038, DOI 10.1016/j.vaccine.2009.04.027; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Rodriguez A, 2003, VACCINE, V21, P458, DOI 10.1016/S0264-410X(02)00478-4; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	39	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9699	10.1371/journal.pone.0009699	http://dx.doi.org/10.1371/journal.pone.0009699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300629	Green Published, Green Submitted, gold			2022-12-25	WOS:000275621000016
J	Kim, JH; Park, JM; Yea, K; Kim, HW; Suh, PG; Ryu, SH				Kim, Jong Hyun; Park, Ji-Man; Yea, Kyungmoo; Kim, Hyun Wook; Suh, Pann-Ghill; Ryu, Sung Ho			Phospholipase D1 Mediates AMP-Activated Protein Kinase Signaling for Glucose Uptake	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; RICH TYROSINE KINASE-2; SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; PHOSPHATIDIC-ACID; REGULATED KINASE; PLASMA-MEMBRANE; CONTRACTION; INSULIN; ENERGY	Background: Glucose homeostasis is maintained by a balance between hepatic glucose production and peripheral glucose utilization. In skeletal muscle cells, glucose utilization is primarily regulated by glucose uptake. Deprivation of cellular energy induces the activation of regulatory proteins and thus glucose uptake. AMP-activated protein kinase (AMPK) is known to play a significant role in the regulation of energy balances. However, the mechanisms related to the AMPK-mediated control of glucose uptake have yet to be elucidated. Methodology/Principal Findings: Here, we found that AMPK-induced phospholipase D1 (PLD1) activation is required for C-14-glucose uptake in muscle cells under glucose deprivation conditions. PLD1 activity rather than PLD2 activity is significantly enhanced by glucose deprivation. AMPK-wild type (WT) stimulates PLD activity, while AMPK-dominant negative (DN) inhibits it. AMPK regulates PLD1 activity through phosphorylation of the Ser-505 and this phosphorylation is increased by the presence of AMP. Furthermore, PLD1-S505Q, a phosphorylation-deficient mutant, shows no changes in activity in response to glucose deprivation and does not show a significant increase in C-14-glucose uptake when compared to PLD1-WT. Taken together, these results suggest that phosphorylation of PLD1 is important for the regulation of C-14-glucose uptake. In addition, extracellular signal-regulated kinase (ERK) is stimulated by AMPK-induced PLD1 activation through the formation of phosphatidic acid (PA), which is a product of PLD. An ERK pharmacological inhibitor, PD98059, and the PLD inhibitor, 1-BtOH, both attenuate C-14-glucose uptake in muscle cells. Finally, the extracellular stresses caused by glucose deprivation or aminoimidazole carboxamide ribonucleotide (AICAR; AMPK activator) regulate C-14-glucose uptake and cell surface glucose transport (GLUT) 4 through ERK stimulation by AMPK-mediated PLD1 activation. Conclusions/Significance: These results suggest that AMPK-mediated PLD1 activation is required for C-14-glucose uptake through ERK stimulation. We propose that the AMPK-mediated PLD1 pathway may provide crucial clues to understanding the mechanisms involved in glucose uptake.	[Kim, Jong Hyun; Park, Ji-Man; Yea, Kyungmoo; Kim, Hyun Wook; Suh, Pann-Ghill; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Kim, Jong Hyun] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, JH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Ryu, Sung Ho/0000-0003-0913-3048	Ministry of Science and Technology in the Republic of Korea; National Institutes of Health (NIH) [GM 68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	Ministry of Science and Technology in the Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the 21st Frontier Proteomics Research of the Ministry of Science and Technology in the Republic of Korea and National Institutes of Health (NIH) grant GM 68849 (W. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Barnes BR, 2005, CURR MOL MED, V5, P341, DOI 10.2174/1566524053766103; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim JH, 2006, J BIOL CHEM, V281, P15747, DOI 10.1074/jbc.M509844200; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; MUSI N, 2003, AM J PHYSIOL-ENDOC M, V280, P677; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Pelletier A, 2005, ENDOCRINOLOGY, V146, P2285, DOI 10.1210/en.2004-1565; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Sajan MP, 2002, BIOCHEM J, V362, P665, DOI 10.1042/0264-6021:3620665; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9600	10.1371/journal.pone.0009600	http://dx.doi.org/10.1371/journal.pone.0009600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231899	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328300016
J	Yi, SM; Narasimhulu, KV; Samoilova, RI; Gennis, RB; Dikanov, SA				Yi, Sophia M.; Narasimhulu, Kuppala V.; Samoilova, Rimma I.; Gennis, Robert B.; Dikanov, Sergei A.			Characterization of the Semiquinone Radical Stabilized by the Cytochrome aa(3)-600 Menaquinol Oxidase of Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; NUCLEAR DOUBLE-RESONANCE; SITE-DIRECTED MUTAGENESIS; UBIQUINONE BINDING-SITE; COLI QUINOL OXIDASE; ESCHERICHIA-COLI; PHOTOSYSTEM-I; Q(H) SITE; HYDROGEN-BOND; Q(H)(CENTER-DOT-) UBISEMIQUINONE	Cytochrome aa(3)-600 is one of the principle respiratory oxidases from Bacillus subtilis and is a member of the heme-copper superfamily of oxygen reductases. This enzyme catalyzes the two-electron oxidation of menaquinol and the four-electron reduction of O-2 to 2H(2)O. Cytochrome aa(3)-600 is of interest because it is a very close homologue of the cytochrome bo(3) ubiquinol oxidase from Escherichia coli, except that it uses menaquinol instead of ubiquinol as a substrate. One question of interest is how the proteins differ in response to the differences in structure and electrochemical properties between ubiquinol and menaquinol. Cytochrome bo(3) has a high affinity binding site for ubiquinol that stabilizes a ubi-semiquinone. This has permitted the use of pulsed EPR techniques to investigate the protein interaction with the ubiquinone. The current work initiates studies to characterize the equivalent site in cytochrome aa(3)-600. Cytochrome aa(3)-600 has been cloned and expressed in a His-tagged form in B. subtilis. After isolation of the enzyme in dodecylmaltoside, it is shown that the pure enzyme contains 1 eq of menaquinone-7 and that the enzyme stabilizes a menasemiquinone. Pulsed EPR studies have shown that there are both similarities as well as significant differences in the interactions of the mena-semiquinone with cytochrome aa(3)-600 in comparison with the ubi-semiquinone in cytochrome bo(3). Our data indicate weaker hydrogen bonds of the menaquinone in cytochrome aa(3)-600 in comparison with ubiquinone in cytochrome bo(3). In addition, the electronic structure of the semiquinone cyt aa(3)-600 is more shifted toward the anionic form from the neutral state in cyt bo(3).	[Yi, Sophia M.; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Narasimhulu, Kuppala V.; Dikanov, Sergei A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Samoilova, Rimma I.] Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS	Gennis, RB (corresponding author), Univ Illinois, Dept Biochem, 600 S Goodwin Ave, Urbana, IL 61801 USA.	r-gennis@illinois.edu; dikanov@illinois.edu	Samoilova, Rimma Ivanovna/T-7956-2017	Samoilova, Rimma Ivanovna/0000-0002-1649-1487; Yi, Sophia/0000-0001-9219-9536	National Institutes of Health [GM062954, S10-RR15878]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy [DE-FG02-08ER15960, DE-FG02-87ER13716]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM062954 (to S. A. D.) and S10-RR15878 (National Center for Research Resources) for instrumentation. This work was also supported by Grants DE-FG02-08ER15960 (to S. A. D.) and DE-FG02-87ER13716 (to R. B. G.) from Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; Dikanov SA, 2004, J BIOL CHEM, V279, P15814, DOI 10.1074/jbc.M313417200; DIKANOV SA, 1982, CHEM PHYS LETT, V90, P149, DOI 10.1016/0009-2614(82)83630-0; Dikanov SA, 1996, J AM CHEM SOC, V118, P8408, DOI 10.1021/ja960781x; DikanovO SA, 2007, J BIOL CHEM, V282, P25831, DOI 10.1074/jbc.M702333200; DOWNEY RJ, 1964, J BACTERIOL, V88, P904, DOI 10.1128/JB.88.4.904-911.1964; Epel B, 2006, J PHYS CHEM B, V110, P11549, DOI 10.1021/jp060548d; FANN YC, 1995, BIOCHEMISTRY-US, V34, P10245, DOI 10.1021/bi00032a019; Flores M, 2007, BIOPHYS J, V92, P671, DOI 10.1529/biophysj.106.092460; Flores M, 2003, CHEM PHYS, V294, P401, DOI 10.1016/S0301-0104(03)00321-5; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gardiner AT, 1999, BIOCHEMISTRY-US, V38, P11773, DOI 10.1021/bi990661c; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2001, BIOCHEMISTRY-US, V40, P1037, DOI 10.1021/bi001641+; Grimaldi S, 2010, J BIOL CHEM, V285, P179, DOI 10.1074/jbc.M109.060251; Hanley J, 1997, BIOCHEMISTRY-US, V36, P11543, DOI 10.1021/bi971360a; Hastings SF, 2000, EUR J BIOCHEM, V267, P5638, DOI 10.1046/j.1432-1327.2000.01643.x; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kobayashi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1599, DOI 10.1271/bbb.90105; LAURAEUS M, 1993, J BIOL CHEM, V268, P11470; LAURAEUS M, 1993, BIOCHEMISTRY-US, V32, P2664, DOI 10.1021/bi00061a026; LEMMA E, 1993, ARCH MICROBIOL, V159, P574, DOI 10.1007/BF00249037; Lin MT, 2008, J AM CHEM SOC, V130, P15768, DOI 10.1021/ja805906a; LUBTITZ W, 1999, APPL MAGN RESON, V17, P1; Ma JX, 1998, BIOCHEMISTRY-US, V37, P11806, DOI 10.1021/bi9809977; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; Matsuura K, 2004, BIOCHEMISTRY-US, V43, P2288, DOI 10.1021/bi0355490; Mattatall NR, 2001, BIOCHEMISTRY-US, V40, P13331, DOI 10.1021/bi011116q; MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; Niklas J, 2009, J PHYS CHEM B, V113, P10367, DOI 10.1021/jp901890z; O'Malley PJ, 1998, CHEM PHYS LETT, V291, P367, DOI 10.1016/S0009-2614(98)00571-5; OMALLEY PJ, 1986, J AM CHEM SOC, V108, P3995, DOI 10.1021/ja00274a024; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pushkar YN, 2004, J MOL STRUCT, V700, P233, DOI 10.1016/j.molstruc.2004.02.015; Puustinen A, 1996, P NATL ACAD SCI USA, V93, P1545, DOI 10.1073/pnas.93.4.1545; Rigby SEJ, 1996, BIOCHEMISTRY-US, V35, P6651, DOI 10.1021/bi952619x; SAFIN IA, 1977, NUCL QUADUPOLE RESON; SANTANA M, 1992, J BIOL CHEM, V267, P10225; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P12744, DOI 10.1021/bi981184l; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schweiger A., 2001, PRINCIPLES PULSE ELE, P359; Sinnecker S, 2004, J AM CHEM SOC, V126, P3280, DOI 10.1021/ja0392014; Teutloff C, 2004, APPL MAGN RESON, V26, P5, DOI 10.1007/BF03166559; Veselov AV, 2000, BIOCHEMISTRY-US, V39, P3169, DOI 10.1021/bi9926835; Villani G, 1999, BIOCHEMISTRY-US, V38, P2287, DOI 10.1021/bi980774g; WELTER R, 1994, J BIOL CHEM, V269, P28834; White GF, 2007, BIOCHEMISTRY-US, V46, P2355, DOI 10.1021/bi062265h; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200	60	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18241	18251		10.1074/jbc.M110.116186	http://dx.doi.org/10.1074/jbc.M110.116186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20351111	Green Published, hybrid			2022-12-25	WOS:000278453900016
J	Bevilacqua, E; Wang, XL; Majumder, M; Gaccioli, F; Yuan, CL; Wang, CP; Zhu, XW; Jordan, LE; Scheuner, D; Kaufman, RJ; Koromilas, AE; Snider, MD; Holcik, M; Hatzoglou, M				Bevilacqua, Elena; Wang, Xinglong; Majumder, Mithu; Gaccioli, Francesca; Yuan, Celvie L.; Wang, Chuanping; Zhu, Xiongwei; Jordan, Lindsay E.; Scheuner, Donalyn; Kaufman, Randal J.; Koromilas, Antonis E.; Snider, Martin D.; Holcik, Martin; Hatzoglou, Maria			eIF2 alpha Phosphorylation Tips the Balance to Apoptosis during Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRES-MEDIATED TRANSLATION; AMINO-ACID TRANSPORTER; NF-KAPPA-B; GENE-EXPRESSION; MESSENGER-RNA; HNRNP A1; CELLULAR-RESPONSE; PROTEIN; KINASE; RELOCALIZATION	Regulation of cell volume is of great importance because persistent swelling or shrinkage leads to cell death. Tissues experience hypertonicity in both physiological (kidney medullar cells) and pathological states (hypernatremia). Hypertonicity induces an adaptive gene expression program that leads to cell volume recovery or apoptosis under persistent stress. We show that the commitment to apoptosis is controlled by phosphorylation of the translation initiation factor eIF2 alpha, the master regulator of the stress response. Studies with cultured mouse fibroblasts and cortical neurons show that mutants deficient in eIF2 alpha phosphorylation are protected from hypertonicity-induced apoptosis. A novel link is revealed between eIF2 alpha phosphorylation and the subcellular distribution of the RNA-binding protein heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1). Stress-induced phosphorylation of eIF2 alpha promotes apoptosis by inducing the cytoplasmic accumulation of hnRNP A1, which attenuates internal ribosome entry site-mediated translation of anti-apoptotic mRNAs, including Bcl-xL that was studied here. Hypertonic stress induced the eIF2 alpha phosphorylation-independent formation of cytoplasmic stress granules (SGs, structures that harbor translationally arrested mRNAs) and the eIF2 alpha phosphorylation-dependent accumulation of hnRNP A1 in SGs. The importance of hnRNP A1 was demonstrated by induction of apoptosis in eIF2 alpha phosphorylation-deficient cells that express exogenous cytoplasmic hnRNP A1. We propose that eIF2 alpha phosphorylation during hypertonic stress promotes apoptosis by sequestration of specific mRNAs in SGs in a process mediated by the cytoplasmic accumulation of hnRNP A1.	[Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Wang, Xinglong; Zhu, Xiongwei] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jordan, Lindsay E.; Holcik, Martin] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Scheuner, Donalyn; Kaufman, Randal J.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Sch Med, Ann Arbor, MI 48109 USA; [Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ H3T 1E2, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; McGill University	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu	Holcik, Martin/E-5372-2011; Zhu, Xiongwei/A-9629-2009; /C-1310-2010; Holcik, Martin/AAC-6660-2019	Zhu, Xiongwei/0000-0003-2092-6508; Holcik, Martin/0000-0002-1922-5299; Gaccioli, Francesca/0000-0001-7178-8921; Wang, Xinglong/0000-0001-8657-0159	National Institutes of Health [DK60596, DK53307, DK42304, HL52173, HL057346]; Canadian Cancer Society Research Institute [CCRSI 17285]; Canadian Institutes of Health Research [MOP 89737, FRN 74740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK060596, R37DK060596, R01DK042304, R37DK042394, R01DK088227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60596 and DK53307 (to M. H.) and DK42304, HL52173, and HL057346 (to R. J. K.). This work was also supported by the Canadian Cancer Society Research Institute Grant CCRSI 17285 (to A. E. K.) and the Canadian Institutes of Health Research Grants MOP 89737 and FRN 74740 (to M. H.).	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Aulak KS, 1999, J BIOL CHEM, V274, P30424, DOI 10.1074/jbc.274.43.30424; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Franchi-Gazzola R, 2001, AM J PHYSIOL-CELL PH, V280, pC1465, DOI 10.1152/ajpcell.2001.280.6.C1465; Fritsch RM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702673200; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lin M, 2005, EMERG MED CLIN N AM, V23, P749, DOI 10.1016/j.emc.2005.03.001; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Maallem S, 2008, NEUROSCIENCE, V153, P95, DOI 10.1016/j.neuroscience.2008.01.047; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Marash L, 2005, CELL DEATH DIFFER, V12, P554, DOI 10.1038/sj.cdd.4401609; Morley SJ, 2002, J BIOL CHEM, V277, P32855, DOI 10.1074/jbc.C200376200; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146	57	70	72	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17098	17111		10.1074/jbc.M110.109439	http://dx.doi.org/10.1074/jbc.M110.109439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20338999	hybrid, Green Published			2022-12-25	WOS:000277982600073
J	Niemeyer, MI; Cid, LP; Pena-Munzenmayer, G; Sepulveda, FV				Isabel Niemeyer, Maria; Pablo Cid, L.; Pena-Munzenmayer, Gaspar; Sepulveda, Francisco V.			Separate Gating Mechanisms Mediate the Regulation of K-2P Potassium Channel TASK-2 by Intra- and Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; 2-PORE DOMAIN; SELECTIVITY FILTER; INTRACELLULAR PH; FATTY-ACIDS; SENSITIVITY; PORE; SENSOR; ROMK; HISTIDINE	TASK-2 (KCNK5 or K(2P)5.1) is a background K+ channel that is opened by extracellular alkalinization and plays a role in renal bicarbonate reabsorption and central chemoreception. Here, we demonstrate that in addition to its regulation by extracellular protons (pH(o)) TASK-2 is gated open by intracellular alkalinization. The following pieces of evidence suggest that the gating process controlled by intracellular pH (pH(i)) is independent from that under the command of pH(o). It was not possible to overcome closure by extracellular acidification by means of intracellular alkalinization. The mutant TASK-2-R224A that lacks sensitivity to pH(o) had normal pH(i)-dependent gating. Increasing extracellular K+ concentration acid shifts pH(o) activity curve of TASK-2 yet did not affect pH(i) gating of TASK-2. pH(o) modulation of TASK-2 is voltage-dependent, whereas pH(i) gating was not altered by membrane potential. These results suggest that pH(o), which controls a selectivity filter external gate, and pH(i) act at different gating processes to open and close TASK-2 channels. We speculate that pH(i) regulates an inner gate. We demonstrate that neutralization of a lysine residue (Lys(245)) located at the C-terminal end of transmembrane domain 4 by mutation to alanine abolishes gating by pH(i). We postulate that this lysine acts as an intracellular pH sensor as its mutation to histidine acid-shifts the pH(i)-dependence curve of TASK-2 as expected from its lower pK(a). We conclude that intracellular pH, together with pH(o), is a critical determinant of TASK-2 activity and therefore of its physiological function.	[Isabel Niemeyer, Maria; Sepulveda, Francisco V.] Ctr Estudios Cient, Ctr Ingn Innovac Asociado, Valdivia 5110466, Chile; [Pena-Munzenmayer, Gaspar] Univ Austral Chile, Valdivia 5110566, Chile	Universidad Austral de Chile	Niemeyer, MI (corresponding author), Ctr Estudios Cient, Ctr Ingn Innovac Asociado, Av Arturo Prat 514, Valdivia 5110466, Chile.	miniemeyer@cecs.cl	Pena-Munzenmayer, Gaspar/ABD-2296-2021	Pena-Munzenmayer, Gaspar/0000-0001-6633-0545; Cid, Pablo/0000-0003-0394-0498; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598	Fondo Nacional de Ciencia y Tecnologia [1090478]; Comision Nacional de Ciencia y Tecnologia [24081049]; Chilean Government through the Millennium Science Initiative; Gobierno Regional de Los Rios	Fondo Nacional de Ciencia y Tecnologia; Comision Nacional de Ciencia y Tecnologia; Chilean Government through the Millennium Science Initiative; Gobierno Regional de Los Rios	This work was supported by Fondo Nacional de Ciencia y Tecnologia Grant 1090478 and Comision Nacional de Ciencia y Tecnologia Grant 24081049.; We are grateful to Drs. Jurgen Daut (Philipps-Universitat, Marburg, Germany) and Donghee Kim (Rosalind Franklin University, Chicago, IL) for generously providing some of the cDNAs used in our experiments and to Robert W. Putnam (Wright State University, Dayton, OH) for advice on changing intracellular pH. F. Danilo Gonzalez-Nilo and Valeria Marquez (Universidad de Talca, Chile) are gratefully acknowledged for insightful discussions concerning the structure of TASK-2. The Centro de Estudios Cientificos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. Centro de Ingenieria de la Innovacion asociado al CECS is funded by Conicyt and the Gobierno Regional de Los Rios.	Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Dedman A, 2009, EUR BIOPHYS J BIOPHY, V38, P293, DOI 10.1007/s00249-008-0318-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; GRINSTEIN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1152, DOI 10.1152/ajpcell.1994.267.4.C1152; GUYENET PG, 2010, RESP PHYSL IN PRESS; Hartzler LK, 2008, ADV EXP MED BIOL, V605, P333; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Niemeyer MI, 2006, BIOCHEM SOC T, V34, P899, DOI 10.1042/BST0340899; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; ROOS A, 1981, PHYSIOL REV, V61, P294; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Thompson J, 2005, J GEN PHYSIOL, V125, P619, DOI 10.1085/jgp.200509251; Thompson J, 2003, J GEN PHYSIOL, V122, P239, DOI 10.1085/jgp.200308848; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yuan YK, 2003, J PHYSIOL-LONDON, V549, P429, DOI 10.1113/jphysiol.2003.042341; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	51	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16467	16475		10.1074/jbc.M110.107060	http://dx.doi.org/10.1074/jbc.M110.107060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351106	Green Published, hybrid			2022-12-25	WOS:000277982600008
J	Jinwal, UK; O'Leary, JC; Borysov, SI; Jones, JR; Li, QY; Koren, J; Abisambra, JF; Vestal, GD; Lawson, LY; Johnson, AG; Blair, LJ; Jin, Y; Miyata, Y; Gestwicki, JE; Dickey, CA				Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Miyata, Yoshinari; Gestwicki, Jason E.; Dickey, Chad A.			Hsc70 Rapidly Engages Tau after Microtubule Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; SHOCK-PROTEIN HSC70; ALZHEIMERS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASES; CONFORMATIONAL-CHANGE; HSP70; AGGREGATION; ASSOCIATION; EXPRESSION	The microtubule-associated protein Tau plays a crucial role in regulating the dynamic stability of microtubules during neuronal development and synaptic transmission. In a group of neurodegenerative diseases, such as Alzheimer disease and other tauopathies, conformational changes in Tau are associated with the initial stages of disease pathology. Folding of Tau into the MC1 conformation, where the amino acids at residues 7-9 interact with residues 312-342, is one of the earliest pathological alterations of Tau in Alzheimer disease. The mechanism of this conformational change in Tau and the subsequent effect on function and association to microtubules is largely unknown. Recent work by our group and others suggests that members of the Hsp70 family play a significant role in Tau regulation. Our new findings suggest that heat shock cognate (Hsc) 70 facilitates Tau-mediated microtubule polymerization. The association of Hsc70 with Tau was rapidly enhanced following treatment with microtubule-destabilizing agents. The fate of Tau released from the microtubule was found to be dependent on ATPase activity of Hsc70. Microtubule destabilization also rapidly increased the MC1 folded conformation of Tau. An in vitro assay suggests that Hsc70 facilitates formation of MC1 Tau. However, in a hyperphosphorylating environment, the formation of MC1 was abrogated, but Hsc70 binding to Tau was enhanced. Thus, under normal circumstances, MC1 formation may be a protective conformation facilitated by Hsc70. However, in a diseased environment, Hsc70 may preserve Tau in a more unstructured state, perhaps facilitating its pathogenicity.	[Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Gestwicki, Jason E.; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Jinwal, Umesh K.; O'Leary, John C., III; Borysov, Sergiy I.; Jones, Jeffrey R.; Li, Qingyou; Koren, John, III; Abisambra, Jose F.; Vestal, Grant D.; Lawson, Lisa Y.; Johnson, Amelia G.; Blair, Laura J.; Jin, Ying; Gestwicki, Jason E.; Dickey, Chad A.] Univ S Florida, Johnnie B Byrd Sr Alzheimers Res Inst, Tampa, FL 33613 USA; [Miyata, Yoshinari] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, 4001 E Fletcher Ave,MDC 36, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Dickey, Chad A/H-4441-2011; Abisambra, Joe/AAP-3269-2020	Abisambra, Jose/0000-0001-6341-679X; Jones, Jeffrey/0000-0002-7570-2571; Blair, Laura/0000-0002-4981-5564; Lawson, Lisa/0000-0002-4436-5357; Koren, John/0000-0002-6017-1763	National Institutes of Health [NS059690, AG031291]; Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291, K99AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059690 (to J. E. G.) and AG031291. This work was also supported by the Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research and CurePSP.	Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Goedert M, 1999, NAT MED, V5, P454, DOI 10.1038/7454; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hardy J, 2006, J NEUROCHEM, V97, P1690, DOI 10.1111/j.1471-4159.2006.03979.x; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Khalilzadeh A, 2007, BIOCHEM PHARMACOL, V74, P407, DOI 10.1016/j.bcp.2007.05.006; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Liang ZH, 2008, J ALZHEIMERS DIS, V13, P295; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rasband MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000340; Ryu K, 2008, BIOCHEM BIOPH RES CO, V373, P74, DOI 10.1016/j.bbrc.2008.05.186; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Sevcik J, 2009, PROTEIN PEPTIDE LETT, V16, P61, DOI 10.2174/092986609787049349; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; TOHGI H, 1995, NEUROSCI LETT, V196, P89, DOI 10.1016/0304-3940(95)11854-P; Tortosa E, 2009, J ALZHEIMERS DIS, V17, P319, DOI 10.3233/JAD-2009-1049; Uboga NV, 2000, NEUROBIOL AGING, V21, P1, DOI 10.1016/S0197-4580(00)00091-9; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200	46	65	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16798	16805		10.1074/jbc.M110.113753	http://dx.doi.org/10.1074/jbc.M110.113753			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308058	hybrid, Green Published			2022-12-25	WOS:000277982600043
J	Staschke, KA; Dey, S; Zaborske, JM; Palam, LR; McClintick, JN; Pan, T; Edenberg, HJ; Wek, RC				Staschke, Kirk A.; Dey, Souvik; Zaborske, John M.; Palam, Lakshmi Reddy; McClintick, Jeanette N.; Pan, Tao; Edenberg, Howard J.; Wek, Ronald C.			Integration of General Amino Acid Control and Target of Rapamycin (TOR) Regulatory Pathways in Nitrogen Assimilation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GCN4; TRANSFER-RNA-BINDING; OPEN READING FRAMES; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSLATIONAL CONTROL; EXPRESSION; STRESS; ACTIVATION; IDENTIFICATION	Two important nutrient-sensing and regulatory pathways, the general amino acid control (GAAC) and the target of rapamycin (TOR), participate in the control of yeast growth and metabolism during changes in nutrient availability. Amino acid starvation activates the GAAC through Gcn2p phosphorylation of translation factor eIF2 and preferential translation of GCN4, a transcription activator. TOR senses nitrogen availability and regulates transcription factors such as Gln3p. We used microarray analyses to address the integration of the GAAC and TOR pathways in directing the yeast transcriptome during amino acid starvation and rapamycin treatment. We found that GAAC is a major effector of the TOR pathway, with Gcn4p and Gln3p each inducing a similar number of genes during rapamycin treatment. Although Gcn4p activates a common core of 57 genes, the GAAC directs significant variations in the transcriptome during different stresses. In addition to inducing amino acid biosynthetic genes, Gcn4p in conjunction with Gln3p activates genes required for the assimilation of secondary nitrogen sources such as gamma-aminobutyric acid (GABA). Gcn2p activation upon shifting to secondary nitrogen sources is suggested to occur by means of a dual mechanism. First, Gcn2p is induced by the release of TOR repression through a mechanism involving Sit4p protein phosphatase. Second, this eIF2 kinase is activated by select uncharged tRNAs, which were shown to accumulate during the shift to the GABA medium. This study highlights the mechanisms by which the GAAC and TOR pathways are integrated to recognize changing nitrogen availability and direct the transcriptome for optimal growth adaptation.	[Staschke, Kirk A.; Dey, Souvik; Palam, Lakshmi Reddy; McClintick, Jeanette N.; Edenberg, Howard J.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zaborske, John M.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015; Staschke, Kirk/HGC-5664-2022	Staschke, Kirk/0000-0001-8722-9585; Edenberg, Howard/0000-0003-0344-9690	National Institutes of Health [R01GM49164]; Indiana Genomics Initiative; Lilly Endowment, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Genomics Initiative; Lilly Endowment, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49164 (to R.C.W.).; We thank Li Jiang for technical assistance, Alan Hinnebusch, Gerhard Braus, and Stephen Zheng for providing reagents, and the Biochemistry Biotechnology Facility at Indiana University for DNA sequencing. We also thank Ron Jerome at the Center for Medical Genomics for processing of microarray chips. Microarray experiments were carried out at the Center for Medical Genomics at Indiana University School of Medicine, which is supported in part by the Indiana Genomics Initiative and the Lilly Endowment, Inc.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; ANDRE B, 1990, MOL GEN GENET, V220, P269; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bomeke K, 2006, MOL BIOL CELL, V17, P2952, DOI 10.1091/mbc.E05-10-0975; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUS GH, 2006, MOL BIOL CELL, V17, P2952; Burke D., 2000, METHODS YEAST GENETI, P171; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HARDY TA, 1993, J BIOL CHEM, V268, P23799; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Iraqui I, 1999, MOL CELL BIOL, V19, P3360; Irniger S, 2003, CURR GENET, V44, P8, DOI 10.1007/s00294-003-0422-3; Ishida C, 2006, MOL MICROBIOL, V59, P1790, DOI 10.1111/j.1365-2958.2006.05055.x; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SENTHESHANMUGANATHAN S, 1960, BIOCHEM J, V74, P568, DOI 10.1042/bj0740568; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shemer R, 2002, MOL CELL BIOL, V22, P5395, DOI 10.1128/MCB.22.15.5395-5404.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2004, TOP CURR GENET, V7, P171; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	79	79	84	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16893	16911		10.1074/jbc.M110.121947	http://dx.doi.org/10.1074/jbc.M110.121947			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20233714	Green Published, hybrid			2022-12-25	WOS:000277982600053
J	Iejima, D; Minegishi, Y; Takenaka, K; Siswanto, A; Watanabe, M; Huang, L; Watanabe, T; Tanaka, F; Kuroda, M; Gotoh, N				Iejima, D.; Minegishi, Y.; Takenaka, K.; Siswanto, A.; Watanabe, M.; Huang, L.; Watanabe, T.; Tanaka, F.; Kuroda, M.; Gotoh, N.			FRS2 beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding	ONCOGENE			English	Article						FRS2; SNT2; FRS3; HER; NSCLC; prognosis	DOCKING-PROTEIN FRS2-ALPHA; FRS2 FAMILY; MAP KINASE; ACTIVATION; MUTATIONS; EXPRESSION; SITES; MOTIF	An adaptor protein FRS2b inhibits epidermal growth factor-receptor (EGFR) tyrosine kinase without being phosphorylated at tyrosine residues after EGF stimulation. Although binding to ERK appears to be important for this inhibition, the precise molecular mechanisms and the role of FRS2b in signal transduction mediated by other EGFR family members, as well as its role in human cancer, remain unclear. In this study, we demonstrate that FRS2b inhibits anchorage-independent cell growth induced by oncogenic ErbB2, another member of EGFR family, and that it inhibits heterodimer formation between EGFR and ErbB2. We mapped the residues important for the FRS2b and ERK interaction to two docking (D) domain-like sequences on FRS2b and two aspartic acid residues in the common docking (CD) domain of ERK. Moreover, in response to EGF, ERK translocated to the plasma membrane in cells expressing FRS2b but not an FRS2b mutant in which four arginine residues in the D domains were replaced with alanines, suggesting that FRS2b serves as a plasma membrane anchor for activated ERK. Finally, a low mRNA expression level of FRS2b was significantly correlated with poor prognosis in a cohort of 60 non-small cell lung cancer patients. Therefore, we have identified the molecular mechanisms by which FRS2b acts as a feedback inhibitor of EGFR family members and suggest a role for FRS2b as a tumor suppressor. Oncogene (2010) 29, 3087-3099; doi: 10.1038/onc.2010.69; published online 15 March 2010	[Iejima, D.; Minegishi, Y.; Siswanto, A.; Watanabe, M.; Gotoh, N.] Univ Tokyo, Inst Med Sci, Dept Syst Biomed Technol, Minato Ku, Tokyo 1088639, Japan; [Takenaka, K.; Tanaka, F.] Kyoto Univ, Sch Med, Dept Thorac Surg, Kyoto 606, Japan; [Takenaka, K.] Koseikai Takeda Hosp, Dept Thorac Surg, Kyoto, Japan; [Siswanto, A.; Watanabe, T.] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; [Huang, L.] RIKEN, Cellular Biochem Lab, Wako, Saitama, Japan; [Tanaka, F.] Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo, Japan; [Kuroda, M.] Tokyo Med Univ, Dept Pathol, Tokyo, Japan	University of Tokyo; Kyoto University; University of Tokyo; RIKEN; Hyogo College of Medicine; Tokyo Medical University	Gotoh, N (corresponding author), Univ Tokyo, Inst Med Sci, Dept Syst Biomed Technol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ngotoh@ims.u-tokyo.ac.jp	Huang, Lin/AAI-5740-2020		Ministry of Health, Labor and Welfare of Japan; Naito Foundation; Cell Science Research Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan)	We are grateful to Dr Toshio Kitamura for valuable reagents for retrovirus expression system and Dr Tadashi Yamamoto for NIH3T3 cells expressing oncogenic ErbB2 and for expression vectors for ErbB2 and VE mutant. This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; from the Naito Foundation; and Cell Science Research Foundation to NG.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Butch ER, 1996, J BIOL CHEM, V271, P4230; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gotoh N, 2005, MOL CELL BIOL, V25, P4105, DOI 10.1128/MCB.25.10.4105-4116.2005; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; Gotoh N, 2004, FEBS LETT, V564, P14, DOI 10.1016/S0014-5793(04)00287-X; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Gotoh N, 2009, INT J BIOCHEM CELL B, V41, P511, DOI 10.1016/j.biocel.2008.06.019; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Huang L, 2006, ONCOGENE, V25, P6457, DOI 10.1038/sj.onc.1209656; Huang L, 2004, BIOCHEM BIOPH RES CO, V324, P1011, DOI 10.1016/j.bbrc.2004.09.152; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sonobe M, 2005, BRIT J CANCER, V93, P355, DOI 10.1038/sj.bjc.6602707; Sonobe M, 2006, J MOL DIAGN, V8, P351, DOI 10.2353/jmoldx.2006.050132; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Yamamoto S, 2005, P NATL ACAD SCI USA, V102, P15983, DOI 10.1073/pnas.0507961102; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	30	8	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2010	29	21					3087	3099		10.1038/onc.2010.69	http://dx.doi.org/10.1038/onc.2010.69			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	602IQ	20228838				2022-12-25	WOS:000278133100006
J	Frondorf, K; Henkels, KM; Frohman, MA; Gomez-Cambronero, J				Frondorf, Kathleen; Henkels, Karen M.; Frohman, Michael A.; Gomez-Cambronero, Julian			Phosphatidic Acid Is a Leukocyte Chemoattractant That Acts through S6 Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PHOSPHOLIPASE-D ACTIVITY; MAMMALIAN TARGET; HUMAN NEUTROPHILS; CELL-MIGRATION; GM-CSF; MTOR; ACTIVATION; PATHWAY; PROTEIN	Phosphatidic acid (PA) is a pleiotropic lipid second messenger in mammalian cells. We report here that extracellular PA acts as a leukocyte chemoattractant, as membrane-soluble di-oleoyl-PA (DOPA) elicits actin polymerization and chemotaxis of human neutrophils and differentiated proleukemic HL-60 cells. We show that the mechanism for this involves the S6 kinase (S6K) signaling enzyme. Chemotaxis was inhibited >90% by the S6K inhibitors rapamycin and bisindolylmaleimide and by S6K1 silencing using double-stranded RNA. However, it was only moderately (similar to 30%) inhibited by mTOR siRNA, indicating the presence of an mTOR-independent mechanism for S6K. Exogenous PA led to robust time-and dose-dependent increases in S6K enzymatic activity and Thr(421)/Ser(424) phosphorylation, further supporting a PA/S6K connection. We also investigated whether intracellular PA production affects cell migration. Overexpression of phospholipase D2 (PLD2) and, to a lesser extent, PLD1, resulted in elevation of both S6K activity and chemokinesis, whereas PLD silencing was inhibitory. Because the lipase-inactive PLD2 mutants K444R and K758R neither activated S6K nor induced chemotaxis, intracellular PA is needed for this form of cell migration. Lastly, we demonstrated a connection between extracellular and intracellular PA. Using an enhanced green fluorescent protein-derived PA sensor (pEGFP-Spo20PABD), we showed that exogenous PA or PA generated in situ by bacterial (Streptomyces chromofuscus) PLD enters the cell and accumulates in vesicle-like cytoplasmic structures. In summary, we report the discovery of PA as a leukocyte chemoattractant via cell entry and activation of S6K to mediate the cytoskeletal actin polymerization and leukocyte chemotaxis required for the immune function of these cells.	[Frondorf, Kathleen; Henkels, Karen M.; Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA	University System of Ohio; Wright State University Dayton; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gomez-Cambronero, J (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653, 667131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 and Research challenge Grant 667131 ( Ohio Board of Regents) ( to J.G.-C.).	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Crouch MF, 1997, BIOCHEM BIOPH RES CO, V233, P193, DOI 10.1006/bbrc.1997.6419; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Di Fulvio M, 2007, J MOL BIOL, V367, P814, DOI 10.1016/j.jmb.2007.01.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Gomez-Cambronero J, 2003, FEBS LETT, V550, P94, DOI 10.1016/S0014-5793(03)00828-7; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kriebel PW, 2009, METHODS MOL BIOL, V571, P111, DOI 10.1007/978-1-60761-198-1_7; Kusner DJ, 2002, J BIOL CHEM, V277, P50683, DOI 10.1074/jbc.M209221200; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Shen L, 2004, CELL IMMUNOL, V230, P23, DOI 10.1016/j.cellimm.2004.08.004; Siddiqui RA, 1997, BBA-LIPID LIPID MET, V1349, P81, DOI 10.1016/S0005-2760(97)00085-4; Sliva D, 2000, BIOCHEM BIOPH RES CO, V268, P471, DOI 10.1006/bbrc.2000.2111; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Tanski WJ, 2005, J VASC SURG, V41, P91, DOI 10.1016/j.jvs.2004.08.058; Taylor RM, 2004, BBA-BIOMEMBRANES, V1663, P201, DOI 10.1016/j.bbamem.2004.03.009; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Uesugi Y, 2009, BBA-MOL CELL BIOL L, V1791, P962, DOI 10.1016/j.bbalip.2009.01.020; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; ZHOU D, 1995, J BIOL CHEM, V270, P25549, DOI 10.1074/jbc.270.43.25549	49	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15837	15847		10.1074/jbc.M109.070524	http://dx.doi.org/10.1074/jbc.M109.070524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304930	hybrid, Green Published			2022-12-25	WOS:000277715900021
J	Owens, RM; Gu, XL; Shin, MR; Springer, TA; Jin, MM				Owens, Roisin M.; Gu, Xiaoling; Shin, Miran; Springer, Timothy A.; Jin, Moonsoo M.			Engineering of Single Ig Superfamily Domain of Intercellular Adhesion Molecule 1 (ICAM-1) for Native Fold and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RHINOVIRUS; CRYSTAL-STRUCTURE; CELL-SURFACE; TRANSENDOTHELIAL MIGRATION; IMMUNOGLOBULIN SUPERFAMILY; DIRECTED EVOLUTION; COXSACKIEVIRUS A21; RECEPTOR MOLECULE; ANTIGEN-1 LFA-1; IN-VIVO	The immunoglobulin (Ig) superfamily is one of the largest families in the vertebrate genome, found most frequently in cell surface molecules. Intercellular adhesion molecule-1 (ICAM-1) contains five extracellular Ig superfamily domains (D1-D5) of which the first domain, D1, is the binding site for the integrin lymphocyte function-associated antigen-1 (LFA-1) and human rhinovirus. Despite the modular nature of many Ig superfamily domains with respect to domain folding and ligand recognition, D1 does not fold on its own due to the loss of its interaction with the second domain. The goal of this study was to engineer ICAM-1D1 by introducing mutations that would stabilize the Ig superfamily domain fold while retaining its ability to bind to LFA-1 and rhinovirus. First, with a directed evolution approach, we isolated mutations in D1 that showed binding to conformation-specific antibodies and the ligand binding domain of LFA-1 called the inserted, or I, domain. Then, with a rational design approach we introduced mutations that contributed to the stability of ICAM-1 D1 in solution. The mutations that restored native folding of D1 in isolation were those that would convert hydrogen bond networks in buried regions into hydrophobic contacts. Notably, for most mutations, identical or similar types of substitutions were found in ICAM-1 molecules of different species and other ICAM family members. The systematic approach demonstrated in this study to engineer a single Ig superfamily fold in ICAM-1 can be broadly applicable to the engineering of modular Ig superfamily domains in other cell surface molecules.	[Springer, Timothy A.; Jin, Moonsoo M.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Owens, Roisin M.; Gu, Xiaoling; Shin, Miran; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Cornell University	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu; mj227@cornell.edu	Owens, Roisin/O-4371-2019; Jin, Moonsoo/D-6128-2011	Owens, Roisin/0000-0001-7856-2108; 	National Institutes of Health [CA31798, AI079532]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA31798 and AI079532.	Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Blackford J, 1996, EUR J IMMUNOL, V26, P525, DOI 10.1002/eji.1830260304; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; GREVE JM, 1991, J VIROL, V65, P6015, DOI 10.1128/JVI.65.11.6015-6023.1991; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grunert HP, 1997, MED MICROBIOL IMMUN, V186, P1, DOI 10.1007/s004300050039; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117, DOI 10.1002/jlb.65.1.117; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Klickstein LB, 1996, J BIOL CHEM, V271, P23920, DOI 10.1074/jbc.271.39.23920; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MARTIN S, 1993, J VIROL, V67, P3561, DOI 10.1128/JVI.67.6.3561-3568.1993; MARTIN S, 1993, ANTIMICROB AGENTS CH, V37, P1278, DOI 10.1128/AAC.37.6.1278; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Owens RM, 2009, J RECEPT SIG TRANSD, V29, P195, DOI 10.1080/10799890903079919; Racaniello VR, 1996, P NATL ACAD SCI USA, V93, P11378, DOI 10.1073/pnas.93.21.11378; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; ROTHLEIN R, 1991, J IMMUNOL, V147, P3788; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Shafren DR, 1997, J VIROL, V71, P4736, DOI 10.1128/JVI.71.6.4736-4743.1997; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1992, J IMMUNOL, V148, P3271; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; TOMASSINI JE, 1986, J VIROL, V58, P290, DOI 10.1128/JVI.58.2.290-295.1986; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	50	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15906	15915		10.1074/jbc.M110.104349	http://dx.doi.org/10.1074/jbc.M110.104349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20304924	Green Published, hybrid			2022-12-25	WOS:000277715900028
J	Smith, KJ; Twal, WO; Soodavar, F; Virella, G; Lopes-Virella, MF; Hammad, SM				Smith, Kent J.; Twal, Waleed O.; Soodavar, Farzan; Virella, Gabriel; Lopes-Virella, Maria F.; Hammad, Samar M.			Heat Shock Protein 70B ' (HSP70B ') Expression and Release in Response to Human Oxidized Low Density Lipoprotein Immune Complexes in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U937 MONOCYTIC CELLS; SPHINGOSINE KINASE; CYTOKINE PRODUCTION; PLASMA-MEMBRANE; STRESS-PROTEINS; LDL; HEAT-SHOCK-PROTEIN-70; SURVIVAL; PATHWAY; ATHEROSCLEROSIS	Heat shock proteins (HSPs) have been implicated in the activation and survival of macrophages. This study examined the role of HSP70B', a poorly characterized member of the HSP70 family, in response to oxidatively modified LDL (oxLDL) and immune complexes prepared with human oxLDL and purified human antibodies to oxLDL (oxLDL-IC) in monocytic and macrophage cell lines. Immunoblot analysis of cell lysates and conditioned medium from U937 cells treated with oxLDL alone revealed an increase in intracellular HSP70B' protein levels accompanied by a concomitant increase in HSP70B' extracellular levels. Fluorescence immunohistochemistry and confocal microscopy, however, demonstrated that oxLDL-IC stimulated the release of HSP70B', which co-localized with cell-associated oxLDL-IC. In HSP70B'-green fluorescent protein-transfected mouse RAW 264.7 cells, oxLDL-IC-induced HSP70B' co-localized with membrane-associated oxLDL-IC as well as the lipid moiety of internalized oxLDL-IC. Furthermore, the data demonstrated that HSP70B' is involved in cell survival, and this effect could be mediated by sphingosine kinase 1 (SK1) activation. An examination of regularly implicated cytokines revealed a significant relationship between HSP70B' and the release of the anti-inflammatory cytokine interleukin-10 (IL-10). Small interfering RNA knockdown of HSP70B' resulted in a corresponding decrease in SK1 mRNA levels and SK1 phosphorylation as well as increased release of IL-10. In conclusion, these findings suggest that oxLDL-IC induce the synthesis and release of HSP70B', and once stimulated, HSP70B' binds to the cell-associated and internalized lipid moiety of oxLDL-IC. The data also implicate HSP70B' in key cellular functions, such as regulation of SK1 activity and release of IL-10, which influence macrophage activation and survival.	[Smith, Kent J.; Twal, Waleed O.; Soodavar, Farzan; Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Virella, Gabriel] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Lopes-Virella, Maria F.] Med Univ S Carolina, Div Endocrinol, Dept Med, Charleston, SC 29425 USA; [Lopes-Virella, Maria F.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hammad, SM (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 114 Doughty St,630B,POB 250776, Charleston, SC 29425 USA.	hammadsm@musc.edu		Hammad, Samar/0000-0002-1313-2542	National Institutes of Health (NIH) [HL079274]; NIH (American Recovery and Investment Act (ARRA)) [R01 HL079274-04S1]; NIH (National Center for Research Resources) [P20 RR17677]; NIH [P01 HL55782, R01 DK081352, R01 DK081352-02S1]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055782, R01HL079274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (American Recovery and Investment Act (ARRA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant HL079274 and NIH (American Recovery and Investment Act (ARRA)) Grant R01 HL079274-04S1 (to S. M. H.); NIH (National Center for Research Resources) Grant P20 RR17677 (South Carolina Center of Biomedical Research Excellence in Lipidomics and Pathobiology) (to S. M. H.); and NIH Grants P01 HL55782, R01 DK081352, and R01 DK081352-02S1 (ARRA) (to M. F. L.-V.). This work was also supported by funding from the Department of Veterans Affairs (to M. F. L.-V.).	ARAI T, 1995, BIOCHEM BIOPH RES CO, V213, P600, DOI 10.1006/bbrc.1995.2174; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Atchley DH, 2002, DIABETOLOGIA, V45, P1562, DOI 10.1007/s00125-002-0962-y; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Bianchi G, 2007, ANN NY ACAD SCI, V1095, P209, DOI 10.1196/annals.1397.025; Brown AJ, 2000, J LIPID RES, V41, P226; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; DAVIDOFF AM, 1992, P NATL ACAD SCI USA, V89, P3439, DOI 10.1073/pnas.89.8.3439; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; DING XZ, 2010, PROSTAGLAND IN PRESS; GRIFFITH RL, 1988, J EXP MED, V168, P1041, DOI 10.1084/jem.168.3.1041; Hammad SM, 2009, ATHEROSCLEROSIS, V202, P394, DOI 10.1016/j.atherosclerosis.2008.05.032; Hammad SM, 2006, PROSTAG OTH LIPID M, V79, P126, DOI 10.1016/j.prostaglandins.2005.12.004; Hengst JA, 2009, ARCH BIOCHEM BIOPHYS, V492, P62, DOI 10.1016/j.abb.2009.09.013; Hirvonen MR, 1996, BIOCHEM J, V315, P845, DOI 10.1042/bj3150845; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; KUSHER DI, 1990, J IMMUNOL, V145, P2925; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; Li W, 1998, FREE RADICAL RES, V29, P389, DOI 10.1080/10715769800300431; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Lopes-Virella MF, 2000, ATHEROSCLEROSIS, V152, P107, DOI 10.1016/S0021-9150(99)00456-6; Luo XJ, 2008, CELL STRESS CHAPERON, V13, P365, DOI 10.1007/s12192-008-0036-2; MANDER EL, 1994, BBA-LIPID LIPID MET, V1212, P80, DOI 10.1016/0005-2760(94)90192-9; Martinet W, 2001, CURR OPIN LIPIDOL, V12, P535, DOI 10.1097/00041433-200110000-00009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehta TA, 2005, EUR J VASC ENDOVASC, V29, P395, DOI 10.1016/j.ejvs.2005.01.005; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Noonan E, 2008, EXP CELL RES, V314, P2468, DOI 10.1016/j.yexcr.2008.05.002; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Oksjoki R, 2006, ARTERIOSCL THROM VAS, V26, P576, DOI 10.1161/01.ATV.0000201041.14438.8d; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Parsian AJ, 2000, BBA-GENE STRUCT EXPR, V1494, P201, DOI 10.1016/S0167-4781(00)00203-7; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Roma P, 1996, ATHEROSCLEROSIS, V127, P147, DOI 10.1016/S0021-9150(96)05952-7; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vicca SP, 2003, FREE RADICAL BIO MED, V35, P603, DOI 10.1016/S0891-5849(03)00361-7; Virella G, 2000, CLIN IMMUNOL, V95, P135, DOI 10.1006/clim.2000.4857; Virella G, 2004, J LIPID RES, V45, P1859, DOI 10.1194/jlr.M400095-JLR200; Virella G, 2003, CLIN DIAGN LAB IMMUN, V10, P499, DOI 10.1128/CDLI.10.4.499-505.2003; VIRELLA G, 1995, CLIN IMMUNOL IMMUNOP, V75, P179, DOI 10.1006/clin.1995.1069; WILLIAMS RS, 1993, J CLIN INVEST, V92, P503, DOI 10.1172/JCI116594; Xu QB, 1996, MOL MED TODAY, V2, P372, DOI 10.1016/S1357-4310(96)10034-4; Yancey PG, 1998, J LIPID RES, V39, P1349	58	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15985	15993		10.1074/jbc.M110.113605	http://dx.doi.org/10.1074/jbc.M110.113605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348092	Green Published, hybrid			2022-12-25	WOS:000277715900036
J	Takeda, A; Sarma, NJ; Abdul-Nabi, AM; Yaseen, NR				Takeda, Akiko; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Yaseen, Nabeel R.			Inhibition of CRM1-mediated Nuclear Export of Transcription Factors by Leukemogenic NUP98 Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PORE COMPLEX; ONCOGENE NUP98-HOXA9; NUCLEOPORIN NUP98; GENE; CRM1; BINDING; IMPORT	NUP98 is a nucleoporin that plays complex roles in the nucleocytoplasmic trafficking of macromolecules. Rearrangements of the NUP98 gene in human leukemia result in the expression of numerous fusion oncoproteins whose effect on nucleocytoplasmic trafficking is poorly understood. The present study was undertaken to determine the effects of leukemogenic NUP98 fusion proteins on CRM1-mediated nuclear export. NUP98-HOXA9, a prototypic NUP98 fusion, inhibited the nuclear export of two known CRM1 substrates: mutated cytoplasmic nucleophosmin and HIV-1 Rev. In vitro binding assays revealed that NUP98-HOXA9 binds CRM1 through the FG repeat motif in a Ran-GTP-dependent manner similar to but stronger than the interaction between CRM1 and its export substrates. Two NUP98 fusions, NUP98-HOXA9 and NUP98-DDX10, whose fusion partners are structurally and functionally unrelated, interacted with endogenous CRM1 in myeloid cells as shown by co-immunoprecipitation. These leukemogenic NUP98 fusion proteins interacted with CRM1, Ran, and the nucleoporin NUP214 in a manner fundamentally different from that of wildtype NUP98. NUP98-HOXA9 and NUP98-DDX10 formed characteristic aggregates within the nuclei of a myeloid cell line and primary human CD34+ cells and caused aberrant localization of CRM1 to these aggregates. These NUP98 fusions caused nuclear accumulation of two transcription factors, NFAT and NF kappa B, that are regulated by CRM1-mediated export. The nuclear entrapment of NFAT and NF kappa B correlated with enhanced transcription from promoters responsive to these transcription factors. Taken together, the results suggest a new mechanism by which NUP98 fusions dysregulate transcription and cause leukemia, namely, inhibition of CRM1-mediated nuclear export with aberrant nuclear retention of transcriptional regulators.	[Takeda, Akiko; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Yaseen, NR (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	nyaseen@path.wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	National Institutes of Health [R01 HL082549, K02 HL084179, T32 CA009547]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL082549 and K02 HL084179 ( to N. R. Y.) and T32 CA009547 ( to A. M. A.).	Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bibak N, 2004, ANAL BIOCHEM, V333, P57, DOI 10.1016/j.ab.2004.06.017; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Im SH, 2004, MOL CELLS, V18, P1; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	51	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16248	16257		10.1074/jbc.M109.048785	http://dx.doi.org/10.1074/jbc.M109.048785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233715	hybrid, Green Published			2022-12-25	WOS:000277715900061
J	Thorpe, CT; Streeter, I; Pinchbeck, GL; Goodship, AE; Clegg, PD; Birch, HL				Thorpe, Chavaunne T.; Streeter, Ian; Pinchbeck, Gina L.; Goodship, Allen E.; Clegg, Peter D.; Birch, Helen L.			Aspartic Acid Racemization and Collagen Degradation Markers Reveal an Accumulation of Damage in Tendon Collagen That Is Enhanced with Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; HUMAN INTERVERTEBRAL DISCS; AGE-RELATED ACCUMULATION; DIGITAL FLEXOR TENDON; EXTRACELLULAR-MATRIX; AGGRECAN TURNOVER; GLYCATION; EXERCISE; HYDROXYPROLINE; MICRODIALYSIS	Little is known about the rate at which protein turnover occurs in living tendon and whether the rate differs between tendons with different physiological roles. In this study, we have quantified the racemization of aspartic acid to calculate the age of the collagenous and non-collagenous components of the high strain injury-prone superficial digital flexor tendon (SDFT) and low strain rarely injured common digital extensor tendon (CDET) in a group of horses with a wide age range. In addition, the turnover of collagen was assessed indirectly by measuring the levels of collagen degradation markers (collagenase-generated neoepitope and cross-linked telopeptide of type I collagen). The fractional increase in D-Asp was similar (p = 0.7) in the SDFT (5.87 x 10(-4)/year) and CDET (5.82 x 10(-4)/year) tissue, and D/L-Asp ratios showed a good correlation with pentosidine levels. We calculated a mean (+/-S.E.) collagen half-life of 197.53 (+/-18.23) years for the SDFT, which increased significantly with horse age (p = 0.03) and was significantly (p < 0.001) higher than that for the CDET (34.03 (+/-3.39) years). Using similar calculations, the half-life of non-collagenous protein was 2.18 (+/-0.41) years in the SDFT and was significantly (p = 0.04) lower than the value of 3.51 (+/-0.51) years for the CDET. Collagen degradation markers were higher in the CDET and suggested an accumulation of partially degraded collagen within the matrix with aging in the SDFT. We propose that increased susceptibility to injury in older individuals results from an inability to remove partially degraded collagen from the matrix leading to reduced mechanical competence.	[Thorpe, Chavaunne T.; Streeter, Ian; Goodship, Allen E.; Birch, Helen L.] UCL, Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, London HA7 4LP, England; [Streeter, Ian] UCL, Dept Chem, London HA7 4LP, England; [Pinchbeck, Gina L.; Clegg, Peter D.] Univ Liverpool, Dept Comparat Mol Med, Leahurst HG4 7TE, Cheshire, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Liverpool	Thorpe, CT (corresponding author), UCL, Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, Stanmore Campus, London HA7 4LP, England.	rejacth@ucl.ac.uk	Thorpe, Chavaunne T/T-7289-2018	Thorpe, Chavaunne T/0000-0001-7051-3504; Birch, Helen/0000-0002-7966-9967; Clegg, Peter/0000-0003-0632-0032; Streeter, Ian/0000-0003-4024-3552	Horse Trust, UK [231748]; MRC [G0700869] Funding Source: UKRI; Medical Research Council [G0700869] Funding Source: researchfish	Horse Trust, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a welfare grant from The Horse Trust, UK (Registered Charity Number 231748).	BADA JL, 1984, METHOD ENZYMOL, V106, P98; BADA JL, 1973, NATURE, V245, P308, DOI 10.1038/245308a0; BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385; BANNISTER DW, 1970, ANALYST, V95, P596, DOI 10.1039/an9709500596; Becher C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-46; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; Birch HL, 2006, MATRIX BIOL, V25, pS74, DOI 10.1016/j.matbio.2006.08.204; Birch HL, 2008, MATRIX BIOL, V27, P182, DOI 10.1016/j.matbio.2007.10.004; Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; FANIBUNDA KB, 1986, J DENT, V14, P160, DOI 10.1016/0300-5712(86)90018-7; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; HELFMAN PM, 1976, NATURE, V262, P279, DOI 10.1038/262279b0; Ker RF, 2002, COMP BIOCHEM PHYS A, V133, P987, DOI 10.1016/S1095-6433(02)00171-X; Langberg H, 2001, J PHYSIOL-LONDON, V534, P297, DOI 10.1111/j.1469-7793.2001.00297.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Lin YL, 2005, J VET MED A, V52, P333, DOI 10.1111/j.1439-0442.2005.00742.x; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Reddy GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P174, DOI 10.1006/abbi.2001.2747; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; Sivan SS, 2006, BIOCHEM J, V399, P29, DOI 10.1042/BJ20060579; Sivan SS, 2008, J BIOL CHEM, V283, P8796, DOI 10.1074/jbc.M709885200; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; Van Duin ACT, 1998, ORG GEOCHEM, V29, P1227, DOI 10.1016/S0146-6380(98)00098-9; Verzijl N, 2001, MATRIX BIOL, V20, P409, DOI 10.1016/S0945-053X(01)00158-5; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WILSON AM, 1994, J BIOMECH, V27, P899, DOI 10.1016/0021-9290(94)90262-3; WU JJ, 1991, J BIOL CHEM, V266, P5625; Yekkala R, 2007, J SEP SCI, V30, P118, DOI 10.1002/jssc.200600191	42	134	137	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15674	15681		10.1074/jbc.M109.077503	http://dx.doi.org/10.1074/jbc.M109.077503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308077	Green Published, hybrid			2022-12-25	WOS:000277715900013
J	Card, DAG; Sierant, ML; Davey, S				Card, Deborah A. Greer; Sierant, Megan L.; Davey, Scott			Rad9A Is Required for G(2) Decatenation Checkpoint and to Prevent Endoreduplication in Response to Topoisomerase II Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND BREAKS; CELL-CYCLE EVENTS; IONIZING-RADIATION; MAMMALIAN-CELLS; PROTEIN; DAMAGE; PHOSPHORYLATION; CHK2; ICRF-193; HRAD9	The Rad9A checkpoint protein interacts with and is required for proper localization of topoisomerase II-binding protein 1 (TopBP1) in response to DNA damage. Topoisomerase II (Topo II), another binding partner of TopBP1, decatenates sister chromatids that become intertwined during replication. Inhibition of Topo II by ICRF-193 (meso-4,4'-(3,2-butanediyl)-bis-(2,6-piperazinedione)), a catalytic inhibitor that does not induce DNA double-strand breaks, causes a mitotic delay known as the G(2) decatenation checkpoint. Here, we demonstrate that this checkpoint, dependent on ATR and BRCA1, also requires Rad9A. Analysis of different Rad9A phosphorylation mutants suggests that these modifications are required to prevent endoreduplication and to maintain decatenation checkpoint arrest. Furthermore, Rad9A Ser(272) is phosphorylated in response to Topo II inhibition. ICRF-193 treatment also causes phosphorylation of an effector kinase downstream of Rad9A in the DNA damage checkpoint pathway, Chk2, at Thr(68). Both of these sites are major targets of phosphorylation by the ATM kinase, although it has previously been shown that ATM is not required for the decatenation checkpoint. Examination of ataxia telangectasia (A-T) cells demonstrates that ATR does not compensate for ATM loss, suggesting that phosphorylation of Rad9A and Chk2 by ATM plays an additional role in response to Topo II inhibition than checkpoint function alone. Finally, we have shown that murine embryonic stem cells deficient for Rad9A have higher levels of catenated mitotic spreads than wild-type counterparts. Together, these results emphasize the importance of Rad9A in preserving genomic integrity in the presence of catenated chromosomes and all types of DNA aberrations.	[Card, Deborah A. Greer; Sierant, Megan L.; Davey, Scott] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Card, Deborah A. Greer; Davey, Scott] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Sierant, Megan L.; Davey, Scott] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Botterell Hall,Rm 364, Kingston, ON K7L 3N6, Canada.	sd13@queensu.ca			National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Breast Cancer Fellowship; Canadian Institute for Health Research; Canada Foundation for Innovation; Ontario Research Fund	National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Breast Cancer Fellowship; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund	This work was supported by the National Cancer Institute of Canada through funds from the Canadian Cancer Society, the Canadian Breast Cancer Fellowship (Ontario Chapter), and the Canadian Institute for Health Research (S. D.). Infrastructure used in the course of this work was purchased with funds from the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (S. D.).	Ahn JY, 2000, CANCER RES, V60, P5934; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Chabalier-Taste C, 2008, BBA-MOL CELL RES, V1783, P2223, DOI 10.1016/j.bbamcr.2008.08.006; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; CLARKE DJ, 1993, J CELL SCI, V105, P563; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Franchitto A, 2003, CANCER RES, V63, P3289; Greer DA, 2003, CANCER RES, V63, P4829; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Hajji N, 2003, MUTAT RES-FUND MOL M, V530, P35, DOI 10.1016/S0027-5107(03)00135-0; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Kaufmann WK, 1998, MUTAT RES-FUND MOL M, V400, P153, DOI 10.1016/S0027-5107(98)00041-4; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Marples B, 2003, RADIAT RES, V160, P38, DOI 10.1667/RR3013; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pastor N, 2002, MUTAT RES-GEN TOX EN, V516, P113, DOI 10.1016/S1383-5718(02)00029-3; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sierant ML, 2010, CELL CYCLE, V9, P548, DOI 10.4161/cc.9.3.10553; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 2001, J BIOL CHEM, V276, P41898, DOI 10.1074/jbc.M105152200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; TANABE K, 1991, CANCER RES, V51, P4903; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1	41	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15653	15661		10.1074/jbc.M109.096156	http://dx.doi.org/10.1074/jbc.M109.096156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20305300	Green Published, hybrid			2022-12-25	WOS:000277399000084
J	Nojima, J; Kanomata, K; Takada, Y; Fukuda, T; Kokabu, S; Ohte, S; Takada, T; Tsukui, T; Yamamoto, TS; Sasanuma, H; Yoneyama, K; Ueno, N; Okazaki, Y; Kamijo, R; Yoda, T; Katagiri, T				Nojima, Junya; Kanomata, Kazuhiro; Takada, Yumi; Fukuda, Toru; Kokabu, Shoichiro; Ohte, Satoshi; Takada, Takatora; Tsukui, Tohru; Yamamoto, Takamasa S.; Sasanuma, Hiroki; Yoneyama, Katsumi; Ueno, Naoto; Okazaki, Yasushi; Kamijo, Ryutaro; Yoda, Tetsuya; Katagiri, Takenobu			Dual Roles of Smad Proteins in the Conversion from Myoblasts to Osteoblastic Cells by Bone Morphogenetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; I RECEPTORS; DIFFERENTIATION; GENE; ACTIVATION; IDENTIFICATION; PROGENITORS; COOPERATION; INHIBITION	Bone morphogenetic proteins (BMPs) induce ectopic bone formation in muscle tissue in vivo and convert myoblasts such that they differentiate into osteoblastic cells in vitro. We report here that constitutively active Smad1 induced osteoblastic differentiation of C2C12 myoblasts in cooperation with Smad4 or Runx2. In floxed Smad4 mice-derived cells, Smad4 ablation partially suppressed BMP-4-induced osteoblast differentiation. In contrast, the BMP-4-induced inhibition of myogenesis was lost by Smad4 ablation and restored by Smad4 overexpression. A nuclear zinc finger protein, E4F1, was identified as a possible component of the Smad4 complex that suppresses myogenic differentiation in response to BMP signaling. In the presence of Smad4, E4F1 stimulated the expression of Ids. Taken together, these findings suggest that the Smad signaling pathway may play a dual role in the BMP-induced conversion of myoblasts to osteoblastic cells.	[Sasanuma, Hiroki; Yoneyama, Katsumi] Saitama Med Univ, Div Pathophysiol, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Tsukui, Tohru] Saitama Med Univ, Anim Expt Lab, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; Saitama Med Univ, Div Funct Genom & Syst Res, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Nojima, Junya; Kokabu, Shoichiro; Yoda, Tetsuya] Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Takada, Yumi; Takada, Takatora; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1425555, Japan; [Yamamoto, Takamasa S.; Ueno, Naoto] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Showa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)		katagiri@saitama-med.ac.jp		Ohte, Satoshi/0000-0002-5153-2176; Okazaki, Yasushi/0000-0003-3241-5502; Ueno, Naoto/0000-0002-8375-2317; Kokabu, Shoichiro/0000-0002-6663-4327	Ministry of Health, Labor and Welfare of Japan; Saitama Medical University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Sankyo Foundation of Life Science; Kawano Masanori Memorial Foundation for Promotion of Pediatrics; Novo Nordisk Award for Growth and Development; Japan Intractable Diseases Research Foundation; Takeda Science Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Saitama Medical University(Saitama Medical University); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); Novo Nordisk Award for Growth and Development(Novo Nordisk); Japan Intractable Diseases Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Health and Labor Sciences Research Grants for Research on Measures for Intractable Research from the Ministry of Health, Labor and Welfare of Japan (to T. K.), grant-in-aids from Saitama Medical University Internal Grants (to T. F. and T. K.), grant-in-aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. F. and T. K.), a grant-in-aid for "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Saitama Medical University Research Center for Genomic Medicine (to T. K.), a grant-in-aid from the Sankyo Foundation of Life Science (to T. K.), a grant-in-aid from the Kawano Masanori Memorial Foundation for Promotion of Pediatrics (to T. K.), a grant-in-aid from the Novo Nordisk Award for Growth and Development (to T. K.), a grant-in-aid from Japan Intractable Diseases Research Foundation (to T. F.), and a grant-in-aid from the Takeda Science Foundation (to T. K.).	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Clever JL, 2010, AM J PHYSIOL-CELL PH, V298, pC1087, DOI 10.1152/ajpcell.00388.2009; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hattori H, 2006, BIOCHEM BIOPH RES CO, V343, P1118, DOI 10.1016/j.bbrc.2006.03.061; He LW, 2005, ANAT EMBRYOL, V209, P401, DOI 10.1007/s00429-005-0454-1; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Katagiri Takenobu, 2008, P121; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rooney RJ, 1998, NUCLEIC ACIDS RES, V26, P1681, DOI 10.1093/nar/26.7.1681; SALMINEN A, 1991, J CELL BIOL, V115, P905, DOI 10.1083/jcb.115.4.905; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yoshida S, 1996, J CELL BIOL, V132, P181, DOI 10.1083/jcb.132.1.181; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200	48	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15577	15586		10.1074/jbc.M109.028019	http://dx.doi.org/10.1074/jbc.M109.028019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231279	Green Published, hybrid			2022-12-25	WOS:000277399000076
J	Necchi, V; Sommi, P; Ricci, V; Solcia, E				Necchi, Vittorio; Sommi, Patrizia; Ricci, Vittorio; Solcia, Enrico			In Vivo Accumulation of Helicobacter pylori Products, NOD1, Ubiquitinated Proteins and Proteasome in a Novel Cytoplasmic Structure	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; VACUOLATING CYTOTOXIN; ENDOPLASMIC-RETICULUM; 26S PROTEASOME; CAGA; EXPRESSION; AUTOPHAGY; PATHWAY; SYSTEM; MUCOSA	In Cell internalization and intracellular fate of H. pylori products/virulence factors in vivo by human gastric epithelium, the main target of H. pylori-induced pathologies (i.e., peptic ulcer and cancer), are still largely unknown. Investigating gastric endoscopic biopsies from dyspeptic patients by means of ultrastructural immunocytochemistry, here we show that, in human superficial-foveolar epithelium and its metaplastic or dysplastic foci, H. pylori virulence factors accumulated in a discrete cytoplasmic structure characterized by 13-nm-thick cylindrical particles of regular punctate-linear substructure resembling the proteasome complex in size and structure. Inside this particle-rich cytoplasmic structure (PaCS) we observed colocalization of VacA, CagA, urease and outer membrane proteins with NOD1 receptor, ubiquitin-activating enzyme E1, polyubiquitinated proteins, proteasome components and potentially oncogenic proteins like SHP2 and ERKs in human gastric epithelium. By means of electron and confocal microscopy, we demonstrate that the in vivo findings were reproduced in vitro by incubating human epithelial cell lines with H. pylori products/virulence factors. PaCSs differed from VacA-induced vacuoles, phagosomes, aggresomes or related bodies. Our data suggest that PaCS is a novel, proteasome-enriched structure arising in ribosome-rich cytoplasm at sites of H. pylori products accumulation. As a site of selective concentration of bacterial virulence factors, the ubiquitin-proteasome system and interactive proteins, PaCS is likely to modulate immune-inflammatory and proliferative responses of the gastric epithelium of potential pathologic relevance.	[Necchi, Vittorio; Solcia, Enrico] Univ Pavia, Dept Human Pathol, Sch Med, I-27100 Pavia, Italy; [Sommi, Patrizia; Ricci, Vittorio] Univ Pavia, Sch Med, Dept Physiol, I-27100 Pavia, Italy; [Sommi, Patrizia; Solcia, Enrico] Policlin San Matteo, Fdn IRCCS, Serv Anat Pathol, I-27100 Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo	Necchi, V (corresponding author), Univ Pavia, Dept Human Pathol, Sch Med, Via Palestro 3, I-27100 Pavia, Italy.	vricci@unipv.it			Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo; University of Pavia	Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo; University of Pavia	This investigation was supported in part by grants from the Italian Ministry of Health to the Fondazione IRCCS Policlinico San Matteo and from the University of Pavia (Fondo di Ateneo per la Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Barrera CA, 2001, HUM IMMUNOL, V62, P1081, DOI 10.1016/S0198-8859(01)00281-6; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLASER MJ, 1995, CANCER RES, V55, P2111; Brooks P, 2000, BIOCHEM J, V352, P611, DOI 10.1042/0264-6021:3520611; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; CHAN WY, 1992, HISTOPATHOLOGY, V21, P521, DOI 10.1111/j.1365-2559.1992.tb00439.x; CORREA P, 1988, CANCER RES, V48, P3554; COVER TL, 1992, HUM PATHOL, V23, P1004, DOI 10.1016/0046-8177(92)90261-Z; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; ENGSTRAND L, 1989, INFECT IMMUN, V57, P827, DOI 10.1128/IAI.57.3.827-832.1989; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; FIOCCA R, 1994, SCAND J GASTROENTERO, V29, P11, DOI 10.3109/00365529409091404; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Munro P, 2007, CURR OPIN MICROBIOL, V10, P39, DOI 10.1016/j.mib.2006.11.002; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Necchi V, 2009, HELICOBACTER, V14, P208, DOI 10.1111/j.1523-5378.2009.00679.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Ricci V, 1997, J PATHOL, V183, P453; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958	54	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9716	10.1371/journal.pone.0009716	http://dx.doi.org/10.1371/journal.pone.0009716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300534	gold, Green Submitted, Green Published			2022-12-25	WOS:000275716400014
J	Pereira-Rodrigues, N; Poleni, PE; Guimard, D; Arakawa, Y; Sakai, Y; Fujii, T				Pereira-Rodrigues, Nazare; Poleni, Paul-Emile; Guimard, Denis; Arakawa, Yasuhiko; Sakai, Yasuyuki; Fujii, Teruo			Modulation of Hepatocarcinoma Cell Morphology and Activity by Parylene-C Coating on PDMS	PLOS ONE			English	Article							SCANNING ELECTROCHEMICAL MICROSCOPY; ADSORBED COLLAGEN; PROTEIN ADSORPTION; SANDWICH CULTURE; LIVING CELLS; ADHESION; LIVER; HEPATOCYTES; ORGANIZATION; EXPRESSION	Background: The ability to understand and locally control the morphogenesis of mammalian cells is a fundamental objective of cell and developmental biology as well as tissue engineering research. We present parylene-C (ParC) deposited on polydimethylsiloxane (PDMS) as a new substratum for in vitro advanced cell culture in the case of Human Hepatocarcinoma (HepG2) cells. Principal Findings: Our findings establish that the intrinsic properties of ParC-coated PDMS (ParC/PDMS) influence and modulate initial extracellular matrix (ECM; here, type-I collagen) surface architecture, as compared to non-coated PDMS substratum. Morphological changes induced by the presence of ParC on PDMS were shown to directly affect liver cell metabolic activity and the expression of transmembrane receptors implicated in cell adhesion and cell-cell interaction. These changes were characterized by atomic force microscopy (AFM), which elucidated differences in HepG2 cell adhesion, spreading, and reorganization into two-or three-dimensional structures by neosynthesis of ECM components. Local modulation of cell aggregation was successfully performed using ParC/PDMS micropatterns constructed by simple microfabrication. Conclusion/Significance: We demonstrated for the first time the modulation of HepG2 cells' behavior in relation to the intrinsic physical properties of PDMS and ParC, enabling the local modulation of cell spreading in a 2D or 3D manner by simple microfabrication techniques. This work will provide promising insights into the development of cell-based platforms that have many applications in the field of in vitro liver tissue engineering, pharmacology and therapeutics.	[Pereira-Rodrigues, Nazare; Poleni, Paul-Emile; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, CIRMM, Meguro Ku, Tokyo, Japan; [Poleni, Paul-Emile; Sakai, Yasuyuki; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, LIMMS, CNRS,Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Pereira-Rodrigues, N (corresponding author), Univ Tokyo, Inst Ind Sci, CIRMM, Meguro Ku, Tokyo, Japan.	poleni2003@yahoo.fr			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was sponsored by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japanese Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2002, SEMIN CELL DEV BIOL, V13, P447, DOI 10.1016/S1084952102001337; [Anonymous], 2004, DEKKER ENCY NANOSCIE; ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396; Bard A.J., 2001, SCANNING ELECTROCHEM; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118; Carloni V, 2001, HEPATOLOGY, V34, P42, DOI 10.1053/jhep.2001.25224; Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o; Du Y, 2008, BIOMATERIALS, V29, P290, DOI 10.1016/j.biomaterials.2007.09.016; Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z; Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29; Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GERLACH JC, 2008, BIOARTIFICIAL LIVER, P575; Grant MA, 2005, COLD SH Q B, V70, P399, DOI 10.1101/sqb.2005.70.017; Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009; Kojima Takashi, 2003, Medical Electron Microscopy, V36, P157, DOI 10.1007/s00795-003-0220-5; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; Liu B, 2001, J ELECTROANAL CHEM, V500, P590, DOI 10.1016/S0022-0728(00)00436-8; LOEB GE, 1977, J BIOMED MATER RES, V11, P195, DOI 10.1002/jbm.820110206; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Omstead DR, 1998, TISSUE ENG, V4, P239, DOI 10.1089/ten.1998.4.239; Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012; PARSONSWINGERTER PA, 1993, BIOTECHNOL PROGR, V9, P600, DOI 10.1021/bp00024a006; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; PESHWA MV, 1994, BIOTECHNOL PROGR, V10, P460, DOI 10.1021/bp00029a002; Pinkse GGM, 2005, J HEPATOL, V42, P87, DOI 10.1016/j.jhep.2004.09.010; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; Pirone DM, 2004, J MAMMARY GLAND BIOL, V9, P405, DOI 10.1007/s10911-004-1410-z; Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.3.CO;2-3; Powers MJ, 1996, BIOTECHNOL BIOENG, V50, P392, DOI 10.1002/(SICI)1097-0290(19960520)50:4<392::AID-BIT6>3.0.CO;2-G; Raghavan S, 2004, ADV MATER, V16, P1303, DOI 10.1002/adma.200400594; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAKAI Y, 2004, LAB CHIPS CELLOMICS; Sharma NS, 2006, BIOTECHNOL BIOENG, V94, P1053, DOI 10.1002/bit.20936; Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010; SPRAY DC, 1987, J CELL BIOL, V105, P541, DOI 10.1083/jcb.105.1.541; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011; Xu JS, 2003, TOXICOL APPL PHARM, V189, P100, DOI 10.1016/S0041-008X(03)00089-9; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	64	15	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9667	10.1371/journal.pone.0009667	http://dx.doi.org/10.1371/journal.pone.0009667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300511	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400003
J	Zhang, QB; Fan, HL; Shen, JK; Hoffman, RM; Xing, HR				Zhang, Qingbei; Fan, Hanli; Shen, Jikun; Hoffman, Robert M.; Xing, H. Rosie			Human Breast Cancer Cell Lines Co-Express Neuronal, Epithelial, and Melanocytic Differentiation Markers In Vitro and In Vivo	PLOS ONE			English	Article							MDA-MB-435 CELLS; EXPRESSION; MELANOMA; GENE	Differentiation programs are aberrant in cancer cells allowing them to express differentiation markers in addition to their tissue of origin. In the present study, we demonstrate the multi-lineage differentiation potential of breast cancer cell lines to express multiple neuronal/glial lineage-specific markers as well as mammary epithelial and melanocytic-specific markers. Multilineage expression was detected in luminal (MCF-7 and SKBR3) and basal (MDA-MB-231) types of human breast cancer cell lines. We also observed comparable co-expression of these three cell lineage markers in MDA-MB-435 cells in vitro, in MDA-MB-435 primary tumors derived from parental and single cell clones and in lung metastases in vivo. Furthermore, ectoderm multi-lineage transdifferentiation was also found in human melanoma (Ul-MeL) and glioblastoma cell lines (U87 and D54). These observations indicate that aberrant multi-lineage transdifferentiation or lineage infidelity may be a wide spread phenomenon in cancer.	[Zhang, Qingbei; Fan, Hanli; Shen, Jikun; Xing, H. Rosie] Univ Chicago, Dept Pathol Cellular & Radiat Oncol, Chicago, IL 60637 USA; [Xing, H. Rosie] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	University of Chicago; University of Chicago; Anti Cancer Inc; University of California System; University of California San Diego	Zhang, QB (corresponding author), Univ Chicago, Dept Pathol Cellular & Radiat Oncol, Chicago, IL 60637 USA.	hxing@bsd.uchicago.edu			University of Chicago	University of Chicago(University of Chicago)	This work is supported by the start-up fund provided to H. R. X. by the University of Chicago. AntiCancer provided the GFP-labeled breast cancer line used in the study as scientific collaboration and contributed to the preparation of the manuscript. The funders had no role in study design, data collection and analysis, or decision to publish.	CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; HOWLETT AR, 1994, J NATL CANCER I, V86, P1838, DOI 10.1093/jnci/86.24.1838; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Quiros I, 2009, INT J CANCER, V125, P1497, DOI 10.1002/ijc.24501; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; You HH, 2001, CELL GROWTH DIFFER, V12, P471	14	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9712	10.1371/journal.pone.0009712	http://dx.doi.org/10.1371/journal.pone.0009712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300523	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400010
J	Yoshihara, K; Tajima, A; Yahata, T; Kodama, S; Fujiwara, H; Suzuki, M; Onishi, Y; Hatae, M; Sueyoshi, K; Fujiwara, H; Kudo, Y; Kotera, K; Masuzaki, H; Tashiro, H; Katabuchi, H; Inoue, I; Tanaka, K				Yoshihara, Kosuke; Tajima, Atsushi; Yahata, Tetsuro; Kodama, Shoji; Fujiwara, Hiroyuki; Suzuki, Mitsuaki; Onishi, Yoshitaka; Hatae, Masayuki; Sueyoshi, Kazunobu; Fujiwara, Hisaya; Kudo, Yoshiki; Kotera, Kohei; Masuzaki, Hideaki; Tashiro, Hironori; Katabuchi, Hidetaka; Inoue, Ituro; Tanaka, Kenichi			Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; C-MYC GENE; PROGNOSTIC-FACTOR; DATA SETS; MICROARRAY; CHEMOTHERAPY; PACLITAXEL; SIGNATURE; CARCINOMA; CYCLOPHOSPHAMIDE	Background: Advanced-stage ovarian cancer patients are generally treated with platinum/taxane-based chemotherapy after primary debulking surgery. However, there is a wide range of outcomes for individual patients. Therefore, the clinicopathological factors alone are insufficient for predicting prognosis. Our aim is to identify a progression-free survival (PFS)-related molecular profile for predicting survival of patients with advanced-stage serous ovarian cancer. Methodology/Principal Findings: Advanced-stage serous ovarian cancer tissues from 110 Japanese patients who underwent primary surgery and platinum/taxane-based chemotherapy were profiled using oligonucleotide microarrays. We selected 88 PFS-related genes by a univariate Cox model (p < 0.01) and generated the prognostic index based on 88 PFS-related genes after adjustment of regression coefficients of the respective genes by ridge regression Cox model using 10-fold cross-validation. The prognostic index was independently associated with PFS time compared to other clinical factors in multivariate analysis [hazard ratio (HR), 3.72; 95% confidence interval (CI), 2.66-5.43; p < 0.0001]. In an external dataset, multivariate analysis revealed that this prognostic index was significantly correlated with PFS time (HR, 1.54; 95% CI, 1.20-1.98; p = 0.0008). Furthermore, the correlation between the prognostic index and overall survival time was confirmed in the two independent external datasets (log rank test, p = 0.0010 and 0.0008). Conclusions/Significance: The prognostic ability of our index based on the 88-gene expression profile in ridge regression Cox hazard model was shown to be independent of other clinical factors in predicting cancer prognosis across two distinct datasets. Further study will be necessary to improve predictive accuracy of the prognostic index toward clinical application for evaluation of the risk of recurrence in patients with advanced-stage serous ovarian cancer.	[Yoshihara, Kosuke; Yahata, Tetsuro; Tanaka, Kenichi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Tajima, Atsushi; Inoue, Ituro] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Kodama, Shoji] Niigata Canc Ctr Hosp, Dept Gynecol, Niigata, Japan; [Fujiwara, Hiroyuki; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Japan; [Onishi, Yoshitaka; Hatae, Masayuki] Kagoshima City Hosp, Dept Obstet & Gynecol, Kagoshima, Japan; [Sueyoshi, Kazunobu] Kagoshima City Hosp, Dept Pathol, Kagoshima, Japan; [Fujiwara, Hisaya; Kudo, Yoshiki] Hiroshima Univ, Dept Obstet & Gynecol, Grad Sch Biomed Sci, Hiroshima, Japan; [Kotera, Kohei] Nagasaki Municipal Hosp, Dept Obstet & Gynecol, Nagasaki, Japan; [Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan; [Tashiro, Hironori; Katabuchi, Hidetaka] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Gynecol, Kumamoto, Japan	Niigata University; Tokai University; Jichi Medical University; Kagoshima City Hospital; Kagoshima City Hospital; Hiroshima University; Nagasaki University; Kumamoto University	Yoshihara, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan.	tanaken@med.niigata-u.ac.jp	Yoshihara, Kosuke/AAU-9874-2020; Tajima, Atsushi/C-1053-2008	Yoshihara, Kosuke/0000-0002-2254-3378; Tajima, Atsushi/0000-0001-6808-5491	Ministry of Health, Labor and Welfare, Japan; Tokai University Educational System General Research Organization	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Tokai University Educational System General Research Organization	This work was supported in part by a Grant-in-Aid for the Third- term Cancer Control Strategy Program from the Ministry of Health, Labor and Welfare, Japan (KT), and 2009 Research and Study Program of Tokai University Educational System General Research Organization (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, CURR OPIN PHARMACOL, V6, P345, DOI 10.1016/j.coph.2006.02.007; [Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Darcy KM, 2009, GYNECOL ONCOL, V114, P472, DOI 10.1016/j.ygyno.2009.05.012; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; FIGO Cancer Committee, 1986, GYNECOL ONCOL, V25, P383; Goodman MT, 2003, CANCER, V97, P2676, DOI 10.1002/cncr.11349; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Iba T, 2004, CANCER SCI, V95, P418, DOI 10.1111/j.1349-7006.2004.tb03225.x; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kommoss S, 2009, VIRCHOWS ARCH, V454, P249, DOI 10.1007/s00428-009-0725-y; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Motoori M, 2005, INT J CANCER, V114, P963, DOI 10.1002/ijc.20808; Okada H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040026; Ozols RF, 2005, INT J GYNECOL CANCER, V15, P3, DOI 10.1111/j.1525-1438.2005.15351.x; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Silverberg SG, 2000, INT J GYNECOL PATHOL, V19, P7, DOI 10.1097/00004347-200001000-00003; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; TAWASSOLI FA, 2003, PATHOLOGY GENETICS T; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Woo HG, 2008, CLIN CANCER RES, V14, P2056, DOI 10.1158/1078-0432.CCR-07-1473; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x	52	99	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9615	10.1371/journal.pone.0009615	http://dx.doi.org/10.1371/journal.pone.0009615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300634	Green Submitted, gold, Green Published			2022-12-25	WOS:000275620900001
J	Newton, SM; Trinh, V; Pi, HL; Klebba, PE				Newton, Salete M.; Trinh, Vy; Pi, Hualiang; Klebba, Phillip E.			Direct Measurements of the Outer Membrane Stage of Ferric Enterobactin Transport POSTUPTAKE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENERGY TRANSDUCTION; IRON TRANSPORT; TONB PROTEIN; VITAMIN-B12; COMPONENTS; HOMOLOGY; KINETICS; MUTANTS; PHI-80	When Gram-negative bacteria acquire iron, the metal crosses both the outer membrane (OM) and the inner membrane, but existing radioisotopic uptake assays only measure its passage through the latter bilayer, as the accumulation of the radionuclide in the cytoplasm. We devised a methodology that exclusively observes OM transport and used it to study the uptake of ferric enterobactin (FeEnt) by Escherichia coli FepA. This technique, called postuptake binding, revealed previously unknown aspects of TonB-dependent transport reactions. The experiments showed, for the first time, that despite the discrepancy in cell envelope concentrations of FepA and TonB (similar to 35:1), all FepA proteins were active and equivalent in FeEnt uptake, with a maximum turnover number of similar to 5/min. FepA-mediated transport of FeEnt progressed through three distinct phases with successively decreasing rates, and from its temperature dependence, the activation energy of the OM stage was 33-35 kcal/mol. The accumulation of FeEnt in the periplasm required the binding protein and inner membrane permease components of its overall transport system; postuptake binding assays on strains devoid of FepB, FepD, or FepG did not show uptake of FeEnt through the OM. However, fluorescence labeling data implied that FepA was active in the Delta fepB strain, suggesting that FeEnt entered the periplasm but then leaked out. Further experiments confirmed this futile cycle; cells without FepB transported FeEnt across the OM, but it immediately escaped through TolC.	[Newton, Salete M.; Trinh, Vy; Pi, Hualiang; Klebba, Phillip E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Klebba, PE (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	peklebba@ou.edu			National Institutes of Health [GM53836]; National Science Foundation [MCB0417694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53836. This work was also supported by National Science Foundation Grant MCB0417694 (to P. E. K. and S. M. N.).	AMES GFL, 1974, J BIOL CHEM, V249, P634; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bowen H.J.M., 1966, TRACE ELEMENTS BIOCH; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Breidenstein E, 2006, J BACTERIOL, V188, P6440, DOI 10.1128/JB.00741-06; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cabrales P, 2007, ANTIOXID REDOX SIGN, V9, P375, DOI 10.1089/ars.2006.1379; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; GUTFREUND H, 1995, KINETICS LIFE SCI RE, P233; HANCOCK REW, 1976, J BACTERIOL, V125, P409, DOI 10.1128/JB.125.2.409-415.1976; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; Khursigara CM, 2005, BIOCHEMISTRY-US, V44, P3441, DOI 10.1021/bi047882p; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2004, IRON TRANSPORT IN BACTERIA, P147; Klebba PE, 2003, FRONT BIOSCI, V8, pS1422, DOI 10.2741/1233; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; KONISKY J, 1979, BACTERIAL OUTER MEMB, P359; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; KREWULAK KD, 2008, J BIOCH BIOPHYS ACTA, V1778, P1781; Larsen RA, 2003, MOL MICROBIOL, V49, P211, DOI 10.1046/j.1365-2958.2003.03579.x; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Miller J. H., 1972, EXPT MOL GENETICS, P433; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; NEILANDS JB, 1974, MICROBIAL IRON METAB, V1, P4; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NORTH ML, 1984, NOUV REV FR HEMATOL, V26, P317; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; PIERCE JR, 1983, J BACTERIOL, V155, P330, DOI 10.1128/JB.155.1.330-336.1983; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; SHEA CM, 1991, MOL MICROBIOL, V5, P1415, DOI 10.1111/j.1365-2958.1991.tb00788.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; STEPHENS DL, 1995, MICROBIOL-SGM, V141, P1647, DOI 10.1099/13500872-141-7-1647; TIDMARSH GF, 1983, J INORG BIOCHEM, V18, P161, DOI 10.1016/0162-0134(83)80019-1; Udho E, 2009, P NATL ACAD SCI USA, V106, P21990, DOI 10.1073/pnas.0910023106; WANG CC, 1971, J BIOL CHEM, V246, P2147; WANG CC, 1969, J BACTERIOL, V98, P1142, DOI 10.1128/JB.98.3.1142-1150.1969; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	67	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17488	17497		10.1074/jbc.M109.100206	http://dx.doi.org/10.1074/jbc.M109.100206			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335169	hybrid, Green Published			2022-12-25	WOS:000278133400027
J	Patel, N; Sundaram, N; Yang, MY; Madigan, C; Kalra, VK; Malik, P				Patel, Nitin; Sundaram, Nambirajan; Yang, Mingyan; Madigan, Catherine; Kalra, Vijay K.; Malik, Punam			Placenta Growth Factor (PlGF), a Novel Inducer of Plasminogen Activator Inhibitor-1 (PAI-1) in Sickle Cell Disease (SCD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; RESPONSE ELEMENT; FACTOR-I; INDUCTION; TRANSCRIPTION; COAGULATION; INSULIN; IDENTIFICATION; INFLAMMATION	Sickle cell disease (SCD) is characterized by a prothrombotic state. Plasminogen activator inhibitor-1 (PAI-1) is known to modulate fibrinolysis, lung injury/fibrosis, and angiogenesis. However, its role in SCD is less understood, and the molecular mechanisms underlying increased PAI-1 are unknown. Herein, we show a novel link between PAI-1 and sickle erythropoiesis. Plasma PAI-1 levels were high in SCD patients at steady state and in two humanized sickle mouse models, with increased PAI-1 immunolabeling in sickle mouse lung, bronchial epithelial cells, alveolar macrophages, and pulmonary microvascular endothelial cells. Placenta growth factor (PlGF), released at high levels by sickle erythroblasts, induced PAI-1 expression in primary human pulmonary microvascular endothelial cells and monocytes through activation of c-Jun N-terminal kinase (JNK), NADPH oxidase, and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Analysis of the human PAI-1 promoter revealed this induction was mediated by hypoxia-response element (HRE)-1, HRE-2, and distal activator protein (AP-1) sites. We also identify the involvement of c-Jun, c-Jun/c-Fos, and JunD, but not JunB, in binding with AP-1 sites of the PAI-1 promoter upon PlGF induction. Consistent with these findings, levels of PAI-1 were low in PlGF knock-out mice and sickle-PlGF knock-out mice; overexpression of PlGF in normal mice increased circulating PAI-1. In conclusion, we identify a novel mechanism of PAI-1 elevation in SCD.	Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90089 USA; [Sundaram, Nambirajan; Yang, Mingyan; Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; [Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA; [Madigan, Catherine] Univ Calif San Diego, Rady Childrens Hosp, Div Hematol, San Diego, CA 92123 USA	University of Southern California; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kalra, VK (corresponding author), HMR-611,2011 Zonal Ave, Los Angeles, CA 90089 USA.	Punam.Malik@cchmc.org	Patel, Nitin/C-9625-2010		National Institutes of Health [R01-HL-079916, HL-070595, P30-DK 048522]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070595, R01HL079916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL-079916 and HL-070595 (to P. M.).; We thank Dr. Peter Carmeliet (Vesalius Research Center, VIB-Vlaams Instituut voor Biotechnologie, Leuven, Belgium) for kindly providing PlGF knock-out mice. We also thank Dr. Timothy Townes (University of Alabama, Birmingham, AL) for providing knock-in sickle mice and AA control mice, Dr. Trine Fink (University of Aalborg, Aalborg, Denmark) for kindly providing PAI-1 WT and individual HRE mutant promoter constructs, Dr. Michael Karin (University of California San Diego, La Jolla, CA) for providing c-Fos, c-Jun, and JunD expression plasmids, Dr. Anupam Agarwal (University of Alabama, Birmingham, AL) for JunB expression plasmid, and Dr. Debbie Johnson (USC Keck School of Medicine, Los Angeles, CA) for providing DnPI3K and phosphatase and tensin homolog plasmids. We thank Dr. Jeffrey Molkentin, Division of Cardiology, Heart Institute, Cincinnati Children's Hospital Medical Center, for providing us with the Ad-PlGF and Ad-GFP vector constructs. We are grateful to Jeff Bailey and Victoria Summey of the Comprehensive Mouse Core, Cincinnati Children's Hospital Medical Center for their assistance with murine injections and the Hematology Repository and the Translational Core Laboratory at the Cincinnati Children's Hospital Medical Center for processing and providing human samples. We also thank the Institutional Core of USC Research Center for Liver Disease for the use of a sequence detection instrument (supported by National Institutes of Health Grant P30-DK 048522) and Dr. Susan Wert, Perinatal Institute, CCHMC, for assistance with immunohistochemistry.	Andrew AS, 2001, AM J PHYSIOL-LUNG C, V281, pL616, DOI 10.1152/ajplung.2001.281.3.L616; Arndt PG, 2005, J IMMUNOL, V175, P4049, DOI 10.4049/jimmunol.175.6.4049; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; BERNEY SI, 1992, AM J HEMATOL, V40, P290, DOI 10.1002/ajh.2830400409; BEVILACQUA MP, 1986, J CLIN INVEST, V78, P587, DOI 10.1172/JCI112613; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimova EY, 2006, ANN NY ACAD SCI, V1090, P355, DOI 10.1196/annals.1378.039; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Fink T, 2002, BLOOD, V99, P2077, DOI 10.1182/blood.V99.6.2077; FRANCIS RB, 1991, BLOOD, V77, P1405; GELEHRTER TD, 1986, J CLIN INVEST, V77, P165, DOI 10.1172/JCI112271; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gordeuk VR, 2006, SEMIN THROMB HEMOST, V32, P289, DOI 10.1055/s-2006-939441; Hillery CA, 2004, MICROCIRCULATION, V11, P195, DOI 10.1080/10739680490278600; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Holmes DIR, 2004, FEBS LETT, V557, P93, DOI 10.1016/S0014-5793(03)01452-2; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; NACHMAN RL, 1986, J EXP MED, V163, P1595, DOI 10.1084/jem.163.6.1595; Nsiri B, 1997, HEMATOL CELL THER, V39, P229, DOI 10.1007/s00282-997-0229-7; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Petzelbauer E, 1996, AM J PATHOL, V149, P923; Rose P, 2008, AM J PHYSIOL-HEART C, V294, pH1075, DOI 10.1152/ajpheart.00913.2007; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Soeda S, 1998, BBA-MOL CELL RES, V1448, P37, DOI 10.1016/S0167-4889(98)00112-8; SPRENGERS ED, 1987, BLOOD, V69, P381; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Vulin AI, 2004, J BIOL CHEM, V279, P25172, DOI 10.1074/jbc.M403184200; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	49	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16713	16722		10.1074/jbc.M110.101691	http://dx.doi.org/10.1074/jbc.M110.101691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351105	Green Published, hybrid			2022-12-25	WOS:000277982600035
J	Sharma, A; Luke, CT; Dower, NA; Stone, JC; Lorenzo, PS				Sharma, Amrish; Luke, Courtney T.; Dower, Nancy A.; Stone, James C.; Lorenzo, Patricia S.			RasGRP1 Is Essential for Ras Activation by the Tumor Promoter 12-O-Tetradecanoylphorbol-13-acetate in Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL-BINDING MOTIFS; NUCLEOTIDE-RELEASING PROTEIN; MAP KINASE; SKIN TUMORIGENESIS; SIGNALING PATHWAY; CELL DEVELOPMENT; PHORBOL ESTERS; R-RAS; GOLGI	RasGRP1 is a guanine nucleotide exchange factor for Ras that binds with high affinity to diacylglycerol analogs like the phorbol esters. Recently, we demonstrated a role for RasGRP1 in skin carcinogenesis and suggested its participation in the action of tumor-promoting phorbol esters like 12-O-tetradecanoylphorbol-13-acetate (TPA) on Ras pathways in epidermal cells. Given the importance of Ras in carcinogenesis, we sought to discern whether RasGRP1 was a critical pathway in Ras activation, using a RasGRP1 knockout (KO) mouse model to examine the response of keratinocytes to TPA. In contrast to the effect seen in wild type keratinocytes, RasGTP levels were barely detected in RasGRP1 KO cells even after 60 min of exposure to phorbol esters. The lack of response was rescued by enforced expression of RasGRP1. Furthermore, small hairpin RNA-induced silencing of RasGRP1 abrogated the effect of TPA on Ras. Analysis of Ras isoforms showed that both H-Ras and N-Ras depended on RasGRP1 for activation by TPA, whereas activation of K-Ras could not be detected. Although RasGRP1 was dispensable for ERK activation in response to TPA, JNK activation was reduced in the KO keratinocytes. Notably, TPA-induced phosphorylation of JNK2, but not JNK1, was reduced by RasGRP1 depletion. These data identify RasGRP1 as a critical molecule in the activation of Ras by TPA in primary mouse keratinocytes and suggest JNK2 as one of the relevant downstream targets. Given the role of TPA as a skin tumor promoter, our findings provide additional support for a role for RasGRP1 in skin carcinogenesis.	[Sharma, Amrish; Luke, Courtney T.; Lorenzo, Patricia S.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Alberta; University of Alberta	Lorenzo, PS (corresponding author), 651 Ilalo St,Ste 222-K, Honolulu, HI 96813 USA.	plorenzo@crch.hawaii.edu						Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Chen NY, 2001, CANCER RES, V61, P3908; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Diez FR, 2009, AM J PATHOL, V175, P392, DOI 10.2353/ajpath.2009.090036; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Feith DJ, 2005, CANCER RES, V65, P572; Gross ND, 2007, CLIN CANCER RES, V13, P5910, DOI 10.1158/1078-0432.CCR-07-0352; HECKER E, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1890; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Lee SH, 2009, J IMMUNOL, V183, P7931, DOI 10.4049/jimmunol.0902012; Li J, 1999, J BIOL CHEM, V274, P4213, DOI 10.1074/jbc.274.7.4213; Li YS, 1996, MOL CELL BIOL, V16, P5947; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Luke CT, 2007, CANCER RES, V67, P10190, DOI 10.1158/0008-5472.CAN-07-2375; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Marks F, 1995, MUTAT RES-FUND MOL M, V333, P161, DOI 10.1016/0027-5107(95)00142-5; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; PUNNONEN K, 1992, J INVEST DERMATOL, V99, P221, DOI 10.1111/1523-1747.ep12650445; Rambaratsingh RA, 2003, J BIOL CHEM, V278, P52792, DOI 10.1074/jbc.M308240200; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; She QB, 2002, CANCER RES, V62, P1343; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Tuthill MC, 2006, MOL CANCER THER, V5, P602, DOI 10.1158/1535-7163.MCT-05-0317; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zhang JY, 2007, CANCER RES, V67, P3827, DOI 10.1158/0008-5472.CAN-06-4017; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	54	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15724	15730		10.1074/jbc.M109.100016	http://dx.doi.org/10.1074/jbc.M109.100016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308057	Green Published, hybrid			2022-12-25	WOS:000277715900007
J	Singleton, C; White, GF; Todd, JD; Marritt, SJ; Cheesman, MR; Johnston, AWB; Le Brun, NE				Singleton, Chloe; White, Gaye F.; Todd, Jonathan D.; Marritt, Sophie J.; Cheesman, Myles R.; Johnston, Andrew W. B.; Le Brun, Nick E.			Heme-responsive DNA Binding by the Global Iron Regulator Irr from Rhizobium leguminosarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMBIOTIC BACTERIUM RHIZOBIUM; FERRIC UPTAKE REGULATOR; BRADYRHIZOBIUM-JAPONICUM; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSOR; ALPHA-PROTEOBACTERIA; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN	Heme, a physiologically crucial form of iron, is a cofactor for a very wide range of proteins and enzymes. These include DNA regulatory proteins in which heme is a sensor to which an analyte molecule binds, effecting a change in the DNA binding affinity of the regulator. Given that heme, and more generally iron, must be carefully regulated, it is surprising that there are no examples yet in bacteria in which heme itself is sensed directly by a reversibly binding DNA regulatory protein. Here we show that the Rhizobium leguminosarum global iron regulatory protein Irr, which has many homologues within the alpha-proteobacteria and is a member of the Fur superfamily, binds heme, resulting in a dramatic decrease in affinity between the protein and its cognate, regulatory DNA operator sequence. Spectroscopic studies of wild-type and mutant Irr showed that the principal (but not only) heme-binding site is at a conserved HXH motif, whose substitution led to loss of DNA binding in vitro and of regulatory function in vivo. The R. leguminosarum Irr behaves very differently to the Irr of Bradyrhizobium japonicum, which is rapidly degraded in vivo by an unknown mechanism in conditions of elevated iron or heme, but whose DNA binding affinity in vitro does not respond to heme.	[White, Gaye F.; Todd, Jonathan D.; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Singleton, Chloe; White, Gaye F.; Marritt, Sophie J.; Cheesman, Myles R.; Le Brun, Nick E.] Univ E Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk; n.le-brun@uea.ac.uk	Johnston, Andrew W B/D-1859-2009; Todd, Jonathan/B-8967-2009	Todd, Jonathan/0000-0003-0777-9312; Le Brun, Nick/0000-0001-9780-4061	UK BBSRC [BB/E003400/1, BB/E013252/1, BB/C007808/1]; Wellcome Trust; BBSRC [BB/D001943/1, BB/E013252/1, BB/E003400/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C502822/1, BB/D001943/1, BB/E003400/1, BB/C007808/1, BB/E013252/1] Funding Source: researchfish	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK BBSRC through Grant BB/E003400/1 (to A. W. B. J. and N. E. L. B.), Grants BB/E013252/1 and BB/C007808/1 (to M. R. C.), and the Wellcome Trust through an award from the Joint Infrastructure Fund for equipment.	Allaway D, 2001, ENVIRON MICROBIOL, V3, P397, DOI 10.1046/j.1462-2920.2001.00205.x; An YJ, 2009, NUCLEIC ACIDS RES, V37, P3442, DOI 10.1093/nar/gkp198; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Carlton TM, 2007, ENVIRON MICROBIOL, V9, P2923, DOI 10.1111/j.1462-2920.2007.01402.x; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Chikira M., 1980, DALTON T, P526; D'Autreaux B, 2007, BIOCHEMISTRY-US, V46, P1329, DOI 10.1021/bi061636r; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; FALK JE, 1964, PORPHYRINS METALLOPO; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Martinez M, 2006, MICROBIOL-SGM, V152, P2591, DOI 10.1099/mic.0.28782-0; Ngok-Ngam P, 2009, J BACTERIOL, V191, P2083, DOI 10.1128/JB.01380-08; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Smith A, 1996, J PROTEIN CHEM, V15, P575, DOI 10.1007/BF01908539; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd JD, 2005, MOL GENET GENOMICS, V273, P197, DOI 10.1007/s00438-005-1127-8; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; Todd JD, 2006, MOL GENET GENOMICS, V275, P564, DOI 10.1007/s00438-006-0115-y; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; Wexler M, 2003, MICROBIOL-SGM, V149, P1357, DOI 10.1099/mic.0.26130-0; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yeoman KH, 2004, MICROBIOL-SGM, V150, P4065, DOI 10.1099/mic.0.27419-0; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	54	41	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16023	16031		10.1074/jbc.M109.067215	http://dx.doi.org/10.1074/jbc.M109.067215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20233710	Green Published, hybrid			2022-12-25	WOS:000277715900040
J	Jiang, XN; Chen, S; Asara, JM; Balk, SP				Jiang, Xinnong; Chen, Sen; Asara, John M.; Balk, Steven P.			Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110 beta and p110 delta Catalytic Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TUMOR-SUPPRESSOR GENE; ONCOGENIC TRANSFORMATION; PHOSPHATIDYLINOSITOL 3'-KINASE; PTEN; P110-ALPHA; GROWTH; PI3K; METABOLISM; DELETION	Class IA phosphoinositide 3-kinase (PI3K) p110 catalytic subunits are activated upon Src homology 2 domain-mediated binding of their p85 regulatory subunits to tyrosine-phosphorylated pYXXM motifs in receptor tyrosine kinases (RTKs) or adaptor proteins. The PI3K pathway is activated by phosphate and tensin homolog (PTEN) loss in most prostate cancers (PCa), but the contribution of upstream RTKs that may be targeted therapeutically has not been assessed. Immunoblotting of p85-associated proteins in serum-starved PTEN-deficient LNCaP and C4-2 PCa cells showed a small set of discrete tyrosine-phosphorylated proteins, but these proteins were not recognized by an anti-pYXXM motif antibody and were not found in PTEN-deficient PC3 PCa cells. LC/MS/MS using label-free proteomics and immunoblotting showed that p85 was associated primarily with p110 beta and p110 delta. An interaction with ErbB3 was also detected but was independent of ErbB3 tyrosine phosphorylation and was not required for basal PI3K activity. Basal tyrosine phosphorylation of p110 beta and p110 delta could be blocked by c-Src inhibitors, but this did not suppress PI3K activity, which was similarly independent of Ras. Basal PI3K activity was mediated by p110 beta in PC3 cells and by both p110 beta and p110 delta in LNCaP cells, whereas p110 alpha was required for PI3K activation in response to RTK stimulation by heregulin-beta 1. These findings show that basal PI3K activity in PTEN-deficient PCa cells is RTK-independent and can be mediated by p110 beta and p110 delta. Increased p110 beta expression in PCa may be required for RTK-independent PI3K pathway activation in adult prostate epithelium with genetic or epigenetic PTEN down-regulation.	[Jiang, Xinnong; Asara, John M.; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Signal Transduct Div, Dept Med,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Balk, SP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	sbalk@bidmc.harvard.edu			National Institutes of Health [P50 CA90381, P01CA89021]; United States Department of Defense [PC073779]; NATIONAL CANCER INSTITUTE [P01CA089021, P30CA006516, P50CA090381, P01CA120964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants Prostate SPORE P50 CA90381 and P01CA89021 ( to S. P. B.). This work was also supported by United States Department of Defense Grant PC073779 ( to S. P. B.).	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Cairns P, 1997, CANCER RES, V57, P4997; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hazeki O, 1998, LIFE SCI, V62, P1555, DOI 10.1016/S0024-3205(98)00106-4; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jia SD, 2009, CURR OPIN CELL BIOL, V21, P199, DOI 10.1016/j.ceb.2008.12.007; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; McMenamin ME, 1999, CANCER RES, V59, P4291; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rubin MA, 2000, HUM PATHOL, V31, P504, DOI 10.1053/hp.2000.6713; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vanaja DK, 2003, CANCER RES, V63, P3877; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Yang Xuemei, 2009, J Biomol Tech, V20, P272; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu Q, 2008, ONCOGENE, V27, P4569, DOI 10.1038/onc.2008.91	42	71	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14980	14989		10.1074/jbc.M109.085696	http://dx.doi.org/10.1074/jbc.M109.085696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231295	Green Published, hybrid			2022-12-25	WOS:000277399000019
J	Fard, SS; Kele, J; Vilar, M; Paratcha, G; Ledda, F				Fard, Shahrzad Shirazi; Kele, Julianna; Vilar, Marcal; Paratcha, Gustavo; Ledda, Fernanda			Tiam1 as a Signaling Mediator of Nerve Growth Factor-Dependent Neurite Outgrowth	PLOS ONE			English	Article							SCHWANN-CELL MIGRATION; RAC1 EXCHANGE FACTOR; RHO-GTPASES; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GUANOSINE TRIPHOSPHATASES; MENTAL-RETARDATION; RAS ACTIVATION; PROTEIN; PATHWAY	Nerve Growth Factor (NGF)-induced neuronal differentiation requires the activation of members of the Rho family of small GTPases. However, the molecular mechanisms through which NGF regulates cytoskeletal changes and neurite outgrowth are not totally understood. In this work, we identify the Rac1-specific guanine exchange factor (GEF) Tiam1 as a novel mediator of NGF/TrkA-dependent neurite elongation. In particular, we report that knockdown of Tiam1 causes a significant reduction in Rac1 activity and neurite outgrowth induced by NGF. Physical interaction between Tiam1 and active Ras (Ras-GTP), but not tyrosine phosphorylation of Tiam1, plays a central role in Rac1 activation by NGF. In addition, our findings indicate that Ras is required to associate Tiam1 with Rac1 and promote Rac1 activation upon NGF stimulation. Taken together, these findings define a novel molecular mechanism through which Tiam1 mediates TrkA signaling and neurite outgrowth induced by NGF.	[Fard, Shahrzad Shirazi; Kele, Julianna; Paratcha, Gustavo; Ledda, Fernanda] Karolinska Inst, Dept Neurosci, Mol & Cellular Neurosci Lab, Stockholm, Sweden; [Paratcha, Gustavo; Ledda, Fernanda] Univ Buenos Aires, Sch Med, CONICET,Div Mol & Cellular Neurosci, Inst Cellular Biol & Neurosci Prof Dr E De Robert, Buenos Aires, DF, Argentina; [Vilar, Marcal] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	Karolinska Institutet; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Valencia	Fard, SS (corresponding author), Karolinska Inst, Dept Neurosci, Mol & Cellular Neurosci Lab, Stockholm, Sweden.	fernanda.ledda@ki.se	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544; Paratcha, Gustavo/0000-0002-0804-4433; Kele, Julianna/0000-0003-3418-1412	Swedish Medical Research Council [33P-15416-01A, 33SX-14773-01A, K2007-68X-20483-01-3, 33PS-14809-01A]; Karolinska Institute [2006FoBi0639, 2006FoBi0977]; Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology [ANPCyT-PICT2007-01034]; Argentine Medical Research Council (CONICET); ParkinsonFonden, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institute(Karolinska Institutet); Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology; Argentine Medical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ParkinsonFonden, Sweden	Financial support was obtained from the Swedish Medical Research Council (33P-15416-01A, 33SX-14773-01A and K2007-68X-20483-01-3), Karolinska Institute (2006FoBi0639 and 2006FoBi0977), Royal Swedish Academy of Science, Argentine Agency for Promotion of Science and Technology (ANPCyT-PICT2007-01034) and Argentine Medical Research Council (CONICET). F. L. was supported by an assistant researcher position from the Swedish Medical Research Council (33P-15416-01A), and G. P. was supported by an assistant researcher position from the Swedish Medical Research Council (33PS-14809-01A) and Karolinska Institute. JKO was supported by ParkinsonFonden, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kita Y, 1998, J CELL SCI, V111, P907; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	48	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9647	10.1371/journal.pone.0009647	http://dx.doi.org/10.1371/journal.pone.0009647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333299	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809700006
J	Hernandez-Vargas, H; Lambert, MP; Le Calvez-Kelm, F; Gouysse, G; McKay-Chopin, S; Tavtigian, SV; Scoazec, JY; Herceg, Z				Hernandez-Vargas, Hector; Lambert, Marie-Pierre; Le Calvez-Kelm, Florence; Gouysse, Geraldine; McKay-Chopin, Sandrine; Tavtigian, Sean V.; Scoazec, Jean-Yves; Herceg, Zdenko			Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; CPG ISLAND HYPERMETHYLATION; GENE-EXPRESSION PROFILES; MICROARRAY DATA; MOLECULAR PATHOGENESIS; INCREASED RISK; HEPATITIS; CANCER; POLYMORPHISMS; HEPATOCARCINOGENESIS	Background: Hepatocellular carcinoma (HCC) is characterized by late detection and fast progression, and it is believed that epigenetic disruption may be the cause of its molecular and clinicopathological heterogeneity. A better understanding of the global deregulation of methylation states and how they correlate with disease progression will aid in the design of strategies for earlier detection and better therapeutic decisions. Methods and Findings: We characterized the changes in promoter methylation in a series of 30 HCC tumors and their respective surrounding tissue and identified methylation signatures associated with major risk factors and clinical correlates. A wide panel of cancer-related gene promoters was analyzed using Illumina bead array technology, and CpG sites were then selected according to their ability to classify clinicopathological parameters. An independent series of HCC tumors and matched surrounding tissue was used for validation of the signatures. We were able to develop and validate a signature of methylation in HCC. This signature distinguished HCC from surrounding tissue and from other tumor types, and was independent of risk factors. However, aberrant methylation of an independent subset of promoters was associated with tumor progression and etiological risk factors (HBV or HCV infection and alcohol consumption). Interestingly, distinct methylation of an independent panel of gene promoters was strongly correlated with survival after cancer therapy. Conclusion: Our study shows that HCC tumors exhibit specific DNA methylation signatures associated with major risk factors and tumor progression stage, with potential clinical applications in diagnosis and prognosis.	[Hernandez-Vargas, Hector; Lambert, Marie-Pierre; Herceg, Zdenko] IARC, Epigenet Grp, Lyon, France; [Le Calvez-Kelm, Florence; McKay-Chopin, Sandrine; Tavtigian, Sean V.] IARC, Genet Canc Susceptibil Grp, Lyon, France; [Gouysse, Geraldine; Scoazec, Jean-Yves] Edouard Herriot Hosp Lyon, Serv Anat Pathol, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon	Hernandez-Vargas, H (corresponding author), IARC, Epigenet Grp, Lyon, France.	herceg@iarc.fr		Lambert, Marie-Pierre/0000-0002-4468-5203; Hernandez-Vargas, Hector/0000-0001-6045-2103; Le Calvez-Kelm, Florence/0000-0003-0063-5068	Ligue Nationale (Francaise) Contre le Cancer; l'Association pour le Recherche Contre le Cancer (l'ARC); l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France); National Institutes of Health/National Cancer Institute, USA; Swiss Bridge Award	Ligue Nationale (Francaise) Contre le Cancer(Ligue nationale contre le cancer); l'Association pour le Recherche Contre le Cancer (l'ARC); l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France)(ANRS); National Institutes of Health/National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss Bridge Award	This work was supported by la Ligue Nationale (Francaise) Contre le Cancer, l'Association pour le Recherche Contre le Cancer (l'ARC), l'Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France), National Institutes of Health/National Cancer Institute, USA, and Swiss Bridge Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1996, PHARMACOGENETICS, V6, P501; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; Kinoshita M, 2002, HEPATOLOGY, V36, P433, DOI 10.1053/jhep.2002.34851; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kong SY, 2008, CANCER SCI, V99, P340, DOI 10.1111/j.1349-7006.2007.00693.x; Korn EL, 2007, STAT MED, V26, P4428, DOI 10.1002/sim.2865; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Tang KS, 2008, BIOCHEM BIOPH RES CO, V366, P643, DOI 10.1016/j.bbrc.2007.11.125; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; VAISSIERE T, 2008, CANC RES IN PRESS; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29; Yu MW, 2000, GUT, V47, P703, DOI 10.1136/gut.47.5.703; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076; Zhang YJ, 2007, CLIN CANCER RES, V13, P2378, DOI 10.1158/1078-0432.CCR-06-1900; Zhong S, 2003, CLIN CANCER RES, V9, P3376; Zhu JD, 2006, J HEPATO-BILIARY-PAN, V13, P265, DOI 10.1007/s00534-005-1054-4	44	153	159	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9749	10.1371/journal.pone.0009749	http://dx.doi.org/10.1371/journal.pone.0009749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305825	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809600018
J	Wilting, A; Cord, A; Hearn, AJ; Hesse, D; Mohamed, A; Traeholdt, C; Cheyne, SM; Sunarto, S; Jayasilan, MA; Ross, J; Shapiro, AC; Sebastian, A; Dech, S; Breitenmoser, C; Sanderson, J; Duckworth, JW; Hofer, H				Wilting, Andreas; Cord, Anna; Hearn, Andrew J.; Hesse, Deike; Mohamed, Azlan; Traeholdt, Carl; Cheyne, Susan M.; Sunarto, Sunarto; Jayasilan, Mohd-Azlan; Ross, Joanna; Shapiro, Aurelie C.; Sebastian, Anthony; Dech, Stefan; Breitenmoser, Christine; Sanderson, Jim; Duckworth, J. W.; Hofer, Heribert			Modelling the Species Distribution of Flat-Headed Cats (Prionailurus planiceps), an Endangered South-East Asian Small Felid	PLOS ONE			English	Article							CONSERVATION STATUS; SAMPLE-SIZE; PALM OIL; FOREST; BENGALENSIS; BIODIVERSITY; PERFORMANCE; MOVEMENTS; IMPROVE; NUMBERS	Background: The flat-headed cat (Prionailurus planiceps) is one of the world's least known, highly threatened felids with a distribution restricted to tropical lowland rainforests in Peninsular Thailand/Malaysia, Borneo and Sumatra. Throughout its geographic range large-scale anthropogenic transformation processes, including the pollution of fresh-water river systems and landscape fragmentation, raise concerns regarding its conservation status. Despite an increasing number of camera-trapping field surveys for carnivores in South-East Asia during the past two decades, few of these studies recorded the flat-headed cat. Methodology/Principal Findings: In this study, we designed a predictive species distribution model using the Maximum Entropy (MaxEnt) algorithm to reassess the potential current distribution and conservation status of the flat-headed cat. Eighty-eight independent species occurrence records were gathered from field surveys, literature records, and museum collections. These current and historical records were analysed in relation to bioclimatic variables (WorldClim), altitude (SRTM) and minimum distance to larger water resources (Digital Chart of the World). Distance to water was identified as the key predictor for the occurrence of flat-headed cats (>50% explanation). In addition, we used different land cover maps (GLC2000, GlobCover and SarVision LLC for Borneo), information on protected areas and regional human population density data to extract suitable habitats from the potential distribution predicted by the MaxEnt model. Between 54% and 68% of suitable habitat has already been converted to unsuitable land cover types (e. g. croplands, plantations), and only between 10% and 20% of suitable land cover is categorised as fully protected according to the IUCN criteria. The remaining habitats are highly fragmented and only a few larger forest patches remain. Conclusion/Significance: Based on our findings, we recommend that future conservation efforts for the flat-headed cat should focus on the identified remaining key localities and be implemented through a continuous dialogue between local stakeholders, conservationists and scientists to ensure its long-term survival. The flat-headed cat can serve as a flagship species for the protection of several other endangered species associated with the threatened tropical lowland forests and surface fresh-water sources in this region.	[Wilting, Andreas; Hofer, Heribert] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Cord, Anna; Dech, Stefan] Univ Wurzburg, Inst Geog, Dept Remote Sensing, Wurzburg, Germany; [Cord, Anna; Dech, Stefan] German Aerosp Ctr DLR, German Remote Sensing Data Ctr, DFD, Wessling, Germany; [Hearn, Andrew J.; Ross, Joanna] Global Canopy Programme, Oxford, England; [Hearn, Andrew J.; Cheyne, Susan M.; Ross, Joanna] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England; [Hesse, Deike] German Inst Human Nutr, Dept Expt Diabet, Potsdam, Germany; [Mohamed, Azlan] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Malaysia; [Mohamed, Azlan] WWF Malaysia, Selangor, Malaysia; [Traeholdt, Carl] Copenhagen Zoo, Dept Res & Conservat, Frederiksberg, Denmark; [Cheyne, Susan M.] Univ Palangka Raya, Orang Utan Trop Peatland Project, Kalimantan, Indonesia; [Sunarto, Sunarto] Virginia Tech, Dept Fisheries & Wildlife Sci, Blacksburg, VA USA; [Sunarto, Sunarto] WWF Indonesia, Pekanbaru, Indonesia; [Jayasilan, Mohd-Azlan] Fac Resource Sci & Technol, Dept Zool, Kota Samarahan, Sarawak, Malaysia; [Jayasilan, Mohd-Azlan] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Shapiro, Aurelie C.] WWF US, Conservat Sci Program, Washington, DC USA; [Sebastian, Anthony] Aonyx Environm, Kuching, Sarawak, Malaysia; [Breitenmoser, Christine] KORA, IUCN, SSC Cat Specialist Grp, Muri, Switzerland; [Sanderson, Jim] Wildlife Conservat Network, Small Wild Cat Conservat Fdn, Los Altos, CA USA; [Duckworth, J. W.] Wildlife Conservat Soc Asia Program, New York, NY USA	Leibniz Institut fur Zoo und Wildtierforschung; University of Wurzburg; Helmholtz Association; German Aerospace Centre (DLR); University of Oxford; University of Oxford; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Universiti Malaysia Sabah; World Wildlife Fund; Universitas Palangka Raya (UPR); Virginia Polytechnic Institute & State University; World Wildlife Fund; Charles Darwin University; World Wildlife Fund; Wildlife Conservation Society	Wilting, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	a.wilting@gmx.de	Cheyne, Susan M/C-9856-2013; Wilting, Andreas/B-1644-2010; Cheyne, Susan M/P-2404-2019; Hesse, Deike/F-5716-2018; Hofer, Heribert/AAF-7854-2021	Cheyne, Susan M/0000-0002-9180-3356; Cheyne, Susan M/0000-0002-9180-3356; Hesse, Deike/0000-0001-5915-8003; Hofer, Heribert/0000-0002-2813-7442; Wilting, Andreas/0000-0001-5073-9186; Cord, Anna F./0000-0003-3183-8482; Shapiro, Aurelie/0000-0001-9693-9394; Mohamed, Azlan/0000-0003-3788-4383; Breitenmoser, Christine/0000-0002-5228-2957	Clouded Leopard Project and Point Defiance Zoo and Aquarium; Panthera Foundation; WWF-Germany; WWF-Malaysia; Minnesota Zoo; Cleveland MetroParks; Houston Zoo; Association for Wild Cat Conservation; Society for the Conservation of Species and Populations; Deutsche Forschungsgemeinschaft [Fi-698/5-1]; Darwin Initiative; Felidae Conservation Fund; International Trust for Nature Conservation; Wild About Cats; HDH Wills 1965 Charitable Trust; Cat Action Treasury	Clouded Leopard Project and Point Defiance Zoo and Aquarium; Panthera Foundation; WWF-Germany; WWF-Malaysia; Minnesota Zoo; Cleveland MetroParks; Houston Zoo; Association for Wild Cat Conservation; Society for the Conservation of Species and Populations; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Darwin Initiative; Felidae Conservation Fund; International Trust for Nature Conservation; Wild About Cats; HDH Wills 1965 Charitable Trust; Cat Action Treasury	The different field work projects of the authors were supported by the Clouded Leopard Project and Point Defiance Zoo and Aquarium, the Panthera Foundation, WWF-Germany, WWF-Malaysia, Minnesota Zoo, Cleveland MetroParks, Houston Zoo, Association for Wild Cat Conservation, the Society for the Conservation of Species and Populations, Deutsche Forschungsgemeinschaft (grant Fi-698/5-1), the Darwin Initiative, Felidae Conservation Fund, International Trust for Nature Conservation, Wild About Cats, HDH Wills 1965 Charitable Trust and the Cat Action Treasury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AW, 1987, US FISH WILDLIFE SER, V82, P47; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; AZLAN MJ, 2007, CAT NEWS, P47; Bezuijen Mark R., 2003, Cat News, V38, P26; Bezuijen MR, 2000, ORYX, V34, P222, DOI 10.1017/S0030605300031227; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Cerioli A, 1997, BIOMETRICS, V53, P619, DOI 10.2307/2533962; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; CHEYNE SM, 2009, CAT NEWS, V51, P16; Cliff A. D., 1981, SPATIAL PROCESSES MO; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO,, 2022, STAT WORLDS FOR 2022; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424; Gaubert P, 2006, BIOL CONSERV, V130, P106, DOI 10.1016/j.biocon.2005.12.006; Grassman LI, 2000, ACTA THERIOL, V45, P421, DOI 10.4098/AT.arch.00-41; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Haining R., 2003, SPATIAL DATA ANAL TH; HEARN A, 2008, IUCN 2009 IUCN RED L; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLMES D, 1999, BIRDS BORNEO; Hughes JB, 2003, J BIOGEOGR, V30, P569, DOI 10.1046/j.1365-2699.2003.00847.x; IZAWA M, 1990, WILDL CONSERV, P140; Jackson P., 1996, BIOL CONSERVATION; KHAN M, 1986, CAT NEWS, V5, P11; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Lekagul B., 1977, MAMMALS THAILAND; Lim BK, 2002, BIODIVERS CONSERV, V11, P1237, DOI 10.1023/A:1016038501986; LIM BL, 1970, J MAMMAL, V51, P806, DOI 10.2307/1378310; LIM BL, 1961, MALAYS NAT HIST J, V15, P8; LYDEKKER R, 1895, HDB CARNIVORA 1; MEDWAY L, 1965, MAMMALS BORNEO FIELD; MEIJAARD E, 1997, CAT NEWS, V27; Meijaard Erik, 2005, Cat News, V43, P24; MIVART G, 1892, CAT; Mohamed A, 2009, CAT NEWS, V51, P12; Mohd-Azlan J, 2007, ORYX, V41, P394, DOI 10.1017/S0030605307000516; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Povey K, 2009, CLOUDED LEOPARD SMAL; PRB (Population Reference Bureau), 2007, 2007 WORLD POP DAT S; RABINOWITZ A, 1990, BIOTROPICA, V22, P397, DOI 10.2307/2388557; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Rautner M, 2005, BORNEO TREASURE ISLA; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Sanchez-Cordero V, 2008, ECOGRAPHY, V31, P757, DOI 10.1111/j.1600-0587.2008.05327.x; Shepherd P.A., 1997, BIODIVESITY SUSTAINA, P191; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sunquist M, 2009, HDB MAMMALS WORLD, VI, P54; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1994, Oryx, V28, P67; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; Tonkin B.A., 1979, CAT BEHAV PREDATORY; *UNESCO IUCN, 2004, TROP RAINF HER SUM I; Uryu Y, 2008, DEFORESTATION FOREST; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; YASUDA M, 2007, CAT NEWS, V47, P12; YASUMA S, 1994, PUSREHUT SPECIAL PUB, V3, P176; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	68	88	101	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9612	10.1371/journal.pone.0009612	http://dx.doi.org/10.1371/journal.pone.0009612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305809	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000275809600001
J	Suwannakarn, K; Chieochansin, T; Thongmee, C; Makkoch, J; Praianantathavorn, K; Theamboonlers, A; Sreevatsan, S; Poovorawan, Y				Suwannakarn, Kamol; Chieochansin, Thaweesak; Thongmee, Chitima; Makkoch, Jarika; Praianantathavorn, Kesmanee; Theamboonlers, Apiradee; Sreevatsan, Srinand; Poovorawan, Yong			Molecular Evolution of Human H1N1 and H3N2 Influenza A Virus in Thailand, 2006-2009	PLOS ONE			English	Article							RECEPTOR-BINDING; NUCLEOPROTEIN	Background: Annual seasonal influenza outbreaks are associated with high morbidity and mortality. Objective: To index and document evolutionary changes among influenza A H1N1 and H3N2 viruses isolated from Thailand during 2006-2009, using complete genome sequences. Methods: Nasopharyngeal aspirates were collected from patients diagnosed with respiratory illness in Thailand during 2006-2009. All samples were screened for Influenza A virus. A total of 13 H1N1 and 21 H3N2 were confirmed and whole genome sequenced for the evolutionary analysis using standard phylogenetic approaches. Results: Phylogenetic analysis of HA revealed a clear diversification of seasonal from vaccine strain lineages. H3N2 seasonal clusters were closely related to the WHO recommended vaccine strains in each season. Most H1N1 isolates could be differentiated into 3 lineages. The A/Brisbane/59/2007 lineage, a vaccine strain for H1N1 since 2008, is closely related with the H1N1 subtypes circulating in 2009. HA sequences were conserved at the receptor-binding site. Amino acid variations in the antigenic site resulted in a possible N-linked glycosylation motif. Recent H3N2 isolates had higher genetic variations compared to H1N1 isolates. Most substitutions in the NP protein were clustered in the T-cell recognition domains. Conclusion: In this study we performed evolutionary genetic analysis of influenza A viruses in Thailand between 2006-2009. Although the current vaccine strain is efficient for controlling the circulating outbreak subtypes, surveillance is necessary to provide unambiguous information on emergent viruses. In summary, the findings of this study contribute the understanding of evolution in influenza A viruses in humans and is useful for routine surveillance and vaccine strain selection.	[Suwannakarn, Kamol; Chieochansin, Thaweesak; Thongmee, Chitima; Makkoch, Jarika; Praianantathavorn, Kesmanee; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Chulalongkorn University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Suwannakarn, K (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Poovorawan, Yong/0000-0002-2337-6807	Thailand Research Fund; Commission on Higher Education, King Chulalongkorn Memorial Hospital; Center of Excellence in Clinical Virology and CU Centenary Academic Development Project; Chulalongkorn University, Bangkok, Thailand; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN266200700007C]	Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education, King Chulalongkorn Memorial Hospital(Office of Higher Education Commission (OHEC)); Center of Excellence in Clinical Virology and CU Centenary Academic Development Project; Chulalongkorn University, Bangkok, Thailand(Chulalongkorn University); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services	This research was supported by the Thailand Research Fund, the Commission on Higher Education, King Chulalongkorn Memorial Hospital, the Center of Excellence in Clinical Virology and CU Centenary Academic Development Project, Chulalongkorn University, Bangkok, Thailand. This work was also funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chutinimitkul S, 2008, VIRUS RES, V132, P122, DOI 10.1016/j.virusres.2007.11.007; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Gupta R., 2004, RESEARCHGATE; Hampson AW, 2002, PERSP MED V, V7, P49; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Lindstrom S, 1996, ARCH VIROL, V141, P1349, DOI 10.1007/BF01718836; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2009, REC COMP INFL VIR VA; *WHO, 2009, WHO EP PAND AL RESP; WINTER G, 1981, VIROLOGY, V114, P423, DOI 10.1016/0042-6822(81)90223-3; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	22	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9717	10.1371/journal.pone.0009717	http://dx.doi.org/10.1371/journal.pone.0009717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300536	gold, Green Published			2022-12-25	WOS:000275716400015
J	Schwartz, RS; Mueller, RL				Schwartz, Rachel S.; Mueller, Rachel Lockridge			Variation in DNA Substitution Rates among Lineages Erroneously Inferred from Simulated Clock-Like Data	PLOS ONE			English	Article							ESTIMATING DIVERGENCE TIMES; EVOLUTIONARY RATE VARIATION; BRANCH-LENGTH ESTIMATION; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; PHYLOGENETIC ANALYSIS; GENERATION TIME; RELATIVE RATES; ABSOLUTE RATES; GENE-SEQUENCES	Background: The observation of variation in substitution rates among lineages has led to (1) a general rejection of the molecular clock model, and (2) the suggestion that a number of biological characteristics of organisms can cause rate variation. Accurate estimates of rate variation, and thus accurate inferences regarding the causes of rate variation, depend on accurate estimates of substitution rates. However, theory suggests that even when the substitution process is clock-like, variable numbers of substitutions can occur among lineages because the substitution process is stochastic. Furthermore, substitution rates along lineages can be misestimated, particularly when multiple substitutions occur at some sites. Although these potential causes of error in rate estimation are well understood in theory, such error has not been examined in detail; consequently, empirical studies that estimate rate variation among lineages have been unable to determine whether their results could be impacted by estimation error. Methodology/Principal Findings: To evaluate the extent to which error in rate estimation could erroneously suggest rate variation among lineages, we examined rate variation estimated for datasets simulated under a molecular clock on trees with equal and variable branch lengths. Thus, any apparent rate variation in these datasets reflects error in rate estimation rather than true differences in the underlying substitution process. We observed substantial rate variation among lineages in our simulations; however, we did not observe rate variation when average substitution rates were compared between different clades. Conclusions/Significance: Our results confirm previous theoretical work suggesting that observations of among lineage rate variation in empirical data may be due to the stochastic substitution process and error in the estimation of substitution rates, rather than true differences in the underlying substitution process among lineages. However, conclusions regarding rate variation drawn from rates averaged across multiple branches are likely due to real, systematic variation in rates between groups.	[Schwartz, Rachel S.; Mueller, Rachel Lockridge] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University	Schwartz, RS (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Rachel.Schwartz@colostate.edu		Schwartz, Rachel/0000-0001-7414-9893	Colorado State University; National Science Foundation [DBI 0906004]	Colorado State University; National Science Foundation(National Science Foundation (NSF))	Funding was provided by Colorado State University and by a National Science Foundation (http://www.nsf.gov) Postdoctoral Research Fellowship in Biology to RSS (DBI 0906004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2006, GENE, V380, P21, DOI 10.1016/j.gene.2006.04.019; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Davies TJ, 2006, EVOLUTION, V60, P476; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FITCH WM, 1987, MOL BIOL EVOL, V4, P381; Galtier N, 2001, MOL BIOL EVOL, V18, P866, DOI 10.1093/oxfordjournals.molbev.a003868; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GILLESPIE JH, 1986, ANNU REV ECOL SYST, V17, P637; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huelsenbeck JP, 2002, MOL BIOL EVOL, V19, P698, DOI 10.1093/oxfordjournals.molbev.a004128; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Jordan IK, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-22; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; LI P, 1992, MOL BIOL EVOL, V9, P1185; Li W. H, 1997, MOL EVOLUTION; LI WH, 1987, MOL BIOL EVOL, V4, P74; LI WH, 1985, MOL BIOL EVOL, V2, P150; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; MUSE SV, 1992, GENETICS, V132, P269; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; Schwartz RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-5; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1993, GENETICS, V135, P599; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; Tuffley C, 1998, MATH BIOSCI, V147, P63, DOI 10.1016/S0025-5564(97)00081-3; Wang HC, 2007, MOL BIOL EVOL, V24, P294, DOI 10.1093/molbev/msl155; Wang YF, 2001, GENETICS, V158, P1311; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; ZUCKERKANDL EMILE, 1965, P97	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9649	10.1371/journal.pone.0009649	http://dx.doi.org/10.1371/journal.pone.0009649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300176	Green Submitted, Green Published, gold			2022-12-25	WOS:000275620600006
J	Joyner, TA; Lukhnova, L; Pazilov, Y; Temiralyeva, G; Hugh-Jones, ME; Aikimbayev, A; Blackburn, JK				Joyner, Timothy Andrew; Lukhnova, Larissa; Pazilov, Yerlan; Temiralyeva, Gulnara; Hugh-Jones, Martin E.; Aikimbayev, Alim; Blackburn, Jason K.			Modeling the Potential Distribution of Bacillus anthracis under Multiple Climate Change Scenarios for Kazakhstan	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PREDICTING DISTRIBUTIONS; GEOGRAPHIC DISTRIBUTIONS; SNOW ACCUMULATION; NORTHERN EURASIA; COUPLED MODEL; NICHE; GARP; RANGE; POPULATION	Anthrax, caused by the bacterium Bacillus anthracis, is a zoonotic disease that persists throughout much of the world in livestock, wildlife, and secondarily infects humans. This is true across much of Central Asia, and particularly the Steppe region, including Kazakhstan. This study employed the Genetic Algorithm for Rule-set Prediction (GARP) to model the current and future geographic distribution of Bacillus anthracis in Kazakhstan based on the A2 and B2 IPCC SRES climate change scenarios using a 5-variable data set at 55 km(2) and 8 km(2) and a 6-variable BioClim data set at 8 km(2). Future models suggest large areas predicted under current conditions may be reduced by 2050 with the A2 model predicting similar to 14-16% loss across the three spatial resolutions. There was greater variability in the B2 models across scenarios predicting similar to 15% loss at 55 km 2, similar to 34% loss at 8 km 2, and similar to 30% loss with the BioClim variables. Only very small areas of habitat expansion into new areas were predicted by either A2 or B2 in any models. Greater areas of habitat loss are predicted in the southern regions of Kazakhstan by A2 and B2 models, while moderate habitat loss is also predicted in the northern regions by either B2 model at 8 km(2). Anthrax disease control relies mainly on livestock vaccination and proper carcass disposal, both of which require adequate surveillance. In many situations, including that of Kazakhstan, vaccine resources are limited, and understanding the geographic distribution of the organism, in tandem with current data on livestock population dynamics, can aid in properly allocating doses. While speculative, contemplating future changes in livestock distributions and B. anthracis spore promoting environments can be useful for establishing future surveillance priorities. This study may also have broader applications to global public health surveillance relating to other diseases in addition to B. anthracis.	[Joyner, Timothy Andrew; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Joyner, Timothy Andrew; Blackburn, Jason K.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Lukhnova, Larissa; Pazilov, Yerlan; Temiralyeva, Gulnara; Aikimbayev, Alim] Kazakh Sci Ctr Quarantine & Zoonot Dis, Alma Ata, Kazakhstan; [Hugh-Jones, Martin E.] Louisiana State Univ, Sch Coast & Environm, Dept Environm Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Louisiana State University System; Louisiana State University	Joyner, TA (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	jkblackburn@ufl.edu	Lukhnova, Larissa/ABE-5682-2021; Blackburn, Jason/AAV-9445-2020	Blackburn, Jason/0000-0003-0928-4831; Luhnova, Larisa/0000-0002-5818-8021; Joyner, Timothy/0000-0003-2790-6817	Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Projec [KZ-1]	Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Projec	This study was funded by the Defense Threat Reduction Agency's Biological Threat Reduction Program under the Cooperative Biological Research Project KZ-1 to the participating institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JCZ, 2006, J MED ENTOMOL, V43, P93, DOI 10.1603/0022-2585(2006)043[0093:AOGAFR]2.0.CO;2; AIKEMBAYEV A, 2010, EMERGING IN IN PRESS; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; ATZMANSTORFER K, 2007, GEOINFORMATION DEV B; Baettig MB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028159; BAKER BB, 1993, CLIMATIC CHANGE, V25, P97, DOI 10.1007/BF01661200; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; BLACKBURN KJ, 2010, SCI PEACE S IN PRESS; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carlson JK, 2003, FISH RES, V60, P405, DOI 10.1016/S0165-7836(02)00135-2; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; Dragon DC, 2001, J APPL MICROBIOL, V91, P435, DOI 10.1046/j.1365-2672.2001.01389.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 2007, ARCGIS 9 2; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; GAINER RS, 1989, CAN VET J, V30, P953; GATES CC, 1995, CAN J VET RES, V59, P256; Giorgi F, 2001, GEOPHYS RES LETT, V28, P3317, DOI 10.1029/2001GL013150; Gordon H B, 2002, 60 CSIRO; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IPCC, 2000, SPECIAL REPORT EMISS; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; KAUFMANN AF, 1990, SALISBURY MED B S, V68, P16; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kimoto M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023383; Lal M, 2001, J METEOROL SOC JPN, V79, P219, DOI 10.2151/jmsj.79.219; MacArthur R.H., 1972, pvii; McNyset KM, 2005, ECOL FRESHW FISH, V14, P243, DOI 10.1111/j.1600-0633.2005.00101.x; McNyset KM, 2006, DIVERS DISTRIB, V12, P782, DOI [10.1111/j.1472-4642.2006.00281.x, 10.1111/j.1366-9516.2006.00281.x]; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Parkinson R, 2003, CAN VET J, V44, P315; Parra-Olea G, 2005, BIOTROPICA, V37, P202, DOI 10.1111/j.1744-7429.2005.00027.x; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; *PSSS, 2008, SPSS V 16 0; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saito K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016341; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smith KL, 1999, J APPL MICROBIOL, V87, P204, DOI 10.1046/j.1365-2672.1999.00871.x; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockman AK, 2006, DIVERS DISTRIB, V12, P81, DOI 10.1111/j.1366-9516.2006.00225.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sweeney AW, 2006, J MED ENTOMOL, V43, P1068, DOI 10.1603/0022-2585(2006)43[1068:EFAWDA]2.0.CO;2; Terribile LC, 2009, ACTA OECOL, V35, P163, DOI 10.1016/j.actao.2008.09.006; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Turner AJ, 1999, J APPL MICROBIOL, V87, P294, DOI 10.1046/j.1365-2672.1999.00894.x; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Watanabe M, 1999, J CLIMATE, V12, P494, DOI 10.1175/1520-0442(1999)012<0494:DCITAC>2.0.CO;2; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wilson RT, 1997, MT RES DEV, V17, P57, DOI 10.2307/3673914; Woods CW, 2004, AM J TROP MED HYG, V71, P48, DOI 10.4269/ajtmh.2004.71.48; Ye HC, 1998, J CLIMATE, V11, P856, DOI 10.1175/1520-0442(1998)011<0856:TCIRWS>2.0.CO;2; Ye HC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016873; Ye HC, 2001, J CLIMATE, V14, P4573, DOI 10.1175/1520-0442(2001)014<4573:QBAQDV>2.0.CO;2; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5	85	57	61	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9596	10.1371/journal.pone.0009596	http://dx.doi.org/10.1371/journal.pone.0009596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231894	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300013
J	Ye, L; Wang, X; Metzger, DS; Riedel, E; Montaner, LJ; Ho, WZ				Ye, Li; Wang, Xu; Metzger, David S.; Riedel, Eric; Montaner, Luis J.; Ho, Wenzhe			Upregulation of SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56(+) T Cells in HCV-Infected Heroin Users	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; BLOOD MONONUCLEAR-CELLS; NATURAL-KILLER-CELLS; DRUG-USERS; HUMAN LIVER; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; INDUCED EXPRESSION; ALPHA EXPRESSION; IMMUNE-SYSTEM	Background: CD56(+) T cells are abundant in liver and play an important role in host innate immunity against viral infections, including hepatitis C virus (HCV) infection, a common infection among heroin abusers. We thus investigated the in vivo impact of heroin use or heroin use plus HCV infection on the CD56(+) T cell frequency and function. Methodology/Principal Findings: A total of 37 heroin users with (17) or without (20) HCV infection and 17 healthy subjects were included in the study. Although there was no significant difference in CD56+ T cell frequency in PBMCs among three study groups, CD56(+) T cells isolated from the heroin users had significantly lower levels of constitutive interferon-gamma (IFN-gamma) expression than those from the normal subjects. In addition, when stimulated by interleukin (IL)-12, CD56(+) natural T cells from HCV-infected heroin users produced significantly lower levels of IFN-gamma than those from the normal subjects. This diminished ability to produce IFN-gamma by CD56(+) T cells was associated with the increased plasma HCV viral loads in the HCV-infected heroin users. Investigation of the mechanisms showed that although heroin use or heroin use plus HCV infection had little impact on the expression of the key positive regulators (IL-12 receptors, STAT-1, 3, 4, 5, JAK-2, and TYK-2) in IL-12 pathway, heroin use or heroin use plus HCV infection induced the expression of suppressor of cytokine signaling protein-3 (SOCS-3) and protein inhibitors of activated STAT-3 (PIAS-3), two key inhibitors of IL-12 pathway. Conclusion/Significance: These findings provide compelling in vivo evidence that heroin use or heroin use plus HCV infection impairs CD56(+) T cell-mediated innate immune function, which may account for HCV infection and persistence in liver.	[Ye, Li; Wang, Xu; Ho, Wenzhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Wang, Xu] Temple Univ, Sch Med, Ctr Studies Addict, Dept Psychiat, Philadelphia, PA 19122 USA; [Riedel, Eric] Childrens Hosp Philadelphia, Dept Pediat, Res Inst Jr, Philadelphia, PA 19104 USA; [Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute	Ye, L (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	wenzheho@temple.edu			National Institutes of Health [DA 22177, 12815, AI 073219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022177, R01DA012815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants (http://projectreporter.nih.gov/reporter.cfm) DA 22177(to Wenzhe Ho), DA 12815 (to Wenzhe Ho), AI 073219 (to Luis J. Montaner). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backmund M, 2003, EUR J EPIDEMIOL, V18, P563, DOI 10.1023/A:1024603517136; Bassani S, 2004, MED CLIN-BARCELONA, V122, P570, DOI 10.1157/13060891; Byrnes AA, 2007, J LEUKOCYTE BIOL, V81, P825, DOI 10.1189/jlb.1006622; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Day C, 2003, DRUG ALCOHOL REV, V22, P317, DOI 10.1080/0959523031000154463; Deignan T, 2002, J HEPATOL, V37, P101, DOI 10.1016/S0168-8278(02)00072-7; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Doherty DG, 1999, J IMMUNOL, V163, P2314; Edlin BR, 2001, NEW ENGL J MED, V345, P211, DOI 10.1056/NEJM200107193450311; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Homan JW, 2002, J ACQ IMMUN DEF SYND, V30, P9, DOI 10.1097/00126334-200205010-00002; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jin YD, 1998, HUM IMMUNOL, V59, P352, DOI 10.1016/S0198-8859(98)00030-5; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kusaba H, 2005, J BIOL CHEM, V280, P1037, DOI 10.1074/jbc.M405204200; Li Y, 2005, J INFECT DIS, V192, P1093, DOI 10.1086/432957; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Li Y, 2007, J INFECT DIS, V196, P719, DOI 10.1086/520093; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; LU PH, 1994, J IMMUNOL, V153, P1687; McCarthy JJ, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n01_03; Ohkawa T, 2001, IMMUNOLOGY, V103, P281, DOI 10.1046/j.1365-2567.2001.01248.x; Okumura A, 2005, HEPATOL RES, V32, P213, DOI 10.1016/j.hepres.2005.02.008; Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P1107, DOI 10.1590/S0100-879X1999000900009; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; PETERSON PK, 1987, J CLIN INVEST, V80, P824, DOI 10.1172/JCI113140; Quaglio G, 2003, CLIN INFECT DIS, V37, P33, DOI 10.1086/375566; Sacerdote P, 2006, PALLIATIVE MED, V20, pS9, DOI 10.1191/0269216306pm1124oa; Sacerdote P, 2001, INT IMMUNOPHARMACOL, V1, P713, DOI 10.1016/S1567-5769(01)00005-4; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; SCHMIDT RE, 1986, J EXP MED, V164, P351, DOI 10.1084/jem.164.1.351; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Smyth BP, 2005, INT J EPIDEMIOL, V34, P166, DOI 10.1093/ije/dyh347; StollKeller F, 1997, INT J IMMUNOPHARMACO, V19, P95, DOI 10.1016/S0192-0561(97)00017-9; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Vitale M, 2000, CYTOMETRY, V39, P189, DOI 10.1002/(SICI)1097-0320(20000301)39:3<189::AID-CYTO3>3.0.CO;2-C; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V310, P1188, DOI 10.1016/j.bbrc.2003.09.140; Yang JH, 2002, J VIROL METHODS, V102, P119, DOI 10.1016/S0166-0934(02)00007-1; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854	54	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9602	10.1371/journal.pone.0009602	http://dx.doi.org/10.1371/journal.pone.0009602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231901	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300018
J	Strathmann, J; Klimo, K; Sauer, SW; Okun, JG; Prehn, JHM; Gerhauser, C				Strathmann, Julia; Klimo, Karin; Sauer, Sven W.; Okun, Juergen G.; Prehn, Jochen H. M.; Gerhaeuser, Clarissa			Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism	FASEB JOURNAL			English	Article						polyphenols; oxidative stress; chemoprevention	OXIDATIVE STRESS; INTRACELLULAR SUPEROXIDE; PERMEABILITY TRANSITION; TRANSFORMED-CELLS; HYDROGEN-PEROXIDE; KAPPA-B; OXYGEN; DEATH; AUTOPHAGY; ROS	Oxidative stress and increased release of reactive oxygen species (ROS) are associated with apoptosis induction. Here we report ROS-mediated induction of apoptosis by xanthohumol (XN) from hops. XN at concentrations of 1.6-25 mu M induced an immediate and transient increase in superoxide anion radical (O-2(-center dot)) formation in 3 human cancer cell lines (average +/- SD EC50 of maximum O-2(-center dot) induction=3.1 +/- 0.8 mu M), murine macrophages (EC50=4.0 +/- 0.3 mu M), and BPH-1 benign prostate hyperplasia cells (EC50=4.3 +/- 0.1 mu M), as evidenced by the O-2(-center dot)-specific indicator dihydroethidium. MitoSOX Red costaining and experiments using isolated mouse liver mitochondria (EC50=11.4 +/- 1.8 mu M) confirmed mitochondria as the site of intracellular O-2(-center dot) formation. Antimycin A served as positive control (EC50=12.4 +/- 0.9 mu M). XN-mediated O-2(-center dot) release was significantly reduced in BPH-1 rho(0) cells harboring nonfunctional mitochondria (EC50>25 mu M) and by treatment of BPH-1 cells with vitamin C, N-acetylcysteine (NAC), or the superoxide dismutase mimetic MnTMPyP. In addition, we demonstrated a rapid 15% increase in oxidized glutathione and a dose-dependent overall thiol depletion within 6 h (IC50=24.3 +/- 11 mu M). Respiratory chain complexes I-III were weakly inhibited by XN in bovine heart submitochondrial particles, but electron flux from complex I and II to complex III was significantly inhibited in BPH-1 cells, with IC50 values of 28.1 +/- 2.4 and 24.4 +/- 5.2 mu M, respectively. Within 15 min, intracellular ATP levels were significantly reduced by XN at 12.5 to 50 mu M concentrations (IC50=26.7 +/- 3.7 mu M). Concomitantly, XN treatment caused a rapid breakdown of the mitochondrial membrane potential and the release of cytochrome c, leading to apoptosis induction. Pre- or coincubation with 2 mM NAC and 50 mu M MnTMPyP at various steps increased XN-mediated IC50 values for cytotoxicity in BPH-1 cells from 6.7 +/- 0.2 to 12.2 +/- 0.1 and 41.4 +/- 7.6 mu M, and it confirmed XN-induced O-2(-center dot) as an essential trigger for apoptosis induction. In summary, we have identified mitochondria as a novel cellular target of XN action, resulting in increased O-2(-center dot) production, disruption of cellular redox balance and mitochondrial integrity, and subsequent apoptosis.-Strathmann, J., Klimo, K., Sauer, S. W., Okun, J. G., Prehn, J. H. M., Gerha " user, C. Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism. FASEB J. 24, 2938-2950 (2010). www.fasebj.org	[Strathmann, Julia; Klimo, Karin; Gerhaeuser, Clarissa] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Sauer, Sven W.; Okun, Juergen G.] Univ Childrens Hosp, Heidelberg, Germany; [Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal College of Surgeons - Ireland	Gerhauser, C (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	c.gerhauser@dkfz.de	Prehn, Jochen HM/A-3928-2010	Prehn, Jochen HM/0000-0003-3479-7794; Gerhauser, Clarissa/0000-0002-5792-3901	Deutsches Krebsforschungszentrum (DKFZ) Light Microscopy Facility (Heidelberg, Germany)	Deutsches Krebsforschungszentrum (DKFZ) Light Microscopy Facility (Heidelberg, Germany)	Support by the Deutsches Krebsforschungszentrum (DKFZ) Light Microscopy Facility (Heidelberg, Germany) is gratefully acknowledged. The authors thank Dr. Matthew Whiteman for critical reviewing of the manuscript and valuable suggestions.	Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Bellion P, 2009, MOL NUTR FOOD RES, V53, P1226, DOI 10.1002/mnfr.200800456; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dussmann H, 2003, J BIOL CHEM, V278, P12645, DOI 10.1074/jbc.M210826200; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gerhauser C, 2005, EUR J CANCER, V41, P1941, DOI 10.1016/j.ejca.2005.04.012; Gerhauser C, 2002, MOL CANCER THER, V1, P959; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo ML, 2007, DALTON T, P4951, DOI 10.1039/b705136k; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Hussong R, 2005, MOL NUTR FOOD RES, V49, P861, DOI 10.1002/mnfr.200500089; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Knudson C. Michael, 2008, V414, P95; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202; Ligeret H, 2004, FREE RADICAL BIO MED, V36, P919, DOI 10.1016/j.freeradbiomed.2003.12.018; Lim HW, 2009, BIOCHEM BIOPH RES CO, V389, P187, DOI 10.1016/j.bbrc.2009.08.121; Lust S, 2009, ANTICANCER RES, V29, P3797; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Monteghirfo S, 2008, MOL CANCER THER, V7, P2692, DOI 10.1158/1535-7163.MCT-08-0132; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pan L, 2005, MOL NUTR FOOD RES, V49, P837, DOI 10.1002/mnfr.200500065; Pang Y, 2007, MOL NUTR FOOD RES, V51, P872, DOI 10.1002/mnfr.200600252; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; Pappa G, 2007, MOL NUTR FOOD RES, V51, P977, DOI 10.1002/mnfr.200700115; Pappa G, 2007, CARCINOGENESIS, V28, P1471, DOI 10.1093/carcin/bgm044; Pappa G, 2006, MUTAT RES-FUND MOL M, V599, P76, DOI 10.1016/j.mrfmmm.2006.01.007; Perez CA, 2009, J INORG BIOCHEM, V103, P326, DOI 10.1016/j.jinorgbio.2008.11.003; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Ralph SJ, 2009, MOL NUTR FOOD RES, V53, P9, DOI 10.1002/mnfr.200800044; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Sauer SW, 2008, BBA-BIOENERGETICS, V1777, P1276, DOI 10.1016/j.bbabio.2008.05.447; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Storz P., 2006, SCI STKE, V2006, pre3, DOI DOI 10.1126/STKE.3322006RE3; Strathmann J, 2009, ACTA HORTIC, V848, P179, DOI 10.17660/ActaHortic.2009.848.20; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Yang JY, 2007, APOPTOSIS, V12, P1953, DOI 10.1007/s10495-007-0130-4; Yuen B, 2005, Ther Umsch, V62, P615, DOI 10.1024/0040-5930.62.9.615; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	68	72	73	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2938	2950		10.1096/fj.10-155846	http://dx.doi.org/10.1096/fj.10-155846			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20335224				2022-12-25	WOS:000285005400033
J	Kuhr, FK; Zhang, YK; Brovkovych, V; Skidgel, RA				Kuhr, Frank K.; Zhang, Yongkang; Brovkovych, Viktor; Skidgel, Randal A.			beta-Arrestin 2 is required for B1 receptor-dependent post-translational activation of inducible nitric oxide synthase	FASEB JOURNAL			English	Article						kinins; G-protein-coupled receptor; extracellular signal-regulated kinase; inflammation; endothelial cells	PROTEIN-COUPLED RECEPTORS; CONVERTING-ENZYME INHIBITORS; SIGNAL-REGULATED KINASES; BRADYKININ B2 RECEPTOR; ENDOTHELIAL-CELLS; S-NITROSYLATION; IN-VIVO; B-1 RECEPTORS; NULL MICE; APOPTOSIS	A major source of "high-output" NO in inflammation is inducible nitric oxide synthase ( iNOS). iNOS is primarily transcriptionally regulated and is thought to function as an uncontrolled generator of high NO. We found that iNOS in cytokine-stimulated human lung microvascular endothelial cells (HLMVECs) is highly regulated post-translationally via activation of the B1 kinin G protein-coupled receptor (B1R). We report here that B1R-mediated iNOS activation was significantly inhibited by knockdown of beta-arrestin 2 with siRNA in cytokine-treated HLMVECs or HEK293 cells transfected with iNOS and B1R. In contrast, beta-arrestin 1 siRNA had no effect. The prolonged phase of B1R-dependent ERK activation was also inhibited by beta-arrestin 2 knockdown. Furthermore, robust ERK activation by the epidermal growth factor receptor (a beta-arrestin 2 independent pathway) had no effect on iNOS-derived NO production. beta-arrestin 2 and iNOS coimmunoprecipitated, and there was significant fluorescence resonance energy transfer between CFP-iNOS and beta-arrestin 2-YFP ( but not beta-arrestin 1-YFP) that increased 3-fold after B1R stimulation. These data show that beta-arrestin 2 mediates B1R-dependent high-output NO by scaffolding iNOS and ERK to allow post-translational activation of iNOS. This could play a critical role in mediating endothelial function in inflammation.-Kuhr, F.K., Zhang, Y., Brovkovych, V., Skidgel, R.A. beta-Arrestin 2 is required for B1 receptor-dependent post-translational activation of inducible nitric oxide synthase. FASEB J. 24, 2475-2483 (2010). www.fasebj.org	[Kuhr, Frank K.; Zhang, Yongkang; Brovkovych, Viktor; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott,M-C 868, Chicago, IL 60612 USA.	rskidgel@uic.edu			U.S. National Institutes of Health [HL60678, DK41431]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK041431, R29DK041431, R01DK041431] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Fulong Tan (Department of Pharmacology, University of Illinois at Chicago) for cloning beta-arrestin 2 and making initial constructs and Dr. Tiffany Sharma and Debra Salvi (Molecular Resources Core, Department of Pharmacology, University of Illinois at Chicago) for generating tagged beta-arrestin 2 and iNOS constructs. The authors are grateful to Svitlana Brovkovych for excellent technical assistance. This work was supported by U.S. National Institutes of Health grants HL60678 and DK41431. F.K.K. is the recipient of an American Heart Association predoctoral fellowship.	Adomeit A, 1999, MOL CELL BIOL, V19, P5289; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; BROVKOVYCH V, 2009, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934.2009.00992.X; Brovkovych V, 2008, AM J PHYSIOL-LUNG C, V295, pL96, DOI 10.1152/ajplung.00450.2007; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Choy JC, 2007, P NATL ACAD SCI USA, V104, P1313, DOI 10.1073/pnas.0607731104; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Geiger M, 1997, AM J PHYSIOL-LUNG C, V273, pL275, DOI 10.1152/ajplung.1997.273.1.L275; Golser R, 2000, J BIOL CHEM, V275, P5291, DOI 10.1074/jbc.275.8.5291; GUO FH, 1995, P NATL ACAD SCI USA, V92, P7809, DOI 10.1073/pnas.92.17.7809; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffman RA, 1997, AM J PHYSIOL-GASTR L, V272, pG383, DOI 10.1152/ajpgi.1997.272.2.G383; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Marjanovic JA, 2008, J BIOL CHEM, V283, P28827, DOI 10.1074/jbc.M801646200; Marrero MB, 1999, BIOCHEM J, V343, P335, DOI 10.1042/0264-6021:3430335; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; SIEGEL RM, 2000, SCI STKE, pPL1; Stanisavljevic S, 2006, J PHARMACOL EXP THER, V316, P1153, DOI 10.1124/jpet.105.093849; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Vodovotz Y, 2004, CURR MOL MED, V4, P753, DOI 10.2174/1566524043359944; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	53	23	24	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2475	2483		10.1096/fj.09-148783	http://dx.doi.org/10.1096/fj.09-148783			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20228252	Green Published			2022-12-25	WOS:000279343600034
J	Wu, F; Schweizer, C; Rudinskiy, N; Taylor, DM; Kazantsev, A; Luthi-Carter, R; Fraering, PC				Wu, Fang; Schweizer, Claude; Rudinskiy, Nikita; Taylor, David M.; Kazantsev, Aleksey; Luthi-Carter, Ruth; Fraering, Patrick C.			Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid-beta peptides; presenilin-1; off-target effect; substrate-binding sites	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IDENTIFICATION; DEACETYLASES; KINASE; NICOTINAMIDE; MECHANISM; COMPLEX; DOMAIN; ALPHA	gamma-Secretase is an intramembrane-cleaving protease responsible for the final proteolytic event in the production of the amyloid-beta peptides (A beta) implicated in Alzheimer's disease ( AD). Inhibition of gamma-secretase activity is thus an attractive therapeutic strategy to slow down the pathogenesis of AD. Drugs often target more than one biomolecule because of conserved 3-dimensional structures in prospective protein binding sites. We have capitalized on this phenomenon of nature to identify new gamma-secretase inhibitors. Here we show that 2-hydroxy naphthyl derivatives, a previously identified subclass of NAD(+) analog inhibitors of sirtuin 2 (SIRT2), are direct gamma-secretase inhibitors. Subsequent structure-activity relationship studies further showed that 2-hydroxy-1-naphthaldehyde is the minimal pharmacophore for gamma-secretase inhibition. In evaluating target protein determinants of inhibition, we identified a common GXG signature nucleotide-binding site (NBS) shared by the gamma-secretase subunit presenilin-1 C-terminal fragment (PS1-CTF), SIRT2, and Janus kinase 3 (JAK3). Because a detailed 3-dimensional structure of gamma-secretase is beyond our knowledge, we took advantage of the known crystal structure of human JAK3 to model the NBS of the PS1-CTF, which includes the catalytic residue D385. Our results suggest that the flexible PS1-CTF 381LGLG384 loop comprises a substrate-docking site capable of recognizing specifically different gamma-secretase substrates.-Wu, F., Schweizer, C., Rudinskiy, N., Taylor, D. M., Kazantsev, A., Luthi-Carter, R., Fraering, P.C. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1. FASEB J. 24, 2464-2474 (2010). www.fasebj.org	[Wu, Fang; Schweizer, Claude; Fraering, Patrick C.] Swiss Fed Inst Technol, Brain Mind Inst, Lab Mol & Cellular Biol Alzheimers Dis, CH-1015 Lausanne, Switzerland; [Rudinskiy, Nikita; Taylor, David M.; Luthi-Carter, Ruth] Swiss Fed Inst Technol, Brain Mind Inst, Lab Funct Neurogenom, CH-1015 Lausanne, Switzerland; Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Kazantsev, Aleksey] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat Dis, Charlestown, MA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Massachusetts General Hospital	Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	patrick.fraering@epfl.ch	Wu, Fang/B-1945-2008	Wu, Fang/0000-0002-4194-2243; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation [310000-116652/1]; National Center for Competence in Research (NCCR); Strauss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Strauss Foundation	The authors thank Dr. M.S. Wolfe (Center for Neurological Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA) for the T20 cells, Dr. Helena Karlstrom (Karolinska Institute, Stockholm, Sweden) for the Pen-2 antibody UD-1, L. Aeschbach for excellent technical support, and Dr. J.R. Alattia for helpful discussions. This work was supported by the Swiss National Science Foundation (to P.C.F.; grant 310000-116652/1) and the National Center for Competence in Research (NCCR; Neural Plasticity and Repair; to P.C.F), and the Strauss Foundation (to P.C.F. and C.S.).	ADAM J, 1997, UNDERSTANDING ORGANI, P132; Asberom T, 2007, BIOORG MED CHEM LETT, V17, P205, DOI 10.1016/j.bmcl.2006.09.064; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bakshi P, 2005, J BIOMOL SCREEN, V10, P1, DOI 10.1177/1087057104270068; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Goslin K., 1998, CULTURING NERVE CELL, P339; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Pissarnitski DA, 2007, BIOORG MED CHEM LETT, V17, P57, DOI 10.1016/j.bmcl.2006.09.094; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; STEINER H, 2008, ALZHEIMERS DEMENT, V4, pT189; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Vickers AEM, 2001, DRUG METAB DISPOS, V29, P1269; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wolfe MS, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S4; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	46	20	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2464	2474		10.1096/fj.09-148031	http://dx.doi.org/10.1096/fj.09-148031			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20237298				2022-12-25	WOS:000279343600033
J	Guglielmi, KM; McDonald, SM; Patton, JT				Guglielmi, Kristen M.; McDonald, Sarah M.; Patton, John T.			Mechanism of Intraparticle Synthesis of the Rotavirus Double-stranded RNA Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLUETONGUE VIRUS CORE; NONSTRUCTURAL PROTEIN NSP2; IN-VITRO RECONSTITUTION; MESSENGER-RNA; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE; IMAGE-RECONSTRUCTION; ANGSTROM RESOLUTION; STRUCTURAL-ANALYSIS; REPLICASE PARTICLE	Rotaviruses perform the remarkable tasks of transcribing and replicating 11 distinct double-stranded RNA genome segments within the confines of a subviral particle. Multiple viral polymerases are tethered to the interior of a particle, each dedicated to a solitary genome segment but acting in synchrony to synthesize RNA. Although the rotavirus polymerase specifically recognizes RNA templates in the absence of other proteins, its enzymatic activity is contingent upon interaction with the viral capsid. This intraparticle strategy of RNA synthesis helps orchestrate the concerted packaging and replication of the viral genome. Here, we review our current understanding of rotavirus RNA synthetic mechanisms.	[Guglielmi, Kristen M.; McDonald, Sarah M.; Patton, John T.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Patton, JT (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	jpatton@niaid.nih.gov	Ogden, Kristen/AAO-9276-2020; Patton, John T/P-1390-2014; Patton, John/V-7651-2018	Ogden, Kristen/0000-0002-2670-4335; Patton, John/0000-0003-1572-0732	National Institutes of Health Intramural Research Program; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000754] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIAID. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ayala-Breton C, 2009, J VIROL, V83, P8819, DOI 10.1128/JVI.02308-08; Barro M, 2001, VIROLOGY, V288, P71, DOI 10.1006/viro.2001.1054; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Carpio RVD, 2006, J MOL BIOL, V362, P539, DOI 10.1016/j.jmb.2006.07.050; Charpilienne A, 2002, J VIROL, V76, P7822, DOI 10.1128/JVI.76.15.7822-7831.2002; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Chen D, 2001, VIROLOGY, V282, P221, DOI 10.1006/viro.2001.0825; Chen DY, 1999, VIROLOGY, V265, P120, DOI 10.1006/viro.1999.0029; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; COHEN J, 1977, J GEN VIROL, V36, P395, DOI 10.1099/0022-1317-36-3-395; COHEN J, 1979, BIOCHEM BIOPH RES CO, V88, P791, DOI 10.1016/0006-291X(79)91477-3; CRAWFORD SE, 1994, J VIROL, V68, P5945, DOI 10.1128/JVI.68.9.5945-5952.1994; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Fujii K, 2009, J GEN VIROL, V90, P1734, DOI 10.1099/vir.0.010355-0; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HELMBERGERJONES M, 1986, VIROLOGY, V155, P655, DOI 10.1016/0042-6822(86)90225-4; HEWAT EA, 1992, VIROLOGY, V189, P10, DOI 10.1016/0042-6822(92)90676-G; IMAI M, 1983, J VIROL, V47, P125, DOI 10.1128/JVI.47.1.125-136.1983; Jayaram H, 2004, VIRUS RES, V101, P67, DOI 10.1016/j.virusres.2003.12.007; Jayaram H, 2002, NATURE, V417, P311, DOI 10.1038/417311a; KOHLI E, 1993, ARCH VIROL, V133, P451, DOI 10.1007/BF01313782; KOHLI E, 1994, ARCH VIROL, V135, P193, DOI 10.1007/BF01309778; LABBE M, 1994, J GEN VIROL, V75, P3423, DOI 10.1099/0022-1317-75-12-3423; LABBE M, 1991, J VIROL, V65, P2946; Lawton JA, 1997, J VIROL, V71, P7353, DOI 10.1128/JVI.71.10.7353-7360.1997; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; Lawton JA, 1999, P NATL ACAD SCI USA, V96, P5428, DOI 10.1073/pnas.96.10.5428; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Lawton JA, 2001, J VIROL, V75, P1632, DOI 10.1128/JVI.75.4.1632-1642.2001; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; LIU M, 1992, VIROLOGY, V188, P77, DOI 10.1016/0042-6822(92)90736-9; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; MANSELL EA, 1990, J VIROL, V64, P4988, DOI 10.1128/JVI.64.10.4988-4996.1990; McClain B, 2010, J MOL BIOL, V397, P587, DOI 10.1016/j.jmb.2010.01.055; McDonald SM, 2009, CURR OPIN STRUC BIOL, V19, P775, DOI 10.1016/j.sbi.2009.10.007; McDonald SM, 2009, VIRAL GENOME REPLICATION, P201, DOI 10.1007/b135974_11; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; MITCHELL DB, 1990, VIROLOGY, V177, P324, DOI 10.1016/0042-6822(90)90487-C; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Ozawa M, 2009, J VIROL, V83, P3384, DOI 10.1128/JVI.02513-08; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Patton JT, 2007, ADV VIRUS RES, V69, P167, DOI 10.1016/S0065-3527(06)69004-0; Patton JT, 1996, J VIROL, V70, P3961, DOI 10.1128/JVI.70.6.3961-3971.1996; Patton JT, 1999, J VIROL, V73, P1382, DOI 10.1128/JVI.73.2.1382-1391.1999; PATTON JT, 1988, VIROLOGY, V166, P358, DOI 10.1016/0042-6822(88)90506-5; Patton JT, 1997, J VIROL, V71, P9618, DOI 10.1128/JVI.71.12.9618-9626.1997; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; PATTON JT, 1990, J GEN VIROL, V71, P1087, DOI 10.1099/0022-1317-71-5-1087; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Poncet D, 1997, J VIROL, V71, P34, DOI 10.1128/JVI.71.1.34-41.1997; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; PRASAD BVV, 1990, NATURE, V343, P476, DOI 10.1038/343476a0; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; Taraporewala ZF, 2001, J VIROL, V75, P4519, DOI 10.1128/JVI.75.10.4519-4527.2001; Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; VALENZUELA S, 1991, J VIROL, V65, P3964, DOI 10.1128/JVI.65.7.3964-3967.1991; VASQUEZ M, 1993, J GEN VIROL, V74, P937, DOI 10.1099/0022-1317-74-5-937; Vende P, 2002, J VIROL, V76, P5291, DOI 10.1128/JVI.76.10.5291-5299.2002; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Wentz MJ, 1996, ARCH VIROL, P59; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Zeng CQY, 1998, J VIROL, V72, P201, DOI 10.1128/JVI.72.1.201-208.1998; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	80	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18123	18128		10.1074/jbc.R110.117671	http://dx.doi.org/10.1074/jbc.R110.117671			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20351108	hybrid, Green Published			2022-12-25	WOS:000278453900001
J	Arnold, T; Zeth, K; Linke, D				Arnold, Thomas; Zeth, Kornelius; Linke, Dirk			Omp85 from the Thermophilic Cyanobacterium Thermosynechococcus elongatus Differs from Proteobacterial Omp85 in Structure and Domain Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL MEMBRANE-PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURE PREDICTION; SERRATIA-MARCESCENS; OUTER ENVELOPE; SECRETION; FAMILY; BIOGENESIS; EVOLUTION	Omp85 proteins are essential proteins located in the bacterial outer membrane. They are involved in outer membrane biogenesis and assist outer membrane protein insertion and folding by an unknown mechanism. Homologous proteins exist in eukaryotes, where they mediate outer membrane assembly in organelles of endosymbiotic origin, the mitochondria and chloroplasts. We set out to explore the homologous relationship between cyanobacteria and chloroplasts, studying the Omp85 protein from the thermophilic cyanobacterium Thermosynechococcus elongatus. Using state-of-the art sequence analysis and clustering methods, we show how this protein is more closely related to its chloroplast homologue Toc75 than to proteobacterial Omp85, a finding supported by single channel conductance measurements. We have solved the structure of the periplasmic part of the protein to 1.97 angstrom resolution, and we demonstrate that in contrast to Omp85 from Escherichia coli the protein has only three, not five, polypeptide transport-associated (POTRA) domains, which recognize substrates and generally interact with other proteins in bigger complexes. We model how these POTRA domains are attached to the outer membrane, based on the relationship of Omp85 to two-partner secretion system proteins, which we show and analyze. Finally, we discuss how Omp85 proteins with different numbers of POTRA domains evolved, and evolve to this day, to accomplish an increasing number of interactions with substrates and helper proteins.	[Arnold, Thomas; Zeth, Kornelius; Linke, Dirk] Max Planck Inst Dev Biol, Dept 1, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept 1, Spemannstr 35, D-72076 Tubingen, Germany.	kornelius.zeth@tuebingen.mpg.de; dirk.linke@tuebingen.mpg.de	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752	Max Planck Society; German Science Foundation [SFB766/B4, ZE522/2-3]; Landesstiftung Baden-Wurttemberg, Functional Nanostructures	Max Planck Society(Max Planck Society); German Science Foundation(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg, Functional Nanostructures	This work was supported by institutional funding from the Max Planck Society, German Science Foundation Grants SFB766/B4 (to D. L.) and ZE522/2-3 (to K. Z.), and the Landesstiftung Baden-Wurttemberg, Functional Nanostructures (to D. L.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Braun V., 1992, FEMS MICROBIOL LETT, V79, P299; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Eswar N., 2007, CURR PROTOC PROTEIN; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mira A, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-50; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesper J, 2008, J BACTERIOL, V190, P4568, DOI 10.1128/JB.00369-08; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petty K.J., 2001, CURR PROTOC PROTEIN; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; REMMERT M, 2010, MOL BIOL EV IN PRESS; Reumann S, 2005, MOL MEMBR BIOL, V22, P73, DOI 10.1080/09687860500041916; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; SCHIEBEL E, 1989, J BIOL CHEM, V264, P16311; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004; Stegmeier JF, 2006, J BIOCHEM, V140, P275, DOI 10.1093/jb/mvj147; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yang FL, 2000, INT J MED MICROBIOL, V290, P529	59	52	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18003	18015		10.1074/jbc.M110.112516	http://dx.doi.org/10.1074/jbc.M110.112516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351097	hybrid, Green Published			2022-12-25	WOS:000278133400076
J	Tokesi, N; Lehotzky, A; Horvath, I; Szabo, B; Olah, J; Lau, P; Ovadi, J				Tokesi, Natalia; Lehotzky, Attila; Horvath, Istvan; Szabo, Balint; Olah, Judit; Lau, Pierre; Ovadi, Judit			TPPP/p25 Promotes Tubulin Acetylation by Inhibiting Histone Deacetylase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN TPPP/P25; OLIGODENDROCYTE DIFFERENTIATION; MICROTUBULE STABILITY; CELL MOTILITY; RAT-BRAIN; HDAC6; TAU; NEURONS	TPPP/p25 (tubulin polymerization-promoting protein/p25) is an unstructured protein that induces microtubule polymerization in vitro and is aligned along the microtubule network in transfected mammalian cells. In normal human brain, TPPP/p25 is expressed predominantly in oligodendrocytes, where its expression is proved to be crucial for their differentiation process. Here we demonstrated that the expression of TPPP/p25 in HeLa cells, in doxycycline-inducible CHO10 cells, and in the oligodendrocyte CG-4 cells promoted the acetylation of alpha-tubulin at residue Lys-40, whereas its down-regulation by specific small interfering RNA in CG-4 cells or by the withdrawal of doxycycline from CHO10 cells decreased the acetylation level of alpha-tubulin. Our results indicate that TPPP/p25 binds to HDAC6 (histone deacetylase 6), an enzyme responsible for tubulin deacetylation. Moreover, we demonstrated that the direct interaction of these two proteins resulted in the inhibition of the deacetylase activity of HDAC6. The measurement of HDAC6 activity showed that TPPP/p25 is able to induce almost complete (90%) inhibition at 3 mu M concentration. In addition, treatment of the cells with nocodazole, vinblastine, or cold exposure revealed that microtubule acetylation induced by trichostatin A, a well known HDAC6 inhibitor, does not cause microtubule stabilization. In contrast, the microtubule bundling activity of TPPP/p25 was able to protect the microtubules from depolymerization. Finally, we demonstrated that, similarly to other HDAC6 inhibitors, TPPP/p25 influences the microtubule dynamics by decreasing the growth velocity of the microtubule plus ends and also affects cell motility as demonstrated by time lapse video experiments. Thus, we suggest that TPPP/p25 is a multiple effector of the microtubule organization.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary; [Szabo, Balint] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Lau, Pierre] NINDS, Sect Dev Genet, NIH, Bethesda, MD 20892 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)		ovadi@enzim.hu	Horvath, Istvan/B-1889-2009	Horvath, Istvan/0000-0003-4262-1430; Olah, Judit/0000-0002-2470-8631; Attila, Lehotzky/0000-0001-5235-1812; Ovadi, Judit/0000-0002-3420-682X	FP6-2003-LIFESCIHEALTH-I: BioSim; Hungarian National Scientific Research Fund [OTKA T-067963, OTKA F-49795]; ELTE CellCom RET	FP6-2003-LIFESCIHEALTH-I: BioSim; Hungarian National Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ELTE CellCom RET	This work was supported by FP6-2003-LIFESCIHEALTH-I: BioSim and by Hungarian National Scientific Research Fund Grants OTKA T-067963 to (J. Ovadi) and OTKA F-49795 and ELTE CellCom RET (to B. S.).	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Kawada J, 2009, J BIOL CHEM, V284, P17102, DOI 10.1074/jbc.M809090200; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Nahhas F, 2007, MOL CELL BIOCHEM, V303, P221, DOI 10.1007/s11010-007-9478-6; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Ovadi J, 2009, BIOESSAYS, V31, P676, DOI 10.1002/bies.200900008; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Stepanova T, 2003, J NEUROSCI, V23, P2655; Suzuki K, 2007, NEUROSCIENCE, V147, P599, DOI 10.1016/j.neuroscience.2007.04.059; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; WEBSTER DR, 1989, J CELL SCI, V92, P57; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	51	75	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17896	17906		10.1074/jbc.M109.096578	http://dx.doi.org/10.1074/jbc.M109.096578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20308065	hybrid, Green Published			2022-12-25	WOS:000278133400066
J	Redmond, KL; Crawford, NT; Farmer, H; D'Costa, ZC; O'Brien, GJ; Buckley, NE; Kennedy, RD; Johnston, PG; Harkin, DP; Mullan, PB				Redmond, K. L.; Crawford, N. T.; Farmer, H.; D'Costa, Z. C.; O'Brien, G. J.; Buckley, N. E.; Kennedy, R. D.; Johnston, P. G.; Harkin, D. P.; Mullan, P. B.			T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells	ONCOGENE			English	Article						TBX2; NDRG1; EGR1; breast cancer	P53-DEPENDENT APOPTOSIS; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; GENE; TBX2; P53; SENESCENCE; EXPRESSION; GROWTH; BRCA1	T-box 2 (TBX2) is a transcription factor involved in mammary development and is known to be overexpressed in a subset of aggressive breast cancers. TBX2 has previously been shown to repress growth control genes such as p14(ARF) and p21(WAF1/cip1). In this study we show that TBX2 drives proliferation in breast cancer cells and this is abrogated after TBX2 small interfering RNA (siRNA) knockdown or after the expression of a dominant-negative TBX2 protein. Using microarray analysis we identified a large cohort of novel TBX2-repressed target genes including the breast tumour suppressor NDRG1 (N-myc downregulated gene 1). We show that TBX2 targets NDRG1 through a previously undescribed mechanism involving the recruitment of early growth response 1 (EGR1). We show EGR1 is required for the ability of TBX2 to repress NDRG1 and drive cell proliferation. We show that TBX2 interacts with EGR1 and that TBX2 requires EGR1 to target the NDRG1 proximal promoter. Abrogation of either TBX2 or EGR1 expression is accompanied by the upregulation of cell senescence and apoptotic markers. NDRG1 can recapitulate these effects when transfected into TBX2-expressing cells. Together, these data identify a novel mechanism for TBX2-driven oncogenesis and highlight the importance of NDRG1 as a growth control gene in breast tissue. Oncogene (2010) 29, 3252-3262; doi: 10.1038/onc.2010.84; published online 29 March 2010	[Redmond, K. L.; Crawford, N. T.; Farmer, H.; D'Costa, Z. C.; Buckley, N. E.; Johnston, P. G.; Harkin, D. P.; Mullan, P. B.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [O'Brien, G. J.; Kennedy, R. D.; Harkin, D. P.] Almac Diagnost, Craigavon, North Ireland	Queens University Belfast	Mullan, PB (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, CCRCB Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	p.mullan@qub.ac.uk	Kennedy, Richard/J-3489-2012	Kennedy, Richard/0000-0003-4737-6163; Buckley, Niamh/0000-0001-9326-8513	Department of Employment and Learning Northern Ireland; Breast Cancer Campaign; Action Cancer; OSF; Cancer Research UK; Research and Development Northern Ireland	Department of Employment and Learning Northern Ireland; Breast Cancer Campaign; Action Cancer; OSF; Cancer Research UK(Cancer Research UK); Research and Development Northern Ireland	Special thanks to Dr James Murray (CCRCB, QUB) for gift of sheep anti-human NDRG1 antibody, Professor Carlos Caldas (University of Cambridge) for TBX2-expressing breast cancer cell lines and Professor Max Costa (University of New York) for NDRG1 promoter luciferase constructs. We also thank Professor Neil Perkins (University of Bristol) for reading this manuscript. This study was supported by the Department of Employment and Learning Northern Ireland (KLR), Breast Cancer Campaign (NTC, PBM), Action Cancer (HF, PBM), OSF (ZCD'C), Cancer Research UK (GJO'B, PGJ, DPH) and Research and Development Northern Ireland (NEB).	Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Buckley NE, 2007, MOL CANCER RES, V5, P261, DOI 10.1158/1541-7786.MCR-06-0250; Carlson H, 2002, ONCOGENE, V21, P3827, DOI 10.1038/sj.onc.1205476; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; de Belle I, 1999, ONCOGENE, V18, P3633, DOI 10.1038/sj.onc.1202696; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Ismail A, 2009, CANCER LETT, V278, P230, DOI 10.1016/j.canlet.2009.01.006; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Krones-Herzig A, 2003, P NATL ACAD SCI USA, V100, P3233, DOI 10.1073/pnas.2628034100; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lu Shaolei, 2008, Endocrinology, V149, P4809, DOI 10.1210/en.2008-0035; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Ronski K, 2005, CANCER-AM CANCER SOC, V104, P925, DOI 10.1002/cncr.21262; Roylance R, 1999, CANCER RES, V59, P1433; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sinclair CS, 2002, CANCER RES, V62, P3587; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Tirkkonen M, 1997, CANCER RES, V57, P1222; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461; Zhang J, 2008, GENE, V417, P5, DOI 10.1016/j.gene.2008.03.002; Zhang P, 2007, CANCER RES, V67, P9125, DOI 10.1158/0008-5472.CAN-07-1525	30	55	56	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 3	2010	29	22					3252	3262		10.1038/onc.2010.84	http://dx.doi.org/10.1038/onc.2010.84			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20348948				2022-12-25	WOS:000278321100008
J	Galdiero, S; Falanga, A; Vitiello, M; Raiola, L; Russo, L; Pedone, C; Isernia, C; Galdiero, M				Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Raiola, Luca; Russo, Luigi; Pedone, Carlo; Isernia, Carla; Galdiero, Massimiliano			The Presence of a Single N-terminal Histidine Residue Enhances the Fusogenic Properties of a Membranotropic Peptide Derived from Herpes Simplex Virus Type 1 Glycoprotein H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; SURFACE-PLASMON RESONANCE; CELL-FUSION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; CYTOPLASMIC TAIL; LYTIC PEPTIDES; HEPTAD-REPEAT; ALPHA-HELIX; DOMAINS	Herpes simplex virus type 1 (HSV-1)-induced membrane fusion remains one of the most elusive mechanisms to be deciphered in viral entry. The structure resolution of glycoprotein gB has revealed the presence of fusogenic domains in this protein and pointed out the key role of gB in the entry mechanism of HSV-1. A second putative fusogenic glycoprotein is represented by the heterodimer comprising the membrane-anchored glycoprotein H (gH) and the small secreted glycoprotein L, which remains on the viral envelope in virtue of its non-covalent interaction with gH. Different domains scattered on the ectodomain of HSV-1 gH have been demonstrated to display membranotropic characteristics. The segment from amino acid 626 to 644 represents the most fusogenic region identified by studies with synthetic peptides and model membranes. Herein we have identified the minimal fusogenic sequence present on gH. An enlongation at the N terminus of a single histidine (His) has proved to profoundly increase the fusogenic activity of the original sequence. Nuclear magnetic resonance (NMR) studies have shown that the addition of the N-terminal His contributes to the formation and stabilization of an alpha-helical domain with high fusion propensity.	[Galdiero, Stefania; Falanga, Annarita; Pedone, Carlo] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, I-80134 Naples, Italy; [Galdiero, Stefania; Pedone, Carlo; Galdiero, Massimiliano] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, I-80134 Naples, Italy; [Vitiello, Mariateresa; Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, I-80138 Naples, Italy; [Galdiero, Stefania; Pedone, Carlo] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Raiola, Luca; Russo, Luigi; Isernia, Carla] Univ Naples 2, Dept Environm Sci, I-81100 Caserta, Italy	University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli	Galdiero, S (corresponding author), Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Via Mezzocannone 16, I-80134 Naples, Italy.	sgaldier@unina.it	Isernia, Carla/ABD-8156-2021; Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Galdiero, Massimiliano/0000-0002-1576-6290; Isernia, Carla/0000-0002-1504-2479; RUSSO, Luigi/0000-0002-1577-176X; FALANGA, Annarita/0000-0001-6538-8585				Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Avitabile E, 2009, J VIROL, V83, P10752, DOI 10.1128/JVI.01287-09; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Brasseur R, 1997, TRENDS BIOCHEM SCI, V22, P167, DOI 10.1016/S0968-0004(97)01047-5; Cairns TM, 2005, VIROLOGY, V332, P550, DOI 10.1016/j.virol.2004.12.006; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chanel-Vos C, 2004, J VIROL, V78, P13543, DOI 10.1128/JVI.78.24.13543-13552.2004; DEGRADO WF, 1990, BIOPOLYMERS, V29, P205, DOI 10.1002/bip.360290125; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Galdiero M, 1997, J VIROL, V71, P2163, DOI 10.1128/JVI.71.3.2163-2170.1997; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; GALDIERO S, 2009, Patent No. 61285619; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; GORDON LM, 1992, BIOCHIM BIOPHYS ACTA, V1139, P257, DOI 10.1016/0925-4439(92)90099-9; Guillen J, 2008, BBA-BIOMEMBRANES, V1778, P2765, DOI 10.1016/j.bbamem.2008.07.021; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Harman A, 2002, J VIROL, V76, P10708, DOI 10.1128/JVI.76.21.10708-10716.2002; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnan A, 2009, J VIROL, V83, P1727, DOI 10.1128/JVI.02026-08; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2000, BIOSCIENCE REP, V20, P535, DOI 10.1023/A:1010411021326; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Vitiello M, 2009, PROTEIN PEPTIDE LETT, V16, P786, DOI 10.2174/092986609788681742; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhu NL, 1998, J VIROL, V72, P1632, DOI 10.1128/JVI.72.2.1632-1639.1998	70	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17123	17136		10.1074/jbc.M110.114819	http://dx.doi.org/10.1074/jbc.M110.114819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348105	Green Published, hybrid			2022-12-25	WOS:000277982600075
J	Leonhardt, RM; Vigneron, N; Rahner, C; van den Eynde, BJ; Cresswell, P				Leonhardt, Ralf M.; Vigneron, Nathalie; Rahner, Christoph; van den Eynde, Benoit J.; Cresswell, Peter			Endoplasmic Reticulum Export, Subcellular Distribution, and Fibril Formation by Pmel17 Require an Intact N-terminal Domain Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII-DEPENDENT EXPORT; SPLICE VARIANT; PROTEIN GP100; REPEAT DOMAIN; ER EXPORT; MELANOMA; GOLGI; MELANOSOMES; CLEAVAGE; PATHWAY	Pmel17 is a melanocyte/melanoma-specific protein that sub-cellularly localizes to melanosomes, where it forms a fibrillar matrix that serves for the sequestration of potentially toxic reaction intermediates of melanin synthesis and deposition of the pigment. As a key factor in melanosomal biogenesis, understanding intracellular trafficking and processing of Pmel17 is of central importance to comprehend how these organelles are formed, how they mature, and how they function in the cell. Using a series of deletion and missense mutants of Pmel17, we are able to show that the integrity of the junction between the N-terminal region and the polycystic kidney disease-like domain is highly crucial for endoplasmic reticulum export, subcellular targeting, and fibril formation by Pmel17 and thus for establishing functional melanosomes.	[Leonhardt, Ralf M.; Vigneron, Nathalie; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Rahner, Christoph; Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Vigneron, Nathalie; van den Eynde, Benoit J.] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Vigneron, Nathalie; van den Eynde, Benoit J.] Catholic Univ Louvain, de Duve Inst, Cellular Genet Unit, B-1200 Brussels, Belgium	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Leonhardt, RM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S669-670, New Haven, CT 06519 USA.	ralf.leonhardt@yale.edu		Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [R37-AI23081]; Howard Hughes Medical Institute; Yale SPORE in Skin Cancer [5P50 CA121974]; Cancer Research Institute; European Union; Fonds National de la Recherche Scientifique, Belgium; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale SPORE in Skin Cancer; Cancer Research Institute; European Union(European Commission); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AI23081 (to P. C.). This work was also supported by the Howard Hughes Medical Institute and Yale SPORE in Skin Cancer Grant 5P50 CA121974 (to P. C.). Furthermore, support was provided by a Cancer Research Institute Fellowship (to R. M. L.) and a Marie Curie Outgoing International Fellowship from the European Union and the Fonds National de la Recherche Scientifique, Belgium (to N.V.).	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kuliawat R, 2009, EUR J CELL BIOL, V88, P653, DOI 10.1016/j.ejcb.2009.07.001; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Seliger B, 2001, CANCER RES, V61, P8647; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tanaka T, 2006, BIOPOLYMERS, V84, P161, DOI 10.1002/bip.20361; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Vigneron N, 2005, TISSUE ANTIGENS, V65, P156, DOI 10.1111/j.1399-0039.2005.00365.x; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Zheng Y, 2005, J MICROBIOL, V43, P529	41	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16166	16183		10.1074/jbc.M109.097725	http://dx.doi.org/10.1074/jbc.M109.097725			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20231267	hybrid, Green Published			2022-12-25	WOS:000277715900054
J	Rajakumari, S; Daum, G				Rajakumari, Sona; Daum, Guenther			Multiple Functions as Lipase, Steryl Ester Hydrolase, Phospholipase, and Acyltransferase of Tgl4p from the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; PHOSPHATIDIC-ACID; TRIACYLGLYCEROL LIPASE; LIPID PARTICLES; FATTY-ACID; LYSOPHOSPHATIDIC ACID; PROTEIN; METABOLISM; PHOSPHATIDYLCHOLINE; ENCODES	Triacylglycerol (TAG) hydrolysis, membrane lipid biosynthesis, and lipid turnover are largely interlinked processes. In yeast, TAG is mobilized by three TAG lipases named Tgl3p, Tgl4p, and Tgl5p, which are localized to lipid particles/droplets. These TAG lipases posses a conserved GXSXG motif that is characteristic of hydrolytic enzymes. Here, we demonstrated that the yeast TAG lipase Tgl4p, the functional ortholog of the adipose TAG lipase, ATGL, catalyzes multiple functions in lipid metabolism. An extended domain and motif search analysis revealed that Tgl4p bears not only a lipase consensus domain but also a conserved motif for calcium-independent phospholipase A(2). We show that Tgl4p exhibits TAG lipase, steryl ester hydrolase, and phospholipase A(2) activities, but surprisingly it also catalyzed the acyl-CoA-dependent acylation of lysophosphatidic acid to phosphatidic acid (PA). Heterologous overexpression of Tgl4p in Pichia pastoris increased total phospholipid and specifically PA synthesis. Moreover, deletion of TGL4 in Saccharomyces cerevisiae showed an altered pattern of phosphatidylcholine and PA molecular species. Altogether, our data suggest that yeast Tgl4p functions as a hydrolytic enzyme in lipid degradation but also contributes to fatty acid channeling and phospholipid remodeling.	[Rajakumari, Sona; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-II, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich [18857, W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich, Projects 18857 and W901-B05 ( to G. D.).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; COOK HW, 1985, CAN J BIOCHEM CELL B, V63, P919, DOI 10.1139/o85-114; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; DAUM G, 1980, MONATSH CHEM, V111, P355, DOI 10.1007/BF00903231; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Gao JG, 2009, MOL GENET METAB, V96, P253, DOI 10.1016/j.ymgme.2008.12.007; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; HAID A, 1983, METHOD ENZYMOL, V96, P192; Holub B J, 1978, Adv Lipid Res, V16, P1; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; INOUE M, 1984, ARCH BIOCHEM BIOPHYS, V231, P29, DOI 10.1016/0003-9861(84)90359-X; IRVINE RF, 1979, BIOCHEM BIOPH RES CO, V91, P1399, DOI 10.1016/0006-291X(79)91222-1; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1963, J BIOL CHEM, V238, P898; LEE KS, 1994, J BIOL CHEM, V269, P19725; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Pinsirodom P, 2000, J AGR FOOD CHEM, V48, P155, DOI 10.1021/jf990338g; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Saarela J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-281; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shan T, 2008, J ANIM SCI, V86, P1781, DOI 10.2527/jas.2007-0659; Stymne S., 1987, Biochemistry of Plants, V9, P175; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wagner A, 2009, BBA-MOL CELL BIOL L, V1791, P118, DOI 10.1016/j.bbalip.2008.11.004; WAGNER S, 1994, YEAST, V10, P1429, DOI 10.1002/yea.320101106; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	63	60	62	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15769	15776		10.1074/jbc.M109.076331	http://dx.doi.org/10.1074/jbc.M109.076331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332534	Green Published, hybrid			2022-12-25	WOS:000277715900014
J	Staruschenko, A; Jeske, NA; Akopian, AN				Staruschenko, Alexander; Jeske, Nathaniel A.; Akopian, Armen N.			Contribution of TRPV1-TRPA1 Interaction to the Single Channel Properties of the TRPA1 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; MUSTARD OIL RESPONSES; RECEPTOR POTENTIAL A1; SENSORY NEURONS; CAPSAICIN RECEPTOR; SUBUNIT STOICHIOMETRY; PLASMA-MEMBRANE; CATION CHANNEL; MICE LACKING; ION-CHANNEL	Several lines of evidence suggest that TRPA1 and TRPV1 mutually control the transduction of inflammation-induced noxious stimuli in sensory neurons. It was recently shown that certain TRPA1 properties are modulated by TRPV1. However, direct interaction between TRPA1 and TRPV1 as well as regulation of TRPA1 intrinsic characteristics by the TRPV1 channel have not been examined. To address these questions, we have studied a complex formation between TRPA1 and TRPV1 and characterized the influence of TRPV1 on single channel TRPA1-mediated currents. Co-immunoprecipitation analysis revealed direct interactions between TRPA1 and TRPV1 in an expression system as well as in sensory neurons. Data generated with total internal reflection fluorescence-based fluorescence resonance energy transfer indicate that a TRPA1-TRPV1 complex can be formed on the plasma membrane. The fluorescence resonance energy transfer interaction between TRPA1 and TRPV1 channels is as effective as for TRPV1 or TRPA1 homomers. Single channel analysis in a heterologous expression system and in sensory neurons of wild type and TRPV1 knockout mice demonstrated that co-expression of TRPV1 with TRPA1 results in outward rectification of single channel mustard oil (I-MO) current-voltage relationships (I-V) and substantial modulation of the open probability at negative holding potentials. TRPV1 also does not influence the characteristics of single channel IMO in Ca2+-free extracellular solution. However, association of TRPA1 with TRPV1 was not affected in Ca2+-free media. To assess a role of intracellular Ca2+ in TRPV1-dependent modulation of TRPA1 modulation, the TRPA1-mediated single channel WIN55,212-2-gated current (I-WIN) was recorded in inside-out configuration. Our data indicate that single channel properties of TRPA1 are regulated by TRPV1 independently of intracellular Ca2+. In summary, our results support the hypothesis that TRPV1 and TRPA1 form a complex and that TRPV1 influences intrinsic characteristics of the TRPA1 channel.	[Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin; Medical College of Wisconsin	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	akopian@uthscsa.edu		Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [DE017696, DE019311, NS061884]; American Heart Association [0730111N]; American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019311, R01DE017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE017696 and DE019311 (to A. N. A.) and NS061884 (to N. A. J.). This work was also supported by American Heart Association Grant 0730111N and a Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (to A. S.).	Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Ambudkar I. S., 2007, V179, P541; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Staruschenko AV, 2006, CELL RES, V16, P723, DOI 10.1038/sj.cr.7310084; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vennekens R, 2001, J PHYSIOL-LONDON, V530, P183, DOI 10.1111/j.1469-7793.2001.0183l.x; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	48	150	153	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15167	15177		10.1074/jbc.M110.106153	http://dx.doi.org/10.1074/jbc.M110.106153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231274	Green Published, hybrid			2022-12-25	WOS:000277399000038
J	Yao, JH; Py, BF; Zhu, H; Bao, JX; Yuan, JY				Yao, Jianhua; Py, Benedicte F.; Zhu, Hong; Bao, Jianxin; Yuan, Junying			Role of Protein Misfolding in DFNA9 Hearing Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-EAR; VESTIBULAR DYSFUNCTION; SENSORINEURAL DEAFNESS; COCHLEAR GENE; A DOMAIN; DISORDER; MOUSE; IDENTIFICATION; LOCALIZATION; MUTATIONS	Mutations in the COCH(coagulation factor Chomology) gene have been attributed to DFNA9 (deafness, autosomal-dominant 9), an autosomal-dominant non-syndromic hearing loss disorder. However, the mechanisms responsible for DFNA9 hearing loss remain unknown. Here, we demonstrate that mutant cochlin, the protein product of the COCH gene, forms a stable dimer that is sensitive to reducing agent. In contrast, wild-type (WT) cochlin may form only dimers transiently. Interestingly, the presence of mutant cochlin can stabilize WT cochlin in dimer conformation, providing a possible mechanism for the dominant nature of DFNA9 mutations. Furthermore, the expression of mutant cochlin eventually induces WT cochlin to form stable oligomers that are resistant to reducing agent. Finally, we show that mutant cochlin is cytotoxic in vitro and in vivo. Our study suggests a possible molecular mechanism underlying DFNA9 hearing loss and provides an in vitro model that may be used to explore protein-misfolding diseases in general.	[Yao, Jianhua; Py, Benedicte F.; Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bao, Jianxin] Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	junying_yuan@hms.harvard.edu	Py, Benedicte/M-6129-2014	Zhu, Hong/0000-0002-2575-4031; py, benedicte/0000-0001-6716-7807	National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award ( to J.Y.).	Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Ferrante RJ, 2009, BBA-MOL BASIS DIS, V1792, P506, DOI 10.1016/j.bbadis.2009.04.001; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Grabski R, 2003, HUM GENET, V113, P406, DOI 10.1007/s00439-003-0992-7; Iguchi F, 2004, ACTA OTO-LARYNGOL, V124, P43, DOI 10.1080/03655230310016816; Ikezono T, 2004, BIOCHEM BIOPH RES CO, V314, P440, DOI 10.1016/j.bbrc.2003.12.106; Ikezono T, 2001, BBA-MOL BASIS DIS, V1535, P258, DOI 10.1016/S0925-4439(00)00101-0; Khetarpal U, 2000, LARYNGOSCOPE, V110, P1379, DOI 10.1097/00005537-200008000-00030; KHETARPAL U, 1991, ARCH OTOLARYNGOL, V117, P1032; Lawlor P, 1999, J NEUROSCI, V19, P9445; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Lipinski MM, 2004, CURR OPIN PHARMACOL, V4, P85, DOI 10.1016/j.coph.2003.09.008; Makishima T, 2005, HUM GENET, V118, P29, DOI 10.1007/s00439-005-0001-4; Merchant SN, 2000, ADV OTO-RHINO-LARYNG, V56, P212; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Nagy I, 2008, FEBS LETT, V582, P4003, DOI 10.1016/j.febslet.2008.10.050; Nakagawa T, 2003, HEARING RES, V176, P122, DOI 10.1016/S0378-5955(02)00768-2; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Robertson NG, 2008, HUM MOL GENET, V17, P3426, DOI 10.1093/hmg/ddn236; Robertson NG, 2003, J MED GENET, V40, P479, DOI 10.1136/jmg.40.7.479; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Robertson NG, 2001, HUM MOL GENET, V10, P2493, DOI 10.1093/hmg/10.22.2493; Rodriguez CI, 2004, ENDOCRINOLOGY, V145, P1410, DOI 10.1210/en.2003-1361; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shen HY, 2007, HEARING RES, V226, P52, DOI 10.1016/j.heares.2006.12.011; Suko T, 2000, HEARING RES, V140, P137, DOI 10.1016/S0378-5955(99)00191-4; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	31	29	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14909	14919		10.1074/jbc.M110.106724	http://dx.doi.org/10.1074/jbc.M110.106724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228067	Green Published, hybrid			2022-12-25	WOS:000277399000012
J	Wang, DQ; Xia, XM; Weiss, RE; Refetoff, S; Yen, PM				Wang, Dongqing; Xia, Xianmin; Weiss, Roy E.; Refetoff, Samuel; Yen, Paul M.			Distinct and Histone-Specific Modifications Mediate Positive versus Negative Transcriptional Regulation of TSH alpha Promoter	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; STIMULATING HORMONE; COREPRESSOR COMPLEX; MOLECULAR-BASIS; SUBUNIT GENE; IN-VIVO; ACETYLATION; RECRUITMENT; METHYLATION; RESISTANCE	Background: Hormonally-regulated histone modifications that govern positive versus negative transcription of target genes are poorly characterized despite their importance for normal and pathological endocrine function. There have been only a few studies examining chromatin modifications on target gene promoters by nuclear hormone receptors. Moreover, these studies have focused on positively-regulated target genes. TSH alpha, a heterodimer partner for thyrotropin (TSH), is secreted by the pituitary gland. T(3) negatively regulates TSH alpha gene expression via thyroid hormone receptors (TRs) which belong to the nuclear hormone receptor superfamily, whereas thyrotropin releasing hormone (TRH) positively regulates via the TRH receptor, a G protein-coupled receptor. Methodology/Principal Findings: We studied regulation of the TSH alpha gene by cAMP and T(3) using chromatin immunoprecipitation (ChIP) assays in stably-transfected rat pituitary cells containing the human TSH alpha promoter. Interestingly, cAMP selectively increased histone H4 acetylation whereas, as previously reported, T(3) induced histone H3 acetylation. In particular, cAMP increased H4K5 and H4K8 acetylation and decreased H4K20 trimethylation, modifications associated with transcriptional activation. T(3) increased H3K9 and H3K18 acetylation and H3K4 trimethylation; however, it also decreased H3K27 acetylation and increased H3K27 trimethylation which are associated with transcriptional repression. Of note, cAMP recruited pCREB, CBP/p300, and PCAF to the promoter whereas T(3) caused dissociation of NCoR/SMRT and HDAC3. Overexpression of a dominant negative mutant thyroid hormone receptor (TR) from a patient with resistance to thyroid hormone (RTH) led to less T(3)-dependent negative regulation and partially blocked histone H3 modifications of the TSH alpha promoter. Conclusions/Significance: Our findings show that non-overlapping and specific histone modifications determine positive versus negative transcriptional regulation, and integrate opposing hormonal and intracellular signals at the TSH alpha promoter. A mutant TR from a patient with RTH exerted dominant negative activity by blocking the histone modifications induced by T(3) on the TSH alpha promoter and likely contributes to the inappropriate TSH production observed in RTH.	[Wang, Dongqing; Yen, Paul M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA; [Yen, Paul M.] Duke Natl Univ Singapore, Grad Sch Med, Lab Hormonal Regulat, Cardiovasc & Metab Dis Program, Singapore, Singapore; [Xia, Xianmin] DJ Biotech, Changzhou, Peoples R China; [Weiss, Roy E.; Refetoff, Samuel] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Weiss, Roy E.; Refetoff, Samuel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	Johns Hopkins University; National University of Singapore; University of Chicago; University of Chicago	Wang, DQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA.	paul.yen@duke-nus.edu.sg	Refetoff, Samuel/ABB-1263-2021; Yen, Paul M/V-9857-2019	Refetoff, Samuel/0000-0003-0164-8231; Yen, Paul/0000-0002-3790-8114	National Institutes of Health [5R01DK69899, 4R37DK15070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069899, R37DK015070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health 5R01DK69899 (P. M. Y.) and NIH 4R37DK15070 (S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; Hayashi Y, 1996, MOL ENDOCRINOL, V10, P100, DOI 10.1210/me.10.1.100; HAYASHI Y, 1994, J BIOL CHEM, V269, P23872; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14272; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KIM DS, 1994, MOL ENDOCRINOL, V8, P528, DOI 10.1210/me.8.4.528; LADENSON PW, 1983, J CLIN ENDOCR METAB, V56, P1252, DOI 10.1210/jcem-56-6-1252; Lee KC, 2003, MOL ENDOCRINOL, V17, P908, DOI 10.1210/me.2002-0308; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Tagami T, 1999, J BIOL CHEM, V274, P22345, DOI 10.1074/jbc.274.32.22345; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Wang DQ, 2009, MOL ENDOCRINOL, V23, P600, DOI 10.1210/me.2008-0389; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9853	10.1371/journal.pone.0009853	http://dx.doi.org/10.1371/journal.pone.0009853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352046	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894500020
J	Ochsner, M; Textor, M; Vogel, V; Smith, ML				Ochsner, Mirjam; Textor, Marcus; Vogel, Viola; Smith, Michael L.			Dimensionality Controls Cytoskeleton Assembly and Metabolism of Fibroblast Cells in Response to Rigidity and Shape	PLOS ONE			English	Article							GENE-EXPRESSION; MATRIX; STIFFNESS; CULTURE; FIBRONECTIN; GROWTH; ARCHITECTURE; ADHESIONS; PHENOTYPE; TENSION	Background: Various physical parameters, including substrate rigidity, size of adhesive islands and micro-and nano-topographies, have been shown to differentially regulate cell fate in two-dimensional (2-D) cell cultures. Cells anchored in a three-dimensional (3-D) microenvironment show significantly altered phenotypes, from altered cell adhesions, to cell migration and differentiation. Yet, no systematic analysis has been performed that studied how the integrated cellular responses to the physical characteristics of the environment are regulated by dimensionality (2-D versus 3-D). Methodology/Principal Findings: Arrays of 5 or 10 mm deep microwells were fabricated in polydimethylsiloxane (PDMS). The actin cytoskeleton was compared for single primary fibroblasts adhering either to microfabricated adhesive islands (2-D) or trapped in microwells (3-D) of controlled size, shape, and wall rigidity. On rigid substrates (Young's Modulus = 1 MPa), cytoskeleton assembly within single fibroblast cells occurred in 3-D microwells of circular, rectangular, square, and triangular shapes with 2-D projected surface areas (microwell bottom surface area) and total surface areas of adhesion (microwell bottom plus wall surface area) that inhibited stress fiber assembly in 2-D. In contrast, cells did not assemble a detectable actin cytoskeleton in soft 3-D microwells (20 kPa), regardless of their shapes, but did so on flat, 2-D substrates. The dependency on environmental dimensionality was also reflected by cell viability and metabolism as probed by mitochondrial activities. Both were upregulated in 3-D cultured cells versus cells on 2-D patterns when surface area of adhesion and rigidity were held constant. Conclusion/Significance: These data indicate that cell shape and rigidity are not orthogonal parameters directing cell fate. The sensory toolbox of cells integrates mechanical (rigidity) and topographical (shape and dimensionality) information differently when cell adhesions are confined to 2-D or occur in a 3-D space.	[Ochsner, Mirjam; Textor, Marcus] Swiss Fed Inst Technol, Surface Sci & Technol Lab, BioInterface Grp, Zurich, Switzerland; [Vogel, Viola; Smith, Michael L.] Swiss Fed Inst Technol, Lab Biol Oriented Mat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ochsner, M (corresponding author), ASTAR, Inst Mat Res & Engn, Singapore, Singapore.	msmith@bu.edu	Vogel, Viola/O-8025-2015; Textor, Marcus/A-6200-2012	Vogel, Viola/0000-0003-2898-7671; Textor, Marcus/0000-0002-0178-1801	ETH Zurich; Swiss National Science Foundation [FN 205321-112323/1]; Swiss Competence Centre for Materials Science and Technology (CCMX); International Human Frontier Science Program Organization (MLS)	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Competence Centre for Materials Science and Technology (CCMX); International Human Frontier Science Program Organization (MLS)(Human Frontier Science Program)	This study was supported by ETH Zurich, the Swiss National Science Foundation (Project FN 205321-112323/1), the Swiss Competence Centre for Materials Science and Technology (CCMX) and the International Human Frontier Science Program Organization (MLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; BOTTARO DP, 2002, MOL SIGNALING BIOENG, P961; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Dusseiller MR, 2006, BIOINTERPHASES, V1, pP1, DOI 10.1116/1.2190698; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Fringer J, 2001, J BIOL CHEM, V276, P31047, DOI 10.1074/jbc.M101898200; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; JIANG G, 2009, BIOPHYS J, V90, P1804; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; KUBOW KE, 2009, INTEGR BIOL IN PRESS; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	50	72	73	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2010	5	3							e9445	10.1371/journal.pone.0009445	http://dx.doi.org/10.1371/journal.pone.0009445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FS	20351781	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894400004
J	Gengler, S; Hamilton, A; Holscher, C				Gengler, Simon; Hamilton, Alison; Hoelscher, Christian			Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; SEIZURES; AMYLOIDOSIS; MODULATION	Background: Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investigated synaptic plasticity in area CA1 in a novel AD mouse model (APPPS1-21) which expresses the Swedish mutation of APP and the L166P mutation of human PS-1. This model shows initial plaque formation at 2 months in the neocortex and 4 months in the hippocampus and displays beta-amyloid-associated pathologies and learning impairments. Methodology/Principal Findings: We tested long-term potentiation (LTP) and short term potentiation (paired-pulse facilitation, PPF) of synaptic transmission in vivo in area CA1 of the hippocampus. There was no difference in LTP or PPF at 4-5 months of age in APPPS1-21 mice compared to littermate controls. At 6 months of age there was also no difference in LTP but APPPS1-21 mice showed slightly increased PPF (p<0.03). In 8 months old mice, LTP was greatly impaired in APPPS-21 animals (p<0.0001) while PPF was not changed. At 15 months of age, APPPS1-21 mice showed again impaired LTP compared to littermate controls (p<0.005), and PPF was also significantly reduced at 80 ms (p<0.005) and 160 ms (p<0.01) interstimulus interval. Immunohistological analysis showed only modest amyloid deposition in the hippocampus at 4 and 6 months with a robust increase up to 15 months of age. Conclusions: Our results suggest that increased formation and aggregation of beta amyloid with aging is responsible for the impaired LTP with aging in this mouse model, while the transient increase of PPF at 6 months of age is caused by some other mechanism.	[Gengler, Simon; Hamilton, Alison; Hoelscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Gengler, S (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	christian_Holscher@mac.com		Holscher, Christian/0000-0002-8159-3260	Alzheimer Research Trust	Alzheimer Research Trust	Alzheimer Research Trust project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ASHE KH, 2005, MECH MEMORY LOSS ABE, P591; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen Y, 1996, NEUROSCI LETT, V218, P204, DOI 10.1016/S0304-3940(96)13149-9; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cummings BJ, 2002, NEUROBIOL AGING, V23, P161, DOI 10.1016/S0197-4580(01)00316-5; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dema A, 1998, Rom J Morphol Embryol, V44, P93; Dewachter I, 2008, NEUROBIOL AGING, V29, P639, DOI 10.1016/j.neurobiolaging.2006.11.019; Dewachter I, 2002, J NEUROSCI, V22, P3445; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Holscher C, 2005, REV NEUROSCIENCE, V16, P181; Holscher C, 2001, NEURONAL MECHANISMS OF MEMORY FORMATION, P146; Kalaria RN, 1996, NEURODEGENERATION, V5, P497, DOI 10.1006/neur.1996.0069; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Priller C, 2009, NEUROBIOL AGING, V30, P1227, DOI 10.1016/j.neurobiolaging.2007.10.016; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Roder S, 2003, NEUROSCIENCE, V120, P705, DOI 10.1016/S0306-4522(03)00381-6; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; STURCHLERPIERRA.C, 2000, PATHOGENIC MECH ALZH, P134; Tsai ML, 2008, EPILEPSY RES, V79, P187, DOI 10.1016/j.eplepsyres.2008.02.001; Tsai ML, 2006, EPILEPSIA, V47, P277, DOI 10.1111/j.1528-1167.2006.00419.x; VOLIANSKIS A, 2008, NEUROBIOL AGING; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; WILCOX R, 2005, INTRO R ESTIMATION H; Wiley CA, 2009, ARCH NEUROL-CHICAGO, V66, P60, DOI 10.1001/archneurol.2008.511; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299	34	114	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9764	10.1371/journal.pone.0009764	http://dx.doi.org/10.1371/journal.pone.0009764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339537	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000275894300009
J	Roy, N; Nageshan, RK; Pallavi, R; Chakravarthy, H; Chandran, S; Kumar, R; Gupta, AK; Singh, RK; Yadav, SC; Tatu, U				Roy, Nainita; Nageshan, Rishi Kumar; Pallavi, Rani; Chakravarthy, Harshini; Chandran, Syama; Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra; Tatu, Utpal			Proteomics of Trypanosoma evansi Infection in Rodents	PLOS ONE			English	Article							PARAFLAGELLAR ROD PROTEINS; PROTECTIVE IMMUNITY; OLIGOPEPTIDASE-B; BLOOD-STREAM; DRUG TARGETS; CRUZI; BRUCEI; EQUIPERDUM; PEPTIDASE; RESPONSES	Background: Trypanosoma evansi infections, commonly called 'surra', cause significant economic losses to livestock industry. While this infection is mainly restricted to large animals such as camels, donkeys and equines, recent reports indicate their ability to infect humans. There are no World Animal Health Organization (WAHO) prescribed diagnostic tests or vaccines available against this disease and the available drugs show significant toxicity. There is an urgent need to develop improved methods of diagnosis and control measures for this disease. Unlike its related human parasites T. brucei and T. cruzi whose genomes have been fully sequenced T. evansi genome sequence remains unavailable and very little efforts are being made to develop improved methods of prevention, diagnosis and treatment. With a view to identify potential diagnostic markers and drug targets we have studied the clinical proteome of T. evansi infection using mass spectrometry (MS). Methodology/Principal Findings: Using shot-gun proteomic approach involving nano-lc Quadrupole Time Of Flight (QTOF) mass spectrometry we have identified over 160 proteins expressed by T. evansi in mice infected with camel isolate. Homology driven searches for protein identification from MS/MS data led to most of the matches arising from related Trypanosoma species. Proteins identified belonged to various functional categories including metabolic enzymes; DNA metabolism; transcription; translation as well as cell-cell communication and signal transduction. TCA cycle enzymes were strikingly missing, possibly suggesting their low abundances. The clinical proteome revealed the presence of known and potential drug targets such as oligopeptidases, kinases, cysteine proteases and more. Conclusions/Significance: Previous proteomic studies on Trypanosomal infections, including human parasites T. brucei and T. cruzi, have been carried out from lab grown cultures. For T. evansi infection this is indeed the first ever proteomic study reported thus far. In addition to providing a glimpse into the biology of this neglected disease, our study is the first step towards identification of diagnostic biomarkers, novel drug targets as well as potential vaccine candidates to fight against T. evansi infections.	[Roy, Nainita; Nageshan, Rishi Kumar; Pallavi, Rani; Chakravarthy, Harshini; Chandran, Syama; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra] Natl Res Ctr Equines, Hisar, Haryana, India	Indian Institute of Science (IISC) - Bangalore; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Roy, N (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Bhowmick, Nainita Roy/AAS-2908-2021; Pallavi, Rani/AAR-7824-2020	Tatu, Utpal/0000-0003-0404-8872; Nageshan, Rishi Kumar/0000-0003-1592-4452; Singh, Rajkumar/0000-0003-4649-2015	Department of Biotechnology, New Delhi, India; Roche; United Grants Commission/Council of Scientific and Industrial Research	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Roche(Roche Holding); United Grants Commission/Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	UT would like to thank Department of Biotechnology, New Delhi, India for financial support. UT would also like to thank the funding support from Roche made available from University of Bern. NR, RK and RP would like to thank United Grants Commission/Council of Scientific and Industrial Research for their scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; GILL B S, 1971, Tropical Animal Health and Production, V3, P195, DOI 10.1007/BF02359579; Graefe SEB, 2002, EUKARYOT CELL, V1, P936, DOI 10.1128/EC.1.6.936-943.2002; Gruszynski AE, 2003, J BIOL CHEM, V278, P24665, DOI 10.1074/jbc.M301497200; Hoare C. A, 1972, TRYPANOSOMES MAMMALS, P288, DOI DOI 10.1017/S003118200900554X; Holzmuller P, 2008, ANN NY ACAD SCI, V1149, P337, DOI 10.1196/annals.1428.097; Hong YC, 2006, FEBS LETT, V580, P603, DOI 10.1016/j.febslet.2005.12.075; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kaminsky R, 1998, ANTIMICROB AGENTS CH, V42, P2858, DOI 10.1128/AAC.42.11.2858; Krauth-Siegel RL, 2003, PARASITOL RES, V90, pS77, DOI 10.1007/s00436-002-0771-8; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Li SQ, 2009, PARASITOL RES, V104, P429, DOI 10.1007/s00436-008-1216-9; LUCKINS AG, 1988, PARASITOL TODAY, V4, P137, DOI 10.1016/0169-4758(88)90188-3; LUMSDEN WHR, 1973, TECHNIQUES TRYPANOSO, P57; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Marcipar IS, 2005, J CLIN MICROBIOL, V43, P5498, DOI 10.1128/JCM.43.11.5498-5503.2005; Michailowsky V, 2003, INFECT IMMUN, V71, P3165, DOI 10.1128/IAI.71.6.3165-3171.2003; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nogueira F, 2009, PARASITOL RES, V104, P835, DOI 10.1007/s00436-008-1264-1; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Pinto APA, 2003, BBA-PROTEINS PROTEOM, V1652, P107, DOI 10.1016/j.bbapap.2003.08.008; Scory Stefan, 2007, Kinetoplastid Biol Dis, V6, P2, DOI 10.1186/1475-9292-6-2; SILVA RAMS, 1995, VET PARASITOL, V60, P167, DOI 10.1016/0304-4017(94)00757-4; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; Tsuji A, 2006, J PEPT SCI, V12, P65, DOI 10.1002/psc.683; Tuntasuvan D, 2003, VET PARASITOL, V110, P227, DOI 10.1016/S0304-4017(02)00304-7; Uzcategui NL, 2007, ANTIMICROB AGENTS CH, V51, P3960, DOI 10.1128/AAC.00423-07; WRIGHTSMAN RA, 1995, INFECT IMMUN, V63, P122, DOI 10.1128/IAI.63.1.122-125.1995; Wrightsman RA, 2000, VACCINE, V18, P1419, DOI 10.1016/S0264-410X(99)00380-1	39	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9796	10.1371/journal.pone.0009796	http://dx.doi.org/10.1371/journal.pone.0009796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339546	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300021
J	Franberg, J; Karlstrom, H; Winblad, B; Tjernberg, LO; Frykman, S				Franberg, Jenny; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.; Frykman, Susanne			gamma-Secretase Dependent Production of Intracellular Domains Is Reduced in Adult Compared to Embryonic Rat Brain Membranes	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; P75 NEUROTROPHIN RECEPTOR; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; IN-VIVO; NOTCH; PRESENILIN; CLEAVAGE; MICE; DEFICIENCY	Background: gamma-Secretase is an intramembrane aspartyl protease whose cleavage of the amyloid precursor protein (APP) generates the amyloid beta-peptide (A beta) and the APP intracellular domain. A beta is widely believed to have a causative role in Alzheimer's disease pathogenesis, and therefore modulation of gamma-secretase activity has become a therapeutic goal. Besides APP, more than 50 substrates of gamma-secretase with different cellular functions during embryogenesis as well as adulthood have been revealed. Prior to gamma-secretase cleavage, substrates are ectodomain shedded, producing membrane bound C-terminal fragments (CTFs). Principal Findings: Here, we investigated gamma-secretase cleavage of five substrates; APP, Notch1, N-cadherin, ephrinB and p75 neurotrophin receptor (p75-NTR) in membranes isolated from embryonic, young or old adult rat brain by analyzing the release of the corresponding intracellular domains (ICDs) or A beta 40 by western blot analysis and ELISA respectively. The highest levels of all ICDs and A beta were produced by embryonic membranes. In adult rat brain only cleavage of APP and Notch1 could be detected and the A beta 40 and ICD production from these substrates was similar in young and old adult rat brain. The CTF levels of Notch1, N-cadherin, ephrinB and p75-NTR were also clearly decreased in the adult brain compared to embryonic brain, whereas the APP CTF levels were only slightly decreased. Conclusions: In summary our data suggests that gamma-secretase dependent ICD production is down-regulated in the adult brain compared to embryonic brain. In addition, the present approach may be useful for evaluating the specificity of gamma-secretase inhibitors.	[Franberg, Jenny; Karlstrom, Helena; Winblad, Bengt; Tjernberg, Lars O.; Frykman, Susanne] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Alzheimers Dis Res Ctr, Huddinge, Sweden	Karolinska Institutet	Franberg, J (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Alzheimers Dis Res Ctr, Huddinge, Sweden.	jenny.franberg@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Socialstyrelsen [2009-22304]; Karolinska Institutets Foundation for Geriatric Research; Demensfonden [33/09]; Gun och Bertil Stohne's Foundation; Foundation for Gamla Tjanarinnor; Foundation for Alzheimer's and Dementia Research (SADF) [1613/09]; H. K. by Swedish Brain Power [2004-00160]	Socialstyrelsen; Karolinska Institutets Foundation for Geriatric Research; Demensfonden; Gun och Bertil Stohne's Foundation; Foundation for Gamla Tjanarinnor; Foundation for Alzheimer's and Dementia Research (SADF); H. K. by Swedish Brain Power	This study was supported by Socialstyrelsen (2009-22304), Karolinska Institutets Foundation for Geriatric Research (2008 Alde0036), Demensfonden (33/09), Gun och Bertil Stohne's Foundation (J. F.) and the Foundation for Gamla Tjanarinnor (S. F.). J. F. was supported by the Foundation for Alzheimer's and Dementia Research (SADF, 1613/09) and H. K. by Swedish Brain Power (2004-00160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Teranishi Y., 2009, J CELL MOL MED; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004	60	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9772	10.1371/journal.pone.0009772	http://dx.doi.org/10.1371/journal.pone.0009772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333303	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809700011
J	Diehl, F; Brown, MA; van Amerongen, MJ; Novoyatleva, T; Wietelmann, A; Harriss, J; Ferrazzi, F; Bottger, T; Harvey, RP; Tucker, PW; Engel, FB				Diehl, Florian; Brown, Mark A.; van Amerongen, Machteld J.; Novoyatleva, Tatyana; Wietelmann, Astrid; Harriss, June; Ferrazzi, Fulvia; Boettger, Thomas; Harvey, Richard P.; Tucker, Philip W.; Engel, Felix B.			Cardiac Deletion of Smyd2 Is Dispensable for Mouse Heart Development	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; CARDIOMYOCYTE PROLIFERATION; MICE LACKING; PROTEIN; CHROMATIN; H3; METHYLATION; HOMOLOG; CELLS	Chromatin modifying enzymes play a critical role in cardiac differentiation. Previously, it has been shown that the targeted deletion of the histone methyltransferase, Smyd1, the founding member of the SET and MYND domain containing (Smyd) family, interferes with cardiomyocyte maturation and proper formation of the right heart ventricle. The highly related paralogue, Smyd2 is a histone 3 lysine 4- and lysine 36-specific methyltransferase expressed in heart and brain. Here, we report that Smyd2 is differentially expressed during cardiac development with highest expression in the neonatal heart. To elucidate the functional role of Smyd2 in the heart, we generated conditional knockout (cKO) mice harboring a cardiomyocyte-specific deletion of Smyd2 and performed histological, functional and molecular analyses. Unexpectedly, cardiac deletion of Smyd2 was dispensable for proper morphological and functional development of the murine heart and had no effect on global histone 3 lysine 4 or 36 methylation. However, we provide evidence for a potential role of Smyd2 in the transcriptional regulation of genes associated with translation and reveal that Smyd2, similar to Smyd3, interacts with RNA Polymerase II as well as to the RNA helicase, HELZ.	[Diehl, Florian; van Amerongen, Machteld J.; Novoyatleva, Tatyana; Wietelmann, Astrid; Boettger, Thomas; Engel, Felix B.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Hessen, Germany; [Brown, Mark A.; Harriss, June; Tucker, Philip W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Brown, Mark A.; Harriss, June; Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Harvey, Richard P.] Victor Chang Cardiac Res Inst, Dev Biol Div, Darlinghurst, NSW, Australia; [Ferrazzi, Fulvia] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Lombardia, Italy	Max Planck Society; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Victor Chang Cardiac Research Institute; University of Pavia	Diehl, F (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Hessen, Germany.	felix.engel@mpi-bn.mpg.de	Ferrazzi, Fulvia/C-1161-2008; Boettger, Thomas/E-3406-2012; van Amerongen, Machteld/C-5032-2008; Engel, Felix/A-1767-2008	Ferrazzi, Fulvia/0000-0003-4011-4638; Boettger, Thomas/0000-0003-4280-8449; Engel, Felix/0000-0003-2605-3429; Harvey, Richard/0000-0002-9950-9792	Alexander von Humboldt-Foundation; Excellence Cluster Cardio-Pulmonary System; NIH (PWT); Marie Betzer Morrow Centennial Endowment (PWT)	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); NIH (PWT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Betzer Morrow Centennial Endowment (PWT)	This work was supported by the Alexander von Humboldt-Foundation (Bonn, Germany; Sofja Kovalevskaja Award to FBE), the Excellence Cluster Cardio-Pulmonary System (Giessen, Germany), the NIH (PWT) and the Marie Betzer Morrow Centennial Endowment (PWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; DENNIS G, 2003, DAVID DATABASE ANNOT; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Holbert MA, 2005, CURR OPIN STRUC BIOL, V15, P673, DOI 10.1016/j.sbi.2005.10.006; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; IWASAWA M, 2009, J CLIN INVEST; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; LI D, 2009, NUCL ACIDS RES; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Sobral RA, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-27; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001; Xiong SB, 2007, CIRCULATION, V115, P2925, DOI 10.1161/CIRCULATIONAHA.107.689901	61	54	58	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9748	10.1371/journal.pone.0009748	http://dx.doi.org/10.1371/journal.pone.0009748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305823	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809600017
J	Fan, JS; Zeller, K; Chen, YC; Watkins, T; Barnes, KC; Becker, KG; Dang, CV; Cheadle, C				Fan, JinShui; Zeller, Karen; Chen, Yu-Chi; Watkins, Tonya; Barnes, Kathleen C.; Becker, Kevin G.; Dang, Chi V.; Cheadle, Chris			Time-Dependent c-Myc Transactomes Mapped by Array-Based Nuclear Run-On Reveal Transcriptional Modules in Human B Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMIC TARGETS; RNA; ACTIVATION	Background: The definition of transcriptional networks through measurements of changes in gene expression profiles and mapping of transcription factor binding sites is limited by the moderate overlap between binding and gene expression changes and the inability to directly measure global nuclear transcription (coined ``transactome''). Methodology/Principal Findings: We developed a method to measure nascent nuclear gene transcription with an Arraybased Nuclear Run-On (ANRO) assay using commercial microarray platforms. This strategy provides the missing component, the transactome, to fully map transcriptional networks. ANRO measurements in an inducible c-Myc expressing human P4936 B cell model reveals time-dependent waves of transcription, with a transactome early after c-Myc induction that does not persist at a late, steady-state phase, when genes that are regulated by c-Myc and E2F predominate. Gene set matrix analysis further uncovers functionally related groups of genes putatively regulated by waves of transcription factor motifs following Myc induction, starting with AP1 and CREB that are followed by EGR1, NFkB and STAT, and ending with E2F, Myc and ARNT/HIF motifs. Conclusions/Significance: By coupling ANRO with previous global mapping of c-Myc binding sites by chromatin immunoprecipitation (ChIP) in P493-6 cells, we define a set of transcriptionally regulated direct c-Myc target genes and pave the way for the use of ANRO to comprehensively map any transcriptional network.	[Fan, JinShui; Chen, Yu-Chi; Watkins, Tonya; Barnes, Kathleen C.; Cheadle, Chris] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy,Lowe Family Genom Core, Baltimore, MD 21205 USA; [Zeller, Karen; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Becker, Kevin G.] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fan, JS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy,Lowe Family Genom Core, Baltimore, MD 21205 USA.	cvdang@jhmi.edu; ccheadl1@jhmi.edu	Dang, Chi/Y-3375-2019	Becker, Kevin/0000-0002-6794-6656; Dang, Chi/0000-0002-4031-2522	National Institute on Aging, NIH [R01CA57341, R01CA51497]; Maryland Stem Cell Research Fund [2007-MSCRFE-0167-00, 2008-MSCRFE-0156-00]; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA051497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Maryland Stem Cell Research Fund; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported in part by the Intramural Research Program of the NIH, National Institute on Aging, NIH grants R01CA57341 and R01CA51497 and Maryland Stem Cell Research Fund grants 2007-MSCRFE-0167-00 and 2008-MSCRFE-0156-00. KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheadle C, 2007, MOL CELL PROBE, V21, P35, DOI 10.1016/j.mcp.2006.07.004; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan JS, 2006, NUCLEIC ACIDS RES, V34, P1492, DOI 10.1093/nar/gkj510; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	27	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9691	10.1371/journal.pone.0009691	http://dx.doi.org/10.1371/journal.pone.0009691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300622	Green Submitted, Green Published, gold			2022-12-25	WOS:000275621000009
J	He, LH; Aleksandrov, LA; Cui, LY; Jensen, TJ; Nesbitt, KL; Riordan, JR				He, Lihua; Aleksandrov, Luba A.; Cui, Liying; Jensen, Timothy J.; Nesbitt, Kenneth L.; Riordan, John R.			Restoration of domain folding and interdomain assembly by second-site suppressors of the Delta F508 mutation in CFTR	FASEB JOURNAL			English	Article						cystic fibrosis; interdomain interactions; cysteine accessibility; cysteine cross-linking	TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN-1; CYSTIC-FIBROSIS MUTATION; CHLORIDE CHANNEL; QUALITY-CONTROL; DEFECTS	Deletion of PHE508 (Delta F508) from the first nucleotide-binding domain (NBD1) of CFTR, which causes most cystic fibrosis, disrupts the folding and assembly of the protein. Although the folding pathways and yield of isolated NBD1 are altered, its global structure is not, and details of the changes in the rest of the protein remain unclear. To gain further insight into how the whole mutant protein is altered, we have determined the influence of known second-site suppressor mutations in NBD1 on the conformation of this domain and key interfaces between domains. We found that the suppressors restored maturation of only those processing mutations located in NBD1, but not in other domains, including those in the C-terminal cytoplasmic loop of the second membrane-spanning domain, which forms an interface with the NBD1 surface. Nevertheless, the suppressors promoted the formation of this interface and others in the absence of F508. The suppressors restored maturation in a Delta F508 construct from which NBD2 was absent but to a lesser extent than in the full-length, indicating that Delta F508 disrupts interactions involving NBD2, as well as other domains. Rescue of Delta F508-CFTR by suppressors required the biosynthesis of the entire full-length protein in continuity, as it did not occur when N- and C-terminal "halves" were coexpressed. Simultaneous with these interdomain perturbations, Delta F508 resulted in suppressor reversed alterations in accessibility of residues both in the F508-containing NBD1 surface loop and in the Q loop within the domain core. Thus, in the context of the full-length protein, Delta F508 mutation causes detectable changes in NBD1 conformation, as well as interdomain interactions.-He, L., Aleksandrov, L. A., Cui, L., Jensen, T. J., Nesbitt, K. L., Riordan, J. R. Restoration of domain folding and interdomain assembly by second-site suppressors of the Delta F508 mutation in CFTR. FASEB J. 24, 3103-3112 (2010). www.fasebj.org	[Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Riordan, JR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 6103 Thurston Bowles,CB 7260, Chapel Hill, NC 27599 USA.	jack_riordan@med.unc.edu			U.S. National Institutes of Health [DK051870]; CFF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619, R01DK051870] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by grants from the U.S. National Institutes of Health (DK051870) and the CFF. The authors also thank Drs. Tamas Hegedus and Adrian W. R. Serohijos for reading the manuscript.	Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; THOMAS PJ, 2008, 2 FEBS SPEC M ABC PR, P69; WANG X, 2008, PEDIATR PULM, V31, P121; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	29	56	58	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					3103	3112		10.1096/fj.09-141788	http://dx.doi.org/10.1096/fj.09-141788			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20233947	Green Published			2022-12-25	WOS:000285005400046
J	Waluk, DP; Schultz, N; Hunt, MC				Waluk, Dominik P.; Schultz, Niklas; Hunt, Mary C.			Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans	FASEB JOURNAL			English	Article						N-oleoyl glycine; N-arachidonoyl glycine; endocannabinoids; N-acyl amino acids; endoplasmic reticulum	ALPHA-AMIDATING MONOOXYGENASE; IN-VITRO SYNTHESIS; ENDOPLASMIC-RETICULUM; ARACHIDONOYL GLYCINE; N(18)TG(2) CELLS; AMINO-ACIDS; FATTY-ACIDS; CONJUGATION; METABOLISM; COA	The discovery of glycine conjugates of long-chain fatty acids (N-acyl glycines) in the brain and other non-neuronal tissues has led to the identification of an emerging class of bioactive lipids. The biological activities of N-acyl glycines include antinociceptive, anti-inflammatory and antiproliferative effects, and activation of G-protein-coupled receptors. However, despite the fact that N-acyl glycines are emerging as a distinct lipid signaling family, pathways for their production are not fully elucidated. Here we report on the characterization of human glycine N-acyltransferase-like 2 (hGLYATL2), a member of a gene family of 4 putative glycine conjugating enzymes, and show that it synthesizes various N-acyl glycines. Recombinantly expressed hGLYATL2 efficiently conjugated oleoyl-CoA, arachidonoyl-CoA, and other medium-and long-chain acyl-CoAs to glycine. The enzyme was specific for glycine as an acceptor molecule, and preferentially produced N-oleoyl glycine. The hGLYATL2 enzyme is localized to the endoplasmic reticulum, and the mRNA shows highest expression in salivary gland and trachea, but is also detected in spinal cord and skin fibroblasts. The expression pattern and the identification of high levels of N-acyl glycines in skin and lung may indicate a role for N-acyl glycines in barrier function/immune response and the potential role of hGLYATL2 in this regard is discussed.-Waluk, D. P., Schultz, N., Hunt, M. C. Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J. 24, 2795-2803 (2010). www.fasebj.org	[Hunt, Mary C.] Stockholm Univ, Dept Genet Microbiol & Toxicol, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden	Stockholm University	Hunt, MC (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, Arrhenius Labs Nat Sci, Svante Arrhenius Vag 20C, SE-10691 Stockholm, Sweden.	mary.hunt@gmt.su.se	Schultz, Niklas/AFQ-8244-2022	Hunt, Mary/0000-0001-6415-2992	Swedish Research Council; Carl Trygger Foundation; Professor Nanna Svartz Fond; Ake Wibergs stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Professor Nanna Svartz Fond; Ake Wibergs stiftelse	The authors are grateful to Professor Stefan Alexson, Karolinska Institutet, for excellent critical discussion on the manuscript and for use of the mass spectrometer. This work was supported by the Swedish Research Council, Carl Trygger Foundation, Professor Nanna Svartz Fond, and Ake Wibergs stiftelse.	Aneetha H, 2009, BIOORG MED CHEM LETT, V19, P237, DOI 10.1016/j.bmcl.2008.10.087; BRAAS KM, 1989, MOL ENDOCRINOL, V3, P1387, DOI 10.1210/mend-3-9-1387; BRAAS KM, 1992, ENDOCRINOLOGY, V130, P2778, DOI 10.1210/en.130.5.2778; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Bradshaw HB, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-14; Burstein SH, 2000, PROSTAG OTH LIPID M, V61, P29, DOI 10.1016/S0090-6980(00)00053-8; Burstein S, 2008, NEUROPHARMACOLOGY, V55, P1259, DOI 10.1016/j.neuropharm.2007.11.011; Carter SMB, 1996, J CHROMATOGR B, V677, P29, DOI 10.1016/0378-4347(95)00415-7; Cascio MG, 2004, BIOCHEM BIOPH RES CO, V314, P192, DOI 10.1016/j.bbrc.2003.12.075; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; GREGERSEN N, 1986, BIOCHEM MED METAB B, V35, P210, DOI 10.1016/0885-4505(86)90076-9; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; KELLER W, 1842, ANN CHEM PHARM, V43, P108; Knights KM, 2007, EXPERT OPIN DRUG MET, V3, P159, DOI 10.1517/17425255.3.2.159; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Mccue JM, 2008, BIOCHEM BIOPH RES CO, V365, P322, DOI 10.1016/j.bbrc.2007.10.175; Merkler DJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P430, DOI 10.1006/abbi.1996.0272; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Mueller GP, 2007, J BIOL CHEM, V282, P22364, DOI 10.1074/jbc.M701801200; NANDI DL, 1979, J BIOL CHEM, V254, P7230; O'Byrne J, 2003, J BIOL CHEM, V278, P34237, DOI 10.1074/jbc.M300987200; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Reilly SJ, 2007, FASEB J, V21, P99, DOI 10.1096/fj.06-6919com; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Ritenour-Rodgers KJ, 2000, BIOCHEM BIOPH RES CO, V267, P521, DOI 10.1006/bbrc.1999.1977; Roy M.-O., 2007, Can. Patent Appl., Patent No. [CA2589393, 2589393]; SCHACHTER D, 1954, J BIOL CHEM, V208, P263; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; van der Westhuizen FH, 2000, J BIOCHEM MOL TOXIC, V14, P102, DOI 10.1002/(SICI)1099-0461(2000)14:2<102::AID-JBT6>3.0.CO;2-H; WEBSTER LT, 1976, J BIOL CHEM, V251, P3352; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang HX, 2007, INT J MOL SCI, V8, P433, DOI 10.3390/i8050433	38	39	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2010	24	8					2795	2803		10.1096/fj.09-148551	http://dx.doi.org/10.1096/fj.09-148551			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20305126				2022-12-25	WOS:000285005400020
J	Lee, M; Cho, T; Jantaratnotai, N; Wang, YT; McGeer, E; McGeer, PL				Lee, Moonhee; Cho, Taesup; Jantaratnotai, Nattinee; Wang, Yu Tian; McGeer, Edith; McGeer, Patrick L.			Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases	FASEB JOURNAL			English	Article						microglia; astroglia; buthionine-S,R-sulfoximine; neuroinflammation; clotrimazole; TRPM2	NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; NITRIC-OXIDE; ADP-RIBOSE; REDUCED GLUTATHIONE; CEREBROSPINAL-FLUID; CALCIUM INFLUX; RAT-BRAIN; IN-VIVO; EXPRESSION	Oxidative stress induced by inhibition of glutathione (GSH) biosynthesis with D,L-buthionine-S,R-sulfoximine (BSO) causes human microglia, human astrocytes, THP-1 cells, and U373 cells to secrete materials toxic to human neuroblastoma SH-SY5Y cells and stimulates them to release TNF-alpha, IL-6, and nitrite ions. The effect is correlated with activation of the inflammatory pathways P38 MAP-kinase, Jun-N-terminal kinase, and NF-kappa B. The effect is reduced by adding to the medium GSH or clotrimazole (CTM), an inhibitor of Ca2+-influx through TRPM2 channels. It is also produced by inhibiting TRPM2 protein expression in microglia and astrocytes through introduction of its small inhibitory RNA (siRNA). TRPM2 mRNA is expressed by glial cells but not by SH-SY5Y cells. BSO in the culture medium causes an almost 3-fold increase in [Ca2+](i) in microglia and astrocytes over a 24-h period, which is reduced to half by the addition of CTM. The data strongly suggest that inhibiting intracellular GSH synthesis induces a neuroinflammatory response in human microglia and astrocytes, which is linked to Ca2+ influx through TRPM2 channels. It represents a new model for inducing neuroinflammation and suggests that increasing GSH levels in glial cells may confer neuroprotection in neurodegenerative diseases, such as Alzheimer disease, which have a prominent neuroinflammatory component.-Lee, M., Cho, T., Jantaratnotai, N., Wang, Y.T., McGeer, E., McGeer, P. L. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 24, 2533-2545 (2010). www.fasebj.org	[Lee, Moonhee; McGeer, Edith; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Cho, Taesup; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Jantaratnotai, Nattinee] Univ British Columbia, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	McGeer, PL (corresponding author), Univ British Columbia, Kinsmen Lab Neurol Res, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	mcgeerpl@interchange.ubc.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008		Pacific Alzheimer Research Foundation	Pacific Alzheimer Research Foundation	This research was supported by the Pacific Alzheimer Research Foundation.	Andersson P, 1998, PROG SYST C, V24, P1; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Cao BJ, 2002, EUR J PHARMACOL, V448, P27, DOI 10.1016/S0014-2999(02)01908-8; Chen Y, 2008, BIOL PHARM BULL, V31, P1496, DOI 10.1248/bpb.31.1496; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; COOPER AJL, 1980, J NEUROCHEM, V35, P1242, DOI 10.1111/j.1471-4159.1980.tb07882.x; Cudkowicz ME, 1999, NEUROLOGY, V52, P1492, DOI 10.1212/WNL.52.7.1492; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gay C, 1999, ANAL BIOCHEM, V273, P143, DOI 10.1006/abio.1999.4207; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Heiner I, 2003, CELL CALCIUM, V33, P533, DOI 10.1016/S0143-4160(03)00058-7; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hirrlinger J, 2002, J NEUROSCI RES, V69, P318, DOI 10.1002/jnr.10308; Hirsch EC, 2005, PARKINSONISM RELAT D, V11, pS9, DOI 10.1016/j.parkreldis.2004.10.013; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hunot S, 1999, J NEUROSCI, V19, P3440; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kim YJ, 2006, BIOCHEM BIOPH RES CO, V347, P731, DOI 10.1016/j.bbrc.2006.06.149; Klegeris A, 1999, NEUROPHARMACOLOGY, V38, P1017, DOI 10.1016/S0028-3908(99)00014-3; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kuhn FJP, 2005, PFLUG ARCH EUR J PHY, V451, P212, DOI 10.1007/s00424-005-1446-y; Lee M, 2008, BRAIN RES, V1195, P1, DOI 10.1016/j.brainres.2007.12.023; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; LOEFFLER DA, 1994, CLIN NEUROPHARMACOL, V17, P370, DOI 10.1097/00002826-199408000-00009; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Meister A, 1981, Curr Top Cell Regul, V18, P21; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Moller T, 2002, GLIA, V40, P184, DOI 10.1002/glia.10152; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; MUFSON RA, 1992, METHODS CELL SCI, V14, P37; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; REHNCRONA S, 1980, J NEUROCHEM, V34, P477, DOI 10.1111/j.1471-4159.1980.tb11170.x; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; SLIVKA A, 1987, BRAIN RES, V409, P275, DOI 10.1016/0006-8993(87)90712-8; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Tohgi H, 1999, ANN NEUROL, V46, P129, DOI 10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179	56	172	177	4	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2533	2545		10.1096/fj.09-149997	http://dx.doi.org/10.1096/fj.09-149997			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20228251				2022-12-25	WOS:000279343600040
J	Albero, MP; Vaquer, JM; Andreu, EJ; Villanueva, JJ; Franch, L; Ivorra, C; Poch, E; Agirre, X; Prosper, F; Perez-Roger, I				Albero, M. P.; Vaquer, J. M.; Andreu, E. J.; Villanueva, J. J.; Franch, L.; Ivorra, C.; Poch, E.; Agirre, X.; Prosper, F.; Perez-Roger, I.			Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells	ONCOGENE			English	Article						Bortezomib; CML; Bcr-Abl1; Imatinib resistance; Rb; apoptosis	PHILADELPHIA-CHROMOSOME; PROTEASOME INHIBITION; PROLIFERATION; LYMPHOMA; THERAPY; CYCLINS; DRUGS; DEATH; TRANSFORMATION; DEGRADATION	The use of c-abl-specific inhibitors such as Imatinib (IM) or Dasatinib has revolutionized the treatment of chronic myeloid leukemia (CML). However, a significant percentage of patients become resistant to IM. In this report, we have analyzed the possibility of using the proteasome as a molecular target in CML. Our results show that cells that express Bcr-Abl1 are more sensitive to the inhibition of the proteasome with Bortezomib (Btz) than control cells. This treatment reduces the proliferation of Bcr-Abl1-expressing cells, by inactivating NF-kappa B2 and decreasing the phosphorylation of Rb, eventually leading to an increase in caspase-dependent apoptosis. Furthermore, we show that Btz also induces cell-cycle arrest and apoptosis in cells expressing Bcr-Abl1 mutants that are resistant to IM. These results unravel a new molecular target of Btz, that is the Rb pathway, and open new possibilities in the treatment of CML especially for patients that become resistant to IM because of the presence of the T315I mutation. Oncogene (2010) 29, 3276-3286; doi: 10.1038/onc.2010.81; published online 22 March 2010	[Albero, M. P.; Vaquer, J. M.; Villanueva, J. J.; Franch, L.; Ivorra, C.; Poch, E.; Perez-Roger, I.] Cardenal Herrera CEU Univ, Dept Chem Biochem & Mol Biol, Moncada, Spain; [Andreu, E. J.; Agirre, X.; Prosper, F.] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Dept Hematol, E-31080 Pamplona, Spain; [Andreu, E. J.; Agirre, X.; Prosper, F.] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Area Cell Therapy, E-31080 Pamplona, Spain	Universidad CEU Cardenal Herrera; University of Navarra; University of Navarra	Perez-Roger, I (corresponding author), Cardenal Herrera CEU Univ, Dept Chem Biochem & Mol Biol, Edif Seminario,Av Seminario, Valencia 46113, Spain.	iperez@uch.ceu.es	Poch, Enric/C-5258-2013; Agirre, Xabier/ABE-4110-2020; Pérez Roger, Ignacio/K-1346-2014; Andreu, Enrique J/F-9813-2016; Prosper, Felipe/H-6859-2017	Pérez Roger, Ignacio/0000-0002-5564-6912; Andreu, Enrique J/0000-0001-5317-9989; Prosper, Felipe/0000-0001-6115-8790; Vaquer Santamaria, Juana Maria/0000-0002-4070-602X; Ivorra, Carmen/0000-0002-4699-6689	Instituto de Salud Carlos III [PI060285, PI070602, RD06/0020]; Conselleria de Sanitat; Cardenal Herrera-CEU University; 'UTE project CIMA'; Generalitat Valenciana; Ramon y Cajal; Ministerio de Ciencia e Innovacion	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Conselleria de Sanitat; Cardenal Herrera-CEU University; 'UTE project CIMA'; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ramon y Cajal(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank Dr Elisabeth Buchdunger at Novartis for providing us with Imatinib and Millenium Pharmaceuticals for the kind gift of Bortezomib. We also thank Dr BJ Druker for the mutant Bcr-Abl1-expressing BaF/3 cells. The study was supported by grants from the Instituto de Salud Carlos III PI060285, PI070602 and RD06/0020 to IPR, FP and EJA; from the Conselleria de Sanitat to IPR; from the Cardenal Herrera-CEU University (PRUCH and Santander-Copernicus) to IPR and 'UTE project CIMA'. Fellowships were from the Cardenal Herrera-CEU University to MPA and JJV and from the Generalitat Valenciana to JMV. EJA is supported by the program Ramon y Cajal from the Ministerio de Ciencia e Innovacion.	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Crawford LJ, 2009, EXP HEMATOL, V37, P357, DOI 10.1016/j.exphem.2008.11.004; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Dasmahapatra G, 2006, LEUKEMIA RES, V30, P1263, DOI 10.1016/j.leukres.2006.01.005; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Galimberti S, 2008, LEUKEMIA RES, V32, P103, DOI 10.1016/j.leukres.2007.05.023; Gatto S, 2003, HAEMATOLOGICA, V88, P853; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Joazeiro CAP, 2006, CANCER RES, V66, P7840, DOI 10.1158/0008-5472.CAN-06-2033; Kano Y, 2007, INVEST NEW DRUG, V25, P31, DOI 10.1007/s10637-006-9000-0; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ramirez P, 2008, ONCOLOGIST, V13, P424, DOI 10.1634/theoncologist.2007-0170; Roman-Gomez J, 2007, HAEMATOLOGICA, V92, P153, DOI 10.3324/haematol.10782; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; SAWYERS CL, 1993, LEUKEMIA LYMPHOMA, V11, P45, DOI 10.3109/10428199309047862; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Stapnes C, 2007, BRIT J HAEMATOL, V136, P814, DOI 10.1111/j.1365-2141.2007.06504.x; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; Van Phan Nguyen Thanh, 2005, Hum Cell, V18, P25; Vink J, 2006, BRIT J HAEMATOL, V134, P253, DOI 10.1111/j.1365-2141.2006.06170.x; Wei AH, 2008, LEUKEMIA LYMPHOMA, V49, P657, DOI 10.1080/10428190801942378; Yan H, 2007, LEUKEMIA, V21, P1488, DOI 10.1038/sj.leu.2404735; Yang DT, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-40; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Zhao XX, 2008, LEUKEMIA RES, V32, P275, DOI 10.1016/j.leukres.2007.05.024	42	17	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3276	3286		10.1038/onc.2010.81	http://dx.doi.org/10.1038/onc.2010.81			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20305692	Green Published			2022-12-25	WOS:000278321100010
J	Khan, MT; Joseph, SK				Khan, M. Tariq; Joseph, Suresh K.			Role of Inositol Trisphosphate Receptors in Autophagy in DT40 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; MAMMALIAN TARGET; ENDOPLASMIC-RETICULUM; CA2+ RELEASE; SIGNAL-TRANSDUCTION; PROMOTES AUTOPHAGY; EPITHELIAL-CELLS; CALCIUM SIGNALS; BECLIN 1; APOPTOSIS	Previous studies have shown that small interfering RNA knockdown and pharmacological inhibition of inositol 1,4,5-trisphosphate receptors (IP(3)Rs) stimulate autophagy. We have investigated autophagy in chicken DT40 cell lines containing targeted deletions of all three IP3R isoforms (triple knock-out (TKO) cells). Using gel shifts of microtubule-associated protein 1 light chain 3 as a marker of autophagy, we find that TKO cells have enhanced basal autophagic flux even under nutrient-replete conditions. Stable DT40 cell lines derived from TKO cells containing the functionally inactive D2550A IP3R mutant did not suppress autophagy in the same manner as wild-type receptors. This suggests that the channel function of the receptor is important in its regulatory role in autophagy. There were no marked differences in the phosphorylation state of AMP-activated protein kinase, Akt, or mammalian target of rapamycin between wild-type and TKO cells. The amount of immunoprecipitated complexes of Bcl-2-Beclin-1 and Beclin-1-Vps34 were also not different between the two cell lines. The major difference noted was a substantially decreased mTORC1 kinase activity in TKO cells based on decreased phosphorylation of S6 kinase and 4E-BP1. The discharge of intracellular stores with thapsigargin stimulated mTORC1 activity (measured as S6 kinase phosphorylation) to a greater extent in wild-type than in TKO cells. We suggest that basal autophagic flux may be negatively regulated by IP3R-dependent Ca2(+) signals acting to maintain an elevated mTORC1 activity in wild-type cells and that Ca2(+) regulation of this enzyme is defective in TKO cells. The protective effect of a higher autophagic flux in cells lacking IP(3)Rsmayplay a role in the delayed apoptotic response observed in these cells.	[Khan, M. Tariq; Joseph, Suresh K.] Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu						Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; CARDENAS C, 2008, J GEN PHYSIOL, V132, pA24; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Eskelinen EL, 2008, INT REV CEL MOL BIO, V266, P207, DOI 10.1016/S1937-6448(07)66005-5; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Guillemette J, 2005, CELL CALCIUM, V37, P97, DOI 10.1016/j.ceca.2004.03.005; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Joseph SK, 1999, BIOCHEM J, V342, P153, DOI 10.1042/0264-6021:3420153; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marchi S, 2008, BIOCHEM BIOPH RES CO, V375, P501, DOI 10.1016/j.bbrc.2008.07.153; Markova B, 2010, ONCOGENE, V29, P739, DOI 10.1038/onc.2009.374; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sekulic A, 2000, CANCER RES, V60, P3504; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625	63	77	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16912	16920		10.1074/jbc.M110.114207	http://dx.doi.org/10.1074/jbc.M110.114207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20308071	Green Published, hybrid			2022-12-25	WOS:000277982600054
J	Barbu, EA; Zhang, J; Siraganian, RP				Barbu, Emilia Alina; Zhang, Juan; Siraganian, Reuben P.			The Limited Contribution of Fyn and Gab2 to the High Affinity IgE Receptor Signaling in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; ACTIVATED PROTEIN-KINASE; BASOPHILIC LEUKEMIA-CELLS; TYROSINE KINASE; CYTOKINE PRODUCTION; T-CELLS; NUCLEAR-FACTOR; KAPPA-B; ALLERGIC RESPONSES; SH2 DOMAIN	Several studies with mast cells from knock-out mice have suggested that the tyrosine kinase Fyn and its downstream substrate Gab2 may play a role in high affinity IgE receptor (Fc epsilon RI)-mediated mast cell activation. To better understand the role of these two molecules and of Syk, we transiently transfected mast cells with small interference RNA (siRNA) targeted to Fyn, Gab2, or Syk to specifically decrease their expression. The siRNA suppression of Gab2 but not Fyn reduced activation of the phosphoinositide-3-kinase (PI3K) pathway as demonstrated by the change in phosphorylation of Akt; this indicates that Gab2 but not Fyn regulates this pathway. The decreased expression of Gab2 and Fyn had minor effects on degranulation. There were also some minor changes in activation of the NFAT or NF kappa B transcription factors in cells with reduced expression of Fyn or Gab2. Decreased Gab2 but not Fyn reduced the Fc epsilon RI-induced activation of the Erk, Jnk, and p38 MAP kinases and the release of TNF-alpha. In contrast, decreased expression of Syk dramatically reduced Fc epsilon RI-induced degranulation, activation of NFAT and NF kappa B. Therefore, the reduction in expression of these proteins in mast cells indicates that Syk is the major regulator of Fc epsilon RI-mediated reactions, whereas Fyn has minor if any effects and Gab2 regulates primarily late events including MAP kinase activation and release of cytokines.	[Barbu, Emilia Alina; Zhang, Juan; Siraganian, Reuben P.] NIH, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIDCR, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Barbu, EA (corresponding author), NIH, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIDCR, Bldg 49-1A16,49 Convent Dr, Bethesda, MD 20892 USA.	barbue@mail.nih.gov			National Institutes of Health, NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIDCR.	Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; BARSUMIAN EL, 1985, CELL IMMUNOL, V90, P131, DOI 10.1016/0008-8749(85)90175-3; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Costello PS, 1996, ONCOGENE, V13, P2595; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Frossi B, 2007, J IMMUNOL, V178, P2549, DOI 10.4049/jimmunol.178.4.2549; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Honda ZI, 2000, MOL CELL BIOL, V20, P1759, DOI 10.1128/MCB.20.5.1759-1771.2000; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Klein M, 2006, J IMMUNOL, V177, P6667, DOI 10.4049/jimmunol.177.10.6667; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Nadler M J, 2000, Adv Immunol, V76, P325; Nadler MJS, 2002, NAT IMMUNOL, V3, P707, DOI 10.1038/ni0802-707; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; OFFERMANNS S, 1994, J IMMUNOL, V152, P250; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Sada K, 2003, CURR MOL MED, V3, P85, DOI 10.2174/1566524033361618; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Sugie K, 2004, P NATL ACAD SCI USA, V101, P14859, DOI 10.1073/pnas.0406168101; Tsygankov AY, 1996, J BIOL CHEM, V271, P27130, DOI 10.1074/jbc.271.43.27130; Welke J, 2002, HUM IMMUNOL, V63, P834, DOI 10.1016/S0198-8859(02)00455-X; Xie ZH, 2002, J IMMUNOL, V168, P4682, DOI 10.4049/jimmunol.168.9.4682; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	47	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15761	15768		10.1074/jbc.M110.109413	http://dx.doi.org/10.1074/jbc.M110.109413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335178	hybrid, Green Published			2022-12-25	WOS:000277715900012
J	Parvatiyar, K; Barber, GN; Harhaj, EW				Parvatiyar, Kislay; Barber, Glen N.; Harhaj, Edward W.			TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; NEGATIVE FEEDBACK-REGULATION; TUMOR-SUPPRESSOR CYLD; EDITING ENZYME A20; RIG-I; IFN-BETA; ADAPTER PROTEIN; FACTOR ACTIVATION; INTERFERON	Induction of type I interferons by the transcription factor IRF3 is essential in the initiation of antiviral innate immunity. Activation of IRF3 requires C-terminal phosphorylation by the upstream kinases TBK1-IKKi, where IRF3 phosphorylation promotes dimerization, and subsequent nuclear translocation to the IFN beta promoter. Recent studies have described the ubiquitin-editing enzyme A20 as a negative regulator of IRF3 signaling by associating with TBK1-IKKi; however, the regulatory mechanism of A20 inhibition remains unclear. Here we describe the adaptor protein, TAX1BP1, as a key regulator of A20 function in terminating signaling to IRF3. Murine embryonic fibroblasts (MEFs) deficient in TAX1BP1 displayed increased amounts of IFN beta production upon viral challenge compared with WT MEFs. TAX1BP1 inhibited virus-mediated activation of IRF3 at the level of TBK1-IKKi. TAX1BP1 and A20 blocked antiviral signaling by disrupting Lys(63)-linked polyubiquitination of TBK1-IKKi independently of the A20 deubiquitination domain. Furthermore, TAX1BP1 was required for A20 effector function because A20 was defective for the targeting and inactivation of TBK1 and IKKi in Tax1bp1(-/-) MEFs. Additionally, we found the E3 ubiquitin ligase TRAF3 to play a critical role in promoting TBK1-IKKi ubiquitination. Collectively, our results demonstrate TBK1-IKKi to be novel substrates for A20 and further identify a novel mechanism whereby A20 and TAX1BP1 restrict antiviral signaling by disrupting a TRAF3-TBK1-IKKi signaling complex.	[Harhaj, Edward W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Barber, Glen N.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, 1550 NW 10 Ave, Miami, FL 33136 USA.	eharhaj@med.miami.edu			National Institutes of Health [RO1GM083143, P01CA128115]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM083143 and P01CA128115.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zheng LY, 2009, ORAL SURG ORAL MED O, V107, P661, DOI 10.1016/j.tripleo.2009.01.039; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	60	123	134	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14999	15009		10.1074/jbc.M110.109819	http://dx.doi.org/10.1074/jbc.M110.109819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304918	hybrid, Green Published			2022-12-25	WOS:000277399000021
J	Wiltshire, TD; Lovejoy, CA; Wang, T; Xia, F; O'Connor, MJ; Cortez, D				Wiltshire, Timothy D.; Lovejoy, Courtney A.; Wang, Tong; Xia, Fen; O'Connor, Mark J.; Cortez, David			Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-RESPONSE; HOMOLOGOUS RECOMBINATION; RAD51 PROTEIN; BRCA1; COMPLEX; MDC1; ENZYME; 53BP1; PHOSPHORYLATION; DETERMINANTS	DNA damage repair and checkpoint responses prevent genome instability and provide a barrier to the development of cancer. Inherited mutations in DNA damage response (DDR) genes such as those that encode the homologous recombination (HR) proteins BRCA1 and BRCA2 cause cancer predisposition syndromes. PARP inhibitors are an exciting new class of targeted therapy for treating patients with HR repair-defective tumors. In this study, we use an RNAi screen to identify genes that when silenced cause synthetic lethality with the PARP inhibitor AZD2281. This screen identified the deubiquitylating enzyme USP11 as a participant in HR repair of DNA double-strand breaks. Silencing USP11 with siRNA leads to spontaneous DDR activation in otherwise undamaged cells and hypersensitivity to PARP inhibition, ionizing radiation, and other genotoxic stress agents. Moreover, we demonstrate that HR repair is defective in USP11-silenced cells. Finally, the recruitment of a subset of double-strand break repair proteins including RAD51 and 53BP1 to repair foci is misregulated in the absence of USP11 catalytic activity. Thus, our synthetic lethal approach identified USP11 as a component of the HR double-strand break repair pathway.	[Wiltshire, Timothy D.; Lovejoy, Courtney A.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Xia, Fen; O'Connor, Mark J.] Vanderbilt Univ, Dept Radiat Oncol, Sch Med, Nashville, TN 37232 USA; [O'Connor, Mark J.] KuDOS Pharmaceut Ltd, Cambridge CB4 OPE, England	Vanderbilt University; Vanderbilt University; AstraZeneca	Cortez, D (corresponding author), 613 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Xia, Fen/G-3708-2013		NCI, National Institutes of Health [R21CA132010, R01CA136933]; Vanderbilt Center for Molecular Toxicology [P30 ES000267]; Vanderbilt-Ingram Cancer Center [P30 CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, R21CA132010, R01CA136933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Center for Molecular Toxicology; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants (R21CA132010 and R01CA136933) and a Susan G. Komen for the Cure grant (to D. C.). Support for research facilities was provided by the Vanderbilt Center for Molecular Toxicology (Grant P30 ES000267) and the Vanderbilt-Ingram Cancer Center (Grant P30 CA068485).	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; SAFFHILL R, 1985, CHROMOSOMA, V92, P218, DOI 10.1007/BF00348697; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	50	95	105	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14565	14571		10.1074/jbc.M110.104745	http://dx.doi.org/10.1074/jbc.M110.104745			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20233726	Green Published, hybrid			2022-12-25	WOS:000277299700053
J	Seifert, EL; Fiehn, O; Bezaire, V; Bickel, DR; Wohlgemuth, G; Adams, SH; Harper, ME				Seifert, Erin L.; Fiehn, Oliver; Bezaire, Veronic; Bickel, David R.; Wohlgemuth, Gert; Adams, Sean H.; Harper, Mary-Ellen			Long-Chain Fatty Acid Combustion Rate Is Associated with Unique Metabolite Profiles in Skeletal Muscle Mitochondria	PLOS ONE			English	Article							INSULIN-RESISTANCE; TRIGLYCERIDE SYNTHESIS; UNCOUPLING PROTEIN-3; CHRONIC EXPOSURE; MALONYL-COA; IN-VIVO; OXIDATION; CYCLE; CITRATE; OBESITY	Background/Aim: Incomplete or limited long-chain fatty acid (LCFA) combustion in skeletal muscle has been associated with insulin resistance. Signals that are responsive to shifts in LCFA beta-oxidation rate or degree of intramitochondrial catabolism are hypothesized to regulate second messenger systems downstream of the insulin receptor. Recent evidence supports a causal link between mitochondrial LCFA combustion in skeletal muscle and insulin resistance. We have used unbiased metabolite profiling of mouse muscle mitochondria with the aim of identifying candidate metabolites within or effluxed from mitochondria and that are shifted with LCFA combustion rate. Methodology/Principal Findings: Large-scale unbiased metabolomics analysis was performed using GC/TOF-MS on buffer and mitochondrial matrix fractions obtained prior to and after 20 min of palmitate catabolism (n = 7 mice/condition). Three palmitate concentrations (2, 9 and 19 mu M; corresponding to low, intermediate and high oxidation rates) and 9 mu M palmitate plus tricarboxylic acid (TCA) cycle and electron transport chain inhibitors were each tested and compared to zero palmitate control incubations. Paired comparisons of the 0 and 20 min samples were made by Student's t-test. False discovery rate were estimated and Type I error rates assigned. Major metabolite groups were organic acids, amines and amino acids, free fatty acids and sugar phosphates. Palmitate oxidation was associated with unique profiles of metabolites, a subset of which correlated to palmitate oxidation rate. In particular, palmitate oxidation rate was associated with distinct changes in the levels of TCA cycle intermediates within and effluxed from mitochondria. Conclusions/Significance: This proof-of-principle study establishes that large-scale metabolomics methods can be applied to organelle-level models to discover metabolite patterns reflective of LCFA combustion, which may lead to identification of molecules linking muscle fat metabolism and insulin signaling. Our results suggest that future studies should focus on the fate of effluxed TCA cycle intermediates and on mechanisms ensuring their replenishment during LCFA metabolism in skeletal muscle.	[Seifert, Erin L.; Bezaire, Veronic; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Fiehn, Oliver; Wohlgemuth, Gert] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Bickel, David R.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Adams, Sean H.] Univ Calif Davis, ARS, Obes & Metab Res Unit, USDA,Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of Ottawa; University of California System; University of California Davis; University of Ottawa; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis	Seifert, EL (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sean.h.adams@ars.usda.gov; Maryellen.Harper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009; Bickel, David/F-9370-2010; Bickel, David/ABF-7206-2021; ADAMS, SEAN/N-9262-2018	Bickel, David/0000-0002-9623-3946; Bickel, David/0000-0002-9623-3946; ADAMS, SEAN/0000-0002-9515-2319; Harper, Mary-Ellen/0000-0003-3864-5886	United States Department of Agriculture Agricultural Research Service (USDA-ARS) [530651530-016-00D]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [R01DK078328]; Canadian Institutes for Health Research [57810]; Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER	United States Department of Agriculture Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part through intramural United States Department of Agriculture Agricultural Research Service (USDA-ARS) Project 530651530-016-00D (S. H. A.) and National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) R01DK078328 (S. H. A. and M-E. H.) and by the Canadian Institutes for Health Research (Nutrition, Metabolism and Diabetes (57810); M-E. H.). E. L. S. was the recipient of a fellowship from the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Bangsbo J, 2006, PFLUG ARCH EUR J PHY, V452, P737, DOI 10.1007/s00424-006-0075-4; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; BICKEL DR, 2004, STAT APPL GENET MOL, V3; Bland JM, 1996, BRIT MED J, V312, P770; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; BRUCE CR, 2008, DIABETES; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; FINK G, 1988, J BIOL CHEM, V263, P18036; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; GUILLAUMEGENTIL C, 1993, DIABETOLOGIA, V36, P899, DOI 10.1007/BF02374470; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; MAILLOUX RJ, 2010, FASEB J IN PRESS; MAIZELS EZ, 1977, BIOCHEM J, V162, P557, DOI 10.1042/bj1620557; MAKOWSKI L, 2008, FASEB J; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; Messer JI, 2004, AM J PHYSIOL-CELL PH, V286, pC565, DOI 10.1152/ajpcell.00146.2003; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Mourtzakis M, 2008, J APPL PHYSIOL, V105, P547, DOI 10.1152/japplphysiol.90394.2008; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; NOSADINI R, 1985, AM J PHYSIOL, V248, pR611, DOI 10.1152/ajpregu.1985.248.5.R611; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pelletier A, 2007, MOL CELL BIOCHEM, V296, P97, DOI 10.1007/s11010-006-9303-7; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Poirier M, 2002, AM J PHYSIOL-HEART C, V283, pH1379, DOI 10.1152/ajpheart.00244.2002; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Saha AK, 1997, AM J PHYSIOL-ENDOC M, V272, pE641, DOI 10.1152/ajpendo.1997.272.4.E641; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205, DOI 10.1152/ajpendo.2001.281.6.E1205; Tretter L, 2000, J NEUROSCI, V20, P8972; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521; Vincent GV, 2004, AM J PHYSIOL-HEART C, V286, pH257, DOI 10.1152/ajpheart.00717.2003; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	64	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9834	10.1371/journal.pone.0009834	http://dx.doi.org/10.1371/journal.pone.0009834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352092	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894500008
J	Siddharthan, R				Siddharthan, Rahul			Dinucleotide Weight Matrices for Predicting Transcription Factor Binding Sites: Generalizing the Position Weight Matrix	PLOS ONE			English	Article							NONADDITIVITY; SEQUENCES; DATABASE; CODE	Background: Identifying transcription factor binding sites (TFBS) in silico is key in understanding gene regulation. TFBS are string patterns that exhibit some variability, commonly modelled as "position weight matrices" (PWMs). Though convenient, the PWM has significant limitations, in particular the assumed independence of positions within the binding motif; and predictions based on PWMs are usually not very specific to known functional sites. Analysis here on binding sites in yeast suggests that correlation of dinucleotides is not limited to near-neighbours, but can extend over considerable gaps. Methodology/Principal Findings: I describe a straightforward generalization of the PWM model, that considers frequencies of dinucleotides instead of individual nucleotides. Unlike previous efforts, this method considers all dinucleotides within an extended binding region, and does not make an attempt to determine a priori the significance of particular dinucleotide correlations. I describe how to use a "dinucleotide weight matrix" (DWM) to predict binding sites, dealing in particular with the complication that its entries are not independent probabilities. Benchmarks show, for many factors, a dramatic improvement over PWMs in precision of predicting known targets. In most cases, significant further improvement arises by extending the commonly defined "core motifs" by about 10bp on either side. Though this flanking sequence shows no strong motif at the nucleotide level, the predictive power of the dinucleotide model suggests that the "signature" in DNA sequence of protein-binding affinity extends beyond the core protein-DNA contact region. Conclusion/Significance: While computationally more demanding and slower than PWM-based approaches, this dinucleotide method is straightforward, both conceptually and in implementation, and can serve as a basis for future improvements.	Inst Math Sci, Madras 600113, Tamil Nadu, India	Institute of Mathematical Sciences (IMSc) India	Siddharthan, R (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	rsidd@imsc.res.in			Department of Biotechnology, Government of India [BT/PR7521/BRB/10/482/2006]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the PRISM project at the author's institution, and (particularly for computational support) by the Department of Biotechnology, Government of India (BT/PR7521/BRB/10/482/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARASH Y, 2003, P 7 ANN INT C RES CO; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; BUTLER G, 1991, MOL CELL BIOL, V11, P476, DOI 10.1128/MCB.11.1.476; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Durbin R., 1998, BIOL SEQUENCE ANAL P; Faiger H, 2007, NUCLEIC ACIDS RES, V35, P4409, DOI 10.1093/nar/gkm451; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lusk Richard W, 2008, Pac Symp Biocomput, P489; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Sinha S, 2006, NUCLEIC ACIDS RES, V34, pW555, DOI 10.1093/nar/gkl224; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	32	57	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9722	10.1371/journal.pone.0009722	http://dx.doi.org/10.1371/journal.pone.0009722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339533	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300004
J	David, M; Wannecq, E; Descotes, F; Jansen, S; Deux, B; Ribeiro, J; Serre, CM; Gres, S; Bendriss-Vermare, N; Bollen, M; Saez, S; Aoki, J; Saulnier-Blache, JS; Clezardin, P; Peyruchaud, O				David, Marion; Wannecq, Estelle; Descotes, Francoise; Jansen, Silvia; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Gres, Sandra; Bendriss-Vermare, Nathalie; Bollen, Mathieu; Saez, Simone; Aoki, Junken; Saulnier-Blache, Jean-Sebastien; Clezardin, Philippe; Peyruchaud, Olivier			Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts	PLOS ONE			English	Article							MOTILITY-STIMULATING PROTEIN; BREAST-CANCER; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; RECEPTOR; GENE; BISPHOSPHONATES; DIFFERENTIATION; PHENOTYPE; CARCINOMA	Background: Bone metastases are highly frequent complications of breast cancers. Current bone metastasis treatments using powerful anti-resorbtive agents are only palliative indicating that factors independent of bone resorption control bone metastasis progression. Autotaxin (ATX/NPP2) is a secreted protein with both oncogenic and pro-metastatic properties. Through its lysosphospholipase D (lysoPLD) activity, ATX controls the level of lysophosphatidic acid (LPA) in the blood. Platelet-derived LPA promotes the progression of osteolytic bone metastases of breast cancer cells. We asked whether ATX was involved in the bone metastasis process. We characterized the role of ATX in osteolytic bone metastasis formation by using genetically modified breast cancer cells exploited on different osteolytic bone metastasis mouse models. Methodology/Principal Findings: Intravenous injection of human breast cancer MDA-B02 cells with forced expression of ATX (MDA-B02/ATX) to inmmunodeficiency BALB/C nude mice enhanced osteolytic bone metastasis formation, as judged by increased bone loss, tumor burden, and a higher number of active osteoclasts at the metastatic site. Mouse breast cancer 4T1 cells induced the formation of osteolytic bone metastases after intracardiac injection in immunocompetent BALB/C mice. These cells expressed active ATX and silencing ATX expression inhibited the extent of osteolytic bone lesions and decreased the number of active osteoclasts at the bone metastatic site. In vitro, osteoclast differentiation was enhanced in presence of MDA-B02/ATX cell conditioned media or recombinant autotaxin that was blocked by the autotaxin inhibitor vpc8a202. In vitro, addition of LPA to active charcoal-treated serum restored the capacity of the serum to support RANK-L/MCSF-induced osteoclastogenesis. Conclusion/Significance: Expression of autotaxin by cancer cells controls osteolytic bone metastasis formation. This work demonstrates a new role for LPA as a factor that stimulates directly cancer growth and metastasis, and osteoclast differentiation. Therefore, targeting the autotaxin/LPA track emerges as a potential new therapeutic approach to improve the outcome of patients with bone metastases.	[David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] INSERM, U664, F-69008 Lyon, France; [David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] Univ Lyon 1, Villeurbanne, France; [Wannecq, Estelle; Gres, Sandra; Saulnier-Blache, Jean-Sebastien] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [David, Marion; Deux, Blandine; Ribeiro, Johnny; Serre, Claire-Marie; Clezardin, Philippe; Peyruchaud, Olivier] Fac Med Laennec, Lyon, France; [Descotes, Francoise; Saez, Simone] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France; [Jansen, Silvia; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, Lab Biosignaling & Therapeut, Louvain, Belgium; [Bendriss-Vermare, Nathalie] INSERM, U590, F-69008 Lyon, France; [Bendriss-Vermare, Nathalie] Ctr Leon Berard, F-69373 Lyon, France; [Aoki, Junken] Tohoku Univ, Sendai, Miyagi 980, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Tohoku University	David, M (corresponding author), INSERM, U664, F-69008 Lyon, France.	Olivier.peyruchaud@inserm.fr	Bendriss-Vermare, Nathalie/M-9197-2018; Clezardin, Philippe/M-8071-2014; Saulnier-Blache, Jean Sebastien/X-7729-2018	Bendriss-Vermare, Nathalie/0000-0002-8771-3585; Clezardin, Philippe/0000-0003-0149-4463; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723; Aoki, Junken/0000-0001-9435-1896; Peyruchaud, Olivier/0000-0002-5393-4945	INSERM; Comite departemental de la Loire de la Ligue Nationale contre le Cancer; French National Institute of Cancer, INCA [0610-3D1616-102/PL 2006]; French Association pour la Recherche sur le Cancer, ARC; Ligue Nationale contre le Cancer; Research Foundation-Flanders (FWO)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite departemental de la Loire de la Ligue Nationale contre le Cancer; French National Institute of Cancer, INCA(Institut National du Cancer (INCA) France); French Association pour la Recherche sur le Cancer, ARC(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Research Foundation-Flanders (FWO)(FWO)	This study was supported by grants from the INSERM (O. P. and P. C.), the Comite departemental de la Loire de la Ligue Nationale contre le Cancer (O. P.), the French National Institute of Cancer, INCA (O. P., contract 0610-3D1616-102/PL 2006) and the French Association pour la Recherche sur le Cancer, ARC (O. P.). M. D. was a recipient of fellowship from the Ligue Nationale contre le Cancer. J. S. holds a postdoctoral fellowship of the Research Foundation-Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bellahcene A, 2007, BREAST CANCER RES TR, V101, P135, DOI 10.1007/s10549-006-9279-8; Boissier S, 2000, CANCER RES, V60, P2949; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Cui P, 2007, BIOORG MED CHEM LETT, V17, P1634, DOI 10.1016/j.bmcl.2006.12.114; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001; Grey A, 2001, ENDOCRINOLOGY, V142, P1098, DOI 10.1210/en.142.3.1098; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hillner BE, 2000, J CLIN ONCOL, V18, P1378, DOI 10.1200/JCO.2000.18.6.1378; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kawagoe H, 1997, CANCER RES, V57, P2516; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; MURATA J, 1994, J BIOL CHEM, V269, P30479; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Peyruchaud O, 2009, BONE AND CANCER, P73, DOI 10.1007/978-1-84882-019-7_5; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Singh AD, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.116947; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Taghavi P, 2008, ONCOGENE, V27, P6806, DOI 10.1038/onc.2008.294; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang GX, 1999, CHINESE MED J-PEKING, V112, P330; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216	52	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9741	10.1371/journal.pone.0009741	http://dx.doi.org/10.1371/journal.pone.0009741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305819	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000275809600013
J	Hines, WC; Bazarov, AV; Mukhopadhyay, R; Yaswen, P				Hines, William C.; Bazarov, Alexey V.; Mukhopadhyay, Rituparna; Yaswen, Paul			BORIS (CTCFL) Is Not Expressed in Most Human Breast Cell Lines and High Grade Breast Carcinomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANCER-TESTIS GENE; FREQUENT AMPLIFICATION; METHYLATION; EPIGENETICS; DEREPRESSION; CTCFL/BORIS; REGULATOR; MELANOMA; MAGE-A1	BORIS (CTCFL) is the only known paralog of the versatile regulatory protein CTCF, a multifunctional DNA binding protein that mediates distinct gene regulatory functions involved in cell growth, differentiation, and apoptosis. Unlike CTCF, the expression of BORIS is normally restricted to specific cells in testes (the only cells where CTCF is not expressed), where it may play a role in reprogramming the methylation pattern of male germ line DNA. Frequent amplification of the 20q13.2 region, which contains the BORIS gene, and expression of BORIS transcripts in diverse human tumors and cell lines have led to the hypothesis that aberrant expression of BORIS may play a role in tumorigenesis by interfering with CTCF functions. However, recent studies using more quantitative methods indicate low frequency of BORIS expression in melanoma, ovarian, prostate, and bladder carcinomas. To investigate the relationship between chromosome 20q13 amplification and BORIS mRNA levels within breast cancer cell lines and tissues, we developed a quantitative RT-PCR assay to measure the levels of BORIS mRNA. Endpoint RT-PCR assays were also used to investigate the possible expression of alternatively spliced variants. Using multiple primer sets and controls, we found that neither mature BORIS transcripts nor spliced variants are commonly expressed at detectable levels in malignant breast cells or tissues, although endogenous BORIS transcripts can be induced in MCF-7 cells following 5-aza-29-deoxycytidine treatment. In conclusion, in most breast cancer cells, endogenous BORIS is unlikely to be expressed at sufficient levels to interfere with CTCF functions. Thus it is improbable that aberrant BORIS expression plays a role in most human breast cancers.	[Hines, William C.; Mukhopadhyay, Rituparna; Yaswen, Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Bazarov, Alexey V.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Hines, WC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	P_Yaswen@lbl.gov		Hines, William/0000-0002-0707-3160	California Breast Cancer Research Program [9WB-0193]; Department of Defense Breast Cancer Research Program [W81XWH-04-1-0283]; Office of Health and Environmental Research, Health Effects Division, United States Department of Energy [DE-AC02-05CH11231]; Komen Foundation [PDF0707408, BCTR0707231]; Flight Attendant Medical Research Institute [032122]	California Breast Cancer Research Program; Department of Defense Breast Cancer Research Program(United States Department of Defense); Office of Health and Environmental Research, Health Effects Division, United States Department of Energy(United States Department of Energy (DOE)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Flight Attendant Medical Research Institute	This work was funded by grants from the California Breast Cancer Research Program (9WB-0193), the Department of Defense Breast Cancer Research Program (W81XWH-04-1-0283), and by the Office of Health and Environmental Research, Health Effects Division, United States Department of Energy (contract no. DE-AC02-05CH11231). W. C. Hines and A. Bazarov received support from the Komen Foundation (fellowship PDF0707408 & grant BCTR0707231) and the Flight Attendant Medical Research Institute (032122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083	29	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9738	10.1371/journal.pone.0009738	http://dx.doi.org/10.1371/journal.pone.0009738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305816	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809600010
J	Ramana, J; Gupta, D				Ramana, Jayashree; Gupta, Dinesh			FaaPred: A SVM-Based Prediction Method for Fungal Adhesins and Adhesin-Like Proteins	PLOS ONE			English	Article							BLASTOMYCES-DERMATITIDIS; IDENTIFICATION; LOCALIZATION; PROGRAM; BINDING; ACID	Adhesion constitutes one of the initial stages of infection in microbial diseases and is mediated by adhesins. Hence, identification and comprehensive knowledge of adhesins and adhesin-like proteins is essential to understand adhesin mediated pathogenesis and how to exploit its therapeutic potential. However, the knowledge about fungal adhesins is rudimentary compared to that of bacterial adhesins. In addition to host cell attachment and mating, the fungal adhesins play a significant role in homotypic and xenotypic aggregation, foraging and biofilm formation. Experimental identification of fungal adhesins is labor- as well as time-intensive. In this work, we present a Support Vector Machine (SVM) based method for the prediction of fungal adhesins and adhesin-like proteins. The SVM models were trained with different compositional features, namely, amino acid, dipeptide, multiplet fractions, charge and hydrophobic compositions, as well as PSI-BLAST derived PSSM matrices. The best classifiers are based on compositional properties as well as PSSM and yield an overall accuracy of 86%. The prediction method based on best classifiers is freely accessible as a world wide web based server at http://bioinfo.icgeb.res.in/faap. This work will aid rapid and rational identification of fungal adhesins, expedite the pace of experimental characterization of novel fungal adhesins and enhance our knowledge about role of adhesins in fungal infections.	[Ramana, Jayashree; Gupta, Dinesh] ICGEB, Struct & Computat Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Ramana, J (corresponding author), ICGEB, Struct & Computat Biol Grp, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Ramana, Jayashree/GQQ-5678-2022; Gupta, Dinesh/AAW-4243-2020; Gupta, Dinesh/C-1079-2009	Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology (DBT, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India)	Department of Biotechnology (DBT, India) grant for Bioinformatics infrastructure Facility at ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM AF, 2008, PROTEIN-STRUCT FUNCT, V70, P659; Andreotti PF, 2005, MICROBES INFECT, V7, P875, DOI 10.1016/j.micinf.2005.02.005; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Brandhorst T, 2000, J BIOL CHEM, V275, P7925, DOI 10.1074/jbc.275.11.7925; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guo J, 2006, BIOINFORMATICS, V22, P1784, DOI 10.1093/bioinformatics/btl180; Halperin SA, 2003, VACCINE, V21, P2298, DOI 10.1016/S0264-410X(03)00173-7; ITZHAK O, 2003, FEMS IMMUNOLOGY MED, V38, P181; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder T, 2008, FUNGAL GENET BIOL, V45, P485, DOI 10.1016/j.fgb.2007.08.002; MANISH K, 2008, PROTEIN-STRUCT FUNCT, V71, P189; MARK ES, 2009, FEMS MICROBIOLOGY LE, V299, P1; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; PAULA S, 2002, CELLULAR MICROBIOLOG, V4, P461; Prinz C, 2003, TRENDS MICROBIOL, V11, P134, DOI 10.1016/S0966-842X(03)00024-6; Ramana J, 2009, BIOINFORMATICS, V25, P1568, DOI 10.1093/bioinformatics/btp258; Rapola S, 2003, VACCINE, V21, P3608, DOI 10.1016/S0264-410X(03)00409-2; Sachdeva G, 2005, BIOINFORMATICS, V21, P483, DOI 10.1093/bioinformatics/bti028; Mendes-Giannini MJS, 2006, MICROBES INFECT, V8, P1550, DOI 10.1016/j.micinf.2006.01.012; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Stanley MS, 2002, PHYTOPATHOLOGY, V92, P378, DOI 10.1094/PHYTO.2002.92.4.378; Upadhyay SK, 2009, J MED MICROBIOL, V58, P714, DOI 10.1099/jmm.0.005991-0; Vapnik N., 1998, STAT LEARNING THEORY; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wuthrich M, 2000, INFECT IMMUN, V68, P7172, DOI 10.1128/IAI.68.12.7172-7174.2000; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011	36	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2010	5	3							e9695	10.1371/journal.pone.0009695	http://dx.doi.org/10.1371/journal.pone.0009695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SM	20300572	Green Published, gold, Green Submitted			2022-12-25	WOS:000275621000013
J	Barlow, J; Gardner, TA; Louzada, J; Peres, CA				Barlow, Jos; Gardner, Toby A.; Louzada, Julio; Peres, Carlos A.			Measuring the Conservation Value of Tropical Primary Forests: The Effect of Occasional Species on Estimates of Biodiversity Uniqueness	PLOS ONE			English	Article							ATLANTIC FOREST; ABUNDANCE DISTRIBUTIONS; PLANTATION FORESTS; UNCERTAIN FUTURE; LAND MANAGEMENT; PATTERNS; ASSEMBLAGES; SIMILARITY; SECONDARY; RARITY	Background: Developing effective conservation plans for multi-functional landscapes requires an accurate knowledge of the relative conservation value of different land-uses. A growing number of tropical ecologists have evaluated conservation value using the number (or proportion) of species that are unique to primary or old-growth forests. However, estimates of the conservation value of modified land-uses may be inflated by the presence of occasional species (e. g. singletons and doubletons) that may be unable to exist as viable populations in isolation. Methodology/Principal Findings: We use a unique 15-taxa dataset from a mixed-use forest landscape in the Brazilian Amazon to test the hypothesis that the removal of occasional species from sample data can increase estimates of the value of primary forest for biodiversity conservation. Conclusions/Significance: Estimates of conservation value that are based on the proportion of species that are unique to tropical primary or old-growth forests are highly sensitive to decisions researchers make regarding the inclusion or exclusion of occasional species. By removing singletons from modified forest samples, and considering only those species known to occur in primary forest, we almost double estimates of the conservation value of tropical primary forests.	[Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Gardner, Toby A.; Louzada, Julio] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Gardner, Toby A.] Univ Cambridge, Dept Zool, Cambridge, England; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Lancaster University; Universidade Federal de Lavras; University of Cambridge; University of East Anglia	Barlow, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	josbarlow@gmail.com	Peres, Carlos A./ABE-8361-2020; Peres, Carlos Augusto/N-8275-2019; Barlow, Jos/E-7861-2014; Bioterra Amazonia, Inct/J-9890-2013; Louzada, Julio/F-1265-2010; Gardner, Toby/B-7516-2008; Peres, Carlos A./B-1276-2013; Barlow, Jos/HGE-9486-2022	Peres, Carlos A./0000-0002-1588-8765; Louzada, Julio/0000-0002-1481-3112; Peres, Carlos A./0000-0002-1588-8765; 	UK Darwin Initiative [162/12/014]; Center for Applied Biodiversity Science of Conservation International; Natural Environment Research Council (NERC); National Geographic Society; Conservation Food and Health Foundation; FAPEMIG [CRA-000343/07]; Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq) [574008/2008-0]; Natural Environmental Research Council [NE/F01614X/1]; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010, NE/F01614X/1] Funding Source: researchfish; NERC [NE/F01614X/1] Funding Source: UKRI	UK Darwin Initiative; Center for Applied Biodiversity Science of Conservation International; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic Society(National Geographic Society); Conservation Food and Health Foundation; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by a UK Darwin Initiative grant 162/12/014, with additional support from the Center for Applied Biodiversity Science of Conservation International, the Natural Environment Research Council (NERC), the National Geographic Society, the Conservation Food and Health Foundation, FAPEMIG CRA-000343/07, and the Instituto Nacional de Ciencia e Tecnologia-Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0). TAG also thanks the Natural Environmental Research Council (NE/F01614X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Bennett AF, 2007, CONSERV SCI PRACT, V1, P201; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; CHAZDON RL, 2009, CONSERVATION BIOL; Clarke KR, 1994, CHANGE MARINE COMMUN; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; DENT DH, BIOL CONSER IN PRESS; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Drake P, 1999, SCI TOTAL ENVIRON, V242, P271, DOI 10.1016/S0048-9697(99)00395-2; Duffy-Anderson JT, 2006, FISH OCEANOGR, V15, P80, DOI 10.1111/j.1365-2419.2005.00348.x; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; FERRIER S, USING GEN DISSIMILAR, P252; GARDNER TA, 2008, ECOLOGY LETT, V11; GARDNER TA, 2008, UNDERSTANDING CONSEQ; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gaston K.J., 1994, RARITY, P1; Goerck JM, 1997, CONSERV BIOL, V11, P112, DOI 10.1046/j.1523-1739.1997.95314.x; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Marchese MR, 2005, RIVER RES APPL, V21, P485, DOI 10.1002/rra.814; Meijaard E, 2007, BIODIVERS CONSERV, V16, P3053, DOI 10.1007/s10531-007-9161-y; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Possingham HP, 2007, CONSERV SCI PRACT, V1, P546, DOI 10.1002/9780470692400.ch45; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Sodhi NS, 2008, BASIC APPL ECOL, V9, P93, DOI 10.1016/j.baae.2007.11.001; TERBORGH J, 1969, Ecology (Washington D C), V50, P765, DOI 10.2307/1933691; Ulrich W, 2004, DIVERS DISTRIB, V10, P263, DOI 10.1111/j.1366-9516.2004.00082.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x	38	55	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9609	10.1371/journal.pone.0009609	http://dx.doi.org/10.1371/journal.pone.0009609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231897	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000275328300021
J	Everaerts, C; Farine, JP; Cobb, M; Ferveur, JF				Everaerts, Claude; Farine, Jean-Pierre; Cobb, Matthew; Ferveur, Jean-Francois			Drosophila Cuticular Hydrocarbons Revisited: Mating Status Alters Cuticular Profiles	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CONTACT SEX-PHEROMONE; CIS-VACCENYL ACETATE; COURTSHIP BEHAVIOR; CHEMICAL COMMUNICATION; MELANOGASTER; IDENTIFICATION; PERCEPTION; QUEENS; BIOSYNTHESIS	Most living organisms use pheromones for inter-individual communication. In Drosophila melanogaster flies, several pheromones perceived either by contact/at a short distance (cuticular hydrocarbons, CHs), or at a longer distance (cis-vaccenyl acetate, cVA), affect courtship and mating behaviours. However, it has not previously been possible to precisely identify all potential pheromonal compounds and simultaneously monitor their variation on a time scale. To overcome this limitation, we combined Solid Phase Micro-Extraction with gas-chromatography coupled with mass-spectrometry. This allowed us (i) to identify 59 cuticular compounds, including 17 new CHs; (ii) to precisely quantify the amount of each compound that could be detected by another fly, and (iii) to measure the variation of these substances as a function of aging and mating. Sex-specific variation appeared with age, while mating affected cuticular compounds in both sexes with three possible patterns: variation was (i) reciprocal in the two sexes, suggesting a passive mechanical transfer during mating, (ii) parallel in both sexes, such as for cVA which strikingly appeared during mating, or (iii) unilateral, presumably as a result of sexual interaction. We provide a complete reassessment of all Drosophila CHs and suggest that the chemical conversation between male and female flies is far more complex than is generally accepted. We conclude that focusing on individual compounds will not provide a satisfactory understanding of the evolution and function of chemical communication in Drosophila.	[Everaerts, Claude; Farine, Jean-Pierre; Ferveur, Jean-Francois] Univ Bourgogne, INRA, CNRS, Ctr Sci Gout & Alimentat,UMR 6265,UMR 1324, Dijon, France; [Cobb, Matthew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Manchester	Everaerts, C (corresponding author), Univ Bourgogne, INRA, CNRS, Ctr Sci Gout & Alimentat,UMR 6265,UMR 1324, Dijon, France.	Claude.Everaerts@u-bourgogne.fr		Cobb, Matthew/0000-0002-8258-4913	CNRS; Burgundy Regional Council; ANR (INSAVEL)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR))	This work was partly funded by grants from the CNRS, Burgundy Regional Council, and ANR (INSAVEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2007, XLSTAT 2007 DAT AN S; [Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Augusto F, 2002, TRAC-TREND ANAL CHEM, V21, P428, DOI 10.1016/S0165-9936(02)00602-7; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Bland JM, 2001, J CHROMATOGR A, V932, P119, DOI 10.1016/S0021-9673(01)01239-0; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chertemps T, 2006, INSECT MOL BIOL, V15, P465, DOI 10.1111/j.1365-2583.2006.00658.x; Cobb M, 1995, BEHAV PROCESS, V35, P35, DOI 10.1016/0376-6357(95)00052-6; Cochran WG., 1963, SAMPLING TECHNIQUES; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Ginzel MD, 2006, J CHEM ECOL, V32, P435, DOI 10.1007/s10886-005-9010-y; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kent C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000962; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Moneti G, 1997, RAPID COMMUN MASS SP, V11, P857; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; PECHINE JM, 1988, J CHEM ECOL, V14, P1071, DOI 10.1007/BF01019336; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Roux E, 2002, J CHEM ECOL, V28, P1221, DOI 10.1023/A:1016237918662; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Sledge MF, 2001, P ROY SOC B-BIOL SCI, V268, P2253, DOI 10.1098/rspb.2001.1799; Sledge MF, 2000, J CHROMATOGR A, V873, P73, DOI 10.1016/S0021-9673(99)01176-0; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Starostina E, 2009, J BIOL CHEM, V284, P585, DOI 10.1074/jbc.M806474200; Subchev M, 2001, ARCH INSECT BIOCHEM, V47, P35, DOI 10.1002/arch.1033; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; Tentschert J, 2001, NATURWISSENSCHAFTEN, V88, P175, DOI 10.1007/s001140100218; Theodoridis G, 2000, J CHROMATOGR B, V745, P49, DOI 10.1016/S0378-4347(00)00203-6; TOMPKINS L, 1983, GENETICS, V103, P179; Turillazzi S, 1998, ETHOL ECOL EVOL, V10, P293, DOI 10.1080/08927014.1998.9522859; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	63	201	201	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9607	10.1371/journal.pone.0009607	http://dx.doi.org/10.1371/journal.pone.0009607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231905	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328300020
J	Lage, R; Vazquez, MJ; Varela, L; Saha, AK; Vidal-Puig, A; Nogueiras, R; Dieguez, C; Lopez, M				Lage, Ricardo; Vazquez, Maria J.; Varela, Luis; Saha, Asish K.; Vidal-Puig, Antonio; Nogueiras, Ruben; Dieguez, Carlos; Lopez, Miguel			Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender	FASEB JOURNAL			English	Article						AMPK; CREB; dimorphism; FoxO1	ENDOPLASMIC-RETICULUM STRESS; AGOUTI-RELATED PROTEIN; MELANIN-CONCENTRATING HORMONE; MESSENGER-RNA LEVELS; DIET-INDUCED OBESITY; FOOD-INTAKE; ENERGY HOMEOSTASIS; LEPTIN RESISTANCE; ARCUATE NUCLEUS; SECRETAGOGUE RECEPTOR	The orexigenic effect of ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP) in the hypothalamic arcuate nucleus (ARC). Recent evidence also indicates that ghrelin promotes feeding through a mechanism involving activation of hypothalamic AMP-activated protein kinase (AMPK) and inactivation of acetyl-CoA carboxylase and fatty acid synthase (FAS). This results in decreased hypothalamic levels of malonyl-CoA, increased carnitine palmitoyltransferase 1 (CPT1) activity, and mitochondrial production of reactive oxygen species. We evaluated whether these molecular events are part of a unique signaling cascade or whether they represent alternative pathways mediating the orexigenic effect of ghrelin. Moreover, we examined the gender dependency of these mechanisms, because recent evidence has proposed that ghrelin orexigenic effect is reduced in female rats. We studied in both genders the effect of ghrelin on the expression of AgRP and NPY, as well as their transcription factors: cAMP response-element binding protein (CREB and its phosphorylated form, pCREB), forkhead box O1 (FoxO1 and its phosphorylated form, pFoxO1), and brain-specific homeobox transcription factor (BSX). In addition, to establish a mechanistic link between ghrelin, fatty acid metabolism, and neuropeptides, we evaluated the effect of ghrelin after blockage of hypothalamic fatty acid beta oxidation, by using the CPT1 inhibitor etomoxir. Ghrelin-induced changes in the AMPK-CPT1 pathway are associated with increased levels of AgRP and NPY mRNA expression through modulation of BSX, pCREB, and FoxO1, as well as decreased expression of endoplasmic reticulum (ER) stress markers in a gender-independent manner. In addition, blockage of hypothalamic fatty acid-oxidation prevents the ghrelin-promoting action on AgRP and NPY mRNA expression, also in a gender-independent manner. Notably, this effect is associated with decreased BSX expression and reduced food intake. Overall, our data suggest that BSX integrates changes in neuronal metabolic status with ARC-derived neuropeptides in a gender-independent manner.-Lage, R., Vazquez, M.J., Varela, L., Saha, A. K., Vidal-Puig, A., Nogueiras, R., Dieguez, C., Lopez, M. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J. 24, 2670-2679 (2010). www.fasebj.org	[Lage, Ricardo; Vazquez, Maria J.; Varela, Luis; Nogueiras, Ruben; Dieguez, Carlos; Lopez, Miguel] Univ Santiago de Compostela, Sch Med, Dept Physiol, Inst Invest Sanitaria, Santiago De Compostela 15782, A Coruna, Spain; [Lage, Ricardo; Vazquez, Maria J.; Varela, Luis; Nogueiras, Ruben; Dieguez, Carlos; Lopez, Miguel] CIBERobn, CIBER Fisiopatol Obesidad & Nutr, Santiago De Compostela, A Coruna, Spain; [Saha, Asish K.] Boston Med Ctr, Diabet Res Unit, Boston, MA USA; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Boston Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lopez, M (corresponding author), Univ Santiago de Compostela, Sch Med, Dept Physiol, Inst Invest Sanitaria, S Francisco S-N, Santiago De Compostela 15782, A Coruna, Spain.	m.lopez@usc.es	Varela, Luis/ABG-7581-2020; Nogueiras, Ruben/AAS-9427-2021; López, Miguel/ABF-4844-2021	Varela, Luis/0000-0001-7794-7241; Nogueiras, Ruben/0000-0002-9976-9930; López, Miguel/0000-0002-7823-1648; Saha, Asish/0000-0003-1001-5110; Vidal-Puig, Antonio/0000-0003-4220-9577; dieguez, carlos/0000-0002-0919-4337; Lage Fernandez, Ricardo/0000-0002-8779-7723	Fondo Investigationes Sanitarias [PI061700, PS09/01880]; Ministerio de Educacion y Ciencia [BFU2008, RyC-2007-00211, RyC-2008-02219]; European Union [Health-F2-2008-223713, AVP FP7MITIN, LSHM-CT-2005-018734]; U.K. Medical Research Council; Wellcome Trust; U.S. Public Health Service [K-19514, DK-67509]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509] Funding Source: NIH RePORTER; Medical Research Council [G0600717, G0802051] Funding Source: researchfish; MRC [G0600717, G0802051] Funding Source: UKRI	Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia(Spanish Government); European Union(European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Pablo B. Martinez de Morentin for his technical assistance. This work has been supported by grants from Fondo Investigationes Sanitarias (M.L.: PI061700 and PS09/01880), Ministerio de Educacion y Ciencia (C.D.: BFU2008; M.L.: RyC-2007-00211; R.N.: RyC-2008-02219), the European Union (C.D., M.L., and R.N.: Health-F2-2008-223713, Reprobesity; AVP FP7MITIN and LSHM-CT-2005-018734, Hepadip, http://www.hepadip.org), the U.K. Medical Research Council (A.V.P.), The Wellcome Trust (A.V.P.), and the U.S. Public Health Service (A.K.S.: K-19514 and DK-67509). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Archer ZA, 2004, J ENDOCRINOL, V182, P409, DOI 10.1677/joe.0.1820409; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Fodor M, 2001, NEUROREPORT, V12, P3989, DOI 10.1097/00001756-200112210-00027; Foster-Schubert KE, 2006, ENDOCR REV, V27, P779, DOI 10.1210/er.2006-0041; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kamegai J, 1999, J NEUROENDOCRINOL, V11, P299; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kim MS, 2006, ELECTROCHEM SOLID ST, V9, pG56, DOI 10.1149/1.2142155; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lee Geung-Joo, 2007, V2, P1; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; de Morentin PBM, 2010, BBA-MOL CELL BIOL L, V1801, P350, DOI 10.1016/j.bbalip.2009.09.016; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mogi K, 2005, ENDOCRINOLOGY, V146, P3325, DOI 10.1210/en.2005-0078; Mystkowski P, 2000, J NEUROSCI, V20, P8637, DOI 10.1523/JNEUROSCI.20-22-08637.2000; Nazarian A, 2009, PSYCHOPHARMACOLOGY, V203, P641, DOI 10.1007/s00213-008-1411-5; Nogueiras R, 2008, ENDOCRINOLOGY, V149, P3009, DOI 10.1210/en.2007-1684; Olofsson LE, 2009, P NATL ACAD SCI USA, V106, P15932, DOI 10.1073/pnas.0904747106; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Santollo J, 2008, BEHAV BRAIN RES, V191, P173, DOI 10.1016/j.bbr.2008.03.019; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Shimizu H, 1996, NEUROSCI LETT, V204, P81, DOI 10.1016/0304-3940(96)12322-3; Shimizu-Albergine M, 2001, J NEUROSCI, V21, P1238; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wang W, 2010, REGUL PEPTIDES, V161, P43, DOI 10.1016/j.regpep.2009.12.017; Wang W, 2010, PEPTIDES, V31, P307, DOI 10.1016/j.peptides.2009.11.011; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; ZAMMIT VA, 1979, BIOCHEM J, V184, P313, DOI 10.1042/bj1840313; Zhang GG, 2009, PEPTIDES, V30, P1109, DOI 10.1016/j.peptides.2009.03.024; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zorrilla EP, 2006, P NATL ACAD SCI USA, V103, P13226, DOI 10.1073/pnas.0605376103	62	92	95	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2010	24	8					2670	2679		10.1096/fj.09-150672	http://dx.doi.org/10.1096/fj.09-150672			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LD	20335227	Green Published			2022-12-25	WOS:000285005400009
J	Liu, Y; Yan, S; Wondimu, A; Bob, D; Weiss, M; Sliwinski, K; Villar, J; Notario, V; Sutherland, M; Colberg-Poley, AM; Ladisch, S				Liu, Y.; Yan, S.; Wondimu, A.; Bob, D.; Weiss, M.; Sliwinski, K.; Villar, J.; Notario, V.; Sutherland, M.; Colberg-Poley, A. M.; Ladisch, S.			Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth	ONCOGENE			English	Article						ganglioside synthesis; ganglioside depletion; tumor model; c-Myc/H-Ras transformation; tumorigenesis	GLUCOSYLCERAMIDE SYNTHASE; CANCER CELLS; KAPPA-B; ACTIVATION; EXPRESSION; PROLIFERATION; CONVERSION; INHIBITOR; MIGRATION; ADHESION	Biologically active membrane gangliosides, expressed and released by many human tumors, are hypothesized to significantly impact tumor progression. Lack of a model of complete and specific tumor ganglioside depletion in vivo, however, has hampered elucidation of their role. Here, we report the creation of a novel, stable, genetically induced tumor cell system resulting in specific and complete blockade of ganglioside synthesis. Wild-type (WT) and GM3 synthase/GM2 synthase double knockout (DKO) murine embryonic fibroblasts were transformed using amphotropic retrovirus-transduced oncogenes (pBABE-c-Myc(T58A) + H-RasG12V). The transformed cells, WTt and DKOt respectively, evidenced comparable integrated copy numbers and oncogene expression. Ganglioside synthesis was completely blocked in the DKOt cells, importantly without triggering an alternate pathway of ganglioside synthesis. Ganglioside depletion (to <0.5 nmol/10(7) cells from 9 to 11 nmol/10(7) WTt or untransfected normal fibroblasts) did not adversely affect cell proliferation kinetics but did reduce cell migration on fibronectin-coated wells, consistent with our previous observations in ganglioside-depleted normal human fibroblasts. Strikingly, despite similar oncogene expression and growth kinetics, DKOt cells evidenced significantly impaired tumor growth in syngeneic immunocompetent mice, underscoring the pivotal role of tumor cell gangliosides and providing an ideal system for probing their mechanisms of action in vivo. Oncogene (2010) 29, 3297-3306; doi: 10.1038/onc.2010.85; published online 22 March 2010	[Liu, Y.; Yan, S.; Wondimu, A.; Bob, D.; Weiss, M.; Sliwinski, K.; Sutherland, M.; Colberg-Poley, A. M.; Ladisch, S.] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, NW, Washington, DC 20010 USA; [Liu, Y.; Colberg-Poley, A. M.; Ladisch, S.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Villar, J.; Notario, V.] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Dept Radiat Med, Washington, DC 20007 USA; [Colberg-Poley, A. M.; Ladisch, S.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Children's National Health System; George Washington University; Georgetown University; George Washington University	Ladisch, S (corresponding author), Childrens Natl Med Ctr, Ctr Canc & Immunol Res, NW, 111 Michigan Ave NW,Suite 5200, Washington, DC 20010 USA.	sladisch@cnmc.org	/AAB-6461-2022; /AFP-0764-2022		NIH [CA61010, CA42361, CA64472, GM62116]; NATIONAL CANCER INSTITUTE [R01CA042361, R01CA064472, R01CA061010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rick Proia for the GM3S mice. This work was supported by NIH grants CA61010 and CA42361 to SL, CA64472 to VN, and GM62116 to the Consortium for Functional Glycomics.	Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Buggins AGS, 2001, J IMMUNOL, V167, P6021, DOI 10.4049/jimmunol.167.10.6021; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; Deng W, 2002, GLYCOBIOLOGY, V12, P145, DOI 10.1093/glycob/12.3.145; FLOUTSIS G, 1989, INT J CANCER, V43, P6, DOI 10.1002/ijc.2910430103; Hakomori S, 1973, Adv Cancer Res, V18, P265, DOI 10.1016/S0065-230X(08)60755-1; Hakomori S, 1996, CANCER RES, V56, P5309; Hyuga S, 1999, INT J CANCER, V83, P685, DOI 10.1002/(SICI)1097-0215(19991126)83:5<685::AID-IJC20>3.0.CO;2-4; INOKUCHI JI, 1989, J CELL PHYSIOL, V141, P573, DOI 10.1002/jcp.1041410316; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; LADISCH S, 1983, CANCER RES, V43, P3808; Ladisch S, 2004, CURR CLIN ONCOL, P145; LADISCH S, 1987, J CLIN INVEST, V79, P1879, DOI 10.1172/JCI113031; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; LEDEEN RW, 1978, J SUPRAMOL STR CELL, V8, P1, DOI 10.1002/jss.400080102; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; LI RX, 1991, BIOCHIM BIOPHYS ACTA, V1083, P57, DOI 10.1016/0005-2760(91)90124-Z; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; Liu YH, 2006, CANCER RES, V66, P10408, DOI 10.1158/0008-5472.CAN-06-1572; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Saha S., 2005, Indian Journal of Experimental Biology, V43, P1130; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; Shevchuk NA, 2007, BBA-MOL CELL BIOL L, V1771, P1226, DOI 10.1016/j.bbalip.2007.05.008; Shurin GV, 2001, CANCER RES, V61, P363; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Uzzo RG, 1999, J CLIN INVEST, V104, P769, DOI 10.1172/JCI6775; VALENTINO L, 1990, BLOOD, V75, P1564; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102	38	24	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3297	3306		10.1038/onc.2010.85	http://dx.doi.org/10.1038/onc.2010.85			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20305696	Green Accepted			2022-12-25	WOS:000278321100012
J	Iwaya, N; Kuwahara, Y; Fujiwara, Y; Goda, N; Tenno, T; Akiyama, K; Mase, S; Tochio, H; Ikegami, T; Shirakawa, M; Hiroaki, H				Iwaya, Naoko; Kuwahara, Yohta; Fujiwara, Yoshie; Goda, Natsuko; Tenno, Takeshi; Akiyama, Kohei; Mase, Shogo; Tochio, Hidehito; Ikegami, Takahisa; Shirakawa, Masahiro; Hiroaki, Hidekazu			A Common Substrate Recognition Mode Conserved between Katanin p60 and VPS4 Governs Microtubule Severing and Membrane Skeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCRT-III RECOGNITION; STRUCTURAL BASIS; MIT DOMAIN; AAA ATPASE; PROTEIN; TUBULIN; IDENTIFICATION; ASSIGNMENT; DATABASE	Katanin p60 (kp60), a microtubule-severing enzyme, plays a key role in cytoskeletal reorganization during various cellular events in an ATP-dependent manner. We show that a single domain isolated from the N terminus of mouse katanin p60 (kp60-NTD) binds to tubulin. The solution structure of kp60-NTD was determined by NMR. Although their sequence similarities were as low as 20%, the structure of kp60-NTD revealed a striking similarity to those of the microtubule interacting and trafficking (MIT) domains, which adopt anti-parallel three-stranded helix bundle. In particular, the arrangement of helices 2 and 3 is well conserved between kp60-NTD and the MIT domain from Vps4, which is a homologous protein that promotes disassembly of the endosomal sorting complexes required for transport III membrane skeleton complex. Mutation studies revealed that the positively charged surface formed by helices 2 and 3 binds tubulin. This binding mode resembles the interaction between the MIT domain of Vps4 and Vps2/CHMP1a, a component of endosomal sorting complexes required for transport III. Our results show that both the molecular architecture and the binding modes are conserved between two AAA-ATPases, kp60 and Vps4. A common mechanism is evolutionarily conserved between two distinct cellular events, one that drives microtubule severing and the other involving membrane skeletal reorganization.	[Iwaya, Naoko; Kuwahara, Yohta; Fujiwara, Yoshie; Goda, Natsuko; Tenno, Takeshi; Mase, Shogo; Hiroaki, Hidekazu] Kobe Univ, Dept Biochem & Mol Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Iwaya, Naoko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Dept Mol Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan; [Iwaya, Naoko; Kuwahara, Yohta; Akiyama, Kohei; Hiroaki, Hidekazu] Yokohama City Univ, Field Supramol Biol, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Kuwahara, Yohta; Goda, Natsuko; Tenno, Takeshi; Mase, Shogo; Hiroaki, Hidekazu] Japan Sci & Technol Corp, Inst Bioinformat Res & Dev, Tokyo 1020081, Japan; [Fujiwara, Yoshie; Hiroaki, Hidekazu] Kobe Univ, Global Ctr Excellence Program Integrat Membrane B, Kobe, Hyogo 6500017, Japan; [Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan	Kobe University; Kyoto University; Yokohama City University; Japan Science & Technology Agency (JST); Kobe University; Osaka University	Hiroaki, H (corresponding author), Kobe Univ, Dept Biochem & Mol Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	hiroakih@med.kobe-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; Ikegami, Takahisa/I-9626-2017; HIROAKI, HIDEKAZU/N-1658-2019; Tochio, Hidehito/GWV-0429-2022; Tochio, Hidehito/F-6109-2011	Ikegami, Takahisa/0000-0002-1429-1844; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Tochio, Hidehito/0000-0003-3843-3330; 	Cooperative Research Program of Institute for Protein Research, Osaka University	Cooperative Research Program of Institute for Protein Research, Osaka University	Apart of this work was performed under the Cooperative Research Program of Institute for Protein Research, Osaka University.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Frohlich KU, 2001, J CELL SCI, V114, P1601; Goda N, 2004, PROTEIN SCI, V13, P652, DOI 10.1110/ps.03439004; GODDARD TD, 2004, SPARKY VERSION 3; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Iwaya N, 2007, J BIOMOL NMR, V37, P53, DOI 10.1007/s10858-006-9103-0; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally FJ, 1996, J CELL SCI, V109, P561; McNally KP, 2000, J CELL SCI, V113, P1623; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	63	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16822	16829		10.1074/jbc.M110.108365	http://dx.doi.org/10.1074/jbc.M110.108365			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20339000	Green Published, hybrid			2022-12-25	WOS:000277982600046
J	Sinha, D; Shogren-Knaak, MA				Sinha, Divya; Shogren-Knaak, Michael A.			Role of Direct Interactions between the Histone H4 Tail and the H2A Core in Long Range Nucleosome Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CHROMATIN COMPACTION; TRANSCRIPTIONAL REPRESSION; ANGSTROM RESOLUTION; SELF-ASSOCIATION; FIBER STRUCTURE; SURFACE; ARRAYS; DNA; DOMAINS; OCTAMER	In eukaryotic nuclei the majority of genomic DNA is believed to exist in higher order chromatin structures. Nonetheless, the nature of direct, long range nucleosome interactions that contribute to these structures is poorly understood. To determine whether these interactions are directly mediated by contacts between the histone H4 amino-terminal tail and the acidic patch of the H2A/H2B interface, as previously demonstrated for short range nucleosomal interactions, we have characterized the extent and effect of disulfide cross-linking between residues in histones contained in different strands of nucleosomal arrays. We show that in 208-12 5 S rDNA and 601-177-12 nucleosomal array systems, direct interactions between histones H4-V21C and H2A-E64C can be captured. This interaction depends on the extent of initial cross-strand association but does not require these specific residues, because interactions with residues flanking H4-V21C can also be captured. Additionally, we find that trapping H2A-H4 intra-array interactions antagonizes the ability of these arrays to undergo intermolecular self-association.	[Sinha, Divya; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu	Sinha, Divya/AAW-4488-2021		National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M.A.S.-K.).	Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Horn PJ, 2002, NAT STRUCT BIOL, V9, P167, DOI 10.1038/nsb762; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; van Holde K.E., 1988, CHROMATIN; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	31	50	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16572	16581		10.1074/jbc.M109.091298	http://dx.doi.org/10.1074/jbc.M109.091298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351095	Green Published, hybrid			2022-12-25	WOS:000277982600020
J	Agle, KA; Vongsa, RA; Dwinell, MB				Agle, Kimberle A.; Vongsa, Rebecca A.; Dwinell, Michael B.			Calcium Mobilization Triggered by the Chemokine CXCL12 Regulates Migration in Wounded Intestinal Epithelial Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; CELL-DERIVED FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; TYROSINE KINASE; IN-VITRO; BARRIER DYSFUNCTION; ION-TRANSPORT; RHO KINASE	Restitution of intestinal epithelial barrier damage involves the coordinated remodeling of focal adhesions in actively migrating enterocytes. Defining the extracellular mediators and the intracellular signaling pathways regulating those dynamic processes is a key step in developing restitution-targeted therapies. Previously we have determined that activation of the chemokine receptor CXCR4 by the cognate ligand CXCL12 enhances intestinal epithelial restitution through reorganization of the actin cytoskeleton. The aim of these studies was to investigate the role of calcium effectors in CXCL12-mediated restitution. CXCL12 stimulated release of intracellular calcium in a dose-dependent manner. Inhibition of intracellular calcium flux impaired CXCL12-mediated migration of IEC-6 and CaCo2 cells. Pharmacological blockade and specific shRNA depletion of the phospholipase-C (PLC beta 3) isoform attenuated CXCL12-enhanced migration, linking receptor activation with intracellular calcium flux. Immunoblot analyses demonstrated CXCL12 activated the calcium-regulated focal adhesion protein proline-rich tyrosine kinase-2 (Pyk2) and the effector proteins paxillin and p130(Cas). Interruption of Pyk2 signaling potently blocked CXCL12-induced wound closure. CXCL12-stimulated epithelial cell migration was enhanced on laminin and abrogated by intracellular calcium chelation. These results suggest CXCL12 regulates restitution through calcium-activated Pyk2 localized to active focal adhesions. Calcium signaling pathways may therefore provide a novel avenue for enhancing barrier repair.	[Agle, Kimberle A.; Vongsa, Rebecca A.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu			National Institutes of Health [DK062066]; American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062066, R56DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062066. This work was also supported by the American Recovery and Reinvestment Act of 2009.	Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Astier A, 1997, J BIOL CHEM, V272, P228; Basson MD, 2002, AM J PATHOL, V161, P1101, DOI 10.1016/S0002-9440(10)64385-4; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; BOUCEK MM, 1976, SCIENCE, V193, P905, DOI 10.1126/science.948752; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Charrier L, 2007, J BIOL CHEM, V282, P16948, DOI 10.1074/jbc.M700158200; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Glogauer M, 1997, J CELL SCI, V110, P11; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kagimoto Y, 2008, J LEUKOCYTE BIOL, V83, P165, DOI 10.1189/jlb.0307137; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V290, P1470, DOI 10.1006/bbrc.2002.6350; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Liu YW, 1998, J SURG RES, V77, P112, DOI 10.1006/jsre.1998.5369; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Malinda KM, 2008, INT J BIOCHEM CELL B, V40, P2771, DOI 10.1016/j.biocel.2008.05.025; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Polk DB, 1999, AM J PHYSIOL-CELL PH, V277, pC1149, DOI 10.1152/ajpcell.1999.277.6.C1149; Rao JN, 2006, AM J PHYSIOL-GASTR L, V290, pG782, DOI 10.1152/ajpgi.00441.2005; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Saha C, 1998, J BIOL CHEM, V273, P21629, DOI 10.1074/jbc.273.34.21629; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Sturm A, 2005, CYTOKINE, V29, P42, DOI 10.1016/j.cyto.2004.09.007; SVANES K, 1982, GASTROENTEROLOGY, V82, P1409; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Turner JR, 1999, AM J PHYSIOL-CELL PH, V277, pC554, DOI 10.1152/ajpcell.1999.277.3.C554; Veldkamp CT, 2007, PROTEIN EXPRES PURIF, V52, P202, DOI 10.1016/j.pep.2006.09.009; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001; Wu SS, 2006, CELL SIGNAL, V18, P1932, DOI 10.1016/j.cellsig.2006.02.013; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yang CC, 2005, AM J PHYSIOL-CELL PH, V288, pC321, DOI 10.1152/ajpcell.00171.2004; Yassin RR, 1998, PEPTIDES, V19, P47, DOI 10.1016/S0196-9781(97)00276-3; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	74	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16066	16075		10.1074/jbc.M109.061416	http://dx.doi.org/10.1074/jbc.M109.061416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348095	hybrid, Green Published			2022-12-25	WOS:000277715900044
J	McNaughton, L; Tikhonenko, I; Banavali, NK; LeMaster, DM; Koonce, MP				McNaughton, Lynn; Tikhonenko, Irina; Banavali, Nilesh K.; LeMaster, David M.; Koonce, Michael P.			A Low Affinity Ground State Conformation for the Dynein Microtubule Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; NMR CHEMICAL-SHIFTS; IMPROVED SENSITIVITY; COILED-COIL; BACKBONE DYNAMICS; MOTOR; STALK; C-13; N-15	Dynein interacts with microtubules through a dedicated binding domain that is dynamically controlled to achieve high or low affinity, depending on the state of nucleotide bound in a distant catalytic pocket. The active sites for microtubule binding and ATP hydrolysis communicate via conformational changes transduced through a similar to 10-nm length antiparallel coiled-coil stalk, which connects the binding domain to the roughly 300kDa motor core. Recently, an x-ray structure of the murine cytoplasmic dynein microtubule binding domain (MTBD) in a weak affinity conformation was published, containing a covalently constrained beta(+) registry for the coiled-coil stalk segment (Carter, A. P., Garbarino, J. E., Wilson-Kubalek, E. M., Shipley, W. E., Cho, C., Milligan, R. A., Vale, R. D., and Gibbons, I. R. (2008) Science 322, 1691-1695). We here present an NMR analysis of the isolated MTBD from Dictyostelium discoideum that demonstrates the coiled-coil beta(+) registry corresponds to the low energy conformation for this functional region of dynein. Addition of sequence encoding roughly half of the coiled-coil stalk proximal to the binding tip results in a decreased affinity of the MTBD for microtubules. In contrast, addition of the complete coiled-coil sequence drives the MTBD to the conformationally unstable, high affinity binding state. These results suggest a thermodynamic coupling between conformational free energy differences in the alpha and beta(+) registries of the coiled-coil stalk that acts as a switch between high and low affinity conformations of the MTBD. A balancing of opposing conformations in the stalk and MTBD enables potentially modest long-range interactions arising from ATP binding in the motor core to induce a relaxation of the MTBD into the stable low affinity state.	[McNaughton, Lynn; Tikhonenko, Irina; LeMaster, David M.; Koonce, Michael P.] Wadsworth Ctr, Div Translat Med, Albany, NY 12201 USA; [Banavali, Nilesh K.] Wadsworth Ctr, Div Genet, Albany, NY 12201 USA; [Banavali, Nilesh K.; LeMaster, David M.; Koonce, Michael P.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	Wadsworth Center; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Koonce, MP (corresponding author), Wadsworth Ctr, Div Translat Med, Empire State Plaza,POB 509, Albany, NY 12201 USA.	koonce@wadsworth.org		Banavali, Nilesh/0000-0003-2206-7049	National Institutes of Health [GM51532]; National Science Foundation l [MCB-0542731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051532, P41GM066354, R01GM051532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation l; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51532 and National Science Foundation Grant MCB-0542731 (to M. P. K.).	Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hook P, 2009, BIOCHEMISTRY-US, V48, P2710, DOI 10.1021/bi900223x; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimizu Y, 2008, J BIOMOL NMR, V41, P89, DOI 10.1007/s10858-008-9242-6; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	45	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15994	16002		10.1074/jbc.M109.083535	http://dx.doi.org/10.1074/jbc.M109.083535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351100	Green Published, hybrid			2022-12-25	WOS:000277715900037
J	Wang, AM; Morishima, Y; Clapp, KM; Peng, HM; Pratt, WB; Gestwicki, JE; Osawa, Y; Lieberman, AP				Wang, Adrienne M.; Morishima, Yoshihiro; Clapp, Kelly M.; Peng, Hwei-Ming; Pratt, William B.; Gestwicki, Jason E.; Osawa, Yoichi; Lieberman, Andrew P.			Inhibition of Hsp70 by Methylene Blue Affects Signaling Protein Function and Ubiquitination and Modulates Polyglutamine Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; BULBAR MUSCULAR-ATROPHY; HEAT-SHOCK PROTEINS; HSP90/HSP70-BASED CHAPERONE MACHINERY; ANDROGEN RECEPTOR PROTEIN; SMALL-MOLECULE MODULATORS; TRANSGENIC MOUSE MODEL; IN-VITRO; AMELIORATES PHENOTYPES; DEPENDENT DEGRADATION	The Hsp90/Hsp70-based chaperone machinery regulates the activity and degradation of many signaling proteins. Cycling with Hsp90 stabilizes client proteins, whereas Hsp70 interacts with chaperone-dependent E3 ubiquitin ligases to promote protein degradation. To probe these actions, small molecule inhibitors of Hsp70 would be extremely useful; however, few have been identified. Here we test the effects of methylene blue, a recently described inhibitor of Hsp70 ATPase activity, in three well established systems of increasing complexity. First, we demonstrate that methylene blue inhibits the ability of the purified Hsp90/Hsp70-based chaperone machinery to enable ligand binding by the glucocorticoid receptor and show that this effect is due to specific inhibition of Hsp70. Next, we establish that ubiquitination of neuronal nitric-oxide synthase by the native ubiquitinating system of reticulocyte lysate is dependent upon both Hsp70 and the E3 ubiquitin ligase CHIP and is blocked by methylene blue. Finally, we demonstrate that methylene blue impairs degradation of the polyglutamine expanded androgen receptor, an Hsp90 client mutated in spinal and bulbar muscular atrophy. In contrast, degradation of an amino-terminal fragment of the receptor, which lacks the ligand binding domain and, therefore, is not a client of the Hsp90/Hsp70-based chaperone machinery, is enhanced through homeostatic induction of autophagy that occurs when Hsp70-dependent proteasomal degradation is inhibited by methylene blue. Our data demonstrate the utility of methylene blue in defining Hsp70-dependent functions and reveal divergent effects on polyglutamine protein degradation depending on whether the substrate is an Hsp90 client.	[Wang, Adrienne M.; Gestwicki, Jason E.; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Clapp, Kelly M.; Peng, Hwei-Ming; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lieberman, AP (corresponding author), 3510 MSRB 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	liebermn@umich.edu			National Institutes of Health [GM77430, NS055746]; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS055746, R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM77430 (to Y. O.) and NS055746 (to A. P. L.). This work was also supported by a McKnight Foundation Neuroscience of Brain Disorders Award (to A. P. L.).	Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kanelakis KC, 2003, METHOD ENZYMOL, V364, P159; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LUO D, 1995, EUR J PHARM-MOLEC PH, V290, P247, DOI 10.1016/0922-4106(95)00084-4; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Mitsui K, 2002, J NEUROSCI, V22, P9267; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	72	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15714	15723		10.1074/jbc.M109.098806	http://dx.doi.org/10.1074/jbc.M109.098806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348093	Green Published, hybrid			2022-12-25	WOS:000277715900006
J	Yanagihara, I; Nakahira, K; Yamane, T; Kaieda, S; Mayanagi, K; Hamada, D; Fukui, T; Ohnishi, K; Kajiyama, S; Shimizu, T; Sato, M; Ikegami, T; Ikeguchi, M; Honda, T; Hashimoto, H				Yanagihara, Itaru; Nakahira, Kumiko; Yamane, Tsutomu; Kaieda, Shuji; Mayanagi, Kouta; Hamada, Daizo; Fukui, Takashi; Ohnishi, Kiyouhisa; Kajiyama, Shin'ichiro; Shimizu, Toshiyuki; Sato, Mamoru; Ikegami, Takahisa; Ikeguchi, Mitsunori; Honda, Takeshi; Hashimoto, Hiroshi			Structure and Functional Characterization of Vibrio parahaemolyticus Thermostable Direct Hemolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMATION; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; SINGLE PARTICLES; ALPHA-HEMOLYSIN; SCATTERING; SYSTEM; MACROMOLECULES; SOFTWARE	Thermostable direct hemolysin (TDH) is a major virulence factor of Vibrio parahaemolyticus that causes pandemic foodborne enterocolitis mediated by seafood. TDH exists as a tetramer in solution, and it possesses extreme hemolytic activity. Here, we present the crystal structure of the TDH tetramer at 1.5 angstrom resolution. The TDH tetramer forms a central pore with dimensions of 23 angstrom in diameter and similar to 50 angstrom in depth. pi-Cation interactions between protomers comprising the tetramer were indispensable for hemolytic activity of TDH. The N-terminal region was intrinsically disordered outside of the pore. Molecular dynamic simulations suggested that water molecules permeate freely through the central and side channel pores. Electron micrographs showed that tetrameric TDH attached to liposomes, and some of the tetramer associated with liposome via one protomer. These findings imply a novel membrane attachment mechanism by a soluble tetrameric pore-forming toxin.	[Yanagihara, Itaru; Nakahira, Kumiko; Hamada, Daizo; Fukui, Takashi; Ohnishi, Kiyouhisa] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi, Osaka 5941101, Japan; [Yamane, Tsutomu; Shimizu, Toshiyuki; Sato, Mamoru; Ikeguchi, Mitsunori; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan; [Kaieda, Shuji; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Lab Struct Prote, Suita, Osaka 5650871, Japan; [Mayanagi, Kouta] Osaka Univ, Inst Prot Res, Takara Bio Endowed Div, Suita, Osaka 5650871, Japan; [Mayanagi, Kouta] Japan Sci & Technol Agcy, Nagahama Inst Biosci & Technol, Shiga 5260829, Japan; [Mayanagi, Kouta] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Shiga 5260829, Japan; [Hamada, Daizo] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Struct Biol, Kobe, Hyogo 6500017, Japan; [Kajiyama, Shin'ichiro] Kinki Univ, Sch Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Suita, Osaka 5650871, Japan	Yokohama City University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe University; Kindai University (Kinki University); Osaka University	Hashimoto, H (corresponding author), 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp	Hamada, Daizo/F-3307-2011; Hamada, Daizo/N-1118-2016; Ikegami, Takahisa/I-9626-2017	Hamada, Daizo/0000-0002-1799-5476; Ikegami, Takahisa/0000-0002-1429-1844; Hashimoto, Hiroshi/0000-0003-1503-6789	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research on Child Health and Development, National Center for Child Health and Development, Japan; Next Generation Supercomputer Project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Child Health and Development, National Center for Child Health and Development, Japan; Next Generation Supercomputer Project	This study was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by a grant for Research on Child Health and Development, National Center for Child Health and Development, Japan. To whom correspondence may be addressed: 840 Murodo-cho, Izumi City, Osaka 5941101, Japan. Fax: 81-725-57-3021. E-mail: itaruy@mch.pref.osaka.jp. 2; Supported by a national project on the next generation integrated life science stimulation (Next Generation Supercomputer Project).	Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; ARRHENIUS S, 1907, IMMUNOCHEMISTRY, P187; BABA K, 1992, MICROB PATHOGENESIS, V12, P279, DOI 10.1016/0882-4010(92)90046-Q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fukui T, 2005, BIOCHEMISTRY-US, V44, P9825, DOI 10.1021/bi050311s; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hamada D, 2007, J MOL BIOL, V365, P187, DOI 10.1016/j.jmb.2006.09.070; Hardy SP, 2004, FEMS MICROBIOL LETT, V240, P81, DOI 10.1016/j.femsle.2004.09.015; Hashido M, 2005, FEBS LETT, V579, P5549, DOI 10.1016/j.febslet.2005.09.018; Honda T., 2008, MICROBE, V3, P462; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iida T, 1997, J TOXICOL-TOXIN REV, V16, P215, DOI 10.3109/15569549709016457; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MIWATANI T, 1972, INFECT IMMUN, V6, P1031, DOI 10.1128/IAI.6.6.1031-1033.1972; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Takahashi A, 2006, INT J TOXICOL, V25, P409, DOI 10.1080/10915810600868181; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	38	45	51	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16267	16274		10.1074/jbc.M109.074526	http://dx.doi.org/10.1074/jbc.M109.074526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335168	hybrid, Green Published			2022-12-25	WOS:000277715900063
J	Nishida, M; Suda, R; Nagamatsu, Y; Tanabe, S; Onohara, N; Nakaya, M; Kanaho, Y; Shibata, T; Uchida, K; Sumimoto, H; Sato, Y; Kurose, H				Nishida, Motohiro; Suda, Reiko; Nagamatsu, Yuichi; Tanabe, Shihori; Onohara, Naoya; Nakaya, Michio; Kanaho, Yasunori; Shibata, Takahiro; Uchida, Koji; Sumimoto, Hideki; Sato, Yoji; Kurose, Hitoshi			Pertussis Toxin Up-regulates Angiotensin Type 1 Receptors through Toll-like Receptor 4-mediated Rac Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; SIGNAL-TRANSDUCTION; VENTRICULAR MYOCYTES; DEPENDENT ACTIVATION; CARDIAC FIBROBLASTS; DOWN-REGULATION; PROTEIN-KINASE; MESSENGER-RNA	Pertussis toxin (PTX) is recognized as a specific tool that uncouples receptors from G(i) and Go through ADP-ribosylation. During the study analyzing the effects of PTX on Ang II type 1 receptor (AT1R) function in cardiac fibroblasts, we found that PTX increases the number of AT1Rs and enhances AT1R-mediated response. Microarray analysis revealed that PTX increases the induction of interleukin (IL)-1 beta among cytokines. Inhibition of IL-1 beta suppressed the enhancement of AT1R-mediated response by PTX. PTX increased the expression of IL-1 beta and AT1R through NF-kappa B, and a small GTP-binding protein, Rac, mediated PTX-induced NF-kappa B activation through NADPH oxidase-dependent production of reactive oxygen species. PTX induced biphasic increases in Rac activity, and the Rac activation in a late but not an early phase was suppressed by IL-1 beta siRNA, suggesting that IL-1 beta-induced Rac activation contributes to the amplification of Rac-dependent signaling induced by PTX. Furthermore, inhibition of TLR4 (Toll-like receptor 4) abolished PTX-induced Rac activation and enhancement of AT1R function. However, ADP-ribosylation of G(i)/G(o) by PTX was not affected by inhibition of TLR4. Thus, PTX binds to two receptors; one is TLR4, which activates Rac, and another is the binding site that is required for ADP-ribosylation of G(i)/G(o).	[Nishida, Motohiro; Suda, Reiko; Nagamatsu, Yuichi; Onohara, Naoya; Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan; [Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 8128582, Japan; [Tanabe, Shihori; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Kyushu University; Kyushu University; National Institute of Health Sciences - Japan; University of Tsukuba; University of Tsukuba; Nagoya University	Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp	Tanabe, Shihori/AAH-6584-2019; Shibata, Takahiro/I-6872-2014	Tanabe, Shihori/0000-0003-3706-0616; Uchida, Koji/0000-0003-3894-5299; Nishida, Motohiro/0000-0002-2587-5458; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nakatomi Foundation; Sapporo Bioscience Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation; Sapporo Bioscience Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Nishida, M. Nakaya, and H. K.); a grant-in-aid for scientific research on Innovative Areas (to M. Nishida); a grant-in-aid for scientific research on Priority Areas (to H. K.); and grants from the Nakatomi Foundation, Sapporo Bioscience Foundation, and Naito Foundation (to M. Nishida).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bai H, 2004, CHINESE MED J-PEKING, V117, P88; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chiloeches A, 1999, J BIOL CHEM, V274, P19762, DOI 10.1074/jbc.274.28.19762; Cowling RT, 2005, AM J PHYSIOL-HEART C, V289, pH1176, DOI 10.1152/ajpheart.00088.2005; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Griendling KK, 2000, REGUL PEPTIDES, V91, P21, DOI 10.1016/S0167-0115(00)00136-1; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Ichiki T, 2001, ARTERIOSCL THROM VAS, V21, P1896, DOI 10.1161/hq1201.099430; Ichiki T, 2001, HYPERTENSION, V37, P535, DOI 10.1161/01.HYP.37.2.535; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255; Ju HS, 1998, CIRCULATION, V97, P892, DOI 10.1161/01.CIR.97.9.892; Kaiser P, 2004, ANIM GENET, V35, P169, DOI 10.1111/j.1365-2052.2004.01121.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KATADA T, 1982, J BIOL CHEM, V257, P7210; KUROSE H, 1993, MOL PHARMACOL, V43, P444; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LANDO Z, 1980, NATURE, V287, P551, DOI 10.1038/287551a0; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Li H, 2001, BIOCHEM BIOPH RES CO, V283, P1077, DOI 10.1006/bbrc.2001.4910; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Melien O, 2000, J CELL PHYSIOL, V184, P27, DOI 10.1002/(SICI)1097-4652(200007)184:1<27::AID-JCP3>3.0.CO;2-Q; MONKS BG, 1994, MOL IMMUNOL, V31, P139, DOI 10.1016/0161-5890(94)90086-8; Nagamatsu Y, 2006, J PHARMACOL SCI, V101, P144, DOI 10.1254/jphs.FP0051036; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Peng JF, 2002, CIRC RES, V91, P1119, DOI 10.1161/01.RES.0000047090.08299.D5; Pracyk JB, 1998, J CLIN INVEST, V102, P929, DOI 10.1172/JCI2552; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sakata Y, 1998, CIRCULATION, V97, P1488; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; TAMURA M, 1983, J BIOL CHEM, V258, P6756; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; VILLARREAL FJ, 1993, CIRCULATION, V88, P2849, DOI 10.1161/01.CIR.88.6.2849; Wang ZY, 2006, EXP HEMATOL, V34, P1115, DOI 10.1016/j.exphem.2006.04.025; Yamani MH, 2004, AM J TRANSPLANT, V4, P1097, DOI 10.1111/j.1600-6143.2004.00463.x; Zocchi MR, 2005, J IMMUNOL, V174, P6054, DOI 10.4049/jimmunol.174.10.6054	61	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15268	15277		10.1074/jbc.M109.076232	http://dx.doi.org/10.1074/jbc.M109.076232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20231290	Green Published, hybrid			2022-12-25	WOS:000277399000047
J	Noda, Y; Yoda, K				Noda, Yoichi; Yoda, Koji			Svp26 Facilitates Endoplasmic Reticulum to Golgi Transport of a Set of Mannosyltransferases in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST GOLGI; MEMBRANE-PROTEIN; ALKALINE-PHOSPHATASE; CARGO BINDING; COPII; COMPLEX; COAT; VESICLES; ER; GLYCOSYLTRANSFERASES	Svp26 is a polytopic integral membrane protein found in the ER and early Golgi compartment. In the Delta svp26 cell, the Golgi mannosyltransferase Ktr3 remains in the ER. Here, we report that two other Golgi mannosyltransferases, Mnn2 and Mnn5 are also mislocalized and found in the ER in the absence of Svp26 and that localization of other mannosyltransferases including Mnn1 are not affected. Mnn2 and Mnn5 bind to Svp26 in vivo as Ktr3 does. Using an in vitro budding assay, the incorporation of Ktr3 and Mnn2 in the COPII vesicles is greatly stimulated by the presence of Svp26. As Svp26 itself is an efficient cargo, Svp26 is likely to support selective incorporation of a set of mannosyltransferases into COPII vesicles by working as their adaptor protein. The domain switching between Svp26-dependent Mnn2 or Ktr3 and Svp26-independent Mnn1 suggests that the lumenal domain of mannosyltransferases, but not the cytoplasmic or transmembrane domain, is responsible for recognition by Svp26.	[Noda, Yoichi; Yoda, Koji] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science; RIKEN Institute of Japan; Noda Institute of Scientific Research	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Institute of Japan; Noda Institute of Scientific Research(Noda Institute for Scientific Research)	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to Y. N. and K. Y.), a grant from the RIKEN Institute of Japan (to K. Y.), and a grant from the Noda Institute of Scientific Research (to Y. N. and K. Y.).	Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bue CA, 2006, MOL BIOL CELL, V17, P4780, DOI 10.1091/mbc.E06-05-0455; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; GRAHAM TR, 1994, J CELL BIOL, V127, P667, DOI 10.1083/jcb.127.3.667; Hashimoto H, 1997, BIOCHEM BIOPH RES CO, V241, P682, DOI 10.1006/bbrc.1997.7888; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Pelham HRB, 1998, TRENDS CELL BIOL, V8, P45, DOI 10.1016/S0962-8924(97)01185-9; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	32	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15420	15429		10.1074/jbc.M109.086272	http://dx.doi.org/10.1074/jbc.M109.086272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20236934	hybrid, Green Published			2022-12-25	WOS:000277399000062
J	Wu, JC; Lei, GH; Mei, M; Tang, Y; Li, HL				Wu, Jianchun; Lei, Guohua; Mei, Mei; Tang, Yi; Li, Honglin			A Novel C53/LZAP-interacting Protein Regulates Stability of C53/LZAP and DDRGK Domain-containing Protein 1 (DDRGK1) and Modulates NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; TUMOR-SUPPRESSOR; PROSTATE-CANCER; CHECKPOINT; INITIATION; DELETION; 6Q	C53/LZAP (also named as Cdk5rap3) is a putative tumor suppressor that plays important roles in multiple cell signaling pathways, including DNA damage response and NF-kappa B signaling. Yet how its function is regulated remains largely unclear. Here we report the isolation and characterization of two novel C53/LZAP-interacting proteins, RCAD (Regulator of C53/LZAP and DDRGK1) and DDRGK1 (DDRGK domain-containing protein 1). Our co-immunoprecipitation assays confirmed their interactions, while gel filtration assay indicated that C53/LZAP and RCAD may form a large protein complex. Intriguingly, we found that RCAD knockdown led to dramatic reduction of C53/LZAP and DDRGK1 proteins. We also found that C53/LZAP and DDRGK1 became more susceptible to the proteasome-mediated degradation in RCAD knockdown cells, whereas their ubiquitination was significantly attenuated by RCAD overexpression. In addition, we found that RCAD, like C53/LZAP, also plays an important role in regulation of NF-kappa B signaling and cell invasion. Taken together, our findings strongly suggest that RCAD is a novel regulator of C53/LZAP tumor suppressor and NF-kappa B signaling.	[Wu, Jianchun; Lei, Guohua; Mei, Mei; Tang, Yi; Li, Honglin] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Childrens Mem Res Ctr, Chicago, IL 60614 USA	Northwestern University; Feinberg School of Medicine	Li, HL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, Childrens Mem Res Ctr, 2430 N Halsted St, Chicago, IL 60614 USA.	h-li2@northwestern.edu	Wu, Jianchun/AAX-3533-2020	Wu, Jianchun/0000-0002-8473-9368	National Institutes of Health [R01 GM081776]; Children's Memorial Research Center; Clarke family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Memorial Research Center; Clarke family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM081776 (to H. L.), the Children's Memorial Research Center, and the Clarke family.	ABRAN D, 1992, EXP EYE RES, V54, P737, DOI 10.1016/0014-4835(92)90029-R; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Li BCY, 2003, DIAGN MOL PATHOL, V12, P193, DOI 10.1097/00019606-200312000-00003; Lu T, 2008, PROSTATE CANCER P D, V11, P357, DOI 10.1038/pcan.2008.4; NEZIRI D, 2009, BIOCHIM BIOPHYS ACTA, V1800, P430; Saito S, 2006, ONCOL REP, V16, P949; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sun M, 2006, DNA CELL BIOL, V25, P597, DOI 10.1089/dna.2006.25.597; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; van Gils W, 2008, MELANOMA RES, V18, P10, DOI 10.1097/CMR.0b013e3282f1d4d9; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; YORKE MA, 1985, CELL TISSUE RES, V241, P629	18	73	80	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15126	15136		10.1074/jbc.M110.110619	http://dx.doi.org/10.1074/jbc.M110.110619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228063	Green Published, hybrid			2022-12-25	WOS:000277399000034
J	Latifi-Navid, S; Ghorashi, SA; Siavoshi, F; Linz, B; Massarrat, S; Khegay, T; Salmanian, AH; Shayesteh, AA; Masoodi, M; Ghanadi, K; Ganji, A; Suerbaum, S; Achtman, M; Malekzadeh, R; Falush, D				Latifi-Navid, Saeid; Ghorashi, Seyed Ali; Siavoshi, Farideh; Linz, Bodo; Massarrat, Sadegh; Khegay, Tanya; Salmanian, Ali-Hatef; Shayesteh, Ali Akbar; Masoodi, Mohsen; Ghanadi, Koroush; Ganji, Azita; Suerbaum, Sebastian; Achtman, Mark; Malekzadeh, Reza; Falush, Daniel			Ethnic and Geographic Differentiation of Helicobacter pylori within Iran	PLOS ONE			English	Article							RECOMBINATION; POPULATIONS; PREVALENCE; INFERENCE; HUMANS	The bacterium Helicobacter pylori colonizes the human stomach, with individual infections persisting for decades. The spread of the bacterium has been shown to reflect both ancient and recent human migrations. We have sequenced housekeeping genes from H. pylori isolated from 147 Iranians with well-characterized geographical and ethnic origins sampled throughout Iran and compared them with sequences from strains from other locations. H. pylori from Iran are similar to others isolated from Western Eurasia and can be placed in the previously described HpEurope population. Despite the location of Iran at the crossroads of Eurasia, we found no evidence that the region been a major source of ancestry for strains across the continent. On a smaller scale, we found genetic affinities between the H. pylori isolated from particular Iranian populations and strains from Turks, Uzbeks, Palestinians and Israelis, reflecting documented historical contacts over the past two thousand years.	[Latifi-Navid, Saeid; Ghorashi, Seyed Ali] Natl Inst Genet Engn & Biotechnol, Dept Bacteriol & Virol, Tehran, Iran; [Latifi-Navid, Saeid; Massarrat, Sadegh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Siavoshi, Farideh] Univ Tehran, Coll Sci, Sch Biol, Dept Microbiol, Tehran, Iran; [Linz, Bodo] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Khegay, Tanya] Uzbek Acad Sci, Inst Immunol, Tashkent 700135, Uzbekistan; [Salmanian, Ali-Hatef] Natl Inst Genet Engn & Biotechnol, Dept Plant Mol Biol, Tehran, Iran; [Shayesteh, Ali Akbar] Ahvaz Jundishapur Univ Med Sci, Imam Khomeini Hosp, Dept Internal Med, Ahvaz, Iran; [Masoodi, Mohsen] Iran Univ Med Sci, GILDRC, Dept Internal Med, Tehran, Iran; [Masoodi, Mohsen] Hormozgan Univ Med Sci, Trop & Infect Dis Res Ctr, Bandar Abbas, Iran; [Ghanadi, Koroush] Lorestan Univ Med Sci, Khorramabad, Iran; [Ganji, Azita] MUMS, Imam Reza Hosp, Dept Gastroenterol, Mashhad, Iran; [Suerbaum, Sebastian] Hannover Med Sch, Inst Med Mikrobiol, D-30623 Hannover, Germany; [Suerbaum, Sebastian] Krankenhaushyg, Hannover, Germany; [Achtman, Mark; Falush, Daniel] Univ Coll Cork, Environm Res Inst, Dept Microbiol, Cork, Ireland	Tehran University of Medical Sciences; University of Tehran; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Academy of Sciences of Uzbekistan; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Iran University of Medical Sciences; Lorestan University of Medical Sciences; Mashhad University Medical Science; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University College Cork	Latifi-Navid, S (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Bacteriol & Virol, Tehran, Iran.	D.Falush@ucc.ie	shayesteh, ali akbar/R-1791-2017; ghanadi, kourosh/P-2513-2016; Masoodi, Mohsen/AAM-6102-2020; Ghorashi, Seyed A/C-1529-2016; Ganji, Azita/AAW-7769-2020; salmanian, ali hatef/ABC-6202-2021; Malekzadeh, Reza/U-1382-2017; Guttman, David S/A-7839-2011; Latifi-Navid, Saeid/Q-1680-2016	shayesteh, ali akbar/0000-0002-7636-1369; ghanadi, kourosh/0000-0002-0990-9590; Masoodi, Mohsen/0000-0001-8471-9220; Ghorashi, Seyed A/0000-0002-9820-5308; Ganji, Azita/0000-0002-8161-6629; salmanian, ali hatef/0000-0002-9984-7441; Malekzadeh, Reza/0000-0002-9820-6335; Guttman, David S/0000-0001-8479-3869; Latifi-Navid, Saeid/0000-0002-6838-9425; Achtman, Mark/0000-0001-6815-0070; Hegay, Tatyana/0000-0003-4764-0841; Malekzadeh, Reza/0000-0003-1043-3814	research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences [301/166]; Science Foundation of Ireland [05/FE1/B882]; Volkswagen Foundation	research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences(Tehran University of Medical Sciences); Science Foundation of Ireland(Science Foundation Ireland); Volkswagen Foundation(Volkswagen)	This study was funded by the research council of Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences grant 301/166 and by Science Foundation of Ireland grant 05/FE1/B882 and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Jackson Peter, 1986, CAMBRIDGE HIST IRAN; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu YZ, 2002, APPL ENVIRON MICROB, V68, P1436, DOI 10.1128/AEM.68.3.1436-1439.2002; Malekzadeh R, 2004, J CLIN PATHOL, V57, P37, DOI 10.1136/jcp.57.1.37; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MASSARRAT S, 1995, EUR J GASTROEN HEPAT, V7, P427; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; MORONY M, 2006, CTR IRANIAN STUDIES; Nasidze I, 2008, ANN HUM GENET, V72, P241, DOI 10.1111/j.1469-1809.2007.00413.x; Nouraie M, 2009, HELICOBACTER, V14, P40, DOI 10.1111/j.1523-5378.2009.00657.x; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; SAVORY RM, 1980, IRAN UNDER SAFAVIDS; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101	26	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9645	10.1371/journal.pone.0009645	http://dx.doi.org/10.1371/journal.pone.0009645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339588	gold, Green Published, Green Submitted			2022-12-25	WOS:000275894300001
J	Middelbos, IS; Boler, BMV; Qu, A; White, BA; Swanson, KS; Fahey, GC				Middelbos, Ingmar S.; Boler, Brittany M. Vester; Qu, Ani; White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.			Phylogenetic Characterization of Fecal Microbial Communities of Dogs Fed Diets with or without Supplemental Dietary Fiber Using 454 Pyrosequencing	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SMALL-INTESTINE; GUT MICROBIOME; DIVERSITY; OBESITY; METAGENOMICS; POPULATIONS; IMBALANCES; DIGESTA; ENERGY	Background: Dogs suffer from many of the same maladies as humans that may be affected by the gut microbiome, but knowledge of the canine microbiome is incomplete. This work aimed to use 16S rDNA tag pyrosequencing to phylogenetically characterize hindgut microbiome in dogs and determine how consumption of dietary fiber affects community structure. Principal Findings: Six healthy adult dogs were used in a crossover design. A control diet without supplemental fiber and a beet pulp-supplemented (7.5%) diet were fed. Fecal DNA was extracted and the V3 hypervariable region of the microbial 16S rDNA gene amplified using primers suitable for 454-pyrosequencing. Microbial diversity was assessed on random 2000-sequence subsamples of individual and pooled DNA samples by diet. Our dataset comprised 77,771 reads with an average length of 141 nt. Individual samples contained approximately 129 OTU, with Fusobacteria (23-40% of reads), Firmicutes (14 -28% of reads) and Bacteroidetes (31-34% of reads) being co- dominant phyla. Feeding dietary fiber generally decreased Fusobacteria and increased Firmicutes, but these changes were not equally apparent in all dogs. UniFrac analysis revealed that structure of the gut microbiome was affected by diet and Firmicutes appeared to play a strong role in by-diet clustering. Conclusions: Our data suggest three co- dominant bacterial phyla in the canine hindgut. Furthermore, a relatively small amount of dietary fiber changed the structure of the gut microbiome detectably. Our data are among the first to characterize the healthy canine gut microbiome using pyrosequencing and provide a basis for studies focused on devising dietary interventions for microbiome-associated diseases.	[Middelbos, Ingmar S.; Boler, Brittany M. Vester; Qu, Ani; White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.; Swanson, Kelly S.; Fahey, George C., Jr.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Qu, Ani; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Middelbos, IS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	gcfahey@illinois.edu		Swanson, Kelly/0000-0001-5518-3076	Illinois Agricultural Experiment Station	Illinois Agricultural Experiment Station	This work was funded by the Illinois Agricultural Experiment Station (http://home.aces.uiuc.edu/ACES_Research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; DAVIS CP, 1977, APPL ENVIRON MICROB, V34, P194, DOI 10.1128/AEM.34.2.194-206.1977; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAHEY GC, 1990, J ANIM SCI, V68, P4221; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; SUCHODOLSKI JS, 2005, THESIS TEXAS A M U C; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YQ, 2009, AUTOMAT SOFTW ENG, V16, P3, DOI 10.1007/s10515-008-0042-8; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	44	169	176	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9768	10.1371/journal.pone.0009768	http://dx.doi.org/10.1371/journal.pone.0009768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339542	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894300012
J	Vellutini, BC; Migotto, AE				Vellutini, Bruno C.; Migotto, Alvaro E.			Embryonic, Larval, and Juvenile Development of the Sea Biscuit Clypeaster subdepressus (Echinodermata: Clypeasteroida)	PLOS ONE			English	Article							SAND DOLLAR; ECHINOIDS; EVOLUTION; URCHIN; METAMORPHOSIS; GASTRULATION; ORIGIN; PERIOD	Sea biscuits and sand dollars diverged from other irregular echinoids approximately 55 million years ago and rapidly dispersed to oceans worldwide. A series of morphological changes were associated with the occupation of sand beds such as flattening of the body, shortening of primary spines, multiplication of podia, and retention of the lantern of Aristotle into adulthood. To investigate the developmental basis of such morphological changes we documented the ontogeny of Clypeaster subdepressus. We obtained gametes from adult specimens by KCl injection and raised the embryos at 26 degrees C. Ciliated blastulae hatched 7.5 h after sperm entry. During gastrulation the archenteron elongated continuously while ectodermal red-pigmented cells migrated synchronously to the apical plate. Pluteus larvae began to feed in 3 d and were similar to 20 d old at metamorphosis; starved larvae died 17 d after fertilization. Postlarval juveniles had neither mouth nor anus nor plates on the aboral side, except for the remnants of larval spicules, but their bilateral symmetry became evident after the resorption of larval tissues. Ossicles of the lantern were present and organized in 5 groups. Each group had 1 tooth, 2 demipyramids, and 2 epiphyses with a rotula in between. Early appendages consisted of 15 spines, 15 podia (2 types), and 5 sphaeridia. Podial types were distributed in accordance to Loven's rule and the first podium of each ambulacrum was not encircled by the skeleton. Seven days after metamorphosis juveniles began to feed by rasping sand grains with the lantern. Juveniles survived in laboratory cultures for similar to 9 months and died with <500 mu m wide, a single open sphaeridium per ambulacrum, aboral anus, and no differentiated food grooves or petaloids. Tracking the morphogenesis of early juveniles is a necessary step to elucidate the developmental mechanisms of echinoid growth and important groundwork to clarify homologies between irregular urchins.	[Vellutini, Bruno C.; Migotto, Alvaro E.] Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil; [Vellutini, Bruno C.; Migotto, Alvaro E.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Vellutini, BC (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Sebastiao, SP, Brazil.	organelas@gmail.com	Migotto, Alvaro E/D-3748-2011; Vellutini, Bruno C./H-3831-2019	Migotto, Alvaro E/0000-0003-3887-1947; Vellutini, Bruno C./0000-0002-0000-9465	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/01898-7]; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305608/2006-1]	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Master's degree scholarship to BCV funded by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo http://www.fapesp.br/ (06/01898-7) and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior http://www.capes.gov.br/. AEM is funded by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://www.cnpq.br/ (305608/2006-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, SEA STARS SEA URCHIN; BURKE RD, 1980, J EXP MAR BIOL ECOL, V47, P223, DOI 10.1016/0022-0981(80)90040-4; CALDWELL JW, 1972, THESIS U FLORIDA; CAMERON RA, 1982, MAR BIOL, V71, P197, DOI 10.1007/BF00394630; CHIA FS, 1977, J EXP MAR BIOL ECOL, V27, P187, DOI 10.1016/0022-0981(77)90138-1; DAVID B, 1995, P 4 EUR C ECH LOND R, P155; EMLET RB, 1986, J EXP MAR BIOL ECOL, V95, P183, DOI 10.1016/0022-0981(86)90202-9; Gordon I, 1926, PHILOS T R SOC LON B, V214, P259, DOI 10.1098/rstb.1926.0007; Gordon I, 1929, PHILOS T R SOC LON B, V217, P289, DOI 10.1098/rstb.1929.0005; GORDON ISABELLA, 1926, PHIL TRANS ROY SOC LONDON B, V215, P255; Gosselin P, 1998, ZOOMORPHOLOGY, V118, P31, DOI 10.1007/s004350050054; Hart MW, 2002, EVOL DEV, V4, P62, DOI 10.1046/j.1525-142x.2002.01052.x; KIER P M, 1977, Paleobiology, V3, P168; KIER PM, 1982, PALAEONTOLOGY, V25, P1; Miller BA, 1999, J EXP MAR BIOL ECOL, V235, P67, DOI 10.1016/S0022-0981(98)00164-6; Miner BG, 2005, J EXP MAR BIOL ECOL, V321, P135, DOI 10.1016/j.jembe.2005.01.008; MOOI R, 1990, PALEOBIOLOGY, V16, P25, DOI 10.1017/S0094837300009714; MOOI R, 1994, ECHINODERMS THROUGH TIME, P87; MOOI R, 1986, ZOOMORPHOLOGY, V106, P75, DOI 10.1007/BF00312110; Mortensen T, 1948, MONOGRAPH ECHINOIDEA; Netto LF, 2005, REV BIOL TROP, V53, P207; Nunes CDP, 2007, ZOOMORPHOLOGY, V126, P103, DOI 10.1007/s00435-007-0032-6; Pearse John S., 1991, P513; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Rasband W., 2006, IMAGEJ; Reitzel AM, 2007, EVOL ECOL RES, V9, P109; Saucede T, 2007, GEOL MAG, V144, P333, DOI 10.1017/S0016756806003001; Smith AB, 2001, PALEOBIOLOGY, V27, P392, DOI 10.1666/0094-8373(2001)027<0392:PTCOOC>2.0.CO;2; Smith MS, 2007, BIOESSAYS, V29, P566, DOI 10.1002/bies.20579; Strathmann MF, 1987, REPROD DEV MARINE IN; Takata H, 2004, ZOOL SCI, V21, P1025, DOI 10.2108/zsj.21.1025; Takata H, 2004, DEV GROWTH DIFFER, V46, P23; TELFORD M, 1987, BIOL BULL, V172, P324, DOI 10.2307/1541712; TOMMASI L. R., 1966, CONTRIB AVULSAS INST OCEANOGR [SAO PAULA], V11, P1; Wray Gregory A., 1997, P309; Zigler KS, 2008, BIOL BULL-US, V215, P191, DOI 10.2307/25470700	36	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9654	10.1371/journal.pone.0009654	http://dx.doi.org/10.1371/journal.pone.0009654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339592	gold, Green Submitted, Green Published			2022-12-25	WOS:000275894300002
J	Rapaport, D; Lugassy, Y; Sprecher, E; Horowitz, M				Rapaport, Debora; Lugassy, Yevgenia; Sprecher, Eli; Horowitz, Mia			Loss of SNAP29 Impairs Endocytic Recycling and Cell Motility	PLOS ONE			English	Article							EARLY ENDOSOMAL TRANSPORT; MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; SNARE PROTEIN; EHD PROTEINS; C-ELEGANS; TRAFFICKING; MIGRATION	Intracellular membrane trafficking depends on the ordered formation and consumption of transport intermediates and requires that membranes fuse with each other in a tightly regulated and highly specific manner. Membrane anchored SNAREs assemble into SNARE complexes that bring membranes together to promote fusion. SNAP29 is a ubiquitous synaptosomal-associated SNARE protein. It interacts with several syntaxins and with the EH domain containing protein EHD1. Loss of functional SNAP29 results in CEDNIK syndrome (Cerebral Dysgenesis, Neuropathy, Ichthyosis and Keratoderma). Using fibroblast cell lines derived from CEDNIK patients, we show that SNAP29 mediates endocytic recycling of transferrin and beta 1-integrin. Impaired beta 1-integrin recycling affected cell motility, as reflected by changes in cell spreading and wound healing. No major changes were detected in exocytosis of VSVG protein from the Golgi apparatus, although the Golgi system acquired a dispersed morphology in SNAP29 deficient cells. Our results emphasize the importance of SNAP29 mediated membrane fusion in endocytic recycling and consequently, in cell motility.	[Rapaport, Debora; Horowitz, Mia] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; [Sprecher, Eli] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-69978 Tel Aviv, Israel; [Lugassy, Yevgenia; Sprecher, Eli] Rappaport Inst, Ctr Translat Genet, Haifa, Israel; [Lugassy, Yevgenia; Sprecher, Eli] Technion Israel Inst Technol, Haifa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Rapaport, D (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	horwitzm@post.tau.ac.il			Foundation for Ichthiosis and Related Skin Disorders (FIRST); Israeli Ministry of Health; Jacqueline Seroussi Foundation	Foundation for Ichthiosis and Related Skin Disorders (FIRST); Israeli Ministry of Health; Jacqueline Seroussi Foundation	This work was supported by grants from the Foundation for Ichthiosis and Related Skin Disorders (FIRST) and from the Israeli Ministry of Health, and by a grant from the Jacqueline Seroussi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; ETAIN B, 2009, MOL PSYCHIAT; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; HENDERSON IC, 1974, CELL, V3, P65, DOI 10.1016/0092-8674(74)90041-5; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; Pierini LM, 2000, BLOOD, V95, P2471; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Sakai K, 2007, EXP DERMATOL, V16, P920, DOI 10.1111/j.1600-0625.2007.00614.x; Schardt A, 2009, J NEUROSCI RES, V87, P3465, DOI 10.1002/jnr.22005; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	54	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9759	10.1371/journal.pone.0009759	http://dx.doi.org/10.1371/journal.pone.0009759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305790	Green Published, Green Submitted, gold			2022-12-25	WOS:000276456300008
J	Tendulkar, AV; Krallinger, M; de la Torre, V; Lopez, G; Wangikar, PP; Valencia, A				Tendulkar, Ashish V.; Krallinger, Martin; de la Torre, Victor; Lopez, Gonzalo; Wangikar, Pramod P.; Valencia, Alfonso			FragKB: Structural and Literature Annotation Resource of Conserved Peptide Fragments and Residues	PLOS ONE			English	Article							DATABASE; PROTEINS; LOOPS	Background: FragKB (Fragment Knowledge-base) is a repository of clusters of structurally similar fragments from proteins. Fragments are annotated with information at the level of sequence, structure and function, integrating biological descriptions derived from multiple existing resources and text mining. Methodology: FragKB contains approximately 400,000 conserved fragments from 4,800 representative proteins from PDB. Literature annotations are extracted from more than 1,700 articles and are available for over 12,000 fragments. The underlying systematic annotation workflow of FragKB ensures efficient update and maintenance of this database. The information in FragKB can be accessed through a web interface that facilitates sequence and structural visualization of fragments together with known literature information on the consequences of specific residue mutations and functional annotations of proteins and fragment clusters. FragKB is accessible online at http://ubio.bioinfo.cnio.es/biotools/fragkb/. Significance: The information presented in FragKB can be used for modeling protein structures, for designing novel proteins and for functional characterization of related fragments. The current release is focused on functional characterization of proteins through inspection of conservation of the fragments.	[Tendulkar, Ashish V.; Krallinger, Martin; de la Torre, Victor; Lopez, Gonzalo; Valencia, Alfonso] Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Centro Nacional de Investigaciones Oncologicas (CNIO); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Tendulkar, AV (corresponding author), Spanish Natl Canc Ctr, Struct Biol & Biocomp Programme, Madrid, Spain.	avtendulkar@cnio.es	Krallinger, Martin/I-2599-2015; Valencia, Alfonso/I-3127-2015; Lopez, Gonzalo/AAG-1169-2019	Valencia, Alfonso/0000-0002-8937-6789; Lopez, Gonzalo/0000-0002-5092-1284; Krallinger, Martin/0000-0002-2646-8782	Spanish projects CONSOLIDER [CSD2007-00050, RED ISCIII: RD07/0067/0014, BIO2007-66855]; Spanish Bioinformatics Institute	Spanish projects CONSOLIDER; Spanish Bioinformatics Institute	This work was funded by the Spanish projects CONSOLIDER: CSD2007-00050, RED ISCIII: RD07/0067/0014 and BIO2007-66855 2007 - 2012. Several of the services used are supported by the Spanish Bioinformatics Institute (www.inab.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Ausiello G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-182; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Burke DF, 2000, BIOINFORMATICS, V16, P513, DOI 10.1093/bioinformatics/16.6.513; BURNS G, 2009, NATURE PRECEDINGS; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Espadaler J, 2004, NUCLEIC ACIDS RES, V32, pD185, DOI 10.1093/nar/gkh002; HULO N, 2008, NUCLEIC ACIDS RES, V245, P20; Karuppasamy M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r52; Kasuya A, 1999, J MOL BIOL, V286, P1673, DOI 10.1006/jmbi.1999.2581; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pD219, DOI 10.1093/nar/gkl897; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; OLDFIELD TJ, 1994, PROTEINS, V18, P324, DOI 10.1002/prot.340180404; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P197, DOI 10.1093/nar/24.1.197; Tendulkar AV, 2005, BIOINFORMATICS, V21, P3622, DOI 10.1093/bioinformatics/bti621; Tendulkar AV, 2004, J MOL BIOL, V338, P611, DOI 10.1016/j.jmb.2004.02.047; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Velankar S, 2005, NUCLEIC ACIDS RES, V33, pD262, DOI 10.1093/nar/gki058	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2010	5	3							e9679	10.1371/journal.pone.0009679	http://dx.doi.org/10.1371/journal.pone.0009679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580NO	20305778	Green Submitted, gold, Green Published			2022-12-25	WOS:000276456300002
J	Vroom, PS; Braun, CL				Vroom, Peter S.; Braun, Cristi L.			Benthic Composition of a Healthy Subtropical Reef: Baseline Species-Level Cover, with an Emphasis on Algae, in the Northwestern Hawaiian Islands	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; CORAL-REEFS; COMMUNITY STRUCTURE; PHASE-SHIFTS; ASSEMBLAGES; SCALE; DEGRADATION; HERBIVORY; ABUNDANCE; TURNOVER	The Northwestern Hawaiian Islands (NWHI) are considered to be among the most pristine coral reef ecosystems remaining on the planet. These reefs naturally contain a high percent cover of algal functional groups with relatively low coral abundance and exhibit thriving fish communities dominated by top predators. Despite their highly protected status, these reefs are at risk from both direct and indirect anthropogenic sources. This study provides the first comprehensive data on percent coverage of algae, coral, and non-coral invertebrates at the species level, and investigates spatial diversity patterns across the archipelago to document benthic communities before further environmental changes occur in response to global warming and ocean acidification. Monitoring studies show that non-calcified macroalgae cover a greater percentage of substrate than corals on many high latitude reef sites. Forereef habitats in atoll systems often contain high abundances of the green macroalga Microdictyon setchellianum and the brown macroalga Lobophora variegata, yet these organisms were uncommon in forereefs of non-atoll systems. Species of the brown macroalgal genera Padina, Sargassum, and Stypopodium and the red macroalgal genus Laurencia became increasingly common in the two northernmost atolls of the island chain but were uncommon components of more southerly islands. Conversely, the scleractinian coral Porites lobata was common on forereefs at southern islands but less common at northern islands. Currently accepted paradigms of what constitutes a "healthy'' reef may not apply to the subtropical NWHI, and metrics used to gauge reef health (e. g., high coral cover) need to be reevaluated.	[Vroom, Peter S.; Braun, Cristi L.] NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA	Vroom, PS (corresponding author), NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	Peter.Vroom@noaa.gov			National Oceanic and Atmospheric Administration (NOAA); Pacific Island Fisheries Science Center (PIFSC); Coral Reef Ecosystem Division (CRED)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Pacific Island Fisheries Science Center (PIFSC); Coral Reef Ecosystem Division (CRED)	Funding to the National Oceanic and Atmospheric Administration (NOAA) Pacific Island Fisheries Science Center (PIFSC) Coral Reef Ecosystem Division (CRED) for scientific expeditions to the Northwestern Hawai'ian Islands was provided through NOAA's Coral Reef Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2003, CORAL REEFS, V22, P256, DOI 10.1007/s00338-003-0309-2; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Boland Raymond, 2006, Atoll Research Bulletin, P461; BRAINARD R, 2008, PIFSC SPECIAL PUBLIC; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Budd AF, 1998, PALAIOS, V13, P170, DOI 10.2307/3515488; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHENEY DP, 1977, J PHYCOL, V13, P12; Coyer J, 1999, GUIDE METHODS UNDERW; Dameron OJ, 2007, MAR POLLUT BULL, V54, P423, DOI 10.1016/j.marpolbul.2006.11.019; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; FRIEDLANDER A, 2008, STATE CORAL REEF ECO, P263; Friedlander A. M., 2004, STATUS CORAL REEFS W, V2, P411; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Galtsoff P. S., 1933, Bulletin Bishop Museum Honolulu, Vno. 107, P1; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; HOEKE R, 2006, P 10 INT COR REEF S, V1, P718; Hoeke Ronald, 2006, Atoll Research Bulletin, P489; HOLZWARTH S, 2006, P 10 INT COR REEF S, V1, P1131; Holzwarth Stephani R., 2006, Atoll Research Bulletin, P257; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JOHANSSON CL, MAR ECOL PR IN PRESS; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 2006, P 10 INT COR REEF S, P390; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kenyon JC, 2006, PAC SCI, V60, P153, DOI 10.1353/psc.2006.0006; KENYON JC, 2007, ATOLL RES B, V549, P1; KENYON JC, 2007, ATOLL RES B, V550, P1; Kenyon Jean C., 2008, Atoll Research Bulletin, V559, P1; Kenyon Jean C., 2008, Atoll Research Bulletin, V558, P1; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Leichter JJ, 1999, CONT SHELF RES, V19, P911, DOI 10.1016/S0278-4343(99)00004-7; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; MacCaughey V, 1916, AM J BOT, V3, P474, DOI 10.2307/2435240; MacCaughey V, 1918, BOT GAZ, V65, P42, DOI 10.1086/332188; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; McClanaban TR, 1999, CORAL REEFS, V18, P195, DOI 10.1007/s003380050181; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; *NAT MAR FISH SERV, 2005, CR05012 NAT MAR FISH; PAGE KN, 2006, THESIS U HAWAII; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Rooney John J., 2008, V1, P519, DOI 10.1007/978-1-4020-6847-8_13; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; SICILIANO D, 2005, THESIS U CALIFORNIA; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Vroom PS, 2009, J PHYCOL, V45, P337, DOI 10.1111/j.1529-8817.2009.00666.x; Vroom Peter S., 2006, Atoll Research Bulletin, P533; Vroom PS, 2006, PAC SCI, V60, P81, DOI 10.1353/psc.2005.0063; Vroom PS, 2005, CORAL REEFS, V24, P574, DOI 10.1007/s00338-005-0028-y; Wilkinson C., 2004, STATUS CORAL REEFS W; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; [No title captured]	66	44	45	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9733	10.1371/journal.pone.0009733	http://dx.doi.org/10.1371/journal.pone.0009733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305808	Green Published, Green Submitted, gold			2022-12-25	WOS:000275809600006
J	Mines, MA; Yuskaitis, CJ; King, MK; Beurel, E; Jope, RS				Mines, Marjelo A.; Yuskaitis, Christopher J.; King, Margaret K.; Beurel, Eleonore; Jope, Richard S.			GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FMR1 KNOCKOUT MOUSE; LITHIUM; MICE; PHOSPHORYLATION; EXPRESSION; CHILDREN; FEATURES	Background: Nearly 1% of children in the United States exhibit autism spectrum disorders, but causes and treatments remain to be identified. Mice with deletion of the fragile X mental retardation 1 (Fmr1) gene are used to model autism because loss of Fmr1 gene function causes Fragile X Syndrome (FXS) and many people with FXS exhibit autistic-like behaviors. Glycogen synthase kinase-3 (GSK3) is hyperactive in brains of Fmr1 knockout mice, and inhibition of GSK3 by lithium administration ameliorates some behavioral impairment in these mice. We extended our studies of this association by testing whether GSK3 contributes to socialization behaviors. This used two mouse models with disrupted regulation of GSK3, Fmr1 knockout mice and GSK3 knockin mice, in which inhibitory serines of the two isoforms of GSK3, GSK3 alpha and GSK3 beta, are mutated to alanines, leaving GSK3 fully active. Methodology/Principal Findings: To assess sociability, test mice were introduced to a restrained stimulus mouse (S1) for 10 min, followed by introduction of a second restrained stimulus mouse (S2) for 10 min, which assesses social preference. Fmr1 knockout and GSK3 knockin mice displayed no deficit in sociability with the S1 mouse, but unlike wild-type mice neither demonstrated social preference for the novel S2 mouse. Fmr1 knockout mice displayed more anxiety-related behaviors during social interaction (grooming, rearing, and digging) than wild-type mice, which was ameliorated by inhibition of GSK3 with chronic lithium treatment. Conclusions/Significance: These results indicate that impaired inhibitory regulation of GSK3 in Fmr1 knockout mice may contribute to some socialization deficits and that lithium treatment can ameliorate certain socialization impairments. As discussed in the present work, these results suggest a role for GSK3 in social behaviors and implicate inhibition of GSK3 as a potential therapeutic.	[Mines, Marjelo A.; Yuskaitis, Christopher J.; King, Margaret K.; Beurel, Eleonore; Jope, Richard S.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Mines, MA (corresponding author), Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	jope@uab.edu			FRAXA Research Foundation; National Institutes of Health [MH38752]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038752, R56MH038752] Funding Source: NIH RePORTER	FRAXA Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by grants from the FRAXA Research Foundation and the National Institutes of Health (MH38752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Berry-Kravis E, 2008, J DEV BEHAV PEDIATR, V29, P293, DOI 10.1097/DBP.0b013e31817dc447; Bitterman A, 2008, J AUTISM DEV DISORD, V38, P1509, DOI 10.1007/s10803-007-0531-9; Brodkin ES, 2008, BEHAV NEUROSCI, V122, P483, DOI 10.1037/0735-7044.122.2.483; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Jope R. S., 2006, GLYCOGEN SYNTHASE KI, P223; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kau ASM, 2004, AM J MED GENET A, V126A, P9, DOI 10.1002/ajmg.a.20218; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koukoui SD, 2007, BRAIN RES REV, V53, P27, DOI 10.1016/j.brainresrev.2006.06.001; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P105, DOI 10.1080/09297040802112564; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rhoades Rachel A, 2007, BMC Pediatr, V7, P37, DOI 10.1186/1471-2431-7-37; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spencer CA, 2008, BEHAV NEUROSCI, V122, P710, DOI 10.1037/0735-7044.122.3.710; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sullivan K, 2006, AM J MED GENET A, V140A, P2275, DOI 10.1002/ajmg.a.31388; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023	38	165	174	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9706	10.1371/journal.pone.0009706	http://dx.doi.org/10.1371/journal.pone.0009706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	570ZC	20300527	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400007
J	Solberg, R; Enot, D; Deigner, HP; Koal, T; Scholl-Burgi, S; Saugstad, OD; Keller, M				Solberg, Ronnaug; Enot, David; Deigner, Hans-Peter; Koal, Therese; Scholl-Buergi, Sabine; Saugstad, Ola D.; Keller, Matthias			Metabolomic Analyses of Plasma Reveals New Insights into Asphyxia and Resuscitation in Pigs	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ROOM-AIR RESUSCITATION; 100-PERCENT OXYGEN; L-CARNITINE; NEWBORN-INFANTS; NEONATAL ENCEPHALOPATHY; TERM INFANTS; BRAIN-INJURY; METAANALYSIS; CHOLESTEROL	Background: Currently, a limited range of biochemical tests for hypoxia are in clinical use. Early diagnostic and functional biomarkers that mirror cellular metabolism and recovery during resuscitation are lacking. We hypothesized that the quantification of metabolites after hypoxia and resuscitation would enable the detection of markers of hypoxia as well as markers enabling the monitoring and evaluation of resuscitation strategies. Methods and Findings: Hypoxemia of different durations was induced in newborn piglets before randomization for resuscitation with 21% or 100% oxygen for 15 min or prolonged hyperoxia. Metabolites were measured in plasma taken before and after hypoxia as well as after resuscitation. Lactate, pH and base deficit did not correlate with the duration of hypoxia. In contrast to these, we detected the ratios of alanine to branched chained amino acids (Ala/BCAA; R-2. adj = 0.58, qvalue, 0.001) and of glycine to BCAA (Gly/BCAA; R-2.adj = 0.45, q-value, 0.005), which were highly correlated with the duration of hypoxia. Combinations of metabolites and ratios increased the correlation to R-2 adjust = 0.92. Reoxygenation with 100% oxygen delayed cellular metabolic recovery. Reoxygenation with different concentrations of oxygen reduced lactate levels to a similar extent. In contrast, metabolites of the Krebs cycle (which is directly linked to mitochondrial function) including alpha keto-glutarate, succinate and fumarate were significantly reduced at different rates depending on the resuscitation, showing a delay in recovery in the 100% reoxygenation groups. Additional metabolites showing different responses to reoxygenation include oxysterols and acylcarnitines (n = 8-11, q<0.001). Conclusions: This study provides a novel strategy and set of biomarkers. It provides biochemical in vivo data that resuscitation with 100% oxygen delays cellular recovery. In addition, the oxysterol increase raises concerns about the safety of 100% O-2 resuscitation. Our biomarkers can be used in a broad clinical setting for evaluation or the prediction of damage in conditions associated with low tissue oxygenation in both infancy and adulthood. These findings have to be validated in human trials.	[Solberg, Ronnaug; Saugstad, Ola D.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0316 Oslo, Norway; [Solberg, Ronnaug] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Surg Res, N-0316 Oslo, Norway; [Enot, David; Deigner, Hans-Peter; Koal, Therese] BIOCRATES Life Sci AG, Innsbruck, Austria; [Scholl-Buergi, Sabine] Innsbruck Med Univ, Dept Pediat 4, Div Neuropediatr & Inherited Metab Disorders, Innsbruck, Austria; [Keller, Matthias] Univ Essen Gesamthsch, Dept Pediat 1, Essen, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Medical University of Innsbruck; University of Duisburg Essen	Solberg, R (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0316 Oslo, Norway.	Matthias.Keller@uk-essen.de	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254; Scholl-Burgi, Sabine/0000-0002-2529-4231	South-Eastern Norway Regional Health Authority; Norwegian SIDS; Stillbirth Society	South-Eastern Norway Regional Health Authority; Norwegian SIDS; Stillbirth Society	Financial support was provided by the South-Eastern Norway Regional Health Authority and the Norwegian SIDS and Stillbirth Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binienda ZK, 2003, ANN NY ACAD SCI, V993, P289, DOI 10.1111/j.1749-6632.2003.tb07536.x; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Briddon A, 1996, ANN CLIN BIOCHEM, V33, P227, DOI 10.1177/000456329603300309; Cai C, 2008, J HUAZHONG U SCI-MED, V28, P207, DOI 10.1007/s11596-008-0224-4; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Chace DH, 2003, PEDIATR RES, V53, P823, DOI 10.1203/01.PDR.0000059220.39578.3D; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; DE V, 1990, BIOL NEONATE S, V58, P54; GEHRKE I, 1990, LUNG, V168, P79, DOI 10.1007/BF02719678; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Groenendaal F, 2000, Semin Neonatol, V5, P17, DOI 10.1053/siny.1999.0119; HASTIE T, 2009, SPRINGER SERIES STAT; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Helton E, 2000, PEDIATRICS, V105, P1260; International Liaison Committee on Resuscitation, 2005, Resuscitation, V67, P293; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Markham EA, 2007, STAND, V7, P62; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; McGuire William, 2006, Clin Evid, P511; Meyburg J, 2001, PEDIATR RES, V49, P125, DOI 10.1203/00006450-200101000-00024; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; REZNICK AZ, 1992, ARCH BIOCHEM BIOPHYS, V296, P394, DOI 10.1016/0003-9861(92)90589-O; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8; Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077; Thoresen M, 2000, Semin Neonatol, V5, P61, DOI 10.1053/siny.1999.0118; TODO G, 1986, INVEST RADIOL, V21, P689, DOI 10.1097/00004424-198609000-00003; Touma EH, 2001, ARCH DIS CHILD, V84, P58, DOI 10.1136/adc.84.1.58; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Wainwright MS, 2006, STROKE, V37, P524, DOI 10.1161/01.STR.0000198892.15269.f7; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; *WHO, 2005, WORLD HTLH REP 2005; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	50	92	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9606	10.1371/journal.pone.0009606	http://dx.doi.org/10.1371/journal.pone.0009606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231903	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300019
J	van Eekelen, M; Sasportas, LS; Kasmieh, R; Yip, S; Figueiredo, JL; Louis, DN; Weissleder, R; Shah, K				van Eekelen, M.; Sasportas, L. S.; Kasmieh, R.; Yip, S.; Figueiredo, J-L; Louis, D. N.; Weissleder, R.; Shah, K.			Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors	ONCOGENE			English	Article						brain tumor; glioma; human neural stem cells; TSP-1; endothelial cells; angiogenesis; in vivo imaging	IN-VIVO; MALIGNANT GLIOMA; THERAPY; CANCER; ABT-510; GROWTH; APOPTOSIS; ENDOSTATIN; INHIBITOR; MIGRATION	Novel therapeutic agents combined with innovative modes of delivery and non-invasive imaging of drug delivery, pharmacokinetics and efficacy are crucial in developing effective clinical anticancer therapies. In this study, we have created and characterized multiple novel variants of anti-angiogenic protein thrombospondin (aaTSP-1) that comprises unique regions of three type-I-repeats of TSP-1 and used engineered human neural stem cells (hNSC) to provide sustained on-site delivery of secretable aaTSP-1 to tumor-vasculature. We show that hNSC-aaTSP-1 has anti-angiogenic effect on human brain and dermal microvascular endothelial cells co-cultured with established glioma cells and CD133+ glioma-initiating cells. Using human glioma cells and hNSC engineered with different combinations of fluorescent and bioluminescent marker proteins and employing multi-modality imaging techniques, we show that aaTSP-1 targets the vascular-component of gliomas and a single administration of hNSC-aaTSP-1 markedly reduces tumor vessel-density that results in inhibition of tumor-progression and increased survival in mice bearing highly malignant human gliomas. We also show that therapeutic hNSC do not proliferate and remain in an un-differentiated state in the brains of glioma-bearing mice. This study provides a platform for accelerated development of future cell-based therapies for cancer. Oncogene (2010) 29, 3185-3195; doi: 10.1038/onc.2010.75; published online 22 March 2010	[van Eekelen, M.; Sasportas, L. S.; Kasmieh, R.; Shah, K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA USA; [van Eekelen, M.; Sasportas, L. S.; Kasmieh, R.; Figueiredo, J-L; Weissleder, R.; Shah, K.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Louis, D. N.; Shah, K.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Yip, S.; Louis, D. N.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Yip, S.; Louis, D. N.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Figueiredo, J-L; Weissleder, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Shah, K (corresponding author), Harvard Univ, Mol Neurotherapy & Imaging Lab, Massachusetts Gen Hosp, Dept Radiol & Neurol,Med Sch, Rm 5403,149,13th St, Charlestown, MA 02129 USA.	kshah@helix.mgh.harvard.edu	Yip, Stephen/E-9994-2012; van Eekelen, Mark/A-6225-2010	Yip, Stephen/0000-0002-8514-9861; /0000-0003-0828-4143	American Cancer Society; Goldhirsh foundation; Alliance for Cancer Gene Therapy [P50 CA86355, R21CA131980]; NATIONAL CANCER INSTITUTE [P50CA086355, R21CA131980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Goldhirsh foundation; Alliance for Cancer Gene Therapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Cancer Society (KS), Goldhirsh foundation (KS), Alliance for Cancer Gene Therapy (KS), P50 CA86355 (KS, RW), R21CA131980 (KS). We thank Dr Rainer Koehler for his help with intravital microscopy and Dr Claudio Vinegoni for his help with processing images. We also thank Dr Jack Lawler (Beth Israel Deaconess Hospital, Boston) for providing us with TSP-1 cDNA construct and Dr Paul van Bergen en Henegouwen (Utrecht University, The Netherlands) for his constructive comments.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Anderson JC, 2007, CANCER BIOL THER, V6, P454, DOI 10.4161/cbt.6.3.3630; ASAISHI K, 1981, CANCER RES, V41, P1898; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bogdanov A. Jr., 1999, Neoplasia (New York), V1, P438, DOI 10.1038/sj.neo.7900044; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Capillo M, 2003, CLIN CANCER RES, V9, P377; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; Drixler TA, 2000, CANCER RES, V60, P1761; Duda DG, 2007, TRENDS MOL MED, V13, P223, DOI 10.1016/j.molmed.2007.04.001; Ehtesham M, 2002, CANCER RES, V62, P7170; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Guerin C, 1997, EXS, V79, P47; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoekstra R, 2006, EUR J CANCER, V42, P467, DOI 10.1016/j.ejca.2005.08.040; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kisker O, 2001, CANCER RES, V61, P7669; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Liu P, 2003, LEUKEMIA RES, V27, P701, DOI 10.1016/S0145-2126(02)00346-6; Markovic SN, 2007, AM J CLIN ONCOL-CANC, V30, P303, DOI 10.1097/01.coc.0000256104.80089.35; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Rusk A, 2006, CLIN CANCER RES, V12, P7444, DOI 10.1158/1078-0432.CCR-06-0109; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2004, CANCER RES, V64, P3236, DOI 10.1158/0008-5472.CAN-03-3516; Shah K, 2003, ONCOGENE, V22, P6865, DOI 10.1038/sj.onc.1206748; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Tuettenberg J, 2006, CRIT REV ONCOL HEMAT, V59, P181, DOI 10.1016/j.critrevonc.2006.01.004; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zhang XF, 2007, CANCER LETT, V247, P143, DOI 10.1016/j.canlet.2006.04.003	37	50	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 3	2010	29	22					3185	3195		10.1038/onc.2010.75	http://dx.doi.org/10.1038/onc.2010.75			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20305695	Green Accepted			2022-12-25	WOS:000278321100002
J	Griner, EM; Caino, MC; Sosa, MS; Colon-Gonzalez, F; Chalmers, MJ; Mischak, H; Kazanietz, MG				Griner, Erin M.; Caino, M. Cecilia; Sosa, Maria Soledad; Colon-Gonzalez, Francheska; Chalmers, Michael J.; Mischak, Harald; Kazanietz, Marcelo G.			A Novel Cross-talk in Diacylglycerol Signaling THE RAC-GAP beta 2-CHIMAERIN IS NEGATIVELY REGULATED BY PROTEIN KINASE C delta-MEDIATED PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEIN; PHORBOL ESTER RECEPTOR; SUBCELLULAR-LOCALIZATION; TUMOR PROMOTERS; BETA-2-CHIMAERIN; PHOSPHORYLATION; DOMAIN; ALPHA-2-CHIMAERIN; BINDING	Although the family of chimaerin Rac-GAPs has recently gained significant attention for their involvement in development, cancer, and neuritogenesis, little is known about their molecular regulation. Chimaerins are activated by the lipid second messenger diacylglycerol via their C1 domain upon activation of tyrosine kinase receptors, thereby restricting the magnitude of Rac signaling in a receptor-regulated manner. Here we identified a novel regulatory mechanism for beta 2-chimaerin via phosphorylation. Epidermal growth factor or the phorbol ester phorbol 12-myristate 13-acetate caused rapid phosphorylation of beta 2-chimaerin on Ser(169) located in the SH2-C1 domain linker region via protein kinase C delta, which retained beta 2-chimaerin in the cytosol and prevented its C1 domain-mediated translocation to membranes. Furthermore, despite the fact that Ser(169) phosphorylation did not alter intrinsic Rac-GAP activity in vitro, a non-phosphorylatable beta 2-chimaerin mutant was highly sensitive to translocation, and displayed enhanced association with activated Rac, enhanced Rac-GAP activity, and anti-migratory properties when expressed in cells. Our results not only revealed a novel regulatory mechanism that facilitates Rac activation, but also identified a novel mechanism of cross-talk between diacylglycerol receptors that restricts beta 2-chimaerin relocalization and activation.	[Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chalmers, Michael J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Mischak, Harald] Mosaiques Diagnost GmbH, D-30625 Hannover, Germany	University of Pennsylvania; Scripps Research Institute; Mosaiques Diagnostics GmbH (MOS)	Kazanietz, MG (corresponding author), 1256 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Mischak, Harald/E-8685-2011	Mischak, Harald/0000-0003-0323-0306; Caino, M. Cecilia/0000-0001-8294-8070; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [CA09677, CA74197]; NATIONAL CANCER INSTITUTE [R01CA074197, T32CA009677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA09677 and CA74197.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; BLUMBERG PM, 1983, ANN NY ACAD SCI, V407, P303, DOI 10.1111/j.1749-6632.1983.tb47836.x; Bruinsma SP, 2007, P NATL ACAD SCI USA, V104, P7098, DOI 10.1073/pnas.0701686104; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; LEUNG T, 1994, J BIOL CHEM, V269, P12888; Menna PL, 2003, CANCER RES, V63, P2284; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2009, J BIOL CHEM, V284, P11354, DOI 10.1074/jbc.M806098200; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; YUAN SX, 1995, CANCER RES, V55, P3456; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	39	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16931	16941		10.1074/jbc.M109.099036	http://dx.doi.org/10.1074/jbc.M109.099036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335173	hybrid, Green Published			2022-12-25	WOS:000277982600056
J	Bergeron, SE; Zhu, M; Thiem, SM; Friderici, KH; Rubenstein, PA				Bergeron, Sarah E.; Zhu, Mei; Thiem, Suzanne M.; Friderici, Karen H.; Rubenstein, Peter A.			Ion-dependent Polymerization Differences between Mammalian beta- and gamma-Nonmuscle Actin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; HAIR-CELLS; YEAST ACTIN; BINDING PROTEIN; ATP HYDROLYSIS; CHARGED RESIDUES; CARDIAC ACTIN; COMPLEX; LOCALIZATION; FILAMENTS	beta- and gamma-nonmuscle actins differ by 4 amino acids at or near the N terminus and distant from polymerization interfaces. gamma-Actin contains an Asp1-Asp2-Asp3 and Val(10) whereas beta-actin has a Glu1-Glu2-Glu3 and Ile10. Despite these small changes, conserved across mammals, fish, and birds, their differential localization in the same cell suggests they may play different roles reflecting differences in their biochemical properties. To test this hypothesis, we established a baculovirus-driven expression system for producing these actins in isoform-pure populations although contaminated with 20-25% insect actin. Surprisingly, Ca-gamma-actin exhibits a slower monomeric nucleotide exchange rate, a much longer nucleation phase, and a somewhat slower elongation rate than gamma-actin. In the Mg-form, this difference between the two is much smaller. Ca-gamma-actin depolymerizes half as fast as does gamma-actin. Mixing experiments with Ca-actins reveal the two will readily co-polymerize. In the Ca-form, phosphate release from polymerizing gamma-actin occurs much more rapidly and extensively than polymerization, whereas phosphate release lags behind polymerization with gamma-actin. Phosphate release during treadmilling is twice as fast with beta-as with gamma-actin. With Mg-actin in the initial stages, phosphate release for both actins correlates much more closely with polymerization. Calcium bound in the high affinity binding site of gamma-actin may cause a selective energy barrier relative to gamma-actin that retards the equilibration between G-and F-monomer conformations resulting in a slower polymerizing actin with greater filament stability. This difference may be particularly important in sites such as the gamma-actin-rich cochlear hair cell stereocilium where local mM calcium concentrations may exist.	[Bergeron, Sarah E.; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Zhu, Mei; Thiem, Suzanne M.; Friderici, Karen H.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Thiem, Suzanne M.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Iowa; Michigan State University; Michigan State University	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy A & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC008803, DC004568]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803, R01DC004568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC008803 (to P. A. R.) and DC004568 (to K. H. F.).	Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1994, ADV EXP MED BIOL, V358, P71; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; COOK RK, 1993, J BIOL CHEM, V268, P2410; COOK RK, 1992, PRACTICAL APPROACHES, P99; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; DECHESNE CJ, 1991, BRAIN RES, V560, P139, DOI 10.1016/0006-8993(91)91224-O; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hannan AJ, 1998, MOL CELL NEUROSCI, V11, P289, DOI 10.1006/mcne.1998.0693; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Henzl MT, 1997, HEARING RES, V106, P105, DOI 10.1016/S0378-5955(97)00005-1; Hofer D, 1997, J CELL SCI, V110, P765; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kashina AS, 2006, TRENDS CELL BIOL, V16, P610, DOI 10.1016/j.tcb.2006.10.001; Khaitlina S, 1999, ARCH BIOCHEM BIOPHYS, V368, P105, DOI 10.1006/abbi.1999.1303; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sakaguchi N, 1998, J HISTOCHEM CYTOCHEM, V46, P29, DOI 10.1177/002215549804600105; SANS A, 1986, BRAIN RES, V364, P190, DOI 10.1016/0006-8993(86)91003-6; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Watanabe H, 1998, J CELL SCI, V111, P1287; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	54	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16087	16095		10.1074/jbc.M110.110130	http://dx.doi.org/10.1074/jbc.M110.110130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20308063	hybrid, Green Published			2022-12-25	WOS:000277715900046
J	Hyun, JK; Radjainia, M; Kingston, RL; Mitra, AK				Hyun, Jae-Kyung; Radjainia, Mazdak; Kingston, Richard L.; Mitra, Alok K.			Proton-driven Assembly of the Rous Sarcoma Virus Capsid Protein Results in the Formation of Icosahedral Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL RECONSTRUCTIONS; INTERSUBUNIT INTERACTIONS; DIMERIZATION DOMAIN; TYPE-1 CORE; MODEL; ORGANIZATION; POLYMORPHISM; IMAGE; VISUALIZATION; ASSOCIATION	In a mature and infectious retroviral particle, the capsid protein (CA) forms a shell surrounding the genomic RNA and the replicative machinery of the virus. The irregular nature of this capsid shell precludes direct atomic resolution structural analysis. CA hexamers and pentamers are the fundamental building blocks of the capsid, however the pentameric state, in particular, remains poorly characterized. We have developed an efficient in vitro protocol for studying the assembly of Rous sarcoma virus (RSV) CA that involves mild acidification and produces structures modeling the authentic viral capsid. These structures include regular spherical particles with T = 1 icosahedral symmetry, built from CA pentamers alone. These particles were subject to cryoelectron microscopy (cryo-EM) and image processing, and a pseudo-atomic model of the icosahedron was created by docking atomic structures of the constituent CA domains into the cryo-EM-derived three-dimensional density map. The N-terminal domain (NTD) of CA forms pentameric turrets, which decorate the surface of the icosahedron, while the C-terminal domain (CTD) of CA is positioned underneath, linking the pentamers. Biophysical analysis of the icosahedral particle preparation reveals that CA monomers and icosahedra are the only detectable species and that these exist in reversible equilibrium at pH 5. These same acidic conditions are known to promote formation of a RSV CA CTD dimer, present within the icosahedral particle, which facilitates capsid assembly. The results are consistent with a model in which RSV CA assembly is a nucleation-limited process driven by very weak protein-protein interactions.	[Hyun, Jae-Kyung; Radjainia, Mazdak; Kingston, Richard L.; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland	Kingston, RL (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	rl.kingston@auckland.ac.nz; a.mitra@auckland.ac.nz	Kingston, Richard/C-2537-2008; Hyun, Jaekyung/AAK-2521-2020; Mitra, Alok/P-7800-2016	Kingston, Richard/0000-0003-0893-6973; Hyun, Jaekyung/0000-0003-2914-537X; Mitra, Alok/0000-0003-0891-5697	National Institutes of Health; New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship	This work was supported, in whole or in part, by National Institutes of Health R21 Grant (to A. K. M.). This work was also supported by the New Zealand Health Research Council Sir Charles Hercus Health Research Fellowship (to R. L. K.).	Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; ADOLPH KW, 1974, J MOL BIOL, V88, P327, DOI 10.1016/0022-2836(74)90485-9; Annunziata O, 2005, LANGMUIR, V21, P12085, DOI 10.1021/la052147f; Aragon S, 2006, BIOPHYS J, V91, P1591, DOI [10.1529/biophysj.105.078188, 10.1529/hiophysj.105.078188]; Auerbach MR, 2007, J VIROL, V81, P12337, DOI 10.1128/JVI.01286-07; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; BATTINO R, 1984, J CHEM EDUC, V61, P51, DOI 10.1021/ed061p51; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, J VIROL, V78, P2606, DOI 10.1128/JVI.78.5.2606-2608.2004; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; CANN JR, 1974, BIOCHEMISTRY-US, V13, P1868, DOI 10.1021/bi00706a015; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; FINSY R, 1994, ADV COLLOID INTERFAC, V52, P79, DOI 10.1016/0001-8686(94)80041-3; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kingston RL, 2001, J STRUCT BIOL, V136, P67, DOI 10.1006/jsbi.2001.4423; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Lepault J, 2001, EMBO J, V20, P1498, DOI 10.1093/emboj/20.7.1498; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lomakin Aleksey, 2004, V299, P153; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Newman RM, 2007, AIDS REV, V9, P114; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Purdy JG, 2009, J MOL BIOL, V389, P438, DOI 10.1016/j.jmb.2009.04.006; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STEVENS FJ, 1989, BIOPHYS J, V55, P1155, DOI 10.1016/S0006-3495(89)82912-1; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Winzor DJ, 2003, J BIOCHEM BIOPH METH, V56, P15, DOI 10.1016/S0165-022X(03)00071-X; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xu R, 2000, PARTICLE CHARACTERIZ; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299; ZIMMERMAN JK, 1974, BIOCHEMISTRY-US, V13, P384, DOI 10.1021/bi00699a025; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	64	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15056	15064		10.1074/jbc.M110.108209	http://dx.doi.org/10.1074/jbc.M110.108209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20228062	Green Published, hybrid			2022-12-25	WOS:000277399000027
J	Efendiev, R; Samelson, BK; Nguyen, BT; Phatarpekar, PV; Baameur, F; Scott, JD; Dessauer, CW				Efendiev, Riad; Samelson, Bret K.; Nguyen, Bao T.; Phatarpekar, Prasad V.; Baameur, Faiza; Scott, John D.; Dessauer, Carmen W.			AKAP79 Interacts with Multiple Adenylyl Cyclase (AC) Isoforms and Scaffolds AC5 and-6 to alpha-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-KINASE-A; SIGNALING COMPLEXES; AKAP150-ANCHORED PKA; RAT-BRAIN; MEMORY; MEMBRANE; BINDING; SITE; PHOSPHORYLATION	Spatiotemporal specificity of cAMP action is best explained by targeting protein kinase A (PKA) to its substrates by A-kinase-anchoring proteins (AKAPs). At synapses in the brain, AKAP79/150 incorporates PKA and other regulatory enzymes into signal transduction networks that include beta-adrenergic receptors, alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA), and N-methyl-D-aspartic acid receptors. We previously showed that AKAP79/150 clusters PKA with type 5 adenylyl cyclase (AC5) to assemble a negative feedback loop in which the anchored kinase phosphorylates AC5 to dynamically suppress cAMP synthesis. We now show that AKAP79 can associate with multiple AC isoforms. The N-terminal regions of AC5, -6, and -9 mediate this protein-protein interaction. Mapping studies located a reciprocal binding surface between residues 77-108 of AKAP79. Intensity-and lifetime-based fluorescence resonance energy transfer demonstrated that deletion of AKAP79(77-108) region abolished AC5-AKAP79 interaction in living cells. The addition of the AKAP79(77-153) polypeptide fragment uncouples AC5/6 interactions with the anchoring protein and prevents PKA-mediated inhibition of AC activity in membranes. Use of the AKAP79(77-153) polypeptide fragment in brain extracts from wild-type and AKAP150(-/-) mice reveals that loss of the anchoring protein results in decreased AMPA receptor-associated AC activity. Thus, we propose that AKAP79/150 mediates protein-protein interactions that place AC5 in proximity to synaptic AMPA receptors.	[Efendiev, Riad; Nguyen, Bao T.; Phatarpekar, Prasad V.; Baameur, Faiza; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Samelson, Bret K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	Carmen.W.Dessauer@uth.tmc.edu	Dessauer, Carmen/N-6933-2018	Dessauer, Carmen/0000-0003-1210-4280	National Institutes of Health [GM60419, GM48231]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R01GM060419, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 (to C. W. D.) and GM48231 (to J. D. S.) and a grant from the American Heart Association (to C. W. D.).	Antoni FA, 1998, J NEUROSCI, V18, P9650; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Chen YB, 1997, P NATL ACAD SCI USA, V94, P14100, DOI 10.1073/pnas.94.25.14100; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dessauer CW, 2002, METHOD ENZYMOL, V345, P112; Diviani D, 2001, J CELL SCI, V114, P1431; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; HOUBRE D, 1991, J BIOL CHEM, V266, P7121; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; JACOBOWITZ O, 1994, P NATL ACAD SCI USA, V91, P10630, DOI 10.1073/pnas.91.22.10630; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; KAWABE J, 1994, J BIOL CHEM, V269, P16554; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lai HL, 1997, J BIOL CHEM, V272, P4970, DOI 10.1074/jbc.272.8.4970; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sadana R, 2009, MOL PHARMACOL, V76, P1256, DOI 10.1124/mol.109.058370; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	45	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14450	14458		10.1074/jbc.M110.109769	http://dx.doi.org/10.1074/jbc.M110.109769			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231277	Green Published, hybrid			2022-12-25	WOS:000277299700041
J	Zhao, F; Mancuso, A; Bui, TV; Tong, X; Gruber, JJ; Swider, CR; Sanchez, PV; Lum, JJ; Sayed, N; Melo, JV; Perl, AE; Carroll, M; Tuttle, SW; Thompson, CB				Zhao, F.; Mancuso, A.; Bui, T. V.; Tong, X.; Gruber, J. J.; Swider, C. R.; Sanchez, P. V.; Lum, J. J.; Sayed, N.; Melo, J. V.; Perl, A. E.; Carroll, M.; Tuttle, S. W.; Thompson, C. B.			Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1 alpha-induced metabolic reprograming	ONCOGENE			English	Article						imatinib (Gleevec, STI571); resistance; HIF-1 alpha; pentose phosphate pathway; glucose metabolism; cell survival	CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITOR; HYPOXIA-INDUCIBLE FACTOR; EXPRESSION LEVELS; POSITIVE CELLS; CLINICAL RESISTANCE; PENTOSE-PHOSPHATE; CYCLE ACTIVITY; GROWTH-FACTOR; SENSITIVITY	As chronic myeloid leukemia (CML) progresses from the chronic phase to blast crisis, the levels of BCR-ABL increase. In addition, blast-transformed leukemic cells display enhanced resistance to imatinib in the absence of BCR-ABL-resistance mutations. In this study, we show that when BCR-ABL-transformed cell lines were selected for imatinib resistance in vitro, the cells that grew out displayed a higher BCR-ABL expression comparable to the increase seen in accelerated forms of the disease. This enhanced expression of BCR-ABL was associated with an increased rate of glycolysis but with a decreased rate of proliferation. The higher level of BCR-ABL expression in the selected cells correlated with a nonhypoxic induction of hypoxia-inducible factor-1 alpha (HIF-1 alpha) that was required for cells to tolerate enhanced BCR-ABL signaling. HIF-1 alpha induction resulted in an enhanced rate of glycolysis but with reduced glucose flux through both the tricarboxylic acid cycle and the oxidative arm of the pentose phosphate pathway (PPP). The reduction in oxidative PPP-mediated ribose synthesis was compensated by the HIF1 alpha-dependent activation of the nonoxidative PPP enzyme, transketolase, in imatinib-resistant CML cells. In both primary cultures of cells from patients exhibiting blast transformation and in vivo xenograft tumors, use of oxythiamine, which can inhibit both the pyruvate dehydrogenase complex and transketolase, resulted in enhanced imatinib sensitivity of tumor cells. Together, these results suggest that oxythiamine can enhance imatinib efficacy in patients who present an accelerated form of the disease. Oncogene (2010) 29, 2962-2972; doi:10.1038/onc.2010.67; published online 15 March 2010	[Zhao, F.; Mancuso, A.; Bui, T. V.; Tong, X.; Gruber, J. J.; Sayed, N.; Thompson, C. B.] Univ Penn, Sch Med, Dept Canc Biol, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Swider, C. R.; Sanchez, P. V.; Perl, A. E.; Carroll, M.] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA; [Lum, J. J.] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Melo, J. V.] SA Pathol, Div Haematol, Adelaide, SA, Australia; [Melo, J. V.] Ctr Canc Biol, Adelaide, SA, Australia; [Tuttle, S. W.] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; British Columbia Cancer Agency; SA Pathology; Centre for Cancer Biology; University of Pennsylvania	Thompson, CB (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Canc Ctr, 421 Curie Blvd, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu	Mancuso, Anthony/AAP-9358-2020	Lum, Julian/0000-0002-5624-3541	NCI; NIH; NATIONAL CANCER INSTITUTE [R01CA105463, P01CA104838, R01CA092660, K01CA129151] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Thompson laboratory, especially Tullia Lindsten, Mondira Kundu, Uma Sachdeva and Scott Olejniczak, for helpful suggestions during the study and careful critique of the paper. We thank Dr E Buchdunger (Novartis, Basel, Switzerland) for providing imatinib and Dr EP Reddy (Temple University, Philadelphia) for providing cell lines expressing either the WT or mutant (T315I) form of BCR-ABL. We are grateful to Dr MC Simon (University of Pennsylvania), Dr JL Riley (University of Pennsylvania) and Dr DA Tuveson (Cancer Research UK Cambridge Research Institute, UK) for providing experimental reagents. This work was supported in part by grants from the NCI and NIH.	Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Barnes K, 2005, ONCOGENE, V24, P3257, DOI 10.1038/sj.onc.1208461; Bell EL, 2007, ESSAYS BIOCHEM, V43, P17, DOI 10.1042/bse0430017; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Chamberlain BR, 1996, ANN CLIN BIOCHEM, V33, P352, DOI 10.1177/000456329603300413; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dewar AL, 2005, IMMUNOL CELL BIOL, V83, P48, DOI 10.1111/j.1440-1711.2004.01296.x; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Giuntoli S, 2006, LEUKEMIA, V20, P1291, DOI 10.1038/sj.leu.2404224; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Gupte SA, 2006, AM J PHYSIOL-HEART C, V290, pH2228, DOI 10.1152/ajpheart.00615.2005; Haseloff RF, 2006, PROTEOMICS, V6, P1803, DOI 10.1002/pmic.200500182; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; KATZ J, 1967, BIOCHEMISTRY-US, V6, P2227, DOI 10.1021/bi00859a046; Keeshan K, 2001, LEUKEMIA, V15, P1823, DOI 10.1038/sj.leu.2402309; Khorashad JS, 2006, LEUKEMIA, V20, P658, DOI 10.1038/sj.leu.2404137; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Modi H, 2007, BLOOD, V109, P5411, DOI 10.1182/blood-2006-06-032490; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Sherbenou DW, 2007, J CLIN INVEST, V117, P2067, DOI 10.1172/JCI31988; Thompson JE, 2007, EXP HEMATOL, V35, P21, DOI 10.1016/j.exphem.2006.08.017; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; TUTTLE SW, 1992, INT J RADIAT ONCOL, V22, P671, DOI 10.1016/0360-3016(92)90500-H; ZAHAREVITZ DW, 1992, EUR J BIOCHEM, V210, P293, DOI 10.1111/j.1432-1033.1992.tb17420.x; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	36	134	139	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2010	29	20					2962	2972		10.1038/onc.2010.67	http://dx.doi.org/10.1038/onc.2010.67			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	599DM	20228846	Green Accepted			2022-12-25	WOS:000277890400007
J	Ang, CW; Dijkstra, JR; de Klerk, MA; Endtz, HP; van Doorn, PA; Jacobs, BC; Jeurissen, SHM; Wagenaar, JA				Ang, C. Wim; Dijkstra, Jeroen R.; de Klerk, Marcel A.; Endtz, Hubert Ph; van Doorn, Pieter A.; Jacobs, Bart C.; Jeurissen, Suzan H. M.; Wagenaar, Jaap A.			Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barre Syndrome Derived Campylobacter jejuni Strain GB11	PLOS ONE			English	Article							LIPOPOLYSACCHARIDES; ANTIBODIES; COLONIZATION; GANGLIOSIDES; INFECTION	Background: Anti-ganglioside antibodies with a pathogenic potential are present in C. jejuni-associated Guillain-Barre syndrome (GBS) patients and are probably induced by molecular mimicry. Immunization studies in rabbits and mice have demonstrated that these anti-ganglioside antibodies can be induced using purified lipo-oligosaccharides (LOS) from C. jejuni in a strong adjuvant. Methodology/Principal Findings: To investigate whether natural colonization of chickens with a ganglioside-mimicking C. jejuni strain induces an anti-ganglioside response, and to investigate the diversity in anti-ganglioside response between and within genetically different chicken lines, we orally challenged chickens with different C. jejuni strains. Oral challenge of chickens with a C. jejuni strain from a GBS patient, containing a LOS that mimics ganglioside GM1, induced specific IgM and IgG anti-LOS and anti-GM1 antibodies. Inoculation of chickens with the Penner HS:3 serostrain, without a GM1-like structure, induced anti-LOS but no anti-ganglioside antibodies. We observed different patterns of anti-LOS/ganglioside response between and within the five strains of chickens. Conclusions: Natural infection of chickens with C. jejuni induces anti-ganglioside antibodies. The production of antibodies is governed by both microbial and host factors.	[Ang, C. Wim] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Ang, C. Wim; de Klerk, Marcel A.; van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ang, C. Wim; de Klerk, Marcel A.; Jacobs, Bart C.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Ang, C. Wim; Endtz, Hubert Ph] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Endtz, Hubert Ph] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Dijkstra, Jeroen R.; Jeurissen, Suzan H. M.; Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; International Centre for Diarrhoeal Disease Research (ICDDR); Wageningen University & Research; Utrecht University	Ang, CW (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	w.ang@vumc.nl	Dijkstra, Jeroen R/N-4383-2015; Jacobs, Bart/ABE-2210-2021					Ang CW, 2000, J NEUROIMMUNOL, V111, P229, DOI 10.1016/S0165-5728(00)00369-6; Ang CW, 2000, J NEUROIMMUNOL, V104, P133, DOI 10.1016/S0165-5728(99)00279-9; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Ang CW, 2001, INFECT IMMUN, V69, P2462, DOI 10.1128/IAI.69.4.2462-2469.2001; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Gilbert M, 2004, INFECT IMMUN, V72, P1162, DOI 10.1128/IAI.72.2.1162-1165.2004; Gilbert M, 2008, CAMPYLOBACTER, 3RD EDITION, P483; Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; Jacobs BC, 1997, J NEUROIMMUNOL, V79, P62, DOI 10.1016/S0165-5728(97)00110-0; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; KRAMER J, 2003, THESIS ERASMUS U ROT; Li CY, 1996, J NEUROL NEUROSUR PS, V61, P279, DOI 10.1136/jnnp.61.3.279; Nachamkin I, 1997, ANN NEUROL, V42, pM80; Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Usuki S, 2006, EXP NEUROL, V200, P50, DOI 10.1016/j.expneurol.2006.01.011; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Willison HJ, 2006, ACTA NEUROL SCAND, V113, P14, DOI 10.1111/j.1600-0404.2006.00607.x; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9820	10.1371/journal.pone.0009820	http://dx.doi.org/10.1371/journal.pone.0009820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339556	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894300032
J	Mednick, SC; Christakis, NA; Fowler, JH				Mednick, Sara C.; Christakis, Nicholas A.; Fowler, James H.			The Spread of Sleep Loss Influences Drug Use in Adolescent Social Networks	PLOS ONE			English	Article							PEER PRESSURE; SUSCEPTIBILITY; DETERIORATION; ASSOCIATION; PERFORMANCE; MEDIATION; PATTERNS; VALIDITY; SMOKING; NIGHT	Troubled sleep is a commonly cited consequence of adolescent drug use, but it has rarely been studied as a cause. Nor have there been any studies of the extent to which sleep behavior can spread in social networks from person to person to person. Here we map the social networks of 8,349 adolescents in order to study how sleep behavior spreads, how drug use behavior spreads, and how a friend's sleep behavior influences one's own drug use. We find clusters of poor sleep behavior and drug use that extend up to four degrees of separation (to one's friends' friends' friends' friends) in the social network. Prospective regression models show that being central in the network negatively influences future sleep outcomes, but not vice versa. Moreover, if a friend sleeps <= 7 hours, it increases the likelihood a person sleeps <= 7 hours by 11%. If a friend uses marijuana, it increases the likelihood of marijuana use by 110%. Finally, the likelihood that an individual uses drugs increases by 19% when a friend sleeps <= 7 hours, and a mediation analysis shows that 20% of this effect results from the spread of sleep behavior from one person to another. This is the first study to suggest that the spread of one behavior in social networks influences the spread of another. The results indicate that interventions should focus on healthy sleep to prevent drug use and targeting specific individuals may improve outcomes across the entire social network.	[Mednick, Sara C.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Med, Boston, MA 02115 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego	Mednick, SC (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	smednick@ucsd.edu	Fowler, James H/C-2750-2008; Christakis, Nicholas A/C-3205-2009	Fowler, James H/0000-0001-7795-1638; mednick, sara/0000-0002-0906-3097	National Institute of Mental Health (NIMH) [K01MH080992]; Christakis and Fowler by National Institute on Aging (NIA) [P01AG031093]; Pioneer Portfolio of the Robert Wood Johnson Foundation [58729]; National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Christakis and Fowler by National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pioneer Portfolio of the Robert Wood Johnson Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mednick was supported by National Institute of Mental Health (NIMH) grant K01MH080992, Christakis and Fowler by National Institute on Aging (NIA) grant P01AG031093 and by grant # 58729 from the Pioneer Portfolio of the Robert Wood Johnson Foundation; the National Longitudinal Study of Adolescent Health was originally funded by National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER I, 1981, J STUD ALCOHOL, V42, P701, DOI 10.15288/jsa.1981.42.701; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARRATT ES, 1974, BIOL PSYCHIAT, V8, P47; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; BOLLA KI, 2008, SLEEP, V31; Bollen K. A., 1990, SOCIOLOGICAL METHODO, P115; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; BONACICH P, 1971, J MATH SOCIOL, V92, P1170; Burke CK, 2008, J SUBST ABUSE TREAT, V35, P328, DOI 10.1016/j.jsat.2007.10.003; CACIOPPO JT, 2009, J PERSONALI IN PRESS; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Califano J., 2007, WASTING BEST BRIGHTE; CARSKADON M A, 1990, Pediatrician, V17, P5; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; COHENZION M, ADDIC BEHAV IN PRESS; Crum RM, 2004, ALCOHOL CLIN EXP RES, V28, P1533, DOI 10.1097/01.ALC.0000141915.56236.40; DIELMAN TE, 1992, J SCHOOL HEALTH, V62, P233, DOI 10.1111/j.1746-1561.1992.tb01233.x; DIELMAN TE, 1987, HEALTH EDUC QUART, V14, P207, DOI 10.1177/109019818701400207; FEINBERG I, 1976, CLIN PHARM THERAPEUT, V19; Foundation NS, 2006, SLEEP AM POLL, P2006; FOWLER JH, 2010, P NATL ACAD IN PRESS; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Kamada T., 1989, INFORM PROCESSING LE, V31; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2008, BEHAV BRAIN RES, V193, P79, DOI 10.1016/j.bbr.2008.04.028; Mednick SC, 2008, BEHAV NEUROSCI, V122, P267, DOI 10.1037/0735-7044.122.2.267; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; MEDNICK SC, 2009, VISION RES; Murphy DA, 2000, AM J EPIDEMIOL, V152, P805, DOI 10.1093/aje/152.9.805; National Instituteon Drug Abuse (NIDA), 2007, NIH PUBL; O'Donnell J A, 1982, Chem Depend, V4, P229; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PHILIP G, 2002, J SLEEP RES, V11, P229; Rosenquist J. N., 2010, ANN INTERNAL MED, V152; ROSENQUIST JN, 2010, MOL PSYCHIAT, V15; Schulenberg, 2007, MONITORING FUTURE NA; Schwartz SJ, 2009, YOUTH SOC, V40, P541, DOI 10.1177/0044118X08327506; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; SZABO G, NETWORK EFFECTS SERV; Tubman J G, 1991, J Subst Abuse, V3, P405; Udry J.R, 2003, NATL LONGITUDINAL ST; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Wong MM, 2009, SLEEP MED, V10, P787, DOI 10.1016/j.sleep.2008.06.015	55	147	151	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9775	10.1371/journal.pone.0009775	http://dx.doi.org/10.1371/journal.pone.0009775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	572EH	20333306	Green Published, gold			2022-12-25	WOS:000275809700014
J	Crabb, DP; Smith, ND; Rauscher, FG; Chisholm, CM; Barbur, JL; Edgar, DF; Garway-Heath, DF				Crabb, David P.; Smith, Nicholas D.; Rauscher, Franziska G.; Chisholm, Catharine M.; Barbur, John L.; Edgar, David F.; Garway-Heath, David F.			Exploring Eye Movements in Patients with Glaucoma When Viewing a Driving Scene	PLOS ONE			English	Article							VISUAL-FIELD LOSS; FIXATION STABILITY; MACULAR DEGENERATION; VISION; PERFORMANCE; FITNESS; SCOTOMAS; DRIVERS; WALKING; SEARCH	Background: Glaucoma is a progressive eye disease and a leading cause of visual disability. Automated assessment of the visual field determines the different stages in the disease process: it would be desirable to link these measurements taken in the clinic with patient's actual function, or establish if patients compensate for their restricted field of view when performing everyday tasks. Hence, this study investigated eye movements in glaucomatous patients when viewing driving scenes in a hazard perception test (HPT). Methodology/Principal Findings: The HPT is a component of the UK driving licence test consisting of a series of short film clips of various traffic scenes viewed from the driver's perspective each containing hazardous situations that require the camera car to change direction or slow down. Data from nine glaucomatous patients with binocular visual field defects and ten age-matched control subjects were considered (all experienced drivers). Each subject viewed 26 different films with eye movements simultaneously monitored by an eye tracker. Computer software was purpose written to pre-process the data, co-register it to the film clips and to quantify eye movements and point-of-regard (using a dynamic bivariate contour ellipse analysis). On average, and across all HPT films, patients exhibited different eye movement characteristics to controls making, for example, significantly more saccades (P<0.001; 95% confidence interval for mean increase: 9.2 to 22.4%). Whilst the average region of 'point-of-regard' of the patients did not differ significantly from the controls, there were revealing cases where patients failed to see a hazard in relation to their binocular visual field defect. Conclusions/Significance: Characteristics of eye movement patterns in patients with bilateral glaucoma can differ significantly from age-matched controls when viewing a traffic scene. Further studies of eye movements made by glaucomatous patients could provide useful information about the definition of the visual field component required for fitness to drive.	[Crabb, David P.; Smith, Nicholas D.; Rauscher, Franziska G.; Barbur, John L.; Edgar, David F.] City Univ London, Dept Optometry & Visual Sci, London, England; [Chisholm, Catharine M.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Garway-Heath, David F.] Moorfields Eye Hosp, NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of Bradford; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Crabb, DP (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	David.Crabb.1@city.ac.uk	Rauscher, Franziska/AAV-8222-2021	Rauscher, Franziska/0000-0003-0183-0340; Barbur, John/0000-0002-2187-5004; Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	Moorfields Eye Hospital Special Trustees; UK Department for Transport; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology	Moorfields Eye Hospital Special Trustees; UK Department for Transport; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); UCL Institute of Ophthalmology	Nicholas Smith was supported by unrestricted funding from the Moorfields Eye Hospital Special Trustees. The authors acknowledge the UK Department for Transport financial support for the project that secured the HPT data in patients with glaucoma. One of the authors (DGH) has received a proportion of his funding from the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altangerel U, 2006, OPHTHAL EPIDEMIOL, V13, P67, DOI 10.1080/09286580500428500; Ang GS, 2007, EYE, V21, P604, DOI 10.1038/sj.eye.6702284; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Cheong AMY, 2008, OPTOMETRY VISION SCI, V85, P26, DOI 10.1097/OPX.0b013e31815ed6fd; Chisholm CM, 2008, BRIT J OPHTHALMOL, V92, P225, DOI 10.1136/bjo.2007.129726; Coeckelbergh TRM, 2002, VISION RES, V42, P669, DOI 10.1016/S0042-6989(01)00297-8; Cornelissen FW, 2005, OPTOMETRY VISION SCI, V82, P27; Crabb DP, 2005, GRAEF ARCH CLIN EXP, V243, P210, DOI 10.1007/s00417-004-0984-x; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Crossland MD, 2006, VISION RES, V46, P590, DOI 10.1016/j.visres.2005.05.015; Crossland MD, 2002, OPTOMETRY VISION SCI, V79, P735, DOI 10.1097/00006324-200211000-00011; Friedman DS, 2007, OPHTHALMOLOGY, V114, P2232, DOI 10.1016/j.ophtha.2007.02.001; Geruschat DR, 2006, OPTOMETRY VISION SCI, V83, P550, DOI 10.1097/01.opx.0000232219.23362.a6; Goldstein RB, 2007, COMPUT BIOL MED, V37, P957, DOI 10.1016/j.compbiomed.2006.08.018; Gonzalez EG, 2006, CAN J OPHTHALMOL, V41, P333, DOI 10.1139/I06-019; Grayson G, 2002, TRL558; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; HEALY HJR, 1972, APPL STAT, V21, P202; Henderson JM, 1997, PERCEPT PSYCHOPHYS, V59, P323, DOI 10.3758/BF03211901; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jampel HD, 2002, INVEST OPHTH VIS SCI, V43, P1059; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Kotecha A, 2008, BRIT MED BULL, V87, P163, DOI 10.1093/bmb/ldn028; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Nelson P, 2003, J GLAUCOMA, V12, P139, DOI 10.1097/00061198-200304000-00009; Noe G, 2003, CLIN EXP OPHTHALMOL, V31, P482, DOI 10.1046/j.1442-9071.2003.00712.x; Owen VMF, 2008, INVEST OPHTH VIS SCI, V49, P2449, DOI 10.1167/iovs.07-0877; RAUSCHER F, 79 UK DEP TRANSP; SMITH ND, 2007, EYE MOVEMENT ANAL GL; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Turano KA, 2001, OPTOMETRY VISION SCI, V78, P667, DOI 10.1097/00006324-200109000-00012; Underwood G, 2005, OPHTHAL PHYSL OPT, V25, P346, DOI 10.1111/j.1475-1313.2005.00290.x; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Underwood G., 2002, TRANSPORT RES F-TRAF, V5, P87, DOI DOI 10.1016/S1369-8478(02)00008-6; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; Vargas-Martin F, 2006, INVEST OPHTH VIS SCI, V47, P5295, DOI 10.1167/iovs.05-1043; Viswanathan AC, 1999, ARCH OPHTHALMOL-CHIC, V117, P450; Westlake W, 2000, BRIT MED J, V321, P972, DOI 10.1136/bmj.321.7267.972; White Stuart C, 2006, Gend Med, V3, P110, DOI 10.1016/S1550-8579(06)80200-7; [No title captured]	45	99	99	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9710	10.1371/journal.pone.0009710	http://dx.doi.org/10.1371/journal.pone.0009710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300522	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000275716400008
J	He, MA; Guo, H; Yang, XB; Zhou, L; Zhang, XM; Cheng, LX; Zeng, HS; Hu, FB; Tanguay, RM; Wu, TC				He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Cheng, Longxian; Zeng, Hesong; Hu, Frank B.; Tanguay, Robert M.; Wu, Tangchun			Genetic Variations in HSPA8 Gene Associated with Coronary Heart Disease Risk in a Chinese Population	PLOS ONE			English	Article							APOPTOSIS; SHOCK; HEAT-SHOCK-PROTEIN-70; MECHANISMS; PROTECTION; HSP70; ATHEROSCLEROSIS; OVEREXPRESSION; CHAPERONES; PROTEINS	Background: There is ample evidence that Hsp70 takes part in the progress of coronary heart disease (CHD). This implies that genetic variants of Hsp70 genes such as HSPA8 (HSC70) gene might contribute to the development of CHD. The present study aimed to investigate whether certain genetic variants of HSPA8 gene are associated with CHD in Han Chinese people. Methodology/Principal Findings: A total of 2006 subjects (1003 CHD cases and 1003 age-and sex-matched healthy controls) were recruited. Genetic variants in the HSPA8 gene were identified by sequencing of the gene in 60 unrelated Chinese. Four tag single nucleotide polymorphisms (tagSNPs) (rs2236659, rs2276077, rs10892958, and rs1461496) were selected and genotyped. The function of the significant SNP was evaluated using luciferase reporter assays in two cell lines. By sequencing the promoter and all exons and introns of the HSPA8 gene, 23 genetic variants were identified. One promoter SNP rs2236659 was associated with susceptibility to CHD. Carriers of the "C'' allele of rs2236659 had decreased CHD risk with odds ratio (OR) of 0.78 (95% CI: 0.62, 0.98; P = 0.033) after adjustment for conventional risk factors. Haplotype analyses indicated that haplotype GCGC contributed to a lower CHD risk (OR = 0.78, 95% CI: 0.65, 0.93; P = 0.006) compared with the common haplotype AGGT. In a transfection assay, the C allele of rs2236659 showed a 37-40% increase in luciferase expression of the reporter gene luciferase in endothelial and non-endothelial cells compared with the T allele. Conclusions/Significance: These findings suggest that genetic variants in HSPA8 gene (especially promoter SNP rs2236659) contribute to the CHD susceptibility by affecting its expression level.	[He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [He, Meian; Guo, Huan; Yang, Xiaobo; Zhou, Li; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll,Minist Educ, Wuhan 430074, Peoples R China; [He, Meian; Cheng, Longxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Zeng, Hesong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tanguay, Robert M.] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Lab Cellular & Dev Genet, Quebec City, PQ G1K 7P4, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Laval University	He, MA (corresponding author), Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Zhang, Xiaomin/F-3206-2018		National Natural Science Foundation [NSFC-30525031, NSFC-30430590, NSFC-30711120579]; Canadian Institutes of Health Research (CIHR); American Heart Association Established Investigator Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); American Heart Association Established Investigator Award(American Heart Association)	This work was supported by grants from the National Natural Science Foundation (grant NSFC-30525031 and NSFC-30430590) and a China-Canada Joint Health Research Grant of the Canadian Institutes of Health Research (CIHR) and the National Natural Science Foundation (grant NSFC-30711120579) to RMT and TW. FBH's work was supported in part by the American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla MK, 1998, DIS MARKERS, V13, P227, DOI 10.1155/1998/235151; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chong KY, 1998, J MOL CELL CARDIOL, V30, P599, DOI 10.1006/jmcc.1997.0623; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de la Rosa EJ, 1998, P NATL ACAD SCI USA, V95, P9950, DOI 10.1073/pnas.95.17.9950; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Ding KY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-38; Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He MA, 2008, CELL STRESS CHAPERON, V13, P231, DOI 10.1007/s12192-008-0025-5; He MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004851; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mugge A, 1998, Z KARDIOL, V87, P851, DOI 10.1007/s003920050241; Steinberg D, 1999, J CLIN INVEST, V103, P1487, DOI 10.1172/JCI7298; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Su CY, 1998, J MOL CELL CARDIOL, V30, P587, DOI 10.1006/jmcc.1997.0622; Suzuki K, 2000, BASIC RES CARDIOL, V95, P397, DOI 10.1007/s003950070039; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Yun JK, 1997, P NATL ACAD SCI USA, V94, P13903, DOI 10.1073/pnas.94.25.13903	26	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9684	10.1371/journal.pone.0009684	http://dx.doi.org/10.1371/journal.pone.0009684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300519	gold, Green Published, Green Submitted			2022-12-25	WOS:000275716400004
J	Samengo, I; Montemurro, MA				Samengo, Ines; Montemurro, Marcelo A.			Conversion of Phase Information into a Spike-Count Code by Bursting Neurons	PLOS ONE			English	Article							EVOKED-POTENTIALS; IN-VIVO; OSCILLATIONS; PRECESSION; MODULATION; POPULATIONS; FREQUENCY; DYNAMICS; CORTEX	Single neurons in the cerebral cortex are immersed in a fluctuating electric field, the local field potential (LFP), which mainly originates from synchronous synaptic input into the local neural neighborhood. As shown by recent studies in visual and auditory cortices, the angular phase of the LFP at the time of spike generation adds significant extra information about the external world, beyond the one contained in the firing rate alone. However, no biologically plausible mechanism has yet been suggested that allows downstream neurons to infer the phase of the LFP at the soma of their pre-synaptic afferents. Therefore, so far there is no evidence that the nervous system can process phase information. Here we study a model of a bursting pyramidal neuron, driven by a time-dependent stimulus. We show that the number of spikes per burst varies systematically with the phase of the fluctuating input at the time of burst onset. The mapping between input phase and number of spikes per burst is a robust response feature for a broad range of stimulus statistics. Our results suggest that cortical bursting neurons could play a crucial role in translating LFP phase information into an easily decodable spike count code.	[Samengo, Ines] Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Samengo, Ines] Inst Balseiro, San Carlos De Bariloche, Rio Negro, Argentina; [Montemurro, Marcelo A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; University of Manchester	Samengo, I (corresponding author), Ctr Atom Bariloche, San Carlos De Bariloche, Rio Negro, Argentina.	M.Montemurro@manchester.ac.uk	Samengo, Ines/AAY-7605-2020	Montemurro, Marcelo/0000-0003-0893-8530	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Comision Nacional de Energi-a Atomica; Agencia Nacional de Promocion Cienti-fica y Tecnologica; Universidad Nacional de Cuyo of Argentina; UK Medical Research Council (MRC); Royal Society; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/C010841/1]; MRC [G0600164] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish; Medical Research Council [G0600164] Funding Source: researchfish	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Comision Nacional de Energi-a Atomica; Agencia Nacional de Promocion Cienti-fica y Tecnologica(ANPCyT); Universidad Nacional de Cuyo of Argentina; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Ines Samengo acknowledges support from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Comision Nacional de Energi-a Atomica, Agencia Nacional de Promocion Cienti-fica y Tecnologica and Universidad Nacional de Cuyo of Argentina (IS). Marcelo A. Montenurro was supported by the UK Medical Research Council (MRC), the Royal Society, and UK Engineering and Physical Sciences Research Council (EPSRC) grant EP/C010841/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFKEN GB, 1999, MATH METHODS PHYS; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; BUCHWALD JS, 1965, NATURE, V205, P1012, DOI 10.1038/2051012a0; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cang JH, 2003, J NEUROSCI, V23, P4108; Coombes S, 1999, PHYS REV E, V60, P2086, DOI 10.1103/PhysRevE.60.2086; Coombes S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041914; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 2006, EU J NEUROSCI, V2, P588; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; FROMM GH, 1967, ELECTROEN CLIN NEURO, V22, P159, DOI 10.1016/0013-4694(67)90156-3; FROMM GH, 1964, ELECTROEN CLIN NEURO, V17, P520, DOI 10.1016/0013-4694(64)90182-8; Gollisch T, 2005, PLOS BIOL, V3, P144, DOI 10.1371/journal.pbio.0030008; Gollisch T, 2002, J NEUROSCI, V22, P10434; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Juergens E, 1999, EXP BRAIN RES, V129, P247, DOI 10.1007/s002210050895; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Latham PE, 2008, CURR BIOL, V18, pR349, DOI 10.1016/j.cub.2008.02.062; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MARSAN CA, 1965, ISRAEL J MED SCI, V1, P104; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nadasdy Z, 1998, NEURONAL ENSEMBLES: STRATEGIES FOR RECORDING AND DECODING, P17; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	45	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9669	10.1371/journal.pone.0009669	http://dx.doi.org/10.1371/journal.pone.0009669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300632	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000275620900006
J	Lauterbach, H; Kassub, R; Patzold, J; Korner, J; Bruckel, M; Verschoor, A; Chaplin, P; Suter, M; Hochrein, H				Lauterbach, Henning; Kassub, Ronny; Paetzold, Juliane; Koerner, Jana; Brueckel, Michael; Verschoor, Admar; Chaplin, Paul; Suter, Mark; Hochrein, Hubertus			Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; POXVIRUS INFECTION; VIRUS ANKARA; PROTECTIVE IMMUNITY; GENETIC-RESISTANCE; ECTROMELIA-VIRUS; CUTTING EDGE; IN-VIVO; B-CELLS; VACCINATION	Current prophylactic vaccines work via the induction of B and T cell mediated memory that effectively control further replication of the pathogen after entry. In the case of therapeutic or post-exposure vaccinations the situation is far more complex, because the pathogen has time to establish itself in the host, start producing immune-inhibitory molecules and spread into distant organs. So far it is unclear which immune parameters have to be activated in order to thwart an existing lethal infection. Using the mousepox model, we investigated the immunological mechanisms responsible for a successful post-exposure immunization with modified vaccinia Ankara (MVA). In contrast to intranasal application of MVA, we found that intravenous immunization fully protected mice infected with ectromelia virus (ECTV) when applied three days after infection. Intravenous MVA immunization induced strong innate and adaptive immune responses in lethally infected mice. By using various gene-targeted and transgenic mouse strains we show that NK cells, CD4 T cells, CD8 T cells and antibodies are essential for the clearance of ECTV after post-exposure immunization. Post-exposure immunization with MVA is an effective measure in a murine model of human smallpox. MVA activates innate and adaptive immune parameters and only a combination thereof is able to purge ECTV from its host. These data not only provide a basis for therapeutic vaccinations in the case of the deliberate release of pathogenic poxviruses but possibly also for the treatment of chronic infections and cancer.	[Lauterbach, Henning; Kassub, Ronny; Paetzold, Juliane; Chaplin, Paul; Suter, Mark; Hochrein, Hubertus] Bavarian Nord GmbH, Dept Res, Martinsried, Germany; [Koerner, Jana; Brueckel, Michael] Bavarian Nord GmbH, Preclin Dev Dept, Martinsried, Germany; [Verschoor, Admar] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Suter, Mark] Univ Zurich, Zurich, Switzerland	Bavarian Nordic; Bavarian Nordic; Technical University of Munich; University of Zurich	Lauterbach, H (corresponding author), Bavarian Nord GmbH, Dept Res, Martinsried, Germany.	henning.lauterbach@bavarian-nordic.com	Hochrein, Hubertus/L-3697-2013	Hochrein, Hubertus/0000-0001-9904-1934; Lauterbach, Henning/0000-0002-6062-5163	Bavarian Nordic GmbH	Bavarian Nordic GmbH	Bavarian Nordic GmbH is the funder of this study. All authors except Admar Verschoor are employees of Bavarian Nordic GmbH. The authors, as employees of Bavarian Nordic GmbH, designed the study, collected and analyzed data, decided to publish and prepared the manuscript.	ANDREWES CH, 1948, BRIT J EXP PATHOL, V29, P329; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; BURNET FM, 1946, J IMMUNOL, V53, P1; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; FENNER F, 1949, AUST J EXP BIOL MED, V27, P19, DOI 10.1038/icb.1949.2; FENNER F, 1949, J IMMUNOL, V63, P341; FENNER F, 1947, AUST J EXP BIOL MED, V25, P257, DOI 10.1038/icb.1947.38; Garza NL, 2009, VACCINE, V27, P5496, DOI 10.1016/j.vaccine.2009.06.105; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Hanke T, 1998, J GEN VIROL, V79, P83, DOI 10.1099/0022-1317-79-1-83; JACOBY RO, 1989, ARCH VIROL, V108, P49, DOI 10.1007/BF01313742; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Jones T, 2008, CURR OPIN MOL THER, V10, P407; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Lehmann MH, 2009, J VIROL, V83, P2540, DOI 10.1128/JVI.01884-08; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Marchal J, 1930, J PATHOL BACTERIOL, V33, P713, DOI 10.1002/path.1700330317; MCCARTHY K, 1948, BRIT J EXP PATHOL, V29, P501; Merrick AE, 2009, CURR OPIN INVEST DR, V10, P1372; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Panchanathan V, 2005, P NATL ACAD SCI USA, V102, P12921, DOI 10.1073/pnas.0505180102; PANCHANATHAN V, 2010, IMMUNOL CELL BIOL; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Parker S, 2009, VIROLOGY, V385, P11, DOI 10.1016/j.virol.2008.11.015; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Prieur E, 2004, P NATL ACAD SCI USA, V101, P290, DOI 10.1073/pnas.0307158101; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wang Y, 2009, J IMMUNOL, V183, P3324, DOI 10.4049/jimmunol.0803985; WERNER GT, 1980, ARCH VIROL, V64, P247, DOI 10.1007/BF01322704; *WHO, 1980, 4 WHO; Zaunders JJ, 2006, J VIROL, V80, P10151, DOI 10.1128/JVI.02670-05	57	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2010	5	3							e9659	10.1371/journal.pone.0009659	http://dx.doi.org/10.1371/journal.pone.0009659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SJ	20300179	Green Submitted, gold, Green Published			2022-12-25	WOS:000275620600014
J	Jemal, A; Ward, E; Thun, M				Jemal, Ahmedin; Ward, Elizabeth; Thun, Michael			Declining Death Rates Reflect Progress against Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; PROSTATE-CANCER; UNITED-STATES; RISK-FACTORS; LUNG-CANCER; GASTROESOPHAGEAL-REFLUX; COLORECTAL-CANCER; TOBACCO USE; MORTALITY; TRENDS	Background: The success of the "war on cancer'' initiated in 1971 continues to be debated, with trends in cancer mortality variably presented as evidence of progress or failure. We examined temporal trends in death rates from all-cancer and the 19 most common cancers in the United States from 1970-2006. Methodology/Principal Findings: We analyzed trends in age-standardized death rates (per 100,000) for all cancers combined, the four most common cancers, and 15 other sites from 1970-2006 in the United States using joinpoint regression model. The age-standardized death rate for all-cancers combined in men increased from 249.3 in 1970 to 279.8 in 1990, and then decreased to 221.1 in 2006, yielding a net decline of 21% and 11% from the 1990 and 1970 rates, respectively. Similarly, the all-cancer death rate in women increased from 163.0 in 1970 to 175.3 in 1991 and then decreased to 153.7 in 2006, a net decline of 12% and 6% from the 1991 and 1970 rates, respectively. These decreases since 1990/91 translate to preventing of 561,400 cancer deaths in men and 205,700 deaths in women. The decrease in death rates from all-cancers involved all ages and racial/ethnic groups. Death rates decreased for 15 of the 19 cancer sites, including the four major cancers, with lung, colorectum and prostate cancers in men and breast and colorectum cancers in women. Conclusions/Significance: Progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The downturn in cancer death rates since 1990 result mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers. Continued and increased investment in cancer prevention and control, access to high quality health care, and research could accelerate this progress.	[Jemal, Ahmedin; Thun, Michael] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA	American Cancer Society	Jemal, A (corresponding author), Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA.	ajemal@cancer.org			American Cancer Society	American Cancer Society(American Cancer Society)	The American Cancer Society funded this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; ANDERSON R, 1998, NATL VITAL STAT REPO, V47, P16; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Balis FM, 2002, PRINCIPLES PRACTICE, V4th, P237; BEGLEY S, 2008, NEWSWEEK, V151, P42; BEGLEY S, 2008, NEWSWEEK, V152, P46; Begley Sharon, 2008, Newsweek, V152, P57; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; BOFFETTA P, 1993, INT J EPIDEMIOL, V22, P377, DOI 10.1093/ije/22.3.377; Bray FI, 2010, INT J CANCER, V126, P1454, DOI 10.1002/ijc.24855; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Brown Linda Morris, 2002, Surg Oncol Clin N Am, V11, P235, DOI 10.1016/S1055-3207(02)00002-9; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; CHU KC, 1991, JNCI-J NATL CANCER I, V83, P1636, DOI 10.1093/jnci/83.22.1636; Cole P, 1996, CANCER, V78, P2045, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2045::AID-CNCR3>3.0.CO;2-N; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; EDWARDS BK, 2009, CANCER; Edwards BK, 2009, CANCER, V116, P544, DOI DOI 10.1002/CNCR.24760; Einhorn L H, 1977, Urol Clin North Am, V4, P407; EINHORN LH, 1977, J UROLOGY, V117, P65, DOI 10.1016/S0022-5347(17)58338-X; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Feuer EJ, 2002, CANCER-AM CANCER SOC, V95, P870, DOI 10.1002/cncr.10726; Feuer EJ, 1999, JNCI-J NATL CANCER I, V91, P1025, DOI 10.1093/jnci/91.12.1025; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; GILES GG, 1991, AUST J PUBLIC HEALTH, V15, P245; HARRIS G, 2009, NEW YORK TIMES  0915; HOEL DG, 1993, JNCI-J NATL CANCER I, V85, P1063, DOI 10.1093/jnci/85.13.1063; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2003, J NATL CANCER I, V95, P1727, DOI 10.1093/jnci/djg116; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KOLATA G, 2009, ADV ELUSIVE LONG DRI; KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737; Leaf C, 2004, FORTUNE, V149, P76; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; *NAT CACN I SURV R, 2009, SEER STAT SOFTW; National Center for Health Statistics, 2009, HLTH US 2008; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Oliver SE, 2001, INT J CANCER, V92, P893, DOI 10.1002/ijc.1260; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Robles Sylvia C., 1996, Boletin de la Oficina Sanitaria Panamericana, V121, P478; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; *SEER, 2009, SEER CAUS DEATH REC; SEER Program, 2009, SEER STAT DAT MORT A; Shafey O, 2003, TOBACCO CONTROL COUN; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; SILVERMAN DT, 1994, JNCI-J NATL CANCER I, V86, P1510, DOI 10.1093/jnci/86.20.1510; SIMONE J, 2010, CANCER, P263; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Tarone RE, 1997, JNCI-J NATL CANCER I, V89, P251, DOI 10.1093/jnci/89.3.251; Taylor RJ, 2001, J EPIDEMIOL COMMUN H, V55, P782, DOI 10.1136/jech.55.11.782; Thun M.J., 2006, CANCER MED-US, V7th, P339; Thun MJ, 2006, TOB CONTROL, V15, P345, DOI 10.1136/tc.2006.017749; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; 2005, MMWR MORB MORTAL WKL, V54, P625	78	165	174	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9584	10.1371/journal.pone.0009584	http://dx.doi.org/10.1371/journal.pone.0009584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231893	Green Published, Green Submitted, gold			2022-12-25	WOS:000275328300007
J	Kennedy, KAM; Ostrakhovitch, EA; Sandiford, SDE; Dayarathna, T; Xie, XJ; Waese, EYL; Chang, WY; Feng, QP; Skerjanc, IS; Stanford, WL; Li, SSC				Kennedy, Karen A. M.; Ostrakhovitch, Elena A.; Sandiford, Shelley D. E.; Dayarathna, Thamara; Xie, Xiaojun; Waese, Elaine Y. L.; Chang, Wing Y.; Feng, Qingping; Skerjanc, Ilona S.; Stanford, William L.; Li, Shawn S. C.			Mammalian Numb-interacting Protein 1/Dual Oxidase Maturation Factor 1 Directs Neuronal Fate in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; NERVE GROWTH-FACTOR; INTERMEDIATE-FILAMENT PROTEIN; LAMIN-A/C EXPRESSION; NUCLEAR LAMIN; INDUCED DIFFERENTIATION; H2O2-INDUCED APOPTOSIS; TRANSCRIPTION FACTORS; MOUSE EMBRYO; PC12 CELLS	In this study, wedescribe a role for the mammalian Numb-interacting protein 1 (Nip1) in regulation of neuronal differentiation in stem cells. The expression of Nip1 was detected in the developing mouse brain, embryonic stem cells, primary neuronal stem cells, and retinoic acid-treated P19 embryonal carcinoma cells. The highest expression of Nip1 was observed in undifferentiated neuronal stem cells and was associated with Duox1-mediated reactive oxygen species ROS production. Ectopic nip1 expression in P19 embryonal carcinoma cells induced neuronal differentiation, and this phenotype was also linked to elevated ROS production. The neuronal differentiation in nip1-overexpressing P19 cells was achieved in a retinoic acid-independent manner and was corroborated by an increase in the expression of the neuronal basic helixloop-helix transcription factors and neural-lineage cell markers. Furthermore, depletion of nip1 by short hairpin RNA led to a decrease in the expression of neuronal basic helix-loop-helix transcription factors and ROS. However, inhibition of ROS production in nip1-overexpressing P19 cells restricted but did not extinguish neuronal differentiation. Microarray and mass spectrometry analysis identified intermediate filaments as the principal cytoskeletal elements affected by up-regulation of nip1. We show here the first evidence for a functional interaction between Nip1 and a component of the nuclear lamina, lamin A/C. associated with a neuronal-specific phenotype. Taken together, our data reveal an important role for Nip1 in the guidance of neuronal differentiation through ROS generation and modulation of intermediate filaments and implicate Nip1 as a novel intrinsic regulator of neuronal cell fate.	[Skerjanc, Ilona S.; Li, Shawn S. C.] Univ Western Ontario, Schulich Sch Med & Dent, Siebens Drake Med Res Inst, Dept Biochem, London, ON N6A 5C1, Canada; [Feng, Qingping] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Waese, Elaine Y. L.; Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada; [Chang, Wing Y.; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Microbiol, Ottawa, ON K1H 8M5, Canada; [Waese, Elaine Y. L.; Skerjanc, Ilona S.] Univ Ottawa, Dept Immunol, Ottawa, ON K1H 8M5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; University of Ottawa; University of Ottawa	Li, SSC (corresponding author), UWO, Schulich Sch Med & Dent, SDRI, 1400 Western Rd, London, ON N6A 5C1, Canada.	sli@uwo.ca	Skerjanc, Ilona/AAN-3318-2020	Feng, Qingping/0000-0001-9739-2765; Stanford, William/0000-0002-5813-8016	Canadian Institute of Health Research; Genome Canada through the Ontario Genomic Institute; University of Western Ontario; University of Toronto	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomic Institute(Genome Canada); University of Western Ontario; University of Toronto(University of Toronto)	This work was supported by grants from the Canadian Institute of Health Research (to I. S. S., W. L. S., and S. S. C. L.) and by Genome Canada through the Ontario Genomic Institute (to S. S. C. L.).; Supported by Ontario graduate scholarships, University of Western Ontario.; Supported by Ontario graduate scholarships, University of Toronto.	AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALETTA JM, 1988, J NEUROCHEM, V51, P1317, DOI 10.1111/j.1471-4159.1988.tb03104.x; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; COCHARD P, 1984, J NEUROSCI, V4, P2080; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; DE D, 2002, EXP CELL RES, V273, P187; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Faussone-Pellegrini MS, 1999, ANAT EMBRYOL, V199, P459, DOI 10.1007/s004290050244; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Grasberger H, 2007, MOL ENDOCRINOL, V21, P1408, DOI 10.1210/me.2007-0018; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Helfand BT, 2003, J CELL SCI, V116, P2345, DOI 10.1242/jcs.00526; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kamata H, 1996, NEUROSCI LETT, V212, P179, DOI 10.1016/0304-3940(96)12806-8; Katoh S, 1997, BIOCHEM BIOPH RES CO, V241, P347, DOI 10.1006/bbrc.1997.7514; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; LANOIX J, 1992, BIOCHEM BIOPH RES CO, V189, P1639, DOI 10.1016/0006-291X(92)90265-M; Laurent A, 2005, CANCER RES, V65, P948; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LEBEL S, 1987, J CELL BIOL, V105, P1099, DOI 10.1083/jcb.105.3.1099; LIN F, 1993, J BIOL CHEM, V268, P16321; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; MATTIA E, 1992, EXP CELL RES, V203, P449, DOI 10.1016/0014-4827(92)90020-9; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Qin HJ, 2004, J BIOL CHEM, V279, P11304, DOI 10.1074/jbc.M311733200; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; ROBER RA, 1989, DEVELOPMENT, V105, P365; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STAINES WA, 1994, NEUROSCIENCE, V58, P735, DOI 10.1016/0306-4522(94)90451-0; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Takamori Y, 2007, EUR J NEUROSCI, V25, P1653, DOI 10.1111/j.1460-9568.2007.05450.x; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wang S, 1998, NEUROREPORT, V9, P3207, DOI 10.1097/00001756-199810050-00014; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	67	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17974	17985		10.1074/jbc.M109.084616	http://dx.doi.org/10.1074/jbc.M109.084616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20233719	hybrid, Green Published			2022-12-25	WOS:000278133400073
J	Kelly, P; Bailey, CL; Fueger, PT; Newgard, CB; Casey, PJ; Kimple, ME				Kelly, Patrick; Bailey, Candice L.; Fueger, Patrick T.; Newgard, Christopher B.; Casey, Patrick J.; Kimple, Michelle E.			Rap1 Promotes Multiple Pancreatic Islet Cell Functions and Signals through Mammalian Target of Rapamycin Complex 1 to Enhance Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; S6 KINASE; CYCLIC-AMP; BETA-CELLS; DIABETES-MELLITUS; INSULIN-RESISTANCE; GENE-PRODUCTS; CAMP; ACTIVATION; PATHWAYS	Recent studies have implicated Epac2, a guanine-nucleotide exchange factor for the Rap subfamily of monomeric G proteins, as an important regulator of insulin secretion from pancreatic beta-cells. Although the Epac proteins were originally identified as cAMP-responsive activators of Rap1 GTPases, the role of Rap1 in beta-cell biology has not yet been defined. In this study, we examined the direct effects of Rap1 signaling on beta-cell biology. Using the Ins-1 rat insulinoma line, we demonstrate that activated Rap1A, but not related monomeric G proteins, promotes ribosomal protein S6 phosphorylation. Using isolated rat islets, we show that this signaling event is rapamycin-sensitive, indicating that it is mediated by the mammalian target of rapamycin complex 1-p70 S6 kinase pathway, a known growth regulatory pathway. This newly defined beta-cell signaling pathway acts downstream of cAMP, in parallel with the stimulation of cAMP-dependent protein kinase, to drive ribosomal protein S6 phosphorylation. Activated Rap1A promotes glucose-stimulated insulin secretion, islet cell hypertrophy, and islet cell proliferation, the latter exclusively through mammalian target of rapamycin complex 1, suggesting that Rap1 is an important regulator of beta-cell function. This newly defined signaling pathway may yield unique targets for the treatment of beta-cell dysfunction in diabetes.	[Kelly, Patrick; Bailey, Candice L.; Fueger, Patrick T.; Newgard, Christopher B.; Casey, Patrick J.; Kimple, Michelle E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Fueger, Patrick T.; Newgard, Christopher B.; Kimple, Michelle E.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Kimple, ME (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	michelle.kimple@duke.edu	Fueger, Patrick/G-8956-2013	Casey, Patrick/0000-0002-7366-9309	National Institutes of Health [DK078732, DK058398, DK076488, DK080845]; Duke University Medical School Alumni Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, K01DK080845, R01DK076488, R00DK078732, K99DK078732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Medical School Alumni Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078732 (to P. T. F.), DK058398 (to C. B. N.), DK076488 (to P. J. C.), and DK080845 (to M. E.; Supported in part by a Duke University Medical School Alumni Scholarship. Present address: Dept. of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bragado MJ, 1997, AM J PHYSIOL-CELL PH, V273, pC101, DOI 10.1152/ajpcell.1997.273.1.C101; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Cass LA, 1998, ENDOCRINOLOGY, V139, P1991, DOI 10.1210/en.139.4.1991; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Fueger PT, 2008, MOL ENDOCRINOL, V22, P1251, DOI 10.1210/me.2007-0500; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Furman B, 2004, J PHARM PHARMACOL, V56, P1477, DOI 10.1211/0022357044805; Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Lecureuil C, 2005, MOL ENDOCRINOL, V19, P1812, DOI 10.1210/me.2004-0289; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shelly C, 2002, J CELL SCI, V115, P1985; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; WITHERS DJ, 1995, J BIOL CHEM, V270, P21411, DOI 10.1074/jbc.270.36.21411; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Xie T, 2007, P NATL ACAD SCI USA, V104, P19601, DOI 10.1073/pnas.0704796104; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256	55	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15777	15785		10.1074/jbc.M109.069112	http://dx.doi.org/10.1074/jbc.M109.069112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20339002	Green Published, hybrid			2022-12-25	WOS:000277715900015
J	Crawford, J; Tonkin, ML; Grujic, O; Boulanger, MJ				Crawford, Joanna; Tonkin, Michelle L.; Grujic, Ognjen; Boulanger, Martin J.			Structural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA VACCINE CANDIDATE; DOMAIN-III; PASSIVE-IMMUNIZATION; ERYTHROCYTE INVASION; MONOCLONAL-ANTIBODY; PROTECTS MICE; PLASMODIUM; HOMOLOG; ENCEPHALITIS; INFECTION	Apical membrane antigen 1 (AMA1) is an essential component of the moving junction complex used by Apicomplexan parasites to invade host cells. We report the 2.0 angstrom resolution x-ray crystal structure of the full ectodomain (domains I, II, and III) of AMA1 from the pervasive protozoan parasite Toxoplasma gondii. The structure of T. gondii AMA1 (TgAMA1) is the most complete of any AMA1 structure to date, with more than 97.5% of the ectodomain unambiguously modeled. Comparative sequence analysis reveals discrete segments of divergence in TgAMA1 that map to areas of established functional importance in AMA1 from Plasmodium vivax (PvAMA1) and Plasmodium falciparum (PfAMA1). Inspection of the TgAMA1 structure reveals a network of apical surface loops, reorganized in both size and chemistry relative to PvAMA1/PfAMA1, that appear to serve as structural filters restricting access to a central hydrophobic groove. The terminal portion of this groove is formed by an extended loop from DII that is 14 residues shorter in TgAMA1. A pair of tryptophan residues (Trp(353) and Trp(354)) anchor the DII loop in the hydrophobic groove and frame a conserved tyrosine (Tyr(230)), forming a contiguous surface that may be critical for moving junction assembly. The minimalist DIII structure folds into a cystine knot that probably stabilizes and orients the bulk of the ectodmain without providing excess surface area to which invasion-inhibitory antibodies can be generated. The detailed structural characterization of TgAMA1 provides valuable insight into the mechanism of host cell invasion by T. gondii.	[Crawford, Joanna; Tonkin, Michelle L.; Grujic, Ognjen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889	Canadian Institutes of Health Research (CIHR) [MOP82915]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP82915 (to M. J. B.).	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Carruthers Vern, 2007, Curr Opin Microbiol, V10, P83, DOI 10.1016/j.mib.2006.06.017; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; DEANS JA, 1984, MOL BIOCHEM PARASIT, V11, P189, DOI 10.1016/0166-6851(84)90065-3; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jones JL, 2003, EMERG INFECT DIS, V9, P1371, DOI 10.3201/eid0911.030098; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; MICHEL R, 1980, INT J PARASITOL, V10, P309, DOI 10.1016/0020-7519(80)90012-0; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	61	38	43	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15644	15652		10.1074/jbc.M109.092619	http://dx.doi.org/10.1074/jbc.M109.092619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304917	hybrid, Green Published			2022-12-25	WOS:000277399000083
J	Jongerius, I; Garcia, BL; Geisbrecht, BV; van Strijp, JAG; Rooijakkers, SHM				Jongerius, Ilse; Garcia, Brandon L.; Geisbrecht, Brian V.; van Strijp, Jos A. G.; Rooijakkers, Suzan H. M.			Convertase Inhibitory Properties of Staphylococcal Extracellular Complement-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY C5 CONVERTASE; IMMUNE EVASION; ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; C3 CONVERTASES; 2 PARTS; AUREUS; IMMUNOLOGY; MOLECULES; PROPERDIN	The human pathogen Staphylococcus aureus secretes several complement evasion molecules to combat the human immune response. Extracellular complement-binding protein (Ecb) binds to the C3d domain of C3 and thereby blocks C3 convertases of the alternative pathway and C5 convertases via all complement pathways. Inhibition of C5 convertases results in complete inhibition of C5a generation and subsequent neutrophil migration. Here, we show that binding of Ecb to the C3d domain of C3b is crucial for inhibition of C5 convertases. Ecb does not interfere with substrate binding to convertases but prevents formation of an active convertase enzyme.	Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Garcia, Brandon L.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Utrecht University; Utrecht University Medical Center; University of Missouri System; University of Missouri Kansas City	Jongerius, I (corresponding author), Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	i.jongerius@umcutrecht.nl	van Strijp, Jos A.G./J-9549-2014	van Strijp, Jos A.G./0000-0001-6253-0830; Jongerius, Ilse/0000-0002-7759-9897	NIAID/National Institutes of Health [AI071028]; Council for Medical Sciences of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council for Medical Sciences of the Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/National Institutes of Health Grant AI071028 ( to B. V. G.). This work was also supported by the Council for Medical Sciences of the Netherlands Organization for Scientific Research ( S. H. M. R. and J.A. G. v. S.).	BODEN MK, 1992, MICROB PATHOGENESIS, V12, P289, DOI 10.1016/0882-4010(92)90047-R; BODEN MK, 1989, INFECT IMMUN, V57, P2358; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; DAHA MR, 1976, J IMMUNOL, V117, P630; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Janssen BJC, 2007, NATURE, V448, pE1, DOI 10.1038/nature06102; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; KOZONO H, 1990, J BIOL CHEM, V265, P14444; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MEDICUS RG, 1976, SCAND J IMMUNOL, V5, P1049, DOI 10.1111/j.1365-3083.1976.tb03056.x; MEDICUS RG, 1976, P NATL ACAD SCI USA, V73, P612, DOI 10.1073/pnas.73.2.612; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Sandoval A, 2000, J IMMUNOL, V165, P1066, DOI 10.4049/jimmunol.165.2.1066; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	43	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14973	14979		10.1074/jbc.M109.091975	http://dx.doi.org/10.1074/jbc.M109.091975			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304920	hybrid, Green Published			2022-12-25	WOS:000277399000018
J	Adams, AC; Astapova, I; Fisher, FM; Badman, MK; Kurgansky, KE; Flier, JS; Hollenberg, AN; Maratos-Flier, E				Adams, Andrew C.; Astapova, Inna; Fisher, Ffolliott M.; Badman, Michael K.; Kurgansky, Katherine E.; Flier, Jeffrey S.; Hollenberg, Anthony N.; Maratos-Flier, Eleftheria			Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPAR alpha-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; NONALCOHOLIC FATTY LIVER; METABOLIC STATE; RECEPTOR; AGONIST; RATS; MICE; FIBROBLAST-GROWTH-FACTOR-21; STEATOSIS; INDUCTION	Thyroid hormone has profound and diverse effects on liver metabolism. Here we show that tri-iodothyronine (T3) treatment in mice acutely and specifically induces hepatic expression of the metabolic regulator fibroblast growth factor 21 (FGF21). Mice treated with T3 showed a dose-dependent increase in hepatic FGF21 expression with significant induction at doses as low as 100 mu g/kg. Time course studies determined that induction is seen as early as 4 h after treatment with a further increase in expression at 6 h after injection. As FGF21 expression is downstream of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha), we treated PPAR alpha knock-out mice with T3 and found no increase in expression, indicating that hepatic regulation of FGF21 by T3 in liver is via a PPAR alpha dependent mechanism. In contrast, in white adipose tissue, FGF21 expression was suppressed by T3 treatment, with other T3 targets unaffected. In cell culture studies with an FGF21 reporter construct, we determined that three transcription factors are required for induction of FGF21 expression: thyroid hormone receptor beta (TR beta), retinoid X receptor (RXR), and PPAR alpha. These findings indicate a novel regulatory pathway whereby T3 positively regulates hepatic FGF21 expression, presenting a novel therapeutic target for diseases such as non-alcoholic fatty liver disease.	[Maratos-Flier, Eleftheria] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol,Ctr Life Sci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maratos-Flier, E (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol,Ctr Life Sci, 3 Blackfan Circle, Boston, MA 02215 USA.	emaratos@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019	Kurgansky, Katherine/0000-0001-9357-0034	National Institutes of Health [RO1-DK56123, RO1-DK069983, R37-DK28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, R01DK069983, R37DK028082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK56123 (to A. N. H.), RO1-DK069983 (to E. M.-F.), and R37-DK28082 (to J. S. F.).	Araki O, 2005, P NATL ACAD SCI USA, V102, P16251, DOI 10.1073/pnas.0508556102; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Buroker NE, 2007, AM J PHYSIOL-ENDOC M, V292, pE453, DOI 10.1152/ajpendo.00267.2006; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Freitas FRS, 2005, J BONE MINER RES, V20, P294, DOI 10.1359/JBMR.041116; Grover GJ, 2007, CURR VASC PHARMACOL, V5, P141, DOI 10.2174/157016107780368271; Hollenberg AN, 1996, J BIOL CHEM, V271, P28516, DOI 10.1074/jbc.271.45.28516; HOLNESS MJ, 1987, BIOCHEM J, V247, P621, DOI 10.1042/bj2470621; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Monden T, 2003, THYROID, V13, P427, DOI 10.1089/105072503322021089; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Ribeiro MO, 2010, ENDOCRINOLOGY, V151, P432, DOI 10.1210/en.2009-0667; Silveira MG, 2009, LIVER INT, V29, P1094, DOI 10.1111/j.1478-3231.2009.02003.x; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Villicev CM, 2007, J ENDOCRINOL, V193, P21, DOI 10.1677/joe.1.07066; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	32	101	105	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14078	14082		10.1074/jbc.C110.107375	http://dx.doi.org/10.1074/jbc.C110.107375			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20236931	hybrid, Green Published			2022-12-25	WOS:000277299700002
J	Redondo, S; Ruiz, E; Gordillo-Moscoso, A; Navarro-Dorado, J; Ramajo, M; Carnero, M; Reguillo, F; Rodriguez, E; Tejerina, T				Redondo, Santiago; Ruiz, Emilio; Gordillo-Moscoso, Antonio; Navarro-Dorado, Jorge; Ramajo, Marta; Carnero, Manuel; Reguillo, Fernando; Rodriguez, Enrique; Tejerina, Teresa			Role of TGF-beta 1 and MAP Kinases in the Antiproliferative Effect of Aspirin in Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROLIFERATION; CLOPIDOGREL; INHIBITION; APOPTOSIS; ATHEROSCLEROSIS; THERAPY; ANGINA	Background: We aimed to test the antiproliferative effect of acetylsalicylic acid (ASA) on vascular smooth muscle cells (VSMC) from bypass surgery patients and the role of transforming growth factor beta 1 (TGF-beta 1). Methodology/Principal Findings: VSMC were isolated from remaining internal mammary artery from patients who underwent bypass surgery. Cell proliferation and DNA fragmentation were assessed by ELISA. Protein expression was assessed by Western blot. ASA inhibited BrdU incorporation at 2 mM. Anti-TGF-beta 1 was able to reverse this effect. ASA (2 mM) induced TGF-beta 1 secretion; however it was unable to induce Smad activation. ASA increased p38(MAPK) phosphorylation in a TGF-beta 1-independent manner. Anti-CD105 (endoglin) was unable to reverse the antiproliferative effect of ASA. Pre-surgical serum levels of TGF-b1 in patients who took at antiplatelet doses ASA were assessed by ELISA and remained unchanged. Conclusions/Significance: In vitro antiproliferative effects of aspirin (at antiinflammatory concentration) on human VSMC obtained from bypass patients are mediated by TGF-beta 1 and p38(MAPK). Pre-surgical serum levels of TGF-beta 1 from bypass patients who took aspirin at antiplatelet doses did not change.	[Redondo, Santiago; Ruiz, Emilio; Gordillo-Moscoso, Antonio; Navarro-Dorado, Jorge; Ramajo, Marta; Tejerina, Teresa] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain; [Carnero, Manuel; Reguillo, Fernando; Rodriguez, Enrique] Hosp Clin Univ San Carlos, Serv Cirugia Cardiaca, Madrid, Spain	Complutense University of Madrid	Redondo, S (corresponding author), Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain.	teje@med.ucm.es	Carnero, Manuel/AAF-4073-2021; Stefanadis, Christodoulos/ABH-2232-2020	Carnero, Manuel/0000-0001-5045-5765; Stefanadis, Christodoulos/0000-0001-5974-6454; Navarro-Dorado, Jorge/0000-0002-4643-3528; REGUILLO, FERNANDO/0000-0001-5610-1335; Carnero Alcazar, Manuel/0000-0002-3536-5996	Fondo de Investigaciones Sanitarias FIS [PI080920]; Red Tematica de Investigacion Cardiovascular RECAVA [RD/06/0014/1007]	Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Red Tematica de Investigacion Cardiovascular RECAVA	This work was funded by Fondo de Investigaciones Sanitarias FIS PI080920 (Health Research Fund from the Spanish Ministry of Health) and by Red Tematica de Investigacion Cardiovascular RECAVA RD/06/0014/1007 (Instituto de Salud Carlos III, Spanish Ministry of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Amann R, 2002, EUR J PHARMACOL, V447, P1, DOI 10.1016/S0014-2999(02)01828-9; Ansari HR, 2009, AM J PHYSIOL-HEART C, V297, pH1032, DOI 10.1152/ajpheart.00374.2009; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Ivanov VO, 1998, ATHEROSCLEROSIS, V140, P25, DOI 10.1016/S0021-9150(98)00102-6; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kropf J, 1997, CLIN CHEM, V43, P1965; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Okrainec K, 2005, J AM COLL CARDIOL, V45, P177, DOI 10.1016/j.jacc.2004.09.065; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; RANKE C, 1993, CIRCULATION, V87, P1873, DOI 10.1161/01.CIR.87.6.1873; RANKE C, 1994, CLIN INVESTIGATOR, V72, P673, DOI 10.1007/BF00212985; Redondo S, 2005, DIABETES, V54, P811, DOI 10.2337/diabetes.54.3.811; Redondo S, 2003, CIRCULATION, V107, P626, DOI 10.1161/01.CIR.0000045664.75269.A5; Redondo S, 2007, CYTOKINE GROWTH F R, V18, P279, DOI 10.1016/j.cytogfr.2007.04.005; Redondo S, 2007, EUR J PHARMACOL, V556, P36, DOI 10.1016/j.ejphar.2006.10.060; Refson JS, 1998, CIRCULATION, V97, P2506, DOI 10.1161/01.CIR.97.25.2506; Ruiz E, 2007, J PHARMACOL EXP THER, V321, P431, DOI 10.1124/jpet.106.114934; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schmidt-Weber CB, 2005, INT IMMUNOL, V17, P921, DOI 10.1093/intimm/dxh272; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Siegert A, 1999, J MOL MED-JMM, V77, P437, DOI 10.1007/s001090050374; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57	31	11	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9800	10.1371/journal.pone.0009800	http://dx.doi.org/10.1371/journal.pone.0009800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FR	20339548	Green Submitted, Green Published, gold			2022-12-25	WOS:000275894300023
J	Stromberg, SP; Carlson, JM				Stromberg, Sean P.; Carlson, Jean M.			The Suppression of Immune System Disorders by Passive Attrition	PLOS ONE			English	Article							HAY-FEVER; T-CELLS; MEMORY; AUTOIMMUNE; HOMEOSTASIS; INFECTIONS; RESISTANCE; CHILDREN; DISEASE; HYGIENE	Exposure to infectious diseases has an unexpected benefit of inhibiting autoimmune diseases and allergies. This is one of many fundamental fitness tradeoffs associated with immune system architecture. The immune system attacks pathogens, but also may (inappropriately) attack the host. Exposure to pathogens can suppress the deleterious response, at the price of illness and the decay of immunity to previous diseases. This "hygiene hypothesis'' has been associated with several possible underlying biological mechanisms. This study focuses on physiological constraints that lead to competition for survival between immune system cell types. Competition maintains a relatively constant total number of cells within each niche. The constraint implies that adding cells conferring new immunity requires loss (passive attrition) of some cells conferring previous immunities. We consider passive attrition as a mechanism to prevent the initial proliferation of autoreactive cells, thus preventing autoimmune disease. We see that this protection is a general property of homeostatic regulation and we look specifically at both the IL-15 and IL-7 regulated niches to make quantitative predictions using a mathematical model. This mathematical model yields insight into the dynamics of the "Hygiene Hypothesis,'' and makes quantitative predictions for experiments testing the ability of passive attrition to suppress immune system disorders. The model also makes a prediction of an anti-correlation between prevalence of immune system disorders and passive attrition rates.	[Stromberg, Sean P.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Stromberg, Sean P.; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Emory University; University of California System; University of California Santa Barbara	Stromberg, SP (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	stromberg@emory.edu			David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies through United States Army research [W911NF-09-D-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies through United States Army research	This work was supported by the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through United States Army research grant W911NF-09-D-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Bach JF, 2005, CELL IMMUNOL, V233, P158, DOI 10.1016/j.cellimm.2005.04.006; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Calcinaro F, 1997, IMMUNOL CELL BIOL, V75, P467, DOI 10.1038/icb.1997.72; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Zorzella SFC, 2007, MEM I OSWALDO CRUZ, V102, P931, DOI 10.1590/S0074-02762007000800007; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Kurtzke JF, 2000, J NEUROVIROL, V6, pS134; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; Pross H F, 1974, Adv Immunol, V18, P133, DOI 10.1016/S0065-2776(08)60309-0; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stromberg SP, 2006, PLOS COMPUT BIOL, V2, P1475, DOI 10.1371/journal.pcbi.0020160; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Utzny C, 2001, J THEOR BIOL, V211, P393, DOI 10.1006/jtbi.2001.2352; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9648	10.1371/journal.pone.0009648	http://dx.doi.org/10.1371/journal.pone.0009648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300517	gold, Green Submitted, Green Published			2022-12-25	WOS:000275716400002
J	Murray, LA; Rosada, R; Moreira, AP; Joshi, A; Kramer, MS; Hesson, DP; Argentieri, RL; Mathai, S; Gulati, M; Herzog, EL; Hogaboam, CM				Murray, Lynne A.; Rosada, Rogerio; Moreira, Ana Paula; Joshi, Amrita; Kramer, Michael S.; Hesson, David P.; Argentieri, Rochelle L.; Mathai, Susan; Gulati, Mridu; Herzog, Erica L.; Hogaboam, Cory M.			Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; ALTERNATIVE ACTIVATION; BLOOD MONOCYTES; INHIBITION; RECEPTOR; CELLS; LUNG; FIBROBLASTS; DIFFERENTIATION; INTERLEUKIN-13	Macrophages promote tissue remodeling but few mechanisms exist to modulate their activity during tissue fibrosis. Serum amyloid P (SAP), a member of the pentraxin family of proteins, signals through Fc gamma receptors which are known to affect macrophage activation. We determined that IPF/UIP patients have increased protein levels of several alternatively activated pro-fibrotic (M2) macrophage-associated proteins in the lung and monocytes from these patients show skewing towards an M2 macrophage phenotype. SAP therapeutically inhibits established bleomycin-induced pulmonary fibrosis, when administered systemically or locally to the lungs. The reduction in aberrant collagen deposition was associated with a reduction in M2 macrophages in the lung and increased IP10/CXCL10. These data highlight the role of macrophages in fibrotic lung disease, and demonstrate a therapeutic action of SAP on macrophages which may extend to many fibrotic indications caused by over-exuberant pro-fibrotic macrophage responses.	[Murray, Lynne A.; Kramer, Michael S.; Hesson, David P.; Argentieri, Rochelle L.] Promedior Inc, Malvern, PA USA; [Rosada, Rogerio; Moreira, Ana Paula; Joshi, Amrita; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Mathai, Susan; Gulati, Mridu; Herzog, Erica L.] Yale Univ, Sch Med, Internal Med Pulm & Crit Care Div, New Haven, CT USA	University of Michigan System; University of Michigan; Yale University	Murray, LA (corresponding author), Promedior Inc, Malvern, PA USA.	MurrayL@MedImmune.com	Rosada, Rogerio/B-1396-2010; Hogaboam, Cory M./AAI-1433-2021; Murray, Lynne/AAB-1793-2020; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; Murray, Lynne/0000-0003-4879-966X; 	Promedior, Inc.	Promedior, Inc.	This study was sponsored by Promedior, Inc. LAM, MSK, DPH, and RLA are employees of Promedior and Promedior is supportive of publishing this manuscript. LAM conceived, designed, analyzed and wrote the paper and provided reagents. MSK provided reagents. DPH conceived and designed experiments and provided reagents, RLA performed experiments and analyzed the data.	Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Jakubzick C, 2004, AM J PATHOL, V164, P1989, DOI 10.1016/S0002-9440(10)63759-5; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Keane MP, 1999, J IMMUNOL, V163, P5686; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; LU J, 2008, STRUCTURAL RECOGNITI; Luzina IG, 2008, J LEUKOCYTE BIOL, V83, P237, DOI 10.1189/jlb.0707504; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Murray LA, 2008, INT J BIOCHEM CELL B, V40, P2174, DOI 10.1016/j.biocel.2008.02.016; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90	26	148	154	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2010	5	3							e9683	10.1371/journal.pone.0009683	http://dx.doi.org/10.1371/journal.pone.0009683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	569SL	20300636	gold, Green Published, Green Submitted			2022-12-25	WOS:000275620900016
J	McDonald, CJ; Jones, MK; Wallace, DF; Summerville, L; Nawaratna, S; Subramaniam, VN				McDonald, Cameron J.; Jones, Malcolm K.; Wallace, Daniel F.; Summerville, Lesa; Nawaratna, Sujeevi; Subramaniam, V. Nathan			Increased Iron Stores Correlate with Worse Disease Outcomes in a Mouse Model of Schistosomiasis Infection	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; HELMINTH INFECTIONS; YOUNG-ADULTS; ANEMIA; HEPCIDIN; JAPONICUM; HEMOCHROMATOSIS; INFLAMMATION; TRANSFERRIN; PHILIPPINES	Schistosomiasis is a significant parasitic infection creating disease burden throughout many of the world's developing nations. Iron deficiency anemia is also a significant health burden resulting from both nutritional deficit as well as parasitic infection in these countries. In this study we investigated the relationships between the disease outcomes of Schistosoma japonicum infection and iron homeostasis. We aimed to determine if host iron status has an effect on schistosome maturation or egg production, and to investigate the response of iron regulatory genes to chronic schistosomiasis infection. Wild-type C57BL/6 and Transferrin Receptor 2 null mice were infected with S. japonicum, and sacrificed at the onset of chronic disease. Transferrin Receptor 2 null mice are a model of type 3 hereditary hemochromatosis and develop significant iron overload providing increased iron stores at the onset of infection. The infectivity of schistosomes and egg production was assessed along with the subsequent development of granulomas and fibrosis. The response of the iron regulatory gene Hepcidin to infection and the changes in iron status were assessed by real-time PCR and Western blotting. Our results show that Hepcidin levels responded to the changing iron status of the animals, but were not significantly influenced by the inflammatory response. We also show that with increased iron availability at the time of infection there was greater development of fibrosis around granulomas. In conclusion, our studies indicate that chronic inflammation may not be the primary cause of the anemia seen in schistosomiasis, and suggest that increased availability of iron, such as through iron supplementation, may actually lead to increased disease severity.	[McDonald, Cameron J.; Wallace, Daniel F.; Summerville, Lesa; Subramaniam, V. Nathan] Queensland Inst Med Res, Div Canc & Cell Biol, Membrane Transport Lab, Brisbane, Qld 4006, Australia; [Jones, Malcolm K.; Nawaratna, Sujeevi] Queensland Inst Med Res, Div Infect Dis & Immunol, Parasite Cell Biol Lab, Brisbane, Qld 4006, Australia; [Jones, Malcolm K.; Nawaratna, Sujeevi] Queensland Inst Med Res, Sch Vet Sci, Brisbane, Qld 4006, Australia; [Subramaniam, V. Nathan] Univ Queensland, Sch Med, Liver Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland	McDonald, CJ (corresponding author), Queensland Inst Med Res, Div Canc & Cell Biol, Membrane Transport Lab, Brisbane, Qld 4006, Australia.	Nathan.Subramaniam@qimr.edu.au	Jones, Malcolm K/A-1097-2009; McDonald, Cameron/M-9928-2016; Subramaniam, V. Nathan/A-1901-2010; Wallace, Daniel F/D-2638-2009	Jones, Malcolm K/0000-0002-0035-6141; McDonald, Cameron/0000-0001-7904-6797; Subramaniam, V. Nathan/0000-0002-4583-7790; Wallace, Daniel F/0000-0002-6019-9424	National Health and Medical Research Council (NHMRC) of Australia [339400]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Program Grant from the National Health and Medical Research Council (NHMRC) of Australia (339400) to VNS. DFW is the recipient of an NHMRC R. D. Wright Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Chang D, 2006, ACTA TROP, V97, P318, DOI 10.1016/j.actatropica.2005.12.006; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; CLEMENS LE, 1989, J PARASITOL, V75, P417, DOI 10.2307/3282599; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; de Mast Q, 2009, BRIT J HAEMATOL, V145, P657, DOI 10.1111/j.1365-2141.2009.07664.x; Denic S, 2007, NUTRITION, V23, P603, DOI 10.1016/j.nut.2007.05.002; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; Ezeamama AE, 2005, J INFECT DIS, V192, P2160, DOI 10.1086/498219; Fleck A, 1985, ACUTE PHASE RESPONSE, P249; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Friis H, 2003, EUR J CLIN NUTR, V57, P573, DOI 10.1038/sj.ejcn.1601568; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Kanzaria HK, 2005, AM J TROP MED HYG, V72, P115, DOI 10.4269/ajtmh.2005.72.115; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Leenstra T, 2006, AM J CLIN NUTR, V83, P371; Leenstra T, 2006, INFECT IMMUN, V74, P6398, DOI 10.1128/IAI.00757-06; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Ramm GA, 1997, J HEPATOL, V26, P584, DOI 10.1016/S0168-8278(97)80424-2; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004; Steinmann P, 2007, ACTA TROP, V104, P38, DOI 10.1016/j.actatropica.2007.07.003; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Wallace DF, 2007, WORLD J GASTROENTERO, V13, P4690, DOI 10.3748/wjg.v13.i35.4690; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	33	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9594	10.1371/journal.pone.0009594	http://dx.doi.org/10.1371/journal.pone.0009594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231891	Green Published, gold, Green Submitted			2022-12-25	WOS:000275328300012
J	Sharma, NS; Nagrath, D; Yarmush, ML				Sharma, Nripen S.; Nagrath, Deepak; Yarmush, Martin L.			Adipocyte-derived basement membrane extract with biological activity: applications in hepatocyte functional augmentation in vitro	FASEB JOURNAL			English	Article						Adipogel; natural biomaterials; metabolic analysis	ISOLATED RAT HEPATOCYTES; METABOLIC FLUX ANALYSIS; LONG-TERM CULTURE; EXTRACELLULAR-MATRIX; PROTEIN-SYNTHESIS; AMINO-ACIDS; SANDWICH CONFIGURATION; COLLAGEN SANDWICH; GROWTH-FACTORS; LIVER	Natural and synthetic biomaterials utilized in tissue engineering applications require a dynamic interplay of complex macromolecular compositions of hydrated extracellular matrices (ECMs) and soluble growth factors. The challenges in utilizing synthetic ECMs is the effective control of temporal and spatial complexity of multiple signal presentation, as compared to natural ECMs that possess the inherent properties of biological recognition, including presentation of receptor-binding ligands, susceptibility to cell-triggered proteolytic degradation, and remodeling. We have developed a murine preadipocyte differentiation system for generating a natural basement membrane extract (Adipogel) comprising ECM proteins (collagen IV, laminin, hyaluronan, and fibronectin) and including relevant growth factors (hepatocyte growth factor, vascular endothelial growth factor, and leukemia inhibitory factor). We have shown the effective utilization of the growth factor-enriched extracellular matrix for enhanced albumin synthesis rate of primary hepatocyte cultures for a period of 10 d as compared to collagen sandwich cultures and comparable or higher function as compared to Matrigel cultures. We have also demonstrated comparable cytochrome P450 1A1 activity for the collagen-Adipogel condition to the collagen double-gel and Matrigel culture conditions. A metabolic analysis revealed that utilization of Adipogel in primary hepatocyte cultures increased serine, glycine, threonine, alanine, tyrosine, valine, methionine, lysine, isoleucine, leucine, phenylalanine, taurine, cysteine, and glucose uptake rates to enhance hepatocyte protein synthesis as compared to collagen double-gel cultures. The demonstrated synthesis, isolation, characterization, and application of Adipogel provide immense potential for tissue engineering and regenerative medicine applications.-Sharma, N. S., Nagrath, D., Yarmush, M. L. Adipocyte-derived basement membrane extract with biological activity: applications in hepatocyte functional augmentation in vitro. FASEB J. 24, 2364-2374 (2010). www.fasebj.org	[Sharma, Nripen S.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA 02114 USA; [Sharma, Nripen S.; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Surg Serv, Boston, MA USA; [Sharma, Nripen S.; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Nagrath, Deepak] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Rutgers State University New Brunswick; Rice University	Yarmush, ML (corresponding author), Shriners Hosp Children, 51 Blossom St, Boston, MA 02114 USA.	ireis@sbi.org		Yarmush, Martin/0000-0003-4986-8444; Nagrath, Deepak/0000-0002-8999-2282	U.S. National Institutes of Health [R01 DK059766, R01 AI063795]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059766, P30DK040561] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants R01 DK059766 and R01 AI063795, and grants from the Shriners Hospitals for Children. Resources were provided by the BioMEMS Resource Center (P41 EB-002503). The authors declare there are no conflicts of interest.	Abberton KM, 2008, CELLS TISSUES ORGANS, V188, P347, DOI 10.1159/000121575; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Berthiaume F, 2003, METAB ENG, V5, P108, DOI 10.1016/S1096-7176(03)00010-7; Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chan C, 2002, BIOTECHNOL BIOENG, V78, P753, DOI 10.1002/bit.10275; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; DUNN JCY, 1993, BIOTECHNOL BIOENG, V41, P593, DOI 10.1002/bit.260410512; Farkas D, 2005, CHEM RES TOXICOL, V18, P1132, DOI 10.1021/tx0500225; Farkas D, 2005, TOXICOL SCI, V85, P927, DOI 10.1093/toxsci/kfi145; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; Kang YH, 2004, EXP CELL RES, V293, P239, DOI 10.1016/j.yexcr.2003.10.011; Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008; LEE JW, 1992, BIOTECHNOL BIOENG, V40, P298, DOI 10.1002/bit.260400214; Lee K, 2003, METAB ENG, V5, P221, DOI 10.1016/S1096-7176(03)00042-9; Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Nagrath D, 2009, METAB ENG, V11, P274, DOI 10.1016/j.ymben.2009.05.005; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Reid L M, 1980, Ann N Y Acad Sci, V349, P70, DOI 10.1111/j.1749-6632.1980.tb29516.x; Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; RYAN CM, 1993, SURGERY, V113, P48; SEGLEN PO, 1978, BIOCHIM BIOPHYS ACTA, V520, P630, DOI 10.1016/0005-2787(78)90148-X; SEGLEN PO, 1978, EUR J BIOCHEM, V85, P15, DOI 10.1111/j.1432-1033.1978.tb12208.x; SELGEN PO, 1976, METHOD CELL BIOL, V13, P29; Sharma NS, 2005, BIOTECHNOL BIOENG, V92, P321, DOI 10.1002/bit.20586; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Washizu J, 2001, TISSUE ENG, V7, P691, DOI 10.1089/107632701753337654; Yamaguchi Y, 1997, SURGERY, V121, P295, DOI 10.1016/S0039-6060(97)90358-5	41	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2010	24	7					2364	2374		10.1096/fj.09-135095	http://dx.doi.org/10.1096/fj.09-135095			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	618HV	20233948	Green Published			2022-12-25	WOS:000279343600023
J	Haruta, M; Burch, HL; Nelson, RB; Barrett-Wilt, G; Kline, KG; Mohsin, SB; Young, JC; Otegui, MS; Sussman, MR				Haruta, Miyoshi; Burch, Heather L.; Nelson, Rachel B.; Barrett-Wilt, Greg; Kline, Kelli G.; Mohsin, Sheher B.; Young, Jeffery C.; Otegui, Marisa S.; Sussman, Michael R.			Molecular Characterization of Mutant Arabidopsis Plants with Reduced Plasma Membrane Proton Pump Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; NA,K-ATPASE; THALIANA; ISOFORM; GROWTH; PROTEIN; IDENTIFICATION; DEFICIENCY; ACTIVATION; EXPRESSION	Arabidopsis mutants containing gene disruptions in AHA1 and AHA2, the two most highly expressed isoforms of the Arabidopsis plasma membrane H+-ATPase family, have been isolated and characterized. Plants containing homozygous loss-of-function mutations in either gene grew normally under laboratory conditions. Transcriptome and mass spectrometric measurements demonstrate that lack of lethality in the single gene mutations is not associated with compensation by increases in RNA or protein levels. Selected reaction monitoring using synthetic heavy isotope-labeled C-terminal tryptic peptides as spiked standards with a triple quadrupole mass spectrometer revealed increased levels of phosphorylation of a regulatory threonine residue in both isoforms in the mutants. Using an extracellular pH assay as a measure of in vivo ATPase activity in roots, less proton secreting activity was found in the aha2 mutant. Among 100 different growth conditions, those that decrease the membrane potential (high external potassium) or pH gradient (high external pH) caused a reduction in growth of the aha2 mutant compared with wild type. Despite the normal appearance of single mutants under ideal laboratory growth conditions, embryos containing homozygous double mutations are lethal, demonstrating that, as expected, this protein is absolutely essential for plant cell function. In conclusion, our results demonstrate that the two genes together perform an essential function and that the effects of their single mutations are mostly masked by overlapping patterns of expression and redundant function as well as by compensation at the post-translational level.	[Young, Jeffery C.; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Nelson, Rachel B.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Otegui, Marisa S.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Mohsin, Sheher B.] Agilent Technol, Schaumburg, IL 60173 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Agilent Technologies	Sussman, MR (corresponding author), 425 Henry Mall, Madison, WI 53706 USA.	msussman@wisc.edu		Haruta, Miyoshi/0000-0003-1686-1860; Otegui, Marisa/0000-0003-4699-6950	Department of Energy; National Science Foundation; National Science Foundation [MCB-0619736]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Department of Energy and the National Science Foundation (to M. R. S.) and by National Science Foundation Grant MCB-0619736 (to M. S. O.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2005, P NATL ACAD SCI USA, V102, P2649, DOI 10.1073/pnas.0406377102; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis MW, 1995, J NEUROSCI, V15, P8408; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Ellertsdottir E, 2006, DEV DYNAM, V235, P1794, DOI 10.1002/dvdy.20800; Feng Y, 1997, Genes Funct, V1, P99; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nelson CJ, 2006, MOL CELL PROTEOMICS, V5, P1382, DOI 10.1074/mcp.M500414-MCP200; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Robertson WR, 2004, GENETICS, V168, P1677, DOI 10.1534/genetics.104.032326; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Shu XD, 2003, DEVELOPMENT, V130, P6165, DOI 10.1242/dev.00844; Vitart V, 2001, PLANT J, V27, P191, DOI 10.1046/j.1365-313x.2001.01081.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; Zhao RM, 2000, PLANT CELL, V12, P535, DOI 10.1105/tpc.12.4.535	33	118	125	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17918	17929		10.1074/jbc.M110.101733	http://dx.doi.org/10.1074/jbc.M110.101733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348108	Green Published, hybrid			2022-12-25	WOS:000278133400068
J	Koenig, P; Mirus, O; Haarmann, R; Sommer, MS; Sinning, I; Schleiff, E; Tews, I				Koenig, Patrick; Mirus, Oliver; Haarmann, Raimund; Sommer, Maik S.; Sinning, Irmgard; Schleiff, Enrico; Tews, Ivo			Conserved Properties of Polypeptide Transport-associated (POTRA) Domains Derived from Cyanobacterial Omp85	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; YAET COMPLEX; BIOGENESIS; CHANNEL; FAMILY; SURA; IDENTIFICATION; COMPONENT; ENVELOPE; CLONING	Proteins of the Omp85 family are conserved in all kingdoms of life. They mediate protein transport across or protein insertion into membranes and reside in the outer membranes of Gram-negative bacteria, mitochondria, and chloroplasts. Omp85 proteins contain a C-terminal transmembrane beta-barrel and a soluble N terminus with a varying number of polypeptide-transport-associated or POTRA domains. Here we investigate Omp85 from the cyanobacterium Anabaena sp. PCC 7120. The crystallographic three-dimensional structure of the N-terminal region shows three POTRA domains, here named P1 to P3 from the N terminus. Molecular dynamics simulations revealed a hinge between P1 and P2 but in contrast show that P2 and P3 are fixed in orientation. The P2-P3 arrangement is identical as seen for the POTRA domains from proteobacterial FhaC, suggesting this orientation is a conserved feature. Furthermore, we define interfaces for protein-protein interaction in P1 and P2. P3 possesses an extended loop unique to cyanobacteria and plantae, which influences pore properties as shown by deletion. It now becomes clear how variations in structure of individual POTRA domains, as well as the different number of POTRA domains with both rigid and flexible connections make the N termini of Omp85 proteins versatile adaptors for a plentitude of functions.	[Mirus, Oliver; Haarmann, Raimund; Sommer, Maik S.; Schleiff, Enrico] JWGU Frankfurt Main, Ctr Membrane Prote & Cluster Excellence Macromol, Dept Biosci, D-60439 Frankfurt, Germany; [Tews, Ivo] Heidelberg Univ, Biochem Ctr BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Schleiff, E (corresponding author), JWGU Frankfurt Main, Ctr Membrane Prote & Cluster Excellence Macromol, Dept Biosci, Max von Laue Str 9, D-60439 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de; ivo.tews@bzh.uni-heidelberg.de	Schleiff, Enrico/C-5105-2017; Tews, Ivo/A-2750-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139	Deutsche Forschungsgemeinschaft (DFG) [SFB 807/P17, TR01/A10, SFB 638]; Cluster of Excellence Frankfurt Macromolecular Complexes; Volkswagenstiftung; Land Baden-Wurttemberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence Frankfurt Macromolecular Complexes; Volkswagenstiftung(Volkswagen); Land Baden-Wurttemberg	The work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SFB 807/P17 (to M. S. S., R. H., and E. S.) and SFB TR01/A10 (to O. M. and E. S.)), the Cluster of Excellence Frankfurt Macromolecular Complexes (to P. K. and E. S.), the Volkswagenstiftung (to E. S.), the interdisciplinary Ph.D. program "Molecular Machines: Mechanisms and Functional Interconnections" of the Land Baden-Wurttemberg (to P. K. and I. S.), and a collaborative research grant from the DFG (SFB 638 to I. S.).	Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eckart K, 2002, EMBO REP, V3, P557, DOI 10.1093/embo-reports/kvf110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koch O, 2009, PROTEINS, V74, P353, DOI 10.1002/prot.22185; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Manning DS, 1998, MICROB PATHOGENESIS, V25, P11, DOI 10.1006/mpat.1998.0206; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moslavac S, 2005, FEBS J, V272, P1367, DOI 10.1111/j.1742-4658.2005.04569.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruffolo CG, 1996, INFECT IMMUN, V64, P3161, DOI 10.1128/IAI.64.8.3161-3167.1996; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; THOMAS WR, 1986, INFECT IMMUN, V52, P812, DOI 10.1128/IAI.52.3.812-817.1986; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Ward R, 2009, STRUCTURE, V17, P1187, DOI 10.1016/j.str.2009.07.011; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; WUNDER T, 2009, ENDOCYT CELL RES, V19, P20	57	45	45	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18016	18024		10.1074/jbc.M110.112649	http://dx.doi.org/10.1074/jbc.M110.112649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348103	Green Published, hybrid			2022-12-25	WOS:000278133400077
J	Odvody, J; Vincent, T; Arrate, MP; Grieb, B; Wang, S; Garriga, J; Lozano, G; Iwakuma, T; Haines, DS; Eischen, CM				Odvody, J.; Vincent, T.; Arrate, M. P.; Grieb, B.; Wang, S.; Garriga, J.; Lozano, G.; Iwakuma, T.; Haines, D. S.; Eischen, C. M.			A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis	ONCOGENE			English	Article						MTBP; Myc; Mdm2; p53; lymphoma	C-MYC; APOPTOSIS; MTBP; P53; HAPLOINSUFFICIENCY; INSTABILITY; MICE	Mdm2 binding protein (MTBP) has been implicated in cell-cycle arrest and the Mdm2/p53 tumor suppressor pathway through its interaction with Mdm2. To determine the function of MTBP in tumorigenesis and its potential role in the Mdm2/p53 pathway, we crossed Mtbp-deficient mice to E mu-myc transgenic mice, in which overexpression of the oncogene c-Myc induces B-cell lymphomas primarily through inactivation of the Mdm2/p53 pathway. We report that Myc-induced B-cell lymphoma development in Mtbp heterozygous mice was profoundly delayed. Surprisingly, reduced levels of Mtbp did not lead to an increase in B-cell apoptosis or affect Mdm2. Instead, an Mtbp deficiency inhibited Myc-induced proliferation and the upregulation of Myc target genes necessary for cell growth. Consistent with a role in proliferation, Mtbp expression was induced by Myc and other factors that promote cell-cycle progression and was elevated in lymphomas from humans and mice. Therefore, Mtbp functioned independent of Mdm2 and was a limiting factor for the proliferative and transforming functions of Myc. Thus, Mtbp is a previously unrecognized regulator of Myc-induced tumorigenesis. Oncogene (2010) 29, 3287-3296; doi: 10.1038/onc.2010.82; published online 22 March 2010	[Eischen, C. M.] Vanderbilt Univ, Dept Pathol, Med Ctr, Sch Med, Nashville, TN 37232 USA; [Wang, S.; Haines, D. S.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA; [Garriga, J.; Haines, D. S.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; [Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; [Iwakuma, T.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; UTMD Anderson Cancer Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Eischen, CM (corresponding author), Vanderbilt Univ, Dept Pathol, Med Ctr, Sch Med, C3321 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	christine.eischen@vanderbilt.edu		Grieb, Brian/0000-0003-3980-8050	NCI [R01CA098139, R01CA117935, P30CA068485]; Leukemia & Lymphoma Society;  [P01CA095569]; NATIONAL CANCER INSTITUTE [R01CA098139, P01CA095569, R01CA117935, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Silvia Plaza, Brandon Metge, Jane Kennedy, and Dr Chris Carbone for expert technical assistance, Dr Xavier Grana for assistance with the adenoviruses and the H1299 cell-cycle studies, and Dr William Dupont and Dale Plummer for Kaplan-Meier analysis. We also thank the following individuals for providing recombinant adenoviruses: Dr Joseph Nevins (Duke University) E2F1 and c-Myc, Dr Juan Fueyo (MD Anderson Cancer Center) p16, Dr Wafik El-Deiry (University of Pennsylvania) p21, and Dr Ruiz-Lozano (Burnham Institute) GFP. This work was supported by NCI Grants R01CA098139, R01CA117935 and P30CA068485 (CME); the Leukemia & Lymphoma Society (CME) and P01CA095569 (DH and JG).	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Iwakuma T, 2008, ONCOGENE, V27, P1813, DOI 10.1038/sj.onc.1210827; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	19	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN 3	2010	29	22					3287	3296		10.1038/onc.2010.82	http://dx.doi.org/10.1038/onc.2010.82			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	605BA	20305689	Green Accepted			2022-12-25	WOS:000278321100011
J	Goto, A; Yano, T; Terashima, J; Iwashita, S; Oshima, Y; Kurata, S				Goto, Akira; Yano, Tamaki; Terashima, Jun; Iwashita, Shinzo; Oshima, Yoshiteru; Kurata, Shoichiro			Cooperative Regulation of the Induction of the Novel Antibacterial Listericin by Peptidoglycan Recognition Protein LE and the JAK-STAT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; IMMUNE-RESPONSE; INNATE IMMUNITY; HOST-DEFENSE; BACTERIAL-INFECTION; DROSOPHILA MUTANTS; SIGNALING PATHWAY; JAK/STAT PATHWAY; LISTERIOLYSIN-O; PGRP-LC	Intracellular bacteria cause serious infectious diseases such as tuberculosis, shigellosis, and listeriosis. The Drosophila peptidoglycan recognition protein (PGRP)-LE functions as an important host pattern recognition receptor against intracellular bacteria such as Listeria monocytogenes. One PGRP-LE-mediated intracellular response against L. monocytogenes infection is the induction of autophagy, a conserved intracellular degradation system. Here, to further elucidate PGRP-LE-mediated intracellular innate immune responses, we performed a strategic microarray analysis and identified the Listericin gene, whose expression is induced in response to L. monocytogenes infection in a PGRP-LE-dependent manner. RNA interference and overexpression experiments demonstrated that Listericin gene induction is cooperatively regulated by PGRP-LE and the JAK-STAT (Janus kinase-signal transducers and activators of transcription) pathway. An in vitro cell culture assay showed that Listericin is secreted as processed forms and suppresses the growth of L. monocytogenes and Gram-negative bacteria. A colony formation unit assay clearly demonstrated that induction of the Listericin gene suppresses not only the growth of L. monocytogenes but also the growth of Gram-negative bacteria in vivo. Based on these findings, we propose that the Listericin gene encodes a novel antibacterial peptide-like protein whose induction is cooperatively regulated by PGRP-LE and the JAK-STAT pathway.	[Goto, Akira; Yano, Tamaki; Terashima, Jun; Iwashita, Shinzo; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Goto, Akira] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University	Kurata, S (corresponding author), 6-3 Aramaki Aoba Ku, Sendai, Miyagi 9808578, Japan.	kurata@mail.pharm.tohoku.ac.jp	Yano, Tamaki/AHB-5620-2022; GOTO, Akira/V-7847-2017	Yano, Tamaki/0000-0002-5576-1128; GOTO, Akira/0000-0003-3395-484X	National Institutes of Health [AI07495]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Sciences; Japan Science and Technology Agency; Uehara Foundation; Naito Foundation; Tohoku University Ecosystem Adaptability; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495, R01AI074958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Tohoku University Ecosystem Adaptability; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI07495. This work was also supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Sciences, the Program for the Promotion of Basic Research Activities for Innovative Biosciences, Strategic International Cooperative program from Japan Science and Technology Agency, the Uehara Foundation, the Naito Foundation, and a Global COE Research Grant (Tohoku University Ecosystem Adaptability).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso A, 2004, INT MICROBIOL, V7, P181; Asha H, 2003, GENETICS, V163, P203; Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; BACH EA, 2003, SIGNAL TRANSDUCERS A, P87; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; BINA S, 2008, AJAK STAT PATHWAY DI, P24; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; Goto A, 2006, ISJ-INVERT SURVIV J, V3, P103; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	61	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15731	15738		10.1074/jbc.M109.082115	http://dx.doi.org/10.1074/jbc.M109.082115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348097	Green Published, hybrid			2022-12-25	WOS:000277715900008
J	Lymperopoulos, A; Rengo, G; Gao, EH; Ebert, SN; Dorn, GW; Koch, WJ				Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Ebert, Steven N.; Dorn, Gerald W., II; Koch, Walter J.			Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(2)-ADRENOCEPTOR SUBTYPES; CATECHOLAMINE RELEASE; RECEPTOR KINASE; NERVOUS-SYSTEM; POLYMORPHISMS; STIMULATION; PHYSIOLOGY; ABLATION; MICE	Chronic heart failure (HF) is characterized by sympathetic over-activity and enhanced circulating catecholamines (CAs), which significantly increase HF morbidity and mortality. We recently reported that adrenal G protein-coupled receptor kinase 2 (GRK2) is up-regulated in chronic HF, leading to enhanced CA release via desensitization/down-regulation of the chromaffin cell alpha(2)-adrenergic receptors that normally inhibit CA secretion. We also showed that adrenal GRK2 inhibition decreases circulating CAs and improves cardiac inotropic reserve and function. Herein, we hypothesized that adrenal-targeted GRK2 gene deletion before the onset of HF might be beneficial by reducing sympathetic activation. To specifically delete GRK2 in the chromaffin cells of the adrenal gland, we crossed PNMTCre mice, expressing Cre recombinase under the chromaffin cell-specific phenylethanolamine N-methyltransferase (PNMT) gene promoter, with floxedGRK2 mice. After confirming a significant (similar to 50%) reduction of adrenal GRK2 mRNA and protein levels, the PNMT-driven GRK2 knockout (KO) offspring underwent myocardial infarction (MI) to induce HF. At 4 weeks post-MI, plasma levels of both norepinephrine and epinephrine were reduced in PNMT-driven GRK2 KO, compared with control mice, suggesting markedly reduced post-MI sympathetic activation. This translated in PNMT-driven GRK2 KO mice into improved cardiac function and dimensions as well as amelioration of abnormal cardiac beta-adrenergic receptor signaling at 4 weeks post-MI. Thus, adrenal-targeted GRK2 gene KO decreases circulating CAs, leading to improved cardiac function and beta-adrenergic reserve in post-MI HF. GRK2 inhibition in the adrenal gland might represent a novel sympatholytic strategy that can aid in blocking HF progression.	[Lymperopoulos, Anastasios] Nova SE Univ, Dept Pharmaceut Sci, Coll Pharm, Ft Lauderdale, FL 33328 USA; [Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Koch, Walter J.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Koch, Walter J.] Thomas Jefferson Univ, Dept Med, George Zallie & Family Lab Cardiovasc Gene Therap, Philadelphia, PA 19107 USA; [Ebert, Steven N.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Dorn, Gerald W., II] Washington Univ, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA	Nova Southeastern University; Jefferson University; Jefferson University; State University System of Florida; University of Central Florida; Washington University (WUSTL)	Lymperopoulos, A (corresponding author), Nova SE Univ, Dept Pharmaceut Sci, Coll Pharm, 3200 S Univ Dr,HPD Terry Bldg,Rm 1338, Ft Lauderdale, FL 33328 USA.	al806@nova.edu	Rengo, Giuseppe/AAA-2870-2021; Lymperopoulos, Tasos/AAA-4366-2020; Rengo, Giuseppe/K-4963-2016	Rengo, Giuseppe/0000-0002-9701-0437; Rengo, Giuseppe/0000-0002-9701-0437; Lymperopoulos, Anastasios/0000-0001-9817-6319	National Institutes of Health [HL56205, HL61690, HL085503, HL075443, P01-HL091799]; American Heart Association [09SDG2010138]; Commonwealth of Pennsylvania Dept. of Health [A75301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R37HL061690, R01HL085503, P01HL091799, R01HL056205, R01HL061690, R01HL087871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Commonwealth of Pennsylvania Dept. of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56205, HL61690, HL085503, and HL075443 (Project 2) and P01-HL091799 (to W. J. K.). This work was also supported by post-doctoral fellowships (to A. L. and G. R.) from the American Heart Association (Great Rivers Affiliate) and by Grant A75301 from the Commonwealth of Pennsylvania Dept. of Health.; Supported by a Scientist Development Grant from the American Heart Association (AHA Grant 09SDG2010138, National Center). To whom correspondence should be addressed: Dept. of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, 3200 S. University Dr., HPD ( Terry) Bldg., Rm. 1338, Ft. Lauderdale, FL 33328. Tel.: 954-262-1338; Fax: 954-262-2278; E-mail: al806@nova.edu.	Brede M, 2003, MOL ENDOCRINOL, V17, P1640, DOI 10.1210/me.2003-0035; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Bristow MR, 2004, CIRCULATION, V110, P1437, DOI 10.1161/01.CIR.0000141297.50027.A4; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Ebert SN, 2004, DEV DYNAM, V231, P849, DOI 10.1002/dvdy.20188; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Floras JS, 2002, CIRCULATION, V105, P1753, DOI 10.1161/01.CIR.0000013788.71817.16; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lymperopoulos A, 2008, MOL THER, V16, P302, DOI 10.1038/sj.mt.6300371; Lymperopoulos A, 2007, TRENDS MOL MED, V13, P503, DOI 10.1016/j.molmed.2007.10.005; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Thomas S, 2007, HEART FAIL CLIN, V3, P381, DOI DOI 10.1016/J.HFC.2007.07.004; Tilley Douglas G, 2006, Expert Rev Cardiovasc Ther, V4, P417, DOI 10.1586/14779072.4.3.417; Wamhoff B R, 2007, Handb Exp Pharmacol, P441; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI; [No title captured]	29	95	97	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16378	16386		10.1074/jbc.M109.077859	http://dx.doi.org/10.1074/jbc.M109.077859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351116	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000277715900074
J	Tamoi, M; Tabuchi, T; Demuratani, M; Otori, K; Tanabe, N; Maruta, T; Shigeoka, S				Tamoi, Masahiro; Tabuchi, Tomoki; Demuratani, Masayo; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru			Point Mutation of a Plastidic Invertase Inhibits Development of the Photosynthetic Apparatus and Enhances Nitrate Assimilation in Sugar-treated Arabidopsis Seedlings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IMMUNOLOGICAL-PROPERTIES; GLUTAMINE-SYNTHETASE; NITROGEN-METABOLISM; SUCROSE METABOLISM; ALKALINE INVERTASE; PLANTS; GLUCOSE; HEXOKINASE; CHLOROPLASTS	Because the photosynthetic apparatus contains a massive amount of nitrogen in plants, the regulation of its development by sugar signals is important to the maintenance of the carbon-nitrogen balance. In this study we isolated an Arabidopsis mutant (sicy-192) whose cotyledon greening was inhibited by treatments with sugars such as sucrose, glucose, and fructose. In the mutant, the gene encoding plastidic alkaline/neutral invertase (INV-E) was point-mutated at codon 294, with Tyr substituted for Cys (C294Y). Interestingly, the greening of cotyledons in the knock-out INV-E lines was not inhibited by treatment with the sugars. In addition, the knock-out INV-E lines expressing an INV-E:C294Y or INV-E:C294A gene had the same phenotype as sicy-192 mutants, whereas the lines expressing a wildtype INV-E gene had the same phenotype as wild-type plants. A recombinant INV-E:C294Y protein had the same enzymatic activity as a recombinant INV-E protein, suggesting that the Cys-294 residue of INV-E is important for its functions in the chloroplasts. On treatment with sucrose, the expression of photosynthesis-related genes was weaker in seedlings of mutant plants than wild-type seedlings, whereas the activity of nitrate reductase was stronger in the mutant plants than wild-type plants. These findings suggest that Cys-294 of INV-E is associated with the development of the photosynthetic apparatus and the assimilation of nitrogen in Arabidopsis seedlings to control the ratio of sucrose content to hexose content.	[Tamoi, Masahiro; Tabuchi, Tomoki; Demuratani, Masayo; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Tamoi, Masahiro; Tabuchi, Tomoki; Otori, Kumi; Tanabe, Noriaki; Maruta, Takanori; Shigeoka, Shigeru] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kindai University (Kinki University); Japan Science & Technology Agency (JST)	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Tamoi, Masahiro/AAJ-1054-2021	Maruta, Takanori/0000-0003-4144-7821	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Core Research for Evolutional Science and Technology Project of the Japan Science and Technology Agency (Grant 2005-2010; to S. S.).	Acevedo-Hernandez GJ, 2005, PLANT J, V43, P506, DOI 10.1111/j.1365-313X.2005.02468.x; Aki T, 2007, J EXP BOT, V58, P3239, DOI 10.1093/jxb/erm169; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam A, 2007, ANAL BIOCHEM, V362, P151, DOI 10.1016/j.ab.2006.12.033; CASTLE LA, 1994, PLANT CELL, V6, P25, DOI 10.1105/tpc.6.1.25; CHEN JQ, 1992, ARCH BIOCHEM BIOPHYS, V295, P61, DOI 10.1016/0003-9861(92)90488-I; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Damari-Weissler H, 2006, PLANTA, V224, P1495, DOI 10.1007/s00425-006-0387-9; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Evans J.R., 1989, PHOTOSYNTHESIS, P183; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gerrits N, 2001, PLANT PHYSIOL, V125, P926, DOI 10.1104/pp.125.2.926; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Giese JO, 2005, FEBS LETT, V579, P827, DOI 10.1016/j.febslet.2004.12.071; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Hikosaka K, 1996, FUNCT ECOL, V10, P335, DOI 10.2307/2390281; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Lee HS, 1996, PLANT PHYSIOL, V112, P1513, DOI 10.1104/pp.112.4.1513; Lejay L, 2003, PLANT CELL, V15, P2218, DOI 10.1105/tpc.013516; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Nemeth K, 1998, GENE DEV, V12, P3059, DOI 10.1101/gad.12.19.3059; Ogawa T, 2009, PLANT J, V57, P289, DOI 10.1111/j.1365-313X.2008.03686.x; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; Rognoni S, 2007, PLANT GROWTH REGUL, V52, P217, DOI 10.1007/s10725-007-9193-z; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Taira M, 2004, PLANT CELL, V16, P2048, DOI 10.1105/tpc.104.022046; Tamoi M, 2006, PLANT CELL PHYSIOL, V47, P380, DOI 10.1093/pcp/pcj004; Tamoi M, 2005, BIOSCI BIOTECH BIOCH, V69, P848, DOI 10.1271/bbb.69.848; Vargas WA, 2008, PLANTA, V227, P795, DOI 10.1007/s00425-007-0657-1; VINCENTZ M, 1993, PLANT J, V3, P315, DOI 10.1046/j.1365-313X.1993.t01-16-00999.x; WALLSGROVE RM, 1983, PLANT CELL ENVIRON, V6, P301; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang P, 2007, SCIENCE, V316, P700, DOI 10.1126/science.1142703	54	27	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15399	15407		10.1074/jbc.M109.055111	http://dx.doi.org/10.1074/jbc.M109.055111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20304912	hybrid, Green Published			2022-12-25	WOS:000277399000060
J	Selvanathan, SP; Thakurta, AG; Dhakshnamoorthy, J; Zhou, M; Veenstra, TD; Dhar, R				Selvanathan, Saravana P.; Thakurta, Anjan G.; Dhakshnamoorthy, Jothy; Zhou, Ming; Veenstra, Timothy D.; Dhar, Ravi			Schizosaccharomyces pombe Dss1p Is a DNA Damage Checkpoint Protein That Recruits Rad24p, Cdc25p, and Rae1p to DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; POLY(A)(+) RNA; RAD51 HOMOLOG; CELL-CYCLE; COMPLEX; GENE; REPLICATION	Schizosaccharomyces pombe Dss1p and its homologs function in multiple cellular processes including recombinational repair of DNA and nuclear export of messenger RNA. We found that Tap-tagged Rad24p, a member of the 14-3-3 class of proteins, co-purified Dss1p along with mitotic activator Cdc25p, messenger RNA export/cell cycle factor Rae1p, 19 S proteasomal factors, and recombination protein Rhp51p (a Rad51p homolog). Using chromatin immunoprecipitation, we found that Dss1p recruited Rad24p and Rae1p to the double-strand break (DSB) sites. Furthermore, Cdc25p also recruited to the DSB site, and its recruitment was dependent on Dss1p, Rad24p, and the protein kinase Chk1p. Following DSB, all nuclear Cdc25p was found to be chromatin-associated. We found that Dss1p and Rae1p have a DNA damage checkpoint function, and upon treatment with UV light Delta dss1 cells entered mitosis prematurely with indistinguishable timing from Delta rad24 cells. Taken together, these results suggest that Dss1p plays a critical role in linking repair and checkpoint factors to damaged DNA sites by specifically recruiting Rad24p and Cdc25p to the DSBs. We suggest that the sequestration of Cdc25p to DNA damage sites could provide a mechanism for S. pombe cells to arrest at G(2)/M boundary in response to DNA damage.	[Selvanathan, Saravana P.; Thakurta, Anjan G.; Dhakshnamoorthy, Jothy; Dhar, Ravi] NCI, Basic Res Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, Sci Applicat Int Corp Frederick Inc,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Dhar, R (corresponding author), NCI, Basic Res Lab, Ctr Canc Res, NIH, Bldg 37,Rm 5016,37 Convent Dr,9000 Rockville Pike, Bethesda, MD 20892 USA.	dharr@mail.nih.gov			National Institutes of Health NCI; NATIONAL CANCER INSTITUTE [ZIABC005643] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI intramural program.	Alfa C., 1993, EXPT FISSION YEAST; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARBET NC, 1993, NATURE, V364, P824, DOI 10.1038/364824a0; Berry L D, 1996, Prog Cell Cycle Res, V2, P99; Bharathi A, 1997, GENE, V198, P251, DOI 10.1016/S0378-1119(97)00322-3; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Bruckmann A, 2004, BIOCHEM J, V382, P867, DOI 10.1042/BJ20031885; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chua G, 2002, GENETICS, V162, P689; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Gudmundsdottir K, 2004, EMBO REP, V5, P989, DOI 10.1038/sj.embor.7400255; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jang YK, 1996, MOL GEN GENET, V251, P167; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Josse L, 2006, BIOCHEM J, V393, P303, DOI 10.1042/BJ20051238; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lopez-Girona A, 2001, CURR BIOL, V11, P50, DOI 10.1016/S0960-9822(00)00026-9; Lygerou Z, 1999, J CELL SCI, V112, P3703; Mannen T, 2008, BIOCHEM BIOPH RES CO, V365, P664, DOI 10.1016/j.bbrc.2007.11.024; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Perez-Hidalgo L, 2008, CELL CYCLE, V7, P3720, DOI 10.4161/cc.7.23.7177; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rhind N, 2001, MOL CELL BIOL, V21, P1499, DOI 10.1128/MCB.21.5.1499-1508.2001; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; ROWLEY R, 1992, EMBO J, V11, P1335, DOI 10.1002/j.1460-2075.1992.tb05178.x; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Simkus C, 2009, IMMUNOLOGY, V128, P206, DOI 10.1111/j.1365-2567.2009.03101.x; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Thakurta AG, 2007, J BIOL CHEM, V282, P17507, DOI 10.1074/jbc.M609727200; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Whalen WA, 1997, YEAST, V13, P1167, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1167::AID-YEA154>3.3.CO;2-F; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000; Zhou QW, 2007, MOL CELL BIOL, V27, P2512, DOI 10.1128/MCB.01907-06	51	6	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14122	14133		10.1074/jbc.M109.083485	http://dx.doi.org/10.1074/jbc.M109.083485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20231270	hybrid, Green Published			2022-12-25	WOS:000277299700008
J	Zhang, YF; Smith, AD; Renfrow, MB; Schneider, DA				Zhang, Yinfeng; Smith, Archer D.; Renfrow, Matthew B.; Schneider, David A.			The RNA Polymerase-associated Factor 1 Complex (Paf1C) Directly Increases the Elongation Rate of RNA Polymerase I and Is Required for Efficient Regulation of rRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; ROLES; PHOSPHORYLATION; METHYLATION; EXPRESSION; PROTEINS; COMPASS; GROWTH	The rate of ribosome synthesis is proportional to the rate of cell proliferation; thus, transcription of rRNA by RNA polymerase I (Pol I) is an important target for the regulation of this process. Most previous investigations into mechanisms that regulate the rate of ribosome synthesis have focused on the initiation step of transcription by Pol I; however, recent studies in yeast and mammals have identified factors that influence transcription elongation by Pol I. The RNA polymerase-associated factor 1 complex (Paf1C) is a transcription elongation factor with known roles in Pol II transcription. We previously identified a role for Paf1C in transcription elongation by Pol I. In this study, genetic interactions between genes for Paf1C and Pol I subunits confirm this conclusion. In vitro studies demonstrate that purified Paf1C directly increases the rate of transcription elongation by Pol I. Finally, we show that Paf1C function is required for efficient control of Pol I transcription in response to target of rapamycin (TOR) signaling or amino acid limitation. These studies demonstrate that Paf1C plays an important direct role in cellular control of rRNA expression.	[Zhang, Yinfeng; Smith, Archer D.; Renfrow, Matthew B.; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, 442 Kaul Human Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091; Renfrow, Matthew B./0000-0002-4193-7305	NCI, National Institutes of Health [CA-13148-31]; American Cancer Society [IRG-60-001-47]; Health Services Foundation-General Endowment Fund;  [GM084946]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Health Services Foundation-General Endowment Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-13148-31 from NCI and Grant GM084946 (to D. A. S.). This work was also supported by American Cancer Society Grant IRG-60-001-47 and by University of Alabama at Birmingham institutional start-up funding from the Health Services Foundation-General Endowment Fund.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moniaux N, 2006, ONCOGENE, V25, P3247, DOI 10.1038/sj.onc.1209353; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2005, EUKARYOT CELL, V4, P209, DOI 10.1128/EC.4.1.209-220.2005; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Tongaonkar P, 2005, P NATL ACAD SCI USA, V102, P10129, DOI 10.1073/pnas.0504563102; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	40	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14152	14159		10.1074/jbc.M110.115220	http://dx.doi.org/10.1074/jbc.M110.115220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20299458	hybrid, Green Published			2022-12-25	WOS:000277299700011
J	Rout, N; Else, JG; Yue, S; Connole, M; Exley, MA; Kaur, A				Rout, Namita; Else, James G.; Yue, Simon; Connole, Michelle; Exley, Mark A.; Kaur, Amitinder			Paucity of CD4(+) Natural Killer T (NKT) Lymphocytes in Sooty Mangabeys Is Associated with Lack of NKT Cell Depletion after SIV Infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HERPES-SIMPLEX-VIRUS; TCR ALPHA-CHAIN; RHESUS MACAQUE SPLEEN; HEPATITIS-B-VIRUS; IN-VIVO; PERIPHERAL-BLOOD; HIV-1 INFECTION; DENDRITIC CELLS; CYTOKINE PRODUCTION	Lack of chronic immune activation in the presence of persistent viremia is a key feature that distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection in natural hosts from pathogenic SIV and HIV infection. To elucidate novel mechanisms downmodulating immune activation in natural hosts of SIV infection, we investigated natural killer T (NKT) lymphocytes in sooty mangabeys. NKT lymphocytes are a potent immunoregulatory arm of the innate immune system that recognize glycolipid antigens presented on the nonpolymorphic MHC-class I-like CD1d molecules. In a cross-sectional analysis of 50 SIV-negative and 50 naturally SIV-infected sooty mangabeys, ligand alpha-galactosylceramide loaded CD1d tetramers co-staining with V alpha 24-positive invariant NKT lymphocytes were detected at frequencies >= 0.002% of circulating T lymphocytes in approximately half of the animals. In contrast to published reports in Asian macaques, sooty mangabey NKT lymphocytes consisted of CD8(+) and CD4/CD8 double-negative T lymphocytes that were CXCR3-positive and CCR5-negative suggesting that they trafficked to sites of inflammation without being susceptible to SIV infection. Consistent with these findings, there was no difference in the frequency or phenotype of NKT lymphocytes between SIV-negative and SIV-infected sooty mangabeys. On stimulation with a-galactosylceramide loaded on human CD1d molecules, sooty mangabey NKT lymphocytes underwent degranulation and secreted IFN-gamma, TNF-alpha, IL-2, IL-13, and IL-10, indicating the presence of both effector and immunoregulatory functional capabilities. The unique absence of CD4(+) NKT lymphocytes in sooty mangabeys, combined with their IL-10 cytokine-secreting ability and preservation following SIV infection, raises the possibility that NKT lymphocytes might play a role in downmodulating immune activation in SIV-infected sooty mangabeys.	[Rout, Namita; Connole, Michelle; Kaur, Amitinder] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Yue, Simon; Exley, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Emory University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rout, N (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA.	amitinder_kaur@hms.harvard.edu		Exley, Mark/0000-0002-5088-1032	Public Health Service [RR00168, RR00165, DK066917, AI049809, AI084810]; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000165, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084810, R01AI049809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants RR00168, RR00165, DK066917, AI049809 and AI084810. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chakrabarti LA, 2000, J VIROL, V74, P1209, DOI 10.1128/JVI.74.3.1209-1223.2000; Chen YG, 2005, J IMMUNOL, V174, P1196, DOI 10.4049/jimmunol.174.3.1196; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Dieli F, 2003, J IMMUNOL, V171, P1961, DOI 10.4049/jimmunol.171.4.1961; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; EXLEY MA, 2003, CURR PROTOC IMMUNOL, pCH14; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fleuridor R, 2003, IMMUNOLOGY, V108, P3, DOI 10.1046/j.1365-2567.2003.01560.x; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gansuvd B, 2003, J IMMUNOL, V171, P2904, DOI 10.4049/jimmunol.171.6.2904; Gansuvd B, 2008, J MED PRIMATOL, V37, P1, DOI 10.1111/j.1600-0684.2007.00222.x; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kashiwase K, 2003, IMMUNOGENETICS, V54, P776, DOI 10.1007/s00251-002-0527-8; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lederer S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000296; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Moll M, 2006, BLOOD, V107, P3081, DOI 10.1182/blood-2005-09-3636; Moll M, 2009, EUR J IMMUNOL, V39, P902, DOI 10.1002/eji.200838780; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; Sandberg JK, 2002, J VIROL, V76, P7528, DOI 10.1128/JVI.76.15.7528-7534.2002; Shaulov A, 2008, EXP HEMATOL, V36, P464, DOI 10.1016/j.exphem.2007.12.010; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Unutmaz D, 2003, MICROBES INFECT, V5, P1041, DOI 10.1016/S1286-4579(03)00185-0; van der Vliet HJJ, 2006, J IMMUNOL, V177, P5775, DOI 10.4049/jimmunol.177.9.5775; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Vasan S, 2007, INT IMMUNOL, V19, P943, DOI 10.1093/intimm/dxm055; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; Wang ZC, 2006, J VIROL, V80, P2771, DOI 10.1128/JVI.80.6.2771-2783.2006; Watte CM, 2008, J LEUKOCYTE BIOL, V83, P928, DOI 10.1189/jlb.0807579; Yang OO, 2007, AIDS RES HUM RETROV, V23, P913, DOI 10.1089/aid.2006.0253	84	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2010	5	3							e9787	10.1371/journal.pone.0009787	http://dx.doi.org/10.1371/journal.pone.0009787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	573FT	20352088	Green Published, Green Submitted, gold			2022-12-25	WOS:000275894500004
J	Liu, LC; Ioannides, AA				Liu, Lichan; Ioannides, Andreas A.			Emotion Separation Is Completed Early and It Depends on Visual Field Presentation	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; SINGLE TRIAL ANALYSIS; HUMAN NEURAL SYSTEM; FACIAL EXPRESSIONS; TIME-COURSE; SPATIOTEMPORAL DYNAMICS; OCCIPITOTEMPORAL CORTEX; AFFECT RECOGNITION	It is now apparent that the visual system reacts to stimuli very fast, with many brain areas activated within 100 ms. It is, however, unclear how much detail is extracted about stimulus properties in the early stages of visual processing. Here, using magnetoencephalography we show that the visual system separates different facial expressions of emotion well within 100 ms after image onset, and that this separation is processed differently depending on where in the visual field the stimulus is presented. Seven right-handed males participated in a face affect recognition experiment in which they viewed happy, fearful and neutral faces. Blocks of images were shown either at the center or in one of the four quadrants of the visual field. For centrally presented faces, the emotions were separated fast, first in the right superior temporal sulcus (STS; 35-48 ms), followed by the right amygdala (57-64 ms) and medial pre-frontal cortex (83-96 ms). For faces presented in the periphery, the emotions were separated first in the ipsilateral amygdala and contralateral STS. We conclude that amygdala and STS likely play a different role in early visual processing, recruiting distinct neural networks for action: the amygdala alerts sub-cortical centers for appropriate autonomic system response for fight or flight decisions, while the STS facilitates more cognitive appraisal of situations and links appropriate cortical sites together. It is then likely that different problems may arise when either network fails to initiate or function properly.	[Liu, Lichan; Ioannides, Andreas A.] RIKEN, Brain Sci Inst, Lab Human Brain Dynam, Wako, Saitama, Japan; [Liu, Lichan; Ioannides, Andreas A.] AAI Sci Cultural Serv Ltd, Lab Human Brain Dynam, Nicosia, Cyprus	RIKEN	Liu, LC (corresponding author), RIKEN, Brain Sci Inst, Lab Human Brain Dynam, Wako, Saitama, Japan.	l.liu@humanbraindynamics.com			Research Promotion Foundation, Cyprus [0308/02]	Research Promotion Foundation, Cyprus	The MEG data of the present study was collected from the Laboratory for Human Brain Dynamics in RIKEN Brain Science Institute, Japan. The data was analyzed in the Laboratory for Human Brain Dynamics, AAI Scientific Cultural Services Ltd., Cyprus. A grant from Research Promotion Foundation, Cyprus, "Upgrading Information System" (no. 0308/02), provided the computer hardware for data storage and analysis, but this grant funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU BA, 2008, HUM BRAIN MAPP, V29, P1313; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; ARMONY JL, 1995, BEHAV NEUROSCI, V109, P246, DOI 10.1037/0735-7044.109.2.246; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BARBAS H, 1990, J COMP NEUROL, V300, P549, DOI 10.1002/cne.903000409; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; BRYDEN MP, 1990, BEHAV BRAIN SCI, V13, P547, DOI 10.1017/S0140525X00080079; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Christamn SD, 1997, CEREBRAL ASYMMETRIES, P263; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Debruille JB, 1998, NEUROREPORT, V9, P3349, DOI 10.1097/00001756-199810260-00002; EFRON R, 1990, DECLINE FALL HEMISPH; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Glascher J, 2003, J NEUROSCI, V23, P10274; GUR RC, 1994, BRAIN COGNITION, V25, P271, DOI 10.1006/brcg.1994.1036; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hanawalt NG, 1944, J GEN PSYCHOL, V31, P23, DOI 10.1080/00221309.1944.10545217; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Indersmitten T, 2003, J NEUROSCI, V23, P3820; Ioannides AA, 2000, HUM BRAIN MAPP, V11, P77, DOI 10.1002/1097-0193(200010)11:2<77::AID-HBM20>3.0.CO;2-0; Ioannides AA, 1995, INT J PSYCHOPHYSIOL, V20, P161, DOI 10.1016/0167-8760(95)00031-3; Ioannides AA, 2005, J NEUROSCI, V25, P7950, DOI 10.1523/JNEUROSCI.1091-05.2005; Ioannides AA, 2004, NEUROIMAGE, V23, P473, DOI 10.1016/j.neuroimage.2004.06.023; Ioannides AA, 2001, CLIN ELECTROENCEPHAL, V32, P98, DOI 10.1177/155005940103200304; IOANNIDES AA, 1990, INVERSE PROBL, V6, P523, DOI 10.1088/0266-5611/6/4/005; IOANNIDES AA, 2002, 5215 SOC NEUR; Ioannides AA, 2006, NEUROSCIENTIST, V12, P524, DOI 10.1177/1073858406293696; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; JAHN O, 1999, RECENT ADV BIOMAGNET, P224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kato Y, 2004, NEUROREPORT, V15, P225, DOI 10.1097/00001756-200402090-00002; KRAVITZ DJ, 2008, 2008 NEUR M PLANN WA; Kravitz DJ, 2008, TRENDS COGN SCI, V12, P114, DOI 10.1016/j.tics.2007.12.006; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Liu LC, 2006, NEUROIMAGE, V31, P1726, DOI 10.1016/j.neuroimage.2006.02.009; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Maruyama M, 2009, HUM BRAIN MAPP, V30, P147, DOI 10.1002/hbm.20495; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Moradi F, 2003, NEUROIMAGE, V18, P595, DOI 10.1016/S1053-8119(02)00053-8; MORAWETZ C, 2008, 2008 NEUR M PLANN WA; Morgan MA, 1999, NEUROBIOL LEARN MEM, V72, P244, DOI 10.1006/nlme.1999.3907; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nelson CA, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P79; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; Okazaki Y, 2008, NEUROSCIENCE, V152, P1130, DOI 10.1016/j.neuroscience.2008.01.056; Peyk P, 2008, BRAIN TOPOGR, V20, P205, DOI 10.1007/s10548-008-0052-7; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; Poghosyan V, 2008, NEURON, V58, P802, DOI 10.1016/j.neuron.2008.04.013; Poghosyan V, 2007, NEUROIMAGE, V35, P759, DOI 10.1016/j.neuroimage.2006.11.052; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; PREVIC FH, 1993, VISION RES, V33, P2697, DOI 10.1016/0042-6989(93)90229-P; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Ross ED, 2007, NEUROSCIENTIST, V13, P433, DOI 10.1177/1073858407305618; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Rudrauf D, 2008, J NEUROSCI, V28, P2793, DOI 10.1523/JNEUROSCI.3476-07.2008; SALK L, 1973, SCI AM, V228, P24, DOI 10.1038/scientificamerican0573-24; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2008, SOC COGN AFFECT NEUR, V3, P224, DOI 10.1093/scan/nsn016; Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748; Sieratzki JS, 1996, LANCET, V347, P1746, DOI 10.1016/S0140-6736(96)90813-2; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Streit M, 2001, AM J PSYCHIAT, V158, P1429, DOI 10.1176/appi.ajp.158.9.1429; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JG, 1999, IEEE T MED IMAGING, V18, P151, DOI 10.1109/42.759120; Tzelepi A, 2001, NEUROIMAGE, V13, P702, DOI 10.1006/nimg.2000.0735; Vauclair J, 2009, INFANT CHILD DEV, V18, P106, DOI 10.1002/icd.594; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; YOUNG AW, 1986, PSYCHOL RES-PSYCH FO, V48, P63, DOI 10.1007/BF00309318	106	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2010	5	3							e9790	10.1371/journal.pone.0009790	http://dx.doi.org/10.1371/journal.pone.0009790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	573FR	20339549	Green Published, gold, Green Submitted			2022-12-25	WOS:000275894300018
J	Mullin, CA; Frazier, M; Frazier, JL; Ashcraft, S; Simonds, R; vanEngelsdorp, D; Pettis, JS				Mullin, Christopher A.; Frazier, Maryann; Frazier, James L.; Ashcraft, Sara; Simonds, Roger; vanEngelsdorp, Dennis; Pettis, Jeffery S.			High Levels of Miticides and Agrochemicals in North American Apiaries: Implications for Honey Bee Health	PLOS ONE			English	Article							APIS-MELLIFERA L; COLONY LOSSES; PESTICIDE-RESIDUES; PYRETHROID INSECTICIDE; SYSTEMIC INSECTICIDES; ACARICIDE RESIDUES; POLLEN; HYMENOPTERA; RESISTANCE; TOXICITY	Background: Recent declines in honey bees for crop pollination threaten fruit, nut, vegetable and seed production in the United States. A broad survey of pesticide residues was conducted on samples from migratory and other beekeepers across 23 states, one Canadian province and several agricultural cropping systems during the 2007-08 growing seasons. Methodology/Principal Findings: We have used LC/MS-MS and GC/MS to analyze bees and hive matrices for pesticide residues utilizing a modified QuEChERS method. We have found 121 different pesticides and metabolites within 887 wax, pollen, bee and associated hive samples. Almost 60% of the 259 wax and 350 pollen samples contained at least one systemic pesticide, and over 47% had both in-hive acaricides fluvalinate and coumaphos, and chlorothalonil, a widely-used fungicide. In bee pollen were found chlorothalonil at levels up to 99 ppm and the insecticides aldicarb, carbaryl, chlorpyrifos and imidacloprid, fungicides boscalid, captan and myclobutanil, and herbicide pendimethalin at 1 ppm levels. Almost all comb and foundation wax samples (98%) were contaminated with up to 204 and 94 ppm, respectively, of fluvalinate and coumaphos, and lower amounts of amitraz degradates and chlorothalonil, with an average of 6 pesticide detections per sample and a high of 39. There were fewer pesticides found in adults and brood except for those linked with bee kills by permethrin (20 ppm) and fipronil (3.1 ppm). Conclusions/Significance: The 98 pesticides and metabolites detected in mixtures up to 214 ppm in bee pollen alone represents a remarkably high level for toxicants in the brood and adult food of this primary pollinator. This represents over half of the maximum individual pesticide incidences ever reported for apiaries. While exposure to many of these neurotoxicants elicits acute and sublethal reductions in honey bee fitness, the effects of these materials in combinations and their direct association with CCD or declining bee health remains to be determined.	[Mullin, Christopher A.; Frazier, Maryann; Frazier, James L.; Ashcraft, Sara] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Simonds, Roger] Agr Mkt Serv, Natl Sci Lab, USDA, Gastonia, NC USA; [vanEngelsdorp, Dennis] Penn Dept Agr, Harrisburg, PA USA; [Pettis, Jeffery S.] ARS, Bee Res Lab, USDA, Beltsville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Mullin, CA (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	camullin@psu.edu	vanEngelsdorp, Dennis/E-7934-2010		Florida State Beekeepers; National Honey Board; Penn State College of Agriculture Sciences; Project Apis mellifera (PAm); Tampa Bay Beekeepers; The Foundation for the Preservation of Honey Bees; United States Department of Agriculture	Florida State Beekeepers; National Honey Board; Penn State College of Agriculture Sciences; Project Apis mellifera (PAm); Tampa Bay Beekeepers; The Foundation for the Preservation of Honey Bees; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding was received from the Florida State Beekeepers, National Honey Board, Penn State College of Agriculture Sciences, Project Apis mellifera (PAm), Tampa Bay Beekeepers, The Foundation for the Preservation of Honey Bees, and the United States Department of Agriculture Critical Issues program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder L, 2006, MASS SPECTROM REV, V25, P838, DOI 10.1002/mas.20091; ALDRIDGE WN, 1969, BIOCHEM J, V115, P147, DOI 10.1042/bj1150147; ANDERSON JF, 1986, J ECON ENTOMOL, V79, P1200, DOI 10.1093/jee/79.5.1200; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; ATKINS EL, 1981, U CALIF DIV AGR SCI, V2883; *BAT CONS INT, 2009, WHAT WE DO WHIT NOS; *BFR, 2009, PAR DET PEST RES; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bogdanov S, 2004, BEE WORLD, V85, P46, DOI 10.1080/0005772X.2004.11099623; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; DeGrandi-Hoffman G, 2009, AM BEE J, V149, P583; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ellis MD, 1997, APIDOLOGIE, V28, P123, DOI 10.1051/apido:19970303; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Everich R, 2009, J ECON ENTOMOL, V102, P20, DOI 10.1603/029.102.0104; Everts S, 2008, CHEM ENG NEWS, V86, P10, DOI 10.1021/cen-v086n021.p010a; Faucon JP, 2002, BEE WORLD, V83, P14, DOI 10.1080/0005772X.2002.11099532; Ferrer I, 2007, J CHROMATOGR A, V1175, P24, DOI 10.1016/j.chroma.2007.09.092; Finley J, 1996, AM BEE J, V136, P805; Fox JE, 2007, P NATL ACAD SCI USA, V104, P10282, DOI 10.1073/pnas.0611710104; Frazier M, 2008, AM BEE J, V148, P521; Ghini S, 2004, ARCH ENVIRON CON TOX, V47, P479, DOI 10.1007/s00244-003-3219-y; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Graham J.M., 1999, HIVE HONEY BEE; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Halmer P., 2000, SEED TECHNOLOGY ITS, P257; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1984, ENVIRON ENTOMOL, V13, P1386, DOI 10.1093/ee/13.5.1386; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kindemba Vicky, 2009, IMPACT NEONICOTINOID; Kubik M, 1999, APIDOLOGIE, V30, P521, DOI 10.1051/apido:19990607; Ladurner E, 2005, APIDOLOGIE, V36, P449, DOI 10.1051/apido:2005032; Lehotay SJ, 2005, J AOAC INT, V88, P615; Lodesani M, 2005, BEE WORLD, V86, P102, DOI 10.1080/0005772X.2005.11417324; LODESANI M, 1992, APIDOLOGIE, V23, P257, DOI 10.1051/apido:19920309; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Martin SJ, 2004, BEE WORLD, V85, P67, DOI 10.1080/0005772X.2004.11099632; Maude, 1996, SEEDBORNE DIS THEIR, P114; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; Mullin CA, 2005, ENVIRON ENTOMOL, V34, P1626, DOI 10.1603/0046-225X-34.6.1626; MUNN MD, 2001, 014077 US GEOL SURV; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Pettis JS, 1998, AM BEE J, V138, P538; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Rohr JR, 2008, ECOL APPL, V18, P1743, DOI 10.1890/07-1429.1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Tierney KB, 2008, ENVIRON SCI TECHNOL, V42, P4996, DOI 10.1021/es800240u; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; *USDA AMS, 2008, PEST DAT PROGR ANN S; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; WALLNER K, 1995, AM BEE J, V135, P817; Walorczyk S, 2009, J CHROMATOGR A, V1216, P6522, DOI 10.1016/j.chroma.2009.07.045; WHEELOCK CE, 1959, J AM CHEM SOC, V81, P1348, DOI 10.1021/ja01515a021	75	902	927	13	675	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2010	5	3							e9754	10.1371/journal.pone.0009754	http://dx.doi.org/10.1371/journal.pone.0009754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EH	20333298	gold, Green Published			2022-12-25	WOS:000275809700007
J	Barelier, S; Linard, D; Pons, J; Clippe, A; Knoops, B; Lancelin, JM; Krimm, I				Barelier, Sarah; Linard, Dominique; Pons, Julien; Clippe, Andre; Knoops, Bernard; Lancelin, Jean-Marc; Krimm, Isabelle			Discovery of Fragment Molecules That Bind the Human Peroxiredoxin 5 Active Site	PLOS ONE			English	Article							LIGAND-BINDING; AUTOMATED DOCKING; CRYSTAL-STRUCTURE; DRUG DESIGN; NMR; EFFICIENCY; AFFINITY; GENERATION; PROTEINS; ENZYME	The search for protein ligands is a crucial step in the inhibitor design process. Fragment screening represents an interesting method to rapidly find lead molecules, as it enables the exploration of a larger portion of the chemical space with a smaller number of compounds as compared to screening based on drug-sized molecules. Moreover, fragment screening usually leads to hit molecules that form few but optimal interactions with the target, thus displaying high ligand efficiencies. Here we report the screening of a homemade library composed of 200 highly diverse fragments against the human Peroxiredoxin 5 protein. Peroxiredoxins compose a family of peroxidases that share the ability to reduce peroxides through a conserved cysteine. The three-dimensional structures of these enzymes ubiquitously found throughout evolution have been extensively studied, however, their biological functions are still not well understood and to date few inhibitors have been discovered against these enzymes. Six fragments from the library were shown to bind to the Peroxiredoxin 5 active site and ligand-induced chemical shift changes were used to drive the docking of these small molecules into the protein structure. The orientation of the fragments in the binding pocket was confirmed by the study of fragment homologues, highlighting the role of hydroxyl functions that hang the ligands to the Peroxiredoxin 5 protein. Among the hit fragments, the small catechol molecule was shown to significantly inhibit Peroxiredoxin 5 activity in a thioredoxin peroxidase assay. This study reports novel data about the ligand-Peroxiredoxin interactions that will help considerably the development of potential Peroxiredoxin inhibitors.	[Barelier, Sarah; Pons, Julien; Lancelin, Jean-Marc; Krimm, Isabelle] Univ Lyon 1, CNRS, Analyt Sci Lab, CNRS,UMR 5180, F-69622 Villeurbanne, France; [Linard, Dominique; Clippe, Andre; Knoops, Bernard] Catholic Univ Louvain, Cell Biol Lab, Inst Sci Vie, B-3000 Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Barelier, S (corresponding author), Univ Lyon 1, CNRS, Analyt Sci Lab, CNRS,UMR 5180, Bat ESCPE Lyon, F-69622 Villeurbanne, France.	isabelle.krimm@univ-lyon1.fr	Krimm, Isabelle/O-4972-2014; Lancelin, Jean-marc/AAC-5686-2019	Krimm, Isabelle/0000-0002-5981-109X; 	"Fonds National de la Recherche Scientifique''; "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture''	"Fonds National de la Recherche Scientifique''(Fonds de la Recherche Scientifique - FNRS); "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture''(Fonds de la Recherche Scientifique - FNRS)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D. L. and B. K. are financially supported by the "Fonds National de la Recherche Scientifique'' (F. N. R. S.) and by the "Fonds pour la formation la Recherche dans L'Industrie et dans l'Agriculture'' (F. R. I. A.).	Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bemis GW, 1999, J MED CHEM, V42, P5095, DOI 10.1021/jm9903996; Bretonnet AS, 2007, J MED CHEM, V50, P1865, DOI 10.1021/jm061460r; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Cioffi M, 2008, J MED CHEM, V51, P2512, DOI 10.1021/jm701194r; Ciulli A, 2007, CURR OPIN BIOTECH, V18, P489, DOI 10.1016/j.copbio.2007.09.003; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2007, ANNU REP MED CHEM, V42, P431, DOI 10.1016/S0065-7743(07)42028-0; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Erlanson DA, 2006, CURR OPIN BIOTECH, V17, P643, DOI 10.1016/j.copbio.2006.10.007; Fejzo J, 1999, CHEM BIOL, V6, P755, DOI 10.1016/S1074-5521(00)80022-8; Flohe Leopold, 2007, V44, P1; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jhoti H, 2007, CURR OPIN CHEM BIOL, V11, P485, DOI 10.1016/j.cbpa.2007.07.010; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karplus P. Andrew, 2007, V44, P41; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Knoops Bernard, 2007, V44, P27; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Liu G, 2010, CHEMMEDCHEM, V5, P41, DOI 10.1002/cmdc.200900391; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McCoy MA, 2000, J BIOMOL NMR, V18, P189, DOI 10.1023/A:1026508025631; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606; Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z; Poole Leslie B., 2007, V44, P61; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Stark J, 2008, J AM CHEM SOC, V130, P535, DOI 10.1021/ja0737974; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Trujillo Madia, 2007, V44, P83; Verdonk ML, 2008, CHEMMEDCHEM, V3, P1179, DOI 10.1002/cmdc.200800132	46	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2010	5	3							e9744	10.1371/journal.pone.0009744	http://dx.doi.org/10.1371/journal.pone.0009744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	572EG	20305821	gold, Green Published, Green Submitted			2022-12-25	WOS:000275809600016
J	Song, ES; Rodgers, DW; Hersh, LB				Song, Eun Suk; Rodgers, David W.; Hersh, Louis B.			A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties	PLOS ONE			English	Article							IN-VIVO; INSULYSIN; GENE; ATP; RECOGNITION; DEGRADATION; DISEASE; TARGET	Background: Insulin degrading enzyme (IDE) is a key enzyme in the metabolism of both insulin and amyloid beta peptides. IDE is unique in that it is subject to allosteric activation which is hypothesized to occur through an oligomeric structuture. Methodology/Principal Findings: IDE is known to exist as an equilibrium mixture of monomers, dimers, and higher oligomers, with the dimer being the predominant form. Based on the crystal structure of IDE we deleted the putative dimer interface in the C-terminal region, which resulted in a monomeric variant. Monomeric IDE retained enzymatic activity, however instead of the allosteric behavior seen with wild type enzyme it displayed Michaelis-Menten kinetic behavior. With the substrate Abz-GGFLRKHGQ-EDDnp, monomeric IDE retained similar to 25% of the wild type activity. In contrast with the larger peptide substrates beta-endorphin and amyloid beta peptide 1-40, monomeric IDE retained only 1 to 0.25% of wild type activity. Unlike wild type IDE neither bradykinin nor dynorphin B-9 activated the monomeric variant of the enzyme. Similarly, monomeric IDE was not activated by polyphosphates under conditions in which the activity of wild type enzyme was increased more than 50 fold. Conclusions/Significance: These findings serve to establish the dimer interface in IDE and demonstrate the requirement for an oligomeric form of the enzyme for its regulatory properties. The data support a mechanism where the binding of activators to oligomeric IDE induces a conformational change that cannot occur in the monomeric variant. Since a conformational change from a closed to a more open structure is likely the rate-determining step in the IDE reaction, the subunit induced conformational change likely shifts the structure of the oligomeric enzyme to a more open conformation.	[Song, Eun Suk] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Song, ES (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	lhersh@uky.edu			NIH [DA02243, NS046517, DA016176, P20RR20171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA02243, NS046517, DA016176, and P20RR20171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GOLDSTEIN BJ, 1981, METABOLISM, V30, P825, DOI 10.1016/0026-0495(81)90030-5; Gu HF, 2004, DIABETES, V53, P2137, DOI 10.2337/diabetes.53.8.2137; HARI J, 1987, ENDOCRINOLOGY, V120, P829, DOI 10.1210/endo-120-2-829; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; YONEZAWA K, 1986, ENDOCRINOLOGY, V118, P1989, DOI 10.1210/endo-118-5-1989	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2010	5	3							e9719	10.1371/journal.pone.0009719	http://dx.doi.org/10.1371/journal.pone.0009719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570ZC	20300529	Green Published, gold, Green Submitted			2022-12-25	WOS:000275716400017
J	Luo, JJ; Wang, J; Ma, TM; Sun, ZR				Luo, Junjie; Wang, Jun; Ma, Ting Martin; Sun, Zhirong			Reverse Engineering of Bacterial Chemotaxis Pathway via Frequency Domain Analysis	PLOS ONE			English	Article							BEHAVIORAL VARIABILITY; ESCHERICHIA-COLI; SINGLE-CELL; ADAPTATION; MODEL; ROBUSTNESS; RESPONSES; NOISE	Chemotaxis is defined as a behavior involving organisms sensing attractants or repellents and leading towards or away from them. Therefore, it is possible to reengineer chemotaxis network to control the movement of bacteria to our advantage. Understanding the design principles of chemotaxis pathway is a prerequisite and an important topic in synthetic biology. Here, we provide guidelines for chemotaxis pathway design by employing control theory and reverse engineering concept on pathway dynamic design. We first analyzed the mathematical models for two most important kinds of E. coli chemotaxis pathway-adaptive and non-adaptive pathways, and concluded that the control units of the pathway de facto function as a band-pass filter and a low-pass filter, respectively, by abstracting the frequency response properties of the pathways. The advantage of the band-pass filter is established, and we demonstrate how to tune the three key parameters of it-A (max amplification), omega(1) (down cut-off frequency) and omega(2) (up cut-off frequency) to optimize the chemotactic effect. Finally, we hypothesized a similar but simpler version of the dynamic pathway model based on the principles discovered and show that it leads to similar properties with native E. coli chemotactic behaviors. Our study provides an example of simulating and designing biological dynamics in silico and indicates how to make use of the native pathway's features in this process. Furthermore, the characteristics we discovered and tested through reverse engineering may help to understand the design principles of the pathway and promote the design of artificial chemotaxis pathways.	[Luo, Junjie; Ma, Ting Martin; Sun, Zhirong] Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Wang, Jun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Luo, JJ (corresponding author), Tsinghua Univ, Minist Educ Key Lab Bioinformat, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	sunzhr@mail.tsinghua.edu.cn	Luo, Junjie/L-3285-2019	Long, Yicheng/0000-0002-0714-2322; Long, Yicheng/0000-0003-3578-5197	Hi-Tech Research and Development 863 Program of China [2006AA02003]; 973 project [2009CB918801]; National Science Foundation of China [30770498]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); 973 project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech Research and Development 863 Program of China (No. 2006AA02003), Foundational Science Research Grant from the 973 project (No. 2009CB918801) and National Science Foundation of China Grant (No. 30770498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; CHIKOFSKY EJ, 1990, IEEE SOFTWARE, V7, P13, DOI 10.1109/52.43044; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Goldstein RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000084; HOSNI YA, 1994, COMPUT IND ENG, V26, P341, DOI 10.1016/0360-8352(94)90066-3; Ingolia NT, 2008, NATURE, V454, P1059, DOI 10.1038/4541059a; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LAUB AJ, 1981, IEEE T AUTOMAT CONTR, V26, P407, DOI 10.1109/TAC.1981.1102602; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Liu ZW, 1996, BIOTECHNOL BIOENG, V51, P120, DOI 10.1002/(SICI)1097-0290(19960705)51:1<120::AID-BIT14>3.0.CO;2-U; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Soyer OS, 2006, J THEOR BIOL, V241, P223, DOI 10.1016/j.jtbi.2005.11.024; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	33	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2010	5	3							e9182	10.1371/journal.pone.0009182	http://dx.doi.org/10.1371/journal.pone.0009182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565XA	20231879	Green Submitted, Green Published, gold			2022-12-25	WOS:000275328300001
J	Huang, HR; Xie, CQ; Sun, X; Ritchie, RP; Zhang, JF; Chen, YE				Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene			miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; HISTONE DEACETYLASES; GENE-EXPRESSION; MYELOID-LEUKEMIA; DOWN-REGULATION; MICRORNA; GROWTH	MicroRNAs (miRs) have been reported to play a critical role in muscle differentiation and function. The purpose of this study is to determine the role of miRs during smooth muscle cell (SMC) differentiation from embryonic stem cells (ESCs). MicroRNA profiling showed that miR-10a expression is steadily increased during in vitro differentiation of mouse ESCs into SMCs. Loss-of-function approaches using miR-10a inhibitors uncovered that miR-10a is a critical mediator for SMC lineage determination in our retinoic acid-induced ESC/SMC differentiation system. In addition, we have documented for the first time that histone deacetylase 4 is a novel target of miR-10a and mediates miR-10a function during ESC/SMC differentiation. To determine the molecular mechanism through which retinoic acid induced miR-10a expression, a consensus NF-kappa B element was identified in the miR-10a gene promoter by bioinformatics analysis, and chromatin immunoprecipitation assay confirmed that NF-kappa B could bind to this element. Finally, inhibition of NF-kappa B nuclear translocation repressed miR-10a expression and decreased SMC differentiation from ESCs. Our data demonstrate for the first time that miR-10a is a novel regulator in SMC differentiation from ESCs. These studies suggest that miR-10a may play important roles in vascular biology and have implications for the diagnosis and treatment of vascular diseases.	[Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Sun, Xuan] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China	University of Michigan System; University of Michigan; Central South University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3,7301E, Ann Arbor, MI 48109 USA.	echenum@umich.edu		Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [HL092421, HL068878, HL89544]; American Heart Association [0825837G, 09SDG2260023, 0835237N, 0840025N]; American Heart Association National Scientific Development [09SDG2260023, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R21HL092421, R01HL068878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association National Scientific Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092421, HL068878, and HL89544 (to Y.E.C.).; Supported by American Heart Association Postdoctoral Fellowship 0825837G.; Supported by American Heart Association National Scientific Development Grant 09SDG2260023.; Supported by a National Institutes of Health Research Supplement to Promote Diversity.; Supported by American Heart Association National Scientific Development Grant 0835237N.; An American Heart Association established investigator (Grant 0840025N).	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Neppl RL, 2009, CELL STEM CELL, V5, P130, DOI 10.1016/j.stem.2009.07.004; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	55	118	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9383	9389		10.1074/jbc.M109.095612	http://dx.doi.org/10.1074/jbc.M109.095612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118242	Green Published, hybrid			2022-12-25	WOS:000276165900010
